Citrus Sinensis ID: 002759
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 884 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGE4 | 882 | Probable LRR receptor-lik | yes | no | 0.990 | 0.993 | 0.660 | 0.0 | |
| Q9LRT1 | 1016 | Probably inactive leucine | no | no | 0.940 | 0.817 | 0.354 | 1e-139 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.886 | 0.711 | 0.334 | 1e-113 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.941 | 0.852 | 0.316 | 1e-110 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.874 | 0.702 | 0.309 | 1e-107 | |
| C0LGF5 | 1072 | Probable LRR receptor-lik | no | no | 0.865 | 0.713 | 0.326 | 1e-107 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.891 | 0.630 | 0.315 | 1e-106 | |
| Q9SYQ8 | 980 | Receptor protein kinase C | no | no | 0.885 | 0.798 | 0.322 | 1e-106 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.889 | 0.627 | 0.321 | 1e-105 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.874 | 0.687 | 0.321 | 1e-104 |
| >sp|C0LGE4|Y1124_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g12460 OS=Arabidopsis thaliana GN=At1g12460 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1134 bits (2934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/890 (66%), Positives = 702/890 (78%), Gaps = 14/890 (1%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPC 60
MR++ F L+ + F + S + + ++++ILLQFKG+I+DDP+N LASWVS G+ C
Sbjct: 1 MRKVHLF-----LVLVHFIYISTSRSDSISERDILLQFKGSISDDPYNSLASWVSDGDLC 55
Query: 61 ENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ 120
+F G+ CNP GFVD+IVLWN SL G L+P LS LK +RVL LFGNRFTGNLP +Y ++Q
Sbjct: 56 NSFNGITCNPQGFVDKIVLWNTSLAGTLAPGLSNLKFIRVLNLFGNRFTGNLPLDYFKLQ 115
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
TLW INVSSNALSG IPEFI +L ++R LDLS+N ++GEIP +LFK+C KTKFVSL+HNN
Sbjct: 116 TLWTINVSSNALSGPIPEFISELSSLRFLDLSKNGFTGEIPVSLFKFCDKTKFVSLAHNN 175
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
+ GSIP SI NC L GFDFS+NNL G LP +IC+IPVL++ISVR N L+G V E+ +C
Sbjct: 176 IFGSIPASIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYISVRNNLLSGDVSEEIQKC 235
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
Q + +DL SNLF GLAPF VL KNI+YFNVS N F GEI E+ C E ++ DAS NE
Sbjct: 236 QRLILVDLGSNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIGEIVDCSESLEFLDASSNE 295
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
G IP + C++LK+LDL N+L GSIP I + L I L NNSI G+IP ++GS+
Sbjct: 296 LTGRIPTGVMGCKSLKLLDLESNKLNGSIPGSIGKMESLSVIRLGNNSIDGVIPRDIGSL 355
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
E L+VL+LHNLNL GEVP+DISNCR LL LDVSGN L G I + L N+T +KILDLH+N
Sbjct: 356 EFLQVLNLHNLNLIGEVPEDISNCRVLLELDVSGNDLEGKISKKLLNLTNIKILDLHRNR 415
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST--IQ 478
LNGS PP LGNLS +Q LDLSQNSLSG IPSSLG+L LTHFN+S NNLSG IP IQ
Sbjct: 416 LNGSIPPELGNLSKVQFLDLSQNSLSGPIPSSLGSLNTLTHFNVSYNNLSGVIPPVPMIQ 475
Query: 479 HFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVV 538
FG S F NN LCG PL T C+ RG S+N LS+S I+ I+AAA+IL GVC+V
Sbjct: 476 AFGSSAFSNNPFLCGDPLVTPCNSRGAAA--KSRNSDALSISVIIVIIAAAVILFGVCIV 533
Query: 539 TIMNIKARRRKRDDETMVVEGTPLGST--DSNVIIGKLVLFSKSLPSKYEDWEAGTKALL 596
+N++AR+R++D+E + VE TPL S+ S VIIGKLVLFSK+LPSKYEDWEAGTKALL
Sbjct: 534 LALNLRARKRRKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALL 593
Query: 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
DKE +IG GSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFE EIGRL ++H NL +F
Sbjct: 594 DKENIIGMGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSF 653
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
QGYY+SSTMQLILSEFVP G+LYDNLH +PGTS+ GN +L+W RRF IALGTA+AL
Sbjct: 654 QGYYFSSTMQLILSEFVPNGSLYDNLHLRIFPGTSS-SYGNTDLNWHRRFQIALGTAKAL 712
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT-KFHNAVGYVA 775
S+LH+DCKP ILHLN+KSTNILLDE YE KLSDYGL K LP++D++GLT KFHNAVGY+A
Sbjct: 713 SFLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIA 772
Query: 776 PELA-QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
PELA QSLR S+KCDVYS+GV+LLELVTGRKPVESP+ N+V++L +YVR+LLE GSAS C
Sbjct: 773 PELAQQSLRASEKCDVYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDC 832
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
FDR LR F ENELIQVMKLGL+CTSE P +RPSMAEVVQVLESIRNG GS
Sbjct: 833 FDRRLREFEENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIRNGFGS 882
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LRT1|Y3804_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At3g28040 OS=Arabidopsis thaliana GN=At3g28040 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 497 bits (1279), Expect = e-139, Method: Compositional matrix adjust.
Identities = 347/978 (35%), Positives = 513/978 (52%), Gaps = 147/978 (15%)
Query: 35 LLQFKGNITDDPHNKLASWVSSGN-PCENFKGVFCNPD-GFVDRIVLWNFSLGGVLSPAL 92
L+ FK ++ +DP + L SW N PC ++ V CNP V + L +L G ++ +
Sbjct: 40 LIVFKSDL-NDPFSHLESWTEDDNTPC-SWSYVKCNPKTSRVIELSLDGLALTGKINRGI 97
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152
L+ L+VL+L N FTGN+ + L K+++S N LSG IP +G + +++ LDL+
Sbjct: 98 QKLQRLKVLSLSNNNFTGNI-NALSNNNHLQKLDLSHNNLSGQIPSSLGSITSLQHLDLT 156
Query: 153 RNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTY------------------ 194
NS+SG + LF C +++SLSHN+L G IP ++ C+
Sbjct: 157 GNSFSGTLSDDLFNNCSSLRYLSLSHNHLEGQIPSTLFRCSVLNSLNLSRNRFSGNPSFV 216
Query: 195 --------LEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNL 246
L D S N+LSG +P I ++ L + ++ N +G + C + +
Sbjct: 217 SGIWRLERLRALDLSSNSLSGSIPLGILSLHNLKELQLQRNQFSGALPSDIGLCPHLNRV 276
Query: 247 DLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIP 306
DLSSN F G P + LK++++F+VS+N G+ P G+ D S NE G +P
Sbjct: 277 DLSSNHFSGELPRTLQKLKSLNHFDVSNNLLSGDFPPWIGDMTGLVHLDFSSNELTGKLP 336
Query: 307 LSITN------------------------CRNLKVLDLGFNRLIGSIPTGITDL------ 336
SI+N C+ L ++ L N G+IP G DL
Sbjct: 337 SSISNLRSLKDLNLSENKLSGEVPESLESCKELMIVQLKGNDFSGNIPDGFFDLGLQEMD 396
Query: 337 ------------------RRLLKISLANNSIGGIIPPNLG-------------------- 358
L+++ L++NS+ G IP +G
Sbjct: 397 FSGNGLTGSIPRGSSRLFESLIRLDLSHNSLTGSIPGEVGLFIHMRYLNLSWNHFNTRVP 456
Query: 359 -SIELLE---VLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKIL 414
IE L+ VLDL N L G VP DI + L +L + GN+L G IP+ + N + LK+L
Sbjct: 457 PEIEFLQNLTVLDLRNSALIGSVPADICESQSLQILQLDGNSLTGSIPEGIGNCSSLKLL 516
Query: 415 DLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
L N+L G P SL NL L++L L N LSG IP LG+L+NL N+S N L G +P
Sbjct: 517 SLSHNNLTGPIPKSLSNLQELKILKLEANKLSGEIPKELGDLQNLLLVNVSFNRLIGRLP 576
Query: 475 --STIQHFGVSTFLNNTGLCGPPLETSCS----------------------GRGKGMTPT 510
Q S N G+C P L C+ R G + T
Sbjct: 577 LGDVFQSLDQSAIQGNLGICSPLLRGPCTLNVPKPLVINPNSYGNGNNMPGNRASGGSGT 636
Query: 511 SKNPKVLSVSAIVAIVAAALILAGVCVVTIMNIKARRRKRDDETMVVEGTPLGSTDS--N 568
LSVS IVAI AA LI +GV ++T++N RRR + +E GS+ S +
Sbjct: 637 FHRRMFLSVSVIVAISAAILIFSGVIIITLLNASVRRRLAFVDN-ALESIFSGSSKSGRS 695
Query: 569 VIIGKLVLFS---KSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVSIAVK 624
+++GKLVL + S +++E ++LL+K IG G G+VY+A E G ++AVK
Sbjct: 696 LMMGKLVLLNSRTSRSSSSSQEFERNPESLLNKASRIGEGVFGTVYKAPLGEQGRNLAVK 755
Query: 625 KLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHG 684
KL ++N E+F+ E+ L+ +H NLV+ +GY+W+ + L++SE++P GNL LH
Sbjct: 756 KLVPSPILQNLEDFDREVRILAKAKHPNLVSIKGYFWTPDLHLLVSEYIPNGNLQSKLHE 815
Query: 685 VNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE 744
P T P L W R+ I LGTA+ L+YLHH +P +H NLK TNILLDE
Sbjct: 816 -REPST-------PPLSWDVRYKIILGTAKGLAYLHHTFRPTTIHFNLKPTNILLDEKNN 867
Query: 745 PKLSDYGLAKLLPILDNYGL--TKFHNAVGYVAPEL-AQSLRLSDKCDVYSFGVILLELV 801
PK+SD+GL++LL D + +F NA+GYVAPEL Q+LR+++KCDVY FGV++LELV
Sbjct: 868 PKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAPELECQNLRVNEKCDVYGFGVLILELV 927
Query: 802 TGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSL-RGFAENELIQVMKLGLICTSE 860
TGR+PVE + V+L ++VR +LE+G+ C D + ++E+E++ V+KL L+CTS+
Sbjct: 928 TGRRPVEY-GEDSFVILSDHVRVMLEQGNVLECIDPVMEEQYSEDEVLPVLKLALVCTSQ 986
Query: 861 VPSRRPSMAEVVQVLESI 878
+PS RP+MAE+VQ+L+ I
Sbjct: 987 IPSNRPTMAEIVQILQVI 1004
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 409 bits (1052), Expect = e-113, Method: Compositional matrix adjust.
Identities = 281/841 (33%), Positives = 441/841 (52%), Gaps = 57/841 (6%)
Query: 74 VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALS 133
++ + L+ L G + L L+SL L L+ N G +P+E + +I+ S NAL+
Sbjct: 267 LETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALT 326
Query: 134 GSIPEFIGDLPNIRLLDLSRNSYSGEIPFAL-----------------------FKYCYK 170
G IP +G++ + LL L N +G IP L F+Y
Sbjct: 327 GEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRG 386
Query: 171 TKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALT 230
+ L N+LSG+IP + + L D S N+LSG +PS +C + +++ N L+
Sbjct: 387 LFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLS 446
Query: 231 GTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIP-EVGICGE 289
G + + C+++ L L+ N +G P + N++ + N F G IP EVG C
Sbjct: 447 GNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNC-S 505
Query: 290 GMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSI 349
+Q + N F G +P I L L++ N+L G +P+ I + + L ++ + N+
Sbjct: 506 ALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNF 565
Query: 350 GGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMT 409
G +P +GS+ LE+L L N NL G +P + N L L + GN G IP+ L ++T
Sbjct: 566 SGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLT 625
Query: 410 YLKI-LDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNN 468
L+I L+L N L G PP L NL L+ L L+ N+LSG IPSS NL +L +N S N+
Sbjct: 626 GLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNS 685
Query: 469 LSGTIPSTIQHFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAA 528
L+G IP +++ +S+F+ N GLCGPPL + + ++ P + S I+AI AA
Sbjct: 686 LTGPIP-LLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAA 744
Query: 529 ALILAGVCVVTIMNIKARRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDW 588
+ + ++ ++ RR R + +G P S + + + F ++D
Sbjct: 745 VIGGVSLMLIALIVYLMRRPVRTVASSAQDGQP-----SEMSLD--IYFPPKEGFTFQDL 797
Query: 589 EAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRN----QEEFELEIGR 644
A T D+ ++G G+ G+VY+A G ++AVKKL + N F EI
Sbjct: 798 VAATDNF-DESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILT 856
Query: 645 LSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSR 704
L NIRH N+V G+ L+L E++PKG+L + LH P + L WS+
Sbjct: 857 LGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD---PSCN--------LDWSK 905
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL 764
RF IALG A+ L+YLHHDCKP I H ++KS NILLD+ +E + D+GLAK++ + + +
Sbjct: 906 RFKIALGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSM 965
Query: 765 TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824
+ + GY+APE A ++++++K D+YS+GV+LLEL+TG+ PV+ VV +VR
Sbjct: 966 SAIAGSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVV--NWVRS 1023
Query: 825 LLERGS-ASACFDRSLRGFAE---NELIQVMKLGLICTSEVPSRRPSMAEVVQVL-ESIR 879
+ R + +S D L E + ++ V+K+ L+CTS P RPSM +VV +L ES R
Sbjct: 1024 YIRRDALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESER 1083
Query: 880 N 880
+
Sbjct: 1084 S 1084
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1026), Expect = e-110, Method: Compositional matrix adjust.
Identities = 304/961 (31%), Positives = 466/961 (48%), Gaps = 129/961 (13%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPC 60
M R VL LF + V+S AT EI FK D +N L W +S P
Sbjct: 1 MALFRDIVL-LGFLFCLSLVATVTSEEGATLLEIKKSFK-----DVNNVLYDWTTS--PS 52
Query: 61 ENF---KGVFCNPDGF-VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEY 116
++ +GV C F V + L + +L G +SPA+ LKSL + L GNR +G +P E
Sbjct: 53 SDYCVWRGVSCENVTFNVVALNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEI 112
Query: 117 AEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL 176
+ +L +++S N LSG IP I L + L L N G IP L + K + L
Sbjct: 113 GDCSSLQNLDLSFNELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIP-NLKILDL 171
Query: 177 SHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQ 236
+ N LSG IP I L+ NNL G + +C + L + VR N+LTG++ E
Sbjct: 172 AQNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPET 231
Query: 237 FSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDA 296
C + + LDLS N G PF + G ++ ++ N G+IP V + + V D
Sbjct: 232 IGNCTAFQVLDLSYNQLTGEIPFDI-GFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDL 290
Query: 297 SWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN 356
S N G IP + N + L L N+L GSIP + ++ +L + L +N + G IPP
Sbjct: 291 SGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPE 350
Query: 357 LGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIP---QTLYNMTYLKI 413
LG + L L++ N +L G +PD +S+C L L+V GN G IP Q L +MTYL +
Sbjct: 351 LGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNL 410
Query: 414 ---------------------LDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSS 452
LDL N +NG P SLG+L +L ++LS+N ++G +P
Sbjct: 411 SSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGD 470
Query: 453 LGNLRNLTHFNLSSNNLSGTIPSTIQH--------------------------------- 479
GNLR++ +LS+N++SG IP +
Sbjct: 471 FGNLRSIMEIDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVS 530
Query: 480 ----------------FGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIV 523
F +F+ N GLCG L + C + + + +S +AI+
Sbjct: 531 HNNLVGDIPKNNNFSRFSPDSFIGNPGLCGSWLNSPCHDSRRTVRVS------ISRAAIL 584
Query: 524 AIVAAALILAGVCVVTIMNIKARRRKRDDETMVVEGTPLGSTDSNVIIG--KLVLFSKSL 581
I L V+ +M + A R + + GS D V KLV+ ++
Sbjct: 585 GIAIGGL------VILLMVLIAACRPHNPPPFLD-----GSLDKPVTYSTPKLVILHMNM 633
Query: 582 P-SKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEL 640
YED T+ L +K +IG G+ +VY+ + +A+K+L + ++ ++FE
Sbjct: 634 ALHVYEDIMRMTENLSEKY-IIGHGASSTVYKCVLKNCKPVAIKRLYS-HNPQSMKQFET 691
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL 700
E+ LS+I+H NLV+ Q Y S L+ +++ G+L+D LHG T L
Sbjct: 692 ELEMLSSIKHRNLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKT---------L 742
Query: 701 HWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILD 760
W R IA G A+ L+YLHHDC P I+H ++KS+NILLD++ E +L+D+G+AK L +
Sbjct: 743 DWDTRLKIAYGAAQGLAYLHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSK 802
Query: 761 NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE 820
++ T +GY+ PE A++ RL++K DVYS+G++LLEL+T RK V+ + +++ +
Sbjct: 803 SHTSTYVMGTIGYIDPEYARTSRLTEKSDVYSYGIVLLELLTRRKAVDDESNLHHLIMSK 862
Query: 821 Y----VRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
V E+ + S C D + + +V +L L+CT P+ RP+M +V +VL
Sbjct: 863 TGNNEVMEMADPDITSTCKDLGV-------VKKVFQLALLCTKRQPNDRPTMHQVTRVLG 915
Query: 877 S 877
S
Sbjct: 916 S 916
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 390 bits (1003), Expect = e-107, Method: Compositional matrix adjust.
Identities = 268/867 (30%), Positives = 422/867 (48%), Gaps = 94/867 (10%)
Query: 77 IVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSI 136
++LW L G + P++ + L VL L N FTG++P+E ++ + ++ + +N L+G I
Sbjct: 240 LILWQNRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEI 299
Query: 137 PEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLE 196
P IG+L + +D S N +G IP F + K + L N L G IP + T LE
Sbjct: 300 PREIGNLIDAAEIDFSENQLTGFIPKE-FGHILNLKLLHLFENILLGPIPRELGELTLLE 358
Query: 197 GFDFSFN------------------------------------------------NLSGE 208
D S N +LSG
Sbjct: 359 KLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGP 418
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
+P+ C L +S+ N L+G + C+S+ L L N G P + L+N++
Sbjct: 419 IPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLT 478
Query: 269 YFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGS 328
+ N G I + ++ + N F G IP I N + ++ N+L G
Sbjct: 479 ALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGH 538
Query: 329 IPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLL 388
IP + + ++ L+ N G I LG + LE+L L + L GE+P + L+
Sbjct: 539 IPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLM 598
Query: 389 LLDVSGNALGGDIPQTLYNMTYLKI-LDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSG 447
L + GN L +IP L +T L+I L++ N+L+G+ P SLGNL L++L L+ N LSG
Sbjct: 599 ELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSG 658
Query: 448 SIPSSLGNLRNLTHFNLSSNNLSGTIPST--IQHFGVSTFLNNTGLCG------PPLETS 499
IP+S+GNL +L N+S+NNL GT+P T Q S F N GLC PL
Sbjct: 659 EIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPH 718
Query: 500 CSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVVTIMNIKARRRKRDDETMVVEG 559
+ + S+ K+L+++ IV + V ++T + + ++R+ + +E
Sbjct: 719 SDSKLNWLINGSQRQKILTITCIV--------IGSVFLITFLGLCWTIKRREPAFVALED 770
Query: 560 TPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKAL--LDKECLIGGGSIGSVYRASFEG 617
T +V + S P K ++ A ++ ++G G+ G+VY+A G
Sbjct: 771 ----QTKPDV------MDSYYFPKKGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSG 820
Query: 618 GVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676
G IAVKKL + G + F EI L IRH N+V G+ + L+L E++ KG
Sbjct: 821 GEVIAVKKLNSRGEGASSDNSFRAEISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKG 880
Query: 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTN 736
+L + L G N L W+ R+ IALG A L YLHHDC+P I+H ++KS N
Sbjct: 881 SLGEQLQR---------GEKNCLLDWNARYRIALGAAEGLCYLHHDCRPQIVHRDIKSNN 931
Query: 737 ILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVI 796
ILLDE ++ + D+GLAKL+ + + ++ + GY+APE A ++++++KCD+YSFGV+
Sbjct: 932 ILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVV 991
Query: 797 LLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS-ACFDRSLRGFAE---NELIQVMK 852
LLEL+TG+ PV+ +V +VR + + FD L + +E+ V+K
Sbjct: 992 LLELITGKPPVQPLEQGGDLV--NWVRRSIRNMIPTIEMFDARLDTNDKRTVHEMSLVLK 1049
Query: 853 LGLICTSEVPSRRPSMAEVVQVLESIR 879
+ L CTS P+ RP+M EVV ++ R
Sbjct: 1050 IALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGF5|Y1341_ARATH Probable LRR receptor-like serine/threonine-protein kinase At1g34110 OS=Arabidopsis thaliana GN=At1g34110 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 390 bits (1001), Expect = e-107, Method: Compositional matrix adjust.
Identities = 280/857 (32%), Positives = 431/857 (50%), Gaps = 92/857 (10%)
Query: 74 VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALS 133
+ + L++ + G + P L LR L L N+ TG++P+E ++Q + + + N+LS
Sbjct: 238 LQTLALYDTEISGTIPPQLGLCSELRNLYLHMNKLTGSIPKELGKLQKITSLLLWGNSLS 297
Query: 134 GSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCT 193
G IP I + ++ + D+S N +G+IP L K + + + LS N +G IP ++NC+
Sbjct: 298 GVIPPEISNCSSLVVFDVSANDLTGDIPGDLGKLVWLEQ-LQLSDNMFTGQIPWELSNCS 356
Query: 194 YLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLF 253
L N LSG +PSQI N+ L + N+++GT+ F C + LDLS N
Sbjct: 357 SLIALQLDKNKLSGSIPSQIGNLKSLQSFFLWENSISGTIPSSFGNCTDLVALDLSRNKL 416
Query: 254 IG------------------------LAPFGVLGLKNISYFNVSHNGFHGEIP-EVGICG 288
G P V +++ V N G+IP E+G
Sbjct: 417 TGRIPEELFSLKRLSKLLLLGNSLSGGLPKSVAKCQSLVRLRVGENQLSGQIPKEIGEL- 475
Query: 289 EGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNS 348
+ + D N F G +P I+N L++LD+ N + G IP + +L L ++ L+ NS
Sbjct: 476 QNLVFLDLYMNHFSGGLPYEISNITVLELLDVHNNYITGDIPAQLGNLVNLEQLDLSRNS 535
Query: 349 IGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNM 408
G IP + G++ L L L+N L G++P I N + L LLD+S N+L G+IPQ L +
Sbjct: 536 FTGNIPLSFGNLSYLNKLILNNNLLTGQIPKSIKNLQKLTLLDLSYNSLSGEIPQELGQV 595
Query: 409 TYLKI-LDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467
T L I LDL N G+ P + +L+ LQ LDLS NSL G I LG+L +L N+S N
Sbjct: 596 TSLTINLDLSYNTFTGNIPETFSDLTQLQSLDLSSNSLHGDI-KVLGSLTSLASLNISCN 654
Query: 468 NLSGTIPST--IQHFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAI 525
N SG IPST + +++L NT LC +CS G K+PK+++++A++
Sbjct: 655 NFSGPIPSTPFFKTISTTSYLQNTNLCHSLDGITCSSH-TGQNNGVKSPKIVALTAVILA 713
Query: 526 VAAALILAGVCVV--------TIMNIKARRRKRDDETMVVEGTP---LGSTDSNVIIGKL 574
ILA ++ T N + +D + P LG T +N++
Sbjct: 714 SITIAILAAWLLILRNNHLYKTSQNSSSSPSTAEDFSYPWTFIPFQKLGITVNNIVTS-- 771
Query: 575 VLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRN 634
L E +IG G G VY+A G +AVKKL + N
Sbjct: 772 ---------------------LTDENVIGKGCSGIVYKAEIPNGDIVAVKKLWKT-KDNN 809
Query: 635 QE------EFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYP 688
+E F EI L NIRH N+V GY + +++L+L + P GNL L G
Sbjct: 810 EEGESTIDSFAAEIQILGNIRHRNIVKLLGYCSNKSVKLLLYNYFPNGNLQQLLQG---- 865
Query: 689 GTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748
N L W R+ IA+G A+ L+YLHHDC P ILH ++K NILLD YE L+
Sbjct: 866 --------NRNLDWETRYKIAIGAAQGLAYLHHDCVPAILHRDVKCNNILLDSKYEAILA 917
Query: 749 DYGLAKLLPILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
D+GLAKL+ NY +++ + GY+APE ++ +++K DVYS+GV+LLE+++GR
Sbjct: 918 DFGLAKLMMNSPNYHNAMSRVAGSYGYIAPEYGYTMNITEKSDVYSYGVVLLEILSGRSA 977
Query: 807 VESPTTNEVVVLCEYVRELLER-GSASACFDRSLRGFAE---NELIQVMKLGLICTSEVP 862
VE P + + + E+V++ + A + D L+G + E++Q + + + C + P
Sbjct: 978 VE-PQIGDGLHIVEWVKKKMGTFEPALSVLDVKLQGLPDQIVQEMLQTLGIAMFCVNPSP 1036
Query: 863 SRRPSMAEVVQVLESIR 879
RP+M EVV +L ++
Sbjct: 1037 VERPTMKEVVTLLMEVK 1053
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 387 bits (993), Expect = e-106, Method: Compositional matrix adjust.
Identities = 274/868 (31%), Positives = 432/868 (49%), Gaps = 80/868 (9%)
Query: 77 IVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSI 136
+ L N +L G LSP++S L +L+ L L+ N G LP+E + ++ L + + N SG I
Sbjct: 389 LYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEI 448
Query: 137 PEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLE 196
P+ IG+ +++++D+ N + GEIP ++ + + + L N L G +P S+ NC L
Sbjct: 449 PQEIGNCTSLKMIDMFGNHFEGEIPPSIGRL-KELNLLHLRQNELVGGLPASLGNCHQLN 507
Query: 197 GFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIG- 255
D + N LSG +PS + L+ + + N+L G + + +++ ++LS N G
Sbjct: 508 ILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGT 567
Query: 256 LAPFGVLGLKNISYFNVSHNGFHGEIP-EVGICGEGMQVFDASWNEFDGVIPLSITNCRN 314
+ P + G + F+V++NGF EIP E+G + + N+ G IP ++ R
Sbjct: 568 IHP--LCGSSSYLSFDVTNNGFEDEIPLELG-NSQNLDRLRLGKNQLTGKIPWTLGKIRE 624
Query: 315 LKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLR 374
L +LD+ N L G+IP + ++L I L NN + G IPP LG + L L L +
Sbjct: 625 LSLLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFV 684
Query: 375 GEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSN 434
+P ++ NC LL+L + GN+L G IPQ + N+ L +L+L +N +GS P ++G LS
Sbjct: 685 ESLPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSK 744
Query: 435 L-------------------------------------------------QVLDLSQNSL 445
L + LDLS N L
Sbjct: 745 LYELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQL 804
Query: 446 SGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLETSCSGRGK 505
+G +P S+G++++L + N+S NNL G + + +FL NTGLCG PL R
Sbjct: 805 TGEVPGSVGDMKSLGYLNVSFNNLGGKLKKQFSRWPADSFLGNTGLCGSPLSRCNRVRSN 864
Query: 506 GMTPTSKNPKVLSVSAIVAIVAAALILAGVCVVTIMNIKARRRKRDDETMVVEG-TPLGS 564
V+ +SAI A+ A L++ + + +++ D V G T S
Sbjct: 865 NKQQGLSARSVVIISAISALTAIGLMILVIALFF-------KQRHDFFKKVGHGSTAYTS 917
Query: 565 TDSNVIIGKLVLFSKSLPSKYEDWEAGTKAL--LDKECLIGGGSIGSVYRASFEGGVSIA 622
+ S+ LF WE +A L +E +IG G G VY+A E G ++A
Sbjct: 918 SSSSSQATHKPLFRNGASKSDIRWEDIMEATHNLSEEFMIGSGGSGKVYKAELENGETVA 977
Query: 623 VKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST--MQLILSEFVPKGNLYD 680
VKK+ + + + F E+ L IRH +LV GY S + + L++ E++ G+++D
Sbjct: 978 VKKILWKDDLMSNKSFSREVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWD 1037
Query: 681 NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD 740
LH + L W R IA+G A+ + YLHHDC PPI+H ++KS+N+LLD
Sbjct: 1038 WLHEDKPVLEKKKKL----LDWEARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLD 1093
Query: 741 ENYEPKLSDYGLAKLLP---ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVIL 797
N E L D+GLAK+L + T F + GY+APE A SL+ ++K DVYS G++L
Sbjct: 1094 SNMEAHLGDFGLAKVLTENCDTNTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVL 1153
Query: 798 LELVTGRKPVESPTTNEVVVLCEYVRELLE-RGSA-SACFDRSLR---GFAENELIQVMK 852
+E+VTG+ P +S E+ ++ +V LE GSA D L+ F E+ QV++
Sbjct: 1154 MEIVTGKMPTDSVFGAEMDMV-RWVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLE 1212
Query: 853 LGLICTSEVPSRRPSMAEVVQVLESIRN 880
+ L CT P RPS + L + N
Sbjct: 1213 IALQCTKTSPQERPSSRQACDSLLHVYN 1240
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SYQ8|CLV1_ARATH Receptor protein kinase CLAVATA1 OS=Arabidopsis thaliana GN=CLV1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 385 bits (990), Expect = e-106, Method: Compositional matrix adjust.
Identities = 287/891 (32%), Positives = 444/891 (49%), Gaps = 108/891 (12%)
Query: 49 KLASWVSSGNPCENFKGVFCNPDGFVDRIVL--WNFSLGGVLSPALSGLKSLRVLTLFGN 106
K+ + ++GN F G VD VL +N + G L P +S LK L+ L+ GN
Sbjct: 121 KVLNISNNGNLTGTFPGEILK--AMVDLEVLDTYNNNFNGKLPPEMSELKKLKYLSFGGN 178
Query: 107 RFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIR------------------- 147
F+G +P+ Y ++Q+L + ++ LSG P F+ L N+R
Sbjct: 179 FFSGEIPESYGDIQSLEYLGLNGAGLSGKSPAFLSRLKNLREMYIGYYNSYTGGVPPEFG 238
Query: 148 ------LLDLSRNSYSGEIPFAL--FKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFD 199
+LD++ + +GEIP +L K+ + T F+ + NNL+G IP ++ L+ D
Sbjct: 239 GLTKLEILDMASCTLTGEIPTSLSNLKHLH-TLFLHI--NNLTGHIPPELSGLVSLKSLD 295
Query: 200 FSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPF 259
S N L+GE+P N+ + I++ N L G + E + ++ ++ N F P
Sbjct: 296 LSINQLTGEIPQSFINLGNITLINLFRNNLYGQIPEAIGELPKLEVFEVWENNFTLQLPA 355
Query: 260 GVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLD 319
+ N+ +VS N G IP+ GE +++ S N F G IP + C++L +
Sbjct: 356 NLGRNGNLIKLDVSDNHLTGLIPKDLCRGEKLEMLILSNNFFFGPIPEELGKCKSLTKIR 415
Query: 320 LGFNRLIGSIPTGITDL-----------------------RRLLKISLANNSIGGIIPPN 356
+ N L G++P G+ +L L +I L+NN G IPP
Sbjct: 416 IVKNLLNGTVPAGLFNLPLVTIIELTDNFFSGELPVTMSGDVLDQIYLSNNWFSGEIPPA 475
Query: 357 LGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDL 416
+G+ L+ L L RG +P +I + L ++ S N + G IP ++ + L +DL
Sbjct: 476 IGNFPNLQTLFLDRNRFRGNIPREIFELKHLSRINTSANNITGGIPDSISRCSTLISVDL 535
Query: 417 HQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST 476
+N +NG P + N+ NL L++S N L+GSIP+ +GN+ +LT +LS N+LSG +P
Sbjct: 536 SRNRINGEIPKGINNVKNLGTLNISGNQLTGSIPTGIGNMTSLTTLDLSFNDLSGRVPLG 595
Query: 477 IQH--FGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAG 534
Q F ++F NT LC P SC R G T + + S S IV V AA + G
Sbjct: 596 GQFLVFNETSFAGNTYLC-LPHRVSCPTR-PGQTSDHNHTALFSPSRIVITVIAA--ITG 651
Query: 535 VCVVTIMNIKARRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKA 594
+ ++++ I+ +K++ +++ KL F K L K ED
Sbjct: 652 LILISVA-IRQMNKKKNQKSLA---------------WKLTAFQK-LDFKSED----VLE 690
Query: 595 LLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV 654
L +E +IG G G VYR S V +A+K+L G R+ F EI L IRH ++V
Sbjct: 691 CLKEENIIGKGGAGIVYRGSMPNNVDVAIKRLVGRGTGRSDHGFTAEIQTLGRIRHRHIV 750
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
GY + L+L E++P G+L + LHG S GG L W R +A+ A+
Sbjct: 751 RLLGYVANKDTNLLLYEYMPNGSLGELLHG------SKGG----HLQWETRHRVAVEAAK 800
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG---LTKFHNAV 771
L YLHHDC P ILH ++KS NILLD ++E ++D+GLAK L +D ++ +
Sbjct: 801 GLCYLHHDCSPLILHRDVKSNNILLDSDFEAHVADFGLAKFL--VDGAASECMSSIAGSY 858
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR----ELLE 827
GY+APE A +L++ +K DVYSFGV+LLEL+ G+KPV E V + +VR E+ +
Sbjct: 859 GYIAPEYAYTLKVDEKSDVYSFGVVLLELIAGKKPVGE--FGEGVDIVRWVRNTEEEITQ 916
Query: 828 RGSAS---ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
A+ A D L G+ +I V K+ ++C E + RP+M EVV +L
Sbjct: 917 PSDAAIVVAIVDPRLTGYPLTSVIHVFKIAMMCVEEEAAARPTMREVVHML 967
|
Involved in the detection of CLV3 and CLV3-like peptides, that act as extracellular signals regulating meristem maintenance. Acts with CLV3 as a ligand-receptor pair in a signal transduction pathway coordinating growth between adjacent meristematic regions and controlling the balance between meristem cell proliferation and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 382 bits (981), Expect = e-105, Method: Compositional matrix adjust.
Identities = 273/848 (32%), Positives = 417/848 (49%), Gaps = 62/848 (7%)
Query: 74 VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALS 133
+ L++ +L G + + L L ++ L+ NRF+G +P E L +I+ N LS
Sbjct: 411 LQEFTLYHNNLEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLS 470
Query: 134 GSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCT 193
G IP IG L ++ L L N G IP +L C++ + L+ N LSGSIP S T
Sbjct: 471 GEIPSSIGRLKDLTRLHLRENELVGNIPASLGN-CHQMTVIDLADNQLSGSIPSSFGFLT 529
Query: 194 YLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEE------------------ 235
LE F N+L G LP + N+ L I+ N G++
Sbjct: 530 ALELFMIYNNSLQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDVTENGFE 589
Query: 236 -----QFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIP-EVGICGE 289
+ + ++ L L N F G P + +S ++S N G IP E+G+C +
Sbjct: 590 GDIPLELGKSTNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKK 649
Query: 290 GMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSI 349
+ D + N GVIP + L L L N+ +GS+PT I L +L + L NS+
Sbjct: 650 LTHI-DLNNNYLSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSL 708
Query: 350 GGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMT 409
G IP +G+++ L L+L L G +P I L L +S NAL G+IP + +
Sbjct: 709 NGSIPQEIGNLQALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQ 768
Query: 410 YLK-ILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNN 468
L+ LDL N+ G P ++ L L+ LDLS N L G +P +G++++L + NLS NN
Sbjct: 769 DLQSALDLSYNNFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNN 828
Query: 469 LSGTIPSTIQHFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAA 528
L G + + F+ N GLCG PL + C+ G SKN + LS +V I++A
Sbjct: 829 LEGKLKKQFSRWQADAFVGNAGLCGSPL-SHCNRAG------SKNQRSLSPKTVV-IISA 880
Query: 529 ALILAGVCVVTIMNIKARRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDW 588
LA + ++ ++ I ++ D V G + SN + LFS W
Sbjct: 881 ISSLAAIALMVLVIILFFKQNHDLFKKVRGGNS--AFSSNSSSSQAPLFSNGGAKSDIKW 938
Query: 589 EAGTKA--LLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLS 646
+ +A L++E +IG G G VY+A + G +IAVKK+ + + + F E+ L
Sbjct: 939 DDIMEATHYLNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLMSNKSFNREVKTLG 998
Query: 647 NIRHFNLVAFQGYYWSST--MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSR 704
IRH +LV GY S + L++ E++ G+++D LH + L W
Sbjct: 999 TIRHRHLVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHA------NENTKKKEVLGWET 1052
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL 764
R IALG A+ + YLH+DC PPI+H ++KS+N+LLD N E L D+GLAK+L NY
Sbjct: 1053 RLKIALGLAQGVEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILT--GNYDT 1110
Query: 765 -----TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC 819
T F + GY+APE A SL+ ++K DVYS G++L+E+VTG+ P E+ +E +
Sbjct: 1111 NTESNTMFAGSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEA-MFDEETDMV 1169
Query: 820 EYVRELLERGSASACFD-------RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872
+V +L+ S + +SL E QV+++ L CT P RPS +
Sbjct: 1170 RWVETVLDTPPGSEAREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQAS 1229
Query: 873 QVLESIRN 880
+ L ++ N
Sbjct: 1230 EYLLNVFN 1237
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 381 bits (979), Expect = e-104, Method: Compositional matrix adjust.
Identities = 281/874 (32%), Positives = 422/874 (48%), Gaps = 101/874 (11%)
Query: 74 VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALS 133
+ ++LW G + + L SL L L+GN G +P E M++L K+ + N L+
Sbjct: 255 LQEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLN 314
Query: 134 GSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFK-------YCYKTKF------------- 173
G+IP+ +G L + +D S N SGEIP L K Y ++ K
Sbjct: 315 GTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRN 374
Query: 174 ---------------------------VSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLS 206
+ L HN+LSG IP + + L DFS N LS
Sbjct: 375 LAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLS 434
Query: 207 GELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKN 266
G++P IC L +++ N + G + +C+S+ L + N G P + L N
Sbjct: 435 GKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVN 494
Query: 267 ISYFNVSHNGFHGEIP-EVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRL 325
+S + N F G +P E+G C + +Q + N+F +P I+ NL ++ N L
Sbjct: 495 LSAIELDQNRFSGPLPPEIGTC-QKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSL 553
Query: 326 IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCR 385
G IP+ I + + L ++ L+ NS G +PP LGS+ LE+L L G +P I N
Sbjct: 554 TGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLT 613
Query: 386 FLLLLDVSGNALGGDIPQTLYNMTYLKI-LDLHQNHLNGSTPPSLGNLSNLQVLDLSQNS 444
L L + GN G IP L ++ L+I ++L N +G PP +GNL L L L+ N
Sbjct: 614 HLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNH 673
Query: 445 LSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST--IQHFGVSTFLNNTGLCGPPLETSCSG 502
LSG IP++ NL +L N S NNL+G +P T Q+ +++FL N GLCG G
Sbjct: 674 LSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCG--------G 725
Query: 503 RGKGMTPT-SKNPKVLSVSAIVA-------IVAAALILAGVCVVTIMNIKARRRKRDDET 554
+ P+ S P + S+ A A IV++ + + ++ I+ R
Sbjct: 726 HLRSCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAP 785
Query: 555 MVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRAS 614
V + P + K K D TK D ++G G+ G+VY+A
Sbjct: 786 YVHDKEPFFQESDIYFVPKERFTVK-------DILEATKGFHDS-YIVGRGACGTVYKAV 837
Query: 615 FEGGVSIAVKKLETLGRIRNQEE------FELEIGRLSNIRHFNLVAFQG--YYWSSTMQ 666
G +IAVKKLE+ N F EI L IRH N+V Y+ S
Sbjct: 838 MPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSN 897
Query: 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPP 726
L+L E++ +G+L + LHG G S + W RF IALG A L+YLHHDCKP
Sbjct: 898 LLLYEYMSRGSLGELLHG----GKSH------SMDWPTRFAIALGAAEGLAYLHHDCKPR 947
Query: 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSD 786
I+H ++KS NIL+DEN+E + D+GLAK++ + + ++ + GY+APE A ++++++
Sbjct: 948 IIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTE 1007
Query: 787 KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS-ASACFDRSLRGFAE- 844
KCD+YSFGV+LLEL+TG+ PV+ + L + R + S S D L +
Sbjct: 1008 KCDIYSFGVVLLELLTGKAPVQP--LEQGGDLATWTRNHIRDHSLTSEILDPYLTKVEDD 1065
Query: 845 ---NELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
N +I V K+ ++CT PS RP+M EVV +L
Sbjct: 1066 VILNHMITVTKIAVLCTKSSPSDRPTMREVVLML 1099
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 884 | ||||||
| 255537155 | 884 | leucine-rich repeat transmembrane protei | 0.995 | 0.995 | 0.757 | 0.0 | |
| 224058643 | 887 | predicted protein [Populus trichocarpa] | 0.975 | 0.971 | 0.772 | 0.0 | |
| 224071617 | 883 | predicted protein [Populus trichocarpa] | 0.967 | 0.968 | 0.775 | 0.0 | |
| 356540486 | 884 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.994 | 0.724 | 0.0 | |
| 356495635 | 886 | PREDICTED: probable LRR receptor-like se | 0.994 | 0.992 | 0.722 | 0.0 | |
| 357481837 | 890 | Protein kinase like protein [Medicago tr | 0.992 | 0.985 | 0.714 | 0.0 | |
| 449460501 | 882 | PREDICTED: probable LRR receptor-like se | 0.995 | 0.997 | 0.704 | 0.0 | |
| 449527711 | 882 | PREDICTED: probable LRR receptor-like se | 0.995 | 0.997 | 0.703 | 0.0 | |
| 27754637 | 882 | putative leucine-rich repeat transmembra | 0.990 | 0.993 | 0.660 | 0.0 | |
| 297844110 | 882 | hypothetical protein ARALYDRAFT_888571 [ | 0.990 | 0.993 | 0.665 | 0.0 |
| >gi|255537155|ref|XP_002509644.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] gi|223549543|gb|EEF51031.1| leucine-rich repeat transmembrane protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1330 bits (3443), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 672/887 (75%), Positives = 761/887 (85%), Gaps = 7/887 (0%)
Query: 1 MRRIRQFVLPHALLFLIFTSLG-VSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNP 59
MR + QF + ALL LI LG +S+ S AT+KEILL+F+ +IT DP+N LA+WV SGNP
Sbjct: 1 MRSLYQFCVSPALLLLISCFLGFISTVSPATEKEILLKFRASITSDPNNSLATWVPSGNP 60
Query: 60 CENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEM 119
C NF GV CN GFV+RIVLWN L G L PALSGL+SLR+LTLFGN+FTGN+PQEYAE+
Sbjct: 61 C-NFSGVSCNSLGFVERIVLWNKHLSGSLPPALSGLRSLRILTLFGNKFTGNIPQEYAEL 119
Query: 120 QTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHN 179
TLWKIN+SSNALSGSIPEFIGDLPNIR LDLSRNSY+GEIP +LFK+CYKTKF SLSHN
Sbjct: 120 STLWKINLSSNALSGSIPEFIGDLPNIRFLDLSRNSYNGEIPSSLFKFCYKTKFASLSHN 179
Query: 180 NLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQ 239
+LSG IP+S+ NC LEGFDFSFNNLSG+LPS+IC+IPVL ++S+R N LTG+V+E+ +
Sbjct: 180 SLSGQIPVSLVNCAKLEGFDFSFNNLSGQLPSEICSIPVLKYMSLRSNVLTGSVQEEILR 239
Query: 240 CQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWN 299
CQ + LDL SN+F GLAPFG LG KN+SYFN S+NGFHGEIPE+ C EG++ FD S N
Sbjct: 240 CQRLNFLDLGSNMFSGLAPFGALGFKNMSYFNASYNGFHGEIPEIETCSEGLEFFDVSGN 299
Query: 300 EFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGS 359
+FDG IPLSITNC+NLKVL+LGFNRL GSIP GI DL+ L +++ANNSI G IP G
Sbjct: 300 DFDGEIPLSITNCKNLKVLNLGFNRLNGSIPPGIADLKSLRVLNMANNSIDGTIPAGFGG 359
Query: 360 IELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQN 419
IELL VLDLHNL+L GE+P DISN L LD+SGN L G+IP T YNMT+L++LDLH+N
Sbjct: 360 IELLLVLDLHNLHLNGEIPRDISNSMTLCELDLSGNDLSGEIPSTFYNMTWLEVLDLHRN 419
Query: 420 HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP--STI 477
NGS P ++GNLSNL+VLDLSQN+LSGSIPSSLGNL NLT+FNLSSN+LSG IP
Sbjct: 420 QFNGSIPETVGNLSNLKVLDLSQNNLSGSIPSSLGNLPNLTYFNLSSNSLSGPIPFMPKF 479
Query: 478 QHFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCV 537
FG S FLNN+ LCGPPLE SCSG PTS KVLS S IVAIVAAALIL GVCV
Sbjct: 480 LAFGASAFLNNSRLCGPPLEISCSGNNTA--PTSNKRKVLSTSVIVAIVAAALILTGVCV 537
Query: 538 VTIMNIKARRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLD 597
V+IMNI+AR RK +DET+VVE TPL STDS+VIIGKLVLFSK+LPSKYEDWEAGTKALLD
Sbjct: 538 VSIMNIRARSRKTEDETVVVESTPLDSTDSSVIIGKLVLFSKTLPSKYEDWEAGTKALLD 597
Query: 598 KECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
KECLIGGGS+G+VYR +FEGG+SIAVKKLETLGRIR+Q+EFE EIGRL N+RH NLVAFQ
Sbjct: 598 KECLIGGGSVGTVYRTNFEGGISIAVKKLETLGRIRSQDEFEQEIGRLGNLRHPNLVAFQ 657
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
GYYWSSTMQL+LSEFVP G+LYDNLHG++YPGTST G+GN ELHWSRRF IALGTARALS
Sbjct: 658 GYYWSSTMQLLLSEFVPNGSLYDNLHGLDYPGTST-GVGNSELHWSRRFQIALGTARALS 716
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
YLHHDC+PPILHLN+KSTNILLDENYE KLSDYGL +LLPILDNYGLTKFHNAVGYVAPE
Sbjct: 717 YLHHDCRPPILHLNIKSTNILLDENYEAKLSDYGLGRLLPILDNYGLTKFHNAVGYVAPE 776
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
LAQSLRLS+KCDVYSFGVILLELVTGRKPVESP+ NEVV+LCEYVR LLE GSAS CFDR
Sbjct: 777 LAQSLRLSEKCDVYSFGVILLELVTGRKPVESPSANEVVILCEYVRSLLETGSASDCFDR 836
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
SLRGF+ENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR+G+ S
Sbjct: 837 SLRGFSENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRSGVES 883
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224058643|ref|XP_002299581.1| predicted protein [Populus trichocarpa] gi|222846839|gb|EEE84386.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1325 bits (3429), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 669/866 (77%), Positives = 748/866 (86%), Gaps = 4/866 (0%)
Query: 21 LGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCENFKGVFCNPDGFVDRIVLW 80
++ S AT+KEILLQFKGNI++DP+N LA+WV S NPC N+ GVFCNP GFV+RIVLW
Sbjct: 23 FAATTVSPATEKEILLQFKGNISNDPYNSLANWVPSSNPC-NYNGVFCNPLGFVERIVLW 81
Query: 81 NFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFI 140
N SL GVLSPALSGL+SLR+LT FGN+FTGN+PQEYAE+ TLWKIN+SSNALSGSIPEFI
Sbjct: 82 NTSLSGVLSPALSGLRSLRILTFFGNQFTGNIPQEYAELSTLWKINLSSNALSGSIPEFI 141
Query: 141 GDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDF 200
GDL IR LDLSRN Y+GEIPFALFK+CYKTKFVS SHN+LSG +P SIANCT LEGFDF
Sbjct: 142 GDLQRIRFLDLSRNGYTGEIPFALFKFCYKTKFVSFSHNSLSGPVPASIANCTNLEGFDF 201
Query: 201 SFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFG 260
SFNNLSG+LPS IC++PVL+++S+R N LTG+V E+ S CQ + LDL SN+F GLAPFG
Sbjct: 202 SFNNLSGQLPSGICDVPVLEYMSLRSNVLTGSVLEEISNCQRLSFLDLGSNMFTGLAPFG 261
Query: 261 VLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDL 320
+LGL+N+SYFN+SHNGF G IPEV C E ++ FDAS NE +G IPL ITNC++L+ +DL
Sbjct: 262 ILGLQNLSYFNLSHNGFQGGIPEVRTCSESLKFFDASSNELEGEIPLGITNCKSLEFIDL 321
Query: 321 GFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDD 380
GFNRL GSIP GI +L RLL L NNSI G IP GSIELL +LDLHNLNL GE+P D
Sbjct: 322 GFNRLNGSIPVGIANLERLLVFKLGNNSIKGTIPREFGSIELLLLLDLHNLNLAGEIPKD 381
Query: 381 ISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDL 440
ISNCRFL LDVSGNAL G+IP TL N+T L++LDLH+N L+G P +LG+LSNL++LDL
Sbjct: 382 ISNCRFLRELDVSGNALDGEIPNTLDNLTSLEVLDLHRNQLDGGIPETLGSLSNLKLLDL 441
Query: 441 SQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS--TIQHFGVSTFLNNTGLCGPPLET 498
SQN+LSG+IP SLGNL NL FN+SSNNLSG IPS IQ FG + FLNN+ LCG PL+
Sbjct: 442 SQNNLSGNIPFSLGNLANLKFFNVSSNNLSGPIPSIPKIQAFGAAAFLNNSRLCGTPLDI 501
Query: 499 SCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVVTIMNIKARRRKRDDETMVVE 558
SCSG G G SK KVLS S IVAIVAAALIL GVCVV+IMNI+AR RK+DD T VVE
Sbjct: 502 SCSGGGNGTGNKSKKNKVLSNSVIVAIVAAALILTGVCVVSIMNIRARSRKKDDVTTVVE 561
Query: 559 GTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGG 618
TPLGSTDSNVIIGKLVLFSK+LPSKYEDWEAGTKALLDKECLIGGGSIG+VYR +FEGG
Sbjct: 562 STPLGSTDSNVIIGKLVLFSKTLPSKYEDWEAGTKALLDKECLIGGGSIGTVYRTTFEGG 621
Query: 619 VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678
V IAVKKLETLGRIR+Q+EFE EIGRL N+RH NLVAFQGYYWSSTMQLILSEF+P GNL
Sbjct: 622 VCIAVKKLETLGRIRSQDEFEQEIGRLGNLRHPNLVAFQGYYWSSTMQLILSEFIPHGNL 681
Query: 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNIL 738
YDNLHG+NYPGTST G+GN EL+WSRRF IAL TARALSYLHHDC+PPILHLN+KSTNIL
Sbjct: 682 YDNLHGLNYPGTST-GVGNRELYWSRRFQIALLTARALSYLHHDCRPPILHLNIKSTNIL 740
Query: 739 LDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILL 798
LDENYE KLSDYGL KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILL
Sbjct: 741 LDENYEAKLSDYGLGKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILL 800
Query: 799 ELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICT 858
ELVTGRKPVESPT NEVVVLCEYVR LLE GSAS CFDRSLRGF+ENELIQVMKLGLICT
Sbjct: 801 ELVTGRKPVESPTANEVVVLCEYVRGLLETGSASDCFDRSLRGFSENELIQVMKLGLICT 860
Query: 859 SEVPSRRPSMAEVVQVLESIRNGLGS 884
SE+PSRRPSMAEVVQVLESIR+G+ S
Sbjct: 861 SELPSRRPSMAEVVQVLESIRSGVES 886
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224071617|ref|XP_002303543.1| predicted protein [Populus trichocarpa] gi|222840975|gb|EEE78522.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1318 bits (3411), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 666/859 (77%), Positives = 741/859 (86%), Gaps = 4/859 (0%)
Query: 23 VSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCENFKGVFCNPDGFVDRIVLWNF 82
++ S AT+KEILLQFK NI++DP+N LA+WV SGNPC+ + GVFCNP GFV RIVLWN
Sbjct: 25 ATTVSPATEKEILLQFKANISNDPYNSLANWVPSGNPCD-YSGVFCNPLGFVQRIVLWNT 83
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGD 142
SL GVLSPALSGL+SLR+LTLFGN+FT N+PQEYAE+ TLWKIN+SSNALSGSIPEFIGD
Sbjct: 84 SLSGVLSPALSGLRSLRILTLFGNKFTSNIPQEYAELSTLWKINLSSNALSGSIPEFIGD 143
Query: 143 LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSF 202
L NIR LDLSRN YSGEIPFALFK+CYKTKFVS SHN+LSGSIP SIANCT LEGFDFSF
Sbjct: 144 LQNIRFLDLSRNGYSGEIPFALFKFCYKTKFVSFSHNSLSGSIPASIANCTNLEGFDFSF 203
Query: 203 NNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVL 262
NN SGELPS IC+IPVL+++S+R N LTG+V E+ S+CQ ++ LDL SNLF GLAPF +L
Sbjct: 204 NNFSGELPSGICDIPVLEYMSLRSNVLTGSVLEEVSKCQRLRFLDLGSNLFTGLAPFEIL 263
Query: 263 GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGF 322
G +N+SYFNVSHN F GEIP + C E ++ FDAS N DG IPL ITNC++L+ +DLGF
Sbjct: 264 GSQNLSYFNVSHNAFQGEIPAMRTCSESLEFFDASSNNLDGEIPLGITNCKSLEFIDLGF 323
Query: 323 NRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDIS 382
NRL GSIP GI +L RLL L +NSI G IP GSIE L +LDLHNLNL GE+P DIS
Sbjct: 324 NRLNGSIPAGIANLERLLVFKLGDNSIQGTIPAEFGSIEWLLLLDLHNLNLSGEIPKDIS 383
Query: 383 NCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQ 442
NCRFL LDVSGNAL G+IP TL NMT L++LDLH+N L+GS P +LG+LSNL++L+LSQ
Sbjct: 384 NCRFLRELDVSGNALDGEIPNTLDNMTSLEVLDLHRNQLDGSIPETLGSLSNLKLLELSQ 443
Query: 443 NSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS--TIQHFGVSTFLNNTGLCGPPLETSC 500
N+LSG+IP SLG L NL +FN+SSNNLSG IPS IQ FG + FLNN+GLCG PL+ SC
Sbjct: 444 NNLSGTIPYSLGKLANLKYFNVSSNNLSGPIPSIPKIQAFGTAAFLNNSGLCGVPLDISC 503
Query: 501 SGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVVTIMNIKARRRKRDDETMVVEGT 560
SG G G SK KVLS S IVAIVAAALIL GVCVV+IMNI+AR RK+D+ T VVE T
Sbjct: 504 SGAGNGTGNGSKKNKVLSNSVIVAIVAAALILTGVCVVSIMNIRARSRKKDNVTTVVEST 563
Query: 561 PLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVS 620
PL STDSNVIIGKLVLFSK+LPSKYEDWEAGTKALLDKECLIGGGSIG+VYR +FEGGVS
Sbjct: 564 PLDSTDSNVIIGKLVLFSKTLPSKYEDWEAGTKALLDKECLIGGGSIGTVYRTTFEGGVS 623
Query: 621 IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYD 680
IAVKKLETLGRIR+Q+EFE EIG L N+RH NLVAFQGYYWSSTMQLILSEFVP GNLYD
Sbjct: 624 IAVKKLETLGRIRSQDEFEQEIGLLGNLRHPNLVAFQGYYWSSTMQLILSEFVPNGNLYD 683
Query: 681 NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD 740
NLHG+NYPGTST G+GN EL+WSRRF IALG ARALSYLHHDC+PPILHLN+KSTNILLD
Sbjct: 684 NLHGLNYPGTST-GVGNRELYWSRRFQIALGIARALSYLHHDCRPPILHLNIKSTNILLD 742
Query: 741 ENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLEL 800
ENYE KLSDYGL +LLPILDNYGLTKFHNAVGYVAPELAQSLR SDKCDVYSFGVILLEL
Sbjct: 743 ENYEAKLSDYGLGRLLPILDNYGLTKFHNAVGYVAPELAQSLRSSDKCDVYSFGVILLEL 802
Query: 801 VTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSE 860
VTGRKPVESPT NEVVVLCEYVR LLE GSAS CFDRSLRGF+ENELIQVMKLGLICTSE
Sbjct: 803 VTGRKPVESPTANEVVVLCEYVRGLLETGSASDCFDRSLRGFSENELIQVMKLGLICTSE 862
Query: 861 VPSRRPSMAEVVQVLESIR 879
VPSRRPSMAEVVQVLESIR
Sbjct: 863 VPSRRPSMAEVVQVLESIR 881
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356540486|ref|XP_003538720.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g12460-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1236 bits (3198), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 643/888 (72%), Positives = 742/888 (83%), Gaps = 9/888 (1%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPC 60
MRR R+ L HALL +F L +ASAAT+KEILL+FKGNIT+DP L+SWVSSGN C
Sbjct: 1 MRRHREIHLSHALLCTVFCLL--VAASAATEKEILLEFKGNITEDPRASLSSWVSSGNLC 58
Query: 61 ENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ 120
++KGV CN +GFV+RIVLWN SLGGVLS +LSGLK LR+LTLFGNRF+G++P+ Y ++
Sbjct: 59 HDYKGVSCNSEGFVERIVLWNTSLGGVLSSSLSGLKRLRILTLFGNRFSGSIPEAYGDLH 118
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
+LWKIN+SSNALSGSIP+FIGDLP+IR LDLS+N ++GEIP ALF+YCYKTKFVSLSHNN
Sbjct: 119 SLWKINLSSNALSGSIPDFIGDLPSIRFLDLSKNDFTGEIPSALFRYCYKTKFVSLSHNN 178
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
L+GSIP S+ NC+ LEGFDFS NNLSG +PS++C+IP L ++S+R NAL+G+V+E S C
Sbjct: 179 LAGSIPASLVNCSNLEGFDFSLNNLSGAVPSRLCDIPRLSYVSLRSNALSGSVQELISTC 238
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
QS+ +LD SN F APF VL ++N++Y N+S+NGF G IPE+ C +++FDAS N
Sbjct: 239 QSLVHLDFGSNRFTDFAPFRVLQMQNLTYLNLSYNGFGGHIPEISACSGRLEIFDASGNS 298
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
DG IP SIT C++LK+L L NRL G IP I +LR L+ I L NNSIGG+IP G++
Sbjct: 299 LDGEIPSSITKCKSLKLLALEMNRLEGIIPVDIQELRGLIVIKLGNNSIGGMIPRGFGNV 358
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
ELLE+LDLHNLNL G++PDDISNC+FLL LDVSGN L G+IPQTLYN+T L+ L+LH N
Sbjct: 359 ELLELLDLHNLNLVGQIPDDISNCKFLLGLDVSGNKLEGEIPQTLYNLTNLESLNLHHNQ 418
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP--STIQ 478
LNGS PPSLGNLS +Q LDLS NSLSG I SLGNL NLTHF+LS NNLSG IP +TIQ
Sbjct: 419 LNGSIPPSLGNLSRIQYLDLSHNSLSGPILPSLGNLNNLTHFDLSFNNLSGRIPDVATIQ 478
Query: 479 HFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVV 538
HFG S+F NN LCGPPL+T C+G P KVLS S IVAIVAAA+IL GVC+V
Sbjct: 479 HFGASSFSNNPFLCGPPLDTPCNGARSSSAP--GKAKVLSTSVIVAIVAAAVILTGVCLV 536
Query: 539 TIMNIKA--RRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALL 596
TIMN++A RRRK DD+ M+VE TPLGST+SNVIIGKLVLFSKSLPSKYEDWEAGTKALL
Sbjct: 537 TIMNMRARGRRRKDDDQIMIVESTPLGSTESNVIIGKLVLFSKSLPSKYEDWEAGTKALL 596
Query: 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
DKE LIGGGSIG+VYR FEGG+SIAVKKLETLGRIRNQEEFE EIGRL N++H +LVAF
Sbjct: 597 DKESLIGGGSIGTVYRTDFEGGISIAVKKLETLGRIRNQEEFEHEIGRLGNLQHPHLVAF 656
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
QGYYWSS+MQLILSEFVP GNLYDNLHG +PGTST GN EL+WSRRF IA+GTARAL
Sbjct: 657 QGYYWSSSMQLILSEFVPNGNLYDNLHGFGFPGTSTSR-GNRELYWSRRFQIAVGTARAL 715
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
+YLHHDC+PPILHLN+KS+NILLD+NYE KLSDYGL KLLPILDNYGLTKFHNAVGYVAP
Sbjct: 716 AYLHHDCRPPILHLNIKSSNILLDDNYEAKLSDYGLGKLLPILDNYGLTKFHNAVGYVAP 775
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836
ELAQ LR S+KCDVYSFGVILLELVTGR+PVESPTTNEVVVLCEYV LLE GSAS CFD
Sbjct: 776 ELAQGLRQSEKCDVYSFGVILLELVTGRRPVESPTTNEVVVLCEYVTGLLETGSASDCFD 835
Query: 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
R+L GFAENELIQVM+LGLICTSE P RRPSMAEVVQVLESIRNGL S
Sbjct: 836 RNLLGFAENELIQVMRLGLICTSEDPLRRPSMAEVVQVLESIRNGLES 883
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356495635|ref|XP_003516680.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g12460-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1234 bits (3192), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 642/888 (72%), Positives = 740/888 (83%), Gaps = 9/888 (1%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPC 60
MRR R+ L HALL +F +ASAAT+KEILL+FKGNITDDP L+SWVSSGNPC
Sbjct: 1 MRRHREIHLSHALLSTVFCLF--VTASAATEKEILLEFKGNITDDPRASLSSWVSSGNPC 58
Query: 61 ENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ 120
++ GV CN +GFV+RIVLWN SLGGVLS +LSGLK LR+L LFGNRF+G +P+ Y E+
Sbjct: 59 NDYNGVSCNSEGFVERIVLWNTSLGGVLSSSLSGLKRLRILALFGNRFSGGIPEGYGELH 118
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
+LWKIN+SSNALSGSIPEFIGD P+IR LDLS+N ++GEIP ALF+YCYKTKFVSLSHNN
Sbjct: 119 SLWKINLSSNALSGSIPEFIGDFPSIRFLDLSKNGFTGEIPSALFRYCYKTKFVSLSHNN 178
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
L+GSIP S+ NC+ LEGFDFSFNNLSG +P ++C IP L ++S+R NAL+G+V+E S C
Sbjct: 179 LAGSIPASLVNCSNLEGFDFSFNNLSGVVPPRLCGIPRLSYVSLRNNALSGSVQELISTC 238
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
QS+ +LD SN F APF VL ++N++Y N+S+NGF G IPE+ C +++FDAS N
Sbjct: 239 QSLVHLDFGSNRFTDFAPFRVLEMQNLTYLNLSYNGFGGHIPEISACSGRLEIFDASGNS 298
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
DG IP SIT C++LK+L L NRL G+IP I +LR L+ I L NN IGG+IP G++
Sbjct: 299 LDGEIPPSITKCKSLKLLALELNRLEGNIPVDIQELRGLIVIKLGNNFIGGMIPSGFGNV 358
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
ELLE+LDLHNLNL G++PDDISNC+FLL LDVSGN L G+IPQTLYN+T L+ L+LH N
Sbjct: 359 ELLELLDLHNLNLVGQIPDDISNCKFLLGLDVSGNKLEGEIPQTLYNLTNLESLNLHHNQ 418
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP--STIQ 478
LNGS PPSLGNLS +Q LDLS NSLSG IP SLGNL NLTHF+LS NNLSG IP +TIQ
Sbjct: 419 LNGSIPPSLGNLSRIQYLDLSHNSLSGPIPPSLGNLNNLTHFDLSFNNLSGRIPDVATIQ 478
Query: 479 HFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVV 538
HFG S F NN LCGPPL+T C+ R + + K KVLS SAIVAIVAAA+IL GVC+V
Sbjct: 479 HFGASAFSNNPFLCGPPLDTPCN-RARSSSAPGK-AKVLSTSAIVAIVAAAVILTGVCLV 536
Query: 539 TIMNIKA--RRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALL 596
TIMN++A RRRK DD+ M+VE TPLGST+SNVIIGKLVLFSKSLPSKYEDWEAGTKALL
Sbjct: 537 TIMNMRARGRRRKDDDQIMIVESTPLGSTESNVIIGKLVLFSKSLPSKYEDWEAGTKALL 596
Query: 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
DKE LIGGGSIG+VYR FEGGVSIAVKKLETLGRIRNQEEFE E+GRL N++H +LVAF
Sbjct: 597 DKESLIGGGSIGTVYRTDFEGGVSIAVKKLETLGRIRNQEEFEHELGRLGNLQHPHLVAF 656
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
QGYYWSS+MQLILSEF+P GNLYDNLHG +PGTST GN EL+WSRRF IA+GTARAL
Sbjct: 657 QGYYWSSSMQLILSEFIPNGNLYDNLHGFGFPGTST-STGNRELYWSRRFQIAVGTARAL 715
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
+YLHHDC+PPILHLN+KS+NILLD+ YE KLSDYGL KLLPILDNYGLTKFHN+VGYVAP
Sbjct: 716 AYLHHDCRPPILHLNIKSSNILLDDKYEAKLSDYGLGKLLPILDNYGLTKFHNSVGYVAP 775
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836
ELAQ LR S+KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR LLE GSAS CFD
Sbjct: 776 ELAQGLRQSEKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRGLLETGSASDCFD 835
Query: 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
R++ GFAENELIQVM+LGLICTSE P RRPSMAEVVQVLESIRNGL S
Sbjct: 836 RNILGFAENELIQVMRLGLICTSEDPLRRPSMAEVVQVLESIRNGLES 883
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357481837|ref|XP_003611204.1| Protein kinase like protein [Medicago truncatula] gi|355512539|gb|AES94162.1| Protein kinase like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 1219 bits (3155), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 636/890 (71%), Positives = 740/890 (83%), Gaps = 13/890 (1%)
Query: 1 MRRIRQFVLPHALL-FLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNP 59
MR Q L HAL F++ +++ S AT+KEILLQFKGNIT+DP++ L+SWVS G+P
Sbjct: 1 MRTHCQIHLFHALFCFILCLFWSIATVSPATEKEILLQFKGNITEDPYSTLSSWVSGGDP 60
Query: 60 CENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEM 119
C+ + GVFCN +GFV+RIVLWN SL GVLSPALSGLK LR+LTLFGNRF+GN+P +YA++
Sbjct: 61 CQGYTGVFCNIEGFVERIVLWNTSLVGVLSPALSGLKRLRILTLFGNRFSGNIPDDYADL 120
Query: 120 QTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHN 179
+LWKIN SSNALSGSIP+F+GDLPNIR LDLS+N ++GEIP ALF+YCYKTKFVSLSHN
Sbjct: 121 HSLWKINFSSNALSGSIPDFMGDLPNIRFLDLSKNGFNGEIPSALFRYCYKTKFVSLSHN 180
Query: 180 NLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQ 239
NL GSIP+S+ NC+ LEGFDFSFNNLSG +PS++C+IP+L ++S+R NAL+G+VEE S
Sbjct: 181 NLVGSIPVSLVNCSNLEGFDFSFNNLSGVVPSRLCDIPMLSYVSLRSNALSGSVEEHISG 240
Query: 240 CQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWN 299
C S+ +LD SN F APF +LGL+N++YFN+S+NGF G+IP++ C E + VFDAS N
Sbjct: 241 CHSLMHLDFGSNRFTDFAPFSILGLQNLTYFNISYNGFEGQIPDITACSERLVVFDASGN 300
Query: 300 EFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGS 359
DGVIP SIT C+NLK+L L N+L GSIP I +LR LL I L NNSIGG+IP G+
Sbjct: 301 NLDGVIPPSITRCKNLKLLSLELNKLKGSIPVDIQELRGLLVIKLGNNSIGGMIPEGFGN 360
Query: 360 IELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQN 419
IELLE+LDL+NLNL GE+P DI+NC+FLL LDVSGN L G+IP ++Y MT L+ LD+H N
Sbjct: 361 IELLELLDLNNLNLIGEIPADITNCKFLLELDVSGNNLDGEIPLSVYKMTNLEALDMHHN 420
Query: 420 HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP--STI 477
L GS P SLGNLS +Q LDLS NS SGSIP SLG+L NLTHF+LS NNLSG IP +TI
Sbjct: 421 QLKGSIPSSLGNLSRIQFLDLSHNSFSGSIPPSLGDLNNLTHFDLSFNNLSGVIPDIATI 480
Query: 478 QHFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNP----KVLSVSAIVAIVAAALILA 533
QHFG F NN LCG PL+ +CS G T +S +P K+LSVSAIVAIVAAA+IL
Sbjct: 481 QHFGAPAFSNNPFLCGAPLDITCSANG---TRSSSSPPGKTKLLSVSAIVAIVAAAVILT 537
Query: 534 GVCVVTIMNIKARRRKR-DDETMVVEGTPLGSTD-SNVIIGKLVLFSKSLPSKYEDWEAG 591
GVC+VTIM+I+ARRRK+ DD+ M+VE TPLGST+ SNVIIGKLVLFSKSLPSKYEDWEAG
Sbjct: 538 GVCLVTIMSIRARRRKKDDDQIMIVESTPLGSTESSNVIIGKLVLFSKSLPSKYEDWEAG 597
Query: 592 TKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHF 651
TKALLDKE LIGGGSIG+VY+ FEGG+SIAVKKLETLGRIRNQEEFE EIGRL N++H
Sbjct: 598 TKALLDKESLIGGGSIGTVYKTDFEGGISIAVKKLETLGRIRNQEEFENEIGRLGNLQHC 657
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
NLV FQGYYWSS+MQLILSEFV GNLYDNLHG YPGTST GN EL+WSRRF IALG
Sbjct: 658 NLVVFQGYYWSSSMQLILSEFVSNGNLYDNLHGFGYPGTSTSR-GNRELYWSRRFQIALG 716
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
TARAL+ LHHDC+PPILHLNLKS+NILLD+ YE KLSDYGL KLLPILDN+GLTKFHNAV
Sbjct: 717 TARALASLHHDCRPPILHLNLKSSNILLDDKYEAKLSDYGLGKLLPILDNFGLTKFHNAV 776
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831
GYVAPELAQS R S+KCDVYSFGVILLELVTGRKPVES T +EVVVLCEYVR LLE GSA
Sbjct: 777 GYVAPELAQSFRQSEKCDVYSFGVILLELVTGRKPVESVTAHEVVVLCEYVRSLLETGSA 836
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881
S CFDR+L+GF ENELIQVMKLGLICTSE P RRPSMAE+VQVLESIR+G
Sbjct: 837 SNCFDRNLQGFVENELIQVMKLGLICTSEDPLRRPSMAEIVQVLESIRDG 886
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449460501|ref|XP_004147984.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g12460-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1216 bits (3146), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 624/886 (70%), Positives = 726/886 (81%), Gaps = 6/886 (0%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPC 60
MR++ Q L HALLF I SA T+K+ILLQFK +T+DP N L +WV+ + C
Sbjct: 1 MRKVNQLCLSHALLFFILFL--FGFCSAVTEKDILLQFKDAVTEDPFNFLRTWVAGEDHC 58
Query: 61 ENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ 120
+F GVFCN DGFV+RIVLWN SL G LSP+LSGLK LR LTL+GNRFTGN+P EY +
Sbjct: 59 RSFNGVFCNSDGFVERIVLWNSSLAGTLSPSLSGLKFLRTLTLYGNRFTGNIPIEYGAIV 118
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
TLWK+N+SSNA SG +PEFIGDLP+IR LDLSRN ++GEIP A+FK C+KT+FVS SHN
Sbjct: 119 TLWKLNLSSNAFSGLVPEFIGDLPSIRFLDLSRNGFTGEIPSAVFKNCFKTRFVSFSHNR 178
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
SG IP +I NC LEGFDFS N+LSG +P Q+C+I L+++SVR NAL+G+V+ QFS C
Sbjct: 179 FSGRIPSTILNCLSLEGFDFSNNDLSGSIPLQLCDIQRLEYVSVRSNALSGSVQGQFSSC 238
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
QS+K +DLSSN+F G PF VLG KNI+YFNVS+N F G I EV C ++V D S N
Sbjct: 239 QSLKLVDLSSNMFTGSPPFEVLGFKNITYFNVSYNRFSGGIAEVVSCSNNLEVLDVSGNG 298
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
+G IPLSIT C ++K+LD N+L+G IP + +L +LL + L +NSI G IP G+I
Sbjct: 299 LNGEIPLSITKCGSIKILDFESNKLVGKIPAELANLNKLLVLRLGSNSITGTIPAIFGNI 358
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
ELL+VL+LHNLNL GE+P+DI++CRFLL LDVSGNAL G+IPQTLYNMTYL+ILDLH NH
Sbjct: 359 ELLQVLNLHNLNLVGEIPNDITSCRFLLELDVSGNALEGEIPQTLYNMTYLEILDLHDNH 418
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS--TIQ 478
LNGS P +LG+L LQ LDLSQN LSGSIP +L NL L HFN+S NNLSGTIPS TIQ
Sbjct: 419 LNGSIPSTLGSLLKLQFLDLSQNLLSGSIPRTLENLTLLHHFNVSFNNLSGTIPSVNTIQ 478
Query: 479 HFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVV 538
+FG S F NN LCG PL+ +G G T SK PKVLS+SAI+AI+AA +IL GVCV+
Sbjct: 479 NFGPSAFSNNPFLCGAPLDPCSAGNTPGTTSISKKPKVLSLSAIIAIIAAVVILVGVCVI 538
Query: 539 TIMNIKARRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDK 598
+I+N+ AR RK T ++E TPLGSTDS VIIGKLVLFSK+LPSKYEDWEAGTKALLDK
Sbjct: 539 SILNLMARTRKARS-TEIIESTPLGSTDSGVIIGKLVLFSKTLPSKYEDWEAGTKALLDK 597
Query: 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
EC+IGGGSIG+VYR SFEGG+SIAVKKLETLGRIR+Q+EFE EIGRL NI+H NLVAFQG
Sbjct: 598 ECIIGGGSIGTVYRTSFEGGISIAVKKLETLGRIRSQDEFETEIGRLGNIKHPNLVAFQG 657
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
YYWSS+MQLILSEFV GNLYDNLH +NYPGTST GIGN ELHWSRR+ IA+GTARAL+Y
Sbjct: 658 YYWSSSMQLILSEFVTNGNLYDNLHSLNYPGTST-GIGNAELHWSRRYKIAIGTARALAY 716
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
LHHDC+PPILHLN+KSTNILLDENYE KLSDYGL KLLP+LDNY LTK+H+AVGYVAPEL
Sbjct: 717 LHHDCRPPILHLNIKSTNILLDENYEGKLSDYGLGKLLPVLDNYILTKYHSAVGYVAPEL 776
Query: 779 AQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838
AQSLR S+KCDVYSFGVILLELVTGRKPVESP N+VV+LCEYVRELLE GSAS CFDR+
Sbjct: 777 AQSLRASEKCDVYSFGVILLELVTGRKPVESPRANQVVILCEYVRELLESGSASDCFDRN 836
Query: 839 LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
LRG AENELIQVMKLGLICTSE+PS+RPSMAEVVQVLESIRNGLGS
Sbjct: 837 LRGIAENELIQVMKLGLICTSEIPSKRPSMAEVVQVLESIRNGLGS 882
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449527711|ref|XP_004170853.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At1g12460-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1213 bits (3139), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 623/886 (70%), Positives = 725/886 (81%), Gaps = 6/886 (0%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPC 60
MR++ Q L HALLF I SA T+K+ILLQFK +T+DP N L +WV+ + C
Sbjct: 1 MRKVNQLCLSHALLFFILFL--FGFCSAVTEKDILLQFKDAVTEDPFNFLRTWVAGEDHC 58
Query: 61 ENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ 120
+F GVFCN DGFV+RIVLWN SL G LSP+LSGLK LR LTL+GNRFTGN+P EY +
Sbjct: 59 RSFNGVFCNSDGFVERIVLWNSSLAGTLSPSLSGLKFLRTLTLYGNRFTGNIPIEYGAIV 118
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
TLWK+N+SSNA SG +PEFIGDLP+IR LDLSRN ++GEIP A+FK C+KT+FVS SHN
Sbjct: 119 TLWKLNLSSNAFSGLVPEFIGDLPSIRFLDLSRNGFTGEIPSAVFKNCFKTRFVSFSHNR 178
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
SG IP +I NC LEGFDFS N+LSG +P Q+C+I L+++SVR NAL+G+V+ QFS C
Sbjct: 179 FSGRIPSTILNCLSLEGFDFSNNDLSGSIPLQLCDIQRLEYVSVRSNALSGSVQGQFSSC 238
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
QS+K +DLSSN+F G PF VLG KNI+YFNVS+N F G I EV C ++V D S N
Sbjct: 239 QSLKLVDLSSNMFTGSPPFEVLGFKNITYFNVSYNRFSGGIAEVVSCSNNLEVLDVSGNG 298
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
+G IPLSIT C ++K+LD N+L+G IP + +L +LL + L +NSI G IP G+I
Sbjct: 299 LNGEIPLSITKCGSIKILDFESNKLVGKIPAELANLNKLLVLRLGSNSITGTIPAIFGNI 358
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
ELL+VL+LHNLNL GE+P+DI++CRFLL LDVSGNAL G+IPQTLYNMTYL+ILDLH NH
Sbjct: 359 ELLQVLNLHNLNLVGEIPNDITSCRFLLELDVSGNALEGEIPQTLYNMTYLEILDLHDNH 418
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS--TIQ 478
LNGS P +LG+L LQ LDLSQN LSGSIP +L NL L HFN+S NNLSGTIPS TIQ
Sbjct: 419 LNGSIPSTLGSLLKLQFLDLSQNLLSGSIPRTLENLTLLHHFNVSFNNLSGTIPSVNTIQ 478
Query: 479 HFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVV 538
+FG S F NN LCG PL+ +G G SK PKVLS+SAI+AI+AA +IL GVCV+
Sbjct: 479 NFGPSAFSNNPFLCGAPLDPCSAGNTPGTISISKKPKVLSLSAIIAIIAAVVILVGVCVI 538
Query: 539 TIMNIKARRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDK 598
+I+N+ AR RK T ++E TPLGSTDS VIIGKLVLFSK+LPSKYEDWEAGTKALLDK
Sbjct: 539 SILNLMARTRKARS-TEIIESTPLGSTDSGVIIGKLVLFSKTLPSKYEDWEAGTKALLDK 597
Query: 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
EC+IGGGSIG+VYR SFEGG+SIAVKKLETLGRIR+Q+EFE EIGRL NI+H NLVAFQG
Sbjct: 598 ECIIGGGSIGTVYRTSFEGGISIAVKKLETLGRIRSQDEFETEIGRLGNIKHPNLVAFQG 657
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
YYWSS+MQLILSEFV GNLYDNLH +NYPGTST GIGN ELHWSRR+ IA+GTARAL+Y
Sbjct: 658 YYWSSSMQLILSEFVTNGNLYDNLHSLNYPGTST-GIGNAELHWSRRYKIAIGTARALAY 716
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
LHHDC+PPILHLN+KSTNILLDENYE KLSDYGL KLLP+LDNY LTK+H+AVGYVAPEL
Sbjct: 717 LHHDCRPPILHLNIKSTNILLDENYEGKLSDYGLGKLLPVLDNYILTKYHSAVGYVAPEL 776
Query: 779 AQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838
AQSLR S+KCDVYSFGVILLELVTGRKPVESP N+VV+LCEYVRELLE GSAS CFDR+
Sbjct: 777 AQSLRASEKCDVYSFGVILLELVTGRKPVESPRANQVVILCEYVRELLESGSASDCFDRN 836
Query: 839 LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
LRG AENELIQVMKLGLICTSE+PS+RPSMAEVVQVLESIRNGLGS
Sbjct: 837 LRGIAENELIQVMKLGLICTSEIPSKRPSMAEVVQVLESIRNGLGS 882
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|27754637|gb|AAO22764.1| putative leucine-rich repeat transmembrane protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1134 bits (2934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 588/890 (66%), Positives = 702/890 (78%), Gaps = 14/890 (1%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPC 60
MR++ F L+ + F + S + + ++++ILLQFKG+I+DDP+N LASWVS G+ C
Sbjct: 1 MRKVHLF-----LVLVHFIYISTSRSDSISERDILLQFKGSISDDPYNSLASWVSDGDLC 55
Query: 61 ENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ 120
+F G+ CNP GFVD+IVLWN SL G L+P LS LK +RVL LFGNRFTGNLP +Y ++Q
Sbjct: 56 NSFNGITCNPQGFVDKIVLWNTSLAGALAPGLSNLKFIRVLNLFGNRFTGNLPLDYFKLQ 115
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
TLW INVSSNALSG IPEFI +L ++R LDLS+N ++GEIP +LFK+C KTKFVSL+HNN
Sbjct: 116 TLWTINVSSNALSGPIPEFISELSSLRFLDLSKNGFTGEIPVSLFKFCDKTKFVSLAHNN 175
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
+ GSIP SI NC L GFDFS+NNL G LP +IC+IPVL++ISVR N L+G V E+ +C
Sbjct: 176 IFGSIPASIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYISVRNNLLSGDVSEEIQKC 235
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
Q + +DL SNLF GLAPF VL KNI+YFNVS N F GEI E+ C E ++ DAS NE
Sbjct: 236 QRLILVDLGSNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIGEIVDCSESLEFLDASSNE 295
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
G IP + C++LK+LDL N+L GSIP I + L I L NNSI G+IP ++GS+
Sbjct: 296 LTGRIPTGVMGCKSLKLLDLESNKLNGSIPGSIGKMESLSVIRLGNNSIDGVIPRDIGSL 355
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
E L+VL+LHNLNL GEVP+DISNCR LL LDVSGN L G I + L N+T +KILDLH+N
Sbjct: 356 EFLQVLNLHNLNLIGEVPEDISNCRVLLELDVSGNDLEGKISKKLLNLTNIKILDLHRNR 415
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST--IQ 478
LNGS PP LGNLS +Q LDLSQNSLSG IPSSLG+L LTHFN+S NNLSG IP IQ
Sbjct: 416 LNGSIPPELGNLSKVQFLDLSQNSLSGPIPSSLGSLNTLTHFNVSYNNLSGVIPPVPMIQ 475
Query: 479 HFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVV 538
FG S F NN LCG PL T C+ RG S+N LS+S I+ I+AAA+IL GVC+V
Sbjct: 476 AFGSSAFSNNPFLCGDPLVTPCNSRGAA--AKSRNSDALSISVIIVIIAAAVILFGVCIV 533
Query: 539 TIMNIKARRRKRDDETMVVEGTPLGST--DSNVIIGKLVLFSKSLPSKYEDWEAGTKALL 596
+N++AR+R++D+E + VE TPL S+ S VIIGKLVLFSK+LPSKYEDWEAGTKALL
Sbjct: 534 LALNLRARKRRKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALL 593
Query: 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
DKE +IG GSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFE EIGRL ++H NL +F
Sbjct: 594 DKENIIGMGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSF 653
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
QGYY+SSTMQLILSEFVP G+LYDNLH +PGTS+ GN +L+W RRF IALGTA+AL
Sbjct: 654 QGYYFSSTMQLILSEFVPNGSLYDNLHLRIFPGTSS-SYGNTDLNWHRRFQIALGTAKAL 712
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT-KFHNAVGYVA 775
S+LH+DCKP ILHLN+KSTNILLDE YE KLSDYGL K LP++D++GLT KFHNAVGY+A
Sbjct: 713 SFLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIA 772
Query: 776 PELA-QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
PELA QSLR S+KCDVYS+GV+LLELVTGRKPVESP+ N+V++L +YVR+LLE GSAS C
Sbjct: 773 PELAQQSLRASEKCDVYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDC 832
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
FDR LR F ENELIQVMKLGL+CTSE P +RPSMAEVVQVLESIRNG GS
Sbjct: 833 FDRRLREFEENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIRNGFGS 882
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297844110|ref|XP_002889936.1| hypothetical protein ARALYDRAFT_888571 [Arabidopsis lyrata subsp. lyrata] gi|297335778|gb|EFH66195.1| hypothetical protein ARALYDRAFT_888571 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1134 bits (2934), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 592/890 (66%), Positives = 702/890 (78%), Gaps = 14/890 (1%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPC 60
MR+I F L+ + F + S + +++ILLQFK +I+DDP+N LASWVS G+ C
Sbjct: 1 MRKIHLF-----LVLVNFIYISSSLSQTINERDILLQFKDSISDDPYNSLASWVSDGDLC 55
Query: 61 ENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ 120
+F GV CNP GFVD+IVLWN SL G L+P LS LK +RVLTLFGNRFTGNLP +Y+++Q
Sbjct: 56 NSFNGVTCNPQGFVDKIVLWNTSLAGTLAPGLSNLKFVRVLTLFGNRFTGNLPLDYSKLQ 115
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
TLW INVSSNALSG IPEFIG+L ++R LDLS+N ++GEIP +LFK+C KTKFVSLSHNN
Sbjct: 116 TLWTINVSSNALSGPIPEFIGELSSLRFLDLSKNGFTGEIPVSLFKFCDKTKFVSLSHNN 175
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
LSGSIP +I NC L GFDFS+NNL G LP +IC+IPVL++I VR N L+G V E+ +C
Sbjct: 176 LSGSIPGTIVNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYILVRNNLLSGDVSEEIKKC 235
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
Q + +D SNLF GLAPF VL KNI+YFNVS N F GEI E+ C E ++ DAS NE
Sbjct: 236 QRLILVDFGSNLFHGLAPFEVLTFKNITYFNVSWNRFGGEIGEIVDCSESLEFLDASSNE 295
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
G IP + C+NLK+LDL N+L GSIP GI + L I L NNSI G IP +GS+
Sbjct: 296 LTGRIPNGVVGCKNLKLLDLESNKLNGSIPGGIEKIETLSVIRLGNNSIDGEIPREIGSL 355
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
E L+VL+LHNLNL GEVP+DISNCR LL LDVSGN L G++P+ L N+T L+ILDLH+N
Sbjct: 356 EFLQVLNLHNLNLIGEVPEDISNCRVLLELDVSGNNLEGEVPRKLLNLTNLEILDLHRNR 415
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP--STIQ 478
LNGS PP LGNLS++Q LDLSQNSLSGSIPSSL NL LTHFN+S NNLSG IP IQ
Sbjct: 416 LNGSIPPELGNLSSIQFLDLSQNSLSGSIPSSLENLNALTHFNVSYNNLSGIIPPVPVIQ 475
Query: 479 HFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVV 538
FG S F NN LCG PL T C+ RG S+N LS+S I+ I+AAA+IL GVC+V
Sbjct: 476 AFGSSAFSNNPFLCGDPLVTPCNSRGAAA--KSRNSNALSISVIIVIIAAAIILFGVCIV 533
Query: 539 TIMNIKARRRKRDDETMVVEGTPLGST--DSNVIIGKLVLFSKSLPSKYEDWEAGTKALL 596
+NI+AR+R++D+E + VE TPL S+ S VIIGKLVLFSK+LPSKYEDWEAGTKALL
Sbjct: 534 LALNIRARKRRKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALL 593
Query: 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
DKE +IG GSIGSVYRASFEGGVSIAVKKL+TLGRIRNQEEFE EIGRL ++H NL +F
Sbjct: 594 DKENIIGMGSIGSVYRASFEGGVSIAVKKLDTLGRIRNQEEFEQEIGRLGGLQHPNLSSF 653
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
QGYY+SSTMQLI SEFVP G+LYDNLH YPGTS+ GN +L+W +RF IALG+A+AL
Sbjct: 654 QGYYFSSTMQLIFSEFVPNGSLYDNLHLRIYPGTSSSH-GNTDLNWHKRFQIALGSAKAL 712
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT-KFHNAVGYVA 775
S+LH+DCKP ILHLN+KSTNILLDE YE KLSDYGL K LP++D++GLT KFHNAVGY+A
Sbjct: 713 SFLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIA 772
Query: 776 PELA-QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
PELA QSLR S+KCDVYS+GV+LLELVTGRKPVESP+ N+V++L +YVR+LLE GSAS C
Sbjct: 773 PELAQQSLRASEKCDVYSYGVVLLELVTGRKPVESPSRNQVLILRDYVRDLLETGSASDC 832
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
FDR LR F ENELIQVMKLGL+CTSE P +RPSMAEVVQVLESIRNG GS
Sbjct: 833 FDRRLREFEENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIRNGFGS 882
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 884 | ||||||
| TAIR|locus:2034725 | 882 | AT1G12460 [Arabidopsis thalian | 0.985 | 0.987 | 0.640 | 1.1e-293 | |
| TAIR|locus:2015504 | 890 | AT1G62950 [Arabidopsis thalian | 0.988 | 0.982 | 0.621 | 7.6e-286 | |
| TAIR|locus:2102499 | 964 | AT3G56370 [Arabidopsis thalian | 0.860 | 0.789 | 0.359 | 3.2e-120 | |
| TAIR|locus:2091353 | 1016 | AT3G28040 [Arabidopsis thalian | 0.867 | 0.754 | 0.353 | 8.2e-115 | |
| TAIR|locus:2181042 | 967 | AT5G01890 [Arabidopsis thalian | 0.871 | 0.796 | 0.346 | 1.1e-110 | |
| TAIR|locus:2167948 | 966 | ERL1 "ERECTA-like 1" [Arabidop | 0.524 | 0.480 | 0.343 | 3.5e-109 | |
| TAIR|locus:2005507 | 976 | ER "ERECTA" [Arabidopsis thali | 0.547 | 0.495 | 0.336 | 1.1e-107 | |
| TAIR|locus:2020457 | 1166 | BRL1 "BRI1 like" [Arabidopsis | 0.548 | 0.415 | 0.322 | 5.5e-106 | |
| TAIR|locus:2182855 | 967 | ERL2 "ERECTA-like 2" [Arabidop | 0.530 | 0.485 | 0.343 | 6.2e-106 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.882 | 0.707 | 0.323 | 4.6e-105 |
| TAIR|locus:2034725 AT1G12460 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2820 (997.7 bits), Expect = 1.1e-293, P = 1.1e-293
Identities = 564/881 (64%), Positives = 669/881 (75%)
Query: 11 HALLFLI-FTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCENFKGVFCN 69
H L L+ F + S + + ++++ILLQFKG+I+DDP+N LASWVS G+ C +F G+ CN
Sbjct: 5 HLFLVLVHFIYISTSRSDSISERDILLQFKGSISDDPYNSLASWVSDGDLCNSFNGITCN 64
Query: 70 PDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSS 129
P GFVD+IVLWN SL G L+P LS LK +RVL LFGNRFTGNLP +Y ++QTLW INVSS
Sbjct: 65 PQGFVDKIVLWNTSLAGTLAPGLSNLKFIRVLNLFGNRFTGNLPLDYFKLQTLWTINVSS 124
Query: 130 NALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI 189
NALSG IPEFI +L ++R LDLS+N ++GEIP +LFK+C KTKFVSL+HNN+ GSIP SI
Sbjct: 125 NALSGPIPEFISELSSLRFLDLSKNGFTGEIPVSLFKFCDKTKFVSLAHNNIFGSIPASI 184
Query: 190 ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLS 249
NC L GFDFS+NNL G LP +IC+IPVL++ISVR N L+G V E+ +CQ + +DL
Sbjct: 185 VNCNNLVGFDFSYNNLKGVLPPRICDIPVLEYISVRNNLLSGDVSEEIQKCQRLILVDLG 244
Query: 250 SNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSI 309
SNLF GLAPF VL KNI+YFNVS N F GEI E+ C E ++ DAS NE G IP +
Sbjct: 245 SNLFHGLAPFAVLTFKNITYFNVSWNRFGGEIGEIVDCSESLEFLDASSNELTGRIPTGV 304
Query: 310 TNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIXXXXXXXXX 369
C++LK+LDL N+L GSIP I + L I L NNSI G+IP ++GS+
Sbjct: 305 MGCKSLKLLDLESNKLNGSIPGSIGKMESLSVIRLGNNSIDGVIPRDIGSLEFLQVLNLH 364
Query: 370 XXXXRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSL 429
GEVP+DISNCR LL LDVSGN L G I + L N+T +KILDLH+N LNGS PP L
Sbjct: 365 NLNLIGEVPEDISNCRVLLELDVSGNDLEGKISKKLLNLTNIKILDLHRNRLNGSIPPEL 424
Query: 430 GNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST--IQHFGVSTFLN 487
GNLS +Q LDLSQNSLSG IPSSLG+L LTHFN+S NNLSG IP IQ FG S F N
Sbjct: 425 GNLSKVQFLDLSQNSLSGPIPSSLGSLNTLTHFNVSYNNLSGVIPPVPMIQAFGSSAFSN 484
Query: 488 NTGLCGPPLETSCSGRGKGMTPTSKNPKXXXXXXXXXXXXXXXXXXXXXXXTIMNIKARR 547
N LCG PL T C+ RG S+N +N++AR+
Sbjct: 485 NPFLCGDPLVTPCNSRGAAAK--SRNSDALSISVIIVIIAAAVILFGVCIVLALNLRARK 542
Query: 548 RKRDDETMVVEGTPLGST-DSN-VIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGG 605
R++D+E + VE TPL S+ DS+ VIIGKLVLFSK+LPSKYEDWEAGTKALLDKE +IG G
Sbjct: 543 RRKDEEILTVETTPLASSIDSSGVIIGKLVLFSKNLPSKYEDWEAGTKALLDKENIIGMG 602
Query: 606 SIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTM 665
SIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFE EIGRL ++H NL +FQGYY+SSTM
Sbjct: 603 SIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGGLQHPNLSSFQGYYFSSTM 662
Query: 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKP 725
QLILSEFVP G+LYDNLH +PGTS+ GN +L+W RRF IALGTA+ALS+LH+DCKP
Sbjct: 663 QLILSEFVPNGSLYDNLHLRIFPGTSSS-YGNTDLNWHRRFQIALGTAKALSFLHNDCKP 721
Query: 726 PILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK-FHNAVGYVAPELAQ-SLR 783
ILHLN+KSTNILLDE YE KLSDYGL K LP++D++GLTK FHNAVGY+APELAQ SLR
Sbjct: 722 AILHLNVKSTNILLDERYEAKLSDYGLEKFLPVMDSFGLTKKFHNAVGYIAPELAQQSLR 781
Query: 784 LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFA 843
S+KCDVYS+GV+LLELVTGRKPVESP+ N+V++L +YVR+LLE GSAS CFDR LR F
Sbjct: 782 ASEKCDVYSYGVVLLELVTGRKPVESPSENQVLILRDYVRDLLETGSASDCFDRRLREFE 841
Query: 844 ENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
ENELIQVMKLGL+CTSE P +RPSMAEVVQVLESIRNG GS
Sbjct: 842 ENELIQVMKLGLLCTSENPLKRPSMAEVVQVLESIRNGFGS 882
|
|
| TAIR|locus:2015504 AT1G62950 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2746 (971.7 bits), Expect = 7.6e-286, P = 7.6e-286
Identities = 551/887 (62%), Positives = 672/887 (75%)
Query: 7 FVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCENFKGV 66
+V+ + +I TS S S T++EILLQFK NI DDP+N LASWVS+ + C +F GV
Sbjct: 8 WVIMFIFVHIIITSSRSFSDSIITEREILLQFKDNINDDPYNSLASWVSNADLCNSFNGV 67
Query: 67 FCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKIN 126
CN +GFV++IVLWN SL G L+PALSGL SLRVLTLFGNR TGNLP +Y ++QTLWKIN
Sbjct: 68 SCNQEGFVEKIVLWNTSLAGTLTPALSGLTSLRVLTLFGNRITGNLPLDYLKLQTLWKIN 127
Query: 127 VSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIP 186
VSSNALSG +PEFIGDLPN+R LDLS+N++ GEIP +LFK+CYKTKFVSLSHNNLSGSIP
Sbjct: 128 VSSNALSGLVPEFIGDLPNLRFLDLSKNAFFGEIPNSLFKFCYKTKFVSLSHNNLSGSIP 187
Query: 187 LSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNL 246
SI NC L GFDFS+N ++G LP +IC+IPVL+F+SVR N L+G V E+ S+C+ + ++
Sbjct: 188 ESIVNCNNLIGFDFSYNGITGLLP-RICDIPVLEFVSVRRNLLSGDVFEEISKCKRLSHV 246
Query: 247 DLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIP 306
D+ SN F G+A F V+G KN++YFNVS N F GEI E+ C E ++ DAS NE G +P
Sbjct: 247 DIGSNSFDGVASFEVIGFKNLTYFNVSGNRFRGEIGEIVDCSESLEFLDASSNELTGNVP 306
Query: 307 LSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIXXXXXX 366
IT C++LK+LDL NRL GS+P G+ + +L I L +N I G +P LG++
Sbjct: 307 SGITGCKSLKLLDLESNRLNGSVPVGMGKMEKLSVIRLGDNFIDGKLPLELGNLEYLQVL 366
Query: 367 XXXXXXXRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTP 426
GE+P+D+SNCR LL LDVSGN L G+IP+ L N+T L+ILDLH+N ++G+ P
Sbjct: 367 NLHNLNLVGEIPEDLSNCRLLLELDVSGNGLEGEIPKNLLNLTNLEILDLHRNRISGNIP 426
Query: 427 PSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFL 486
P+LG+LS +Q LDLS+N LSG IPSSL NL+ LTHFN+S NNLSG IP IQ G S+F
Sbjct: 427 PNLGSLSRIQFLDLSENLLSGPIPSSLENLKRLTHFNVSYNNLSGIIPK-IQASGASSFS 485
Query: 487 NNTGLCGPPLETSCSGRGKGMTPTSKNPKXXXXXXXXXXXXXXXXXXXXXXXTIMNIKAR 546
NN LCG PLET C+ G S+ K ++N++AR
Sbjct: 486 NNPFLCGDPLETPCNALRTGSR--SRKTKALSTSVIIVIIAAAAILVGICLVLVLNLRAR 543
Query: 547 RR--KRDDETMVVEGT-PL-GSTDSN---VIIGKLVLFSKSLPSKYEDWEAGTKALLDKE 599
+R KR++E + + T P ST+S V GKLVLFSKSLPSKYEDWEAGTKALLDK+
Sbjct: 544 KRRKKREEEIVTFDTTTPTQASTESGNGGVTFGKLVLFSKSLPSKYEDWEAGTKALLDKD 603
Query: 600 CLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+IG GSIG+VYRASFEGGVSIAVKKLETLGRIRNQEEFE EIGRL ++ H NL +FQGY
Sbjct: 604 NIIGIGSIGAVYRASFEGGVSIAVKKLETLGRIRNQEEFEQEIGRLGSLSHPNLASFQGY 663
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHG-VNY-PGTSTGGIGNPELHWSRRFHIALGTARALS 717
Y+SSTMQLILSEFV G+LYDNLH V++ +S+ GN EL+W RRF IA+GTA+ALS
Sbjct: 664 YFSSTMQLILSEFVTNGSLYDNLHPRVSHRTSSSSSSHGNTELNWHRRFQIAVGTAKALS 723
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
+LH+DCKP ILHLN+KSTNILLDE YE KLSDYGL K LP+L++ GLTKFHNAVGY+APE
Sbjct: 724 FLHNDCKPAILHLNVKSTNILLDERYEAKLSDYGLEKFLPVLNSSGLTKFHNAVGYIAPE 783
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
LAQSLR+SDKCDVYS+GV+LLELVTGRKPVESP+ NEVV+L ++VR LLE GSAS CFDR
Sbjct: 784 LAQSLRVSDKCDVYSYGVVLLELVTGRKPVESPSENEVVILRDHVRNLLETGSASDCFDR 843
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
LRGF ENELIQVMKLGLICT+E P +RPS+AEVVQVLE IRNG+ S
Sbjct: 844 RLRGFEENELIQVMKLGLICTTENPLKRPSIAEVVQVLELIRNGMES 890
|
|
| TAIR|locus:2102499 AT3G56370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1183 (421.5 bits), Expect = 3.2e-120, P = 3.2e-120
Identities = 293/815 (35%), Positives = 430/815 (52%)
Query: 86 GVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPN 145
G + + L +LR L L N G P++ + L +++S N LSG IP IG
Sbjct: 181 GSMPLGIWSLNTLRSLDLSRNELEGEFPEKIDRLNNLRALDLSRNRLSGPIPSEIGSCML 240
Query: 146 IRLLDLSRNSYSGEIP--FALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFN 203
++ +DLS NS SG +P F CY ++L N L G +P I LE D S N
Sbjct: 241 LKTIDLSENSLSGSLPNTFQQLSLCYS---LNLGKNALEGEVPKWIGEMRSLETLDLSMN 297
Query: 204 NLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVL- 262
SG++P I N+ L ++ GN L G++ + C ++ LDLS N G P +
Sbjct: 298 KFSGQVPDSIGNLLALKVLNFSGNGLIGSLPVSTANCINLLALDLSGNSLTGKLPMWLFQ 357
Query: 263 -GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLG 321
G +++S + ++ G I ++ QV D S N F G I + + R+L+ L L
Sbjct: 358 DGSRDVSA--LKNDNSTGGIKKI-------QVLDLSHNAFSGEIGAGLGDLRDLEGLHLS 408
Query: 322 FNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIXXXXXXXXXXXXXRGEVPDDI 381
N L G IP+ I +L+ L + +++N + G+IP G G +P I
Sbjct: 409 RNSLTGPIPSTIGELKHLSVLDVSHNQLNGMIPRETGGAVSLEELRLENNLLEGNIPSSI 468
Query: 382 SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLS 441
NC L L +S N L G IP L +T L+ +DL N L G+ P L NL L ++S
Sbjct: 469 KNCSSLRSLILSHNKLLGSIPPELAKLTRLEEVDLSFNELAGTLPKQLANLGYLHTFNIS 528
Query: 442 QNSLSGSIPSSLGNLRNLTHFNLSSN-NLSGTIPS-TIQHFGVSTFLNNTGLCGPPLETS 499
N L G +P+ G L+ ++S N + G + + + + N P
Sbjct: 529 HNHLFGELPAG-GIFNGLSPSSVSGNPGICGAVVNKSCPAISPKPIVLNPNATFDPYN-- 585
Query: 500 CSGRGKGMTPTSKNPKXXXXXXXXXXXXXXXXXXXXXXX-TIMNIKARRR--KRDDETMV 556
G+ + P + + + T++N++ R R +
Sbjct: 586 ----GEIVPPGAGHKRILLSISSLIAISAAAAIVVGVIAITVLNLRVRASTVSRSAVPLT 641
Query: 557 VEG----TPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYR 612
G + +TDSN GKLV+FS P D+ GT ALL+K+C +G G G+VYR
Sbjct: 642 FSGGDDFSRSPTTDSNS--GKLVMFSGE-P----DFSTGTHALLNKDCELGRGGFGAVYR 694
Query: 613 ASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672
G +A+KKL +++Q+EFE E+ +L +RH NLV +GYYW++++QL++ EF
Sbjct: 695 TVIRDGYPVAIKKLTVSSLVKSQDEFEREVKKLGKLRHSNLVKLEGYYWTTSLQLLIYEF 754
Query: 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNL 732
+ G+LY LH PG GN L W+ RF+I LGTA+ L+YLH I+H N+
Sbjct: 755 LSGGSLYKQLHEA--PG------GNSSLSWNDRFNIILGTAKCLAYLHQS---NIIHYNI 803
Query: 733 KSTNILLDENYEPKLSDYGLAKLLPILDNYGLT-KFHNAVGYVAPELA-QSLRLSDKCDV 790
KS+N+LLD + EPK+ DYGLA+LLP+LD Y L+ K +A+GY+APE A +++++++KCDV
Sbjct: 804 KSSNVLLDSSGEPKVGDYGLARLLPMLDRYVLSSKIQSALGYMAPEFACRTVKITEKCDV 863
Query: 791 YSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRG-FAENELIQ 849
Y FGV++LE+VTG+KPVE ++VVVLC+ VRE LE G A C D L+G F E +
Sbjct: 864 YGFGVLVLEVVTGKKPVEY-MEDDVVVLCDMVREALEDGRADECIDPRLQGKFPVEEAVA 922
Query: 850 VMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLGS 884
V+KLGLICTS+VPS RP M E V +L IR GS
Sbjct: 923 VIKLGLICTSQVPSSRPHMGEAVNILRMIRCPSGS 957
|
|
| TAIR|locus:2091353 AT3G28040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1132 (403.5 bits), Expect = 8.2e-115, P = 8.2e-115
Identities = 284/804 (35%), Positives = 431/804 (53%)
Query: 95 LKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRN 154
L+ LR L L N +G++P + L ++ + N SG++P IG P++ +DLS N
Sbjct: 222 LERLRALDLSSNSLSGSIPLGILSLHNLKELQLQRNQFSGALPSDIGLCPHLNRVDLSSN 281
Query: 155 SYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC 214
+SGE+P L K F +S+N LSG P I + T L DFS N L+G+LPS I
Sbjct: 282 HFSGELPRTLQKLKSLNHF-DVSNNLLSGDFPPWIGDMTGLVHLDFSSNELTGKLPSSIS 340
Query: 215 NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGV--LGLKNISYFNV 272
N+ L +++ N L+G V E C+ + + L N F G P G LGL+ + +
Sbjct: 341 NLRSLKDLNLSENKLSGEVPESLESCKELMIVQLKGNDFSGNIPDGFFDLGLQEMDF--- 397
Query: 273 SHNGFHGEIPEVGI-CGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPT 331
S NG G IP E + D S N G IP + +++ L+L +N +P
Sbjct: 398 SGNGLTGSIPRGSSRLFESLIRLDLSHNSLTGSIPGEVGLFIHMRYLNLSWNHFNTRVPP 457
Query: 332 GITDLRRLLKISLANNSIGGIIPPNLGSIXXXXXXXXXXXXXRGEVPDDISNCRFLLLLD 391
I L+ L + L N+++ G +P ++ G +P+ I NC L LL
Sbjct: 458 EIEFLQNLTVLDLRNSALIGSVPADICESQSLQILQLDGNSLTGSIPEGIGNCSSLKLLS 517
Query: 392 VSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS 451
+S N L G IP++L N+ LKIL L N L+G P LG+L NL ++++S N L G +P
Sbjct: 518 LSHNNLTGPIPKSLSNLQELKILKLEANKLSGEIPKELGDLQNLLLVNVSFNRLIGRLP- 576
Query: 452 SLGNL-RNLTHFNLSSN-NLSGTI---PSTIQHFGVSTFLNNTGLCGPPLETSCSGRGKG 506
LG++ ++L + N + + P T+ + N G R G
Sbjct: 577 -LGDVFQSLDQSAIQGNLGICSPLLRGPCTLNV--PKPLVINPNSYGNG-NNMPGNRASG 632
Query: 507 MTPTSKNPKXXXXXXXXXXXXXXXXXXXXXXXTIMNIKARRRKRDDETMVVEGTPLGSTD 566
+ T T++N RRR + +E GS+
Sbjct: 633 GSGTFHRRMFLSVSVIVAISAAILIFSGVIIITLLNASVRRRLAFVDN-ALESIFSGSSK 691
Query: 567 S--NVIIGKLVLFSKSLP---SKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVS 620
S ++++GKLVL + S +++E ++LL+K IG G G+VY+A E G +
Sbjct: 692 SGRSLMMGKLVLLNSRTSRSSSSSQEFERNPESLLNKASRIGEGVFGTVYKAPLGEQGRN 751
Query: 621 IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYD 680
+AVKKL ++N E+F+ E+ L+ +H NLV+ +GY+W+ + L++SE++P GNL
Sbjct: 752 LAVKKLVPSPILQNLEDFDREVRILAKAKHPNLVSIKGYFWTPDLHLLVSEYIPNGNLQS 811
Query: 681 NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD 740
LH P T P L W R+ I LGTA+ L+YLHH +P +H NLK TNILLD
Sbjct: 812 KLHE-REPST-------PPLSWDVRYKIILGTAKGLAYLHHTFRPTTIHFNLKPTNILLD 863
Query: 741 ENYEPKLSDYGLAKLLPILDNYGLT--KFHNAVGYVAPEL-AQSLRLSDKCDVYSFGVIL 797
E PK+SD+GL++LL D + +F NA+GYVAPEL Q+LR+++KCDVY FGV++
Sbjct: 864 EKNNPKISDFGLSRLLTTQDGNTMNNNRFQNALGYVAPELECQNLRVNEKCDVYGFGVLI 923
Query: 798 LELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRG-FAENELIQVMKLGLI 856
LELVTGR+PVE + V+L ++VR +LE+G+ C D + ++E+E++ V+KL L+
Sbjct: 924 LELVTGRRPVEYGE-DSFVILSDHVRVMLEQGNVLECIDPVMEEQYSEDEVLPVLKLALV 982
Query: 857 CTSEVPSRRPSMAEVVQVLESIRN 880
CTS++PS RP+MAE+VQ+L+ I +
Sbjct: 983 CTSQIPSNRPTMAEIVQILQVINS 1006
|
|
| TAIR|locus:2181042 AT5G01890 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1093 (389.8 bits), Expect = 1.1e-110, P = 1.1e-110
Identities = 281/810 (34%), Positives = 431/810 (53%)
Query: 84 LGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDL 143
L G L + LKSL+ L N G++P + L IN+S N SG +P IG
Sbjct: 177 LSGRLPRDIWFLKSLKSLDFSHNFLQGDIPDGLGGLYDLRHINLSRNWFSGDVPSDIGRC 236
Query: 144 PNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFN 203
+++ LDLS N +SG +P ++ K + L N+L G IP I + LE D S N
Sbjct: 237 SSLKSLDLSENYFSGNLPDSM-KSLGSCSSIRLRGNSLIGEIPDWIGDIATLEILDLSAN 295
Query: 204 NLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIG-LAPFGVL 262
N +G +P + N+ L +++ N L G + + S C ++ ++D+S N F G + +
Sbjct: 296 NFTGTVPFSLGNLEFLKDLNLSANMLAGELPQTLSNCSNLISIDVSKNSFTGDVLKWMFT 355
Query: 263 G---LKNISYFNV-SHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVL 318
G ++S F++ +G +P VG +G++V D S N F G +P +I +L L
Sbjct: 356 GNSESSSLSRFSLHKRSGNDTIMPIVGFL-QGLRVLDLSSNGFTGELPSNIWILTSLLQL 414
Query: 319 DLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIXXXXXXXXXXXXXRGEVP 378
++ N L GSIPTGI L+ + L++N + G +P +G G++P
Sbjct: 415 NMSTNSLFGSIPTGIGGLKVAEILDLSSNLLNGTLPSEIGGAVSLKQLHLHRNRLSGQIP 474
Query: 379 DDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVL 438
ISNC L +++S N L G IP ++ +++ L+ +DL +N+L+GS P + LS+L
Sbjct: 475 AKISNCSALNTINLSENELSGAIPGSIGSLSNLEYIDLSRNNLSGSLPKEIEKLSHLLTF 534
Query: 439 DLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLET 498
++S N+++G +P+ G N + + N S S + +S L P +
Sbjct: 535 NISHNNITGELPA--GGFFNTIPLSAVTGNPS-LCGSVVNRSCLSVHPKPIVL-NP--NS 588
Query: 499 SCSGRGKGMTPTSKNPKXXXXXXXXXXXXXXXXXXXXXXXTIMNIKARRRKRDDETMVVE 558
S G +T + T++N+ AR +
Sbjct: 589 SNPTNGPALTGQIRK-SVLSISALIAIGAAAVIAIGVVAVTLLNVHARSSVSRHDAAAAL 647
Query: 559 GTPLGSTDS-----NVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRA 613
+G T S + GKLV+FS + ++ G ALL+K+ +G G G VY+
Sbjct: 648 ALSVGETFSCSPSKDQEFGKLVMFSGEV-DVFDT--TGADALLNKDSELGRGGFGVVYKT 704
Query: 614 SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673
S + G +AVKKL G I++QEEFE E+ +L +RH N+V +GYYW+ ++QL++ EFV
Sbjct: 705 SLQDGRPVAVKKLTVSGLIKSQEEFEREMRKLGKLRHKNVVEIKGYYWTQSLQLLIHEFV 764
Query: 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLK 733
G+LY +LHG + L W +RF I LG AR L++LH I H N+K
Sbjct: 765 SGGSLYRHLHGDE----------SVCLTWRQRFSIILGIARGLAFLHSS---NITHYNMK 811
Query: 734 STNILLDENYEPKLSDYGLAKLLP-ILDNYGLT-KFHNAVGYVAPELA-QSLRLSDKCDV 790
+TN+L+D E K+SD+GLA+LL LD L+ K +A+GY APE A ++++++D+CDV
Sbjct: 812 ATNVLIDAAGEAKVSDFGLARLLASALDRCVLSGKVQSALGYTAPEFACRTVKITDRCDV 871
Query: 791 YSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRG-FAENELIQ 849
Y FG+++LE+VTG++PVE ++VVVLCE VRE LE G C D LRG F E I
Sbjct: 872 YGFGILVLEVVTGKRPVEY-AEDDVVVLCETVREGLEEGRVEECVDPRLRGNFPAEEAIP 930
Query: 850 VMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
V+KLGL+C S+VPS RP M EVV++LE I+
Sbjct: 931 VIKLGLVCGSQVPSNRPEMEEVVKILELIQ 960
|
|
| TAIR|locus:2167948 ERL1 "ERECTA-like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 629 (226.5 bits), Expect = 3.5e-109, Sum P(2) = 3.5e-109
Identities = 164/478 (34%), Positives = 251/478 (52%)
Query: 3 RIRQFVLPHALL-FLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASW--VSSGNP 59
++++ VL A++ F++F GV+SA K L+ KG+ ++ N L W V + +
Sbjct: 4 KMQRMVLSLAMVGFMVF---GVASAMNNEGKA-LMAIKGSFSNLV-NMLLDWDDVHNSDL 58
Query: 60 CENFKGVFCNPDGF-VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAE 118
C +++GVFC+ + V + L + +LGG +SPA+ L++L+ + L GN+ G +P E
Sbjct: 59 C-SWRGVFCDNVSYSVVSLNLSSLNLGGEISPAIGDLRNLQSIDLQGNKLAGQIPDEIGN 117
Query: 119 MQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSH 178
+L +++S N L G IP I L + L+L N +G +P L + K + L+
Sbjct: 118 CASLVYLDLSENLLYGDIPFSISKLKQLETLNLKNNQLTGPVPATLTQIP-NLKRLDLAG 176
Query: 179 NNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFS 238
N+L+G I + L+ N L+G L S +C + L + VRGN LTGT+ E
Sbjct: 177 NHLTGEISRLLYWNEVLQYLGLRGNMLTGTLSSDMCQLTGLWYFDVRGNNLTGTIPESIG 236
Query: 239 QCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEV-GICGEGMQVFDAS 297
C S + LD+S N G P+ + G ++ ++ N G IPEV G+ + + V D S
Sbjct: 237 NCTSFQILDISYNQITGEIPYNI-GFLQVATLSLQGNRLTGRIPEVIGLM-QALAVLDLS 294
Query: 298 WNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNL 357
NE G IP + N L L N L G IP+ + ++ RL + L +N + G IPP L
Sbjct: 295 DNELVGPIPPILGNLSFTGKLYLHGNMLTGPIPSELGNMSRLSYLQLNDNKLVGTIPPEL 354
Query: 358 GSIXXXXXXXXXXXXXRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLH 417
G + G +P +IS+C L +V GN L G IP N+ L L+L
Sbjct: 355 GKLEQLFELNLANNRLVGPIPSNISSCAALNQFNVHGNLLSGSIPLAFRNLGSLTYLNLS 414
Query: 418 QNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
N+ G P LG++ NL LDLS N+ SGSIP +LG+L +L NLS N+LSG +P+
Sbjct: 415 SNNFKGKIPVELGHIINLDKLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLSGQLPA 472
|
|
| TAIR|locus:2005507 ER "ERECTA" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 633 (227.9 bits), Expect = 1.1e-107, Sum P(2) = 1.1e-107
Identities = 168/500 (33%), Positives = 245/500 (49%)
Query: 1 MRRIRQFVLPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNP- 59
M R VL LF + V+S AT EI FK D +N L W +S +
Sbjct: 1 MALFRDIVLL-GFLFCLSLVATVTSEEGATLLEIKKSFK-----DVNNVLYDWTTSPSSD 54
Query: 60 -CENFKGVFCNPDGF-VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYA 117
C ++GV C F V + L + +L G +SPA+ LKSL + L GNR +G +P E
Sbjct: 55 YCV-WRGVSCENVTFNVVALNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIG 113
Query: 118 EMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLS 177
+ +L +++S N LSG IP I L + L L N G IP L + K + L+
Sbjct: 114 DCSSLQNLDLSFNELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIP-NLKILDLA 172
Query: 178 HNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQF 237
N LSG IP I L+ NNL G + +C + L + VR N+LTG++ E
Sbjct: 173 QNKLSGEIPRLIYWNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETI 232
Query: 238 SQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEV-GICGEGMQVFDA 296
C + + LDLS N G PF + G ++ ++ N G+IP V G+ + + V D
Sbjct: 233 GNCTAFQVLDLSYNQLTGEIPFDI-GFLQVATLSLQGNQLSGKIPSVIGLM-QALAVLDL 290
Query: 297 SWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN 356
S N G IP + N + L L N+L GSIP + ++ +L + L +N + G IPP
Sbjct: 291 SGNLLSGSIPPILGNLTFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPE 350
Query: 357 LGSIXXXXXXXXXXXXXRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDL 416
LG + G +PD +S+C L L+V GN G IP+ + + L+L
Sbjct: 351 LGKLTDLFDLNVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNL 410
Query: 417 HQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST 476
N++ G P L + NL LDLS N ++G IPSSLG+L +L NLS N+++G +P
Sbjct: 411 SSNNIKGPIPVELSRIGNLDTLDLSNNKINGIIPSSLGDLEHLLKMNLSRNHITGVVPGD 470
Query: 477 IQHFG--VSTFLNNTGLCGP 494
+ + L+N + GP
Sbjct: 471 FGNLRSIMEIDLSNNDISGP 490
|
|
| TAIR|locus:2020457 BRL1 "BRI1 like" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 656 (236.0 bits), Expect = 5.5e-106, Sum P(2) = 5.5e-106
Identities = 163/506 (32%), Positives = 259/506 (51%)
Query: 387 LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLS 446
++ D+S NA+ G IP NM YL++L+L N + G+ P S G L + VLDLS N+L
Sbjct: 641 MIYFDISYNAVSGFIPPGYGNMGYLQVLNLGHNRITGTIPDSFGGLKAIGVLDLSHNNLQ 700
Query: 447 GSIPSSLGNLRNLTHFNLSSNNLSGTIP--STIQHFGVSTFLNNTGLCGPPLETSCSGRG 504
G +P SLG+L L+ ++S+NNL+G IP + F VS + NN+GLCG PL S
Sbjct: 701 GYLPGSLGSLSFLSDLDVSNNNLTGPIPFGGQLTTFPVSRYANNSGLCGVPLRPCGSAPR 760
Query: 505 KGMTPTSKNPKXXXXXXXXXXXXXXXXXXXXXXXTIMNIKARRRKRDDETMVVEGTPL-G 563
+ +T K + ++ ++K +E P G
Sbjct: 761 RPITSRIHAKKQTVATAVIAGIAFSFMCFVMLVMALYRVRKVQKKEQKREKYIESLPTSG 820
Query: 564 STD---SNV---IIGKLVLFSKSLPS-KYEDWEAGTKALLDKECLIGGGSIGSVYRASFE 616
S S+V + + F K L + T E ++G G G VY+A
Sbjct: 821 SCSWKLSSVPEPLSINVATFEKPLRKLTFAHLLEATNGF-SAETMVGSGGFGEVYKAQLR 879
Query: 617 GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676
G +A+KKL + + EF E+ + I+H NLV GY +L++ E++ G
Sbjct: 880 DGSVVAIKKLIRITG-QGDREFMAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKWG 938
Query: 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTN 736
+L LH + + GGI L+W+ R IA+G AR L++LHH C P I+H ++KS+N
Sbjct: 939 SLETVLHEKS---SKKGGI---YLNWAARKKIAIGAARGLAFLHHSCIPHIIHRDMKSSN 992
Query: 737 ILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGV 795
+LLDE++E ++SD+G+A+L+ LD + ++ GYV PE QS R + K DVYS+GV
Sbjct: 993 VLLDEDFEARVSDFGMARLVSALDTHLSVSTLAGTPGYVPPEYYQSFRCTAKGDVYSYGV 1052
Query: 796 ILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSL--RGFAENELIQVMKL 853
ILLEL++G+KP++ E L + ++L + D L + EL +K+
Sbjct: 1053 ILLELLSGKKPIDPGEFGEDNNLVGWAKQLYREKRGAEILDPELVTDKSGDVELFHYLKI 1112
Query: 854 GLICTSEVPSRRPSMAEVVQVLESIR 879
C + P +RP+M +++ + + ++
Sbjct: 1113 ASQCLDDRPFKRPTMIQLMAMFKEMK 1138
|
|
| TAIR|locus:2182855 ERL2 "ERECTA-like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 6.2e-106, Sum P(2) = 6.2e-106
Identities = 165/480 (34%), Positives = 243/480 (50%)
Query: 1 MRRIRQFV-LPHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASW--VSSG 57
MRRI L L ++F LG S + + + L+ K + ++ N L W V +
Sbjct: 1 MRRIETMKGLFFCLGMVVFMLLG-SVSPMNNEGKALMAIKASFSNVA-NMLLDWDDVHNH 58
Query: 58 NPCENFKGVFC-NPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEY 116
+ C +++GVFC N V + L N +LGG +S AL L +L+ + L GN+ G +P E
Sbjct: 59 DFC-SWRGVFCDNVSLNVVSLNLSNLNLGGEISSALGDLMNLQSIDLQGNKLGGQIPDEI 117
Query: 117 AEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL 176
+L ++ S+N L G IP I L + L+L N +G IP L + K + L
Sbjct: 118 GNCVSLAYVDFSTNLLFGDIPFSISKLKQLEFLNLKNNQLTGPIPATLTQIP-NLKTLDL 176
Query: 177 SHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQ 236
+ N L+G IP + L+ N L+G L +C + L + VRGN LTGT+ E
Sbjct: 177 ARNQLTGEIPRLLYWNEVLQYLGLRGNMLTGTLSPDMCQLTGLWYFDVRGNNLTGTIPES 236
Query: 237 FSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEV-GICGEGMQVFD 295
C S + LD+S N G+ P+ + G ++ ++ N G IPEV G+ + + V D
Sbjct: 237 IGNCTSFEILDVSYNQITGVIPYNI-GFLQVATLSLQGNKLTGRIPEVIGLM-QALAVLD 294
Query: 296 ASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPP 355
S NE G IP + N L L N+L G IP + ++ RL + L +N + G IPP
Sbjct: 295 LSDNELTGPIPPILGNLSFTGKLYLHGNKLTGQIPPELGNMSRLSYLQLNDNELVGKIPP 354
Query: 356 NLGSIXXXXXXXXXXXXXRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILD 415
LG + G +P +IS+C L +V GN L G +P N+ L L+
Sbjct: 355 ELGKLEQLFELNLANNNLVGLIPSNISSCAALNQFNVHGNFLSGAVPLEFRNLGSLTYLN 414
Query: 416 LHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
L N G P LG++ NL LDLS N+ SGSIP +LG+L +L NLS N+L+GT+P+
Sbjct: 415 LSSNSFKGKIPAELGHIINLDTLDLSGNNFSGSIPLTLGDLEHLLILNLSRNHLNGTLPA 474
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1040 (371.2 bits), Expect = 4.6e-105, P = 4.6e-105
Identities = 264/815 (32%), Positives = 416/815 (51%)
Query: 77 IVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSI 136
+ L+ L G + + L + N TG +P E ++ L + + N L+G+I
Sbjct: 294 LYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTI 353
Query: 137 PEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLE 196
P + L N+ LDLS N+ +G IP F+Y + L N+LSG+IP + + L
Sbjct: 354 PVELSTLKNLSKLDLSINALTGPIPLG-FQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLW 412
Query: 197 GFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256
D S N+LSG +PS +C + +++ N L+G + + C+++ L L+ N +G
Sbjct: 413 VLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGR 472
Query: 257 APFGVLGLKNISYFNVSHNGFHGEIP-EVGICGEGMQVFDASWNEFDGVIPLSITNCRNL 315
P + N++ + N F G IP EVG C +Q + N F G +P I L
Sbjct: 473 FPSNLCKQVNVTAIELGQNRFRGSIPREVGNCS-ALQRLQLADNGFTGELPREIGMLSQL 531
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIXXXXXXXXXXXXXRG 375
L++ N+L G +P+ I + + L ++ + N+ G +P +GS+ G
Sbjct: 532 GTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSG 591
Query: 376 EVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKI-LDLHQNHLNGSTPPSLGNLSN 434
+P + N L L + GN G IP+ L ++T L+I L+L N L G PP L NL
Sbjct: 592 TIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVM 651
Query: 435 LQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGP 494
L+ L L+ N+LSG IPSS NL +L +N S N+L+G IP +++ +S+F+ N GLCGP
Sbjct: 652 LEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGPIP-LLRNISMSSFIGNEGLCGP 710
Query: 495 PLETSCSGRGKGMTPTSKNPKXXXXXXXXXXXXXXXXXXXXXXXTIMNIKARRRKRDDET 554
PL + + ++ P ++ RR R +
Sbjct: 711 PLNQCIQTQPFAPSQSTGKPGGMRSSKIIAITAAVIGGVSLMLIALIVYLMRRPVRTVAS 770
Query: 555 MVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRAS 614
+G P S + + + F ++D A T D+ ++G G+ G+VY+A
Sbjct: 771 SAQDGQP-----SEMSLD--IYFPPKEGFTFQDLVAATDNF-DESFVVGRGACGTVYKAV 822
Query: 615 FEGGVSIAVKKLETL---GRIRNQEE-FELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670
G ++AVKKL + G N + F EI L NIRH N+V G+ L+L
Sbjct: 823 LPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNIRHRNIVKLHGFCNHQGSNLLLY 882
Query: 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHL 730
E++PKG+L + LH P + L WS+RF IALG A+ L+YLHHDCKP I H
Sbjct: 883 EYMPKGSLGEILHD---PSCN--------LDWSKRFKIALGAAQGLAYLHHDCKPRIFHR 931
Query: 731 NLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDV 790
++KS NILLD+ +E + D+GLAK++ + + ++ + GY+APE A ++++++K D+
Sbjct: 932 DIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYAYTMKVTEKSDI 991
Query: 791 YSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS-ASACFDRSLRGFAE---NE 846
YS+GV+LLEL+TG+ PV+ VV +VR + R + +S D L E +
Sbjct: 992 YSYGVVLLELLTGKAPVQPIDQGGDVV--NWVRSYIRRDALSSGVLDARLTLEDERIVSH 1049
Query: 847 LIQVMKLGLICTSEVPSRRPSMAEVVQVL-ESIRN 880
++ V+K+ L+CTS P RPSM +VV +L ES R+
Sbjct: 1050 MLTVLKIALLCTSVSPVARPSMRQVVLMLIESERS 1084
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| C0LGE4 | Y1124_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6606 | 0.9909 | 0.9931 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 884 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-80 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-61 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-33 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-32 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-32 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-31 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-30 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-29 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-28 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-27 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-23 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 9e-23 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-22 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-22 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-21 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 7e-21 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-20 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-20 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-20 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 4e-19 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-18 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-18 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-18 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-17 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-17 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-17 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-17 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-16 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 1e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-15 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-15 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-15 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 6e-15 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 2e-14 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-14 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-14 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-14 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-14 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-14 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-14 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-13 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-13 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-13 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-13 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 3e-13 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-13 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-12 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-12 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-12 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-12 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 3e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-12 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-12 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 7e-12 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 1e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-11 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-11 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 1e-11 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-11 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 3e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-11 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 4e-11 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-11 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-10 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-10 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-10 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-10 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-10 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-10 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-10 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-10 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-09 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-09 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-09 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-09 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 5e-09 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-09 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 5e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 5e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-09 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-09 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-09 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 9e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-09 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-08 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-08 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-08 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-08 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-08 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 4e-08 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 4e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 6e-08 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-08 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 7e-08 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-08 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 9e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-07 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-07 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-07 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-07 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-07 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 3e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 3e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-07 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-07 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-07 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-07 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 5e-07 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 5e-07 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-07 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-07 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-07 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-07 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-07 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 8e-07 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-07 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 8e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-06 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-06 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-06 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-06 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-06 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-06 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-06 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 4e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 6e-06 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-06 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 7e-06 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-06 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-06 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 8e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 9e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 9e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 9e-06 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-05 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-05 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-05 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-05 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-05 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-05 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 4e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 4e-05 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-05 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 5e-05 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-05 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 6e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 7e-05 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 1e-04 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-04 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-04 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-04 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 3e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-04 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-04 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 5e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 6e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 6e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 8e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 0.001 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.001 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.001 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 0.001 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.002 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 0.002 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 0.002 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.002 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.002 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 0.003 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.003 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 279 bits (716), Expect = 1e-80
Identities = 226/806 (28%), Positives = 367/806 (45%), Gaps = 113/806 (14%)
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGD 142
+L G + +L LK+L+ L L+ N+ +G +P +Q L +++S N+LSG IPE +
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306
Query: 143 LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSF 202
L N+ +L L N+++G+IP AL + + + L N SG IP ++ L D S
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLP-RLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLST 365
Query: 203 NNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVL 262
NNL+GE+P +C+ L + + N+L G + + C+S++ + L N F G P
Sbjct: 366 NNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFT 425
Query: 263 GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGF 322
L + + ++S+N G I +Q+ + N+F G +P S + L+ LDL
Sbjct: 426 KLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS-FGSKRLENLDLSR 484
Query: 323 NRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDIS 382
N+ G++P + L L+++ L+ N + G E+PD++S
Sbjct: 485 NQFSGAVPRKLGSLSELMQLKLSENKLSG------------------------EIPDELS 520
Query: 383 NCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQ 442
+C+ L+ LD+S N L G IP + M P L LDLSQ
Sbjct: 521 SCKKLVSLDLSHNQLSGQIPASFSEM------------------PVLSQ------LDLSQ 556
Query: 443 NSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGV--STFLNNTGLCGPPLETSC 500
N LSG IP +LGN+ +L N+S N+L G++PST + S N LCG
Sbjct: 557 NQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCG------- 609
Query: 501 SGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVVTIMNIKARR----RKRDDETMV 556
G+ P + K S + A ++ + + I+ R ++ ++E
Sbjct: 610 GDTTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGT 669
Query: 557 VEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRA-SF 615
E S S I +L S L +E +I G G+ Y+ S
Sbjct: 670 WELQFFDSKVSKSITINDILSS-----------------LKEENVISRGKKGASYKGKSI 712
Query: 616 EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675
+ G+ VK++ + I EI + ++H N+V G S ++ E++
Sbjct: 713 KNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767
Query: 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKST 735
NL + L L W RR IA+G A+AL +LH C P ++ NL
Sbjct: 768 KNLSEVLRN---------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPE 812
Query: 736 NILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGV 795
I++D EP L L LL F ++ YVAPE ++ +++K D+Y FG+
Sbjct: 813 KIIIDGKDEPHLR-LSLPGLLCT----DTKCFISS-AYVAPETRETKDITEKSDIYGFGL 866
Query: 796 ILLELVTGRKPVESPT-TNEVVVLCEYVRELLERGSASACFDRSLRGFA---ENELIQVM 851
IL+EL+TG+ P ++ + +V E+ R D S+RG +NE+++VM
Sbjct: 867 ILIELLTGKSPADAEFGVHGSIV--EWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVM 924
Query: 852 KLGLICTSEVPSRRPSMAEVVQVLES 877
L L CT+ P+ RP +V++ LES
Sbjct: 925 NLALHCTATDPTARPCANDVLKTLES 950
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 1e-61
Identities = 152/466 (32%), Positives = 234/466 (50%), Gaps = 6/466 (1%)
Query: 10 PHALLFLIFTSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCENFKGVFCN 69
L+F++F S A + E+LL FK +I +DP L++W SS + C ++G+ CN
Sbjct: 9 CPYLIFMLFFLFLNFSMLHAEELELLLSFKSSI-NDPLKYLSNWNSSADVC-LWQGITCN 66
Query: 70 PDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVS 128
V I L ++ G +S A+ L ++ + L N+ +G +P + + +L +N+S
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 129 SNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLS 188
+N +GSIP G +PN+ LDLS N SGEIP + + K + L N L G IP S
Sbjct: 127 NNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSF-SSLKVLDLGGNVLVGKIPNS 183
Query: 189 IANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDL 248
+ N T LE + N L G++P ++ + L +I + N L+G + + S+ +LDL
Sbjct: 184 LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDL 243
Query: 249 SSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLS 308
N G P + LKN+ Y + N G IP + + D S N G IP
Sbjct: 244 VYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPEL 303
Query: 309 ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDL 368
+ +NL++L L N G IP +T L RL + L +N G IP NLG L VLDL
Sbjct: 304 VIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDL 363
Query: 369 HNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPS 428
NL GE+P+ + + L L + N+L G+IP++L L+ + L N +G P
Sbjct: 364 STNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSE 423
Query: 429 LGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
L + LD+S N+L G I S ++ +L +L+ N G +P
Sbjct: 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP 469
|
Length = 968 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 78/290 (26%), Positives = 128/290 (44%), Gaps = 42/290 (14%)
Query: 596 LDKECLIGGGSIGSVYRA-----SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRH 650
L+ +G G+ G VY+ +AVK L+ +EEF E + + H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
N+V G I++E++P G+L D L +L +AL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHG-----------EKLTLKDLLQMAL 109
Query: 711 GTARALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY---GLTK 766
A+ + YL + +H +L + N L+ EN K+SD+GL++ + D Y G K
Sbjct: 110 QIAKGMEYLESKNF----VHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGK 165
Query: 767 FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVREL 825
+ ++APE + + + K DV+SFGV+L E+ T G +P + EV+ EL
Sbjct: 166 L--PIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL-------EL 216
Query: 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
LE G + +EL ++M C + P RP+ +E+V+ L
Sbjct: 217 LEDGYRLPRPE-----NCPDELYELMLQ---CWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 1e-32
Identities = 65/205 (31%), Positives = 91/205 (44%), Gaps = 24/205 (11%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660
+G G G+VY A + G +A+K ++ EE EI L + H N+V G +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH 720
++ E+ G+L D L L I L L YLH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKENEGK-----------LSEDEILRILLQILEGLEYLH 109
Query: 721 HDCKPPILHLNLKSTNILLDE-NYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAP 776
+ I+H +LK NILLD N + KL+D+GL+KLL + VG Y+AP
Sbjct: 110 SN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLL----TSDKSLLKTIVGTPAYMAP 162
Query: 777 E-LAQSLRLSDKCDVYSFGVILLEL 800
E L S+K D++S GVIL EL
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 35/285 (12%)
Query: 602 IGGGSIGSVYRASFEGG----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G G+ G VY+ +G +AVK L+ +++F E + + H N+V
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLL 62
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
G ++ E++ G+L D L S L A+ A+ +
Sbjct: 63 GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEK---STLSLKDLLSFAIQIAKGME 119
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYV 774
YL +H +L + N L+ E+ K+SD+GL++ + D Y K + ++
Sbjct: 120 YLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY--RKKTGGKLPIRWM 174
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSA 831
APE + + K DV+SFGV+L E+ T G P + EV+ EY+R+ L +
Sbjct: 175 APESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVL---EYLRKGYRLPKP-- 229
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
C D EL ++M C P RP+ +E+V+ LE
Sbjct: 230 EYCPD---------ELYELMLS---CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 3e-31
Identities = 64/210 (30%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G GS G VY A + G +A+K ++ +++E EI L ++H N+V
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ ++ E+ G+L+D L G + E AL YL
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLK-------KRGRLSEDEAR-----FYLRQILSALEYL 113
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAP 776
H I+H +LK NILLDE+ KL+D+GLA+ L K VG Y+AP
Sbjct: 114 HSKG---IVHRDLKPENILLDEDGHVKLADFGLARQLD-----PGEKLTTFVGTPEYMAP 165
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
E+ D++S GVIL EL+TG+ P
Sbjct: 166 EVLLGKGYGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 86/282 (30%), Positives = 129/282 (45%), Gaps = 42/282 (14%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFEL-EIGRLSNIRHFNLVAFQGY 659
+G GS G+VY+A +G G +AVK L+ +++ EI L + H N+V
Sbjct: 7 LGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDA 66
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ ++ E+ G+L+D L S GG L IAL R L YL
Sbjct: 67 FEDKDHLYLVMEYCEGGDLFDYL--------SRGGP----LSEDEAKKIALQILRGLEYL 114
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAP 776
H + I+H +LK NILLDEN K++D+GLAK L + VG Y+AP
Sbjct: 115 HSN---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSS----SSLTTFVGTPWYMAP 167
Query: 777 ELAQSLRLSD----KCDVYSFGVILLELVTGRKPV-ESPTTNEVVVLCEYVRELLERGSA 831
E+ L + K DV+S GVIL EL+TG+ P +++ ++ + LE
Sbjct: 168 EV---LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLE---- 220
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
FD E ++K + PS+RP+ E++Q
Sbjct: 221 ---FDEPKWSSGSEEAKDLIK-KCLNK--DPSKRPTAEEILQ 256
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-29
Identities = 65/221 (29%), Positives = 118/221 (53%), Gaps = 7/221 (3%)
Query: 70 PDGFVD-----RIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWK 124
P+G +++L++ SL G + +L +SLR + L N F+G LP E+ ++ ++
Sbjct: 373 PEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYF 432
Query: 125 INVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGS 184
+++S+N L G I D+P++++L L+RN + G +P + + + LS N SG+
Sbjct: 433 LDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP--DSFGSKRLENLDLSRNQFSGA 490
Query: 185 IPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIK 244
+P + + + L S N LSGE+P ++ + L + + N L+G + FS+ +
Sbjct: 491 VPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS 550
Query: 245 NLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVG 285
LDLS N G P + ++++ N+SHN HG +P G
Sbjct: 551 QLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTG 591
|
Length = 968 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 79/289 (27%), Positives = 125/289 (43%), Gaps = 40/289 (13%)
Query: 596 LDKECLIGGGSIGSVYRA-----SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRH 650
L +G G+ G VY+ V +AVK L+ + EEF E + + H
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
N+V G +I+ E++P G+L D L EL S AL
Sbjct: 61 PNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN----------RPKELSLSDLLSFAL 110
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
AR + YL +H +L + N L+ EN K+SD+GL++ L + K
Sbjct: 111 QIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRD---LYDDDYYKVKGG 164
Query: 771 ---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826
+ ++APE + + + K DV+SFGV+L E+ T G +P + EV+ E L
Sbjct: 165 KLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL-------EYL 217
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
++G EL ++M C +E P RP+ +E+V++L
Sbjct: 218 KKGYRLPKPPN-----CPPELYKLMLQ---CWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-27
Identities = 78/288 (27%), Positives = 123/288 (42%), Gaps = 39/288 (13%)
Query: 596 LDKECLIGGGSIGSVYRA-----SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRH 650
L +G G+ G VY+ + V +AVK L+ + EEF E + + H
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDH 60
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
N+V G I+ E++ G+L L + + +L AL
Sbjct: 61 PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR------KNRPKLSLSDLL-----SFAL 109
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY--GLTKFH 768
AR + YL +H +L + N L+ EN K+SD+GL++ L D Y K
Sbjct: 110 QIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKL- 165
Query: 769 NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827
+ ++APE + + + K DV+SFGV+L E+ T G +P +N E V E L+
Sbjct: 166 -PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQP-YPGMSN------EEVLEYLK 217
Query: 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
G EL +M C +E P RP+ +E+V++L
Sbjct: 218 NGYRLPQPPN-----CPPELYDLMLQ---CWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 3e-23
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 598 KECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVA 655
+ L+G GS GSVY A + G +AVK +E G + E E EI LS+++H N+V
Sbjct: 4 RGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR 63
Query: 656 FQGYYWSST--MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALG 711
+ G I E+V G+L L G + P + R++ I G
Sbjct: 64 YYGSERDEEKNTLNIFLEYVSGGSLSSLLKKF-------GKLPEPVI---RKYTRQILEG 113
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
L+YLH I+H ++K NIL+D + KL+D+G AK L D +
Sbjct: 114 ----LAYLH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLG--DIETGEGTGSVR 164
Query: 772 G---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
G ++APE+ + D++S G ++E+ TG+ P
Sbjct: 165 GTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 9e-23
Identities = 59/218 (27%), Positives = 92/218 (42%), Gaps = 42/218 (19%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLVAFQ 657
IG G G VY+A G +A+K + ++ ++E+ E EI L +H N+V +
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI----KLESKEKKEKIINEIQILKKCKHPNIVKYY 63
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF---HIA---LG 711
G Y I+ EF G+L D L ++ IA
Sbjct: 64 GSYLKKDELWIVMEFCSGGSLKDLLK-----------------STNQTLTESQIAYVCKE 106
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
+ L YLH I+H ++K+ NILL + E KL D+GL+ + V
Sbjct: 107 LLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSA-----QLSDTKARNTMV 158
Query: 772 G---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
G ++APE+ K D++S G+ +EL G+ P
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 64/175 (36%), Positives = 93/175 (53%), Gaps = 38/175 (21%)
Query: 366 LDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGST 425
L L N LRG +P+DIS R L +++SGN++ G+IP +L ++T L++LDL N NGS
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 426 PPSLGNLSNLQVLDLSQNSLSGSIPSSLGN-LRNLTHFNLSSNNLSGTIPSTIQHFGVST 484
P SLG L++L++L+L+ NSLSG +P++LG L + FN
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFN--------------------- 521
Query: 485 FLNNTGLCGPPLETSCSGRGKGMTPTSKNPKVLSVSAIVAI---VAAALILAGVC 536
F +N GLCG P +C P LSV A + I V+ A + +C
Sbjct: 522 FTDNAGLCGIPGLRACG-------PH------LSVGAKIGIAFGVSVAFLFLVIC 563
|
Length = 623 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 4e-22
Identities = 71/282 (25%), Positives = 123/282 (43%), Gaps = 35/282 (12%)
Query: 601 LIGGGSIGSVYRASFE--GG--VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+G GS G V R + GG + +AVK L++ ++F E + ++ H NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
G + + ++ +E P G+L D L S A+ A +
Sbjct: 62 YGVVLTHPLMMV-TELAPLGSLLDRLRKD----------ALGHFLISTLCDYAVQIANGM 110
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV--GYV 774
YL +H +L + NILL + + K+ D+GL + LP +++ + + H V +
Sbjct: 111 RYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWC 167
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASA 833
APE ++ S DV+ FGV L E+ T G +P + ++++ + E LER A
Sbjct: 168 APESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLER--PEA 225
Query: 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
C ++ VM C + P+ RP+ A + + L
Sbjct: 226 C---------PQDIYNVMLQ---CWAHNPADRPTFAALREFL 255
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 9e-22
Identities = 72/286 (25%), Positives = 128/286 (44%), Gaps = 47/286 (16%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G G V+ ++ V +A+K L++ + Q++F+ E+ L +RH +L++
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKS-DDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE---LHWSRRFHIALGTARALSY 718
I++E + KG+L L +PE L + +A A ++Y
Sbjct: 73 VGEPVYIITELMEKGSLLAFL-------------RSPEGQVLPVASLIDMACQVAEGMAY 119
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN-AVGYVAPE 777
L +H +L + NIL+ E+ K++D+GLA+L I ++ L+ + APE
Sbjct: 120 LEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL--IKEDVYLSSDKKIPYKWTAPE 174
Query: 778 LAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG----SAS 832
A S K DV+SFG++L E+ T G+ P +EV + + G +
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY-------DQITAGYRMPCPA 227
Query: 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
C E+ ++M L C + P RPS + + L++I
Sbjct: 228 KC---------PQEIYKIM---LECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 77/298 (25%), Positives = 132/298 (44%), Gaps = 45/298 (15%)
Query: 602 IGGGSIGSVYRASFE-----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+G G G V ++ G +AVK L G +++ +FE EI L + H N+V +
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71
Query: 657 QGYYWS-----STMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
+G +++LI+ E++P G+L D L +++ R +
Sbjct: 72 KG--VCEKPGGRSLRLIM-EYLPSGSLRDYL-----QRHR------DQINLKRLLLFSSQ 117
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF--HN 769
+ + YL +H +L + NIL++ K+SD+GLAK+LP +Y K +
Sbjct: 118 ICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174
Query: 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVR----- 823
+ + APE ++ + S DV+SFGV L EL T G P ++ +
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTR 234
Query: 824 --ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
ELL+ G +E+ +MKL C P RPS A+++ +++ +R
Sbjct: 235 LLELLKEGERLPRPPS-----CPDEVYDLMKL---CWEAEPQDRPSFADLILIVDRLR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 92.9 bits (232), Expect = 7e-21
Identities = 73/283 (25%), Positives = 118/283 (41%), Gaps = 45/283 (15%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQG 658
IG GS G VY G +K+++ + +E+ E+ L + H N++ +
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE---LHWSRRFHIALGTARA 715
+ I+ E+ G+L + G PE L W + L A
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPF-----PEEQILDWF--VQLCL----A 115
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG--- 772
L YLH ILH ++K NI L N KL D+G++K+L + T VG
Sbjct: 116 LKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV----VGTPY 168
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV--VLCEYVRELLERGS 830
Y++PEL Q+ + K D++S G +L EL T + P E E+ +L +
Sbjct: 169 YLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI----- 223
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ + LR L+ + L + P RPS+A+++Q
Sbjct: 224 -PSQYSSELR-----NLVSSL-L-----QKDPEERPSIAQILQ 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 3e-20
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 41/272 (15%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G G V+ + +AVK L+ G + + ++F E + +RH L+ Y
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTLKP-GTM-DPKDFLAEAQIMKKLRHPKLIQL---YA 68
Query: 662 SSTMQ---LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
T++ I++E + G+L + L G L + +A A ++Y
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQG----------GAGRALKLPQLIDMAAQVASGMAY 118
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP--ILDNYGLTKFHNAVGYVAP 776
L +H +L + N+L+ EN K++D+GLA+++ I + KF + + AP
Sbjct: 119 LE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAP 173
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
E A R S K DV+SFG++L E+VT GR P T EV+ + +++G C
Sbjct: 174 EAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQVDQGYRMPCP 226
Query: 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
EL +M L C E P RP+
Sbjct: 227 PG-----CPKELYDIM---LDCWKEDPDDRPT 250
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 62/232 (26%), Positives = 110/232 (47%), Gaps = 24/232 (10%)
Query: 596 LDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV 654
L++ ++G GS G VY+ + G A+KK+ G +++ E+ L + +V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVV 62
Query: 655 AFQG-YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
G +Y + ++L E++ G+L +L G I P L +IA
Sbjct: 63 KCYGAFYKEGEISIVL-EYMDGGSL-ADLLK------KVGKIPEPVLA-----YIARQIL 109
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
+ L YLH I+H ++K +N+L++ E K++D+G++K +L+N L + + VG
Sbjct: 110 KGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISK---VLEN-TLDQCNTFVGT 163
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822
Y++PE Q S D++S G+ LLE G+ P P L + +
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 5e-20
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 25/214 (11%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IGGG+ G VY A + + G +AVK++ + +E E+ L ++H NLV + G
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
I E+ G L + L G I + H R + + L L+YL
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEH--------GRI--LDEHVIRVYTLQL--LEGLAYL 115
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL-PILDNYGLTKFHNAVG---YVA 775
H I+H ++K NI LD N KL D+G A L G + + G Y+A
Sbjct: 116 H---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG-EEVQSLAGTPAYMA 171
Query: 776 PELAQSLRLSDK---CDVYSFGVILLELVTGRKP 806
PE+ + D++S G ++LE+ TG++P
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 37/292 (12%)
Query: 588 WEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSN 647
W +K L IG G G V + G +AVK L+ F E ++
Sbjct: 1 WAINSKELKLGAT-IGKGEFGDVMLGDYRGQ-KVAVKCLKDDSTAAQA--FLAEASVMTT 56
Query: 648 IRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH 707
+RH NLV G I++E++ KG+L D L G + +++
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR----------GRAVITLAQQLG 106
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
AL + YL +H +L + N+L+ E+ K+SD+GLAK + G
Sbjct: 107 FALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAK----EASQGQDSG 159
Query: 768 HNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826
V + APE + + S K DV+SFG++L E+ + GR P +VV +V +
Sbjct: 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PHVEKGY 216
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+ C E+ +VMK C P++RP+ ++ + L I
Sbjct: 217 RMEAPEGCPP---------EVYKVMKD---CWELDPAKRPTFKQLREQLALI 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 4e-19
Identities = 57/212 (26%), Positives = 101/212 (47%), Gaps = 24/212 (11%)
Query: 600 CLIGGGSIGSVYRA-SFEGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQ 657
LIG G+ G VY+ + E G +A+K++ + + EI L N++H N+V +
Sbjct: 6 DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
G +S I+ E+ G+L + G PE + + L + L+
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK-------KFGPF--PESLVAVYVYQVL---QGLA 113
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
YLH + ++H ++K+ NIL ++ KL+D+G+A L + + VG ++
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK----DDASVVGTPYWM 166
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ + S D++S G ++EL+TG P
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 69/244 (28%), Positives = 118/244 (48%), Gaps = 35/244 (14%)
Query: 596 LDKECLIGGGSIGSVYRASF--EG---GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRH 650
L+K ++G G+ G+VY+ + EG + +A+K L + +E E ++++ H
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE-LHWSRRFHIA 709
++V G SS +QLI ++ +P G L D + IG+ L+W + IA
Sbjct: 69 PHVVRLLGICLSSQVQLI-TQLMPLGCLLDYVR------NHKDNIGSQYLLNWCVQ--IA 119
Query: 710 LGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN-YGLTK 766
G +SYL ++H +L + N+L+ K++D+GLAKLL + + Y
Sbjct: 120 KG----MSYLEEKR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEG 170
Query: 767 FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVREL 825
+ ++A E + K DV+S+GV + EL+T G KP E E + +L
Sbjct: 171 GKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-------IPDL 223
Query: 826 LERG 829
LE+G
Sbjct: 224 LEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 86/290 (29%), Positives = 130/290 (44%), Gaps = 55/290 (18%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLE--TLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G G V+ ++ G +AVK L+ T+ + E F E + +RH LV Q Y
Sbjct: 14 LGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLV--QLY 67
Query: 660 YWSSTMQ--LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
S + I++E++ KG+L D L + G +L + +A A ++
Sbjct: 68 AVCSEEEPIYIVTEYMSKGSLLDFLK------SGEGK----KLRLPQLVDMAAQIAEGMA 117
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN----YGLTKFHNAVGY 773
YL +H +L + NIL+ EN K++D+GLA+L I D+ KF + +
Sbjct: 118 YLE---SRNYIHRDLAARNILVGENLVCKIADFGLARL--IEDDEYTAREGAKF--PIKW 170
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG--- 829
APE A R + K DV+SFG++L E+VT GR P T EV+ E +ERG
Sbjct: 171 TAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL-------EQVERGYRM 223
Query: 830 -SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
C EL +M L C + P RP+ + LE
Sbjct: 224 PRPPNC---------PEELYDLM---LQCWDKDPEERPTFEYLQSFLEDY 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 68/280 (24%), Positives = 126/280 (45%), Gaps = 39/280 (13%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQ 657
+G GS GSVY+ A+K+++ LG + +E + EI L+++ H N+++++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVD-LGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ I+ E+ P G+L + + + W + G +AL
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAIS----KRKKKRKLIPEQEIWRIFIQLLRGL-QAL- 119
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
H+ K ILH +LKS NILL N K+ D G++K+L + K +G Y+
Sbjct: 120 ---HEQK--ILHRDLKSANILLVANDLVKIGDLGISKVL----KKNMAK--TQIGTPHYM 168
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
APE+ + S K D++S G +L E+ T P E+ + + +R ++RG
Sbjct: 169 APEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD-------LRYKVQRGK---- 217
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874
+ +++ +L ++ L P RP+ +++
Sbjct: 218 YPPIPPIYSQ-DLQNFIRSMLQVK---PKLRPNCDKILAS 253
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 6e-18
Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQG 658
IG G+ G VY+A+ G +A+KK+ R+R Q + + EI + + +H N+V +
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM----RLRKQNKELIINEILIMKDCKHPNIVDYYD 82
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
Y ++ E++ G+L D + E + + + L Y
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIIT--QNFVRMN------EPQIAY---VCREVLQGLEY 131
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVA 775
LH ++H ++KS NILL ++ KL+D+G A L +K ++ VG ++A
Sbjct: 132 LH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQL----TKEKSKRNSVVGTPYWMA 184
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
PE+ + K D++S G++ +E+ G P
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 86.3 bits (212), Expect = 7e-18
Identities = 74/285 (25%), Positives = 112/285 (39%), Gaps = 29/285 (10%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRH-FNLVAFQ 657
+G GS G VY A V A+K L + + + E F EI L+++ H N+V
Sbjct: 7 KLGEGSFGEVYLARDRKLV--ALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLY 64
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
++ ++ E+V G+L D L + G + S I AL
Sbjct: 65 DFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSE---------SEALFILAQILSALE 115
Query: 718 YLHHDCKPPILHLNLKSTNILLDENY-EPKLSDYGLAKLLP-----ILDNYGLTKFHNAV 771
YLH I+H ++K NILLD + KL D+GLAKLLP +
Sbjct: 116 YLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTP 172
Query: 772 GYVAPELAQSLRL---SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828
GY+APE+ L L S D++S G+ L EL+TG P E + +++
Sbjct: 173 GYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS---ATSQTLKIILE 229
Query: 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ E L ++ P R S + +
Sbjct: 230 LPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274
|
Length = 384 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 84/282 (29%), Positives = 129/282 (45%), Gaps = 38/282 (13%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKL-ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+GGG G VY ++ +++AVK L E + EEF E + I+H NLV G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV---EEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
I++EF+ GNL D L N E++ ++A + A+ YL
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLRECN----------RQEVNAVVLLYMATQISSAMEYL 120
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP--ILDNYGLTKFHNAVGYVAPE 777
K +H +L + N L+ EN+ K++D+GL++L+ + KF + + APE
Sbjct: 121 E---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTAPE 175
Query: 778 LAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836
+ S K DV++FGV+L E+ T G P + V ELLE+G +
Sbjct: 176 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG-------IDLSQVYELLEKGYR---ME 225
Query: 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
R E +V +L C PS RPS AE+ Q E++
Sbjct: 226 R-----PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 69/230 (30%), Positives = 108/230 (46%), Gaps = 26/230 (11%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVK--KLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ G V + G +AVK +LE I+ Q EL+I L +V F G
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDI--LHKCNSPYIVGFYG 66
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
++++ I E++ G+L L V G I PE + IA+ + L+Y
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKILKEV------QGRI--PERILGK---IAVAVLKGLTY 115
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
LH K I+H ++K +NIL++ + KL D+G++ L +++ T F Y+APE
Sbjct: 116 LHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL--VNSLAKT-FVGTSSYMAPER 170
Query: 779 AQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828
Q S K D++S G+ L+EL TGR P + ELL+
Sbjct: 171 IQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF-----ELLQY 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 1e-17
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 28/219 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQ---------EEFELEIGRLSNIRH 650
LIG G+ G VY A + G +AVK++E I + + EI L ++ H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
N+V + G+ + I E+VP G++ G+ G E R
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSI----------GSCLRTYGRFEEQLVR--FFTE 115
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP-ILDNYGLTKFHN 769
L+YLH ILH +LK+ N+L+D + K+SD+G++K I DN
Sbjct: 116 QVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQG 172
Query: 770 AVGYVAPELAQSLR--LSDKCDVYSFGVILLELVTGRKP 806
+V ++APE+ S S K D++S G ++LE+ GR+P
Sbjct: 173 SVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-17
Identities = 74/287 (25%), Positives = 131/287 (45%), Gaps = 40/287 (13%)
Query: 602 IGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ G VY+ G S+A+K L+ + Q+EF E +S+++H N+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNL-----HGVNYPGTSTGGIGNPELHWSRRFHIAL 710
G +L E++ G+L++ L H + + + L S HIA+
Sbjct: 73 LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS-LDCSDFLHIAI 131
Query: 711 GTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
A + YL HH +H +L + N L+ E K+SD+GL++ + D Y +
Sbjct: 132 QIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ--S 184
Query: 769 NA---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824
+ V ++ PE + + + D++SFGV+L E+ + G +P + EV+ E +R
Sbjct: 185 KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI---EMIRS 241
Query: 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEV 871
R L E+ +V L + C +E+P+RRP ++
Sbjct: 242 ------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 3e-17
Identities = 69/278 (24%), Positives = 125/278 (44%), Gaps = 39/278 (14%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IG GS G V++ + A+K+++ R +EE E L+ + ++ +
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE-LHWSRRFHIALGTARALSY 718
+ I+ E+ G+L+ L G PE W I LG L++
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK-------MQRGRPLPEDQVWRFFIQILLG----LAH 116
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVA 775
LH ILH ++KS N+ LD K+ D G+AKLL N+ T VG Y++
Sbjct: 117 LH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT----IVGTPYYLS 169
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
PEL + ++K DV++ GV+L E TG+ P ++ N+ ++ + +R + S
Sbjct: 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDA--NNQGALILKIIRGVFPPVSQ---- 223
Query: 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+++ +L Q++ C ++ +RP ++++
Sbjct: 224 -----MYSQ-QLAQLIDQ---CLTKDYRQRPDTFQLLR 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 84/290 (28%), Positives = 134/290 (46%), Gaps = 33/290 (11%)
Query: 588 WEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSN 647
WE ++L + +G G G V+ ++ G +A+K L+ G + E F E +
Sbjct: 1 WEIPRESL-RLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP-GTM-MPEAFLQEAQIMKK 57
Query: 648 IRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH 707
+RH LV S I++EF+ KG+L D L G G L +
Sbjct: 58 LRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFL---------KEGDGK-YLKLPQLVD 106
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
+A A ++Y+ + +H +L++ NIL+ +N K++D+GLA+L+ +
Sbjct: 107 MAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA 163
Query: 768 HNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826
+ + APE A R + K DV+SFG++L ELVT GR P EV+ E +
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL-------EQV 216
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
ERG C +G E+ L ++MKL C + P RP+ + LE
Sbjct: 217 ERGYRMPC----PQGCPES-LHELMKL---CWKKDPDERPTFEYIQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 58/211 (27%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 600 CLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G GS GSVY+A E G +A+K + + +E EI L +V + G
Sbjct: 9 EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDL---QEIIKEISILKQCDSPYIVKYYG 65
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
Y+ +T I+ E+ G++ D + I N L I T + L Y
Sbjct: 66 SYFKNTDLWIVMEYCGAGSVSDIMK-----------ITNKTLTEEEIAAILYQTLKGLEY 114
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVA 775
LH +H ++K+ NILL+E + KL+D+G++ L + K + +G ++A
Sbjct: 115 LH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQL----TDTMAKRNTVIGTPFWMA 167
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
PE+ Q + ++K D++S G+ +E+ G+ P
Sbjct: 168 PEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 1e-16
Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 32/230 (13%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
IG G G+V + + G +AVK ++ + F E ++ + H NLV G
Sbjct: 14 IGEGEFGAVLQGEYTGQ-KVAVKNIKC---DVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH 721
+ + I+ E + KGNL VN+ T G + + +L A + YL
Sbjct: 70 HNGLY-IVMELMSKGNL------VNFLRTR----GRALVSVIQLLQFSLDVAEGMEYLE- 117
Query: 722 DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGLTKFHNAVGYVAPELAQ 780
++H +L + NIL+ E+ K+SD+GLA++ + +DN L V + APE +
Sbjct: 118 --SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKL-----PVKWTAPEALK 170
Query: 781 SLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829
+ S K DV+S+GV+L E+ + GR P + E V+E +E+G
Sbjct: 171 HKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKG 213
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 78/290 (26%), Positives = 126/290 (43%), Gaps = 33/290 (11%)
Query: 588 WEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSN 647
WE ++L E +G G G V+ ++ G +A+K L+ G + + E F E +
Sbjct: 1 WEIPRESL-RLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTM-SPEAFLQEAQVMKK 57
Query: 648 IRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH 707
+RH LV S I++E++ KG+L D L G G L +
Sbjct: 58 LRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKG------EMGKY----LRLPQLVD 106
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
+A A ++Y+ + +H +L++ NIL+ EN K++D+GLA+L+ +
Sbjct: 107 MAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA 163
Query: 768 HNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826
+ + APE A R + K DV+SFG++L EL T GR P EV+ + +
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQV 216
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
ERG C + L C + P RP+ + LE
Sbjct: 217 ERGYRMPCPPECPESLHD--------LMCQCWRKEPEERPTFEYLQAFLE 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 65/217 (29%), Positives = 103/217 (47%), Gaps = 36/217 (16%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVK--KLETLGRIRNQEEFEL---EIGRLSNIRHFNLVA 655
IG G+ G VY+A G +A+K KLE ++FE+ EI L RH N+VA
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE------PGDDFEIIQQEISMLKECRHPNIVA 64
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
+ G Y I+ E+ G+L D P EL + ++ T +
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGP--------LSELQIA---YVCRETLKG 113
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG--- 772
L+YLH K +H ++K NILL E+ + KL+D+G++ L + K + +G
Sbjct: 114 LAYLHETGK---IHRDIKGANILLTEDGDVKLADFGVSAQL----TATIAKRKSFIGTPY 166
Query: 773 YVAPELAQSLRLSD---KCDVYSFGVILLELVTGRKP 806
++APE+A R KCD+++ G+ +EL + P
Sbjct: 167 WMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 82/310 (26%), Positives = 134/310 (43%), Gaps = 67/310 (21%)
Query: 601 LIGGGSIGSVYRASFE-----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ GSV ++ G +AVKKL+ + +FE EI L +++H N+V
Sbjct: 11 QLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQH-STAEHLRDFEREIEILKSLQHDNIVK 69
Query: 656 FQGYYWSS---TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
++G +S+ ++L++ E++P G+L D L + H R H L
Sbjct: 70 YKGVCYSAGRRNLRLVM-EYLPYGSLRDYL----------------QKHRERLDHRKL-- 110
Query: 713 ARALSYLHHDCK-------PPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT 765
L Y CK +H +L + NIL++ K+ D+GL K+LP Y
Sbjct: 111 ---LLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167
Query: 766 K--FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTT----------N 813
+ + + + APE + S DV+SFGV+L EL T SP
Sbjct: 168 REPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQ 227
Query: 814 EVVVLCEYVRELLERGS----ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA 869
+++ + ELL+ C E+ +MK C + PS+RPS +
Sbjct: 228 GQMIVYHLI-ELLKNNGRLPAPPGCPA---------EIYAIMKE---CWNNDPSQRPSFS 274
Query: 870 EVVQVLESIR 879
E+ +E+IR
Sbjct: 275 ELALQVEAIR 284
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-16
Identities = 85/308 (27%), Positives = 134/308 (43%), Gaps = 47/308 (15%)
Query: 593 KALLDKECLIGGGSIGSV----YRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSN 647
K L K ++G G G V Y + +G G +AVK L+ +N ++ EI L
Sbjct: 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKT 62
Query: 648 IRHFNLVAFQG---YYWSSTMQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNPELHW 702
+ H N+V ++G +QLI+ E+VP G+L D L H +N
Sbjct: 63 LYHENIVKYKGCCSEQGGKGLQLIM-EYVPLGSLRDYLPKHKLNL--------------- 106
Query: 703 SRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY 762
++ A ++YLH +H +L + N+LLD + K+ D+GLAK +P Y
Sbjct: 107 AQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY 163
Query: 763 GLTKFH--NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTN--EVV-- 816
+ + V + A E + + S DV+SFGV L EL+T +SP E++
Sbjct: 164 YRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP 223
Query: 817 --VLCEYVR--ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872
VR ELLERG C E+ +MK C RP+ ++
Sbjct: 224 KQGQMTVVRLIELLERGMRLPCPKN-----CPQEVYILMKN---CWETEAKFRPTFRSLI 275
Query: 873 QVLESIRN 880
+L+ + +
Sbjct: 276 PILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 90/296 (30%), Positives = 138/296 (46%), Gaps = 45/296 (15%)
Query: 588 WEAGTKAL-LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLS 646
WE ++L L K+ +G G G V+ ++ G +AVK L+ G + + E F E +
Sbjct: 1 WEIPRESLQLIKK--LGNGQFGEVWMGTWNGNTKVAVKTLKP-GTM-SPESFLEEAQIMK 56
Query: 647 NIRHFNLVAFQGYYWSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRR 705
+RH LV Q Y S + I++E++ KG+L D L G G L
Sbjct: 57 KLRHDKLV--QLYAVVSEEPIYIVTEYMSKGSLLDFL---------KDGEGR-ALKLPNL 104
Query: 706 FHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT 765
+A A ++Y+ + +H +L+S NIL+ + K++D+GLA+L I DN
Sbjct: 105 VDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARL--IEDNEYTA 159
Query: 766 ----KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCE 820
KF + + APE A R + K DV+SFG++L ELVT GR P EV+
Sbjct: 160 RQGAKF--PIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL---- 213
Query: 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
E +ERG C ++ I + +L L C + P RP+ + LE
Sbjct: 214 ---EQVERGYRMPC--------PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLE 258
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 81/282 (28%), Positives = 130/282 (46%), Gaps = 44/282 (15%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G G V+ + G +A+K L+ G + + E F E + ++H LV Y
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQ-GSM-SPEAFLAEANLMKQLQHPRLVRL---YA 68
Query: 662 SSTMQ--LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
T + I++E++ G+L D L T G +L ++ +A A ++++
Sbjct: 69 VVTQEPIYIITEYMENGSLVDFLK------TPEG----IKLTINKLIDMAAQIAEGMAFI 118
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL----TKFHNAVGYVA 775
+ +H +L++ NIL+ E K++D+GLA+L I DN KF + + A
Sbjct: 119 E---RKNYIHRDLRAANILVSETLCCKIADFGLARL--IEDNEYTAREGAKF--PIKWTA 171
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
PE + K DV+SFG++L E+VT GR P T EV+ + LERG
Sbjct: 172 PEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-------QNLERGYRMPR 224
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
D EL ++M+L C E P RP+ + VLE
Sbjct: 225 PDN-----CPEELYELMRL---CWKEKPEERPTFEYLRSVLE 258
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 1e-15
Identities = 67/282 (23%), Positives = 113/282 (40%), Gaps = 37/282 (13%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660
IG G+ G VY+ +G +AVK + + +F E L H N+V G
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH 720
I+ E VP G+L L L + ++L A + YL
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRK-----------KKNRLTVKKLLQMSLDAAAGMEYLE 110
Query: 721 HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK----LLPILDNYGLTKFHNAVGYVAP 776
+H +L + N L+ EN K+SD+G+++ + + + GL + + + AP
Sbjct: 111 SKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD-GLKQI--PIKWTAP 164
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
E R + + DV+S+G++L E + G P + + RE +E G
Sbjct: 165 EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ-------TRERIESGYRMPAP 217
Query: 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
E+ ++M L C + P RPS +E+ L+
Sbjct: 218 Q-----LCPEEIYRLM---LQCWAYDPENRPSFSEIYNELQI 251
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 65/215 (30%), Positives = 98/215 (45%), Gaps = 29/215 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVK--KLETLGRIRNQ--EEFELEIGRLSNIRHFNLVA 655
L+G GS GSVY + + G AVK L G+ + ++ E EI LS ++H N+V
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 656 FQGYYWSSTMQLILSEFVPKG---NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ G I E VP G L P ++R+ I LG
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL---------YTRQ--ILLG- 114
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
L YLH +H ++K NIL+D N KL+D+G+AK +++ F +
Sbjct: 115 ---LEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAK--QVVEFSFAKSFKGSPY 166
Query: 773 YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKP 806
++APE +AQ D++S G +LE+ TG+ P
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 2e-15
Identities = 70/286 (24%), Positives = 127/286 (44%), Gaps = 57/286 (19%)
Query: 602 IGGGSIGS--VYRASFEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQ 657
+G G+ G +YR + + S+ V K L R+ +E + EI LS ++H N++A+
Sbjct: 8 LGKGAFGEATLYRRTEDD--SLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL--GTARA 715
++ LI E+ G LYD + + + + A
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKI------------VRQKGQLFEEEMVLWYLFQIVSA 113
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VG 772
+SY+H K ILH ++K+ NI L + KL D+G++K+L +++ A VG
Sbjct: 114 VSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG-------SEYSMAETVVG 163
Query: 773 ---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV---VLCEYVRELL 826
Y++PEL Q ++ + K D+++ G +L EL+T ++ ++ +V V Y +
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV-V 222
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872
S+ ELI ++ + P +RP+ EV+
Sbjct: 223 SVYSS--------------ELISLVHS---LLQQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-15
Identities = 64/223 (28%), Positives = 105/223 (47%), Gaps = 29/223 (13%)
Query: 598 KECLIGGGSIGSVYRA-SFEGGVSIAVKKLET-LGRIRNQ-------EEFELEIGRLSNI 648
K LIG GS GSVY + G +AVK++E ++ + EI L +
Sbjct: 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
+H N+V + G + I E+VP G++ L+ NY G E R F
Sbjct: 64 QHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NY--------GAFEETLVRNF-- 111
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK-----LLPILDNYG 763
+ L+YLH+ I+H ++K NIL+D K+SD+G++K L N
Sbjct: 112 VRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGA 168
Query: 764 LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+V ++APE+ + + K D++S G +++E++TG+ P
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 4e-15
Identities = 72/281 (25%), Positives = 123/281 (43%), Gaps = 27/281 (9%)
Query: 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
EC G G +Y + +A+K L+ + + EF+ E ++ + H N+V G
Sbjct: 15 ECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLG 74
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTG------GIGNPELHWSRRFHIALGT 712
+L E++ +G+L++ L + P + G G L HIA+
Sbjct: 75 VVTQEQPVCMLFEYLNQGDLHEFLI-MRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQI 133
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL-TKFHNAV 771
A + YL +H +L + NIL+ E K+SD GL++ + D Y + K +
Sbjct: 134 AAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830
++ PE + S D++SFGV+L E+ + G +P + EV+ E VR+
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI---EMVRK------ 241
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEV 871
R L +E+ ++ L C E PSRRP ++
Sbjct: 242 ------RQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 60/213 (28%), Positives = 86/213 (40%), Gaps = 30/213 (14%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLGRI-RNQEEF---ELEIGRLSNIRHFNLVAF 656
+G G G V + + A+K ++ + Q+E E EI L H +V
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEI--LEECNHPFIVKL 58
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
+ +L E+ G L+ L T RF+IA A
Sbjct: 59 YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA-----------RFYIA-CVVLAF 106
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---Y 773
YLH+ I++ +LK N+LLD N KL D+G AK L K G Y
Sbjct: 107 EYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL-----KSGQKTWTFCGTPEY 158
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
VAPE+ + D +S G++L EL+TGR P
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 69/278 (24%), Positives = 119/278 (42%), Gaps = 38/278 (13%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
IG G G V+ + +A+K + ++E+F E + + H LV G
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIRE--GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH 721
+ ++ EF+ G L D L G L + L ++YL
Sbjct: 70 ERSPICLVFEFMEHGCLSDYLR------AQRGKFSQETL-----LGMCLDVCEGMAYLES 118
Query: 722 DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL---TKFHNAVGYVAPEL 778
++H +L + N L+ EN K+SD+G+ + + + D Y TKF V + +PE+
Sbjct: 119 SN---VIHRDLAARNCLVGENQVVKVSDFGMTRFV-LDDQYTSSTGTKF--PVKWSSPEV 172
Query: 779 AQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
+ S K DV+SFGV++ E+ + G+ P E+ + +EVV + +A F
Sbjct: 173 FSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV------------ETINAGFRL 220
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
A + ++M+ C E P RPS + ++ L
Sbjct: 221 YKPRLASQSVYELMQH---CWKERPEDRPSFSLLLHQL 255
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 67/236 (28%), Positives = 97/236 (41%), Gaps = 55/236 (23%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLE-TLGRIRNQEEF---ELEIGRLSNIRHFNLV-- 654
+G GS G V + G A+K L+ R + E E I LS I H +V
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNI--LSRINHPFIVKL 58
Query: 655 --AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
AFQ + L+L E+ P G L+ H S+ +
Sbjct: 59 HYAFQTE---EKLYLVL-EYAPGGELFS--------------------HLSKEGRFSEER 94
Query: 713 AR--------ALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG 763
AR AL YLH I++ +LK NILLD + KL+D+GLAK L
Sbjct: 95 ARFYAAEIVLALEYLHSLG----IIYRDLKPENILLDADGHIKLTDFGLAKELS----SE 146
Query: 764 LTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
++ + G Y+APE+ D +S GV+L E++TG+ P + E+
Sbjct: 147 GSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIY 202
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 4e-14
Identities = 66/185 (35%), Positives = 97/185 (52%), Gaps = 7/185 (3%)
Query: 313 RNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
NLK LDL N+ I S+P+ + +L L + L+ N + +P L ++ L LDL
Sbjct: 140 SNLKELDLSDNK-IESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNK 197
Query: 373 LRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL 432
+ ++P +I L LD+S N++ ++ +L N+ L L+L N L P S+GNL
Sbjct: 198 IS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNL 254
Query: 433 SNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLC 492
SNL+ LDLS N +S SSLG+L NL +LS N+LS +P + L N L
Sbjct: 255 SNLETLDLSNNQIS--SISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLT 312
Query: 493 GPPLE 497
LE
Sbjct: 313 LKALE 317
|
Length = 394 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 5e-14
Identities = 60/219 (27%), Positives = 104/219 (47%), Gaps = 25/219 (11%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLE-----TLGRIRNQEEFELEIGRLSNIRHFNLVA 655
++G G+ G+VY G IAVK++E L + E+ + E+ L +++H N+V
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
+ G I EFVP G++ L+ G + PE + + L
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILN-------RFGPL--PEPVFCKYTKQIL---DG 114
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG-----LTKFHNA 770
++YLH++C ++H ++K N++L N KL D+G A+ L + +G L H
Sbjct: 115 VAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGT 171
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809
++APE+ K D++S G + E+ TG+ P+ S
Sbjct: 172 PYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-14
Identities = 70/285 (24%), Positives = 120/285 (42%), Gaps = 52/285 (18%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G G V+ + G + +A+K + G + ++++F E + + H NLV G
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCT 69
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH 721
I++E++ G L + L G E + A+ YL
Sbjct: 70 KQRPIFIVTEYMANGCLLNYLR-------ERKGKLGTEWLLD----MCSDVCEAMEYLES 118
Query: 722 DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY---GLTKFHNAVGYVAPEL 778
+ +H +L + N L+ E+ K+SD+GLA+ + + D Y TKF V + PE+
Sbjct: 119 NG---FIHRDLAARNCLVGEDNVVKVSDFGLARYV-LDDQYTSSQGTKF--PVKWAPPEV 172
Query: 779 AQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
R S K DV+SFGV++ E+ + G+ P E + +EVV +
Sbjct: 173 FDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-------------------ES 213
Query: 838 SLRGF-------AENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
G+ A E+ +M C E P RP+ +++ L
Sbjct: 214 VSAGYRLYRPKLAPTEVYTIMYS---CWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 9e-14
Identities = 76/295 (25%), Positives = 133/295 (45%), Gaps = 43/295 (14%)
Query: 588 WEAGTKAL-LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLS 646
WE ++L L+K+ +G G G V+ A++ +AVK ++ G + + E F E +
Sbjct: 1 WEIPRESLKLEKK--LGAGQFGEVWMATYNKHTKVAVKTMKP-GSM-SVEAFLAEANVMK 56
Query: 647 NIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF 706
++H LV + I++EF+ KG+L D L G+ + +
Sbjct: 57 TLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKSDE---------GS-KQPLPKLI 105
Query: 707 HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT- 765
+ A ++++ + +H +L++ NIL+ + K++D+GLA++ I DN
Sbjct: 106 DFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARV--IEDNEYTAR 160
Query: 766 ---KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEY 821
KF + + APE + K DV+SFG++L+E+VT GR P + EV+
Sbjct: 161 EGAKF--PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI----- 213
Query: 822 VRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
LERG + EL +M + C P RP+ + VL+
Sbjct: 214 --RALERGYRMPRPEN-----CPEELYNIM---MRCWKNRPEERPTFEYIQSVLD 258
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 9e-14
Identities = 63/220 (28%), Positives = 96/220 (43%), Gaps = 29/220 (13%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ---EEFELEIGRLSNIRHFNLVAFQG 658
IG G G V + G +AVK I+N + F E ++ +RH NLV G
Sbjct: 14 IGKGEFGDVMLGDYRG-NKVAVKC------IKNDATAQAFLAEASVMTQLRHSNLVQLLG 66
Query: 659 YYWSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
L I++E++ KG+L D L G L +L A+
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAME 116
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
YL + +H +L + N+L+ E+ K+SD+GL K + G V + APE
Sbjct: 117 YLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPE 169
Query: 778 LAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816
+ + S K DV+SFG++L E+ + GR P +VV
Sbjct: 170 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 209
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-13
Identities = 75/294 (25%), Positives = 138/294 (46%), Gaps = 38/294 (12%)
Query: 602 IGGGSIGSVYRASFEGGVS------IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
IG G+ G V++A G + +AVK L+ Q +F+ E ++ H N+V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYD--------NLHGVNYPGTSTG--GIGNPELHWSRR 705
G +L E++ G+L + +++ +S G+ L + +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 706 FHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT 765
IA A ++YL +H +L + N L+ EN K++D+GL++ + D Y +
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 766 KFHNA--VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYV 822
+ ++A + ++ PE R + + DV+++GV+L E+ + G +P EV+ YV
Sbjct: 190 E-NDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI---YYV 245
Query: 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
R+ G+ +C D EL +M+L C S++PS RPS A + ++L+
Sbjct: 246 RD----GNVLSCPDNC-----PLELYNLMRL---CWSKLPSDRPSFASINRILQ 287
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 75/303 (24%), Positives = 127/303 (41%), Gaps = 53/303 (17%)
Query: 600 CLIGGGSIGSVYRASF------EGGVSIAVKKLETLGRIRNQEEF-----ELE----IGR 644
+G G+ G V +A ++AVK L+ +++ E+E IG+
Sbjct: 18 KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD---DATEKDLSDLVSEMEMMKMIGK 74
Query: 645 LSNIRHFNLVAF---QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGN---- 697
NI NL+ +G + ++ E+ GNL D L PG
Sbjct: 75 HKNI--INLLGVCTQEGPLY------VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757
L A AR + +L +H +L + N+L+ E++ K++D+GLA+ +
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIH 183
Query: 758 ILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEV 815
+D Y T V ++APE + + DV+SFGV+L E+ T G P E+
Sbjct: 184 HIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243
Query: 816 VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
+LL+ G ++ EL +M C EVPS+RP+ ++V+ L
Sbjct: 244 F-------KLLKEGYR---MEKPQ--NCTQELYHLM---RDCWHEVPSQRPTFKQLVEDL 288
Query: 876 ESI 878
+ +
Sbjct: 289 DRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 1e-13
Identities = 82/314 (26%), Positives = 137/314 (43%), Gaps = 37/314 (11%)
Query: 581 LPSKYEDWE-AGTKALLDKECLIGGGSIGSVYRASFEG--------GVSIAVKKLETLGR 631
LP+ WE + T+ L K +G G G V A G V++AVK L+
Sbjct: 1 LPAD-PKWELSRTRLTLGKP--LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT 57
Query: 632 IRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGT 690
++ + E+ + I +H N++ G +L E+ KGNL + L PG
Sbjct: 58 DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 691 S----TGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746
T + +L + A AR + YL +H +L + N+L+ E+ K
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMK 174
Query: 747 LSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GR 804
++D+GLA+ + +D Y T V ++APE + + DV+SFGV+L E+ T G
Sbjct: 175 IADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGG 234
Query: 805 KPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSR 864
P E+ L ++E + C +EL +M+ C VPS+
Sbjct: 235 SPYPGIPVEELFKL---LKEGHRMDKPANC---------THELYMIMRE---CWHAVPSQ 279
Query: 865 RPSMAEVVQVLESI 878
RP+ ++V+ L+ +
Sbjct: 280 RPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 58/220 (26%), Positives = 98/220 (44%), Gaps = 33/220 (15%)
Query: 600 CLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+IG G+ VY A +A+K+++ + +E E+ +S H N+V
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVV---K 63
Query: 659 YYWSSTMQ---LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL---GT 712
YY S + ++ ++ G+L D + G G E IA
Sbjct: 64 YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRG------GLDE------AIIATVLKEV 111
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF--HNA 770
+ L YLH +H ++K+ NILL E+ K++D+G++ L D T+
Sbjct: 112 LKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASL--ADGGDRTRKVRKTF 166
Query: 771 VG---YVAPELAQSLRLSD-KCDVYSFGVILLELVTGRKP 806
VG ++APE+ + + D K D++SFG+ +EL TG P
Sbjct: 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 67/286 (23%), Positives = 111/286 (38%), Gaps = 42/286 (14%)
Query: 602 IGGGSIGSV----YRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G G+ GSV Y V +AVK L+ ++EF E ++ + H +V
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
G + L++ E P G L L + A A ++
Sbjct: 63 GVCKGEPLMLVM-ELAPLGPLLKYL--KKRREIPVSDL----KEL------AHQVAMGMA 109
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA----VGY 773
YL +H +L + N+LL ++ K+SD+G+++ L +Y + A + +
Sbjct: 110 YLE-SKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY--YRATTAGRWPLKW 164
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSAS 832
APE + S K DV+S+GV L E + G KP EV+ +LE G
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI-------AMLESGERL 217
Query: 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+ + E+ +M L C P RP+ +E+
Sbjct: 218 PRPEECPQ-----EIYSIM---LSCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-13
Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 38/287 (13%)
Query: 601 LIGGGSIGSVYRASF--EGGVSI--AVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+IG G G VY + G I AVK L + + E+F E + + H N+++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 657 QGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
G S L++ ++ G+L + + + T IG L A+
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-----------FGLQVAKG 110
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VG 772
+ YL +H +L + N +LDE++ K++D+GLA+ + + Y + A V
Sbjct: 111 MEYL---ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVK 167
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSA 831
++A E Q+ + + K DV+SFGV+L EL+T G P + ++ V R LL+
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---- 223
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+ + L +VM L C P RP+ +E+V +E I
Sbjct: 224 --------PEYCPDPLYEVM---LSCWHPKPEMRPTFSELVSRIEQI 259
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 70.9 bits (173), Expect = 3e-13
Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 23/229 (10%)
Query: 602 IGGGSIGSVYRASF------EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ G V+ A + + +AVK L+ +++F E L+N++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD-NARKDFHREAELLTNLQHEHIVK 71
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNP--ELHWSRRFHIALG 711
F G +++ E++ G+L L HG P GN EL S+ HIA
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHG---PDAVLMAEGNRPAELTQSQMLHIAQQ 128
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY---GLTKFH 768
A + YL +H +L + N L+ EN K+ D+G+++ + D Y G T
Sbjct: 129 IAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTML- 184
Query: 769 NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816
+ ++ PE + + + DV+S GV+L E+ T G++P + NEV+
Sbjct: 185 -PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-13
Identities = 71/279 (25%), Positives = 121/279 (43%), Gaps = 40/279 (14%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G G V+ + + +A+K + G + ++E+F E + + H LV G
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAINE-GAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH 721
I++EF+ G L +NY G + L + + YL
Sbjct: 70 QQKPLYIVTEFMENGCL------LNYLRQRQGKLSKDML-----LSMCQDVCEGMEYLER 118
Query: 722 DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT---KFHNAVGYVAPEL 778
+ +H +L + N L+ K+SD+G+ + + + D Y + KF V + PE+
Sbjct: 119 N---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV-LDDEYTSSSGAKF--PVKWSPPEV 172
Query: 779 AQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
+ S K DV+SFGV++ E+ T G+ P E + EVV E++ RG R
Sbjct: 173 FNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-------EMISRG------FR 219
Query: 838 SLR-GFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
R A + +VM C E P RP+ AE+++ +
Sbjct: 220 LYRPKLASMTVYEVM---YSCWHEKPEGRPTFAELLRAI 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 7e-13
Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 45/283 (15%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G G V+ + +AVK L+ G + Q E E + ++H LV
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKP-GTMSVQAFLE-EANLMKTLQHDKLVRLYAVVT 71
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH 721
I++E++ KG+L D L + GG ++ + + A ++Y+
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLK------SDEGG----KVLLPKLIDFSAQIAEGMAYIE- 120
Query: 722 DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN-YGL---TKFHNAVGYVAPE 777
+ +H +L++ N+L+ E+ K++D+GLA++ I DN Y KF + + APE
Sbjct: 121 --RKNYIHRDLRAANVLVSESLMCKIADFGLARV--IEDNEYTAREGAKF--PIKWTAPE 174
Query: 778 LAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836
+ K DV+SFG++L E+VT G+ P + ++V+ L+RG
Sbjct: 175 AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS-------ALQRGY------ 221
Query: 837 RSLRGFAEN---ELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
R R EN EL +MK C E RP+ + VL+
Sbjct: 222 RMPR--MENCPDELYDIMKT---CWKEKAEERPTFDYLQSVLD 259
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 66/229 (28%), Positives = 112/229 (48%), Gaps = 30/229 (13%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IG GS G +Y A + V K L + ++ +E + E+ L+ ++H N+V F
Sbjct: 8 IGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFAS 67
Query: 660 YWSSTMQLILSEFVPKGNLYDNL---HGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
+ + I+ E+ G+L + GV + L W I+LG L
Sbjct: 68 FQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQI-------LSWF--VQISLG----L 114
Query: 717 SYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGLAKLLPILDNYGLTKFHNAVG--- 772
++H D K ILH ++KS NI L +N KL D+G+A+ L N + + VG
Sbjct: 115 KHIH-DRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL----NDSMELAYTCVGTPY 167
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV-LCE 820
Y++PE+ Q+ ++K D++S G +L EL T + P E +++V+ +C+
Sbjct: 168 YLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQ 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 32/246 (13%)
Query: 602 IGGGSIGSVYRASFEGGVS------IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ G V+ +AVK L+ +++FE E L+N +H N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNL--HG-----VNYPGTSTGGIGNPELHWSRRFHI 708
F G +++ E++ G+L L HG + P + G + +L I
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQ-----I 127
Query: 709 ALGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY---G 763
A+ A + YL H +H +L + N L+ + K+ D+G+++ + D Y G
Sbjct: 128 AVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGG 182
Query: 764 LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYV 822
T + ++ PE + + + DV+SFGV+L E+ T G++P +NE V+ C
Sbjct: 183 HTML--PIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYG-LSNEEVIECITQ 239
Query: 823 RELLER 828
LL+R
Sbjct: 240 GRLLQR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 76/286 (26%), Positives = 120/286 (41%), Gaps = 46/286 (16%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQGY 659
IG GS G+V + + I V K G + +E+ +L E+ L ++H N+V Y
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV---RY 64
Query: 660 Y-----WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
Y S+ I+ E+ G+L + E W + L
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQ--KC--KKERKYIEEEFIWRILTQLLL---- 116
Query: 715 ALSYLHH--DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
AL H+ D +LH +LK NI LD N KL D+GLAK+L D+ + VG
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH-DSSFAKTY---VG 172
Query: 773 ---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829
Y++PE + +K D++S G ++ EL P + + L ++E
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ---LASKIKE----- 224
Query: 830 SASACFDRSLRGFAE--NELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
F R ++ NE+I+ M L + P +RPS E++Q
Sbjct: 225 ---GKFRRIPYRYSSELNEVIKSM-LNV-----DPDKRPSTEELLQ 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 74/293 (25%), Positives = 127/293 (43%), Gaps = 35/293 (11%)
Query: 602 IGGGSIGSVYRASFEG--------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFN 652
+G G G V A G V++AVK L+ ++ + E+ + I +H N
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTS----TGGIGNPELHWSRRFHI 708
++ G ++ E+ KGNL + L PG + + ++ +
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 709 ALGTARALSYL-HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
AR + YL C +H +L + N+L+ EN K++D+GLA+ + +D Y T
Sbjct: 143 TYQVARGMEYLASQKC----IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 768 HN-AVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVREL 825
V ++APE + + DV+SFGV++ E+ T G P E+ +L
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF-------KL 251
Query: 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
L+ G D+ NEL +M+ C +PS RP+ ++V+ L+ I
Sbjct: 252 LKEGHR---MDKPAN--CTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 48/147 (32%), Positives = 70/147 (47%), Gaps = 18/147 (12%)
Query: 728 LHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA--VGYVAPELAQSLRLS 785
+H +L + N+LL + K+SD+GL+K L +NY K H V + APE + S
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176
Query: 786 DKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAE 844
K DV+SFGV++ E + G+KP + NEV ++E G C R
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ-------MIESGERMECPQRCPP---- 225
Query: 845 NELIQVMKLGLICTSEVPSRRPSMAEV 871
E+ +MKL C + RP A V
Sbjct: 226 -EMYDLMKL---CWTYGVDERPGFAVV 248
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 67/291 (23%), Positives = 130/291 (44%), Gaps = 42/291 (14%)
Query: 598 KECLIGGGSIGSVYRASFE----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNL 653
K+ +IG G G V+R + V++A+K L+ + +++F E + H N+
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+ +G +I++E++ G L L + +S +G + G A
Sbjct: 69 IRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG-----------MLRGIA 117
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN----YGLTKFHN 769
+ YL +H +L + NIL++ N E K+SD+GL+++L D+ Y +
Sbjct: 118 AGMKYL---SDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSGGKI 172
Query: 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV-VLCEYVRELLE 827
+ + APE + + DV+SFG+++ E+++ G +P + +EV+ + + R
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAP 232
Query: 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
SA V +L L C + +RRP ++V +L+ +
Sbjct: 233 MDCPSA----------------VYQLMLQCWQQDRARRPRFVDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 44/222 (19%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIR-NQEEFEL-----EIGRLSNIRHF--- 651
LIG G+ G+VYR G + ++ L I + + ++ E+ LS +R
Sbjct: 8 LIGRGAYGAVYR-----GKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL- 710
N+ + G Y I+ E+ G++ + G I +I++
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM--------KAGPIAEK--------YISVI 106
Query: 711 --GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
AL Y+H ++H ++K+ NIL+ KL D+G+A LL N +K
Sbjct: 107 IREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALL----NQNSSKRS 159
Query: 769 NAVG---YVAPELAQSLRLSD-KCDVYSFGVILLELVTGRKP 806
VG ++APE+ + D K D++S G+ + E+ TG P
Sbjct: 160 TFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 2e-12
Identities = 62/219 (28%), Positives = 105/219 (47%), Gaps = 38/219 (17%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFE---LEIGRLSNIRHFNLVAFQ 657
+G G+ G VY+A + E G A K +ET +++EE E +EI L+ H +V
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIET----KSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 658 G-YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
G +YW + I+ EF P G + + ++ G+ P++ I AL
Sbjct: 76 GAFYWDGKLW-IMIEFCPGGAVDAIMLELDR------GLTEPQIQ-----VICRQMLEAL 123
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA----KLLPILDNYGLTKFHNAVG 772
YLH I+H +LK+ N+LL + + KL+D+G++ K L D++ T +
Sbjct: 124 QYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPY----- 175
Query: 773 YVAPELAQSLRLSD-----KCDVYSFGVILLELVTGRKP 806
++APE+ + D K D++S G+ L+E+ P
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 214
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 2e-12
Identities = 64/243 (26%), Positives = 107/243 (44%), Gaps = 39/243 (16%)
Query: 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELE---IGRLSN--- 647
L D IG G+ G+V + G +AVK++ + + Q+ ++ + R S+
Sbjct: 6 LKDLG-EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPY 64
Query: 648 -IRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGV---NYPGTSTGGIGNPELHWS 703
++ + + +G W M+L+ Y ++ V P G
Sbjct: 65 IVKFYGALFREGDCWIC-MELMDISL---DKFYKYVYEVLKSVIPEEILG---------- 110
Query: 704 RRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG 763
IA+ T +AL+YL + K I+H ++K +NILLD N KL D+G++ L +D+
Sbjct: 111 ---KIAVATVKALNYLKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQL--VDSIA 163
Query: 764 LTKFHNAVGYVAPELAQSLRLSD---KCDVYSFGVILLELVTGRKPVESPTTNEVVV-LC 819
T+ Y+APE + DV+S G+ L E+ TG+ P P N V L
Sbjct: 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLT 221
Query: 820 EYV 822
+ V
Sbjct: 222 QVV 224
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 3e-12
Identities = 61/253 (24%), Positives = 102/253 (40%), Gaps = 53/253 (20%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLET--LGRIRNQEEFELE---IGRLSNIRHFNLV 654
+IG GS +V A E A+K L+ L + + + ++E + RL+ H ++
Sbjct: 8 IIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLN--GHPGII 65
Query: 655 ----AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
FQ + +L E+ P G L + G+ + +R A
Sbjct: 66 KLYYTFQD---EENLYFVL-EYAPNGELLQYIRKY----------GSLDEKCTR--FYAA 109
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILD---------- 760
AL YLH I+H +LK NILLD++ K++D+G AK+L
Sbjct: 110 EILLALEYLH-SKG--IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDAT 166
Query: 761 ------NYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT 811
+F + VG YV+PEL D+++ G I+ +++TG+ P
Sbjct: 167 NIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226
Query: 812 TNEV---VVLCEY 821
++ EY
Sbjct: 227 EYLTFQKILKLEY 239
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 33/292 (11%)
Query: 602 IGGGSIGSVYRASFEGG--------VSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFN 652
+G G G V A G +AVK L++ ++ + E+ + I +H N
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGT--STGGIGNPELHWSRR--FHI 708
++ G ++ E+ KGNL + L PG PE S +
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY-GLTKF 767
A AR + YL +H +L + N+L+ E+ K++D+GLA+ + +D Y T
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202
Query: 768 HNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826
V ++APE + + DV+SFGV+L E+ T G P E+ L ++E
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL---LKEGH 259
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
S C NEL +M+ C VPS+RP+ ++V+ L+ I
Sbjct: 260 RMDKPSNC---------TNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 4e-12
Identities = 41/117 (35%), Positives = 65/117 (55%), Gaps = 9/117 (7%)
Query: 57 GNPC----ENFKGVFCNPDG-----FVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNR 107
G+PC + G C D F+D + L N L G + +S L+ L+ + L GN
Sbjct: 394 GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNS 453
Query: 108 FTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFAL 164
GN+P + +L +++S N+ +GSIPE +G L ++R+L+L+ NS SG +P AL
Sbjct: 454 IRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 4e-12
Identities = 72/243 (29%), Positives = 122/243 (50%), Gaps = 43/243 (17%)
Query: 601 LIGGGSIGSVYRASF--EG---GVSIAVKKL-ETLGRIRNQEEFELEIGRLSNIRHFNLV 654
++G G+ G+VY+ + EG + +A+K L ET G N E F E ++++ H +LV
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVE-FMDEALIMASMDHPHLV 72
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL-HWSRRFHIALGTA 713
G S T+QL+ ++ +P G L D +H IG+ L +W + A
Sbjct: 73 RLLGVCLSPTIQLV-TQLMPHGCLLDYVH------EHKDNIGSQLLLNW------CVQIA 119
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
+ + YL + ++H +L + N+L+ K++D+GLA+LL G K +NA G
Sbjct: 120 KGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-----GDEKEYNADGG 171
Query: 773 -----YVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826
++A E + + + DV+S+GV + EL+T G KP + T E + +LL
Sbjct: 172 KMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-------IPDLL 224
Query: 827 ERG 829
E+G
Sbjct: 225 EKG 227
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 71/304 (23%), Positives = 132/304 (43%), Gaps = 43/304 (14%)
Query: 588 WE-AGTKALLDKECLIGGGSIGSVYRASFEGGVS------IAVKKLETLGRIRNQEEFEL 640
WE A K + +E +G GS G VY +G V +A+K + +R + EF
Sbjct: 1 WEVAREKITMSRE--LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 58
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL 700
E + ++V G L++ E + +G+L L + + P L
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSL 118
Query: 701 HWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILD 760
+ +A A ++YL+ + +H +L + N ++ E++ K+ D+G+ + + D
Sbjct: 119 --KKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 761 NY-----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNE 814
Y GL V +++PE + + DV+SFGV+L E+ T +P + + +
Sbjct: 174 YYRKGGKGLL----PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
Query: 815 VVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872
V+ +V E LL++ C D L ++M++ C P RPS E++
Sbjct: 230 VL---RFVMEGGLLDK--PDNCPDM---------LFELMRM---CWQYNPKMRPSFLEII 272
Query: 873 QVLE 876
++
Sbjct: 273 SSIK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 59/219 (26%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G+ G VY+A + A K+ + E+F +EI LS +H N+V Y+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 662 SSTMQLILSEFVPKGNLYDNL-----HGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
IL EF G L D++ G+ P ++ AL
Sbjct: 73 YENKLWILIEFCDGGAL-DSIMLELERGLTEPQIR---------------YVCRQMLEAL 116
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL-AKLLPILDNYGLTKFHNAVG--- 772
++LH ++H +LK+ NILL + + KL+D+G+ AK L K +G
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-----KRDTFIGTPY 168
Query: 773 YVAPELAQSLRLSD-----KCDVYSFGVILLELVTGRKP 806
++APE+ D K D++S G+ L+EL P
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 7e-12
Identities = 39/132 (29%), Positives = 60/132 (45%), Gaps = 24/132 (18%)
Query: 705 RFHI-----ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL 759
RF++ A+ L Y+H D KP N L+D + KL+D+GL+K
Sbjct: 104 RFYMAEMFEAVDALHELGYIHRDLKP---------ENFLIDASGHIKLTDFGLSK----- 149
Query: 760 DNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
+T ++ VG Y+APE+ + D +S G +L E + G P T NE
Sbjct: 150 --GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETW 207
Query: 817 VLCEYVRELLER 828
+Y +E L+R
Sbjct: 208 ENLKYWKETLQR 219
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 8e-12
Identities = 73/281 (25%), Positives = 125/281 (44%), Gaps = 46/281 (16%)
Query: 602 IGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQG 658
IG GS G+VY A+ +AVKK+ G+ N++ ++ E+ L ++H N + ++G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
Y ++ E+ G+ D L P L I G + L+Y
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHKKP-----------LQEVEIAAITHGALQGLAY 136
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
LH +H ++K+ NILL E + KL+D+G A +++ T + ++APE+
Sbjct: 137 LHSHNM---IHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTPY-----WMAPEV 188
Query: 779 AQSL---RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS---AS 832
++ + K DV+S G+ +EL RKP P N + Y + + S S
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIELAE-RKP---PLFNMNAMSALY--HIAQNDSPTLQS 242
Query: 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ S RGF + C ++P RP+ AE+++
Sbjct: 243 NEWTDSFRGFVD-----------YCLQKIPQERPASAELLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 8e-12
Identities = 75/285 (26%), Positives = 119/285 (41%), Gaps = 45/285 (15%)
Query: 601 LIGGGSIGSVYRASF-------EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNL 653
+G G+ G VY + G + +AVK L + ++EF E +SN H N+
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
V G + Q I+ E + G+L L G P L I L A
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARV--ERFGP---PLLTLKELLDICLDVA 116
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEP-----KLSDYGLAKLLPILDNY-----G 763
+ YL + +H +L + N L+ E K+ D+GLA+ + D Y G
Sbjct: 117 KGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEG 173
Query: 764 LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYV 822
L V ++APE + + + DV+SFGV++ E++T G++P P N VL ++V
Sbjct: 174 LLP----VRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPY--PALNNQEVL-QHV 226
Query: 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
C D ++ Q+M C ++ PS RP+
Sbjct: 227 TAGGRLQKPENCPD---------KIYQLMTN---CWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 66/239 (27%), Positives = 109/239 (45%), Gaps = 41/239 (17%)
Query: 576 LFSKSLPSK-YEDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIR 633
LFSK P K + D IG GS G+VY A +A+KK+ G+ +
Sbjct: 7 LFSKDDPEKLFTDLRE-----------IGHGSFGAVYFARDVRTNEVVAIKKMSYSGK-Q 54
Query: 634 NQEEFE---LEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGT 690
+ E+++ E+ L +RH N + ++G Y ++ E+ G+ D L P
Sbjct: 55 SNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDILEVHKKP-- 111
Query: 691 STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750
L I G + L+YLH + +H ++K+ NILL E KL+D+
Sbjct: 112 ---------LQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADF 159
Query: 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSL---RLSDKCDVYSFGVILLELVTGRKP 806
G A L+ +++ T + ++APE+ ++ + K DV+S G+ +EL RKP
Sbjct: 160 GSASLVSPANSFVGTPY-----WMAPEVILAMDEGQYDGKVDVWSLGITCIELAE-RKP 212
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 24/224 (10%)
Query: 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVK--KLETLGRIRNQEEFELEIGRLSNIRHFN 652
+K +G G+ G V + G+ +A K LE IRNQ EL++ N +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY-- 60
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+V F G ++S I E + G+L L G I PE + I++
Sbjct: 61 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK-------KAGRI--PENILGK---ISIAV 108
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA-KLLPILDNYGLTKFHNAV 771
R L+YL K I+H ++K +NIL++ E KL D+G++ +L+ + N F
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN----SFVGTR 162
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Y++PE Q + + D++S G+ L+E+ GR P+ P E+
Sbjct: 163 SYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 41/231 (17%)
Query: 593 KALLDKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNI 648
++ LD IG GS G V A+ G +AVKK++ +R Q+ EL E+ + +
Sbjct: 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD----LRKQQRRELLFNEVVIMRDY 73
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
+H N+V Y ++ EF+ G L D + T T ++ + +
Sbjct: 74 QHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIV-------THT------RMNEEQIATV 120
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG----LAKLLPILDNYGL 764
L +ALS+LH ++H ++KS +ILL + KLSD+G ++K +P
Sbjct: 121 CLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP------- 170
Query: 765 TKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV--ESP 810
+ + VG ++APE+ L + D++S G++++E+V G P E P
Sbjct: 171 -RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP 220
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/216 (27%), Positives = 105/216 (48%), Gaps = 33/216 (15%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLVAFQ 657
+G G+ G VY+A + G AVK + ++ ++F L EI + +H N+VA+
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVKII----KLEPGDDFSLIQQEIFMVKECKHCNIVAYF 72
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
G Y S I E+ G+L D H TG + ++ + R T + L+
Sbjct: 73 GSYLSREKLWICMEYCGGGSLQDIYH-------VTGPLSELQIAYVCR-----ETLQGLA 120
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
YLH K +H ++K NILL +N + KL+D+G+A + + K + +G ++
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKI----TATIAKRKSFIGTPYWM 173
Query: 775 APELAQSLR---LSDKCDVYSFGVILLELVTGRKPV 807
APE+A + + CD+++ G+ +EL + P+
Sbjct: 174 APEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 33/216 (15%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLVAFQ 657
IG G+ G VY+A + G A+K + ++ E+F + EI + + +H N+VA+
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVI----KLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
G Y I EF G+L D H TG + ++ + R T + L
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYH-------VTGPLSESQIAYVSR-----ETLQGLY 120
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
YLH K +H ++K NILL +N KL+D+G++ + + K + +G ++
Sbjct: 121 YLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQI----TATIAKRKSFIGTPYWM 173
Query: 775 APELAQSLR---LSDKCDVYSFGVILLELVTGRKPV 807
APE+A R + CD+++ G+ +EL + P+
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 41/296 (13%)
Query: 602 IGGGSIGSVYRASFEG--------GVSIAVKKLETLGRIRNQEEF--ELEIGRLSNIRHF 651
+G G G V RA G V++AVK L+ ++ + E+E+ +L +H
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG-KHK 78
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGT--STGGIGNPE--LHWSRRFH 707
N++ G ++ E+ KGNL + L PG + PE L +
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 708 IALGTARALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK 766
A AR + YL C +H +L + N+L+ E+ K++D+GLA+ + +D Y K
Sbjct: 139 CAYQVARGMEYLESRRC----IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY--KK 192
Query: 767 FHNA---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYV 822
N V ++APE + + DV+SFG+++ E+ T G P E+ L +
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKL---L 249
Query: 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
RE S C +EL +M+ C VP++RP+ ++V+ L+ +
Sbjct: 250 REGHRMDKPSNC---------THELYMLMRE---CWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 74/288 (25%), Positives = 123/288 (42%), Gaps = 50/288 (17%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKL-ETLGRIRNQEEFELEIGRLSNIR------HFNL 653
L+G G+ G V++ + + +AVK E L + EL+I LS R H N+
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ-------ELKIKFLSEARILKQYDHPNI 54
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
V G I+ E VP G+ L EL + AL A
Sbjct: 55 VKLIGVCTQRQPIYIVMELVPGGDFLSFLRK-----------KKDELKTKQLVKFALDAA 103
Query: 714 RALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP--ILDNYGLTKFHNA 770
++YL +C +H +L + N L+ EN K+SD+G+++ I + GL +
Sbjct: 104 AGMAYLESKNC----IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI--P 157
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829
+ + APE R S + DV+S+G++L E + G P T + RE +E+G
Sbjct: 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQVEKG 210
Query: 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
+C + +++ +VM+ C P RP +E+ + L +
Sbjct: 211 YRMSCPQK-----CPDDVYKVMQR---CWDYKPENRPKFSELQKELAA 250
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 2e-11
Identities = 62/236 (26%), Positives = 104/236 (44%), Gaps = 26/236 (11%)
Query: 600 CLIGGGSIGSVYRASFEGGVSIAVKKL---ETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+G G+ G V + + I +KL E IRNQ EL++ N + +V F
Sbjct: 11 SELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY--IVGF 68
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNL-HGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
G ++S I E + G+L L P G +++ R
Sbjct: 69 YGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-------------KVSIAVLRG 115
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVA 775
L+YL K I+H ++K +NIL++ E KL D+G++ L +D+ F Y++
Sbjct: 116 LAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMA-NSFVGTRSYMS 170
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831
PE Q S + D++S G+ L+EL GR P+ P E+ + + R +++
Sbjct: 171 PERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI--FGRPVVDGEEG 224
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 31/221 (14%)
Query: 593 KALLDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFEL---EIGRLSNI 648
+ LD IG GS G V A+ + G +AVKK++ +R Q+ EL E+ + +
Sbjct: 19 RTYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMD----LRKQQRRELLFNEVVIMRDY 74
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
+H N+V Y ++ EF+ G L D + + ++ + +
Sbjct: 75 QHENVVEMYNSYLVGDELWVVMEFLEGGALTDI-------------VTHTRMNEEQIAAV 121
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
L +ALS LH ++H ++KS +ILL + KLSD+G + + + +
Sbjct: 122 CLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQV----SKEVPRRK 174
Query: 769 NAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ VG ++APEL L + D++S G++++E+V G P
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 60/225 (26%), Positives = 111/225 (49%), Gaps = 30/225 (13%)
Query: 602 IGGGSIG-SVYRASFEGGVSIAVKKLETLGRIRNQE--EFELEIGRLSNIRHFNLVAFQG 658
IG GS G ++ S E G +K++ + ++ +E E E+ LSN++H N+V +Q
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEI-NISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE---LHWSRRFHIALGTARA 715
+ + I+ ++ G+LY ++ G+ PE L W + +AL
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQR-------GVLFPEDQILDWFVQICLALKHV-- 117
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG--- 772
HD K ILH ++KS NI L ++ KL D+G+A++L N + +G
Sbjct: 118 -----HDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVL----NSTVELARTCIGTPY 166
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV 817
Y++PE+ ++ ++K D+++ G +L E+ T + E+ +V+
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVL 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 77/307 (25%), Positives = 133/307 (43%), Gaps = 47/307 (15%)
Query: 588 WEAGTKAL-LDKECLIGGGSIGSVYRA------SFEGGVSIAVKKLETLGRIRNQEEFEL 640
WE + + L +E G GS G VY E +A+K + +R + EF
Sbjct: 1 WELPREKITLIREL--GQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN 58
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQ--LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNP 698
E + ++V G ST Q L++ E + KG+L L + G+G P
Sbjct: 59 EASVMKEFNCHHVVRLLGV--VSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPP 116
Query: 699 ELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758
L + +A A ++YL K +H +L + N ++ E+ K+ D+G+ + +
Sbjct: 117 TL--QKFIQMAAEIADGMAYLA-AKK--FVHRDLAARNCMVAEDLTVKIGDFGMTRDIYE 171
Query: 759 LDNY-----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTT 812
D Y GL V ++APE + + K DV+SFGV+L E+ T +P + +
Sbjct: 172 TDYYRKGGKGLL----PVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227
Query: 813 NEVVVLCEYV--RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAE 870
EV+ ++V L+ C ++L+++M++ C P RP+ E
Sbjct: 228 EEVL---KFVIDGGHLDL--PENC---------PDKLLELMRM---CWQYNPKMRPTFLE 270
Query: 871 VVQVLES 877
+V L+
Sbjct: 271 IVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 52/221 (23%), Positives = 99/221 (44%), Gaps = 20/221 (9%)
Query: 602 IGGGSIGSVYRAS----FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
IGGG G V R + + +A+K L+ + + +F E + H N++ +
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
G S +I++E++ G+L L G + + + G A +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLR--ENDG---------KFTVGQLVGMLRGIASGMK 120
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN-AVGYVAP 776
YL +H +L + NIL++ N K+SD+GL++ L + TK + + AP
Sbjct: 121 YLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAP 177
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816
E + + DV+SFG+++ E+++ G +P + +V+
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI 218
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 3e-11
Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 39/222 (17%)
Query: 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHF 651
LD IG GS G V A+ + G +AVKK++ +R Q+ EL E+ + + H
Sbjct: 24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMD----LRKQQRRELLFNEVVIMRDYHHE 79
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
N+V Y ++ EF+ G L D + + ++ + + L
Sbjct: 80 NVVDMYNSYLVGDELWVVMEFLEGGALTDI-------------VTHTRMNEEQIATVCLS 126
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG----LAKLLPILDNYGLTKF 767
RALSYLH+ ++H ++KS +ILL + KLSD+G ++K +P K
Sbjct: 127 VLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--------KR 175
Query: 768 HNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ VG ++APE+ L + D++S G++++E++ G P
Sbjct: 176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 3e-11
Identities = 70/284 (24%), Positives = 119/284 (41%), Gaps = 39/284 (13%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQGYY 660
IG GS G V++ + K+ L ++ E+ + EI LS + + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH 720
T I+ E++ G+ D L PG L ++ I + L YLH
Sbjct: 72 LKDTKLWIIMEYLGGGSALDLLE----PGP---------LDETQIATILREILKGLDYLH 118
Query: 721 HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPE 777
+ K +H ++K+ N+LL E+ E KL+D+G+A L K + VG ++APE
Sbjct: 119 SEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----IKRNTFVGTPFWMAPE 171
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
+ + K D++S G+ +EL G P +V+ L G+ + +
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN----YSK 227
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881
L+ F E C ++ PS RP+ E+++ +R
Sbjct: 228 PLKEFVE-----------ACLNKEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 30/213 (14%)
Query: 601 LIGGGSIGSVYRASFEG-GVSIAVKKL---ETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
IG GS G VY+A + +A+K + E I E+ + EI LS R + +
Sbjct: 8 CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI---EDIQQEIQFLSQCRSPYITKY 64
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
G + + I+ E+ G+ D L T I L L
Sbjct: 65 YGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLL-------------GL 111
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---Y 773
YLH + K +H ++K+ NILL E + KL+D+G++ L ++K + VG +
Sbjct: 112 EYLHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQL----TSTMSKRNTFVGTPFW 164
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+APE+ + +K D++S G+ +EL G P
Sbjct: 165 MAPEVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 4e-11
Identities = 60/222 (27%), Positives = 100/222 (45%), Gaps = 30/222 (13%)
Query: 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEE-----FELEIGRLSNIRHFNLV 654
IG G+ G VY+ F+ G +AVK + R N+EE +L++ S+ + +V
Sbjct: 22 EIGSGTCGQVYKMRFKKTGHVMAVK---QMRRTGNKEENKRILMDLDVVLKSHDCPY-IV 77
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
GY+ + + I E + D L +G + + +
Sbjct: 78 KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILG----------KMTVAIVK 125
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL YL K ++H ++K +NILLD + KL D+G++ L +D+ T+ Y+
Sbjct: 126 ALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRL--VDSKAKTRSAGCAAYM 181
Query: 775 APELAQSLRLSDK----CDVYSFGVILLELVTGRKPVESPTT 812
APE + K DV+S G+ L+EL TG+ P ++ T
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT 223
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 75/293 (25%), Positives = 131/293 (44%), Gaps = 39/293 (13%)
Query: 602 IGGGSIGSVYRAS------FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ G V+ A + + +AVK L+ + +++F+ E L+N++H ++V
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PTLAARKDFQREAELLTNLQHEHIVK 71
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNP-----ELHWSRRFHI 708
F G +++ E++ G+L L HG P G P EL S+ HI
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHG---PDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY---GLT 765
A A + YL +H +L + N L+ N K+ D+G+++ + D Y G T
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHT 185
Query: 766 KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825
+ ++ PE + + + DV+SFGVIL E+ T K +N V+ C +
Sbjct: 186 ML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV 243
Query: 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
LER C E+ +M L C P +R ++ E+ ++L ++
Sbjct: 244 LER--PRVC---------PKEVYDIM---LGCWQREPQQRLNIKEIYKILHAL 282
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 4e-11
Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 22/217 (10%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKL---ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ G V++ S + I +KL E IRNQ EL++ N + +V F G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY--IVGFYG 70
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
++S I E + G+L L G I PE + +++ + L+Y
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVL-------KKAGRI--PEQILGK---VSIAVIKGLTY 118
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
L K I+H ++K +NIL++ E KL D+G++ L +D+ F Y++PE
Sbjct: 119 LRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMA-NSFVGTRSYMSPER 173
Query: 779 AQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Q S + D++S G+ L+E+ GR P+ P E+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 29/284 (10%)
Query: 601 LIGGGSIGSVYRASFEGG---VSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAF 656
+IG G+ G V +A + + A+K+++ + +F E+ L + H N++
Sbjct: 14 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 73
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNY----PGTSTGGIGNPELHWSRRFHIALGT 712
G + E+ P GNL D L P + L + H A
Sbjct: 74 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
AR + YL + +H +L + NIL+ ENY K++D+GL++ + + + V
Sbjct: 134 ARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--PVR 188
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSA 831
++A E + DV+S+GV+L E+V+ G P T C + E L +G
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKLPQGYR 241
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
++ L ++E+ +M+ C E P RPS A+++ L
Sbjct: 242 ---LEKPLN--CDDEVYDLMRQ---CWREKPYERPSFAQILVSL 277
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 58/225 (25%), Positives = 104/225 (46%), Gaps = 22/225 (9%)
Query: 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
++G GS G A+K++ E+ E L+ ++H N+VAF+
Sbjct: 7 VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 660 YWSSTMQLILSEFVPKGNLYDNL---HGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
+ + I+ E+ G+L + G +P + L W + LG
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-------LQWF--VQMCLG----- 112
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
+ H + +LH ++KS NI L +N + KL D+G A+LL Y T + YV P
Sbjct: 113 --VQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT-YVGTPYYVPP 169
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT-TNEVVVLCE 820
E+ +++ ++K D++S G IL EL T + P ++ + N ++ +C+
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 61/215 (28%), Positives = 90/215 (41%), Gaps = 25/215 (11%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLG---RIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ GSV + + I K T ++ Q ELEI + + + +V + G
Sbjct: 9 LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINK--SCKSPYIVKYYG 66
Query: 659 YYW--SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGG--IGNPELHWSRRFHIALGTAR 714
+ SS+ I E+ G+L V G G +G IA +
Sbjct: 67 AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGK----------IAESVLK 116
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
LSYLH I+H ++K +NILL + KL D+G++ L N F Y+
Sbjct: 117 GLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV---NSLAGTFTGTSFYM 170
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809
APE Q S DV+S G+ LLE+ R P
Sbjct: 171 APERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 55/226 (24%), Positives = 92/226 (40%), Gaps = 28/226 (12%)
Query: 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLET--LGRIRNQEEFELEIGRLSNIRHFN 652
L++ +G G+ G V+ A+K + + R++ ++ E L + H
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
++ +L E+VP G L+ L STG F+ A
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG-----------LFY-ASEI 110
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
AL YLH I++ +LK NILLD+ KL+D+G AK L + G
Sbjct: 111 VCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-------RDRTWTLCG 160
Query: 773 ---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Y+APE+ QS + D ++ G+++ E++ G P +
Sbjct: 161 TPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGI 206
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 64/246 (26%), Positives = 118/246 (47%), Gaps = 39/246 (15%)
Query: 596 LDKECLIGGGSIGSVYRASF--EGG---VSIAVKKLETL-GRIRNQE--EFELEIGRLSN 647
L K L+G G G+V++ + EG + +A+K ++ GR QE + L +G L
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD- 67
Query: 648 IRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE--LHWSRR 705
H +V G +++QL+ ++ P G+L D++ +P+ L+W
Sbjct: 68 --HAYIVRLLGICPGASLQLV-TQLSPLGSLLDHVR-------QHRDSLDPQRLLNW--- 114
Query: 706 FHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILD-NYGL 764
+ A+ + YL ++H NL + NILL + +++D+G+A LL D Y
Sbjct: 115 ---CVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFY 168
Query: 765 TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVR 823
++ + ++A E R + + DV+S+GV + E+++ G +P +E V
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VP 221
Query: 824 ELLERG 829
+LLE+G
Sbjct: 222 DLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-10
Identities = 67/279 (24%), Positives = 111/279 (39%), Gaps = 45/279 (16%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQGYY 660
IG GS G V++ + K+ L ++ E+ + EI LS + + G Y
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL---GTARALS 717
T I+ E++ G+ D L + F IA + L
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLRAGPFD----------------EFQIATMLKEILKGLD 115
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
YLH + K +H ++K+ N+LL E + KL+D+G+A L K + VG ++
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----IKRNTFVGTPFWM 168
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
APE+ Q K D++S G+ +EL G P V+ L G
Sbjct: 169 APEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGE---- 224
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
F + + F + C ++ PS RP+ E+++
Sbjct: 225 FSKPFKEFID-----------ACLNKDPSFRPTAKELLK 252
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 31/226 (13%)
Query: 593 KALLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNI 648
++LL+ IG GS G V A + G +AVK ++ +R Q+ EL E+ + +
Sbjct: 20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD----LRKQQRRELLFNEVVIMRDY 75
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
+H N+V Y +L EF+ G L D + L+ + +
Sbjct: 76 QHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-------------RLNEEQIATV 122
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
+AL YLH ++H ++KS +ILL + KLSD+G + + + K
Sbjct: 123 CESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQI----SKDVPKRK 175
Query: 769 NAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT 811
+ VG ++APE+ + D++S G++++E+V G P S +
Sbjct: 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 63/280 (22%), Positives = 115/280 (41%), Gaps = 40/280 (14%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G G V + G +A+K ++ G + +++EF E + + H LV G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE-GSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH 721
I++E++ G L +NY +L + ++YL
Sbjct: 70 KQRPIYIVTEYMSNGCL------LNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLE- 117
Query: 722 DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL----TKFHNAVGYVAPE 777
+H +L + N L+D+ K+SD+GL++ +LD+ +KF V + PE
Sbjct: 118 --SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSSVGSKF--PVRWSPPE 171
Query: 778 LAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836
+ + S K DV++FGV++ E+ + G+ P E +E V L AS
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLAS---- 227
Query: 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
++ +M C E RP+ +++ +E
Sbjct: 228 --------EKVYAIM---YSCWHEKAEERPTFQQLLSSIE 256
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 2e-10
Identities = 37/100 (37%), Positives = 57/100 (57%), Gaps = 3/100 (3%)
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP--ILDNYGLTKFHNAVGYVAP 776
+HH ++H ++KS NILL N KL D+G +K+ + D+ G T F YVAP
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT-FCGTPYYVAP 214
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
E+ + S K D++S GV+L EL+T ++P + EV+
Sbjct: 215 EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM 254
|
Length = 496 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 3e-10
Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 28/213 (13%)
Query: 600 CLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL-EIGRLSNIRHFNLVAFQ 657
++G G+ G V + + G +A+KK + + ++ L E+ L +RH N+V +
Sbjct: 7 GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ ++ E+V + L + L PG G+ P+ S + + +A++
Sbjct: 67 EAFRRKGRLYLVFEYVER-TLLELLE--ASPG----GLP-PDAVRSYIWQLL----QAIA 114
Query: 718 YLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
Y H H+ I+H ++K NIL+ E+ KL D+G A+ L LT + Y AP
Sbjct: 115 YCHSHN----IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAP 170
Query: 777 ELAQSLRLSDK-----CDVYSFGVILLELVTGR 804
EL + D DV++ G I+ EL+ G
Sbjct: 171 ELL----VGDTNYGKPVDVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 3e-10
Identities = 55/215 (25%), Positives = 90/215 (41%), Gaps = 26/215 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETL---GRIRNQ-EEFELEIGRLSNIRHFNLVA 655
L+G G+ G VY + G +AVK++ + + E EI L N++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+ G I E++P G++ D L +G T T L
Sbjct: 69 YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA-LTETVTRKYTRQILE------------ 115
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI--LDNYGLTKFHNAV 771
+ YLH + I+H ++K NIL D KL D+G +K L G+
Sbjct: 116 -GVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+++PE+ K DV+S G ++E++T + P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 56/213 (26%), Positives = 100/213 (46%), Gaps = 28/213 (13%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQG 658
IG GS G+VY A +A+KK+ G+ N++ ++ E+ L +RH N + ++G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
Y ++ E+ G+ D L P L + G + L+Y
Sbjct: 83 CYLREHTAWLVMEYC-LGSASDLLEVHKKP-----------LQEVEIAAVTHGALQGLAY 130
Query: 719 LH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
LH H+ ++H ++K+ NILL E KL D+G A ++ + + T + ++APE
Sbjct: 131 LHSHN----MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPY-----WMAPE 181
Query: 778 LAQSL---RLSDKCDVYSFGVILLELVTGRKPV 807
+ ++ + K DV+S G+ +EL + P+
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 65/246 (26%), Positives = 120/246 (48%), Gaps = 39/246 (15%)
Query: 596 LDKECLIGGGSIGSVYRASF--EG---GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRH 650
L K ++G G+ G+VY+ + +G + +A+K L + +E E ++ +
Sbjct: 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL-HWSRRFHIA 709
+ G +ST+QL+ ++ +P G L D Y + IG+ +L +W
Sbjct: 69 PYVCRLLGICLTSTVQLV-TQLMPYGCLLD------YVRENKDRIGSQDLLNW------C 115
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN 769
+ A+ +SYL + ++H +L + N+L+ K++D+GLA+LL I + T++H
Sbjct: 116 VQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE----TEYHA 168
Query: 770 AVG-----YVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVR 823
G ++A E R + + DV+S+GV + EL+T G KP + E +
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IP 221
Query: 824 ELLERG 829
+LLE+G
Sbjct: 222 DLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 7e-10
Identities = 36/102 (35%), Positives = 59/102 (57%), Gaps = 3/102 (2%)
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLS-NLQVLDLSQNSLSGS 448
+D+SG + G I ++ + Y++ ++L N L+G P + S +L+ L+LS N+ +GS
Sbjct: 74 IDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGS 133
Query: 449 IPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTG 490
IP G++ NL +LS+N LSG IP+ I F L+ G
Sbjct: 134 IPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGG 173
|
Length = 968 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 8e-10
Identities = 64/252 (25%), Positives = 111/252 (44%), Gaps = 40/252 (15%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL----ETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
L+G G+ G VY + G +AVK++ E+ + E EI L N+ H +V
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 656 FQGYYWSSTMQLILS---EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ G M+ LS E +P G++ D L G T + +R++ +
Sbjct: 69 YYGCL-RDPMERTLSIFMEHMPGGSIKDQLKSY---GALTENV-------TRKYTRQI-- 115
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI--LDNYGLTKFHNA 770
+SYLH + I+H ++K NIL D KL D+G +K L L G+
Sbjct: 116 LEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP------------VESPTTNEVVV- 817
+++PE+ K D++S G ++E++T + P + + TN V+
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPP 232
Query: 818 -LCEYVRELLER 828
+ ++ R+ L+R
Sbjct: 233 HVSDHCRDFLKR 244
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 1e-09
Identities = 69/294 (23%), Positives = 126/294 (42%), Gaps = 42/294 (14%)
Query: 602 IGGGSIGSVYRASFEGGV------SIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G VY+ G ++A+K L+ +EEF+ E S ++H N+V
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVC 72
Query: 656 FQGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE-----LHWSRRFHIA 709
G + +I S + +L++ L + P + G + + L + HI
Sbjct: 73 LLGVVTKEQPLSMIFS-YCSHSDLHEFLV-MRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 710 LGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
A + +L HH H +L + N+L+ + K+SD GL + + D Y L
Sbjct: 131 TQIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKL--M 183
Query: 768 HNA---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVR 823
N+ + +++PE + S D++S+GV+L E+ + G +P + +V+ E +R
Sbjct: 184 GNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI---EMIR 240
Query: 824 ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
+R + ++ V L L C +E PSRRP ++ L +
Sbjct: 241 ------------NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 70/291 (24%), Positives = 110/291 (37%), Gaps = 43/291 (14%)
Query: 601 LIGGGSIGSVYRASFEGGVS------IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV 654
+G G G V+ A +G + VK L+ Q EF E+ + H N+V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
G + ++ E+ G+L L + P L ++ + A
Sbjct: 72 RLLGLCREAEPHYMILEYTDLGDLKQFLR-ATKSKDEK--LKPPPLSTKQKVALCTQIAL 128
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG--LTKFHNA-- 770
+ +L +H +L + N L+ E K+S L+K D Y K NA
Sbjct: 129 GMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSK-----DVYNSEYYKLRNALI 180
Query: 771 -VGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL---- 825
+ ++APE Q S K DV+SFGV++ E+ T + ++E E + L
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE-----EVLNRLQAGK 235
Query: 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
LE C R + KL C + P RPS +E+V L
Sbjct: 236 LELPVPEGCPSR------------LYKLMTRCWAVNPKDRPSFSELVSALG 274
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-09
Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 26/212 (12%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQG 658
IG GS G+VY A +A+KK+ G+ N++ ++ E+ L I+H N + ++G
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
Y ++ E+ G+ D L P L I G + L+Y
Sbjct: 93 CYLREHTAWLVMEYC-LGSASDLLEVHKKP-----------LQEVEIAAITHGALQGLAY 140
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
LH ++H ++K+ NILL E + KL+D+G A + +++ T + ++APE+
Sbjct: 141 LHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPY-----WMAPEV 192
Query: 779 AQSL---RLSDKCDVYSFGVILLELVTGRKPV 807
++ + K DV+S G+ +EL + P+
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQGYY 660
IG GS G VY+ + K+ L ++ E+ + EI LS + + G Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH 720
T I+ E++ G+ D L PG L + I + L YLH
Sbjct: 72 LKGTKLWIIMEYLGGGSALDLLK----PGP---------LEETYIATILREILKGLDYLH 118
Query: 721 HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPE 777
+ K +H ++K+ N+LL E + KL+D+G+A L K + VG ++APE
Sbjct: 119 SERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----IKRNTFVGTPFWMAPE 171
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ + K D++S G+ +EL G P
Sbjct: 172 VIKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-09
Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL---TKFHNAV 771
AL +H ++H +LKS NI L KL D+G +K D+ L + F
Sbjct: 181 ALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYS--DSVSLDVASSFCGTP 235
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
Y+APEL + R S K D++S GVIL EL+T +P + P+ E++
Sbjct: 236 YYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIM 280
|
Length = 478 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 2e-09
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL----ETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
L+G G+ G VY + G +A K++ E+ + E EI L N++H +V
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 656 FQGYYWSSTMQL--ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+ G + I E++P G++ D L G T + +R++ +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY---GALTESV-------TRKYTRQI--L 116
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI--LDNYGLTKFHNAV 771
+SYLH + I+H ++K NIL D KL D+G +K L + G+
Sbjct: 117 EGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTP 173
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+++PE+ K DV+S G ++E++T + P
Sbjct: 174 YWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 2e-09
Identities = 37/106 (34%), Positives = 55/106 (51%), Gaps = 4/106 (3%)
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
A AL +LH I++ +LK NILLDE KL+D+GL+K I F V
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVE 163
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVL 818
Y+APE+ + D +SFGV++ E++TG P + E + +
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTM 209
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 2e-09
Identities = 14/42 (33%), Positives = 23/42 (54%)
Query: 28 AATDKEILLQFKGNITDDPHNKLASWVSSGNPCENFKGVFCN 69
D++ LL FK ++ DP L+SW S + ++ GV C+
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 2e-09
Identities = 53/229 (23%), Positives = 105/229 (45%), Gaps = 27/229 (11%)
Query: 599 ECLIGGGSIGSVYRASFEGG----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV 654
E +IG G G V R + + +A+K L++ + + +F E + H N++
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+G S +I++EF+ G L L + T +G + G A
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG-----------MLRGIAA 117
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
+ YL + +H +L + NIL++ N K+SD+GL++ L D+ + +++G
Sbjct: 118 GMKYL---SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE--DDTSDPTYTSSLGGK 172
Query: 773 ----YVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816
+ APE + + DV+S+G+++ E+++ G +P + +V+
Sbjct: 173 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI 221
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 2e-09
Identities = 25/59 (42%), Positives = 32/59 (54%)
Query: 411 LKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNL 469
LK LDL N L + L NL+VLDLS N+L+ P + L +L +LS NNL
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 594 ALLDKECLIGGGSIGSVY--RASFEGGVSIAVKK--LETLGRIRNQEEFELEIGRLSN-- 647
A+L+ +G G+ G VY R G +A+K+ + +++ E + IG + +
Sbjct: 3 AVLE---HLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59
Query: 648 ------IRHFNLVAF-----QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIG 696
+RH N+V + + M LI E P G +++L
Sbjct: 60 TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLI--EGAPLGEHFNSL-------KEKKQRF 110
Query: 697 NPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756
E W+ + L AL YLH + + I+H +L NI+L E+ + ++D+GLAK
Sbjct: 111 TEERIWNIFVQMVL----ALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164
Query: 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809
LT + Y PE+ ++ +K DV++FG IL ++ T + P S
Sbjct: 165 Q--PESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 59/216 (27%), Positives = 101/216 (46%), Gaps = 38/216 (17%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLG---RIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ GSV + ++ KK+ +G +R Q EL+I + R +V+F G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQI--MHECRSPYIVSFYG 70
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
+ + + EF+ G+L D ++ GG E+ IA+ L+Y
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKK-------GGPIPVEILG----KIAVAVVEGLTY 118
Query: 719 L---HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL--PILDNYGLTKFHNAVG- 772
L H I+H ++K +NIL++ + KL D+G++ L I D + VG
Sbjct: 119 LYNVHR-----IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF--------VGT 165
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
Y++PE Q + + K DV+S G+ ++EL G+ P
Sbjct: 166 STYMSPERIQGGKYTVKSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 45/182 (24%), Positives = 78/182 (42%), Gaps = 39/182 (21%)
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYD-----------NLHGVNYPG 689
E+ L + +H N++A I P G + +LH + +
Sbjct: 54 ELKILRHFKHDNIIA------------IRDILRPPGADFKDVYVVMDLMESDLHHIIHSD 101
Query: 690 TSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749
R F L R L Y+H ++H +LK +N+L++E+ E ++ D
Sbjct: 102 ------QPLTEEHIRYFLYQL--LRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGD 150
Query: 750 YGLAKLL---PILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRK 805
+G+A+ L P Y +T++ Y APEL SL + D++S G I E++ GR+
Sbjct: 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRR 209
Query: 806 PV 807
+
Sbjct: 210 QL 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 66/230 (28%), Positives = 99/230 (43%), Gaps = 37/230 (16%)
Query: 602 IGGGSIGSVYRA---SFEGGVSI-AVKKLETLGRIRNQEEF-ELEIGRLSNIRHFNLVAF 656
I G+ G V+ A S +I +KK + + + + + E +I LS + +V
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDI--LSQAQSPYVVKL 58
Query: 657 QGYYWS----STMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
Y+S + L++ E++P G+L L V E R +IA
Sbjct: 59 ---YYSFQGKKNLYLVM-EYLPGGDLASLLENVGS---------LDEDV--ARIYIA-EI 102
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL----LPILDNYGLTKFH 768
AL YLH I+H +LK NIL+D N KL+D+GL+K+ I N +
Sbjct: 103 VLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159
Query: 769 NAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
VG Y+APE+ S D +S G IL E + G P T E+
Sbjct: 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEI 209
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 4e-09
Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 26/213 (12%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFE---LEIGRLSNIRHFNLVAFQ 657
+G G+ G VY+A + E GV A K ++T +++EE E +EI L++ H N+V
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDT----KSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
++ IL EF G + + + P T P++ + T AL+
Sbjct: 69 DAFYYENNLWILIEFCAGGAVDAVMLELERPLTE------PQIRV-----VCKQTLEALN 117
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA----KLLPILDNYGLTKFHNAVGY 773
YLH + I+H +LK+ NIL + + KL+D+G++ + + D++ T + A
Sbjct: 118 YLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 174
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
V E ++ K DV+S G+ L+E+ P
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 5e-09
Identities = 32/114 (28%), Positives = 51/114 (44%), Gaps = 13/114 (11%)
Query: 701 HWSRRFHIALGTAR--------ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752
H S++ + + AL YLH I+H ++K NILLDE ++D+ +
Sbjct: 90 HLSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNI 146
Query: 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
A + + T GY+APE+ S D +S GV E + G++P
Sbjct: 147 ATKVT--PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.3 bits (142), Expect = 5e-09
Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 43/218 (19%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL------EIGRLSNIRHFNLV 654
+G G+ G VY+A + G +A+KK+ R+ N+EE + EI L ++H N+V
Sbjct: 7 LGEGTYGVVYKARDKKTGEIVALKKI----RLDNEEE-GIPSTALREISLLKELKHPNIV 61
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+ ++ E+ +L Y G + + + I R
Sbjct: 62 KLLDVIHTERKLYLVFEYCDM-----DLK--KYLDKRPGPL---SPNLIK--SIMYQLLR 109
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGLTKFHNAVG- 772
L+Y H ILH +LK NIL++ + KL+D+GLA+ I L Y T H V
Sbjct: 110 GLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY--T--HEVVTL 162
Query: 773 -YVAPELAQSLRLSDKC-----DVYSFGVILLELVTGR 804
Y APE+ L L K D++S G I E++TG+
Sbjct: 163 WYRAPEI---L-LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 5e-09
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 29/282 (10%)
Query: 599 ECLIGGGSIGSVYRASFEGG---VSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLV 654
E +IG G+ G V RA + ++ A+K L+ + +F E+ L + H N++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI---GNPELHWSRRF-HIAL 710
G + I E+ P GNL D L T G S++ A
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
A + YL + +H +L + N+L+ EN K++D+GL++ + + +
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL--P 181
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829
V ++A E + K DV+SFGV+L E+V+ G P T C + E L +G
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT-------CAELYEKLPQG 234
Query: 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEV 871
+ ++E+ ++M+ C + P RP A++
Sbjct: 235 -----YRMEKPRNCDDEVYELMRQ---CWRDRPYERPPFAQI 268
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 62/235 (26%), Positives = 97/235 (41%), Gaps = 36/235 (15%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFE-----LEIGRLSNIRHFNLVA 655
IG G+ G VY+A G +A+KK+ ++R + E EI L + H N++
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKI----KLRFESEGIPKTALREIKLLKELNHPNIIK 62
Query: 656 FQGYYWSSTMQLILSEFVPKGNLY---DNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+L F KG+LY + + Y G PE
Sbjct: 63 ------------LLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIK---SYLYQL 107
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+ L++ H ILH +LK N+L++ KL+D+GLA+ T +
Sbjct: 108 LQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGS-PVRPYTHYVVTRW 163
Query: 773 YVAPELAQSLRL-SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826
Y APEL + S D++S G I EL++ R P+ P +E+ L + L
Sbjct: 164 YRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR-PL-FPGKSEIDQLF-KIFRTL 215
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 30/116 (25%), Positives = 53/116 (45%), Gaps = 14/116 (12%)
Query: 702 WSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN 761
W++++ + LH I+H ++K N+L+D+ KL+D+GL++
Sbjct: 98 WAKQY--IAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN------ 146
Query: 762 YGLT--KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
GL KF Y+APE + D +S G ++ E + G P + T + V
Sbjct: 147 -GLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAV 201
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 66/287 (22%), Positives = 111/287 (38%), Gaps = 41/287 (14%)
Query: 601 LIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
IG G G VY+ + +++AVK + +E+F E + H ++V
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
G + + +++ E P G L L Y L + + + AL
Sbjct: 73 IGVITENPVWIVM-ELAPLGELRSYLQVNKY-----------SLDLASLILYSYQLSTAL 120
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
+YL +H ++ + N+L+ KL D+GL++ L Y +K + ++AP
Sbjct: 121 AYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAP 177
Query: 777 ELAQSLRLSDKCDVYSFGVILLE-LVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
E R + DV+ FGV + E L+ G KP + N+V+ +E G
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG-------RIENGERLPM- 229
Query: 836 DRSLRGFAEN---ELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
N L +M C + PS+RP E+ L I
Sbjct: 230 -------PPNCPPTLYSLMTK---CWAYDPSKRPRFTELKAQLSDIL 266
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 62/234 (26%), Positives = 106/234 (45%), Gaps = 38/234 (16%)
Query: 584 KYEDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFE--- 639
+YE E G + +L G G+ G VY A V IA+K++ R+ +
Sbjct: 4 EYEYDENGERVVL------GKGTYGIVYAARDLSTQVRIAIKEIP----ERDSRYVQPLH 53
Query: 640 LEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE 699
EI S ++H N+V + G + I E VP G+L L + G + + E
Sbjct: 54 EEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLR------SKWGPLKDNE 107
Query: 700 ---LHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP--KLSDYGLAK 754
+ ++++ L YLH + I+H ++K N+L++ Y K+SD+G +K
Sbjct: 108 QTIIFYTKQI------LEGLKYLHDN---QIVHRDIKGDNVLVN-TYSGVVKISDFGTSK 157
Query: 755 LLPILDNYGLTKFHNAVGYVAPELA-QSLR-LSDKCDVYSFGVILLELVTGRKP 806
L + N F + Y+APE+ + R D++S G ++E+ TG+ P
Sbjct: 158 RLAGI-NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPP 210
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 59/233 (25%), Positives = 100/233 (42%), Gaps = 38/233 (16%)
Query: 586 EDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKL-------ETLGRIRNQEE 637
+W G L+G G+ G VY + G +AVK++ ET +
Sbjct: 2 VNWRLGK--------LLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEV---NA 50
Query: 638 FELEIGRLSNIRHFNLVAFQGYYWSSTMQ--LILSEFVPKGNLYDNLHGVNYPGTSTGGI 695
E EI L N+RH +V + G + I E++P G++ D L G T +
Sbjct: 51 LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY---GALTENV 107
Query: 696 GNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755
+RR+ + + +SYLH + I+H ++K NIL D KL D+G +K
Sbjct: 108 -------TRRYTRQI--LQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155
Query: 756 LPI--LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ + G+ +++PE+ K DV+S ++E++T + P
Sbjct: 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (139), Expect = 5e-09
Identities = 68/280 (24%), Positives = 119/280 (42%), Gaps = 29/280 (10%)
Query: 601 LIGGGSIGSVYRASFEGG---VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHF-NLVAF 656
+IG G+ G V +A + + A+K+++ + +F E+ L + H N++
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI---GNPELHWSRRF-HIALGT 712
G + E+ P GNL D L T S++ H A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
AR + YL + +H +L + NIL+ ENY K++D+GL++ + + + V
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--PVR 176
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSA 831
++A E + DV+S+GV+L E+V+ G P T C + E L +G
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-------CAELYEKLPQG-- 227
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEV 871
+ ++E+ +M+ C E P RPS A++
Sbjct: 228 ---YRLEKPLNCDDEVYDLMRQ---CWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 6e-09
Identities = 64/244 (26%), Positives = 108/244 (44%), Gaps = 35/244 (14%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLVAFQ 657
IG G+ G+VY A G +A+K++ ++ Q + EL EI + +H N+V +
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMN----LQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
Y ++ E++ G+L D V G I + +AL
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAA----------VCRECLQALE 129
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL-AKLLPILDNYGLTKFHNAVG---Y 773
+LH + ++H ++KS NILL + KL+D+G A++ P +K VG +
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYW 181
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV--ESPTTNEVVVLCEYVRELLERGSA 831
+APE+ K D++S G++ +E+V G P E+P ++ EL
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKL 241
Query: 832 SACF 835
SA F
Sbjct: 242 SAIF 245
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 8e-09
Identities = 30/92 (32%), Positives = 53/92 (57%), Gaps = 4/92 (4%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
L +LH K I++ +LK N+LLD++ K++D+G+ K + T F Y+
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST-FCGTPDYI 163
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ + + ++ D +SFGV+L E++ G+ P
Sbjct: 164 APEILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 8e-09
Identities = 36/106 (33%), Positives = 60/106 (56%), Gaps = 8/106 (7%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
IA+ +AL YLH ++H ++K +N+L++ N + KL D+G++ L +D+ T
Sbjct: 108 IAVSIVKALEYLHSKLS--VIHRDVKPSNVLINRNGQVKLCDFGISGYL--VDSVAKTID 163
Query: 768 HNAVGYVAPEL---AQSLRLSD-KCDVYSFGVILLELVTGRKPVES 809
Y+APE + + D K DV+S G+ ++EL TGR P +S
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 25/214 (11%)
Query: 609 SVYRASFEGG-VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQL 667
S+Y+ F V I K G + E EI L I N++ G+ L
Sbjct: 35 SIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 668 ----ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDC 723
++ E+ +G L + L +L + + +A+ + L L+
Sbjct: 95 PRLSLILEYCTRGYLREVLDK------------EKDLSFKTKLDMAIDCCKGLYNLYKYT 142
Query: 724 KPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL- 782
P + NL S + L+ ENY+ K+ +GL K+L K N + Y + ++ +
Sbjct: 143 NKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPP----FKNVNFMVYFSYKMLNDIF 196
Query: 783 -RLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
+ K D+YS GV+L E+ TG+ P E+ TT E+
Sbjct: 197 SEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEI 230
|
Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 9e-09
Identities = 38/106 (35%), Positives = 58/106 (54%), Gaps = 7/106 (6%)
Query: 705 RFHIALGTARALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG 763
RF+ A T AL +LH H +++ +LK NILLD KL+D+G+ K IL+
Sbjct: 99 RFYAAEVTL-ALMFLHRHG----VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVT 152
Query: 764 LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809
T F Y+APE+ Q L D ++ GV++ E++ G+ P E+
Sbjct: 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEA 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.2 bits (139), Expect = 1e-08
Identities = 64/226 (28%), Positives = 98/226 (43%), Gaps = 56/226 (24%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFE-------LEIGRLSNIRHFNLV 654
IG G+ G VY+A + +L L +IR + E E EI L +RH N+V
Sbjct: 7 IGEGTYGQVYKAR-----NKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIV 61
Query: 655 AFQGYYWSSTMQLILSEFV---PKGNLY------DN-LHGVNYPGTSTGGIGNPELHWS- 703
+L E V KG++Y D+ L TG + +PE+ ++
Sbjct: 62 -----------RLK--EIVTSKGKGSIYMVFEYMDHDL---------TGLLDSPEVKFTE 99
Query: 704 -RRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY 762
+ L YLH + ILH ++K +NIL++ + KL+D+GLA+
Sbjct: 100 SQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLAR---PYTKR 153
Query: 763 GLTKFHNAV---GYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
+ N V Y PE L + R + D++S G IL EL G+
Sbjct: 154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 1e-08
Identities = 67/237 (28%), Positives = 104/237 (43%), Gaps = 28/237 (11%)
Query: 602 IGGGSIGSVYRASFEGGVSIA---VKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
IG G G V G+S A VK+L Q F E+ + H N++ G
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI-GNPELHWSRRFHIALGTARALS 717
S L++ EF P G+L NY ++ G + + +R +A A L
Sbjct: 63 QCIESIPYLLVLEFCPLGDLK------NYLRSNRGMVAQMAQKDVLQR--MACEVASGLL 114
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG--YVA 775
+LH + +H +L N L + K+ DYGLA L ++Y +TK +AV ++A
Sbjct: 115 WLH---QADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLA 170
Query: 776 PELAQSL-------RLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824
PEL + + K +++S GV + EL T +P P ++ VL + VRE
Sbjct: 171 PELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY--PDLSDEQVLKQVVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 15/115 (13%)
Query: 705 RFHI------ALGTARALSY-------LHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751
++HI ARA+ Y L H + I++ +LK N+LLD++ ++SD G
Sbjct: 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLG 140
Query: 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
LA L + GY+APE+ Q D ++ G L E++ GR P
Sbjct: 141 LAVELK--GGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 1e-08
Identities = 66/238 (27%), Positives = 93/238 (39%), Gaps = 67/238 (28%)
Query: 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL----------EIGRL 645
+K +G G+ VY+A E G +A+KK I+ E E EI L
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKK------IKLGERKEAKDGINFTALREIKLL 56
Query: 646 SNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL--------YDNLHGVNYPGTSTGGIGN 697
++H N++ +L F K N+ D L V I +
Sbjct: 57 QELKHPNIIG------------LLDVFGHKSNINLVFEFMETD-LEKV---------IKD 94
Query: 698 PELHWSRRF---HI---ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751
+ I L T R L YLH + ILH +LK N+L+ + KL+D+G
Sbjct: 95 KSI----VLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFG 147
Query: 752 LAKLLPILDNYGLTKFHNAVG--YVAPELAQSLRL-SDKCDVYSFGVILLELVTGRKP 806
LA+ N +T H V Y APEL R D++S G I EL+ R P
Sbjct: 148 LARSFGS-PNRKMT--HQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVP 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 50/222 (22%), Positives = 96/222 (43%), Gaps = 31/222 (13%)
Query: 598 KECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQ--------EEFELEIGRLSNI 648
K +G G+ S Y+A + G +AVK++ +RN E EI ++ +
Sbjct: 4 KGQQLGTGAFSSCYQARDVKTGTLMAVKQVT---YVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
H +++ G + + E++ G++ L Y G + +
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS--KY-GAFKEAVIINYTE-----QL 112
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGLA-KLLPILDNYGLTK 766
G LSYLH + I+H ++K N+L+D +++D+G A +L G +
Sbjct: 113 LRG----LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ 165
Query: 767 --FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ ++APE+ + + CDV+S G +++E+ T + P
Sbjct: 166 GQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPP 207
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 2e-08
Identities = 62/224 (27%), Positives = 105/224 (46%), Gaps = 37/224 (16%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIG---RLSNIRHFNLVAF 656
+IG G+ G VY+A + G +A+K ++ + +EE + E + SN H N+ F
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED--EEEEIKEEYNILRKYSN--HPNIATF 68
Query: 657 QGYYWSSTM-----QLILS-EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
G + QL L E G++ D + G+ G E + +I
Sbjct: 69 YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRL-----KEEWIA---YILR 120
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
T R L+YLH + ++H ++K NILL +N E KL D+G++ L + L + +
Sbjct: 121 ETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL----DSTLGRRNTF 173
Query: 771 VG---YVAPEL---AQSLRLS--DKCDVYSFGVILLELVTGRKP 806
+G ++APE+ + S + DV+S G+ +EL G+ P
Sbjct: 174 IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 60/235 (25%), Positives = 114/235 (48%), Gaps = 32/235 (13%)
Query: 598 KECLIGGGSIGSVYRASF--EG---GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFN 652
K ++G G+ G+VY+ + EG + +A+K+L + +E E ++++ + +
Sbjct: 11 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPH 70
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL-HWSRRFHIALG 711
+ G +ST+QLI ++ +P G L D Y IG+ L +W +
Sbjct: 71 VCRLLGICLTSTVQLI-TQLMPFGCLLD------YVREHKDNIGSQYLLNW------CVQ 117
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
A+ ++YL + ++H +L + N+L+ K++D+GLAKLL ++H
Sbjct: 118 IAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL----GADEKEYHAEG 170
Query: 772 G-----YVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCE 820
G ++A E + + DV+S+GV + EL+T G KP + +E+ + E
Sbjct: 171 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 225
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 3e-08
Identities = 31/92 (33%), Positives = 45/92 (48%)
Query: 267 ISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLI 326
I + + G G IP +Q + S N G IP S+ + +L+VLDL +N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFN 479
Query: 327 GSIPTGITDLRRLLKISLANNSIGGIIPPNLG 358
GSIP + L L ++L NS+ G +P LG
Sbjct: 480 GSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 13/116 (11%)
Query: 701 HWSRRFHIALGTAR--------ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752
H +R H R AL +LH + I++ ++K NILLD L+D+GL
Sbjct: 95 HLYQREHFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGL 151
Query: 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ--SLRLSDKCDVYSFGVILLELVTGRKP 806
+K + F + Y+APE+ + S D +S GV+ EL+TG P
Sbjct: 152 SKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 3e-08
Identities = 42/143 (29%), Positives = 61/143 (42%), Gaps = 42/143 (29%)
Query: 705 RFHI-----ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK----- 754
RF+I AL + L ++H D KP NIL+D + KL+D+GL K
Sbjct: 104 RFYIAELVLALDSVHKLGFIHRDIKP---------DNILIDADGHIKLADFGLCKKMNKA 154
Query: 755 -----------LLPILDNYGL---------TKFHNAVG---YVAPELAQSLRLSDKCDVY 791
L DN + + ++ VG Y+APE+ + +CD +
Sbjct: 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWW 214
Query: 792 SFGVILLELVTGRKPVESPTTNE 814
S GVIL E++ G P S T E
Sbjct: 215 SLGVILYEMLYGFPPFYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 4/100 (4%)
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVA 775
L +LH I++ +LK N++LD + K++D+G+ K DN T F Y+A
Sbjct: 109 LQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIA 164
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
PE+ Q L+ + D +SFGV+L E++ G+ P +E+
Sbjct: 165 PEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 4e-08
Identities = 35/111 (31%), Positives = 59/111 (53%), Gaps = 5/111 (4%)
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL 764
RF+ A T+ AL +LH I++ +LK N+LLD KL+D+G+ K I +
Sbjct: 99 RFYAAEITS-ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTT 153
Query: 765 TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
+ F Y+APE+ Q + D ++ GV+L E++ G P E+ +++
Sbjct: 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 61/221 (27%), Positives = 95/221 (42%), Gaps = 24/221 (10%)
Query: 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGR---LSNIRHFNLVAF 656
+IG GS G V A + G AVK L+ + +E+ + R L N++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGV-NYPGTSTGGIGNPELHWSRRFHIALGTARA 715
+ ++ + +FV G L+ +L ++P RF+ A A A
Sbjct: 62 HYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA------------RFYAA-EIASA 108
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL-LPILDNYGLTKFHNAVGYV 774
L YLH I++ +LK NILLD L+D+GL K + D T F Y+
Sbjct: 109 LGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--TTTFCGTPEYL 163
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
APE+ + + D + G +L E++ G P E+
Sbjct: 164 APEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 6e-08
Identities = 77/311 (24%), Positives = 133/311 (42%), Gaps = 50/311 (16%)
Query: 593 KALLDKECLIGGGSIGSVYRA-SFE-----GGVSIAVKKLETLGRIRNQEEFEL-----E 641
+L K +G G G V +A +F G ++AVK L+ N EL E
Sbjct: 1 NLVLGK--TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-----ENASSSELRDLLSE 53
Query: 642 IGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLH-----GVNYPGTSTGGIG 696
L + H +++ G L++ E+ G+L L G +Y G+
Sbjct: 54 FNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNS 113
Query: 697 NPELHWSRR-------FHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749
+ + R A +R + YL + ++H +L + N+L+ E + K+SD
Sbjct: 114 SYLDNPDERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISD 170
Query: 750 YGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPV 807
+GL++ + D+Y +K V ++A E + + DV+SFGV+L E+VT G P
Sbjct: 171 FGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
Query: 808 ESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
+ E + LL+ G +R EN ++ L L C + P +RP+
Sbjct: 231 PG-------IAPERLFNLLKTGYR---MER-----PENCSEEMYNLMLTCWKQEPDKRPT 275
Query: 868 MAEVVQVLESI 878
A++ + LE +
Sbjct: 276 FADISKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 20/219 (9%)
Query: 601 LIGGGSIGSVYRASFEGG-VSIAVKKLETLGRIRNQEEFELEIGR---LSNIRHFNLVAF 656
+IG GS G V A + AVK L+ ++ +EE + R L N++H LV
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 61
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
+ ++ + +++ G L+ +L L RF+ A A AL
Sbjct: 62 HFSFQTADKLYFVLDYINGGELFYHLQRERC-----------FLEPRARFYAA-EIASAL 109
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
YLH I++ +LK NILLD L+D+GL K I N + F Y+AP
Sbjct: 110 GYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK-ENIEHNGTTSTFCGTPEYLAP 165
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
E+ D + G +L E++ G P S T E+
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 7e-08
Identities = 34/94 (36%), Positives = 56/94 (59%), Gaps = 6/94 (6%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL-LPILDNYG-LTKFHNAV 771
R L Y+H +LH +LK +N+LL+ N + K+ D+GLA++ P D+ G LT++
Sbjct: 117 RGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 772 GYVAPELAQSLRLSDKC-DVYSFGVILLELVTGR 804
Y APE+ + + K D++S G IL E+++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 7e-08
Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 38/216 (17%)
Query: 602 IGGGSIGSV-YRASFEGGVSIAVKKL-----ETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ G+V G +A+KKL L R E L L +++H N++
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL----LKHMKHENVIG 78
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHG----VNYPGTSTGGIGNPE-LHWSRRFHIAL 710
+L F P +L D H + + GT G + E L R +
Sbjct: 79 ------------LLDVFTPDLSL-DRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVY 125
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGLTKFHN 769
+ L Y+H I+H +LK N+ ++E+ E K+ D+GLA+ + Y +T++
Sbjct: 126 QMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRW-- 180
Query: 770 AVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGR 804
Y APE+ + + + D++S G I+ E++TG+
Sbjct: 181 ---YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 20/171 (11%)
Query: 707 HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK 766
H+A+ A +SYLH K ++H ++ + N ++DE + K++D L++ L +D + L
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 767 FHN-AVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824
N V ++A E + S DV+SFGV+L EL+T G+ P E+ Y+++
Sbjct: 178 NENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAA---YLKD 234
Query: 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
C D EL VM C + P RPS +++VQ L
Sbjct: 235 GYRLAQPINCPD---------ELFAVM---ACCWALDPEERPSFSQLVQCL 273
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 8e-08
Identities = 58/223 (26%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHF-NLVAFQG 658
L+G G+ G VY+ + G A+K ++ G +EE + EI L H N+ + G
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 659 YYWSSTM-----QL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ QL ++ EF G++ D + N G + + W +I
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTL------KEEWIA--YICREI 120
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
R LS+LH ++H ++K N+LL EN E KL D+G++ L + + + + +G
Sbjct: 121 LRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIG 173
Query: 773 ---YVAPELAQSLRLSD-----KCDVYSFGVILLELVTGRKPV 807
++APE+ D K D++S G+ +E+ G P+
Sbjct: 174 TPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 9e-08
Identities = 61/240 (25%), Positives = 110/240 (45%), Gaps = 20/240 (8%)
Query: 602 IGGGSIGSVYRASF------EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ G V+ A + + +AVK L+ Q+ F+ E L+ ++H ++V
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQD-FQREAELLTVLQHQHIVR 71
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNP-ELHWSRRFHIALGT 712
F G L++ E++ G+L L HG + + G P +L + IA
Sbjct: 72 FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY---GLTKFHN 769
A + YL +H +L + N L+ + K+ D+G+++ + D Y G T
Sbjct: 132 ASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML-- 186
Query: 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828
+ ++ PE + + + D++SFGV+L E+ T G++P + E + RE LER
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRE-LER 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-07
Identities = 29/94 (30%), Positives = 48/94 (51%), Gaps = 4/94 (4%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
L +LH + I++ +LK N+LLD K++D+G+ K IL + F Y+
Sbjct: 108 GLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKE-GILGGVTTSTFCGTPDYI 163
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVE 808
APE+ D ++ GV+L E++ G+ P E
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 1e-07
Identities = 58/218 (26%), Positives = 91/218 (41%), Gaps = 42/218 (19%)
Query: 602 IGGGSIGSVYRASFEGGVSI-AVKKLETLGRIRN-QEEF---ELEIGRLSNIRHFNLVAF 656
+G GS G V +G A+K L ++ Q E E I L +IRH LV
Sbjct: 9 LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRI--LQSIRHPFLV-- 64
Query: 657 QGYYWSSTMQ-----LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
+ S L++ E+VP G L+ +L RF+ A
Sbjct: 65 --NLYGSFQDDSNLYLVM-EYVPGGELFSHLRKSGRFPEPVA-----------RFYAAQV 110
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
AL YLH I++ +LK N+LLD + K++D+G AK + + +
Sbjct: 111 VL-ALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK-------GRTYTLC 159
Query: 772 G---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
G Y+APE+ S D ++ G+++ E++ G P
Sbjct: 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-07
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 602 IGGGSIGSVY--RASFEG---GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+G G G V R EG G +AVK L+ + + + EI L N+ H N+V +
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 657 QGYY---WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+G + ++LI+ EF+P G+L + Y + I + A+
Sbjct: 72 KGICTEDGGNGIKLIM-EFLPSGSLKE------YLPRNKNKINLKQQL-----KYAVQIC 119
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK--FHNAV 771
+ + YL +H +L + N+L++ ++ K+ D+GL K + Y K + V
Sbjct: 120 KGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPV 176
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTT 812
+ APE + DV+SFGV L EL+T SP T
Sbjct: 177 FWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 1e-07
Identities = 40/131 (30%), Positives = 68/131 (51%), Gaps = 11/131 (8%)
Query: 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK--L 755
PE H RF+ A AL++LH + I++ +LK N+LLD + KL+DYG+ K L
Sbjct: 94 PEEH--ARFYAA-EICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL 147
Query: 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
P + F Y+APE+ + D ++ GV++ E++ GR P + T N
Sbjct: 148 GP---GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
Query: 816 VVLCEYVRELL 826
+ +Y+ +++
Sbjct: 205 MNTEDYLFQVI 215
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 69/280 (24%), Positives = 106/280 (37%), Gaps = 34/280 (12%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660
IG G+ G V+ +AVK + +F E L H N+V G
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 62
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH 720
I+ E V G+ L + G P L + A + YL
Sbjct: 63 TQKQPIYIVMELVQGGDFLTFLR-------TEG----PRLKVKELIQMVENAAAGMEYLE 111
Query: 721 HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP--ILDNYGLTKFHNAVGYVAPEL 778
+H +L + N L+ E K+SD+G+++ + + G K V + APE
Sbjct: 112 SKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK-QIPVKWTAPEA 167
Query: 779 AQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
R S + DV+SFG++L E + G P + + + RE +E+G C
Sbjct: 168 LNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ-------TREAIEQGVRLPC--- 217
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
E V +L C P +RPS + V Q L+S
Sbjct: 218 -----PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 71/292 (24%), Positives = 128/292 (43%), Gaps = 39/292 (13%)
Query: 601 LIGGGSIGSVYRA--SFEGGVS--IAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVA 655
++G G GSV S + G +AVK ++ ++ EEF E + + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMK 65
Query: 656 FQGY-YWSSTMQ-----LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
G + +S++Q +++ F+ G+L+ ++ S G +L
Sbjct: 66 LIGVCFEASSLQKIPKPMVILPFMKHGDLH------SFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN 769
+ A + YL + +H +L + N +L E+ ++D+GL+K + D Y +
Sbjct: 120 VDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAK 176
Query: 770 -AVGYVAPE-LAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826
V ++A E LA + S K DV++FGV + E+ T G+ P +E+ +Y+R
Sbjct: 177 MPVKWIAIESLADRVYTS-KSDVWAFGVTMWEIATRGQTPYPGVENHEIY---DYLRHGN 232
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
C D EL +M C P RP+ ++ +VLE+I
Sbjct: 233 RLKQPEDCLD---------ELYDLMYS---CWRADPKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 77/301 (25%), Positives = 130/301 (43%), Gaps = 55/301 (18%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR---HFNLVAFQ 657
IG G+ G+VY A G +A+K++ ++ Q + EL I + +R + N+V +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
Y ++ E++ G+L D V G I + +AL
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAA----------VCRECLQALD 129
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL-AKLLPILDNYGLTKFHNAVG---Y 773
+LH + ++H ++KS NILL + KL+D+G A++ P +K VG +
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYW 181
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV--ESPTTNEVVVLCEYVRELLERGSA 831
+APE+ K D++S G++ +E+V G P E+P ++ EL
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERL 241
Query: 832 SACF----------DRSLRGFAENELIQ--VMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
SA F D RG A+ EL+Q +KL +S P ++ E+I+
Sbjct: 242 SAVFRDFLNRCLEMDVDRRGSAK-ELLQHPFLKLAKPLSSLTPL-------IIAAKEAIK 293
Query: 880 N 880
N
Sbjct: 294 N 294
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 54.0 bits (129), Expect = 1e-07
Identities = 52/213 (24%), Positives = 98/213 (46%), Gaps = 33/213 (15%)
Query: 602 IGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLVAFQ 657
IG G+ G+V+ A G +A+K++ ++ Q + EL EI + +++ N+V F
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQIN----LQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ ++ E++ G+L D + + L +AL
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL-------------QALE 129
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL-AKLLPILDNYGLTKFHNAVG---Y 773
+LH + ++H ++KS N+LL + KL+D+G A++ P +K VG +
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYW 181
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+APE+ K D++S G++ +E+V G P
Sbjct: 182 MAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 31/217 (14%)
Query: 602 IGGGSIGSVYRASFE-GGVSIAVK--KLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ GSVY+ GV++A+K +LE NQ EL+I L +V F G
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDI--LHKAVSPYIVDFYG 66
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
++ + E++ G+L D L+ G +T GI L RR I + L +
Sbjct: 67 AFFIEGAVYMCMEYMDAGSL-DKLYA---GGVATEGIPEDVL---RR--ITYAVVKGLKF 117
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA-KLLPIL--DNYGLTKFHNAVGYVA 775
L + I+H ++K TN+L++ N + KL D+G++ L+ L N G Y+A
Sbjct: 118 LKEEHN--IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQS------YMA 169
Query: 776 PELAQSLRLSD------KCDVYSFGVILLELVTGRKP 806
PE +S + + DV+S G+ +LE+ GR P
Sbjct: 170 PERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 53/227 (23%), Positives = 102/227 (44%), Gaps = 25/227 (11%)
Query: 599 ECLIGGGSIGSVY--RASFEGG--VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV 654
E +IG G G V R G + +A+K L+ + + +F E + H N++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+G S +I++E++ G+L L + T +G + G A
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG-----------MLRGIAS 117
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN----YGLTKFHNA 770
+ YL +H +L + NIL++ N K+SD+GL+++L D+ Y
Sbjct: 118 GMKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEAAYTTRGGKIP 172
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816
+ + APE + + DV+S+G+++ E+++ G +P + +V+
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI 219
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 19/219 (8%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G GS G V G +KKL R R ++ E E LS ++H N+VA++
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRE 66
Query: 659 YYWSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ L I+ F G+LY L G PE F + A AL
Sbjct: 67 SWEGEDGLLYIVMGFCEGGDLYHKL-------KEQKGKLLPENQVVEWF---VQIAMALQ 116
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
YLH ILH +LK+ N+ L K+ D G+A++L + T Y++PE
Sbjct: 117 YLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPY-YMSPE 172
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
L + + K DV++ G + E+ T + + N +V
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 43/158 (27%), Positives = 82/158 (51%), Gaps = 24/158 (15%)
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEP-KLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
LHH ILH +LK+ NILLD++ K+ D+G++K+L +K + VG Y+
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-----SKSKAYTVVGTPCYI 168
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
+PEL + + K D+++ G +L EL + ++ E+ +V+ + G+ +
Sbjct: 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVL-------KIMSGTFAPI 221
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872
DR +L Q++ L ++ PS+RP +++++
Sbjct: 222 SDR-----YSPDLRQLI-LSMLNLD--PSKRPQLSQIM 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 36/117 (30%), Positives = 62/117 (52%), Gaps = 15/117 (12%)
Query: 705 RFHI-ALGTA-----RALSYLHHDC-------KPPILHLNLKSTNILLDENYEPKLSDYG 751
+FHI +G A RA+ Y C + I++ +LK NILLD++ ++SD G
Sbjct: 88 KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLG 147
Query: 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVE 808
LA +P + + VGY+APE+ ++ R + D ++ G +L E++ G+ P +
Sbjct: 148 LAVHVP--EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 31/110 (28%), Positives = 55/110 (50%), Gaps = 10/110 (9%)
Query: 728 LHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA--VGYVAPELAQSLRLS 785
+H +L + N+LL + K+SD+GL+K L D+Y + + + APE + S
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 786 DKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
+ DV+S+G+ + E + G+KP + EV+ +E+G C
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGKRLDC 219
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 2e-07
Identities = 36/101 (35%), Positives = 57/101 (56%), Gaps = 18/101 (17%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL---------PILDNYGL 764
+AL Y+H ++H +LK +NILL+ + KL+D+GLA+ L P+L +Y
Sbjct: 118 KALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 765 TKFHNAVGYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
T++ Y APE L S R + D++S G IL E++ G+
Sbjct: 175 TRW-----YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 33/112 (29%), Positives = 54/112 (48%), Gaps = 5/112 (4%)
Query: 695 IGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
+GNP R A L LH + ++ +LK NILLD+ ++SD GLA
Sbjct: 94 MGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAV 150
Query: 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+P + + VGY+APE+ + R + D + G ++ E++ G+ P
Sbjct: 151 KIP--EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 3e-07
Identities = 55/215 (25%), Positives = 91/215 (42%), Gaps = 31/215 (14%)
Query: 616 EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLI-LSEF 672
G +A+K L T + F E + + H N+VA + L + E+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 673 VPKGNLYDNL--HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHL 730
VP L + L G G TG + L AL+ H+ I+H
Sbjct: 61 VPGRTLREVLAADGALPAGE-TG-------------RLMLQVLDALACAHNQ---GIVHR 103
Query: 731 NLKSTNILL---DENYEPKLSDYGLAKLLP---ILDNYGLTKFHNAVG---YVAPELAQS 781
+LK NI++ K+ D+G+ LLP D LT+ +G Y APE +
Sbjct: 104 DLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG 163
Query: 782 LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
++ D+Y++G+I LE +TG++ V+ + E++
Sbjct: 164 EPVTPNSDLYAWGLIFLECLTGQRVVQGASVAEIL 198
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 38/113 (33%), Positives = 59/113 (52%), Gaps = 11/113 (9%)
Query: 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK--L 755
PE H RF+ A + AL+YLH + I++ +LK N+LLD KL+DYG+ K L
Sbjct: 94 PEEH--ARFYSA-EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL 147
Query: 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVE 808
P + F Y+APE+ + D ++ GV++ E++ GR P +
Sbjct: 148 RP---GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 62/287 (21%), Positives = 118/287 (41%), Gaps = 36/287 (12%)
Query: 602 IGGGSIGSVYRA------SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G GS G VY E +AVK + +R + EF E + ++V
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
G L++ E + G+L L + + G P +A A
Sbjct: 74 LLGVVSKGQPTLVVMELMAHGDLKSYLRSLR--PEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY-----GLTKFHNA 770
++YL+ +H +L + N ++ ++ K+ D+G+ + + D Y GL
Sbjct: 132 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLL----P 184
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829
V ++APE + + D++SFGV+L E+ + +P + + +V ++ +++ G
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQV------LKFVMDGG 238
Query: 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
D+ +N +V L +C P RP+ E+V +L+
Sbjct: 239 Y----LDQ-----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 33/96 (34%), Positives = 57/96 (59%), Gaps = 11/96 (11%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL-PILDNYGLTKFHNAVG 772
R L Y+H ++H +LK +NIL++EN + K+ D+GLA++ P + Y T++
Sbjct: 119 RGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170
Query: 773 YVAPELAQSLRLSD-KCDVYSFGVILLELVTGRKPV 807
Y APE+ + + D + D++S G I E++ G KP+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL 205
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-07
Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 32/218 (14%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVK---KLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G GS G V A +G G A+K K E L +++ + E L + H +V
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIKCLKKREIL-KMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ L EFV G L+ +L G N ++ +H L A
Sbjct: 85 CSFQDENRVYFLLEFVVGGELFTHLR-------KAGRFPNDV---AKFYHAEL--VLAFE 132
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
YLH I++ +LK N+LLD K++D+G AK +P + G Y+
Sbjct: 133 YLH-SKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKKVP-------DRTFTLCGTPEYL 182
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPV--ESP 810
APE+ QS D ++ GV+L E + G P ++P
Sbjct: 183 APEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220
|
Length = 329 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 3/96 (3%)
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK-FHNA 770
TA+ +S L H + I++ +LK N+LLD + ++SD GLA + + D TK +
Sbjct: 103 TAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA--VELKDGQSKTKGYAGT 160
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
G++APEL Q D ++ GV L E++ R P
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-07
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 32/215 (14%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+IG GS G VY A + +A+KK+ + +N+E L I + N+ H N++ + Y
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRE---LLI--MKNLNHINIIFLKDY 127
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH---------IAL 710
Y++ + + N++ N+ P T + H++R H +
Sbjct: 128 YYTECFK------KNEKNIFLNVVMEFIPQT----VHKYMKHYARNNHALPLFLVKLYSY 177
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGLAKLLPILDNYGLTKFHN 769
RAL+Y+H I H +LK N+L+D N + KL D+G AK L L +
Sbjct: 178 QLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--LAGQRSVSYIC 232
Query: 770 AVGYVAPELA-QSLRLSDKCDVYSFGVILLELVTG 803
+ Y APEL + + D++S G I+ E++ G
Sbjct: 233 SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 63/218 (28%), Positives = 95/218 (43%), Gaps = 42/218 (19%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFE-------LEIGRLSNIRHFNL 653
IG G+ G VY+A + G +A+KK IR E E EI L + H N+
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKK------IRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
V + ++ EF L+ +L + GI P + S F + G
Sbjct: 62 VKLLDVIHTENKLYLVFEF-----LHQDLKKF-MDASPLSGIPLPLIK-SYLFQLLQG-- 112
Query: 714 RALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL---TKFHN 769
L++ H H +LH +LK N+L++ KL+D+GLA+ +G+ T H
Sbjct: 113 --LAFCHSHR----VLHRDLKPQNLLINTEGAIKLADFGLARA------FGVPVRTYTHE 160
Query: 770 AVG--YVAPELAQSLRL-SDKCDVYSFGVILLELVTGR 804
V Y APE+ + S D++S G I E+VT R
Sbjct: 161 VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 38/150 (25%), Positives = 70/150 (46%), Gaps = 34/150 (22%)
Query: 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH----IALGTARALSYLHHDC 723
++ E++P G+L + + + P W+R + +AL ++ ++H D
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK-----------WARFYTAEVVLALDAIHSMGFIHRDV 168
Query: 724 KPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPELAQ 780
KP N+LLD++ KL+D+G ++ G+ + AVG Y++PE+ +
Sbjct: 169 KP---------DNMLLDKSGHLKLADFGTCMK---MNKEGMVRCDTAVGTPDYISPEVLK 216
Query: 781 SL----RLSDKCDVYSFGVILLELVTGRKP 806
S +CD +S GV L E++ G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 5e-07
Identities = 64/245 (26%), Positives = 109/245 (44%), Gaps = 42/245 (17%)
Query: 579 KSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYR-ASFEGGVSIAVKKLETLGRIRNQEE 637
+SL + WE IG G+ G VY+ + + G AVK L+ + + + E
Sbjct: 15 ESLGDPTDTWEIIET--------IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIE 66
Query: 638 FELEIGR-LSNIRHFNLVAFQGYYWSS------TMQLILSEFVPKGNLYDNLHGVNYPGT 690
E I + L N H N+V F G ++ + + L+L E G++ + + G+ G
Sbjct: 67 AEYNILQSLPN--HPNVVKFYGMFYKADKLVGGQLWLVL-ELCNGGSVTELVKGLLICGQ 123
Query: 691 STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750
L + +I G L +LH++ I+H ++K NILL KL D+
Sbjct: 124 --------RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDF 172
Query: 751 GLAKLLPILDNYGLTKFHNAVG---YVAPELAQSLRLSD-----KCDVYSFGVILLELVT 802
G++ L + + +VG ++APE+ + D +CDV+S G+ +EL
Sbjct: 173 GVSAQL----TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGD 228
Query: 803 GRKPV 807
G P+
Sbjct: 229 GDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 36/102 (35%), Positives = 54/102 (52%), Gaps = 20/102 (19%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL----LPILDNYGLTKFHN 769
R L Y+H +LH +LK +N+LL+ N + K+ D+GLA+ + Y +T++
Sbjct: 119 RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW-- 173
Query: 770 AVGYVAPELAQSLRLSDK----CDVYSFGVILLELVTGRKPV 807
Y APEL L + DV+S G I EL+ GRKP+
Sbjct: 174 ---YRAPEL---LLNCSEYTTAIDVWSVGCIFAELL-GRKPL 208
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 5e-07
Identities = 33/107 (30%), Positives = 56/107 (52%), Gaps = 20/107 (18%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
IA+ + L Y+H D KP NIL+D N +L+D+G L ++++ G +
Sbjct: 113 IAIDSVHQLHYVHRDIKP---------DNILMDMNGHIRLADFG--SCLKLMED-GTVQS 160
Query: 768 HNAVG---YVAPELAQSL-----RLSDKCDVYSFGVILLELVTGRKP 806
AVG Y++PE+ Q++ + +CD +S GV + E++ G P
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 5e-07
Identities = 61/244 (25%), Positives = 108/244 (44%), Gaps = 35/244 (14%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR---HFNLVAFQ 657
IG G+ G+VY A G +A++++ ++ Q + EL I + +R + N+V +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
Y ++ E++ G+L D V G I + +AL
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDV---VTETCMDEGQIAA----------VCRECLQALE 130
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL-AKLLPILDNYGLTKFHNAVG---Y 773
+LH + ++H ++KS NILL + KL+D+G A++ P +K VG +
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-----EQSKRSTMVGTPYW 182
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV--ESPTTNEVVVLCEYVRELLERGSA 831
+APE+ K D++S G++ +E++ G P E+P ++ EL
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 832 SACF 835
SA F
Sbjct: 243 SAIF 246
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 5e-07
Identities = 34/101 (33%), Positives = 50/101 (49%), Gaps = 20/101 (19%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
R L YLH ++H +LK +NIL++ N + K+ D+GLA+ +D K Y
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLAR---GVDPDEDEK-GFLTEY 166
Query: 774 V------APELAQSLRLSDKC----DVYSFGVILLELVTGR 804
V APEL L S + D++S G I EL+T +
Sbjct: 167 VVTRWYRAPEL---LLSSSRYTKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 37/112 (33%), Positives = 55/112 (49%), Gaps = 6/112 (5%)
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL 764
+F+IA AL +LH K I++ +LK NILLD L D+GL+K + DN
Sbjct: 99 KFYIA-ELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSK-ANLTDNKTT 153
Query: 765 TKFHNAVGYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
F Y+APE L + D +S GV++ E+ G P + T ++
Sbjct: 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM 205
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 6e-07
Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 20/98 (20%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
R L Y+H I+H +LK +NI ++E+ E K+ D+GLA+ + +T GY
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHT----DDEMT------GY 175
Query: 774 V------APELAQS-LRLSDKCDVYSFGVILLELVTGR 804
V APE+ + + + D++S G I+ EL+TG+
Sbjct: 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 6e-07
Identities = 63/221 (28%), Positives = 93/221 (42%), Gaps = 37/221 (16%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEE----FEL-EIGRLSNIRHFN-- 652
IG G+ G+VY+A G +A+KK+ R+ EE L EI L + F
Sbjct: 6 EIGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHP 61
Query: 653 -----LVAFQGYYWSSTMQLILS-EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF 706
L G ++L L E V + +L L PG I R+
Sbjct: 62 NIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETI----KDLMRQL 116
Query: 707 HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK 766
R + +LH I+H +LK NIL+ + + K++D+GLA++ LT
Sbjct: 117 ------LRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTS 165
Query: 767 FHNAVGYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ Y APE L QS + D++S G I EL R+P
Sbjct: 166 VVVTLWYRAPEVLLQSSYAT-PVDMWSVGCIFAELFR-RRP 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 7e-07
Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 5/112 (4%)
Query: 695 IGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
+G L R H + + +LH I++ ++K N+LLD+ +LSD GLA
Sbjct: 87 VGERGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAV 143
Query: 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
L D +T+ GY+APE+ + S D ++ G + E+V GR P
Sbjct: 144 ELK--DGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 70/229 (30%), Positives = 96/229 (41%), Gaps = 42/229 (18%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGR---LSNIRHFNLVAFQ 657
IG GS G V A G AVK L+ ++ +E+ + R L N++H LV
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV--- 59
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL--HWSR---------RF 706
G ++S F LY L VN GG EL H R RF
Sbjct: 60 GLHYS---------FQTADKLYFVLDYVN------GG----ELFFHLQRERSFPEPRARF 100
Query: 707 HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK 766
+ A A AL YLH I++ +LK NILLD L+D+GL K I + +
Sbjct: 101 YAA-EIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTST 155
Query: 767 FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
F Y+APE+ + D + G +L E++ G P S T E+
Sbjct: 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEM 204
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 8e-07
Identities = 74/320 (23%), Positives = 130/320 (40%), Gaps = 58/320 (18%)
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
L ++++ N L +I E + +L N+ LDL N+ + +IP + K + LS N
Sbjct: 94 PLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNK 151
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
+ S+P + N L+ D SFN+LS +LP + N+ L+ + + GN ++ + +
Sbjct: 152 IE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELL 208
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
+++ LDLS+N I
Sbjct: 209 SALEELDLSNNSII---------------------------------------------- 222
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
+ S++N +NL L+L N+L +P I +L L + L+NN I +LGS+
Sbjct: 223 ---ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQI--SSISSLGSL 276
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
L LDL + N I+ LL L ++ + L ++ + +
Sbjct: 277 TNLRELDL-SGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSNGET 335
Query: 421 LNGSTPPSLGNLSNLQVLDL 440
+ L +L+NL LD
Sbjct: 336 SSPEALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 37/105 (35%), Positives = 58/105 (55%), Gaps = 12/105 (11%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV-- 771
+ +++ H + +LH +LK N+L+++ E KL+D+GLA+ I N F N V
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN----TFSNEVVT 163
Query: 772 -GYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
Y AP+ L S S D++S G I+ E++TGR P+ T NE
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNE 207
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 8e-07
Identities = 65/227 (28%), Positives = 97/227 (42%), Gaps = 54/227 (23%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEE-----FELEIGRLSNIRHFNLVA 655
IG G+ G VY+ + G +A+KK+ R+ ++EE EI L ++H N+V
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63
Query: 656 FQGYYWSSTMQLILSEF-----------VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSR 704
Q + ++ EF +PKG D EL S
Sbjct: 64 LQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMD-----------------AELVKSY 106
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYG 763
+ I G + + H +LH +LK N+L+D KL+D+GLA+ I + Y
Sbjct: 107 LYQILQG----ILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159
Query: 764 LTKFHNAVG--YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPV 807
H V Y APE L S R S D++S G I E+ T +KP+
Sbjct: 160 ----HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMAT-KKPL 201
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 8e-07
Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 36/148 (24%)
Query: 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI-----ALGTARALSYLHHDCKP 725
E++P G+L NL NY PE W+R F+ AL ++ ++H D KP
Sbjct: 123 EYMPGGDLV-NLMS-NYD--------IPE-KWAR-FYTAEVVLALDAIHSMGFIHRDVKP 170
Query: 726 PILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPELAQSL 782
N+LLD++ KL+D+G +D G+ + AVG Y++PE+ +S
Sbjct: 171 ---------DNMLLDKSGHLKLADFGTCMK---MDANGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 783 R----LSDKCDVYSFGVILLELVTGRKP 806
+CD +S GV L E++ G P
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 1e-06
Identities = 68/289 (23%), Positives = 120/289 (41%), Gaps = 59/289 (20%)
Query: 541 MNIKARRR--------KRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGT 592
+ RRR +RD V P S+ S+ S S S A +
Sbjct: 20 TKSRPRRRPDLTLPLPQRDPSLAVPLPLPPPSSSSSSS-------SSSSASGSAPSAAKS 72
Query: 593 KALLDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGR----IRNQEEFELEIGRLSN 647
+ L++ IG G+ G+VY+ G A+K + G +R Q E+EI L +
Sbjct: 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVI--YGNHEDTVRRQICREIEI--LRD 128
Query: 648 IRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF- 706
+ H N+V + + +L EF+ G+L + H +F
Sbjct: 129 VNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL-EGTH-----------------IADEQFL 170
Query: 707 -HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT 765
+A ++YLH + I+H ++K +N+L++ K++D+G++++L +
Sbjct: 171 ADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRIL----AQTMD 223
Query: 766 KFHNAVG---YVAPE-----LAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+++VG Y++PE L D++S GV +LE GR P
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 65/237 (27%), Positives = 89/237 (37%), Gaps = 77/237 (32%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFE-------LEIGRLSNIRHFNL 653
IG G+ G VY+A G +A+KK IR + E E EI L + H N+
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKK------IRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 654 VAFQG--------Y------------YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTG 693
V Y Y S+ L + K LY L G+ Y
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY------ 114
Query: 694 GIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753
H S R +LH +LK N+L+D KL+D+GLA
Sbjct: 115 ------CH-SHR---------------------VLHRDLKPQNLLIDREGALKLADFGLA 146
Query: 754 KLLPI-LDNYGLTKFHNAVG--YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ + + Y H V Y APE L S + S D++S G I E+V R+P
Sbjct: 147 RAFGVPVRTYT----HEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVN-RRP 198
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 1e-06
Identities = 59/218 (27%), Positives = 90/218 (41%), Gaps = 34/218 (15%)
Query: 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEL------EIGRLSNIRH 650
K +G GS +VY+ G S +L L IR + E E L +++H
Sbjct: 8 KKLDKLGEGSYATVYK-----GRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKH 62
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKG-NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
N+V + ++ E++ Y + G GG+ +H R F
Sbjct: 63 ANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCG--------GGL---SMHNVRLFLFQ 111
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN 769
L R L+Y H +LH +LK N+L+ E E KL+D+GLA+ + T +
Sbjct: 112 L--LRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK---TYSNE 163
Query: 770 AVG--YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
V Y P+ L S S D++ G I E+ TGR
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 66/287 (22%), Positives = 123/287 (42%), Gaps = 40/287 (13%)
Query: 602 IGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLV 654
+G G+ G V A+ G + +AVK L+ +E E+ +S++ H N+V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
G L+++E+ G+L + L + L +S + +A G A
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTL----EDLLSFS--YQVAKGMAF 156
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY---GLTKFHNAV 771
S +C +H +L + N+LL K+ D+GLA+ + NY G + V
Sbjct: 157 LAS---KNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARL--PV 207
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830
++APE + + + DV+S+G++L E+ + G P + +L++ G
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFY------KLIKEG- 260
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
+ + A E+ +MK C P +RP+ ++VQ++
Sbjct: 261 ----YRMAQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 34/112 (30%), Positives = 56/112 (50%), Gaps = 5/112 (4%)
Query: 695 IGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
+GNP R A L LH + I++ +LK NILLD+ ++SD GLA
Sbjct: 94 MGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAV 150
Query: 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+P + + VGY+APE+ ++ R + D + G ++ E++ G+ P
Sbjct: 151 EIP--EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 61/212 (28%), Positives = 95/212 (44%), Gaps = 35/212 (16%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVK--KLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ G+VY+A +AVK L+ ++ Q ELEI L ++ F G
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEI--LYKCDSPYIIGFYG 66
Query: 659 YYWSSTMQLILSEFVPKGNL--YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
++ I +EF+ G+L Y + PE R IA+ + L
Sbjct: 67 AFFVENRISICTEFMDGGSLDVYRKI---------------PEHVLGR---IAVAVVKGL 108
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL--PILDNYGLTKFHNAVGYV 774
+YL ILH ++K +N+L++ + KL D+G++ L I Y T NA Y+
Sbjct: 109 TYL---WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT---NA--YM 160
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE + DV+S G+ +EL GR P
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 70/279 (25%), Positives = 118/279 (42%), Gaps = 37/279 (13%)
Query: 602 IGGGSIGSVYRAS---FEGGVSIAVKKLETLGRIRNQEEFE--LEIGRLSNIRHFNLVAF 656
+G GS G+VY + V K +G + E + E LS + H +V F
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKF 67
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL-HWSRRFHIALGTARA 715
+ I++E+ +L L + + G + + ++ W + LG
Sbjct: 68 HASFLERDAFCIITEYCEGRDLDCKLEELKHTGKT---LSENQVCEWF--IQLLLG---- 118
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL-TKFHNAVGYV 774
+ Y+H + ILH +LK+ NI L N K+ D+G+++LL + + L T F Y+
Sbjct: 119 VHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL--MGSCDLATTFTGTPYYM 172
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
+PE + K D++S G IL E+ E N + V+ V S
Sbjct: 173 SPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG--QNFLSVVLRIVEG--PTPSLPET 228
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ R L N ++Q M ++ PS RPS AE+++
Sbjct: 229 YSRQL-----NSIMQSM------LNKDPSLRPSAAEILR 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-06
Identities = 54/212 (25%), Positives = 94/212 (44%), Gaps = 27/212 (12%)
Query: 600 CLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFE----LEIGRLSNIRHFNLV 654
+G G+ GSV A G +A+KKL R E F E+ L +++H N++
Sbjct: 21 KQVGSGAYGSVCSAIDKRTGEKVAIKKLS---RPFQSEIFAKRAYRELTLLKHMQHENVI 77
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+ T + EF D + Y T I L + ++
Sbjct: 78 GLLDVF---TSAVSGDEF------QDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLC 128
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGLTKFHNAVGY 773
L Y+H I+H +LK N+ ++E+ E K+ D+GLA+ + Y +T++ Y
Sbjct: 129 GLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW-----Y 180
Query: 774 VAPELAQS-LRLSDKCDVYSFGVILLELVTGR 804
APE+ + + + D++S G I+ E++TG+
Sbjct: 181 RAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 2e-06
Identities = 27/76 (35%), Positives = 44/76 (57%)
Query: 303 GVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIEL 362
G IP I+ R+L+ ++L N + G+IP + + L + L+ NS G IP +LG +
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 363 LEVLDLHNLNLRGEVP 378
L +L+L+ +L G VP
Sbjct: 492 LRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 67/220 (30%), Positives = 102/220 (46%), Gaps = 31/220 (14%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEE-FEL----EIGRLSNIRHFNLVA 655
IG G+ G VY+A + G +A+KK+ R+ N++E F + EI L + H N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKV----RLDNEKEGFPITAIREIKILRQLNHRNIVN 70
Query: 656 FQGYYWSSTMQLILSEFVPKGNLY-------DNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
+ + Q L KG Y +L G+ G +H+S HI
Sbjct: 71 LKEIV--TDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL---------VHFSED-HI 118
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
+ L L++ K LH ++K +NILL+ + KL+D+GLA+L ++ T
Sbjct: 119 KSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 769 NAVGYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPV 807
+ Y PE L R DV+S G IL EL T +KP+
Sbjct: 179 ITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 2e-06
Identities = 63/221 (28%), Positives = 97/221 (43%), Gaps = 37/221 (16%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQE---------EFELEIGRLSNIRHF 651
IG G+ G+VY+A G +A+K + R++ E E L + RL H
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSV----RVQTNEDGLPLSTVREVAL-LKRLEAFDHP 62
Query: 652 NLVAFQGYYWSS-----TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF 706
N+V +S T ++ E V + +L L V PG I + R+F
Sbjct: 63 NIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKD----LMRQF 117
Query: 707 HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK 766
R L +LH +C I+H +LK NIL+ + KL+D+GLA++ LT
Sbjct: 118 ------LRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTP 166
Query: 767 FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV 807
+ Y APE+ + D++S G I E+ RKP+
Sbjct: 167 VVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 30/91 (32%), Positives = 50/91 (54%), Gaps = 4/91 (4%)
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVA 775
L +LH I++ +LK NILLD + K++D+G+ K +L + F Y+A
Sbjct: 109 LQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKE-NMLGDAKTCTFCGTPDYIA 164
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
PE+ + + D +SFGV+L E++ G+ P
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 35/215 (16%)
Query: 602 IGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFE-------LEIGRLSNIRHFNL 653
IG G+ G VY+A +IA+KK IR ++E E EI L ++H N+
Sbjct: 10 IGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
V Q S ++ E++ +L H + P + NP L + + I
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAK----NPRLIKTYLYQIL---- 112
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEP-KLSDYGLAKLLPILDNYGLTKFHNAVG 772
R ++Y H +LH +LK N+L+D KL+D+GLA+ I T H V
Sbjct: 113 RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR---TFTHEVVT 166
Query: 773 --YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y APE L S S D++S G I E+V +
Sbjct: 167 LWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 2e-06
Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 7/109 (6%)
Query: 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757
PE H RF+ A + AL++LH + I++ +LK N+LLD KL+DYG+ K
Sbjct: 94 PEEH--ARFYSA-EISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK-EG 146
Query: 758 ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
I + F Y+APE+ + D ++ GV++ E++ GR P
Sbjct: 147 IRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 71/254 (27%), Positives = 113/254 (44%), Gaps = 43/254 (16%)
Query: 570 IIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLET 628
+ GK ++F S P + WE IG G+ G V++ + + G AVK L+
Sbjct: 3 LSGKTIIFD-SFPDPSDTWEIIET--------IGKGTYGKVFKVLNKKNGSKAAVKILDP 53
Query: 629 LGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQ------LILSEFVPKGNLYDN 681
+ I EE E E L + H N+V F G Y+ ++ L+L E G++ D
Sbjct: 54 IHDI--DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVL-ELCNGGSVTDL 110
Query: 682 LHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE 741
+ G G E + H AL L +LH + +H ++K NILL
Sbjct: 111 VKGFLKRGERME-----EPIIAYILHEAL---MGLQHLHVN---KTIHRDVKGNNILLTT 159
Query: 742 NYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPEL---AQSLRLS--DKCDVYSF 793
KL D+G++ L + L + + +VG ++APE+ Q L + +CDV+S
Sbjct: 160 EGGVKLVDFGVSAQ---LTSTRLRR-NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSL 215
Query: 794 GVILLELVTGRKPV 807
G+ +EL G P+
Sbjct: 216 GITAIELGDGDPPL 229
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 41/108 (37%), Positives = 53/108 (49%), Gaps = 17/108 (15%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL--AKLLPILDNYGLTK-FHNA 770
R LSY H ILH +LK N+L++E E KL+D+GL AK +P TK + N
Sbjct: 114 RGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP-------TKTYSNE 163
Query: 771 V---GYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
V Y P+ L S S D++ G IL E+ TGR T E
Sbjct: 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 63/229 (27%), Positives = 97/229 (42%), Gaps = 37/229 (16%)
Query: 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEL------EIGRLSNIR 649
LDK +G G+ +VY+ G S L L IR + E E+ L +++
Sbjct: 11 LDK---LGEGTYATVYK-----GRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK 62
Query: 650 HFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
H N+V + ++ E++ K +L L G N +H + F
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYL-------DDCGNSIN--MHNVKLFLFQ 112
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN 769
L R L+Y H + +LH +LK N+L++E E KL+D+GLA+ I + N
Sbjct: 113 L--LRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI----PTKTYSN 163
Query: 770 AV---GYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
V Y P+ L S S + D++ G I E+ TGR T E
Sbjct: 164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 33/94 (35%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL +LH K I++ ++K NILLD N L+D+GL+K + F + Y+
Sbjct: 117 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 775 APELAQSLRLS-DKC-DVYSFGVILLELVTGRKP 806
AP++ + DK D +S GV++ EL+TG P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 34/116 (29%), Positives = 54/116 (46%), Gaps = 21/116 (18%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
+A+ + + Y+H D KP N+L+D KL+D+G A L + +K
Sbjct: 113 LAIHSVHQMGYVHRDIKP---------ENVLIDRTGHIKLADFGSAARLTA-NKMVNSKL 162
Query: 768 HNAVG---YVAPELAQSLRLSDK------CDVYSFGVILLELVTGRKPVESPTTNE 814
VG Y+APE+ ++ K CD +S GVI E++ GR P T+ +
Sbjct: 163 --PVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK 216
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 45/171 (26%), Positives = 72/171 (42%), Gaps = 34/171 (19%)
Query: 645 LSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSR 704
L N RH L + + + + + E+V G L+ H SR
Sbjct: 49 LKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELF--------------------FHLSR 88
Query: 705 ---------RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755
RF+ A AL YLH I++ +LK N++LD++ K++D+GL K
Sbjct: 89 ERVFSEDRTRFYGA-EIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE 144
Query: 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
I D + F Y+APE+ + D + GV++ E++ GR P
Sbjct: 145 -GITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 29/84 (34%), Positives = 46/84 (54%), Gaps = 10/84 (11%)
Query: 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV---GYVAPE-LAQSL 782
+++ +LK NILLDE+ ++SD GLA ++ K H +V GY+APE L + +
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPEVLQKGV 171
Query: 783 RLSDKCDVYSFGVILLELVTGRKP 806
D +S G +L +L+ G P
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 63/279 (22%), Positives = 110/279 (39%), Gaps = 33/279 (11%)
Query: 602 IGGGSIGSVYRASFE-GGVSIAVKKLET--LGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
IG G VYRA+ GV +A+KK++ L + + + EI L + H N++ +
Sbjct: 10 IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
+ I+ E G+L + PE + F + AL +
Sbjct: 70 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI-----PEKTVWKYF---VQLCSALEH 121
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVA 775
+H ++H ++K N+ + KL D GL + + T H+ VG Y++
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMS 174
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
PE + K D++S G +L E+ + P N + LC+ + + S +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEQCDYPPLPSDHY 233
Query: 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874
LR +L +C + P +RP + V V
Sbjct: 234 SEELR-----------QLVNMCINPDPEKRPDITYVYDV 261
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 3e-06
Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 1/85 (1%)
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
L L G IP + K + ++LS N++ G+IP S+ + T LE D S+N+ +G
Sbjct: 423 LGLDNQGLRGFIPNDISKL-RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 209 LPSQICNIPVLDFISVRGNALTGTV 233
+P + + L +++ GN+L+G V
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 3e-06
Identities = 35/104 (33%), Positives = 51/104 (49%), Gaps = 1/104 (0%)
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
TA L L + K +++ +LK NILLD L D+GL KL + D+ F
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCGTP 157
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Y+APEL + D ++ GV+L E++TG P NE+
Sbjct: 158 EYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM 201
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 3/92 (3%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL YLH + +++ +LK N++LD++ K++D+GL K I D + F Y+
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYL 163
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ + D + GV++ E++ GR P
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 38/150 (25%), Positives = 69/150 (46%), Gaps = 34/150 (22%)
Query: 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH----IALGTARALSYLHHDC 723
++ E++P G+L + + + P W++ + +AL ++ +H D
Sbjct: 120 MVMEYMPGGDLVNLMSNYDVPEK-----------WAKFYTAEVVLALDAIHSMGLIHRDV 168
Query: 724 KPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPELAQ 780
KP N+LLD++ KL+D+G +D G+ + AVG Y++PE+ +
Sbjct: 169 KP---------DNMLLDKHGHLKLADFGTCMK---MDETGMVRCDTAVGTPDYISPEVLK 216
Query: 781 SL----RLSDKCDVYSFGVILLELVTGRKP 806
S +CD +S GV L E++ G P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-06
Identities = 33/121 (27%), Positives = 60/121 (49%), Gaps = 1/121 (0%)
Query: 174 VSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTV 233
+ L + L G IP I+ +L+ + S N++ G +P + +I L+ + + N+ G++
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 234 EEQFSQCQSIKNLDLSSNLFIGLAPFGVLG-LKNISYFNVSHNGFHGEIPEVGICGEGMQ 292
E Q S++ L+L+ N G P + G L + + FN + N IP + CG +
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACGPHLS 542
Query: 293 V 293
V
Sbjct: 543 V 543
|
Length = 623 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 4e-06
Identities = 26/89 (29%), Positives = 46/89 (51%), Gaps = 1/89 (1%)
Query: 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSD 786
I++ +LK N++LD K++D+G+ K + D F Y+APE+
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180
Query: 787 KCDVYSFGVILLELVTGRKPVESPTTNEV 815
D ++FGV+L E++ G+ P E +E+
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 4e-06
Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 30/212 (14%)
Query: 602 IGGGSIGSVYRASFEG--GVSIAVKKL-ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ GSV A+F+ G+ +AVKKL I + + E+ L +++H N++
Sbjct: 25 VGSGAYGSVC-AAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG--- 80
Query: 659 YYWSSTMQLILSEFVPKGNL--YDNLHGVNY-PGTSTGGIGN-PELHWSRRFHIALGTAR 714
+L F P +L +++++ V + G I +L + R
Sbjct: 81 ---------LLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILR 131
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGLTKFHNAVGY 773
L Y+H I+H +LK +N+ ++E+ E K+ D+GLA+ + Y T++ Y
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-----Y 183
Query: 774 VAPELAQS-LRLSDKCDVYSFGVILLELVTGR 804
APE+ + + + D++S G I+ EL+TGR
Sbjct: 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 4e-06
Identities = 37/123 (30%), Positives = 63/123 (51%), Gaps = 25/123 (20%)
Query: 705 RFHI-----ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL 759
RF++ A+ + L Y+H D KP N+LLD+N +L+D+G L +L
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKP---------DNVLLDKNGHIRLADFG--SCLRLL 153
Query: 760 DNYGLTKFHNAVG---YVAPELAQSL-----RLSDKCDVYSFGVILLELVTGRKPVESPT 811
+ G + + AVG Y++PE+ Q++ R +CD +S GV + E++ G P + +
Sbjct: 154 AD-GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212
Query: 812 TNE 814
E
Sbjct: 213 LVE 215
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 64/292 (21%), Positives = 112/292 (38%), Gaps = 46/292 (15%)
Query: 602 IGGGSIGSVYRASFEGG------VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ G VY + G + +AVK L +++ +F +E +S H N+V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNL-HGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
G + + IL E + G+L L P + L A A+
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPS------SLTMKDLLFCARDVAK 127
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLD---ENYEPKLSDYGLAKLLPILDNYGLTKFHNA- 770
YL + +H ++ + N LL K++D+G+A+ D Y + +
Sbjct: 128 GCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGG 179
Query: 771 -----VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824
+ ++ PE + K DV+SFGV+L E+ + G P T EV+ E+V
Sbjct: 180 RAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---EFVTG 236
Query: 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
C V ++ C P RP+ A +++ ++
Sbjct: 237 GGRLDPPKGCPGP------------VYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 5e-06
Identities = 46/152 (30%), Positives = 72/152 (47%), Gaps = 20/152 (13%)
Query: 728 LHLNLKSTNILLDENYEPKLSDYGLAKLL---PILDNYGLTKFHNAVGYVAPELAQSLRL 784
+H +L + NILL EN K+ D+GLA+ + P G + + ++APE
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL--PLKWMAPETIFDRVY 258
Query: 785 SDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFA 843
+ + DV+SFGV+L E+ + G P +E E+ R L E A +
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-----EFCRRLKEGTRMRA------PDYT 307
Query: 844 ENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
E+ Q M L C PS+RP+ +E+V+ L
Sbjct: 308 TPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 30/98 (30%), Positives = 49/98 (50%), Gaps = 5/98 (5%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
+ L R L YLH + I+H +LK +N+LL + K++D+GLA+ + +T
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK-PMTPK 168
Query: 768 HNAVGYVAPELAQSLRLSDKC-DVYSFGVILLELVTGR 804
+ Y APEL D+++ G IL EL+ +
Sbjct: 169 VVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 5e-06
Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
RAL Y+H + H +LK NIL + + + K+ D+GLA++ D + + V
Sbjct: 114 RALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVA-FNDTPTAIFWTDYVAT 169
Query: 773 --YVAPELAQSL--RLSDKCDVYSFGVILLELVTGR 804
Y APEL S + + D++S G I E++TG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 6e-06
Identities = 41/160 (25%), Positives = 56/160 (35%), Gaps = 67/160 (41%)
Query: 705 RFHI-----ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL 759
RF+I A+ + L Y+H D KP N+LLD KLSD+GL
Sbjct: 104 RFYIAETILAIDSIHKLGYIHRDIKP---------DNLLLDAKGHIKLSDFGLCT----- 149
Query: 760 DNYGLTKFH------------------------------------------NAVG---YV 774
GL K H + VG Y+
Sbjct: 150 ---GLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYI 206
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
APE+ + +CD +S GVI+ E++ G P S E
Sbjct: 207 APEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 64/236 (27%), Positives = 102/236 (43%), Gaps = 26/236 (11%)
Query: 602 IGGGSIGSVYRASFEGGVS---IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
IG G G V G + + VK+L ++ Q +F E +++H NL+ G
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
T L++ EF P G+L L T P+ +R +A A L +
Sbjct: 63 QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMT-----PDPTTLQR--MACEIALGLLH 115
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT--KFHNAVGYVAP 776
LH K +H +L N LL + K+ DYGL+ ++Y +T + + ++AP
Sbjct: 116 LH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAP 171
Query: 777 ELAQ----SLRLSDKC---DVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824
EL +L + D+ +V+S GV + EL G +P + + VL VRE
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 6e-06
Identities = 40/152 (26%), Positives = 61/152 (40%), Gaps = 46/152 (30%)
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA----------- 753
RF+IA T A+ +H K +H ++K NIL+D + KL+D+GL
Sbjct: 104 RFYIAELTC-AIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159
Query: 754 ---------------KLLPILDNYGLT-------------KFHNAVG---YVAPELAQSL 782
+ +D L H+ VG Y+APE+
Sbjct: 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRT 219
Query: 783 RLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
+ CD +S GVIL E++ G+ P + T E
Sbjct: 220 GYTQLCDWWSVGVILYEMLVGQPPFLADTPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 7e-06
Identities = 32/107 (29%), Positives = 54/107 (50%), Gaps = 20/107 (18%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
+A+ + L Y+H D KP N+LLD N +L+D+G L + + G +
Sbjct: 113 LAIHSIHQLHYVHRDIKP---------DNVLLDMNGHIRLADFG--SCLKMNQD-GTVQS 160
Query: 768 HNAVG---YVAPELAQSL-----RLSDKCDVYSFGVILLELVTGRKP 806
AVG Y++PE+ Q++ + +CD +S GV + E++ G P
Sbjct: 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 7e-06
Identities = 36/103 (34%), Positives = 53/103 (51%), Gaps = 18/103 (17%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA--------KLLPILDNYGLT 765
L Y+H +LH +LK N+L++ + E K+ D+GLA + + Y T
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172
Query: 766 KFHNAVGYVAPELAQSLRLSDKC-DVYSFGVILLELVTGRKPV 807
++ Y APE+ S + K DV+S G IL EL+ GRKPV
Sbjct: 173 RW-----YRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 32/112 (28%), Positives = 54/112 (48%), Gaps = 5/112 (4%)
Query: 695 IGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
+GNP R A L L + I++ +LK NILLD+ ++SD GLA
Sbjct: 94 MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAV 150
Query: 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+P + + VGY+APE+ + + + D + G ++ E++ G+ P
Sbjct: 151 QIP--EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 8e-06
Identities = 57/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 600 CLIGGGSIGSVYRASFEGGV---SIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
C +G G+ G VY+A + G A+K++E G + EI L ++H N++A
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACR---EIALLRELKHPNVIAL 63
Query: 657 QGYYWSSTMQLI--LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
Q + S + + + L ++ +D H + + S +L S +
Sbjct: 64 QKVFLSHSDRKVWLLFDYAE----HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILD 119
Query: 715 ALSYLHHDCKPPILHLNLKSTNILL----DENYEPKLSDYGLAKLL--PILDNYGLTKFH 768
+ YLH + +LH +LK NIL+ E K++D G A+L P+ L
Sbjct: 120 GIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176
Query: 769 NAVGYVAPELAQSLRLSDKC-DVYSFGVILLELVT 802
Y APEL R K D+++ G I EL+T
Sbjct: 177 VTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 25/168 (14%)
Query: 713 ARALSYL-HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA- 770
AR + +L C +H +L + NILL EN K+ D+GLA+ I + + +A
Sbjct: 184 ARGMEFLASRKC----IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGSAR 237
Query: 771 --VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827
+ ++APE + + DV+SFGV+L E+ + G P NE E+ + L +
Sbjct: 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-----EFCQRLKD 292
Query: 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
A EN ++ ++ L C P RP+ + +V++L
Sbjct: 293 GTRMRA---------PENATPEIYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 9e-06
Identities = 28/92 (30%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL YLH +++ ++K N++LD++ K++D+GL K I D + F Y+
Sbjct: 107 ALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYL 162
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ + D + GV++ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 9e-06
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 57/302 (18%)
Query: 601 LIGGGSIGSVYRASFE----GGVSIAVKKLET-LGRIRNQEEFELEIGRLSNIRHFNLVA 655
++G G GSV A + +AVK L+ + + EEF E + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65
Query: 656 FQGYYWSSTMQ------LILSEFVPKGNLYDNLHGVNYPGTSTGGIG-NP---ELHWSRR 705
G S + +++ F+ G+L+ L IG P L R
Sbjct: 66 LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL--------LMSRIGEEPFTLPLQTLVR 117
Query: 706 FHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY--- 762
F I + A + YL +H +L + N +L+EN ++D+GL+K + D Y
Sbjct: 118 FMIDI--ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQG 172
Query: 763 GLTKFHNAVGYVAPE-LAQSLRLSDKCDVYSFGVILLELVT-GRKP---VESPTTNEVVV 817
+K V ++A E LA ++ + DV++FGV + E++T G+ P VE+ ++
Sbjct: 173 CASKL--PVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLI 229
Query: 818 LCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
+++ + C + ++ ++M C S P RPS + LE
Sbjct: 230 KGNRLKQPPD------CLE---------DVYELMCQ---CWSPEPKCRPSFQHLRDQLEL 271
Query: 878 IR 879
I
Sbjct: 272 IW 273
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-05
Identities = 79/375 (21%), Positives = 135/375 (36%), Gaps = 89/375 (23%)
Query: 121 TLWKINVSSNAL---SGSIPEFIGDLPNIRLLDLSRNSY--SGEIPFALFKYCYKTKFVS 175
L + V+ AL S ++ L + LDL S S + L +
Sbjct: 41 NLESVAVNRLALNLSSNTLLLLPSSLSRLLSLDLLSPSGISSLDGSENL-LNLLPLPSLD 99
Query: 176 LSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPV-LDFISVRGNALTGTVE 234
L+ N L +I + T L D NN++ ++P I + L + + N + ++
Sbjct: 100 LNLNRLRSNI-SELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLP 156
Query: 235 EQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVF 294
++KNLDLS N + P + L N++ ++S N
Sbjct: 157 SPLRNLPNLKNLDLSFND-LSDLPKLLSNLSNLNNLDLSGNKIS---------------- 199
Query: 295 DASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP 354
+P I L+ LDL N +I + + +++L+ L + L+NN +
Sbjct: 200 ---------DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKL----- 244
Query: 355 PNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKIL 414
D+P+++ N++ L+ L
Sbjct: 245 --------------------------------------------EDLPESIGNLSNLETL 260
Query: 415 DLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSS-LGNLRNLTHFNLSSNNLSGTI 473
DL N S+ SLG+L+NL+ LDLS NSLS ++P L L NL + +
Sbjct: 261 DLSNN--QISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALEL 318
Query: 474 PSTIQHFGVSTFLNN 488
+ N
Sbjct: 319 KLNSILLNNNILSNG 333
|
Length = 394 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 1e-05
Identities = 44/185 (23%), Positives = 86/185 (46%), Gaps = 4/185 (2%)
Query: 619 VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678
V +AVK L + +F EI +S +++ N++ G S +++E++ G+L
Sbjct: 45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNIL 738
L T T P + + ++A+ A + YL +H +L + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 739 LDENYEPKLSDYGLAKLLPILDNYGLT-KFHNAVGYVAPELAQSLRLSDKCDVYSFGVIL 797
+ +Y K++D+G+++ L D Y + + + ++A E + + DV++FGV L
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221
Query: 798 LELVT 802
E+ T
Sbjct: 222 WEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 1e-05
Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 8/94 (8%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
R L YLH ILH ++K N+L++ N K+ D+GLA++ ++ +T V
Sbjct: 114 RGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMT--QEVVTQ 168
Query: 773 -YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y APE L S + D++S G I EL+ R
Sbjct: 169 YYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 62/285 (21%), Positives = 115/285 (40%), Gaps = 35/285 (12%)
Query: 602 IGGGSIGSVYRAS-FEGGVSIAVKKLETLGRI--RNQEEFELEIGRLSNIRHFNLVAFQG 658
IG G VYRA+ +A+KK++ + + +++ EI L + H N++ +
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELH-WSRRFHIALGTARALS 717
+ I+ E G+L + Y I PE W ++ + L +A
Sbjct: 70 SFIEDNELNIVLELADAGDLS---QMIKYFKKQKRLI--PERTVW--KYFVQLCSA---- 118
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
+ H ++H ++K N+ + KL D GL + + T H+ VG Y+
Sbjct: 119 -VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYM 173
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
+PE + K D++S G +L E+ + P N + LC+ + + +
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIEQCDYPPLPTEH 232
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
+ LR EL+ +C P +RP + V Q+ + +
Sbjct: 233 YSEKLR-----ELVS------MCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 61/223 (27%), Positives = 101/223 (45%), Gaps = 45/223 (20%)
Query: 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKK-LETLGRIRNQEEFEL-------EIGRLSN 647
+K IG GS G V++ + E G +A+KK +E+ E+ + EI L
Sbjct: 4 EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-------EDDPVIKKIALREIRMLKQ 56
Query: 648 IRHFNLVAF-QGYYWSSTMQLILSEFVPKGNLYD---NLHGVNYPGTSTGGIGNPELHWS 703
++H NLV + + + L+ E+ L + N GV PE
Sbjct: 57 LKHPNLVNLIEVFRRKRKLHLVF-EYCDHTVLNELEKNPRGV------------PEHLIK 103
Query: 704 RRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL-PILDN 761
+ I T +A+++ H H+C +H ++K NIL+ + + KL D+G A++L D+
Sbjct: 104 K---IIWQTLQAVNFCHKHNC----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
Query: 762 YGLTKFHNAVGYVAPEL-AQSLRLSDKCDVYSFGVILLELVTG 803
Y T + Y APEL + DV++ G + EL+TG
Sbjct: 157 Y--TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 1e-05
Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 602 IGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRN--QEEFELEIGRLSNIRHFNLVAFQG 658
IG G+ G V++A E G ++A+KK+ L R+ + EI L +H +V
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKV-ALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
+ + +++ E++P L + L P PE + L + ++Y
Sbjct: 67 VFPHGSGFVLVMEYMPSD-LSEVLRDEERP--------LPEAQVKSYMRMLL---KGVAY 114
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVA 775
+H I+H +LK N+L+ + K++D+GLA+L + + V Y A
Sbjct: 115 MH---ANGIMHRDLKPANLLISADGVLKIADFGLARL---FSEEEPRLYSHQVATRWYRA 168
Query: 776 PELAQSLRLSDK-CDVYSFGVILLELVTGR 804
PEL R D D+++ G I EL+ G
Sbjct: 169 PELLYGARKYDPGVDLWAVGCIFAELLNGS 198
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 10/92 (10%)
Query: 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV---GYVAPELAQSLR 783
+++ +LK NILLDE+ ++SD GLA ++ K H +V GY+APE+ Q
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLAC------DFSKKKPHASVGTHGYMAPEVLQKGT 171
Query: 784 LSD-KCDVYSFGVILLELVTGRKPVESPTTNE 814
D D +S G +L +L+ G P T +
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 23/68 (33%), Positives = 39/68 (57%)
Query: 77 IVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSI 136
I L S+ G + P+L + SL VL L N F G++P+ ++ +L +N++ N+LSG +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 137 PEFIGDLP 144
P +G
Sbjct: 507 PAALGGRL 514
|
Length = 623 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 35/106 (33%), Positives = 54/106 (50%), Gaps = 8/106 (7%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL +LH K I++ ++K NILLD L+D+GL+K + F + Y+
Sbjct: 117 ALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYM 173
Query: 775 APELAQSLRLSDKC-DVYSFGVILLELVTGRKPV----ESPTTNEV 815
APE+ + K D +S G+++ EL+TG P E T +EV
Sbjct: 174 APEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 59/285 (20%), Positives = 111/285 (38%), Gaps = 33/285 (11%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRI--RNQEEFELEIGRLSNIRHFNLVAFQG 658
IG G VY+A G +A+KK++ + + +++ EI L + H N++ +
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
+ + I+ E G+L + I + W + AL +
Sbjct: 70 SFIENNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTI-WKYFVQLC----SALEH 121
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVA 775
+H I+H ++K N+ + KL D GL + + T H+ VG Y++
Sbjct: 122 MH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTPYYMS 174
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
PE + K D++S G +L E+ + P N + LC+ + + + +
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKIEKCDYPPLPADHY 233
Query: 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880
LR C + P +RP ++ V+QV + +
Sbjct: 234 SEELRDLVS-----------RCINPDPEKRPDISYVLQVAKEMHA 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 42/152 (27%), Positives = 72/152 (47%), Gaps = 20/152 (13%)
Query: 728 LHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRL 784
+H +L + NILL EN K+ D+GLA+ I + + +A + ++APE
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252
Query: 785 SDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFA 843
+ + DV+SFGV+L E+ + G P +E C ++E + +A
Sbjct: 253 TTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLKEGTRMRAPE---------YA 301
Query: 844 ENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
E+ +M L C P RP+ +E+V++L
Sbjct: 302 TPEIYSIM---LDCWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 30/92 (32%), Positives = 46/92 (50%), Gaps = 4/92 (4%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL +LH I++ +LK NILLD KL+D+GL K I + F + Y+
Sbjct: 112 ALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEGTVTHTFCGTIEYM 167
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ D +S G ++ +++TG P
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 3e-05
Identities = 30/92 (32%), Positives = 50/92 (54%), Gaps = 4/92 (4%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL YLH C +++ +LK N++LD++ K++D+GL K I D + F Y+
Sbjct: 107 ALGYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYL 162
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ + D + GV++ E++ GR P
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 35/223 (15%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHF-NLVAFQG 658
++G G+ G VY+ + G A+K ++ +EE +LEI L H N+ + G
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED--EEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 659 YYWSSTM-----QL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ + QL ++ EF G++ D + N G + L +I
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVK--NTKGNA--------LKEDWIAYICREI 130
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
R L++LH ++H ++K N+LL EN E KL D+G++ L + + + + +G
Sbjct: 131 LRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIG 183
Query: 773 ---YVAPELAQSLRLSD-----KCDVYSFGVILLELVTGRKPV 807
++APE+ D + D++S G+ +E+ G P+
Sbjct: 184 TPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 34/220 (15%)
Query: 601 LIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGR---LSNIRHFNLVAF 656
+IG GS G V A + G AVK L+ ++ +E+ + R L N++H LV
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGL 61
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF------HIAL 710
+ ++ + ++V G L+ H L R F A
Sbjct: 62 HYSFQTAEKLYFVLDYVNGGELF--FH----------------LQRERCFLEPRARFYAA 103
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK-FHN 769
A A+ YLH I++ +LK NILLD L+D+GL K ++ T F
Sbjct: 104 EVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCG 158
Query: 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809
Y+APE+ + D + G +L E++ G P S
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 4e-05
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 25/168 (14%)
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
RH N++ + + + ++S F+ G+ L G S IGN I
Sbjct: 57 RHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----------I 106
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN------- 761
G R L+YLH + +H N+K+++IL+ + LS GL+ L ++ N
Sbjct: 107 LFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVV 161
Query: 762 YGLTKFHNAV-GYVAPEL-AQSLR-LSDKCDVYSFGVILLELVTGRKP 806
Y +F +V +++PEL Q L + K D+YS G+ EL TGR P
Sbjct: 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 38/215 (17%)
Query: 602 IGGGSIGSVYRASFEG--GVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLVAF 656
IG G+ G V A+F+ G+++AVKKL +NQ + E+ L + H N+++
Sbjct: 29 IGSGAQGIVC-AAFDTVLGINVAVKKLSR--PFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 657 QGYYWSSTMQLILSEF--------VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
+ T Q L EF + NL +H EL R ++
Sbjct: 86 LNVF---TPQKSLEEFQDVYLVMELMDANLCQVIH--------------MELDHERMSYL 128
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
+ +LH I+H +LK +NI++ + K+ D+GLA+ N+ +T +
Sbjct: 129 LYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT--NFMMTPYV 183
Query: 769 NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTG 803
Y APE+ + + D++S G I+ ELV G
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 4e-05
Identities = 61/255 (23%), Positives = 95/255 (37%), Gaps = 68/255 (26%)
Query: 583 SKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEL-- 640
SK D+E K +G G+ G VY+A I ++ L +I E +
Sbjct: 5 SKLRDYEILGK--------LGEGTFGEVYKA-----RQIKTGRVVALKKILMHNEKDGFP 51
Query: 641 -----EIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTS---- 691
EI L ++H N+V ++ V + + G Y T
Sbjct: 52 ITALREIKILKKLKHPNVVP------------LIDMAVERPDKSKRKRGSVYMVTPYMDH 99
Query: 692 --TGGIGNPELHWSRRFHIAL-------GTARALSYLHHDCKPPILHLNLKSTNILLDEN 742
+G + NP + + I G YLH + ILH ++K+ NIL+D
Sbjct: 100 DLSGLLENPSVKLTES-QIKCYMLQLLEGIN----YLH---ENHILHRDIKAANILIDNQ 151
Query: 743 YEPKLSDYGLAKLLPILDN---------YGLTKFHNAV---GYVAPEL-AQSLRLSDKCD 789
K++D+GLA+ P G K+ N V Y PEL R + D
Sbjct: 152 GILKIADFGLAR--PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVD 209
Query: 790 VYSFGVILLELVTGR 804
++ G + E+ T R
Sbjct: 210 IWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (110), Expect = 5e-05
Identities = 61/248 (24%), Positives = 96/248 (38%), Gaps = 48/248 (19%)
Query: 601 LIGGGSIGSVYRASFEG-GVSIAVK---KLETLGRIR-NQEEFELEIGRLSNIRHFNLVA 655
L+G G +G V+ +G G A+K K E + R + + E EI L+ + H L
Sbjct: 8 LLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEI--LATLDHPFLPT 65
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
+ + T ++ ++ P G L+ L G E RF+ A A
Sbjct: 66 LYASFQTETYLCLVMDYCPGGELFRLLQ------RQPGKC-LSEEV--ARFYAAEVLL-A 115
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL--------PILDNYGLTKF 767
L YLH I++ +LK NILL E+ LSD+ L+K L
Sbjct: 116 LEYLH--LLG-IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSS 172
Query: 768 HNA-----------------VG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV 807
N+ VG Y+APE+ D ++ G++L E++ G P
Sbjct: 173 VNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF 232
Query: 808 ESPTTNEV 815
+ +E
Sbjct: 233 KGSNRDET 240
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 60/212 (28%), Positives = 89/212 (41%), Gaps = 34/212 (16%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEE----FEL--EIGRLSNIRHFNLVA 655
+G GS +VY+ G S KL L IR QEE F E L ++H N+V
Sbjct: 13 LGEGSYATVYK-----GKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL 67
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
+ ++ E+V + +L Y GG LH R
Sbjct: 68 LHDIIHTKETLTLVFEYV-----HTDL--CQYMDKHPGG-----LHPENVKLFLFQLLRG 115
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV---G 772
LSY+H ILH +LK N+L+ + E KL+D+GLA+ + + + N V
Sbjct: 116 LSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH----TYSNEVVTLW 168
Query: 773 YVAPE-LAQSLRLSDKCDVYSFGVILLELVTG 803
Y P+ L S S D++ G I +E++ G
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 53/221 (23%), Positives = 104/221 (47%), Gaps = 43/221 (19%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEE----FEL-EIGRLSNIRHFNLVA 655
IG G+ G+V++A + E +A+K++ R+ + +E L EI L ++H N+V
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRV----RLDDDDEGVPSSALREICLLKELKHKNIVR 63
Query: 656 FQGYYWSSTMQLILSEFVPKG--NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
S ++ E+ + +D+ +G + + + F L
Sbjct: 64 LYDVLHSDKKLTLVFEYCDQDLKKYFDSCNG------------DIDPEIVKSFMFQL--L 109
Query: 714 RALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL-TKFHNA- 770
+ L++ H H+ +LH +LK N+L+++N E KL+D+GLA+ +G+ + ++A
Sbjct: 110 KGLAFCHSHN----VLHRDLKPQNLLINKNGELKLADFGLAR------AFGIPVRCYSAE 159
Query: 771 ---VGYVAPELAQSLRLSD-KCDVYSFGVILLELVTGRKPV 807
+ Y P++ +L D++S G I EL +P+
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 5e-05
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 43/218 (19%)
Query: 601 LIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFEL------EIGRLSNIRHFNL 653
L+G GS G V + E G +A+KK + ++++ + EI L +RH NL
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKF-----LESEDDKMVKKIAMREIRMLKQLRHENL 62
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRR--FHIALG 711
V + ++ EFV + D+L YP G+ + R+ F I
Sbjct: 63 VNLIEVFRRKKRLYLVFEFVDH-TVLDDLE--KYPN----GL---DESRVRKYLFQIL-- 110
Query: 712 TARALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP----ILDNYGLTK 766
R + + H H+ I+H ++K NIL+ ++ KL D+G A+ L + +Y T+
Sbjct: 111 --RGIEFCHSHN----IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR 164
Query: 767 FHNAVGYVAPEL-AQSLRLSDKCDVYSFGVILLELVTG 803
+ Y APEL + D+++ G ++ E++TG
Sbjct: 165 W-----YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 8/97 (8%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
L Y+H + ILH ++K+ NIL+ ++ KL+D+GLA+ + N ++ N V
Sbjct: 131 GLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTL 187
Query: 773 -YVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKPV 807
Y PEL R D++ G I+ E+ T R P+
Sbjct: 188 WYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSPI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 6e-05
Identities = 42/175 (24%), Positives = 86/175 (49%), Gaps = 25/175 (14%)
Query: 707 HIALGTARALSYL-HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT 765
+ A+ + +L +C +H ++ + N+LL + K+ D+GLA+ + NY +
Sbjct: 216 RFSSQVAQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271
Query: 766 KFHNA---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEY 821
NA V ++APE + + DV+S+G++L E+ + G+ P N
Sbjct: 272 G--NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN------SK 323
Query: 822 VRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
++++RG + D FA E+ +MK+ C + P+ RP+ +++ Q+++
Sbjct: 324 FYKMVKRGYQMSRPD-----FAPPEIYSIMKM---CWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 6e-05
Identities = 34/100 (34%), Positives = 53/100 (53%), Gaps = 16/100 (16%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG--LTKF-HNA 770
+++LH + ILH +LK++N+LL+ K+ D+GLA+ YG L +
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLARE------YGSPLKPYTQLV 167
Query: 771 VG--YVAPELAQSLRL-SDKCDVYSFGVILLELVTGRKPV 807
V Y APEL + S D++S G I EL+T +KP+
Sbjct: 168 VTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLT-KKPL 206
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 7e-05
Identities = 29/108 (26%), Positives = 56/108 (51%), Gaps = 8/108 (7%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
I++G L +LH + I++ +LK N++LD K++D+G+ K ++D F
Sbjct: 110 ISVG----LFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTF 161
Query: 768 HNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Y+APE+ D +++GV+L E++ G+ P + +E+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 8e-05
Identities = 35/122 (28%), Positives = 53/122 (43%), Gaps = 19/122 (15%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK---LLPILDNYGL 764
I L L+ LH K +H +L NI ++ K++D+GLA+ P D
Sbjct: 124 ILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180
Query: 765 TKFHN----------AVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTN 813
+ + Y APEL + + D++S G I EL+TG KP+ P N
Sbjct: 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL-FPGEN 238
Query: 814 EV 815
E+
Sbjct: 239 EI 240
|
Length = 335 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 9e-05
Identities = 48/215 (22%), Positives = 94/215 (43%), Gaps = 35/215 (16%)
Query: 602 IGGGSIGSVYRASFEGG--VSIAVKKLETLGRIRNQEEFELEIGR--LSNIRHFNLVAFQ 657
+G GS G V A+++ +A+K+ E I+ ++ + R L+ I H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG---TAR 714
G + + ++ EFV G + L ++RF +G A+
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRR------------------NKRFPNDVGCFYAAQ 139
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
+ + I++ +LK N+LLD++ K++D+G AK++ T+ + G
Sbjct: 140 IVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-------TRTYTLCGTP 192
Query: 773 -YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
Y+APE+ ++ D ++ G+ + E++ G P
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 1e-04
Identities = 21/56 (37%), Positives = 30/56 (53%)
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSL 445
LD+S N L + LK+LDL N+L +P + L +L+ LDLS N+L
Sbjct: 5 LDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 1e-04
Identities = 58/282 (20%), Positives = 110/282 (39%), Gaps = 34/282 (12%)
Query: 599 ECLIGGGSIGSVYRASFE----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV 654
E ++G G G + R + + +A+ L + + F E L H N+V
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+G +I++E++ G L L + G +L + + G A
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLR--KHEG---------QLVAGQLMGMLPGLAS 118
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
+ YL + +H L + +L++ + K+S + + Y + V +
Sbjct: 119 GMKYL---SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWA 175
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASA 833
APE Q S DV+SFG+++ E+++ G +P + +V+ + +E G
Sbjct: 176 APEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI-------KAVEDG---- 224
Query: 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875
F N L Q+M L C + RP +++ +L
Sbjct: 225 -FRLPAPRNCPNLLHQLM---LDCWQKERGERPRFSQIHSIL 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 1e-04
Identities = 31/108 (28%), Positives = 53/108 (49%), Gaps = 8/108 (7%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
IA+G L +LH I++ +LK N++LD K++D+G+ K I F
Sbjct: 110 IAIG----LFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTF 161
Query: 768 HNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Y+APE+ D ++FGV+L E++ G+ P + +E+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 11/95 (11%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV-- 771
R L+Y H + +LH +LK N+L++E E KL+D+GLA+ + + N V
Sbjct: 115 RGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV----PTKTYSNEVVT 167
Query: 772 -GYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y P+ L S S + D++ G I E+ +GR
Sbjct: 168 LWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 62/226 (27%), Positives = 99/226 (43%), Gaps = 38/226 (16%)
Query: 599 ECL--IGGGSIGSVYRAS--FEGGVSIAVKKLETLGRIRNQEE-------FELEIGR-LS 646
EC+ IG G+ G V++A GG +A+K++ R++ EE E+ + R L
Sbjct: 4 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLE 59
Query: 647 NIRHFNLVAFQGYYWSS-----TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELH 701
H N+V S T ++ E V + +L L V PG T I +
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKD---- 114
Query: 702 WSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN 761
+ R L +LH ++H +LK NIL+ + + KL+D+GLA++
Sbjct: 115 ------MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--Q 163
Query: 762 YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV 807
LT + Y APE+ + D++S G I E+ RKP+
Sbjct: 164 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 2e-04
Identities = 18/54 (33%), Positives = 24/54 (44%)
Query: 434 NLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLN 487
NL+ LDLS N L+ + L NL +LS NNL+ P L+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLD 54
|
Length = 60 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 44.7 bits (105), Expect = 2e-04
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 57/223 (25%)
Query: 627 ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQL-ILSEFVPKGNLYDNLHGV 685
E +G IR + + +E L ++ F Y + + L ++ EF+P G++ L
Sbjct: 43 EQVGHIRAERDILVEADSLWVVKMF-------YSFQDKLNLYLIMEFLPGGDMMTLLMKK 95
Query: 686 NYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745
+ T T +F+IA T A+ +H + +H ++K N+LLD
Sbjct: 96 D---TLT--------EEETQFYIA-ETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHV 140
Query: 746 KLSDYGLAKLLPILD--------NYGLTK---FHN--------------------AVG-- 772
KLSD+GL L N+ L F N VG
Sbjct: 141 KLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP 200
Query: 773 -YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
Y+APE+ + CD +S GVI+ E++ G P S T E
Sbjct: 201 DYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 42/168 (25%), Positives = 68/168 (40%), Gaps = 20/168 (11%)
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN-AV 771
A + YL +H +L + N +L+EN ++D+GL+K + D Y + V
Sbjct: 122 ASGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV 178
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830
++A E + K DV+SFGV + E+ T G+ P +E+ +Y+R+
Sbjct: 179 KWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY---DYLRQGNRLKQ 235
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
C D + L C P RPS + LE
Sbjct: 236 PPDCLD------------GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 13/206 (6%)
Query: 621 IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYD 680
+AVK L + +F E+ LS ++ N++ G +++E++ G+L
Sbjct: 49 VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108
Query: 681 NL-HGVNYPGTSTGGIGNPELH------WSRRFHIALGTARALSYLHHDCKPPILHLNLK 733
L G P H +S H+AL A + YL +H +L
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165
Query: 734 STNILLDENYEPKLSDYGLAKLLPILDNYGLT-KFHNAVGYVAPELAQSLRLSDKCDVYS 792
+ N L+ EN K++D+G+++ L D Y + + + ++A E + + DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225
Query: 793 FGVILLEL--VTGRKPVESPTTNEVV 816
FGV L E+ + +P T +V+
Sbjct: 226 FGVTLWEILMLCKEQPYGELTDEQVI 251
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 3e-04
Identities = 47/193 (24%), Positives = 80/193 (41%), Gaps = 30/193 (15%)
Query: 313 RNLKVLDLGFNRLI------GSIPTGITDLRRLLKISLANNSIGGIIP---PNLGSIELL 363
+LK L L N S+ G+T L ++ L++N++G +L L
Sbjct: 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSL 110
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLL-------LLDVSGNALGG----DIPQTLYNMTYLK 412
+ L L+N N G+ + + L L + N L G + + L LK
Sbjct: 111 QELKLNN-NGLGDRGLRLL-AKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLK 168
Query: 413 ILDLHQNHLNG----STPPSLGNLSNLQVLDLSQNSL----SGSIPSSLGNLRNLTHFNL 464
L+L N + + L NL+VLDL+ N L + ++ +L +L++L NL
Sbjct: 169 ELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNL 228
Query: 465 SSNNLSGTIPSTI 477
NNL+ + +
Sbjct: 229 GDNNLTDAGAAAL 241
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.4 bits (103), Expect = 3e-04
Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 39/222 (17%)
Query: 602 IGGGSIGSVYRA---SFEGGVSIAVKKLETLGR---------IRNQEEFELEIGRLSNIR 649
IG G+ G VY+A + + G A+KK + R EI L ++
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACR-------EIALLRELK 60
Query: 650 HFNLVAFQGYYWSSTMQLI--LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH 707
H N+V+ + + + L ++ +D + + + P + S +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQ 116
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILL----DENYEPKLSDYGLAKLL--PILDN 761
I G + YLH + +LH +LK NIL+ E K+ D GLA+L P+
Sbjct: 117 ILNG----VHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPL 169
Query: 762 YGLTKFHNAVGYVAPELAQSLRLSDKC-DVYSFGVILLELVT 802
L + Y APEL R K D+++ G I EL+T
Sbjct: 170 ADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 29/96 (30%), Positives = 46/96 (47%), Gaps = 9/96 (9%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG-LAKLLPILDNYGLTKFHNAVGY 773
AL LH + I+ +L NILLD+ +L+ + +++ D + Y
Sbjct: 97 ALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM-----Y 148
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809
APE+ ++ CD +S G IL EL+TG+ VE
Sbjct: 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 27/92 (29%), Positives = 51/92 (55%), Gaps = 8/92 (8%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
R L Y+H I+H +LK +N+ ++E+ E ++ D+GLA+ + +T + Y
Sbjct: 129 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQA----DDEMTGYVATRWY 181
Query: 774 VAPELAQS-LRLSDKCDVYSFGVILLELVTGR 804
APE+ + + + D++S G I+ EL+ G+
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 5e-04
Identities = 33/105 (31%), Positives = 56/105 (53%), Gaps = 14/105 (13%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL---PILDNYGLTKFHNAV 771
L+++H K H +LK N+L+ K++D+GLA+ + P +Y T++
Sbjct: 111 GLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRW---- 163
Query: 772 GYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Y APE L +S S D+++ G I+ EL T R P+ P ++E+
Sbjct: 164 -YRAPEILLRSTSYSSPVDIWALGCIMAELYTLR-PL-FPGSSEI 205
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 6e-04
Identities = 16/37 (43%), Positives = 23/37 (62%), Gaps = 2/37 (5%)
Query: 434 NLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
NL+ LDLS N ++ +P L NL NL +LS N ++
Sbjct: 2 NLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 6e-04
Identities = 30/97 (30%), Positives = 45/97 (46%), Gaps = 17/97 (17%)
Query: 727 ILHLNLKSTNILLDENYEPKLSDYGLAK--------LLPILDNYGLTKFHN------AVG 772
+LH +LK NILL E + D+G A LL I + + + VG
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVG 193
Query: 773 ---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
Y+APE + S+ D+Y+ GVIL +++T P
Sbjct: 194 TPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 25/90 (27%), Positives = 46/90 (51%), Gaps = 9/90 (10%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL--DNYGLTKFHNAV 771
L YLH I+H ++K+ NI +++ + + D G A+ P++ GL V
Sbjct: 168 EGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLA---GTV 220
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELV 801
APE+ + + K D++S G++L E++
Sbjct: 221 ETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 7e-04
Identities = 40/158 (25%), Positives = 74/158 (46%), Gaps = 30/158 (18%)
Query: 728 LHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRL 784
+H +L + NILL K+ D+GLA+ + NY + NA V ++APE +
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG--NARLPVKWMAPESIFNCVY 293
Query: 785 SDKCDVYSFGVILLELVT------GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838
+ + DV+S+G++L E+ + PV+S ++++ G +
Sbjct: 294 TFESDVWSYGILLWEIFSLGSSPYPGMPVDSK-----------FYKMIKEG-----YRML 337
Query: 839 LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
A +E+ +MK C P +RP+ ++VQ++E
Sbjct: 338 SPECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIE 372
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 32/98 (32%), Positives = 48/98 (48%), Gaps = 5/98 (5%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
+A+ + H K I+H ++K N+L+ N KL D+G A+ L N T++ Y
Sbjct: 111 KAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWY 167
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRK--PVES 809
+PEL D++S G IL EL G+ P ES
Sbjct: 168 RSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 25/67 (37%), Positives = 34/67 (50%), Gaps = 3/67 (4%)
Query: 431 NLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVST-FLN-- 487
N S + +DLS ++SG I S++ L + NLS+N LSG IP I S +LN
Sbjct: 67 NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 488 NTGLCGP 494
N G
Sbjct: 127 NNNFTGS 133
|
Length = 968 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.001
Identities = 51/225 (22%), Positives = 82/225 (36%), Gaps = 56/225 (24%)
Query: 277 FHGEIPE-VGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITD 335
G IP + +G+ L+ LDL N L +
Sbjct: 62 ETGRIPRGLQSLLQGLT------------------KGCGLQELDLSDNALGPDGCGVLES 103
Query: 336 LRR---LLKISLANNSIGGIIPPNLG-----SIELLEVLDLHNLNLRGEVPDDISN---- 383
L R L ++ L NN +G L LE L L L G + ++
Sbjct: 104 LLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRA 163
Query: 384 CRFLLLLDVSGNALGGD----IPQTLYNMTYLKILDLHQNHLN-------GSTPPSLGNL 432
R L L+++ N +G + + L L++LDL+ N L T SL
Sbjct: 164 NRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL--- 220
Query: 433 SNLQVLDLSQNSLSG--------SIPSSLGNLRNLTHFNLSSNNL 469
+L+VL+L N+L+ ++ S +L L +LS N++
Sbjct: 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTL---SLSCNDI 262
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 27/94 (28%), Positives = 47/94 (50%), Gaps = 9/94 (9%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
RA+ YLH + I+H ++K+ NI ++ + L D+G A P+ + K++ G
Sbjct: 193 RAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPV--DINANKYYGWAGT 246
Query: 774 VA---PELAQSLRLSDKCDVYSFGVILLELVTGR 804
+A PEL D++S G++L E+ T
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 0.001
Identities = 52/213 (24%), Positives = 82/213 (38%), Gaps = 40/213 (18%)
Query: 605 GSIGSVYRASFEGGVS------IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV-AFQ 657
GS G V+ + G AV +T GR EI L I H ++
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPGR---------EIDILKTISHRAIINLIH 153
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
Y W ST+ +++ ++ K +L+ + L + I AL+
Sbjct: 154 AYRWKSTVCMVMPKY--KCDLFTYVDRSG------------PLPLEQAITIQRRLLEALA 199
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDN----YGLTKFHNAVGY 773
YLH I+H ++K+ NI LDE L D+G A L + YG + +
Sbjct: 200 YLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYG---WSGTLET 253
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+PEL K D++S G++L E+
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 38/149 (25%), Positives = 52/149 (34%), Gaps = 59/149 (39%)
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
+A+ L ++H D KP N+LLD KLSD+GL GL K
Sbjct: 112 LAIDAIHQLGFIHRDIKP---------DNLLLDAKGHVKLSDFGLCT--------GLKKA 154
Query: 768 H---------------------------------------NAVG---YVAPELAQSLRLS 785
H + VG Y+APE+ +
Sbjct: 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN 214
Query: 786 DKCDVYSFGVILLELVTGRKPVESPTTNE 814
CD +S GVI+ E++ G P S T E
Sbjct: 215 KLCDWWSLGVIMYEMLIGYPPFCSETPQE 243
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 30/98 (30%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
R L Y+H +LH +LK N+ ++ E+ K+ D+GLA+ I+D + K + + G
Sbjct: 125 RGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLAR---IVDPHYSHKGYLSEG 178
Query: 773 -----YVAPELAQSLRLSDKC-DVYSFGVILLELVTGR 804
Y +P L S K D+++ G I E++TG+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 23/81 (28%), Positives = 45/81 (55%), Gaps = 8/81 (9%)
Query: 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLP---ILDNYGLTKFHNAVGYVAPELAQSLR 783
I+H +LK +NI++ + K+ D+GLA+ ++ Y +T++ Y APE+ +
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMG 201
Query: 784 LSDKCDVYSFGVILLELVTGR 804
+ D++S G I+ E++ G
Sbjct: 202 YKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 10/103 (9%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
R L+Y+H ILH +LK N+L+ E KL+D+GLA+ I T V
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ---TYSSEVVTL 167
Query: 773 -YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTN 813
Y P+ L + S D++ G I +E++ G +P ++
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQG-QPAFPGVSD 209
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 51/202 (25%), Positives = 92/202 (45%), Gaps = 13/202 (6%)
Query: 621 IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYD 680
+AVK L +E+F E+ LS + N+ G ++ E++ G+L
Sbjct: 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 681 NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL-HHDCKPPILHLNLKSTNILL 739
L + TS + L +S ++A A + YL + +H +L + N L+
Sbjct: 109 FLQK-HVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN----FVHRDLATRNCLV 163
Query: 740 DENYEPKLSDYGLAKLLPILDNYGLTKFHNAV---GYVAPELAQSLRLSDKCDVYSFGVI 796
+NY K++D+G+++ L D Y + A ++A E + + K DV++FGV
Sbjct: 164 GKNYTIKIADFGMSRNLYSSDYYRVQG--RAPLPIRWMAWESVLLGKFTTKSDVWAFGVT 221
Query: 797 LLELVT--GRKPVESPTTNEVV 816
L E++T +P E T +V+
Sbjct: 222 LWEILTLCREQPYEHLTDQQVI 243
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.002
Identities = 20/50 (40%), Positives = 29/50 (58%), Gaps = 3/50 (6%)
Query: 768 HNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
H+ VG Y+APE+ + CD +S GVIL E++ G+ P +PT E
Sbjct: 206 HSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTE 255
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 23/81 (28%), Positives = 45/81 (55%), Gaps = 8/81 (9%)
Query: 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLP---ILDNYGLTKFHNAVGYVAPELAQSLR 783
I+H +LK +NI++ + K+ D+GLA+ ++ Y +T++ Y APE+ +
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMG 193
Query: 784 LSDKCDVYSFGVILLELVTGR 804
+ D++S G I+ E++ G
Sbjct: 194 YKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 28/105 (26%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 186 PLSIANCTY--------LEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQF 237
P S A+C + ++G L G +P+ I + L I++ GN++ G +
Sbjct: 403 PWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSL 462
Query: 238 SQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIP 282
S++ LDLS N F G P + L ++ N++ N G +P
Sbjct: 463 GSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 0.003
Identities = 48/198 (24%), Positives = 73/198 (36%), Gaps = 71/198 (35%)
Query: 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA-----LGTARALSYLHHD 722
++ EF+P G+L L + Y S RF++A + L ++H D
Sbjct: 78 LIMEFLPGGDLMTML--IKYDTFSED---------VTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 723 CKPPILHLNLKSTNILLDENYEPKLSDYGLA-------------KLLP------------ 757
KP NIL+D KLSD+GL+ KLL
Sbjct: 127 IKP---------DNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN 177
Query: 758 --ILDNYGLT----------------KFHNAVG---YVAPELAQSLRLSDKCDVYSFGVI 796
+D+ LT ++ VG Y+APE+ +CD +S G I
Sbjct: 178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237
Query: 797 LLELVTGRKPVESPTTNE 814
+ E + G P S ++E
Sbjct: 238 MFECLIGWPPFCSENSHE 255
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.004
Identities = 23/78 (29%), Positives = 44/78 (56%), Gaps = 8/78 (10%)
Query: 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLP---ILDNYGLTKFHNAVGYVAPELAQSLR 783
I+H +LK +NI++ + K+ D+GLA+ ++ Y +T++ Y APE+ +
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMG 194
Query: 784 LSDKCDVYSFGVILLELV 801
+ D++S G I+ E+V
Sbjct: 195 YKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 884 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.98 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.98 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.98 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.98 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.96 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.93 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.91 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.8 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.78 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.72 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.65 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.61 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.59 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.51 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.51 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.49 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.48 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.44 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.32 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.2 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.19 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.17 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.16 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.15 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.14 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.12 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.12 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.12 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.1 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.09 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.08 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.06 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 99.05 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 99.0 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.99 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.98 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.87 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.85 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.79 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.78 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.73 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.62 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.6 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.57 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.54 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.52 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.51 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.49 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.48 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.42 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-102 Score=970.49 Aligned_cols=803 Identities=32% Similarity=0.531 Sum_probs=516.9
Q ss_pred ccCCchhHHHHHHHHHhhcCCCCCCcccCccCCCCCCCCCcceEecCCCCEEEEEecCccccccccccccCCCCCCeEee
Q 002759 24 SSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTL 103 (884)
Q Consensus 24 ~~~~~~~~~~~ll~~k~~~~~~~~~~l~sW~~~~~~c~~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L 103 (884)
.+...+.|++||++||+++. +|.+.+.+|+. .++||.|.||+|+..++|+.++|.+++++|.+++++..+++|++|+|
T Consensus 23 ~~~~~~~~~~~l~~~~~~~~-~~~~~~~~w~~-~~~~c~w~gv~c~~~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~L 100 (968)
T PLN00113 23 FSMLHAEELELLLSFKSSIN-DPLKYLSNWNS-SADVCLWQGITCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINL 100 (968)
T ss_pred ccCCCHHHHHHHHHHHHhCC-CCcccCCCCCC-CCCCCcCcceecCCCCcEEEEEecCCCccccCChHHhCCCCCCEEEC
Confidence 34446789999999999995 78888999964 45677999999998889999999999999999989999999999999
Q ss_pred cCCcCcccCchhhh-cccCCeEeecCCCCCCC----------------------CCCccCCCCCCcceEeCCCCccCCCC
Q 002759 104 FGNRFTGNLPQEYA-EMQTLWKINVSSNALSG----------------------SIPEFIGDLPNIRLLDLSRNSYSGEI 160 (884)
Q Consensus 104 ~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~----------------------~~p~~~~~l~~L~~L~Ls~N~l~g~i 160 (884)
++|+++|.+|..+. .+++|++|+|++|.++| .+|..++++++|++|+|++|.+.+.+
T Consensus 101 s~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~ 180 (968)
T PLN00113 101 SNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180 (968)
T ss_pred CCCccCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccC
Confidence 99999888887755 66666666666666554 44445555555555555555555555
Q ss_pred chhhhhccccCcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccC
Q 002759 161 PFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240 (884)
Q Consensus 161 p~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l 240 (884)
|.. +..+++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|++++.+|..|+++
T Consensus 181 p~~-~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l 259 (968)
T PLN00113 181 PNS-LTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNL 259 (968)
T ss_pred Chh-hhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCC
Confidence 543 2344555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred CeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCC------------------
Q 002759 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFD------------------ 302 (884)
Q Consensus 241 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~------------------ 302 (884)
++|++|+|++|++++..|.++.++++|++|+|++|++.+.+|..+..+++|+.|++++|.+.
T Consensus 260 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L 339 (968)
T PLN00113 260 KNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQL 339 (968)
T ss_pred CCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEEC
Confidence 55555555555555544555555555555555555555444444444444444444444444
Q ss_pred ------CCCCcccccccccceecccCCcccccCCCCccc------------------------ccCccEEEccCCccCCC
Q 002759 303 ------GVIPLSITNCRNLKVLDLGFNRLIGSIPTGITD------------------------LRRLLKISLANNSIGGI 352 (884)
Q Consensus 303 ------~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~------------------------l~~L~~L~L~~N~l~~~ 352 (884)
+.+|..++.+++|+.|+|++|++++.+|.++.. +++|+.|++++|++++.
T Consensus 340 ~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~ 419 (968)
T PLN00113 340 WSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGE 419 (968)
T ss_pred cCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeE
Confidence 444444444444444444444444333322221 22233333333333333
Q ss_pred CCCCccCccc-----------------------------------------------ccEEecCCCcCCCCCCcCCcCCC
Q 002759 353 IPPNLGSIEL-----------------------------------------------LEVLDLHNLNLRGEVPDDISNCR 385 (884)
Q Consensus 353 ~p~~~~~l~~-----------------------------------------------L~~L~L~~n~l~~~~p~~~~~l~ 385 (884)
+|..+..+++ |+.|++++|++++..|..+.+++
T Consensus 420 ~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~ 499 (968)
T PLN00113 420 LPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLS 499 (968)
T ss_pred CChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhh
Confidence 3322222222 23333333444444444555566
Q ss_pred CCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEcc
Q 002759 386 FLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLS 465 (884)
Q Consensus 386 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 465 (884)
+|+.|+|++|++.+.+|..+.++++|++|+|++|.+++.+|..++++++|+.|||++|+++|.+|..+..+++|+.|+++
T Consensus 500 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls 579 (968)
T PLN00113 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNIS 579 (968)
T ss_pred ccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEecc
Confidence 66666666666666677777777777777777777777777777777777777777777777777777777778888888
Q ss_pred CCcCcccCCcc--ccccCccccccCCCCCCCCCC---CCCCCCCCCCCCCCCCCccchhhHHHHHHHHHHHHHHhhhhhh
Q 002759 466 SNNLSGTIPST--IQHFGVSTFLNNTGLCGPPLE---TSCSGRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVVTI 540 (884)
Q Consensus 466 ~N~l~~~~p~~--~~~~~~~~~~~n~~lc~~p~~---~~c~~~~~~~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~ 540 (884)
+|+++|.+|.. +..+....+.+|+++||.+.. ++|.... +...... .+++++++++++++++ +++
T Consensus 580 ~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~-------~~~~~~~--~~~~~~~~~~~~~~~~-~~~ 649 (968)
T PLN00113 580 HNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVR-------KTPSWWF--YITCTLGAFLVLALVA-FGF 649 (968)
T ss_pred CCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCcccc-------ccceeee--ehhHHHHHHHHHHHHH-HHH
Confidence 88887777753 455667788899999986532 2453210 1111111 1111222222222222 222
Q ss_pred hhhhhccccccccccccccCCCCCCCCcceeceEEEecCCC--CCCHHHHHHHhhcccccCceeccCCceEEEEEEE-cC
Q 002759 541 MNIKARRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSL--PSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EG 617 (884)
Q Consensus 541 ~~~~~rrr~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~ 617 (884)
..+++|++.+.+......+ .+ ....+.... ...+++... . +...++||+|+||+||+|.. .+
T Consensus 650 ~~~~~~~~~~~~~~~~~~~-~~----------~~~~~~~~~~~~~~~~~~~~---~-~~~~~~ig~G~~g~Vy~~~~~~~ 714 (968)
T PLN00113 650 VFIRGRNNLELKRVENEDG-TW----------ELQFFDSKVSKSITINDILS---S-LKEENVISRGKKGASYKGKSIKN 714 (968)
T ss_pred HHHHhhhcccccccccccc-cc----------cccccccccchhhhHHHHHh---h-CCcccEEccCCCeeEEEEEECCC
Confidence 2222222211111000000 00 000111110 122333322 1 34667899999999999976 57
Q ss_pred CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCC
Q 002759 618 GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGN 697 (884)
Q Consensus 618 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~ 697 (884)
+..||||++..... ....|++.+++++||||++++|+|.+++..++||||+++|+|.++++
T Consensus 715 ~~~vavK~~~~~~~-----~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~-------------- 775 (968)
T PLN00113 715 GMQFVVKEINDVNS-----IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-------------- 775 (968)
T ss_pred CcEEEEEEccCCcc-----ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------------
Confidence 88999999864321 12346888999999999999999999999999999999999999995
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCcccccccccccccCcc
Q 002759 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777 (884)
Q Consensus 698 ~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE 777 (884)
.++|.++.+++.|||+||+|||..+.++|+|||+||+||+++.++.+++. ||.+..... .....++..|+|||
T Consensus 776 -~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~aPE 848 (968)
T PLN00113 776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYVAPE 848 (968)
T ss_pred -cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCCccccccccCcc
Confidence 36899999999999999999997766799999999999999999888875 555443211 12236788999999
Q ss_pred ccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCC---CcHHHHHHHHHHH
Q 002759 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRG---FAENELIQVMKLG 854 (884)
Q Consensus 778 ~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~---~~~~~~~~l~~l~ 854 (884)
++.+..++.++|||||||++|||+||+.||..... ......+|.+............|+.+.. ...++..++++++
T Consensus 849 ~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 927 (968)
T PLN00113 849 TRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA 927 (968)
T ss_pred cccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHH
Confidence 99999999999999999999999999999964322 2233455655544443344445554432 3456777899999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 855 LICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 855 ~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
.+||+.+|++||||+|+++.|+++.+.
T Consensus 928 ~~Cl~~~P~~RPt~~evl~~L~~~~~~ 954 (968)
T PLN00113 928 LHCTATDPTARPCANDVLKTLESASRS 954 (968)
T ss_pred HhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence 999999999999999999999998653
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-48 Score=421.42 Aligned_cols=286 Identities=41% Similarity=0.734 Sum_probs=250.2
Q ss_pred CCCHHHHHHHhhcccccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEe
Q 002759 582 PSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661 (884)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 661 (884)
.+.+.++..+|++|. ..++||+|+||.||+|...++..||||++....... ..+|.+|+.++.+++|||+|+++|||.
T Consensus 64 ~fs~~el~~AT~~Fs-~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~ 141 (361)
T KOG1187|consen 64 SFSYDELRKATNNFS-ESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG-EREFLNEVEILSRLRHPNLVKLLGYCL 141 (361)
T ss_pred eeeHHHHHHHHhCCc-hhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence 467999999998886 678999999999999999999999999887654332 566999999999999999999999999
Q ss_pred cCC-ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC
Q 002759 662 SST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD 740 (884)
Q Consensus 662 ~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~ 740 (884)
+.+ ..++|||||++|+|.++++... .. .++|..+++||.++|+||+|||..+.++||||||||+|||+|
T Consensus 142 e~~~~~~LVYEym~nGsL~d~L~~~~---------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD 211 (361)
T KOG1187|consen 142 EGGEHRLLVYEYMPNGSLEDHLHGKK---------GE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLD 211 (361)
T ss_pred cCCceEEEEEEccCCCCHHHHhCCCC---------CC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeEC
Confidence 988 4999999999999999998654 11 789999999999999999999999988999999999999999
Q ss_pred CCCCeeEccccCccccCCccCcccccc-cccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 002759 741 ENYEPKLSDYGLAKLLPILDNYGLTKF-HNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC 819 (884)
Q Consensus 741 ~~~~vkl~Dfg~s~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~ 819 (884)
+++++||+|||+|+..+.. ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+.........+.
T Consensus 212 ~~~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~ 290 (361)
T KOG1187|consen 212 EDFNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLV 290 (361)
T ss_pred CCCCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHH
Confidence 9999999999999765431 1111112 8999999999999999999999999999999999999988865544455588
Q ss_pred HHHHHHHHcCCCcccccccCC-C-CcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 820 EYVRELLERGSASACFDRSLR-G-FAE-NELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 820 ~~~~~~~~~~~~~~~~d~~~~-~-~~~-~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
.|....+..++..+++|+.+. + +.. +++.++.+++..|++.+|.+||+|.||++.|+.+..
T Consensus 291 ~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~ 354 (361)
T KOG1187|consen 291 EWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS 354 (361)
T ss_pred HHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence 999999999999999999986 3 443 688899999999999999999999999999977653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=482.16 Aligned_cols=382 Identities=32% Similarity=0.480 Sum_probs=347.3
Q ss_pred CCCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCC-CCCCcceEeCCCCccCCCCchhhhhccccCcEE
Q 002759 96 KSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIG-DLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFV 174 (884)
Q Consensus 96 ~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L 174 (884)
.+++.|||++|+++|.+|..|..+++|++|+|++|.++|.+|..+. .+++|++|+|++|+++|.+|.. .+++|++|
T Consensus 69 ~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~---~l~~L~~L 145 (968)
T PLN00113 69 SRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRG---SIPNLETL 145 (968)
T ss_pred CcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCcc---ccCCCCEE
Confidence 4789999999999999999999999999999999999999998866 9999999999999999999863 46889999
Q ss_pred EccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccC
Q 002759 175 SLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFI 254 (884)
Q Consensus 175 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~ 254 (884)
+|++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|++++.+|..++++++|++|+|++|+++
T Consensus 146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~ 225 (968)
T PLN00113 146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLS 225 (968)
T ss_pred ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcc
Q 002759 255 GLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGIT 334 (884)
Q Consensus 255 ~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 334 (884)
+..|..+.++++|++|+|++|++++.+|..+..+++|+.|++++|++.+.+|..+.++++|++|+|++|++.+.+|..+.
T Consensus 226 ~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~ 305 (968)
T PLN00113 226 GEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVI 305 (968)
T ss_pred CcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHc
Confidence 99999999999999999999999999999888999999999999999999999999999999999999999989999999
Q ss_pred cccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCccCcEE
Q 002759 335 DLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKIL 414 (884)
Q Consensus 335 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L 414 (884)
++++|++|++++|.+++..|..++.+++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|
T Consensus 306 ~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L 385 (968)
T PLN00113 306 QLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKL 385 (968)
T ss_pred CCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEE
Confidence 99999999999999999999999999999999999999998899889999999999999999988888888888888888
Q ss_pred EecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCCcCcccCCcccccc
Q 002759 415 DLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHF 480 (884)
Q Consensus 415 ~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~ 480 (884)
++++|.+.+.+|..++.+++|+.|+|++|++++.+|..+..++.|+.|++++|++++.+|..+..+
T Consensus 386 ~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l 451 (968)
T PLN00113 386 ILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451 (968)
T ss_pred ECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccC
Confidence 888888888888888888888888888888888888888888888888888888888777654433
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=407.76 Aligned_cols=254 Identities=29% Similarity=0.420 Sum_probs=219.6
Q ss_pred cCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCc
Q 002759 598 KECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
..+.||+|.||+||.|.+.+...||+|.++... ...++|.+|+++|++++|+|||+++|+|..++..+||||||+.|+
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~--m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS--MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEeccc--cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 456799999999999999988899999998653 566889999999999999999999999999889999999999999
Q ss_pred hhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|.+||+... +..+...+.+.++.|||+||+||+++ ++|||||+++||||+++..|||+|||+|+...
T Consensus 288 Ll~yLr~~~----------~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 288 LLDYLRTRE----------GGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred HHHHhhhcC----------CCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccC
Confidence 999998633 45788999999999999999999999 99999999999999999999999999999666
Q ss_pred CccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccccc
Q 002759 758 ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836 (884)
Q Consensus 758 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 836 (884)
+..+.......-++.|.|||.+....++.|||||||||+|||++| |+.||..+...++. +.+.+..+.+.+..
T Consensus 355 d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~---~~le~GyRlp~P~~--- 428 (468)
T KOG0197|consen 355 DDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVL---ELLERGYRLPRPEG--- 428 (468)
T ss_pred CCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHH---HHHhccCcCCCCCC---
Confidence 555555566667889999999999999999999999999999999 99999998876654 33333333333332
Q ss_pred ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 837 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
++.++.++|..||+.+|++||||+.+...++++...
T Consensus 429 ---------CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 429 ---------CPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---------CCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 333566677779999999999999999999998654
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=422.24 Aligned_cols=266 Identities=27% Similarity=0.407 Sum_probs=229.6
Q ss_pred cCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 598 KECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
..+.||+|+||+||+|... +...||||.+++........+|++|++.++.++|||||+++|+|.+++..++|+|
T Consensus 490 ~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFE 569 (774)
T KOG1026|consen 490 FKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFE 569 (774)
T ss_pred ehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEE
Confidence 5567999999999999653 3467999999988776788999999999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCC-CCCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 672 FVPKGNLYDNLHGVNYPGTST-GGIG-NPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~-~~~~-~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
||..|||.+||+.+....... .+.. +.+++..+.+.||.|||.||.||-++ .+|||||+++|+||.++..|||+|
T Consensus 570 Ym~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 570 YMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred ecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecc
Confidence 999999999998776543332 3333 55699999999999999999999999 999999999999999999999999
Q ss_pred ccCccccCCccCcccc-cccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 750 YGLAKLLPILDNYGLT-KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 750 fg~s~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
||+++.+-..+++... ...-+++|||||.|+..+++++||||||||++||+++ |+.||.....+|+... ++
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~-------i~ 719 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC-------IR 719 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHH-------HH
Confidence 9999988777777654 5566899999999999999999999999999999999 9999999887776532 23
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
.++.. +.++.++.++..||..||+.+|++||+|+||-.+|++....
T Consensus 720 ~g~lL--------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 720 AGQLL--------SCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred cCCcc--------cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 33332 23556677888899999999999999999999999987543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=392.49 Aligned_cols=256 Identities=34% Similarity=0.504 Sum_probs=211.4
Q ss_pred CceeccCCceEEEEEEEcCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC-ceeEEEEecCCC
Q 002759 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST-MQLILSEFVPKG 676 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~g 676 (884)
.+.+|+|+||+||+|.+.+...||||++..... ....++|.+|+.++.+++|||||+++|+|.++. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 445999999999999999776699999975431 222679999999999999999999999999887 789999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-eEeccCCCCceEeCCCC-CeeEccccCcc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPP-ILHLNLKSTNILLDENY-EPKLSDYGLAK 754 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~-ivH~Dlk~~Nil~~~~~-~vkl~Dfg~s~ 754 (884)
+|.++++... ...+++..++++|.|||+||.|||++ + ||||||||+|||++.++ ++||+|||+++
T Consensus 126 sL~~~l~~~~----------~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr 192 (362)
T KOG0192|consen 126 SLSVLLHKKR----------KRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSR 192 (362)
T ss_pred cHHHHHhhcc----------cCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence 9999998632 24799999999999999999999998 6 99999999999999997 99999999998
Q ss_pred ccCCccCcccccccccccccCccccC--CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQ--SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
...... ...+...||..|||||++. ...|+.|+||||||+++|||+||+.||........ +..........
T Consensus 193 ~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~------~~~v~~~~~Rp 265 (362)
T KOG0192|consen 193 EKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV------ASAVVVGGLRP 265 (362)
T ss_pred eecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHHhcCCCC
Confidence 765321 3345578999999999999 56899999999999999999999999998765222 11222111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhccc
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~~ 882 (884)
. .+..+...+..++..||+.||.+||++.+++..|+.+....
T Consensus 266 ~--------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 266 P--------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred C--------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 1 11224456777788899999999999999999999987644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=367.25 Aligned_cols=247 Identities=27% Similarity=0.378 Sum_probs=207.1
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC-ceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST-MQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~lv~e~~~~ 675 (884)
....||+|..|+||++.++ +++-+|+|++....+....+++.+|+++++..+||+||.++|.|+... ...++||||++
T Consensus 83 ~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDg 162 (364)
T KOG0581|consen 83 RLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDG 162 (364)
T ss_pred hhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCC
Confidence 4568999999999999775 678899999966556667889999999999999999999999999888 49999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.+++...+ .+++...-+|+.+|++||.|||+. ++||||||||+|||++..|.|||||||.+..
T Consensus 163 GSLd~~~k~~g------------~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 163 GSLDDILKRVG------------RIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGI 228 (364)
T ss_pred CCHHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHH
Confidence 99999997544 689999999999999999999963 2999999999999999999999999999998
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCC--CcchhhHHHHHHHHHHcCCCcc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT--TNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
+.+. ......||..|||||.+.+..|+.++||||||++++|+.+|+.||.... ......+..++ ...+ +..
T Consensus 229 lvnS---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---v~~p-pP~ 301 (364)
T KOG0581|consen 229 LVNS---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---VDEP-PPR 301 (364)
T ss_pred hhhh---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---hcCC-CCC
Confidence 7632 4467889999999999999999999999999999999999999998752 22333333322 2211 111
Q ss_pred cccccCCCCcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 CFDRSLRGFAE-NELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~-~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.++ ....++..++..|+++||.+|||++|+++
T Consensus 302 --------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 302 --------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred --------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 111 23446888888999999999999999984
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=392.38 Aligned_cols=255 Identities=22% Similarity=0.371 Sum_probs=223.8
Q ss_pred ccCceeccCCceEEEEEEEc----CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
.++++||.|.||+||+|+++ ....||||.++....++...+|..|+.+|.+++||||+++.|+.+..+..++|+||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 36789999999999999774 34679999999988888899999999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
|++|+|..||+.++ ..|++.+..-|.++||.||.||.+. ++|||||.++||||+.+..+||+|||+
T Consensus 712 MENGsLDsFLR~~D-----------GqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGL 777 (996)
T KOG0196|consen 712 MENGSLDSFLRQND-----------GQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGL 777 (996)
T ss_pred hhCCcHHHHHhhcC-----------CceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccc
Confidence 99999999999776 3699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccCccc--ccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 753 AKLLPILDNYGL--TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 753 s~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
++.+.+...... ..-.-+.+|.|||.+...+++.++||||||++|||.++ |..||+++..+++. +.+.+.++.+
T Consensus 778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVI---kaIe~gyRLP 854 (996)
T KOG0196|consen 778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---KAIEQGYRLP 854 (996)
T ss_pred eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHH---HHHHhccCCC
Confidence 998865432222 22334788999999999999999999999999999998 99999999888765 4444444444
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
.+++ ++..|.+||..||++|-.+||+|.||+..|+++-.
T Consensus 855 pPmD------------CP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr 893 (996)
T KOG0196|consen 855 PPMD------------CPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR 893 (996)
T ss_pred CCCC------------CcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence 4443 45578899999999999999999999999999854
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=378.44 Aligned_cols=248 Identities=26% Similarity=0.361 Sum_probs=214.0
Q ss_pred cccccCceeccCCceEEEEEEE-cCCeEEEEEEcccc--CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 594 ALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETL--GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
..|..+++||+|+|+.||.++. ..|..||+|++.+. ......+.+.+||++.+.++|||||+++++|++.+..|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 3466889999999999999977 88999999999653 34466788999999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
|+|+.++|.++++.. +++++.+++.+.+||+.||.|||+. +|+|||||..|+|++++.+|||+||
T Consensus 98 ELC~~~sL~el~Krr------------k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDF 162 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR------------KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDF 162 (592)
T ss_pred EecCCccHHHHHHhc------------CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEeccc
Confidence 999999999999743 4899999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 751 g~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
|+|..+.. ++......+||+-|+|||++....++..+||||+||++|-|+.|++||+...-.+.+..+....
T Consensus 163 GLAt~le~-~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~------- 234 (592)
T KOG0575|consen 163 GLATQLEY-DGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNE------- 234 (592)
T ss_pred ceeeeecC-cccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcC-------
Confidence 99999864 3456678899999999999999999999999999999999999999999876555543222111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+ .++.....+..++|.++++.+|.+|||+++|+.
T Consensus 235 Y---------~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 Y---------SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred c---------ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1 012233345667788899999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=360.48 Aligned_cols=204 Identities=27% Similarity=0.426 Sum_probs=181.6
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|...+.||+|+||+||+|+++ ++..||||.+.... ..+..+-+..|+.++++++|||||.++++++.++..|+|||||
T Consensus 12 y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC 91 (429)
T KOG0595|consen 12 YELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYC 91 (429)
T ss_pred ceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeC
Confidence 345566999999999999764 57899999997543 3456777899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC------CCeeE
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN------YEPKL 747 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~------~~vkl 747 (884)
+||+|.+|++..+ .+++.+++.++.|+|.||++||++ +||||||||+|||++.. -.+||
T Consensus 92 ~gGDLs~yi~~~~------------~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKI 156 (429)
T KOG0595|consen 92 NGGDLSDYIRRRG------------RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKI 156 (429)
T ss_pred CCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEe
Confidence 9999999998664 689999999999999999999999 99999999999999865 46899
Q ss_pred ccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~ 816 (884)
+|||+|+.+. ........+|++-|||||+++...|+.|+|+||+|+++|++++|+.||......|..
T Consensus 157 ADFGfAR~L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 157 ADFGFARFLQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred cccchhhhCC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 9999999987 344456789999999999999999999999999999999999999999976665543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=361.88 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=205.2
Q ss_pred hhcccccCceeccCCceEEEEE-EEcCCeEEEEEEccccCcc------CCHHHHHHHHHHHhcCCCCCcceeeeEEecCC
Q 002759 592 TKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRI------RNQEEFELEIGRLSNIRHFNLVAFQGYYWSST 664 (884)
Q Consensus 592 ~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 664 (884)
..+.|...+.+|+|+||.|-+| ...+|+.||||++++.... .....+.+|+++|++++|||||++++++.+++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 4556667889999999999999 5568999999999643211 13445689999999999999999999999999
Q ss_pred ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC--
Q 002759 665 MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-- 742 (884)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-- 742 (884)
..|+||||++||+|.+++..+. .+.+..-..+++|++.|+.|||++ ||+||||||+|||++.+
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk------------~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e 314 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK------------YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAE 314 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc------------ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCc
Confidence 9999999999999999997554 566777789999999999999999 99999999999999766
Q ss_pred -CCeeEccccCccccCCccCcccccccccccccCccccCCCCCC---CccCchhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 002759 743 -YEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLS---DKCDVYSFGVILLELVTGRKPVESPTTNEVVVL 818 (884)
Q Consensus 743 -~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~ 818 (884)
..+||+|||+|+..+ +.......+||+.|.|||++.+..+. .+.|+||+||++|-+++|.+||.......
T Consensus 315 ~~llKItDFGlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~---- 388 (475)
T KOG0615|consen 315 DCLLKITDFGLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP---- 388 (475)
T ss_pred ceEEEecccchhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc----
Confidence 789999999999876 34456778999999999999765443 37899999999999999999998754332
Q ss_pred HHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 819 CEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 819 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+++..+++... +. .......+...+|.+|+..||++|||+.|+++
T Consensus 389 --sl~eQI~~G~y~f~--p~---~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 --SLKEQILKGRYAFG--PL---QWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred --cHHHHHhcCccccc--Ch---hhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 12333444443321 11 11233346677888999999999999999884
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=404.62 Aligned_cols=262 Identities=29% Similarity=0.417 Sum_probs=222.5
Q ss_pred ccCceeccCCceEEEEEEEcC--C----eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFEG--G----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~--~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
+..+.||+|+||+||.|...+ + ..||||+++...+..+..+|.+|+.+|++++|||||+++|+|.+....++++
T Consensus 695 ~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~l 774 (1025)
T KOG1095|consen 695 TLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILL 774 (1025)
T ss_pred EeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEe
Confidence 456789999999999997753 3 3499999998888888999999999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
|||++|+|..||++.+..... ...++..+.+.++.|||+|+.||+++ ++|||||+++|+|++....|||+||
T Consensus 775 eyM~gGDL~sflr~~r~~~~~-----~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 775 EYMEGGDLLSFLRESRPAPFQ-----PSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred hhcccCcHHHHHHhcccccCC-----CCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence 999999999999987643322 45789999999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCccCcccccc-cccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 751 GLAKLLPILDNYGLTKF-HNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 751 g~s~~~~~~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|+|+.+.+.+++..... .-++.|||||.++...++.|+|||||||++||++| |..||......++... ..+.
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~------~~~g 920 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD------VLEG 920 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH------HHhC
Confidence 99997766666665544 55789999999999999999999999999999999 9999998877665421 1222
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
++.. .++.++..+.++|..||+.+|++||+|..+++.++++.+.
T Consensus 921 gRL~---------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~ 964 (1025)
T KOG1095|consen 921 GRLD---------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA 964 (1025)
T ss_pred CccC---------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence 2111 1223344677888889999999999999999999887543
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=371.69 Aligned_cols=374 Identities=18% Similarity=0.213 Sum_probs=347.8
Q ss_pred CCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhccccCcEEEc
Q 002759 97 SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL 176 (884)
Q Consensus 97 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 176 (884)
.-++|||++|+++..-+..|.++++|+.++|..|.++ .||...+...+|+.|+|.+|.|+ ++.....+.++.|+.|||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~-sv~se~L~~l~alrslDL 156 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLIS-SVTSEELSALPALRSLDL 156 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccc-cccHHHHHhHhhhhhhhh
Confidence 4567999999999999999999999999999999999 89998888889999999999998 888888888999999999
Q ss_pred cCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccCCc
Q 002759 177 SHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256 (884)
Q Consensus 177 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 256 (884)
|.|.|+...-.+|..-.++++|+|++|+|+..-...|.++.+|..|.|++|+++..++..|.++++|+.|+|..|+|.-.
T Consensus 157 SrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~iriv 236 (873)
T KOG4194|consen 157 SRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIV 236 (873)
T ss_pred hhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeee
Confidence 99999976667888888999999999999988889999999999999999999999999999999999999999999988
Q ss_pred CCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccc
Q 002759 257 APFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDL 336 (884)
Q Consensus 257 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 336 (884)
.-..|.+|++|+.|.|..|+++..-...|..+.++++|+|+.|++..+-..++-+++.|+.|+||+|.|....++++.-.
T Consensus 237 e~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsft 316 (873)
T KOG4194|consen 237 EGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFT 316 (873)
T ss_pred hhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhc
Confidence 78899999999999999999999888899999999999999999999999999999999999999999998889999999
Q ss_pred cCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcch---hhcCCccCcE
Q 002759 337 RRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQ---TLYNMTYLKI 413 (884)
Q Consensus 337 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~---~~~~l~~L~~ 413 (884)
++|++|+|++|+|+...+..|..+..|+.|.|+.|++....-..|..+++|+.|||++|.|++.+.+ .|..|++|+.
T Consensus 317 qkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~Lrk 396 (873)
T KOG4194|consen 317 QKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRK 396 (873)
T ss_pred ccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhh
Confidence 9999999999999999999999999999999999999988888899999999999999999866543 5788999999
Q ss_pred EEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCCcCcccC
Q 002759 414 LDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTI 473 (884)
Q Consensus 414 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~ 473 (884)
|+|.+|+|..+.-.+|.++.+|+.|||.+|.|...-|.+|..+ .|+.|-+..-.|.+.+
T Consensus 397 L~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssflCDC 455 (873)
T KOG4194|consen 397 LRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSFLCDC 455 (873)
T ss_pred eeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccceEEec
Confidence 9999999996556799999999999999999998889999999 8999988766665444
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-42 Score=361.47 Aligned_cols=254 Identities=29% Similarity=0.438 Sum_probs=211.7
Q ss_pred HHHHHHhhcccccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCc
Q 002759 586 EDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTM 665 (884)
Q Consensus 586 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (884)
+.|++.-+.+. ..+-+|+|+.|.||+|+++ ++.||||+++... +.+|+-+++++||||+.+.|+|....-
T Consensus 117 e~WeiPFe~Is-ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk--------ETdIKHLRkLkH~NII~FkGVCtqsPc 186 (904)
T KOG4721|consen 117 ELWEIPFEEIS-ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK--------ETDIKHLRKLKHPNIITFKGVCTQSPC 186 (904)
T ss_pred hhccCCHHHhh-hhhhhccCcccceeeeecc-CceehhHHHhhhh--------hhhHHHHHhccCcceeeEeeeecCCce
Confidence 34444444443 3456899999999999998 5689999997432 567888999999999999999999999
Q ss_pred eeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCe
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~v 745 (884)
+|||||||..|-|++.|+..+ ++.......+..+||.||.|||.+ +|||||||+-||||+.+..|
T Consensus 187 yCIiMEfCa~GqL~~VLka~~------------~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~V 251 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGR------------PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVV 251 (904)
T ss_pred eEEeeeccccccHHHHHhccC------------ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceE
Confidence 999999999999999998655 688888999999999999999998 99999999999999999999
Q ss_pred eEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 002759 746 KLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
||+|||-++...+ ......+.||+.|||||++...+.++|+||||||||+|||+||..||.+.+...+..-+.
T Consensus 252 KIsDFGTS~e~~~--~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVG----- 324 (904)
T KOG4721|consen 252 KISDFGTSKELSD--KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVG----- 324 (904)
T ss_pred EeccccchHhhhh--hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEecc-----
Confidence 9999999998764 345677899999999999999999999999999999999999999998765443321100
Q ss_pred HHcCCCcccccccC-CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 826 LERGSASACFDRSL-RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 826 ~~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
. ..+ ...+++++..+.-|++.||+..|..||+|.+++.-|+-....
T Consensus 325 ------s----NsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe 371 (904)
T KOG4721|consen 325 ------S----NSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE 371 (904)
T ss_pred ------C----CcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence 0 001 113455666777788889999999999999999988866543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=335.24 Aligned_cols=257 Identities=23% Similarity=0.328 Sum_probs=204.0
Q ss_pred ccCceeccCCceEEEEE-EEcCCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeee-EEecCC-ceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQG-YYWSST-MQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~-~~~lv~e~ 672 (884)
.+.+.||+|.||+||++ ...+|..+|.|.++-. -+.+...+...|+.++++++|||||++++ .+.++. ..++||||
T Consensus 22 ~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~ 101 (375)
T KOG0591|consen 22 QILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMEL 101 (375)
T ss_pred HHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHh
Confidence 35678999999999999 4578999999999732 23344677899999999999999999998 344444 48999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCC-CeEeccCCCCceEeCCCCCeeEcccc
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKP-PILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~-~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
+.+|+|...++... .....++++++++++.|++.||.++|.+..+ -|+||||||.||+++.+|.||++|||
T Consensus 102 c~~GDLsqmIk~~K--------~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 102 CDAGDLSQMIKHFK--------KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hcccCHHHHHHHHH--------hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 99999999986544 1245789999999999999999999985332 28999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
+++++... .......+||+.||+||.+.+.+|+.+|||||+||++|||+.-++||.+.. ...+ .+.+..+..
T Consensus 174 L~r~l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L----~~KI~qgd~ 245 (375)
T KOG0591|consen 174 LGRFLSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSL----CKKIEQGDY 245 (375)
T ss_pred hHhHhcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHH----HHHHHcCCC
Confidence 99998642 223456789999999999999999999999999999999999999999863 2222 233333333
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
..+.+ +....++..+|..|+..||+.||+.-.+++.+.
T Consensus 246 ~~~p~-------~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 246 PPLPD-------EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred CCCcH-------HHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 32221 334457778888899999999998554444443
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=364.92 Aligned_cols=266 Identities=29% Similarity=0.476 Sum_probs=213.1
Q ss_pred HHHHHHhhcccccCceeccCCceEEEEEEEcCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC
Q 002759 586 EDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST 664 (884)
Q Consensus 586 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 664 (884)
.+|.+..+++. ..+.||+|.||+||+|.|.+ .||||+++... .+...+.|.+|+..+++-||.||+-+.|+|..+.
T Consensus 385 ~~WeIp~~ev~-l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 385 EEWEIPPEEVL-LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccCHHHhh-ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 45555544443 67789999999999999985 58999997543 3446788999999999999999999999998877
Q ss_pred ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCC
Q 002759 665 MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE 744 (884)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~ 744 (884)
. .||+.+|+|.+|+.+++-.+ .+|+..+.++||+|||+||.|||.+ +|||||||..||++.++++
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~e-----------tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~k 526 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQE-----------TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLK 526 (678)
T ss_pred e-eeeehhccCchhhhhccchh-----------hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCc
Confidence 7 99999999999999998544 5789999999999999999999999 9999999999999999999
Q ss_pred eeEccccCccccCC-ccCcccccccccccccCccccCC---CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 002759 745 PKLSDYGLAKLLPI-LDNYGLTKFHNAVGYVAPELAQS---LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE 820 (884)
Q Consensus 745 vkl~Dfg~s~~~~~-~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~ 820 (884)
|||+|||++..-.. ..........|..-|||||++.. .+|++.+||||||+++|||++|..||.....+.+..++
T Consensus 527 VkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmV- 605 (678)
T KOG0193|consen 527 VKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMV- 605 (678)
T ss_pred EEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEe-
Confidence 99999999865321 12233445667788999999963 46889999999999999999999999954444333211
Q ss_pred HHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 821 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
..+... .| .......+..++.+|+..||..++++||.|.+|+..|+++..
T Consensus 606 ------GrG~l~--pd--~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 606 ------GRGYLM--PD--LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ------cccccC--cc--chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 111111 11 111234455677788888999999999999999999988865
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=342.75 Aligned_cols=240 Identities=25% Similarity=0.355 Sum_probs=199.1
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCcc--CCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRI--RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
++..++||+|+||+||.++. ++++.+|+|++++.... .+.+....|..++.+++||+||++...|.+.+..|+|+||
T Consensus 27 F~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~ 106 (357)
T KOG0598|consen 27 FEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDY 106 (357)
T ss_pred eeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEec
Confidence 45788999999999999965 46788999999765433 3478889999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+.||.|+..|++.+ .+++..+..++..|+.||.|||++ +||||||||+|||+|++|+++|+|||+
T Consensus 107 ~~GGeLf~hL~~eg------------~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL 171 (357)
T KOG0598|consen 107 LNGGELFYHLQREG------------RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGL 171 (357)
T ss_pred cCCccHHHHHHhcC------------CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEecccc
Confidence 99999999998654 689999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++.... ++......+||+.|||||++.+..|+.++|+||+|+++|||++|.+||...+..+++. .... .+..
T Consensus 172 ~k~~~~-~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~------~I~~-~k~~ 243 (357)
T KOG0598|consen 172 CKEDLK-DGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD------KILK-GKLP 243 (357)
T ss_pred chhccc-CCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH------HHhc-CcCC
Confidence 986543 2334455799999999999999999999999999999999999999999876554432 1111 1100
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP 866 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 866 (884)
.......+ +...++.+.+..||++|.
T Consensus 244 -----~~p~~ls~---~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 244 -----LPPGYLSE---EARDLLKKLLKRDPRQRL 269 (357)
T ss_pred -----CCCccCCH---HHHHHHHHHhccCHHHhc
Confidence 01111222 345566678999999996
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=366.74 Aligned_cols=368 Identities=23% Similarity=0.248 Sum_probs=342.5
Q ss_pred EEEEEecCccccccccccccCCCCCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCC
Q 002759 74 VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSR 153 (884)
Q Consensus 74 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~ 153 (884)
+..++++++.|+..-...|.++++|+.++|..|.++ .||...+...+|+.|+|.+|.|+..-.+++..++.|+.||||.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 567889999999888888999999999999999999 8998888888999999999999988888999999999999999
Q ss_pred CccCCCCchhhhhccccCcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCc
Q 002759 154 NSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTV 233 (884)
Q Consensus 154 N~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~ 233 (884)
|.++ +||...|..-.++++|+|++|.|+..-...|.++.+|..|.|+.|+++...+..|.+|+.|+.|+|..|+|.-.-
T Consensus 159 N~is-~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 159 NLIS-EIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred chhh-cccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 9998 999998888889999999999999888889999999999999999999666678888999999999999999666
Q ss_pred ccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCCCCCCccccccc
Q 002759 234 EEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCR 313 (884)
Q Consensus 234 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~ 313 (884)
--.|.++.+|+.|.|..|.+..+....|.++.++++|+|..|+++..-..+..++..|+.|++|+|.|..+.++.+.-++
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq 317 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ 317 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence 77899999999999999999999999999999999999999999988778889999999999999999999999999999
Q ss_pred ccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCc---CCcCCCCCcEE
Q 002759 314 NLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPD---DISNCRFLLLL 390 (884)
Q Consensus 314 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~---~~~~l~~L~~L 390 (884)
+|++|+|++|+|+...+.+|..|..|++|+|++|+++..-...|..+++|+.|||++|.|++.+.+ .|.+|++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 999999999999988899999999999999999999988888999999999999999999877654 47889999999
Q ss_pred eccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCc
Q 002759 391 DVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNS 444 (884)
Q Consensus 391 ~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 444 (884)
++.+|+|....-..|..+++|++|||.+|.|..+-|.+|..+ .|++|.+..-.
T Consensus 398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSss 450 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSS 450 (873)
T ss_pred eecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccc
Confidence 999999995555689999999999999999999999999999 99999875433
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=327.29 Aligned_cols=262 Identities=21% Similarity=0.266 Sum_probs=204.5
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+...++|+|+||+||+++.+ +|+-||||++....+ +...+-.++|++++++++|||+|.++++|...+..++|+||+
T Consensus 4 YE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~ 83 (396)
T KOG0593|consen 4 YEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYC 83 (396)
T ss_pred HhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeec
Confidence 345567999999999999775 589999999976654 334566799999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+. ++.+-+.... ..++...+.++++|++.|+.|+|++ ++|||||||+||||+.+|.+|+||||+|
T Consensus 84 dh-TvL~eLe~~p-----------~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFA 148 (396)
T KOG0593|consen 84 DH-TVLHELERYP-----------NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFA 148 (396)
T ss_pred ch-HHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhh
Confidence 76 6666665433 3477888999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHHHHc---
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE-YVRELLER--- 828 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~-~~~~~~~~--- 828 (884)
+.+.. .+...+.++.|-.|+|||.+.+ .+|+..+||||+||++.||++|.+-|.+..+-+....+. -....++.
T Consensus 149 R~L~~-pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~ 227 (396)
T KOG0593|consen 149 RTLSA-PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS 227 (396)
T ss_pred HhhcC-CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH
Confidence 99874 3445678889999999999987 789999999999999999999999998876544432221 11111111
Q ss_pred ----CC-Ccc--ccccc----CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 ----GS-ASA--CFDRS----LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ----~~-~~~--~~d~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. +.- ..++. ++.-.+....-++.++..|++.||++|++.+|++.
T Consensus 228 iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 228 IFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 11 000 01110 00011122235677888999999999999999873
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=356.12 Aligned_cols=265 Identities=30% Similarity=0.420 Sum_probs=223.4
Q ss_pred HHHHHHHhhcccccCceeccCCceEEEEEEEcC-CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002759 585 YEDWEAGTKALLDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS 663 (884)
Q Consensus 585 ~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 663 (884)
+++|+-.+.++. -..+||.|.||+||.|.|+. .-.||||.++... ...++|..|+.+|+.++|||+|+++|+|+.+
T Consensus 259 ~DkWEmeRtdIt-MkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt--MeveEFLkEAAvMKeikHpNLVqLLGVCT~E 335 (1157)
T KOG4278|consen 259 ADKWEMERTDIT-MKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE 335 (1157)
T ss_pred cchhhccchhee-eeeccCCCcccceeeeeeeccceeeehhhhhhcc--hhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence 367776666655 56789999999999999975 4679999998644 6789999999999999999999999999999
Q ss_pred CceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC
Q 002759 664 TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY 743 (884)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~ 743 (884)
..+|||+|||..|+|.+||+++. +..++.-..+.||.||+.||+||..+ ++|||||.++|+||.++.
T Consensus 336 pPFYIiTEfM~yGNLLdYLRecn----------r~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnh 402 (1157)
T KOG4278|consen 336 PPFYIITEFMCYGNLLDYLRECN----------RSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENH 402 (1157)
T ss_pred CCeEEEEecccCccHHHHHHHhc----------hhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccc
Confidence 99999999999999999999776 55677778899999999999999998 999999999999999999
Q ss_pred CeeEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 002759 744 EPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 744 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~ 822 (884)
.|||+|||+++.+..+.+.......-++.|.|||.+....++.|+|||+|||++||+.| |-.||.+.+...++
T Consensus 403 iVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY------ 476 (1157)
T KOG4278|consen 403 IVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY------ 476 (1157)
T ss_pred eEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHH------
Confidence 99999999999987544433444445788999999999999999999999999999999 99999987655444
Q ss_pred HHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
.+++.+..++ .++.++..+.++|+.||++.|.+||+|+|+-+.++.|-.
T Consensus 477 -~LLEkgyRM~--------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~ 525 (1157)
T KOG4278|consen 477 -GLLEKGYRMD--------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS 525 (1157)
T ss_pred -HHHhcccccc--------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence 3333332222 123344467778888999999999999999999998854
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=346.85 Aligned_cols=267 Identities=23% Similarity=0.268 Sum_probs=212.2
Q ss_pred HHHHHhhcccccCceeccCCceEEEEE-EEcCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC-
Q 002759 587 DWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS- 663 (884)
Q Consensus 587 ~~~~~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~- 663 (884)
.|.....+.|+..++||+|.||.||+| +..+|+.||+|++.... ++.......+||.++++++||||+++.+...+.
T Consensus 110 ~w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 110 GWGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKL 189 (560)
T ss_pred cccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecC
Confidence 555555566677889999999999999 45789999999997543 455677889999999999999999999988776
Q ss_pred -CceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC
Q 002759 664 -TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN 742 (884)
Q Consensus 664 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~ 742 (884)
...|+|+|||+. +|.-++...+ -.|+..++..++.|+++||+|+|++ +|+|||||.+|||||.+
T Consensus 190 ~~siYlVFeYMdh-DL~GLl~~p~-----------vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~ 254 (560)
T KOG0600|consen 190 SGSIYLVFEYMDH-DLSGLLSSPG-----------VKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNN 254 (560)
T ss_pred CceEEEEEecccc-hhhhhhcCCC-----------cccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCC
Confidence 689999999966 8988886433 3799999999999999999999999 99999999999999999
Q ss_pred CCeeEccccCccccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 002759 743 YEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEY 821 (884)
Q Consensus 743 ~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~ 821 (884)
|.+||+|||+|+++........+..+.|..|+|||.+.+. .|+.+.|+||.|||+.||++|++.|++.++.+....+
T Consensus 255 G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kI-- 332 (560)
T KOG0600|consen 255 GVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKI-- 332 (560)
T ss_pred CCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHH--
Confidence 9999999999999877666667888899999999998864 7899999999999999999999999987654433221
Q ss_pred HHHHHHcCCCcccccc------------------cCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 822 VRELLERGSASACFDR------------------SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 822 ~~~~~~~~~~~~~~d~------------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.-.. +.+.+++ .+++..........+|+..++..||.+|.||.++++
T Consensus 333 -fklcGS--P~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 333 -FKLCGS--PTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred -HHHhCC--CChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 111111 1111111 011100011123456777899999999999999874
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.80 Aligned_cols=265 Identities=25% Similarity=0.364 Sum_probs=212.8
Q ss_pred HHHHHHhhcccccCceeccCCceEEEEEEEcC--C--eE-EEEEEccc--cCccCCHHHHHHHHHHHhcCCCCCcceeee
Q 002759 586 EDWEAGTKALLDKECLIGGGSIGSVYRASFEG--G--VS-IAVKKLET--LGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658 (884)
Q Consensus 586 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~--~--~~-vavK~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (884)
..|+..-++.. ..+.||+|+||+||+|.+.. + .. ||||..+. ........+|+.|++++++++|||||+++|
T Consensus 150 ~~Wel~H~~v~-l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yG 228 (474)
T KOG0194|consen 150 QKWELSHSDIE-LGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYG 228 (474)
T ss_pred cccEEeccCcc-ccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence 44443333332 44789999999999997643 2 23 89999874 233456789999999999999999999999
Q ss_pred EEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceE
Q 002759 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNIL 738 (884)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil 738 (884)
++..+.+.++|||+|.||+|.++|+... ..++..++..++.++|.||+|||++ ++|||||.++|+|
T Consensus 229 Va~~~~Pl~ivmEl~~gGsL~~~L~k~~-----------~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL 294 (474)
T KOG0194|consen 229 VAVLEEPLMLVMELCNGGSLDDYLKKNK-----------KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCL 294 (474)
T ss_pred EEcCCCccEEEEEecCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHhe
Confidence 9999999999999999999999998654 2589999999999999999999999 9999999999999
Q ss_pred eCCCCCeeEccccCccccCCccCcccc-cccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchh
Q 002759 739 LDENYEPKLSDYGLAKLLPILDNYGLT-KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816 (884)
Q Consensus 739 ~~~~~~vkl~Dfg~s~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~ 816 (884)
++.++.+||+|||+++.-. ...... ...-+.+|+|||.+....+++++|||||||++||+++ |..||.+....++
T Consensus 295 ~~~~~~vKISDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v- 371 (474)
T KOG0194|consen 295 YSKKGVVKISDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV- 371 (474)
T ss_pred ecCCCeEEeCccccccCCc--ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH-
Confidence 9999999999999998643 111111 2245789999999999999999999999999999999 9999998765432
Q ss_pred hHHHHHHHHH-HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhccc
Q 002759 817 VLCEYVRELL-ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 817 ~~~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~~ 882 (884)
+..+ ..+..... +...+.++.+++..||..+|++||||.++.+.++.+....
T Consensus 372 ------~~kI~~~~~r~~~--------~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 372 ------KAKIVKNGYRMPI--------PSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred ------HHHHHhcCccCCC--------CCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 2222 22211111 1234456777778999999999999999999999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=346.41 Aligned_cols=263 Identities=24% Similarity=0.337 Sum_probs=219.8
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
....++||+|-||+|..+....+..||||+++.........+|.+|+++|.+++||||++++|+|..++..++|+|||+.
T Consensus 540 L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEn 619 (807)
T KOG1094|consen 540 LRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMEN 619 (807)
T ss_pred eehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhc
Confidence 34677899999999999999988999999999877667779999999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.+|+..+.. +...-....+|+.|||.||+||.+. ++||||+.++|+|++.++++||+|||.++.
T Consensus 620 GDLnqFl~ahea----------pt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 620 GDLNQFLSAHEL----------PTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred CcHHHHHHhccC----------cccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccc
Confidence 999999987752 1234455677999999999999998 999999999999999999999999999997
Q ss_pred cCCccCccc-ccccccccccCccccCCCCCCCccCchhHHHHHHHHHh--CCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 756 LPILDNYGL-TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT--GRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 756 ~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t--G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+-..+++.. ....-+.+|||||.+..++++.++|||+|||++||+++ ...||....++++. +-.....+.+...
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---en~~~~~~~~~~~ 763 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---ENAGEFFRDQGRQ 763 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---HhhhhhcCCCCcc
Confidence 765555543 45566889999999999999999999999999999988 88999987765543 2222333222211
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
. ....+.-++.++.+++..||+.+.++||+|+++...|.+..
T Consensus 764 ~-----~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 764 V-----VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred e-----eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 1 11234446668889999999999999999999999887653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=334.13 Aligned_cols=257 Identities=22% Similarity=0.313 Sum_probs=206.9
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..++||.|..++||+|.. +.+..||||++.-.....+.+.+.+|+..++.++||||++++..|..+...|+||.||.
T Consensus 28 YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa 107 (516)
T KOG0582|consen 28 YELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMA 107 (516)
T ss_pred eeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhc
Confidence 45677899999999999954 56789999999755544567899999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+|++.+.++..- ..-+++..+..|.+++++||.|||++ |.||||+|+.||||+.+|.|||+|||.+.
T Consensus 108 ~GS~ldIik~~~----------~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa 174 (516)
T KOG0582|consen 108 GGSLLDIIKTYY----------PDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSA 174 (516)
T ss_pred CCcHHHHHHHHc----------cccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeee
Confidence 999999997654 23488899999999999999999999 99999999999999999999999999988
Q ss_pred ccCCccCc---ccccccccccccCccccCC--CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 755 LLPILDNY---GLTKFHNAVGYVAPELAQS--LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 755 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
.+.+.... ......|++.|||||+++. ..|+.|+||||||++..|+.+|..||....+..+.. ......+
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl-----~tLqn~p 249 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLL-----LTLQNDP 249 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHH-----HHhcCCC
Confidence 77643311 1145689999999999653 468899999999999999999999999877655431 1111111
Q ss_pred CCcccccccCCC--CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRG--FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.+....+ ........+.+++..|+++||++|||++++++
T Consensus 250 ---p~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 250 ---PTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred ---CCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 111111111 11222336777888899999999999999984
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=339.60 Aligned_cols=250 Identities=29% Similarity=0.379 Sum_probs=197.4
Q ss_pred cCceeccCCceEEEEEEEcC-CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC--ceeEEEEecC
Q 002759 598 KECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST--MQLILSEFVP 674 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~e~~~ 674 (884)
..+.||+|+||.||++...+ |...|||.+....... .+.+++|+.++.+++|||||+++|...... .++++|||++
T Consensus 21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~-~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~ 99 (313)
T KOG0198|consen 21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT-SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAP 99 (313)
T ss_pred hhccccCccceEEEEEEecCCCcceeeeeeecccchh-HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccC
Confidence 56689999999999997754 8899999997543222 677899999999999999999999854444 6899999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC-CCCeeEccccCc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-NYEPKLSDYGLA 753 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-~~~vkl~Dfg~s 753 (884)
+|+|.+++...+ . .+++..++.+++||++||+|||++ +||||||||+|||++. ++.+||+|||.+
T Consensus 100 ~GsL~~~~~~~g----------~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a 165 (313)
T KOG0198|consen 100 GGSLSDLIKRYG----------G-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLA 165 (313)
T ss_pred CCcHHHHHHHcC----------C-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccc
Confidence 999999998654 2 689999999999999999999998 9999999999999999 799999999999
Q ss_pred cccCC--ccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 754 KLLPI--LDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 754 ~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+.... ..........||+.|||||++..+ ....++||||+||++.||+||+.||... .. ...+.........
T Consensus 166 ~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-~~----~~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 166 KKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-FE----EAEALLLIGREDS 240 (313)
T ss_pred cccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-cc----hHHHHHHHhccCC
Confidence 87653 122234467899999999999953 3345999999999999999999999864 11 1111222221111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
. |. .++....+..+++.+|++++|++||||+++++--
T Consensus 241 ~-----P~---ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 241 L-----PE---IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred C-----CC---CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 1 11 1222333566677789999999999999998643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=343.79 Aligned_cols=257 Identities=24% Similarity=0.305 Sum_probs=206.3
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCC-ceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSST-MQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~~lv~e~ 672 (884)
|...+.+|.|.||.||+|+. .++..||||+++..-..-+.-.-.+|+..++++. ||||+++.+++.+.+ ..++||||
T Consensus 12 Y~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~ 91 (538)
T KOG0661|consen 12 YTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEF 91 (538)
T ss_pred HHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHh
Confidence 34567899999999999954 5688999999986543333334578999999998 999999999998887 89999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
| ..+|++.++.++ ..+++.+++.|+.||++||+|+|.+ |+.|||+||+|||+..+..+||+|||+
T Consensus 92 M-d~NLYqLmK~R~-----------r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGL 156 (538)
T KOG0661|consen 92 M-DCNLYQLMKDRN-----------RLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGL 156 (538)
T ss_pred h-hhhHHHHHhhcC-----------CcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccc
Confidence 9 459999997654 5799999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC-CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHHHHcCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV-VLCEYVRELLERGS 830 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~-~~~~~~~~~~~~~~ 830 (884)
||.+.. ....+.++.|-.|+|||++. ..-|+.+.||||+||+++|+.+=++-|.+..+.+.. .+++ .+..+.
T Consensus 157 ARev~S--kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~----VLGtP~ 230 (538)
T KOG0661|consen 157 AREVRS--KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE----VLGTPD 230 (538)
T ss_pred cccccc--CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH----HhCCCc
Confidence 998763 33457788899999999875 567899999999999999999999999886543332 2222 222221
Q ss_pred Cccc-----------------ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASAC-----------------FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~-----------------~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... ....+....+....+.++++.+|+.+||++||||+|+++
T Consensus 231 ~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 231 KDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred cccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 1111 011111233346678899999999999999999999986
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=339.65 Aligned_cols=246 Identities=24% Similarity=0.313 Sum_probs=203.4
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
..++.||+|+|++|++|+. .+++.+|||++.+.. +....+.+..|-.+|.++ .||.|++++..|.++...|+|+||
T Consensus 76 ~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~ 155 (604)
T KOG0592|consen 76 KFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEY 155 (604)
T ss_pred chhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEe
Confidence 3678899999999999954 568899999996543 334466778888889999 899999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.++|++.+ .+++..++.+|.+|+.|++|||+. |||||||||+|||+|++|++||+|||.
T Consensus 156 A~nGdll~~i~K~G------------sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGs 220 (604)
T KOG0592|consen 156 APNGDLLDLIKKYG------------SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGS 220 (604)
T ss_pred cCCCcHHHHHHHhC------------cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccc
Confidence 99999999998766 799999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCccCc------------ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 002759 753 AKLLPILDNY------------GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE 820 (884)
Q Consensus 753 s~~~~~~~~~------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~ 820 (884)
|+.+.+.... .....+||..|.+||++.....++.+|+|+|||++|+|+.|++||....+.-+...+.
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~ 300 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQ 300 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHH
Confidence 9988642211 1145789999999999999999999999999999999999999999866433221111
Q ss_pred HHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 821 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. - |.. +++.....+..|+.+.+..||.+|+|.+||.+
T Consensus 301 ~-----l--------~y~---fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 301 A-----L--------DYE---FPEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred H-----h--------ccc---CCCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1 1 111 11222235666777899999999999988764
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=340.94 Aligned_cols=247 Identities=22% Similarity=0.318 Sum_probs=204.8
Q ss_pred cccCceeccCCceEEEEEE-EcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+.-..||+|+.|.||.|. ..+++.||||++.... ....+-+.+|+.+|+..+|+|||.+++.|...+..|+|||||+
T Consensus 275 y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~-Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 275 YTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK-QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hcchhhhccccccceeeeeeccCCceEEEEEEEecc-CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3445679999999999994 4568889999996543 2446678999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
||+|.|.+... .+++.++..|++++++||+|||.+ +|+|||||.+|||++.+|.+||+|||++.
T Consensus 354 ggsLTDvVt~~-------------~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFca 417 (550)
T KOG0578|consen 354 GGSLTDVVTKT-------------RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCA 417 (550)
T ss_pred CCchhhhhhcc-------------cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeee
Confidence 99999998754 388999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.+.... .......||+.|||||++....|+++.||||+|++++||+-|.+||-...+-.... -....+.+.-
T Consensus 418 qi~~~~-~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly------LIa~ng~P~l- 489 (550)
T KOG0578|consen 418 QISEEQ-SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTPKL- 489 (550)
T ss_pred cccccc-CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH------HHhhcCCCCc-
Confidence 886533 25667889999999999999999999999999999999999999998744332221 1111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+ ..+.....+.+++.+|++.||++||++.|+++
T Consensus 490 -----k-~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 490 -----K-NPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred -----C-CccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 1 12223346677778899999999999999985
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=340.03 Aligned_cols=254 Identities=26% Similarity=0.401 Sum_probs=218.9
Q ss_pred ccCceeccCCceEEEEEEEcC---C--eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASFEG---G--VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~---~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
...+.||+|.||.||+|.+.+ | -.||||.-+......+.+.|..|+.+|+.++||||++++|+|.+ ...|+|||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 367789999999999997642 2 45899999987777889999999999999999999999999975 57899999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
.++-|.|..|++.+. ..++..+...++.||..||+|||+. ++|||||.++||||....-||++|||
T Consensus 471 L~~~GELr~yLq~nk-----------~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFG 536 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK-----------DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFG 536 (974)
T ss_pred cccchhHHHHHHhcc-----------ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccc
Confidence 999999999998544 4688899999999999999999999 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+++.+.+..++..+...-+..|||||.+.-.+++.++|||-|||.+||+++ |..||+.....++... ++.+.
T Consensus 537 LSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-------iEnGe 609 (974)
T KOG4257|consen 537 LSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-------IENGE 609 (974)
T ss_pred hhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-------ecCCC
Confidence 999998877776666666888999999999999999999999999999999 9999998776655421 12222
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
.. ..++.++..+..++.+||..+|.+||++.|+...|.++..
T Consensus 610 Rl--------P~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 610 RL--------PCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred CC--------CCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 11 2344556677788899999999999999999999988754
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.67 Aligned_cols=248 Identities=28% Similarity=0.376 Sum_probs=209.4
Q ss_pred ccccCceeccCCceEEEEEE-EcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 595 LLDKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
.|...++||+|.||+||+|. ...++.||+|++.-.....+.+++++|+.++++++++||.++++.+..+...+++|||+
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 34556789999999999995 46788999999987666677889999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
.||++.+.+.... .+++....-+.+++..|+.|||.+ +.+|||||+.||++..+|.||++|||.+
T Consensus 94 ~gGsv~~lL~~~~------------~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa 158 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN------------ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVA 158 (467)
T ss_pred cCcchhhhhccCC------------CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEeccee
Confidence 9999999997544 346777778899999999999999 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
..+...... .....||+.|||||++.+..|+.|+||||+|++.+||.+|.+|+...++..+..++ . +
T Consensus 159 ~ql~~~~~r-r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI-------p-----k 225 (467)
T KOG0201|consen 159 GQLTNTVKR-RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI-------P-----K 225 (467)
T ss_pred eeeechhhc-cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec-------c-----C
Confidence 888754333 36789999999999999999999999999999999999999999987765544221 1 1
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...|.+.+ .....+.+++..|+.++|+.||+|.++++
T Consensus 226 ~~PP~L~~---~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 226 SAPPRLDG---DFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred CCCCcccc---ccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 12223333 22334666777799999999999999884
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=304.98 Aligned_cols=259 Identities=22% Similarity=0.255 Sum_probs=204.6
Q ss_pred cccCceeccCCceEEEEE-EEcCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|...+++|+|.||.||+| +.++|+.||||+++.... ........+|++.+++++|+||+.++++|-..+...+|+|||
T Consensus 4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm 83 (318)
T KOG0659|consen 4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM 83 (318)
T ss_pred hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence 345678999999999999 557899999999975432 223567799999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+. +|+..++... ..++..++..++.++++|++|||++ .|+||||||.|+|++++|.+||+|||+|
T Consensus 84 ~t-dLe~vIkd~~-----------i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLA 148 (318)
T KOG0659|consen 84 PT-DLEVVIKDKN-----------IILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLA 148 (318)
T ss_pred cc-cHHHHhcccc-----------cccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccch
Confidence 65 9999997654 4688899999999999999999999 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+.+...+ ...+..+.|-.|+|||.+.|. .|+...||||.||++.||+-|.+-|.+..+-+.. ..+.+.+..+...
T Consensus 149 r~f~~p~-~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL---~~If~~LGTP~~~ 224 (318)
T KOG0659|consen 149 RFFGSPN-RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQL---SKIFRALGTPTPD 224 (318)
T ss_pred hccCCCC-cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHH---HHHHHHcCCCCcc
Confidence 9987533 223444778899999988764 6899999999999999999999999886654332 2222332222221
Q ss_pred cccc---------------ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 ACFD---------------RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d---------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+ +.....-+.+..+..+++..++..||.+|+|++|+++
T Consensus 225 ~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~ 280 (318)
T KOG0659|consen 225 QWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK 280 (318)
T ss_pred cCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence 1111 1111112223345678888999999999999999885
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=347.93 Aligned_cols=269 Identities=26% Similarity=0.369 Sum_probs=204.9
Q ss_pred cccCceeccCCceEEEEEEE------cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecC-Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASF------EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSS-TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~ 667 (884)
++..+.||+|+||.||+|.. .++..||||+++..........+.+|+.++..+ +||||+++++++... ...+
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (338)
T cd05102 9 LRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLM 88 (338)
T ss_pred ceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceE
Confidence 45678899999999999964 234679999997544334456789999999999 899999999988754 4578
Q ss_pred EEEEecCCCchhhhcccCCCCCCC--------------------------------------------------CCCCCC
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTS--------------------------------------------------TGGIGN 697 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~--------------------------------------------------~~~~~~ 697 (884)
+||||+++|+|.+++......... ..+...
T Consensus 89 lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (338)
T cd05102 89 VIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWK 168 (338)
T ss_pred EEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcccccc
Confidence 999999999999998753210000 000012
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCc-ccccccccccccCc
Q 002759 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAP 776 (884)
Q Consensus 698 ~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aP 776 (884)
..+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++........ ......++..|+||
T Consensus 169 ~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 169 SPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 3588899999999999999999998 9999999999999999999999999999865432221 12234456789999
Q ss_pred cccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHh
Q 002759 777 ELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGL 855 (884)
Q Consensus 777 E~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~ 855 (884)
|++.+..++.++|||||||++|||++ |..||......+.. . .....+.... .+.....++.+++.
T Consensus 246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~-----~-~~~~~~~~~~--------~~~~~~~~l~~li~ 311 (338)
T cd05102 246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF-----C-QRLKDGTRMR--------APENATPEIYRIML 311 (338)
T ss_pred HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH-----H-HHHhcCCCCC--------CCCCCCHHHHHHHH
Confidence 99998899999999999999999997 99999875432211 1 1111111111 01122346778889
Q ss_pred hccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 856 ICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 856 ~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
+||+.||++|||+.|+++.|+++..+
T Consensus 312 ~cl~~dp~~RPs~~el~~~l~~~~~~ 337 (338)
T cd05102 312 ACWQGDPKERPTFSALVEILGDLLQE 337 (338)
T ss_pred HHccCChhhCcCHHHHHHHHHHHHhc
Confidence 99999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=311.75 Aligned_cols=234 Identities=24% Similarity=0.320 Sum_probs=196.3
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEcccc--CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+..+.+|.|+||+|.+++.+ ++..+|+|++... .+.++.+...+|..+++.+.||+++++.+.+.+.+..++||||+
T Consensus 47 e~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv 126 (355)
T KOG0616|consen 47 ERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYV 126 (355)
T ss_pred hheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEecc
Confidence 35678999999999999664 6788999999653 34556778899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+||.|+.+++..+ +++++.++.+|.||+.|++|||+. .|++|||||+|||+|.+|.+||+|||+|
T Consensus 127 ~GGElFS~Lrk~~------------rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFA 191 (355)
T KOG0616|consen 127 PGGELFSYLRKSG------------RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFA 191 (355)
T ss_pred CCccHHHHHHhcC------------CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccce
Confidence 9999999998766 799999999999999999999999 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
+.+.. ..-..+||+.|+|||++...+|..++|+|||||++|||+.|.+||....+..++. .+-.++..
T Consensus 192 K~v~~----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~-------KI~~~~v~- 259 (355)
T KOG0616|consen 192 KRVSG----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE-------KILEGKVK- 259 (355)
T ss_pred EEecC----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH-------HHHhCccc-
Confidence 98752 2456899999999999999999999999999999999999999999877643331 11111111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRR 865 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 865 (884)
++.-...++..++...++.|-.+|
T Consensus 260 --------fP~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 260 --------FPSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred --------CCcccCHHHHHHHHHHHhhhhHhh
Confidence 112222245566667788887777
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=319.42 Aligned_cols=262 Identities=24% Similarity=0.339 Sum_probs=201.2
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHh--cCCCCCcceeeeEEecC----CceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLS--NIRHFNLVAFQGYYWSS----TMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~----~~~~lv~ 670 (884)
...+.||+|.||+||+|.|+ |+.||||++.. ++.+.+.+|.++++ .++|+||+.+++.=..+ ...++|+
T Consensus 214 ~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s----rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvT 288 (513)
T KOG2052|consen 214 VLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS----RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVT 288 (513)
T ss_pred EEEEEecCccccceeecccc-CCceEEEEecc----cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEee
Confidence 35678999999999999998 56899999975 34455556666655 46999999998864332 3579999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEeccCCCCceEeCCCCCe
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHD-----CKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~-----~~~~ivH~Dlk~~Nil~~~~~~v 745 (884)
+|.+.|||+|||... .++....++++..+|.||++||-. .+|.|.|||||++||||..++.+
T Consensus 289 dYHe~GSL~DyL~r~-------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C 355 (513)
T KOG2052|consen 289 DYHEHGSLYDYLNRN-------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC 355 (513)
T ss_pred ecccCCcHHHHHhhc-------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcE
Confidence 999999999999753 589999999999999999999965 48889999999999999999999
Q ss_pred eEccccCccccCCccC---cccccccccccccCccccCCCCCC------CccCchhHHHHHHHHHh----------CCCC
Q 002759 746 KLSDYGLAKLLPILDN---YGLTKFHNAVGYVAPELAQSLRLS------DKCDVYSFGVILLELVT----------GRKP 806 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~------~~sDvwS~Gv~l~el~t----------G~~p 806 (884)
.|+|+|+|........ ......+||.+|||||++...... ..+||||||.++||+.- -+.|
T Consensus 356 ~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~P 435 (513)
T KOG2052|consen 356 CIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLP 435 (513)
T ss_pred EEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCC
Confidence 9999999987654321 224567899999999998653221 26899999999999986 2367
Q ss_pred CCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 807 VESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
|.+..+.+-- .+..++.+-..+.+..++... ...+.+..+.|+|+.||..+|.-|-|+-.+.+.|.++.+
T Consensus 436 yyd~Vp~DPs--~eeMrkVVCv~~~RP~ipnrW--~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 436 YYDVVPSDPS--FEEMRKVVCVQKLRPNIPNRW--KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred cccCCCCCCC--HHHHhcceeecccCCCCCccc--ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 7663322111 122233322223332222222 346788899999999999999999999999999998863
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=339.43 Aligned_cols=253 Identities=26% Similarity=0.368 Sum_probs=205.8
Q ss_pred cccccCceeccCCceEEEEEEE-cCCeEEEEEEccccC---c-cCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCcee
Q 002759 594 ALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG---R-IRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQL 667 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~---~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 667 (884)
..|..++.||+|+||+|+.|.. .++..||+|++.... . ....+.+.+|+.+++.++ ||||+++++++......+
T Consensus 17 g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ 96 (370)
T KOG0583|consen 17 GKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIY 96 (370)
T ss_pred CceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEE
Confidence 3456788999999999999955 567999999775431 1 134566778999999998 999999999999999999
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC-CCee
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPK 746 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-~~vk 746 (884)
+||||+.+|+|++++...+ .+.+.++.++++|++.|++|+|+. +|+||||||+||+++.+ +.+|
T Consensus 97 ivmEy~~gGdL~~~i~~~g------------~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~K 161 (370)
T KOG0583|consen 97 IVMEYCSGGDLFDYIVNKG------------RLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLK 161 (370)
T ss_pred EEEEecCCccHHHHHHHcC------------CCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEE
Confidence 9999999999999998643 688899999999999999999999 99999999999999999 9999
Q ss_pred EccccCccccCCccCcccccccccccccCccccCCCC-CC-CccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLR-LS-DKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~ 824 (884)
|+|||++.... .........+|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||...+..... .
T Consensus 162 l~DFG~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~-------~ 233 (370)
T KOG0583|consen 162 LSDFGLSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY-------R 233 (370)
T ss_pred EeccccccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH-------H
Confidence 99999999874 2344567789999999999999877 86 6899999999999999999999984433222 1
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.+..+.+. +..... ..++..++.+|+..+|.+|+|+.+++ .-.-+
T Consensus 234 ki~~~~~~------~p~~~~--S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~ 278 (370)
T KOG0583|consen 234 KIRKGEFK------IPSYLL--SPEARSLIEKMLVPDPSTRITLLEIL-EHPWF 278 (370)
T ss_pred HHhcCCcc------CCCCcC--CHHHHHHHHHHcCCCcccCCCHHHHh-hChhh
Confidence 12222211 111110 34677888899999999999999998 43333
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=344.78 Aligned_cols=255 Identities=25% Similarity=0.419 Sum_probs=216.1
Q ss_pred ccCceeccCCceEEEEEEEc-CC----eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE-GG----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
....+||+|+||+||+|.|- ++ -+||+|++......+...++.+|+.+|+.++|||+++++|+|.... ..+|++
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 45678999999999999763 33 4689999988777778899999999999999999999999997655 889999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
||+.|+|.++++..+ ..+-.+..+.|..|||+||.|||.+ ++|||||.++||||..-..+||.|||
T Consensus 778 ~mP~G~LlDyvr~hr-----------~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfg 843 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREHR-----------DNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFG 843 (1177)
T ss_pred hcccchHHHHHHHhh-----------ccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecc
Confidence 999999999998755 4677889999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccC-cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 752 LAKLLPILDN-YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 752 ~s~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+++....++. +......-++.|||-|.+....|+.++|||||||++||++| |..||+....+++. +.++.+
T Consensus 844 la~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~-------dlle~g 916 (1177)
T KOG1025|consen 844 LAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIP-------DLLEKG 916 (1177)
T ss_pred hhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhh-------HHHhcc
Confidence 9998865432 22233344677999999999999999999999999999999 99999988766554 333333
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
... ..++.+..++..++.+||..|+..||+|+++...+.++...
T Consensus 917 eRL--------sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ard 960 (1177)
T KOG1025|consen 917 ERL--------SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARD 960 (1177)
T ss_pred ccC--------CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcC
Confidence 221 23455667888899999999999999999999999988654
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=329.70 Aligned_cols=248 Identities=23% Similarity=0.339 Sum_probs=199.3
Q ss_pred ceeccCCceEEEEEEEcCCeEEEEEEccccCccC--CHHHHHHHHHHHhcCCCCCcceeeeEEec----CCceeEEEEec
Q 002759 600 CLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIR--NQEEFELEIGRLSNIRHFNLVAFQGYYWS----STMQLILSEFV 673 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~ 673 (884)
..||+|++|.||+|.+ +++.||||+++...... ..+.+.+|+.++.+++||||++++|++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999988 47899999997543211 14678899999999999999999999876 34678999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++|+|.+++.... .+++....+++.|++.||.|||+.. +++||||||+||++++++.+||+|||++
T Consensus 105 ~~g~L~~~l~~~~------------~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~ 170 (283)
T PHA02988 105 TRGYLREVLDKEK------------DLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLE 170 (283)
T ss_pred CCCcHHHHHhhCC------------CCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchH
Confidence 9999999997533 5789999999999999999999732 7889999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCC--CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQS--LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
+...... ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.. ....... .
T Consensus 171 ~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~------~~i~~~~-~ 239 (283)
T PHA02988 171 KILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY------DLIINKN-N 239 (283)
T ss_pred hhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHhcC-C
Confidence 8654221 23457889999999976 67899999999999999999999999875543322 1111111 1
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
...+ +.....++.+++.+||+.||++|||++|+++.|+.++.
T Consensus 240 ~~~~-------~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 240 SLKL-------PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCC-------CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 1111 11233467788889999999999999999999999874
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=329.32 Aligned_cols=254 Identities=21% Similarity=0.331 Sum_probs=202.9
Q ss_pred cccCceeccCCceEEEEEEEc----CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+...+.||+|+||.||+|.+. .+..||+|.++..........+.+|+..+++++||||+++++++..++..++|||
T Consensus 7 ~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 86 (266)
T cd05064 7 IKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTE 86 (266)
T ss_pred eEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEE
Confidence 346778999999999999653 3568999999765444445678999999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++|+|.+++.... ..+++.+++.++.|++.||+|||++ +++||||||+||+++.++.++++|||
T Consensus 87 ~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg 152 (266)
T cd05064 87 YMSNGALDSFLRKHE-----------GQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR 152 (266)
T ss_pred eCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCc
Confidence 999999999986432 3588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
.+...............++..|+|||.+.+..++.++|||||||++||+++ |+.||......+.. . .+....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~---~----~~~~~~ 225 (266)
T cd05064 153 RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI---K----AVEDGF 225 (266)
T ss_pred ccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---H----HHHCCC
Confidence 876543211111122334678999999999899999999999999999875 99999875543221 1 112111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
... .+......+.+++.+||+.+|.+||+++|+.+.|+++
T Consensus 226 ~~~--------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 226 RLP--------APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred CCC--------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 110 1122334677888899999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=319.15 Aligned_cols=244 Identities=24% Similarity=0.375 Sum_probs=206.6
Q ss_pred ccCceeccCCceEEEEEE-EcCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+..+.+|+|.||+|-+|. ...|+.||||.+++.. +.++.-.+.+||++|+.++||||+.++++|++.+...+||||.
T Consensus 56 E~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYa 135 (668)
T KOG0611|consen 56 EITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYA 135 (668)
T ss_pred HHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEec
Confidence 355679999999999994 4789999999997543 3445667889999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
.+|.|+||+.+.+ .+++.+++++++||..|+.|+|.+ +++|||||.+|||+|.++.+||+|||++
T Consensus 136 S~GeLYDYiSer~------------~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLS 200 (668)
T KOG0611|consen 136 SGGELYDYISERG------------SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLS 200 (668)
T ss_pred CCccHHHHHHHhc------------cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchh
Confidence 9999999998766 799999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCC-CCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRL-SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
..+. +..-.+.++|++-|.+||++.+.+| ++..|.||+||++|-++.|..||++.+-... + +++..+.+.
T Consensus 201 Nly~--~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l------v-rQIs~GaYr 271 (668)
T KOG0611|consen 201 NLYA--DKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL------V-RQISRGAYR 271 (668)
T ss_pred hhhc--cccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH------H-HHhhccccc
Confidence 8876 3445678899999999999999998 5789999999999999999999998653322 1 222333333
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
+- +.+.+..-+|++|+..+|++|-|..+|..-
T Consensus 272 EP----------~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 EP----------ETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred CC----------CCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 21 122244567889999999999999998753
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=319.87 Aligned_cols=263 Identities=27% Similarity=0.379 Sum_probs=197.5
Q ss_pred cCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHh--cCCCCCcceeeeEEecCC----ceeEEEE
Q 002759 598 KECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLS--NIRHFNLVAFQGYYWSST----MQLILSE 671 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~--~l~h~niv~~~~~~~~~~----~~~lv~e 671 (884)
..+++|+|.||.||+|.+.+ +.||||++.. ++.+.|.+|-++++ .++|+||++++++-...+ .+++|++
T Consensus 214 l~eli~~Grfg~V~KaqL~~-~~VAVKifp~----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDN-RLVAVKIFPE----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred hHHHhhcCccceeehhhccC-ceeEEEecCH----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 45579999999999999985 7999999975 44566666666554 568999999999875554 7899999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEeccCCCCceEeCCCCCe
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHD------CKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~------~~~~ivH~Dlk~~Nil~~~~~~v 745 (884)
|.+.|+|.++|..+ .++|.+..+|+..+++||+|||+. ++|+|+|||||++||||..|+++
T Consensus 289 fh~kGsL~dyL~~n-------------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 289 FHPKGSLCDYLKAN-------------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred eccCCcHHHHHHhc-------------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 99999999999854 489999999999999999999976 47899999999999999999999
Q ss_pred eEccccCccccCCccCcc-cccccccccccCccccCCCCCC------CccCchhHHHHHHHHHhCCCCCC--------CC
Q 002759 746 KLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLS------DKCDVYSFGVILLELVTGRKPVE--------SP 810 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~------~~sDvwS~Gv~l~el~tG~~p~~--------~~ 810 (884)
.|+|||+|..+.+..... ....+||.+|||||++.+...- .+.||||+|.++|||++...-+. .+
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp 435 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP 435 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc
Confidence 999999999887533222 2347899999999999875322 26899999999999999554332 11
Q ss_pred CCcchh--hHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 811 TTNEVV--VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 811 ~~~~~~--~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
...++. .-.+..+..+-..+.+..+....... ..+..+.+.+..||+.||+.|.|+.=+.+++.++..
T Consensus 436 fe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h--~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~ 505 (534)
T KOG3653|consen 436 FEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKH--AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMM 505 (534)
T ss_pred hhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcC--ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhc
Confidence 111111 01112222222222221111111111 455667788889999999999999999998888754
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=334.19 Aligned_cols=271 Identities=23% Similarity=0.315 Sum_probs=204.1
Q ss_pred cccCceeccCCceEEEEEEEcC-----------------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeee
Q 002759 596 LDKECLIGGGSIGSVYRASFEG-----------------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (884)
+...+.||+|+||.||+|.+.+ +..||+|.+..........++.+|+.++.+++||||+++++
T Consensus 7 ~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 86 (304)
T cd05096 7 LLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLG 86 (304)
T ss_pred CeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence 4467789999999999997532 34699999875433334567899999999999999999999
Q ss_pred EEecCCceeEEEEecCCCchhhhcccCCCCCCCCC-------CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 002759 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTG-------GIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLN 731 (884)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~-------~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~D 731 (884)
++.+.+..++||||+++++|.+++........... ......+++.++.+++.||+.||+|||+. +|+|||
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~d 163 (304)
T cd05096 87 VCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRD 163 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccC
Confidence 99998999999999999999999865332111100 01124578899999999999999999998 999999
Q ss_pred CCCCceEeCCCCCeeEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh--CCCCCC
Q 002759 732 LKSTNILLDENYEPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT--GRKPVE 808 (884)
Q Consensus 732 lk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t--G~~p~~ 808 (884)
|||+||+++.++.+||+|||+++.....+... .....++..|+|||++.+..++.++||||||+++|||++ +..||.
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~ 243 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG 243 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence 99999999999999999999998664322221 223445788999999988889999999999999999987 667887
Q ss_pred CCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 809 SPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
.....+.. ................ ...+.....+.+++.+||+.+|++|||+.||.+.|++
T Consensus 244 ~~~~~~~~---~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 244 ELTDEQVI---ENAGEFFRDQGRQVYL-----FRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred cCCHHHHH---HHHHHHhhhccccccc-----cCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 65443332 1122211111110000 0111233467888999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=327.25 Aligned_cols=249 Identities=23% Similarity=0.250 Sum_probs=201.9
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+....||+|+||+||.|+. .+|..+|+|+++++. ...+.+.+..|-.+|...++|+||+++..|.+.+..|+||||
T Consensus 143 Fe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEy 222 (550)
T KOG0605|consen 143 FELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEY 222 (550)
T ss_pred chhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEe
Confidence 34667899999999999965 468899999997654 234577889999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
++||++..+|...+ .+++..+..++.+++.|++.+|+. |+|||||||+|+|||..|++|++|||+
T Consensus 223 lPGGD~mTLL~~~~------------~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGL 287 (550)
T KOG0605|consen 223 LPGGDMMTLLMRKD------------TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGL 287 (550)
T ss_pred cCCccHHHHHHhcC------------cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccc
Confidence 99999999998665 799999999999999999999998 999999999999999999999999999
Q ss_pred ccccCC----------------------ccCc-----cc-------------------ccccccccccCccccCCCCCCC
Q 002759 753 AKLLPI----------------------LDNY-----GL-------------------TKFHNAVGYVAPELAQSLRLSD 786 (884)
Q Consensus 753 s~~~~~----------------------~~~~-----~~-------------------~~~~~~~~y~aPE~~~~~~~~~ 786 (884)
+.-+.. .+.. .. -...||+.|||||++.+..|+.
T Consensus 288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~ 367 (550)
T KOG0605|consen 288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGK 367 (550)
T ss_pred cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCc
Confidence 854321 0000 00 0135789999999999999999
Q ss_pred ccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 002759 787 KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP 866 (884)
Q Consensus 787 ~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 866 (884)
.+|+||+|||+|||+.|.+||...++.+....+...+..+..+.... ...+..++|.+|+. ||++|.
T Consensus 368 ~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~------------~s~eA~DLI~rll~-d~~~RL 434 (550)
T KOG0605|consen 368 ECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVD------------LSDEAKDLITRLLC-DPENRL 434 (550)
T ss_pred cccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCc------------ccHHHHHHHHHHhc-CHHHhc
Confidence 99999999999999999999999888777654444333332221111 11355667777888 999997
Q ss_pred C---HHHHH
Q 002759 867 S---MAEVV 872 (884)
Q Consensus 867 t---~~ell 872 (884)
. ++||.
T Consensus 435 G~~G~~EIK 443 (550)
T KOG0605|consen 435 GSKGAEEIK 443 (550)
T ss_pred CcccHHHHh
Confidence 5 44443
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=299.76 Aligned_cols=247 Identities=24% Similarity=0.339 Sum_probs=207.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
++.++.+|+|-||.||.|+.+ ++--||+|++.+.. ......++.+|+++-+.++||||+++++++.+....|+++||
T Consensus 24 feigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEy 103 (281)
T KOG0580|consen 24 FEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEY 103 (281)
T ss_pred ccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEe
Confidence 457889999999999999664 56789999996543 223467889999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
..+|+++..++... ...+++.....+..|+|.|+.|+|.. +|+||||||+|+|++.++..||+|||.
T Consensus 104 a~~gel~k~L~~~~----------~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGw 170 (281)
T KOG0580|consen 104 APRGELYKDLQEGR----------MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGW 170 (281)
T ss_pred cCCchHHHHHHhcc----------cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCc
Confidence 99999999998554 44688899999999999999999988 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+..-+ .......+||..|.|||+..+..++...|+|++|++.||++.|.+||+.....+.+..+...+
T Consensus 171 sV~~p---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~--------- 238 (281)
T KOG0580|consen 171 SVHAP---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD--------- 238 (281)
T ss_pred eeecC---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc---------
Confidence 97643 344567899999999999999999999999999999999999999999876555442222111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
..+ ++....+..++|.+|+..+|.+|.+..|+++-
T Consensus 239 -~~~------p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 239 -LKF------PSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred -ccC------CcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 12223356678889999999999999998763
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=329.51 Aligned_cols=244 Identities=26% Similarity=0.390 Sum_probs=205.0
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...+.||+|+||.||+|+.+ +.+.||+|.+.+..+ .++.+.+.+|+++++.++||||+.++++|+...+.++|+||+.
T Consensus 5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~ 84 (808)
T KOG0597|consen 5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV 84 (808)
T ss_pred hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence 35567999999999999665 578899999965543 4457789999999999999999999999999999999999997
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
| +|+.++...+ .+++..+..++.|+..||.|||+. +|.|||+||+||+++.++++|++|||+|+
T Consensus 85 g-~L~~il~~d~------------~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 85 G-DLFTILEQDG------------KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLAR 148 (808)
T ss_pred h-hHHHHHHhcc------------CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhh
Confidence 6 9999997544 689999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.+.. .....+...||+-|||||...+.+|+..+|+||+||++||+++|++||.... +..+ ++....++..
T Consensus 149 ~m~~-~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s---i~~L---v~~I~~d~v~--- 218 (808)
T KOG0597|consen 149 AMST-NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS---ITQL---VKSILKDPVK--- 218 (808)
T ss_pred hccc-CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH---HHHH---HHHHhcCCCC---
Confidence 8763 4455678899999999999999999999999999999999999999997532 2222 2222221111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.+....+..++...+.+||.+|.|..+++.
T Consensus 219 -------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 219 -------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred -------CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 12244456777888899999999999998873
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=332.28 Aligned_cols=243 Identities=28% Similarity=0.337 Sum_probs=204.1
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
.++.||+|+.|.|-.|++ .+|+.+|||++.... .......+++|+-+|+-+.||||+++++++++..++|+|.||++
T Consensus 16 LgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~ 95 (786)
T KOG0588|consen 16 LGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVP 95 (786)
T ss_pred ccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecC
Confidence 456799999999999965 679999999996542 22335678999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+|.|++++...+ ++.+.++.+++.||+.|+.|+|.. +|+|||+||+|+|+|..+.+||+|||+|.
T Consensus 96 gGELFdylv~kG------------~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAs 160 (786)
T KOG0588|consen 96 GGELFDYLVRKG------------PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMAS 160 (786)
T ss_pred CchhHHHHHhhC------------CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceee
Confidence 999999997655 789999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCCCCCC-CccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLS-DKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
.-. .+......+|.+.|.|||++++.+|. .++||||+|||+|.|+||+.||++.+-. .+. ..+..+.+.
T Consensus 161 Le~--~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~LL----lKV~~G~f~- 230 (786)
T KOG0588|consen 161 LEV--PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VLL----LKVQRGVFE- 230 (786)
T ss_pred ccc--CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HHH----HHHHcCccc-
Confidence 643 34556778999999999999999995 6899999999999999999999964422 111 222222222
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
++.....+...|+.+|+..||++|.|++||++
T Consensus 231 --------MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~k 262 (786)
T KOG0588|consen 231 --------MPSNISSEAQDLLRRMLDVDPSTRITTEEILK 262 (786)
T ss_pred --------CCCcCCHHHHHHHHHHhccCccccccHHHHhh
Confidence 12233346677788899999999999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=327.26 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=198.1
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+..+.||+|+||+||+|.. .+++.||+|++.... .......+.+|+.+++.++|++++++.+++.+.+..++||||+
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05631 3 RHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEec
Confidence 4567899999999999965 578899999986432 1223456788999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++|+|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||++
T Consensus 83 ~~g~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~ 149 (285)
T cd05631 83 NGGDLKFHIYNMG----------NPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLA 149 (285)
T ss_pred CCCcHHHHHHhhC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCc
Confidence 9999988875432 23588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
+..... .......|+..|+|||++.+..++.++||||+||++|||++|+.||.......... ...........
T Consensus 150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~-- 222 (285)
T cd05631 150 VQIPEG--ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKEDQE-- 222 (285)
T ss_pred EEcCCC--CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhcccc--
Confidence 875422 12234568999999999999999999999999999999999999998754332211 11111111100
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~ell~ 873 (884)
.+......++.+++.+||+.||++||+ ++++++
T Consensus 223 -------~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 223 -------EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred -------cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 011122336778888999999999997 777775
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=322.56 Aligned_cols=248 Identities=23% Similarity=0.376 Sum_probs=201.4
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
+..+.||+|+||.||+|.+.++..+|+|.+.... ....++.+|+.++++++||||+++++++......++||||+++|
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 84 (256)
T cd05114 7 TFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA--MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84 (256)
T ss_pred EEeeEecCCcCceEEEEEeccCceEEEEecccCC--ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCC
Confidence 4567899999999999999888889999886432 34578899999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.++++... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.++..
T Consensus 85 ~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~ 150 (256)
T cd05114 85 CLLNYLRQRQ-----------GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYV 150 (256)
T ss_pred cHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCcccc
Confidence 9999986432 2578999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
............++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..... .... .
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~------~~i~~-~~~~--~ 221 (256)
T cd05114 151 LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV------EMISR-GFRL--Y 221 (256)
T ss_pred CCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH------HHHHC-CCCC--C
Confidence 4322222233345678999999998889999999999999999999 99999765433221 11111 1110 0
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
.+ .....++.+++.+||+.+|++||+++++++.|
T Consensus 222 ~~------~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 222 RP------KLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred CC------CCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 11 11223678889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=314.42 Aligned_cols=266 Identities=23% Similarity=0.282 Sum_probs=223.8
Q ss_pred cccCceeccCCceEEEEEEEcC------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEe-cCCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW-SSTMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~l 668 (884)
++...++-+|.||+||.|.|.+ .+.|.+|.++....+.+...+..|.-.+....|||+.++.+++. +.+..++
T Consensus 286 v~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V 365 (563)
T KOG1024|consen 286 VRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFV 365 (563)
T ss_pred eechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceE
Confidence 3455678999999999996643 45678999988777778888999999999999999999999875 4567899
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
++.++.-|+|+.|+...+.... .....++..+...++.|++.||+|||++ +|||.||.++|++|++..+||++
T Consensus 366 ~y~~~~~gNLK~FL~~Cr~~~~----~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 366 LYPATGVGNLKSFLQICRGDDP----SYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred EEeccCcchHHHHHHHhccCCC----ccccchhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEec
Confidence 9999999999999985552221 1235677888999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCccccc-ccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTK-FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|-.+++.+.+.+++..+. ...+..||+||.+....|+.++|||||||++|||+| |+.||...++.|+. .+..+.+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~---~ylkdGy 515 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME---HYLKDGY 515 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH---HHHhccc
Confidence 999999998888776543 456889999999999999999999999999999999 99999998887765 3444444
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcccC
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLG 883 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~~~ 883 (884)
+...+.. ++.+++.+|..||...|++||+++|++.-|.++..+++
T Consensus 516 RlaQP~N------------CPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~qlt 560 (563)
T KOG1024|consen 516 RLAQPFN------------CPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQLT 560 (563)
T ss_pred eecCCCC------------CcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHHh
Confidence 4444443 34478888899999999999999999999999987654
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=331.10 Aligned_cols=250 Identities=35% Similarity=0.539 Sum_probs=195.6
Q ss_pred cCceeccCCceEEEEEEEc-----CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 598 KECLIGGGSIGSVYRASFE-----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
..+.||.|.||.||+|.+. .+..|+||.++........+.+.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999877 35789999997654444578999999999999999999999999988889999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... ...+++.++..|+.||++||+|||+. +++||||+++||+++.++.+||+|||+
T Consensus 83 ~~~g~L~~~L~~~~----------~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~ 149 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN----------KEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGL 149 (259)
T ss_dssp -TTEBHHHHHHHTC----------TTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred cccccccccccccc----------cccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence 99999999998762 24689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccC-cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 753 AKLLPILDN-YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 753 s~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
++....... ........+..|+|||.+....++.++||||||+++||+++ |+.||......+. .... ....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~------~~~~-~~~~ 222 (259)
T PF07714_consen 150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEI------IEKL-KQGQ 222 (259)
T ss_dssp GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHH------HHHH-HTTE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccc-cccc
Confidence 987632211 12233456778999999988889999999999999999999 7899876543321 1222 2221
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
... .+......+.+++..||+.+|++|||++++++.|
T Consensus 223 ~~~--------~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLP--------IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETT--------SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cce--------eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 111 1112234677888899999999999999999876
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=338.59 Aligned_cols=266 Identities=23% Similarity=0.341 Sum_probs=204.0
Q ss_pred cccCceeccCCceEEEEEEE------cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASF------EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (884)
++..+.||+|+||.||+|.+ .++..||||+++........+.+.+|+.+++.+ +||||+++++++...+..++
T Consensus 37 ~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~l 116 (375)
T cd05104 37 LSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLV 116 (375)
T ss_pred eehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCccee
Confidence 44678999999999999964 235689999997554444567789999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhcccCCCCCCC-------------------------------------------C-------------
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTS-------------------------------------------T------------- 692 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------~------------- 692 (884)
||||+++|+|.++++........ .
T Consensus 117 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (375)
T cd05104 117 ITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYID 196 (375)
T ss_pred eehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecc
Confidence 99999999999998653210000 0
Q ss_pred -------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCcc-c
Q 002759 693 -------GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG-L 764 (884)
Q Consensus 693 -------~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~-~ 764 (884)
-......+++..+.+++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++......... .
T Consensus 197 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 197 QDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred cccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 000112578899999999999999999998 99999999999999999999999999998764322211 1
Q ss_pred ccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCc
Q 002759 765 TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFA 843 (884)
Q Consensus 765 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 843 (884)
....++..|+|||++.+..++.++|||||||++|||++ |..||........ ....+..+.... ....
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~------~~~~~~~~~~~~-----~~~~- 341 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK------FYKMIKEGYRML-----SPEC- 341 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH------HHHHHHhCccCC-----CCCC-
Confidence 22345677999999999999999999999999999998 8999976543221 111112111110 0011
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 844 ENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 844 ~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
...++.+++.+||+.||++|||+.|+++.|++.
T Consensus 342 --~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 --APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred --CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 123677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=339.51 Aligned_cols=267 Identities=22% Similarity=0.337 Sum_probs=203.5
Q ss_pred cccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (884)
++..+.||+|+||.||+|... ++..||+|+++..........+.+|+.+++.+ +|+||+++++++......++
T Consensus 40 ~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~l 119 (374)
T cd05106 40 LQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLV 119 (374)
T ss_pred ceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEE
Confidence 457789999999999998642 23579999997544334456788999999999 89999999999999999999
Q ss_pred EEEecCCCchhhhcccCCCCC----------------------------------------------------------C
Q 002759 669 LSEFVPKGNLYDNLHGVNYPG----------------------------------------------------------T 690 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~----------------------------------------------------------~ 690 (884)
||||+++|+|.++++...... .
T Consensus 120 v~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (374)
T cd05106 120 ITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKD 199 (374)
T ss_pred eHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccc
Confidence 999999999999986432100 0
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCcc-cccccc
Q 002759 691 STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG-LTKFHN 769 (884)
Q Consensus 691 ~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~-~~~~~~ 769 (884)
.........+++.++++++.||++||+|||+. +|+||||||+||++++++.+||+|||+++......... .....+
T Consensus 200 ~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred hhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 00001123578889999999999999999998 99999999999999999999999999998654322111 122334
Q ss_pred cccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHH
Q 002759 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELI 848 (884)
Q Consensus 770 ~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~ 848 (884)
+..|+|||++.+..++.++|||||||++|||++ |+.||......+. ............ .... ...
T Consensus 277 ~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~------~~~~~~~~~~~~-----~~~~---~~~ 342 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK------FYKMVKRGYQMS-----RPDF---APP 342 (374)
T ss_pred ccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH------HHHHHHcccCcc-----CCCC---CCH
Confidence 668999999998899999999999999999997 9999986543221 111111111100 0111 123
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 849 QVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 849 ~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
++.+++.+||+.||++|||+.++++.|+++.
T Consensus 343 ~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 343 EIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 6778888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=322.04 Aligned_cols=253 Identities=23% Similarity=0.383 Sum_probs=204.9
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++..+.||+|++|.||+|...++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++...+..++||||+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05072 8 IKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT--MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAK 85 (261)
T ss_pred eEEeeecCCcCCceEEEEEecCCceEEEEEccCCc--hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCC
Confidence 34677899999999999998888889999986432 3467889999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.++++... ...+++.+++.++.|+++|++|||+. +++||||||+||+++.++.++|+|||.++.
T Consensus 86 ~~L~~~l~~~~----------~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 152 (261)
T cd05072 86 GSLLDFLKSDE----------GGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV 152 (261)
T ss_pred CcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCcccee
Confidence 99999986532 23578889999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.............++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. .. +......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~----~~~~~~~-- 223 (261)
T cd05072 153 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVM---SA----LQRGYRM-- 223 (261)
T ss_pred cCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHH---HH----HHcCCCC--
Confidence 65322222233445678999999988889999999999999999998 99999764433211 11 1111110
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
+... ....++.+++.+||+.+|++||+++++.+.|+++
T Consensus 224 --~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 --PRME----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred --CCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1111 1223577888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=334.84 Aligned_cols=242 Identities=23% Similarity=0.289 Sum_probs=195.4
Q ss_pred ceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 600 CLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
+.||+|+||.||+|.. .+++.||+|+++... .......+.+|+.+++.++||||+++.+++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999966 468899999986432 2233466788999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~------------~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSRER------------VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 9999987543 578999999999999999999998 9999999999999999999999999998754
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 836 (884)
.. .........|+..|+|||++.+..++.++||||+||++|||++|+.||...+..... ..+.....
T Consensus 146 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-------~~~~~~~~----- 212 (323)
T cd05571 146 IS-DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEI----- 212 (323)
T ss_pred cc-CCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHH-------HHHHcCCC-----
Confidence 22 122234457899999999999989999999999999999999999999765432211 11111111
Q ss_pred ccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 837 RSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 837 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
. ++.....++.+++.+||+.||++|| ++.++++
T Consensus 213 -~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 213 -R---FPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -C---CCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 0 1112233577788899999999999 7888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=324.38 Aligned_cols=264 Identities=27% Similarity=0.421 Sum_probs=207.1
Q ss_pred ccCceeccCCceEEEEEEEcC------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
+..+.||+|+||.||+|.... ...|++|.+...........+.+|+..+++++||||+++++++......+++|
T Consensus 8 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 87 (283)
T cd05048 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLF 87 (283)
T ss_pred chhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEE
Confidence 466789999999999997643 25789999875443344567899999999999999999999999888999999
Q ss_pred EecCCCchhhhcccCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 671 EFVPKGNLYDNLHGVNYPGT----STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
||+++++|.+++........ .........+++.+++.++.|++.||+|||+. +++||||||+||++++++.++
T Consensus 88 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 164 (283)
T cd05048 88 EYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVK 164 (283)
T ss_pred ecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEE
Confidence 99999999999975431110 00011124688999999999999999999998 999999999999999999999
Q ss_pred EccccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 002759 747 LSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~ 824 (884)
|+|||+++.....+.. ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+.. .
T Consensus 165 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~-------~ 237 (283)
T cd05048 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI-------E 237 (283)
T ss_pred ECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------H
Confidence 9999999865432221 2233456788999999988889999999999999999998 99999875543322 1
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.+....... .+.....++.+++.+||+.+|.+||+++||++.|+++
T Consensus 238 ~i~~~~~~~--------~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 238 MIRSRQLLP--------CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHcCCcCC--------CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 122211111 1223445788889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=330.71 Aligned_cols=240 Identities=22% Similarity=0.290 Sum_probs=197.5
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+....+||+|+||+|++|..+ +++.+|||++++... ..+.+..+.|.+++... +||.++.++.++...++.|+|||
T Consensus 370 F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvme 449 (694)
T KOG0694|consen 370 FRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVME 449 (694)
T ss_pred eEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEE
Confidence 346779999999999999775 567899999986542 34567778888877666 69999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+.||++..+.+. ..+++..+..+|..|+.||+|||++ +|||||||.+|||+|.+|++||+|||
T Consensus 450 y~~Ggdm~~~~~~-------------~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFG 513 (694)
T KOG0694|consen 450 YVAGGDLMHHIHT-------------DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFG 513 (694)
T ss_pred ecCCCcEEEEEec-------------ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccc
Confidence 9999995555442 3699999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
+++..-. .+......+||+.|||||++.+..|+.++|+|||||++|||+.|.+||.+.++++...-+ +.+
T Consensus 514 lcKe~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI------~~d--- 583 (694)
T KOG0694|consen 514 LCKEGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI------VND--- 583 (694)
T ss_pred cccccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH------hcC---
Confidence 9986432 234567889999999999999999999999999999999999999999988777654211 111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM 868 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 868 (884)
|+. ++.-...+.+.++.+.+.++|++|..+
T Consensus 584 ----~~~---yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 ----EVR---YPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred ----CCC---CCCcccHHHHHHHHHHhccCcccccCC
Confidence 111 112223456677778999999999865
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=328.71 Aligned_cols=200 Identities=25% Similarity=0.373 Sum_probs=173.3
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|++++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (331)
T cd06649 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (331)
T ss_pred ceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCC
Confidence 456778999999999999765 5778899988754333445679999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~ 152 (331)
T cd06649 87 GGSLDQVLKEAK------------RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (331)
T ss_pred CCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccc
Confidence 999999987533 5788999999999999999999852 69999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCC
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTT 812 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~ 812 (884)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 153 ~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 207 (331)
T cd06649 153 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA 207 (331)
T ss_pred ccccc---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 65421 22345688999999999998999999999999999999999999976543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=331.79 Aligned_cols=249 Identities=24% Similarity=0.383 Sum_probs=205.2
Q ss_pred cCceeccCCceEEEEEEEc--CC--eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 598 KECLIGGGSIGSVYRASFE--GG--VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
..++||+|+||.|++|.|. +| ..||||+++...-.....+|.+|+.+|.+++|||+++++|+..+ ....+|||.+
T Consensus 114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa 192 (1039)
T KOG0199|consen 114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA 192 (1039)
T ss_pred HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence 4467999999999999875 34 46899999876544578999999999999999999999999987 6778999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+.|+|.+.|+... ...+-......++.|||.||.||.++ ++|||||.++|+++-....|||+|||+.
T Consensus 193 plGSLldrLrka~----------~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLm 259 (1039)
T KOG0199|consen 193 PLGSLLDRLRKAK----------KAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLM 259 (1039)
T ss_pred ccchHHHHHhhcc----------ccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccce
Confidence 9999999998732 34678889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCccC-ccccc-ccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 754 KLLPILDN-YGLTK-FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 754 ~~~~~~~~-~~~~~-~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+-+...+. |.+.. ..-+..|+|||.+....++.++|||+|||++|||+| |..||.+-....+...++ +++
T Consensus 260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-------~~e 332 (1039)
T KOG0199|consen 260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-------AGE 332 (1039)
T ss_pred eccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------ccc
Confidence 99875443 33322 234678999999999999999999999999999999 999998866554433222 111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
. ..-++.+..++.+++..||..+|++||||..|.+.+
T Consensus 333 r--------LpRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 333 R--------LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred c--------CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 1 111334556788888899999999999999997443
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=318.79 Aligned_cols=252 Identities=31% Similarity=0.433 Sum_probs=202.7
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||+|+||.||+|... .+..||+|++.... .....+.+|++.++.++|||++++++++..+...++||||+++
T Consensus 9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (263)
T cd05052 9 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTY 86 (263)
T ss_pred EEeeecCCcccceEEEEEEecCCceEEEEEecCCc--hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCC
Confidence 35678999999999999764 57789999986432 3467789999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||++++++.+||+|||.++.
T Consensus 87 ~~L~~~~~~~~----------~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~ 153 (263)
T cd05052 87 GNLLDYLRECN----------RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRL 153 (263)
T ss_pred CcHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccc
Confidence 99999986533 23578999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
..............+..|+|||.+.+..++.++||||||+++|||++ |..||......+.. .........
T Consensus 154 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~-- 224 (263)
T cd05052 154 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-------ELLEKGYRM-- 224 (263)
T ss_pred cccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HHHHCCCCC--
Confidence 65322222222334568999999998899999999999999999998 99999765433221 111111110
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
. .+.....++.+++.+||+.+|++|||+.++++.|+.+
T Consensus 225 ---~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ---E---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---C---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 1112234677888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=335.14 Aligned_cols=270 Identities=23% Similarity=0.332 Sum_probs=207.1
Q ss_pred cccccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCce
Q 002759 594 ALLDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 666 (884)
+-++..++||+|+||.||+|... .+..||||++.........+.+.+|+.+++.+. ||||+++++++.+....
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPI 116 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCce
Confidence 34557789999999999999753 134699999975544445678999999999996 99999999999999999
Q ss_pred eEEEEecCCCchhhhcccCCCCCCC-------------------------------------------------------
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTS------------------------------------------------------- 691 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~------------------------------------------------------- 691 (884)
++||||+++|+|.++++........
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (400)
T cd05105 117 YIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKE 196 (400)
T ss_pred EEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhh
Confidence 9999999999999998653210000
Q ss_pred -----------------C------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC
Q 002759 692 -----------------T------------GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN 742 (884)
Q Consensus 692 -----------------~------------~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~ 742 (884)
. .......+++.++..++.||++||+|||+. +|+||||||+||+++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~ 273 (400)
T cd05105 197 ASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCC
Confidence 0 000123578889999999999999999998 99999999999999999
Q ss_pred CCeeEccccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 002759 743 YEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCE 820 (884)
Q Consensus 743 ~~vkl~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~ 820 (884)
+.+||+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~---- 349 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF---- 349 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH----
Confidence 99999999999876432221 1223456778999999998889999999999999999997 99999764332211
Q ss_pred HHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 821 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
........... .......++.+++.+||+.+|++|||+.++.+.|+++..
T Consensus 350 --~~~~~~~~~~~--------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 350 --YNKIKSGYRMA--------KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred --HHHHhcCCCCC--------CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 11111111100 112233467888899999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=344.52 Aligned_cols=371 Identities=24% Similarity=0.308 Sum_probs=261.8
Q ss_pred CCCCCeEeecCCcCc-ccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhccccCcE
Q 002759 95 LKSLRVLTLFGNRFT-GNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKF 173 (884)
Q Consensus 95 l~~L~~L~L~~n~~~-~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~ 173 (884)
|+..+-.|+++|.|+ +..|....+|++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+... .+.++.|+.
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGE-Ls~Lp~LRs 82 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGE-LSDLPRLRS 82 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhh-hccchhhHH
Confidence 444555555556555 345555556666666666555555 55555666666666666666554 22211 133455555
Q ss_pred EEccCCccC-CCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCc
Q 002759 174 VSLSHNNLS-GSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNL 252 (884)
Q Consensus 174 L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 252 (884)
+.+.+|++. .-+|..+-.|..|+.||||+|++. +.|..+..-+++-.|+|++|+|..++...|-+++.|-.||||+|+
T Consensus 83 v~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~Nr 161 (1255)
T KOG0444|consen 83 VIVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNR 161 (1255)
T ss_pred HhhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccch
Confidence 555555553 234555555666666666666666 566666666666666666666665555556666666666666666
Q ss_pred cCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCC-CCCCcccccccccceecccCCcccccCCC
Q 002759 253 FIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFD-GVIPLSITNCRNLKVLDLGFNRLIGSIPT 331 (884)
Q Consensus 253 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 331 (884)
+..+ |..+..|.+|++|.|++|.+...--..+-.+++|++|.+++.+=+ ..+|.++..+.||..+|||.|.+. .+|+
T Consensus 162 Le~L-PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPe 239 (1255)
T KOG0444|consen 162 LEML-PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPE 239 (1255)
T ss_pred hhhc-CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchH
Confidence 6655 334556666666666666554322222333456666666665432 457888889999999999999998 8899
Q ss_pred CcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCC-CCcchhhcCCcc
Q 002759 332 GITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALG-GDIPQTLYNMTY 410 (884)
Q Consensus 332 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~-~~~p~~~~~l~~ 410 (884)
.+-++++|+.|+||+|+|+ .+....+...+|+.|+||.|+++ .+|+.++.++.|+.|.+.+|+++ .-+|..++.+.+
T Consensus 240 cly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~ 317 (1255)
T KOG0444|consen 240 CLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQ 317 (1255)
T ss_pred HHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhh
Confidence 9999999999999999998 45556677788999999999998 78999999999999999999875 237899999999
Q ss_pred CcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCCcCcccCCc
Q 002759 411 LKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475 (884)
Q Consensus 411 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~ 475 (884)
|+++..++|.+. ..|+.++.+..|+.|.|+.|++- .+|+.+.-|+.|+.|||..|+-.-..|+
T Consensus 318 Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 318 LEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred hHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 999999999997 89999999999999999999988 7999999999999999999976544443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=317.66 Aligned_cols=249 Identities=22% Similarity=0.348 Sum_probs=200.6
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
...+.||+|+||.||.|.+.++..+|+|.+.... ...+.+.+|+.++++++||||+++++++......++||||++++
T Consensus 7 ~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05113 7 TFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNG 84 (256)
T ss_pred EEeeEecCcccceEEEEEecCCCcEEEEEcCCCc--ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCC
Confidence 3556899999999999988877789999987432 34678999999999999999999999999888899999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... ..+++..++.++.||+.||+|||+. +++|+||||+||+++.++.+||+|||.++..
T Consensus 85 ~l~~~i~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~ 150 (256)
T cd05113 85 CLLNYLREHG-----------KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV 150 (256)
T ss_pred cHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceec
Confidence 9999987533 2578999999999999999999998 9999999999999999999999999999866
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
............++..|+|||...+..++.++||||||+++|||++ |+.||......+.. ... ........
T Consensus 151 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~------~~~-~~~~~~~~- 222 (256)
T cd05113 151 LDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV------EKV-SQGLRLYR- 222 (256)
T ss_pred CCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH------HHH-hcCCCCCC-
Confidence 4322222223345678999999988889999999999999999999 99999765433221 111 11111100
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.......+.+++.+||+.+|++|||+.++++.|+
T Consensus 223 -------~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 223 -------PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred -------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0112346788888999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=317.20 Aligned_cols=253 Identities=26% Similarity=0.389 Sum_probs=204.3
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++..+.||+|++|.||+|...++..||+|.++... ...+++.+|+.++++++||||+++++++...+..++||||+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 85 (261)
T cd05068 8 IQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT--MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKY 85 (261)
T ss_pred eeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc--ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccC
Confidence 44668899999999999988778889999986533 3467789999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++..+..++.|++.|+.|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 86 ~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~ 152 (261)
T cd05068 86 GSLLEYLQGGA----------GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARV 152 (261)
T ss_pred CcHHHHHhccC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEE
Confidence 99999986432 23588999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
..............+..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..+.......
T Consensus 153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~~~~~- 224 (261)
T cd05068 153 IKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVL-------QQVDQGYRMP- 224 (261)
T ss_pred ccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHHcCCCCC-
Confidence 65322222222333568999999998889999999999999999999 99999765432211 1111111000
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
........+.+++.+||+.+|++||++.++++.|+++
T Consensus 225 -------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 225 -------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0112234677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=334.58 Aligned_cols=381 Identities=27% Similarity=0.423 Sum_probs=268.0
Q ss_pred EEEEecCccccccccccccCCCCCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCCC
Q 002759 75 DRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRN 154 (884)
Q Consensus 75 ~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N 154 (884)
+.+.+.++.++. +|++++.+..++.|+.++|+++ ++|.+++.+.+|..|+.++|.+. .+|++++.+-.|..|+..+|
T Consensus 71 ~vl~~~~n~l~~-lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~N 147 (565)
T KOG0472|consen 71 TVLNVHDNKLSQ-LPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATNN 147 (565)
T ss_pred eEEEeccchhhh-CCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhcccc
Confidence 455556666553 5677888888888888888887 77888888888888888888887 77777888888888888888
Q ss_pred ccCCCCchhhhhccccCcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcc
Q 002759 155 SYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVE 234 (884)
Q Consensus 155 ~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~ 234 (884)
+++ ++|.+.+ .+.+|..|++.+|+++...|..+. ++.|++||...|-++ .+|+.++.+.+|+.|+|.+|+|... |
T Consensus 148 ~i~-slp~~~~-~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~l-P 222 (565)
T KOG0472|consen 148 QIS-SLPEDMV-NLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFL-P 222 (565)
T ss_pred ccc-cCchHHH-HHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccccC-C
Confidence 887 6666553 356677777777777755444444 777777777777776 7777788888888888888887743 3
Q ss_pred cccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccc
Q 002759 235 EQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRN 314 (884)
Q Consensus 235 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~ 314 (884)
.|.+|..|++|+++.|+|.-++.....++++|..|||.+|++. +.|+....+.+|+.||+|+|.|++. |.+++++ .
T Consensus 223 -ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~L-p~sLgnl-h 298 (565)
T KOG0472|consen 223 -EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISSL-PYSLGNL-H 298 (565)
T ss_pred -CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccccC-Ccccccc-e
Confidence 6777777777777777777665555557777777788777777 4555556667777778887777754 5567777 7
Q ss_pred cceecccCCcccc----------------------------------------------------------------cCC
Q 002759 315 LKVLDLGFNRLIG----------------------------------------------------------------SIP 330 (884)
Q Consensus 315 L~~L~L~~N~l~~----------------------------------------------------------------~~p 330 (884)
|+.|-+.+|.+.. .+|
T Consensus 299 L~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VP 378 (565)
T KOG0472|consen 299 LKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVP 378 (565)
T ss_pred eeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCC
Confidence 7777777776531 111
Q ss_pred CCcccccC---ccEEEccCCccCC-----------------------CCCCCccCcccccEEecCCCcCCCCCCcCCcCC
Q 002759 331 TGITDLRR---LLKISLANNSIGG-----------------------IIPPNLGSIELLEVLDLHNLNLRGEVPDDISNC 384 (884)
Q Consensus 331 ~~~~~l~~---L~~L~L~~N~l~~-----------------------~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l 384 (884)
+....-.+ ....+++.|++.. .+|..++.+++|..|+|++|-+. .+|..++.+
T Consensus 379 dEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~l 457 (565)
T KOG0472|consen 379 DEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSL 457 (565)
T ss_pred HHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhh
Confidence 10000001 3345555555541 33444555666777777776665 566666666
Q ss_pred CCCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEc
Q 002759 385 RFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNL 464 (884)
Q Consensus 385 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 464 (884)
..|+.||+|.|+|. .+|..+..+..|+.+-.++|++....|..+.+|.+|.+|||.+|.+. .+|+.+++|.+|++|++
T Consensus 458 v~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL 535 (565)
T KOG0472|consen 458 VRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLEL 535 (565)
T ss_pred hhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEe
Confidence 66777777777776 56666666666666666667776444555888999999999999998 88999999999999999
Q ss_pred cCCcCc
Q 002759 465 SSNNLS 470 (884)
Q Consensus 465 ~~N~l~ 470 (884)
++|+|.
T Consensus 536 ~gNpfr 541 (565)
T KOG0472|consen 536 DGNPFR 541 (565)
T ss_pred cCCccC
Confidence 999987
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=328.52 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=202.3
Q ss_pred cccCceeccCCceEEEEEEEc-CCe----EEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGV----SIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
|+..+.||+|+||.||+|.+. ++. .||+|+++........+++.+|+.+++.++||||++++|++... ..++|+
T Consensus 9 f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~ 87 (316)
T cd05108 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLIT 87 (316)
T ss_pred ceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cceeee
Confidence 457788999999999999763 232 48999987544444567889999999999999999999998764 567999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
||+++|+|.+++.... ..+++..++.++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 88 e~~~~g~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~Df 153 (316)
T cd05108 88 QLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDF 153 (316)
T ss_pred ecCCCCCHHHHHHhcc-----------ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccc
Confidence 9999999999997543 3578889999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 751 GLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 751 g~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|+++........ .......+..|+|||++.+..++.++||||||+++|||++ |+.||......+. ......
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-------~~~~~~ 226 (316)
T cd05108 154 GLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-------SSILEK 226 (316)
T ss_pred cccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHhC
Confidence 999876532221 1122334678999999999899999999999999999998 9999976543221 112222
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
...... ......++.+++.+||+.+|++|||+.+++..+.++.+.
T Consensus 227 ~~~~~~--------~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~ 271 (316)
T cd05108 227 GERLPQ--------PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 271 (316)
T ss_pred CCCCCC--------CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence 111100 111224677888999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=332.65 Aligned_cols=251 Identities=22% Similarity=0.261 Sum_probs=201.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... +++.||+|+++... .......+..|++++..++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 82 (333)
T cd05600 3 FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEY 82 (333)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeC
Confidence 446778999999999999775 57899999986432 123456788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~g~~L~~~l~~~~------------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~ 147 (333)
T cd05600 83 VPGGDFRTLLNNLG------------VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGL 147 (333)
T ss_pred CCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcC
Confidence 99999999996443 578899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++.... ......|+..|+|||++.+..++.++||||+||++|||++|+.||......+..............
T Consensus 148 a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---- 219 (333)
T cd05600 148 SKGIVT----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQR---- 219 (333)
T ss_pred Cccccc----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccC----
Confidence 986542 234457899999999999989999999999999999999999999875544332211111100000
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+...........++.+++.+||+.+|.+||+++++++
T Consensus 220 ----~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~ 256 (333)
T cd05600 220 ----PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKN 256 (333)
T ss_pred ----CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHh
Confidence 0000000122346777888899999999999999985
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=317.66 Aligned_cols=254 Identities=24% Similarity=0.412 Sum_probs=204.1
Q ss_pred cccCceeccCCceEEEEEEEcC----CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+...+.||+|+||.||+|.+.. ...||+|++...........+.+|+.++++++||||+++++++...+..++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 85 (266)
T cd05033 6 VTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITE 85 (266)
T ss_pred ceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEE
Confidence 3467889999999999997742 457899998755444456778999999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++.... ..+++..+++++.|++.|++|||+. +|+||||||+||++++++.++++|||
T Consensus 86 ~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg 151 (266)
T cd05033 86 YMENGSLDKFLREND-----------GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG 151 (266)
T ss_pred cCCCCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccc
Confidence 999999999986533 2688999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccC-cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 752 LAKLLPILDN-YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 752 ~s~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+++....... .......++..|+|||.+.+..++.++||||||+++||+++ |..||......+.. ..+...
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~-------~~~~~~ 224 (266)
T cd05033 152 LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVI-------KAVEDG 224 (266)
T ss_pred hhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHH-------HHHHcC
Confidence 9987752121 11222344678999999998899999999999999999998 99999765433211 111111
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.... . .......+.+++.+||+.+|++||++.|+++.|+++
T Consensus 225 ~~~~----~----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 225 YRLP----P----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred CCCC----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1100 0 111234677888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=321.76 Aligned_cols=263 Identities=18% Similarity=0.201 Sum_probs=199.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||+|+||.||+|... +++.||+|+++... .....+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 82 (287)
T cd07848 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82 (287)
T ss_pred ceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecC
Confidence 446678999999999999775 57889999986543 2234567889999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~l~~~~~~------------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~ 147 (287)
T cd07848 83 EKNMLELLEEM------------PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFA 147 (287)
T ss_pred CCCHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCc
Confidence 88766554432 12578899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH---------HH
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV---------RE 824 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~---------~~ 824 (884)
+..............++..|+|||++.+..++.++||||+||++|||++|+.||......+........ ..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (287)
T cd07848 148 RNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKL 227 (287)
T ss_pred ccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHh
Confidence 876533322334456889999999999888999999999999999999999999875433221111100 00
Q ss_pred HHHcCCCcccccccCCC-------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 825 LLERGSASACFDRSLRG-------FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~-------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
............+.... ........+.+++.+|++.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 228 FYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred hhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000000000 01112345788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=329.75 Aligned_cols=239 Identities=25% Similarity=0.305 Sum_probs=191.9
Q ss_pred eccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 602 IGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 602 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
||+|+||.||+|... +++.||+|++.... .......+.+|+.++++++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999765 57889999986432 223456788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 ~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~ 145 (312)
T cd05585 81 FHHLQREG------------RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK 145 (312)
T ss_pred HHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc
Confidence 99986533 588999999999999999999998 999999999999999999999999999976432
Q ss_pred ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 759 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
. ........|+..|+|||++.+..++.++||||+||++|||++|+.||......+. ....... .. .
T Consensus 146 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~~-~~------~ 211 (312)
T cd05585 146 D-DDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQE-PL------R 211 (312)
T ss_pred C-CCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHcC-CC------C
Confidence 1 2223445689999999999998999999999999999999999999986543221 1221111 10 0
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCCCH---HHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRPSM---AEVV 872 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~---~ell 872 (884)
++.....++.+++.+||+.||++||++ .|++
T Consensus 212 ---~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l 245 (312)
T cd05585 212 ---FPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK 245 (312)
T ss_pred ---CCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence 111122356778889999999999864 5554
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=340.16 Aligned_cols=255 Identities=23% Similarity=0.300 Sum_probs=204.8
Q ss_pred ccCceeccCCceEEEEEEEcCC-eEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeee-EEec------CCcee
Q 002759 597 DKECLIGGGSIGSVYRASFEGG-VSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQG-YYWS------STMQL 667 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~-~~~~------~~~~~ 667 (884)
++++.|.+|||+.||.|....+ ..+|+|++... ++.....+.+|+++|+.++ |+|||.+++ .... .-+++
T Consensus 40 ~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~-de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~Evl 118 (738)
T KOG1989|consen 40 TVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN-DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVL 118 (738)
T ss_pred EEEEEEccCCcEEEEEEEecCCCceeeeeeeecC-CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEE
Confidence 4678899999999999977665 99999999765 5677889999999999997 999999999 3321 13568
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+.||||.+|.|.|++..+- ...+++.++++|++|+++|+++||.. +++|||||||-+|||++.++..||
T Consensus 119 lLmEyC~gg~Lvd~mn~Rl----------q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KL 187 (738)
T KOG1989|consen 119 LLMEYCKGGSLVDFMNTRL----------QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKL 187 (738)
T ss_pred eehhhccCCcHHHHHHHHH----------hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEe
Confidence 9999999999999997544 23499999999999999999999987 889999999999999999999999
Q ss_pred ccccCccccCCcc--Cccc------ccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh
Q 002759 748 SDYGLAKLLPILD--NYGL------TKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816 (884)
Q Consensus 748 ~Dfg~s~~~~~~~--~~~~------~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~ 816 (884)
||||.+.-..... .... -...-|+.|+|||++. +...++|+|||++||+||.|+....||+..-.-.+.
T Consensus 188 CDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIl 267 (738)
T KOG1989|consen 188 CDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAIL 267 (738)
T ss_pred CcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEE
Confidence 9999986432111 1110 1234588999999874 678899999999999999999999999874322211
Q ss_pred hHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 817 VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
. +++ .+. -.+.....+..||..||++||.+||++.|++..+.+|+..
T Consensus 268 n-----------g~Y--~~P-----~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~ 314 (738)
T KOG1989|consen 268 N-----------GNY--SFP-----PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK 314 (738)
T ss_pred e-----------ccc--cCC-----CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence 0 000 000 1134566788899999999999999999999999998754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=326.65 Aligned_cols=243 Identities=24% Similarity=0.316 Sum_probs=197.1
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... +++.||+|++.... ..+..+.+.+|+.++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 82 (291)
T cd05612 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEY 82 (291)
T ss_pred ceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeC
Confidence 345678999999999999765 68899999986422 223456788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~L~~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~ 147 (291)
T cd05612 83 VPGGELFSYLRNSG------------RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGF 147 (291)
T ss_pred CCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCc
Confidence 99999999997543 578899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++..... .....|+..|+|||++.+..++.++||||+||++|||++|+.||......+.. .... .....
T Consensus 148 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~------~~i~-~~~~~ 216 (291)
T cd05612 148 AKKLRDR----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIY------EKIL-AGKLE 216 (291)
T ss_pred chhccCC----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHH-hCCcC
Confidence 9865421 22356889999999999988999999999999999999999999875433221 1111 11110
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~ell~ 873 (884)
++......+.+++.+||+.||.+||+ ++|+++
T Consensus 217 ---------~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 253 (291)
T cd05612 217 ---------FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN 253 (291)
T ss_pred ---------CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence 01111235677888999999999995 777764
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=329.63 Aligned_cols=242 Identities=23% Similarity=0.285 Sum_probs=194.5
Q ss_pred ceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 600 CLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
+.||+|+||.||+|.. .++..||+|++.... .......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 3689999999999976 468899999986432 2234566788999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSRER------------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 9998886433 588999999999999999999998 9999999999999999999999999998753
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 836 (884)
.. .........|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+.. .... .....
T Consensus 146 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~~~-~~~~~---- 213 (323)
T cd05595 146 IS-DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELIL-MEEIR---- 213 (323)
T ss_pred cC-CCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHh-cCCCC----
Confidence 22 122233456899999999999989999999999999999999999999865433221 1111 11110
Q ss_pred ccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 837 RSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 837 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
++.....++.+++.+||+.||++|| ++.++++
T Consensus 214 -----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 214 -----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -----CCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 1111223567888899999999998 7888764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=329.20 Aligned_cols=241 Identities=23% Similarity=0.294 Sum_probs=194.8
Q ss_pred eeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCc
Q 002759 601 LIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
.||+|+||.||+|.. .+++.||+|++.... .......+.+|+.+++.++||||+++.+++...+..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 689999999999966 468899999996432 22345678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 82 L~~~l~~~~------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~ 146 (328)
T cd05593 82 LFFHLSRER------------VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGI 146 (328)
T ss_pred HHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCC
Confidence 998886433 588999999999999999999998 99999999999999999999999999987543
Q ss_pred CccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccc
Q 002759 758 ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837 (884)
Q Consensus 758 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 837 (884)
. .........|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+.. .. +.....
T Consensus 147 ~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~------~~-~~~~~~------ 212 (328)
T cd05593 147 T-DAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF------EL-ILMEDI------ 212 (328)
T ss_pred C-cccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHH------HH-hccCCc------
Confidence 2 112233456899999999999889999999999999999999999999765433221 11 111110
Q ss_pred cCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 838 SLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 838 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
. ++.....++.+++.+||+.||++|| ++.|+++
T Consensus 213 ~---~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 250 (328)
T cd05593 213 K---FPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR 250 (328)
T ss_pred c---CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence 0 1111223567888899999999997 8888874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=331.13 Aligned_cols=244 Identities=21% Similarity=0.279 Sum_probs=190.4
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
..+.||+|+||.||+|... +++.||||++...........+.+|+++++.++|+||+++++++...+..++||||++++
T Consensus 78 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 157 (353)
T PLN00034 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGG 157 (353)
T ss_pred hhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCC
Confidence 4567999999999999764 678999999865443344577899999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+.. ...+..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+++.+
T Consensus 158 ~L~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~ 218 (353)
T PLN00034 158 SLEGTH----------------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRIL 218 (353)
T ss_pred cccccc----------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceec
Confidence 986432 245677889999999999999998 9999999999999999999999999999876
Q ss_pred CCccCcccccccccccccCccccCC-----CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQS-----LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
... ........|+..|+|||++.. ...+.++|||||||++|||++|+.||......+........ .....
T Consensus 219 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~----~~~~~ 293 (353)
T PLN00034 219 AQT-MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI----CMSQP 293 (353)
T ss_pred ccc-cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH----hccCC
Confidence 422 112234578999999998743 23346899999999999999999999854333222111111 11000
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. . .......++.+++.+||+.||++|||+.|+++
T Consensus 294 ~-----~---~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~ 327 (353)
T PLN00034 294 P-----E---APATASREFRHFISCCLQREPAKRWSAMQLLQ 327 (353)
T ss_pred C-----C---CCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 0 11122346778888999999999999999986
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.81 Aligned_cols=252 Identities=29% Similarity=0.417 Sum_probs=203.0
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
|+..+.||+|+||.||+|...+...||+|++.... ...+.+.+|+++++.++||||+++++++. ....++||||+++
T Consensus 8 ~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (262)
T cd05071 8 LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSK 84 (262)
T ss_pred eeEeeecCCCCCCcEEEEEecCCceEEEEecccCc--cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCC
Confidence 45778899999999999988777789999997532 34567899999999999999999999874 4567999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.++.
T Consensus 85 ~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~ 151 (262)
T cd05071 85 GSLLDFLKGEM----------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL 151 (262)
T ss_pred CcHHHHHhhcc----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceee
Confidence 99999997432 23578999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.............++..|+|||+..+..++.++||||||+++||+++ |+.||......+.. .........
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~-------~~~~~~~~~-- 222 (262)
T cd05071 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------DQVERGYRM-- 222 (262)
T ss_pred ccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHH-------HHHhcCCCC--
Confidence 65333222233446678999999988889999999999999999999 88898765433221 111111100
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
....+....+.+++.+||+.+|++||+++++++.|+++
T Consensus 223 ------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 223 ------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ------CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 01123345678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=319.78 Aligned_cols=263 Identities=24% Similarity=0.347 Sum_probs=205.8
Q ss_pred ccCceeccCCceEEEEEEEcC------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
...+.||+|+||.||+|...+ +..||+|+++..........+.+|+++++.++||||+++++++......++||
T Consensus 8 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 87 (280)
T cd05049 8 VLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVF 87 (280)
T ss_pred hHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEE
Confidence 456789999999999997633 47899999876544334678999999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCC--CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTST--GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||+++++|.+++.......... .......+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+
T Consensus 88 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~ 164 (280)
T cd05049 88 EYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIG 164 (280)
T ss_pred ecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEEC
Confidence 9999999999997553211000 011234688999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||.++.....+.. ......++..|+|||++.+..++.++||||+|+++|||++ |+.||......+.. .. .
T Consensus 165 d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~---~~----~ 237 (280)
T cd05049 165 DFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVI---EC----I 237 (280)
T ss_pred CcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH---HH----H
Confidence 99999865432221 1223345678999999999999999999999999999998 99999765443322 11 1
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
..+.... ........+.+++.+||+.+|++|||+.|+++.|++
T Consensus 238 ~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQGRLLQ--------RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HcCCcCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1111111 111233467888899999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=315.33 Aligned_cols=248 Identities=25% Similarity=0.377 Sum_probs=199.6
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
+..+.||+|+||.||+|.+.++..+|+|++.... .....+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 7 ~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 84 (256)
T cd05059 7 TFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA--MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84 (256)
T ss_pred chhhhhccCCCceEEEeEecCCccEEEEEeccCC--CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCC
Confidence 3567899999999999988877789999986432 34567889999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||++++++.+||+|||.++..
T Consensus 85 ~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~ 150 (256)
T cd05059 85 CLLNYLRERK-----------GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYV 150 (256)
T ss_pred CHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceec
Confidence 9999987533 2578999999999999999999998 9999999999999999999999999999866
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
.+..........++..|+|||.+.+..++.++||||||+++||+++ |+.||......+.. .. ........
T Consensus 151 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~~-~~~~~~~~-- 221 (256)
T cd05059 151 LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV------ES-VSAGYRLY-- 221 (256)
T ss_pred ccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH------HH-HHcCCcCC--
Confidence 4322222222334567999999998899999999999999999999 89999765433221 11 11111000
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
.......++.+++.+||+.+|++|||+.|+++.|
T Consensus 222 ------~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 222 ------RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 0111234678888999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=321.69 Aligned_cols=259 Identities=22% Similarity=0.259 Sum_probs=196.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|+||.||+|... ++..||+|+++..........+.+|+.++++++||||+++++++..++..++||||++
T Consensus 7 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (288)
T cd07871 7 YVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD 86 (288)
T ss_pred ceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC
Confidence 456778999999999999664 6789999998754434445677899999999999999999999998889999999997
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+ +|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~-~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~ 151 (288)
T cd07871 87 S-DLKQYLDNCG-----------NLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLAR 151 (288)
T ss_pred c-CHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCccee
Confidence 5 8998886432 2478889999999999999999998 99999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC--
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA-- 831 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 831 (884)
..... ........++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... .......+..
T Consensus 152 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~ 227 (288)
T cd07871 152 AKSVP-TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL---IFRLLGTPTEET 227 (288)
T ss_pred eccCC-CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChHH
Confidence 65321 112234567889999998865 5688999999999999999999999987554332211 1111110000
Q ss_pred ----------cccccccCCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 ----------SACFDRSLRG-----FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ----------~~~~d~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.....+.... .......+..+++.+|++.||.+|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 228 WPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 0000000000 00011235678888999999999999999974
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=297.80 Aligned_cols=257 Identities=24% Similarity=0.240 Sum_probs=197.8
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEec--CCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 671 (884)
|+..+.|++|+||.||+|+. ++++.||+|+++-... ..---.-.+||.++.+++|||||.+-++... -+..|+|||
T Consensus 78 fe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe 157 (419)
T KOG0663|consen 78 FEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVME 157 (419)
T ss_pred HHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHH
Confidence 34667899999999999955 5688999999975432 1223456899999999999999999998753 356899999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
||+. +|...+.... +++...++..++.|+++|++|||.. .|+|||||++|+|++..|.+||+|||
T Consensus 158 ~~Eh-DLksl~d~m~-----------q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFG 222 (419)
T KOG0663|consen 158 YVEH-DLKSLMETMK-----------QPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFG 222 (419)
T ss_pred HHHh-hHHHHHHhcc-----------CCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccc
Confidence 9976 8999887543 5789999999999999999999998 89999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+|+.+... ....+..+.|..|+|||.+.+. .|+++.|+||+|||+.|++++++-|.+..+.+.. ..+.+... .
T Consensus 223 LAR~ygsp-~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl---~~If~llG--t 296 (419)
T KOG0663|consen 223 LAREYGSP-LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL---DKIFKLLG--T 296 (419)
T ss_pred hhhhhcCC-cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH---HHHHHHhC--C
Confidence 99988643 3346778889999999998765 5899999999999999999999999886543322 11222221 1
Q ss_pred CcccccccCCC--------------------CcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRG--------------------FAEN-ELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~--------------------~~~~-~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+.+.+++.+.. |... ....=++++...+..||.+|.||+|.++
T Consensus 297 Pte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 297 PSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred CccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 11111111100 1000 1123345667799999999999999874
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=325.23 Aligned_cols=200 Identities=25% Similarity=0.383 Sum_probs=172.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||.||+|... ++..+|+|.+...........+.+|++++++++||||+++++++.+++..++||||++
T Consensus 7 y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 86 (333)
T cd06650 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 86 (333)
T ss_pred hheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCC
Confidence 456778999999999999775 5778888888654333345678999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .+++..+..++.|++.||.|||+.. +|+||||||+||+++.++.+||+|||++.
T Consensus 87 ~~~L~~~l~~~~------------~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~ 152 (333)
T cd06650 87 GGSLDQVLKKAG------------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 152 (333)
T ss_pred CCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcch
Confidence 999999996533 5788899999999999999999742 79999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCC
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTT 812 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~ 812 (884)
..... ......++..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 153 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~ 207 (333)
T cd06650 153 QLIDS---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA 207 (333)
T ss_pred hhhhh---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence 65321 12345688999999999988899999999999999999999999986543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=319.86 Aligned_cols=268 Identities=26% Similarity=0.349 Sum_probs=200.7
Q ss_pred cccCceeccCCceEEEEEEE-----cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeE
Q 002759 596 LDKECLIGGGSIGSVYRASF-----EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 668 (884)
+...+.||+|+||+||++.+ .++..||+|.+...........+.+|+++++.++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 34667899999999988653 356789999987543334567788999999999999999999987653 45789
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||++++++.++|+
T Consensus 86 v~e~~~~~~l~~~~~~~-------------~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~ 149 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH-------------KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIG 149 (283)
T ss_pred EecCCCCCCHHHHHHHc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEe
Confidence 99999999999998642 489999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCcc--cccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYG--LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||+++......... .....++..|+|||.+.+..++.++||||||+++|||++|+.||....... ...........
T Consensus 150 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~ 228 (283)
T cd05080 150 DFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM 228 (283)
T ss_pred ecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc
Confidence 999998765322111 122344667999999988889999999999999999999999987543211 00000000000
Q ss_pred HcCCCcccccccC-CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 827 ERGSASACFDRSL-RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 827 ~~~~~~~~~d~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
.........+... .........++.+++..||+.+|++|||++++++.|++++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 0000000000000 01112234578888999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=330.27 Aligned_cols=242 Identities=24% Similarity=0.307 Sum_probs=196.7
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... +++.||+|++.... .....+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 20 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 99 (329)
T PTZ00263 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEF 99 (329)
T ss_pred eEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcC
Confidence 346778999999999999775 57899999986432 223456789999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 100 ~~~~~L~~~l~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~ 164 (329)
T PTZ00263 100 VVGGELFTHLRKAG------------RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGF 164 (329)
T ss_pred CCCChHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccC
Confidence 99999999987543 578888999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++..... .....|++.|+|||++.+..++.++|||||||++|||++|+.||......+.. . .+..+...
T Consensus 165 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~-~i~~~~~~ 233 (329)
T PTZ00263 165 AKKVPDR----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY------E-KILAGRLK 233 (329)
T ss_pred ceEcCCC----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH------H-HHhcCCcC
Confidence 9876421 22356899999999999989999999999999999999999999765432211 1 11111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVV 872 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~ell 872 (884)
+ ... ...++.+++.+||+.||.+||+ +++++
T Consensus 234 --~----p~~---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll 269 (329)
T PTZ00263 234 --F----PNW---FDGRARDLVKGLLQTDHTKRLGTLKGGVADVK 269 (329)
T ss_pred --C----CCC---CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHh
Confidence 0 111 1225677888999999999997 57765
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=331.30 Aligned_cols=256 Identities=16% Similarity=0.169 Sum_probs=194.0
Q ss_pred ccccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
-|...+.||+|+||.||+|.. .+++.||+|+... ..+.+|++++++++||||+++++++......++|+|++
T Consensus 93 ~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~-------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 93 GFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR-------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh-------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 366778999999999999965 5678899997542 34678999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
. ++|.+++.... .+++.+++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 166 ~-~~L~~~l~~~~------------~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a 229 (391)
T PHA03212 166 K-TDLYCYLAAKR------------NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229 (391)
T ss_pred C-CCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcc
Confidence 5 68888886433 578999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcc----hhhHHHHHHHHHHcC
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE----VVVLCEYVRELLERG 829 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~----~~~~~~~~~~~~~~~ 829 (884)
+..............||..|+|||++.+..++.++||||+||++|||++|+.||......+ .......+.......
T Consensus 230 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~ 309 (391)
T PHA03212 230 CFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTH 309 (391)
T ss_pred cccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCC
Confidence 7643322223345678999999999999899999999999999999999998875432110 000001010000000
Q ss_pred C--Cc-----------------ccccccCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 S--AS-----------------ACFDRSLRG---FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~--~~-----------------~~~d~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .. ....+.... .......++..++.+|++.||++|||++|+++
T Consensus 310 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 310 PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred hhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00 000000000 01123457888999999999999999999984
|
|
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=318.82 Aligned_cols=262 Identities=22% Similarity=0.357 Sum_probs=202.3
Q ss_pred cccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (884)
++..+.||+|+||.||+|... .+..||+|++..........++.+|+.+++.++||||+++++++.+....++|
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv 87 (277)
T cd05062 8 ITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVI 87 (277)
T ss_pred ceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEE
Confidence 456788999999999999653 24679999986543334456788999999999999999999999988999999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
|||+++++|.++++....... .......+++..+..++.|+++|++|||+. +++||||||+||++++++.++++|
T Consensus 88 ~e~~~~~~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~d 162 (277)
T cd05062 88 MELMTRGDLKSYLRSLRPEME--NNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGD 162 (277)
T ss_pred EecCCCCCHHHHHHHcCcccc--ccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECC
Confidence 999999999999865331100 001123467889999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 750 YGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 750 fg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |..||......+.. . ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~------~-~~~ 235 (277)
T cd05062 163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL------R-FVM 235 (277)
T ss_pred CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH------H-HHH
Confidence 99998654322221 122344678999999998889999999999999999999 78899765433221 1 111
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
...... ........+.+++.+||+.+|++|||+.|+++.|++
T Consensus 236 ~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 236 EGGLLD--------KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred cCCcCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 111111 111223467888999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=314.55 Aligned_cols=253 Identities=26% Similarity=0.404 Sum_probs=205.8
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
|+..+.||+|+||.||+|...++..+++|.+.... .....++..|+.+++.++||||+++++++...+..++||||+++
T Consensus 8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (261)
T cd05148 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD-LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEK 86 (261)
T ss_pred HHHhhhhccCCCccEEEeEecCCCcEEEEeccccc-hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeeccc
Confidence 34667899999999999998888899999987543 23467789999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.+||+|||.+..
T Consensus 87 ~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~ 153 (261)
T cd05148 87 GSLLAFLRSPE----------GQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARL 153 (261)
T ss_pred CCHHHHHhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhh
Confidence 99999997543 24578999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.... ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+... . ....... .
T Consensus 154 ~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~---~---~~~~~~~-~- 224 (261)
T cd05148 154 IKED-VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYD---Q---ITAGYRM-P- 224 (261)
T ss_pred cCCc-cccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHH---H---HHhCCcC-C-
Confidence 6432 222233445778999999988889999999999999999998 899997655332221 1 1111000 0
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
........+.+++.+||+.+|++|||++++++.|+.+
T Consensus 225 -------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 225 -------CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 0112234577888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=310.80 Aligned_cols=249 Identities=22% Similarity=0.247 Sum_probs=192.0
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCc-------------cCCHHHHHHHHHHHhcCCCCCcceeeeEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR-------------IRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~ 661 (884)
|+....||+|.||.|-+|.. .+++.||||++.+... ....+...+||.++++++|||||+++++..
T Consensus 99 y~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLD 178 (576)
T KOG0585|consen 99 YELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLD 178 (576)
T ss_pred eehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeec
Confidence 55677899999999999955 4688999999854321 112358899999999999999999999997
Q ss_pred cC--CceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEe
Q 002759 662 SS--TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILL 739 (884)
Q Consensus 662 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~ 739 (884)
+. +..|+|+|||..|.+... . .....++..+++++++++..||+|||.+ +||||||||+|+|+
T Consensus 179 DP~s~~~YlVley~s~G~v~w~----p--------~d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl 243 (576)
T KOG0585|consen 179 DPESDKLYLVLEYCSKGEVKWC----P--------PDKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLL 243 (576)
T ss_pred CcccCceEEEEEeccCCccccC----C--------CCcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEE
Confidence 65 578999999998876322 1 1123489999999999999999999999 99999999999999
Q ss_pred CCCCCeeEccccCccccCCcc----CcccccccccccccCccccCCCC----CCCccCchhHHHHHHHHHhCCCCCCCCC
Q 002759 740 DENYEPKLSDYGLAKLLPILD----NYGLTKFHNAVGYVAPELAQSLR----LSDKCDVYSFGVILLELVTGRKPVESPT 811 (884)
Q Consensus 740 ~~~~~vkl~Dfg~s~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gv~l~el~tG~~p~~~~~ 811 (884)
+++|+|||+|||.+....... ........||+.|+|||...++. .+.+.||||+||++|.|+.|+.||-+..
T Consensus 244 ~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~ 323 (576)
T KOG0585|consen 244 SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF 323 (576)
T ss_pred cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch
Confidence 999999999999998763211 12234578999999999987632 2468899999999999999999998654
Q ss_pred CcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 812 TNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..+.+ .+.+..+ ... ...++...++..++.+++++||++|.+..+|..
T Consensus 324 ~~~l~------~KIvn~p--L~f------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 324 ELELF------DKIVNDP--LEF------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred HHHHH------HHHhcCc--ccC------CCcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 33222 1111111 000 011223446777888999999999999998864
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=316.83 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=200.0
Q ss_pred ccCceeccCCceEEEEEEEc-CCe----EEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGV----SIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+..+.||+|+||+||+|.+. ++. .+++|++..........++..|+..+++++||||+++++++. ....++++|
T Consensus 10 ~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e 88 (279)
T cd05111 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQ 88 (279)
T ss_pred eeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEE
Confidence 45678999999999999774 333 477787754332233467788888999999999999999875 455788999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++|+|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||++++++.+||+|||
T Consensus 89 ~~~~gsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg 154 (279)
T cd05111 89 LSPLGSLLDHVRQHR-----------DSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFG 154 (279)
T ss_pred eCCCCcHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCc
Confidence 999999999997433 3588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccC-cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 752 LAKLLPILDN-YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 752 ~s~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
.++....... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||......+. .+.+..+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-------~~~~~~~ 227 (279)
T cd05111 155 VADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-------PDLLEKG 227 (279)
T ss_pred cceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHCC
Confidence 9987643222 12234456778999999998899999999999999999998 9999986543322 1222222
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhccc
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~~ 882 (884)
.... .+. . ...++..++.+||..+|++|||+.|+++.|..+.+.-
T Consensus 228 ~~~~--~~~---~---~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 228 ERLA--QPQ---I---CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred CcCC--CCC---C---CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 2111 111 1 1235667788999999999999999999999976543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=291.59 Aligned_cols=263 Identities=23% Similarity=0.307 Sum_probs=204.2
Q ss_pred ccccCceeccCCceEEEEEE-EcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC-----CceeE
Q 002759 595 LLDKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS-----TMQLI 668 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 668 (884)
.|++.+.+|+|||+-||.++ ..++..+|+|++.... .++.+..++|++..++++|||+++++++...+ ...|+
T Consensus 22 Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~-~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl 100 (302)
T KOG2345|consen 22 RYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS-QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL 100 (302)
T ss_pred eEEEeeeecCCCceeeeeecccCcccchhhheeeccc-hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence 35677899999999999996 4567889999997654 46778899999999999999999999987543 34899
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
+++|...|+|.+.+.... ..+..+++.+.++|+.+|++||++||+. .++++||||||.||++++.+.+++.
T Consensus 101 l~Pyy~~Gsl~d~i~~~k--------~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~ 171 (302)
T KOG2345|consen 101 LLPYYKRGSLLDEIERLK--------IKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLM 171 (302)
T ss_pred EeehhccccHHHHHHHHh--------hcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEE
Confidence 999999999999997665 2345789999999999999999999998 5579999999999999999999999
Q ss_pred cccCccccCCccCc--------ccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhh
Q 002759 749 DYGLAKLLPILDNY--------GLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV 817 (884)
Q Consensus 749 Dfg~s~~~~~~~~~--------~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~ 817 (884)
|||.++.....-.. .......|..|+|||.+. +...++++||||+||++|+|+.|..||+.......-
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS- 250 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS- 250 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe-
Confidence 99999876421110 112345688999999986 456688999999999999999999999753221100
Q ss_pred HHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 818 LCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
+.-.+. .+ .-.++. .......+.+++.+|++.||.+||++.+++..++++.
T Consensus 251 laLAv~----n~--q~s~P~-----~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 251 LALAVQ----NA--QISIPN-----SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred EEEeee----cc--ccccCC-----CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 000000 00 000000 0113346778888999999999999999999998764
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=312.42 Aligned_cols=248 Identities=23% Similarity=0.339 Sum_probs=197.0
Q ss_pred eeccCCceEEEEEEEc---CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCc
Q 002759 601 LIGGGSIGSVYRASFE---GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
.||+|+||.||+|.+. ++..||+|.+.........+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999764 355799999875543344577899999999999999999999885 457899999999999
Q ss_pred hhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|.+++.... ..+++.++.+++.|++.||+|||+. +++||||||+||+++.++.+|++|||+++...
T Consensus 81 L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~ 146 (257)
T cd05115 81 LNKFLSGKK-----------DEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALG 146 (257)
T ss_pred HHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCcccccc
Confidence 999986432 3588999999999999999999998 99999999999999999999999999998654
Q ss_pred CccCcc--cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 758 ILDNYG--LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 758 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
...... .....++..|+|||.+....++.++||||||+++||+++ |..||......+.. ..+..+....
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~~~~~~- 218 (257)
T cd05115 147 ADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-------SFIEQGKRLD- 218 (257)
T ss_pred CCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-------HHHHCCCCCC-
Confidence 322211 122233568999999988889999999999999999996 99999875543221 1222221111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.+.....++.+++.+||..+|++||++.++.+.|+++
T Consensus 219 -------~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 -------CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1122234677888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=312.20 Aligned_cols=252 Identities=29% Similarity=0.434 Sum_probs=201.9
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++..+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++|+|++++++++. ....++||||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~ 84 (260)
T cd05070 8 LQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT--MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSK 84 (260)
T ss_pred hhhhheeccccCceEEEEEecCCceeEEEEecCCC--CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCC
Confidence 34667899999999999988888889999987533 34567899999999999999999999875 4567899999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.++++... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++|+|||.+..
T Consensus 85 ~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~ 151 (260)
T cd05070 85 GSLLDFLKDGE----------GRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARL 151 (260)
T ss_pred CcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeee
Confidence 99999987533 23578999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.............++..|+|||++.+..++.++||||||+++|||++ |..||......+.. .. ........
T Consensus 152 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~------~~-~~~~~~~~- 223 (260)
T cd05070 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVL------EQ-VERGYRMP- 223 (260)
T ss_pred ccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH------HH-HHcCCCCC-
Confidence 64322222223345678999999988889999999999999999999 89999765433221 11 11111110
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
........+.+++.+||+.+|++|||++++.+.|+++
T Consensus 224 -------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 260 (260)
T cd05070 224 -------CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLEDY 260 (260)
T ss_pred -------CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 1112234678888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.32 Aligned_cols=247 Identities=26% Similarity=0.329 Sum_probs=196.6
Q ss_pred eeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchh
Q 002759 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLY 679 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 679 (884)
.||+|+||.||+|... +++.+|+|.+...........+.+|++++++++||||+++++++......++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 6899999999999764 688899998865433344577899999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCc
Q 002759 680 DNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL 759 (884)
Q Consensus 680 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~ 759 (884)
+++.... ..+++.+++.++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+......
T Consensus 82 ~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 147 (252)
T cd05084 82 TFLRTEG-----------PRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDG 147 (252)
T ss_pred HHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccc
Confidence 9986432 3578999999999999999999998 9999999999999999999999999998765421
Q ss_pred cCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccc
Q 002759 760 DNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837 (884)
Q Consensus 760 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 837 (884)
.... ......+..|+|||.+.+..++.++||||+|+++|||++ |..||......+. ...........
T Consensus 148 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~-------~~~~~~~~~~~---- 216 (252)
T cd05084 148 VYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQT-------REAIEQGVRLP---- 216 (252)
T ss_pred cccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHH-------HHHHHcCCCCC----
Confidence 1111 111223567999999998889999999999999999998 9999976443221 11111111111
Q ss_pred cCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 838 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.+.....++.+++.+||+.+|++|||+.|+.+.|+
T Consensus 217 ----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 217 ----CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred ----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 11122346788889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.37 Aligned_cols=252 Identities=28% Similarity=0.426 Sum_probs=201.6
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+...+.||+|++|.||+|...++..+|+|.+.... ...+.+.+|+.++++++|||++++++++. ....++||||+++
T Consensus 8 ~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05069 8 LRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT--MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGK 84 (260)
T ss_pred eeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC--ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCC
Confidence 44667899999999999988877789999886432 34567899999999999999999999875 4567899999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.++++... ...+++..+..++.|+++||+|||+. +++||||||+||++++++.++|+|||.++.
T Consensus 85 ~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~ 151 (260)
T cd05069 85 GSLLDFLKEGD----------GKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARL 151 (260)
T ss_pred CCHHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceE
Confidence 99999997533 23578999999999999999999988 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.............++..|+|||...+..++.++||||||+++|||++ |+.||......+.. .. ........
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~-~~~~~~~~- 223 (260)
T cd05069 152 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVL------EQ-VERGYRMP- 223 (260)
T ss_pred ccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HH-HHcCCCCC-
Confidence 64322222233445678999999998889999999999999999999 99999865433221 11 11111100
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
........+.+++.+||+.+|++||+++++++.|+++
T Consensus 224 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 260 (260)
T cd05069 224 -------CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260 (260)
T ss_pred -------CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 1122334677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=329.10 Aligned_cols=243 Identities=21% Similarity=0.282 Sum_probs=196.0
Q ss_pred cccCceeccCCceEEEEEEEcC--CeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG--GVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
|...+.||+|+||.||+|...+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 32 y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~E 111 (340)
T PTZ00426 32 FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLE 111 (340)
T ss_pred cEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEe
Confidence 3466789999999999997543 3689999986432 23345678899999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 112 y~~~g~L~~~i~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG 176 (340)
T PTZ00426 112 FVIGGEFFTFLRRNK------------RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFG 176 (340)
T ss_pred CCCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCC
Confidence 999999999997543 588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
+++.... ......||..|+|||++.+..++.++||||+||++|||++|+.||...+..... ... .....
T Consensus 177 ~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~------~~i-~~~~~ 245 (340)
T PTZ00426 177 FAKVVDT----RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY------QKI-LEGII 245 (340)
T ss_pred CCeecCC----CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHH------HHH-hcCCC
Confidence 9987542 123457899999999999888999999999999999999999999875432211 111 11111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
.++ .. ....+.+++.+|++.||++|+ +++++++
T Consensus 246 --~~p----~~---~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~ 283 (340)
T PTZ00426 246 --YFP----KF---LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE 283 (340)
T ss_pred --CCC----CC---CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence 011 11 122456788889999999995 7888764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-38 Score=297.16 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=199.8
Q ss_pred cccCceeccCCceEEEEEE-EcCCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..++||+|.|+.||++. ..+|+..|+|.+... -...+.+++.+|+++.+.++||||+++.+.+......++|+|+|
T Consensus 13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m 92 (355)
T KOG0033|consen 13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV 92 (355)
T ss_pred hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence 3355679999999999994 467888888887532 23357889999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC---CCCeeEccc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE---NYEPKLSDY 750 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~---~~~vkl~Df 750 (884)
.|++|..-+.... .+++..+-+.++||+++|.|+|.. +|||||+||+|+++.. .--+|++||
T Consensus 93 ~G~dl~~eIV~R~------------~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~F 157 (355)
T KOG0033|consen 93 TGGELFEDIVARE------------FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADF 157 (355)
T ss_pred cchHHHHHHHHHH------------HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeeccc
Confidence 9999976664332 578888999999999999999998 9999999999999953 446999999
Q ss_pred cCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 751 g~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
|+|..+. ++..-....||++|||||++...+|+..+|||+.||++|-++.|..||.+.+..+.+. .+..+.
T Consensus 158 GvAi~l~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye-------~I~~g~ 228 (355)
T KOG0033|consen 158 GLAIEVN--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYE-------QIKAGA 228 (355)
T ss_pred ceEEEeC--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHH-------HHhccc
Confidence 9999887 5555677899999999999999999999999999999999999999999865544332 222222
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
+. +++.-.+-..+ +...++.+|+..||.+|.|+.|.+
T Consensus 229 yd--~~~~~w~~is~---~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 229 YD--YPSPEWDTVTP---EAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred cC--CCCcccCcCCH---HHHHHHHHHhccChhhhccHHHHh
Confidence 11 11111112223 445667789999999999998876
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=295.72 Aligned_cols=249 Identities=25% Similarity=0.359 Sum_probs=199.3
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCcc---CC----HHHHHHHHHHHhcC-CCCCcceeeeEEecCCce
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRI---RN----QEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~---~~----~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (884)
++..+.+|.|..++|-++.. .++...|+|++...... +. .+.-.+|+.+++++ .||+|+.+.+++..+...
T Consensus 19 y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~ 98 (411)
T KOG0599|consen 19 YEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFV 98 (411)
T ss_pred cChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchh
Confidence 34677899999999999844 56788899988533211 11 23345689999998 699999999999999999
Q ss_pred eEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
++|+|.|+.|.|+|++...- .+++++..+|++|+.+|++|||.. +||||||||+|||++++.++|
T Consensus 99 FlVFdl~prGELFDyLts~V------------tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~ 163 (411)
T KOG0599|consen 99 FLVFDLMPRGELFDYLTSKV------------TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIK 163 (411)
T ss_pred hhhhhhcccchHHHHhhhhe------------eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceE
Confidence 99999999999999997554 789999999999999999999999 999999999999999999999
Q ss_pred EccccCccccCCccCcccccccccccccCccccC------CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ------SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE 820 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~ 820 (884)
|+|||+|+.+.+ +......+||++|.|||.+. ...|+...|+||+||++|.++.|.+||+.... +.
T Consensus 164 isDFGFa~~l~~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ--ml---- 235 (411)
T KOG0599|consen 164 ISDFGFACQLEP--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ--ML---- 235 (411)
T ss_pred EeccceeeccCC--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH--HH----
Confidence 999999999874 45567889999999999985 34577789999999999999999999985321 11
Q ss_pred HHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 821 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.-+++-.+++... .+ ...+.......+|.+|++.||.+|.|++|+++
T Consensus 236 -MLR~ImeGkyqF~-sp----eWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 236 -MLRMIMEGKYQFR-SP----EWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred -HHHHHHhcccccC-Cc----chhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 1122223332210 11 12233345677888999999999999999885
|
|
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=310.85 Aligned_cols=247 Identities=26% Similarity=0.342 Sum_probs=199.0
Q ss_pred eeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchhh
Q 002759 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYD 680 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 680 (884)
+||+|+||.||+|...++..+|+|.+...........+.+|++++++++||||+++++++...+..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 68999999999998888889999998754433345578899999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCcc
Q 002759 681 NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILD 760 (884)
Q Consensus 681 ~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~ 760 (884)
++.... ..+++..+..++.|++.||.|+|+. +++||||||+||+++.++.+|++|||++.......
T Consensus 82 ~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 147 (250)
T cd05085 82 FLRKKK-----------DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI 147 (250)
T ss_pred HHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccc
Confidence 886432 2478999999999999999999988 99999999999999999999999999997654221
Q ss_pred CcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccC
Q 002759 761 NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSL 839 (884)
Q Consensus 761 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~ 839 (884)
........++..|+|||++.+..++.++||||||+++||+++ |..||......+.. ..........
T Consensus 148 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~-------~~~~~~~~~~------ 214 (250)
T cd05085 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR-------EQVEKGYRMS------ 214 (250)
T ss_pred cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHHcCCCCC------
Confidence 111222344667999999998889999999999999999999 99999765432211 1111111111
Q ss_pred CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 840 RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 840 ~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.......++.+++.+||..+|++||++.|+++.|.
T Consensus 215 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 215 --CPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred --CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 01112346788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=313.24 Aligned_cols=252 Identities=27% Similarity=0.429 Sum_probs=203.2
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++..++||+|+||.||+|...+++.||+|.+.... ...+++.+|+.++++++|+|++++++++. .+..++||||+++
T Consensus 8 ~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~ 84 (260)
T cd05067 8 LKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS--MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMEN 84 (260)
T ss_pred ceeeeeeccCccceEEeeecCCCceEEEEEecCCC--CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCC
Confidence 44678899999999999998888999999987533 45678999999999999999999999874 4578999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++.++..++.|++.||+|||+. +++||||||+||++++++.++++|||.+..
T Consensus 85 ~~L~~~~~~~~----------~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 151 (260)
T cd05067 85 GSLVDFLKTPE----------GIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARL 151 (260)
T ss_pred CCHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceee
Confidence 99999986433 23688999999999999999999988 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.............++..|+|||++.+..++.++||||||+++||+++ |+.||......+.. ... ........
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~------~~~-~~~~~~~~ 224 (260)
T cd05067 152 IEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI------QNL-ERGYRMPR 224 (260)
T ss_pred cCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH------HHH-HcCCCCCC
Confidence 65322222233445678999999998889999999999999999999 99999865433221 111 11111110
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
......++.+++.+||+.+|++|||++++...|+.+
T Consensus 225 --------~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 260 (260)
T cd05067 225 --------PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF 260 (260)
T ss_pred --------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence 111223688888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=325.53 Aligned_cols=242 Identities=23% Similarity=0.312 Sum_probs=193.6
Q ss_pred ceeccCCceEEEEEEE----cCCeEEEEEEccccC---ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 600 CLIGGGSIGSVYRASF----EGGVSIAVKKLETLG---RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+.||+|+||.||+|.. .+++.||+|+++... .......+..|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 4799999999999965 357889999986432 223345678899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .+.+..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 82 ~~~~~L~~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~ 146 (323)
T cd05584 82 LSGGELFMHLEREG------------IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGL 146 (323)
T ss_pred CCCchHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcC
Confidence 99999999986443 577888899999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++..... ........|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+. ...... ...
T Consensus 147 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~------~~~~~~-~~~- 217 (323)
T cd05584 147 CKESIHE-GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT------IDKILK-GKL- 217 (323)
T ss_pred CeecccC-CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH------HHHHHc-CCC-
Confidence 8754321 1222345689999999999988899999999999999999999999986543221 111111 111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
.+ +.....++.+++.+||+.+|++|| +++++++
T Consensus 218 -----~~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 218 -----NL---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred -----CC---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 01 111223567888899999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=318.77 Aligned_cols=260 Identities=20% Similarity=0.251 Sum_probs=195.7
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||+||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.++...++||||+.
T Consensus 7 y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 86 (303)
T cd07869 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH 86 (303)
T ss_pred ceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC
Confidence 556789999999999999775 6789999998754444445677899999999999999999999999999999999995
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... ..++...+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++
T Consensus 87 -~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 151 (303)
T cd07869 87 -TDLCQYMDKHP-----------GGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLAR 151 (303)
T ss_pred -cCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcce
Confidence 68888876432 3578889999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc-
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS- 832 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 832 (884)
..... ........++..|+|||++.+ ..++.++||||+||++|||++|+.||...... .............+...
T Consensus 152 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~~ 228 (303)
T cd07869 152 AKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI--QDQLERIFLVLGTPNEDT 228 (303)
T ss_pred eccCC-CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH--HHHHHHHHHHhCCCChhh
Confidence 54321 122234567889999999865 45788999999999999999999999864321 11111111111110000
Q ss_pred -------cccccc-CC----CCcH------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 -------ACFDRS-LR----GFAE------NELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 -------~~~d~~-~~----~~~~------~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..+++. .. .... ....++.+++.+|++.||++|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 229 WPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000 00 0000 01134667888999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=336.37 Aligned_cols=380 Identities=23% Similarity=0.356 Sum_probs=334.3
Q ss_pred CEEEEEecCcccc-ccccccccCCCCCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeC
Q 002759 73 FVDRIVLWNFSLG-GVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDL 151 (884)
Q Consensus 73 ~v~~l~l~~~~l~-g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~L 151 (884)
.|..|+++++.++ +..|.....+++++.|.|...++. .+|.+++.|.+|++|.+++|++. .+-..++.|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 4778889999998 567889999999999999999998 89999999999999999999998 67788999999999999
Q ss_pred CCCccC-CCCchhhhhccccCcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCC-CCCCCCCcccEEEccCCcc
Q 002759 152 SRNSYS-GEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELP-SQICNIPVLDFISVRGNAL 229 (884)
Q Consensus 152 s~N~l~-g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~n~l 229 (884)
..|++. ..||..+|. +..|..|+||+|+++ ..|..+..-+++-.|+||+|+|. .+| +.|-+|..|-+|+|++|++
T Consensus 86 R~N~LKnsGiP~diF~-l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFR-LKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hccccccCCCCchhcc-cccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchh
Confidence 999985 468988876 589999999999999 78888999999999999999998 555 5567899999999999999
Q ss_pred CCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccc-cccccccccCCCCcEEecCCCcCCCCCCcc
Q 002759 230 TGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFH-GEIPEVGICGEGMQVFDASWNEFDGVIPLS 308 (884)
Q Consensus 230 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~ 308 (884)
. ..|..+..+..|++|+|++|.+.-.--..+-.+++|+.|.+++.+-+ ..+|..+..+.+|..+|+|.|++. ..|..
T Consensus 163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec 240 (1255)
T KOG0444|consen 163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC 240 (1255)
T ss_pred h-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence 9 55667889999999999999887654555566788899999986533 467888889999999999999998 67889
Q ss_pred cccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCC-CCcCCcCCCCC
Q 002759 309 ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGE-VPDDISNCRFL 387 (884)
Q Consensus 309 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L 387 (884)
+-++++|+.|+||+|+|+ .+........+|++|+||.|+++ .+|..+.+++.|+.|++.+|+++-. +|+.++.+.+|
T Consensus 241 ly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L 318 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL 318 (1255)
T ss_pred HhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence 999999999999999999 66777788899999999999999 7999999999999999999998743 89999999999
Q ss_pred cEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCc-cCcccEEEc
Q 002759 388 LLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGN-LRNLTHFNL 464 (884)
Q Consensus 388 ~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~-l~~L~~L~l 464 (884)
+.+..++|++. .+|+.++.+..|+.|.|+.|++- .+|+++.-|+.|+.|||.+|.-. .+|+.-.. -++|+.-|+
T Consensus 319 evf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL-VMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 319 EVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL-VMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred HHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc-cCCCCcchhhhcceeeec
Confidence 99999999999 89999999999999999999998 89999999999999999999766 45543322 245554443
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=312.00 Aligned_cols=260 Identities=19% Similarity=0.302 Sum_probs=204.7
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... ++..||||.+.... .......+.+|+++++.++|||++++++++...+..++|+||
T Consensus 4 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 83 (267)
T cd08228 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEe
Confidence 346778999999999999764 67899999875422 223356788999999999999999999999988999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++..... ....+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.
T Consensus 84 ~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~ 152 (267)
T cd08228 84 ADAGDLSQMIKYFKK--------QKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred cCCCcHHHHHHHhhh--------ccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECcccc
Confidence 999999988853220 123578889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+....... .......++..|+|||.+.+..++.++||||+|+++|||++|+.||...... .. .... .+......
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~---~~~~-~~~~~~~~ 226 (267)
T cd08228 153 GRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LF---SLCQ-KIEQCDYP 226 (267)
T ss_pred ceeccchh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HH---HHHH-HHhcCCCC
Confidence 98764322 1122346788899999998888899999999999999999999999754321 11 1111 11111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
. . ........+.+++.+||+.+|++||+++++++.+++++
T Consensus 227 ~----~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 227 P----L---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C----C---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 1 0 11223346788888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=308.68 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=193.6
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----ceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST-----MQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~ 670 (884)
...+++|.|+||.||+|... ++..||||++-...+ .-.+|+++|+.++|||||++..+|.... ...+||
T Consensus 27 ~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVl 101 (364)
T KOG0658|consen 27 EAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVL 101 (364)
T ss_pred EeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHH
Confidence 45678999999999999664 568999999864432 2356899999999999999999885432 235899
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC-CCeeEcc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSD 749 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-~~vkl~D 749 (884)
|||+. +|+++++... ..+..++...+.-+..||.+||+|||+. +|+||||||+|+|+|.+ |.+||||
T Consensus 102 eymP~-tL~~~~r~~~--------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicD 169 (364)
T KOG0658|consen 102 EYMPE-TLYRVIRHYT--------RANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICD 169 (364)
T ss_pred HhchH-HHHHHHHHHh--------hcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEecc
Confidence 99966 9999997532 1134577778889999999999999998 99999999999999976 9999999
Q ss_pred ccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 750 fg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
||.|+.+... .....+..+-.|+|||.+.+ ..|+.+.||||.||++.||+-|++-|.+.+..+.... +-+.+..
T Consensus 170 FGSAK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e---Iik~lG~ 244 (364)
T KOG0658|consen 170 FGSAKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE---IIKVLGT 244 (364)
T ss_pred CCcceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH---HHHHhCC
Confidence 9999988643 33456677888999999876 4689999999999999999999999998654433321 1122111
Q ss_pred CCC--------c--ccccccCCC------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 GSA--------S--ACFDRSLRG------FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~~--------~--~~~d~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+.. . +.-.+.+.. +......+.++++.++++.+|++|.++.|++.
T Consensus 245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 110 0 110111111 22334457788889999999999999999883
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=317.88 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=192.4
Q ss_pred cccCceeccCCceEEEEEEEc--CCeEEEEEEccccCcc-CCHHHHHHHHHHHhcC---CCCCcceeeeEEe-----cCC
Q 002759 596 LDKECLIGGGSIGSVYRASFE--GGVSIAVKKLETLGRI-RNQEEFELEIGRLSNI---RHFNLVAFQGYYW-----SST 664 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~~~ 664 (884)
|+..+.||+|+||+||+|... ++..||+|++...... .....+.+|+.+++.+ +||||+++++++. ...
T Consensus 3 Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~ 82 (290)
T cd07862 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 82 (290)
T ss_pred cceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCC
Confidence 446678999999999999763 4678999998643322 2334566777776655 6999999999885 235
Q ss_pred ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCC
Q 002759 665 MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE 744 (884)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~ 744 (884)
..++||||+. ++|.+++.... ...+++.++..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 83 ~~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~ 148 (290)
T cd07862 83 KLTLVFEHVD-QDLTTYLDKVP----------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQ 148 (290)
T ss_pred cEEEEEccCC-CCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCC
Confidence 6799999996 58999886433 23578999999999999999999998 9999999999999999999
Q ss_pred eeEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002759 745 PKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 745 vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~ 824 (884)
+||+|||+++..... .......++..|+|||.+.+..++.++||||+||++|||++|+.||......+... .+.+
T Consensus 149 ~kl~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~---~i~~ 223 (290)
T cd07862 149 IKLADFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILD 223 (290)
T ss_pred EEEccccceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHH
Confidence 999999999875422 22345568899999999988889999999999999999999999998765433221 1111
Q ss_pred HHHcCCCc----------ccccccCCC----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 825 LLERGSAS----------ACFDRSLRG----FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 825 ~~~~~~~~----------~~~d~~~~~----~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
....+... ..+.+.... ........+.+++.+|++.||++|||+.|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 224 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 11100000 000000000 11112235678899999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=324.55 Aligned_cols=250 Identities=21% Similarity=0.287 Sum_probs=195.0
Q ss_pred ccCceeccCCceEEEEEEE----cCCeEEEEEEccccC---ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeE
Q 002759 597 DKECLIGGGSIGSVYRASF----EGGVSIAVKKLETLG---RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (884)
+..+.||+|+||.||+|.. .+++.||+|++.... .....+.+..|+.++..+ +||+|+++++++...+..++
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (332)
T cd05614 3 ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHL 82 (332)
T ss_pred eEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEE
Confidence 4567899999999999965 357889999986432 223356778899999999 59999999999999999999
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+
T Consensus 83 v~e~~~~g~L~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~ 147 (332)
T cd05614 83 ILDYVSGGEMFTHLYQRD------------NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLT 147 (332)
T ss_pred EEeCCCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEe
Confidence 999999999999986443 588999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
|||+++..............||..|+|||++.+. .++.++|||||||++|||++|+.||......... .........
T Consensus 148 DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~~~~ 225 (332)
T cd05614 148 DFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRRILK 225 (332)
T ss_pred eCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHHHhc
Confidence 9999986543333333446789999999999865 4788999999999999999999999754322211 111111111
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
. ++.... .....+.+++.+||+.||++|| +++++++
T Consensus 226 ~-------~~~~~~---~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 226 C-------DPPFPS---FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred C-------CCCCCC---CCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 1 111111 1223566778889999999999 6667764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.35 Aligned_cols=251 Identities=22% Similarity=0.280 Sum_probs=198.4
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 345678999999999999764 68899999986432 122345678899999999999999999999988999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||++++++.++|+|||+
T Consensus 82 ~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~ 148 (285)
T cd05605 82 MNGGDLKFHIYNMG----------NPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGL 148 (285)
T ss_pred cCCCcHHHHHHhcC----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCC
Confidence 99999998886432 23588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++..... .......++..|+|||++.+..++.++||||+||++||+++|+.||......... ......+.....
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~~~- 222 (285)
T cd05605 149 AVEIPEG--ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKEDQE- 222 (285)
T ss_pred ceecCCC--CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhccc-
Confidence 9875422 1223446789999999999888999999999999999999999999865432211 111111111110
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
.........+.+++.+||+.||++|| +++++++
T Consensus 223 --------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 223 --------EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred --------ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 11122334577888999999999999 7888864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=315.32 Aligned_cols=263 Identities=25% Similarity=0.375 Sum_probs=202.7
Q ss_pred ccCceeccCCceEEEEEEE-----cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASF-----EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+..+.||+|+||.||+|.. .++..|++|.+...........+.+|+.++++++||||+++++++..+...++|||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 87 (283)
T cd05090 8 RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFE 87 (283)
T ss_pred eeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEE
Confidence 3567899999999999974 24578999999754433445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCC-----CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 672 FVPKGNLYDNLHGVNYPG-----TSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~-----~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
|+++++|.+++....... ....+.....+++.+++.++.|++.||+|||++ +++||||||+||++++++.+|
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~k 164 (283)
T cd05090 88 YLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVK 164 (283)
T ss_pred cCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEE
Confidence 999999999985432100 000111134578899999999999999999998 999999999999999999999
Q ss_pred EccccCccccCCccC-cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 002759 747 LSDYGLAKLLPILDN-YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~ 824 (884)
++|||+++....... .......++..|+|||++.+..++.++||||||+++|||++ |..||......+.. +
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~-------~ 237 (283)
T cd05090 165 ISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI-------E 237 (283)
T ss_pred eccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-------H
Confidence 999999987643221 11233345678999999988889999999999999999999 99999765432221 1
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
.+....... .......++..++.+||+.+|++||++.++.+.|+.
T Consensus 238 ~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 MVRKRQLLP--------CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCCcCC--------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 122111111 111122367778889999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.74 Aligned_cols=264 Identities=23% Similarity=0.298 Sum_probs=207.5
Q ss_pred cccCceeccCCceEEEEEEEcC-----CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEec-CCceeEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG-----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS-STMQLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv 669 (884)
|...++||+|+||.||+|...+ +..|++|++...........+.+|+.++++++|||++++++++.. +...+++
T Consensus 8 ~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 87 (280)
T cd05043 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVL 87 (280)
T ss_pred eEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEE
Confidence 3467889999999999998765 678999998755444556778999999999999999999998765 5678999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
+||+++++|.+++........ .....+++.++..++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 88 ~~~~~~~~L~~~l~~~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 88 YPYMNWGNLKLFLQQCRLGEA----NNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred EEcCCCCcHHHHHHhcccccc----ccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 999999999999865431110 0124689999999999999999999988 999999999999999999999999
Q ss_pred ccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 750 YGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 750 fg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
||+++.+...+... .....++..|+|||++.+..++.++||||||+++||+++ |+.||......+. ..+ ..
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~ 233 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEM---AAY----LK 233 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHH---HHH----HH
Confidence 99998664322211 122345678999999998889999999999999999999 9999976543321 111 11
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
...... . ......++.+++.+||+.+|++|||+.++++.|+++.++
T Consensus 234 ~~~~~~-----~---~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 234 DGYRLA-----Q---PINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred cCCCCC-----C---CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 111100 0 111223677888999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.89 Aligned_cols=248 Identities=20% Similarity=0.270 Sum_probs=193.5
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++||+|+||.||+|... +++.||+|+++... .......+..|..++..+ +||||+++++++.+....++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36899999999999764 67889999997532 223356678899999888 799999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 g~L~~~~~~~~------------~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQRQR------------KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccc
Confidence 99998886433 589999999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHHHcCCCcc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE--VVVLCEYVRELLERGSASA 833 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 833 (884)
... .........|+..|+|||++.+..++.++||||+||++|||++|+.||......+ .....++....+......
T Consensus 146 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~- 223 (329)
T cd05588 146 GIR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR- 223 (329)
T ss_pred ccc-CCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC-
Confidence 321 1222344678999999999999999999999999999999999999997422111 111112222222222111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC------HHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS------MAEVV 872 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt------~~ell 872 (884)
+ +.....++.+++.+|++.||.+||+ +++++
T Consensus 224 -----~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~ 260 (329)
T cd05588 224 -----I---PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK 260 (329)
T ss_pred -----C---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence 0 1112235677888999999999998 55665
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=315.58 Aligned_cols=267 Identities=25% Similarity=0.379 Sum_probs=206.6
Q ss_pred ccCceeccCCceEEEEEEE------cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASF------EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
...+.||+|+||+||++.. .++..+|+|.+.... ......+.+|++++++++|||++++++++......++||
T Consensus 8 ~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (288)
T cd05093 8 VLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS-DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVF 86 (288)
T ss_pred eeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEE
Confidence 4677899999999999964 234568899886533 234567899999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCC-CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 671 EFVPKGNLYDNLHGVNYPGT-STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
||+++++|.+++........ ...+.....+++.+++.++.|++.||+|||+. +++||||||+||++++++.+||+|
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~d 163 (288)
T cd05093 87 EYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGD 163 (288)
T ss_pred EcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEecc
Confidence 99999999999865431110 00111223589999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 750 YGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 750 fg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
||.++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......+.. ..+.
T Consensus 164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~-------~~i~ 236 (288)
T cd05093 164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI-------ECIT 236 (288)
T ss_pred CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHH
Confidence 9999865432211 1123345678999999998889999999999999999999 99999765433221 1111
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhccc
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~~ 882 (884)
.+..... ......++.+++.+||+.+|.+|||+.|+.+.|+++.+..
T Consensus 237 ~~~~~~~--------~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 237 QGRVLQR--------PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred cCCcCCC--------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 1111110 1112235788899999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=322.74 Aligned_cols=240 Identities=21% Similarity=0.292 Sum_probs=189.2
Q ss_pred eeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhc-CCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSN-IRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
.||+|+||+||+|... +++.||+|+++... .....+.+..|..++.. .+||||+++++++...+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6899999999999764 57789999986432 22334555667777664 48999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~L~~~~~~~~------------~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~ 146 (316)
T cd05592 82 DLMFHIQSSG------------RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKEN 146 (316)
T ss_pred cHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeEC
Confidence 9999886433 588899999999999999999998 9999999999999999999999999999764
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 836 (884)
.... .......|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+.. ... ..... .++
T Consensus 147 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~------~~i-~~~~~--~~~ 216 (316)
T cd05592 147 MNGE-GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELF------DSI-LNDRP--HFP 216 (316)
T ss_pred CCCC-CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHH------HHH-HcCCC--CCC
Confidence 3222 2234456899999999999989999999999999999999999999875543222 111 11110 011
Q ss_pred ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002759 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMA-EVV 872 (884)
Q Consensus 837 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-ell 872 (884)
.....++.+++.+||+.+|++||++. +++
T Consensus 217 -------~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 217 -------RWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -------CCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11223566778889999999999876 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.81 Aligned_cols=262 Identities=23% Similarity=0.328 Sum_probs=202.2
Q ss_pred cCceeccCCceEEEEEEEcC------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 598 KECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
..+.||+|+||.||+|...+ +..||+|++.........+.+..|+.++..++||||+++++++......++++|
T Consensus 9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e 88 (283)
T cd05091 9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS 88 (283)
T ss_pred HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence 45679999999999997632 478999999754433335678899999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCC----CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 672 FVPKGNLYDNLHGVNYPG----TSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
|+.+++|.+++....... ..........+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl 165 (283)
T cd05091 89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKI 165 (283)
T ss_pred cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEe
Confidence 999999999985332110 000111134578889999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 002759 748 SDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
+|||+++........ ......++..|+|||.+.+..++.++||||+|+++|||++ |..||......+. . +.
T Consensus 166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~------~-~~ 238 (283)
T cd05091 166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV------I-EM 238 (283)
T ss_pred cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHH------H-HH
Confidence 999998876432221 1233445778999999988889999999999999999998 8889876543322 1 11
Q ss_pred HHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 826 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
+....... .+......+.+++..||+.+|++||+++++++.|+.
T Consensus 239 i~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQVLP--------CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCcCC--------CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22221111 112233467788899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.24 Aligned_cols=253 Identities=29% Similarity=0.417 Sum_probs=204.8
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+...+.||+|+||.||+|...++..+|||.+.... ...+++.+|+.++++++|+|++++++++......++||||+++
T Consensus 8 ~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 85 (261)
T cd05034 8 LKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT--MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSK 85 (261)
T ss_pred eeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc--cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCC
Confidence 34677899999999999988888889999987533 4567899999999999999999999999988899999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||.++.
T Consensus 86 ~~L~~~i~~~~----------~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~ 152 (261)
T cd05034 86 GSLLDFLKSGE----------GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARL 152 (261)
T ss_pred CCHHHHHhccc----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECcccccee
Confidence 99999997543 24689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
..............+..|+|||.+.+..++.++||||+|+++||+++ |+.||......+.. ..........
T Consensus 153 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~------~~~~~~~~~~-- 224 (261)
T cd05034 153 IEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVL------EQVERGYRMP-- 224 (261)
T ss_pred ccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHcCCCCC--
Confidence 65322222223344678999999998889999999999999999999 99999765432211 1111110000
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.......++.+++.+||+.+|++||+++++.+.|+.+
T Consensus 225 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~~ 261 (261)
T cd05034 225 -------RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLEDY 261 (261)
T ss_pred -------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhcC
Confidence 0011134677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=327.39 Aligned_cols=242 Identities=23% Similarity=0.279 Sum_probs=193.9
Q ss_pred ceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 600 CLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
+.||+|+||.||+|.. .+++.||+|++.... .......+..|+++++.++||||+++.+++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 3689999999999965 468899999986432 2234566788999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH-DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
+|.+++.... .+++..+..++.||+.||+|||+ . +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~L~~~l~~~~------------~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~ 145 (325)
T cd05594 81 ELFFHLSRER------------VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE 145 (325)
T ss_pred cHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCee
Confidence 9998886433 58899999999999999999997 6 899999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
.... ........|+..|+|||++.+..++.++||||+||++|||++|+.||......+.. ..+......
T Consensus 146 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~-------~~i~~~~~~--- 214 (325)
T cd05594 146 GIKD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF-------ELILMEEIR--- 214 (325)
T ss_pred cCCC-CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHH-------HHHhcCCCC---
Confidence 4321 12223456899999999999989999999999999999999999999765433221 111111110
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
++.....++.+++.+||+.||++|+ +++++++
T Consensus 215 ------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 215 ------FPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred ------CCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 0111223567788899999999996 8988874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=317.62 Aligned_cols=271 Identities=23% Similarity=0.310 Sum_probs=202.1
Q ss_pred cccCceeccCCceEEEEEEEcC---------------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG---------------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~ 660 (884)
|+..+.||+|+||.||+|...+ ...||+|++...........+.+|++++++++|||++++++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~ 86 (295)
T cd05097 7 LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVC 86 (295)
T ss_pred CeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEE
Confidence 4466789999999999986542 2358999987543333456789999999999999999999999
Q ss_pred ecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC
Q 002759 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD 740 (884)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~ 740 (884)
......++||||+++++|.+++.................+++..++.++.|++.||+|||+. +++||||||+||+++
T Consensus 87 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~ 163 (295)
T cd05097 87 VSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVG 163 (295)
T ss_pred cCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEc
Confidence 99999999999999999999986543111100001123578899999999999999999998 999999999999999
Q ss_pred CCCCeeEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh--CCCCCCCCCCcchhh
Q 002759 741 ENYEPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT--GRKPVESPTTNEVVV 817 (884)
Q Consensus 741 ~~~~vkl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t--G~~p~~~~~~~~~~~ 817 (884)
+++.+||+|||+++......... .....++..|+|||+..+..++.++||||||+++|||++ |..||......+...
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~ 243 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence 99999999999998654322211 223345678999999988889999999999999999998 677887654433221
Q ss_pred HHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 818 LCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
............. ... ........+.+++.+||+.+|++|||+.+|++.|++
T Consensus 244 ---~~~~~~~~~~~~~-~~~----~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 244 ---NTGEFFRNQGRQI-YLS----QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred ---HHHHhhhhccccc-cCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1111111100000 000 011123478889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=326.93 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=192.7
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC-----CceeE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS-----TMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 668 (884)
|+..+.||+|+||.||+|.. .++..||||++.... .......+.+|+.+++.++||||+++++++... ...++
T Consensus 2 y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~l 81 (338)
T cd07859 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYV 81 (338)
T ss_pred eEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEE
Confidence 34567899999999999975 468899999986432 223456788999999999999999999987543 24799
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+. ++|.+++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+
T Consensus 82 v~e~~~-~~L~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~ 145 (338)
T cd07859 82 VFELME-SDLHQVIKAND------------DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKIC 145 (338)
T ss_pred EEecCC-CCHHHHHHhcc------------cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEc
Confidence 999995 68998886433 588999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCc--ccccccccccccCccccCC--CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002759 749 DYGLAKLLPILDNY--GLTKFHNAVGYVAPELAQS--LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 749 Dfg~s~~~~~~~~~--~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~ 824 (884)
|||+++........ ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......+... ....
T Consensus 146 Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~---~~~~ 222 (338)
T cd07859 146 DFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD---LITD 222 (338)
T ss_pred cCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH---HHHH
Confidence 99999865322111 1234568999999999875 578899999999999999999999997654322111 1111
Q ss_pred HHHcC-----------CCcccc-------cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 825 LLERG-----------SASACF-------DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 825 ~~~~~-----------~~~~~~-------d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
....+ .....+ ........+.....+.+++.+||+.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~ 289 (338)
T cd07859 223 LLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA 289 (338)
T ss_pred HhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence 00000 000000 00000000011235678889999999999999999985
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-37 Score=313.92 Aligned_cols=266 Identities=23% Similarity=0.269 Sum_probs=215.5
Q ss_pred EecCCCCCCHHHHHHHhhcccccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCC
Q 002759 576 LFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFN 652 (884)
Q Consensus 576 ~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 652 (884)
.|.+..+++|-+++..+...+..-++||+|+||+||-++. .+|+.+|.|++.+.. .........+|-.++.++..+.
T Consensus 167 yf~rFlQWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~F 246 (591)
T KOG0986|consen 167 YFTRFLQWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPF 246 (591)
T ss_pred HHHHHHHHHHHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCc
Confidence 3455678888899888999998999999999999999965 468899999885332 2244566788999999999999
Q ss_pred cceeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 002759 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNL 732 (884)
Q Consensus 653 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl 732 (884)
||.+...|+..+..++|+..|+||+|.=+|...+ .+.++++.++.+|.+|+.||++||+. +||+||+
T Consensus 247 iVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g----------~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDL 313 (591)
T KOG0986|consen 247 IVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHG----------NPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDL 313 (591)
T ss_pred EEEEeeeecCCCceEEEEEeecCCceeEEeeccC----------CCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccC
Confidence 9999999999999999999999999988887665 45799999999999999999999999 9999999
Q ss_pred CCCceEeCCCCCeeEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCC
Q 002759 733 KSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTT 812 (884)
Q Consensus 733 k~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~ 812 (884)
||+|||+|+.|+|+|+|.|+|..+.. +.......||.+|||||++..+.|+...|+||+||++|||+.|+.||....+
T Consensus 314 KPeNILLDd~GhvRISDLGLAvei~~--g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 314 KPENILLDDHGHVRISDLGLAVEIPE--GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred ChhheeeccCCCeEeeccceEEecCC--CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 99999999999999999999998874 4445566999999999999999999999999999999999999999986443
Q ss_pred cchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002759 813 NEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM 868 (884)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 868 (884)
.... -+..+....... .+++....+...+....+++||++|...
T Consensus 392 Kvk~--eEvdrr~~~~~~----------ey~~kFS~eakslc~~LL~Kdp~~RLGc 435 (591)
T KOG0986|consen 392 KVKR--EEVDRRTLEDPE----------EYSDKFSEEAKSLCEGLLTKDPEKRLGC 435 (591)
T ss_pred hhhH--HHHHHHHhcchh----------hcccccCHHHHHHHHHHHccCHHHhccC
Confidence 2111 011122221110 1122233345556666899999998644
|
|
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.56 Aligned_cols=267 Identities=25% Similarity=0.353 Sum_probs=205.4
Q ss_pred ccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
+..+.||+|+||.||+|... +...+++|.+..........++.+|+.+++.++||||+++++.+..++..++|+
T Consensus 3 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 82 (290)
T cd05045 3 VLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIV 82 (290)
T ss_pred cccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEE
Confidence 45678999999999999653 235688888865443344567899999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCC------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceE
Q 002759 671 EFVPKGNLYDNLHGVNYPGTST------------GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNIL 738 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~------------~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil 738 (884)
||+.+++|.+++.......... .......+++.+++.++.|++.|++|||+. +|+||||||+||+
T Consensus 83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nil 159 (290)
T cd05045 83 EYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVL 159 (290)
T ss_pred EecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEE
Confidence 9999999999986533111000 001124588999999999999999999988 9999999999999
Q ss_pred eCCCCCeeEccccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchh
Q 002759 739 LDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816 (884)
Q Consensus 739 ~~~~~~vkl~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~ 816 (884)
+++++.+||+|||.++.......+ ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 999999999999999865432221 1223345678999999988889999999999999999998 99999765433322
Q ss_pred hHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 817 VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
. ......... .+.....++.+++.+||+.+|++||+++|+++.|+++-.+
T Consensus 240 ---~----~~~~~~~~~--------~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 240 ---N----LLKTGYRME--------RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred ---H----HHhCCCCCC--------CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 1 111111100 0111224677888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.70 Aligned_cols=237 Identities=24% Similarity=0.306 Sum_probs=190.6
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||+||+|... +++.||+|++.... .....+.+..|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999765 57889999986432 223456677888888776 699999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 g~L~~~i~~~~------------~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 81 GDLMFHIQKSR------------RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE 145 (320)
T ss_pred chHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCee
Confidence 99999886543 588999999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
... .........|+..|+|||++.+..++.++||||+||++|||++|+.||......+.. .. +......
T Consensus 146 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~------~~-i~~~~~~--- 214 (320)
T cd05590 146 GIF-NGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF------EA-ILNDEVV--- 214 (320)
T ss_pred cCc-CCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH------HH-HhcCCCC---
Confidence 432 122234457899999999999989999999999999999999999999875543221 11 1111110
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSM 868 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 868 (884)
. +.....++.+++.+|++.||++||++
T Consensus 215 ---~---~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 ---Y---PTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred ---C---CCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 0 11122356778889999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=344.25 Aligned_cols=274 Identities=26% Similarity=0.377 Sum_probs=216.5
Q ss_pred HHHHHhhcccccCceeccCCceEEEEEEEc--------CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceee
Q 002759 587 DWEAGTKALLDKECLIGGGSIGSVYRASFE--------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQ 657 (884)
Q Consensus 587 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~ 657 (884)
.|+...+.. ...+.+|+|.||.|++|... ....||||.++......+.+.+..|++++..+ +|+||+.++
T Consensus 290 ~~e~~~~~l-~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENL-KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhc-cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 566555555 35559999999999999643 14579999999877777889999999999998 699999999
Q ss_pred eEEecCCceeEEEEecCCCchhhhcccCCC-CCCCCCC-CCC--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCC
Q 002759 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNY-PGTSTGG-IGN--PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLK 733 (884)
Q Consensus 658 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~-~~~--~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk 733 (884)
|+|......++|+||++.|+|.++++..+. ......+ ... ..++..+.+.++.|||.||+||++. ++|||||+
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLA 445 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLA 445 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhh
Confidence 999999999999999999999999987761 1111110 011 2488999999999999999999999 99999999
Q ss_pred CCceEeCCCCCeeEccccCccccCCccCccccccc--ccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCC
Q 002759 734 STNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH--NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESP 810 (884)
Q Consensus 734 ~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~ 810 (884)
++|||++++..+||+|||+|+.....+.+...... -+..|||||.+....|+.++|||||||++||++| |..||...
T Consensus 446 aRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 446 ARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred hhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 99999999999999999999977655555433333 3667999999999999999999999999999999 99999874
Q ss_pred CCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 811 TTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
...+. +.+++++..+..++ ..+..++..+|..||+.+|++||+|.|+.+.++.+
T Consensus 526 ~~~~~--l~~~l~~G~r~~~P------------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 526 PPTEE--LLEFLKEGNRMEQP------------EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CcHHH--HHHHHhcCCCCCCC------------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 31111 12233332222222 22234566777779999999999999999999984
|
|
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=321.54 Aligned_cols=244 Identities=20% Similarity=0.269 Sum_probs=190.0
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||+||+|... +++.+|+|+++... .......+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 57889999987532 223455678888888776 799999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|..++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~L~~~~~~~~------------~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~ 145 (329)
T cd05618 81 GDLMFHMQRQR------------KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCcccc
Confidence 99998886433 588999999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHHHHcCCCcc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE--VVVLCEYVRELLERGSASA 833 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~ 833 (884)
... .........|+..|+|||++.+..++.++|||||||++|||++|+.||....... ......+....+......
T Consensus 146 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~- 223 (329)
T cd05618 146 GLR-PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR- 223 (329)
T ss_pred ccC-CCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC-
Confidence 422 1222344578999999999999999999999999999999999999996421111 111112222222221111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM 868 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 868 (884)
++.....++.+++.+||+.||++||++
T Consensus 224 --------~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 --------IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred --------CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111222356778889999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=309.74 Aligned_cols=249 Identities=26% Similarity=0.365 Sum_probs=197.7
Q ss_pred ceeccCCceEEEEEEEcC----CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++||+|+||.||+|.+.. +..+|+|.+.........+++.+|+.++++++|||++++++++. ....++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 368999999999996532 26899999875543335677899999999999999999999875 4568999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 80 ~~L~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~ 144 (257)
T cd05060 80 GPLLKYLKKRR------------EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRA 144 (257)
T ss_pred CcHHHHHHhCC------------CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccce
Confidence 99999997433 578999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCccc--ccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 756 LPILDNYGL--TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 756 ~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
......... ....++..|+|||...+..++.++||||||+++||+++ |..||......+.. ... ......
T Consensus 145 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~---~~~----~~~~~~ 217 (257)
T cd05060 145 LGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVI---AML----ESGERL 217 (257)
T ss_pred eecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHH---HHH----HcCCcC
Confidence 643222111 11223467999999998899999999999999999998 99999765433221 111 111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
.. +......+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 ~~--------~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 PR--------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred CC--------CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 11 1112346778889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=328.08 Aligned_cols=260 Identities=20% Similarity=0.256 Sum_probs=196.3
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----ceeEE
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST-----MQLIL 669 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~lv 669 (884)
+..+.||+|+||.||+|.. .+++.||+|++... ......+.+.+|+++++.++||||+++++++.... ..++|
T Consensus 3 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 82 (372)
T cd07853 3 EPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVV 82 (372)
T ss_pred cccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEE
Confidence 4677899999999999976 46889999998643 22234567889999999999999999999997766 78999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
|||+. ++|.+++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 83 ~e~~~-~~l~~~~~~~------------~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~D 146 (372)
T cd07853 83 TELMQ-SDLHKIIVSP------------QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICD 146 (372)
T ss_pred eeccc-cCHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEecc
Confidence 99996 5788877533 2588999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHH--------
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE-------- 820 (884)
Q Consensus 750 fg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~-------- 820 (884)
||+++..............++..|+|||++.+. .++.++||||+||++|||++|+.||......+....+.
T Consensus 147 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~ 226 (372)
T cd07853 147 FGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226 (372)
T ss_pred ccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCH
Confidence 999987643333333445678899999998764 47889999999999999999999998755432221110
Q ss_pred --------HHHHHHH-cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 821 --------YVRELLE-RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 821 --------~~~~~~~-~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..+..+. ........ ........+...++.+++.+|++.||++|||++|+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 287 (372)
T cd07853 227 EAMRSACEGARAHILRGPHKPPSL-PVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA 287 (372)
T ss_pred HHHHHhhHHHHHHHHhCCCCCCch-HHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence 0000110 00000000 0000011112346778889999999999999999985
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=315.93 Aligned_cols=265 Identities=27% Similarity=0.399 Sum_probs=205.9
Q ss_pred ccCceeccCCceEEEEEEEcC------CeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEE
Q 002759 597 DKECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv 669 (884)
+..+.||+|+||.||+|...+ ...+|+|.+......+....+.+|+.++.++ +|+||+++++++..++..++|
T Consensus 15 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li 94 (293)
T cd05053 15 TLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVV 94 (293)
T ss_pred EEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEE
Confidence 466789999999999997642 3678999987544334456788999999999 899999999999999999999
Q ss_pred EEecCCCchhhhcccCCCCCCCCC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCe
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTG----GIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~----~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~v 745 (884)
|||+++++|.++++.......... ......+++..+++++.|++.|++|||+. +|+||||||+||++++++.+
T Consensus 95 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~ 171 (293)
T cd05053 95 VEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM 171 (293)
T ss_pred EEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeE
Confidence 999999999999975432111100 01234689999999999999999999988 99999999999999999999
Q ss_pred eEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 002759 746 KLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVR 823 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~ 823 (884)
|++|||.++.+....... .....++..|+|||++.+..++.++|||||||++||+++ |..||......+..
T Consensus 172 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------- 244 (293)
T cd05053 172 KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF------- 244 (293)
T ss_pred EeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH-------
Confidence 999999998765332211 122334678999999988889999999999999999998 99999765433221
Q ss_pred HHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 824 ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 824 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
+......... .......++.+++.+||+.+|++|||+.|+++.|+++-
T Consensus 245 ~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 245 KLLKEGYRME--------KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHcCCcCC--------CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 1111111110 11122346778999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=312.71 Aligned_cols=256 Identities=23% Similarity=0.374 Sum_probs=201.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCe----EEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGV----SIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
++..+.||+|+||+||+|.+. ++. .||+|.++..........+.+|+.+++.+.||||+++++++.. ...++++
T Consensus 9 ~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~ 87 (279)
T cd05109 9 LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVT 87 (279)
T ss_pred eeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEE
Confidence 446678999999999999753 343 4899998755444456778899999999999999999999875 4567999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
||+++|+|.++++... ..+++.+++.++.||+.||+|||+. +|+||||||+||++++++.+||+||
T Consensus 88 ~~~~~g~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~df 153 (279)
T cd05109 88 QLMPYGCLLDYVRENK-----------DRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDF 153 (279)
T ss_pred EcCCCCCHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCC
Confidence 9999999999987532 3588999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 751 GLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 751 g~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|+++........ ......++..|+|||...+..++.++||||||+++|||++ |..||......+. ...+..
T Consensus 154 G~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~-------~~~~~~ 226 (279)
T cd05109 154 GLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI-------PDLLEK 226 (279)
T ss_pred CceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-------HHHHHC
Confidence 999876432211 1122344678999999998899999999999999999998 9999976443221 111222
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
...... ......++.+++.+||+.||++||++.++++.++++...
T Consensus 227 ~~~~~~--------~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05109 227 GERLPQ--------PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD 271 (279)
T ss_pred CCcCCC--------CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence 111110 111234677888999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=312.49 Aligned_cols=247 Identities=23% Similarity=0.267 Sum_probs=192.4
Q ss_pred eccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 602 IGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 602 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
||+|+||+||++... +++.+|+|++..... ......+..|++++++++||||+++.+++..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999764 588999999864221 12234556799999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+++.... ...+++..+..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++.....
T Consensus 81 ~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNVG----------ERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 98886433 23578899999999999999999998 999999999999999999999999999987643
Q ss_pred ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 759 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
. .......++..|+|||++.+..++.++||||+||++|||++|+.||........ .....+..... ... ..
T Consensus 148 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~-~~~----~~ 218 (277)
T cd05607 148 G--KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLED-EVK----FE 218 (277)
T ss_pred C--ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhcc-ccc----cc
Confidence 2 223345688999999999988899999999999999999999999976432211 11111111111 100 00
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
......++.+++.+||+.||++||+++|+++.
T Consensus 219 ----~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 219 ----HQNFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ----cccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 01122356788888999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=327.41 Aligned_cols=274 Identities=24% Similarity=0.337 Sum_probs=207.8
Q ss_pred HHHHhhcccccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeeeEE
Q 002759 588 WEAGTKALLDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYY 660 (884)
Q Consensus 588 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~ 660 (884)
|....+++ ...+.||+|+||.||+|.+. .++.||+|+++..........+.+|+.++.++. ||||+++++++
T Consensus 32 ~~~~~~~~-~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 32 WEMPRDNL-VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred ceecHHHe-ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 54444443 36789999999999999764 346799999976443344567889999999997 99999999999
Q ss_pred ecCCceeEEEEecCCCchhhhcccCCCCCC--------C-----------------------------------------
Q 002759 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGT--------S----------------------------------------- 691 (884)
Q Consensus 661 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~--------~----------------------------------------- 691 (884)
...+..++||||+++|+|.++++....... .
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 998999999999999999999975431000 0
Q ss_pred -------------------------------------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 002759 692 -------------------------------------TGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKS 734 (884)
Q Consensus 692 -------------------------------------~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~ 734 (884)
..-.....+++..++.++.|++.||+|||+. +++||||||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp 267 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAA 267 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCc
Confidence 0000123578888999999999999999988 999999999
Q ss_pred CceEeCCCCCeeEccccCccccCCccC-cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCC
Q 002759 735 TNILLDENYEPKLSDYGLAKLLPILDN-YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTT 812 (884)
Q Consensus 735 ~Nil~~~~~~vkl~Dfg~s~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~ 812 (884)
+||++++++.+|++|||+++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999986532221 11223456788999999998889999999999999999998 8999976543
Q ss_pred cchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 813 NEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
.+.. ...+..+.... .+.....++.+++.+||+.+|.+||+++|+++.|+++.
T Consensus 348 ~~~~------~~~~~~~~~~~--------~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 348 NEQF------YNAIKRGYRMA--------KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred hHHH------HHHHHcCCCCC--------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 3211 11111111100 01112346778888999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=329.63 Aligned_cols=251 Identities=20% Similarity=0.266 Sum_probs=192.0
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|.. .+++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~ 82 (381)
T cd05626 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (381)
T ss_pred ceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEec
Confidence 45677899999999999965 467899999996432 223356788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++++||+|||+
T Consensus 83 ~~gg~L~~~l~~~~------------~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl 147 (381)
T cd05626 83 IPGGDMMSLLIRME------------VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGL 147 (381)
T ss_pred CCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcC
Confidence 99999999987543 578889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccC----------------------------------------------cccccccccccccCccccCCCCCCC
Q 002759 753 AKLLPILDN----------------------------------------------YGLTKFHNAVGYVAPELAQSLRLSD 786 (884)
Q Consensus 753 s~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 786 (884)
++.+..... .......||..|+|||++.+..++.
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (381)
T cd05626 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQ 227 (381)
T ss_pred CcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCC
Confidence 764311000 0012346899999999999888999
Q ss_pred ccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhh--ccCCCCCC
Q 002759 787 KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLI--CTSEVPSR 864 (884)
Q Consensus 787 ~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~--cl~~~P~~ 864 (884)
++||||+||++|||++|+.||......+.. ........... +. ......+ +..+++.+ |+..+|..
T Consensus 228 ~~DiwSlG~il~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~-~~-~~~~~s~----~~~dli~~ll~~~~~~~~ 295 (381)
T cd05626 228 LCDWWSVGVILFEMLVGQPPFLAPTPTETQ------LKVINWENTLH-IP-PQVKLSP----EAVDLITKLCCSAEERLG 295 (381)
T ss_pred ccceeehhhHHHHHHhCCCCCcCCCHHHHH------HHHHccccccC-CC-CCCCCCH----HHHHHHHHHccCcccccC
Confidence 999999999999999999999875533221 11111000000 00 0001122 34444444 66667777
Q ss_pred CCCHHHHHH
Q 002759 865 RPSMAEVVQ 873 (884)
Q Consensus 865 RPt~~ell~ 873 (884)
||+++|++.
T Consensus 296 R~~~~~~l~ 304 (381)
T cd05626 296 RNGADDIKA 304 (381)
T ss_pred CCCHHHHhc
Confidence 999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=322.48 Aligned_cols=244 Identities=22% Similarity=0.309 Sum_probs=191.4
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHH---hcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRL---SNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
+..+.||+|+||.||+|... +++.||||+++... .....+.+.+|++++ +.++||||+++++++......++||
T Consensus 2 ~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~ 81 (324)
T cd05589 2 RCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVM 81 (324)
T ss_pred eEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEE
Confidence 34578999999999999764 67899999996432 123345666676554 5678999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
||+++++|..+++. ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 82 E~~~~~~L~~~~~~-------------~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Df 145 (324)
T cd05589 82 EYAAGGDLMMHIHT-------------DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADF 145 (324)
T ss_pred cCCCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcc
Confidence 99999999888753 2489999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 751 g~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
|+++..... ........|+..|+|||.+.+..++.++|||||||++|||++|+.||...+..+.. ..... ..
T Consensus 146 g~~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~------~~i~~-~~ 217 (324)
T cd05589 146 GLCKEGMGF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVF------DSIVN-DE 217 (324)
T ss_pred cCCccCCCC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CC
Confidence 998754321 22234467899999999999989999999999999999999999999875543221 11111 11
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
.. ++.....++.+++.+||+.||.+|| ++.++++
T Consensus 218 ~~---------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 VR---------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CC---------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 10 0111223567788899999999999 4555554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=305.78 Aligned_cols=255 Identities=22% Similarity=0.293 Sum_probs=197.6
Q ss_pred CceeccCCceEEEEEEE-cCCeEEEEEEcc-ccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEec-----CCceeEEEE
Q 002759 599 ECLIGGGSIGSVYRASF-EGGVSIAVKKLE-TLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS-----STMQLILSE 671 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~lv~e 671 (884)
.+.||+|+||.|+.|.. .+|..||||++. ........++-.+|++.++.++|+||+.+.+++.. -...|+|+|
T Consensus 27 ~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~e 106 (359)
T KOG0660|consen 27 IEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFE 106 (359)
T ss_pred cccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehh
Confidence 46799999999999955 578999999996 34445667888999999999999999999998865 356799999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
+| +.+|...++... .++...+..+.+|+++||.|+|+. +|+||||||.|++++.+...||+|||
T Consensus 107 lM-etDL~~iik~~~------------~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFG 170 (359)
T KOG0660|consen 107 LM-ETDLHQIIKSQQ------------DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFG 170 (359)
T ss_pred HH-hhHHHHHHHcCc------------cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEecccc
Confidence 99 559999997543 589999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCcc-CcccccccccccccCccccC-CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHH---------
Q 002759 752 LAKLLPILD-NYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE--------- 820 (884)
Q Consensus 752 ~s~~~~~~~-~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~--------- 820 (884)
+|+...... ....+.+..|-.|.|||.+. ...|+.+.||||.||++.||++|+.-|.+.+.-+...++-
T Consensus 171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e 250 (359)
T KOG0660|consen 171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE 250 (359)
T ss_pred ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence 999875421 22346778899999999875 5678999999999999999999999998755433221110
Q ss_pred --------HHHHHHHc-CCC-cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 821 --------YVRELLER-GSA-SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 821 --------~~~~~~~~-~~~-~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.++..+.. +.. ...+...+. ..-...++++.+|+..||.+|+|++|+++
T Consensus 251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp----~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFP----NANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHHHhccHHHHHHHHhCCCCCCCCHHHHcC----CCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 11111111 000 000111111 12224556777899999999999999885
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=320.90 Aligned_cols=268 Identities=25% Similarity=0.346 Sum_probs=202.5
Q ss_pred cccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEec-CCcee
Q 002759 596 LDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWS-STMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~~~~~ 667 (884)
|+..+.||+|+||.||+|... +++.||+|++...........+..|+.++.++ +|+||+++++++.. +...+
T Consensus 9 ~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~ 88 (337)
T cd05054 9 LKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (337)
T ss_pred hhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEE
Confidence 446789999999999999532 24689999987543333456678899999999 89999999998764 45678
Q ss_pred EEEEecCCCchhhhcccCCCCC----CCC---------------------------------------------CCCCCC
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPG----TST---------------------------------------------GGIGNP 698 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~----~~~---------------------------------------------~~~~~~ 698 (884)
++|||+++++|.+++......- ... ......
T Consensus 89 ~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (337)
T cd05054 89 VIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKE 168 (337)
T ss_pred EEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhc
Confidence 9999999999999885432100 000 000123
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCc-ccccccccccccCcc
Q 002759 699 ELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPE 777 (884)
Q Consensus 699 ~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE 777 (884)
.+++..+.+++.||+.||+|||+. +|+||||||+||+++.++.++|+|||+++.+...... ......++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 688999999999999999999998 9999999999999999999999999999876432221 122344567899999
Q ss_pred ccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhh
Q 002759 778 LAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLI 856 (884)
Q Consensus 778 ~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~ 856 (884)
++.+..++.++||||+||++|||++ |..||......+. ............ .+.....++.+++.+
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~------~~~~~~~~~~~~--------~~~~~~~~~~~l~~~ 311 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE------FCRRLKEGTRMR--------APEYATPEIYSIMLD 311 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH------HHHHHhccCCCC--------CCccCCHHHHHHHHH
Confidence 9999999999999999999999998 9999976433221 111111111111 011223467888899
Q ss_pred ccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 857 CTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 857 cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
||+.+|++||++.|+++.|+++-.
T Consensus 312 cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 312 CWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HccCChhhCcCHHHHHHHHHHHHh
Confidence 999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=309.91 Aligned_cols=247 Identities=25% Similarity=0.365 Sum_probs=195.5
Q ss_pred eeccCCceEEEEEEE---cCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 601 LIGGGSIGSVYRASF---EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~---~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
.||+|+||+||+|.+ .++..+|+|+++.... ....+++.+|+.+++.++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999965 3568899999864332 223567899999999999999999999885 45678999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||++++++.+||+|||.++..
T Consensus 81 ~L~~~l~~~~------------~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 81 PLNKFLQKNK------------HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKAL 145 (257)
T ss_pred cHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCcccccc
Confidence 9999986432 578999999999999999999998 9999999999999999999999999999876
Q ss_pred CCccCcc--cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 757 PILDNYG--LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 757 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
....... .....++..|+|||.+....++.++||||||+++|||++ |+.||......+.. . .++......
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~----~i~~~~~~~ 218 (257)
T cd05116 146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT---Q----MIESGERME 218 (257)
T ss_pred CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----HHHCCCCCC
Confidence 4322211 122234578999999988888999999999999999998 99999865433221 1 122221111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
. +.....++.+++.+||+.||++||++++|.+.|+++
T Consensus 219 ~--------~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 219 C--------PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred C--------CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1 111234677888999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=314.37 Aligned_cols=270 Identities=22% Similarity=0.298 Sum_probs=204.0
Q ss_pred cccCceeccCCceEEEEEEEc-----------------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeee
Q 002759 596 LDKECLIGGGSIGSVYRASFE-----------------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (884)
|+..+.||+|+||.||+|... +...+|+|++..........++.+|+.+++.++|+||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~ 86 (296)
T cd05095 7 LTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLA 86 (296)
T ss_pred ceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEE
Confidence 456778999999999998543 234689999875443344578899999999999999999999
Q ss_pred EEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceE
Q 002759 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNIL 738 (884)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil 738 (884)
++...+..++||||+++++|.+++........ ........+++.++..++.|++.|++|||+. +++||||||+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nil 162 (296)
T cd05095 87 VCITSDPLCMITEYMENGDLNQFLSRHEPQEA-AEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCL 162 (296)
T ss_pred EEecCCccEEEEEeCCCCcHHHHHHhcCcccc-cccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEE
Confidence 99999999999999999999999976442111 1112234588899999999999999999998 9999999999999
Q ss_pred eCCCCCeeEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh--CCCCCCCCCCcch
Q 002759 739 LDENYEPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT--GRKPVESPTTNEV 815 (884)
Q Consensus 739 ~~~~~~vkl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t--G~~p~~~~~~~~~ 815 (884)
++.++.++++|||+++.+....... ......+..|+|||+..+..++.++|||||||++|||++ |..||......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05095 163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV 242 (296)
T ss_pred EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence 9999999999999998654322211 222344678999999888889999999999999999998 7788876544333
Q ss_pred hhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 816 VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
.. ............. ..+. ...+...+.+++.+||+.||++||++.|+++.|++
T Consensus 243 ~~---~~~~~~~~~~~~~-~~~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 243 IE---NTGEFFRDQGRQV-YLPK----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HH---HHHHHHhhccccc-cCCC----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 21 1111111110000 0011 11122467788889999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=316.93 Aligned_cols=262 Identities=26% Similarity=0.386 Sum_probs=202.5
Q ss_pred cccccCceeccCCceEEEEEEE-----cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--Cce
Q 002759 594 ALLDKECLIGGGSIGSVYRASF-----EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQ 666 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~ 666 (884)
.++...+.||+|+||.||+|.+ .++..||+|.++..........+.+|+.+++.++|||++++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3456778899999999999974 347789999987554445567899999999999999999999988765 567
Q ss_pred eEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
++||||+++++|.+++.... ..+++.++..++.|++.||+|||+. +++||||||+||+++.++.++
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~ 149 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK-----------NKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK 149 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEE
Confidence 89999999999999986432 2578999999999999999999998 999999999999999999999
Q ss_pred EccccCccccCCccCc--ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCc---------ch
Q 002759 747 LSDYGLAKLLPILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTN---------EV 815 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~---------~~ 815 (884)
|+|||+++.+...... ......++..|+|||++.+..++.++||||||+++||+++++.|+...... ..
T Consensus 150 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd05079 150 IGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQ 229 (284)
T ss_pred ECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhccccccc
Confidence 9999999876532221 112345667899999998888999999999999999999987765432110 00
Q ss_pred hhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 816 VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
....... .....+.... .......++.+++.+||+.+|++|||+.++++.++++
T Consensus 230 ~~~~~~~-~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 230 MTVTRLV-RVLEEGKRLP--------RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred ccHHHHH-HHHHcCccCC--------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 0011111 1111111110 1112334688899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=309.43 Aligned_cols=253 Identities=23% Similarity=0.388 Sum_probs=201.1
Q ss_pred ccCceeccCCceEEEEEEEc----CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+..+.||+|+||.||+|... .+..+|+|.++........+.+.+|+.++++++||||+++++++..++..++||||
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 86 (267)
T cd05066 7 KIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEY 86 (267)
T ss_pred EeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEc
Confidence 45678999999999999763 23478999987544334457889999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.
T Consensus 87 ~~~~~L~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~ 152 (267)
T cd05066 87 MENGSLDAFLRKHD-----------GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGL 152 (267)
T ss_pred CCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCc
Confidence 99999999996432 3578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccc--cccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 753 AKLLPILDNYGLT--KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 753 s~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
++........... ...++..|+|||++.+..++.++|+||||+++||+++ |+.||......+.. ... ...
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~---~~~----~~~ 225 (267)
T cd05066 153 SRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVI---KAI----EEG 225 (267)
T ss_pred ccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHH---HHH----hCC
Confidence 9876532222111 1223567999999998889999999999999999887 99999765433221 111 111
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
... +. .......+.+++.+||+.+|.+||++.++++.|+++
T Consensus 226 ~~~----~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 226 YRL----PA----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred CcC----CC----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 100 00 111233567888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=326.31 Aligned_cols=239 Identities=25% Similarity=0.337 Sum_probs=192.2
Q ss_pred ceeccCCceEEEEEEE----cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 600 CLIGGGSIGSVYRASF----EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+.||+|+||.||++.. .+++.+|+|++.... .......+..|++++++++||||+++++++......++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999964 357899999986432 22344567889999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .+++.++..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 82 ~~~L~~~l~~~~------------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 146 (318)
T cd05582 82 GGDLFTRLSKEV------------MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK 146 (318)
T ss_pred CCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCc
Confidence 999999986433 588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
...... .......|+..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..... ...
T Consensus 147 ~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~------~~i~~-~~~--- 215 (318)
T cd05582 147 ESIDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM------TMILK-AKL--- 215 (318)
T ss_pred ccCCCC-CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH------HHHHc-CCC---
Confidence 654321 2233456899999999999888999999999999999999999999865432221 11111 111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAE 870 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 870 (884)
..+.....++.+++.+||+.||++||++.+
T Consensus 216 ------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 216 ------GMPQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 011112235677888999999999999655
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=297.69 Aligned_cols=261 Identities=23% Similarity=0.241 Sum_probs=200.1
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCC-cceeeeEEecCC------ceeE
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFN-LVAFQGYYWSST------MQLI 668 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~------~~~l 668 (884)
..++||+|+||+||+|.. .+|+.||+|++.-... +..-....+|+.++..++|+| |+++++++...+ ..++
T Consensus 15 ~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~l 94 (323)
T KOG0594|consen 15 KVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYL 94 (323)
T ss_pred HHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEE
Confidence 445699999999999954 5788999999975543 223456689999999999999 999999998776 7889
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
|+||++. +|.+++....... ..++...+..+++|++.||+|||++ +|+||||||+||+|+++|.+||+
T Consensus 95 vfe~~d~-DL~~ymd~~~~~~--------~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKla 162 (323)
T KOG0594|consen 95 VFEFLDR-DLKKYMDSLPKKP--------QGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLA 162 (323)
T ss_pred EEEeecc-cHHHHHHhccccc--------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeee
Confidence 9999954 9999997654211 2355688999999999999999999 99999999999999999999999
Q ss_pred cccCccccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
|||+|+...- .....+...+|..|+|||++.+. .|+...||||+||+++||++++.-|.+..+.+ ....+.+...
T Consensus 163 DFGlAra~~i-p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~---ql~~If~~lG 238 (323)
T KOG0594|consen 163 DFGLARAFSI-PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEID---QLFRIFRLLG 238 (323)
T ss_pred ccchHHHhcC-CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHH---HHHHHHHHcC
Confidence 9999996642 12235677889999999999876 78999999999999999999999998866522 2222333332
Q ss_pred cCCCcc--------ccccc------CCCCcHHHH---HHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 828 RGSASA--------CFDRS------LRGFAENEL---IQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 828 ~~~~~~--------~~d~~------~~~~~~~~~---~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
.+.... .++.. .+....... .+..+++.+|++.+|.+|.|++.+++.
T Consensus 239 tP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 239 TPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 221111 01100 011111111 256778889999999999999999864
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.10 Aligned_cols=240 Identities=23% Similarity=0.341 Sum_probs=190.3
Q ss_pred eeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhc-CCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSN-IRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
.||+|+||+||+|... +++.||+|+++... .......+..|..++.. .+||||+++++++.+.+..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6899999999999765 57889999986532 12334556777777775 48999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... .+++.++..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~L~~~l~~~~------------~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 82 DLMFHIQSCH------------KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred cHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 9999986433 578899999999999999999998 9999999999999999999999999998753
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 836 (884)
... ........|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+.. .. +..... .++
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~---~~----i~~~~~--~~~ 216 (316)
T cd05619 147 MLG-DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELF---QS----IRMDNP--CYP 216 (316)
T ss_pred CCC-CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHH---HH----HHhCCC--CCC
Confidence 221 12234456899999999999989999999999999999999999999875533221 11 111111 011
Q ss_pred ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002759 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMA-EVV 872 (884)
Q Consensus 837 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-ell 872 (884)
.. ...++.+++.+||+.+|++||++. ++.
T Consensus 217 ----~~---~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 217 ----RW---LTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ----cc---CCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 11 123566788899999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=328.78 Aligned_cols=250 Identities=22% Similarity=0.270 Sum_probs=199.5
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|+++++.++||||+++++++.+++..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (350)
T cd05573 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEY 82 (350)
T ss_pred ceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcC
Confidence 446678999999999999765 68899999986432 223456788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~L~~~l~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~ 147 (350)
T cd05573 83 MPGGDLMNLLIRKD------------VFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGL 147 (350)
T ss_pred CCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCC
Confidence 99999999997543 588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc----------------------------CcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCC
Q 002759 753 AKLLPILD----------------------------NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804 (884)
Q Consensus 753 s~~~~~~~----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~ 804 (884)
++...... ........|+..|+|||++.+..++.++|||||||++|||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~ 227 (350)
T cd05573 148 CKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227 (350)
T ss_pred CccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCC
Confidence 98765322 11223456899999999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002759 805 KPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-MAEVVQ 873 (884)
Q Consensus 805 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~ell~ 873 (884)
.||......+.. ......... ..+.. ... ...++..++.+|++ +|.+||+ ++|+++
T Consensus 228 ~Pf~~~~~~~~~------~~i~~~~~~-~~~p~-~~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~ 284 (350)
T cd05573 228 PPFYSDTLQETY------NKIINWKES-LRFPP-DPP----VSPEAIDLICRLLC-DPEDRLGSFEEIKS 284 (350)
T ss_pred CCCCCCCHHHHH------HHHhccCCc-ccCCC-CCC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence 999875532211 111110000 00000 000 23356777788997 9999999 999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.66 Aligned_cols=261 Identities=20% Similarity=0.307 Sum_probs=206.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEcccc--CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|++|.||+|... +++.||+|.++.. ......+.+.+|++++++++|+|++++++++...+..++||||
T Consensus 4 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 83 (267)
T cd08224 4 FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLEL 83 (267)
T ss_pred eeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEec
Confidence 446778999999999999776 7889999988632 2233467889999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .....+++.++..++.|++.|++|||+. +|+||||+|+||+++.++.++++|||.
T Consensus 84 ~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~ 152 (267)
T cd08224 84 ADAGDLSRMIKHFK--------KQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGL 152 (267)
T ss_pred CCCCCHHHHHHHhc--------ccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccce
Confidence 99999999886432 0123578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||...... . .+.. +........
T Consensus 153 ~~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~---~~~~-~~~~~~~~~ 226 (267)
T cd08224 153 GRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-L---YSLC-KKIEKCDYP 226 (267)
T ss_pred eeeccCCC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-H---HHHH-hhhhcCCCC
Confidence 88654321 1223346788899999999888999999999999999999999999654321 1 1111 111111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
... .+.....+.+++.+||+.+|++|||+.++++.++++.+
T Consensus 227 ~~~-------~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~~ 267 (267)
T cd08224 227 PLP-------ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267 (267)
T ss_pred CCC-------hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhcC
Confidence 110 11233467788899999999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=315.27 Aligned_cols=267 Identities=27% Similarity=0.368 Sum_probs=202.8
Q ss_pred cccCceeccCCceEEEEEEEcC-C--eEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG-G--VSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 671 (884)
++..+.||+|+||.||+|...+ + ..+++|.++........+.+.+|+.+++++ +||||+++++++......++|+|
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e 83 (297)
T cd05089 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIE 83 (297)
T ss_pred ceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEE
Confidence 3467789999999999997653 3 346888877543334456789999999999 79999999999998889999999
Q ss_pred ecCCCchhhhcccCCCCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 672 FVPKGNLYDNLHGVNYPGTS----TGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
|+++++|.++++........ ........+++..++.++.|++.|++|||+. +|+||||||+||++++++.+||
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 84 YAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred ecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEE
Confidence 99999999999654321100 0001123588999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
+|||++..... .........+..|+|||++.+..++.++|||||||++|||++ |..||......+.. .. .
T Consensus 161 ~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~------~~-~ 231 (297)
T cd05089 161 ADFGLSRGEEV--YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------EK-L 231 (297)
T ss_pred CCcCCCccccc--eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH------HH-H
Confidence 99999864321 111112233567999999998889999999999999999998 99999875543221 11 1
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhccc
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~~ 882 (884)
....... . .......+.+++.+||+.+|.+|||++++++.|+++..+.
T Consensus 232 ~~~~~~~-----~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~ 279 (297)
T cd05089 232 PQGYRME-----K---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR 279 (297)
T ss_pred hcCCCCC-----C---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence 1111000 0 1112236778889999999999999999999999887643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=314.97 Aligned_cols=248 Identities=22% Similarity=0.272 Sum_probs=193.4
Q ss_pred eccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 602 IGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 602 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
||+|+||+||+|... +++.+|+|++..... ....+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999664 678999999864321 12345678899999999999999999999988999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++.++|+|||.++....
T Consensus 81 ~~~~~~~~--------~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVD--------EENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhcc--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 88875322 0124688999999999999999999998 999999999999999999999999999986643
Q ss_pred ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 759 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
.. .......++..|+|||++.+..++.++||||||+++|||++|+.||......... ......... ...
T Consensus 150 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~-~~~------- 218 (280)
T cd05608 150 GQ-SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRILN-DSV------- 218 (280)
T ss_pred CC-ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhcc-cCC-------
Confidence 22 1223456889999999999999999999999999999999999999864332111 011111111 000
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
........++.+++.+||+.||++|| +++++++
T Consensus 219 --~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 219 --TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred --CCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 11122334677888899999999999 6677764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=315.43 Aligned_cols=267 Identities=26% Similarity=0.402 Sum_probs=206.9
Q ss_pred cccCceeccCCceEEEEEEEc--------CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCce
Q 002759 596 LDKECLIGGGSIGSVYRASFE--------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (884)
++..+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.+ +||||+++++++......
T Consensus 17 ~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (304)
T cd05101 17 LTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 96 (304)
T ss_pred eeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCce
Confidence 346789999999999999642 24578999987543334567889999999999 899999999999999999
Q ss_pred eEEEEecCCCchhhhcccCCCCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTS----TGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN 742 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~ 742 (884)
++||||+++++|.+++......... ........+++.++..++.||++||+|||+. +++||||||+||+++++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~ 173 (304)
T cd05101 97 YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTEN 173 (304)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCC
Confidence 9999999999999999764321100 0001234688999999999999999999998 99999999999999999
Q ss_pred CCeeEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 002759 743 YEPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCE 820 (884)
Q Consensus 743 ~~vkl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~ 820 (884)
+.+||+|||.++......... .....++..|+|||++.+..++.++||||||+++||+++ |..||......+..
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~---- 249 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF---- 249 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHH----
Confidence 999999999998765332221 222345678999999988889999999999999999998 88888765433221
Q ss_pred HHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 821 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
+.+....... ........+.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 250 ---~~~~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 250 ---KLLKEGHRMD--------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred ---HHHHcCCcCC--------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 1111111111 011233467788899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=309.31 Aligned_cols=254 Identities=25% Similarity=0.439 Sum_probs=201.8
Q ss_pred cccCceeccCCceEEEEEEEc-CC---eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GG---VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
++..+.||+|+||.||+|... ++ ..+++|++...........+..|++++++++|||++++.+++...+..++|||
T Consensus 7 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (268)
T cd05063 7 ITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITE 86 (268)
T ss_pred ceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEE
Confidence 346778999999999999764 22 36899998754433446778999999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 87 ~~~~~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg 152 (268)
T cd05063 87 YMENGALDKYLRDHD-----------GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFG 152 (268)
T ss_pred cCCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCc
Confidence 999999999986432 3588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccc--cccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 752 LAKLLPILDNYGLT--KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 752 ~s~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
++............ ....+..|+|||++.+..++.++||||||+++||+++ |+.||......+. .+. +..
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~------~~~-i~~ 225 (268)
T cd05063 153 LSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEV------MKA-IND 225 (268)
T ss_pred cceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHH-Hhc
Confidence 99876432221111 1223457999999998889999999999999999998 9999976543221 111 111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.... +. ..+...++.+++.+||+.+|++||++.++++.|+++
T Consensus 226 ~~~~----~~----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 226 GFRL----PA----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred CCCC----CC----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 1110 01 112234678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=308.78 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=202.3
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+...+.||+|+||.||+|...++..+++|.+.... ...+.+.+|++++++++|+|++++.+++.. ...+++|||+++
T Consensus 8 ~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~ 84 (260)
T cd05073 8 LKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS--MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAK 84 (260)
T ss_pred eeEEeEecCccceEEEEEEecCCccEEEEecCCCh--hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCC
Confidence 45778899999999999988777889999886432 345778999999999999999999999877 778999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++.+++.++.|++.||+|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 85 ~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~ 151 (260)
T cd05073 85 GSLLDFLKSDE----------GSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV 151 (260)
T ss_pred CcHHHHHHhCC----------ccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceee
Confidence 99999997532 23578889999999999999999988 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.............++..|+|||++....++.++|+||||+++||+++ |+.||...+..+.. ..+.......
T Consensus 152 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~-------~~~~~~~~~~- 223 (260)
T cd05073 152 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-------RALERGYRMP- 223 (260)
T ss_pred ccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhCCCCCC-
Confidence 65322222233445677999999998889999999999999999999 99999865432221 1111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.......++.+++.+||+.+|++||++.++.+.|+.+
T Consensus 224 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 224 -------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -------CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 0112234677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=322.47 Aligned_cols=241 Identities=23% Similarity=0.321 Sum_probs=192.4
Q ss_pred eeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
+||+|+||+||+|... +++.||+|++.... .....+.+..|.+++..+ +||||+++++++...+..++||||++++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 6899999999999765 57899999986432 223455677888888765 7999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~L~~~l~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 82 DLMFQIQRSR------------KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred cHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceec
Confidence 9998886443 578899999999999999999998 9999999999999999999999999998764
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 836 (884)
... ........|+..|+|||++.+..++.++||||+||++|||++|+.||......+.. ..... .... +
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~------~~i~~-~~~~--~- 215 (321)
T cd05591 147 ILN-GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF------ESILH-DDVL--Y- 215 (321)
T ss_pred ccC-CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH------HHHHc-CCCC--C-
Confidence 321 22234456899999999999989999999999999999999999999875543221 11111 1110 0
Q ss_pred ccCCCCcHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 002759 837 RSLRGFAENELIQVMKLGLICTSEVPSRRP-------SMAEVVQ 873 (884)
Q Consensus 837 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-------t~~ell~ 873 (884)
.. ....++.+++.+|++.||++|| +++++++
T Consensus 216 ---p~---~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 216 ---PV---WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---CC---CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 01 1123567788889999999999 7777763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=314.98 Aligned_cols=263 Identities=22% Similarity=0.373 Sum_probs=203.1
Q ss_pred cccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (884)
|+..+.||+|+||.||+|... .+..||+|.+...........+.+|+..++.++||||+++++++.+....++|
T Consensus 8 ~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (288)
T cd05061 8 ITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVV 87 (288)
T ss_pred ceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 346788999999999999643 24579999886544334455688899999999999999999999999999999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
|||+++|+|.++++....... ...+....++..+.+++.|++.||+|||+. +|+||||||+||++++++.++++|
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 88 MELMAHGDLKSYLRSLRPEAE--NNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred EeCCCCCCHHHHHHHhccccc--cCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECc
Confidence 999999999999975431111 111234567888999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 750 YGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 750 fg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
||+++......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......+.. .....
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~ 236 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL------KFVMD 236 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHc
Confidence 99998654322211 122234678999999998889999999999999999999 88899765433221 11111
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
+.... ........+.+++.+||+.+|++|||+.++++.|++.
T Consensus 237 -~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 237 -GGYLD--------QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred -CCCCC--------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 11111 1112234688888999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-35 Score=310.66 Aligned_cols=258 Identities=24% Similarity=0.367 Sum_probs=200.5
Q ss_pred ccCceeccCCceEEEEEEEcC----CeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCc------
Q 002759 597 DKECLIGGGSIGSVYRASFEG----GVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTM------ 665 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------ 665 (884)
...+.||+|+||.||+|.... +..||+|+++.... ......+.+|+..++.++||||+++++++.....
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 81 (273)
T cd05035 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPK 81 (273)
T ss_pred ccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcc
Confidence 356789999999999997642 36799999875322 2335678999999999999999999998865544
Q ss_pred eeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCe
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~v 745 (884)
.++|+||+++++|.+++...... .....+++..+..++.|++.||+|||+. +++||||||+||++++++.+
T Consensus 82 ~~~v~e~~~~~~l~~~l~~~~~~------~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~ 152 (273)
T cd05035 82 PMVILPFMKHGDLHSFLLYSRLG------GLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTV 152 (273)
T ss_pred cEEEEeccCCCCHHHHHHHhhcc------CCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeE
Confidence 79999999999999988543311 1123688999999999999999999998 99999999999999999999
Q ss_pred eEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 002759 746 KLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVR 823 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~ 823 (884)
||+|||.++......... ......+..|+|||++.+..++.++||||||+++|||++ |..||......+.. +.
T Consensus 153 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~---~~-- 227 (273)
T cd05035 153 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY---DY-- 227 (273)
T ss_pred EECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH---HH--
Confidence 999999998765333221 122334678999999988889999999999999999999 89999765433221 11
Q ss_pred HHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 824 ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 824 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
...+.... .+.....++.+++.+||+.||++|||+.|+++.|+++
T Consensus 228 --~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 228 --LRHGNRLK--------QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred --HHcCCCCC--------CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 11111111 1112334678888899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=313.59 Aligned_cols=266 Identities=24% Similarity=0.371 Sum_probs=206.2
Q ss_pred ccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
...+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+..+++++||||+++++++......++||
T Consensus 8 ~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (291)
T cd05094 8 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT-LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVF 86 (291)
T ss_pred EEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc-HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEE
Confidence 35678999999999999642 34568888886432 233467899999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 671 EFVPKGNLYDNLHGVNYPGT----STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
||+++++|.+++........ .........+++..++.++.||+.|++|||+. +|+||||||+||+++.++.++
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~ 163 (291)
T cd05094 87 EYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVK 163 (291)
T ss_pred ecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEE
Confidence 99999999999975432100 00011224589999999999999999999998 999999999999999999999
Q ss_pred EccccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 002759 747 LSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~ 824 (884)
|+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. +
T Consensus 164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~---- 236 (291)
T cd05094 164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVI---E---- 236 (291)
T ss_pred ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H----
Confidence 9999999765432211 1233455778999999998899999999999999999999 99999765443221 1
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
....+.... ........+.+++.+||+.+|++|||+.++++.|+++.+.
T Consensus 237 ~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 237 CITQGRVLE--------RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHhCCCCCC--------CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 112211111 1111234677888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=312.64 Aligned_cols=258 Identities=24% Similarity=0.364 Sum_probs=200.9
Q ss_pred cccCceeccCCceEEEEEEEcC------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (884)
+...+.||+|++|.||+|.+.+ +..|++|.............+.+|+.+++.++|+||+++++++.+....++|
T Consensus 8 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 87 (277)
T cd05036 8 ITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFIL 87 (277)
T ss_pred cEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEE
Confidence 3466789999999999997753 5678999886544334456789999999999999999999999888899999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC---Cee
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY---EPK 746 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~---~vk 746 (884)
|||+++++|.+++........ ....+++.++++++.||+.|++|||+. +++||||||+||+++.++ .+|
T Consensus 88 ~e~~~g~~L~~~i~~~~~~~~-----~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~k 159 (277)
T cd05036 88 LELMAGGDLKSFLRENRPRPE-----RPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAK 159 (277)
T ss_pred EecCCCCCHHHHHHHhCCCCC-----CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceE
Confidence 999999999999976542111 123589999999999999999999998 999999999999998654 599
Q ss_pred EccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 002759 747 LSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~ 824 (884)
++|||+++......... ......+..|+|||++.+..++.++|||||||++|||++ |..||......+.. .
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~---~---- 232 (277)
T cd05036 160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM---E---- 232 (277)
T ss_pred eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---H----
Confidence 99999998764222111 112233568999999998889999999999999999997 99999865543321 1
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.+....... .+......+.+++.+||+.+|++|||+.++++.|+
T Consensus 233 ~~~~~~~~~--------~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 233 FVTGGGRLD--------PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred HHHcCCcCC--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 111111100 01112346778889999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=335.99 Aligned_cols=251 Identities=24% Similarity=0.274 Sum_probs=198.9
Q ss_pred cccCceeccCCceEEEEEEEc-C-CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-G-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|...+.||+|++|.||+|... + +..||+|++... .......+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 69 y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~-~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 69 YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN-DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred EEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 557789999999999999654 3 567888876432 2234456788999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++|+|.++++... .....+++.++..++.||+.||.|||+. +|+||||||+||+++.++.+||+|||++
T Consensus 148 ~gg~L~~~l~~~~--------~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla 216 (478)
T PTZ00267 148 SGGDLNKQIKQRL--------KEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFS 216 (478)
T ss_pred CCCCHHHHHHHHH--------hccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCc
Confidence 9999999886422 0123588899999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccC-cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 754 KLLPILDN-YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 754 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+.+..... .......||..|+|||++.+..++.++|||||||++|||++|+.||......+. ...... +...
T Consensus 217 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~------~~~~~~-~~~~ 289 (478)
T PTZ00267 217 KQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI------MQQVLY-GKYD 289 (478)
T ss_pred eecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHHh-CCCC
Confidence 87653221 123445689999999999998999999999999999999999999976543222 111111 1111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+ .+.....++.+++.+||+.+|++||++++++.
T Consensus 290 ----~----~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 290 ----P----FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred ----C----CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 1 11112236778888999999999999999874
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=326.77 Aligned_cols=250 Identities=19% Similarity=0.262 Sum_probs=195.6
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... ++..||+|++.... .....+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus 45 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05596 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEY 124 (370)
T ss_pred cEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcC
Confidence 346678999999999999764 67899999986422 223345678899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++... .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 125 ~~gg~L~~~l~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~ 188 (370)
T cd05596 125 MPGGDLVNLMSNY-------------DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (370)
T ss_pred CCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccc
Confidence 9999999998642 367888889999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCC----CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSL----RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
++..............|++.|+|||++.+. .++.++||||+||++|||++|+.||......+.. ......
T Consensus 189 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~ 262 (370)
T cd05596 189 CMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDH 262 (370)
T ss_pred eeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcC
Confidence 987643222223445789999999998653 4788999999999999999999999875432211 111111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSR--RPSMAEVVQ 873 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~ell~ 873 (884)
..... ++. . .....++.+++.+|++.+|.+ |||++|+++
T Consensus 263 ~~~~~-~~~-~----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~ 303 (370)
T cd05596 263 KNSLT-FPD-D----IEISKQAKDLICAFLTDREVRLGRNGVDEIKS 303 (370)
T ss_pred CCcCC-CCC-c----CCCCHHHHHHHHHHccChhhccCCCCHHHHhc
Confidence 11111 110 0 012235667888899999988 999999964
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=311.03 Aligned_cols=257 Identities=23% Similarity=0.301 Sum_probs=197.5
Q ss_pred cCceeccCCceEEEEEEEcCC---eEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------Ccee
Q 002759 598 KECLIGGGSIGSVYRASFEGG---VSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQL 667 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 667 (884)
.++.||+|+||.||+|.+.+. ..+|+|.++... .....+.+..|+.+++.++||||+++++++... ...+
T Consensus 3 i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 82 (272)
T cd05075 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPV 82 (272)
T ss_pred cccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcE
Confidence 567899999999999987543 258999886432 223456788999999999999999999987432 2468
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+++|+|.+++...... .....+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||
T Consensus 83 ~v~e~~~~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl 153 (272)
T cd05075 83 VILPFMKHGDLHSFLLYSRLG------DCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCV 153 (272)
T ss_pred EEEEeCCCCcHHHHHHHhccc------CCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEE
Confidence 999999999999887432210 0123588999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 002759 748 SDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
+|||+++......... .....++..|+|||+..+..++.++||||||+++|||++ |+.||......+.. +.
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~-------~~ 226 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIY-------DY 226 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-------HH
Confidence 9999998765322211 122345678999999999899999999999999999999 89999764432211 11
Q ss_pred HHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 826 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
+..+.... ........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 227 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 227 LRQGNRLK--------QPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHcCCCCC--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22221111 0112233577888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=309.45 Aligned_cols=259 Identities=27% Similarity=0.410 Sum_probs=198.0
Q ss_pred eeccCCceEEEEEEEcC-C--eEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 601 LIGGGSIGSVYRASFEG-G--VSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~-~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
.||+|+||.||+|...+ + ..+++|.++..........+.+|++++.++ +||||+++++++......++||||++++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 58999999999997753 3 346888887543334456788999999999 7999999999999988999999999999
Q ss_pred chhhhcccCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 677 NLYDNLHGVNYPGT----STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 677 sL~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+|.+++........ .........+++.++..++.|++.|++|||+. +++||||||+||++++++.+|++|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCC
Confidence 99999975432110 00111123578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
++.... .........+..|+|||++....++.++||||||+++|||++ |..||...+..+.. .. ......
T Consensus 159 ~~~~~~--~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~------~~-~~~~~~ 229 (270)
T cd05047 159 SRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EK-LPQGYR 229 (270)
T ss_pred ccccch--hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHH------HH-HhCCCC
Confidence 864321 111112233567999999988889999999999999999997 99999764432211 11 111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
.+ .......++.+++.+||+.+|.+|||+.++++.|+++-
T Consensus 230 ~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LE--------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC--------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 11 01112236778899999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=310.39 Aligned_cols=256 Identities=25% Similarity=0.367 Sum_probs=203.0
Q ss_pred cccCceeccCCceEEEEEEEcC----CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+...+.||+|+||.||+|...+ ...|++|...........+.+.+|+.++++++||||+++++++.+ ...++|||
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e 86 (270)
T cd05056 8 ITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVME 86 (270)
T ss_pred ceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEE
Confidence 3466789999999999997643 246889988654433456788999999999999999999998865 55789999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++.... ..+++..++.++.|++.|++|||+. +++||||||+||+++.++.++++|||
T Consensus 87 ~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g 152 (270)
T cd05056 87 LAPLGELRSYLQVNK-----------YSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFG 152 (270)
T ss_pred cCCCCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCc
Confidence 999999999996432 2578999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+++.......+......++..|+|||.+....++.++||||||+++||+++ |..||......+... . +....
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~-~~~~~ 225 (270)
T cd05056 153 LSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIG------R-IENGE 225 (270)
T ss_pred eeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH------H-HHcCC
Confidence 998765432222233344568999999988889999999999999999996 999997655432211 1 11111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
... .......++.+++.+||..+|++|||+.++++.|+++.++
T Consensus 226 ~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 226 RLP--------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred cCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 110 0112234677888899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=326.26 Aligned_cols=251 Identities=20% Similarity=0.214 Sum_probs=197.3
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|...+.||+|+||+||+|... +++.||+|+++... .......+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 3 y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (330)
T cd05601 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEY 82 (330)
T ss_pred ceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECC
Confidence 346678999999999999664 68899999997432 223456788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~ 148 (330)
T cd05601 83 QPGGDLLSLLNRYE-----------DQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGS 148 (330)
T ss_pred CCCCCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCC
Confidence 99999999997542 3588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC------CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ------SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
++..............++..|+|||++. ...++.++|||||||++|||++|+.||......+. .....
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~ 222 (330)
T cd05601 149 AARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIM 222 (330)
T ss_pred CeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHH
Confidence 9876543332233456899999999986 45677899999999999999999999986543322 11221
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.........+ ......++..++..|++ +|++|||+++++.
T Consensus 223 ~~~~~~~~~~------~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 223 NFQRFLKFPE------DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred cCCCccCCCC------CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 1111111000 00122346667778997 9999999999874
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=320.33 Aligned_cols=242 Identities=21% Similarity=0.289 Sum_probs=193.3
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||+||+|... ++..||+|+++... .......+..|..+++.+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999765 57789999987432 223456677888888877 799999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||+++.
T Consensus 81 ~~L~~~~~~~~------------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 81 GDLMFHIQRSG------------RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKE 145 (318)
T ss_pred CCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCee
Confidence 99998886543 588999999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
.... ........++..|+|||++.+..++.++||||+||++|||++|+.||......+.. ... ...... +
T Consensus 146 ~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~------~~i-~~~~~~--~ 215 (318)
T cd05570 146 GILG-GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELF------QSI-LEDEVR--Y 215 (318)
T ss_pred cCcC-CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHH------HHH-HcCCCC--C
Confidence 3221 12223456889999999999999999999999999999999999999765432221 111 111110 1
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSM-----AEVVQ 873 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~-----~ell~ 873 (884)
+.....++.+++.+||+.||++|||+ .++++
T Consensus 216 -------~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 216 -------PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred -------CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 11122356788889999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=316.91 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=208.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCc-eeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTM-QLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~ 672 (884)
|...+++|+|+||.++.+..+ ++..+++|++.-. ......+...+|+.++++++|||||.+.+.+.+++. .+|||+|
T Consensus 6 Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y 85 (426)
T KOG0589|consen 6 YEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEY 85 (426)
T ss_pred hhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEee
Confidence 456778999999999999654 5678999998633 233445578999999999999999999999988888 8999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
++||++.+.+.+.. +..++++.+..++.|++.|+.|||+. .|+|||||+.|||++.++.|||+|||+
T Consensus 86 ~eGg~l~~~i~~~k----------~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGl 152 (426)
T KOG0589|consen 86 CEGGDLAQLIKEQK----------GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGL 152 (426)
T ss_pred cCCCCHHHHHHHHh----------hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhh
Confidence 99999999997654 45789999999999999999999988 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
|+.+...+ .......||+.||.||.+.+.+|..|+||||+||++|||++-+++|...+-.... .+..+..
T Consensus 153 aK~l~~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li------~ki~~~~--- 222 (426)
T KOG0589|consen 153 AKILNPED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELI------LKINRGL--- 222 (426)
T ss_pred hhhcCCch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHH------HHHhhcc---
Confidence 99987543 2345688999999999999999999999999999999999999999876543221 1111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
++ ..+.....++..++..|++.+|..||++.+++..
T Consensus 223 --~~----Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 --YS----PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred --CC----CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 11 1233445578888889999999999999999875
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=314.30 Aligned_cols=256 Identities=23% Similarity=0.356 Sum_probs=202.9
Q ss_pred cccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (884)
+...+.||+|+||.||+|... .+..||+|+++........+.+.+|+.+++++ +||||+++++++...+..++
T Consensus 37 ~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l 116 (302)
T cd05055 37 LSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILV 116 (302)
T ss_pred eEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEE
Confidence 457789999999999999642 34579999987544334456789999999999 79999999999999999999
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+.+++|.++++... ...+++.++..++.|++.|++|||+. +|+|+||||+||+++.++.++++
T Consensus 117 v~e~~~~~~L~~~i~~~~----------~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~ 183 (302)
T cd05055 117 ITEYCCYGDLLNFLRRKR----------ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKIC 183 (302)
T ss_pred EEEcCCCCcHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEEC
Confidence 999999999999997533 22479999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||.++........ ......++..|+|||.+.+..++.++||||+||++|||++ |+.||......+. .....
T Consensus 184 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~------~~~~~ 257 (302)
T cd05055 184 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK------FYKLI 257 (302)
T ss_pred CCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH------HHHHH
Confidence 99999865432211 1222345678999999998889999999999999999998 9999976543221 11111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
..+.... .......++.+++.+||+.+|++|||+.|+++.|+++
T Consensus 258 ~~~~~~~--------~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 258 KEGYRMA--------QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred HcCCcCC--------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 1111110 0111223677888999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=314.38 Aligned_cols=265 Identities=27% Similarity=0.393 Sum_probs=201.2
Q ss_pred ccCceeccCCceEEEEEEEc-CCe--EEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGV--SIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+..+.||+|+||.||+|.+. ++. .+++|.++..........+.+|++++.++ +||||+++++++...+..++||||
T Consensus 10 ~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~ 89 (303)
T cd05088 10 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 89 (303)
T ss_pred eeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEe
Confidence 46678999999999999764 343 45777776433333456788999999999 899999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 673 VPKGNLYDNLHGVNYPGT----STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
+++++|.++++....... .........+++.+++.++.|++.|++|||+. +|+||||||+||++++++.+||+
T Consensus 90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~ 166 (303)
T cd05088 90 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIA 166 (303)
T ss_pred CCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeC
Confidence 999999999975432110 00011234688999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
|||+++.... .........+..|+|||++.+..++.++|||||||++|||+| |..||......+.. . ...
T Consensus 167 dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~-~~~ 237 (303)
T cd05088 167 DFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------E-KLP 237 (303)
T ss_pred ccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHH------H-HHh
Confidence 9999864321 111112234567999999988888999999999999999998 99999765433221 1 111
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
...... .......++.+++.+||+.+|++||+++++++.++++..+
T Consensus 238 ~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~ 283 (303)
T cd05088 238 QGYRLE--------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 283 (303)
T ss_pred cCCcCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence 110000 0111223577888999999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=325.21 Aligned_cols=203 Identities=24% Similarity=0.309 Sum_probs=173.1
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|... +++.||+|++.... .......+..|+.++.+++||||+++++++.+....++||||
T Consensus 3 y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~ 82 (363)
T cd05628 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEF 82 (363)
T ss_pred ceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcC
Confidence 346778999999999999664 57899999986432 123346778899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~~~------------~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGl 147 (363)
T cd05628 83 LPGGDMMTLLMKKD------------TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGL 147 (363)
T ss_pred CCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccC
Confidence 99999999997543 588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccC----------------------------------cccccccccccccCccccCCCCCCCccCchhHHHHHH
Q 002759 753 AKLLPILDN----------------------------------YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILL 798 (884)
Q Consensus 753 s~~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~ 798 (884)
++.+..... .......||..|+|||++.+..++.++|||||||++|
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ 227 (363)
T cd05628 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (363)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHH
Confidence 876532110 0012346899999999999989999999999999999
Q ss_pred HHHhCCCCCCCCCCc
Q 002759 799 ELVTGRKPVESPTTN 813 (884)
Q Consensus 799 el~tG~~p~~~~~~~ 813 (884)
||++|+.||......
T Consensus 228 ell~G~~Pf~~~~~~ 242 (363)
T cd05628 228 EMLIGYPPFCSETPQ 242 (363)
T ss_pred HHHhCCCCCCCCCHH
Confidence 999999999875543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=315.74 Aligned_cols=268 Identities=26% Similarity=0.385 Sum_probs=205.7
Q ss_pred cccCceeccCCceEEEEEEEc--------CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCce
Q 002759 596 LDKECLIGGGSIGSVYRASFE--------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (884)
+...+.||+|+||.||+|... +...+|+|.+..........++..|+.+++.+ +||||+++++++...+..
T Consensus 20 ~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 99 (307)
T cd05098 20 LVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPL 99 (307)
T ss_pred eEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 457789999999999999653 22469999987543334456788899999999 799999999999999999
Q ss_pred eEEEEecCCCchhhhcccCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGT----STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN 742 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~ 742 (884)
++||||+++++|.+++........ .........+++.++++++.|++.||+|||+. +++||||||+||+++++
T Consensus 100 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 100 YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTED 176 (307)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCC
Confidence 999999999999999976432110 00001123588999999999999999999998 99999999999999999
Q ss_pred CCeeEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 002759 743 YEPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCE 820 (884)
Q Consensus 743 ~~vkl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~ 820 (884)
+.+||+|||.++......... .....++..|+|||++.+..++.++||||+||++|||++ |+.||......+..
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~---- 252 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---- 252 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH----
Confidence 999999999998664322111 112234568999999998889999999999999999998 88998764432221
Q ss_pred HHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 821 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
.........+ .+.....++.+++.+||+.+|++|||+.++++.|+++...
T Consensus 253 ---~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 253 ---KLLKEGHRMD--------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred ---HHHHcCCCCC--------CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 1111111111 1122334677888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=306.52 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=191.9
Q ss_pred eeccCCceEEEEEEEcC---CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCc
Q 002759 601 LIGGGSIGSVYRASFEG---GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
.||+|+||.||+|...+ +..+|+|.++..........+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999997643 457899988755443445678899999999999999999999998889999999999999
Q ss_pred hhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|.++++..... .....++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++...
T Consensus 82 L~~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 82 LKGYLRSCRKA-------ELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred HHHHHHHhhhc-------ccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999754310 122456778889999999999999998 99999999999999999999999999997644
Q ss_pred CccCcc-cccccccccccCccccCCC-------CCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 758 ILDNYG-LTKFHNAVGYVAPELAQSL-------RLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 758 ~~~~~~-~~~~~~~~~y~aPE~~~~~-------~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
...... .....++..|+|||++.+. .++.++||||||+++|||++ |+.||......+... . ...
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---~---~~~- 224 (269)
T cd05087 152 KEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLT---Y---TVR- 224 (269)
T ss_pred CcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHH---H---Hhh-
Confidence 322211 2234567889999998642 35789999999999999997 999997654332211 1 111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.......++.......+ .+.+++..|| .+|++|||++||++.|+
T Consensus 225 ~~~~~~~~~~~~~~~~~---~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 225 EQQLKLPKPRLKLPLSD---RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred cccCCCCCCccCCCCCh---HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111112222211222 3555667799 58999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=299.27 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=200.3
Q ss_pred cCceeccCCceEEEEEEEcC-CeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 598 KECLIGGGSIGSVYRASFEG-GVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
..+.||+|.-|+||+|...+ +...|+|++.+.. ......+.+.|-++|+.++||.++.+++.+..++..|+|||||+
T Consensus 81 llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCp 160 (459)
T KOG0610|consen 81 LLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCP 160 (459)
T ss_pred HHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCC
Confidence 45679999999999998875 4789999996433 23445678889999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
||+|....+... ...+++..++.+|..|+.||+|||-. |||+|||||+||||-++|+|.++||.++.
T Consensus 161 GGdL~~LrqkQp----------~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~ 227 (459)
T KOG0610|consen 161 GGDLHSLRQKQP----------GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL 227 (459)
T ss_pred CccHHHHHhhCC----------CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence 999998887544 56899999999999999999999999 99999999999999999999999999985
Q ss_pred ccCC-------cc--------------------------C----------------------cccccccccccccCcccc
Q 002759 755 LLPI-------LD--------------------------N----------------------YGLTKFHNAVGYVAPELA 779 (884)
Q Consensus 755 ~~~~-------~~--------------------------~----------------------~~~~~~~~~~~y~aPE~~ 779 (884)
...- .. . ......+||-+|.|||++
T Consensus 228 ~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI 307 (459)
T KOG0610|consen 228 RCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVI 307 (459)
T ss_pred cCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceee
Confidence 4421 00 0 001224577889999999
Q ss_pred CCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccC
Q 002759 780 QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTS 859 (884)
Q Consensus 780 ~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~ 859 (884)
.+..++.++|+|+|||++|||+.|+-||.+....+.. ++.+..+ ..+.+ .+.......+||++.+.
T Consensus 308 ~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl------~NIv~~~-------l~Fp~-~~~vs~~akDLIr~LLv 373 (459)
T KOG0610|consen 308 RGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETL------RNIVGQP-------LKFPE-EPEVSSAAKDLIRKLLV 373 (459)
T ss_pred ecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhH------HHHhcCC-------CcCCC-CCcchhHHHHHHHHHhc
Confidence 9999999999999999999999999999998766543 2222211 01111 11344567788889999
Q ss_pred CCCCCCCC----HHHHH
Q 002759 860 EVPSRRPS----MAEVV 872 (884)
Q Consensus 860 ~~P~~RPt----~~ell 872 (884)
+||++|.. ++||.
T Consensus 374 KdP~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 374 KDPSKRLGSKRGAAEIK 390 (459)
T ss_pred cChhhhhccccchHHhh
Confidence 99999987 66664
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=308.00 Aligned_cols=252 Identities=26% Similarity=0.387 Sum_probs=193.9
Q ss_pred ceeccCCceEEEEEEEc----CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEe-cCCceeEEEEecC
Q 002759 600 CLIGGGSIGSVYRASFE----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW-SSTMQLILSEFVP 674 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~ 674 (884)
+.||+|+||.||+|... +...||+|++.........+.+.+|+.+++.++|||++++++++. .++..++||||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999753 235789999864433344678889999999999999999999775 4556789999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ...++..+..++.|+++|++|||+. +++||||||+||++++++.+||+|||+++
T Consensus 81 ~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~ 146 (262)
T cd05058 81 HGDLRNFIRSET-----------HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLAR 146 (262)
T ss_pred CCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccc
Confidence 999999996432 2457788899999999999999998 99999999999999999999999999997
Q ss_pred ccCCccCc---ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 755 LLPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTG-RKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 755 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG-~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
........ ......++..|+|||.+.+..++.++||||||+++|||++| ..||......+. .... ..+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~------~~~~-~~~~ 219 (262)
T cd05058 147 DIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI------TVYL-LQGR 219 (262)
T ss_pred cccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH------HHHH-hcCC
Confidence 65432111 11233456789999999888899999999999999999995 566654432221 1111 1111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
... .....+..+.+++..||+.+|++||++.|+++.|+++..
T Consensus 220 ~~~--------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLL--------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCC--------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 110 011122367788889999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=319.18 Aligned_cols=241 Identities=23% Similarity=0.317 Sum_probs=190.4
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||.||+|... ++..||+|+++... ..........|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36899999999999775 57889999997532 123455667788777654 899999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 g~L~~~i~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 81 GDLMFHIQDKG------------RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKE 145 (316)
T ss_pred CcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCee
Confidence 99999886433 578899999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
... .........|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+.. + .+.....
T Consensus 146 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~---~----~~~~~~~---- 213 (316)
T cd05620 146 NVF-GDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELF---E----SIRVDTP---- 213 (316)
T ss_pred ccc-CCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH---H----HHHhCCC----
Confidence 321 122234567899999999999989999999999999999999999999865433221 1 1111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA-EVV 872 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~-ell 872 (884)
..... ...++.+++.+||+.||++||++. ++.
T Consensus 214 --~~~~~---~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 214 --HYPRW---ITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred --CCCCC---CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 11111 123566788889999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=315.09 Aligned_cols=266 Identities=26% Similarity=0.394 Sum_probs=205.4
Q ss_pred ccCceeccCCceEEEEEEEc--------CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcee
Q 002759 597 DKECLIGGGSIGSVYRASFE--------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQL 667 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 667 (884)
...+.||+|+||.||+|... ....+|+|+++..........+..|+.+++++ +||||+++++++......+
T Consensus 15 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~ 94 (314)
T cd05099 15 VLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLY 94 (314)
T ss_pred eeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceE
Confidence 46789999999999999642 24568999987544334466788999999999 6999999999999888999
Q ss_pred EEEEecCCCchhhhcccCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGT----STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY 743 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~ 743 (884)
+||||+++|+|.+++........ .........+++.++.+++.|++.||.|||+. +++||||||+||+++.++
T Consensus 95 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~ 171 (314)
T cd05099 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDN 171 (314)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCC
Confidence 99999999999999975432110 00111234689999999999999999999998 999999999999999999
Q ss_pred CeeEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 002759 744 EPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEY 821 (884)
Q Consensus 744 ~vkl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~ 821 (884)
.+||+|||.++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||......+...
T Consensus 172 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~---- 247 (314)
T cd05099 172 VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK---- 247 (314)
T ss_pred cEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH----
Confidence 99999999998764322211 112234567999999998889999999999999999999 899997654333221
Q ss_pred HHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 822 VRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 822 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
......... .......++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 248 ---~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 248 ---LLREGHRMD--------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred ---HHHcCCCCC--------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 111111111 111223367788899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=309.86 Aligned_cols=254 Identities=23% Similarity=0.382 Sum_probs=201.1
Q ss_pred cccCceeccCCceEEEEEEEcC-C---eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG-G---VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+...+.||+|+||.||+|.... + ..||+|++..........++..|+.++++++||||+++.+++.++...++|||
T Consensus 6 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 85 (269)
T cd05065 6 VKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITE 85 (269)
T ss_pred eEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEe
Confidence 3467789999999999997643 2 36999998754444456789999999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++.... ..+++.+++.++.|++.|++|||+. +++||||||+||+++.++.+|++|||
T Consensus 86 ~~~~~~L~~~l~~~~-----------~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg 151 (269)
T cd05065 86 FMENGALDSFLRQND-----------GQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFG 151 (269)
T ss_pred cCCCCcHHHHHhhCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCc
Confidence 999999999986432 3578999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCc-cccccc---ccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 002759 752 LAKLLPILDNY-GLTKFH---NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 752 ~s~~~~~~~~~-~~~~~~---~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
.++........ ...... .+..|+|||.+.+..++.++||||+|+++||+++ |..||......+.. ..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~---~~i---- 224 (269)
T cd05065 152 LSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVI---NAI---- 224 (269)
T ss_pred cccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHH---HHH----
Confidence 98766432211 111111 2457999999998899999999999999999887 99999765433221 111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
...... + ...+.+..+.+++..||+.+|++||++.+++..|+++
T Consensus 225 ~~~~~~----~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 225 EQDYRL----P----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HcCCcC----C----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111000 0 0112234577888899999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=318.86 Aligned_cols=245 Identities=20% Similarity=0.260 Sum_probs=191.6
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||+||+|... +++.||+|+++... .......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999764 56889999997532 223356678899998888 699999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~L~~~~~~~~------------~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 81 GDLMFHMQRQR------------KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKE 145 (327)
T ss_pred CcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecccccee
Confidence 99998886433 589999999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
.... ........|+..|+|||++.+..++.++||||+||++|||++|+.||.............+........... +
T Consensus 146 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~ 222 (327)
T cd05617 146 GLGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR--I 222 (327)
T ss_pred ccCC-CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC--C
Confidence 3221 122344678999999999999999999999999999999999999997543222222222222222221111 0
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA 869 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 869 (884)
+.....++.+++.+|++.||++|+++.
T Consensus 223 -------p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 -------PRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred -------CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 111123566788889999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=313.41 Aligned_cols=269 Identities=24% Similarity=0.322 Sum_probs=204.5
Q ss_pred cccCceeccCCceEEEEEEEcC-----------------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeee
Q 002759 596 LDKECLIGGGSIGSVYRASFEG-----------------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (884)
++..+.||+|+||.||+|...+ +..||+|++.........+.+.+|++++++++||||+++++
T Consensus 7 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~ 86 (296)
T cd05051 7 LNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLG 86 (296)
T ss_pred CcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence 3467789999999999996642 24589999875544445678899999999999999999999
Q ss_pred EEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceE
Q 002759 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNIL 738 (884)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil 738 (884)
++..+...++||||+++++|.+++.......... ......+++..++.++.|++.||+|||+. +|+||||||+||+
T Consensus 87 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nil 162 (296)
T cd05051 87 VCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-ACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCL 162 (296)
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhcee
Confidence 9998899999999999999999986543111100 11234689999999999999999999998 9999999999999
Q ss_pred eCCCCCeeEccccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh--CCCCCCCCCCcch
Q 002759 739 LDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT--GRKPVESPTTNEV 815 (884)
Q Consensus 739 ~~~~~~vkl~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t--G~~p~~~~~~~~~ 815 (884)
++.++.++++|||.++.....+.. ......++..|+|||++.+..++.++||||||+++|||++ |..||......+.
T Consensus 163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~ 242 (296)
T cd05051 163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV 242 (296)
T ss_pred ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence 999999999999999865432221 1233455778999999988889999999999999999998 7788865443322
Q ss_pred hhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 816 VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
. ................ ........++.+++.+||+.+|++|||+.|+++.|+
T Consensus 243 ~---~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~ 295 (296)
T cd05051 243 I---ENAGHFFRDDGRQIYL-----PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ 295 (296)
T ss_pred H---HHHHhccccccccccC-----CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence 1 1111111111111100 011122347888999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.61 Aligned_cols=250 Identities=22% Similarity=0.268 Sum_probs=196.3
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+..+.||+|+||.||+|... +++.||+|.+..... ......+..|+.++++++|++++++.+.+.+.+..++||||+
T Consensus 3 ~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05630 3 RQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLM 82 (285)
T ss_pred eeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEec
Confidence 45678999999999999664 678999999864322 122356778999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++.... ...+++.++..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++
T Consensus 83 ~g~~L~~~l~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~ 149 (285)
T cd05630 83 NGGDLKFHIYHMG----------EAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA 149 (285)
T ss_pred CCCcHHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccce
Confidence 9999999886433 23588999999999999999999988 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
...... .......++..|+|||++.+..++.++||||+|+++|||++|+.||............ ........ .
T Consensus 150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~~~--~ 222 (285)
T cd05630 150 VHVPEG--QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKEVQ--E 222 (285)
T ss_pred eecCCC--ccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhhhh--h
Confidence 765422 1223456899999999999989999999999999999999999999864432111111 11111000 0
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~ell~ 873 (884)
. .......++.+++.+||+.||++||| ++|+++
T Consensus 223 ~-------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 E-------YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h-------cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 01112235677888899999999999 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=320.21 Aligned_cols=240 Identities=21% Similarity=0.290 Sum_probs=190.3
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCC-CcceeeeEEecCCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHF-NLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~ 672 (884)
+..+.||+|+||.||+|... +++.||+|++.... .....+.+..|++++..++|+ +|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (324)
T cd05587 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEY 82 (324)
T ss_pred eEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcC
Confidence 45678999999999999765 56789999986432 223456788899999998765 588888999888999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~g~L~~~~~~~~------------~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~ 147 (324)
T cd05587 83 VNGGDLMYHIQQVG------------KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGM 147 (324)
T ss_pred CCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCc
Confidence 99999999886443 578899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++.... .........|+..|+|||++.+..++.++||||+||++|||++|+.||......+.. ... ......
T Consensus 148 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~------~~i-~~~~~~ 219 (324)
T cd05587 148 CKENIF-GGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF------QSI-MEHNVS 219 (324)
T ss_pred ceecCC-CCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHH-HcCCCC
Confidence 875321 112233456899999999999989999999999999999999999999865433221 111 111110
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM 868 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 868 (884)
+ +.....++.+++.+||+.+|.+|++.
T Consensus 220 --~-------~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 220 --Y-------PKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred --C-------CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 11122356778888999999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=298.35 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=209.7
Q ss_pred hhcccccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 592 TKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 592 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
.++.|++..++|+|+||.||+|.+ ..|..+|||++... .+..++..|+.++++++.|+||+++|.|......|+||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~---sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD---TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc---chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 445566778899999999999954 57899999999754 46788999999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
|||..|++.+.++.++ +++++.++..+++..+.||+|||.. .-||||||+.|||++.+|++|++||
T Consensus 108 EYCGAGSiSDI~R~R~-----------K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADF 173 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARR-----------KPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADF 173 (502)
T ss_pred hhcCCCcHHHHHHHhc-----------CCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhc
Confidence 9999999999998654 6899999999999999999999998 8899999999999999999999999
Q ss_pred cCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 751 g~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
|.|-.+.+. -.......||+.|||||++..-.|..++||||+|++..||..|++||.+..+.....+ ++..
T Consensus 174 GVAGQLTDT-MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-------IPT~- 244 (502)
T KOG0574|consen 174 GVAGQLTDT-MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-------IPTK- 244 (502)
T ss_pred cccchhhhh-HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-------ccCC-
Confidence 999877532 1234567899999999999999999999999999999999999999998665433211 1111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+ .|.++ -++.-..++-++++.|+-+.|++|-|+.++++
T Consensus 245 P----PPTF~-KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~ 282 (502)
T KOG0574|consen 245 P----PPTFK-KPEEWSSEFNDFIRSCLIKKPEERKTALRLCE 282 (502)
T ss_pred C----CCCCC-ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence 1 11111 13334457788889999999999999988875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=324.16 Aligned_cols=251 Identities=19% Similarity=0.261 Sum_probs=193.1
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... +++.+|+|++.... .......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 45 y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (370)
T cd05621 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEY 124 (370)
T ss_pred CeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcC
Confidence 456778999999999999775 57889999986422 223455678999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|||+
T Consensus 125 ~~gg~L~~~l~~~-------------~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~ 188 (370)
T cd05621 125 MPGGDLVNLMSNY-------------DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGT 188 (370)
T ss_pred CCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccc
Confidence 9999999998632 367888999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCC----CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLR----LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
++..............||..|+|||++.+.. ++.++||||+||++|||++|+.||......+. .......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~ 262 (370)
T cd05621 189 CMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDH 262 (370)
T ss_pred ceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhC
Confidence 9876433222234567899999999987543 67899999999999999999999986543222 1122111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSR--RPSMAEVVQV 874 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~ell~~ 874 (884)
..... +... ......+.+++..|++.+|.+ |||++|+++.
T Consensus 263 ~~~~~-~p~~-----~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 263 KNSLN-FPED-----VEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CcccC-CCCc-----ccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 11111 0000 011234556667788755544 8899998763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=306.12 Aligned_cols=248 Identities=25% Similarity=0.387 Sum_probs=199.5
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
+..+.||+|+||.||+|.+.++..+|+|.+.... ....++.+|++++++++|||++++++++......++||||++++
T Consensus 7 ~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 84 (256)
T cd05112 7 TLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA--MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHG 84 (256)
T ss_pred EEEeeecCcccceEEEEEEeCCCeEEEEECCCCC--CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCC
Confidence 3567899999999999988777889999986432 34567899999999999999999999999989999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++..
T Consensus 85 ~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~ 150 (256)
T cd05112 85 CLSDYLRAQR-----------GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFV 150 (256)
T ss_pred cHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeec
Confidence 9999986432 2578899999999999999999998 9999999999999999999999999999865
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
............++.+|+|||.+.+..++.++||||+|+++|||++ |+.||......+.. .. ..... ...
T Consensus 151 ~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~------~~-~~~~~--~~~ 221 (256)
T cd05112 151 LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV------ET-INAGF--RLY 221 (256)
T ss_pred ccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHH------HH-HhCCC--CCC
Confidence 4322211223335678999999998889999999999999999998 99999765433221 11 11110 111
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
.+.. ....+.+++.+||+.+|++|||+.|+++.|
T Consensus 222 ~~~~------~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 222 KPRL------ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred CCCC------CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 1111 124677888999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=307.60 Aligned_cols=249 Identities=22% Similarity=0.292 Sum_probs=194.1
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..++||+|+||.||+|.. .++..||+|.+...........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 83 (279)
T cd06619 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDG 83 (279)
T ss_pred hheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCC
Confidence 4567899999999999965 567889999986543333456788999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|..+. .+++..+..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||++..
T Consensus 84 ~~l~~~~----------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~ 144 (279)
T cd06619 84 GSLDVYR----------------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQ 144 (279)
T ss_pred CChHHhh----------------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCccee
Confidence 9886542 357788899999999999999998 999999999999999999999999999986
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
.... ......++..|+|||++.+..++.++||||||+++|||++|+.||......+...................
T Consensus 145 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-- 219 (279)
T cd06619 145 LVNS---IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPV-- 219 (279)
T ss_pred cccc---cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCC--
Confidence 5421 22345788899999999988899999999999999999999999976432211111111111111111110
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
.. ......++.+++.+||+.+|++||+++|+++.
T Consensus 220 ---~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 220 ---LP--VGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred ---CC--CCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 01122356788889999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=306.29 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=200.4
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||+|+||.||++... ++..+|+|.++........+.+.+|+.+++.++|||++++.+++..++..++||||+++
T Consensus 3 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (255)
T cd08219 3 NVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDG 82 (255)
T ss_pred eEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCC
Confidence 45678999999999999764 67889999986444345567888999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...++...+..++.|++.||.|||+. +|+|+||||+||++++++.++++|||.++.
T Consensus 83 ~~l~~~~~~~~----------~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~ 149 (255)
T cd08219 83 GDLMQKIKLQR----------GKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARL 149 (255)
T ss_pred CcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCccee
Confidence 99999886432 23578899999999999999999998 999999999999999999999999999976
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
..... .......++..|+|||++.+..++.++|+||||+++|+|++|+.||...+.... .. .+.......
T Consensus 150 ~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~------~~-~~~~~~~~~-- 219 (255)
T cd08219 150 LTSPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL------IL-KVCQGSYKP-- 219 (255)
T ss_pred ecccc-cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH------HH-HHhcCCCCC--
Confidence 64322 122345678889999999988899999999999999999999999986443221 11 111111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
.......++.+++.+||+.||++|||+.+++..
T Consensus 220 ------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 220 ------LPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ------CCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 111122357788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=319.40 Aligned_cols=247 Identities=27% Similarity=0.385 Sum_probs=199.3
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
-++|+|.||+||-|+.. +...+|||-+.... .+....+..||...++++|.|||+++|.+.+++..-+.||.++||+|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekd-sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKD-SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeeccccc-chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 37999999999999665 56678999886543 35667788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC-CCCCeeEccccCccccC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~-~~~~vkl~Dfg~s~~~~ 757 (884)
.+.++... +.-+-.+.+.-.+..||++||.|||++ .|||||||-+||||+ ..|.+||+|||-++.+.
T Consensus 660 SsLLrskW---------GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 660 SSLLRSKW---------GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred HHHHHhcc---------CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhc
Confidence 99998665 111226778888999999999999999 999999999999996 68999999999998876
Q ss_pred CccCcccccccccccccCccccCCC--CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 758 ILDNYGLTKFHNAVGYVAPELAQSL--RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 758 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
... .......||..|||||++..+ .|+.++|||||||++.||.||++||......... ++.-+-+.
T Consensus 728 gin-P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGmyK--- 795 (1226)
T KOG4279|consen 728 GIN-PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGMYK--- 795 (1226)
T ss_pred cCC-ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhccee---
Confidence 432 234567899999999999865 4778999999999999999999999764322111 11111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.-...+++...+...+|.+|+.+||.+||+++++++
T Consensus 796 --vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 796 --VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred --cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 111245666677888899999999999999999985
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=335.04 Aligned_cols=253 Identities=24% Similarity=0.337 Sum_probs=198.5
Q ss_pred ccccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC--------
Q 002759 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST-------- 664 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------- 664 (884)
-|...+.||+|+||+||+|.. .+++.||||++.... .......+.+|+..+..++|+|++++.+.+...+
T Consensus 33 rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~ 112 (496)
T PTZ00283 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVL 112 (496)
T ss_pred CEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccce
Confidence 355778999999999999965 568899999986432 2234567889999999999999999988764332
Q ss_pred ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCC
Q 002759 665 MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE 744 (884)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~ 744 (884)
..++||||+++|+|.+++.... .....+++..+..++.|++.||.|||+. +|+||||||+||+++.++.
T Consensus 113 ~i~lV~Ey~~~gsL~~~l~~~~--------~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 113 MIALVLDYANAGDLRQEIKSRA--------KTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL 181 (496)
T ss_pred EEEEEEeCCCCCcHHHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence 3579999999999999986432 1134688999999999999999999998 9999999999999999999
Q ss_pred eeEccccCccccCCcc-CcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 002759 745 PKLSDYGLAKLLPILD-NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR 823 (884)
Q Consensus 745 vkl~Dfg~s~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~ 823 (884)
+||+|||+++.+.... ........||..|+|||++.+..++.++|||||||++|||++|+.||......+. ..
T Consensus 182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~------~~ 255 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEV------MH 255 (496)
T ss_pred EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HH
Confidence 9999999998764321 1122345789999999999998999999999999999999999999986543222 11
Q ss_pred HHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 824 ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 824 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... +... + .+.....++.+++.+||+.+|.+||++.++++
T Consensus 256 ~~~~-~~~~----~----~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 256 KTLA-GRYD----P----LPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred HHhc-CCCC----C----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 1111 1111 1 11122346778888999999999999999875
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=314.95 Aligned_cols=250 Identities=25% Similarity=0.330 Sum_probs=207.1
Q ss_pred cccccCceeccCCceEEEEEEEcC-CeEEEEEEccccCc--cCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEE
Q 002759 594 ALLDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGR--IRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 669 (884)
..|+..+.||+|.||.||++..+. |+.+|+|++.+... ..+.+.+.+|+.+|+++. ||||+.+.+++.+....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 345566889999999999997764 89999999965432 234578999999999998 99999999999999999999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC----CCCe
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE----NYEP 745 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~----~~~v 745 (884)
||++.||.|++.+... .+++.++..++.||++++.|||+. +|+|||+||+|+|+.. ++.+
T Consensus 115 mEL~~GGeLfd~i~~~-------------~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~i 178 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-------------HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRI 178 (382)
T ss_pred EEecCCchHHHHHHHc-------------cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcE
Confidence 9999999999999642 288999999999999999999998 9999999999999964 3579
Q ss_pred eEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 002759 746 KLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
|++|||++..... .......+||+.|+|||++.+..|+..+||||+||++|.|++|.+||......+... .
T Consensus 179 k~~DFGla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~ 249 (382)
T KOG0032|consen 179 KLIDFGLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------A 249 (382)
T ss_pred EEeeCCCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------H
Confidence 9999999998864 556778899999999999999999999999999999999999999999876554432 2
Q ss_pred HHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 826 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+..+.+. ++... -+........++..|+..||.+|+|+.++++
T Consensus 250 i~~~~~~--f~~~~---w~~is~~akd~i~~ll~~dp~~R~ta~~~L~ 292 (382)
T KOG0032|consen 250 ILRGDFD--FTSEP---WDDISESAKDFIRKLLEFDPRKRLTAAQALQ 292 (382)
T ss_pred HHcCCCC--CCCCC---ccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence 2222221 11111 1122334556677899999999999999987
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=312.45 Aligned_cols=264 Identities=25% Similarity=0.396 Sum_probs=204.2
Q ss_pred cccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (884)
++..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++|||++++++++.++...++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (288)
T cd05050 7 IEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLL 86 (288)
T ss_pred ceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEE
Confidence 456778999999999999753 46789999987544334457789999999999999999999999998999999
Q ss_pred EEecCCCchhhhcccCCCCCCCC----------CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEe
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTST----------GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILL 739 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~----------~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~ 739 (884)
|||+++++|.+++.......... .......+++.+++.++.|++.||+|||+. +++||||||+||++
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~ 163 (288)
T cd05050 87 FEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLV 163 (288)
T ss_pred EecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEe
Confidence 99999999999997433111000 011123578899999999999999999998 99999999999999
Q ss_pred CCCCCeeEccccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhh
Q 002759 740 DENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVV 817 (884)
Q Consensus 740 ~~~~~vkl~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~ 817 (884)
+.++.++|+|||.++........ .......+..|+|||.+.+..++.++|||||||++|||++ |..||......+..
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~- 242 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI- 242 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-
Confidence 99999999999998765432211 1222334667999999998899999999999999999998 88898765433221
Q ss_pred HHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 818 LCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
. .+....... .......++.+++.+||+.+|++|||+.|+++.|++
T Consensus 243 -----~-~~~~~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 243 -----Y-YVRDGNVLS--------CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred -----H-HHhcCCCCC--------CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1 122222111 111223467888899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=310.28 Aligned_cols=261 Identities=25% Similarity=0.371 Sum_probs=203.8
Q ss_pred ccCceeccCCceEEEEEEEcC------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
...+.||+|+||.||+|...+ +..||+|.+...........+.+|+.+++.++||||+++++++......++||
T Consensus 9 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~ 88 (277)
T cd05032 9 TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM 88 (277)
T ss_pred eEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEE
Confidence 466789999999999997642 36899999875443344567889999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
||+++++|.+++......... ......+++..++.++.|++.|+.|||+. +|+||||||+||+++.++.+||+||
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~df 163 (277)
T cd05032 89 ELMAKGDLKSYLRSRRPEAEN--NPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDF 163 (277)
T ss_pred ecCCCCCHHHHHHhcccchhh--ccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCc
Confidence 999999999998654311100 01123578899999999999999999988 9999999999999999999999999
Q ss_pred cCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 751 GLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 751 g~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|+++.....+.. ......++..|+|||.+.+..++.++||||||+++||+++ |..||......+.. . ....
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~---~----~~~~ 236 (277)
T cd05032 164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVL---K----FVID 236 (277)
T ss_pred ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHH---H----HHhc
Confidence 999866433221 1233456788999999988889999999999999999998 99999765433221 1 1111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
...... +.....++.+++.+||+.+|++|||+.++++.|++
T Consensus 237 ~~~~~~--------~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GGHLDL--------PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCCCC--------CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 111111 11123467788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=326.19 Aligned_cols=250 Identities=22% Similarity=0.273 Sum_probs=194.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|... +++.||||++.... .......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (364)
T cd05599 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEY 82 (364)
T ss_pred ceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECC
Confidence 446778999999999999764 67899999996432 123346678899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~g~L~~~l~~~~------------~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 147 (364)
T cd05599 83 LPGGDMMTLLMKKD------------TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGL 147 (364)
T ss_pred CCCcHHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeeccc
Confidence 99999999987533 588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCc-------------------------------------ccccccccccccCccccCCCCCCCccCchhHHH
Q 002759 753 AKLLPILDNY-------------------------------------GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGV 795 (884)
Q Consensus 753 s~~~~~~~~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv 795 (884)
++.+...... ......||+.|+|||++.+..++.++||||+||
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 227 (364)
T cd05599 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGV 227 (364)
T ss_pred ceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchh
Confidence 8765321100 001235899999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 002759 796 ILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS---MAEVV 872 (884)
Q Consensus 796 ~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt---~~ell 872 (884)
++|||++|..||......+.. ........... +... ... . .++.+++.+|+. +|.+|++ ++|++
T Consensus 228 il~el~~G~~Pf~~~~~~~~~------~~i~~~~~~~~-~~~~-~~~-s---~~~~~li~~ll~-~p~~R~~~~~~~~ll 294 (364)
T cd05599 228 IMYEMLVGYPPFCSDNPQETY------RKIINWKETLQ-FPDE-VPL-S---PEAKDLIKRLCC-EAERRLGNNGVNEIK 294 (364)
T ss_pred HHHHhhcCCCCCCCCCHHHHH------HHHHcCCCccC-CCCC-CCC-C---HHHHHHHHHHcc-CHhhcCCCCCHHHHh
Confidence 999999999999875533221 11111110000 0000 011 1 245566677886 8999997 88876
Q ss_pred H
Q 002759 873 Q 873 (884)
Q Consensus 873 ~ 873 (884)
+
T Consensus 295 ~ 295 (364)
T cd05599 295 S 295 (364)
T ss_pred c
Confidence 5
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=320.76 Aligned_cols=238 Identities=26% Similarity=0.331 Sum_probs=188.0
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHH-HHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIG-RLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||+||+|... +++.||+|++.... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36899999999999764 68899999986432 1223344555554 45778999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 g~L~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~ 145 (323)
T cd05575 81 GELFFHLQRER------------SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (323)
T ss_pred CCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcc
Confidence 99999886433 578899999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
.... ........|+..|+|||++.+..++.++|||||||++|||++|+.||...+..+.. ...... ...
T Consensus 146 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~-~~~--- 214 (323)
T cd05575 146 GIEH-SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY------DNILNK-PLR--- 214 (323)
T ss_pred cccC-CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH------HHHHcC-CCC---
Confidence 4321 22234456899999999999989999999999999999999999999875433221 111111 110
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA 869 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 869 (884)
.. ......+.+++.+|++.||.+||++.
T Consensus 215 ---~~---~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 215 ---LK---PNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred ---CC---CCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 11 11233567788899999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=306.30 Aligned_cols=259 Identities=20% Similarity=0.332 Sum_probs=204.1
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
...+.||+|++|.||+|.. .++..++||.+.... ......++.+|+.+++.++||||+++++++..++..+++|||+
T Consensus 5 ~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 84 (267)
T cd08229 5 RIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELA 84 (267)
T ss_pred hhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEec
Confidence 3566899999999999975 578899999886432 1223467889999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++.... .....+++..++.++.||+.||+|||+. +++|+||||+||+++.++.++++|||.+
T Consensus 85 ~~~~L~~~~~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~ 153 (267)
T cd08229 85 DAGDLSRMIKHFK--------KQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLG 153 (267)
T ss_pred CCCCHHHHHHHhh--------ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhh
Confidence 9999999886432 0123688999999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
....... .......++..|+|||.+.+..++.++||||||+++|||++|..||...... .. .... .+.......
T Consensus 154 ~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~---~~~~-~~~~~~~~~ 227 (267)
T cd08229 154 RFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LY---SLCK-KIEQCDYPP 227 (267)
T ss_pred hccccCC-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HH---HHhh-hhhcCCCCC
Confidence 8664322 1223446788999999998888999999999999999999999999754321 11 1111 111111110
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
.. .......+.+++.+||+.+|++|||+.+|++.++++.
T Consensus 228 -----~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 228 -----LP--SDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred -----CC--cccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00 1123346778888999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=303.77 Aligned_cols=246 Identities=28% Similarity=0.400 Sum_probs=197.1
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEe-cCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW-SSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~~ 675 (884)
+..+.||+|+||.||+|... +..+++|.++.. ...+.+.+|+.++++++|+|++++++++. .+...++||||+++
T Consensus 9 ~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~ 84 (256)
T cd05082 9 KLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAK 84 (256)
T ss_pred eeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC---chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCC
Confidence 46678999999999999776 667899988643 34567899999999999999999999764 45678999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++..++.++.|++.||+|||++ +++||||||+||++++++.+|++|||+++.
T Consensus 85 ~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~ 151 (256)
T cd05082 85 GSLVDYLRSRG----------RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE 151 (256)
T ss_pred CcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCcccee
Confidence 99999987543 23578999999999999999999998 999999999999999999999999999876
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.... ......+..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..+.......
T Consensus 152 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~~~- 219 (256)
T cd05082 152 ASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PRVEKGYKMD- 219 (256)
T ss_pred cccc----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHhcCCCCC-
Confidence 4321 123344668999999998889999999999999999998 99999764432211 1111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 220 -------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 220 -------APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -------CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 1112234677888899999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=320.73 Aligned_cols=241 Identities=25% Similarity=0.296 Sum_probs=188.4
Q ss_pred eeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHH-HHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIG-RLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
.||+|+||+||+|... +++.||+|++.... .......+..|.. +++.++||||+++++++...+..++||||++++
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6899999999999765 56789999986432 1122334444544 467789999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... .+....+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++..
T Consensus 82 ~L~~~~~~~~------------~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 82 ELFYHLQRER------------CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred cHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 9999986533 577888889999999999999998 9999999999999999999999999999754
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 836 (884)
... ........|+..|+|||++.+..++.++||||+||++|||++|+.||......+.. ....... .. +.
T Consensus 147 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~------~~i~~~~-~~--~~ 216 (325)
T cd05602 147 IEH-NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMY------DNILNKP-LQ--LK 216 (325)
T ss_pred ccC-CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHH------HHHHhCC-cC--CC
Confidence 321 12234457899999999999989999999999999999999999999865543221 1111111 10 11
Q ss_pred ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 837 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+.....+.+++.+|++.+|.+||++.+.+.
T Consensus 217 -------~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 217 -------PNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred -------CCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 112235677888899999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=305.41 Aligned_cols=249 Identities=25% Similarity=0.409 Sum_probs=198.4
Q ss_pred ceeccCCceEEEEEEEcC--C--eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFEG--G--VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|++|.||+|.+.+ + ..||+|.+.........+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999997643 2 36899998764433456788999999999999999999999887 889999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++..++.++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 80 ~~L~~~l~~~~----------~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~ 146 (257)
T cd05040 80 GSLLDRLRKDA----------LGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRA 146 (257)
T ss_pred CcHHHHHHhcc----------cccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccc
Confidence 99999997543 13589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCc--ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 756 LPILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 756 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ..........
T Consensus 147 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~------~~~~~~~~~~ 220 (257)
T cd05040 147 LPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQIL------KKIDKEGERL 220 (257)
T ss_pred ccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHhcCCcC
Confidence 7542221 1123456778999999998899999999999999999999 99999765433221 1111111100
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
. ........+.+++.+||+.+|++|||+.++++.|.
T Consensus 221 ~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 E--------RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred C--------CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 11122346778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=318.28 Aligned_cols=240 Identities=22% Similarity=0.309 Sum_probs=190.7
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+..+.||+|+||+||+|... ++..||+|++.... .......+..|..++... +|++|+++++++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~ 82 (323)
T cd05616 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEY 82 (323)
T ss_pred eEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcC
Confidence 45678999999999999765 56789999986432 123345567788887776 589999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+
T Consensus 83 ~~~g~L~~~~~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~ 147 (323)
T cd05616 83 VNGGDLMYQIQQVG------------RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred CCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCC
Confidence 99999999886433 578899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++.... .........|+..|+|||++.+..++.++|||||||++|||++|+.||......+.. ..... ....
T Consensus 148 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~------~~i~~-~~~~ 219 (323)
T cd05616 148 CKENMW-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF------QSIME-HNVA 219 (323)
T ss_pred ceecCC-CCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH------HHHHh-CCCC
Confidence 975432 122234457899999999999999999999999999999999999999875543221 11111 1110
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM 868 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~ 868 (884)
++.....++..++.+|++.+|++|+++
T Consensus 220 ---------~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 220 ---------YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred ---------CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 111122356778889999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=313.68 Aligned_cols=264 Identities=19% Similarity=0.265 Sum_probs=198.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|+||.||+|... ++..||+|.++..........+.+|+.++++++||||+++++++..++..++||||++
T Consensus 8 y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 87 (309)
T cd07872 8 YIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD 87 (309)
T ss_pred eEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC
Confidence 456778999999999999764 5778999998754444445677889999999999999999999999999999999997
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+ +|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 88 ~-~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~ 152 (309)
T cd07872 88 K-DLKQYMDDCG-----------NIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (309)
T ss_pred C-CHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccce
Confidence 5 8888875432 2478899999999999999999998 99999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc-
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS- 832 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~- 832 (884)
...... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+..+..... ......+...
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~ 228 (309)
T cd07872 153 AKSVPT-KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI---FRLLGTPTEET 228 (309)
T ss_pred ecCCCc-cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCCHHH
Confidence 643211 12233456889999998865 46788999999999999999999999875543322111 1111000000
Q ss_pred --------cc--cc-ccC-----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHh
Q 002759 833 --------AC--FD-RSL-----RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ--VLESI 878 (884)
Q Consensus 833 --------~~--~d-~~~-----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~--~L~~~ 878 (884)
.. .+ +.. .........++.+++.+|++.||.+|||++|+++ .++.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~ 292 (309)
T cd07872 229 WPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292 (309)
T ss_pred HhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence 00 00 000 0000112235678889999999999999999986 44443
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=304.52 Aligned_cols=248 Identities=29% Similarity=0.439 Sum_probs=202.1
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++..+.||+|+||.||+|... ++.||+|.+..... ..+++.+|+.+++.++|+|++++++++.+....++||||+++
T Consensus 8 ~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 8 LKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST--AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred ccceeeeecCCCceEEEEEec-CcEEEEEEeccchh--HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 346778999999999999876 67899999975432 567889999999999999999999999988999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||.++.
T Consensus 85 ~~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~ 151 (256)
T cd05039 85 GSLVDYLRSRG----------RAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKE 151 (256)
T ss_pred CcHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccc
Confidence 99999987543 23589999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.... ......+..|+|||.+....++.++||||||+++||+++ |..||......+.. ..........
T Consensus 152 ~~~~----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~-------~~~~~~~~~~- 219 (256)
T cd05039 152 ASQG----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-------PHVEKGYRME- 219 (256)
T ss_pred cccc----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-------HHHhcCCCCC-
Confidence 6321 122344678999999988889999999999999999998 99999765433221 1111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.+.....++.+++.+||..+|++|||++|+++.|+++
T Consensus 220 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 220 -------APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -------CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 0111234677888999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-35 Score=312.76 Aligned_cols=261 Identities=28% Similarity=0.413 Sum_probs=197.7
Q ss_pred cccCceeccCCceEEEEEEEc-----CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEec--CCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 668 (884)
+...+.||+|+||.||+|... ++..||+|++.... ....+.+.+|++++++++||||+++.+++.. ....++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 84 (284)
T cd05081 6 LKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST-AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRL 84 (284)
T ss_pred ceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEE
Confidence 345678999999999999743 57789999986432 2345678999999999999999999998754 346789
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+
T Consensus 85 v~e~~~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~ 150 (284)
T cd05081 85 VMEYLPYGSLRDYLQKHR-----------ERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIG 150 (284)
T ss_pred EEEecCCCCHHHHHHhcC-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEEC
Confidence 999999999999986432 2578999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCcc--cccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh---------h
Q 002759 749 DYGLAKLLPILDNYG--LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV---------V 817 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~---------~ 817 (884)
|||+++......... .....++..|+|||++.+..++.++||||||+++|||++|..|+......-.. .
T Consensus 151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd05081 151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQM 230 (284)
T ss_pred CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhccccccccc
Confidence 999998765322211 11222345699999999888999999999999999999988776543211000 0
Q ss_pred HHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 818 LCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
......+........ ........++.+++.+||+.+|++|||+.|+++.|++++
T Consensus 231 ~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 231 IVYHLIELLKNNGRL--------PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred chHHHHHHHhcCCcC--------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 000011111111000 011122346888889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=314.61 Aligned_cols=267 Identities=28% Similarity=0.415 Sum_probs=206.0
Q ss_pred cccCceeccCCceEEEEEEEcC--------CeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCce
Q 002759 596 LDKECLIGGGSIGSVYRASFEG--------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~ 666 (884)
+...+.||+|+||.||+|...+ ...||+|.++..........+.+|+.+++++ +||||+++++++...+..
T Consensus 14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 93 (334)
T cd05100 14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL 93 (334)
T ss_pred eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence 4567899999999999996421 2368999887544334567889999999999 799999999999999999
Q ss_pred eEEEEecCCCchhhhcccCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGT----STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN 742 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~ 742 (884)
++|+||+++|+|.+++........ .........+++.++..++.|++.||+|||+. +++||||||+||+++.+
T Consensus 94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~ 170 (334)
T cd05100 94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTED 170 (334)
T ss_pred EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCC
Confidence 999999999999999975431100 00011234688999999999999999999998 99999999999999999
Q ss_pred CCeeEccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 002759 743 YEPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCE 820 (884)
Q Consensus 743 ~~vkl~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~ 820 (884)
+.+||+|||+++......... .....++..|+|||++.+..++.++||||||+++|||++ |..||...+..+..
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---- 246 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF---- 246 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH----
Confidence 999999999998764322211 122334567999999999899999999999999999998 88999765433221
Q ss_pred HHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 821 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
. .+....... .+.....++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 247 --~-~~~~~~~~~--------~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 247 --K-LLKEGHRMD--------KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred --H-HHHcCCCCC--------CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 1 111111111 111223467888999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=312.26 Aligned_cols=260 Identities=22% Similarity=0.285 Sum_probs=197.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||.||+|... ++..+|+|.+..........++.+|++++.+++||||+++++++..++..++||||++
T Consensus 3 ~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~ 82 (308)
T cd06615 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMD 82 (308)
T ss_pred ceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccC
Confidence 456778999999999999764 5778888888654333345678899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .+++..+..++.|+++||.|||+.+ +++||||||+||+++.++.+||+|||.+.
T Consensus 83 ~~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 148 (308)
T cd06615 83 GGSLDQVLKKAG------------RIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSG 148 (308)
T ss_pred CCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcc
Confidence 999999997543 5788999999999999999999732 89999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc-
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA- 833 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~- 833 (884)
..... ......++..|+|||.+.+..++.++||||||+++|||++|+.||...+......................
T Consensus 149 ~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (308)
T cd06615 149 QLIDS---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRP 225 (308)
T ss_pred ccccc---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCccc
Confidence 65321 12345678899999999888889999999999999999999999975432221111000000000000000
Q ss_pred -----------------------cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 834 -----------------------CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 834 -----------------------~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
...+.... .....++.+++.+||+.+|++|||++|+++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 226 VSGHPPDSPRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred ccCCCCCccchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000000 0123357889999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.39 Aligned_cols=254 Identities=24% Similarity=0.287 Sum_probs=188.9
Q ss_pred eeccCCceEEEEEEEcC---CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCc
Q 002759 601 LIGGGSIGSVYRASFEG---GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
.||+|+||+||+|...+ ...+++|.+...........+.+|+..++.++||||+++++++......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999996543 346788877644433445678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|.+++...... .....++.....++.||+.|++|||+. +|+||||||+||+++.++.+||+|||+++...
T Consensus 82 L~~~l~~~~~~-------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~ 151 (269)
T cd05042 82 LKNYLRSNRGM-------VAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQY 151 (269)
T ss_pred HHHHHHhcccc-------ccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccc
Confidence 99999754311 112356778899999999999999998 99999999999999999999999999987643
Q ss_pred CccCc-ccccccccccccCccccC-------CCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 758 ILDNY-GLTKFHNAVGYVAPELAQ-------SLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 758 ~~~~~-~~~~~~~~~~y~aPE~~~-------~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
..+.. ......++..|+|||+.. ...++.++||||||+++|||++ |..||......+. .......
T Consensus 152 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~------~~~~~~~ 225 (269)
T cd05042 152 PEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV------LKQVVRE 225 (269)
T ss_pred cchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH------HHHHhhc
Confidence 22211 122334567899999864 3456789999999999999999 8888876543321 1111111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
.. ....++..... ....+..++..|| .||++|||++||++.|
T Consensus 226 ~~-~~~~~~~~~~~---~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l 267 (269)
T cd05042 226 QD-IKLPKPQLDLK---YSDRWYEVMQFCW-LDPETRPTAEEVHELL 267 (269)
T ss_pred cC-ccCCCCccccc---CCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence 11 11112222211 2234455666788 5999999999999886
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=305.12 Aligned_cols=247 Identities=23% Similarity=0.290 Sum_probs=209.5
Q ss_pred ccccCceeccCCceEEEEEEE-cCCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
.|+.++.||+|.|++|-+|++ -+|..||||++.+. -+......+.+|++.|+-++|||||+++++...+...|+|.|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 456677899999999999954 47899999999543 3445678899999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC-CCCCeeEcccc
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYG 751 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~-~~~~vkl~Dfg 751 (884)
-++|+|+|||.++. ..+.+.-+.++++||+.|+.|+|+. .+|||||||+||.+- .-|-||+.|||
T Consensus 99 GD~GDl~DyImKHe-----------~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFG 164 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE-----------EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFG 164 (864)
T ss_pred cCCchHHHHHHhhh-----------ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeecc
Confidence 99999999997665 3588899999999999999999998 899999999999875 56899999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCC-CccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLS-DKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
++..+.+ +...+..+|...|.|||++.+..|+ ++.||||+||++|-++.|+.||+..++.|...++--
T Consensus 165 FSNkf~P--G~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImD--------- 233 (864)
T KOG4717|consen 165 FSNKFQP--GKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMD--------- 233 (864)
T ss_pred ccccCCC--cchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhc---------
Confidence 9988764 4456788999999999999998887 578999999999999999999998877665532211
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
| -...+.....+...+|..|+..||++|.+.+||+.
T Consensus 234 ---C----KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 234 ---C----KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ---c----cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 0 01133445567778888999999999999999974
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=326.52 Aligned_cols=250 Identities=20% Similarity=0.237 Sum_probs=191.4
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... +++.||+|++.... .......+.+|++++++++||||+++++.+.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~ 82 (376)
T cd05598 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDY 82 (376)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeC
Confidence 456778999999999999764 57899999986432 123456788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~g~L~~~i~~~~------------~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~ 147 (376)
T cd05598 83 IPGGDMMSLLIRLG------------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (376)
T ss_pred CCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCC
Confidence 99999999997543 578888899999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc------------------------------------------CcccccccccccccCccccCCCCCCCccCc
Q 002759 753 AKLLPILD------------------------------------------NYGLTKFHNAVGYVAPELAQSLRLSDKCDV 790 (884)
Q Consensus 753 s~~~~~~~------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 790 (884)
+..+.... ........||..|+|||++.+..++.++||
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 227 (376)
T cd05598 148 CTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227 (376)
T ss_pred CccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence 75321000 000113468999999999999999999999
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC---C
Q 002759 791 YSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP---S 867 (884)
Q Consensus 791 wS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---t 867 (884)
||+||++|||++|+.||......+... .......... + +....... ++.+++.+|+ .+|.+|+ |
T Consensus 228 wSlGvilyell~G~~Pf~~~~~~~~~~------~i~~~~~~~~-~-~~~~~~s~----~~~~li~~l~-~~p~~R~~~~t 294 (376)
T cd05598 228 WSVGVILYEMLVGQPPFLADTPAETQL------KVINWETTLH-I-PSQAKLSR----EASDLILRLC-CGAEDRLGKNG 294 (376)
T ss_pred eeccceeeehhhCCCCCCCCCHHHHHH------HHhccCcccc-C-CCCCCCCH----HHHHHHHHHh-cCHhhcCCCCC
Confidence 999999999999999998765433211 1111000000 0 01111122 3444555555 4999999 8
Q ss_pred HHHHHH
Q 002759 868 MAEVVQ 873 (884)
Q Consensus 868 ~~ell~ 873 (884)
+.|+++
T Consensus 295 ~~ell~ 300 (376)
T cd05598 295 ADEIKA 300 (376)
T ss_pred HHHHhC
Confidence 888874
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=303.80 Aligned_cols=256 Identities=27% Similarity=0.380 Sum_probs=203.4
Q ss_pred ceeccCCceEEEEEEEcC----CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||.||+|.... +..|++|.+.........+.+.+|++.+..++|+|++++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999997754 7789999997654333478899999999999999999999999998999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++....... .......+++.++++++.|++.|++|||++ +++||||||+||+++.++.++++|||.++.
T Consensus 81 ~~L~~~l~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~ 154 (262)
T cd00192 81 GDLLDYLRKSRPVF---PSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRD 154 (262)
T ss_pred CcHHHHHhhccccc---cccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccc
Confidence 99999997642000 000124689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccC-cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 756 LPILDN-YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 756 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
...... .......++..|+|||.+....++.++||||+|+++|||++ |..||......+. .... .......
T Consensus 155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~~-~~~~~~~ 227 (262)
T cd00192 155 VYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV------LEYL-RKGYRLP 227 (262)
T ss_pred cccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH------HHHH-HcCCCCC
Confidence 754321 12334556788999999988889999999999999999999 6999987643322 1111 1111111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.......++.+++.+||+.+|++|||+.|+++.|+
T Consensus 228 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 228 --------KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred --------CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 11222346788888999999999999999998874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=303.86 Aligned_cols=248 Identities=24% Similarity=0.333 Sum_probs=200.7
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...+.||+|++|.||+|... ++..|++|.+... ........+.+|+++++.++|||++++++++.+.+..++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08529 3 EILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAE 82 (256)
T ss_pred eEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCC
Confidence 35578999999999999764 6788999988632 223456788999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ...+++..++.++.|++.||.|||+. +++||||||+||+++.++.++++|||.++
T Consensus 83 ~~~L~~~l~~~~----------~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~ 149 (256)
T cd08529 83 NGDLHKLLKMQR----------GRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAK 149 (256)
T ss_pred CCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccce
Confidence 999999997542 23688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
....... ......++..|+|||+..+..++.++|+||||+++|||++|+.||......+. .... .......
T Consensus 150 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~-~~~~~~~- 220 (256)
T cd08529 150 LLSDNTN-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL------ILKI-IRGVFPP- 220 (256)
T ss_pred eccCccc-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH------HHHH-HcCCCCC-
Confidence 7653222 12334678899999999988899999999999999999999999976543211 1111 1111111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.......++.+++.+||+.+|++||++.++++
T Consensus 221 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 252 (256)
T cd08529 221 -------VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR 252 (256)
T ss_pred -------CccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence 11123346788889999999999999999986
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=326.10 Aligned_cols=202 Identities=21% Similarity=0.278 Sum_probs=170.7
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|.. .+++.||+|++.... .......+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 3 f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~ 82 (382)
T cd05625 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 82 (382)
T ss_pred cEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeC
Confidence 45678899999999999966 467889999986432 123356788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~~~------------~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGl 147 (382)
T cd05625 83 IPGGDMMSLLIRMG------------IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGL 147 (382)
T ss_pred CCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCC
Confidence 99999999986433 578888999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccC----------------------------------------------cccccccccccccCccccCCCCCCC
Q 002759 753 AKLLPILDN----------------------------------------------YGLTKFHNAVGYVAPELAQSLRLSD 786 (884)
Q Consensus 753 s~~~~~~~~----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~ 786 (884)
++.+..... .......||..|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~ 227 (382)
T cd05625 148 CTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQ 227 (382)
T ss_pred CccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCC
Confidence 753310000 0011246889999999999989999
Q ss_pred ccCchhHHHHHHHHHhCCCCCCCCCC
Q 002759 787 KCDVYSFGVILLELVTGRKPVESPTT 812 (884)
Q Consensus 787 ~sDvwS~Gv~l~el~tG~~p~~~~~~ 812 (884)
++||||+||++|||++|+.||.....
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 228 LCDWWSVGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred eeeEEechHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999987554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=325.62 Aligned_cols=250 Identities=20% Similarity=0.241 Sum_probs=192.0
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|...+.||+|+||+||+|.. .+++.||||++.... .......+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~ 82 (377)
T cd05629 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEF 82 (377)
T ss_pred ceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeC
Confidence 34667899999999999965 468899999985432 123356788899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~~~------------~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGl 147 (377)
T cd05629 83 LPGGDLMTMLIKYD------------TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGL 147 (377)
T ss_pred CCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccc
Confidence 99999999986433 578889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCc----------------------------------------------ccccccccccccCccccCCCCCCC
Q 002759 753 AKLLPILDNY----------------------------------------------GLTKFHNAVGYVAPELAQSLRLSD 786 (884)
Q Consensus 753 s~~~~~~~~~----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~ 786 (884)
++.+...... ......||..|+|||++.+..++.
T Consensus 148 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 227 (377)
T cd05629 148 STGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQ 227 (377)
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCC
Confidence 9643211000 001245899999999999989999
Q ss_pred ccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCC-
Q 002759 787 KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRR- 865 (884)
Q Consensus 787 ~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~R- 865 (884)
++||||+||++|||++|..||......+.. ............ +... ....++.+++.+|++ +|.+|
T Consensus 228 ~~DiwSlGvil~elltG~~Pf~~~~~~~~~------~~i~~~~~~~~~--p~~~----~~s~~~~dli~~lL~-~~~~r~ 294 (377)
T cd05629 228 ECDWWSLGAIMFECLIGWPPFCSENSHETY------RKIINWRETLYF--PDDI----HLSVEAEDLIRRLIT-NAENRL 294 (377)
T ss_pred ceeeEecchhhhhhhcCCCCCCCCCHHHHH------HHHHccCCccCC--CCCC----CCCHHHHHHHHHHhc-CHhhcC
Confidence 999999999999999999999865543221 111110000000 0000 112356677778887 66665
Q ss_pred --CCHHHHHH
Q 002759 866 --PSMAEVVQ 873 (884)
Q Consensus 866 --Pt~~ell~ 873 (884)
+|+.|++.
T Consensus 295 ~r~~~~~~l~ 304 (377)
T cd05629 295 GRGGAHEIKS 304 (377)
T ss_pred CCCCHHHHhc
Confidence 69998875
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=307.61 Aligned_cols=250 Identities=21% Similarity=0.280 Sum_probs=196.1
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+..+.||+|+||+||+|... +++.+|+|.+.... .......+.+|+++++.++|+|++++.+++..++..++||||+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 82 (285)
T cd05632 3 RQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIM 82 (285)
T ss_pred eEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEec
Confidence 34568999999999999664 67899999986432 1223456788999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++.... ...+++..+..++.|++.||.|||+. +|+||||||+||++++++.++|+|||++
T Consensus 83 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~ 149 (285)
T cd05632 83 NGGDLKFHIYNMG----------NPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLA 149 (285)
T ss_pred cCccHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcc
Confidence 9999998886432 23589999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
...... .......++..|+|||++.+..++.++|+||+|+++|||++|+.||......... ............
T Consensus 150 ~~~~~~--~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~---~~~~~~~~~~~~-- 222 (285)
T cd05632 150 VKIPEG--ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR---EEVDRRVLETEE-- 222 (285)
T ss_pred eecCCC--CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhhhcccc--
Confidence 765421 1223456899999999999888999999999999999999999999865432221 111111111110
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~ell~ 873 (884)
.+ ......++.+++..||+.+|++||+ +.+++.
T Consensus 223 ~~-------~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 223 VY-------SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred cc-------CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 01 1112235677888899999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=302.01 Aligned_cols=249 Identities=25% Similarity=0.350 Sum_probs=199.3
Q ss_pred ceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchh
Q 002759 600 CLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLY 679 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 679 (884)
++||+|+||.||+|...+++.|++|++...........+.+|++++++++||||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 36899999999999887789999999875443335678899999999999999999999999999999999999999999
Q ss_pred hhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCc
Q 002759 680 DNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL 759 (884)
Q Consensus 680 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~ 759 (884)
+++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.++.....
T Consensus 81 ~~l~~~~-----------~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~ 146 (251)
T cd05041 81 TFLRKKK-----------NRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGG 146 (251)
T ss_pred HHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCC
Confidence 9986432 2578899999999999999999998 9999999999999999999999999999765421
Q ss_pred cCccc-ccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccc
Q 002759 760 DNYGL-TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837 (884)
Q Consensus 760 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 837 (884)
..... .....+..|+|||.+.+..++.++||||+|+++|||++ |..||......+.. ..........
T Consensus 147 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~-------~~~~~~~~~~---- 215 (251)
T cd05041 147 IYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR-------ERIESGYRMP---- 215 (251)
T ss_pred cceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH-------HHHhcCCCCC----
Confidence 11111 12233667999999988889999999999999999999 88998765432211 1111111000
Q ss_pred cCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 838 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
.......++.+++.+||+.+|++|||+.|+++.|++
T Consensus 216 ----~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 216 ----APQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred ----CCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 111223468888899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=329.27 Aligned_cols=256 Identities=24% Similarity=0.326 Sum_probs=188.2
Q ss_pred ccccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--------Cc
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--------TM 665 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~ 665 (884)
-|...+.||+|+||.||+|... +++.||||++.... ....+|+.+++.++||||+++.+++... ..
T Consensus 67 ~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 67 SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred eEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceE
Confidence 3567789999999999999764 67899999885422 3345799999999999999998876432 23
Q ss_pred eeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC-C
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY-E 744 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~-~ 744 (884)
.++||||+++ ++.+++.... .....+++..+..++.||+.||+|||+. +|+||||||+||+++.++ .
T Consensus 142 l~lvmE~~~~-~l~~~~~~~~--------~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~ 209 (440)
T PTZ00036 142 LNVVMEFIPQ-TVHKYMKHYA--------RNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHT 209 (440)
T ss_pred EEEEEecCCc-cHHHHHHHHh--------hcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCc
Confidence 5689999965 7777764321 0124688999999999999999999998 999999999999999665 7
Q ss_pred eeEccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 002759 745 PKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR 823 (884)
Q Consensus 745 vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~ 823 (884)
+||+|||+|+.+... .......++..|+|||++.+ ..++.++||||+||++|||++|.+||......+.... ..
T Consensus 210 vkL~DFGla~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~--i~- 284 (440)
T PTZ00036 210 LKLCDFGSAKNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR--II- 284 (440)
T ss_pred eeeeccccchhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH--HH-
Confidence 999999999876432 22334567899999999865 4689999999999999999999999987554332211 11
Q ss_pred HHHHcC----------CCcc-cccc----cCCC-CcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 824 ELLERG----------SASA-CFDR----SLRG-FAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 824 ~~~~~~----------~~~~-~~d~----~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
.....+ .... .++. .+.. ++.....++.+++.+||+.||.+|||+.|++
T Consensus 285 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l 349 (440)
T PTZ00036 285 QVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL 349 (440)
T ss_pred HHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence 110000 0000 0000 0000 1112234678889999999999999999998
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=337.87 Aligned_cols=268 Identities=21% Similarity=0.201 Sum_probs=203.3
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..++||+|+||.||+|... +++.||+|++..... ....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 4 YeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY 83 (932)
T PRK13184 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPY 83 (932)
T ss_pred eEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEc
Confidence 456778999999999999765 588999999864322 22356789999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++........ .........++..++.++.||++||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 84 ~eGGSL~~lL~s~~~~~~-l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGL 159 (932)
T PRK13184 84 IEGYTLKSLLKSVWQKES-LSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGA 159 (932)
T ss_pred CCCCCHHHHHHHhhhccc-cchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCc
Confidence 999999999864321110 0001123467788899999999999999998 999999999999999999999999999
Q ss_pred ccccCCccC-----------------cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcch
Q 002759 753 AKLLPILDN-----------------YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815 (884)
Q Consensus 753 s~~~~~~~~-----------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~ 815 (884)
++....... .......||+.|+|||++.+..++.++||||+||++|||++|+.||......+.
T Consensus 160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 987621110 001224689999999999999999999999999999999999999976443222
Q ss_pred hhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhhc
Q 002759 816 VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-SMAEVVQVLESIRN 880 (884)
Q Consensus 816 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-t~~ell~~L~~~~~ 880 (884)
.. ...... .... ....+.+..+.+++.+|++.||++|| +++++.+.|+.+..
T Consensus 240 ~~-----~~~i~~--P~~~------~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 240 SY-----RDVILS--PIEV------APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh-----hhhccC--hhhc------cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 011000 0000 00112234577888999999999995 67888888887744
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=317.05 Aligned_cols=269 Identities=24% Similarity=0.336 Sum_probs=201.8
Q ss_pred cccCceeccCCceEEEEEEE------cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecC-Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASF------EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSS-TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-~~~~ 667 (884)
|+..+.||+|+||+||+|.+ .+++.||||+++..........+.+|+.++.++ +||||+++++++... ...+
T Consensus 9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~ 88 (343)
T cd05103 9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM 88 (343)
T ss_pred hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence 45778999999999999963 346789999997544333456788999999999 689999999987654 4678
Q ss_pred EEEEecCCCchhhhcccCCCCCCC-------------------------------------------------------C
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTS-------------------------------------------------------T 692 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~-------------------------------------------------------~ 692 (884)
+||||+++|+|.++++........ .
T Consensus 89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (343)
T cd05103 89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ 168 (343)
T ss_pred EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence 999999999999998643210000 0
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCc-ccccccccc
Q 002759 693 GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAV 771 (884)
Q Consensus 693 ~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~-~~~~~~~~~ 771 (884)
.......+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||+++........ ......++.
T Consensus 169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 169 EDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 000113478889999999999999999998 9999999999999999999999999999875322211 122234567
Q ss_pred cccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHH
Q 002759 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQV 850 (884)
Q Consensus 772 ~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l 850 (884)
.|+|||.+.+..++.++||||||+++|||++ |..||......+. .......+..... .... ..++
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~------~~~~~~~~~~~~~-----~~~~---~~~~ 311 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FCRRLKEGTRMRA-----PDYT---TPEM 311 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH------HHHHHhccCCCCC-----CCCC---CHHH
Confidence 7999999988889999999999999999997 9999976433211 1111111111110 0111 1357
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 851 MKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 851 ~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
.+++..||+.+|++|||+.|+++.|+.+.+.
T Consensus 312 ~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~ 342 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 342 (343)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence 7888999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=319.72 Aligned_cols=241 Identities=26% Similarity=0.311 Sum_probs=189.0
Q ss_pred ceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHH-HHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIG-RLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||+||+|.. .+++.+|+|++.... .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 3689999999999966 468899999986432 1223345555654 46778999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~L~~~l~~~~------------~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~ 145 (325)
T cd05604 81 GELFFHLQRER------------SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKE 145 (325)
T ss_pred CCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCccc
Confidence 99998886433 588999999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
... .........|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+.. ...... .. .+
T Consensus 146 ~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~------~~~~~~-~~--~~ 215 (325)
T cd05604 146 GIA-QSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY------DNILHK-PL--VL 215 (325)
T ss_pred CCC-CCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH------HHHHcC-Cc--cC
Confidence 422 122234557899999999999989999999999999999999999999875433221 111111 11 00
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
. +.....+.+++.+|++.+|.+||++.+.+
T Consensus 216 ~-------~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 R-------PGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred C-------CCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 1 11223566788889999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=308.15 Aligned_cols=262 Identities=21% Similarity=0.337 Sum_probs=201.0
Q ss_pred ccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
+..+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|+||+++++++......++||
T Consensus 8 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 86 (280)
T cd05092 8 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS-ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVF 86 (280)
T ss_pred eeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC-HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEE
Confidence 45678999999999999542 35678889886432 244568999999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCC---CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 671 EFVPKGNLYDNLHGVNYPGT---STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~---~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
||+++++|.+++........ .........+++..+..++.|++.|++|||+. +++||||||+||++++++.+||
T Consensus 87 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL 163 (280)
T cd05092 87 EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKI 163 (280)
T ss_pred ecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEE
Confidence 99999999999975431100 00011123588999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcc-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHH
Q 002759 748 SDYGLAKLLPILDNYG-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
+|||+++......... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.. ..
T Consensus 164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~------~~- 236 (280)
T cd05092 164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAI------EC- 236 (280)
T ss_pred CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHH------HH-
Confidence 9999997654322111 123344678999999998899999999999999999998 99999764433221 11
Q ss_pred HHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 826 ~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
...+..... +......+.+++.+||+.||.+||++.|+.+.|++
T Consensus 237 ~~~~~~~~~--------~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 237 ITQGRELER--------PRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHcCccCCC--------CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 111111110 01122357788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=303.85 Aligned_cols=238 Identities=24% Similarity=0.336 Sum_probs=186.5
Q ss_pred eeccCCceEEEEEEEcC-------------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCcee
Q 002759 601 LIGGGSIGSVYRASFEG-------------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQL 667 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (884)
.||+|+||.||+|...+ ...|++|.+.... ......+.+|+.+++.++||||+++++++......+
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH-RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 58999999999997532 2357888875432 234557888999999999999999999999888999
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCC---
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE--- 744 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~--- 744 (884)
+||||+++++|..++.... ..+++..+.+++.||++||+|||+. +|+||||||+||+++.++.
T Consensus 81 lv~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~ 146 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRKS-----------DVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGE 146 (262)
T ss_pred EEEecccCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCC
Confidence 9999999999988886432 3588999999999999999999998 9999999999999987664
Q ss_pred ----eeEccccCccccCCccCcccccccccccccCccccC-CCCCCCccCchhHHHHHHHHH-hCCCCCCCCCCcchhhH
Q 002759 745 ----PKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELV-TGRKPVESPTTNEVVVL 818 (884)
Q Consensus 745 ----vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gv~l~el~-tG~~p~~~~~~~~~~~~ 818 (884)
++++|||.+..... .....++..|+|||.+. +..++.++|||||||++|||+ +|..||......+..
T Consensus 147 ~~~~~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-- 219 (262)
T cd05077 147 CGPFIKLSDPGIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-- 219 (262)
T ss_pred CCceeEeCCCCCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH--
Confidence 89999999875432 12345678899999886 566888999999999999998 588888754322211
Q ss_pred HHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 819 CEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 819 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
.... .... .......++.+++.+||+.||++||++.++++.+
T Consensus 220 -----~~~~-~~~~---------~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 220 -----RFYE-GQCM---------LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----HHHh-cCcc---------CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 1111 1110 0111234677888999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=302.81 Aligned_cols=249 Identities=23% Similarity=0.341 Sum_probs=197.8
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCc----cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR----IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
+...+.||+|++|.||+|.. .+++.+|+|.+..... ......+.+|++++++++||||+++++++......++|+
T Consensus 4 ~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 83 (263)
T cd06625 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFM 83 (263)
T ss_pred ccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEE
Confidence 34678999999999999965 4688999998864321 123457889999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
||+++++|.+++.... .+++..+..++.|++.|++|||+. +|+||||+|+||++++++.++|+||
T Consensus 84 e~~~~~~l~~~~~~~~------------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~df 148 (263)
T cd06625 84 EYMPGGSVKDQLKAYG------------ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDF 148 (263)
T ss_pred EECCCCcHHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeec
Confidence 9999999999986433 578889999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCccCccc--ccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 751 GLAKLLPILDNYGL--TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 751 g~s~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|.++.......... ....++..|+|||.+.+..++.++||||+|+++||+++|+.||...+..+.. ......
T Consensus 149 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~ 222 (263)
T cd06625 149 GASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI------FKIATQ 222 (263)
T ss_pred ccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH------HHHhcc
Confidence 99976543221111 2345778899999999888999999999999999999999999765332211 111111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .. .. .+......+.+++.+||+.+|.+|||+.|+++
T Consensus 223 ~-~~----~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 259 (263)
T cd06625 223 P-TN----PQ---LPSHVSPDARNFLRRTFVENAKKRPSAEELLR 259 (263)
T ss_pred C-CC----CC---CCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence 1 11 01 11222335777888999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.35 Aligned_cols=203 Identities=24% Similarity=0.345 Sum_probs=162.4
Q ss_pred cCceeccCCceEEEEEEEc---CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEec--CCceeEEEEe
Q 002759 598 KECLIGGGSIGSVYRASFE---GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLILSEF 672 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 672 (884)
.+++||+|+||+||+|... +++.+|+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||
T Consensus 5 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG---ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred cccccccCCCeEEEEEEEccCCCCceEEEEEECCCC---CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 4568999999999999764 45789999986432 34557889999999999999999998854 4567899999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEe----CCCCCeeEc
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILL----DENYEPKLS 748 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~----~~~~~vkl~ 748 (884)
+. ++|.+++......... .....+++..+..++.||+.||+|||++ +|+||||||+||++ +.++.+||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07868 82 AE-HDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred cC-CCHHHHHHhccccccc---CCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEe
Confidence 85 5888887543321111 1123588899999999999999999998 99999999999999 466799999
Q ss_pred cccCccccCCccC--cccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCC
Q 002759 749 DYGLAKLLPILDN--YGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESP 810 (884)
Q Consensus 749 Dfg~s~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~ 810 (884)
|||+++....... .......+|..|+|||++.+ ..++.++||||+||++|||++|+.||...
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 9999987643211 12345677899999999876 45789999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=317.73 Aligned_cols=238 Identities=25% Similarity=0.314 Sum_probs=186.6
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHH-HHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIG-RLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++||+|+||.||+|... +++.||+|++.... .......+..|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36899999999999774 57889999986432 1223344555554 57888999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+.+.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 ~~L~~~l~~~~------------~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~ 145 (321)
T cd05603 81 GELFFHLQRER------------CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKE 145 (321)
T ss_pred CCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCcc
Confidence 99988886432 578888999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
.... ........|+..|+|||++.+..++.++||||+||++|||++|+.||...+..+. ....... .. .
T Consensus 146 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~i~~~-~~-~-- 214 (321)
T cd05603 146 GVEP-EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM------YDNILHK-PL-Q-- 214 (321)
T ss_pred CCCC-CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH------HHHHhcC-CC-C--
Confidence 3221 1223345689999999999988999999999999999999999999987543221 1111111 11 0
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA 869 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 869 (884)
.+.....++.+++.+|++.+|.+||++.
T Consensus 215 ------~~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 215 ------LPGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------CCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1111223577888899999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=322.01 Aligned_cols=399 Identities=28% Similarity=0.364 Sum_probs=317.2
Q ss_pred CCcceEecCCCCEEEEEecCccccccccccccCCCCCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCC
Q 002759 62 NFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIG 141 (884)
Q Consensus 62 ~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~ 141 (884)
||..|.= ..+.+.++.+.. +.+.+.+|..|.+|++++|+++ ..|++++++..++.|+.++|+++ .+|+.++
T Consensus 41 wW~qv~l------~~lils~N~l~~-l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~ 111 (565)
T KOG0472|consen 41 WWEQVDL------QKLILSHNDLEV-LREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIG 111 (565)
T ss_pred hhhhcch------hhhhhccCchhh-ccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHh
Confidence 5665543 345566665543 4567889999999999999999 89999999999999999999999 9999999
Q ss_pred CCCCcceEeCCCCccCCCCchhhhhccccCcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccE
Q 002759 142 DLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDF 221 (884)
Q Consensus 142 ~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~ 221 (884)
.+.+|+.|++++|.+. ++|++++ .+..|..|+..+|+++ ..|..+.++.+|..|++.+|++....|..+ +++.|++
T Consensus 112 s~~~l~~l~~s~n~~~-el~~~i~-~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i-~m~~L~~ 187 (565)
T KOG0472|consen 112 SLISLVKLDCSSNELK-ELPDSIG-RLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHI-AMKRLKH 187 (565)
T ss_pred hhhhhhhhhcccccee-ecCchHH-HHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHH-HHHHHHh
Confidence 9999999999999998 8887764 4678999999999999 778889999999999999999995444444 4999999
Q ss_pred EEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcC
Q 002759 222 ISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301 (884)
Q Consensus 222 L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l 301 (884)
|+...|.++ .+|..++.+.+|.-|+|..|+|..++ .|.++..|.+|+++.|+|.-...+....++++.+||+..|++
T Consensus 188 ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~~lP--ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNkl 264 (565)
T KOG0472|consen 188 LDCNSNLLE-TLPPELGGLESLELLYLRRNKIRFLP--EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKL 264 (565)
T ss_pred cccchhhhh-cCChhhcchhhhHHHHhhhcccccCC--CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeecccccc
Confidence 999999998 67778999999999999999999884 899999999999999999977777788999999999999999
Q ss_pred CCCCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCC----------------------------
Q 002759 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGII---------------------------- 353 (884)
Q Consensus 302 ~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~---------------------------- 353 (884)
. ..|..+.-+++|++||+|+|.|+ ..|.+++++ .|+.|-+.+|.+..+-
T Consensus 265 k-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se 341 (565)
T KOG0472|consen 265 K-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSE 341 (565)
T ss_pred c-cCchHHHHhhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCc
Confidence 8 56888999999999999999999 678889999 8999999999763210
Q ss_pred ---------CC-Ccc---Cccc--------------------------ccEEecCCCcCC--------------------
Q 002759 354 ---------PP-NLG---SIEL--------------------------LEVLDLHNLNLR-------------------- 374 (884)
Q Consensus 354 ---------p~-~~~---~l~~--------------------------L~~L~L~~n~l~-------------------- 374 (884)
|. .+. .+.+ ....+++.|++.
T Consensus 342 ~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsn 421 (565)
T KOG0472|consen 342 GGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSN 421 (565)
T ss_pred ccccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhc
Confidence 00 000 0111 333455555554
Q ss_pred ---CCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCC
Q 002759 375 ---GEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS 451 (884)
Q Consensus 375 ---~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 451 (884)
+-+|..++.+++|..|+|++|-+. .+|..++.+..|+.||+|.|+|. .+|..+..+..|+.+-.++|++....|.
T Consensus 422 n~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~ 499 (565)
T KOG0472|consen 422 NKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPS 499 (565)
T ss_pred CccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChH
Confidence 123334455666667777766666 56666666666777777777666 5666666666666666666777644445
Q ss_pred CcCccCcccEEEccCCcCcccCCccccccCc
Q 002759 452 SLGNLRNLTHFNLSSNNLSGTIPSTIQHFGV 482 (884)
Q Consensus 452 ~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~~ 482 (884)
.+.++.+|..|||.+|.+. .||+.++++..
T Consensus 500 ~l~nm~nL~tLDL~nNdlq-~IPp~Lgnmtn 529 (565)
T KOG0472|consen 500 GLKNMRNLTTLDLQNNDLQ-QIPPILGNMTN 529 (565)
T ss_pred HhhhhhhcceeccCCCchh-hCChhhccccc
Confidence 5889999999999999987 67877666554
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=314.74 Aligned_cols=201 Identities=26% Similarity=0.388 Sum_probs=173.0
Q ss_pred cccCceeccCCceEEEEE-EEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC------CCCcceeeeEEecCCceeE
Q 002759 596 LDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR------HFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~l 668 (884)
|++.++||+|+||.|.+| +..+++.||||+++... .-..+...|+.++..++ .-|+|++++++...++.|+
T Consensus 188 Y~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k--~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 188 YEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK--RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEecccccceeEEEEecCCCcEEEEEeeccCh--HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 567889999999999999 55679999999998654 34566678999998885 3499999999999999999
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC--CCee
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN--YEPK 746 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~--~~vk 746 (884)
|+|.+ .-+|+++++.+.. ..++...++.|+.||+.||.+||+. +|||+||||+|||+.+- ..||
T Consensus 266 VfELL-~~NLYellK~n~f----------~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vK 331 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNNKF----------RGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIK 331 (586)
T ss_pred eehhh-hhhHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCcee
Confidence 99999 5599999988762 3588999999999999999999988 99999999999999753 3799
Q ss_pred EccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~ 816 (884)
|+|||.|++... ....+..+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+.++.+..
T Consensus 332 VIDFGSSc~~~q----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 332 VIDFGSSCFESQ----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL 397 (586)
T ss_pred EEecccccccCC----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence 999999997542 223566778899999999999999999999999999999999888886654443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=306.56 Aligned_cols=256 Identities=25% Similarity=0.393 Sum_probs=202.4
Q ss_pred cccCceeccCCceEEEEEEEcC-C----eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG-G----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
++..+.||+|+||+||+|.... + ..+|+|.............+.+|+.++++++|||++++++++.. ...++||
T Consensus 9 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~ 87 (279)
T cd05057 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLIT 87 (279)
T ss_pred cEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEE
Confidence 3466789999999999997642 2 35889988655443445778899999999999999999999876 7889999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
||+++|+|.+++.... ..+++..+..++.||+.|++|||+. +++||||||+||++++++.+||+||
T Consensus 88 e~~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~df 153 (279)
T cd05057 88 QLMPLGCLLDYVRNHK-----------DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDF 153 (279)
T ss_pred ecCCCCcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCC
Confidence 9999999999987543 2588999999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 751 GLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 751 g~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|.++........ ......++..|+|||.+....++.++|+||||+++||+++ |+.||......+.. ..+..
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-------~~~~~ 226 (279)
T cd05057 154 GLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-------DLLEK 226 (279)
T ss_pred cccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-------HHHhC
Confidence 999876532221 1112223567999999988889999999999999999999 99999875433221 12222
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
..... .+.....++..++.+||..+|++|||+.++++.++++.+.
T Consensus 227 ~~~~~--------~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~ 271 (279)
T cd05057 227 GERLP--------QPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD 271 (279)
T ss_pred CCCCC--------CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence 11110 0111223577888899999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=300.96 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=188.2
Q ss_pred eeccCCceEEEEEEEcCC---eEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCc
Q 002759 601 LIGGGSIGSVYRASFEGG---VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
.||+|+||+||+|...++ ..+++|.+.........+.+.+|+..++.++||||+++++++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999965433 34566666544333456789999999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|.++++.... .....++..+..++.||++||+|||+. +++||||||+||+++.++.++|+|||++....
T Consensus 82 L~~~l~~~~~--------~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~ 150 (268)
T cd05086 82 LKSYLSQEQW--------HRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRY 150 (268)
T ss_pred HHHHHHhhhc--------ccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccC
Confidence 9999975431 122456777889999999999999998 99999999999999999999999999986432
Q ss_pred CccC-cccccccccccccCccccCC-------CCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 758 ILDN-YGLTKFHNAVGYVAPELAQS-------LRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 758 ~~~~-~~~~~~~~~~~y~aPE~~~~-------~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
.... .......++..|+|||++.. ..++.++||||||+++|||++ |..||......+.. ......
T Consensus 151 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~------~~~~~~ 224 (268)
T cd05086 151 KEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVL------NHVIKD 224 (268)
T ss_pred cchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHHHhh
Confidence 2111 11234567889999998753 245779999999999999997 67788654432221 111111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
......++.......+ .+.+++..|| .+|++||+++++++.|.
T Consensus 225 -~~~~~~~~~~~~~~~~---~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 225 -QQVKLFKPQLELPYSE---RWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred -cccccCCCccCCCCcH---HHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 1122223333322223 4555667799 57999999999998773
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=320.31 Aligned_cols=251 Identities=18% Similarity=0.235 Sum_probs=192.5
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... +++.+|+|++.... .......+.+|+.+++.++||||+++++++.++...++||||
T Consensus 45 y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey 124 (371)
T cd05622 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEY 124 (371)
T ss_pred cEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcC
Confidence 446788999999999999765 57889999986422 223345678899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++... .++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 125 ~~gg~L~~~~~~~-------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~ 188 (371)
T cd05622 125 MPGGDLVNLMSNY-------------DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGT 188 (371)
T ss_pred CCCCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCc
Confidence 9999999998643 367888899999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCC----CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLR----LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
++..............||..|+|||++.+.. ++.++||||+||++|||++|+.||...+.... .......
T Consensus 189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~ 262 (371)
T cd05622 189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT------YSKIMNH 262 (371)
T ss_pred eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH------HHHHHcC
Confidence 9876533222334567899999999987543 78899999999999999999999986543221 1122111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSR--RPSMAEVVQV 874 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~ell~~ 874 (884)
.......+ . ......+..++..|+..++.+ ||+++|+++.
T Consensus 263 ~~~~~~~~--~----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 263 KNSLTFPD--D----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCcccCCC--c----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 11111111 0 112234566777899744433 7888888763
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=304.37 Aligned_cols=251 Identities=24% Similarity=0.331 Sum_probs=196.0
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||.||+|.. .+++.||+|++.... ......+.+|+.++++++||||+++++++..+...++||||++
T Consensus 11 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~ 89 (267)
T cd06646 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP-GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCG 89 (267)
T ss_pred cchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc-cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCC
Confidence 45678899999999999976 467889999986432 2345678899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.++++... .+++..+..++.|+++|+.|||+. +|+|||++|+||+++.++.++|+|||.++
T Consensus 90 ~~~L~~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~ 154 (267)
T cd06646 90 GGSLQDIYHVTG------------PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAA 154 (267)
T ss_pred CCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccce
Confidence 999999886432 578999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
...... .......++..|+|||.+. ...++.++||||+||++|||++|+.||......+... .......
T Consensus 155 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~-------~~~~~~~ 226 (267)
T cd06646 155 KITATI-AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF-------LMSKSNF 226 (267)
T ss_pred eecccc-cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe-------eeecCCC
Confidence 664221 1223456788999999884 3456789999999999999999999996543221110 0000000
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
. .+.... .......+.+++.+||+.+|++|||++++++.
T Consensus 227 ~---~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 265 (267)
T cd06646 227 Q---PPKLKD-KTKWSSTFHNFVKISLTKNPKKRPTAERLLTH 265 (267)
T ss_pred C---CCCCcc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence 0 011111 11123467788889999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=308.19 Aligned_cols=259 Identities=23% Similarity=0.264 Sum_probs=191.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCcc-CCHHHHHHHHHHHhcC---CCCCcceeeeEEec-----CCc
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRI-RNQEEFELEIGRLSNI---RHFNLVAFQGYYWS-----STM 665 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~~ 665 (884)
|+..+.||+|+||+||+|... +++.||+|.++..... .....+.+|+.+++.+ +||||+++++++.. ...
T Consensus 2 y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~ 81 (288)
T cd07863 2 YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETK 81 (288)
T ss_pred ceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCce
Confidence 345678999999999999665 6788999988643221 2234556677766554 79999999998754 245
Q ss_pred eeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCe
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~v 745 (884)
.++||||+. ++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+
T Consensus 82 ~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~ 147 (288)
T cd07863 82 VTLVFEHVD-QDLRTYLDKVP----------PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQV 147 (288)
T ss_pred EEEEEcccc-cCHHHHHHhcC----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 789999997 48988886533 23588999999999999999999998 99999999999999999999
Q ss_pred eEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 002759 746 KLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
||+|||+++.... ........++..|+|||++.+..++.++||||+||++|||++|+.||......+... . ....
T Consensus 148 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~--~-~~~~ 222 (288)
T cd07863 148 KLADFGLARIYSC--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG--K-IFDL 222 (288)
T ss_pred EECccCccccccC--cccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH--H-HHHH
Confidence 9999999987642 222334567889999999998899999999999999999999999997654332211 1 1111
Q ss_pred HHcCCC----------cccccccC----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 826 LERGSA----------SACFDRSL----RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 826 ~~~~~~----------~~~~d~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...... ...+.+.. ....++...++.+++.+|++.||++|||+.|++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 100000 00011000 0111122345678889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=303.86 Aligned_cols=248 Identities=24% Similarity=0.348 Sum_probs=201.6
Q ss_pred ccccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
.|+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++|||++++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 3456678999999999999764 578899998875433344677899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++... .+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+
T Consensus 85 ~~~~L~~~i~~~-------------~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~ 148 (277)
T cd06640 85 GGGSALDLLRAG-------------PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred CCCcHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccc
Confidence 999999988632 477888999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
....... .......++..|+|||++.+..++.++|+||||+++|||++|+.||......+... .......
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~~-- 218 (277)
T cd06640 149 GQLTDTQ-IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-------LIPKNNP-- 218 (277)
T ss_pred eeccCCc-cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-------hhhcCCC--
Confidence 7764322 12233457888999999988889999999999999999999999998654332211 1111100
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
..........+.+++.+||+.+|++||++.+++..
T Consensus 219 ------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 219 ------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 11233455678889999999999999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=314.53 Aligned_cols=241 Identities=21% Similarity=0.316 Sum_probs=190.9
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+..+.||+|+||+||+|... +++.||+|++.... .....+.+..|..+++.+. |++|+++.+++...+..++||||
T Consensus 3 ~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey 82 (323)
T cd05615 3 NFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEY 82 (323)
T ss_pred eEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcC
Confidence 45678999999999999764 67899999986432 2234566778888888875 57788899999888999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++.++..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~g~L~~~i~~~~------------~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~ 147 (323)
T cd05615 83 VNGGDLMYHIQQVG------------KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGM 147 (323)
T ss_pred CCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEecccc
Confidence 99999999986543 588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++.... .........|+..|+|||++.+..++.++||||+||++|||++|+.||......... ...... ...
T Consensus 148 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~------~~i~~~-~~~ 219 (323)
T cd05615 148 CKEHMV-DGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELF------QSIMEH-NVS 219 (323)
T ss_pred ccccCC-CCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHhC-CCC
Confidence 875432 122233456899999999999889999999999999999999999999875433221 111111 110
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA 869 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 869 (884)
.+.....++.+++.+|++.+|.+|++..
T Consensus 220 ---------~p~~~~~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05615 220 ---------YPKSLSKEAVSICKGLMTKHPSKRLGCG 247 (323)
T ss_pred ---------CCccCCHHHHHHHHHHcccCHhhCCCCC
Confidence 0111223567788899999999999853
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=307.59 Aligned_cols=247 Identities=25% Similarity=0.357 Sum_probs=198.7
Q ss_pred ccccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
.|...+.||+|+||.||+|... ++..||+|.+.........+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3445567999999999999654 577899998864443344567899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++.. ..+++..+..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||++
T Consensus 85 ~~~~L~~~~~~-------------~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~ 148 (277)
T cd06642 85 GGGSALDLLKP-------------GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVA 148 (277)
T ss_pred CCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcccccc
Confidence 99999998853 2478899999999999999999988 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
....... .......++..|+|||++.+..++.++||||||+++|||++|+.||......+... ......
T Consensus 149 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-------~~~~~~--- 217 (277)
T cd06642 149 GQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-------LIPKNS--- 217 (277)
T ss_pred ccccCcc-hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-------hhhcCC---
Confidence 7664321 12223457888999999998889999999999999999999999997544322110 111111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+. .......++.+++.+||+.+|++|||+.++++
T Consensus 218 --~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 218 --PPT---LEGQYSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred --CCC---CCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 111 11223346778889999999999999999997
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=311.00 Aligned_cols=255 Identities=24% Similarity=0.390 Sum_probs=199.0
Q ss_pred ccCceeccCCceEEEEEEEc-CCe----EEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGV----SIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+..+.||+|+||.||+|.+. ++. .||+|.+...........+.+|+.+++.++||||+++++++... ..++++|
T Consensus 10 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e 88 (303)
T cd05110 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQ 88 (303)
T ss_pred eeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeeh
Confidence 45678999999999999763 343 47888886544333445788999999999999999999998654 4678999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||
T Consensus 89 ~~~~g~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg 154 (303)
T cd05110 89 LMPHGCLLDYVHEHK-----------DNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFG 154 (303)
T ss_pred hcCCCCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccc
Confidence 999999999986432 2578899999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 752 LAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 752 ~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+++........ ......++..|+|||++.+..++.++||||||+++||+++ |+.||......+.. +.....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~-------~~~~~~ 227 (303)
T cd05110 155 LARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIP-------DLLEKG 227 (303)
T ss_pred ccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH-------HHHHCC
Confidence 99876432211 1223345678999999998889999999999999999998 99999765432221 112211
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
..... ......++..++..||..+|++||+++++++.++++...
T Consensus 228 ~~~~~--------~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 228 ERLPQ--------PPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred CCCCC--------CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 11100 011223677888899999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.06 Aligned_cols=254 Identities=28% Similarity=0.430 Sum_probs=198.3
Q ss_pred eeccCCceEEEEEEEcC-------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 601 LIGGGSIGSVYRASFEG-------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
.||+|+||.||+|...+ +..+++|.+...........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 58999999999997642 25789998865443345678899999999999999999999999989999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC-----CeeEc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY-----EPKLS 748 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~-----~vkl~ 748 (884)
++++|.+++........ ....+++.++..++.|++.|++|||+. +++|+||||+||+++.++ .++++
T Consensus 82 ~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~ 153 (269)
T cd05044 82 EGGDLLSYLRDARVERF-----GPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIG 153 (269)
T ss_pred CCCcHHHHHHHhhhccc-----CCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEEC
Confidence 99999999975331110 123578999999999999999999988 999999999999999877 89999
Q ss_pred cccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||+++.....+.. ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+.. ...
T Consensus 154 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~---~~~---- 226 (269)
T cd05044 154 DFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL---QHV---- 226 (269)
T ss_pred CcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHH---HHH----
Confidence 99999765432211 1122345678999999998899999999999999999998 99999754432211 111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
....... ........+.+++.+||+.+|.+||++.++++.|++
T Consensus 227 ~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 227 TAGGRLQ--------KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred hcCCccC--------CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 1111000 111233467788899999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=303.19 Aligned_cols=251 Identities=23% Similarity=0.306 Sum_probs=195.4
Q ss_pred cccccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 594 ALLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
++++..+.||+|+||.||+|... ++..+++|.+.... ......+.+|+++++.++|||++++++++..+...++|+||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS-EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC-HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 34456678999999999999775 46778888875432 23456788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... ..+++..+..++.|+++||+|||+. +++||||||+||+++.++.+||+|||+
T Consensus 84 ~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~ 149 (282)
T cd06643 84 CAGGAVDAVMLELE-----------RPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGV 149 (282)
T ss_pred cCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccc
Confidence 99999988876422 3588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
++..... ........++..|+|||++. +..++.++|||||||++|||++|+.||......+.. .....
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~ 222 (282)
T cd06643 150 SAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL------LKIAK 222 (282)
T ss_pred ccccccc-ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH------HHHhh
Confidence 8765421 11223446788999999984 445678999999999999999999999765432221 11111
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
....... .......++.+++.+||+.+|.+|||++++++
T Consensus 223 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 223 SEPPTLA-------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred cCCCCCC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 1111000 01112236778888999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=304.90 Aligned_cols=262 Identities=28% Similarity=0.450 Sum_probs=203.3
Q ss_pred cccCceeccCCceEEEEEEEc-----CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEec--CCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 668 (884)
+...+.||+|+||.||+|.+. ++..+|+|++.........+.+.+|+++++.++||||+++++++.. ....++
T Consensus 6 ~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~l 85 (284)
T cd05038 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRL 85 (284)
T ss_pred chhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEE
Confidence 345678999999999999754 3678999999754432346789999999999999999999999876 557899
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++++|.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++
T Consensus 86 v~e~~~~~~l~~~l~~~~-----------~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 151 (284)
T cd05038 86 IMEYLPSGSLRDYLQRHR-----------DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKIS 151 (284)
T ss_pred EEecCCCCCHHHHHHhCc-----------cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEc
Confidence 999999999999997543 2589999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCc-c-cccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh--------hH
Q 002759 749 DYGLAKLLPILDNY-G-LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV--------VL 818 (884)
Q Consensus 749 Dfg~s~~~~~~~~~-~-~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~--------~~ 818 (884)
|||.+......... . .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......... ..
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 231 (284)
T cd05038 152 DFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMI 231 (284)
T ss_pred ccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccccc
Confidence 99999876532211 1 11234456799999998888999999999999999999999998754322110 00
Q ss_pred HHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 819 CEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 819 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
.............. ........++.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 232 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 232 VTRLLELLKEGERL--------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHHHHHcCCcC--------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 11111111111110 011122356888999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=304.59 Aligned_cols=254 Identities=20% Similarity=0.298 Sum_probs=201.1
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||+|+||+||+|... ++..+|+|++.........+.+.+|+++++.++||||+++++++......++||||+++
T Consensus 8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 87 (284)
T cd06620 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDC 87 (284)
T ss_pred HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCC
Confidence 34568999999999999764 57889999886544445567899999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... .+++..+..++.|++.||.|||+.+ +++||||+|+||+++.++.++|+|||++..
T Consensus 88 ~~L~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~ 153 (284)
T cd06620 88 GSLDRIYKKGG------------PIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGE 153 (284)
T ss_pred CCHHHHHHhcc------------CCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccc
Confidence 99999886433 5789999999999999999999732 899999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcc-----hhhHHHHHHHHHHcCC
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE-----VVVLCEYVRELLERGS 830 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~-----~~~~~~~~~~~~~~~~ 830 (884)
.... ......++..|+|||++.+..++.++|||||||++||+++|+.||......+ ................
T Consensus 154 ~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd06620 154 LINS---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP 230 (284)
T ss_pred hhhh---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC
Confidence 4321 1234568899999999988889999999999999999999999998644321 1111122222221111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
. .+. ..+...++.+++.+||+.||++|||+.|+++..
T Consensus 231 ~------~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~ 267 (284)
T cd06620 231 P------RLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP 267 (284)
T ss_pred C------CCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence 1 000 112334678888999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=304.98 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=198.1
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|++|.||+|.. .+++.|++|.+.... ......+.+|+.+++.++|||++++++++..+...++||||++
T Consensus 22 y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~ 100 (296)
T cd06654 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (296)
T ss_pred eeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCC-cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccC
Confidence 34567899999999999975 467899999886533 2345778899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+.
T Consensus 101 ~~~L~~~~~~~-------------~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~ 164 (296)
T cd06654 101 GGSLTDVVTET-------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (296)
T ss_pred CCCHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccch
Confidence 99999998532 478889999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
...... .......++..|+|||.+.+..++.++|||||||++|||++|+.||......+.. ..........
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~------~~~~~~~~~~-- 235 (296)
T cd06654 165 QITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNGTPE-- 235 (296)
T ss_pred hccccc-cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH------HHHhcCCCCC--
Confidence 654322 1123346788999999999888899999999999999999999999765432211 1111111100
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .........+.+++.+||..+|++|||+.|+++
T Consensus 236 ----~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 236 ----L-QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred ----C-CCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 0 011223346778889999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=304.07 Aligned_cols=261 Identities=26% Similarity=0.367 Sum_probs=202.0
Q ss_pred cccCceeccCCceEEEEEEEc------CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (884)
++....||+|+||+||+|..+ +.+.|++|.+...........+.+|++++++++|||++++++++.+....++|
T Consensus 7 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 86 (275)
T cd05046 7 LQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMI 86 (275)
T ss_pred ceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEE
Confidence 346678999999999999764 24578888886543222456789999999999999999999999988899999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
|||+++++|.+++........ ......+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 87 ~e~~~~~~L~~~i~~~~~~~~---~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 87 LEYTDLGDLKQFLRATKSKDE---KLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred EEecCCCcHHHHHHhcccccc---cccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 999999999999865431100 01123589999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 750 fg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
||++...............++..|+|||.+.+..++.++||||||+++||+++ |..||......... .. ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~------~~-~~~ 233 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL------NR-LQA 233 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHH------HH-HHc
Confidence 99987554323333334456778999999988888999999999999999999 88899754433221 11 111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
...... ........+.+++.+||+.+|++|||+.|+++.|.
T Consensus 234 ~~~~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 234 GKLELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred CCcCCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 111100 01122346788889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=304.23 Aligned_cols=238 Identities=25% Similarity=0.350 Sum_probs=185.1
Q ss_pred eeccCCceEEEEEEEcC-------------------------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcce
Q 002759 601 LIGGGSIGSVYRASFEG-------------------------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~ 655 (884)
.||+|+||.||+|.... ...|++|.+..... .....+.+|+.+++.++||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~-~~~~~~~~~~~~~~~l~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR-DIALAFFETASLMSQVSHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH-HHHHHHHHHHHHHhcCCCCCeee
Confidence 58999999999996421 13578888864321 23456788999999999999999
Q ss_pred eeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCC
Q 002759 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKST 735 (884)
Q Consensus 656 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~ 735 (884)
+++++.+....++||||+++++|..++.... ..+++..+..++.||++||+|||++ +|+||||||+
T Consensus 81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~ 146 (274)
T cd05076 81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEK-----------GRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAK 146 (274)
T ss_pred EEEEEEeCCceEEEEecCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcc
Confidence 9999999999999999999999999886432 3578899999999999999999998 9999999999
Q ss_pred ceEeCCCC-------CeeEccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHH-hCCCC
Q 002759 736 NILLDENY-------EPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELV-TGRKP 806 (884)
Q Consensus 736 Nil~~~~~-------~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~-tG~~p 806 (884)
||++++.+ .+|++|||.+..... .....++..|+|||.+.+ ..++.++||||||+++||++ +|+.|
T Consensus 147 Nill~~~~~~~~~~~~~kl~d~g~~~~~~~-----~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p 221 (274)
T cd05076 147 NILLARLGLAEGTSPFIKLSDPGVSFTALS-----REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVP 221 (274)
T ss_pred cEEEeccCcccCccceeeecCCcccccccc-----ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 99997643 489999998865422 122356778999998865 56789999999999999995 69999
Q ss_pred CCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 807 VESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
|......+.. .. ...... + +.....++.+++.+||+.+|++|||++++++.|
T Consensus 222 ~~~~~~~~~~---~~----~~~~~~---~-------~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 222 LKERTPSEKE---RF----YEKKHR---L-------PEPSCKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred ccccChHHHH---HH----HHhccC---C-------CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 9765433221 11 111100 0 011123577888999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=304.72 Aligned_cols=251 Identities=31% Similarity=0.459 Sum_probs=197.8
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCC-HHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRN-QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|+||+||+|... +++.+|+|++........ .....+|+..+++++||||+++++++.+....++||||++
T Consensus 2 ~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~ 81 (260)
T PF00069_consen 2 RLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCP 81 (260)
T ss_dssp EEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEET
T ss_pred EEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccc
Confidence 35678999999999999776 456899999976442222 2233559999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++... ..+++.++..++.|+++||++||+. +|+||||||+||+++.++.++|+|||.+.
T Consensus 82 ~~~L~~~l~~~------------~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~ 146 (260)
T PF00069_consen 82 GGSLQDYLQKN------------KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSV 146 (260)
T ss_dssp TEBHHHHHHHH------------SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTE
T ss_pred ccccccccccc------------ccccccccccccccccccccccccc---ccccccccccccccccccccccccccccc
Confidence 99999999732 2689999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccC-CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH-HHHcCCCc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE-LLERGSAS 832 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 832 (884)
.... .........++..|+|||++. +..++.++||||+|+++|+|++|..||......+.......... ........
T Consensus 147 ~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (260)
T PF00069_consen 147 KLSE-NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQ 225 (260)
T ss_dssp ESTS-TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTS
T ss_pred cccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccc
Confidence 6421 223345567788999999998 88889999999999999999999999997632222211111111 11100000
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
......++.+++.+||+.||++|||+.++++
T Consensus 226 ----------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 226 ----------SREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp ----------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ----------cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 0001257888889999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.82 Aligned_cols=258 Identities=23% Similarity=0.273 Sum_probs=192.1
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC------cee
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST------MQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 667 (884)
|+..+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++.++||||+++++++.... ..+
T Consensus 23 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 102 (359)
T cd07876 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVY 102 (359)
T ss_pred eEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeE
Confidence 45678999999999999966 468899999986432 2234567889999999999999999999886443 469
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+++ ++.+.++. .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 103 lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl 164 (359)
T cd07876 103 LVMELMDA-NLCQVIHM--------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 164 (359)
T ss_pred EEEeCCCc-CHHHHHhc--------------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEE
Confidence 99999965 66666531 367888999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhH---------
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVL--------- 818 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~--------- 818 (884)
+|||+++.... ........++..|+|||++.+..++.++||||+||++|||++|+.||...+..+....
T Consensus 165 ~Dfg~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 165 LDFGLARTACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ecCCCcccccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99999976432 2223456788999999999999999999999999999999999999986543221100
Q ss_pred -------HHHHHHHHHc-CCCcc-cccccC--------CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 819 -------CEYVRELLER-GSASA-CFDRSL--------RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 819 -------~~~~~~~~~~-~~~~~-~~d~~~--------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.......... +.... .+.... .........++.+++.+||+.||++|||++|+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~ 314 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR 314 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence 0000111000 00000 000000 0000111235678889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=308.32 Aligned_cols=259 Identities=20% Similarity=0.277 Sum_probs=196.1
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|+||.||+|... ++..||+|.+...........+.+|+.+++.++||||+++++++..+...++||||++
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~ 87 (301)
T cd07873 8 YIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD 87 (301)
T ss_pred eEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc
Confidence 456778999999999999764 5788999998654444455677899999999999999999999999999999999996
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... ..+++..+..++.||++||+|||+. +|+||||||+||+++.++.++|+|||++.
T Consensus 88 -~~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~ 152 (301)
T cd07873 88 -KDLKQYLDDCG-----------NSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLAR 152 (301)
T ss_pred -cCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchh
Confidence 58988886432 3578899999999999999999998 99999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC--
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA-- 831 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 831 (884)
...... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+.. ............
T Consensus 153 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~ 228 (301)
T cd07873 153 AKSIPT-KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEET 228 (301)
T ss_pred ccCCCC-CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhh
Confidence 643211 12233456888999998865 35788999999999999999999999875433221 111111110000
Q ss_pred -c--------cccc-ccCC-----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 -S--------ACFD-RSLR-----GFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 -~--------~~~d-~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. ...+ +... ........++.+++.+|++.||.+|||++|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 229 WPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred chhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0 0000 0000 001112235678889999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=299.14 Aligned_cols=250 Identities=32% Similarity=0.478 Sum_probs=201.0
Q ss_pred cCceeccCCceEEEEEEEcC-----CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 598 KECLIGGGSIGSVYRASFEG-----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
..+.||.|+||.||+|...+ +..||+|++.........+.+..|+..+..++|+||+++++++.+.+..+++|||
T Consensus 3 ~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~ 82 (258)
T smart00219 3 LGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEY 82 (258)
T ss_pred ccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEec
Confidence 45789999999999997754 3789999997554333577899999999999999999999999998999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.
T Consensus 83 ~~~~~l~~~~~~~~----------~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~ 149 (258)
T smart00219 83 MEGGDLLDYLRKNR----------PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGL 149 (258)
T ss_pred cCCCCHHHHHHhhh----------hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCC
Confidence 99999999987543 11289999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
++..............++..|+|||.+.+..++.++||||+|+++|||++ |..||......+.. ... .....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~------~~~-~~~~~ 222 (258)
T smart00219 150 SRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVL------EYL-KKGYR 222 (258)
T ss_pred ceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHH------HHH-hcCCC
Confidence 98765433322223346789999999988889999999999999999998 88888764332221 111 11111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
.. .......++.+++.+||..+|++|||+.|+++.|
T Consensus 223 ~~--------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 223 LP--------KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred CC--------CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 11 1111334677888999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-34 Score=309.34 Aligned_cols=203 Identities=25% Similarity=0.348 Sum_probs=161.7
Q ss_pred cCceeccCCceEEEEEEEc---CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEec--CCceeEEEEe
Q 002759 598 KECLIGGGSIGSVYRASFE---GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLILSEF 672 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 672 (884)
.+..||+|+||+||+|... ++..||+|.+.... ....+.+|+.++++++||||+++++++.. +...++||||
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG---ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC---CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 3468999999999999765 34689999886432 34567889999999999999999998853 4567899999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEe----CCCCCeeEc
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILL----DENYEPKLS 748 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~----~~~~~vkl~ 748 (884)
++ ++|.+++......... .....+++..+..++.||+.||.|||+. +|+||||||+||++ +.++.+||+
T Consensus 82 ~~-~~l~~~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~ 154 (317)
T cd07867 82 AE-HDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIA 154 (317)
T ss_pred eC-CcHHHHHHhhhccccC---CCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEe
Confidence 86 4888877543211110 1123588899999999999999999998 99999999999999 567899999
Q ss_pred cccCccccCCccC--cccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCC
Q 002759 749 DYGLAKLLPILDN--YGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESP 810 (884)
Q Consensus 749 Dfg~s~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~ 810 (884)
|||+++....... .......++..|+|||++.+ ..++.++||||+||++|||+||+.||...
T Consensus 155 DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 155 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 9999987643221 12234567889999999876 45788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=304.29 Aligned_cols=251 Identities=22% Similarity=0.356 Sum_probs=196.8
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||+|+||.||+|... ++..||+|.+...........+.+|+.++++++||||+++++++...+..++||||+++
T Consensus 4 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (286)
T cd06622 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83 (286)
T ss_pred hhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCC
Confidence 45678999999999999775 67899999886543333456788999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|..++.... ....+++..+..++.|++.||.|||+.+ +|+||||||+||+++.++.++|+|||.+..
T Consensus 84 ~~l~~~~~~~~---------~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 152 (286)
T cd06622 84 GSLDKLYAGGV---------ATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGN 152 (286)
T ss_pred CCHHHHHHhcc---------ccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccc
Confidence 99998886432 1236899999999999999999999632 899999999999999999999999999976
Q ss_pred cCCccCcccccccccccccCccccCCC------CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSL------RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+... ......++..|+|||.+.+. .++.++||||+||++|||++|+.||......... ........ .
T Consensus 153 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~-~ 225 (286)
T cd06622 153 LVAS---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF---AQLSAIVD-G 225 (286)
T ss_pred ccCC---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH---HHHHHHhh-c
Confidence 5321 12334577889999998544 3478999999999999999999999764433222 11111111 1
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
... ........++..++.+||+.+|++||++++++.
T Consensus 226 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 261 (286)
T cd06622 226 DPP--------TLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE 261 (286)
T ss_pred CCC--------CCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence 111 111223346778888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=309.81 Aligned_cols=244 Identities=25% Similarity=0.372 Sum_probs=196.5
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|...+.||.|+||.||-|.. .+...||||++.-.+. .+.-.++..|+..+++++|||++.+.|||......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 44566799999999999955 5678899999965443 23346789999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
|- |+-.|.+.-. .+++.+.++-.|+.+.+.||+|||+. +.||||||+.|||+++.|.||++|||.
T Consensus 108 Cl-GSAsDlleVh-----------kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGS 172 (948)
T KOG0577|consen 108 CL-GSASDLLEVH-----------KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGS 172 (948)
T ss_pred Hh-ccHHHHHHHH-----------hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccc
Confidence 94 5777777533 35678888899999999999999999 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
|....+. ..++||+.|||||++. .+.|+-++||||+|++..|+.-.++|+-.++.......+. ..
T Consensus 173 Asi~~PA-----nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA-------QN 240 (948)
T KOG0577|consen 173 ASIMAPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA-------QN 240 (948)
T ss_pred hhhcCch-----hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH-------hc
Confidence 9876543 3578999999999985 5678999999999999999999999998766433221111 11
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. |.+. ..+-...+..++..|+++-|.+|||.++++.
T Consensus 241 es-----PtLq--s~eWS~~F~~Fvd~CLqKipqeRptse~ll~ 277 (948)
T KOG0577|consen 241 ES-----PTLQ--SNEWSDYFRNFVDSCLQKIPQERPTSEELLK 277 (948)
T ss_pred CC-----CCCC--CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence 11 1111 1222335677888899999999999998874
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=318.63 Aligned_cols=203 Identities=24% Similarity=0.300 Sum_probs=173.1
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... +++.||+|++.... .......+..|+.++.+++||+|+++++++.+.+..++||||
T Consensus 3 f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~ 82 (360)
T cd05627 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEF 82 (360)
T ss_pred ceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 345678999999999999764 57899999986432 223456788899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~~~------------~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~ 147 (360)
T cd05627 83 LPGGDMMTLLMKKD------------TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGL 147 (360)
T ss_pred CCCccHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccC
Confidence 99999999987543 578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccC----------------------------------cccccccccccccCccccCCCCCCCccCchhHHHHHH
Q 002759 753 AKLLPILDN----------------------------------YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILL 798 (884)
Q Consensus 753 s~~~~~~~~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~ 798 (884)
++....... .......||..|+|||++.+..++.++||||+||++|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvily 227 (360)
T cd05627 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227 (360)
T ss_pred CcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceee
Confidence 875432110 0011346899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCc
Q 002759 799 ELVTGRKPVESPTTN 813 (884)
Q Consensus 799 el~tG~~p~~~~~~~ 813 (884)
||++|+.||......
T Consensus 228 el~tG~~Pf~~~~~~ 242 (360)
T cd05627 228 EMLIGYPPFCSETPQ 242 (360)
T ss_pred ecccCCCCCCCCCHH
Confidence 999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=297.90 Aligned_cols=238 Identities=24% Similarity=0.340 Sum_probs=188.8
Q ss_pred ceeccCCceEEEEEEEcCCe-----------EEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeE
Q 002759 600 CLIGGGSIGSVYRASFEGGV-----------SIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (884)
+.||+|+||.||+|...+.. .+++|.+..... ....+.+|+.+++.++||||+++++++.. ...++
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~l 77 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR--DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIM 77 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh--hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEE
Confidence 36899999999999775432 467777654332 26788999999999999999999999887 77899
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC-----
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY----- 743 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~----- 743 (884)
||||+++++|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++
T Consensus 78 v~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~ 143 (259)
T cd05037 78 VEEYVKFGPLDVFLHREK-----------NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGY 143 (259)
T ss_pred EEEcCCCCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCC
Confidence 999999999999987543 2578999999999999999999998 999999999999999887
Q ss_pred --CeeEccccCccccCCccCcccccccccccccCccccCCC--CCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 002759 744 --EPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL--RLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVL 818 (884)
Q Consensus 744 --~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~ 818 (884)
.+|++|||++..... .....++..|+|||++.+. .++.++||||||+++||+++ |..||......+..
T Consensus 144 ~~~~kl~Dfg~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-- 216 (259)
T cd05037 144 VPFIKLSDPGIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-- 216 (259)
T ss_pred ceeEEeCCCCccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH--
Confidence 799999999986542 2233456789999999876 78899999999999999999 67788665432211
Q ss_pred HHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 819 CEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 819 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.. ......... + ....+.+++.+||..+|.+|||+.++++.|+
T Consensus 217 -~~----~~~~~~~~~--~--------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 217 -RF----YQDQHRLPM--P--------DCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred -HH----HhcCCCCCC--C--------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 11 111111000 0 1157788889999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.53 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=197.0
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCc-----cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGR-----IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
...+.||+|+||+||+|...+++.+|+|.+..... .+....+.+|++++++++|+||+++.+++.+.+..++|+|
T Consensus 3 ~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (265)
T cd06631 3 TKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82 (265)
T ss_pred cccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEe
Confidence 35678999999999999888888999998864321 1223568899999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +|+|+||+|+||++++++.++|+|||
T Consensus 83 ~~~~~~L~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg 147 (265)
T cd06631 83 FVPGGSISSILNRFG------------PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFG 147 (265)
T ss_pred cCCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccch
Confidence 999999999996433 578889999999999999999998 99999999999999999999999999
Q ss_pred CccccCCcc-----CcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 752 LAKLLPILD-----NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 752 ~s~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
.++...... ........++..|+|||++.+..++.++||||+|+++||+++|+.||...+..+.. ....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~ 221 (265)
T cd06631 148 CARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM------FYIG 221 (265)
T ss_pred hhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH------HHhh
Confidence 987653211 11123346788999999999888999999999999999999999999764322111 1111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...... +... .....++..++.+||+.+|++||++.|+++
T Consensus 222 ~~~~~~----~~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 222 AHRGLM----PRLP---DSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hccCCC----CCCC---CCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 110010 1111 112335677888999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.89 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=196.6
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEE---EEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCc--eeEE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIA---VKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTM--QLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~va---vK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv 669 (884)
.....+||+|+|-+||+|.+ .+|..|| ||.-.....++..++|..|+.+++.++||||++++.++.+... ..+|
T Consensus 42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence 34556899999999999944 4566665 4433334445667899999999999999999999999876654 6789
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC-CCCeeEc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-NYEPKLS 748 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-~~~vkl~ 748 (884)
+|.+..|+|+.|..+.+ .++.+....|++||++||.|||++ .|+|||||||-+||||+. .|.|||+
T Consensus 122 TEL~TSGtLr~Y~kk~~------------~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIG 188 (632)
T KOG0584|consen 122 TELFTSGTLREYRKKHR------------RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIG 188 (632)
T ss_pred eecccCCcHHHHHHHhc------------cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeec
Confidence 99999999999998766 688899999999999999999998 789999999999999975 5899999
Q ss_pred cccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCC-CCCcchhhHHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES-PTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~-~~~~~~~~~~~~~~~~~~ 827 (884)
|.|+|+.... .+ .....||+.|||||+.. ..|.+.+||||||+.++||+|+.+||.. ..... +.+.+-
T Consensus 189 DLGLAtl~r~--s~-aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ-------IYKKV~ 257 (632)
T KOG0584|consen 189 DLGLATLLRK--SH-AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ-------IYKKVT 257 (632)
T ss_pred chhHHHHhhc--cc-cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH-------HHHHHH
Confidence 9999988642 22 23478999999999998 6899999999999999999999999974 23222 222333
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.....+.+.- . .++.++|.+|+.. .++|||+.|++.
T Consensus 258 SGiKP~sl~kV~----d---Pevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 258 SGIKPAALSKVK----D---PEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred cCCCHHHhhccC----C---HHHHHHHHHHhcC-chhccCHHHHhh
Confidence 333322222111 1 2577888899999 999999999985
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=317.29 Aligned_cols=254 Identities=19% Similarity=0.194 Sum_probs=194.0
Q ss_pred cccCceeccCCceEEEEEEEc---CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE---GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|...+.||+|+||.||+|... .+..||+|.+... ....+|++++++++||||+++++++......++|||+
T Consensus 94 y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~ 167 (392)
T PHA03207 94 YNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG------KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPK 167 (392)
T ss_pred eEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehh
Confidence 557788999999999999653 3577899988642 2356899999999999999999999988999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+. ++|.+++... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.++|+|||+
T Consensus 168 ~~-~~l~~~l~~~------------~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~ 231 (392)
T PHA03207 168 YK-CDLFTYVDRS------------GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGA 231 (392)
T ss_pred cC-CCHHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCcc
Confidence 95 6888888432 3689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 753 AKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
++........ ......||..|+|||++.+..++.++||||+||++|||++|+.||..............+.+.......
T Consensus 232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~ 311 (392)
T PHA03207 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPL 311 (392)
T ss_pred ccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcc
Confidence 9876532221 223457899999999999989999999999999999999999999765432211111111111111000
Q ss_pred c-----------------------ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 S-----------------------ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~-----------------------~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. ...+..+.. .....++..++.+|++.||++|||+.|++.
T Consensus 312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~ 374 (392)
T PHA03207 312 EFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRK--YGMHMDVEYLIAKMLTFDQEFRPSAQDILS 374 (392)
T ss_pred ccCCccchhHHHHHHhhcccccCCccccchhhc--cCcchhHHHHHHHHhccChhhCCCHHHHhh
Confidence 0 000000000 011235677888999999999999999985
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=317.11 Aligned_cols=241 Identities=22% Similarity=0.263 Sum_probs=185.1
Q ss_pred eccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcC---CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 602 IGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNI---RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 602 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
||+|+||+||+|... +++.||+|++.... .......+..|..++... +||||+++++++......++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999764 58899999985422 112334455666666554 699999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.+++.... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||+|||+++.
T Consensus 81 g~L~~~l~~~~------------~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 81 GELFWHLQKEG------------RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKA 145 (330)
T ss_pred ChHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcC
Confidence 99999886433 588999999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.... ........|+..|+|||++.+. .++.++||||+||++|||++|+.||......+.. ..+......
T Consensus 146 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~-------~~i~~~~~~-- 215 (330)
T cd05586 146 NLTD-NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMY-------RNIAFGKVR-- 215 (330)
T ss_pred CCCC-CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHH-------HHHHcCCCC--
Confidence 4321 1223445789999999998754 4789999999999999999999999865433221 111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPS----MAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt----~~ell~ 873 (884)
+.. .. ...++.+++.+||+.||++||+ +.++++
T Consensus 216 ~~~---~~---~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 216 FPK---NV---LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCC---cc---CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 000 11 1235567888899999999984 555543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=297.83 Aligned_cols=248 Identities=25% Similarity=0.369 Sum_probs=199.8
Q ss_pred ccccCceeccCCceEEEEEEEcC-CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 595 LLDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
.|+..+.||+|+||.||+|...+ +..+++|.+.... ..+++.+|++++++++||||+++++++......++++||+
T Consensus 4 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 4 VFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE---DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred cchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH---HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 34567789999999999998764 7889999986533 2678999999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++.... ..+++..+..++.|+++|+.|||+. +++||||+|+||+++.++.++|+|||.+
T Consensus 81 ~~~~L~~~l~~~~-----------~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~ 146 (256)
T cd06612 81 GAGSVSDIMKITN-----------KTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVS 146 (256)
T ss_pred CCCcHHHHHHhCc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccc
Confidence 9999999986432 3689999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
........ ......++..|+|||++.+..++.++||||||+++|||++|+.||......+.. .. ......
T Consensus 147 ~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~------~~-~~~~~~-- 216 (256)
T cd06612 147 GQLTDTMA-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI------FM-IPNKPP-- 216 (256)
T ss_pred hhcccCcc-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh------hh-hccCCC--
Confidence 87653221 223345788999999999888999999999999999999999999864432211 00 000000
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+.. ........++.+++.+||+.+|++|||+.|+++
T Consensus 217 ---~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 ---PTL-SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred ---CCC-CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000 011222346778888999999999999999985
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=299.36 Aligned_cols=248 Identities=24% Similarity=0.365 Sum_probs=192.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecC------Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSS------TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------~~~~ 667 (884)
|+..+.||+|+||+||+|... +++.||+|++.... .....+..|+..+.++ +|||++++.+++... ...+
T Consensus 8 y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (272)
T cd06637 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG--DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLW 85 (272)
T ss_pred hhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC--ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEE
Confidence 445678999999999999764 57889999986433 4556788999999988 799999999998643 4578
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+++++|.+++.... ...+++..+..++.|++.|++|||+. +|+||||||+||++++++.++|
T Consensus 86 iv~e~~~~~~L~~~l~~~~----------~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l 152 (272)
T cd06637 86 LVMEFCGAGSVTDLIKNTK----------GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKL 152 (272)
T ss_pred EEEEcCCCCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEE
Confidence 9999999999999987532 23588999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~ 822 (884)
+|||+++...... .......++..|+|||++. ...++.++||||+||++|||++|+.||.........
T Consensus 153 ~Dfg~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~------ 225 (272)
T cd06637 153 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL------ 225 (272)
T ss_pred ccCCCceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH------
Confidence 9999998654221 1233456788999999986 345788999999999999999999999754322111
Q ss_pred HHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
............+ .....++.+++.+||+.+|.+|||+.|+++
T Consensus 226 -~~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 226 -FLIPRNPAPRLKS-------KKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred -HHHhcCCCCCCCC-------CCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0111111111100 112235778888999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=310.53 Aligned_cols=190 Identities=20% Similarity=0.269 Sum_probs=161.1
Q ss_pred cccccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 594 ALLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
.-|...+.||+|+||.||+|... ++..||+|+.... ....|+.++++++||||+++++++......++|+||
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~-------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 138 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG-------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH 138 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc-------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence 34667889999999999999775 4678888875432 235689999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+. ++|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||.
T Consensus 139 ~~-~~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~ 203 (357)
T PHA03209 139 YS-SDLYTYLTKRS-----------RPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGA 203 (357)
T ss_pred cC-CcHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcc
Confidence 94 68888886432 3689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV 807 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~ 807 (884)
++.... ........|+..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 204 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 204 AQFPVV--APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred cccccc--CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 975331 12233456899999999999989999999999999999999955554
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=296.67 Aligned_cols=250 Identities=22% Similarity=0.330 Sum_probs=201.1
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||.|+||.||.+.. .++..+++|.+.... .......+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (256)
T cd08221 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYA 81 (256)
T ss_pred ceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEec
Confidence 34667899999999999965 457889999886432 3345677899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 82 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~ 148 (256)
T cd08221 82 NGGTLYDKIVRQK----------GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGIS 148 (256)
T ss_pred CCCcHHHHHHhcc----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcce
Confidence 9999999987542 23578999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
........ ......++..|+|||...+..++.++||||+|+++|||++|..||......+. ..... .+....
T Consensus 149 ~~~~~~~~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~-~~~~~~ 220 (256)
T cd08221 149 KILGSEYS-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNL------VVKIV-QGNYTP 220 (256)
T ss_pred EEcccccc-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-cCCCCC
Confidence 87643221 23345678899999999888889999999999999999999999976443221 11111 111111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
. ......++.+++.+||+.+|++||+++|+++.
T Consensus 221 ~--------~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 221 V--------VSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred C--------ccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 1 12223457788889999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=302.56 Aligned_cols=261 Identities=23% Similarity=0.256 Sum_probs=194.0
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...+.||+|++|.||+|... ++..||+|++.... .......+.+|+.++.+++|||++++++++.++...++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (285)
T cd07861 3 TKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS 82 (285)
T ss_pred eEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC
Confidence 35678999999999999764 68899999986432 22335678899999999999999999999999999999999997
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... ....+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 83 -~~l~~~~~~~~---------~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 149 (285)
T cd07861 83 -MDLKKYLDSLP---------KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149 (285)
T ss_pred -CCHHHHHhcCC---------CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECccccee
Confidence 58888886432 124688999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc-----
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER----- 828 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~----- 828 (884)
..... ........++..|+|||++.+ ..++.++||||+|+++|||++|+.||......+.. ....+.....
T Consensus 150 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~--~~~~~~~~~~~~~~~ 226 (285)
T cd07861 150 AFGIP-VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQL--FRIFRILGTPTEDVW 226 (285)
T ss_pred ecCCC-cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHhCCCChhhh
Confidence 65422 111233456788999998865 35688999999999999999999999865432111 1111000000
Q ss_pred ------CCCccccc----ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 ------GSASACFD----RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ------~~~~~~~d----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
......++ ............++.+++.+||+.||++|||+.+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 227 PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred hcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0000001112235678888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=296.10 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=200.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.+|+|+||.||+|... ++..+++|.+..... ...+.+.+|++++++++||||+++++++.+....+++|||++
T Consensus 5 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~ 83 (262)
T cd06613 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG-DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83 (262)
T ss_pred eEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch-hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCC
Confidence 446678999999999999764 567899999875432 356788999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ..+++.++..++.|++.||+|||+. +++||||+|+||++++++.++|+|||.+.
T Consensus 84 ~~~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~ 149 (262)
T cd06613 84 GGSLQDIYQVTR-----------GPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSA 149 (262)
T ss_pred CCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccch
Confidence 999999886542 3588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCC---CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSL---RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
..... ........++..|+|||.+.+. .++.++||||||+++|||++|+.||......+... . ......
T Consensus 150 ~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~------~-~~~~~~ 221 (262)
T cd06613 150 QLTAT-IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALF------L-ISKSNF 221 (262)
T ss_pred hhhhh-hhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH------H-HHhccC
Confidence 65432 1122345678889999999876 78899999999999999999999997654322211 0 111100
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+...........++.+++.+||+.+|.+|||+.+++.
T Consensus 222 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 222 ----PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred ----CCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00001112333456888999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.32 Aligned_cols=202 Identities=21% Similarity=0.281 Sum_probs=171.1
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|... +++.||+|++.... .......+.+|+.++..++|+||+++++++.+++..++||||
T Consensus 3 y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (331)
T cd05597 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDY 82 (331)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEec
Confidence 446678999999999999764 57899999986421 223456688899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... ..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~g~~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~ 148 (331)
T cd05597 83 YVGGDLLTLLSKFE-----------DRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGS 148 (331)
T ss_pred CCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCc
Confidence 99999999996432 3578899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCC-----CCCCCccCchhHHHHHHHHHhCCCCCCCCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQS-----LRLSDKCDVYSFGVILLELVTGRKPVESPT 811 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~ 811 (884)
+...............|+..|+|||++.. ..++.++||||+||++|||++|+.||....
T Consensus 149 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 149 CLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred eeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 97664333222333568999999999863 356789999999999999999999997654
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=310.46 Aligned_cols=260 Identities=17% Similarity=0.224 Sum_probs=191.4
Q ss_pred CceeccC--CceEEEEEEE-cCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 599 ECLIGGG--SIGSVYRASF-EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 599 ~~~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
.++||+| +|++||++.. .+++.||+|++..... ....+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4578999 6789999965 5788999999965432 2234567889999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+.
T Consensus 83 ~~~l~~~~~~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~ 149 (327)
T cd08227 83 YGSAKDLICTHF----------MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNL 149 (327)
T ss_pred CCcHHHHHHhhc----------cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhh
Confidence 999999986432 22478999999999999999999998 99999999999999999999999998654
Q ss_pred ccCCccCc------ccccccccccccCccccCC--CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 755 LLPILDNY------GLTKFHNAVGYVAPELAQS--LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 755 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
........ ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... ........
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~ 227 (327)
T cd08227 150 SMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML--LEKLNGTV 227 (327)
T ss_pred ccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH--HHHhcCCc
Confidence 43211110 0112345677999999975 46889999999999999999999999764322111 00000000
Q ss_pred H---------cCC-----Cccccccc------------------CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 E---------RGS-----ASACFDRS------------------LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~---------~~~-----~~~~~d~~------------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+ ... .....+.. ..........++.+++.+||+.||++|||++|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 228 PCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred cccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 0 000 00000000 00011122346788999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=300.72 Aligned_cols=247 Identities=21% Similarity=0.307 Sum_probs=198.7
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||.|++|.||+|.. .+++.|++|.+.... ....+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 21 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 21 YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK-QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred EEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc-CchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 45667899999999999965 568899999986433 2446778899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.+||+|||++.
T Consensus 100 ~~~L~~~~~~~-------------~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~ 163 (296)
T cd06655 100 GGSLTDVVTET-------------CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCA 163 (296)
T ss_pred CCcHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccch
Confidence 99999988532 478999999999999999999998 99999999999999999999999999988
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
....... ......++..|+|||.+.+..++.++|||||||++|++++|+.||...+..+.. ....... ....
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~------~~~~~~~-~~~~ 235 (296)
T cd06655 164 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL------YLIATNG-TPEL 235 (296)
T ss_pred hcccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhcC-Cccc
Confidence 6543222 223346788999999999888999999999999999999999999875532221 1111111 0000
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.........+.+++.+||+.+|++|||+.++++
T Consensus 236 ------~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 ------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ------CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011122335777888999999999999999984
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=297.92 Aligned_cols=246 Identities=26% Similarity=0.392 Sum_probs=194.7
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccCccC--------CHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeE
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIR--------NQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (884)
....||+|++|.||+|.. .+++.+|+|.+....... ..+.+.+|+.++++++||||+++++++.+....++
T Consensus 4 ~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (267)
T cd06628 4 KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNI 83 (267)
T ss_pred ccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEE
Confidence 456899999999999966 457889999885432111 12568889999999999999999999999999999
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++|+
T Consensus 84 v~e~~~~~~L~~~l~~~~------------~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~ 148 (267)
T cd06628 84 FLEYVPGGSVAALLNNYG------------AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKIS 148 (267)
T ss_pred EEEecCCCCHHHHHHhcc------------CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEec
Confidence 999999999999996533 578889999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCc-----ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 002759 749 DYGLAKLLPILDNY-----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR 823 (884)
Q Consensus 749 Dfg~s~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~ 823 (884)
|||.++........ ......++..|+|||.+.+..++.++||||+|+++|||++|+.||........ ..
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~ 222 (267)
T cd06628 149 DFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IF 222 (267)
T ss_pred ccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HH
Confidence 99999876521110 11234577889999999988899999999999999999999999986432211 11
Q ss_pred HHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 824 ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 824 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... .. .+. .+......+.+++.+||+.+|.+||++.|+++
T Consensus 223 ~~~~-~~-----~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 223 KIGE-NA-----SPE---IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred HHhc-cC-----CCc---CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 1111 10 011 11222346777888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=301.62 Aligned_cols=262 Identities=21% Similarity=0.271 Sum_probs=197.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+....||+|++|.||+|... +++.||+|++.... .....+.+.+|+.++++++|||++++++++......++||||+
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~ 82 (286)
T cd07847 3 YEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYC 82 (286)
T ss_pred eeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEecc
Confidence 445678999999999999775 58899999986433 2233466889999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+++.+..++... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++
T Consensus 83 ~~~~l~~~~~~~------------~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~ 147 (286)
T cd07847 83 DHTVLNELEKNP------------RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFA 147 (286)
T ss_pred CccHHHHHHhCC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccc
Confidence 998887776432 2588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHH-------
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC-EYVRE------- 824 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~-~~~~~------- 824 (884)
........ ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+..... .....
T Consensus 148 ~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07847 148 RILTGPGD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 226 (286)
T ss_pred eecCCCcc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 87653221 2233456788999999875 45788999999999999999999999875543322111 00000
Q ss_pred HHHcCCC-c--ccccccCC----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 825 LLERGSA-S--ACFDRSLR----GFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 825 ~~~~~~~-~--~~~d~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
....... . ...++... ...+.....+.+++.+||+.+|++|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 227 IFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred hcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 0000000 0 00000000 001112346778899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=313.30 Aligned_cols=258 Identities=22% Similarity=0.239 Sum_probs=192.2
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 667 (884)
|+..+.||+|+||.||+|.. ..++.||+|++.... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 19 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 98 (355)
T cd07874 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVY 98 (355)
T ss_pred eeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeE
Confidence 45677899999999999965 467889999986432 223356778899999999999999999988543 3468
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+++ ++.+.+.. .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||
T Consensus 99 lv~e~~~~-~l~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl 160 (355)
T cd07874 99 LVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_pred EEhhhhcc-cHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEE
Confidence 99999965 67666641 367888999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhH-H-------
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVL-C------- 819 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~-~------- 819 (884)
+|||+++.... ........++..|+|||++.+..++.++|||||||++|||++|+.||...+..+.... .
T Consensus 161 ~Dfg~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 161 LDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eeCcccccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999986542 2223456789999999999998999999999999999999999999986542221100 0
Q ss_pred --------HHHHHHHHc-CCCccc-----ccccCC----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 820 --------EYVRELLER-GSASAC-----FDRSLR----GFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 820 --------~~~~~~~~~-~~~~~~-----~d~~~~----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
......... +..... +..... ........++.+++.+|++.||++|||+.|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 000011100 000000 000000 011112345678889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=314.35 Aligned_cols=191 Identities=19% Similarity=0.184 Sum_probs=162.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|+||.||+|... .++.||||.... ..+.+|++++++++|+||+++++++...+..++|||++.
T Consensus 171 y~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~-------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~ 243 (461)
T PHA03211 171 FAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY-------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR 243 (461)
T ss_pred eEEEEEEccCCCeEEEEEEECCCCCEEEEecccc-------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC
Confidence 456678999999999999775 467899996432 335789999999999999999999999999999999994
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... ..+++.+++.++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 244 -~~L~~~l~~~~-----------~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~ 308 (461)
T PHA03211 244 -SDLYTYLGARL-----------RPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAAC 308 (461)
T ss_pred -CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCce
Confidence 68988886432 2589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCC
Q 002759 755 LLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVE 808 (884)
Q Consensus 755 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~ 808 (884)
........ ......||..|+|||++.+..++.++|||||||++|||++|..|+.
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 76432111 1224568999999999999999999999999999999999887654
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=296.82 Aligned_cols=245 Identities=29% Similarity=0.452 Sum_probs=195.3
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
++..+.||+|+||.||+|.. .++.||+|.+... .....+.+|+.+++.++|||++++++++... ..++||||+++
T Consensus 8 ~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~---~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~ 82 (254)
T cd05083 8 LTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD---VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSK 82 (254)
T ss_pred ceeeeeeccCCCCceEeccc-CCCceEEEeecCc---chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCC
Confidence 34678899999999999975 4668999998642 2356788999999999999999999988654 47999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ...+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+||+|||.++.
T Consensus 83 ~~L~~~l~~~~----------~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~ 149 (254)
T cd05083 83 GNLVNFLRTRG----------RALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARV 149 (254)
T ss_pred CCHHHHHHhcC----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCcccee
Confidence 99999997543 23578899999999999999999988 999999999999999999999999999876
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.... ......+..|+|||.+.+..++.++||||+|+++|||++ |+.||......+. ...........
T Consensus 150 ~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-------~~~~~~~~~~~- 217 (254)
T cd05083 150 GSMG----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV-------KECVEKGYRME- 217 (254)
T ss_pred cccc----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH-------HHHHhCCCCCC-
Confidence 4321 122334567999999988889999999999999999998 9999976543322 11122111111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
+ .......+.+++.+||+.+|++||+++++++.|++
T Consensus 218 --~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 218 --P-----PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred --C-----CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 11123467788889999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=297.40 Aligned_cols=256 Identities=22% Similarity=0.329 Sum_probs=202.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||.|+||+||+|... ++..+++|++...........+.+|++.++.++|+|++++++.+..++..++|+||++
T Consensus 3 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 82 (267)
T cd06610 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82 (267)
T ss_pred ceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccC
Confidence 346678999999999999764 6778999998654433467789999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ....+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||++.
T Consensus 83 ~~~l~~~~~~~~---------~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~ 150 (267)
T cd06610 83 GGSLLDIMKSSY---------PRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSA 150 (267)
T ss_pred CCcHHHHHHHhc---------ccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHH
Confidence 999999997543 123588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCc---ccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 755 LLPILDNY---GLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 755 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
.+...... ......++..|+|||++... .++.++|+||||+++|||++|+.||......+.. .+......
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~------~~~~~~~~ 224 (267)
T cd06610 151 SLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL------MLTLQNDP 224 (267)
T ss_pred HhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH------HHHhcCCC
Confidence 76543222 12334578899999998776 7889999999999999999999999865443211 11111111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .++... .......++.+++.+||+.+|++|||++|+++
T Consensus 225 ~--~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 P--SLETGA--DYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred C--CcCCcc--ccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 011100 01123346778888999999999999999975
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=326.54 Aligned_cols=258 Identities=22% Similarity=0.244 Sum_probs=186.8
Q ss_pred ccccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC------CCCcceeeeEEecC-Cce
Q 002759 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR------HFNLVAFQGYYWSS-TMQ 666 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~-~~~ 666 (884)
.|...++||+|+||+||+|.. ..++.||||+++... .....+..|+.++..++ |++++++++++... ...
T Consensus 130 ~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~--~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~ 207 (467)
T PTZ00284 130 RFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP--KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHM 207 (467)
T ss_pred cEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch--hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceE
Confidence 355778999999999999966 457889999986432 23344566777766664 45588888888654 568
Q ss_pred eEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC---
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY--- 743 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~--- 743 (884)
++|||++ +++|.+++...+ .+++..+..++.||+.||+|||++. +||||||||+|||++.++
T Consensus 208 ~iv~~~~-g~~l~~~l~~~~------------~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~ 272 (467)
T PTZ00284 208 CIVMPKY-GPCLLDWIMKHG------------PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVV 272 (467)
T ss_pred EEEEecc-CCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccc
Confidence 8999988 778998886443 5889999999999999999999731 899999999999998765
Q ss_pred -------------CeeEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCC
Q 002759 744 -------------EPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESP 810 (884)
Q Consensus 744 -------------~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~ 810 (884)
.+||+|||.+.... .......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 348 (467)
T PTZ00284 273 DPVTNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH 348 (467)
T ss_pred ccccccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 49999999886432 2234567899999999999999999999999999999999999999875
Q ss_pred CCcchhhHHHHHH-----------------HHHHc-CCCcccccccC-----C--CCc-HHHHHHHHHHHhhccCCCCCC
Q 002759 811 TTNEVVVLCEYVR-----------------ELLER-GSASACFDRSL-----R--GFA-ENELIQVMKLGLICTSEVPSR 864 (884)
Q Consensus 811 ~~~~~~~~~~~~~-----------------~~~~~-~~~~~~~d~~~-----~--~~~-~~~~~~l~~l~~~cl~~~P~~ 864 (884)
...+....+.... ..... .....+.++.. . ... ......+.+++.+|++.||++
T Consensus 349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~ 428 (467)
T PTZ00284 349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK 428 (467)
T ss_pred ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence 5433322111100 00000 00000011000 0 000 001234678999999999999
Q ss_pred CCCHHHHHH
Q 002759 865 RPSMAEVVQ 873 (884)
Q Consensus 865 RPt~~ell~ 873 (884)
|||++|+++
T Consensus 429 R~ta~e~L~ 437 (467)
T PTZ00284 429 RLNARQMTT 437 (467)
T ss_pred CCCHHHHhc
Confidence 999999986
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=298.59 Aligned_cols=246 Identities=25% Similarity=0.367 Sum_probs=198.8
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||.|++|.||+|... ++..||+|.+...........+.+|+++++.++|+|++++.+++.++...++|+||+++
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~ 83 (274)
T cd06609 4 TLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGG 83 (274)
T ss_pred hhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCC
Confidence 35567999999999999765 67899999987544345567789999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++... .+++..+..++.|++.|+.|||++ +++||||+|+||++++++.++++|||.++.
T Consensus 84 ~~L~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~ 147 (274)
T cd06609 84 GSCLDLLKPG-------------KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQ 147 (274)
T ss_pred CcHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccccccee
Confidence 9999998632 478999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
..... .......++..|+|||++.+..++.++||||||+++|||++|+.||...+..+.. . .........
T Consensus 148 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~------~-~~~~~~~~~-- 217 (274)
T cd06609 148 LTSTM-SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL------F-LIPKNNPPS-- 217 (274)
T ss_pred ecccc-cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHH------H-HhhhcCCCC--
Confidence 75322 2223456778899999999888999999999999999999999999765432211 1 111111111
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... ....++.+++.+||..+|++|||++++++
T Consensus 218 ---~~~~--~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 218 ---LEGN--KFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred ---Cccc--ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 1110 02335777888999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-33 Score=307.90 Aligned_cols=253 Identities=17% Similarity=0.220 Sum_probs=192.5
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|...+.||+|+||+||+|... +++.||+|.+.... .......+.+|..++..++|++|+++++++.+.+..++||||
T Consensus 3 y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey 82 (331)
T cd05624 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDY 82 (331)
T ss_pred ceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeC
Confidence 446678999999999999765 57789999986421 223345678899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~gg~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~ 148 (331)
T cd05624 83 YVGGDLLTLLSKFE-----------DRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGS 148 (331)
T ss_pred CCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccc
Confidence 99999999997532 2578889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCC-----CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQS-----LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
++..............|+..|+|||++.+ ..++.++||||+||++|||++|+.||......+.. .....
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~ 222 (331)
T cd05624 149 CLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMN 222 (331)
T ss_pred eeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH------HHHHc
Confidence 98765333222334568999999999875 46788999999999999999999999865432211 11111
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHH
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSR--RPSMAEVVQ 873 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPt~~ell~ 873 (884)
.. ....++.... ....++.+++.+|+..++++ |++++++++
T Consensus 223 ~~-~~~~~p~~~~----~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~ 265 (331)
T cd05624 223 HE-ERFQFPSHIT----DVSEEAKDLIQRLICSRERRLGQNGIEDFKK 265 (331)
T ss_pred CC-CcccCCCccc----cCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence 11 1001111111 12235666777788765544 467887764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=311.77 Aligned_cols=258 Identities=22% Similarity=0.251 Sum_probs=192.3
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 667 (884)
|...+.||+|+||.||+|.. ..++.||||++.... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 26 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~ 105 (364)
T cd07875 26 YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVY 105 (364)
T ss_pred eeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEE
Confidence 45677899999999999965 457889999986432 233456788999999999999999999987543 3569
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+++ ++.+.+.. .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||
T Consensus 106 lv~e~~~~-~l~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL 167 (364)
T cd07875 106 IVMELMDA-NLCQVIQM--------------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 167 (364)
T ss_pred EEEeCCCC-CHHHHHHh--------------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEE
Confidence 99999965 77776641 367888999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHH-H------
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC-E------ 820 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~-~------ 820 (884)
+|||+++.... ........++..|+|||++.+..++.++||||+||++|||++|+.||...+..+..... .
T Consensus 168 ~DfG~a~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 168 LDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred EeCCCccccCC--CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999986542 22234557899999999999999999999999999999999999999865433221110 0
Q ss_pred ---------HHHHHHHc-CCCcc-cccccCCC--------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 821 ---------YVRELLER-GSASA-CFDRSLRG--------FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 821 ---------~~~~~~~~-~~~~~-~~d~~~~~--------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
........ +.... .++..... .......++.+++.+|++.||.+|||+.|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~ 317 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ 317 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 00000000 00000 00000000 00111235678889999999999999999986
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=301.51 Aligned_cols=247 Identities=22% Similarity=0.312 Sum_probs=198.0
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|++|.||+|.. .+++.||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++||||++
T Consensus 21 y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 99 (297)
T cd06656 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 99 (297)
T ss_pred ceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCc-cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccC
Confidence 44667899999999999975 578899999986433 2345678899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++... .+++.++..++.|++.||.|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 100 ~~~L~~~~~~~-------------~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~ 163 (297)
T cd06656 100 GGSLTDVVTET-------------CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (297)
T ss_pred CCCHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccce
Confidence 99999998632 468889999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
...... .......++..|+|||.+.+..++.++|||||||++|++++|+.||...+...... .....+...
T Consensus 164 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~------~~~~~~~~~-- 234 (297)
T cd06656 164 QITPEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY------LIATNGTPE-- 234 (297)
T ss_pred EccCCc-cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee------eeccCCCCC--
Confidence 654322 12234567888999999998889999999999999999999999997654322110 000000000
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .........+.+++.+||+.+|++||+++++++
T Consensus 235 ----~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 ----L-QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----C-CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 011222335677888999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=298.02 Aligned_cols=248 Identities=24% Similarity=0.319 Sum_probs=193.7
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
..+.||+|+||.||+|... +++.||+|.++... ......+.+|+.+++.++||||+++++++...+..++||||++++
T Consensus 13 ~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 91 (267)
T cd06645 13 LIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP-GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG 91 (267)
T ss_pred HHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence 4567999999999999664 57889999886432 234456788999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... .+++.++..++.|++.|+.|||+. +++|+||||+||+++.++.++|+|||.+...
T Consensus 92 ~L~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd06645 92 SLQDIYHVTG------------PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQI 156 (267)
T ss_pred cHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEc
Confidence 9999986433 588999999999999999999998 9999999999999999999999999998765
Q ss_pred CCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
... ........++..|+|||++. ...++.++||||+||++|||++|+.||.......... .... ....
T Consensus 157 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~------~~~~-~~~~- 227 (267)
T cd06645 157 TAT-IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTK-SNFQ- 227 (267)
T ss_pred cCc-ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHH------hhhc-cCCC-
Confidence 421 22223456888999999874 4457889999999999999999999997644322110 0000 0100
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.... .......+.+++.+||+.+|++|||++++++
T Consensus 228 --~~~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 228 --PPKLKD-KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred --CCcccc-cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 000000 0011235677888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=331.33 Aligned_cols=258 Identities=22% Similarity=0.334 Sum_probs=195.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEec--CCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e 671 (884)
|...+.||+|+||+||+|... ++..+|+|.+.... .......+..|+.++++++||||+++++++.. ....++|||
T Consensus 15 YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVME 94 (1021)
T PTZ00266 15 YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILME 94 (1021)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEe
Confidence 456788999999999999764 56788899886432 22345678999999999999999999998754 356899999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC----CCCeEeccCCCCceEeCC------
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDC----KPPILHLNLKSTNILLDE------ 741 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~----~~~ivH~Dlk~~Nil~~~------ 741 (884)
|+++++|.+++.... .....+++..++.|+.||+.||+|||+.. ..+||||||||+|||++.
T Consensus 95 Y~~gGSL~~lL~k~~--------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 95 FCDAGDLSRNIQKCY--------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CCCCCcHHHHHHHHh--------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 999999999986432 01236899999999999999999999852 125999999999999964
Q ss_pred -----------CCCeeEccccCccccCCccCcccccccccccccCccccCC--CCCCCccCchhHHHHHHHHHhCCCCCC
Q 002759 742 -----------NYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS--LRLSDKCDVYSFGVILLELVTGRKPVE 808 (884)
Q Consensus 742 -----------~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gv~l~el~tG~~p~~ 808 (884)
.+.+||+|||++..+... .......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~ 244 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFH 244 (1021)
T ss_pred cccccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCC
Confidence 335899999999876422 12234578999999999854 457889999999999999999999997
Q ss_pred CCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH--HHHHHh
Q 002759 809 SPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV--QVLESI 878 (884)
Q Consensus 809 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell--~~L~~~ 878 (884)
...... .........+.. .... ...++.++|..||+.+|.+||++.|++ ..+..+
T Consensus 245 ~~~~~~-----qli~~lk~~p~l------pi~~----~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i 301 (1021)
T PTZ00266 245 KANNFS-----QLISELKRGPDL------PIKG----KSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV 301 (1021)
T ss_pred cCCcHH-----HHHHHHhcCCCC------CcCC----CCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence 644321 111111111110 0111 124677888899999999999999998 445443
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=311.05 Aligned_cols=254 Identities=20% Similarity=0.283 Sum_probs=189.9
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 667 (884)
|...+.||+|+||.||+|.. .++..||||++.... .......+.+|+.++++++||||+++++++... ...+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07878 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVY 96 (343)
T ss_pred hhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEE
Confidence 45677899999999999965 467889999986432 223456678899999999999999999987533 3468
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
++++++ +++|.+++... .+++..+..++.||++||+|||+. +|+||||||+||+++.++.+||
T Consensus 97 ~~~~~~-~~~l~~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl 159 (343)
T cd07878 97 LVTNLM-GADLNNIVKCQ-------------KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRI 159 (343)
T ss_pred EEeecC-CCCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEE
Confidence 999988 77998877532 488999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
+|||+++.... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||......+.. .......
T Consensus 160 ~Dfg~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~~~~~~ 232 (343)
T cd07878 160 LDFGLARQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL---KRIMEVV 232 (343)
T ss_pred cCCccceecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHHh
Confidence 99999986542 2234568899999999876 56789999999999999999999999764432211 1111100
Q ss_pred HcCCCc----------ccccccCCCCcH--------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGSAS----------ACFDRSLRGFAE--------NELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~----------~~~d~~~~~~~~--------~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...... ..+...+..... .....+.+++.+|++.||.+|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~ 297 (343)
T cd07878 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA 297 (343)
T ss_pred CCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 000000 000000000000 11124678889999999999999999984
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=295.15 Aligned_cols=249 Identities=25% Similarity=0.355 Sum_probs=196.7
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEec-CCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS-STMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 672 (884)
|+..+.||+|++|.||+|... +++.+|+|++.... .....+.+.+|++++++++|+|++++.+.+.. ....++||||
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~ 81 (257)
T cd08223 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81 (257)
T ss_pred ceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecc
Confidence 345678999999999999764 56789999986432 22345678899999999999999999988754 4457899999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||+
T Consensus 82 ~~~~~l~~~l~~~~----------~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~ 148 (257)
T cd08223 82 CEGGDLYHKLKEQK----------GKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGI 148 (257)
T ss_pred cCCCcHHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccc
Confidence 99999999997532 23588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+....... .......++..|+|||+..+..++.++||||+|+++||+++|+.||...+..+. ...... ....
T Consensus 149 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~-~~~~ 220 (257)
T cd08223 149 ARVLENQC-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRIIE-GKLP 220 (257)
T ss_pred eEEecccC-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-cCCC
Confidence 98764322 222345678899999999998899999999999999999999999975432211 111111 1111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
........++.+++.+||+.+|++|||+.++++
T Consensus 221 --------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 221 --------PMPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred --------CCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 111223346778889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=298.01 Aligned_cols=249 Identities=25% Similarity=0.371 Sum_probs=200.0
Q ss_pred hcccccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 593 KALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 593 ~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+++|+..+.||+|+||.||+|.. .++..+|+|.............+.+|+.++++++||||+++++++..+...++|||
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 34566778899999999999976 46788999988644333445678899999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||
T Consensus 83 ~~~~~~l~~~i~~~-------------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg 146 (277)
T cd06641 83 YLGGGSALDLLEPG-------------PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG 146 (277)
T ss_pred eCCCCcHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecc
Confidence 99999999988532 478999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
++....... .......++..|+|||.+.+..++.++|+|||||++|||++|..||......... . .......
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~------~-~~~~~~~ 218 (277)
T cd06641 147 VAGQLTDTQ-IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL------F-LIPKNNP 218 (277)
T ss_pred cceecccch-hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHH------H-HHhcCCC
Confidence 987664321 1223345788899999998888899999999999999999999999764432211 1 1111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. . .......++.+++.+||+.+|.+||++.++++
T Consensus 219 ~-----~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 219 P-----T---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred C-----C---CCcccCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1 1 11122345777888999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=293.55 Aligned_cols=248 Identities=22% Similarity=0.351 Sum_probs=197.7
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||+|++|.||+|.. .++..+|+|.+.... .......+.+|++++++++|||++++++.+..++..++||||+
T Consensus 2 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08220 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYA 81 (256)
T ss_pred ceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecC
Confidence 34567899999999999966 467889999986432 2334678899999999999999999999998889999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC-CCeeEccccC
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGL 752 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-~~vkl~Dfg~ 752 (884)
++++|.+++.... ...+++..+.+++.|+++|++|||++ +++||||+|+||+++++ +.+|++|||.
T Consensus 82 ~~~~L~~~~~~~~----------~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~ 148 (256)
T cd08220 82 PGGTLAEYIQKRC----------NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGI 148 (256)
T ss_pred CCCCHHHHHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCC
Confidence 9999999997543 23578999999999999999999998 99999999999999865 4689999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+...... .......++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..... ...... ...
T Consensus 149 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~------~~~~~~-~~~ 219 (256)
T cd08220 149 SKILSSK--SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV------LKIMSG-TFA 219 (256)
T ss_pred ceecCCC--ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH------HHHHhc-CCC
Confidence 9876432 1223356788999999999888899999999999999999999999765433211 111111 111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .......++..++.+||+.+|++|||+.|+++
T Consensus 220 ~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 220 P--------ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred C--------CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 11112336778888999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=295.73 Aligned_cols=248 Identities=23% Similarity=0.355 Sum_probs=198.6
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|+||.||.+.. .+++.+|+|.+.... .......+.+|+.++++++||||+++.+++...+..++||||++
T Consensus 3 ~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd08218 3 VKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCE 82 (256)
T ss_pred eEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCC
Confidence 4567899999999999965 467899999986432 23345688999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ...+++.++.+++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+.
T Consensus 83 ~~~l~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~ 149 (256)
T cd08218 83 GGDLYKKINAQR----------GVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIAR 149 (256)
T ss_pred CCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeecccee
Confidence 999999886533 23578899999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
...... .......++..|+|||+..+..++.++|+||||+++||+++|+.||......+. ...... +....
T Consensus 150 ~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~-~~~~~- 220 (256)
T cd08218 150 VLNSTV-ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIR-GSYPP- 220 (256)
T ss_pred ecCcch-hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhc-CCCCC-
Confidence 664321 112234578889999999888889999999999999999999999976433221 111111 11110
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.......++.+++.+||+.+|++||++.|+++
T Consensus 221 -------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 221 -------VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -------CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11222346788888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=295.48 Aligned_cols=248 Identities=24% Similarity=0.363 Sum_probs=190.1
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCc----cCCHHHHHHHHHHHhcCCCCCcceeeeEEec--CCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR----IRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l 668 (884)
|+..+.||+|+||.||+|.. .++..|++|++..... .+....+.+|+.++++++||||+++++++.+ ....++
T Consensus 4 ~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 83 (266)
T cd06651 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTI 83 (266)
T ss_pred ccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEE
Confidence 34677899999999999966 4578999998853321 1234568889999999999999999998865 356789
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
++||+++++|.+++.... .+++.....++.|++.||+|||+. +|+||||||+||+++.++.++|+
T Consensus 84 ~~e~~~~~~L~~~l~~~~------------~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~ 148 (266)
T cd06651 84 FMEYMPGGSVKDQLKAYG------------ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLG 148 (266)
T ss_pred EEeCCCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEc
Confidence 999999999999986433 478899999999999999999988 99999999999999999999999
Q ss_pred cccCccccCCcc--CcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILD--NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||+++...... ........++..|+|||.+.+..++.++||||+|+++||+++|+.||...+..+. .....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~ 222 (266)
T cd06651 149 DFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIA 222 (266)
T ss_pred cCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHh
Confidence 999997653211 1112234578899999999988899999999999999999999999986432211 11111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... .+.+. ......+..++ .||..+|++||+++|++.
T Consensus 223 ~~~~-----~~~~~---~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 223 TQPT-----NPQLP---SHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred cCCC-----CCCCc---hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 1110 11111 11122334444 688899999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=307.09 Aligned_cols=247 Identities=22% Similarity=0.308 Sum_probs=196.7
Q ss_pred cCceeccCCceEEEEEEEcCCeE-EEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 598 KECLIGGGSIGSVYRASFEGGVS-IAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
+...+|.|+||.||+|..++... .|.|++... .....+++..||++++.++||+||++++.|+..+..+++.|||.||
T Consensus 36 IiGELGDGAFGKVyKA~nket~~lAAaKvIetk-seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GG 114 (1187)
T KOG0579|consen 36 IIGELGDGAFGKVYKAVNKETKLLAAAKVIETK-SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGG 114 (1187)
T ss_pred HHhhhcCccchhhhhhhcccchhhhhhhhhccc-chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCc
Confidence 34468999999999997765444 455666443 3467889999999999999999999999888888999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
.+...+-+.+ ..+++.++..+++|++.||.|||++ +|||||||+.|||++-+|.|+++|||.+...
T Consensus 115 AVDaimlEL~-----------r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn 180 (1187)
T KOG0579|consen 115 AVDAIMLELG-----------RVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKN 180 (1187)
T ss_pred hHhHHHHHhc-----------cccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccc
Confidence 9888775443 3689999999999999999999999 9999999999999999999999999998654
Q ss_pred CCccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
.. .......+.||+.|||||+.+ ..+|+.++||||||+++.||..+.+|.....+..+. +... +..+
T Consensus 181 ~~-t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVl--lKia-----KSeP 252 (1187)
T KOG0579|consen 181 KS-TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL--LKIA-----KSEP 252 (1187)
T ss_pred hh-HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHH--HHHh-----hcCC
Confidence 32 223345688999999999875 458999999999999999999999999876554332 1111 1111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.-.+. +..-...+.+++.+|+.++|..||+++++++
T Consensus 253 PTLlq------PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 253 PTLLQ------PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred CcccC------cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11111 2223345667778899999999999999874
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=295.35 Aligned_cols=254 Identities=22% Similarity=0.357 Sum_probs=197.1
Q ss_pred ccCceeccCCceEEEEEEEcC--CeEEEEEEccccC---------ccCCHHHHHHHHHHHhc-CCCCCcceeeeEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFEG--GVSIAVKKLETLG---------RIRNQEEFELEIGRLSN-IRHFNLVAFQGYYWSST 664 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~--~~~vavK~~~~~~---------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~ 664 (884)
+..+.||+|+||.||+|.... ++.+|+|.+.... ......++..|+.++.+ ++||||+++++++.+.+
T Consensus 3 ~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~ 82 (269)
T cd08528 3 AVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEND 82 (269)
T ss_pred hhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCC
Confidence 356689999999999998764 6789999875321 12234557778887765 79999999999999999
Q ss_pred ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCC
Q 002759 665 MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE 744 (884)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~ 744 (884)
..++||||+++++|.+++.... .....+++..+++++.|++.||.|||+. .+++||||+|+||+++.++.
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~ 152 (269)
T cd08528 83 RLYIVMDLIEGAPLGEHFNSLK--------EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDK 152 (269)
T ss_pred eEEEEEecCCCCcHHHHHHHHH--------hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCc
Confidence 9999999999999998875322 0123588899999999999999999963 18999999999999999999
Q ss_pred eeEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002759 745 PKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 745 vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~ 824 (884)
++|+|||.+....... ......++..|+|||.+.+..++.++||||||+++|||++|+.||........ ...
T Consensus 153 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~------~~~ 224 (269)
T cd08528 153 VTITDFGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL------ATK 224 (269)
T ss_pred EEEecccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH------HHH
Confidence 9999999998765322 33456678899999999988899999999999999999999999975432211 111
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.. ....... ... ....++.+++.+||+.||++||++.|+..+++
T Consensus 225 ~~-~~~~~~~----~~~---~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 IV-EAVYEPL----PEG---MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred Hh-hccCCcC----Ccc---cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 11 1111110 010 12235777888999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=296.86 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=191.5
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
....||+|+||.||+|... ++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||++++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 90 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD-SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGG 90 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCcEEEEEEecCCC-HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCC
Confidence 3457999999999999754 57789999886432 234567899999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC-CCCeeEccccCc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPEL--HWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-NYEPKLSDYGLA 753 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~--~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-~~~vkl~Dfg~s 753 (884)
+|.+++.... ..+ ++..+..++.||+.|++|||+. +|+||||||+||+++. ++.++|+|||.+
T Consensus 91 ~L~~~l~~~~-----------~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 91 SLSALLRSKW-----------GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred CHHHHHHHhc-----------ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999997532 123 7788889999999999999998 9999999999999976 679999999998
Q ss_pred cccCCccCcccccccccccccCccccCCCC--CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLR--LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
....... .......++..|+|||++.... ++.++||||||+++|+|++|+.||......... .+.......
T Consensus 157 ~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~~--- 229 (268)
T cd06624 157 KRLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFKI--- 229 (268)
T ss_pred eecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhcc---
Confidence 7654221 1223345788999999986543 788999999999999999999999754321111 000000000
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+. .+.....++.+++.+||+.+|++|||+.|+++
T Consensus 230 ----~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 230 ----HPE---IPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred ----CCC---CCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 011 11223346778889999999999999999875
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=295.10 Aligned_cols=251 Identities=21% Similarity=0.353 Sum_probs=197.6
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEccccCc-----cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEE
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR-----IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
+..+.||+|++|.||+|.. .++..+|+|.+..... ....+.+.+|+.++++++|+|++++++++.+.+..++|+
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~ 82 (268)
T cd06630 3 LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFV 82 (268)
T ss_pred cccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEE
Confidence 4567899999999999965 5688999999864321 112467899999999999999999999999999999999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC-CeeEcc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY-EPKLSD 749 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~-~vkl~D 749 (884)
||+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++ .++|+|
T Consensus 83 e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~d 147 (268)
T cd06630 83 EWMAGGSVSHLLSKYG------------AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIAD 147 (268)
T ss_pred eccCCCcHHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcc
Confidence 9999999999986433 578899999999999999999998 999999999999998776 599999
Q ss_pred ccCccccCCccC---cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 750 YGLAKLLPILDN---YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 750 fg~s~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
||.+........ .......++..|+|||.+.+..++.++||||+|+++|++++|..||.......... ......
T Consensus 148 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~---~~~~~~ 224 (268)
T cd06630 148 FGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA---LIFKIA 224 (268)
T ss_pred cccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH---HHHHHh
Confidence 999987653211 11223457889999999988889999999999999999999999997544322211 111111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
... .. ...+.....++.+++.+||+.+|++|||+.|++.
T Consensus 225 ~~~-~~-------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 225 SAT-TA-------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred ccC-CC-------CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 00 1122233456778889999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=295.29 Aligned_cols=251 Identities=27% Similarity=0.393 Sum_probs=194.2
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccCc--cC-------CHHHHHHHHHHHhcCCCCCcceeeeEEecCCcee
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR--IR-------NQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQL 667 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (884)
..+.||+|++|.||+|.. .+++.+|+|.++.... .. ..+.+.+|+.+++.++|||++++++++...+..+
T Consensus 5 ~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (272)
T cd06629 5 KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLS 84 (272)
T ss_pred ecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceE
Confidence 567899999999999965 4678999998753211 01 1246788999999999999999999999999999
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+++++|.++++... .+++..+..++.||+.||.|||+. +++||||+|+||+++.++.+++
T Consensus 85 lv~e~~~~~~L~~~l~~~~------------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l 149 (272)
T cd06629 85 IFLEYVPGGSIGSCLRTYG------------RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKI 149 (272)
T ss_pred EEEecCCCCcHHHHHhhcc------------CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEE
Confidence 9999999999999987543 578899999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccC-cccccccccccccCccccCCCC--CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002759 748 SDYGLAKLLPILDN-YGLTKFHNAVGYVAPELAQSLR--LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~ 824 (884)
+|||.++....... .......++..|+|||++.... ++.++|+||+|+++||+++|..||......+. ..+
T Consensus 150 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~------~~~ 223 (272)
T cd06629 150 SDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA------MFK 223 (272)
T ss_pred eeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH------HHH
Confidence 99999976542211 1123456788999999987654 78899999999999999999999965332211 111
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... .....++.. ........+.+++.+||+.+|++|||++++++
T Consensus 224 ~~~~-~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 224 LGNK-RSAPPIPPD---VSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred hhcc-ccCCcCCcc---ccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 1111 111111111 11223456778888999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=304.76 Aligned_cols=254 Identities=18% Similarity=0.205 Sum_probs=191.1
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|...+.||+|+||+||++... +++.+|+|++.... .......+..|+.++..++|++|+++++++.+.+..++||||
T Consensus 3 y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey 82 (332)
T cd05623 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDY 82 (332)
T ss_pred ceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEec
Confidence 346678999999999999775 46789999985421 122345578899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++|+|.+++.... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+|||+
T Consensus 83 ~~~g~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~ 148 (332)
T cd05623 83 YVGGDLLTLLSKFE-----------DRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGS 148 (332)
T ss_pred cCCCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecch
Confidence 99999999997532 2578889999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
+...............||..|+|||++. ...++.++|||||||++|||++|+.||...+..+.. .....
T Consensus 149 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~------~~i~~ 222 (332)
T cd05623 149 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY------GKIMN 222 (332)
T ss_pred heecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHH------HHHhC
Confidence 9765432222233457899999999986 345788999999999999999999999865433221 11111
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHH
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEV--PSRRPSMAEVVQV 874 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~--P~~RPt~~ell~~ 874 (884)
.. ....+...... ...++.+++.+|+..+ +..|++++|+++.
T Consensus 223 ~~-~~~~~p~~~~~----~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 223 HK-ERFQFPAQVTD----VSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CC-ccccCCCcccc----CCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11 10001111111 1224555666666544 4447899988754
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=296.10 Aligned_cols=250 Identities=25% Similarity=0.336 Sum_probs=199.8
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||+|++|.||+|... +++.+++|.+..........++.+|++++++++||||+++++++......++|+||+++
T Consensus 4 ~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (265)
T cd06605 4 EYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDG 83 (265)
T ss_pred hHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCC
Confidence 34567999999999999775 57889999987654445567889999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH-DCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... ..++...+..++.|+++|++|||+ . +++||||||+||++++++.++|+|||.+.
T Consensus 84 ~~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~ 149 (265)
T cd06605 84 GSLDKILKEVQ-----------GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSG 149 (265)
T ss_pred CcHHHHHHHcc-----------CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccch
Confidence 99999987542 367889999999999999999998 7 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
...... .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ....+............
T Consensus 150 ~~~~~~---~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~-- 223 (265)
T cd06605 150 QLVNSL---AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPPPR-- 223 (265)
T ss_pred hhHHHH---hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCCCC--
Confidence 653211 112667889999999998899999999999999999999999997643211 11122222222211111
Q ss_pred ccccCCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAEN-ELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... ...++.+++..||..+|++|||+.|++.
T Consensus 224 -------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 224 -------LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred -------CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 1111 3345778888999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=296.74 Aligned_cols=257 Identities=25% Similarity=0.336 Sum_probs=197.0
Q ss_pred cCceeccCCceEEEEEEEc----CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC------ce
Q 002759 598 KECLIGGGSIGSVYRASFE----GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST------MQ 666 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 666 (884)
..+.||+|+||.||+|.+. ++..||||.+.... .....+++.+|+.++++++||||+++++++.... ..
T Consensus 3 ~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 82 (273)
T cd05074 3 LGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIP 82 (273)
T ss_pred chhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccce
Confidence 4568999999999999753 36789999986532 2234567889999999999999999999875432 24
Q ss_pred eEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
+++++|+++|+|.+++....... ....+++..+.+++.|++.|++|||+. +|+||||||+||+++.++.+|
T Consensus 83 ~~~~~~~~~~~l~~~~~~~~~~~------~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~k 153 (273)
T cd05074 83 MVILPFMKHGDLHTFLLMSRIGE------EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVC 153 (273)
T ss_pred EEEEecCCCCcHHHHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEE
Confidence 78899999999998875332111 112478889999999999999999998 999999999999999999999
Q ss_pred EccccCccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 002759 747 LSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~ 824 (884)
++|||.++........ ......++..|++||.+....++.++||||||+++|||++ |+.||...+..+.. .
T Consensus 154 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~---~---- 226 (273)
T cd05074 154 VADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY---N---- 226 (273)
T ss_pred ECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH---H----
Confidence 9999999876432211 1223345678999999998889999999999999999999 88998765432211 1
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~ 878 (884)
.+....... ........+.+++.+||+.+|++||++.++++.|+++
T Consensus 227 ~~~~~~~~~--------~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 227 YLIKGNRLK--------QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred HHHcCCcCC--------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 111111110 0112234788888999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.20 Aligned_cols=238 Identities=23% Similarity=0.326 Sum_probs=185.7
Q ss_pred eeccCCceEEEEEEEcC--------CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 601 LIGGGSIGSVYRASFEG--------GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
.||+|+||.||+|.... ...+++|.+.... ....+.+.+|+.+++.++|||++++++++..+...++||||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH-RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh-HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 68999999999996642 2347777775322 23356788899999999999999999999988899999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCC--------
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE-------- 744 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~-------- 744 (884)
+++|+|.++++... ..+++..+..++.||+.||+|||+. +|+||||||+||+++.++.
T Consensus 81 ~~~g~L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~ 146 (258)
T cd05078 81 VKFGSLDTYLKKNK-----------NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPF 146 (258)
T ss_pred CCCCcHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCce
Confidence 99999999997543 2578899999999999999999998 9999999999999987765
Q ss_pred eeEccccCccccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCC-CCCCCCCCcchhhHHHHH
Q 002759 745 PKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGR-KPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 745 vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~-~p~~~~~~~~~~~~~~~~ 822 (884)
++++|||.+..... .....++..|+|||++.+. .++.++||||||+++|||++|. .||...+..... .
T Consensus 147 ~~l~d~g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~---~-- 216 (258)
T cd05078 147 IKLSDPGISITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL---Q-- 216 (258)
T ss_pred EEecccccccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH---H--
Confidence 69999998875432 1234567889999999864 5788999999999999999985 666543322111 1
Q ss_pred HHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
..... .. .+.....++.+++.+||+.+|++|||++++++.|
T Consensus 217 --~~~~~--~~--------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 217 --FYEDR--HQ--------LPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred --HHHcc--cc--------CCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 11110 00 1111224677888999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=301.03 Aligned_cols=245 Identities=24% Similarity=0.346 Sum_probs=194.3
Q ss_pred CceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCc
Q 002759 599 ECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
...||+|+||.||++... ++..||+|++.... ....+.+.+|+..++.++|||++++++.+..++..++||||+++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK-QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecch-HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 346999999999999764 67889999885432 2345678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|.+++... .+++.++..++.||+.||+|||+. +|+||||||+||++++++.++|+|||++....
T Consensus 106 L~~~~~~~-------------~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 106 LTDIVTHT-------------RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred HHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 99987532 478899999999999999999998 99999999999999999999999999987654
Q ss_pred CccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccc
Q 002759 758 ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837 (884)
Q Consensus 758 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 837 (884)
.. ........++..|+|||+..+..++.++||||||+++|||++|+.||......+.. ..... . +.+
T Consensus 170 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---~~~~~---~------~~~ 236 (292)
T cd06658 170 KE-VPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAM---RRIRD---N------LPP 236 (292)
T ss_pred cc-cccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHh---c------CCC
Confidence 22 11223456788999999998888999999999999999999999999864432211 11111 0 011
Q ss_pred cCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 838 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
.... .......+..++..||+.+|++|||++|+++.
T Consensus 237 ~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 237 RVKD-SHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred cccc-ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 1111 01122356677788999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=300.71 Aligned_cols=262 Identities=23% Similarity=0.299 Sum_probs=196.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCcc-CCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRI-RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||+|+||.||+|... +++.||+|++...... ...+.+.+|+++++.++||||+++++++..++..++||||+
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (286)
T cd07846 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFV 82 (286)
T ss_pred eeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecC
Confidence 345678999999999999875 5789999998643322 23567889999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+++++.++..... .+++.++..++.||++||+|||+. +++||||+|+||++++++.++|+|||++
T Consensus 83 ~~~~l~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~ 147 (286)
T cd07846 83 DHTVLDDLEKYPN------------GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFA 147 (286)
T ss_pred CccHHHHHHhccC------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeee
Confidence 9988887765322 478999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHH-------
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV-LCEYVRE------- 824 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~-~~~~~~~------- 824 (884)
....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... .......
T Consensus 148 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (286)
T cd07846 148 RTLAAPG-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQE 226 (286)
T ss_pred eeccCCc-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHH
Confidence 8764322 22233457888999999875 346789999999999999999999997644322110 0000000
Q ss_pred HHHcCCC-cccccccCCC------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 825 LLERGSA-SACFDRSLRG------FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 825 ~~~~~~~-~~~~d~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
....... .....+.... ..+.....+.+++.+||+.+|++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 227 IFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 0000000 0000000000 01122356788899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=290.87 Aligned_cols=246 Identities=27% Similarity=0.354 Sum_probs=196.2
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc----cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR----IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+..+.||+|++|.||+|... ++..|++|.+..... ....+.+.+|+.+++.++|+|++++++++......++|+|
T Consensus 3 ~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (258)
T cd06632 3 RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLE 82 (258)
T ss_pred cccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEE
Confidence 35678999999999999776 788999998854321 1245678999999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||+++.++.+||+|||
T Consensus 83 ~~~~~~L~~~~~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~ 147 (258)
T cd06632 83 LVPGGSLAKLLKKYG------------SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFG 147 (258)
T ss_pred ecCCCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCc
Confidence 999999999986432 578999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCC-CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
.+....... ......++..|+|||.+.... ++.++|+||||+++|++++|+.||......+. .........
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~------~~~~~~~~~ 219 (258)
T cd06632 148 MAKQVVEFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA------VFKIGRSKE 219 (258)
T ss_pred cceeccccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH------HHHHHhccc
Confidence 987654322 234456788899999987766 88999999999999999999999976542211 111111011
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. . .......++.+++.+||+.+|++||++.+++.
T Consensus 220 ~~-~-------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 220 LP-P-------IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred CC-C-------cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11 1 11112235677888999999999999999875
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=295.15 Aligned_cols=247 Identities=23% Similarity=0.359 Sum_probs=196.8
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC---CCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR---HFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e 671 (884)
|+..+.||+|+||.||+|.. .++..+|+|.+.........+++.+|+.++++++ |||++++++++.+....++|||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e 82 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIME 82 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEe
Confidence 34566899999999999976 5688999999865444455678889999999886 9999999999999899999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.++++.. .+++..+..++.|+++||.|||+. +|+||||+|+||++++++.++++|||
T Consensus 83 ~~~~~~L~~~~~~~-------------~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg 146 (277)
T cd06917 83 YAEGGSVRTLMKAG-------------PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFG 146 (277)
T ss_pred cCCCCcHHHHHHcc-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCC
Confidence 99999999988532 478999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
.+....... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||......... .......
T Consensus 147 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~~ 218 (277)
T cd06917 147 VAALLNQNS-SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKSK 218 (277)
T ss_pred ceeecCCCc-cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccCC
Confidence 998765432 22234467889999998865 45688999999999999999999999764332111 0011110
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. +.+.. .....++.+++.+||+.||++||++.|++.
T Consensus 219 ~-----~~~~~--~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 219 P-----PRLED--NGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred C-----CCCCc--ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 1 11111 013346778888999999999999999975
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=299.41 Aligned_cols=260 Identities=22% Similarity=0.289 Sum_probs=193.4
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|++|.||+|... +++.||+|.+...........+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 7 y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07844 7 YKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD 86 (291)
T ss_pred eeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC
Confidence 456778999999999999765 6789999998654333334567789999999999999999999999999999999997
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+ +|.+++.... ..+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 ~-~L~~~~~~~~-----------~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 151 (291)
T cd07844 87 T-DLKQYMDDCG-----------GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151 (291)
T ss_pred C-CHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECcccccc
Confidence 5 8998886433 2578899999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
...... .......++..|+|||++.+ ..++.++||||+|+++|||++|+.||....... .......+....+....
T Consensus 152 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 228 (291)
T cd07844 152 AKSVPS-KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE--DQLHKIFRVLGTPTEET 228 (291)
T ss_pred ccCCCC-ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHhcCCCChhh
Confidence 543211 11122345788999999865 457889999999999999999999997654211 11111111111000000
Q ss_pred ---------cc--------cccCCCCcHH--HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 ---------CF--------DRSLRGFAEN--ELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ---------~~--------d~~~~~~~~~--~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. ...+...... ...++.+++.+|++.+|++|||+.|+++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 229 WPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred hhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 00 0000000000 1146678889999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=298.73 Aligned_cols=245 Identities=23% Similarity=0.308 Sum_probs=195.5
Q ss_pred CceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCc
Q 002759 599 ECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
...||+|+||.||+|.. .++..||+|.+.... ....+.+.+|+.+++.++|||++++++++..++..++|+||+++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRK-QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecc-cchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 34699999999999966 468899999986432 2345678899999999999999999999999999999999999999
Q ss_pred hhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|.+++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+||+|||++....
T Consensus 105 L~~~~~~-------------~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 105 LTDIVSQ-------------TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred HHHHHhh-------------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 9987753 2478999999999999999999998 99999999999999999999999999987654
Q ss_pred CccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccc
Q 002759 758 ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837 (884)
Q Consensus 758 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~ 837 (884)
.. ........++..|+|||++.+..++.++||||||+++|||++|+.||......+.. ... ....... ..
T Consensus 169 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------~~~-~~~~~~~--~~ 238 (297)
T cd06659 169 KD-VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM------KRL-RDSPPPK--LK 238 (297)
T ss_pred cc-cccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-hccCCCC--cc
Confidence 32 12223456788999999999888999999999999999999999999764432221 111 1111000 00
Q ss_pred cCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 838 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
. .......+.+++.+||+.+|++||+++++++.
T Consensus 239 ~----~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 239 N----AHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred c----cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0 11122356778889999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=295.48 Aligned_cols=249 Identities=23% Similarity=0.318 Sum_probs=194.5
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||.||+|... ++..+++|.+.... ....+.+.+|+.+++.++|||++++++++..+...++||||++
T Consensus 14 y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 92 (292)
T cd06644 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS-EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCP 92 (292)
T ss_pred hhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC-HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCC
Confidence 446678999999999999775 47889999986432 2345678899999999999999999999988899999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|..++.... ..+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+.
T Consensus 93 ~~~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~ 158 (292)
T cd06644 93 GGAVDAIMLELD-----------RGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSA 158 (292)
T ss_pred CCcHHHHHHhhc-----------CCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccce
Confidence 999988875432 2578999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
..... ........++..|+|||++. ...++.++|||||||++|||++|+.||......+. ........
T Consensus 159 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~~~~ 231 (292)
T cd06644 159 KNVKT-LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE 231 (292)
T ss_pred ecccc-ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH------HHHHhcCC
Confidence 54321 11223445788899999984 34567899999999999999999999976443211 11111111
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. ... .......++.+++.+||+.+|++||+++|+++
T Consensus 232 ~~-~~~------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 232 PP-TLS------QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred Cc-cCC------CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11 000 01122335777888999999999999999975
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=297.96 Aligned_cols=259 Identities=22% Similarity=0.254 Sum_probs=198.3
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...+.||+|++|.||+|... ++..||+|++..... ......+.+|+.++++++|||++++++++..+...++||||+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~- 81 (286)
T cd07832 3 KILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM- 81 (286)
T ss_pred eEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-
Confidence 45678999999999999764 688999999865432 234578899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.++++|||.+.
T Consensus 82 ~~~L~~~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~ 147 (286)
T cd07832 82 PSDLSEVLRDEE-----------RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLAR 147 (286)
T ss_pred CCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecc
Confidence 999999986432 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC--
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA-- 831 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~-- 831 (884)
..............++..|+|||.+.+. .++.++||||+|+++|||++|..||......+.. .........+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 224 (286)
T cd07832 148 LFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL---AIVFRTLGTPNEET 224 (286)
T ss_pred cccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH---HHHHHHcCCCChHH
Confidence 7654322223445678899999998654 4688999999999999999998888764432211 111111111000
Q ss_pred ----------cc-ccccc----CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 ----------SA-CFDRS----LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ----------~~-~~d~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. .+... +....++....+.+++.+|++.+|++|||+++++.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 225 WPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 00 00000 00011122357788899999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.22 Aligned_cols=259 Identities=23% Similarity=0.262 Sum_probs=197.1
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~~ 673 (884)
+..+.||.|++|.||+|... ++..+|+|.+..........++.+|+++++.++||||+++++++.+. ...++||||+
T Consensus 4 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~ 83 (287)
T cd06621 4 VELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83 (287)
T ss_pred EEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEec
Confidence 45678999999999999774 57889999887544334567789999999999999999999988643 4679999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++..... ....++...+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||++
T Consensus 84 ~~~~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~ 152 (287)
T cd06621 84 EGGSLDSIYKKVKK--------RGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS 152 (287)
T ss_pred CCCCHHHHHHHHHh--------cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeecccc
Confidence 99999988753220 123578889999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
...... ......++..|+|||.+.+..++.++||||+|+++|||++|+.||....... ....+....... .....
T Consensus 153 ~~~~~~---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~-~~~~~ 227 (287)
T cd06621 153 GELVNS---LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP-LGPIELLSYIVN-MPNPE 227 (287)
T ss_pred cccccc---ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC-CChHHHHHHHhc-CCchh
Confidence 754321 1223456788999999998899999999999999999999999998653211 111111111111 11111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+..... ........+.+++.+||+.+|++|||+.|+++
T Consensus 228 -~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 228 -LKDEPG-NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -hccCCC-CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 110000 00112346778889999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=291.24 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=202.1
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||+|++|.||+|... +++.|++|++...........+.+|+..+.+++|+|++++++++......++||||+++
T Consensus 4 ~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (264)
T cd06623 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDG 83 (264)
T ss_pred eeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCC
Confidence 45678999999999999776 48899999987544334567899999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH-DCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... .+++..+..++.|+++|++|||+ . +++||||+|+||+++.++.++++|||.+.
T Consensus 84 ~~L~~~l~~~~------------~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~ 148 (264)
T cd06623 84 GSLADLLKKVG------------KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISK 148 (264)
T ss_pred CcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccce
Confidence 99999997433 58899999999999999999999 8 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
....... ......++..|+|||.+....++.++|+||||+++|||++|+.||............ ....... ..
T Consensus 149 ~~~~~~~-~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~---~~~~~~~-~~-- 221 (264)
T cd06623 149 VLENTLD-QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELM---QAICDGP-PP-- 221 (264)
T ss_pred ecccCCC-cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHH---HHHhcCC-CC--
Confidence 7643221 122456788899999999888899999999999999999999999876432222111 1111111 10
Q ss_pred ccccCCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAEN-ELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..... ....+..++..||+.+|++|||+.|+++
T Consensus 222 ------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~ 255 (264)
T cd06623 222 ------SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255 (264)
T ss_pred ------CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence 01111 3346778888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=298.62 Aligned_cols=263 Identities=22% Similarity=0.254 Sum_probs=198.5
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||+|++|.||+|... +++.|++|+++... .......+.+|+++++.++|+||+++++++..++..++||||+
T Consensus 3 y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 82 (288)
T cd07833 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV 82 (288)
T ss_pred eeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecC
Confidence 446678999999999999775 57889999986432 2334578899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+++.+..+.... ..+++.++..++.||+.|++|||+. +++||||+|+||++++++.+||+|||.+
T Consensus 83 ~~~~l~~~~~~~------------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~ 147 (288)
T cd07833 83 ERTLLELLEASP------------GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFA 147 (288)
T ss_pred CCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecc
Confidence 887666555432 2478999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH-HHHH----
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR-ELLE---- 827 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~-~~~~---- 827 (884)
...............++..|+|||++.+. .++.++||||||+++|||++|+.||......+......... ...+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd07833 148 RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQE 227 (288)
T ss_pred cccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhh
Confidence 87654332233445678889999999887 78899999999999999999999997654322211110000 0000
Q ss_pred ----cCCCc--ccccccCC-----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 828 ----RGSAS--ACFDRSLR-----GFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 828 ----~~~~~--~~~d~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..... ...+.... .+......++.+++.+||..+|++|||++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 228 LFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred hcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 00000 00000000 011112456888899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=292.02 Aligned_cols=250 Identities=26% Similarity=0.329 Sum_probs=196.6
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...+.||+|+||.||+|... +++.|++|.++.... ......+.+|+.+++.++|+||+++++++...+..++|+||++
T Consensus 3 ~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (264)
T cd06626 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCS 82 (264)
T ss_pred eeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCC
Confidence 45678999999999999764 678999999865432 2356788999999999999999999999998999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .+++..+..++.|++.|++|||+. +|+||||+|+||++++++.+||+|||.+.
T Consensus 83 ~~~L~~~~~~~~------------~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~ 147 (264)
T cd06626 83 GGTLEELLEHGR------------ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAV 147 (264)
T ss_pred CCcHHHHHhhcC------------CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccccccc
Confidence 999999987432 478889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCccc---ccccccccccCccccCCCC---CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 755 LLPILDNYGL---TKFHNAVGYVAPELAQSLR---LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 755 ~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
.......... ....++..|+|||++.+.. ++.++||||||+++||+++|+.||........ ...... .
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~-----~~~~~~-~ 221 (264)
T cd06626 148 KLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ-----IMFHVG-A 221 (264)
T ss_pred ccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH-----HHHHHh-c
Confidence 7654322211 1345788999999998766 78899999999999999999999975432111 111111 1
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
... +..... ......+.+++.+||+.+|.+|||+.|++.
T Consensus 222 ~~~-----~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 222 GHK-----PPIPDS-LQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCC-----CCCCcc-cccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 111 011110 111335667888999999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=296.90 Aligned_cols=260 Identities=22% Similarity=0.235 Sum_probs=193.5
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|++|.||+|... ++..||||++.... .......+.+|++++++++||||+++++++.+.+..++||||+.
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~ 82 (284)
T cd07860 3 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH 82 (284)
T ss_pred eeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc
Confidence 45678999999999999764 67899999886433 22334678899999999999999999999999999999999995
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||++++++.+|++|||+++
T Consensus 83 -~~l~~~~~~~~----------~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~ 148 (284)
T cd07860 83 -QDLKKFMDASP----------LSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLAR 148 (284)
T ss_pred -cCHHHHHHhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchh
Confidence 58988886433 24688999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCCCC-CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc-----
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER----- 828 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~----- 828 (884)
...... .......++..|+|||.+.+.. ++.++||||||+++|||+||+.||......+. ..+..+.....
T Consensus 149 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 225 (284)
T cd07860 149 AFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ--LFRIFRTLGTPDEVVW 225 (284)
T ss_pred hcccCc-cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH--HHHHHHHhCCCChhhh
Confidence 654211 1123334678899999886644 57899999999999999999999976443221 11111100000
Q ss_pred ------C----CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 ------G----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ------~----~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+ ..............+....++.+++.+||+.||++|||+++++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 226 PGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred hhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 0 00000000000001112235667889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=290.70 Aligned_cols=248 Identities=23% Similarity=0.305 Sum_probs=191.6
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc----cCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR----IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 668 (884)
|...+.||+|+||.||.|... +++.||+|.+..... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (265)
T cd06652 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSI 83 (265)
T ss_pred ceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEE
Confidence 346778999999999999764 588999998753211 12345788899999999999999999988653 45789
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++++|.+++.... .+++..+.+++.|++.||+|||+. +++||||||+||+++.++.++|+
T Consensus 84 v~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~ 148 (265)
T cd06652 84 FMEHMPGGSIKDQLKSYG------------ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLG 148 (265)
T ss_pred EEEecCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEEC
Confidence 999999999999986433 478888999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccC--cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILDN--YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||.++....... .......++..|+|||.+.+..++.++||||||+++|||++|+.||........ .....
T Consensus 149 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~~~~~ 222 (265)
T cd06652 149 DFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA------IFKIA 222 (265)
T ss_pred cCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH------HHHHh
Confidence 9999986542111 112334578899999999888889999999999999999999999975432211 11111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..... + ..+......+..++.+||. +|++||+++|+++
T Consensus 223 ~~~~~-----~---~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 223 TQPTN-----P---VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred cCCCC-----C---CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 11100 1 1122333456677778885 8999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=299.29 Aligned_cols=251 Identities=25% Similarity=0.327 Sum_probs=197.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCcc--CCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRI--RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|++|.||+|... +++.+|+|.+...... ...+.+..|+++++.++||||+++++++......++||||
T Consensus 3 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 82 (316)
T cd05574 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDY 82 (316)
T ss_pred eEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEe
Confidence 345678999999999999775 4889999998653322 2456788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+.+++|.+++.... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++|+|||+
T Consensus 83 ~~~~~L~~~~~~~~----------~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~ 149 (316)
T cd05574 83 CPGGELFRLLQRQP----------GKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDL 149 (316)
T ss_pred cCCCCHHHHHHhCC----------CCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecch
Confidence 99999999986432 24688999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCc----------------------------ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCC
Q 002759 753 AKLLPILDNY----------------------------GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804 (884)
Q Consensus 753 s~~~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~ 804 (884)
+......... ......|+..|+|||++.+..++.++||||||+++|+|++|+
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~ 229 (316)
T cd05574 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229 (316)
T ss_pred hhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCC
Confidence 8765321110 011235678899999999888999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002759 805 KPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS----MAEVVQ 873 (884)
Q Consensus 805 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt----~~ell~ 873 (884)
.||......+.. ....... .. +. . ......++.+++.+||+.+|++||| ++|++.
T Consensus 230 ~pf~~~~~~~~~------~~~~~~~-~~--~~----~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 230 TPFKGSNRDETF------SNILKKE-VT--FP----G-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred CCCCCCchHHHH------HHHhcCC-cc--CC----C-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 999765433221 1111111 00 00 0 1113446788888999999999999 777665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=297.10 Aligned_cols=254 Identities=21% Similarity=0.240 Sum_probs=196.3
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... .++.|++|.+..... ......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus 3 y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 82 (305)
T cd05609 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEY 82 (305)
T ss_pred ceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEec
Confidence 345678999999999999765 567899998864321 23346788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.
T Consensus 83 ~~g~~L~~~l~~~~------------~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~ 147 (305)
T cd05609 83 VEGGDCATLLKNIG------------ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGL 147 (305)
T ss_pred CCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCC
Confidence 99999999996533 578899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCcc--------------CcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 002759 753 AKLLPILD--------------NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVL 818 (884)
Q Consensus 753 s~~~~~~~--------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~ 818 (884)
++...... ........++..|+|||.+.+..++.++|+||||+++||+++|..||......+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~-- 225 (305)
T cd05609 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF-- 225 (305)
T ss_pred ccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence 86421100 00112235677899999998888999999999999999999999999765433211
Q ss_pred HHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 819 CEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 819 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
...... ... .+... .....++.+++.+||+.+|++||++.++.+.|+.
T Consensus 226 ----~~~~~~-~~~---~~~~~---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 226 ----GQVISD-DIE---WPEGD---EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred ----HHHHhc-ccC---CCCcc---ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 111111 100 01100 1123357788889999999999997666665543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=293.95 Aligned_cols=252 Identities=24% Similarity=0.313 Sum_probs=190.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHH-HhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGR-LSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||+|+||.||+|... +++.||+|+++.........++..|+.. ++..+|||++++++++..+...++||||+
T Consensus 3 ~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~ 82 (283)
T cd06617 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVM 82 (283)
T ss_pred ceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhh
Confidence 345678999999999999765 6889999998754333344556666665 55668999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+ ++|.+++..... ....+++..++.++.||+.||+|||+++ +++||||||+||+++.++.+||+|||.+
T Consensus 83 ~-~~l~~~l~~~~~--------~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~ 151 (283)
T cd06617 83 D-TSLDKFYKKVYD--------KGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS 151 (283)
T ss_pred c-ccHHHHHHHhcc--------CCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccc
Confidence 6 688888754320 1246899999999999999999999743 7999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCC----CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQS----LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+.... ........++..|+|||.+.+ ..++.++|+||+|+++|||++|+.||....... +.........
T Consensus 152 ~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-----~~~~~~~~~~ 224 (283)
T cd06617 152 GYLVD--SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-----QQLKQVVEEP 224 (283)
T ss_pred ccccc--ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-----HHHHHHHhcC
Confidence 86542 222233467888999998865 456889999999999999999999997533210 1111111111
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. .. . ......++.+++.+||..+|++||++.++++
T Consensus 225 ~~-~~-----~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 225 SP-QL-----P--AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred CC-CC-----C--ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11 00 0 0112346778888999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=293.96 Aligned_cols=251 Identities=23% Similarity=0.330 Sum_probs=191.6
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEe-----cCCceeEE
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYW-----SSTMQLIL 669 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~~lv 669 (884)
+..+.||+|+||.||+|... +++.+|+|++.... .....+.+|+.+++.+ +||||+++++++. .+...++|
T Consensus 21 ~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 98 (286)
T cd06638 21 EIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH--DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLV 98 (286)
T ss_pred eeeeeeccCCCcEEEEEEECCCCceeEEEeecccc--chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEE
Confidence 46678999999999999664 57889999876432 2346778899999998 6999999999874 34568999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
|||+++++|.+++.... .....+++..+..++.|+++||.|||+. +++||||||+||++++++.++++|
T Consensus 99 ~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 99 LELCNGGSVTDLVKGFL--------KRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred EeecCCCCHHHHHHHhh--------ccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEcc
Confidence 99999999999875321 0123578899999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCccCcccccccccccccCccccCC-----CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-----LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 750 fg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~ 824 (884)
||.++..... ........++..|+|||++.. ..++.++||||+||++|||++|+.||......+.. ..
T Consensus 168 fg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~------~~ 240 (286)
T cd06638 168 FGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL------FK 240 (286)
T ss_pred CCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH------hh
Confidence 9999876432 222234468899999998753 44788999999999999999999999765432211 00
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
. .........++ .....++..++.+||+.+|++|||+.|+++.
T Consensus 241 ~-~~~~~~~~~~~------~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 241 I-PRNPPPTLHQP------ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred c-cccCCCcccCC------CCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 0 01110111111 1112357788899999999999999999864
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=295.19 Aligned_cols=255 Identities=20% Similarity=0.241 Sum_probs=192.1
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecC--CceeEEEEec
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSS--TMQLILSEFV 673 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e~~ 673 (884)
..+.||+|+||.||+|... ++..+|+|+++............+|+..+.++. |+|++++++++.+. +..++||||+
T Consensus 3 ~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 82 (282)
T cd07831 3 ILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELM 82 (282)
T ss_pred eEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecC
Confidence 4567999999999999754 678899999875433333445567888888885 99999999999877 8899999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+ +++.+++.... ..+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.+
T Consensus 83 ~-~~l~~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~ 146 (282)
T cd07831 83 D-MNLYELIKGRK-----------RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSC 146 (282)
T ss_pred C-ccHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccc
Confidence 6 58888876432 3589999999999999999999998 9999999999999999 99999999999
Q ss_pred cccCCccCcccccccccccccCccccC-CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH-----
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE----- 827 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~----- 827 (884)
+...... ......++..|+|||.+. +..++.++||||+||++|||++|+.||...+..+.. ........
T Consensus 147 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~ 221 (282)
T cd07831 147 RGIYSKP--PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAE 221 (282)
T ss_pred cccccCC--CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHH
Confidence 8764322 223345788899999764 445688999999999999999999999875543321 11111110
Q ss_pred ------cCCCcc-ccccc----CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 828 ------RGSASA-CFDRS----LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 828 ------~~~~~~-~~d~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...... .+... +.........++.+++.+||+++|++|||++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 222 VLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 000000 00000 00111234567889999999999999999999975
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=291.80 Aligned_cols=253 Identities=22% Similarity=0.308 Sum_probs=197.7
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEec--CCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~ 672 (884)
+..+.+|+|+||.||+|.. .++..+|+|.+.... .....+++..|++++++++|||++++++++.. +...+++|||
T Consensus 3 ~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~ 82 (265)
T cd08217 3 EVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEY 82 (265)
T ss_pred eeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehh
Confidence 4567899999999999965 467889999886432 22345678889999999999999999997753 4567899999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDC--KPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~--~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
+++++|.+++.... .....+++..++.++.|+++|++|||..+ +.+++||||+|+||+++.++.+|++||
T Consensus 83 ~~~~~L~~~l~~~~--------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~ 154 (265)
T cd08217 83 CEGGDLAQLIQKCK--------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDF 154 (265)
T ss_pred ccCCCHHHHHHHHh--------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecc
Confidence 99999999986532 11346899999999999999999999221 229999999999999999999999999
Q ss_pred cCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 751 g~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
|.+........ ......++..|+|||++.+..++.++|+||||+++|+|++|+.||......+. .+.+..+.
T Consensus 155 g~~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-------~~~~~~~~ 226 (265)
T cd08217 155 GLAKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQL-------ASKIKEGK 226 (265)
T ss_pred cccccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHH-------HHHHhcCC
Confidence 99987653222 12345678899999999988899999999999999999999999987542221 11112111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. ........++.+++.+|++.+|++|||+.++++
T Consensus 227 ~~--------~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~ 261 (265)
T cd08217 227 FR--------RIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ 261 (265)
T ss_pred CC--------CCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 11 112233456788888999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.05 Aligned_cols=249 Identities=25% Similarity=0.353 Sum_probs=195.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||.||+|... ++..+|+|.+... .....+.+.+|++++++++||||+++++++..+...++||||++
T Consensus 7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (280)
T cd06611 7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE-SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCD 85 (280)
T ss_pred HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccC
Confidence 345667999999999999764 5788999998643 22345678899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++...+ ..+++..+..++.|++.||.|||+. +|+||||||+||+++.++.++|+|||.+.
T Consensus 86 ~~~L~~~~~~~~-----------~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~ 151 (280)
T cd06611 86 GGALDSIMLELE-----------RGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSA 151 (280)
T ss_pred CCcHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccch
Confidence 999999986533 3588999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
..... ........++..|+|||.+. ...++.++||||+|+++|||++|+.||......+. ..... ..
T Consensus 152 ~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~ 223 (280)
T cd06611 152 KNKST-LQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV------LLKIL-KS 223 (280)
T ss_pred hhccc-ccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH------HHHHh-cC
Confidence 65322 11223456788999999874 34567799999999999999999999976543221 11111 11
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
... .++ .+.....++.+++.+||+.+|.+||++.++++
T Consensus 224 ~~~-~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 261 (280)
T cd06611 224 EPP-TLD-----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK 261 (280)
T ss_pred CCC-CcC-----CcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence 110 000 01112235677888999999999999999985
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=293.53 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=193.3
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecC-----CceeE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSS-----TMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~-----~~~~l 668 (884)
|...+.||+|+||.||+|.. .+++.+|+|++.... .....+.+|+.+++++ +|||++++++++... ...++
T Consensus 24 y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~--~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~l 101 (291)
T cd06639 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS--DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101 (291)
T ss_pred eEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc--cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEE
Confidence 44667899999999999976 467889999986432 3356778899999988 799999999998643 35799
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++++|.++++... .....+++..++.++.|++.||+|||+. +++||||||+||+++.++.+||+
T Consensus 102 v~ey~~~~sL~~~~~~~~--------~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~ 170 (291)
T cd06639 102 VLELCNGGSVTELVKGLL--------ICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLV 170 (291)
T ss_pred EEEECCCCcHHHHHHHhh--------hcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEe
Confidence 999999999999886422 0124688999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCcccccccccccccCccccCCC-----CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-----RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR 823 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~ 823 (884)
|||.++....... ......++..|+|||++... .++.++|||||||++|||++|+.||......+.. .
T Consensus 171 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~------~ 243 (291)
T cd06639 171 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL------F 243 (291)
T ss_pred ecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH------H
Confidence 9999987543221 22334678889999997643 2578999999999999999999999865432211 1
Q ss_pred HHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 824 ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 824 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... .......+ .+.....+..++.+||+.+|++||++.|+++
T Consensus 244 ~~~~-~~~~~~~~------~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 244 KIPR-NPPPTLLH------PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred HHhc-CCCCCCCc------ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 1111 11111111 1223346788889999999999999999975
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=297.30 Aligned_cols=259 Identities=21% Similarity=0.228 Sum_probs=191.9
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|+||.||+|... +|..+|+|++..... ......+.+|++++++++|||++++++++.+....++|+||++
T Consensus 3 ~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (284)
T cd07839 3 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82 (284)
T ss_pred eeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC
Confidence 35578999999999999764 688999999864322 2234567889999999999999999999999999999999996
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... ..+++..+..++.||++||.|||+. +|+||||||+||+++.++.+||+|||.++
T Consensus 83 -~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~ 147 (284)
T cd07839 83 -QDLKKYFDSCN-----------GDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLAR 147 (284)
T ss_pred -CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhh
Confidence 57888775432 3589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc-----
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER----- 828 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~----- 828 (884)
...... .......++..|+|||++.+. .++.++||||+||++|||++|+.|+......+. ..+...+....
T Consensus 148 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~ 224 (284)
T cd07839 148 AFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEES 224 (284)
T ss_pred ccCCCC-CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHH
Confidence 654221 122334567889999998764 468899999999999999999998654332211 11111111100
Q ss_pred -------CCCc--ccccccC--CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 -------GSAS--ACFDRSL--RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 -------~~~~--~~~d~~~--~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... ..+.... ....+....++.+++.+||+.||.+|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 225 WPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred hHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0000 0000000 0011122346678889999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=294.96 Aligned_cols=260 Identities=19% Similarity=0.280 Sum_probs=197.6
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||+|++|.||+|... ++..||+|++.........+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 82 (284)
T cd07836 3 KQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK 82 (284)
T ss_pred eEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc
Confidence 45678999999999999775 68899999987654444567788899999999999999999999999999999999975
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
+|.+++.... ....+++..+..++.|+++||+|||+. +++||||||+||++++++.++++|||.++.
T Consensus 83 -~l~~~~~~~~---------~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~ 149 (284)
T cd07836 83 -DLKKYMDTHG---------VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARA 149 (284)
T ss_pred -cHHHHHHhcC---------CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhh
Confidence 8888876433 123589999999999999999999998 999999999999999999999999999976
Q ss_pred cCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC-----
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG----- 829 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~----- 829 (884)
.... ........++..|+|||++.+. .++.++||||+|+++||+++|+.||...+..+.... ..+....+
T Consensus 150 ~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 225 (284)
T cd07836 150 FGIP-VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLK---IFRIMGTPTESTW 225 (284)
T ss_pred hcCC-ccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHH---HHHHhCCCChhhH
Confidence 5421 1122334567889999988653 568899999999999999999999987654332211 11110000
Q ss_pred -------CCccccc----ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 -------SASACFD----RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 -------~~~~~~d----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.....+. .......+.....+.+++.+|++.+|.+||+++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 226 PGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 0000000 0000011222346778899999999999999999874
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=303.87 Aligned_cols=266 Identities=24% Similarity=0.290 Sum_probs=202.1
Q ss_pred cCceeccCCceEEEEEE-EcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------CceeEEE
Q 002759 598 KECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQLILS 670 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~ 670 (884)
-.+.+|+|+||.||+|+ ..+|+.||||.++.....+..+...+|++++++++|||||+++++-... +...+||
T Consensus 17 ~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvm 96 (732)
T KOG4250|consen 17 MDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVM 96 (732)
T ss_pred ehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEE
Confidence 34579999999999998 5679999999998877778899999999999999999999999976543 4568999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC--CC--Cee
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE--NY--EPK 746 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~--~~--~vk 746 (884)
|||.+|||+..++.-. +...+++.+.+.+..+++.||.|||+. +||||||||.||++-. +| ..|
T Consensus 97 EyC~gGsL~~~L~~PE---------N~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 97 EYCSGGSLRKVLNSPE---------NAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred eecCCCcHHHHhcCcc---------cccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEe
Confidence 9999999999997543 234589999999999999999999988 9999999999999942 23 589
Q ss_pred EccccCccccCCccCcccccccccccccCccccC-CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
|+|||.|+.+++ ....+..+||..|.+||... +..|+..+|.|||||++||.+||..||.......-.....|.. .
T Consensus 165 LtDfG~Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~-~ 241 (732)
T KOG4250|consen 165 LTDFGAARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHI-I 241 (732)
T ss_pred eecccccccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhh-h
Confidence 999999999874 44678899999999999998 4888999999999999999999999997633221100111111 1
Q ss_pred HHcCCCcc-cccc----------c---CCCCcHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHh
Q 002759 826 LERGSASA-CFDR----------S---LRGFAENELIQVMKLGLICTSEVPSRRP--SMAEVVQVLESI 878 (884)
Q Consensus 826 ~~~~~~~~-~~d~----------~---~~~~~~~~~~~l~~l~~~cl~~~P~~RP--t~~ell~~L~~~ 878 (884)
.+.+.... ..++ . ...........+-+....++..+|.+|. .+.+....+..|
T Consensus 242 tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 242 TKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred ccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 11111100 0000 0 1112333444555666667788888888 666665555554
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=296.35 Aligned_cols=242 Identities=24% Similarity=0.318 Sum_probs=196.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|++|.||+|... +++.+|+|++.... .....+.+.+|++++++++||||+++++++.+....++||||
T Consensus 3 y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 82 (290)
T cd05580 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEY 82 (290)
T ss_pred eEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEec
Confidence 345678999999999999765 57899999986432 223456788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.+||+|||+
T Consensus 83 ~~~~~L~~~~~~~~------------~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~ 147 (290)
T cd05580 83 VPGGELFSHLRKSG------------RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGF 147 (290)
T ss_pred CCCCCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCC
Confidence 99999999986543 588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++..... .....++..|+|||.+.+...+.++||||+|+++|+|++|+.||......+. ..... .....
T Consensus 148 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~~~~ 216 (290)
T cd05580 148 AKRVKGR----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQI------YEKIL-EGKVR 216 (290)
T ss_pred ccccCCC----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHH------HHHHh-cCCcc
Confidence 9876432 2344678899999999888889999999999999999999999976542211 11111 11110
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVV 872 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell 872 (884)
+ +......+.+++.+||..+|.+|| +++|++
T Consensus 217 --~-------~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 217 --F-------PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred --C-------CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1 111123667788899999999999 677765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=297.17 Aligned_cols=254 Identities=22% Similarity=0.304 Sum_probs=190.7
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
..+.||+|+||+||++... ++..+|+|++...........+.+|+.++.++. ||||+++++++..+...+++|||+..
T Consensus 8 ~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~ 87 (288)
T cd06616 8 DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI 87 (288)
T ss_pred HHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC
Confidence 4457999999999999664 578999999875443345667889999999996 99999999999888899999999854
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++.++...... .....+++..+.+++.|+++||+|||+.. +++||||||+||+++.++.++|+|||+++.
T Consensus 88 -~l~~l~~~~~~-------~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 157 (288)
T cd06616 88 -SLDKFYKYVYE-------VLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQ 157 (288)
T ss_pred -CHHHHHHHHHH-------hhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHH
Confidence 55443321100 01236889999999999999999999632 899999999999999999999999999976
Q ss_pred cCCccCcccccccccccccCccccCCC---CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSL---RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
.... .......++..|+|||++.+. .++.++||||+||++|||++|+.||..... ...............
T Consensus 158 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~~~~~~~ 230 (288)
T cd06616 158 LVDS--IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVVKGDPPI 230 (288)
T ss_pred hccC--CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhcCCCCCc
Confidence 5422 122334678889999998765 688999999999999999999999975431 111122211111111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+.. ........++.+++.+||+.+|++|||+++++.
T Consensus 231 --~~~---~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~ 266 (288)
T cd06616 231 --LSN---SEEREFSPSFVNFINLCLIKDESKRPKYKELLE 266 (288)
T ss_pred --CCC---cCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 111223446788889999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=297.11 Aligned_cols=258 Identities=22% Similarity=0.241 Sum_probs=195.2
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCcc----CCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRI----RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+..+.||+|++|.||+|... +++.||+|++...... .....+..|++++++++|+||+++++++.+....++|||
T Consensus 3 ~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 82 (298)
T cd07841 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82 (298)
T ss_pred eeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEc
Confidence 35568999999999999764 6889999999654321 224566789999999999999999999999899999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+ +++|.+++.... ..+++..+..++.||++||+|||++ +|+||||+|+||+++.++.++|+|||
T Consensus 83 ~~-~~~L~~~i~~~~-----------~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg 147 (298)
T cd07841 83 FM-ETDLEKVIKDKS-----------IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFG 147 (298)
T ss_pred cc-CCCHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccce
Confidence 99 889999986432 2588999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+++...... .......++..|+|||.+.+ ..++.++|||||||++|||++|..||......+... . .......+.
T Consensus 148 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~--~-~~~~~~~~~ 223 (298)
T cd07841 148 LARSFGSPN-RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG--K-IFEALGTPT 223 (298)
T ss_pred eeeeccCCC-ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH--H-HHHHcCCCc
Confidence 998765322 12233455778999998854 456889999999999999999988887654322211 1 111110000
Q ss_pred ---------Cccc------ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ---------ASAC------FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ---------~~~~------~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... ..............++.+++.+||+.+|++|||++|+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~ 281 (298)
T cd07841 224 EENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE 281 (298)
T ss_pred hhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence 0000 000000011223456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=294.72 Aligned_cols=259 Identities=27% Similarity=0.315 Sum_probs=196.6
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 672 (884)
+..+.||+|++|.||+|... ++..+|+|++.... .......+.+|++++++++|||++++++++... +..++|+||
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07840 2 EKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81 (287)
T ss_pred eeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecc
Confidence 35568999999999999776 47899999997543 234456788999999999999999999999887 789999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++ +|.+++.... ..+++..++.++.||++||+|||+. +++|+||+|+||++++++.+||+|||.
T Consensus 82 ~~~-~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~ 146 (287)
T cd07840 82 MDH-DLTGLLDSPE-----------VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGL 146 (287)
T ss_pred ccc-cHHHHHhccC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccc
Confidence 974 8888876432 3688999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
+...............++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.. ....+.......
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~ 223 (287)
T cd07840 147 ARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTD 223 (287)
T ss_pred eeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCch
Confidence 98765433222334456788999997764 45788999999999999999999999865533221 111111110000
Q ss_pred c-----------------ccccccCCCCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 S-----------------ACFDRSLRGFAEN-ELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~-----------------~~~d~~~~~~~~~-~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. ......+.+.... ...++.+++.+||+.+|++||+++++++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 0 0000000000011 1456788999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=293.56 Aligned_cols=242 Identities=21% Similarity=0.211 Sum_probs=185.5
Q ss_pred eeccCCceEEEEEEEc-CCeEEEEEEccccCcc--CCHHHHHHHHHHH---hcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 601 LIGGGSIGSVYRASFE-GGVSIAVKKLETLGRI--RNQEEFELEIGRL---SNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+||+|+||.||+|... +++.+|+|.+...... .....+.+|...+ ...+|||++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999764 5789999988643221 1223344444333 33479999999999998899999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||++++++.++++|||++.
T Consensus 81 ~~~L~~~i~~~~------------~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~ 145 (279)
T cd05633 81 GGDLHYHLSQHG------------VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 145 (279)
T ss_pred CCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcce
Confidence 999999886433 589999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccC-CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
..... ......++..|+|||.+. +..++.++||||+||++|||++|..||......... .........
T Consensus 146 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~~~~~~~~~---- 214 (279)
T cd05633 146 DFSKK---KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTV---- 214 (279)
T ss_pred ecccc---CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH----HHHHHhhcC----
Confidence 65321 223346889999999986 456789999999999999999999999765432221 111111100
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
+.. .++....++.+++.+||+.||++|| |++|+++
T Consensus 215 --~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~ 254 (279)
T cd05633 215 --NVE---LPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE 254 (279)
T ss_pred --CcC---CccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence 011 1122334677888899999999999 5888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=289.58 Aligned_cols=243 Identities=24% Similarity=0.284 Sum_probs=194.8
Q ss_pred eccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 602 IGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 602 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
||+|++|.||+|... ++..+|+|++.... .....+.+.+|+.+++.++||||+++++++.++...++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 699999999999775 47899999986432 223457789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+++.... .+++..+..++.|+++||+|||+. +++|+||+|+||+++.++.++|+|||.++....
T Consensus 81 ~~~l~~~~------------~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRDRG------------LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 99997543 478899999999999999999998 999999999999999999999999999987653
Q ss_pred ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 759 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
.. ......++..|+|||.+.+..++.++|+||+|+++|||++|+.||........ ............. .
T Consensus 146 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~-~---- 214 (262)
T cd05572 146 GQ--KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM----EIYNDILKGNGKL-E---- 214 (262)
T ss_pred cc--ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH----HHHHHHhccCCCC-C----
Confidence 21 22334678889999999888889999999999999999999999987553211 1111111101110 0
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVVQ 873 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-----~~ell~ 873 (884)
++.....++.+++.+||+.+|++||+ ++|+++
T Consensus 215 ---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 215 ---FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ---CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11112346788888999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=295.23 Aligned_cols=246 Identities=22% Similarity=0.295 Sum_probs=193.1
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccc-cCccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLET-LGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|++.+.||+||.++||++...+.+.+|+|++.. ..+.....-|..|+..|.+++ |.+|+++++|-..++..|+||||-
T Consensus 363 Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G 442 (677)
T KOG0596|consen 363 YEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG 442 (677)
T ss_pred hhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc
Confidence 456778999999999999988888888888764 345556788999999999994 999999999999999999999986
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
..+|..+|+... .....| .++.+..|++.|+.++|++ ||||.||||.|+++-. |.+||+|||+|
T Consensus 443 -d~DL~kiL~k~~----------~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA 506 (677)
T KOG0596|consen 443 -DIDLNKILKKKK----------SIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIA 506 (677)
T ss_pred -cccHHHHHHhcc----------CCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechh
Confidence 559999998655 222334 7788999999999999999 9999999999999965 69999999999
Q ss_pred cccCCccCc-ccccccccccccCccccCCCC-----------CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 002759 754 KLLPILDNY-GLTKFHNAVGYVAPELAQSLR-----------LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEY 821 (884)
Q Consensus 754 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-----------~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~ 821 (884)
..+..+... .....+||+-||+||.+.... .+.++||||+||++|+|+.|+.||..... .
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-----~--- 578 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-----Q--- 578 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-----H---
Confidence 988654332 245678999999999886432 45689999999999999999999985221 1
Q ss_pred HHHHHHcCCCcccccccC----CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 822 VRELLERGSASACFDRSL----RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 822 ~~~~~~~~~~~~~~d~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..+.. .+.||.. .+..+ ..+++.+|+.|+..||++|||..|+++
T Consensus 579 ~aKl~------aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 579 IAKLH------AITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred HHHHH------hhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 11111 1112211 11111 123777888899999999999999985
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=293.42 Aligned_cols=248 Identities=22% Similarity=0.355 Sum_probs=191.0
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEec------CCcee
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWS------STMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~------~~~~~ 667 (884)
++..+.+|+|+||.||+|.. .+++.+|+|.+.... ....++..|+.++.++ +|+|++++++++.. ....+
T Consensus 18 ~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 95 (282)
T cd06636 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE--DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW 95 (282)
T ss_pred hhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh--HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEE
Confidence 44667899999999999976 457889999885432 3456788899999888 69999999998853 45679
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
++|||+++++|.+++.... ...+++..+..++.|+++|++|||+. +|+||||+|+||++++++.++|
T Consensus 96 iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l 162 (282)
T cd06636 96 LVMEFCGAGSVTDLVKNTK----------GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKL 162 (282)
T ss_pred EEEEeCCCCcHHHHHHHcc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 9999999999999986533 23577888999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~ 822 (884)
+|||.+....... .......++..|+|||.+. ...++.++|||||||++|||++|+.||......+...
T Consensus 163 ~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~----- 236 (282)
T cd06636 163 VDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALF----- 236 (282)
T ss_pred eeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhh-----
Confidence 9999987653211 1223456788999999875 3467789999999999999999999997543221110
Q ss_pred HHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...... .. ... ......++.+++.+||+.||.+|||+.|+++
T Consensus 237 -~~~~~~-~~-----~~~--~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 237 -LIPRNP-PP-----KLK--SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred -hHhhCC-CC-----CCc--ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 111110 00 000 1112346788888999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=291.60 Aligned_cols=245 Identities=22% Similarity=0.264 Sum_probs=191.3
Q ss_pred eccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 602 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
||+|+||+||+|.. .+++.+|+|.+.... .......+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999965 468899999986432 223355677899999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+++.... ...+++.++..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~~l~~~~----------~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~ 147 (277)
T cd05577 81 KYHIYNVG----------EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG 147 (277)
T ss_pred HHHHHHcC----------cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc
Confidence 99986543 23588999999999999999999998 999999999999999999999999999876542
Q ss_pred ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 759 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
........++..|+|||++.+..++.++||||+|+++|+|++|+.||.......... ........ . ..
T Consensus 148 --~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~~~~~~----~--~~- 215 (277)
T cd05577 148 --GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELKRRTLE----M--AV- 215 (277)
T ss_pred --CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHHhcccc----c--cc-
Confidence 222233456788999999988889999999999999999999999997654321110 01111000 0 00
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
........++.+++.+||+.+|++|| ++.+++.
T Consensus 216 --~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 216 --EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred --cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 01111234677888899999999999 6666653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=290.06 Aligned_cols=246 Identities=20% Similarity=0.212 Sum_probs=198.0
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+..+.||.|+||.||+|... ++..+|+|.+.... .....+.+.+|++++++++||||+++++++.++...++|+||+
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 82 (258)
T cd05578 3 ELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLL 82 (258)
T ss_pred eEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCC
Confidence 45678999999999999765 58889999986432 2234678899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
++++|.+++.... .+++.++..++.|+++||.|||+. +++|+||+|+||++++++.++|+|||.+
T Consensus 83 ~~~~L~~~l~~~~------------~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~ 147 (258)
T cd05578 83 LGGDLRYHLSQKV------------KFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA 147 (258)
T ss_pred CCCCHHHHHHhcC------------CcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccc
Confidence 9999999986432 578899999999999999999998 9999999999999999999999999998
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
....... ......++..|+|||.+....++.++|+||+|+++|+|++|+.||.......... ....... ...
T Consensus 148 ~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~--~~~ 219 (258)
T cd05578 148 TKVTPDT--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ----IRAKQET--ADV 219 (258)
T ss_pred cccCCCc--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHH----HHHHhcc--ccc
Confidence 8764321 2234567888999999988888999999999999999999999998755421111 1111111 000
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM--AEVV 872 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~--~ell 872 (884)
..+.....++.+++.+||+.||.+||++ +|++
T Consensus 220 -------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 220 -------LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred -------cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1112223577788889999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=290.22 Aligned_cols=248 Identities=23% Similarity=0.334 Sum_probs=196.8
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...+.||+|+||.||+|... ++..+|+|.+.... .....+.+.+|+.+++.++|+|++++++++......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (257)
T cd08225 3 EIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCD 82 (257)
T ss_pred eEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCC
Confidence 35678999999999999765 57889999985432 22345678899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC-CeeEccccCc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY-EPKLSDYGLA 753 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~-~vkl~Dfg~s 753 (884)
+++|.+++.... ...+++..+..++.|+++||+|||+. +++|+||||+||++++++ .+|++|||.+
T Consensus 83 ~~~L~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~ 149 (257)
T cd08225 83 GGDLMKRINRQR----------GVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIA 149 (257)
T ss_pred CCcHHHHHHhcc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccc
Confidence 999999986433 23578999999999999999999998 999999999999999886 4699999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
....... .......++..|+|||+..+..++.++||||||+++||+++|+.||......+ ....... ....
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~- 220 (257)
T cd08225 150 RQLNDSM-ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQ-GYFA- 220 (257)
T ss_pred hhccCCc-ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhc-ccCC-
Confidence 8764321 12233457888999999988889999999999999999999999997543222 1122111 1111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+. ......++.+++.+||+.+|++|||+.|+++
T Consensus 221 ---~~----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 221 ---PI----SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred ---CC----CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 11 1112236778888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-32 Score=290.54 Aligned_cols=260 Identities=20% Similarity=0.223 Sum_probs=191.8
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|+||.||+|.. .++..||+|.+...........+.+|+.+++.++|+||+++.+++..++..++||||+.
T Consensus 7 y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~ 86 (291)
T cd07870 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH 86 (291)
T ss_pred eEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc
Confidence 44667899999999999965 46789999998754433445577899999999999999999999999899999999995
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++.+++.... ..+.+..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||+++
T Consensus 87 -~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~ 151 (291)
T cd07870 87 -TDLAQYMIQHP-----------GGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLAR 151 (291)
T ss_pred -CCHHHHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEecccccc
Confidence 67777765322 2467888899999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH------
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE------ 827 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~------ 827 (884)
...... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||....... ...........
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~~ 228 (291)
T cd07870 152 AKSIPS-QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVF--EQLEKIWTVLGVPTEDT 228 (291)
T ss_pred ccCCCC-CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHH--HHHHHHHHHcCCCChhh
Confidence 643211 11233456888999999875 357889999999999999999999998644321 11111111000
Q ss_pred ------cCCCcc-----cccccCCCC--cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 828 ------RGSASA-----CFDRSLRGF--AENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 828 ------~~~~~~-----~~d~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.... +........ ......++.+++.+|++.||++|||+.|++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred hhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 000000 000000000 0011345677888999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=294.11 Aligned_cols=259 Identities=24% Similarity=0.234 Sum_probs=194.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 671 (884)
|+..+.||+|+||.||+|... +++.+++|.++.... ......+.+|+.++++++||||+++.+++... ...++|||
T Consensus 7 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e 86 (293)
T cd07843 7 YEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVME 86 (293)
T ss_pred hhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEeh
Confidence 345678999999999999775 578899999864332 22344677899999999999999999998776 88999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+. ++|.+++.... ..+++..+..++.||+.||+|||+. +++||||||+||+++.++.++|+|||
T Consensus 87 ~~~-~~L~~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g 151 (293)
T cd07843 87 YVE-HDLKSLMETMK-----------QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFG 151 (293)
T ss_pred hcC-cCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecC
Confidence 996 48988886433 2589999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc--
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER-- 828 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~-- 828 (884)
.++...... .......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||......+..... ......
T Consensus 152 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~---~~~~~~~~ 227 (293)
T cd07843 152 LAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI---FKLLGTPT 227 (293)
T ss_pred ceeeccCCc-cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---HHHhCCCc
Confidence 998765321 122334567889999998754 4588999999999999999999999865433222111 000000
Q ss_pred ----------C-----CCcccccccCCC-CcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 ----------G-----SASACFDRSLRG-FAEN-ELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ----------~-----~~~~~~d~~~~~-~~~~-~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .........+.. +... ....+.+++.+||+.+|++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 0 000000000001 1111 2345678888999999999999999975
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=292.50 Aligned_cols=248 Identities=23% Similarity=0.327 Sum_probs=197.6
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|+||.||+|.. .++..|++|.+... .....+.+.+|+.+++.++|||++++++++...+..++|+||++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~ 99 (293)
T cd06647 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ-QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLA 99 (293)
T ss_pred ceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc-cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCC
Confidence 34567899999999999965 46788999998543 22445778899999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++... .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++|+|||++.
T Consensus 100 ~~~L~~~~~~~-------------~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~ 163 (293)
T cd06647 100 GGSLTDVVTET-------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 163 (293)
T ss_pred CCcHHHHHhhc-------------CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCccee
Confidence 99999998642 368889999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
....... ......++..|+|||.+.+..++.++||||||+++||+++|+.||......+.... ....+...
T Consensus 164 ~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~~~~-- 234 (293)
T cd06647 164 QITPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNGTPE-- 234 (293)
T ss_pred ccccccc-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCCCCC--
Confidence 6543222 22334678889999999888889999999999999999999999976543222110 00001000
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
. .........+.+++.+||+.+|++||++.+++..
T Consensus 235 ----~-~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 235 ----L-QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred ----C-CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 0111223457788889999999999999999853
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-32 Score=288.77 Aligned_cols=245 Identities=23% Similarity=0.334 Sum_probs=195.3
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
....||+|++|.||+|.. .++..+++|++.... ....+.+.+|+.+++.++|||++++++++...+..++|+||++++
T Consensus 23 ~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~ 101 (285)
T cd06648 23 NFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101 (285)
T ss_pred cceEeccCCCeEEEEEEECCCCCEEEEEEEeccc-hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence 346899999999999975 467889999885432 234566889999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++... .+++.++..++.|++.||+|||+. +++||||+|+||+++.++.++++|||.+...
T Consensus 102 ~L~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~ 165 (285)
T cd06648 102 ALTDIVTHT-------------RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQV 165 (285)
T ss_pred CHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhh
Confidence 999998642 478899999999999999999998 9999999999999999999999999988765
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d 836 (884)
... ........++..|+|||...+..++.++||||||+++|||++|+.||......+. .+.... .....
T Consensus 166 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~------~~~~~~-~~~~~--- 234 (285)
T cd06648 166 SKE-VPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA------MKRIRD-NLPPK--- 234 (285)
T ss_pred ccC-CcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHH------HHHHHh-cCCCC---
Confidence 421 1122334678899999999888899999999999999999999999976443221 111111 11110
Q ss_pred ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 837 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
... .......+.+++.+||+.+|++|||+.++++
T Consensus 235 --~~~-~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 235 --LKN-LHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred --Ccc-cccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 000 1112346788888999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=304.02 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=192.4
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC-----CceeEE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS-----TMQLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 669 (884)
|...+.||+|+||.||+|.. .++..||+|++...........+.+|+.++++++||||+++++++... ...++|
T Consensus 7 y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv 86 (336)
T cd07849 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86 (336)
T ss_pred eEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEE
Confidence 45678899999999999965 468899999986544334556788999999999999999999987544 347899
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
+||+.+ ++.+.+.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+||+|
T Consensus 87 ~e~~~~-~l~~~~~~-------------~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~d 149 (336)
T cd07849 87 QELMET-DLYKLIKT-------------QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICD 149 (336)
T ss_pred ehhccc-CHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECc
Confidence 999964 88777753 2588999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCccCc--ccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 750 YGLAKLLPILDNY--GLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 750 fg~s~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
||+++........ ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+.... ........
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~ 226 (336)
T cd07849 150 FGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVL 226 (336)
T ss_pred ccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHc
Confidence 9999876432211 1123467888999998754 4678899999999999999999999976432211 11111111
Q ss_pred HcCCCc-----------cc---ccc-cCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 827 ERGSAS-----------AC---FDR-SLRG---FAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 827 ~~~~~~-----------~~---~d~-~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
..+... .. .+. .... ..+....++.+++.+||+.+|++|||+.|+++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 110000 00 000 0000 011123467888999999999999999999864
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=294.35 Aligned_cols=260 Identities=23% Similarity=0.240 Sum_probs=194.3
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|++|.||+|... ++..||+|++..... ......+.+|++.++.++|||++++++++.++...++||||++
T Consensus 2 ~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~ 81 (283)
T cd07835 2 QKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD 81 (283)
T ss_pred chheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC
Confidence 35678999999999999764 688999999864332 2234678899999999999999999999999999999999995
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++|.+++.... ...+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++|+|||.++
T Consensus 82 -~~l~~~~~~~~----------~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~ 147 (283)
T cd07835 82 -LDLKKYMDSSP----------LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLAR 147 (283)
T ss_pred -cCHHHHHhhCC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeeccccc
Confidence 68999886433 23689999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH------
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE------ 827 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~------ 827 (884)
...... .......++..|+|||++.+. .++.++||||||+++|||++|+.||...+..+. .....+....
T Consensus 148 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~ 224 (283)
T cd07835 148 AFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVW 224 (283)
T ss_pred ccCCCc-cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHh
Confidence 654221 112223457889999988654 568899999999999999999999976543221 1111110000
Q ss_pred -----cCCCc----ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 828 -----RGSAS----ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 828 -----~~~~~----~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..... ...........+....++.+++.+||+.+|++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 225 PGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00000 00000000111112246778899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-33 Score=267.26 Aligned_cols=246 Identities=23% Similarity=0.363 Sum_probs=194.8
Q ss_pred CceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 599 ECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
...+|.|+-|.||+++.. +|...|||.+......++.+++...++++..- ++|+||+.+|||......++-||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 346899999999999775 47889999998777667777888888887665 589999999999999999999999843
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
.....++... +++++.-+-++...+..||.||.+++ +|+|||+||+|||+|+.|++|+||||++-.+
T Consensus 176 C~ekLlkrik-----------~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrl 242 (391)
T KOG0983|consen 176 CAEKLLKRIK-----------GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRL 242 (391)
T ss_pred HHHHHHHHhc-----------CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeeccccccee
Confidence 5666665433 45778888899999999999999876 9999999999999999999999999999877
Q ss_pred CCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCC-CcchhhHHHHHHHHHHcCCCc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPT-TNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~ 832 (884)
- ++...+...|.+.|||||.+. ...|+.++||||||++++|+.||..||..-+ +.++. .. .... .+
T Consensus 243 v--dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l--tk----vln~-eP- 312 (391)
T KOG0983|consen 243 V--DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL--TK----VLNE-EP- 312 (391)
T ss_pred e--cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH--HH----HHhc-CC-
Confidence 5 444556778899999999986 3468889999999999999999999998743 22222 11 1111 11
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.++++.. .....+.+++..|+++|+.+||...++++
T Consensus 313 P~L~~~~-----gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~ 348 (391)
T KOG0983|consen 313 PLLPGHM-----GFSPDFQSFVKDCLTKDHRKRPKYNKLLE 348 (391)
T ss_pred CCCCccc-----CcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence 2222211 12335777788899999999999988874
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-32 Score=288.77 Aligned_cols=248 Identities=23% Similarity=0.329 Sum_probs=198.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+....+|+|++|.||+|... ++..+++|++..... ..+.+.+|++.++.++|+|++++++++......++|+||++
T Consensus 21 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 98 (286)
T cd06614 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ--NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMD 98 (286)
T ss_pred chHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch--hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccC
Confidence 445568999999999999776 678899999875432 56778999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ..+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++|+|||.+.
T Consensus 99 ~~~L~~~l~~~~-----------~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~ 164 (286)
T cd06614 99 GGSLTDIITQNF-----------VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAA 164 (286)
T ss_pred CCcHHHHHHHhc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhh
Confidence 999999997532 2588999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
...... .......++..|+|||.+.+..++.++|||||||++|+|++|+.||......... ..... ......
T Consensus 165 ~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~~~ 236 (286)
T cd06614 165 QLTKEK-SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL------FLITT-KGIPPL 236 (286)
T ss_pred hhccch-hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHh-cCCCCC
Confidence 654321 1223345678899999998888999999999999999999999999764432211 11111 111110
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .......++..++.+||+.+|.+|||+.+++.
T Consensus 237 ~------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 237 K------NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred c------chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0 01112346778889999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=288.63 Aligned_cols=261 Identities=22% Similarity=0.268 Sum_probs=195.5
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|++|+||+|... +++.|++|++.............+|+..+++++ |||++++++++.+++..++||||+
T Consensus 2 ~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~- 80 (283)
T cd07830 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM- 80 (283)
T ss_pred eeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-
Confidence 35678999999999999875 477899999865433334445667999999998 999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... ...+++..+..++.|++.+|.|||+. +++|+||+|+||++++++.++|+|||.+.
T Consensus 81 ~~~l~~~~~~~~----------~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~ 147 (283)
T cd07830 81 EGNLYQLMKDRK----------GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAR 147 (283)
T ss_pred CCCHHHHHHhcc----------cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccce
Confidence 789998886432 23679999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccC-CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHH-HH---------HH
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC-EY---------VR 823 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~-~~---------~~ 823 (884)
...... ......++..|+|||++. ...++.++|+||||+++|||++|+.||......+..... .. ..
T Consensus 148 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (283)
T cd07830 148 EIRSRP--PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225 (283)
T ss_pred eccCCC--CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhh
Confidence 664321 223456788899999874 445788999999999999999999999765433222110 00 00
Q ss_pred HHHHcCCCccccccc----CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 824 ELLERGSASACFDRS----LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 824 ~~~~~~~~~~~~d~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...........+... .....+....++.+++.+||+.+|++|||++|++.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred HhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000000000000000 00011112356888999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=290.57 Aligned_cols=253 Identities=17% Similarity=0.212 Sum_probs=178.7
Q ss_pred cccCceeccCCceEEEEEEEcCC----eEEEEEEccccCccCCH----------HHHHHHHHHHhcCCCCCcceeeeEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFEGG----VSIAVKKLETLGRIRNQ----------EEFELEIGRLSNIRHFNLVAFQGYYW 661 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~----~~vavK~~~~~~~~~~~----------~~~~~E~~~l~~l~h~niv~~~~~~~ 661 (884)
|...++||+|+||.||+|...+. ..+|+|+.......... .....+...+..++|++++++++++.
T Consensus 14 y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~ 93 (294)
T PHA02882 14 WKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGS 93 (294)
T ss_pred eEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeee
Confidence 45778999999999999977543 44555553322111111 11223344556778999999999765
Q ss_pred cCC----ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCce
Q 002759 662 SST----MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNI 737 (884)
Q Consensus 662 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Ni 737 (884)
... ..+++++++. .++.+.+.... ..++..+..++.|+++||+|||+. +|+||||||+||
T Consensus 94 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~------------~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Ni 157 (294)
T PHA02882 94 FKRCRMYYRFILLEKLV-ENTKEIFKRIK------------CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENI 157 (294)
T ss_pred EecCCceEEEEEEehhc-cCHHHHHHhhc------------cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 443 3467777763 35666554322 356778899999999999999998 999999999999
Q ss_pred EeCCCCCeeEccccCccccCCccC------cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCC
Q 002759 738 LLDENYEPKLSDYGLAKLLPILDN------YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT 811 (884)
Q Consensus 738 l~~~~~~vkl~Dfg~s~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~ 811 (884)
+++.++.++|+|||+|+.+..... .......||..|+|||+..+..++.++|||||||++|||++|+.||....
T Consensus 158 ll~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 158 MVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred EEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999999999987642211 11123468999999999999999999999999999999999999998753
Q ss_pred C-cchhhHH--HHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 812 T-NEVVVLC--EYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 812 ~-~~~~~~~--~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
. .+..... ++..+. ..+... .......+.+++..||+.+|++||+++++.+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~-~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRL-HEGKIK----------IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred cchHHHHHhHHHHHHHh-hhhhhc----------cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 2 2221111 111111 111110 111234677788889999999999999999876
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=292.55 Aligned_cols=244 Identities=25% Similarity=0.375 Sum_probs=191.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... +++.||+|++..... .....++.+|+++++.++|||++++.+++.+.+..++||||
T Consensus 17 y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 96 (307)
T cd06607 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEY 96 (307)
T ss_pred hhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHh
Confidence 446678999999999999764 688999998854321 22345688999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+. |++.+++.... ..+++..+..++.|++.||.|||+. +|+||||+|+||++++++.++|+|||+
T Consensus 97 ~~-g~l~~~~~~~~-----------~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~ 161 (307)
T cd06607 97 CL-GSASDILEVHK-----------KPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGS 161 (307)
T ss_pred hC-CCHHHHHHHcc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCc
Confidence 96 57777765322 2578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+...... ....++..|+|||++. ...++.++||||||+++|||++|+.||......... ..... .
T Consensus 162 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~------~~~~~-~ 229 (307)
T cd06607 162 ASLVSPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQ-N 229 (307)
T ss_pred ceecCCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH------HHHhc-C
Confidence 8765422 2345678899999874 456788999999999999999999999765432211 11111 1
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
... .. .......++.+++.+||+.+|++||++.+++.
T Consensus 230 ~~~-----~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 266 (307)
T cd06607 230 DSP-----TL--SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266 (307)
T ss_pred CCC-----CC--CchhhCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 110 00 01223346788889999999999999999986
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=315.15 Aligned_cols=267 Identities=16% Similarity=0.155 Sum_probs=184.4
Q ss_pred cccCceeccCCceEEEEEEEcC--CeEEEEEE--------------ccc--cCccCCHHHHHHHHHHHhcCCCCCcceee
Q 002759 596 LDKECLIGGGSIGSVYRASFEG--GVSIAVKK--------------LET--LGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~--~~~vavK~--------------~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~ 657 (884)
|+..+.||+|+||+||+|..+. +..+++|. +.. .........+.+|+.++++++||||++++
T Consensus 150 Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~ 229 (501)
T PHA03210 150 FRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIE 229 (501)
T ss_pred cEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEe
Confidence 5677899999999999986532 22222221 100 01112345688999999999999999999
Q ss_pred eEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCce
Q 002759 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNI 737 (884)
Q Consensus 658 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Ni 737 (884)
+++...+..++|++++ ++++.+++....... .......++..++.||+.||+|||++ +||||||||+||
T Consensus 230 ~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~-------~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NI 298 (501)
T PHA03210 230 EILRSEANTYMITQKY-DFDLYSFMYDEAFDW-------KDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENI 298 (501)
T ss_pred EEEEECCeeEEEEecc-ccCHHHHHhhccccc-------cccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence 9999999999999998 457888775432110 11234567788999999999999998 999999999999
Q ss_pred EeCCCCCeeEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCC-CCCCCCcchh
Q 002759 738 LLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP-VESPTTNEVV 816 (884)
Q Consensus 738 l~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p-~~~~~~~~~~ 816 (884)
|++.++.+||+|||+++.+............|+..|+|||++.+..++.++|||||||++|||++|..+ +.........
T Consensus 299 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~ 378 (501)
T PHA03210 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378 (501)
T ss_pred EECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence 999999999999999987754333333446789999999999998999999999999999999998754 4332222211
Q ss_pred hHHHHHHHHHH-cCCCcc-------c-----ccc---cCCCCc--HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 817 VLCEYVRELLE-RGSASA-------C-----FDR---SLRGFA--ENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 817 ~~~~~~~~~~~-~~~~~~-------~-----~d~---~~~~~~--~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.+....... ...+.. . ++. .+.... .....++..++.+|++.||.+|||+.|+++
T Consensus 379 ~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 379 QLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111111000 000000 0 000 000000 001124566788899999999999999985
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=282.32 Aligned_cols=247 Identities=26% Similarity=0.395 Sum_probs=199.8
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+..+.||+|++|.||+|... ++..+++|++..... .....+.+|++.++.++|++++++.+++......++++||+++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~ 81 (253)
T cd05122 3 EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK-EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSG 81 (253)
T ss_pred eeeeeeccCCceEEEEEEECCCCcEEEEEEecccch-hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCC
Confidence 45678999999999999775 678899999975432 4567899999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ..+++..+..++.|+++|++|||+. +++||||+|+||++++++.++|+|||.+..
T Consensus 82 ~~L~~~~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~ 147 (253)
T cd05122 82 GSLKDLLKSTN-----------QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQ 147 (253)
T ss_pred CcHHHHHhhcC-----------CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccc
Confidence 99999986432 3689999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
...... .....++..|+|||.+.+..++.++||||||+++|+|++|+.||...+..+.. ..... .......
T Consensus 148 ~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~-~~~~~~~ 218 (253)
T cd05122 148 LSDTKA--RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKAL------FKIAT-NGPPGLR 218 (253)
T ss_pred cccccc--ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHH------HHHHh-cCCCCcC
Confidence 653221 34456788999999998888899999999999999999999999865422211 11111 1111110
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+ ......++.+++..||+.||++|||+.|+++
T Consensus 219 ~------~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 N------PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred c------ccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 0 0111346778888999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=287.27 Aligned_cols=251 Identities=25% Similarity=0.381 Sum_probs=194.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCC------cee
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSST------MQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~------~~~ 667 (884)
|+..+.||+|++|.||+|... +++.+++|++.... ...+++.+|+.+++++ +|+||+++++++.... ..+
T Consensus 8 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~ 85 (275)
T cd06608 8 FELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE--DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW 85 (275)
T ss_pred eeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEE
Confidence 456788999999999999774 56789999886543 3457789999999998 7999999999986544 479
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+++++|.+++..... ....+++..+..++.|+++||+|||+. +++||||+|+||++++++.+++
T Consensus 86 lv~e~~~~~~L~~~~~~~~~--------~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l 154 (275)
T cd06608 86 LVMELCGGGSVTDLVKGLRK--------KGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKL 154 (275)
T ss_pred EEEEcCCCCcHHHHHHHHhh--------cCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEE
Confidence 99999999999998864220 123688999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCC-----CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-----LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~ 822 (884)
+|||.+....... .......++..|+|||++.. ..++.++||||+|+++|||++|+.||........ .
T Consensus 155 ~d~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~ 227 (275)
T cd06608 155 VDFGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA------L 227 (275)
T ss_pred CCCccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH------H
Confidence 9999987654321 12234567889999998753 3467789999999999999999999975432211 1
Q ss_pred HHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...... .... .. .......++.+++.+||..||++|||+.|+++
T Consensus 228 ~~~~~~-~~~~-----~~-~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 228 FKIPRN-PPPT-----LK-SPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred HHhhcc-CCCC-----CC-chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 111111 1111 11 11223346778889999999999999999975
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-32 Score=293.58 Aligned_cols=259 Identities=25% Similarity=0.283 Sum_probs=192.4
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e 671 (884)
|+..+.||+|+||.||+|... ++..||+|+++.... ......+.+|+.++++++|+|++++++++... +..++|||
T Consensus 9 y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e 88 (309)
T cd07845 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVME 88 (309)
T ss_pred eeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEe
Confidence 456778999999999999764 588999999864322 22234567899999999999999999998654 46799999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+.+ +|.+++.... ..+++.++..++.|+++|++|||+. +++||||||+||++++++.+||+|||
T Consensus 89 ~~~~-~l~~~l~~~~-----------~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg 153 (309)
T cd07845 89 YCEQ-DLASLLDNMP-----------TPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFG 153 (309)
T ss_pred cCCC-CHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccc
Confidence 9964 8888876432 3589999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
.+....... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+..+.... .......+.
T Consensus 154 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~---~~~~~~~~~ 229 (309)
T cd07845 154 LARTYGLPA-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL---IIQLLGTPN 229 (309)
T ss_pred eeeecCCcc-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCC
Confidence 998765322 12233345778999999865 4578899999999999999999999987654333211 111111000
Q ss_pred -----------Cccccc--ccCCCC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 -----------ASACFD--RSLRGF----AENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 -----------~~~~~d--~~~~~~----~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
....+. ...... ......++.+++.+|++.||++|||++|++.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 230 ESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 000000 000000 0012345667889999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-32 Score=295.04 Aligned_cols=247 Identities=23% Similarity=0.345 Sum_probs=201.9
Q ss_pred cccccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 594 ALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
..|.....||+|.|++|.+|.. .++..||||.+.+.. .......+.+|++++..++|||||+++.+...+...|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 4456778899999999999965 468899999996543 33344668999999999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+.+|.+++++...+ .....++..++.|+..|++|+|++ .|||||||++||+++.+..+||+|||
T Consensus 136 ya~~ge~~~yl~~~g------------r~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfg 200 (596)
T KOG0586|consen 136 YASGGELFDYLVKHG------------RMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFG 200 (596)
T ss_pred eccCchhHHHHHhcc------------cchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccc
Confidence 999999999998765 455588899999999999999999 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCC-CCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRL-SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
++.++. ........+|++.|.|||++.+..| .+++|+||+|+++|-|+.|..||++..-.+... +.+. ++
T Consensus 201 fS~~~~--~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~------rvl~-gk 271 (596)
T KOG0586|consen 201 FSTFFD--YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRP------RVLR-GK 271 (596)
T ss_pred cceeec--ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccc------hhee-ee
Confidence 999886 3445677899999999999999887 479999999999999999999999755332210 1100 00
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+. + +.-...+.-+++++++-.+|.+|++++++.+
T Consensus 272 ~r------I---p~~ms~dce~lLrk~lvl~Pskr~~~dqim~ 305 (596)
T KOG0586|consen 272 YR------I---PFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK 305 (596)
T ss_pred ec------c---cceeechhHHHHHHhhccCccccCCHHHhhh
Confidence 00 0 0111124456777789999999999999864
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=286.64 Aligned_cols=259 Identities=24% Similarity=0.282 Sum_probs=192.7
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCcc-CCHHHHHHHHHHHhcC---CCCCcceeeeEEecCCc-----e
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRI-RNQEEFELEIGRLSNI---RHFNLVAFQGYYWSSTM-----Q 666 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----~ 666 (884)
+..+.||+|+||.||+|... ++..+|+|++...... .....+.+|+.++.++ +|||++++++++...+. .
T Consensus 2 ~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~ 81 (287)
T cd07838 2 EELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKL 81 (287)
T ss_pred eEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCcee
Confidence 35678999999999999876 4889999999643221 2234566777766555 69999999999987766 8
Q ss_pred eEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
+++|||+.+ +|.+++.... ...+++..++.++.|+++||+|||+. +++|+||+|+||++++++.+|
T Consensus 82 ~l~~e~~~~-~l~~~l~~~~----------~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~ 147 (287)
T cd07838 82 TLVFEHVDQ-DLATYLSKCP----------KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVK 147 (287)
T ss_pred EEEehhccc-CHHHHHHHcc----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEE
Confidence 999999964 8988886533 23588999999999999999999998 999999999999999999999
Q ss_pred EccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|+|||.+....... ......++..|+|||++.+..++.++||||||+++|||++|+.||......+... .......
T Consensus 148 l~dfg~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~ 223 (287)
T cd07838 148 IADFGLARIYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIG 223 (287)
T ss_pred EeccCcceeccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcC
Confidence 99999998764321 2233456888999999998889999999999999999999999998654432211 1111000
Q ss_pred HcCC---C------ccccc----ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGS---A------SACFD----RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~---~------~~~~d----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... . ...+. .......+.....+.+++.+||+.||++||++.|++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0000 0 00000 0001112233456778899999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=286.51 Aligned_cols=244 Identities=19% Similarity=0.228 Sum_probs=186.4
Q ss_pred ceeccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHH-HhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 600 CLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGR-LSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+.||+|+||.||+|... +++.||+|.+..... ......+..|... ....+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 35899999999999764 578999999864321 1122334445444 3455899999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... .+++..+..++.|++.||.|||+. +++||||+|+||++++++.++|+|||.++.
T Consensus 82 ~~L~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 82 GDCASLIKTLG------------GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRN 146 (260)
T ss_pred CCHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeeccccee
Confidence 99999986543 578899999999999999999998 999999999999999999999999999875
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
... .....++..|+|||...+..++.++||||+|+++|||++|..||...+..+.. ... ...... .
T Consensus 147 ~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~------~~~-~~~~~~--~ 212 (260)
T cd05611 147 GLE-----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVF------DNI-LSRRIN--W 212 (260)
T ss_pred ccc-----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HhcccC--C
Confidence 432 22345778899999998888899999999999999999999999765443221 111 111110 0
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
.... ......++.+++.+||+.+|++||++.++.+.+
T Consensus 213 ~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 213 PEEV---KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCcc---cccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1111 112234678888899999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=288.62 Aligned_cols=250 Identities=24% Similarity=0.356 Sum_probs=189.7
Q ss_pred ccCceeccCCceEEEEEEEcC-CeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|++|.||+|...+ +..||||.++..........+..|+..+.+. .||||+++++++.+....++||||+.
T Consensus 18 ~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 97 (296)
T cd06618 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS 97 (296)
T ss_pred eeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC
Confidence 356789999999999998864 8899999997544333455667777766666 49999999999999999999999985
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++.++..... ..+++..+..++.|++.||+|||+.. +|+||||+|+||++++++.+||+|||.+.
T Consensus 98 -~~l~~l~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~ 163 (296)
T cd06618 98 -TCLDKLLKRIQ-----------GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISG 163 (296)
T ss_pred -cCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccch
Confidence 47776665422 26889999999999999999999732 89999999999999999999999999997
Q ss_pred ccCCccCcccccccccccccCccccCCCC----CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLR----LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
.+... .......++..|+|||.+.+.. ++.++||||||+++|||++|+.||....... +..........
T Consensus 164 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----~~~~~~~~~~~ 236 (296)
T cd06618 164 RLVDS--KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-----EVLTKILQEEP 236 (296)
T ss_pred hccCC--CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-----HHHHHHhcCCC
Confidence 66432 1223345678899999987554 7889999999999999999999997532211 11112211111
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
. ...+ ......++.+++.+||+.+|.+||++.++++.
T Consensus 237 ~-~~~~------~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 P-SLPP------NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred C-CCCC------CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1 0000 00123467888889999999999999999753
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=291.28 Aligned_cols=248 Identities=24% Similarity=0.353 Sum_probs=193.4
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|...+.||+|+||.||+|... ++..+|+|++..... ......+.+|+++++.++|||++++++++.++...++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 445678999999999999764 678899999864322 22345788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+. |++.+.+.... ..+++.++..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||+
T Consensus 107 ~~-g~l~~~~~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~ 171 (317)
T cd06635 107 CL-GSASDLLEVHK-----------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 171 (317)
T ss_pred CC-CCHHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCC
Confidence 96 47777765322 3588999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+..... .....++..|+|||.+. ...++.++|||||||++|||++|+.||......+.. .......
T Consensus 172 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~ 240 (317)
T cd06635 172 ASIASP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNE 240 (317)
T ss_pred ccccCC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHHhcc
Confidence 875432 22346788899999973 456788999999999999999999999764322211 1111111
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
.... ........+.+++.+||+.+|.+||++.++++....
T Consensus 241 ~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~ 280 (317)
T cd06635 241 SPTL--------QSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280 (317)
T ss_pred CCCC--------CCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence 1000 011223357788889999999999999999975443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=292.66 Aligned_cols=256 Identities=19% Similarity=0.227 Sum_probs=188.1
Q ss_pred eccCCceEEEEEEEcCCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchhh
Q 002759 602 IGGGSIGSVYRASFEGGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYD 680 (884)
Q Consensus 602 lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 680 (884)
+|.|+++.||++.. +++.||+|++... ......+.+.+|+++++.++||||+++++++.+.+..+++|||+++++|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44455555555544 5889999998754 234556789999999999999999999999999999999999999999999
Q ss_pred hcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCcc
Q 002759 681 NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILD 760 (884)
Q Consensus 681 ~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~ 760 (884)
++.... ...+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+|++|||.+.......
T Consensus 89 ~l~~~~----------~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~ 155 (314)
T cd08216 89 LLKTHF----------PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHG 155 (314)
T ss_pred HHHHhc----------ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccc
Confidence 987543 23578888999999999999999998 99999999999999999999999999887654221
Q ss_pred Cc------ccccccccccccCccccCC--CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH----c
Q 002759 761 NY------GLTKFHNAVGYVAPELAQS--LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE----R 828 (884)
Q Consensus 761 ~~------~~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~----~ 828 (884)
.. ......++..|+|||++.+ ..++.++|||||||++|||++|+.||......... .+....... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~ 233 (314)
T cd08216 156 KRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDK 233 (314)
T ss_pred ccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCcccccc
Confidence 11 1123346778999999875 35788999999999999999999999864432211 111110000 0
Q ss_pred CC-------Ccc----cccccCC-----CCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 GS-------ASA----CFDRSLR-----GFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~-------~~~----~~d~~~~-----~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. ... ..++... ........++.+++..||+.+|++|||++++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 234 STYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00 000 0000000 011222346778889999999999999999985
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.5e-32 Score=288.99 Aligned_cols=243 Identities=24% Similarity=0.341 Sum_probs=193.6
Q ss_pred ceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 600 CLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
..||+|+||.||+|.. .++..||+|++.... ......+.+|+.+++.++|+|++++++++..++..++||||+++++|
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 104 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK-QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccc-hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence 3689999999999976 468899999885422 23456789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+++... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+.....
T Consensus 105 ~~~~~~~-------------~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 105 TDIVTHT-------------RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 9887432 478899999999999999999998 999999999999999999999999999876542
Q ss_pred ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 759 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
.. .......++..|+|||...+..++.++|+||+|+++|||++|+.||......+.. .......+ +.
T Consensus 169 ~~-~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~---~~~~~~~~---------~~ 235 (292)
T cd06657 169 EV-PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAM---KMIRDNLP---------PK 235 (292)
T ss_pred cc-ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHhhCC---------cc
Confidence 21 1223356788999999998888899999999999999999999999764432221 11111110 01
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
... .......+.+++.+||+.+|.+||++.++++
T Consensus 236 ~~~-~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 236 LKN-LHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred cCC-cccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 100 1112235667788899999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=288.63 Aligned_cols=245 Identities=24% Similarity=0.297 Sum_probs=193.4
Q ss_pred eccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 602 IGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 602 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
||+|+||.||+|... +++.+++|.+..... ....+.+.+|++++++++|||++++++.+......++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 589999999999876 488999999864321 23456788999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+++.... .+++..+..++.||++||+|||+. +++||||+|+||++++++.++|+|||++.....
T Consensus 81 ~~~l~~~~------------~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~ 145 (265)
T cd05579 81 ASLLENVG------------SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLV 145 (265)
T ss_pred HHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhccc
Confidence 99987432 578999999999999999999998 999999999999999999999999999876432
Q ss_pred ccC-------cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 759 LDN-------YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 759 ~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
... .......++..|+|||.......+.++||||||+++||+++|+.||......+.. ... .....
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~-~~~~~ 218 (265)
T cd05579 146 RRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIF------QNI-LNGKI 218 (265)
T ss_pred CcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH------HHH-hcCCc
Confidence 211 1223345678899999998888899999999999999999999999765433221 111 11111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVL 875 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L 875 (884)
.. +... .....+..++.+||+.+|++|||+.++.+.|
T Consensus 219 ~~---~~~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 219 EW---PEDV----EVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred CC---Cccc----cCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 10 0000 0134677888899999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=289.26 Aligned_cols=254 Identities=22% Similarity=0.284 Sum_probs=196.3
Q ss_pred ccCceeccCCceEEEEEEE----cCCeEEEEEEccccC---ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeE
Q 002759 597 DKECLIGGGSIGSVYRASF----EGGVSIAVKKLETLG---RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (884)
+..+.||+|++|.||+|.. .++..||||+++... .....+.+..|+.++.++ +||||+++++++..+...++
T Consensus 3 ~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~l 82 (288)
T cd05583 3 ELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHL 82 (288)
T ss_pred eEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEE
Confidence 3567899999999999964 356789999986432 223456788999999999 59999999999998889999
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++++|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||+++.++.++++
T Consensus 83 v~e~~~~~~L~~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~ 147 (288)
T cd05583 83 ILDYVNGGELFTHLYQRE------------HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLT 147 (288)
T ss_pred EEecCCCCcHHHHHhhcC------------CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEE
Confidence 999999999999986432 578899999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCcccccccccccccCccccCCCC--CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLR--LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||+++..............++..|+|||...+.. .+.++||||||+++|||++|..||........ .....+...
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~ 225 (288)
T cd05583 148 DFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRIL 225 (288)
T ss_pred ECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHH
Confidence 99998875433222223346788999999987654 67899999999999999999999965332211 111122221
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~ 877 (884)
... +. .+......+.+++.+||+.+|++|||+.++.+.|+.
T Consensus 226 ~~~-------~~---~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~ 266 (288)
T cd05583 226 KSK-------PP---FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH 266 (288)
T ss_pred ccC-------CC---CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence 111 00 111122356778889999999999999888776653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=9e-32 Score=294.56 Aligned_cols=254 Identities=22% Similarity=0.287 Sum_probs=189.1
Q ss_pred eeccC--CceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 601 LIGGG--SIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 601 ~lg~G--~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
.||+| +||+||+|.. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++..++..++|+||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999976 478999999986432 2233567889999999999999999999999999999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
++.+++.... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++||+.+...
T Consensus 85 ~l~~~l~~~~----------~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~ 151 (328)
T cd08226 85 SANSLLKTYF----------PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSL 151 (328)
T ss_pred CHHHHHHhhc----------ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhh
Confidence 9999987543 23578899999999999999999988 9999999999999999999999999865433
Q ss_pred CCccCcc------cccccccccccCccccCC--CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc
Q 002759 757 PILDNYG------LTKFHNAVGYVAPELAQS--LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 757 ~~~~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
....... .....++..|+|||++.+ ..++.++||||+||++|||++|+.||......+.. . .....
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-----~-~~~~~ 225 (328)
T cd08226 152 VRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML-----L-QKLKG 225 (328)
T ss_pred hccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH-----H-HHhcC
Confidence 2111100 011234567999999876 34788999999999999999999999764432211 0 00000
Q ss_pred CCC------------------------------------cccccccCCC-CcHHHHHHHHHHHhhccCCCCCCCCCHHHH
Q 002759 829 GSA------------------------------------SACFDRSLRG-FAENELIQVMKLGLICTSEVPSRRPSMAEV 871 (884)
Q Consensus 829 ~~~------------------------------------~~~~d~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~el 871 (884)
... ....+..... ........+.+++.+||+.||++|||++|+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~ 305 (328)
T cd08226 226 PPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSL 305 (328)
T ss_pred CCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHH
Confidence 000 0000000010 122344578899999999999999999999
Q ss_pred HH
Q 002759 872 VQ 873 (884)
Q Consensus 872 l~ 873 (884)
++
T Consensus 306 l~ 307 (328)
T cd08226 306 LS 307 (328)
T ss_pred hh
Confidence 73
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=7e-32 Score=292.23 Aligned_cols=260 Identities=23% Similarity=0.242 Sum_probs=192.7
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC---------
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST--------- 664 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------- 664 (884)
|+..+.||+|+||.||+|... +++.||+|+++... .......+.+|+++++.++|||++++++++.+..
T Consensus 9 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 88 (302)
T cd07864 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDK 88 (302)
T ss_pred hheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccC
Confidence 446778999999999999775 57889999986432 2234467788999999999999999999887654
Q ss_pred -ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC
Q 002759 665 -MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY 743 (884)
Q Consensus 665 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~ 743 (884)
..++|+||+++ ++.+.+.... ..+++..+..++.||+.||+|||+. +|+||||||+||++++++
T Consensus 89 ~~~~lv~e~~~~-~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~ 153 (302)
T cd07864 89 GAFYLVFEYMDH-DLMGLLESGL-----------VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKG 153 (302)
T ss_pred CcEEEEEcccCc-cHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence 78999999976 7777765322 3589999999999999999999998 999999999999999999
Q ss_pred CeeEccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002759 744 EPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 744 ~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~ 822 (884)
.+||+|||.+...............++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+... .+
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~---~~ 230 (302)
T cd07864 154 QIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE---LI 230 (302)
T ss_pred cEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HH
Confidence 99999999998765332212222345778999998864 356889999999999999999999998654332221 11
Q ss_pred HHHHHcCCCccc-----------ccc------cCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 823 RELLERGSASAC-----------FDR------SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 823 ~~~~~~~~~~~~-----------~d~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.......... .++ ............+.+++..||+.+|++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 231 SRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred HHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111111100000 000 000001112346788888999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=290.57 Aligned_cols=263 Identities=19% Similarity=0.190 Sum_probs=191.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCc-----ee
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTM-----QL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----~~ 667 (884)
|+..+.||+|+||.||+|... +++.||+|++..... ......+.+|+.+++.++ ||||+++++++..... .+
T Consensus 3 y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~ 82 (295)
T cd07837 3 YEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLY 82 (295)
T ss_pred ceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEE
Confidence 446678999999999999765 688999998864322 223467888999999995 6999999998876655 79
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC-CCCee
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-NYEPK 746 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-~~~vk 746 (884)
+||||+++ +|.+++..... .....+++..++.++.||++||+|||+. +|+||||||+||+++. ++.+|
T Consensus 83 lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~k 151 (295)
T cd07837 83 LVFEYLDS-DLKKFMDSNGR-------GPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLK 151 (295)
T ss_pred EEeeccCc-CHHHHHHHhcc-------cCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEE
Confidence 99999975 89888864321 0123689999999999999999999998 9999999999999998 89999
Q ss_pred EccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
|+|||.++.+.... .......++..|+|||.+.+ ..++.++||||||+++|||++|..||......+.. ..... .
T Consensus 152 l~dfg~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~-~ 227 (295)
T cd07837 152 IADLGLGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFK-L 227 (295)
T ss_pred EeecccceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHH-H
Confidence 99999998653211 11223345778999998865 45788999999999999999999999865432211 11111 1
Q ss_pred HHcCCCccc-----------cc----ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 826 LERGSASAC-----------FD----RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 826 ~~~~~~~~~-----------~d----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+..... +. .......+....++.+++.+||+.+|.+||++.|++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 100000000 00 0000011123346778899999999999999999874
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=292.42 Aligned_cols=205 Identities=24% Similarity=0.305 Sum_probs=166.1
Q ss_pred ccCceeccCCceEEEEEEEc---CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeEE
Q 002759 597 DKECLIGGGSIGSVYRASFE---GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLIL 669 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~---~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv 669 (884)
+..+.||+|++|.||+|... ++..||+|.+.... .......+.+|+.++.+++||||+++++++.+. ...++|
T Consensus 3 ~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 82 (316)
T cd07842 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLL 82 (316)
T ss_pred eEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEE
Confidence 35567999999999999775 47899999987532 123346678899999999999999999999887 789999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC----CCCe
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE----NYEP 745 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~----~~~v 745 (884)
|||+++ ++.+++...... ....++...+..++.||+.||+|||+. +|+||||||+||+++. ++.+
T Consensus 83 ~e~~~~-~l~~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 83 FDYAEH-DLWQIIKFHRQA-------KRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred EeCCCc-CHHHHHHhhccC-------CCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceE
Confidence 999965 677766433210 123678899999999999999999998 9999999999999999 9999
Q ss_pred eEccccCccccCCccC--cccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCC
Q 002759 746 KLSDYGLAKLLPILDN--YGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTT 812 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~ 812 (884)
||+|||+++....... .......++..|+|||++.+ ..++.++||||||+++|||++|+.||.....
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 9999999987643221 11233456888999998866 4578899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.3e-32 Score=284.98 Aligned_cols=248 Identities=24% Similarity=0.313 Sum_probs=200.2
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|+||.||++... ++..+++|++.... .......+.+|+++++.++|+||+++.+++......++||||++
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd08530 3 KVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAP 82 (256)
T ss_pred eEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcC
Confidence 45678999999999999654 67889999986432 22345677889999999999999999999998899999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .....+++..++.++.|+++||+|||+. +++||||+|+||++++++.+|++|||+++
T Consensus 83 ~~~L~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~ 151 (256)
T cd08530 83 FGDLSKAISKRK--------KKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISK 151 (256)
T ss_pred CCCHHHHHHHHH--------hhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchh
Confidence 999999986532 1124688999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
..... ......++..|+|||.+.+..++.++|+||+|+++||+++|+.||...+..+.. ..+......
T Consensus 152 ~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~-------~~~~~~~~~-- 219 (256)
T cd08530 152 VLKKN---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLR-------YKVQRGKYP-- 219 (256)
T ss_pred hhccC---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHhcCCCC--
Confidence 76532 222345788999999999988999999999999999999999999865533211 111111111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
........++.+++.+||+.+|++|||+.|+++
T Consensus 220 ------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 ------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred ------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 112234456888999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=292.60 Aligned_cols=263 Identities=21% Similarity=0.229 Sum_probs=190.3
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC--------c
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST--------M 665 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~ 665 (884)
|+..+.||+|+||.||+|... +++.||||++..... ......+.+|+.++++++||||+++++++.... .
T Consensus 14 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 93 (310)
T cd07865 14 YEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGS 93 (310)
T ss_pred eEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCce
Confidence 446778999999999999764 688999998864322 223445678999999999999999999986554 3
Q ss_pred eeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCe
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~v 745 (884)
.++||||+. +++.+.+.... ..+++.+++.++.||++||+|||+. +++|+||||+||+++.++.+
T Consensus 94 ~~lv~e~~~-~~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~ 158 (310)
T cd07865 94 FYLVFEFCE-HDLAGLLSNKN-----------VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGIL 158 (310)
T ss_pred EEEEEcCCC-cCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcE
Confidence 499999996 48888775432 3588999999999999999999998 99999999999999999999
Q ss_pred eEccccCccccCCccCc---ccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 002759 746 KLSDYGLAKLLPILDNY---GLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEY 821 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~ 821 (884)
||+|||.+......... ......++..|+|||.+.+. .++.++||||||+++|||++|+.||..............
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~ 238 (310)
T cd07865 159 KLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQ 238 (310)
T ss_pred EECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 99999999876432211 11234567889999988664 468899999999999999999999976544322222111
Q ss_pred HHHHHHcCCCc-----cccc-----ccCCCCcH------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 822 VRELLERGSAS-----ACFD-----RSLRGFAE------NELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 822 ~~~~~~~~~~~-----~~~d-----~~~~~~~~------~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.....+..... ...+ ........ .....+.+++.+||+.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 239 LCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred HhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 11000000000 0000 00000000 01134567899999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=282.99 Aligned_cols=248 Identities=22% Similarity=0.325 Sum_probs=192.7
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEcccc----CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETL----GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l 668 (884)
|+..+.||+|+||.||+|.. .++..||+|.+... ........+.+|++++++++||||+++++++.+. ...++
T Consensus 4 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (264)
T cd06653 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSI 83 (264)
T ss_pred eeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEE
Confidence 34678999999999999976 45889999987432 1123346788999999999999999999988654 45789
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
|+||+++++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.++|+
T Consensus 84 v~e~~~~~~L~~~~~~~~------------~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~ 148 (264)
T cd06653 84 FVEYMPGGSIKDQLKAYG------------ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLG 148 (264)
T ss_pred EEEeCCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence 999999999999986433 478889999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCcc--CcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILD--NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||.++...... ........++..|+|||.+.+..++.++|||||||++||+++|+.||......+. .....
T Consensus 149 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~ 222 (264)
T cd06653 149 DFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA------IFKIA 222 (264)
T ss_pred ccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH------HHHHH
Confidence 999998653211 1122345678899999999988889999999999999999999999976432211 11111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..+ .... .+.....++..++.+||+ +|.+||++.+++.
T Consensus 223 ~~~-~~~~-------~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 223 TQP-TKPM-------LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred cCC-CCCC-------CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 111 1111 122233467778888999 5799999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=290.55 Aligned_cols=260 Identities=22% Similarity=0.251 Sum_probs=191.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||+|++|+||+|... +++.||+|++..... ....+.+.+|++++++++|||++++++++.+....++||||+
T Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (294)
T PLN00009 4 YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYL 83 (294)
T ss_pred eEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecc
Confidence 446678999999999999765 678999999864332 233467889999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC-CCCeeEccccC
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-NYEPKLSDYGL 752 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-~~~vkl~Dfg~ 752 (884)
+ +++.+++.... ...+++..+..++.||+.||+|||+. +++||||+|+||+++. ++.+||+|||+
T Consensus 84 ~-~~l~~~~~~~~----------~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~ 149 (294)
T PLN00009 84 D-LDLKKHMDSSP----------DFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGL 149 (294)
T ss_pred c-ccHHHHHHhCC----------CCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEccccc
Confidence 5 58888775432 22457888889999999999999998 9999999999999985 56799999999
Q ss_pred ccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
++..... ........++..|+|||++.+ ..++.++||||+|+++|+|++|+.||......+... ... .....+..
T Consensus 150 ~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~~~-~~~~~~~~ 225 (294)
T PLN00009 150 ARAFGIP-VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--KIF-RILGTPNE 225 (294)
T ss_pred ccccCCC-ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHH-HHhCCCCh
Confidence 9765321 111233456788999998865 457889999999999999999999998654322211 110 00000000
Q ss_pred ------------ccc----ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 ------------SAC----FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ------------~~~----~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
... .........+....++.+++.+|++.+|++||++.++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 226 ETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred hhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 000 000000011122345778888999999999999999985
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=295.45 Aligned_cols=259 Identities=20% Similarity=0.254 Sum_probs=193.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEec----CCceeEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS----STMQLIL 669 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 669 (884)
|+..+.||+|++|.||+|... ++..||+|++.... .......+.+|+.++++++||||+++.+++.. ....++|
T Consensus 7 y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv 86 (334)
T cd07855 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86 (334)
T ss_pred eeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEE
Confidence 446678999999999999654 68899999986532 22345677889999999999999999998753 3467999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
|||+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||+|
T Consensus 87 ~e~~~-~~l~~~~~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~d 150 (334)
T cd07855 87 MDLME-SDLHHIIHSDQ------------PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGD 150 (334)
T ss_pred Eehhh-hhHHHHhccCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecc
Confidence 99995 68988886433 589999999999999999999998 999999999999999999999999
Q ss_pred ccCccccCCccCc---ccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 002759 750 YGLAKLLPILDNY---GLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 750 fg~s~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
||.++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...+..... ......
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~---~~~~~~ 227 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL---KLILSV 227 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH---HHHHHH
Confidence 9999765432211 1234467889999998865 46789999999999999999999999765432221 111111
Q ss_pred HHcC-----------CCccc---cccc----CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 826 LERG-----------SASAC---FDRS----LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 826 ~~~~-----------~~~~~---~d~~----~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+ ..... +... .....+....++.+++..||+.+|++|||+++++.
T Consensus 228 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 228 LGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 0000 00000 0000 00011223456888899999999999999999885
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-33 Score=273.11 Aligned_cols=240 Identities=23% Similarity=0.246 Sum_probs=193.7
Q ss_pred ccccCceeccCCceEEEEEEE-cCCeEEEEEEccccCcc--CCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRI--RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
.++..+++|+|.||+|-.++- .+++.+|+|++++.... .....-..|-++++..+||.+..+...+...+..|+|||
T Consensus 169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe 248 (516)
T KOG0690|consen 169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME 248 (516)
T ss_pred hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence 345667899999999999955 46889999999765321 234455778899999999999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|..||.|+-.+...+ .+++...+.+...|..||.|||++ +||+||+|.+|.++|.+|++||+|||
T Consensus 249 yanGGeLf~HLsrer------------~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFG 313 (516)
T KOG0690|consen 249 YANGGELFFHLSRER------------VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFG 313 (516)
T ss_pred EccCceEeeehhhhh------------cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecc
Confidence 999999988886544 688888999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
+++.-. ..+......+||+.|.|||++....|+.+.|+|.+||++|||+.|+.||...+......++- .++-++
T Consensus 314 LCKE~I-~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl-----~ed~kF 387 (516)
T KOG0690|consen 314 LCKEEI-KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL-----MEDLKF 387 (516)
T ss_pred cchhcc-cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH-----hhhccC
Confidence 998643 23444567899999999999999999999999999999999999999999866543332211 111111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP 866 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 866 (884)
. .....+...+....+.+||.+|.
T Consensus 388 P-----------r~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 388 P-----------RTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred C-----------ccCCHHHHHHHHHHhhcChHhhc
Confidence 1 11122344555668899999995
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=289.44 Aligned_cols=257 Identities=23% Similarity=0.244 Sum_probs=197.5
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
..+.||+|++|.||+|... +++.+++|++..... ......+..|+.++++++|+||+++++++..++..++|+||+++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 82 (283)
T cd05118 3 KLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT 82 (283)
T ss_pred cceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC
Confidence 4568999999999999764 688899999865432 23457788999999999999999999999999999999999965
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++.+++.... ..+++.++..++.|+++||+|||+. +|+||||||+||+++.++.++|+|||.+..
T Consensus 83 -~l~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~ 147 (283)
T cd05118 83 -DLYKLIKDRQ-----------RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARS 147 (283)
T ss_pred -CHHHHHHhhc-----------ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEe
Confidence 8888876432 3588999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC---
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA--- 831 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 831 (884)
..... .......++..|+|||.+.+. .++.++||||+|+++|++++|+.||...+..+.. .........+..
T Consensus 148 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 223 (283)
T cd05118 148 FGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVW 223 (283)
T ss_pred cCCCc-ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhc
Confidence 65432 122334567889999998776 7889999999999999999999999765533221 111111111000
Q ss_pred ---c-----------ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 ---S-----------ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ---~-----------~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. ...+.......+....++.+++.+||+.||.+||++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 224 PKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred ccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 0 00000000112234457889999999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=282.61 Aligned_cols=250 Identities=25% Similarity=0.346 Sum_probs=200.8
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+..+.||+|++|.||+|... ++..+++|++.... .......+.+|+++++.++|||++++.+.+......++|+||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~ 82 (258)
T cd08215 3 EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYAD 82 (258)
T ss_pred eEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecC
Confidence 35678999999999999765 57889999986543 22456778999999999999999999999998899999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++..... ....+++.++..++.|+++||+|||+. +++|+||+|+||++++++.++|+|||.+.
T Consensus 83 ~~~L~~~l~~~~~--------~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~ 151 (258)
T cd08215 83 GGDLSQKIKKQKK--------EGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISK 151 (258)
T ss_pred CCcHHHHHHHhhc--------cCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCcccee
Confidence 9999999875421 124689999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
...... .......++..|+|||...+..++.++||||+|+++|+|++|+.||......+ ....... .....
T Consensus 152 ~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~~-~~~~~- 222 (258)
T cd08215 152 VLSSTV-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKILK-GQYPP- 222 (258)
T ss_pred ecccCc-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHhc-CCCCC-
Confidence 765322 12233467888999999988889999999999999999999999997654222 1122211 11111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.......++.+++.+||..+|++|||+.|+++
T Consensus 223 -------~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 223 -------IPSQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred -------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 11122346778888999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=294.97 Aligned_cols=258 Identities=21% Similarity=0.267 Sum_probs=192.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 667 (884)
|+..+.||+|+||.||+|... +++.||+|++... ........+.+|+.+++.++||||+++++++... ...+
T Consensus 18 y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 97 (353)
T cd07850 18 YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVY 97 (353)
T ss_pred eEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEE
Confidence 556778999999999999664 6889999998642 2233456778899999999999999999987543 3469
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+. ++|.+.+.. .++...+..++.|++.||+|||+. +|+||||||+||+++.++.+||
T Consensus 98 lv~e~~~-~~l~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL 159 (353)
T cd07850 98 LVMELMD-ANLCQVIQM--------------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 159 (353)
T ss_pred EEEeccC-CCHHHHHhh--------------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEE
Confidence 9999995 588887742 267888999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHH--------
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC-------- 819 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~-------- 819 (884)
+|||.++.... ........++..|+|||.+.+..++.++||||+||++|+|++|+.||...+..+....+
T Consensus 160 ~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 160 LDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ccCccceeCCC--CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999987643 22233456788999999999989999999999999999999999999765422111000
Q ss_pred ----H----HHHHHHHcCC-C-----cccccccCCC-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 820 ----E----YVRELLERGS-A-----SACFDRSLRG-----FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 820 ----~----~~~~~~~~~~-~-----~~~~d~~~~~-----~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. .......... . ...+...... .......++.+++.+||+.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~ 310 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ 310 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 0 0000000000 0 0000000000 01123445778899999999999999999984
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.4e-31 Score=279.69 Aligned_cols=249 Identities=28% Similarity=0.386 Sum_probs=200.6
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecC--CceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS--TMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e~ 672 (884)
...+.||+|++|.||+|... +++.|++|++..... ....+.+.+|+..+++++||||+++++++... ...++|+||
T Consensus 3 ~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~ 82 (260)
T cd06606 3 TRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEY 82 (260)
T ss_pred eeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEe
Confidence 35678999999999999776 688999999864321 23467889999999999999999999999888 889999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+++++|.+++.... .+++.++..++.|+++|++|||+. +++||||+|+||+++.++.++|+|||.
T Consensus 83 ~~~~~L~~~~~~~~------------~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~ 147 (260)
T cd06606 83 VSGGSLSSLLKKFG------------KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGC 147 (260)
T ss_pred cCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccccc
Confidence 99999999987432 689999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCc-ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 753 AKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 s~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
+......... ......++..|+|||.+.+...+.++||||+|+++|+|++|..||...... .............
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~ 222 (260)
T cd06606 148 AKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGSSGEP 222 (260)
T ss_pred EEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccccCCC
Confidence 9876543211 133456788999999998888999999999999999999999999865411 1111111110011
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+......+.+++.+|++.+|++||++.|+++
T Consensus 223 --------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 223 --------PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred --------cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 1112222457888888999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=286.62 Aligned_cols=250 Identities=22% Similarity=0.292 Sum_probs=192.0
Q ss_pred ccCceeccCCceEEEEEEE----cCCeEEEEEEccccC---ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeE
Q 002759 597 DKECLIGGGSIGSVYRASF----EGGVSIAVKKLETLG---RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~----~~~~~vavK~~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l 668 (884)
+..+.||+|+||.||.|.. .++..||+|++.... .....+.+.+|+.++.++ +|+||+++++++..+...++
T Consensus 3 ~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (290)
T cd05613 3 ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHL 82 (290)
T ss_pred eeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEE
Confidence 4567899999999999976 367889999986432 123356788899999999 59999999999988888999
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||+++++|.+++.... .+++..+..++.|+++||.|||+. +++||||+|+||+++.++.+||+
T Consensus 83 v~e~~~~~~L~~~l~~~~------------~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~ 147 (290)
T cd05613 83 ILDYINGGELFTHLSQRE------------RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLT 147 (290)
T ss_pred EEecCCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEe
Confidence 999999999999986433 578889999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCcccccccccccccCccccCCC--CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL--RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||+++..............++..|+|||.+.+. .++.++||||||+++|+|++|+.||........ .........
T Consensus 148 dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~ 225 (290)
T cd05613 148 DFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRIL 225 (290)
T ss_pred eCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhh
Confidence 9999987643322223345678899999998753 467899999999999999999999975322111 111111111
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
..... .+......+..++.+||+.+|++|| ++++++.
T Consensus 226 ~~~~~----------~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 226 KSEPP----------YPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ccCCC----------CCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11100 1111223566788889999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=294.73 Aligned_cols=262 Identities=24% Similarity=0.283 Sum_probs=192.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEcccc-CccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecC--CceeEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL-GRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSS--TMQLILS 670 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~ 670 (884)
|+..+.||+|+||.||+|... ++..+|+|++... ........+.+|+.+++++ +||||+++++++... ...++||
T Consensus 9 y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~ 88 (337)
T cd07852 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF 88 (337)
T ss_pred HHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEe
Confidence 345678999999999999765 5788999988532 2233456678899999999 999999999988643 3679999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
||++ ++|.+++... .+++..+..++.||+.||+|||+. +|+||||||+||+++.++.+||+||
T Consensus 89 e~~~-~~L~~~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~ 151 (337)
T cd07852 89 EYME-TDLHAVIRAN-------------ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADF 151 (337)
T ss_pred cccc-cCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeec
Confidence 9996 5898887532 478889999999999999999998 9999999999999999999999999
Q ss_pred cCccccCCccCc----ccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH--
Q 002759 751 GLAKLLPILDNY----GLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR-- 823 (884)
Q Consensus 751 g~s~~~~~~~~~----~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~-- 823 (884)
|.++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+.........
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~ 231 (337)
T cd07852 152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231 (337)
T ss_pred cchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 999876533221 2234567889999998754 457889999999999999999999997654332211100000
Q ss_pred ------HHHHcCCCccccc----c---cCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 824 ------ELLERGSASACFD----R---SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 824 ------~~~~~~~~~~~~d----~---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
............+ . ...........++.+++.+||+.+|++|||+.++++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000000000000 0 0000111134567888999999999999999999863
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=284.71 Aligned_cols=242 Identities=21% Similarity=0.215 Sum_probs=184.7
Q ss_pred eeccCCceEEEEEEE-cCCeEEEEEEccccCcc--CCHHHHHHHHH---HHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 601 LIGGGSIGSVYRASF-EGGVSIAVKKLETLGRI--RNQEEFELEIG---RLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~E~~---~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
+||+|+||.||+|.. .+++.||+|.+...... .....+..|.. .++...||+|+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 379999999999966 45789999998643211 11222334433 3444579999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.++
T Consensus 81 g~~L~~~l~~~~------------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~ 145 (278)
T cd05606 81 GGDLHYHLSQHG------------VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLAC 145 (278)
T ss_pred CCcHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCcc
Confidence 999998886432 589999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
..... ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.......... ........
T Consensus 146 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~---- 214 (278)
T cd05606 146 DFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMTLTM---- 214 (278)
T ss_pred ccCcc---CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHhhcc----
Confidence 65422 1233468899999999874 368899999999999999999999998753322211 11111110
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----t~~ell~ 873 (884)
+.... .....++.+++.+|+..+|.+|| ++.++++
T Consensus 215 --~~~~~---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 215 --AVELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CCCCC---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 01111 11234677788899999999999 9999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-33 Score=272.35 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=197.7
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
....||.|+||+|++-.+ +.|+..|||++.......++.++..|.+...+- +.||||+++|.+..++..|+-||.|.
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd- 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD- 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-
Confidence 344699999999999965 578899999998777667788899998876554 79999999999999999999999994
Q ss_pred Cchhhh---cccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 676 GNLYDN---LHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 676 gsL~~~---l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
-|+..+ ++... ...+++.-.-+|+.....||.||.... .|||||+||+|||++..|.||+||||+
T Consensus 147 ~SlDklYk~vy~vq----------~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGI 214 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQ----------KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGI 214 (361)
T ss_pred hhHHHHHHHHHHHH----------hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccc
Confidence 465433 33222 335777777888889999999999875 899999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC--CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ--SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+-.+. ++...+.-.|...|||||.+. ...|+.++||||+|+++||+.||+.||...+. ..+.+...+....
T Consensus 215 cGqLv--~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~Vv~gdp 287 (361)
T KOG1006|consen 215 CGQLV--DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQVVIGDP 287 (361)
T ss_pred hHhHH--HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHHHcCCC
Confidence 97764 445566677888999999996 33588899999999999999999999987653 2344444444333
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+.-..+..- .+....+.+++..|+.+|-..||.+.++.+
T Consensus 288 p~l~~~~~~----~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 288 PILLFDKEC----VHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred CeecCcccc----cccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 222222221 123446778888899999999999998864
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-32 Score=296.02 Aligned_cols=266 Identities=24% Similarity=0.308 Sum_probs=201.6
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----ceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST-----MQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~l 668 (884)
|+..+.||+|++|.||+|... ++..+|+|++..... ....+.+.+|+.+++.++||||+++.+++.... ..++
T Consensus 2 y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~l 81 (330)
T cd07834 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYI 81 (330)
T ss_pred ceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEE
Confidence 345678999999999999775 478999999865332 345678899999999999999999999987765 7899
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||||++ ++|.+++.... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++|+
T Consensus 82 v~e~~~-~~l~~~l~~~~------------~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~ 145 (330)
T cd07834 82 VTELME-TDLHKVIKSPQ------------PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKIC 145 (330)
T ss_pred Eecchh-hhHHHHHhCCC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEc
Confidence 999997 58988886432 688999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccC--cccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHH
Q 002759 749 DYGLAKLLPILDN--YGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 749 Dfg~s~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
|||.+........ .......++..|+|||.+.+. .++.++|+||+|+++|+|++|+.||......+.... ....
T Consensus 146 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~---i~~~ 222 (330)
T cd07834 146 DFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL---IVEV 222 (330)
T ss_pred ccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHH---HHHh
Confidence 9999987654321 122344568889999999887 788999999999999999999999987654322211 1111
Q ss_pred HHcCCCc-----------cccc-------ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhhc
Q 002759 826 LERGSAS-----------ACFD-------RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ--VLESIRN 880 (884)
Q Consensus 826 ~~~~~~~-----------~~~d-------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~--~L~~~~~ 880 (884)
....... .... ............++.+++.+||+.+|++|||+++++. .++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 223 LGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred cCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 0000000 0000 0000011113346778889999999999999999997 3555543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=296.79 Aligned_cols=264 Identities=23% Similarity=0.258 Sum_probs=196.2
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC-----CceeE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS-----TMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 668 (884)
|...+.||+|+||.||+|.. .++..||||++... ........+.+|+.+++.++||||+++++++... ...++
T Consensus 7 y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~l 86 (337)
T cd07858 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYI 86 (337)
T ss_pred eeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEE
Confidence 44667899999999999965 46889999998643 2233456778899999999999999999987644 34799
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
|+||+. ++|.+++.... .+++..+..++.|++.||.|||+. +++||||||+||+++.++.+||+
T Consensus 87 v~e~~~-~~L~~~~~~~~------------~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~ 150 (337)
T cd07858 87 VYELMD-TDLHQIIRSSQ------------TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKIC 150 (337)
T ss_pred EEeCCC-CCHHHHHhcCC------------CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEC
Confidence 999995 68988886433 588999999999999999999998 99999999999999999999999
Q ss_pred cccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
|||+++...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+.. ........
T Consensus 151 Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~ 226 (337)
T cd07858 151 DFGLARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQL---KLITELLG 226 (337)
T ss_pred cCccccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHH---HHHHHHhC
Confidence 999998764322 12234457888999998764 46889999999999999999999999765422211 11111110
Q ss_pred cCC------------------CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHhh
Q 002759 828 RGS------------------ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV--LESIR 879 (884)
Q Consensus 828 ~~~------------------~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~--L~~~~ 879 (884)
... .....++......+....++.+++.+||+.+|++|||++|+++. ++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 227 SPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred CCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 000 00000000011112234567788999999999999999999865 55543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-33 Score=320.84 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=194.5
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
.+.+||.|.||.||.|.. .+|.-.|+|-++-.. ..+......+|..++..++|||+|+++|+-.+.+..++.||||++
T Consensus 1239 rg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~ 1318 (1509)
T KOG4645|consen 1239 RGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEG 1318 (1509)
T ss_pred cccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhcc
Confidence 456899999999999955 567788999885332 234456778999999999999999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.+.+...+ -.++.....+..|++.|++|||++ +||||||||.||+++.+|.+|.+|||.|..
T Consensus 1319 GsLa~ll~~gr------------i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1319 GSLASLLEHGR------------IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred CcHHHHHHhcc------------hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeE
Confidence 99999997654 245555667888999999999999 999999999999999999999999999988
Q ss_pred cCCcc---CcccccccccccccCccccCCCC---CCCccCchhHHHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHHHHc
Q 002759 756 LPILD---NYGLTKFHNAVGYVAPELAQSLR---LSDKCDVYSFGVILLELVTGRKPVESPTTN-EVVVLCEYVRELLER 828 (884)
Q Consensus 756 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~---~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~-~~~~~~~~~~~~~~~ 828 (884)
+.... ........||+.|||||++.+.. ..-++||||+|||+.||+||+.||...+.. .++. .+..
T Consensus 1384 i~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy-------~V~~ 1456 (1509)
T KOG4645|consen 1384 IKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY-------HVAA 1456 (1509)
T ss_pred ecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh-------HHhc
Confidence 76432 12235678999999999997643 456899999999999999999999875432 1111 1111
Q ss_pred CCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+... ++++....+=.+++..|+..||++|+++.|+++
T Consensus 1457 gh~P--------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1457 GHKP--------QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred cCCC--------CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence 1111 122223334566778899999999999988775
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=311.02 Aligned_cols=248 Identities=27% Similarity=0.379 Sum_probs=182.1
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC-----------
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST----------- 664 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----------- 664 (884)
+..++||+||||.||+++.+ ||+.+|||++.-.........+.+|+..+++++|||||+++..+.+..
T Consensus 482 EEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~ 561 (1351)
T KOG1035|consen 482 EELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVAS 561 (1351)
T ss_pred HHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccccccc
Confidence 35568999999999999875 899999999976555566778899999999999999999876432110
Q ss_pred --------------------------------------------------------------------------------
Q 002759 665 -------------------------------------------------------------------------------- 664 (884)
Q Consensus 665 -------------------------------------------------------------------------------- 664 (884)
T Consensus 562 ~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~ 641 (1351)
T KOG1035|consen 562 DSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVI 641 (1351)
T ss_pred chhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccc
Confidence
Q ss_pred ----------------------------ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCC-CHHHHHHHHHHHHHH
Q 002759 665 ----------------------------MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL-HWSRRFHIALGTARA 715 (884)
Q Consensus 665 ----------------------------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~-~~~~~~~i~~qia~~ 715 (884)
..||=||||+...+.++++.+. .. .....++++++|++|
T Consensus 642 ~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~------------~~~~~d~~wrLFreIlEG 709 (1351)
T KOG1035|consen 642 LDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH------------FNSQRDEAWRLFREILEG 709 (1351)
T ss_pred cCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc------------cchhhHHHHHHHHHHHHH
Confidence 0133445555444444443322 11 245679999999999
Q ss_pred HHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC----C-------------ccCcccccccccccccCccc
Q 002759 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP----I-------------LDNYGLTKFHNAVGYVAPEL 778 (884)
Q Consensus 716 L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~----~-------------~~~~~~~~~~~~~~y~aPE~ 778 (884)
|+|+|++ +||||||||.||+++++..|||+|||+|+... . ......+...||.-|+|||.
T Consensus 710 LaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEl 786 (1351)
T KOG1035|consen 710 LAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPEL 786 (1351)
T ss_pred HHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHH
Confidence 9999999 99999999999999999999999999998721 0 11113466788999999999
Q ss_pred cCCCC---CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHh
Q 002759 779 AQSLR---LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGL 855 (884)
Q Consensus 779 ~~~~~---~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~ 855 (884)
+.+.. |+.|+||||+||+++||+. ||....+ .... + ..++.+..... .++..+....=.++|.
T Consensus 787 l~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME--Ra~i---L-~~LR~g~iP~~-----~~f~~~~~~~e~slI~ 852 (1351)
T KOG1035|consen 787 LSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME--RASI---L-TNLRKGSIPEP-----ADFFDPEHPEEASLIR 852 (1351)
T ss_pred hcccccccccchhhhHHHHHHHHHHhc---cCCchHH--HHHH---H-HhcccCCCCCC-----cccccccchHHHHHHH
Confidence 87654 8999999999999999997 6765332 2211 2 22233333322 2223334445568889
Q ss_pred hccCCCCCCCCCHHHHHH
Q 002759 856 ICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 856 ~cl~~~P~~RPt~~ell~ 873 (884)
++++.||++||||.|++.
T Consensus 853 ~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 853 WLLSHDPSKRPTATELLN 870 (1351)
T ss_pred HHhcCCCccCCCHHHHhh
Confidence 999999999999999985
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=294.15 Aligned_cols=257 Identities=22% Similarity=0.254 Sum_probs=192.3
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccCccC-------------CHHHHHHHHHHHhcCCCCCcceeeeEEecC
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIR-------------NQEEFELEIGRLSNIRHFNLVAFQGYYWSS 663 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 663 (884)
..+.||+|+||+||+|... +++.||+|+++...... ....+.+|+++++.++||||+++++++...
T Consensus 13 ~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 92 (335)
T PTZ00024 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG 92 (335)
T ss_pred hhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC
Confidence 4567999999999999754 68899999986432211 112577899999999999999999999999
Q ss_pred CceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC
Q 002759 664 TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY 743 (884)
Q Consensus 664 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~ 743 (884)
+..++||||+. ++|.+++.... .+++.....++.|++.||+|||+. +++||||+|+||+++.++
T Consensus 93 ~~~~lv~e~~~-~~l~~~l~~~~------------~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~ 156 (335)
T PTZ00024 93 DFINLVMDIMA-SDLKKVVDRKI------------RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKG 156 (335)
T ss_pred CcEEEEEeccc-cCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCC
Confidence 99999999996 68998886432 578899999999999999999998 999999999999999999
Q ss_pred CeeEccccCccccCCcc-------------CcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCC
Q 002759 744 EPKLSDYGLAKLLPILD-------------NYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVES 809 (884)
Q Consensus 744 ~vkl~Dfg~s~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~ 809 (884)
.++++|||.++...... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||..
T Consensus 157 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~ 236 (335)
T PTZ00024 157 ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG 236 (335)
T ss_pred CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 99999999997654110 1111223457789999998764 468899999999999999999999987
Q ss_pred CCCcchhhHHHHHHHHHHcCCCc---c--------cc----cccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 810 PTTNEVVVLCEYVRELLERGSAS---A--------CF----DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 810 ~~~~~~~~~~~~~~~~~~~~~~~---~--------~~----d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+..+.. ..+......+... . .+ .+...........++.+++.+||+.+|++|||++|++.
T Consensus 237 ~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 237 ENEIDQL---GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred CCHHHHH---HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 6543322 1111111111100 0 00 00000011122346778889999999999999999985
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-33 Score=280.16 Aligned_cols=257 Identities=23% Similarity=0.287 Sum_probs=199.1
Q ss_pred ccCceeccCCceEEEEE-EEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC--CC----CcceeeeEEecCCceeEE
Q 002759 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR--HF----NLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~~~~~~~~~~~~~lv 669 (884)
.+...+|+|.||.|..+ +...+..||+|+++.... -.+...-|++++.++. .| .++.+.+++.-.++.++|
T Consensus 92 ~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k--YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCiv 169 (415)
T KOG0671|consen 92 EIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK--YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIV 169 (415)
T ss_pred ehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH--HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEE
Confidence 35668999999999999 445578999999986553 3455677899998883 22 467788888888999999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC--------
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-------- 741 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-------- 741 (884)
+|.+ |-|+++++..+. ..+++...+..|++|++++++|||+. +++|.||||+||++.+
T Consensus 170 fell-G~S~~dFlk~N~----------y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~ 235 (415)
T KOG0671|consen 170 FELL-GLSTFDFLKENN----------YIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYN 235 (415)
T ss_pred Eecc-ChhHHHHhccCC----------ccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEec
Confidence 9998 669999998765 45788899999999999999999999 9999999999999942
Q ss_pred ------------CCCeeEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCC
Q 002759 742 ------------NYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809 (884)
Q Consensus 742 ------------~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~ 809 (884)
+..|||+|||.|++.. ........|..|.|||++.+..++.++||||+|||++|++||..-|+.
T Consensus 236 ~k~~~~~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqt 311 (415)
T KOG0671|consen 236 PKKKVCFIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQT 311 (415)
T ss_pred cCCccceeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceeccc
Confidence 3469999999998743 223567788999999999999999999999999999999999999998
Q ss_pred CCCcchhhHHHHHHHH-----HHcC-----CCccccc---------------cc-----CCCCcHHHHHHHHHHHhhccC
Q 002759 810 PTTNEVVVLCEYVREL-----LERG-----SASACFD---------------RS-----LRGFAENELIQVMKLGLICTS 859 (884)
Q Consensus 810 ~~~~~~~~~~~~~~~~-----~~~~-----~~~~~~d---------------~~-----~~~~~~~~~~~l~~l~~~cl~ 859 (884)
.+..|...+.+.+-.. +... .....+| +. .....+.+..+|++++.+++.
T Consensus 312 Hen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~ 391 (415)
T KOG0671|consen 312 HENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLE 391 (415)
T ss_pred CCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHc
Confidence 7766544322211110 0000 0000111 00 001245667789999999999
Q ss_pred CCCCCCCCHHHHHH
Q 002759 860 EVPSRRPSMAEVVQ 873 (884)
Q Consensus 860 ~~P~~RPt~~ell~ 873 (884)
.||.+|+|+.|+++
T Consensus 392 fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 392 FDPARRITLREALS 405 (415)
T ss_pred cCccccccHHHHhc
Confidence 99999999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=266.70 Aligned_cols=246 Identities=23% Similarity=0.256 Sum_probs=192.7
Q ss_pred CceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEec----CCceeEEEEe
Q 002759 599 ECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWS----STMQLILSEF 672 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~~~~lv~e~ 672 (884)
.++||-|-.|.|..+.. .+++..|+|++... ....+|++..-.. .|||||.++++|.+ ..-..+|||.
T Consensus 67 ~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 67 WQVLGAGINGKVVQCVHKRTQEKFALKVLLDS------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhhccccCCceEEEEeccchhhhHHHHHhcC------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 35799999999999955 57888999999653 2345666664333 69999999998854 3456799999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC---CCCeeEcc
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE---NYEPKLSD 749 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~---~~~vkl~D 749 (884)
|+||.|+..++..+ ...+++.++-.|+.||+.|+.|||+. +|.||||||+|+|.+. |..+|++|
T Consensus 141 meGGeLfsriq~~g----------~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 141 MEGGELFSRIQDRG----------DQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ccchHHHHHHHHcc----------cccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence 99999999998765 56799999999999999999999999 9999999999999964 56799999
Q ss_pred ccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 750 fg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
||+|+.-. ........+.|+.|.|||++....|+...|+||+||++|-|+.|.+||.......+- .-.+..++.+
T Consensus 208 fGFAK~t~--~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais---pgMk~rI~~g 282 (400)
T KOG0604|consen 208 FGFAKETQ--EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKRRIRTG 282 (400)
T ss_pred cccccccC--CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC---hhHHhHhhcc
Confidence 99998643 234456778899999999999999999999999999999999999999986653222 2233334433
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+. ..++ ..++......++|+..++.+|++|.|+.|+++
T Consensus 283 qy~-FP~p----EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 283 QYE-FPEP----EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred Ccc-CCCh----hHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 322 1111 11222334456777899999999999999874
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=278.51 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=197.9
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...+.||+|++|.||+|... +++.+++|.+..... ......+.+|++++++++|||++++.+++.++...++||||++
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (254)
T cd06627 3 QLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAE 82 (254)
T ss_pred eeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCC
Confidence 35678999999999999765 577899999875432 1345778999999999999999999999998899999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+++|.+++.... .+++..+..++.|++.|+.|||+. +|+||||+|+||+++.++.++|+|||.+.
T Consensus 83 ~~~L~~~~~~~~------------~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~ 147 (254)
T cd06627 83 NGSLRQIIKKFG------------PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVAT 147 (254)
T ss_pred CCcHHHHHHhcc------------CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccce
Confidence 999999986432 588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
........ .....++..|+|||...+..++.++||||+|+++|+|++|+.||......... ..... .. ...
T Consensus 148 ~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~------~~~~~-~~-~~~ 218 (254)
T cd06627 148 KLNDVSKD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL------FRIVQ-DD-HPP 218 (254)
T ss_pred ecCCCccc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH------HHHhc-cC-CCC
Confidence 76543221 23456788999999998878889999999999999999999999764422111 11111 11 111
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+ .......+..++.+||..+|++|||+.|++.
T Consensus 219 ~-------~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 219 L-------PEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C-------CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 1 1112336678888999999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=264.78 Aligned_cols=263 Identities=23% Similarity=0.321 Sum_probs=198.3
Q ss_pred CHHHHHHHhhcccccCceeccCCceEEEEE-EEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEe
Q 002759 584 KYEDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYW 661 (884)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~ 661 (884)
+++++..-+ .+.+|+|+||.|..+ ...++..+|||++.+. ......++.+|++++.+. .|+||++++++|+
T Consensus 74 ~F~d~YkLt------~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE 146 (463)
T KOG0607|consen 74 KFEDMYKLT------SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFE 146 (463)
T ss_pred hHHHHHHhH------HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc
Confidence 455665543 346899999999999 5578999999999765 346678899999999998 5999999999999
Q ss_pred cCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC
Q 002759 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE 741 (884)
Q Consensus 662 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~ 741 (884)
+++.+|+|||-|.||+|...|++.. .+++.++.++..+|+.||.|||.+ +|.|||+||+|||..+
T Consensus 147 dd~~FYLVfEKm~GGplLshI~~~~------------~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~ 211 (463)
T KOG0607|consen 147 DDTRFYLVFEKMRGGPLLSHIQKRK------------HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCES 211 (463)
T ss_pred ccceEEEEEecccCchHHHHHHHhh------------hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecC
Confidence 9999999999999999999998654 799999999999999999999998 9999999999999965
Q ss_pred CC---CeeEccccCccccCC------ccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhCCCCC
Q 002759 742 NY---EPKLSDYGLAKLLPI------LDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPV 807 (884)
Q Consensus 742 ~~---~vkl~Dfg~s~~~~~------~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG~~p~ 807 (884)
.. -|||+||.+..-+.. .........+|+..|||||+.. ...|+.+.|.||+||++|-|++|.+||
T Consensus 212 pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPF 291 (463)
T KOG0607|consen 212 PNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPF 291 (463)
T ss_pred CCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCc
Confidence 43 489999988754421 1222334567888999999864 346788999999999999999999999
Q ss_pred CCCCCc-------chhhHH-HHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 808 ESPTTN-------EVVVLC-EYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 808 ~~~~~~-------~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+.-.. +.-... +...+.+.++.+. ..|+... .++.+ -.+++...+..|+.+|.++.+++.
T Consensus 292 vG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYe-FPdkdWa-hIS~e---akdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 292 VGHCGADCGWDRGEVCRVCQNKLFESIQEGKYE-FPDKDWA-HISSE---AKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred cCccCCcCCccCCCccHHHHHHHHHHHhccCCc-CChhhhH-HhhHH---HHHHHHHHHhccHHhhhhhhhccC
Confidence 874332 221111 1122223333221 1111111 12222 234555577789999999988875
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=285.25 Aligned_cols=244 Identities=25% Similarity=0.366 Sum_probs=190.3
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+...+.||+|+||+||+|.. .++..|++|++..... ......+.+|+++++.++|||++++++++.+....++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 44556799999999999976 4678899999864322 12335688899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+. +++.+++.... ..+++.++..++.|++.|++|||+. +++||||+|+||+++.++.+||+|||.
T Consensus 103 ~~-~~l~~~l~~~~-----------~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~ 167 (313)
T cd06633 103 CL-GSASDLLEVHK-----------KPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGS 167 (313)
T ss_pred CC-CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCC
Confidence 95 57877775322 3578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+.... ......++..|+|||++. ...++.++||||||+++|||++|..||...+..... .......
T Consensus 168 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~------~~~~~~~ 236 (313)
T cd06633 168 ASKSS-----PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQND 236 (313)
T ss_pred CcccC-----CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcC
Confidence 86432 123456788899999984 456788999999999999999999999765432211 1111111
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..... .......+..++.+||+.+|.+||++.+++.
T Consensus 237 -~~~~~-------~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~ 272 (313)
T cd06633 237 -SPTLQ-------SNEWTDSFRGFVDYCLQKIPQERPASAELLR 272 (313)
T ss_pred -CCCCC-------ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11000 0111235677888999999999999999985
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=278.37 Aligned_cols=234 Identities=19% Similarity=0.259 Sum_probs=180.8
Q ss_pred eccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCCCchh
Q 002759 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGNLY 679 (884)
Q Consensus 602 lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~ 679 (884)
+|+|+||.||++.. .++..+|+|.+..... .. . |+.....+ +|||++++++++...+..++||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NA---I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEEEEEEEehhhc-ch---h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 69999999999965 4677888988864321 11 1 22222212 7999999999999999999999999999999
Q ss_pred hhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC-CeeEccccCccccCC
Q 002759 680 DNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY-EPKLSDYGLAKLLPI 758 (884)
Q Consensus 680 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~-~vkl~Dfg~s~~~~~ 758 (884)
+++.... .+++.++..++.|+++|+.|||+. +++||||||+||+++.++ .++|+|||.++....
T Consensus 98 ~~l~~~~------------~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 162 (267)
T PHA03390 98 DLLKKEG------------KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT 162 (267)
T ss_pred HHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCC
Confidence 9996432 689999999999999999999998 999999999999999998 999999999876542
Q ss_pred ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 759 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
. ....++..|+|||++.+..++.++||||+|+++|||++|+.||......+. ....+.... . ....
T Consensus 163 ~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~-~--~~~~----- 228 (267)
T PHA03390 163 P-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL-DLESLLKRQ-Q--KKLP----- 228 (267)
T ss_pred C-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh-hHHHHHHhh-c--ccCC-----
Confidence 1 234578899999999988899999999999999999999999986543322 111121111 1 0000
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRPS-MAEVVQ 873 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt-~~ell~ 873 (884)
........+.+++.+||+.+|.+||+ ++|+++
T Consensus 229 ---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 229 ---FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ---cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 11122335777888899999999996 688874
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=287.06 Aligned_cols=245 Identities=24% Similarity=0.363 Sum_probs=190.4
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|++|.||+|... ++..+++|.+.... ......++.+|+++++.++|+|++++.+++......++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 345567999999999999764 57789999886321 122345678899999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+. |++.+.+.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||+
T Consensus 97 ~~-~~l~~~~~~~~-----------~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~ 161 (308)
T cd06634 97 CL-GSASDLLEVHK-----------KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGS 161 (308)
T ss_pred cC-CCHHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCccc
Confidence 96 58877765322 3578899999999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
+...... ....++..|+|||.+. ...++.++|||||||++|||++|+.||......+.. ......
T Consensus 162 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------~~~~~~- 229 (308)
T cd06634 162 ASIMAPA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQN- 229 (308)
T ss_pred ceeecCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH------HHHhhc-
Confidence 8765421 2345788899999874 346788999999999999999999998764332211 111111
Q ss_pred CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
.... .. .......+.+++.+||+.+|++||++++++..
T Consensus 230 ~~~~-----~~--~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 230 ESPA-----LQ--SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred CCCC-----cC--cccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 1100 00 11223457788889999999999999998864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.5e-32 Score=264.31 Aligned_cols=204 Identities=25% Similarity=0.290 Sum_probs=167.7
Q ss_pred cccCceeccCCceEEEEEEEcC-----CeEEEEEEccccCccC-CHHHHHHHHHHHhcCCCCCcceeeeEEec-CCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFEG-----GVSIAVKKLETLGRIR-NQEEFELEIGRLSNIRHFNLVAFQGYYWS-STMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~l 668 (884)
|+....||+|.||.||+|...+ .+.+|+|+++...+.. ......+|+..+++++|||++.+..++.. +...++
T Consensus 26 ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l 105 (438)
T KOG0666|consen 26 YEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWL 105 (438)
T ss_pred hhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEE
Confidence 4566789999999999994432 2368999998654322 24567899999999999999999998876 778899
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC----CC
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN----YE 744 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~----~~ 744 (884)
++||.+. +|.+.++-.+... ...++...+..|+.||+.|+.|||+. =|+||||||.||+|..+ |.
T Consensus 106 ~fdYAEh-DL~~II~fHr~~~-------~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~ 174 (438)
T KOG0666|consen 106 LFDYAEH-DLWHIIKFHRASK-------AKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGR 174 (438)
T ss_pred Eehhhhh-hHHHHHHHhccch-------hccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCe
Confidence 9999976 8999987655221 24678889999999999999999998 79999999999999877 89
Q ss_pred eeEccccCccccCCcc--CcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCC
Q 002759 745 PKLSDYGLAKLLPILD--NYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESP 810 (884)
Q Consensus 745 vkl~Dfg~s~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~ 810 (884)
|||+|+|+++.+.+.- -+...+.+.|..|+|||.+.+. .|+.+.||||.||++.||+|-.+-|...
T Consensus 175 VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 175 VKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred eEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999999886421 1234566779999999999875 5788999999999999999988888763
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=285.27 Aligned_cols=247 Identities=23% Similarity=0.330 Sum_probs=197.2
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e 671 (884)
|...+.||+|++|.||+|... ++..||+|++.... .....+.+..|+.++++++ ||||+++++++...+..++|||
T Consensus 3 y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd05581 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLE 82 (280)
T ss_pred ceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEc
Confidence 345678999999999999764 68899999986432 2233567888999999998 9999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||+|+||+++.++.++++|||
T Consensus 83 ~~~~~~L~~~l~~~~------------~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~ 147 (280)
T cd05581 83 YAPNGELLQYIRKYG------------SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFG 147 (280)
T ss_pred CCCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCc
Confidence 999999999997543 689999999999999999999998 99999999999999999999999999
Q ss_pred CccccCCccC-------------------cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCC
Q 002759 752 LAKLLPILDN-------------------YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTT 812 (884)
Q Consensus 752 ~s~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~ 812 (884)
.+........ .......++..|+|||......++.++||||+|+++|++++|+.||.....
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 148 TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred cccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 9987643221 112234567889999999888889999999999999999999999987552
Q ss_pred cchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 002759 813 NEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM----AEVVQ 873 (884)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~----~ell~ 873 (884)
... ......... ..+......+.+++.+||+.+|++|||+ +|+++
T Consensus 228 ~~~------~~~~~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 228 YLT------FQKILKLEY----------SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHH------HHHHHhcCC----------CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 211 111111100 0111123457788889999999999999 77653
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=280.23 Aligned_cols=257 Identities=23% Similarity=0.261 Sum_probs=196.1
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
..+.||+|++|.||+|... +++.+|+|++.... .....+.+..|+.+++.++|+|++++++++.+.+..++||||++
T Consensus 3 ~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~- 81 (282)
T cd07829 3 KLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD- 81 (282)
T ss_pred eehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-
Confidence 4567999999999999775 48899999987543 23345678899999999999999999999999899999999997
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
++|.+++.... ..+++..+..++.|++.||+|||+. +|+||||+|+||++++++.++|+|||.++.
T Consensus 82 ~~l~~~i~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~ 147 (282)
T cd07829 82 MDLKKYLDKRP-----------GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARA 147 (282)
T ss_pred cCHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccc
Confidence 58999997542 2588999999999999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC---
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA--- 831 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--- 831 (884)
...... ......++..|+|||.+.+. .++.++||||+|+++||+++|+.||......+.. ....+.......
T Consensus 148 ~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 223 (282)
T cd07829 148 FGIPLR-TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESW 223 (282)
T ss_pred cCCCcc-ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHH
Confidence 643221 22334456789999998766 7889999999999999999999999775432221 111111000000
Q ss_pred -----cccccccCCC--------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 -----SACFDRSLRG--------FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 -----~~~~d~~~~~--------~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
....+..... ..+....++.+++.+||+.+|++||++++++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 224 PGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000 01112346888999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=279.45 Aligned_cols=249 Identities=24% Similarity=0.302 Sum_probs=190.9
Q ss_pred ccCceeccCCceEEEEEEEcC-CeEEEEEEccccC----ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 597 DKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLG----RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
...+.||+|+||.||+|.... +..+++|.++... ......++..|+.+++.++||||+++++++.+.+..++|||
T Consensus 3 ~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (260)
T cd08222 3 ILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITE 82 (260)
T ss_pred eeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEE
Confidence 456789999999999997653 3345555554321 22334567789999999999999999999988889999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++.... .....+++..++.++.|+++|+.|||+. +++|+||+|+||+++. +.++++|||
T Consensus 83 ~~~~~~l~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g 150 (260)
T cd08222 83 YCEGRDLDCKLEELK--------HTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFG 150 (260)
T ss_pred eCCCCCHHHHHHHHh--------hcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccC
Confidence 999999999886432 1134689999999999999999999998 9999999999999975 569999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
.++...... .......++..|+|||...+..++.++|+||||+++|+|++|..||...... ........ ...
T Consensus 151 ~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~~-~~~ 222 (260)
T cd08222 151 VSRLLMGSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIVE-GPT 222 (260)
T ss_pred ceeecCCCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHHc-CCC
Confidence 987764321 2223455788899999998888899999999999999999999999653321 11111111 111
Q ss_pred cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
. ........++.+++.+||+.+|++||++.|+++
T Consensus 223 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 223 P--------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred C--------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 1 112233446778889999999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=288.04 Aligned_cols=260 Identities=22% Similarity=0.258 Sum_probs=188.7
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC--------c
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST--------M 665 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--------~ 665 (884)
|+..+.||+|+||.||+|... +++.+|+|++..... ......+.+|+++++.++||||+++++++.+.. .
T Consensus 10 y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 89 (311)
T cd07866 10 YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGS 89 (311)
T ss_pred EEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCce
Confidence 446778999999999999765 578899998864322 223456788999999999999999999875433 4
Q ss_pred eeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCe
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~v 745 (884)
.++|+||+.+ ++...+.... ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.+
T Consensus 90 ~~lv~~~~~~-~l~~~~~~~~-----------~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~ 154 (311)
T cd07866 90 VYMVTPYMDH-DLSGLLENPS-----------VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGIL 154 (311)
T ss_pred EEEEEecCCc-CHHHHHhccc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence 5899999965 6777665322 3589999999999999999999998 99999999999999999999
Q ss_pred eEccccCccccCCccCc----------ccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcc
Q 002759 746 KLSDYGLAKLLPILDNY----------GLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~ 814 (884)
+|+|||+++........ ..+...++..|+|||.+.+. .++.++||||||+++|||++|+.||.......
T Consensus 155 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~ 234 (311)
T cd07866 155 KIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDID 234 (311)
T ss_pred EECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 99999999865432111 11223457789999987653 57889999999999999999999998654432
Q ss_pred hhhHHHHHHHHHHcCCC---------cc--------cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 815 VVVLCEYVRELLERGSA---------SA--------CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 815 ~~~~~~~~~~~~~~~~~---------~~--------~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... .......... .. ..++............+.+++.+|++.+|++|||+.|++.
T Consensus 235 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 235 QLHL---IFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHHH---HHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 2111 1110000000 00 0000000000112246778999999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-31 Score=286.36 Aligned_cols=255 Identities=22% Similarity=0.275 Sum_probs=190.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEcccc-CccCCHHHHHHHHHHHhcCCCCCcceeeeEEec-CCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL-GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS-STMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|... ++..||+|++... ......+.+..|+++++.++|||++++.+++.. ....++|+||
T Consensus 12 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~ 91 (328)
T cd07856 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91 (328)
T ss_pred eEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeeh
Confidence 556789999999999999654 7889999987542 222345678899999999999999999998865 5678899999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||+|+||++++++.++|+|||.
T Consensus 92 ~-~~~L~~~~~~~-------------~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~ 154 (328)
T cd07856 92 L-GTDLHRLLTSR-------------PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGL 154 (328)
T ss_pred h-ccCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCcccc
Confidence 8 56898887532 467888889999999999999998 999999999999999999999999999
Q ss_pred ccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHc---
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER--- 828 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~--- 828 (884)
++.... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......... ...+....
T Consensus 155 ~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~---~~~~~~~~~~~ 227 (328)
T cd07856 155 ARIQDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFS---IITDLLGTPPD 227 (328)
T ss_pred ccccCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCH
Confidence 975432 1233456788999998765 568899999999999999999999997654321111 11111000
Q ss_pred --------CCCccc---cc---c-cCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 829 --------GSASAC---FD---R-SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 829 --------~~~~~~---~d---~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
....+. .. + ......+....++.+++.+||+.+|++|||+++++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 228 DVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00 0 0000011123467788899999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=285.78 Aligned_cols=261 Identities=20% Similarity=0.205 Sum_probs=187.7
Q ss_pred ccCceeccCCceEEEEEEEc-C--CeEEEEEEccccC-ccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecC----Ccee
Q 002759 597 DKECLIGGGSIGSVYRASFE-G--GVSIAVKKLETLG-RIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSS----TMQL 667 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~--~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~~~ 667 (884)
+..+.||+|+||.||+|... . +..||+|++.... .....+.+.+|+.+++++ .||||+++++++... ...+
T Consensus 3 ~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~ 82 (332)
T cd07857 3 ELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELY 82 (332)
T ss_pred eEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEE
Confidence 35568999999999999765 3 6789999986432 222356778899999998 599999999875322 4568
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
++++|+. ++|.+++.... .+++..+..++.||+.||+|||+. +|+||||||+||++++++.+||
T Consensus 83 ~~~e~~~-~~L~~~l~~~~------------~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl 146 (332)
T cd07857 83 LYEELME-ADLHQIIRSGQ------------PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKI 146 (332)
T ss_pred EEEeccc-CCHHHHHhcCC------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEe
Confidence 8889885 68988886432 588999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCc---ccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHH---
Q 002759 748 SDYGLAKLLPILDNY---GLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE--- 820 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~--- 820 (884)
+|||.++........ ......++..|+|||++.+ ..++.++||||+||++|++++|+.||...+..+......
T Consensus 147 ~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 226 (332)
T cd07857 147 CDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226 (332)
T ss_pred CcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHh
Confidence 999999876432211 1233567889999998765 467899999999999999999999997644322111000
Q ss_pred ------HHHHHHHcC------CCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 821 ------YVRELLERG------SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 821 ------~~~~~~~~~------~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
......... .........+..........+..++.+|++.+|++|||+.|++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred CCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 00000000000000111346778889999999999999999873
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=274.65 Aligned_cols=237 Identities=27% Similarity=0.342 Sum_probs=191.1
Q ss_pred eccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 602 IGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 602 lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
||+|+||.||++... +++.+++|.+..... ......+..|+.++++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999765 478899999865332 22456789999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+++.... .+++..+..++.|+++|+.|||+. +++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~~l~~~~------------~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSKEG------------RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 99996443 578999999999999999999998 999999999999999999999999999987643
Q ss_pred ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 759 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
.. .......++..|+|||...+...+.++|+||||+++||+++|+.||...+..+. .+.... ... .
T Consensus 146 ~~-~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~------~~~~~~-~~~------~ 211 (250)
T cd05123 146 EG-SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI------YEKILK-DPL------R 211 (250)
T ss_pred CC-CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHhc-CCC------C
Confidence 21 223445678899999999888889999999999999999999999976543211 111111 111 0
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRPSMAE 870 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 870 (884)
++.....++.+++.+||..||++||++++
T Consensus 212 ---~~~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 212 ---FPEFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11111346677888899999999999954
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=288.06 Aligned_cols=259 Identities=20% Similarity=0.260 Sum_probs=189.9
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 667 (884)
|.....||+|+||.||+|... +++.||+|++.... .......+.+|+.+++.++||||+++++++... ...+
T Consensus 17 y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~ 96 (342)
T cd07879 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY 96 (342)
T ss_pred eEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEE
Confidence 446678999999999999764 68899999986432 222345688999999999999999999988644 2458
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+|+||+.. ++.++.. ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.+|+
T Consensus 97 lv~e~~~~-~l~~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL 158 (342)
T cd07879 97 LVMPYMQT-DLQKIMG--------------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKI 158 (342)
T ss_pred EEeccccc-CHHHHHc--------------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence 99999954 6665542 2478899999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
+|||+++.... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..... .......
T Consensus 159 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~---~~~~~~~ 231 (342)
T cd07879 159 LDFGLARHADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL---TQILKVT 231 (342)
T ss_pred eeCCCCcCCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhc
Confidence 99999876432 1233456788999999876 46788999999999999999999999864422211 1110000
Q ss_pred HcC-----------C-------CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH--HHHHhh
Q 002759 827 ERG-----------S-------ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ--VLESIR 879 (884)
Q Consensus 827 ~~~-----------~-------~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~--~L~~~~ 879 (884)
... . .............+....++.+++.+||+.||++||+++|++. .++.++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 000 0 0000000000000112235778889999999999999999983 365554
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=290.05 Aligned_cols=254 Identities=21% Similarity=0.281 Sum_probs=188.1
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------Ccee
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~ 667 (884)
|+..+.||+|+||.||+|.. .++..||+|++.... .....+.+.+|+.++++++||||+++.+++... ...+
T Consensus 19 y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 98 (345)
T cd07877 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 98 (345)
T ss_pred eEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEE
Confidence 55677899999999999965 568899999986432 223356788899999999999999999987543 3467
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
++++++ +++|.+++... .+++..+..++.|+++||+|||+. +|+||||||+||++++++.+||
T Consensus 99 lv~~~~-~~~L~~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl 161 (345)
T cd07877 99 LVTHLM-GADLNNIVKCQ-------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKI 161 (345)
T ss_pred EEehhc-ccCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEE
Confidence 888877 77998877532 478999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
+|||+++.... ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.......... . .....
T Consensus 162 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~-~~~~~ 234 (345)
T cd07877 162 LDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK--L-ILRLV 234 (345)
T ss_pred ecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHh
Confidence 99999876432 2234567888999998865 467889999999999999999999997644322111 0 00000
Q ss_pred HcCC------------------CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGS------------------ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~------------------~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.... ..................++.+++.+|++.||.+||++.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 299 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 299 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhc
Confidence 0000 0000000000000012235678889999999999999999874
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=290.88 Aligned_cols=257 Identities=22% Similarity=0.237 Sum_probs=187.3
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC-----------
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS----------- 663 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----------- 663 (884)
|...+.||.|+||.||+|.. .++..||+|++.... ....+.+.+|++++++++||||+++++++...
T Consensus 7 y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~ 85 (342)
T cd07854 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD-PQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSL 85 (342)
T ss_pred eEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC-CchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccc
Confidence 45677899999999999966 467899999986543 24567788999999999999999999876543
Q ss_pred ---CceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC
Q 002759 664 ---TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD 740 (884)
Q Consensus 664 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~ 740 (884)
...++||||++ ++|.+++... .+++..+..++.||++||.|||+. +|+||||||+||+++
T Consensus 86 ~~~~~~~lv~e~~~-~~L~~~~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~ 148 (342)
T cd07854 86 TELNSVYIVQEYME-TDLANVLEQG-------------PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFIN 148 (342)
T ss_pred cccceEEEEeeccc-ccHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEc
Confidence 35689999996 5888887532 478899999999999999999998 999999999999997
Q ss_pred -CCCCeeEccccCccccCCccCc--ccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh
Q 002759 741 -ENYEPKLSDYGLAKLLPILDNY--GLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816 (884)
Q Consensus 741 -~~~~vkl~Dfg~s~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~ 816 (884)
+++.+|++|||.++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+..
T Consensus 149 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~ 228 (342)
T cd07854 149 TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM 228 (342)
T ss_pred CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4567899999999765422111 1123356788999998754 46788999999999999999999999765432221
Q ss_pred hHHHHHHHHHHcCCC-----------ccc------ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 817 VLCEYVRELLERGSA-----------SAC------FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 817 ~~~~~~~~~~~~~~~-----------~~~------~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.. .. ...+.... ... ..............++.+++.+||+.||++|||+.|++.
T Consensus 229 ~~--~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 229 QL--IL-ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred HH--HH-HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 10 00 00000000 000 000000001112346778889999999999999999983
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=286.74 Aligned_cols=254 Identities=21% Similarity=0.283 Sum_probs=188.6
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCC------cee
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST------MQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~ 667 (884)
|+..+.||+|+||.||+|.. .++..||||++.... .......+.+|+.++++++||||+++++++.... ..+
T Consensus 17 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07880 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFY 96 (343)
T ss_pred eEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEE
Confidence 55677899999999999965 468899999985432 1223456789999999999999999999886543 358
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+||||+ +++|.+++.. ..+++..+..++.|+++||+|||+. +|+||||||+||+++.++.+++
T Consensus 97 lv~e~~-~~~l~~~~~~-------------~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl 159 (343)
T cd07880 97 LVMPFM-GTDLGKLMKH-------------EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI 159 (343)
T ss_pred EEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence 999998 7789888753 2478999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH---
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR--- 823 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~--- 823 (884)
+|||.+..... ......++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||.......... ....
T Consensus 160 ~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~--~~~~~~~ 233 (343)
T cd07880 160 LDFGLARQTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLM--EIMKVTG 233 (343)
T ss_pred eeccccccccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcC
Confidence 99999986532 1233456788999999875 457889999999999999999999998644321110 0000
Q ss_pred -------HHHHcCCC-------cccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 824 -------ELLERGSA-------SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 824 -------~~~~~~~~-------~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
..+..... .................++.+++.+|++.||++|||+.+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 00000000 00000000001112233577889999999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=287.94 Aligned_cols=254 Identities=20% Similarity=0.299 Sum_probs=190.8
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCc------ee
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTM------QL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~ 667 (884)
|+..+.||+|++|.||+|... ++..||+|++.... .......+.+|+.++++++|||++++.+++...+. .+
T Consensus 17 y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 96 (343)
T cd07851 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVY 96 (343)
T ss_pred eEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEE
Confidence 446678999999999999775 57889999986432 22344667889999999999999999998765544 89
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+|+||+ +++|.+++.. ..+++.++..++.|+++||+|||+. +|+||||||+||++++++.++|
T Consensus 97 lv~e~~-~~~L~~~~~~-------------~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL 159 (343)
T cd07851 97 LVTHLM-GADLNNIVKC-------------QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKI 159 (343)
T ss_pred EEEecC-CCCHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEE
Confidence 999998 6699988863 2488999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
+|||++...... .....++..|+|||.+.+ ..++.++||||+|+++||+++|+.||......+.. ....+..
T Consensus 160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~---~~i~~~~ 232 (343)
T cd07851 160 LDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL---KRIMNLV 232 (343)
T ss_pred cccccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHhc
Confidence 999999865421 234466788999998865 46788999999999999999999999765432221 1111110
Q ss_pred HcCCC--------------ccccc----ccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 827 ERGSA--------------SACFD----RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~--------------~~~~d----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+.... ..... +...........++.+++.+|++.+|++|||+.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 00000 00000 0000000112346778899999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=283.38 Aligned_cols=234 Identities=23% Similarity=0.263 Sum_probs=186.7
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
....+|.|+|+.|-.+.. .+++..++|++.... .+..+|+.++... +|||++++.+++.+....|+|||++.+
T Consensus 326 ~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g 400 (612)
T KOG0603|consen 326 FREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDG 400 (612)
T ss_pred cccccCCCCccceeeeeccccccchhheeccccc-----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccc
Confidence 455699999999999854 567788999997642 2334566555444 799999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEe-CCCCCeeEccccCcc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILL-DENYEPKLSDYGLAK 754 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~-~~~~~vkl~Dfg~s~ 754 (884)
+-+.+.+.... .+. .++..|+++|+.|+.|||++ +||||||||+|||+ +..++++|+|||.++
T Consensus 401 ~ell~ri~~~~------------~~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 401 GELLRRIRSKP------------EFC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWS 464 (612)
T ss_pred cHHHHHHHhcc------------hhH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhh
Confidence 98888776543 233 77889999999999999998 99999999999999 689999999999998
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
..... ....+-|..|.|||+.....|++++||||+|+++|+|++|+.||.....+ ..+...+..++..+
T Consensus 465 ~~~~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~------~ei~~~i~~~~~s~- 533 (612)
T KOG0603|consen 465 ELERS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG------IEIHTRIQMPKFSE- 533 (612)
T ss_pred hCchh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch------HHHHHhhcCCcccc-
Confidence 77532 33446688999999999999999999999999999999999999886544 11223333332221
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..++ ....++.+|++.||.+||++.++..
T Consensus 534 -------~vS~---~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 534 -------CVSD---EAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred -------ccCH---HHHHHHHHhccCChhhCcChhhhcc
Confidence 2223 3445667799999999999999864
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=268.26 Aligned_cols=237 Identities=22% Similarity=0.310 Sum_probs=190.6
Q ss_pred cCceeccCCceEEEEEEEcC-CeEEEEEEccccCcc--CCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEec
Q 002759 598 KECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRI--RNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
...+||+|+||+|.+|..++ .+.+|||++++.... .+.+--+.|-++++-. +-|.+++++.++..-+..|+||||+
T Consensus 353 Fl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyv 432 (683)
T KOG0696|consen 353 FLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYV 432 (683)
T ss_pred eEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEe
Confidence 45689999999999997654 567899999765322 2334445666777665 6889999999999889999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
.||+|--.+++.+ .+.+..+..+|..||-||-|||++ +||+||||.+||+++.+|++||+|||++
T Consensus 433 nGGDLMyhiQQ~G------------kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 433 NGGDLMYHIQQVG------------KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMC 497 (683)
T ss_pred cCchhhhHHHHhc------------ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccc
Confidence 9999988887655 688889999999999999999999 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
+.-- .+.......+||+.|+|||++...+|+..+|+|||||++|||+.|++||++.++++... .+ .+...
T Consensus 498 KEni-~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~---aI----~ehnv-- 567 (683)
T KOG0696|consen 498 KENI-FDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQ---AI----MEHNV-- 567 (683)
T ss_pred cccc-cCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HH----HHccC--
Confidence 7532 23444567899999999999999999999999999999999999999999977665431 11 11111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRP 866 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 866 (884)
.++.....+.+.++...+.+.|.+|.
T Consensus 568 -------syPKslSkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 568 -------SYPKSLSKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred -------cCcccccHHHHHHHHHHhhcCCcccc
Confidence 12233334566677778888999885
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-33 Score=308.67 Aligned_cols=377 Identities=29% Similarity=0.368 Sum_probs=297.0
Q ss_pred EEEEEecCccccccccccccCCCCCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCC
Q 002759 74 VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSR 153 (884)
Q Consensus 74 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~ 153 (884)
..+++++++.++ ..|..+..+.+|+.|+++.|.+. ..|.+...+.+|++|+|.+|.+. ..|..+..+++|++||+|.
T Consensus 47 L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 47 LKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 456777665544 46677999999999999999998 78999999999999999999998 8999999999999999999
Q ss_pred CccCCCCchhhhhc------------------cccCcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCC
Q 002759 154 NSYSGEIPFALFKY------------------CYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICN 215 (884)
Q Consensus 154 N~l~g~ip~~~~~~------------------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~ 215 (884)
|++. .+|.-+... -...+.++|..|.+.+.++..+.+++. .|||.+|.+.. ..+.+
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~~---~dls~ 197 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEMEV---LDLSN 197 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhhh---hhhhh
Confidence 9997 777644221 112566677777777788877777766 68888888761 22333
Q ss_pred CCc--------------------ccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecC
Q 002759 216 IPV--------------------LDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHN 275 (884)
Q Consensus 216 l~~--------------------L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N 275 (884)
+++ |+.|+.++|.++... .-..-.+|+++|++.|++++++ .+++.+.+|+.|+..+|
T Consensus 198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~--~~p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N 274 (1081)
T KOG0618|consen 198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLD--VHPVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHN 274 (1081)
T ss_pred ccchhhhhhhhcccceEEecCcchheeeeccCcceeec--cccccccceeeecchhhhhcch-HHHHhcccceEecccch
Confidence 333 444444455444111 1122457999999999999985 99999999999999999
Q ss_pred ccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCc----------------------
Q 002759 276 GFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI---------------------- 333 (884)
Q Consensus 276 ~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~---------------------- 333 (884)
+|+ .+|.......+|+.|++.+|.+..+ |.....++.|+.|+|..|+|. ..|+.+
T Consensus 275 ~l~-~lp~ri~~~~~L~~l~~~~nel~yi-p~~le~~~sL~tLdL~~N~L~-~lp~~~l~v~~~~l~~ln~s~n~l~~lp 351 (1081)
T KOG0618|consen 275 RLV-ALPLRISRITSLVSLSAAYNELEYI-PPFLEGLKSLRTLDLQSNNLP-SLPDNFLAVLNASLNTLNVSSNKLSTLP 351 (1081)
T ss_pred hHH-hhHHHHhhhhhHHHHHhhhhhhhhC-CCcccccceeeeeeehhcccc-ccchHHHhhhhHHHHHHhhhhccccccc
Confidence 995 5666666777888888888888754 446777888888888888877 333321
Q ss_pred ----ccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCc
Q 002759 334 ----TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMT 409 (884)
Q Consensus 334 ----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 409 (884)
..++.|+.|++.+|+++...-+.+..+.+|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|..+.+++
T Consensus 352 ~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~ 430 (1081)
T KOG0618|consen 352 SYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLG 430 (1081)
T ss_pred cccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhh
Confidence 12345788999999999888888999999999999999998555566789999999999999999 7999999999
Q ss_pred cCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCcc-CCCcCccCcccEEEccCCcC
Q 002759 410 YLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI-PSSLGNLRNLTHFNLSSNNL 469 (884)
Q Consensus 410 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l 469 (884)
.|++|...+|++. ..| .+..++.|+.+|+|.|+|+... |... ..++|++|||++|..
T Consensus 431 ~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~-p~p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 431 RLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEAL-PSPNLKYLDLSGNTR 488 (1081)
T ss_pred hhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhC-CCcccceeeccCCcc
Confidence 9999999999998 677 8999999999999999998543 4333 338999999999984
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-32 Score=258.70 Aligned_cols=262 Identities=21% Similarity=0.267 Sum_probs=195.9
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEcc-ccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEec--------CCce
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLE-TLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--------STMQ 666 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~-~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~~ 666 (884)
+...+||+|.||+||+|+.+ +++.||+|++- ......--....+|++++..++|+|++.+++.|.. ....
T Consensus 20 ek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ 99 (376)
T KOG0669|consen 20 EKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATF 99 (376)
T ss_pred HHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccccee
Confidence 34557999999999999654 57788888763 22223335667899999999999999999998742 2347
Q ss_pred eEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
|+||++|+. +|+-.+.... ..++..++.+++.++..||.|+|+. .|+|||+||.|+||+.+|.+|
T Consensus 100 ylVf~~ceh-DLaGlLsn~~-----------vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilk 164 (376)
T KOG0669|consen 100 YLVFDFCEH-DLAGLLSNRK-----------VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILK 164 (376)
T ss_pred eeeHHHhhh-hHHHHhcCcc-----------ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEE
Confidence 999999976 8888886432 4689999999999999999999998 999999999999999999999
Q ss_pred EccccCccccCCccC---cccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002759 747 LSDYGLAKLLPILDN---YGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~ 822 (884)
|+|||+++.+...+. ...+....|..|.+||.+.+ ..|+++.|||+.||++.||+||.+.++...+.....+++..
T Consensus 165 lADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~L 244 (376)
T KOG0669|consen 165 LADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQL 244 (376)
T ss_pred eeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHH
Confidence 999999987653222 22344556899999998875 46899999999999999999999999987766555444443
Q ss_pred HHHHHcCCCcccc----------cccCCC---CcHHHHH------HHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 823 RELLERGSASACF----------DRSLRG---FAENELI------QVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 823 ~~~~~~~~~~~~~----------d~~~~~---~~~~~~~------~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+.+.....+. +|..++ ..++... +-.+++..++..||.+|+++.+++.
T Consensus 245 cGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln 314 (376)
T KOG0669|consen 245 CGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN 314 (376)
T ss_pred hccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence 3222221111110 110000 1112222 3456677799999999999999874
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=240.15 Aligned_cols=202 Identities=24% Similarity=0.308 Sum_probs=168.1
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
....||+|+||.|-+-++ .+|...|+|.+......+..++...|+.+..+. .+|.+|.++|.+.+....++.||.|.-
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~t 129 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMDT 129 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhhh
Confidence 566799999999988755 578889999998766666778888999886554 799999999999889999999999954
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
||..|-++.- ..+..+++...-+||..|.+||.|||++. .++|||+||+|||++.+|+||+||||.+-.
T Consensus 130 -Sldkfy~~v~--------~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 130 -SLDKFYRKVL--------KKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred -hHHHHHHHHH--------hcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 7766654322 11346788888899999999999999985 899999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccC----CCCCCCccCchhHHHHHHHHHhCCCCCCCCCC
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQ----SLRLSDKCDVYSFGVILLELVTGRKPVESPTT 812 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~ 812 (884)
+. ++-..+--.|...|||||.+. ...|+.++||||+|+++.||.+++.||+....
T Consensus 199 L~--dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t 257 (282)
T KOG0984|consen 199 LV--DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT 257 (282)
T ss_pred eh--hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence 65 333344466788999999985 34788999999999999999999999987643
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=299.56 Aligned_cols=204 Identities=21% Similarity=0.275 Sum_probs=178.7
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
++..+||+|+||+|..++.+ +++.+|+|++++.. ...+...|..|-.+|..-+.+.|+.++..|.+..+.|+|||||
T Consensus 78 eilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~ 157 (1317)
T KOG0612|consen 78 EILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYM 157 (1317)
T ss_pred HHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecc
Confidence 46778999999999999764 57888999997532 2245678899999999999999999999999999999999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+||+|...+...+ .+++.-++.++..|..||..+|+. |+|||||||+|||+|..|++|++|||.+
T Consensus 158 pGGDlltLlSk~~------------~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsC 222 (1317)
T KOG0612|consen 158 PGGDLLTLLSKFD------------RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSC 222 (1317)
T ss_pred cCchHHHHHhhcC------------CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhH
Confidence 9999999997544 588888999999999999999999 9999999999999999999999999999
Q ss_pred cccCCccCcccccccccccccCccccC----C-CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcch
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQ----S-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~ 815 (884)
-.+...+.......+||+.|++||++. + +.|++.+|+||+||++|||+.|..||....-.+.
T Consensus 223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT 289 (1317)
T KOG0612|consen 223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET 289 (1317)
T ss_pred HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH
Confidence 888765555566789999999999985 3 5788999999999999999999999987554433
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=300.35 Aligned_cols=144 Identities=24% Similarity=0.253 Sum_probs=127.0
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|...+.||+|+||.||+|... +++.||||+++.... ......+..|+.+++.++||||+++++++......++||||
T Consensus 6 y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy 85 (669)
T cd05610 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEY 85 (669)
T ss_pred EEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeC
Confidence 456788999999999999775 678999999864321 22246788999999999999999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
+.+++|.+++.... .+++..++.++.||+.||+|||+. +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~g~~L~~li~~~~------------~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGl 150 (669)
T cd05610 86 LIGGDVKSLLHIYG------------YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGL 150 (669)
T ss_pred CCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCC
Confidence 99999999986433 478889999999999999999998 999999999999999999999999999
Q ss_pred cc
Q 002759 753 AK 754 (884)
Q Consensus 753 s~ 754 (884)
++
T Consensus 151 s~ 152 (669)
T cd05610 151 SK 152 (669)
T ss_pred Cc
Confidence 86
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-30 Score=235.22 Aligned_cols=201 Identities=26% Similarity=0.340 Sum_probs=168.6
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
..++||+|.||+||+|+. .+++-||+|++.-..+ +.......+|+-++++++|.|||+++++...+....+|+|||.
T Consensus 6 kmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd- 84 (292)
T KOG0662|consen 6 KMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD- 84 (292)
T ss_pred HHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-
Confidence 445799999999999965 4578899999974433 3345678999999999999999999999999999999999995
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
.+|..+..... ..++.+.+..++.|+++|+.|+|++ ++.|||+||+|.+|+.+|+.|++|||+++-
T Consensus 85 qdlkkyfdsln-----------g~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglara 150 (292)
T KOG0662|consen 85 QDLKKYFDSLN-----------GDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARA 150 (292)
T ss_pred HHHHHHHHhcC-----------CcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhh
Confidence 48988886543 3688899999999999999999999 999999999999999999999999999997
Q ss_pred cCCccCcccccccccccccCccccCCCC-CCCccCchhHHHHHHHHHh-CCCCCCCCCCcc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLR-LSDKCDVYSFGVILLELVT-GRKPVESPTTNE 814 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~ 814 (884)
++.. .........|..|.+|.++.+.. |+...|+||.||++.|+.. |++-|.+.+..+
T Consensus 151 fgip-vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvdd 210 (292)
T KOG0662|consen 151 FGIP-VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD 210 (292)
T ss_pred cCCc-eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHH
Confidence 6532 11234456689999999998754 6889999999999999998 777777755443
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=266.27 Aligned_cols=220 Identities=21% Similarity=0.208 Sum_probs=173.5
Q ss_pred CCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchhhhcc
Q 002759 605 GSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLH 683 (884)
Q Consensus 605 G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~ 683 (884)
|.+|.||+|.. .+++.+|+|++.... .+.+|...+....|||++++++++.+.+..++||||+++++|.+++.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 77 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHIS 77 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHH
Confidence 89999999965 567899999986532 23345555555679999999999999999999999999999999986
Q ss_pred cCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCcc
Q 002759 684 GVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG 763 (884)
Q Consensus 684 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~ 763 (884)
... .+++..+..++.|+++||+|||+. +|+||||||+||+++.++.++++|||.+......
T Consensus 78 ~~~------------~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~---- 138 (237)
T cd05576 78 KFL------------NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS---- 138 (237)
T ss_pred Hhc------------CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----
Confidence 433 478999999999999999999998 9999999999999999999999999988765421
Q ss_pred cccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCc
Q 002759 764 LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFA 843 (884)
Q Consensus 764 ~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 843 (884)
.....++..|+|||...+..++.++||||+|+++|||++|+.|+...... . .... ... .+
T Consensus 139 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~-----------~~~~-----~~~---~~ 198 (237)
T cd05576 139 CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-I-----------NTHT-----TLN---IP 198 (237)
T ss_pred cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-c-----------cccc-----ccC---Cc
Confidence 12234566799999998888899999999999999999999887642211 0 0000 000 11
Q ss_pred HHHHHHHHHHHhhccCCCCCCCCCHH
Q 002759 844 ENELIQVMKLGLICTSEVPSRRPSMA 869 (884)
Q Consensus 844 ~~~~~~l~~l~~~cl~~~P~~RPt~~ 869 (884)
.....++.+++.+|++.||++||++.
T Consensus 199 ~~~~~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 199 EWVSEEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred ccCCHHHHHHHHHHccCCHHHhcCCC
Confidence 11223577788899999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=274.58 Aligned_cols=245 Identities=20% Similarity=0.333 Sum_probs=191.2
Q ss_pred cCceeccCCceEEEEEEE-cCCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCC
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
.++++|+|.||+||-|.. ++|+.||||++.+.. ..+...++.+|+.+++++.||.||.+...|+..+..++|||-+ .
T Consensus 568 ~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~ 646 (888)
T KOG4236|consen 568 ADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-H 646 (888)
T ss_pred hHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-c
Confidence 567899999999999955 579999999996543 2345678899999999999999999999999999999999999 4
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC---CCeeEccccC
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN---YEPKLSDYGL 752 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~---~~vkl~Dfg~ 752 (884)
|+..+.+-... ...+++.....+..||+.||.|||.+ +|||+||||+|||+... -.+||||||+
T Consensus 647 GDMLEMILSsE----------kgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGf 713 (888)
T KOG4236|consen 647 GDMLEMILSSE----------KGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGF 713 (888)
T ss_pred chHHHHHHHhh----------cccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccc
Confidence 56666664333 34688888889999999999999999 99999999999999754 3799999999
Q ss_pred ccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCc
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
|+.++. ..-.....||+.|.|||++....|...-|+||.||++|--++|..||...+ ++- +++....
T Consensus 714 ARiIgE--ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIn-------dQIQNAa-- 780 (888)
T KOG4236|consen 714 ARIIGE--KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DIN-------DQIQNAA-- 780 (888)
T ss_pred eeecch--hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chh-------HHhhccc--
Confidence 999873 334567889999999999999999999999999999999999999997533 222 2222111
Q ss_pred ccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
.++.+......++ +.+++|...++..=.+|-|..+.+
T Consensus 781 FMyPp~PW~eis~---~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 781 FMYPPNPWSEISP---EAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred cccCCCchhhcCH---HHHHHHHHHHHHHHHHhcchHhhc
Confidence 1222222222222 344555667777777787776543
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-30 Score=266.48 Aligned_cols=252 Identities=23% Similarity=0.306 Sum_probs=190.5
Q ss_pred cCceeccCCceEEEEE-EEcCCeEEEEEEccccCccCC------HHHHHHHHHHHhcCCCCCcceeeeEEe-cCCceeEE
Q 002759 598 KECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRN------QEEFELEIGRLSNIRHFNLVAFQGYYW-SSTMQLIL 669 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv 669 (884)
...++|+|+|++||+| +....+.||||+-.....+++ .+...+|.++.+.++||.||++++++. +.+.+|-|
T Consensus 467 lLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTV 546 (775)
T KOG1151|consen 467 LLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTV 546 (775)
T ss_pred HHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceee
Confidence 3467999999999999 556788999998754333333 356789999999999999999999985 56778999
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC---CCCCee
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD---ENYEPK 746 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~---~~~~vk 746 (884)
.|||+|-+|.=+++... .+++++++.|+.||+.||.||.+. +++|||-||||.|||+- .-|.+|
T Consensus 547 LEYceGNDLDFYLKQhk------------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK 613 (775)
T KOG1151|consen 547 LEYCEGNDLDFYLKQHK------------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK 613 (775)
T ss_pred eeecCCCchhHHHHhhh------------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence 99999999988887655 689999999999999999999987 88999999999999994 457899
Q ss_pred EccccCccccCCccCcc------cccccccccccCccccCCC----CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh
Q 002759 747 LSDYGLAKLLPILDNYG------LTKFHNAVGYVAPELAQSL----RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~----~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~ 816 (884)
|.|||+++.+++..+.. .....||..|.|||.+.-+ ..+.++||||.||++|..+.|+.||.........
T Consensus 614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI 693 (775)
T KOG1151|consen 614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI 693 (775)
T ss_pred eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence 99999999987533221 2345789999999987533 3567999999999999999999999875332111
Q ss_pred hHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 817 VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
.++. ..+...+.. |.+ ...+.. +...+|++|+++--++|....++.
T Consensus 694 --LqeN-TIlkAtEVq--FP~--KPvVss---eAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 --LQEN-TILKATEVQ--FPP--KPVVSS---EAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred --Hhhh-chhcceecc--CCC--CCccCH---HHHHHHHHHHHhhhhhhhhHHHHc
Confidence 1110 001111110 111 111222 345567789999888888777664
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-31 Score=274.10 Aligned_cols=239 Identities=23% Similarity=0.256 Sum_probs=198.0
Q ss_pred cCceeccCCceEEEEEEEcCCe-EEEEEEcccc--CccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 598 KECLIGGGSIGSVYRASFEGGV-SIAVKKLETL--GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~~~-~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
....+|-|+||.|=++...... ..|+|++++. .+.++.+.+..|-.+|.+.+.|.||+++-.|.+....|+.||-|-
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 3456999999999999776543 3788888643 344567788999999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
||.+...++..+ .|+..++..++..+.+|++|||++ +||+|||||+|.+++.+|-+|+.|||+|+
T Consensus 504 GGElWTiLrdRg------------~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAK 568 (732)
T KOG0614|consen 504 GGELWTILRDRG------------SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAK 568 (732)
T ss_pred CchhhhhhhhcC------------CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHH
Confidence 999999998665 688899999999999999999999 99999999999999999999999999999
Q ss_pred ccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccc
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.+.. +...-..+||+.|.|||++....++.++|.||+|+++||+++|.+||...++...+.++-..-+.+.
T Consensus 569 ki~~--g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~------- 639 (732)
T KOG0614|consen 569 KIGS--GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE------- 639 (732)
T ss_pred Hhcc--CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-------
Confidence 8863 3344568999999999999999999999999999999999999999999877655533322222221
Q ss_pred ccccCCCCcHHHHHHHHHHHhhccCCCCCCCCC
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt 867 (884)
++......-.++|++.++.+|.+|..
T Consensus 640 -------~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 640 -------FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred -------cccccchhHHHHHHHHHhcCcHhhhc
Confidence 12222334556667788889999975
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-32 Score=302.85 Aligned_cols=380 Identities=26% Similarity=0.323 Sum_probs=275.8
Q ss_pred EEEEEecCccccccccccccCCCCCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCC
Q 002759 74 VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSR 153 (884)
Q Consensus 74 v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~ 153 (884)
++.+.+..+.+-.-.-+.+-+--+|+.|||++|.+. ..|..+..+.+|+.|+++.|.|. ..|.+++++.+|++|.|.+
T Consensus 23 ~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~ 100 (1081)
T KOG0618|consen 23 LQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKN 100 (1081)
T ss_pred HHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheecc
Confidence 344444443332211233334445999999999987 88999999999999999999998 8889999999999999999
Q ss_pred CccCCCCchhhhhccccCcEEEccCCccCCCccccccccCCCCeeEcccC-------------------CCCCCCCCCCC
Q 002759 154 NSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFN-------------------NLSGELPSQIC 214 (884)
Q Consensus 154 N~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N-------------------~l~~~~p~~l~ 214 (884)
|.+. ..|.++ ..+.+|++|+++.|++. .+|..+..++.++.+..++| .+.+.++..+.
T Consensus 101 n~l~-~lP~~~-~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~ 177 (1081)
T KOG0618|consen 101 NRLQ-SLPASI-SELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY 177 (1081)
T ss_pred chhh-cCchhH-HhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh
Confidence 9987 888765 66789999999999998 66766666666666666655 34444444444
Q ss_pred CCCcccEEEccCCccCCCcccccccCCee--------------------cEEEcCCCccCCcCCCCCCCCCCccEEEeec
Q 002759 215 NIPVLDFISVRGNALTGTVEEQFSQCQSI--------------------KNLDLSSNLFIGLAPFGVLGLKNISYFNVSH 274 (884)
Q Consensus 215 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L--------------------~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 274 (884)
++.. .|+|+.|.+... .+..+.+| +.|+.+.|.++...+. .--.+|+++++++
T Consensus 178 ~l~~--~ldLr~N~~~~~---dls~~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~ 250 (1081)
T KOG0618|consen 178 NLTH--QLDLRYNEMEVL---DLSNLANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISH 250 (1081)
T ss_pred hhhe--eeecccchhhhh---hhhhccchhhhhhhhcccceEEecCcchheeeeccCcceeeccc--cccccceeeecch
Confidence 4444 467777766511 12233333 3333333333322111 1113667777777
Q ss_pred CccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCC
Q 002759 275 NGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP 354 (884)
Q Consensus 275 N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 354 (884)
|++++.+ ++...+.+|+.+++.+|+|+ .+|..+...++|+.|++.+|.+. .+|.....++.|++|+|..|+|....+
T Consensus 251 n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~ 327 (1081)
T KOG0618|consen 251 NNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPD 327 (1081)
T ss_pred hhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccch
Confidence 7777443 77777777777777777773 55666666777777777777776 677777778888888888888874332
Q ss_pred CCccC-------------------------cccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCc
Q 002759 355 PNLGS-------------------------IELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMT 409 (884)
Q Consensus 355 ~~~~~-------------------------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 409 (884)
..+.. ++.|+.|++.+|.++...-..+.+..+|+.|+|++|++.......+.++.
T Consensus 328 ~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle 407 (1081)
T KOG0618|consen 328 NFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLE 407 (1081)
T ss_pred HHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchH
Confidence 22211 23467788888888877777788899999999999999943344688899
Q ss_pred cCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCCcCcc
Q 002759 410 YLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSG 471 (884)
Q Consensus 410 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~ 471 (884)
.|+.|+||+|+++ .+|..+.++..|++|...+|+|. ..| .+.++++|+.+|+|.|+++-
T Consensus 408 ~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~ 466 (1081)
T KOG0618|consen 408 ELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSE 466 (1081)
T ss_pred HhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhh
Confidence 9999999999999 79999999999999999999998 788 89999999999999999974
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=269.96 Aligned_cols=209 Identities=22% Similarity=0.300 Sum_probs=174.7
Q ss_pred hhcccccCceeccCCceEEEEEEE-cCCeEEEEEEccccC--ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeE
Q 002759 592 TKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 592 ~~~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (884)
.+.+|...+.||-|+||+|.++.. .+...+|+|.+.+.. .......+..|-++|++-+.+.||+++..|.+.+..|+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYF 706 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYF 706 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEE
Confidence 345666788899999999999954 445668999986532 12346678889999999999999999999999999999
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~ 748 (884)
||+|++||++-.+|...+ -|.+.-++.++..+..|+++.|.. |+|||||||+|||||.+|++|++
T Consensus 707 VMdYIPGGDmMSLLIrmg------------IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 707 VMDYIPGGDMMSLLIRMG------------IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred EEeccCCccHHHHHHHhc------------cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeee
Confidence 999999999999987665 578888899999999999999999 99999999999999999999999
Q ss_pred cccCcccc---CCccCccc--------------------------------------ccccccccccCccccCCCCCCCc
Q 002759 749 DYGLAKLL---PILDNYGL--------------------------------------TKFHNAVGYVAPELAQSLRLSDK 787 (884)
Q Consensus 749 Dfg~s~~~---~~~~~~~~--------------------------------------~~~~~~~~y~aPE~~~~~~~~~~ 787 (884)
|||++.-+ .+..++.. ...+||..|+|||++....|+..
T Consensus 772 DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~ 851 (1034)
T KOG0608|consen 772 DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL 851 (1034)
T ss_pred eccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc
Confidence 99998533 11111000 11347888999999999999999
Q ss_pred cCchhHHHHHHHHHhCCCCCCCCCCcch
Q 002759 788 CDVYSFGVILLELVTGRKPVESPTTNEV 815 (884)
Q Consensus 788 sDvwS~Gv~l~el~tG~~p~~~~~~~~~ 815 (884)
+|+||.||++|||+.|+.||....+.+.
T Consensus 852 cdwws~gvil~em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 852 CDWWSVGVILYEMLVGQPPFLADTPGET 879 (1034)
T ss_pred chhhHhhHHHHHHhhCCCCccCCCCCcc
Confidence 9999999999999999999988765544
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=276.11 Aligned_cols=251 Identities=23% Similarity=0.348 Sum_probs=200.8
Q ss_pred cccccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEe-----cCCce
Q 002759 594 ALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYW-----SSTMQ 666 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~-----~~~~~ 666 (884)
+.+++.++||+|.+|.||++.. ++++.+|+|+..... ...++.+.|..+++.. .|||++.++|++. .++..
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~--d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE--DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc--cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 3445778999999999999955 467778888876533 3456678888888777 6999999999885 34778
Q ss_pred eEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCee
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vk 746 (884)
|+|||||.+||..|+++... +..+.|..+..|++.++.|+.+||.. .++|||+|-.|||++.++.||
T Consensus 97 WLVMEfC~gGSVTDLVKn~~----------g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTK----------GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred EEEeeccCCccHHHHHhhhc----------ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEE
Confidence 99999999999999997554 44689999999999999999999998 999999999999999999999
Q ss_pred EccccCccccCCccCcccccccccccccCccccCC-----CCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-----LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEY 821 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~ 821 (884)
++|||.+..+... ........||+.|||||++.. ..|+.++|+||+|++..||--|.+|+.++.+.....
T Consensus 164 LvDFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---- 238 (953)
T KOG0587|consen 164 LVDFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---- 238 (953)
T ss_pred Eeeeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc----
Confidence 9999999987642 334456789999999999863 346678999999999999999999999887643321
Q ss_pred HHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 822 VRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 822 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+. ..+.+. -+..-..++..+|..|+.+|-.+||++.++++
T Consensus 239 --~IpRN------PPPkLk-rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 239 --LIPRN------PPPKLK-RPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred --cCCCC------CCcccc-chhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 11111 111221 12334457888899999999999999998874
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=256.27 Aligned_cols=239 Identities=28% Similarity=0.346 Sum_probs=192.0
Q ss_pred CceEEEEEEEcC-CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchhhhccc
Q 002759 606 SIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHG 684 (884)
Q Consensus 606 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~ 684 (884)
+||.||+|...+ +..+++|++.........+.+.+|++.+++++|+|++++.+++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999998764 8899999997544322268899999999999999999999999988999999999999999999864
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCccc
Q 002759 685 VNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL 764 (884)
Q Consensus 685 ~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~ 764 (884)
.. .+++..+..++.++++++.|||+. +++|+||+|+||++++++.++++|||.+....... ..
T Consensus 81 ~~------------~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~ 143 (244)
T smart00220 81 RG------------RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LL 143 (244)
T ss_pred cc------------CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--cc
Confidence 33 378899999999999999999998 99999999999999999999999999998765322 33
Q ss_pred ccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcH
Q 002759 765 TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAE 844 (884)
Q Consensus 765 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~ 844 (884)
....++..|+|||...+..++.++||||+|+++|++++|..||......+. ..+.......... ....
T Consensus 144 ~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~------~~~~~~~~~~~~~------~~~~ 211 (244)
T smart00220 144 TTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE------LFKKIGKPKPPFP------PPEW 211 (244)
T ss_pred ccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH------HHHHHhccCCCCc------cccc
Confidence 455678889999999888889999999999999999999999976322111 1111111111100 0000
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 845 NELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 845 ~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
....++.+++.+||..+|++||++.++++
T Consensus 212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 212 KISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 02346778889999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=279.51 Aligned_cols=259 Identities=25% Similarity=0.317 Sum_probs=195.4
Q ss_pred CCCHHHHHHH-----hhcccccCceeccCCceE-EEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcc
Q 002759 582 PSKYEDWEAG-----TKALLDKECLIGGGSIGS-VYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLV 654 (884)
Q Consensus 582 ~~~~~~~~~~-----~~~~~~~~~~lg~G~~g~-V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 654 (884)
....+.|..+ .+.++...+++|.|+.|+ ||+|.++ ++.||||++-. .......+|+..++.- +|||||
T Consensus 492 ~~~~~~~~~~~~~v~~k~~~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~----e~~~~A~rEi~lL~eSD~H~Nvi 566 (903)
T KOG1027|consen 492 ASSLDGPEAGGKVVVGKLFFSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE----EFFDFAQREIQLLQESDEHPNVI 566 (903)
T ss_pred cccccccccccceeeeeeeeccHHHcccCCCCcEEEEEeeC-CceehHHHHhh----HhHHHHHHHHHHHHhccCCCceE
Confidence 3344555544 356666777899999985 7999997 67999999853 2345678999999888 599999
Q ss_pred eeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCC
Q 002759 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKS 734 (884)
Q Consensus 655 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~ 734 (884)
++++.-.++...|+..|.| ..+|.+++.... .. .........+.+..|++.||++||+. +||||||||
T Consensus 567 Ryyc~E~d~qF~YIalELC-~~sL~dlie~~~-~d-------~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkP 634 (903)
T KOG1027|consen 567 RYYCSEQDRQFLYIALELC-ACSLQDLIESSG-LD-------VEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKP 634 (903)
T ss_pred EEEeeccCCceEEEEehHh-hhhHHHHHhccc-cc-------hhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCC
Confidence 9999988999999999999 459999997631 00 01111145678899999999999997 999999999
Q ss_pred CceEeCC---C--CCeeEccccCccccCCccCc--ccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh-CCCC
Q 002759 735 TNILLDE---N--YEPKLSDYGLAKLLPILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKP 806 (884)
Q Consensus 735 ~Nil~~~---~--~~vkl~Dfg~s~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t-G~~p 806 (884)
.||||+. + ..++|+|||+++.++..... ......||-+|+|||.+....-+.++||||+||++|+.++ |.+|
T Consensus 635 QNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~Hp 714 (903)
T KOG1027|consen 635 QNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHP 714 (903)
T ss_pred ceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccC
Confidence 9999975 2 57999999999998753322 2355678999999999998888889999999999999999 5999
Q ss_pred CCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 807 VESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
|.+.-..+. ..+........ +...... +..++|.+|++++|..||+|.+|+
T Consensus 715 FGd~~~R~~--------NIl~~~~~L~~----L~~~~d~---eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 715 FGDSLERQA--------NILTGNYTLVH----LEPLPDC---EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred CCchHHhhh--------hhhcCccceee----eccCchH---HHHHHHHHhcCCCcccCCCHHHHh
Confidence 987433221 11111111111 1111111 566788899999999999999997
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=283.28 Aligned_cols=263 Identities=22% Similarity=0.179 Sum_probs=165.6
Q ss_pred cccCceeccCCceEEEEEEEc-C----CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeE------EecCC
Q 002759 596 LDKECLIGGGSIGSVYRASFE-G----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY------YWSST 664 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~~~~ 664 (884)
|...+.||+|+||.||+|... + +..||+|++.... ..+....| .+....+.++..+... .....
T Consensus 134 y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~---~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~ 208 (566)
T PLN03225 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG---AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKED 208 (566)
T ss_pred eEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc---hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCC
Confidence 557789999999999999775 4 6889999886432 11211111 1111122222222221 23456
Q ss_pred ceeEEEEecCCCchhhhcccCCCCCCC--------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 002759 665 MQLILSEFVPKGNLYDNLHGVNYPGTS--------TGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTN 736 (884)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~--------~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 736 (884)
..++||||+.+++|.+++.....+... .............+..++.|++.||+|||++ +|+||||||+|
T Consensus 209 ~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLKP~N 285 (566)
T PLN03225 209 EYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVKPQN 285 (566)
T ss_pred ceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCCHHH
Confidence 789999999999999998754321000 0000011122345668999999999999998 99999999999
Q ss_pred eEeCC-CCCeeEccccCccccCCccCcccccccccccccCccccCCC----------------------CCCCccCchhH
Q 002759 737 ILLDE-NYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL----------------------RLSDKCDVYSF 793 (884)
Q Consensus 737 il~~~-~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~sDvwS~ 793 (884)
||++. ++.+||+|||+|+.+.....+......+++.|+|||.+... .++.++||||+
T Consensus 286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl 365 (566)
T PLN03225 286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365 (566)
T ss_pred EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence 99985 68999999999987654333444556788999999965322 23346799999
Q ss_pred HHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC--------cccccccCC---CCcHHHHHHHHHHHhhccCCCC
Q 002759 794 GVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA--------SACFDRSLR---GFAENELIQVMKLGLICTSEVP 862 (884)
Q Consensus 794 Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~d~~~~---~~~~~~~~~l~~l~~~cl~~~P 862 (884)
||++|||+++..|+... .. .+.+........ .....+... ...........+++.+|++.||
T Consensus 366 GviL~el~~~~~~~~~~----~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP 438 (566)
T PLN03225 366 GLIFLQMAFPNLRSDSN----LI---QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG 438 (566)
T ss_pred HHHHHHHHhCcCCCchH----HH---HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence 99999999977665421 11 111110000000 000000000 0000111234578889999999
Q ss_pred CCCCCHHHHHH
Q 002759 863 SRRPSMAEVVQ 873 (884)
Q Consensus 863 ~~RPt~~ell~ 873 (884)
++|||++|+++
T Consensus 439 ~kR~ta~e~L~ 449 (566)
T PLN03225 439 RQRISAKAALA 449 (566)
T ss_pred ccCCCHHHHhC
Confidence 99999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-30 Score=248.68 Aligned_cols=261 Identities=23% Similarity=0.304 Sum_probs=195.8
Q ss_pred ccCceeccCCceEEEEEEE-cCCeEEEEEEccc-cCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC-----CceeEE
Q 002759 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLET-LGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS-----TMQLIL 669 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~lv 669 (884)
+.++.||-|+||.||.++. ++|+.||.|++.. .......+.+.+|++++..++|.|++..+++..-. .+.|+|
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3667899999999999966 5789999999853 23344568899999999999999999988876433 345789
Q ss_pred EEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcc
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~D 749 (884)
+|.| ..+|.+.+.. ...++...+.-+.+||++||.|||+. +|.||||||.|.+++.+...||+|
T Consensus 136 TELm-QSDLHKIIVS------------PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICD 199 (449)
T KOG0664|consen 136 TELM-QSDLHKIIVS------------PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICD 199 (449)
T ss_pred HHHH-Hhhhhheecc------------CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecc
Confidence 9998 5588888753 34677888888999999999999999 999999999999999999999999
Q ss_pred ccCccccCCccCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHH--------
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE-------- 820 (884)
Q Consensus 750 fg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~-------- 820 (884)
||+++..+..+....+....|..|.|||.+++. .|+.+.||||.||++.|++-.+.-|+...+.+...++.
T Consensus 200 FGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~ 279 (449)
T KOG0664|consen 200 FGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQ 279 (449)
T ss_pred cccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcH
Confidence 999998876666667777889999999999875 57889999999999999999999998765543332221
Q ss_pred --------HHHHHHHcCCCccccc-ccCCCC--cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 821 --------YVRELLERGSASACFD-RSLRGF--AENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 821 --------~~~~~~~~~~~~~~~d-~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
-++..+-..... -.+ +.+... ....-.+-..+.+.++..||++|.+.++.+.-
T Consensus 280 EaMr~ACEGAk~H~LR~~~k-~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 280 EAMKYACEGAKNHVLRAGLR-APDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred HHHHHHhhhhHHHhhccCCC-CCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 111111111110 001 011111 11122234445566899999999998887653
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-28 Score=270.32 Aligned_cols=272 Identities=18% Similarity=0.159 Sum_probs=175.2
Q ss_pred ccccCceeccCCceEEEEEEE-----------------cCCeEEEEEEccccCcc-------------CCHHHHHHHHHH
Q 002759 595 LLDKECLIGGGSIGSVYRASF-----------------EGGVSIAVKKLETLGRI-------------RNQEEFELEIGR 644 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~-------------~~~~~~~~E~~~ 644 (884)
.|+..++||+|+||.||+|.. ..++.||||++...... ...+....|+..
T Consensus 146 ~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~ 225 (507)
T PLN03224 146 DFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYM 225 (507)
T ss_pred CceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHH
Confidence 456788999999999999954 23467999998643210 012233456777
Q ss_pred HhcCCCCCc-----ceeeeEEec--------CCceeEEEEecCCCchhhhcccCCCCC------------CCCCCCCCCC
Q 002759 645 LSNIRHFNL-----VAFQGYYWS--------STMQLILSEFVPKGNLYDNLHGVNYPG------------TSTGGIGNPE 699 (884)
Q Consensus 645 l~~l~h~ni-----v~~~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~------------~~~~~~~~~~ 699 (884)
+.+++|.++ ++++++|.. ....++||||+++++|.++++...... ..........
T Consensus 226 l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~ 305 (507)
T PLN03224 226 CAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDK 305 (507)
T ss_pred HHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccccc
Confidence 777766554 667777643 356799999999999999987432100 0001111234
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCcccccccccccccCcccc
Q 002759 700 LHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELA 779 (884)
Q Consensus 700 ~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~ 779 (884)
+++..+..++.|+++||.|||+. +|+||||||+||+++.++.+||+|||+++..............+++.|+|||.+
T Consensus 306 ~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l 382 (507)
T PLN03224 306 RDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382 (507)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhh
Confidence 67888999999999999999998 999999999999999999999999999976543222112223347899999987
Q ss_pred CCCC--------------------C--CCccCchhHHHHHHHHHhCCC-CCCCCCCcchh-hHHHHHHHHHHcCCCcccc
Q 002759 780 QSLR--------------------L--SDKCDVYSFGVILLELVTGRK-PVESPTTNEVV-VLCEYVRELLERGSASACF 835 (884)
Q Consensus 780 ~~~~--------------------~--~~~sDvwS~Gv~l~el~tG~~-p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 835 (884)
.... + ..+.||||+||++|||++|.. ||......... .........++... ...+
T Consensus 383 ~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~-~~~~ 461 (507)
T PLN03224 383 VMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK-GQKY 461 (507)
T ss_pred cCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc-ccCC
Confidence 5422 1 124799999999999999875 77542211100 00000001111100 0011
Q ss_pred cccCCCCcHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 002759 836 DRSLRGFAENELIQVMKLGLICTSEVP---SRRPSMAEVVQ 873 (884)
Q Consensus 836 d~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPt~~ell~ 873 (884)
+....+...+ ...+++.+++.++| .+|+|++|+++
T Consensus 462 ~~~~~d~~s~---~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 462 DFSLLDRNKE---AGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred CcccccccCh---HHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 1111111222 44555666777655 78999999975
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=243.63 Aligned_cols=198 Identities=23% Similarity=0.320 Sum_probs=168.5
Q ss_pred cccCceeccCCceEEEEEEEc-CCeEEEEEEcccc--CccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 671 (884)
++..++||+|+|++|..+.+. +.+-+|+|++++. .+.++..-++.|-.+..+- +||.+|-+..++..+...++|.|
T Consensus 252 f~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvie 331 (593)
T KOG0695|consen 252 FDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIE 331 (593)
T ss_pred ceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEE
Confidence 346789999999999999765 5677899998653 2334444456666665554 79999999999999999999999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|++||+|-=.++..+ +++++.++.+...|.-||.|||+. |||+||||.+||++|..|++|++|||
T Consensus 332 yv~ggdlmfhmqrqr------------klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdyg 396 (593)
T KOG0695|consen 332 YVNGGDLMFHMQRQR------------KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYG 396 (593)
T ss_pred EecCcceeeehhhhh------------cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccc
Confidence 999999965555443 688999999999999999999999 99999999999999999999999999
Q ss_pred CccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCC
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809 (884)
Q Consensus 752 ~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~ 809 (884)
.++.--. ++......+||+.|+|||++.+..|....|+|++||+++||+.|+.||..
T Consensus 397 mcke~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 397 MCKEGLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred hhhcCCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 9986432 34456678999999999999999999999999999999999999999975
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.7e-28 Score=252.32 Aligned_cols=130 Identities=24% Similarity=0.280 Sum_probs=110.9
Q ss_pred cccCceeccCCceEEEEE-EEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC--------CCCcceeeeEEec----
Q 002759 596 LDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR--------HFNLVAFQGYYWS---- 662 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~~---- 662 (884)
|.+.++||-|.|++||+| +..+.+.||+|+.+... .-.+....||+++++++ -..||++++.|..
T Consensus 80 Y~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq--hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpN 157 (590)
T KOG1290|consen 80 YHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ--HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPN 157 (590)
T ss_pred EEEEEeccccccceeEEEeeccCCeEEEEEEEehhh--HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCC
Confidence 557789999999999999 66778899999998643 34567789999999883 2479999998863
Q ss_pred CCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC
Q 002759 663 STMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD 740 (884)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~ 740 (884)
+.+.++|+|++ |.+|..+|.... ..-++...+.+|++||+.||.|||.+| +|||.||||+|||+.
T Consensus 158 G~HVCMVfEvL-GdnLLklI~~s~----------YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 158 GQHVCMVFEVL-GDNLLKLIKYSN----------YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CcEEEEEehhh-hhHHHHHHHHhC----------CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 46789999999 779999998766 345788999999999999999999998 999999999999993
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=257.13 Aligned_cols=205 Identities=21% Similarity=0.296 Sum_probs=171.8
Q ss_pred HHHHHhhcc--cccCceeccCCceEEEEEEEcC-CeEEEEEEccccC-------ccCCHHHHHHHHHHHhcCC---CCCc
Q 002759 587 DWEAGTKAL--LDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLG-------RIRNQEEFELEIGRLSNIR---HFNL 653 (884)
Q Consensus 587 ~~~~~~~~~--~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~-------~~~~~~~~~~E~~~l~~l~---h~ni 653 (884)
+|+.....+ |...+.+|+|+||.|+.|.++. ...|+||.+.+.. +.+..-.+-.||.+|+.++ |+||
T Consensus 552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI 631 (772)
T KOG1152|consen 552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI 631 (772)
T ss_pred cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence 344333444 5567789999999999997764 5678888886543 1223344667999999997 9999
Q ss_pred ceeeeEEecCCceeEEEEec-CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 002759 654 VAFQGYYWSSTMQLILSEFV-PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNL 732 (884)
Q Consensus 654 v~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl 732 (884)
++++++|++++.+|++||-. ++.+|++++... +.+++.++..|+.||+.|+++||++ +||||||
T Consensus 632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k------------p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdi 696 (772)
T KOG1152|consen 632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK------------PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDI 696 (772)
T ss_pred hhhhheeecCCeeEEEecCCCCCcchhhhhhcc------------CccchHHHHHHHHHHHhcccccccc---Cceeccc
Confidence 99999999999999999965 456999999754 3789999999999999999999999 9999999
Q ss_pred CCCceEeCCCCCeeEccccCccccCCccCcccccccccccccCccccCCCCCC-CccCchhHHHHHHHHHhCCCCCCC
Q 002759 733 KSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLS-DKCDVYSFGVILLELVTGRKPVES 809 (884)
Q Consensus 733 k~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwS~Gv~l~el~tG~~p~~~ 809 (884)
|-+||.++.+|-+|++|||.|.... .......+||.+|.|||++.+..|- ..-|||++|+++|.++...-||..
T Consensus 697 kdenvivd~~g~~klidfgsaa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 697 KDENVIVDSNGFVKLIDFGSAAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccccEEEecCCeEEEeeccchhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 9999999999999999999997653 3345667899999999999998884 568999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.5e-26 Score=230.91 Aligned_cols=211 Identities=33% Similarity=0.464 Sum_probs=181.0
Q ss_pred eccCCceEEEEEEEcC-CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchhh
Q 002759 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYD 680 (884)
Q Consensus 602 lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~ 680 (884)
||+|.+|.||++...+ ++.+++|++...........+.+|+..++.++|++++++++++......++++||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999997764 789999999764422235789999999999999999999999998889999999999899999
Q ss_pred hcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC-CCCeeEccccCccccCCc
Q 002759 681 NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-NYEPKLSDYGLAKLLPIL 759 (884)
Q Consensus 681 ~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-~~~vkl~Dfg~s~~~~~~ 759 (884)
++.... ..+++..+..++.++++++++||+. +++|+||+|.||+++. ++.++|+|||.+......
T Consensus 81 ~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKENE-----------GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 987432 2578999999999999999999998 9999999999999999 899999999999876432
Q ss_pred cCcccccccccccccCccccCCC-CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCccccccc
Q 002759 760 DNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRS 838 (884)
Q Consensus 760 ~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~ 838 (884)
.. ......+...|++||..... .++.++|+|++|++++++
T Consensus 147 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------- 187 (215)
T cd00180 147 KS-LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------- 187 (215)
T ss_pred cc-hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------
Confidence 11 13345567889999999877 778899999999999999
Q ss_pred CCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 839 LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 839 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
..+.+++..|++.+|++||+++++++.
T Consensus 188 ---------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ---------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ---------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 256677788999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-25 Score=281.03 Aligned_cols=339 Identities=18% Similarity=0.229 Sum_probs=227.1
Q ss_pred hhhhcccCCeEeecCCCC------CCCCCCccCCCCC-CcceEeCCCCccCCCCchhhhhccccCcEEEccCCccCCCcc
Q 002759 114 QEYAEMQTLWKINVSSNA------LSGSIPEFIGDLP-NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIP 186 (884)
Q Consensus 114 ~~~~~l~~L~~L~Ls~n~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p 186 (884)
..|.+|.+|+.|.+..+. +...+|..+..++ +|+.|++.+|.+. .+|..+ ...+|+.|+|++|++. .+|
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f--~~~~L~~L~L~~s~l~-~L~ 627 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF--RPENLVKLQMQGSKLE-KLW 627 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC--CccCCcEEECcCcccc-ccc
Confidence 345666666666665442 2234555555553 4666666666665 566543 2456666777776665 455
Q ss_pred ccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCC
Q 002759 187 LSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKN 266 (884)
Q Consensus 187 ~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 266 (884)
..+..+++|+.|+|++|.....+|. ++.+++|+.|+|++|.....+|..+.++++|+.|++++|...+..|..+ ++++
T Consensus 628 ~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 628 DGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 5666677777777776654445553 6667777777777766555666677777777777777754333344443 5677
Q ss_pred ccEEEeecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCccc-------ccCCCCcccccCc
Q 002759 267 ISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLI-------GSIPTGITDLRRL 339 (884)
Q Consensus 267 L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-------~~~p~~~~~l~~L 339 (884)
|++|+|++|...+.+|.. ..+|+.|++++|.+.. +|..+ .+++|+.|++.++... ...|..+...++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 777777777555555543 3467777777777653 44443 5677777777764321 1112222334678
Q ss_pred cEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCccCcEEEecCc
Q 002759 340 LKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQN 419 (884)
Q Consensus 340 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 419 (884)
+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|++++|..-..+|.. .++|+.|+|++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 888888888777888888888888888888876555677666 6888888898887655456643 357888889999
Q ss_pred ccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCCc
Q 002759 420 HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNN 468 (884)
Q Consensus 420 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~ 468 (884)
.++ .+|..+..+++|+.|+|++|+-...+|..+..+++|+.+++++|.
T Consensus 857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCc-cChHHHhcCCCCCEEECCCCCCcCccCcccccccCCCeeecCCCc
Confidence 887 688888888999999998854333688888888888888888875
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-25 Score=276.78 Aligned_cols=338 Identities=19% Similarity=0.234 Sum_probs=278.2
Q ss_pred ccccCCCCCCeEeecCCc------CcccCchhhhccc-CCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCch
Q 002759 90 PALSGLKSLRVLTLFGNR------FTGNLPQEYAEMQ-TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPF 162 (884)
Q Consensus 90 ~~l~~l~~L~~L~L~~n~------~~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~ 162 (884)
.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..+ ...+|+.|+|++|++. .+|.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 468899999999997664 3446788888875 6999999999997 788887 5799999999999987 6776
Q ss_pred hhhhccccCcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCe
Q 002759 163 ALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQS 242 (884)
Q Consensus 163 ~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~ 242 (884)
.. ..+++|+.|+|++++..+.+| .++.+++|+.|+|++|..-..+|..+.++++|+.|++++|..-+.+|..+ ++++
T Consensus 629 ~~-~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~s 705 (1153)
T PLN03210 629 GV-HSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKS 705 (1153)
T ss_pred cc-ccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCC
Confidence 54 678999999999887666777 48899999999999988777999999999999999999985444566555 7999
Q ss_pred ecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcC-------CCCCCccccccccc
Q 002759 243 IKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF-------DGVIPLSITNCRNL 315 (884)
Q Consensus 243 L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l-------~~~~p~~~~~l~~L 315 (884)
|+.|+|++|......|.. ..+|++|+|++|.+.. +|..+ .+.+|+.|++.++.. ....+..+...++|
T Consensus 706 L~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL 780 (1153)
T PLN03210 706 LYRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSL 780 (1153)
T ss_pred CCEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhhccccccccchhhhhccccc
Confidence 999999999766555543 4689999999999874 45433 567888888877432 22223334445789
Q ss_pred ceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCc
Q 002759 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGN 395 (884)
Q Consensus 316 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N 395 (884)
+.|+|++|...+.+|.+++++++|+.|++++|..-+.+|..+ .+++|+.|++++|.....+|.. .++|+.|+|++|
T Consensus 781 ~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n 856 (1153)
T PLN03210 781 TRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRT 856 (1153)
T ss_pred hheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCC
Confidence 999999998888999999999999999999987655778766 7899999999998765566653 368999999999
Q ss_pred cCCCCcchhhcCCccCcEEEecCc-ccCCCCCccccCCCCCCEEEccCCc
Q 002759 396 ALGGDIPQTLYNMTYLKILDLHQN-HLNGSTPPSLGNLSNLQVLDLSQNS 444 (884)
Q Consensus 396 ~l~~~~p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~L~~N~ 444 (884)
.++ .+|..+..+++|+.|+|++| ++. .+|..+..+++|+.|++++|.
T Consensus 857 ~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 857 GIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred CCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 999 68999999999999999995 555 688889999999999999885
|
syringae 6; Provisional |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=230.14 Aligned_cols=254 Identities=21% Similarity=0.247 Sum_probs=189.6
Q ss_pred CceeccCCceEEEEE-EEcCCeEEEEEEccc-cCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecC------CceeEEE
Q 002759 599 ECLIGGGSIGSVYRA-SFEGGVSIAVKKLET-LGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQLILS 670 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~-~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~lv~ 670 (884)
...+|.|.. .|..| +.-.+++||+|++.. .......+...+|...+..+.|+|+++++.+++-. ...|+||
T Consensus 22 L~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~ 100 (369)
T KOG0665|consen 22 LKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVM 100 (369)
T ss_pred ecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHH
Confidence 345788888 56666 445678999999853 23344567789999999999999999999998654 3568999
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccc
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Df 750 (884)
|+| ..+|...+.. +++-.+...+..|++.|+.|||+. +|+||||||+||++..++.+||.||
T Consensus 101 e~m-~~nl~~vi~~--------------elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df 162 (369)
T KOG0665|consen 101 ELM-DANLCQVILM--------------ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF 162 (369)
T ss_pred Hhh-hhHHHHHHHH--------------hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence 999 5589888762 467888999999999999999999 9999999999999999999999999
Q ss_pred cCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchh--------------
Q 002759 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV-------------- 816 (884)
Q Consensus 751 g~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~-------------- 816 (884)
|+|+.... ....+++..+-.|.|||++.+..+.+.+||||.||++.||++|+.-|.+.+.-+..
T Consensus 163 g~ar~e~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F 240 (369)
T KOG0665|consen 163 GLARTEDT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSF 240 (369)
T ss_pred hhhcccCc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHH
Confidence 99987542 25678888999999999999999999999999999999999999998754321111
Q ss_pred --hHHHHHHHHHHcCC------Ccc-cccccCCC---CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 817 --VLCEYVRELLERGS------ASA-CFDRSLRG---FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 817 --~~~~~~~~~~~~~~------~~~-~~d~~~~~---~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
.+...++...+... ..+ ..|..... ...-.......++.+|+-.+|++|.+++++++
T Consensus 241 ~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 241 MKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 12222222222100 000 01111111 11112233456777899999999999999874
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-26 Score=242.08 Aligned_cols=260 Identities=23% Similarity=0.257 Sum_probs=201.2
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC------CCCcceeeeEEecCCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR------HFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~~~~~~~~l 668 (884)
|.+....|+|-|++|.+|.. ..|..||||++..... -.+.=..|+++|.++. --++++++..|....+.|+
T Consensus 434 Y~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~--M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLCl 511 (752)
T KOG0670|consen 434 YEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV--MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCL 511 (752)
T ss_pred eEEEeccccceeeeeeeccccCCCCeeEEEEeecchH--HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEE
Confidence 44555679999999999954 4577999999976432 2334478999999884 3478999999999999999
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC-CCeeE
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKL 747 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-~~vkl 747 (884)
|+|-+ ..+|.+.+...+ ....+....+..++.|+.-||..|-.. +|+|.||||+||||++. ...||
T Consensus 512 VFE~L-slNLRevLKKyG---------~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKL 578 (752)
T KOG0670|consen 512 VFEPL-SLNLREVLKKYG---------RNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKL 578 (752)
T ss_pred Eehhh-hchHHHHHHHhC---------cccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeee
Confidence 99988 559999998766 233578899999999999999999987 99999999999999875 46899
Q ss_pred ccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH-----
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV----- 822 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~----- 822 (884)
||||.|.... ....+++..+-.|.|||++.+.+|+...|+||.||++||++||+.-|.+.....+..+.--+
T Consensus 579 CDfGSA~~~~---eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 579 CDFGSASFAS---ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccCccccccc---cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 9999998764 33456677777899999999999999999999999999999999999987766555332111
Q ss_pred HHHHHcCCCc-cccccc--------------------------------------CCCCcHHHHHHHHHHHhhccCCCCC
Q 002759 823 RELLERGSAS-ACFDRS--------------------------------------LRGFAENELIQVMKLGLICTSEVPS 863 (884)
Q Consensus 823 ~~~~~~~~~~-~~~d~~--------------------------------------~~~~~~~~~~~l~~l~~~cl~~~P~ 863 (884)
..+++.+.+. ..||.. +.+.....+.++..|+..|+..||+
T Consensus 656 ~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~ 735 (752)
T KOG0670|consen 656 NKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPE 735 (752)
T ss_pred HHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChh
Confidence 1222222211 111111 1112334556788899999999999
Q ss_pred CCCCHHHHHH
Q 002759 864 RRPSMAEVVQ 873 (884)
Q Consensus 864 ~RPt~~ell~ 873 (884)
+|.|..++++
T Consensus 736 KRit~nqAL~ 745 (752)
T KOG0670|consen 736 KRITVNQALK 745 (752)
T ss_pred hcCCHHHHhc
Confidence 9999999874
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-28 Score=245.38 Aligned_cols=361 Identities=18% Similarity=0.172 Sum_probs=209.8
Q ss_pred CCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCC-CccCCCCchhhhhccccCcEEEc
Q 002759 98 LRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSR-NSYSGEIPFALFKYCYKTKFVSL 176 (884)
Q Consensus 98 L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~g~ip~~~~~~l~~L~~L~L 176 (884)
-..++|..|+|+...|..|+.+++|+.||||+|.|+-+-|++|.+|++|..|-+.+ |+|+ .+|...|+.+..|+.|.+
T Consensus 69 tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~-~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 69 TVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT-DLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred ceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh-hhhhhHhhhHHHHHHHhc
Confidence 34667777777755556677777777777777777777777777777766655544 6666 777777777777777777
Q ss_pred cCCccCCCccccccccCCCCeeEcccCCCCCCCCC-CCCCCCcccEEEccCCc------------cCCCcccccccCCee
Q 002759 177 SHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPS-QICNIPVLDFISVRGNA------------LTGTVEEQFSQCQSI 243 (884)
Q Consensus 177 ~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~-~l~~l~~L~~L~L~~n~------------l~~~~~~~~~~l~~L 243 (884)
.-|++.-.....|..|++|..|.+.+|.+. .++. .|..+.+++.+.+..|. +....|-.++..+-.
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~ 226 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCV 226 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceec
Confidence 777777666667777777777777777776 4443 66777777777777766 222344455555555
Q ss_pred cEEEcCCCccCCcCCCCCCC-CCCccEEEeecCcccccccc-ccccCCCCcEEecCCCcCCCCCCcccccccccceeccc
Q 002759 244 KNLDLSSNLFIGLAPFGVLG-LKNISYFNVSHNGFHGEIPE-VGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLG 321 (884)
Q Consensus 244 ~~L~L~~N~l~~~~~~~~~~-l~~L~~L~L~~N~l~~~~p~-~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~ 321 (884)
....|.++++..+.+..|.. +..+..=..+.+...+..|. .|..+++|+.|+|++|+|+++-+.+|..+..+++|.|.
T Consensus 227 ~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~ 306 (498)
T KOG4237|consen 227 SPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLT 306 (498)
T ss_pred chHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcC
Confidence 55666666665555444422 11221111122223333333 35555666666666666666666666666666666666
Q ss_pred CCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCC-----------------CCcCCcCC
Q 002759 322 FNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGE-----------------VPDDISNC 384 (884)
Q Consensus 322 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~-----------------~p~~~~~l 384 (884)
.|+|...-...|.++..|+.|+|.+|+|+...|.+|..+.+|..|+|-.|.+.-. .|. -+.-
T Consensus 307 ~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~~~~~~-Cq~p 385 (498)
T KOG4237|consen 307 RNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSVVGNPR-CQSP 385 (498)
T ss_pred cchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCCCCCCC-CCCC
Confidence 6666544445555666666666666666666666666666666666655543210 000 0111
Q ss_pred CCCcEEeccCccCCC------------------------------------CcchhhcCCccCcEEEecCcccCCCCCcc
Q 002759 385 RFLLLLDVSGNALGG------------------------------------DIPQTLYNMTYLKILDLHQNHLNGSTPPS 428 (884)
Q Consensus 385 ~~L~~L~ls~N~l~~------------------------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 428 (884)
..++.++++.+.+.. .+|..+. ..-..|++.+|.++ .+|.+
T Consensus 386 ~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP--~d~telyl~gn~~~-~vp~~ 462 (498)
T KOG4237|consen 386 GFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIP--VDVTELYLDGNAIT-SVPDE 462 (498)
T ss_pred chhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCC--chhHHHhcccchhc-ccCHH
Confidence 133444444443321 2222211 12345667777776 56655
Q ss_pred ccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCC
Q 002759 429 LGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467 (884)
Q Consensus 429 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 467 (884)
.+.+| .+|+++|+++..--..|.++++|.+|-|++|
T Consensus 463 --~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 463 --LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred --HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 55566 6777777776444556667777777766665
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-26 Score=217.52 Aligned_cols=249 Identities=17% Similarity=0.229 Sum_probs=183.6
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecC--CceeEEEE
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSS--TMQLILSE 671 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e 671 (884)
|+..+.+|+|-|++||.|.. .+.+.++||+++. ...+.+.+|+.++..++ ||||++++++..++ ..+.+|+|
T Consensus 40 Yeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP----VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 40 YEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP----VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred HHHHHHHcCccHhhHhcccccCCCceEEEeeech----HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 44567899999999999954 5677899999975 44678899999999997 99999999998765 45689999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC-CCeeEccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDY 750 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-~~vkl~Df 750 (884)
|+++.+....- +.++..++..++.+++.||.|+|++ ||.|||+||.|++||.. ...+++|+
T Consensus 116 ~v~n~Dfk~ly---------------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDW 177 (338)
T KOG0668|consen 116 YVNNTDFKQLY---------------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDW 177 (338)
T ss_pred hhccccHHHHh---------------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeec
Confidence 99886554433 2577888999999999999999999 99999999999999964 57999999
Q ss_pred cCccccCCccCcccccccccccccCccccCC-CCCCCccCchhHHHHHHHHHhCCCCCCCC-CCcchh-hHHHH-----H
Q 002759 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESP-TTNEVV-VLCEY-----V 822 (884)
Q Consensus 751 g~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwS~Gv~l~el~tG~~p~~~~-~~~~~~-~~~~~-----~ 822 (884)
|+|.++.+...+. -...+-.|--||.+.. ..|+..-|+|||||++..|+..+.||-.- +..+.. ..... .
T Consensus 178 GLAEFYHp~~eYn--VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el 255 (338)
T KOG0668|consen 178 GLAEFYHPGKEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDEL 255 (338)
T ss_pred chHhhcCCCceee--eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHH
Confidence 9999887544332 2233455788998864 45788899999999999999999998542 222221 11110 0
Q ss_pred HHHHHcCCCcccccccC--------------------CCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 823 RELLERGSASACFDRSL--------------------RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~--------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+.+... .+|+.. +.... .+.++++.+.++.|..+|||++|...
T Consensus 256 ~~Yl~KY~i--~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~---peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 256 YAYLNKYQI--DLDPQFEDILGRHSRKPWSRFINSENQHLVS---PEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHHHHHcc--CCChhHhhHhhccccccHHHhCCccccccCC---hHHHHHHHHHHhhccccccchHHHhc
Confidence 011111111 011111 11121 35667777899999999999999863
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.6e-26 Score=219.83 Aligned_cols=246 Identities=20% Similarity=0.333 Sum_probs=178.5
Q ss_pred ccccCceeccCCceEEEEEEEc-CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeE-EecCCceeEEEE
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGY-YWSSTMQLILSE 671 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~lv~e 671 (884)
.|++.+.+|+|.||.+-+|.++ +...+++|.+.... ...++|.+|..---.+ .|.||+.-+++ |...+.+++++|
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~--tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ--TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch--hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3567788999999999999775 46778889887543 5678899998765555 59999987775 455678889999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC--CCCCeeEcc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD--ENYEPKLSD 749 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~--~~~~vkl~D 749 (884)
|++.|+|...+...+ +.+....+++.|++.|+.|+|++ ++||||||.+||||- +..+||+||
T Consensus 103 ~aP~gdL~snv~~~G-------------igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcD 166 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAAG-------------IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCD 166 (378)
T ss_pred cCccchhhhhcCccc-------------ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeee
Confidence 999999998886443 56777889999999999999999 999999999999993 334899999
Q ss_pred ccCccccCCccCcccccccccccccCccccCCC-----CCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-----RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 750 fg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~ 824 (884)
||.++..+ ........+..|.|||..... ...+.+|||.||+++|.++||+.||+.....+. ...+|.
T Consensus 167 FG~t~k~g----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~-- 239 (378)
T KOG1345|consen 167 FGLTRKVG----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWE-- 239 (378)
T ss_pred cccccccC----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHH--
Confidence 99998643 122233446679999976432 345789999999999999999999996422211 112222
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAE 870 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~e 870 (884)
.+..+... ........+.+ ..+++.++-+..+|++|=-..+
T Consensus 240 ~w~~rk~~-~~P~~F~~fs~----~a~r~Fkk~lt~~~~drcki~~ 280 (378)
T KOG1345|consen 240 QWLKRKNP-ALPKKFNPFSE----KALRLFKKSLTPRFKDRCKIWT 280 (378)
T ss_pred HHhcccCc-cCchhhcccCH----HHHHHHHHhcCCcccccchhHH
Confidence 22222222 22222333343 4666777789999999933333
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=250.01 Aligned_cols=248 Identities=24% Similarity=0.332 Sum_probs=194.5
Q ss_pred cccCceeccCCceEEEEEEE-cCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+....+|+|.||.||+|+. ..++..|+|+++-... .+..-.++|+-+++..+||||+.++|.+...+..++.|||+.
T Consensus 17 yellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~-dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycg 95 (829)
T KOG0576|consen 17 YELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG-DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCG 95 (829)
T ss_pred hhheeeecCCcccchhhhcccccCchhhheeeeccCC-ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecC
Confidence 44667899999999999955 5688899999875432 455667889999999999999999999999999999999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+|+|.+.-+-.+ ++++-++-.+++...+|++|||++ +=+|||||-.||++++.|.+|++|||.+.
T Consensus 96 ggslQdiy~~Tg------------plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsa 160 (829)
T KOG0576|consen 96 GGSLQDIYHVTG------------PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSA 160 (829)
T ss_pred CCcccceeeecc------------cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchh
Confidence 999998877544 788999999999999999999999 88999999999999999999999999998
Q ss_pred ccCCccCcccccccccccccCccccC---CCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCC
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
.+.. .........||+.|||||+.. .+.|...+|||+.|+...|+---+.|.-...+.....+.. ....++
T Consensus 161 qita-ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-----kS~~qp 234 (829)
T KOG0576|consen 161 QITA-TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-----KSGFQP 234 (829)
T ss_pred hhhh-hhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-----ccCCCC
Confidence 7653 223345678999999999874 4578889999999999999988777765544332221111 000111
Q ss_pred cccccccCCC--CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 832 SACFDRSLRG--FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
+.+++ --.+ -+-.+++.|+.++|++|||++.+++
T Consensus 235 -----p~lkDk~kws~---~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 235 -----PTLKDKTKWSE---FFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred -----CcccCCccchH---HHHHHHHHHhcCCCccCCChhhhee
Confidence 11111 1122 2345566699999999999988764
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-25 Score=227.84 Aligned_cols=198 Identities=31% Similarity=0.425 Sum_probs=169.8
Q ss_pred cCceeccCCceEEEEEEEcC-CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCC
Q 002759 598 KECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
..+.||+|++|.||+|...+ ++.+++|.+...........+.+|++.++.++|+|++++++++......++++||++++
T Consensus 3 ~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 82 (225)
T smart00221 3 LGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGG 82 (225)
T ss_pred eeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCC
Confidence 45689999999999998765 78899999975432225678899999999999999999999999889999999999999
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+|.+++.... ..+++..+..++.+++.++.+||+. +++|+|++|+||+++.++.++|+|||.+...
T Consensus 83 ~L~~~~~~~~-----------~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~ 148 (225)
T smart00221 83 DLFDYLRKKG-----------GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFI 148 (225)
T ss_pred CHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEe
Confidence 9999987543 1178899999999999999999998 9999999999999999999999999999876
Q ss_pred CCccCcccccccccccccCcccc-CCCCCCCccCchhHHHHHHHHHhCCCCCCC
Q 002759 757 PILDNYGLTKFHNAVGYVAPELA-QSLRLSDKCDVYSFGVILLELVTGRKPVES 809 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~-~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~ 809 (884)
............++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 149 HRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 54321122345667789999998 667778899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.4e-25 Score=253.98 Aligned_cols=265 Identities=27% Similarity=0.273 Sum_probs=163.2
Q ss_pred EEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCc
Q 002759 173 FVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNL 252 (884)
Q Consensus 173 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 252 (884)
.|+|++|+|+ .+|..+. ++|+.|++++|+|+ .+|.. +++|++|+|++|+|+.+ |.. .++|+.|+|++|.
T Consensus 205 ~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~l---p~~Lk~LdLs~N~LtsL-P~l---p~sL~~L~Ls~N~ 273 (788)
T PRK15387 205 VLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPAL---PPELRTLEVSGNQLTSL-PVL---PPGLLELSIFSNP 273 (788)
T ss_pred EEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCCC---CCCCcEEEecCCccCcc-cCc---ccccceeeccCCc
Confidence 3444444444 3333332 24444444444444 23321 24445555555555432 211 2345555555555
Q ss_pred cCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCC
Q 002759 253 FIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTG 332 (884)
Q Consensus 253 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 332 (884)
++.+.. . .++|+.|+|++|+++.. |. ..++|+.|++++|+|++. |.. ..+|+.|++++|+|+ .+|..
T Consensus 274 L~~Lp~-l---p~~L~~L~Ls~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~-~LP~l 340 (788)
T PRK15387 274 LTHLPA-L---PSGLCKLWIFGNQLTSL-PV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLT-SLPTL 340 (788)
T ss_pred hhhhhh-c---hhhcCEEECcCCccccc-cc---cccccceeECCCCccccC-CCC---cccccccccccCccc-ccccc
Confidence 544321 1 13455555555555532 22 124466666666666543 221 235667777888777 35532
Q ss_pred cccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCccCc
Q 002759 333 ITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLK 412 (884)
Q Consensus 333 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 412 (884)
..+|++|+|++|+|++ +|.. .++|+.|++++|+|+. +|.. ..+|+.|++++|+|++ +|.. .++|+
T Consensus 341 ---p~~Lq~LdLS~N~Ls~-LP~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l---~s~L~ 405 (788)
T PRK15387 341 ---PSGLQELSVSDNQLAS-LPTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVL---PSELK 405 (788)
T ss_pred ---ccccceEecCCCccCC-CCCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCc---ccCCC
Confidence 1467888888888884 4433 2467778888888874 5543 3568899999999984 6643 35788
Q ss_pred EEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCCcCcccCCccccccC
Q 002759 413 ILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFG 481 (884)
Q Consensus 413 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 481 (884)
.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|+|.+|..+..+.
T Consensus 406 ~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L~~l~ 469 (788)
T PRK15387 406 ELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREIT 469 (788)
T ss_pred EEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHHHHHh
Confidence 9999999998 477543 46888999999998 7999999999999999999999998887765543
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=253.84 Aligned_cols=267 Identities=25% Similarity=0.266 Sum_probs=159.9
Q ss_pred CCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhccccCcEEEccCCccCCCccccccccCCCCeeEc
Q 002759 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDF 200 (884)
Q Consensus 121 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 200 (884)
.-..|+|++|.|+ .+|+.+. ++|+.|++++|+++ .+|. .+++|++|+|++|+|+ .+|.. .++|+.|+|
T Consensus 202 ~~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lt-sLP~l---p~sL~~L~L 269 (788)
T PRK15387 202 GNAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLT-SLPVL---PPGLLELSI 269 (788)
T ss_pred CCcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccC-cccCc---ccccceeec
Confidence 3556777777776 5666654 36777777777776 4553 2356666666666666 33422 245666666
Q ss_pred ccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccc
Q 002759 201 SFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGE 280 (884)
Q Consensus 201 s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 280 (884)
++|.++ .+|..+ ++|+.|+|++|+|+..+ . ..++|+.|+|++|+|+++.+ . ..+|+.|++++|+|
T Consensus 270 s~N~L~-~Lp~lp---~~L~~L~Ls~N~Lt~LP-~---~p~~L~~LdLS~N~L~~Lp~-l---p~~L~~L~Ls~N~L--- 334 (788)
T PRK15387 270 FSNPLT-HLPALP---SGLCKLWIFGNQLTSLP-V---LPPGLQELSVSDNQLASLPA-L---PSELCKLWAYNNQL--- 334 (788)
T ss_pred cCCchh-hhhhch---hhcCEEECcCCcccccc-c---cccccceeECCCCccccCCC-C---cccccccccccCcc---
Confidence 666665 333321 34555555555555332 1 12445555555555554321 1 12344444444444
Q ss_pred cccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCc
Q 002759 281 IPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360 (884)
Q Consensus 281 ~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 360 (884)
++ +|.. ..+|++|+|++|+|+ .+|... .+|+.|++++|+|++ +|.. .
T Consensus 335 ---------------------~~-LP~l---p~~Lq~LdLS~N~Ls-~LP~lp---~~L~~L~Ls~N~L~~-LP~l---~ 381 (788)
T PRK15387 335 ---------------------TS-LPTL---PSGLQELSVSDNQLA-SLPTLP---SELYKLWAYNNRLTS-LPAL---P 381 (788)
T ss_pred ---------------------cc-cccc---ccccceEecCCCccC-CCCCCC---cccceehhhcccccc-Cccc---c
Confidence 43 2211 135666666666666 344322 345666677777663 4432 2
Q ss_pred ccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEc
Q 002759 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDL 440 (884)
Q Consensus 361 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 440 (884)
.+|+.|+|++|+|++ +|.. .++|+.|++++|+|+ .+|..+ .+|+.|+|++|+|+ .+|..+.++++|+.|+|
T Consensus 382 ~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Ls-sIP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL 452 (788)
T PRK15387 382 SGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLT-SLPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL 452 (788)
T ss_pred cccceEEecCCcccC-CCCc---ccCCCEEEccCCcCC-CCCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence 457777777777773 4433 256888888888888 466543 46778899999988 68888888999999999
Q ss_pred cCCccCCccCCCcCcc
Q 002759 441 SQNSLSGSIPSSLGNL 456 (884)
Q Consensus 441 ~~N~l~~~~p~~~~~l 456 (884)
++|+|++.+|..+..+
T Consensus 453 s~N~Ls~~~~~~L~~l 468 (788)
T PRK15387 453 EGNPLSERTLQALREI 468 (788)
T ss_pred CCCCCCchHHHHHHHH
Confidence 9999998877766443
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.5e-27 Score=236.98 Aligned_cols=354 Identities=20% Similarity=0.275 Sum_probs=272.3
Q ss_pred cCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhccccCcEEEccC-CccCCCccccc
Q 002759 111 NLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSH-NNLSGSIPLSI 189 (884)
Q Consensus 111 ~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L~~-n~l~~~~p~~~ 189 (884)
++|..+. ..-+.++|..|+|+...|.+|+.+++|+.||||+|+|+ .|-+..|+.+.+|..|-+-+ |+|+...-..|
T Consensus 60 eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is-~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F 136 (498)
T KOG4237|consen 60 EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNIS-FIAPDAFKGLASLLSLVLYGNNKITDLPKGAF 136 (498)
T ss_pred cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchh-hcChHhhhhhHhhhHHHhhcCCchhhhhhhHh
Confidence 3444433 24567899999999888889999999999999999999 88888899988887776555 99997777899
Q ss_pred cccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccC------------CcC
Q 002759 190 ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFI------------GLA 257 (884)
Q Consensus 190 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~------------~~~ 257 (884)
++|.+|+.|.+.-|++.-.....|..+++|..|.+.+|.+..+.-..|..+.+++.+.+..|.+. ...
T Consensus 137 ~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~ 216 (498)
T KOG4237|consen 137 GGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMN 216 (498)
T ss_pred hhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhc
Confidence 99999999999999999777789999999999999999999777779999999999999999832 344
Q ss_pred CCCCCCCCCccEEEeecCccccccccccccC-CCCcEEecCCCcCCCCCC-cccccccccceecccCCcccccCCCCccc
Q 002759 258 PFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIP-LSITNCRNLKVLDLGFNRLIGSIPTGITD 335 (884)
Q Consensus 258 ~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~-~~L~~L~ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 335 (884)
|..+++.....-..|.++++..+-+..|... .++..-..+.....++.| ..|..+++|+.|+|++|+|++.-+.+|.+
T Consensus 217 ~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~ 296 (498)
T KOG4237|consen 217 PIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEG 296 (498)
T ss_pred hhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcc
Confidence 6667777777777777777765555443322 222222233333444444 45999999999999999999999999999
Q ss_pred ccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCC-----cchhh-----
Q 002759 336 LRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGD-----IPQTL----- 405 (884)
Q Consensus 336 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~-----~p~~~----- 405 (884)
+..+++|.|..|+|..+-...|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|.+.-. +-+++
T Consensus 297 ~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~Wlr~~~~ 376 (498)
T KOG4237|consen 297 AAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEWLRKKSV 376 (498)
T ss_pred hhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHHHhhCCC
Confidence 99999999999999988888999999999999999999999999999999999999998876411 11111
Q ss_pred ------cCCccCcEEEecCcccCC---CCCccccC---------C----------------------CCCCEEEccCCcc
Q 002759 406 ------YNMTYLKILDLHQNHLNG---STPPSLGN---------L----------------------SNLQVLDLSQNSL 445 (884)
Q Consensus 406 ------~~l~~L~~L~Ls~N~l~~---~~p~~~~~---------l----------------------~~L~~L~L~~N~l 445 (884)
.+-..++.+.++.+.+.. ..|++.+- + ..-.+|++.+|.+
T Consensus 377 ~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk~lp~~iP~d~telyl~gn~~ 456 (498)
T KOG4237|consen 377 VGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLKLLPRGIPVDVTELYLDGNAI 456 (498)
T ss_pred CCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchhhcCCCCCchhHHHhcccchh
Confidence 112335566666655431 12222111 0 1335678888888
Q ss_pred CCccCCCcCccCcccEEEccCCcCcc
Q 002759 446 SGSIPSSLGNLRNLTHFNLSSNNLSG 471 (884)
Q Consensus 446 ~~~~p~~~~~l~~L~~L~l~~N~l~~ 471 (884)
+ .+|.+ .+.+| .+|+++|+|+.
T Consensus 457 ~-~vp~~--~~~~l-~~dls~n~i~~ 478 (498)
T KOG4237|consen 457 T-SVPDE--LLRSL-LLDLSNNRISS 478 (498)
T ss_pred c-ccCHH--HHhhh-hcccccCceeh
Confidence 7 67766 56677 78888888763
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.2e-24 Score=246.89 Aligned_cols=246 Identities=21% Similarity=0.347 Sum_probs=138.4
Q ss_pred CCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhccccCcEEEccCCccCCCccccccccCCCCeeEc
Q 002759 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDF 200 (884)
Q Consensus 121 ~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L 200 (884)
+.+.|+|+++.++ .+|..+. ++|+.|+|++|+++ .+|..++ .+|+.|++++|+|+ .+|..+. .+|+.|+|
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~---~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ---GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc---cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 4567777777776 4565553 46777777777776 6666553 46777777777776 4454443 36777777
Q ss_pred ccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccc
Q 002759 201 SFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGE 280 (884)
Q Consensus 201 s~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 280 (884)
++|++. .+|..+. ++|+.|+|++|+|+. +|..+. .+|+.|+|++|+|++++ ..+. ++|+.|+|++|+++..
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~LP-~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTLP-AHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccCc-ccch--hhHHHHHhcCCccccC
Confidence 777777 5666553 467777887777774 444443 47888888888887653 2221 3566677777766642
Q ss_pred cccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCc
Q 002759 281 IPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360 (884)
Q Consensus 281 ~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 360 (884)
|..+ .++|+.|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+.
T Consensus 320 -P~~l--~~sL~~L~Ls~N~Lt~-------------------------LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp-- 366 (754)
T PRK15370 320 -PETL--PPGLKTLEAGENALTS-------------------------LPASLP--PELQVLDVSKNQIT-VLPETLP-- 366 (754)
T ss_pred -Cccc--cccceeccccCCcccc-------------------------CChhhc--CcccEEECCCCCCC-cCChhhc--
Confidence 2211 1334444444444443 333222 34444444444444 2333221
Q ss_pred ccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchh----hcCCccCcEEEecCcccC
Q 002759 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQT----LYNMTYLKILDLHQNHLN 422 (884)
Q Consensus 361 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~----~~~l~~L~~L~Ls~N~l~ 422 (884)
++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|.. +..++.+..|+|.+|.++
T Consensus 367 ~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls 428 (754)
T PRK15370 367 PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFS 428 (754)
T ss_pred CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCcc
Confidence 34555555555554 2333332 24555556666655 33332 233456666667666665
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-24 Score=223.01 Aligned_cols=197 Identities=23% Similarity=0.312 Sum_probs=162.2
Q ss_pred hcccccCceeccCCceEEEEEEEc----CCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCcee
Q 002759 593 KALLDKECLIGGGSIGSVYRASFE----GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQL 667 (884)
Q Consensus 593 ~~~~~~~~~lg~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~ 667 (884)
...+...++||+|.|++||+|... ..+.||+|.+.... ....+.+|++.+..+ -+.||+++.+++...+...
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts---~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS---SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc---CchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 344567889999999999999543 46789999996533 456789999999998 5999999999999999999
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC-CCCee
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-NYEPK 746 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-~~~vk 746 (884)
+|+||++...-.++.. .++..++..+++.+..||+++|.+ ||||||+||.|++.+. .+.-.
T Consensus 112 ivlp~~~H~~f~~l~~---------------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~ 173 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR---------------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGV 173 (418)
T ss_pred EEecccCccCHHHHHh---------------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCce
Confidence 9999999988887775 467889999999999999999998 9999999999999984 57789
Q ss_pred EccccCccccCCcc---------------------------------Cc----------ccccccccccccCccccCCCC
Q 002759 747 LSDYGLAKLLPILD---------------------------------NY----------GLTKFHNAVGYVAPELAQSLR 783 (884)
Q Consensus 747 l~Dfg~s~~~~~~~---------------------------------~~----------~~~~~~~~~~y~aPE~~~~~~ 783 (884)
|.|||+|....... ++ ......||+||.|||++...+
T Consensus 174 LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~ 253 (418)
T KOG1167|consen 174 LVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCP 253 (418)
T ss_pred EEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhcc
Confidence 99999997321100 00 001134789999999987654
Q ss_pred -CCCccCchhHHHHHHHHHhCCCCCCCC
Q 002759 784 -LSDKCDVYSFGVILLELVTGRKPVESP 810 (884)
Q Consensus 784 -~~~~sDvwS~Gv~l~el~tG~~p~~~~ 810 (884)
-+++.||||.||++.-++++++||-..
T Consensus 254 ~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 254 RQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred CcCCccceeeccceeehhhccccccccC
Confidence 478999999999999999999999653
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=210.52 Aligned_cols=246 Identities=25% Similarity=0.378 Sum_probs=188.9
Q ss_pred ceeccCCceEEEEEEEcCCeEEEEEEccc-cCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCch
Q 002759 600 CLIGGGSIGSVYRASFEGGVSIAVKKLET-LGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
.+|.+...|+.|+|+|+++ .+++|++.. ....+..++|..|.-.++-+.||||.+++|.|..+....++..||+.|+|
T Consensus 196 tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 3578889999999999966 456677653 22345567899999999999999999999999999999999999999999
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEc--cccCcccc
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS--DYGLAKLL 756 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~--Dfg~s~~~ 756 (884)
+..+++.. .-.++..++.++|.+||+||+|||+. .+-|-.--|.++.++||++.+++|+ |--++.
T Consensus 275 ynvlhe~t----------~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsf-- 341 (448)
T KOG0195|consen 275 YNVLHEQT----------SVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-- 341 (448)
T ss_pred HHHHhcCc----------cEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeee--
Confidence 99998654 34577789999999999999999997 4334445689999999999988885 322221
Q ss_pred CCccCcccccccccccccCccccCCCCCC---CccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcc
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLS---DKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~---~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
......-.+.||+||.++..+.+ .++|+|||++++||+.|...||....+.|....+.. + ..+.
T Consensus 342 ------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial-----e--glrv 408 (448)
T KOG0195|consen 342 ------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL-----E--GLRV 408 (448)
T ss_pred ------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh-----c--cccc
Confidence 12233446789999999876544 479999999999999999999998776654422111 1 1111
Q ss_pred cccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
. .++.....+.+++..|+..||.+||.|..++-.|+++.
T Consensus 409 ~-------ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 409 H-------IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred c-------CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1 12223334556666699999999999999999999875
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3e-24 Score=261.33 Aligned_cols=194 Identities=19% Similarity=0.199 Sum_probs=137.3
Q ss_pred CCC-CCcceeeeEE-------ecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH
Q 002759 648 IRH-FNLVAFQGYY-------WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719 (884)
Q Consensus 648 l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~L 719 (884)
.+| +||+++++++ .+.+..+.++||+ +++|.+++.... ..+++.++..++.||++||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~l 96 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----------RSVDAFECFHVFRQIVEIVNAA 96 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----------ccccHHHHHHHHHHHHHHHHHH
Confidence 345 5777777776 2334567788887 669999996422 3589999999999999999999
Q ss_pred HhcCCCCeEeccCCCCceEeCC-------------------CCCeeEccccCccccCCccC---------------cccc
Q 002759 720 HHDCKPPILHLNLKSTNILLDE-------------------NYEPKLSDYGLAKLLPILDN---------------YGLT 765 (884)
Q Consensus 720 H~~~~~~ivH~Dlk~~Nil~~~-------------------~~~vkl~Dfg~s~~~~~~~~---------------~~~~ 765 (884)
|++ +|+||||||+|||++. ++.+|++|||+++....... ....
T Consensus 97 H~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (793)
T PLN00181 97 HSQ---GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQI 173 (793)
T ss_pred HhC---CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCccccc
Confidence 998 9999999999999954 45567777777764321000 0011
Q ss_pred cccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHH
Q 002759 766 KFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAEN 845 (884)
Q Consensus 766 ~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~ 845 (884)
...+|..|||||++.+..++.++|||||||++|||++|..|+..... . ........ +++.. ..
T Consensus 174 ~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~---~~~~~~~~--------~~~~~----~~ 236 (793)
T PLN00181 174 LAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR--T---MSSLRHRV--------LPPQI----LL 236 (793)
T ss_pred ccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH--H---HHHHHHhh--------cChhh----hh
Confidence 23568889999999999999999999999999999999888753211 0 11111100 01100 01
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 846 ELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 846 ~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
...+...++.+||+++|.+||++.|+++
T Consensus 237 ~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 237 NWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred cCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 1223456778899999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=207.34 Aligned_cols=169 Identities=24% Similarity=0.252 Sum_probs=126.9
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|+|.++++..+ ..+++.+++.++.||+.||+|||++ + ||+||+++.++.+|+ ||.++.
T Consensus 1 GsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~ 58 (176)
T smart00750 1 VSLADILEVRG-----------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAF 58 (176)
T ss_pred CcHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEe
Confidence 68888886432 3589999999999999999999988 5 999999999999999 999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccc
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (884)
.... ...++..|+|||++.+..++.++|||||||++|||++|+.||........ ............
T Consensus 59 ~~~~------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~------ 124 (176)
T smart00750 59 KTPE------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA--ILEILLNGMPAD------ 124 (176)
T ss_pred eccc------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH--HHHHHHHHhccC------
Confidence 5432 22578999999999999999999999999999999999999975432111 111111111110
Q ss_pred cccCCCCcHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhc
Q 002759 836 DRSLRGFAENEL--IQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 836 d~~~~~~~~~~~--~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~ 880 (884)
++.......... .++.+++.+||+.+|++|||+.|+++.+..+..
T Consensus 125 ~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 125 DPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred CccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 000001111222 258889999999999999999999998877643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.6e-21 Score=208.04 Aligned_cols=260 Identities=18% Similarity=0.211 Sum_probs=190.7
Q ss_pred cccCceeccCCceEEEEEEEcCC--eEEEEEEccccCccCCHHHHHHHHHHHhcCCC----CCcceeeeEE-ecCCceeE
Q 002759 596 LDKECLIGGGSIGSVYRASFEGG--VSIAVKKLETLGRIRNQEEFELEIGRLSNIRH----FNLVAFQGYY-WSSTMQLI 668 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~~~~~~-~~~~~~~l 668 (884)
+...+.||+|+||.||.|..... ..+|+|........... .+..|..++..+.. +++..+++.. ......++
T Consensus 20 ~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~-~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 20 YKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS-VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred eEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc-cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 45778999999999999977553 47888887654332322 67778888877752 5888888888 47778899
Q ss_pred EEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC-----C
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-----Y 743 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-----~ 743 (884)
||+.+ |.+|.++..... ...++..++..|+.|++.+|+++|+. |++||||||.|+.+... .
T Consensus 99 VM~l~-G~sL~dl~~~~~----------~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~ 164 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP----------PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVR 164 (322)
T ss_pred EEecc-CccHHHHHHhCC----------CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccc
Confidence 99988 779999775432 34799999999999999999999999 99999999999999865 4
Q ss_pred CeeEccccCcc--ccCCccCc----c---cccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcc
Q 002759 744 EPKLSDYGLAK--LLPILDNY----G---LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814 (884)
Q Consensus 744 ~vkl~Dfg~s~--~~~~~~~~----~---~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~ 814 (884)
.+.+.|||+++ .+...... . .....||..|+++....+...+.+.|+||++.++.|+..|..||.......
T Consensus 165 ~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~ 244 (322)
T KOG1164|consen 165 TLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTD 244 (322)
T ss_pred eEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccc
Confidence 69999999998 33221111 1 123559999999999999999999999999999999999999997754332
Q ss_pred hhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcc
Q 002759 815 VVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~ 881 (884)
............. .. . .....+.+...+.+ .+-..+..++|....+...+++....
T Consensus 245 ~~~~~~~~~~~~~---~~----~-~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~ 300 (322)
T KOG1164|consen 245 LKSKFEKDPRKLL---TD----R-FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDS 300 (322)
T ss_pred hHHHHHHHhhhhc---cc----c-ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHh
Confidence 2211111111100 00 0 11223344444444 34557899999999999998877554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-22 Score=236.78 Aligned_cols=267 Identities=23% Similarity=0.369 Sum_probs=199.4
Q ss_pred CCcceEeCCCCccCCCCchhhhhccccCcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEE
Q 002759 144 PNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFIS 223 (884)
Q Consensus 144 ~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 223 (884)
.+...|+|+++.++ .+|..+ .+.|+.|+|++|+++ .+|..+. ++|++|+|++|+|+ .+|..+. ++|+.|+
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~I---p~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~ 247 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACI---PEQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEME 247 (754)
T ss_pred cCceEEEeCCCCcC-cCCccc---ccCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEE
Confidence 45788999999998 788654 357999999999999 5665554 58999999999998 6676554 4799999
Q ss_pred ccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCCC
Q 002759 224 VRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDG 303 (884)
Q Consensus 224 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~ 303 (884)
|++|+++. +|..+. .+|+.|+|++|+|+.+ |..+. ++|++|+|++|+|++.
T Consensus 248 Ls~N~L~~-LP~~l~--s~L~~L~Ls~N~L~~L-P~~l~--~sL~~L~Ls~N~Lt~L----------------------- 298 (754)
T PRK15370 248 LSINRITE-LPERLP--SALQSLDLFHNKISCL-PENLP--EELRYLSVYDNSIRTL----------------------- 298 (754)
T ss_pred CcCCccCc-CChhHh--CCCCEEECcCCccCcc-ccccC--CCCcEEECCCCccccC-----------------------
Confidence 99999984 455553 5799999999999865 54443 4677777777776632
Q ss_pred CCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcC
Q 002759 304 VIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISN 383 (884)
Q Consensus 304 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~ 383 (884)
|..+. ++|+.|+|++|+++ .+|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+.
T Consensus 299 --P~~lp--~sL~~L~Ls~N~Lt-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp- 366 (754)
T PRK15370 299 --PAHLP--SGITHLNVQSNSLT-ALPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP- 366 (754)
T ss_pred --cccch--hhHHHHHhcCCccc-cCCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc-
Confidence 21121 36788888888887 4555443 689999999999985 565553 68999999999998 5676553
Q ss_pred CCCCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccc----cCCCCCCEEEccCCccCCccCCCcCccCcc
Q 002759 384 CRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSL----GNLSNLQVLDLSQNSLSGSIPSSLGNLRNL 459 (884)
Q Consensus 384 l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 459 (884)
++|+.|+|++|+|+ .+|..+. ..|+.|++++|+|+ .+|..+ +.++++..|+|.+|.++. ..+.+|
T Consensus 367 -~~L~~LdLs~N~Lt-~LP~~l~--~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L 435 (754)
T PRK15370 367 -PTITTLDVSRNALT-NLPENLP--AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNM 435 (754)
T ss_pred -CCcCEEECCCCcCC-CCCHhHH--HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHH
Confidence 68999999999999 5676664 46999999999998 566544 445888999999999872 345555
Q ss_pred cEEEccCCcCcccC
Q 002759 460 THFNLSSNNLSGTI 473 (884)
Q Consensus 460 ~~L~l~~N~l~~~~ 473 (884)
+.| ++.+.+.|.+
T Consensus 436 ~~L-l~s~~~~gp~ 448 (754)
T PRK15370 436 QRL-MSSVGYQGPR 448 (754)
T ss_pred HHh-hhcccccCCc
Confidence 555 5556666543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.9e-21 Score=209.40 Aligned_cols=163 Identities=19% Similarity=0.152 Sum_probs=124.5
Q ss_pred cccccCceeccCCceEEEEEEEc--CCeEEEEEEccccC----ccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCcee
Q 002759 594 ALLDKECLIGGGSIGSVYRASFE--GGVSIAVKKLETLG----RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQL 667 (884)
Q Consensus 594 ~~~~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 667 (884)
.-|+..+.||+|+||+||+|... ++..||||++.... .....+.+.+|++++++++|+|+++.+.. ....+
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~ 94 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDG 94 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcE
Confidence 34567889999999999999764 57778999875321 11235668999999999999999863332 24579
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCceEeCCCCCee
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNL-KSTNILLDENYEPK 746 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl-k~~Nil~~~~~~vk 746 (884)
+||||+++++|... . . .. ...++.|++++|+|||++ +|+|||| ||+||+++.++.+|
T Consensus 95 LVmE~~~G~~L~~~-~--~-------------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ik 152 (365)
T PRK09188 95 LVRGWTEGVPLHLA-R--P-------------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAA 152 (365)
T ss_pred EEEEccCCCCHHHh-C--c-------------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEE
Confidence 99999999999632 1 0 00 136788999999999998 9999999 99999999999999
Q ss_pred EccccCccccCCccCc-------ccccccccccccCccccCC
Q 002759 747 LSDYGLAKLLPILDNY-------GLTKFHNAVGYVAPELAQS 781 (884)
Q Consensus 747 l~Dfg~s~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~ 781 (884)
|+|||+|+.+...... ..+...++..|+|||.+.-
T Consensus 153 LiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 153 VIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999876542211 1134567788999998863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.7e-21 Score=191.90 Aligned_cols=262 Identities=13% Similarity=0.141 Sum_probs=199.4
Q ss_pred cccCceeccCCceEEEEEE-EcCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|.++++||+|+||+++.|. .-++++||||.-.... +.-++..|.+..+.+ ..+.|...+.+..++.+..+|+|.+
T Consensus 30 yrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS---~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL 106 (449)
T KOG1165|consen 30 YRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS---EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL 106 (449)
T ss_pred ceeccccccCcceeeecccccccCceEEEEeccccC---CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh
Confidence 4578899999999999995 4578899999876443 345666777777776 5789999888888888889999998
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCC-----CCCeeEc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-----NYEPKLS 748 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~-----~~~vkl~ 748 (884)
|-||+|....++ ..|+.+++..+|.|++.-++|+|++ .+|+|||||+|+||.. ...|.|+
T Consensus 107 -GPSLEDLFD~Cg-----------R~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~Ihii 171 (449)
T KOG1165|consen 107 -GPSLEDLFDLCG-----------RRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHII 171 (449)
T ss_pred -CcCHHHHHHHhc-----------CcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEE
Confidence 779999987665 3799999999999999999999999 9999999999999974 3469999
Q ss_pred cccCccccCCccCcc------cccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 002759 749 DYGLAKLLPILDNYG------LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 749 Dfg~s~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~ 822 (884)
|||+|+.+-+.+... .....||.+||+=....+..-+.+.|+=|+|-++.+.+-|..||++.....-...-
T Consensus 172 DFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY--- 248 (449)
T KOG1165|consen 172 DFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY--- 248 (449)
T ss_pred eccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH---
Confidence 999999986544332 34457899999998888888899999999999999999999999985433221111
Q ss_pred HHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhcccC
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLG 883 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~~~~~ 883 (884)
+.+.+.+..- .+...++..+.++.+.+...-+.+-.+-|..+-+...+.++-+.+|
T Consensus 249 -eKIGe~Kr~T----~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g 304 (449)
T KOG1165|consen 249 -EKIGETKRST----PIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLG 304 (449)
T ss_pred -HHhccccccC----CHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcC
Confidence 1111111111 1111233344455555555666678888998888877777766554
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=8e-21 Score=181.28 Aligned_cols=258 Identities=15% Similarity=0.187 Sum_probs=191.9
Q ss_pred cccCceeccCCceEEEEEE-EcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEEec
Q 002759 596 LDKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+...+.||+|+||.+|.|. ..+|..||||.-+... ...++..|.++...++ -..|..+..+..+.....+||+..
T Consensus 17 y~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a---~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL 93 (341)
T KOG1163|consen 17 YKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA---KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL 93 (341)
T ss_pred eEEEEeecCCchhheeeeeeccCCceEEEEeecccC---CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc
Confidence 4466789999999999995 4678999999987543 3456678888888886 456777777888888899999998
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC---CCeeEccc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN---YEPKLSDY 750 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~---~~vkl~Df 750 (884)
|.+|.+.+.-+. ..++.++++-.|-|++.-++|+|.+ ++|||||||+|+|..-+ ..+.++||
T Consensus 94 -GPsLEdLfnfC~-----------R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDF 158 (341)
T KOG1163|consen 94 -GPSLEDLFNFCS-----------RRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDF 158 (341)
T ss_pred -CccHHHHHHHHh-----------hhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEec
Confidence 779999886543 3689999999999999999999998 99999999999999743 46899999
Q ss_pred cCccccCCccCcc------cccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 002759 751 GLAKLLPILDNYG------LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 751 g~s~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~ 824 (884)
|+|+.+-+..... .....||.+|.+-....+..-+.+.|+-|+|.++.++--|..||++.......... +
T Consensus 159 GLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKy----E 234 (341)
T KOG1163|consen 159 GLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKY----E 234 (341)
T ss_pred cchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHH----H
Confidence 9998876533222 23456899999877777767788999999999999999999999986543222111 1
Q ss_pred HHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
.+.+.+....+.. .+...+.++.-.+..|-..--++-|...-+-+.++-+.
T Consensus 235 kI~EkK~s~~ie~----LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 235 KISEKKMSTPIEV----LCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred HHHHhhcCCCHHH----HhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 1222122111111 22233345666666788877888888877776666554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-21 Score=224.91 Aligned_cols=253 Identities=19% Similarity=0.183 Sum_probs=183.4
Q ss_pred cCceeccCCceEEEEEEEc-CCeEEEEEEcc----ccCccCC-HHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLE----TLGRIRN-QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~----~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
..+++|.|++|.|+.+... .....+.|... ....... ...+..|+.+-..+.|||++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 5668999999988877443 23333333322 1111111 1225567777788899999888887766666666699
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++ +|+.++.... .++..++..++.|+..|+.|+|+. +|.|||+|++|++++.+|.+||+|||
T Consensus 402 ~~~~-Dlf~~~~~~~------------~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg 465 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNG------------KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFG 465 (601)
T ss_pred cccH-HHHHHHhccc------------ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecC
Confidence 9999 9999997542 578889999999999999999999 99999999999999999999999999
Q ss_pred CccccCCccC---cccccccccccccCccccCCCCCCC-ccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHH
Q 002759 752 LAKLLPILDN---YGLTKFHNAVGYVAPELAQSLRLSD-KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 752 ~s~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~-~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
.+..+.-... .......|...|+|||++.+..|.+ ..||||.|+++..|.+|+.||..+...+... .....
T Consensus 466 ~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~ 540 (601)
T KOG0590|consen 466 AASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNY 540 (601)
T ss_pred cceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhcc
Confidence 9876543222 4456778899999999999999987 5899999999999999999998765443221 00000
Q ss_pred cCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~ 873 (884)
..... ............+.+-..++.++++.+|.+|.|+++|++
T Consensus 541 ~~~~~--~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 541 SDQRN--IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred ccccc--cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 00000 000001122333445667888899999999999999985
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.3e-19 Score=192.13 Aligned_cols=259 Identities=28% Similarity=0.324 Sum_probs=195.3
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCccC--CHHHHHHHHHHHhcCCCC-CcceeeeEEecCCceeEEEEec
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIR--NQEEFELEIGRLSNIRHF-NLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~~ 673 (884)
...+.+|.|+||.||++... ..+++|.+....... ....+.+|+..++.+.|+ +++++.+++......+++++|+
T Consensus 3 ~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 3 RILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred eeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 34567899999999999877 678999987655444 378899999999999988 7999999997777789999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC-CeeEccccC
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY-EPKLSDYGL 752 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~-~vkl~Dfg~ 752 (884)
.++++.+++...... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.
T Consensus 81 ~~~~l~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~ 148 (384)
T COG0515 81 DGGSLEDLLKKIGRK---------GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGL 148 (384)
T ss_pred CCCcHHHHHHhcccc---------cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCc
Confidence 999999777643210 2578889999999999999999999 899999999999999988 799999999
Q ss_pred ccccCCccCc-----ccccccccccccCccccCC---CCCCCccCchhHHHHHHHHHhCCCCCCCCCCc-chhhHHHHHH
Q 002759 753 AKLLPILDNY-----GLTKFHNAVGYVAPELAQS---LRLSDKCDVYSFGVILLELVTGRKPVESPTTN-EVVVLCEYVR 823 (884)
Q Consensus 753 s~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~---~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~-~~~~~~~~~~ 823 (884)
++........ ......++..|+|||.+.+ ..+....|+||+|++++++++|..||...... .........
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~- 227 (384)
T COG0515 149 AKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII- 227 (384)
T ss_pred ceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHH-
Confidence 9865533221 2466788999999999987 57888999999999999999999997665431 011111111
Q ss_pred HHHHcCCCcccccccCCC-CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 824 ELLERGSASACFDRSLRG-FAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 824 ~~~~~~~~~~~~d~~~~~-~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
...... ........ ........+.+++..|+..+|..|.+..+....
T Consensus 228 ---~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 228 ---LELPTP-SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ---HhcCCc-ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 111111 00000000 001223456777888999999999998877653
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-22 Score=180.10 Aligned_cols=168 Identities=32% Similarity=0.495 Sum_probs=118.9
Q ss_pred CCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCC-CCCcCCc
Q 002759 304 VIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRG-EVPDDIS 382 (884)
Q Consensus 304 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~-~~p~~~~ 382 (884)
.+|..+..+.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. ..|..||+++.|+.|||.+|++.. .+|..|-
T Consensus 47 ~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff 124 (264)
T KOG0617|consen 47 VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFF 124 (264)
T ss_pred ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchh
Confidence 34445677777777777777777 67777777777777777777777 677777777777777777777753 3667777
Q ss_pred CCCCCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCc---c
Q 002759 383 NCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRN---L 459 (884)
Q Consensus 383 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~---L 459 (884)
.++.|+.|+|+.|.+. .+|..++++++|+.|.+..|.+- .+|..++.++.|++|++++|+++ .+|+.++++.- =
T Consensus 125 ~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-vlppel~~l~l~~~k 201 (264)
T KOG0617|consen 125 YMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-VLPPELANLDLVGNK 201 (264)
T ss_pred HHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-ecChhhhhhhhhhhH
Confidence 7777777777777777 67777777777777777777776 67777777777777777777777 67777666532 2
Q ss_pred cEEEccCCcCcccCCcc
Q 002759 460 THFNLSSNNLSGTIPST 476 (884)
Q Consensus 460 ~~L~l~~N~l~~~~p~~ 476 (884)
+.+.+.+|+|-..|-.+
T Consensus 202 ~v~r~E~NPwv~pIaeQ 218 (264)
T KOG0617|consen 202 QVMRMEENPWVNPIAEQ 218 (264)
T ss_pred HHHhhhhCCCCChHHHH
Confidence 34556666665544443
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.6e-19 Score=177.64 Aligned_cols=141 Identities=16% Similarity=0.165 Sum_probs=107.6
Q ss_pred CceeccCCceEEEEEEEcCCeEEEEEEccccCcc-CC------------------------HHHHHHHHHHHhcCCCCCc
Q 002759 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRI-RN------------------------QEEFELEIGRLSNIRHFNL 653 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~------------------------~~~~~~E~~~l~~l~h~ni 653 (884)
...||+|++|.||+|...+|+.||||+++..... .. ......|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999998888999999999653211 11 1123459999999988776
Q ss_pred ceeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccC
Q 002759 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL-HHDCKPPILHLNL 732 (884)
Q Consensus 654 v~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~L-H~~~~~~ivH~Dl 732 (884)
.....+.. ...++||||++++++...... ...++..++.+++.|++.+|.|+ |+. +|+||||
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~------------~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDl 144 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK------------DAPLSESKARELYLQVIQIMRILYQDC---RLVHADL 144 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh------------cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCC
Confidence 44433322 234899999988766544221 12578899999999999999999 677 9999999
Q ss_pred CCCceEeCCCCCeeEccccCccccC
Q 002759 733 KSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 733 k~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
||+||+++ ++.++++|||+|....
T Consensus 145 kP~NIli~-~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 145 SEYNLLYH-DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CHHHEEEE-CCcEEEEEccccccCC
Confidence 99999998 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.3e-19 Score=193.36 Aligned_cols=217 Identities=29% Similarity=0.445 Sum_probs=163.7
Q ss_pred HhcCCCCCcceeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 002759 645 LSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCK 724 (884)
Q Consensus 645 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~ 724 (884)
++.+.|.|+.+++|.+.++...+.|.+|+..|+|.|.+.... ..++|.....+.++|+.||+|||+-
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~-----------~~~d~~F~~s~~rdi~~Gl~ylh~s-- 67 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED-----------IKLDYFFILSFIRDISKGLAYLHNS-- 67 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc-----------cCccHHHHHHHHHHHHHHHHHHhcC--
Confidence 356789999999999999999999999999999999997533 4689999999999999999999976
Q ss_pred CCe-EeccCCCCceEeCCCCCeeEccccCccccCCc-cCcccccccccccccCccccCCCC-------CCCccCchhHHH
Q 002759 725 PPI-LHLNLKSTNILLDENYEPKLSDYGLAKLLPIL-DNYGLTKFHNAVGYVAPELAQSLR-------LSDKCDVYSFGV 795 (884)
Q Consensus 725 ~~i-vH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-------~~~~sDvwS~Gv 795 (884)
+| .|+.++++|++++....+|++|||+....... +...........-|.|||.+.... .+.+.||||||+
T Consensus 68 -~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~i 146 (484)
T KOG1023|consen 68 -PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGI 146 (484)
T ss_pred -cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHH
Confidence 44 99999999999999999999999998776421 111112223344599999987641 356799999999
Q ss_pred HHHHHHhCCCCCCCCCCcch-hhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 796 ILLELVTGRKPVESPTTNEV-VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 796 ~l~el~tG~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
+++|+++.+.||......+. ..++..+++ .+. ..+-|.+.... +...++..++..||..+|.+||+++++-..
T Consensus 147 i~~ei~~r~~~~~~~~~~~~~~eii~~~~~---~~~--~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 147 IMYEILFRSGPFDLRNLVEDPDEIILRVKK---GGS--NPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred HHHHHHhccCccccccccCChHHHHHHHHh---cCC--CCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 99999999999987432222 122222222 111 11222222111 333368888899999999999999999999
Q ss_pred HHHhhcc
Q 002759 875 LESIRNG 881 (884)
Q Consensus 875 L~~~~~~ 881 (884)
++.+...
T Consensus 221 ~~~~~~~ 227 (484)
T KOG1023|consen 221 LLTINKG 227 (484)
T ss_pred hhhhccc
Confidence 9887654
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=2e-21 Score=212.09 Aligned_cols=284 Identities=22% Similarity=0.274 Sum_probs=142.5
Q ss_pred eEeCCCCccCCCCchhhhhccccCcEEEccCCccCCC----ccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEE
Q 002759 148 LLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGS----IPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFIS 223 (884)
Q Consensus 148 ~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 223 (884)
.|+|+++++++.--...+..+..|+.|+++++.++.. ++..+...++|++|++++|.+.+ .+..+
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~~---------- 70 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRGL---------- 70 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchHH----------
Confidence 4677777776443334555666677777777776432 34445555666666666666542 11100
Q ss_pred ccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCC---ccEEEeecCccccccccccccCCCCcEEecCCCc
Q 002759 224 VRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKN---ISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300 (884)
Q Consensus 224 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~ 300 (884)
..++..+..+++|+.|+|++|.+.+..+..+..+.+ |++|++++|++++.....
T Consensus 71 -------~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~---------------- 127 (319)
T cd00116 71 -------QSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRL---------------- 127 (319)
T ss_pred -------HHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHH----------------
Confidence 112334444555555555555555433333333333 555566555554211110
Q ss_pred CCCCCCcccccc-cccceecccCCccccc----CCCCcccccCccEEEccCCccCCC----CCCCccCcccccEEecCCC
Q 002759 301 FDGVIPLSITNC-RNLKVLDLGFNRLIGS----IPTGITDLRRLLKISLANNSIGGI----IPPNLGSIELLEVLDLHNL 371 (884)
Q Consensus 301 l~~~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~n 371 (884)
+...+..+ ++|+.|+|++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|+.|+|++|
T Consensus 128 ----l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n 203 (319)
T cd00116 128 ----LAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNN 203 (319)
T ss_pred ----HHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCC
Confidence 00111122 3333444444433311 122233334444444444444421 1122233345555555555
Q ss_pred cCCCC----CCcCCcCCCCCcEEeccCccCCCCcchhhcC-----CccCcEEEecCcccCC----CCCccccCCCCCCEE
Q 002759 372 NLRGE----VPDDISNCRFLLLLDVSGNALGGDIPQTLYN-----MTYLKILDLHQNHLNG----STPPSLGNLSNLQVL 438 (884)
Q Consensus 372 ~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~-----l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L 438 (884)
.+++. ++..+..+++|+.|++++|.+++.....+.. .+.|+.|++++|.++. .+...+..+++|+.+
T Consensus 204 ~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l 283 (319)
T cd00116 204 GLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLEL 283 (319)
T ss_pred ccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEE
Confidence 55422 2233455666777777777766432222221 3677777777777752 233445556778888
Q ss_pred EccCCccCCc----cCCCcCcc-CcccEEEccCCcC
Q 002759 439 DLSQNSLSGS----IPSSLGNL-RNLTHFNLSSNNL 469 (884)
Q Consensus 439 ~L~~N~l~~~----~p~~~~~l-~~L~~L~l~~N~l 469 (884)
++++|.++.. +...+... +.|+.|++.+|+|
T Consensus 284 ~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 284 DLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred ECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 8888877743 33344444 5777788777764
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=3.9e-21 Score=209.82 Aligned_cols=281 Identities=22% Similarity=0.257 Sum_probs=149.5
Q ss_pred EeecCCCCCC-CCCCccCCCCCCcceEeCCCCccCCC----CchhhhhccccCcEEEccCCccCC------Ccccccccc
Q 002759 124 KINVSSNALS-GSIPEFIGDLPNIRLLDLSRNSYSGE----IPFALFKYCYKTKFVSLSHNNLSG------SIPLSIANC 192 (884)
Q Consensus 124 ~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~g~----ip~~~~~~l~~L~~L~L~~n~l~~------~~p~~~~~l 192 (884)
.|+|..+.++ ...+..+..+.+|+.|++++|.+++. ++.. ....+.++.|+++++.+.+ .++..+.++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~-l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~ 80 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASA-LRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKG 80 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHH-HhhCCCceEEeccccccCCcchHHHHHHHHHHhc
Confidence 5789999998 45666677888999999999998643 3322 3455779999999998873 234566777
Q ss_pred CCCCeeEcccCCCCCCCCCCCCCCCc---ccEEEccCCccCCC----cccccccC-CeecEEEcCCCccCCcC----CCC
Q 002759 193 TYLEGFDFSFNNLSGELPSQICNIPV---LDFISVRGNALTGT----VEEQFSQC-QSIKNLDLSSNLFIGLA----PFG 260 (884)
Q Consensus 193 ~~L~~L~Ls~N~l~~~~p~~l~~l~~---L~~L~L~~n~l~~~----~~~~~~~l-~~L~~L~L~~N~l~~~~----~~~ 260 (884)
++|++|++++|.+.+..+..+..+.. |++|++++|++++. +...+..+ ++|++|+|++|.+++.. +..
T Consensus 81 ~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~ 160 (319)
T cd00116 81 CGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKA 160 (319)
T ss_pred CceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHH
Confidence 78888888888887555554444443 66666666666531 22233334 45555555555554211 112
Q ss_pred CCCCCCccEEEeecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccccCcc
Q 002759 261 VLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLL 340 (884)
Q Consensus 261 ~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 340 (884)
+..+++|++|+|++|.+++... ..++..+..+++|++|+|++|.+++....
T Consensus 161 ~~~~~~L~~L~l~~n~l~~~~~--------------------~~l~~~l~~~~~L~~L~L~~n~i~~~~~~--------- 211 (319)
T cd00116 161 LRANRDLKELNLANNGIGDAGI--------------------RALAEGLKANCNLEVLDLNNNGLTDEGAS--------- 211 (319)
T ss_pred HHhCCCcCEEECcCCCCchHHH--------------------HHHHHHHHhCCCCCEEeccCCccChHHHH---------
Confidence 2223333333333333332100 01111222333455555555544321111
Q ss_pred EEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCc-----CCCCCcEEeccCccCCC----CcchhhcCCccC
Q 002759 341 KISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDIS-----NCRFLLLLDVSGNALGG----DIPQTLYNMTYL 411 (884)
Q Consensus 341 ~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~-----~l~~L~~L~ls~N~l~~----~~p~~~~~l~~L 411 (884)
.++..+..+++|+.|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|
T Consensus 212 -----------~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L 280 (319)
T cd00116 212 -----------ALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL 280 (319)
T ss_pred -----------HHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCc
Confidence 0111223334444444444444432111111 12456666666666651 233345555667
Q ss_pred cEEEecCcccCCC----CCccccCC-CCCCEEEccCCcc
Q 002759 412 KILDLHQNHLNGS----TPPSLGNL-SNLQVLDLSQNSL 445 (884)
Q Consensus 412 ~~L~Ls~N~l~~~----~p~~~~~l-~~L~~L~L~~N~l 445 (884)
++|++++|.++.. +...+... +.|++|++.+|++
T Consensus 281 ~~l~l~~N~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 281 LELDLRGNKFGEEGAQLLAESLLEPGNELESLWVKDDSF 319 (319)
T ss_pred cEEECCCCCCcHHHHHHHHHHHhhcCCchhhcccCCCCC
Confidence 7777777777643 33333333 5677777766653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.9e-19 Score=179.87 Aligned_cols=170 Identities=12% Similarity=0.091 Sum_probs=128.7
Q ss_pred hcccccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCC--HH------HHHHHHHHHhcCCCCCcceeeeEEecC-
Q 002759 593 KALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRN--QE------EFELEIGRLSNIRHFNLVAFQGYYWSS- 663 (884)
Q Consensus 593 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--~~------~~~~E~~~l~~l~h~niv~~~~~~~~~- 663 (884)
...+...+++|.|+||.||.++. ++..+|+|.+........ .. .+++|+..++++.||+|..+.+++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 44566788999999999999866 466899999964432111 11 268999999999999999999886533
Q ss_pred -------CceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCc
Q 002759 664 -------TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTN 736 (884)
Q Consensus 664 -------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~N 736 (884)
...++||||++|.+|.++.. ++. ....+++.++..+|+. +++|||+||+|
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~----------------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~N 165 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE----------------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGN 165 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh----------------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHH
Confidence 35789999999999977632 122 2456999999999999 99999999999
Q ss_pred eEeCCCCCeeEccccCccccCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHH
Q 002759 737 ILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLEL 800 (884)
Q Consensus 737 il~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el 800 (884)
|++++++ ++++|||........... ..+.....+..++|+|+||+++...
T Consensus 166 ili~~~g-i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 166 FIVSKNG-LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred EEEeCCC-EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHH
Confidence 9999988 999999988755321110 1133444566789999999987543
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=5.9e-20 Score=209.01 Aligned_cols=248 Identities=24% Similarity=0.277 Sum_probs=178.4
Q ss_pred ccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHH--HhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGR--LSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...+.+|++.|=+|.+|+++.|. |+||++.+.......+.|.++++- ...++|||++++.-+....+..|+|-+|..
T Consensus 26 ~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvk 104 (1431)
T KOG1240|consen 26 HYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVK 104 (1431)
T ss_pred eeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHh
Confidence 35567999999999999998885 899998765544555555544433 445689999999888777778889989985
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
+ +|+|.+..+ +-+...+..-|+.|++.|+..+|.. +|+|||||.+||||+.=.=+.++||..-+
T Consensus 105 h-nLyDRlSTR------------PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFK 168 (1431)
T KOG1240|consen 105 H-NLYDRLSTR------------PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFK 168 (1431)
T ss_pred h-hhhhhhccc------------hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccC
Confidence 4 999999643 3577788889999999999999999 99999999999999998889999997654
Q ss_pred c--cCCccCccc----ccccccccccCccccCCC----------C-CCCccCchhHHHHHHHHHh-CCCCCCCCCCcchh
Q 002759 755 L--LPILDNYGL----TKFHNAVGYVAPELAQSL----------R-LSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816 (884)
Q Consensus 755 ~--~~~~~~~~~----~~~~~~~~y~aPE~~~~~----------~-~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~ 816 (884)
. ++.+..... ........|+|||.+... . .+++-||||.||++.|+++ |++||.-.
T Consensus 169 PtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------ 242 (1431)
T KOG1240|consen 169 PTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------ 242 (1431)
T ss_pred CccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------
Confidence 3 222111112 222334569999987531 1 4678899999999999999 88888631
Q ss_pred hHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002759 817 VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~ 876 (884)
.+.+|.+ +. .......++...+. .+..++..|++.||++|.++++.++.-+
T Consensus 243 QL~aYr~-----~~-~~~~e~~Le~Ied~---~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 243 QLLAYRS-----GN-ADDPEQLLEKIEDV---SLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred HHHhHhc-----cC-ccCHHHHHHhCcCc---cHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1111111 10 00000011111111 4667888899999999999999998743
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=170.10 Aligned_cols=187 Identities=16% Similarity=0.089 Sum_probs=139.7
Q ss_pred cCceeccCCceEEEEEEEcCCeEEEEEEccccCccCC---HHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEEec
Q 002759 598 KECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRN---QEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~---~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+...+++|+||+||.+.. ++.+++.+.+........ ...+.+|+++++++. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 556899999999998876 566788777765442111 235789999999995 5889998886 3468999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC-CCCceEeCCCCCeeEccccC
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNL-KSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl-k~~Nil~~~~~~vkl~Dfg~ 752 (884)
+|.+|.+.... ....++.|+++++.++|++ ||+|||| ||+||+++.++.++|+|||+
T Consensus 81 ~G~~L~~~~~~-------------------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~ 138 (218)
T PRK12274 81 AGAAMYQRPPR-------------------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQL 138 (218)
T ss_pred cCccHHhhhhh-------------------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCC
Confidence 99888653310 1134778999999999999 9999999 79999999999999999999
Q ss_pred ccccCCccCc----c--------cccccccccccCccccCCC-CCC-CccCchhHHHHHHHHHhCCCCCCCCC
Q 002759 753 AKLLPILDNY----G--------LTKFHNAVGYVAPELAQSL-RLS-DKCDVYSFGVILLELVTGRKPVESPT 811 (884)
Q Consensus 753 s~~~~~~~~~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~sDvwS~Gv~l~el~tG~~p~~~~~ 811 (884)
|......... . ......+++|++|+...-. ..+ .+.++++-|.-+|+++||..|+....
T Consensus 139 A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 139 AVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred ceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 9865432210 0 0112346677788754322 233 57899999999999999999887644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=6.7e-19 Score=179.61 Aligned_cols=195 Identities=20% Similarity=0.226 Sum_probs=135.1
Q ss_pred CCCCcceeeeEEecC---------------------------CceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCC
Q 002759 649 RHFNLVAFQGYYWSS---------------------------TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELH 701 (884)
Q Consensus 649 ~h~niv~~~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~ 701 (884)
+|||||++.++|.+. ...|+||.-.+ .+|.+++.... .+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~-------------~s 339 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH-------------RS 339 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC-------------Cc
Confidence 699999998876432 34588998774 48999986443 56
Q ss_pred HHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC--CCC--CeeEccccCccccCCcc---Cc--cccccccccc
Q 002759 702 WSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD--ENY--EPKLSDYGLAKLLPILD---NY--GLTKFHNAVG 772 (884)
Q Consensus 702 ~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~--~~~--~vkl~Dfg~s~~~~~~~---~~--~~~~~~~~~~ 772 (884)
.....-|+.|+++|+.|||++ +|.|||+|++|||+. +|+ ...|+|||++---+... .+ ......|...
T Consensus 340 ~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~ 416 (598)
T KOG4158|consen 340 YRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAK 416 (598)
T ss_pred hHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcce
Confidence 667777899999999999999 999999999999993 333 47889999874221100 00 1123345667
Q ss_pred ccCccccCCCCC------CCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHH
Q 002759 773 YVAPELAQSLRL------SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENE 846 (884)
Q Consensus 773 y~aPE~~~~~~~------~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~ 846 (884)
-||||+....+- -.|+|.|+.|.+.||++...-||...-+. ..+...|... .+...++.+
T Consensus 417 lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Yqe~-------------qLPalp~~v 482 (598)
T KOG4158|consen 417 LMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTYQES-------------QLPALPSRV 482 (598)
T ss_pred ecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhhhhh-------------hCCCCcccC
Confidence 999999865332 24899999999999999999999873211 1111112111 111233344
Q ss_pred HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002759 847 LIQVMKLGLICTSEVPSRRPSMAEVVQV 874 (884)
Q Consensus 847 ~~~l~~l~~~cl~~~P~~RPt~~ell~~ 874 (884)
+..+.+++...++.||++|++..=....
T Consensus 483 pp~~rqlV~~lL~r~pskRvsp~iAANv 510 (598)
T KOG4158|consen 483 PPVARQLVFDLLKRDPSKRVSPNIAANV 510 (598)
T ss_pred ChHHHHHHHHHhcCCccccCCccHHHhH
Confidence 4567778888999999999987554443
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=3e-18 Score=170.93 Aligned_cols=140 Identities=20% Similarity=0.172 Sum_probs=109.9
Q ss_pred CceeccCCceEEEEEEEcCCeEEEEEEccccCcc-C-------------------C-----HHHHHHHHHHHhcCCCCCc
Q 002759 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRI-R-------------------N-----QEEFELEIGRLSNIRHFNL 653 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~-------------------~-----~~~~~~E~~~l~~l~h~ni 653 (884)
...||+|++|.||+|...+|+.||||++...... . . ...+..|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3579999999999998778999999998754211 0 0 1224678899999999987
Q ss_pred ceeeeEEecCCceeEEEEecCCCchhhh-cccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecc
Q 002759 654 VAFQGYYWSSTMQLILSEFVPKGNLYDN-LHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH-DCKPPILHLN 731 (884)
Q Consensus 654 v~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~D 731 (884)
.....+... ..++||||++++++... +.. ..++..+...++.|++.++.++|+ . +|+|||
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-------------~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrD 143 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-------------VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGD 143 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-------------ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence 655544433 24899999988755332 321 246778889999999999999999 7 999999
Q ss_pred CCCCceEeCCCCCeeEccccCccccC
Q 002759 732 LKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 732 lk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|||+||+++ ++.++|+|||++....
T Consensus 144 lkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 144 LSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CChhhEEEE-CCCEEEEEcccceecC
Confidence 999999999 8899999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-20 Score=171.06 Aligned_cols=166 Identities=31% Similarity=0.565 Sum_probs=153.3
Q ss_pred cccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCc
Q 002759 309 ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLL 388 (884)
Q Consensus 309 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~ 388 (884)
+-++.+++.|.||+|+++ .+|..+..+.+|+.|++++|+|+ .+|..+++++.|+.|+++-|++. ..|..|+.++.|+
T Consensus 29 Lf~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~le 105 (264)
T KOG0617|consen 29 LFNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALE 105 (264)
T ss_pred ccchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhh
Confidence 346788999999999999 78889999999999999999999 68899999999999999999998 8999999999999
Q ss_pred EEeccCccCCC-CcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCC
Q 002759 389 LLDVSGNALGG-DIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467 (884)
Q Consensus 389 ~L~ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N 467 (884)
.|||+.|++.. .+|..|..++.|+.|+|++|.+. .+|+.++++++|+.|.+..|.+- .+|..++.+..|+.|.+.+|
T Consensus 106 vldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgn 183 (264)
T KOG0617|consen 106 VLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGN 183 (264)
T ss_pred hhhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccc
Confidence 99999999874 57999999999999999999998 89999999999999999999998 89999999999999999999
Q ss_pred cCcccCCcccccc
Q 002759 468 NLSGTIPSTIQHF 480 (884)
Q Consensus 468 ~l~~~~p~~~~~~ 480 (884)
+++ .+|+.+..+
T Consensus 184 rl~-vlppel~~l 195 (264)
T KOG0617|consen 184 RLT-VLPPELANL 195 (264)
T ss_pred eee-ecChhhhhh
Confidence 998 566655443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-19 Score=197.61 Aligned_cols=186 Identities=26% Similarity=0.285 Sum_probs=154.8
Q ss_pred eccCCceEEEEEEE----cCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEEecCC
Q 002759 602 IGGGSIGSVYRASF----EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 602 lg~G~~g~V~~~~~----~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+|+|+||.|+.+.. ..+..+|+|+.+.... .........|-.++..++ ||.++++...+..+...+++.+|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 69999999998733 3356678887754321 111224456777788886 99999999999999999999999999
Q ss_pred CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
|.+...+.... .+++.....+...++-+++++|+. +|+|||+|++||+++.+|++++.|||.++.
T Consensus 82 g~lft~l~~~~------------~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske 146 (612)
T KOG0603|consen 82 GDLFTRLSKEV------------MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKE 146 (612)
T ss_pred chhhhccccCC------------chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhH
Confidence 99988886544 577777788888999999999998 999999999999999999999999999987
Q ss_pred cCCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCC
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~ 809 (884)
.-+.+. .+||..|||||++. .+..++|.||||++++||+||..||..
T Consensus 147 ~v~~~~-----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 147 AVKEKI-----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hHhhhh-----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 643222 28999999999998 567899999999999999999999987
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.8e-18 Score=175.67 Aligned_cols=236 Identities=18% Similarity=0.199 Sum_probs=149.8
Q ss_pred ccCceeccCCceEEEEEEEc-CCeEEEEEEcccc--CccCCHHHHHHHHHHHhcCCC----------CCcceeeeEEec-
Q 002759 597 DKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFELEIGRLSNIRH----------FNLVAFQGYYWS- 662 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~~- 662 (884)
..++.||.|+++.||.++.. +++++|+|+.... ......+++.+|......+.+ -.++..++....
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 46778999999999999775 5899999988533 233446777777766655322 223333332211
Q ss_pred --------C---C-----ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 002759 663 --------S---T-----MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPP 726 (884)
Q Consensus 663 --------~---~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ 726 (884)
. . ..+++|+-+ .++|.+++....... ..........+..+..|+++.+++||+. |
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~-----~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---G 165 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA-----QTHSPLAFAARLSLTVQMIRLVANLHSY---G 165 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT-----TTSHHHHHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc-----cccchhHHHHHHHHHHHHHHHHHHHhhc---c
Confidence 1 1 225677777 568887764211000 0011234456678889999999999999 9
Q ss_pred eEeccCCCCceEeCCCCCeeEccccCccccCCccCcccccccccccccCccccCC--------CCCCCccCchhHHHHHH
Q 002759 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS--------LRLSDKCDVYSFGVILL 798 (884)
Q Consensus 727 ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~sDvwS~Gv~l~ 798 (884)
+||+||+|+|++++.+|.++++||+.....+. . ......+..|.|||.... ..++++.|.|++|+++|
T Consensus 166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~--~--~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT--R--YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp EEEST-SGGGEEE-TTS-EEE--GGGEEETTE--E--EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCCCEEEcChHHHeecCc--e--eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999999999999999999988775432 1 111345678999997643 34678899999999999
Q ss_pred HHHhCCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCC
Q 002759 799 ELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRR 865 (884)
Q Consensus 799 el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~R 865 (884)
.|++|..||.......... ..+..+. +.+..+..+|..+++.+|.+|
T Consensus 242 ~lWC~~lPf~~~~~~~~~~-------------------~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADPE-------------------WDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTSG-------------------GGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCcccccc-------------------ccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999999998754322110 0222233 566678889999999999988
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=193.63 Aligned_cols=151 Identities=31% Similarity=0.542 Sum_probs=118.8
Q ss_pred CCchhHHHHHHHHHhhcCCCCCCcccCccCCCCCCC----CCcceEecCC---C--CEEEEEecCccccccccccccCCC
Q 002759 26 ASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCE----NFKGVFCNPD---G--FVDRIVLWNFSLGGVLSPALSGLK 96 (884)
Q Consensus 26 ~~~~~~~~~ll~~k~~~~~~~~~~l~sW~~~~~~c~----~w~gv~C~~~---~--~v~~l~l~~~~l~g~~~~~l~~l~ 96 (884)
...+.|.+||++||+++. +|.. .+|+ +++|+ .|.||.|+.+ + +|+.++|.++++.|.+|+.++.|+
T Consensus 368 ~t~~~~~~aL~~~k~~~~-~~~~--~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~ 442 (623)
T PLN03150 368 KTLLEEVSALQTLKSSLG-LPLR--FGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLR 442 (623)
T ss_pred ccCchHHHHHHHHHHhcC-Cccc--CCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCC
Confidence 345679999999999985 4432 4895 46774 6999999532 2 478888888888888888888888
Q ss_pred CCCeEeecCCcCcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhccccCcEEEc
Q 002759 97 SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL 176 (884)
Q Consensus 97 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~L~L 176 (884)
+|+.|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|+.+++|++|++|+|++|+++|.+|..+.....++..+++
T Consensus 443 ~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~ 522 (623)
T PLN03150 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNF 522 (623)
T ss_pred CCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEe
Confidence 88888888888888888888888888888888888888888888888888888888888888888776544344455555
Q ss_pred cCCcc
Q 002759 177 SHNNL 181 (884)
Q Consensus 177 ~~n~l 181 (884)
.+|..
T Consensus 523 ~~N~~ 527 (623)
T PLN03150 523 TDNAG 527 (623)
T ss_pred cCCcc
Confidence 55543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-16 Score=159.71 Aligned_cols=136 Identities=17% Similarity=0.197 Sum_probs=103.7
Q ss_pred cCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-----CCCCcceeeeEEecCC---c-eeE
Q 002759 598 KECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-----RHFNLVAFQGYYWSST---M-QLI 668 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~-~~l 668 (884)
...+||+|+||.||. .-.++. .+||++.... ....+.+.+|+..++.+ +||||++++|++.++. . ..+
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~-~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRG-DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE-CCCCcC-eEEEEEeccc-cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 456899999999996 333343 4688876432 23567899999999999 5799999999997763 3 337
Q ss_pred EEEe--cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEeccCCCCceEeCC----
Q 002759 669 LSEF--VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL-SYLHHDCKPPILHLNLKSTNILLDE---- 741 (884)
Q Consensus 669 v~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L-~~LH~~~~~~ivH~Dlk~~Nil~~~---- 741 (884)
|+|| +.+++|.+++... .+++. ..++.|++.++ +|||++ +|+||||||+||+++.
T Consensus 83 I~e~~G~~~~tL~~~l~~~-------------~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~ 144 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQC-------------RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISES 144 (210)
T ss_pred EecCCCCcchhHHHHHHcc-------------cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCC
Confidence 8999 5578999999642 24444 35677888777 999999 9999999999999974
Q ss_pred CCCeeEccccCcc
Q 002759 742 NYEPKLSDYGLAK 754 (884)
Q Consensus 742 ~~~vkl~Dfg~s~ 754 (884)
++.++|+||+.+.
T Consensus 145 ~~~~~LiDg~G~~ 157 (210)
T PRK10345 145 EVIPVVCDNIGES 157 (210)
T ss_pred CCcEEEEECCCCc
Confidence 3479999955443
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=9.2e-17 Score=187.80 Aligned_cols=192 Identities=18% Similarity=0.230 Sum_probs=152.5
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCC---CCCcceeeeEEecCCceeEEEEe
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR---HFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+.+...+|+|+||+||.|...+|+.||+|+-+....++ |.--.+++.+++ -+-|..+...+.-.+.-++|+||
T Consensus 700 ~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey 775 (974)
T KOG1166|consen 700 FCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY 775 (974)
T ss_pred EEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee----eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence 44777899999999999988889999999987654332 222223333443 22334444444445667899999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC-------CCCCe
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD-------ENYEP 745 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~-------~~~~v 745 (884)
.+.|+|.+++... +..+|.-++.+++|++..+++||.. +||||||||+|+++. +...+
T Consensus 776 ~~~Gtlld~~N~~------------~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l 840 (974)
T KOG1166|consen 776 SPYGTLLDLINTN------------KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGL 840 (974)
T ss_pred cccccHHHhhccC------------CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccce
Confidence 9999999999733 3688999999999999999999999 999999999999994 34569
Q ss_pred eEccccCccccCC-ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCC
Q 002759 746 KLSDYGLAKLLPI-LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806 (884)
Q Consensus 746 kl~Dfg~s~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p 806 (884)
+|+|||.+..+.- .+.......++|-.+--+|+..+..+++.+|.|.++.+++-|+.|++-
T Consensus 841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999976642 233456777889999999999999999999999999999999998853
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.65 E-value=6.4e-16 Score=158.70 Aligned_cols=143 Identities=19% Similarity=0.114 Sum_probs=108.7
Q ss_pred ccccCceeccCCceEEEEEE--EcCCeEEEEEEccccCcc-C----------------------CHHHHHHHHHHHhcCC
Q 002759 595 LLDKECLIGGGSIGSVYRAS--FEGGVSIAVKKLETLGRI-R----------------------NQEEFELEIGRLSNIR 649 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~--~~~~~~vavK~~~~~~~~-~----------------------~~~~~~~E~~~l~~l~ 649 (884)
.+...+.||+|++|.||+|. ..+|..||+|++...... . ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567889999999999997 568899999998643210 0 0123568999999986
Q ss_pred CCC--cceeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC-
Q 002759 650 HFN--LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPP- 726 (884)
Q Consensus 650 h~n--iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~- 726 (884)
+.. +.+++++ ...++||||+++.++....... ......+...++.||+.++++||+. +
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~---g~ 169 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD------------VEPEEEEEFELYDDILEEMRKLYKE---GE 169 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccccc------------CCcchHHHHHHHHHHHHHHHHHHhc---CC
Confidence 533 3344432 2358999999998886654211 1345566789999999999999998 8
Q ss_pred eEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 727 ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|+||||||+||+++ ++.++++|||.+....
T Consensus 170 iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 170 LVHGDLSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999999999 8899999999987543
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.2e-15 Score=155.63 Aligned_cols=135 Identities=21% Similarity=0.289 Sum_probs=112.4
Q ss_pred ceeccCCceEEEEEEEcCCeEEEEEEccccCcc-C------CHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEe
Q 002759 600 CLIGGGSIGSVYRASFEGGVSIAVKKLETLGRI-R------NQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+.||+|++|.||+|.+ .+..+++|+....... . ....+.+|+..+..++|+++.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999987 4667888876532211 1 124578899999999999998888777777888999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccC
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~ 752 (884)
++|++|.+++.... . ++..++.+++.+|.++|+. +++|||++|+||+++ ++.++++|||.
T Consensus 81 ~~G~~L~~~~~~~~---------------~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~ 140 (211)
T PRK14879 81 IEGEPLKDLINSNG---------------M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGL 140 (211)
T ss_pred eCCcCHHHHHHhcc---------------H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCc
Confidence 99999999885322 1 7889999999999999998 999999999999999 78999999999
Q ss_pred ccc
Q 002759 753 AKL 755 (884)
Q Consensus 753 s~~ 755 (884)
++.
T Consensus 141 a~~ 143 (211)
T PRK14879 141 AEF 143 (211)
T ss_pred ccC
Confidence 875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.2e-15 Score=152.03 Aligned_cols=131 Identities=24% Similarity=0.304 Sum_probs=106.0
Q ss_pred eeccCCceEEEEEEEcCCeEEEEEEccccCccC-------CHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIR-------NQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
+||+|++|.||+|.+. +..|++|+........ ...++.+|++++..++|+++.....++......++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3799999999999864 6688999864322111 1356778999999998887666655566667779999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+|++|.+++.... . .++.+++.+|.++|+. +++|||++|+||+++ ++.++++|||.+
T Consensus 80 ~g~~l~~~~~~~~------------~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a 136 (199)
T TIGR03724 80 EGKPLKDVIEEGN------------D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLG 136 (199)
T ss_pred CCccHHHHHhhcH------------H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCC
Confidence 9999998875321 0 7899999999999998 999999999999999 889999999998
Q ss_pred cc
Q 002759 754 KL 755 (884)
Q Consensus 754 ~~ 755 (884)
+.
T Consensus 137 ~~ 138 (199)
T TIGR03724 137 KY 138 (199)
T ss_pred cC
Confidence 75
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.61 E-value=4.5e-15 Score=149.39 Aligned_cols=138 Identities=16% Similarity=0.083 Sum_probs=106.7
Q ss_pred ccccCceeccCCceEEEEEEEcCCeEEEEEEccccCc-c--------------------CCHHHHHHHHHHHhcCCCCC-
Q 002759 595 LLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGR-I--------------------RNQEEFELEIGRLSNIRHFN- 652 (884)
Q Consensus 595 ~~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~--------------------~~~~~~~~E~~~l~~l~h~n- 652 (884)
++...+.||+|+||.||+|...+++.||||++..... . .....+..|+..+..+.|++
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 4556788999999999999888899999998653210 0 01123677888888887774
Q ss_pred -cceeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEecc
Q 002759 653 -LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLN 731 (884)
Q Consensus 653 -iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~D 731 (884)
+...++ ....++||||+++++|.+.... .....++.+++.++.++|+. +|+|||
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------------------~~~~~~~~~i~~~l~~lh~~---gi~H~D 150 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------------------EDPEEVLDEILEEIVKAYKH---GIIHGD 150 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------------------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence 444433 2445899999999988654320 23457889999999999998 999999
Q ss_pred CCCCceEeCCCCCeeEccccCccccC
Q 002759 732 LKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 732 lk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|||+||++++++.++|+|||.+....
T Consensus 151 l~p~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.2e-16 Score=177.35 Aligned_cols=208 Identities=23% Similarity=0.275 Sum_probs=138.4
Q ss_pred hcccccCceeccCCceEEEEEEEcC-CeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 593 KALLDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 593 ~~~~~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+.-++..++|..|+||.||.++++. .++.|+ ++.+.. .+.+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~------lilRn--ilt~a~npfvv----------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN------LILRN--ILTFAGNPFVV----------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhh-cccccc------hhhhc--cccccCCccee-----------------
Confidence 3445577899999999999997763 456677 443321 01111 11122223222
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+=.+.+...+ ++.. +++.+++|+|+. +|+|||+||+|.+|+.-|++|+.|||
T Consensus 136 ----gDc~tllk~~g------------~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfg 188 (1205)
T KOG0606|consen 136 ----GDCATLLKNIG------------PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFG 188 (1205)
T ss_pred ----chhhhhcccCC------------CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchh
Confidence 33333343222 1111 227899999998 99999999999999999999999999
Q ss_pred CccccCC--------------ccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhh
Q 002759 752 LAKLLPI--------------LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV 817 (884)
Q Consensus 752 ~s~~~~~--------------~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~ 817 (884)
+++..-. .........+||+.|+|||++....|...+|+|++|+++||.+.|+.||.+..+++.+.
T Consensus 189 Lsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg 268 (1205)
T KOG0606|consen 189 LSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFG 268 (1205)
T ss_pred hhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHh
Confidence 9876421 00111244689999999999999999999999999999999999999999987766542
Q ss_pred HHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCC
Q 002759 818 LCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP 866 (884)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP 866 (884)
. .+.+.+. +.+. | +....+...++...++.+|..|-
T Consensus 269 ~--visd~i~---wpE~-d-------ea~p~Ea~dli~~LL~qnp~~Rl 304 (1205)
T KOG0606|consen 269 Q--VISDDIE---WPEE-D-------EALPPEAQDLIEQLLRQNPLCRL 304 (1205)
T ss_pred h--hhhhhcc---cccc-C-------cCCCHHHHHHHHHHHHhChHhhc
Confidence 1 1211111 1111 1 12223555666678999999995
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.4e-15 Score=173.40 Aligned_cols=135 Identities=21% Similarity=0.263 Sum_probs=109.1
Q ss_pred cCceeccCCceEEEEEEEcCCeEEEEEEccccCcc------CCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 598 KECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRI------RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
..+.||+|+||+||+|.+.+...++.+++...... ...+.+.+|++++..++|++++....++......++|||
T Consensus 337 ~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E 416 (535)
T PRK09605 337 PDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME 416 (535)
T ss_pred ccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence 56789999999999998865543333323221111 113568899999999999999988888777778899999
Q ss_pred ecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEcccc
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg 751 (884)
|+++++|.+++. ....++.|++++|.|||+. +++|||+||+||++ +++.++|+|||
T Consensus 417 ~~~g~~L~~~l~--------------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG 472 (535)
T PRK09605 417 YIGGKDLKDVLE--------------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG 472 (535)
T ss_pred ecCCCcHHHHHH--------------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence 999999988774 2457899999999999998 99999999999999 67899999999
Q ss_pred Ccccc
Q 002759 752 LAKLL 756 (884)
Q Consensus 752 ~s~~~ 756 (884)
+++..
T Consensus 473 la~~~ 477 (535)
T PRK09605 473 LGKYS 477 (535)
T ss_pred ccccC
Confidence 99753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.3e-16 Score=166.10 Aligned_cols=123 Identities=27% Similarity=0.377 Sum_probs=108.4
Q ss_pred ceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCC
Q 002759 665 MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE 744 (884)
Q Consensus 665 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~ 744 (884)
..++.|++++..+|.+|+...+ .....++.....++.|++.|+.| + +.+|+|+||.||++..+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~---------~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRR---------TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCC---------cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchh
Confidence 4689999999999999997554 24467888899999999999999 5 8999999999999999999
Q ss_pred eeEccccCccccCCcc-----CcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHh
Q 002759 745 PKLSDYGLAKLLPILD-----NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT 802 (884)
Q Consensus 745 vkl~Dfg~s~~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~t 802 (884)
+||.|||+........ ....+...||..||+||.+.+..|+.++||||+|++++|+++
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 9999999998775433 224566789999999999999999999999999999999998
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.6e-14 Score=167.55 Aligned_cols=116 Identities=41% Similarity=0.708 Sum_probs=102.2
Q ss_pred CCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEcc
Q 002759 386 FLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLS 465 (884)
Q Consensus 386 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~ 465 (884)
.++.|+|++|.++|.+|..++.+++|+.|+|++|.++|.+|..++.+++|+.|||++|+++|.+|..++++++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 37889999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcCcccCCcccccc----CccccccCCCCCCCCCCCCCC
Q 002759 466 SNNLSGTIPSTIQHF----GVSTFLNNTGLCGPPLETSCS 501 (884)
Q Consensus 466 ~N~l~~~~p~~~~~~----~~~~~~~n~~lc~~p~~~~c~ 501 (884)
+|+++|.+|..+... ....+.+|+++|+.|....|.
T Consensus 499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred CCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 999999999876543 235678899999988766785
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.51 E-value=8.3e-14 Score=133.70 Aligned_cols=135 Identities=20% Similarity=0.146 Sum_probs=112.4
Q ss_pred CceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCC--CCcceeeeEEecCCceeEEEEecCCC
Q 002759 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRH--FNLVAFQGYYWSSTMQLILSEFVPKG 676 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g 676 (884)
.+.+|+|.++.||++...+ ..+++|....... ...+..|+..+..++| ..+++++++...++..+++|||++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~---~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK---GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc---hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 3579999999999998865 6789998865332 5678899999999976 58899998888778899999999887
Q ss_pred chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 677 NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 677 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
.+..+ +......++.+++++++++|....++++|||++|+||++++.+.++++|||.++..
T Consensus 79 ~~~~~-------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV-------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC-------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 66432 34556778999999999999864457999999999999999899999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=8.2e-16 Score=164.34 Aligned_cols=134 Identities=31% Similarity=0.509 Sum_probs=64.5
Q ss_pred CcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCC
Q 002759 306 PLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCR 385 (884)
Q Consensus 306 p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~ 385 (884)
|..++++..|++|||+.|+++ ..|..++.|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++++.
T Consensus 114 p~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~ 189 (722)
T KOG0532|consen 114 PEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLT 189 (722)
T ss_pred chhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHH
Confidence 344444455555555555544 4444444443 444444555444 34444444444444555555444 3444444555
Q ss_pred CCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccC
Q 002759 386 FLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLS 446 (884)
Q Consensus 386 ~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 446 (884)
+|+.|.+..|++. .+|.+++.|+ |..||+|.|+++ .+|-.|.+|+.|++|-|.+|.|.
T Consensus 190 slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 190 SLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred HHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecchhhhhhhhheeeeeccCCCC
Confidence 5555555555544 3444444333 444555555554 45555555555555555555554
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.8e-13 Score=139.46 Aligned_cols=138 Identities=18% Similarity=0.168 Sum_probs=105.0
Q ss_pred cCceec-cCCceEEEEEEEcCCeEEEEEEccccC------------ccCCHHHHHHHHHHHhcCCCCCc--ceeeeEEec
Q 002759 598 KECLIG-GGSIGSVYRASFEGGVSIAVKKLETLG------------RIRNQEEFELEIGRLSNIRHFNL--VAFQGYYWS 662 (884)
Q Consensus 598 ~~~~lg-~G~~g~V~~~~~~~~~~vavK~~~~~~------------~~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~ 662 (884)
....+| .|+.|+||.+... +..+++|.+.... .......+.+|+..+..++|+++ ++.+++...
T Consensus 35 ~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 35 QARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred cCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 456788 8999999999886 5578888774311 01234567889999999988875 666666433
Q ss_pred C-Cc---eeEEEEecCC-CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCce
Q 002759 663 S-TM---QLILSEFVPK-GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNI 737 (884)
Q Consensus 663 ~-~~---~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Ni 737 (884)
. .. .++|||++++ .+|.+++... .++.. .+.+|++++.+||+. ||+||||||+||
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~-------------~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NI 173 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEA-------------PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNI 173 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcC-------------CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhE
Confidence 2 22 2599999997 6898887532 23332 356899999999999 999999999999
Q ss_pred EeCCCCCeeEccccCcccc
Q 002759 738 LLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 738 l~~~~~~vkl~Dfg~s~~~ 756 (884)
|++.++.++|+|||.++..
T Consensus 174 Lv~~~~~v~LIDfg~~~~~ 192 (239)
T PRK01723 174 LLDPDGKFWLIDFDRGELR 192 (239)
T ss_pred EEcCCCCEEEEECCCcccC
Confidence 9999999999999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=7.7e-14 Score=139.25 Aligned_cols=137 Identities=20% Similarity=0.179 Sum_probs=96.4
Q ss_pred CceeccCCceEEEEEEEcCCeEEEEEEccccCcc-CCHHH----------------------HHHHHHHHhcCCCC--Cc
Q 002759 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRI-RNQEE----------------------FELEIGRLSNIRHF--NL 653 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~----------------------~~~E~~~l~~l~h~--ni 653 (884)
.+.||+|+||.||+|...+++.||||++...... ..... ...|...+..+.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3579999999999998888899999988643211 11111 13455555555333 23
Q ss_pred ceeeeEEecCCceeEEEEecCCCchhh-hcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEecc
Q 002759 654 VAFQGYYWSSTMQLILSEFVPKGNLYD-NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH-DCKPPILHLN 731 (884)
Q Consensus 654 v~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~-~~~~~ivH~D 731 (884)
.+.+++ ...++||||++++.+.. .+.... .. .++..++.+++.++.++|. . +|+|||
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-------------~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~D 140 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-------------LL-EDPEELYDQILELMRKLYREA---GLVHGD 140 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh-------------hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCC
Confidence 344432 24689999999865422 111110 01 5678899999999999998 6 999999
Q ss_pred CCCCceEeCCCCCeeEccccCccccC
Q 002759 732 LKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 732 lk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
|||+||+++ ++.++++|||.+....
T Consensus 141 l~p~Nili~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 141 LSEYNILVD-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CChhhEEEE-CCcEEEEECccccccc
Confidence 999999999 8999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.2e-15 Score=161.12 Aligned_cols=178 Identities=31% Similarity=0.444 Sum_probs=159.1
Q ss_pred CcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCC
Q 002759 291 MQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHN 370 (884)
Q Consensus 291 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 370 (884)
-...||+.|++. .+|..+..+..|+.|.|..|.+. .+|..+.++..|.+|+|+.|+++ .+|..+..++ |+.|-+++
T Consensus 77 t~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvli~sN 152 (722)
T KOG0532|consen 77 TVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVLIVSN 152 (722)
T ss_pred hhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeEEEec
Confidence 345666677766 56778888999999999999998 89999999999999999999999 6787788776 89999999
Q ss_pred CcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccC
Q 002759 371 LNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIP 450 (884)
Q Consensus 371 n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 450 (884)
|+++ .+|+.++.+..|..||.+.|.+. .+|..++.+.+|+.|++..|++. .+|..+..| .|..||+|.|+++ .+|
T Consensus 153 Nkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iP 227 (722)
T KOG0532|consen 153 NKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLP 227 (722)
T ss_pred Cccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecc
Confidence 9998 88999999999999999999999 78999999999999999999998 688888855 5999999999999 999
Q ss_pred CCcCccCcccEEEccCCcCcccCCcccc
Q 002759 451 SSLGNLRNLTHFNLSSNNLSGTIPSTIQ 478 (884)
Q Consensus 451 ~~~~~l~~L~~L~l~~N~l~~~~p~~~~ 478 (884)
..|.+|+.|++|-|.+|++. ..|.++-
T Consensus 228 v~fr~m~~Lq~l~LenNPLq-SPPAqIC 254 (722)
T KOG0532|consen 228 VDFRKMRHLQVLQLENNPLQ-SPPAQIC 254 (722)
T ss_pred hhhhhhhhheeeeeccCCCC-CChHHHH
Confidence 99999999999999999998 5565543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.44 E-value=2.4e-14 Score=165.11 Aligned_cols=252 Identities=24% Similarity=0.235 Sum_probs=181.3
Q ss_pred ccCceeccCCceEEEEEEEc--CCeEEEEEEccccC-ccCCHHHHHHHHHHHhcCC-CCCcceeeeEEecCCceeEEEEe
Q 002759 597 DKECLIGGGSIGSVYRASFE--GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 597 ~~~~~lg~G~~g~V~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
...+.||+|+|+.|-.+... ....+|+|.+.... .....+....|..+-..+. |+|++.+++...+.+..+++.+|
T Consensus 23 ~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~ 102 (601)
T KOG0590|consen 23 KLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSY 102 (601)
T ss_pred cccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCc
Confidence 34556899999999988653 34556677665443 2233444555777766675 99999999999999999999999
Q ss_pred cCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEeccCCCCceEeCCCC-CeeEccc
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILLDENY-EPKLSDY 750 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH-~~~~~~ivH~Dlk~~Nil~~~~~-~vkl~Df 750 (884)
..++++++.+.... ....+...+-.+..|+..++.|+| .. +++|||+||+|.+++..+ ..+++||
T Consensus 103 s~g~~~f~~i~~~~----------~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df 169 (601)
T KOG0590|consen 103 SDGGSLFSKISHPD----------STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADF 169 (601)
T ss_pred ccccccccccccCC----------ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCc
Confidence 99999988884222 113445566778999999999999 66 999999999999999999 9999999
Q ss_pred cCccccCC--ccCcccccccc-cccccCccccCCCC-CCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHH
Q 002759 751 GLAKLLPI--LDNYGLTKFHN-AVGYVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 751 g~s~~~~~--~~~~~~~~~~~-~~~y~aPE~~~~~~-~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|+|..+.. ..........| +..|+|||...+.. ..+..|+||.|+++.-+++|..|+......... ...|....
T Consensus 170 ~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~- 247 (601)
T KOG0590|consen 170 GLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK- 247 (601)
T ss_pred hhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-
Confidence 99988765 22223445667 99999999998854 467899999999999999999999876543311 01111100
Q ss_pred HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
...... ..........++..+++..+|..|.+.+++.
T Consensus 248 --~~~~~~-------~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 248 --GRFTQL-------PWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --cccccC-------ccccCChhhhhcccccccCCchhcccccccc
Confidence 000000 1111222455666678889999999988764
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-13 Score=153.36 Aligned_cols=179 Identities=28% Similarity=0.430 Sum_probs=81.1
Q ss_pred CCCCeeEcccCCCCCCCCCCCCCCC-cccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEE
Q 002759 193 TYLEGFDFSFNNLSGELPSQICNIP-VLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFN 271 (884)
Q Consensus 193 ~~L~~L~Ls~N~l~~~~p~~l~~l~-~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 271 (884)
+.++.|++.+|+++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++|+++.+.+ ....+++|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l~~-~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDLPK-LLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhhhhhh-hhhhhhhhhhee
Confidence 34444444444444 3333333332 4444444444444 222334444555555555555544422 222444555555
Q ss_pred eecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCC
Q 002759 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGG 351 (884)
Q Consensus 272 L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 351 (884)
+++|+++...+ .......|++|++++|++. ..+..+..+.++..+.+.+|++..
T Consensus 193 ls~N~i~~l~~-------------------------~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~ 246 (394)
T COG4886 193 LSGNKISDLPP-------------------------EIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED 246 (394)
T ss_pred ccCCccccCch-------------------------hhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee
Confidence 55555542211 1122233555555555322 334444555555555555555542
Q ss_pred CCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcch
Q 002759 352 IIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQ 403 (884)
Q Consensus 352 ~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 403 (884)
.+..++.+++++.|++++|.++...+ +..+.+|+.|++++|.+....|.
T Consensus 247 -~~~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 247 -LPESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred -ccchhccccccceecccccccccccc--ccccCccCEEeccCccccccchh
Confidence 24445555555555555555552222 55555566666666665544333
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.43 E-value=1.2e-13 Score=155.29 Aligned_cols=183 Identities=29% Similarity=0.421 Sum_probs=101.5
Q ss_pred ccCCCCCCeEeecCCcCcccCchhhhccc-CCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhcccc
Q 002759 92 LSGLKSLRVLTLFGNRFTGNLPQEYAEMQ-TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYK 170 (884)
Q Consensus 92 l~~l~~L~~L~L~~n~~~~~~p~~~~~l~-~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~ 170 (884)
+..++.++.|++.+|.++ .+|...+.+. +|+.|++++|.+. .+|..++.+++|+.|++++|+++ .+|... ..++.
T Consensus 112 ~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~-~~~~~ 187 (394)
T COG4886 112 LLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLL-SNLSN 187 (394)
T ss_pred hhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhh-hhhhh
Confidence 344455666666666666 5555555553 6666666666665 45555666666666666666665 454432 13455
Q ss_pred CcEEEccCCccCCCccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCC
Q 002759 171 TKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSS 250 (884)
Q Consensus 171 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~ 250 (884)
|+.|++++|+++ .+|..++.+..|++|++++|++. ..+..+.++.++..+.+.+|++... +..++.+++|+.|++++
T Consensus 188 L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~~~~~~l~~l~~L~~s~ 264 (394)
T COG4886 188 LNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-PESIGNLSNLETLDLSN 264 (394)
T ss_pred hhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-cchhccccccceecccc
Confidence 666666666665 44444444445666666666433 4455555555555555555555522 44455555566666666
Q ss_pred CccCCcCCCCCCCCCCccEEEeecCcccccccc
Q 002759 251 NLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPE 283 (884)
Q Consensus 251 N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~ 283 (884)
|+++.+.. +..+.+|++|++++|.+...+|.
T Consensus 265 n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 265 NQISSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred cccccccc--ccccCccCEEeccCccccccchh
Confidence 66555543 55555555555555555544443
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.9e-12 Score=130.13 Aligned_cols=204 Identities=24% Similarity=0.290 Sum_probs=138.6
Q ss_pred HHHHhcCCCCCcceeeeEEecC-----CceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 002759 642 IGRLSNIRHFNLVAFQGYYWSS-----TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716 (884)
Q Consensus 642 ~~~l~~l~h~niv~~~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L 716 (884)
..-+-++.|-|+++++.|+.+. ....+++|||+.|++..+|++... ....+....-.+|+-||..||
T Consensus 118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~--------~~~a~~~~~wkkw~tqIlsal 189 (458)
T KOG1266|consen 118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK--------NQKALFQKAWKKWCTQILSAL 189 (458)
T ss_pred HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH--------hhhhhhHHHHHHHHHHHHhhh
Confidence 3445556799999999987644 346889999999999999987652 234566677789999999999
Q ss_pred HHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccC---CccCcccccccccccccCccccCCCCCCCccCchhH
Q 002759 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP---ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSF 793 (884)
Q Consensus 717 ~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~---~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~ 793 (884)
.|||+. .|+|+|+++..+-|++..+|-+||.--.-..... ...........+-++|.|||+-.....+.++|||+|
T Consensus 190 ~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~f 268 (458)
T KOG1266|consen 190 SYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKF 268 (458)
T ss_pred hhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhh
Confidence 999995 8999999999999999999999985211111100 001111223345678999998877777789999999
Q ss_pred HHHHHHHHhCCCCCCCC-CCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 794 GVILLELVTGRKPVESP-TTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 794 Gv~l~el~tG~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
|+-..||..|..--... ...+...-...+-...+ ++.-+ ..+.+|++..|..||+|.+++
T Consensus 269 gmcAlemailEiq~tnseS~~~~ee~ia~~i~~le--------n~lqr-----------~~i~kcl~~eP~~rp~ar~ll 329 (458)
T KOG1266|consen 269 GMCALEMAILEIQSTNSESKVEVEENIANVIIGLE--------NGLQR-----------GSITKCLEGEPNGRPDARLLL 329 (458)
T ss_pred hHHHHHHHHheeccCCCcceeehhhhhhhheeecc--------Ccccc-----------CcCcccccCCCCCCcchhhhh
Confidence 99999999877543221 11111100000000000 01111 234459999999999999876
Q ss_pred H
Q 002759 873 Q 873 (884)
Q Consensus 873 ~ 873 (884)
.
T Consensus 330 f 330 (458)
T KOG1266|consen 330 F 330 (458)
T ss_pred c
Confidence 3
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=6.9e-12 Score=140.59 Aligned_cols=143 Identities=23% Similarity=0.245 Sum_probs=99.5
Q ss_pred CceeccCCceEEEEEEEcCCeEEEEEEccccCccC-------------------------C--------------HHHHH
Q 002759 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIR-------------------------N--------------QEEFE 639 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-------------------------~--------------~~~~~ 639 (884)
.+.||+|++|.||+|++.+|+.||||+.+...... . .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 35799999999999999999999999985431000 0 01244
Q ss_pred HHHHHHhcC----CCCCcceeeeEEe-cCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q 002759 640 LEIGRLSNI----RHFNLVAFQGYYW-SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714 (884)
Q Consensus 640 ~E~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~ 714 (884)
+|+..+.++ +|.+-+.+-.++. ..+..++||||++|++|.++..... ... ...+++.+++.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~-----------~~~---~~~~ia~~~~~ 267 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE-----------AGL---DRKALAENLAR 267 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----------cCC---CHHHHHHHHHH
Confidence 455544444 2333333333332 2355799999999999988764321 011 23456666666
Q ss_pred -HHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCC
Q 002759 715 -ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758 (884)
Q Consensus 715 -~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~ 758 (884)
.+..+|.. |++|+|+||.||++++++.++++|||++..+.+
T Consensus 268 ~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 46788887 999999999999999999999999999987753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=2e-10 Score=127.20 Aligned_cols=167 Identities=20% Similarity=0.218 Sum_probs=127.8
Q ss_pred EEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCC
Q 002759 614 SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTG 693 (884)
Q Consensus 614 ~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~ 693 (884)
...++.+|.|+..+.... .......+.++.++.+|||||+++++.+...+..|+|+|-+. .|..++.+
T Consensus 33 ~k~~~~~vsVF~~~~~~~-~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~--------- 100 (690)
T KOG1243|consen 33 RKADGGPVSVFVYKRSNG-EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE--------- 100 (690)
T ss_pred eeccCCceEEEEEeCCCc-hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH---------
Confidence 445677888888876543 445677888999999999999999999999999999999874 45556643
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCcccccccccccc
Q 002759 694 GIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773 (884)
Q Consensus 694 ~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~~~~~~~~~y 773 (884)
+......-.+.||+.||.|||+.+ +++|+++...-|+|++.|+.||++|.++........ ......--..|
T Consensus 101 ------l~~~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~ 171 (690)
T KOG1243|consen 101 ------LGKEEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESF 171 (690)
T ss_pred ------hHHHHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcc
Confidence 234556667889999999999776 899999999999999999999999998865432211 11222223346
Q ss_pred cCccccCCCCCCCccCchhHHHHHHHHHhC
Q 002759 774 VAPELAQSLRLSDKCDVYSFGVILLELVTG 803 (884)
Q Consensus 774 ~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG 803 (884)
..|+.+.... -..|.|-||+++||++.|
T Consensus 172 ~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 172 DDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 7776554322 245999999999999999
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=2.5e-12 Score=144.57 Aligned_cols=245 Identities=24% Similarity=0.312 Sum_probs=120.0
Q ss_pred cCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEE
Q 002759 192 CTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFN 271 (884)
Q Consensus 192 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~ 271 (884)
+..++.+++..|.+. .+-..+..+++|+.|++.+|+|..+. ..+..+++|++|+|++|+|+.+. .+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~-~~~~~l~~~~~l~~l~l~~n~i~~i~-~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIA-KILNHLSKLKSLEALDLYDNKIEKIE-NLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhh-hhhcccccccceeeeeccccchhhcc-cchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 344444445555554 22233445555555555555555322 22555666666666666666653 334455566666
Q ss_pred eecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCC-CCcccccCccEEEccCCccC
Q 002759 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIP-TGITDLRRLLKISLANNSIG 350 (884)
Q Consensus 272 L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 350 (884)
+++|.|+..- .+..+++|+.+++++|++...-+ . ...+.+|+.+++.+|.+.
T Consensus 147 l~~N~i~~~~--------------------------~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 147 LSGNLISDIS--------------------------GLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred eccCcchhcc--------------------------CCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 6666655211 12223444444444444442211 1 234444444444444444
Q ss_pred CCCCCCccCcccccEEecCCCcCCCCCCcCCcCCC--CCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCcc
Q 002759 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCR--FLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPS 428 (884)
Q Consensus 351 ~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~--~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 428 (884)
.. ..+..+..+..+++..|.++..-+ +..+. .|+.+++++|.+. .++..+..+.++..|++.+|++... ..
T Consensus 200 ~i--~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~~ 272 (414)
T KOG0531|consen 200 EI--EGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--EG 272 (414)
T ss_pred cc--cchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--cc
Confidence 21 122223333333445554442211 11111 2556666666665 3334555666666666666666532 22
Q ss_pred ccCCCCCCEEEccCCccCCc---cCCC-cCccCcccEEEccCCcCcccCC
Q 002759 429 LGNLSNLQVLDLSQNSLSGS---IPSS-LGNLRNLTHFNLSSNNLSGTIP 474 (884)
Q Consensus 429 ~~~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~L~l~~N~l~~~~p 474 (884)
+.....+..+.+..|.+... .... ....+.+..+.+.+|+.....+
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 273 LERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 44455666666666665521 1111 4556677777777777765444
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.19 E-value=8.6e-11 Score=115.18 Aligned_cols=130 Identities=18% Similarity=0.124 Sum_probs=94.8
Q ss_pred ceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcc-eeeeEEecCCceeEEEEecCCCch
Q 002759 600 CLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV-AFQGYYWSSTMQLILSEFVPKGNL 678 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~gsL 678 (884)
+.++.|.++.||+++.. +..+++|....... ....+..|+..+..+.+.+++ +++.+. ....++||||+++.++
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~--~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE--LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc--cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 46899999999999876 66899998764331 233567888888888655544 444433 3346899999999876
Q ss_pred hhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEeccCCCCceEeCCCCCeeEccccCccc
Q 002759 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDC--KPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 679 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~--~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~ 755 (884)
.+.- . ....++.+++++++.||+.. ...++|||++|.||+++ ++.++++|||.+..
T Consensus 79 ~~~~-----------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5420 0 01245678999999999872 12369999999999999 66899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.17 E-value=4.1e-12 Score=132.54 Aligned_cols=209 Identities=23% Similarity=0.256 Sum_probs=119.3
Q ss_pred cccCCeEeecCCCCCCCCCC--ccCCCCCCcceEeCCCCccCCCCc-hhhhhccccCcEEEccCCccCCCccc-cccccC
Q 002759 118 EMQTLWKINVSSNALSGSIP--EFIGDLPNIRLLDLSRNSYSGEIP-FALFKYCYKTKFVSLSHNNLSGSIPL-SIANCT 193 (884)
Q Consensus 118 ~l~~L~~L~Ls~n~l~~~~p--~~~~~l~~L~~L~Ls~N~l~g~ip-~~~~~~l~~L~~L~L~~n~l~~~~p~-~~~~l~ 193 (884)
++.+|+...|.+.... ..+ .....+++++.||||+|-|..--| ..+...+++|+.|+|+.|++.-.... .-..++
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 4555666666665554 222 244456666666666665541111 12344556666666666666422211 112356
Q ss_pred CCCeeEcccCCCCCCCC-CCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCC-CCCCCCCCccEEE
Q 002759 194 YLEGFDFSFNNLSGELP-SQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAP-FGVLGLKNISYFN 271 (884)
Q Consensus 194 ~L~~L~Ls~N~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~ 271 (884)
+|+.|.|+.|.|+..-- ..+..+|+|+.|+|..|.....-.....-+..|++|||++|++..... ...+.++.|+.|+
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 67777777776663211 223445677777777775333334444556677777777777665432 3456677777777
Q ss_pred eecCccccc-cccc-----cccCCCCcEEecCCCcCCCC-CCcccccccccceecccCCcccc
Q 002759 272 VSHNGFHGE-IPEV-----GICGEGMQVFDASWNEFDGV-IPLSITNCRNLKVLDLGFNRLIG 327 (884)
Q Consensus 272 L~~N~l~~~-~p~~-----~~~~~~L~~L~ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~ 327 (884)
++.+.+... .|+. .....+|++|+++.|+|... .-..+..+.+|+.|....|.|+.
T Consensus 278 ls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln~ 340 (505)
T KOG3207|consen 278 LSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLNK 340 (505)
T ss_pred ccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhcccccccc
Confidence 777776642 2322 34456778888888877532 11235556788888888998874
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.5e-12 Score=124.37 Aligned_cols=135 Identities=28% Similarity=0.352 Sum_probs=103.5
Q ss_pred cccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCccCc
Q 002759 333 ITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLK 412 (884)
Q Consensus 333 ~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 412 (884)
+.....|++|||++|.|+ .+.+++.-++.++.|++|.|.|+.. +.+..+++|+.||||+|.++ .+..+-..+.+++
T Consensus 280 ~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIK 355 (490)
T KOG1259|consen 280 ADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIK 355 (490)
T ss_pred cchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEe
Confidence 334456777777777777 4556666677788888888887632 33778888999999999888 5666666788899
Q ss_pred EEEecCcccCCCCCccccCCCCCCEEEccCCccCCcc-CCCcCccCcccEEEccCCcCcccC
Q 002759 413 ILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI-PSSLGNLRNLTHFNLSSNNLSGTI 473 (884)
Q Consensus 413 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~l~~N~l~~~~ 473 (884)
.|.|++|.|.. -..++++-+|..||+++|+|...- ...++++|-|+.+.|.+|++.+.+
T Consensus 356 tL~La~N~iE~--LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 356 TLKLAQNKIET--LSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred eeehhhhhHhh--hhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 99999998862 345778889999999999998322 468999999999999999998543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.15 E-value=4.4e-12 Score=132.36 Aligned_cols=161 Identities=19% Similarity=0.196 Sum_probs=77.5
Q ss_pred cccCCCCeeEcccCCCCCCCC--CCCCCCCcccEEEccCCccCCCc--ccccccCCeecEEEcCCCccCCcCCCCC-CCC
Q 002759 190 ANCTYLEGFDFSFNNLSGELP--SQICNIPVLDFISVRGNALTGTV--EEQFSQCQSIKNLDLSSNLFIGLAPFGV-LGL 264 (884)
Q Consensus 190 ~~l~~L~~L~Ls~N~l~~~~p--~~l~~l~~L~~L~L~~n~l~~~~--~~~~~~l~~L~~L~L~~N~l~~~~~~~~-~~l 264 (884)
+++.+|++..|.+.... ..+ .....+++++.|+|+.|-+.... .....++++|+.|+|+.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 45667777777776665 222 24445666666666666555322 2233456666666666666543321111 123
Q ss_pred CCccEEEeecCccccccccccccCCCCcEEecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccccCccEEEc
Q 002759 265 KNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISL 344 (884)
Q Consensus 265 ~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 344 (884)
++|+.|.|+.|.++-. .+-..+..+++|+.|+|.+|.....-.....-+..|++|+|
T Consensus 197 ~~lK~L~l~~CGls~k-----------------------~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdL 253 (505)
T KOG3207|consen 197 SHLKQLVLNSCGLSWK-----------------------DVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDL 253 (505)
T ss_pred hhhheEEeccCCCCHH-----------------------HHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccc
Confidence 3444444444443310 01111233455666666666422222333344455566666
Q ss_pred cCCccCCCC-CCCccCcccccEEecCCCcCC
Q 002759 345 ANNSIGGII-PPNLGSIELLEVLDLHNLNLR 374 (884)
Q Consensus 345 ~~N~l~~~~-p~~~~~l~~L~~L~L~~n~l~ 374 (884)
++|++.... -...+.++.|+.|+++.+.+.
T Consensus 254 s~N~li~~~~~~~~~~l~~L~~Lnls~tgi~ 284 (505)
T KOG3207|consen 254 SNNNLIDFDQGYKVGTLPGLNQLNLSSTGIA 284 (505)
T ss_pred cCCcccccccccccccccchhhhhccccCcc
Confidence 665554221 123445555555555555554
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=4.9e-12 Score=142.21 Aligned_cols=219 Identities=28% Similarity=0.371 Sum_probs=153.1
Q ss_pred CCCcccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEE
Q 002759 215 NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVF 294 (884)
Q Consensus 215 ~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L 294 (884)
.+..++.++++.|.+.. +...+..+++|+.|++..|+|..+... +..+ .+|++|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i~~~-l~~~------------------------~~L~~L 123 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKIENL-LSSL------------------------VNLQVL 123 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhcccc-hhhh------------------------hcchhe
Confidence 34455555566666653 233345555566666666655554221 3334 445555
Q ss_pred ecCCCcCCCCCCcccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCC-CCccCcccccEEecCCCcC
Q 002759 295 DASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP-PNLGSIELLEVLDLHNLNL 373 (884)
Q Consensus 295 ~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~n~l 373 (884)
++++|.|+.+.+ +..++.|+.|++++|.|+.. ..+..++.|+.+++++|++...-+ . ...+.+++.+++.+|.+
T Consensus 124 ~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i 198 (414)
T KOG0531|consen 124 DLSFNKITKLEG--LSTLTLLKELNLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSI 198 (414)
T ss_pred eccccccccccc--hhhccchhhheeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCch
Confidence 555555554433 55677799999999999832 456679999999999999996655 3 57889999999999999
Q ss_pred CCCCCcCCcCCCCCcEEeccCccCCCCcchhhcCCcc--CcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCC
Q 002759 374 RGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTY--LKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS 451 (884)
Q Consensus 374 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~--L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 451 (884)
. ....+..+..+..+++..|.++..-+ +..+.. |+.+++++|.+. .++..+..+..+..|++.+|++... .
T Consensus 199 ~--~i~~~~~~~~l~~~~l~~n~i~~~~~--l~~~~~~~L~~l~l~~n~i~-~~~~~~~~~~~l~~l~~~~n~~~~~--~ 271 (414)
T KOG0531|consen 199 R--EIEGLDLLKKLVLLSLLDNKISKLEG--LNELVMLHLRELYLSGNRIS-RSPEGLENLKNLPVLDLSSNRISNL--E 271 (414)
T ss_pred h--cccchHHHHHHHHhhcccccceeccC--cccchhHHHHHHhcccCccc-cccccccccccccccchhhcccccc--c
Confidence 7 34456666677777999999984322 233333 899999999998 5657788899999999999999843 2
Q ss_pred CcCccCcccEEEccCCcCcc
Q 002759 452 SLGNLRNLTHFNLSSNNLSG 471 (884)
Q Consensus 452 ~~~~l~~L~~L~l~~N~l~~ 471 (884)
.+...+.+..+.+..|.+..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~ 291 (414)
T KOG0531|consen 272 GLERLPKLSELWLNDNKLAL 291 (414)
T ss_pred cccccchHHHhccCcchhcc
Confidence 35556778888888888763
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.1e-11 Score=122.91 Aligned_cols=135 Identities=27% Similarity=0.322 Sum_probs=114.3
Q ss_pred cccccccccceecccCCcccccCCCCcccccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCC
Q 002759 307 LSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRF 386 (884)
Q Consensus 307 ~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~ 386 (884)
..+.....|++||||+|.|+ .+.++..-+++++.|++++|.|..+. .+..+++|+.||||+|.++ .+-.+-..+.+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeeh--hhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 34445678999999999998 78888888999999999999999543 3888999999999999998 55666678889
Q ss_pred CcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCC-CccccCCCCCCEEEccCCccCC
Q 002759 387 LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGST-PPSLGNLSNLQVLDLSQNSLSG 447 (884)
Q Consensus 387 L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 447 (884)
.+.|.|++|.|.. + ..++.+-+|..||+++|+|.... -..+++++-|+.|.|.+|.+.+
T Consensus 354 IKtL~La~N~iE~-L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 354 IKTLKLAQNKIET-L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred EeeeehhhhhHhh-h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 9999999999973 3 46788999999999999997421 2578999999999999999994
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.12 E-value=2.4e-12 Score=130.88 Aligned_cols=14 Identities=36% Similarity=0.325 Sum_probs=7.2
Q ss_pred CCCCcEEeccCccC
Q 002759 384 CRFLLLLDVSGNAL 397 (884)
Q Consensus 384 l~~L~~L~ls~N~l 397 (884)
.+.|..|+|++|.+
T Consensus 297 k~dL~kLnLngN~l 310 (382)
T KOG1909|consen 297 KPDLEKLNLNGNRL 310 (382)
T ss_pred chhhHHhcCCcccc
Confidence 44455555555555
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.12 E-value=9.6e-11 Score=128.85 Aligned_cols=244 Identities=23% Similarity=0.205 Sum_probs=171.9
Q ss_pred cCceecc--CCceEEEEEEE---cCCeEEEEEEcccc-CccCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEE
Q 002759 598 KECLIGG--GSIGSVYRASF---EGGVSIAVKKLETL-GRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 598 ~~~~lg~--G~~g~V~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~ 670 (884)
....+|. |.+|.||.+.. .++..+|+|+-+.. ........-.+|+...+.+ .|++.++....+...+..++-+
T Consensus 118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt 197 (524)
T KOG0601|consen 118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT 197 (524)
T ss_pred cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence 4556899 99999999965 45778888884322 2223344446777777777 4999999888888888888888
Q ss_pred EecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEeccCCCCceEeCCC-CCe
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR----ALSYLHHDCKPPILHLNLKSTNILLDEN-YEP 745 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~----~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-~~v 745 (884)
|++ +.++.++.+... ..+.....+.+..+..+ |+.++|+. +++|-|+||.||+...+ ..+
T Consensus 198 E~~-~~sl~~~~~~~~-----------~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 198 ELC-GESLQSYCHTPC-----------NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred ccc-cchhHHhhhccc-----------ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheeccccccee
Confidence 988 568887776443 12455666677777777 99999998 99999999999999999 899
Q ss_pred eEccccCccccCCccCcc----cccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 002759 746 KLSDYGLAKLLPILDNYG----LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEY 821 (884)
Q Consensus 746 kl~Dfg~s~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~ 821 (884)
+++|||+...+.+..-.. .....+...|++||...+ .++...|+|++|.+..+..+|.++........ |
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~------W 335 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSS------W 335 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCC------c
Confidence 999999998876533111 112256677999999887 67889999999999999999877765431110 0
Q ss_pred HHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002759 822 VRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872 (884)
Q Consensus 822 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell 872 (884)
.+ .+... ..+. +.+....++...+..+++.+|..|++++.+.
T Consensus 336 ~~--~r~~~---ip~e----~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~ 377 (524)
T KOG0601|consen 336 SQ--LRQGY---IPLE----FCEGGSSSLRSVTSQMLDEDPRLRLTAQILT 377 (524)
T ss_pred cc--ccccc---Cchh----hhcCcchhhhhHHHHhcCcchhhhhHHHHHh
Confidence 00 00000 0011 1112222344466779999999999987765
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.1e-10 Score=108.39 Aligned_cols=137 Identities=13% Similarity=0.103 Sum_probs=97.0
Q ss_pred ceeccCCceEEEEEEEcC-------CeEEEEEEccccC------------cc---------CCHHHHH----HHHHHHhc
Q 002759 600 CLIGGGSIGSVYRASFEG-------GVSIAVKKLETLG------------RI---------RNQEEFE----LEIGRLSN 647 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~-------~~~vavK~~~~~~------------~~---------~~~~~~~----~E~~~l~~ 647 (884)
..||.|--+.||.|...+ +..+|||+.+... +. ...+.+. +|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999996543 4789999875321 00 0122333 78888888
Q ss_pred CCC--CCcceeeeEEecCCceeEEEEecCCCchhh-hcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcC
Q 002759 648 IRH--FNLVAFQGYYWSSTMQLILSEFVPKGNLYD-NLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL-HHDC 723 (884)
Q Consensus 648 l~h--~niv~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~L-H~~~ 723 (884)
+.. -++.+++++ ...++||||+.+..+.. .+.. ..++..+...+..+++.+|..+ |+.
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-------------~~~~~~~~~~i~~~i~~~l~~l~H~~- 144 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-------------AKLNDEEMKNAYYQVLSMMKQLYKEC- 144 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-------------cccCHHHHHHHHHHHHHHHHHHHHhC-
Confidence 843 455566654 45789999997643321 1211 1234456677889999999999 777
Q ss_pred CCCeEeccCCCCceEeCCCCCeeEccccCccccC
Q 002759 724 KPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 724 ~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~ 757 (884)
++|||||++.||+++ ++.+.|+|||.+....
T Consensus 145 --glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 145 --NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred --CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence 999999999999997 4689999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.10 E-value=5.8e-11 Score=114.07 Aligned_cols=110 Identities=24% Similarity=0.283 Sum_probs=28.9
Q ss_pred ccCCCCCCeEeecCCcCcccCchhhh-cccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhcccc
Q 002759 92 LSGLKSLRVLTLFGNRFTGNLPQEYA-EMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYK 170 (884)
Q Consensus 92 l~~l~~L~~L~L~~n~~~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~ 170 (884)
+.+...+++|+|++|.|+. | +.++ .+.+|+.|+|++|.|+. ++ .+..+++|++|++++|+++ .++..+...+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS-SISEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS----S-CHHHHHH-TT
T ss_pred ccccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC-ccccchHHhCCc
Confidence 4455566777777777762 2 2444 46667777777777763 32 3566677777777777776 454444344556
Q ss_pred CcEEEccCCccCCCcc-ccccccCCCCeeEcccCCCC
Q 002759 171 TKFVSLSHNNLSGSIP-LSIANCTYLEGFDFSFNNLS 206 (884)
Q Consensus 171 L~~L~L~~n~l~~~~p-~~~~~l~~L~~L~Ls~N~l~ 206 (884)
|+.|+|++|+|...-- ..++.+++|+.|+|.+|.++
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 6666666666542111 23344455555555555443
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=6.3e-12 Score=127.88 Aligned_cols=182 Identities=21% Similarity=0.277 Sum_probs=130.8
Q ss_pred CCCcEEecCCCcCCCCCCcc----cccccccceecccCCcccccC-------------CCCcccccCccEEEccCCccCC
Q 002759 289 EGMQVFDASWNEFDGVIPLS----ITNCRNLKVLDLGFNRLIGSI-------------PTGITDLRRLLKISLANNSIGG 351 (884)
Q Consensus 289 ~~L~~L~ls~N~l~~~~p~~----~~~l~~L~~L~L~~N~l~~~~-------------p~~~~~l~~L~~L~L~~N~l~~ 351 (884)
+.|++||||.|.|.-..+.. +..+++|++|+|.+|.+.-.- ..-..+-++|+.+...+|++..
T Consensus 92 ~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen 171 (382)
T KOG1909|consen 92 PKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLEN 171 (382)
T ss_pred CceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccccc
Confidence 35666666666665444433 345677888888888765211 1123445789999999999984
Q ss_pred CCC----CCccCcccccEEecCCCcCCCC----CCcCCcCCCCCcEEeccCccCCCC----cchhhcCCccCcEEEecCc
Q 002759 352 IIP----PNLGSIELLEVLDLHNLNLRGE----VPDDISNCRFLLLLDVSGNALGGD----IPQTLYNMTYLKILDLHQN 419 (884)
Q Consensus 352 ~~p----~~~~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N 419 (884)
... ..|...+.|+.+.++.|.|... +...+..+++|+.|||..|.|+.. +...+..+++|+.|++++|
T Consensus 172 ~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dc 251 (382)
T KOG1909|consen 172 GGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDC 251 (382)
T ss_pred ccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccc
Confidence 432 3456678999999999988633 234568899999999999999743 3446778899999999999
Q ss_pred ccCCCCCccc-----cCCCCCCEEEccCCccCC----ccCCCcCccCcccEEEccCCcCc
Q 002759 420 HLNGSTPPSL-----GNLSNLQVLDLSQNSLSG----SIPSSLGNLRNLTHFNLSSNNLS 470 (884)
Q Consensus 420 ~l~~~~p~~~-----~~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~l~~N~l~ 470 (884)
.+...-..+| ...++|+.|.|.+|.++- .+...+...+.|..|+|++|.+.
T Consensus 252 ll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 252 LLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred ccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 9986544333 236899999999999983 23445666889999999999883
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.08 E-value=9e-11 Score=112.75 Aligned_cols=122 Identities=30% Similarity=0.407 Sum_probs=40.5
Q ss_pred ccCccEEEccCCccCCCCCCCcc-CcccccEEecCCCcCCCCCCcCCcCCCCCcEEeccCccCCCCcchhh-cCCccCcE
Q 002759 336 LRRLLKISLANNSIGGIIPPNLG-SIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTL-YNMTYLKI 413 (884)
Q Consensus 336 l~~L~~L~L~~N~l~~~~p~~~~-~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~-~~l~~L~~ 413 (884)
..++++|+|++|.|+.+ +.++ .+.+|+.|+|++|.|+.. +.+..++.|+.|++++|+|+ .++..+ ..+++|+.
T Consensus 18 ~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~-~i~~~l~~~lp~L~~ 92 (175)
T PF14580_consen 18 PVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRIS-SISEGLDKNLPNLQE 92 (175)
T ss_dssp --------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS----S-CHHHHHH-TT--E
T ss_pred ccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCC-ccccchHHhCCcCCE
Confidence 33455566666655532 2343 355666666666666632 24666777777777777777 344334 35777788
Q ss_pred EEecCcccCCCC-CccccCCCCCCEEEccCCccCCccCC----CcCccCcccEEE
Q 002759 414 LDLHQNHLNGST-PPSLGNLSNLQVLDLSQNSLSGSIPS----SLGNLRNLTHFN 463 (884)
Q Consensus 414 L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 463 (884)
|+|++|+|...- -..+..+++|+.|+|.+|.++. .+. .+..+|+|+.||
T Consensus 93 L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~-~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 93 LYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE-KKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp EE-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG-STTHHHHHHHH-TT-SEET
T ss_pred EECcCCcCCChHHhHHHHcCCCcceeeccCCcccc-hhhHHHHHHHHcChhheeC
Confidence 888888776421 1345667777777777777763 232 345567777665
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.1e-10 Score=129.81 Aligned_cols=141 Identities=16% Similarity=0.135 Sum_probs=92.1
Q ss_pred ceeccCCceEEEEEEEcC-CeEEEEEEccccCcc-------------------------CC--------H------HHHH
Q 002759 600 CLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRI-------------------------RN--------Q------EEFE 639 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-------------------------~~--------~------~~~~ 639 (884)
+.+|+|++|.||+|..++ |+.||||+....... -. . -++.
T Consensus 125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~ 204 (537)
T PRK04750 125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM 204 (537)
T ss_pred hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence 579999999999999987 999999999643100 00 1 1234
Q ss_pred HHHHHHhcC----CCCCcceeeeEEec-CCceeEEEEecCCCchhhhc--ccCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q 002759 640 LEIGRLSNI----RHFNLVAFQGYYWS-STMQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNPELHWSRRFHIALGT 712 (884)
Q Consensus 640 ~E~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi 712 (884)
+|+..+.++ .+...+.+-.++++ .+..++||||++|+.+.+.- ...+ .....+....+..++.|+
T Consensus 205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g--------~d~~~la~~~v~~~~~Qi 276 (537)
T PRK04750 205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAG--------TDMKLLAERGVEVFFTQV 276 (537)
T ss_pred HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcC--------CCHHHHHHHHHHHHHHHH
Confidence 444444443 24444444444433 35678999999999997742 2111 111122233333333443
Q ss_pred HHHHHHHHhcCCCCeEeccCCCCceEeCCCC----CeeEccccCccccCC
Q 002759 713 ARALSYLHHDCKPPILHLNLKSTNILLDENY----EPKLSDYGLAKLLPI 758 (884)
Q Consensus 713 a~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~----~vkl~Dfg~s~~~~~ 758 (884)
... |++|+|+||.||+++.++ .++++|||++..+..
T Consensus 277 -------f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -------FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -------HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 334 999999999999999988 999999999988754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=6.4e-09 Score=108.62 Aligned_cols=268 Identities=15% Similarity=0.121 Sum_probs=160.7
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcC-CCCCcceeeeE-------EecCCcee
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGY-------YWSSTMQL 667 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-------~~~~~~~~ 667 (884)
+..++.+|+|+.+.+|..---.+ .+.|++..... ....+ ....+... .||-+-.=+.+ -..+....
T Consensus 13 i~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Ppp-a~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 13 IPPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPP-AAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred cCCCccccCCccceeeecchhhc--hhheeecCCCc-hHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 34677899999999997632212 24466544321 11221 22223333 56644331111 01222356
Q ss_pred EEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeE
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl 747 (884)
+.|..+.+..=-..+.. +. .+...-+..+|...+++++.+|.+.+.||.. |.+-||+.++|+||++++.|.+
T Consensus 87 flmP~v~g~~pI~~~y~---p~--tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~L 158 (637)
T COG4248 87 FLMPKVSGKEPIHMIYS---PA--TRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVL 158 (637)
T ss_pred EecccCCCccchhhhcC---ch--hhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEE
Confidence 77777766421111211 11 1223456789999999999999999999998 9999999999999999999999
Q ss_pred ccccCccccCCccCcccccccccccccCccccC-----CCCCCCccCchhHHHHHHHHHhC-CCCCCCCC-------Ccc
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTG-RKPVESPT-------TNE 814 (884)
Q Consensus 748 ~Dfg~s~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~sDvwS~Gv~l~el~tG-~~p~~~~~-------~~~ 814 (884)
.|-..-.... .+.......|...|.+||.-. +..-+...|-|.+||++++++.| ++||.+.. ..|
T Consensus 159 VdsDsfqi~~--ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E 236 (637)
T COG4248 159 VDSDSFQINA--NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE 236 (637)
T ss_pred Ecccceeecc--CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch
Confidence 9754333221 222334566788899999654 44556789999999999999995 99997632 111
Q ss_pred hhhHHHHHHHHH-HcCCCcccccccCCCCcHHHHHHHHHHHhhccCCC--CCCCCCHHHHHHHHHHhhccc
Q 002759 815 VVVLCEYVRELL-ERGSASACFDRSLRGFAENELIQVMKLGLICTSEV--PSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 815 ~~~~~~~~~~~~-~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~--P~~RPt~~ell~~L~~~~~~~ 882 (884)
.. +...+-.. .+........+.-.. -+-.+..+..+...|+... |.-|||++.++..|.++++++
T Consensus 237 ~~--Ia~g~f~ya~~~~~g~~p~P~~~P-~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 237 TD--IAHGRFAYASDQRRGLKPPPRSIP-LSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred hh--hhcceeeechhccCCCCCCCCCCC-hhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 00 00000000 000000001111000 0111234556666788764 568999999999999998875
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.4e-09 Score=102.35 Aligned_cols=132 Identities=25% Similarity=0.284 Sum_probs=101.1
Q ss_pred eeccCCceEEEEEEEcCCeEEEEEEc-cccCccCC------HHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEec
Q 002759 601 LIGGGSIGSVYRASFEGGVSIAVKKL-ETLGRIRN------QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 601 ~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~~~~------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
.+++|+-+.+|.+.+.+. ++++|.- .+..+... ...-.+|++++++++--.|....=+..+.....++|||+
T Consensus 3 ~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 578999999999988754 4555543 33222111 234567899998887666666666667788889999999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCc
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s 753 (884)
+|..|.+.+... ...++..|-.-+.-||.. +||||||.++||.+..+. +.++|||++
T Consensus 82 ~G~~lkd~l~~~-------------------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg 138 (204)
T COG3642 82 EGELLKDALEEA-------------------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLG 138 (204)
T ss_pred CChhHHHHHHhc-------------------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCcc
Confidence 999999888643 135677888888999998 999999999999998765 999999999
Q ss_pred ccc
Q 002759 754 KLL 756 (884)
Q Consensus 754 ~~~ 756 (884)
.+-
T Consensus 139 ~~s 141 (204)
T COG3642 139 EFS 141 (204)
T ss_pred ccc
Confidence 753
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.05 E-value=2.9e-10 Score=136.10 Aligned_cols=178 Identities=20% Similarity=0.235 Sum_probs=108.5
Q ss_pred CCCCeEeecCCc--CcccCchhhhcccCCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCccCCCCchhhhhccccCcE
Q 002759 96 KSLRVLTLFGNR--FTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKF 173 (884)
Q Consensus 96 ~~L~~L~L~~n~--~~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~~l~~L~~ 173 (884)
+.|++|-+..|. +....+..|..|+.|+.|||++|.=-+.+|++|+.|-+|++|+|++..++ .+|.++ +.+++|.+
T Consensus 545 ~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l-~~Lk~L~~ 622 (889)
T KOG4658|consen 545 PKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGL-GNLKKLIY 622 (889)
T ss_pred CccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHH-HHHHhhhe
Confidence 367888888875 44333344777888888888887666688888888888888888888887 777765 66678888
Q ss_pred EEccCCccCCCccccccccCCCCeeEcccCCC--CCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeec----EEE
Q 002759 174 VSLSHNNLSGSIPLSIANCTYLEGFDFSFNNL--SGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIK----NLD 247 (884)
Q Consensus 174 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l--~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~----~L~ 247 (884)
|++.++.-...+|.....|++|++|.+..-.. +...-..+.++.+|+.+....... .+-..+..++.|. .+.
T Consensus 623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~ 700 (889)
T KOG4658|consen 623 LNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLS 700 (889)
T ss_pred eccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhh
Confidence 88887766556666666688888888766542 222233344455555554433322 1111222222222 222
Q ss_pred cCCCccCCcCCCCCCCCCCccEEEeecCccc
Q 002759 248 LSSNLFIGLAPFGVLGLKNISYFNVSHNGFH 278 (884)
Q Consensus 248 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 278 (884)
+.++... ..+.++..+.+|+.|.+.++.+.
T Consensus 701 ~~~~~~~-~~~~~~~~l~~L~~L~i~~~~~~ 730 (889)
T KOG4658|consen 701 IEGCSKR-TLISSLGSLGNLEELSILDCGIS 730 (889)
T ss_pred hcccccc-eeecccccccCcceEEEEcCCCc
Confidence 2222211 22345566677777777777665
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.7e-09 Score=111.13 Aligned_cols=143 Identities=20% Similarity=0.233 Sum_probs=108.8
Q ss_pred ceeccCCceEEEEEEEcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCC--CCcceeeeEEecCC---ceeEEEEecC
Q 002759 600 CLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRH--FNLVAFQGYYWSST---MQLILSEFVP 674 (884)
Q Consensus 600 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~---~~~lv~e~~~ 674 (884)
+.++.|.++.||++...+|+.+++|.............+..|+++++.+++ ..+.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998877678999998654322245678899999998865 34566777765532 5689999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDC------------------------------- 723 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~------------------------------- 723 (884)
|.++.+.+.. ..++..+...++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (223)
T cd05154 84 GRVLRDRLLR-------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASR 150 (223)
T ss_pred CEecCCCCCC-------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhc
Confidence 9888765431 13566777788888888888888531
Q ss_pred ----------------------CCCeEeccCCCCceEeCC--CCCeeEccccCccc
Q 002759 724 ----------------------KPPILHLNLKSTNILLDE--NYEPKLSDYGLAKL 755 (884)
Q Consensus 724 ----------------------~~~ivH~Dlk~~Nil~~~--~~~vkl~Dfg~s~~ 755 (884)
...++|+|+++.||+++. ++.+.|+||+.+..
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 151 TDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred ccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 235799999999999998 66789999998874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.5e-10 Score=81.57 Aligned_cols=41 Identities=34% Similarity=0.688 Sum_probs=30.3
Q ss_pred hhHHHHHHHHHhhcCCCCCCcccCccCCC-CCCCCCcceEec
Q 002759 29 ATDKEILLQFKGNITDDPHNKLASWVSSG-NPCENFKGVFCN 69 (884)
Q Consensus 29 ~~~~~~ll~~k~~~~~~~~~~l~sW~~~~-~~c~~w~gv~C~ 69 (884)
.+|++||++||+++..+|.+.+.+|+.+. .+||+|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 57999999999999877889999998663 456689999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=3.5e-10 Score=135.48 Aligned_cols=151 Identities=22% Similarity=0.256 Sum_probs=99.8
Q ss_pred cCCeEeecCCCCCCCCCCccCCCCCCcceEeCCCCcc-CCCCchhhhhccccCcEEEccCCccCCCccccccccCCCCee
Q 002759 120 QTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSY-SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGF 198 (884)
Q Consensus 120 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l-~g~ip~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L 198 (884)
...+...+-+|.+. .++.... .++|++|-+..|.. ...++...|..++.|++|||++|.=-+.+|..+++|-+|++|
T Consensus 523 ~~~rr~s~~~~~~~-~~~~~~~-~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL 600 (889)
T KOG4658|consen 523 NSVRRMSLMNNKIE-HIAGSSE-NPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYL 600 (889)
T ss_pred hheeEEEEeccchh-hccCCCC-CCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcc
Confidence 45555666666554 3333332 23677777777752 236777777777788888887776666788888888888888
Q ss_pred EcccCCCCCCCCCCCCCCCcccEEEccCCccCCCcccccccCCeecEEEcCCCc--cCCcCCCCCCCCCCccEEEee
Q 002759 199 DFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNL--FIGLAPFGVLGLKNISYFNVS 273 (884)
Q Consensus 199 ~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~--l~~~~~~~~~~l~~L~~L~L~ 273 (884)
+|++..++ .+|..+.+|..|.+|++..+.-...++.....+++|++|.+..-. .+...-..+..+.+|+.+...
T Consensus 601 ~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~ 676 (889)
T KOG4658|consen 601 DLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSIT 676 (889)
T ss_pred cccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheee
Confidence 88888887 788888888888888888776555556667778888888776654 222222333444455554443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.98 E-value=3.6e-09 Score=98.84 Aligned_cols=143 Identities=24% Similarity=0.258 Sum_probs=103.8
Q ss_pred CceeccCCceEEEEEEEcCCeEEEEEEc-cccCcc------CCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEE
Q 002759 599 ECLIGGGSIGSVYRASFEGGVSIAVKKL-ETLGRI------RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~~~~~vavK~~-~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
..++-+|+-+.|+++.+.+ +..+||.- .+..+- -...+-.+|++.+.+++--.|....-++.+...-.++||
T Consensus 12 l~likQGAEArv~~~~~~G-e~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFSG-EAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccCC-ceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4578999999999999984 45555543 222111 113456789999988865555555555666677789999
Q ss_pred ecCC-CchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCC---CeeE
Q 002759 672 FVPK-GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY---EPKL 747 (884)
Q Consensus 672 ~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~---~vkl 747 (884)
|+++ .++.+++..... ..........++.+|-+.+.-||.. .|+||||..+||++.+++ .+.+
T Consensus 91 ~~~g~~~vk~~i~~~~~----------~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~l 157 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME----------DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPIL 157 (229)
T ss_pred eccchhHHHHHHHHHcc----------CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEE
Confidence 9976 488888876541 1222333367889999999999998 999999999999997654 3589
Q ss_pred ccccCccc
Q 002759 748 SDYGLAKL 755 (884)
Q Consensus 748 ~Dfg~s~~ 755 (884)
+|||++..
T Consensus 158 Idfgls~~ 165 (229)
T KOG3087|consen 158 IDFGLSSV 165 (229)
T ss_pred Eeecchhc
Confidence 99999864
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.87 E-value=1.7e-09 Score=85.35 Aligned_cols=61 Identities=30% Similarity=0.514 Sum_probs=43.0
Q ss_pred CcccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCcc
Q 002759 217 PVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGF 277 (884)
Q Consensus 217 ~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 277 (884)
|+|++|++++|+|+.+.++.|.++++|++|++++|.++.+.+.+|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4566667777777666666777777777777777777777777777777777777777754
|
... |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.1e-09 Score=118.39 Aligned_cols=244 Identities=24% Similarity=0.240 Sum_probs=163.7
Q ss_pred cCceeccCCceEEEEEEE--cCCeEEEEEEccccCc-cCCHHHHHHHHHHHhcC-CCCCcceeeeEEecCCceeEEEEec
Q 002759 598 KECLIGGGSIGSVYRASF--EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~--~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
....||.|.|+.|+.... .++..+++|-+..... ..+...-..|+.+.+.+ .|.+++.+...+..-+..++=-||+
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~ 348 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFC 348 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhh
Confidence 455799999999999854 3567788887754321 12222234555555555 5888888877776667777888999
Q ss_pred CCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCC-CCeeEccccC
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGL 752 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~-~~vkl~Dfg~ 752 (884)
+++++...+... ..++...++++..|++.++.++|+. .++|+|+||+||++..+ +..++.|||.
T Consensus 349 ~~~s~~l~~~~~------------~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~ 413 (524)
T KOG0601|consen 349 EGGSSSLRSVTS------------QMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGC 413 (524)
T ss_pred cCcchhhhhHHH------------HhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccc
Confidence 999887766322 2467778899999999999999988 99999999999999886 8899999999
Q ss_pred ccccCCccCccccccccccccc--CccccCCCCCCCccCchhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHHHHcCC
Q 002759 753 AKLLPILDNYGLTKFHNAVGYV--APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 753 s~~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+..+. .. .+......+++ +|+......+..++|++|||..+.|.++|..--+....... +..+.
T Consensus 414 ~t~~~---~~-~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~----------i~~~~ 479 (524)
T KOG0601|consen 414 WTRLA---FS-SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT----------IRSGD 479 (524)
T ss_pred ccccc---ee-cccccccccccccchhhccccccccccccccccccccccccCcccCccccccee----------eeccc
Confidence 87432 11 11222333444 55555667778899999999999999997754433211100 00010
Q ss_pred CcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ell~~L~~~~ 879 (884)
. +...+.. .++..+...+...++..||.+.++....+-+.
T Consensus 480 ~-----p~~~~~~----~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 480 T-----PNLPGLK----LQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred c-----cCCCchH----HhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 0 0111111 23344444588899999999988876655443
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=2.4e-09 Score=123.73 Aligned_cols=244 Identities=20% Similarity=0.203 Sum_probs=156.4
Q ss_pred cCceeccCCceEEEEEEEcC-CeEEEEEEccccCc--cCCHHHHHHHHHHHhcCCCCCcceeeeEEecCCceeEEEEecC
Q 002759 598 KECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 598 ~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
...-+-+|.++.++.+.-.. +...+.|....... ..+.+....+-.+.-..++|.+++...-+......++|++|..
T Consensus 808 i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~ 887 (1205)
T KOG0606|consen 808 ITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLN 887 (1205)
T ss_pred ecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhc
Confidence 34467789999988874332 22223333221110 0111111122222222345777766555556677899999999
Q ss_pred CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcc
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~ 754 (884)
++++...++... ..+...+......+..+.+|||.. .+.|+|++|.|.++..+++.+++|||...
T Consensus 888 ~~~~~Skl~~~~------------~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~ 952 (1205)
T KOG0606|consen 888 GGDLPSKLHNSG------------CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLS 952 (1205)
T ss_pred cCCchhhhhcCC------------CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccc
Confidence 999999998654 234444455666778999999987 79999999999999999999999998332
Q ss_pred ccCCc---cC---------------------------cccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCC
Q 002759 755 LLPIL---DN---------------------------YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804 (884)
Q Consensus 755 ~~~~~---~~---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~ 804 (884)
..... .. .......+|..|.+||...+......+|+|+.|+.++|.++|.
T Consensus 953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~ 1032 (1205)
T KOG0606|consen 953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGI 1032 (1205)
T ss_pred ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCC
Confidence 22100 00 0012345688899999999999999999999999999999999
Q ss_pred CCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002759 805 KPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA 869 (884)
Q Consensus 805 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPt~~ 869 (884)
.||.....+.+. +.... .....+. .+.+...+..+++...+..+|.+|-.+.
T Consensus 1033 pp~na~tpq~~f------~ni~~----~~~~~p~---g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1033 PPFNAETPQQIF------ENILN----RDIPWPE---GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCCCCcchhhhh------hcccc----CCCCCCC---CccccChhhhhhhhhhhccCchhccCcc
Confidence 999987665433 11111 1111111 2222233444555567778888886654
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.78 E-value=5.1e-09 Score=82.67 Aligned_cols=61 Identities=46% Similarity=0.653 Sum_probs=40.1
Q ss_pred ccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCccCcccEEEccCCcC
Q 002759 409 TYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNL 469 (884)
Q Consensus 409 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l 469 (884)
++|++|++++|+++...+..|.++++|++|++++|.++...|..|..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 3566666777766655455666667777777777777655556666777777777776654
|
... |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.7e-08 Score=99.79 Aligned_cols=143 Identities=13% Similarity=0.012 Sum_probs=98.8
Q ss_pred CceeccCCceEEEEEEEcCCeEEEEEEccccCcc----------CCHHHHHHHHHHHhcCCCCCcc--eeeeEEec----
Q 002759 599 ECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRI----------RNQEEFELEIGRLSNIRHFNLV--AFQGYYWS---- 662 (884)
Q Consensus 599 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv--~~~~~~~~---- 662 (884)
++.+-.-....|+++.+. |+.+.||........ .....+.+|...+..+...+|. +++++...
T Consensus 27 ~e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 344555555567787664 678999976432211 1112477888888777433333 33444432
Q ss_pred -CCceeEEEEecCCC-chhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeC
Q 002759 663 -STMQLILSEFVPKG-NLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD 740 (884)
Q Consensus 663 -~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~ 740 (884)
....++|||++++. +|.+++.... ..+.+...+..++.+++..+.-||.. ||+|+|++++|||++
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~----------~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~ 172 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWA----------TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLH 172 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhc----------ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEe
Confidence 23468999999876 7888875321 11345567778999999999999999 999999999999997
Q ss_pred C-------CCCeeEccccCccc
Q 002759 741 E-------NYEPKLSDYGLAKL 755 (884)
Q Consensus 741 ~-------~~~vkl~Dfg~s~~ 755 (884)
. +..+.++||+.+..
T Consensus 173 ~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 173 LPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred ccccCCCCCceEEEEECCcccc
Confidence 5 46899999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=1.3e-07 Score=92.72 Aligned_cols=126 Identities=23% Similarity=0.204 Sum_probs=82.7
Q ss_pred EEEEEEEcCCeEEEEEEccccC------------ccC---------C----HHHHHHHHHHHhcCCCC--CcceeeeEEe
Q 002759 609 SVYRASFEGGVSIAVKKLETLG------------RIR---------N----QEEFELEIGRLSNIRHF--NLVAFQGYYW 661 (884)
Q Consensus 609 ~V~~~~~~~~~~vavK~~~~~~------------~~~---------~----~~~~~~E~~~l~~l~h~--niv~~~~~~~ 661 (884)
.||.|...++..+|+|..+... ..+ . .....+|++.|.++... ++.+++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899999889999999875321 011 1 23467899999999765 455665442
Q ss_pred cCCceeEEEEecC--CCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEeccCCCCceE
Q 002759 662 SSTMQLILSEFVP--KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL-HHDCKPPILHLNLKSTNIL 738 (884)
Q Consensus 662 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~L-H~~~~~~ivH~Dlk~~Nil 738 (884)
..++||||++ |..+..... .. ++......++.+++..+..+ |.. +|+|||+.+.||+
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~-~~-------------~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIl 139 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKD-VD-------------LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNIL 139 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHH-CG-------------GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEE
T ss_pred ---CCEEEEEecCCCccchhhHHh-cc-------------ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEE
Confidence 4579999998 545544332 11 12344566778888866664 676 9999999999999
Q ss_pred eCCCCCeeEccccCcccc
Q 002759 739 LDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 739 ~~~~~~vkl~Dfg~s~~~ 756 (884)
++++ .+.|+|||.+...
T Consensus 140 v~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 140 VDDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp EETT-CEEE--GTTEEET
T ss_pred eecc-eEEEEecCcceec
Confidence 9988 9999999998754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.3e-07 Score=92.88 Aligned_cols=137 Identities=20% Similarity=0.120 Sum_probs=97.7
Q ss_pred cccCceeccCCceEEEEEEEcCCeEEEEEEcccc----------C---------c--cCCHHHHHHHHHHHhcCCCC--C
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETL----------G---------R--IRNQEEFELEIGRLSNIRHF--N 652 (884)
Q Consensus 596 ~~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~----------~---------~--~~~~~~~~~E~~~l~~l~h~--n 652 (884)
...+..||-|--+.||.|..+.|.++|||.-+.. . . .......++|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3466889999999999999999999999854211 0 0 01124567899999988644 6
Q ss_pred cceeeeEEecCCceeEEEEecCCCchhhhcccCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccC
Q 002759 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNL 732 (884)
Q Consensus 653 iv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dl 732 (884)
|.+.+++ +...+||||++|-.|+..= ++....-.++..|++-+.-+-.. ||||||+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----------------~~~en~~~il~~il~~~~~~~~~---GiVHGDl 228 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----------------LDVENPDEILDKILEEVRKAYRR---GIVHGDL 228 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----------------CcccCHHHHHHHHHHHHHHHHHc---CccccCC
Confidence 6666654 4568999999886654321 12233334555555555555555 9999999
Q ss_pred CCCceEeCCCCCeeEccccCcccc
Q 002759 733 KSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 733 k~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
.+-||+++++|.+.++||-.+...
T Consensus 229 SefNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 229 SEFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred chheEEEecCCCEEEEeCcccccC
Confidence 999999999999999999877644
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.7e-08 Score=112.77 Aligned_cols=150 Identities=17% Similarity=0.288 Sum_probs=101.2
Q ss_pred HHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCccccCCccCcccc--------cccccccccCccccC
Q 002759 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT--------KFHNAVGYVAPELAQ 780 (884)
Q Consensus 709 ~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~~~~~~~~~~--------~~~~~~~y~aPE~~~ 780 (884)
+.+++.|+.|+|... ++||++|.|++|.++.++..||+.|+++........+... .......|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999864 8999999999999999999999999988765432212111 112245699999999
Q ss_pred CCCCCCccCchhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHHHHcCCCcccccccCCCCcHHHHHHHHHHHhhccC
Q 002759 781 SLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTS 859 (884)
Q Consensus 781 ~~~~~~~sDvwS~Gv~l~el~t-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~l~~~cl~ 859 (884)
....+.++|+||+|+++|.++. |+.-+........+... +.. .+-....+..+.+.++.+=+.+.+.
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---~~~---------~~~~~~~~s~~~p~el~~~l~k~l~ 250 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---RNL---------LNAGAFGYSNNLPSELRESLKKLLN 250 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---hcc---------cccccccccccCcHHHHHHHHHHhc
Confidence 9888999999999999999995 66555543322222110 000 1111111222333455555666899
Q ss_pred CCCCCCCCHHHHH
Q 002759 860 EVPSRRPSMAEVV 872 (884)
Q Consensus 860 ~~P~~RPt~~ell 872 (884)
.++..||++.++.
T Consensus 251 ~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 251 GDSAVRPTLDLLL 263 (700)
T ss_pred CCcccCcchhhhh
Confidence 9999999776654
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=1.5e-09 Score=119.98 Aligned_cols=127 Identities=23% Similarity=0.324 Sum_probs=84.7
Q ss_pred cccEEEccCCccCCCcccccccCCeecEEEcCCCccCCcCCCCCCCCCCccEEEeecCccccccccccccCCCCcEEecC
Q 002759 218 VLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDAS 297 (884)
Q Consensus 218 ~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~ls 297 (884)
.|...+.+.|++. ....++.-++.|+.|||++|+++... .+..++.|++|||+.|.++ .+|........|+.|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhhheeeeec
Confidence 4566667777776 45566667777777888888777663 6667777777777777776 455554445557777777
Q ss_pred CCcCCCCCCcccccccccceecccCCcccccC-CCCcccccCccEEEccCCccC
Q 002759 298 WNEFDGVIPLSITNCRNLKVLDLGFNRLIGSI-PTGITDLRRLLKISLANNSIG 350 (884)
Q Consensus 298 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 350 (884)
+|.++... .+.++++|+.|||++|-|.+-- -..+..|..|+.|+|.+|.+.
T Consensus 241 nN~l~tL~--gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTLR--GIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhhh--hHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 77776442 3567777777777777776321 123455666777777777665
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=2.1e-09 Score=94.89 Aligned_cols=115 Identities=23% Similarity=0.336 Sum_probs=64.3
Q ss_pred ccEEecCCCcCCCCCCcCC-cCCCCCcEEeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEcc
Q 002759 363 LEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLS 441 (884)
Q Consensus 363 L~~L~L~~n~l~~~~p~~~-~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 441 (884)
|+..+|++|.+. ..|..| ...+.++.|+|++|.|+ .+|.++..++.|+.|+++.|.+. ..|..+..|.+|-.||..
T Consensus 55 l~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Lds~ 131 (177)
T KOG4579|consen 55 LTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLDSP 131 (177)
T ss_pred EEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhcCC
Confidence 344444444444 222222 22335566666666666 56666777777777777777776 566666667777777777
Q ss_pred CCccCCccCCCcCccCcccEEEccCCcCcccCCccccccC
Q 002759 442 QNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFG 481 (884)
Q Consensus 442 ~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~~~ 481 (884)
+|.+. .+|..+---...-..++.++++.+..|..+|.|+
T Consensus 132 ~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~k 170 (177)
T KOG4579|consen 132 ENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQALK 170 (177)
T ss_pred CCccc-cCcHHHhccccHHHHHhcCCcccccCcccccccC
Confidence 77766 4554322222233334456666666555554443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.52 E-value=1.2e-08 Score=101.62 Aligned_cols=81 Identities=20% Similarity=0.287 Sum_probs=45.0
Q ss_pred cccEEEccCCccCCCcc-ccc-ccCCeecEEEcCCCccCC--cCCCCCCCCCCccEEEeecCccccccccccccCCCCcE
Q 002759 218 VLDFISVRGNALTGTVE-EQF-SQCQSIKNLDLSSNLFIG--LAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQV 293 (884)
Q Consensus 218 ~L~~L~L~~n~l~~~~~-~~~-~~l~~L~~L~L~~N~l~~--~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~ 293 (884)
.++.|.+.++.|..... ..| +.++.+++|||.+|+|+. .+..-+.+|+.|+.|+|++|++...|........+|++
T Consensus 46 a~ellvln~~~id~~gd~~~~~~~~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~ 125 (418)
T KOG2982|consen 46 ALELLVLNGSIIDNEGDVMLFGSSVTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRV 125 (418)
T ss_pred chhhheecCCCCCcchhHHHHHHHhhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEE
Confidence 44455555555543322 122 346778888888888764 22333566788888888888877555433223333333
Q ss_pred EecCC
Q 002759 294 FDASW 298 (884)
Q Consensus 294 L~ls~ 298 (884)
|-|.+
T Consensus 126 lVLNg 130 (418)
T KOG2982|consen 126 LVLNG 130 (418)
T ss_pred EEEcC
Confidence 33333
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.51 E-value=1.5e-09 Score=119.93 Aligned_cols=18 Identities=17% Similarity=0.178 Sum_probs=9.0
Q ss_pred cccCCeecEEEcCCCccC
Q 002759 237 FSQCQSIKNLDLSSNLFI 254 (884)
Q Consensus 237 ~~~l~~L~~L~L~~N~l~ 254 (884)
+..+.+|+.|.|.++.|.
T Consensus 105 ifpF~sLr~LElrg~~L~ 122 (1096)
T KOG1859|consen 105 IFPFRSLRVLELRGCDLS 122 (1096)
T ss_pred eccccceeeEEecCcchh
Confidence 344455555555555443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.49 E-value=4.6e-06 Score=90.19 Aligned_cols=179 Identities=18% Similarity=0.214 Sum_probs=127.1
Q ss_pred CceEEEEEE-EcCCeEEEEEEccccCccCCHHHHHHHHHHHhcCCCCCcceeeeEEe----cCCceeEEEEecCCC-chh
Q 002759 606 SIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW----SSTMQLILSEFVPKG-NLY 679 (884)
Q Consensus 606 ~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~~lv~e~~~~g-sL~ 679 (884)
-..+.|++. ..+|..+++|++..... .....-..-++.++++.|.|+|++.+++. .+...++||+|.++. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~-~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD-QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc-cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 346789994 45888999999943221 12212234467788999999999999875 234578999998764 777
Q ss_pred hhcccCCCCC---CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEeccCCCCceEeCCCCCeeEccccCcccc
Q 002759 680 DNLHGVNYPG---TSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756 (884)
Q Consensus 680 ~~l~~~~~~~---~~~~~~~~~~~~~~~~~~i~~qia~~L~~LH~~~~~~ivH~Dlk~~Nil~~~~~~vkl~Dfg~s~~~ 756 (884)
+.-....... .......+...++...|.++.|+..||.++|+. |+.-+-|.+++|+++.+.+++|+..|....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl 443 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVL 443 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeee
Confidence 6543322211 011112234567889999999999999999999 9999999999999999999999988887665
Q ss_pred CCccCcccccccccccccCccccCCCCCCCccCchhHHHHHHHHHhCCCC
Q 002759 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806 (884)
Q Consensus 757 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwS~Gv~l~el~tG~~p 806 (884)
..... |-+.+ -.+-|.-.+|.++..+.||..-
T Consensus 444 ~~d~~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 444 QEDPT---------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred cCCCC---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 43220 11111 1256888899999999999654
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.1e-09 Score=93.08 Aligned_cols=140 Identities=23% Similarity=0.258 Sum_probs=103.8
Q ss_pred cccceecccCCcccccCCCCcc---cccCccEEEccCCccCCCCCCCccCcccccEEecCCCcCCCCCCcCCcCCCCCcE
Q 002759 313 RNLKVLDLGFNRLIGSIPTGIT---DLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389 (884)
Q Consensus 313 ~~L~~L~L~~N~l~~~~p~~~~---~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~ 389 (884)
..+..++|+.|+|- .+++... ....|+..+|++|.+....+..-...+.++.|+|++|+|+ .+|..+..++.|+.
T Consensus 27 kE~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~ 104 (177)
T KOG4579|consen 27 KELHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRS 104 (177)
T ss_pred HHhhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhh
Confidence 35677888888775 4555443 4455667789999988554444455668899999999998 67888999999999
Q ss_pred EeccCccCCCCcchhhcCCccCcEEEecCcccCCCCCccccCCCCCCEEEccCCccCCccCCCcCcc
Q 002759 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNL 456 (884)
Q Consensus 390 L~ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l 456 (884)
|+++.|.+. ..|..+..+.+|-.|+..+|.+. .+|..+-.-+..-..++.++.+.+.-|..+..+
T Consensus 105 lNl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klqa~ 169 (177)
T KOG4579|consen 105 LNLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQAL 169 (177)
T ss_pred cccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccccc
Confidence 999999998 67888888999999999999987 666654444455556677888887666554443
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.42 E-value=7.2e-08 Score=96.22 Aligned_cols=84 Identities=21% Similarity=0.278 Sum_probs=40.1
Q ss_pred cccCcEEEccCCccCC--CccccccccCCCCeeEcccCCCCCCCCCCCCCCCcccEEEccCCccCCCccc-ccccCCeec
Q 002759 168 CYKTKFVSLSHNNLSG--SIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEE-QFSQCQSIK 244 (884)
Q Consensus 168 l~~L~~L~L~~n~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~-~~~~l~~L~ 244 (884)
++.++.|||..|+|+. .+-.-+.+|+.|+.|+|+.|+++..+-..-..+.+|+.|-|.+..+.-.-.. .+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3445555555555541 2223345666666666666666533222112344555666655555433222 223444444
Q ss_pred EEEcCCC
Q 002759 245 NLDLSSN 251 (884)
Q Consensus 245 ~L~L~~N 251 (884)
+|.+|.|
T Consensus 150 elHmS~N 156 (418)
T KOG2982|consen 150 ELHMSDN 156 (418)
T ss_pred hhhhccc
Confidence 4444444
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 884 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-43 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-43 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 1e-39 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 2e-33 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-39 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-33 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-30 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-24 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-24 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 5e-24 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-22 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 4e-22 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-21 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-20 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-19 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-19 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 6e-18 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-18 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-17 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 5e-16 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-17 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-17 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-17 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-17 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-17 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-17 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-17 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-17 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-17 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-17 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-17 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 8e-17 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 8e-17 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-16 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-16 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-16 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 4e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-16 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-15 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 1e-15 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 2e-15 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-15 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 4e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 4e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 4e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 4e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 4e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 5e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-15 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-15 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-14 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-14 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-14 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-14 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-14 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 2e-14 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-14 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-14 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-14 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-14 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 8e-14 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 8e-14 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-13 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-13 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-13 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-13 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-13 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-13 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-13 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 2e-13 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-13 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-13 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-13 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-13 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-13 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 3e-13 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-13 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-13 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-13 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-13 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 4e-13 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-13 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 4e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 6e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-13 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-13 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-13 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-13 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 8e-13 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-13 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-12 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-12 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-12 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-12 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-12 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-12 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-12 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-12 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-12 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-12 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-12 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-12 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-12 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-12 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-12 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-12 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-12 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 3e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-12 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 5e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-12 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-12 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 7e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 7e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 7e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-12 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-12 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 1e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-11 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-11 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-11 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-11 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-11 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-11 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-11 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-11 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-11 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-11 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-11 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-11 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-11 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 4e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 6e-11 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 6e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 7e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-11 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-11 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-10 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-10 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-10 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-10 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-10 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-10 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-10 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 3e-10 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 3e-10 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 3e-10 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 3e-10 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-10 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-10 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-10 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-10 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 4e-10 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-10 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-10 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 6e-10 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-10 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 9e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-09 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-09 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-09 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-09 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-09 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-09 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-09 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-09 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-09 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-09 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-09 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 3e-09 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-09 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-09 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-09 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-09 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-09 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 4e-09 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-09 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-09 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-09 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 7e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-09 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-09 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-09 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 8e-09 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-09 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-09 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-09 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-08 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-08 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-08 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-08 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-08 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-08 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-08 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 3e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-08 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-08 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-08 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-08 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-08 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-08 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-08 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 5e-08 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-08 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 5e-08 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-08 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-08 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-08 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-08 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-08 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-08 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-08 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-08 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 8e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-08 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 8e-08 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 8e-08 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 8e-08 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 8e-08 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-08 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-08 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 9e-08 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 9e-08 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-08 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 9e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 9e-08 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 9e-08 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-07 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-07 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-07 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 1e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 1e-07 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 1e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 1e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-07 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-07 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-07 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-07 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-07 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-07 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-07 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-07 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-07 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 3e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-07 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-07 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-07 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-07 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-07 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-07 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-07 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 4e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 4e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-07 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-07 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 4e-07 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-07 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-07 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 4e-07 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-07 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-07 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-07 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-07 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 4e-07 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 4e-07 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-07 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 4e-07 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-07 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 4e-07 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 4e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 4e-07 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-07 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-07 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 5e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 5e-07 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 5e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 5e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 5e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 5e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 5e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-07 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 5e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 5e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 6e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 6e-07 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-07 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-07 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 6e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 6e-07 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 6e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 6e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 6e-07 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 6e-07 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-07 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-07 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-07 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-07 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-07 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 7e-07 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-07 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 7e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-07 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-07 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 7e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-07 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-07 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 8e-07 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-07 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-07 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-07 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-07 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-06 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-06 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 1e-06 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-06 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-06 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-06 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-06 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-06 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-06 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-06 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-06 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-06 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-06 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-06 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-06 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-06 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-06 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-06 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-06 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-06 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-06 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 2e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-06 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-06 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-06 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 3e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-06 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-06 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-06 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 4e-06 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-06 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 4e-06 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-06 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-06 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-06 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-06 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 6e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-06 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-06 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-06 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 7e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 7e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 8e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 8e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 9e-06 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 9e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 9e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-06 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 9e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-06 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 9e-06 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-05 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 1e-05 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 1e-05 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 1e-05 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-05 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-05 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 2e-05 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-05 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-05 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-05 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-05 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-05 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-05 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-05 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-05 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-05 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-05 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-05 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-05 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-05 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-05 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 5e-05 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-05 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 6e-05 | ||
| 3zyn_A | 321 | Crystal Structure Of The N-Terminal Leucine Rich Re | 6e-05 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 6e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 7e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-05 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 7e-05 | ||
| 3zyo_A | 411 | Crystal Structure Of The N-Terminal Leucine Rich Re | 7e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 7e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 7e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 8e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-04 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-04 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-04 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-04 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-04 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-04 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-04 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-04 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-04 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-04 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-04 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-04 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-04 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-04 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-04 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-04 | ||
| 1xku_A | 330 | Crystal Structure Of The Dimeric Protein Core Of De | 1e-04 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-04 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-04 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-04 | ||
| 1xcd_A | 329 | Dimeric Bovine Tissue-Extracted Decorin, Crystal Fo | 1e-04 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 1e-04 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-04 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-04 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-04 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-04 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-04 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 2e-04 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-04 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-04 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-04 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-04 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 2e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 2e-04 | ||
| 3cig_A | 697 | Crystal Structure Of Mouse Tlr3 Ectodomain Length = | 2e-04 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-04 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-04 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 3e-04 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 4e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-04 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 4e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-04 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-04 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-04 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 6e-04 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-04 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-04 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-04 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 7e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-04 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 7e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-04 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 8e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 8e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 9e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 9e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XKU|A Chain A, Crystal Structure Of The Dimeric Protein Core Of Decorin, The Archetypal Small Leucine-Rich Repeat Proteoglycan Length = 330 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1XCD|A Chain A, Dimeric Bovine Tissue-Extracted Decorin, Crystal Form 1 Length = 329 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CIG|A Chain A, Crystal Structure Of Mouse Tlr3 Ectodomain Length = 697 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 358 bits (920), Expect = e-111
Identities = 132/439 (30%), Positives = 206/439 (46%), Gaps = 15/439 (3%)
Query: 83 SLGGVLSP-ALSGLKSLRVLTLFGNRFTGNLPQEYAEM-QTLWKINVSSNALSGSIPEFI 140
+ G L L ++ L+VL L N F+G LP+ + +L +++SSN SG I +
Sbjct: 329 NFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNL 388
Query: 141 GD--LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGF 198
++ L L N ++G+IP L C + + LS N LSG+IP S+ + + L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSN-CSELVSLHLSFNYLSGTIPSSLGSLSKLRDL 447
Query: 199 DFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAP 258
N L GE+P ++ + L+ + + N LTG + S C ++ + LS+N G P
Sbjct: 448 KLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Query: 259 FGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIPLSITNCRNLKV 317
+ L+N++ +S+N F G IP + + D + N F+G IP ++
Sbjct: 508 KWIGRLENLAILKLSNNSFSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQS---- 562
Query: 318 LDLGFNRLIGSIPTGITDLRRLLKISLANN--SIGGIIPPNLGSIELLEVLDLHNLNLRG 375
+ N + G I + + A N GI L + ++ + G
Sbjct: 563 GKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGG 622
Query: 376 EVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNL 435
N ++ LD+S N L G IP+ + +M YL IL+L N ++GS P +G+L L
Sbjct: 623 HTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGL 682
Query: 436 QVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST--IQHFGVSTFLNNTGLCG 493
+LDLS N L G IP ++ L LT +LS+NNLSG IP + F + FLNN GLCG
Sbjct: 683 NILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742
Query: 494 PPLETSCSGRGKGMTPTSK 512
PL G +
Sbjct: 743 YPLPRCDPSNADGYAHHQR 761
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 336 bits (863), Expect = e-103
Identities = 118/404 (29%), Positives = 198/404 (49%), Gaps = 13/404 (3%)
Query: 92 LSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDL 151
+S +L L + N F+ +P + L +++S N LSG I ++LL++
Sbjct: 196 VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNI 254
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIA-NCTYLEGFDFSFNNLSGELP 210
S N + G IP K +++SL+ N +G IP ++ C L G D S N+ G +P
Sbjct: 255 SSNQFVGPIPPLPLK---SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVP 311
Query: 211 SQICNIPVLDFISVRGNALTGTV-EEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLK-NIS 268
+ +L+ +++ N +G + + + + +K LDLS N F G P + L ++
Sbjct: 312 PFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLL 371
Query: 269 YFNVSHNGFHGEIPEV--GICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLI 326
++S N F G I +Q N F G IP +++NC L L L FN L
Sbjct: 372 TLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLS 431
Query: 327 GSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRF 386
G+IP+ + L +L + L N + G IP L ++ LE L L +L GE+P +SNC
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTN 491
Query: 387 LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLS 446
L + +S N L G+IP+ + + L IL L N +G+ P LG+ +L LDL+ N +
Sbjct: 492 LNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFN 551
Query: 447 GSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTG 490
G+IP+++ +++N ++G I++ G+ + G
Sbjct: 552 GTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAG 591
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 309 bits (795), Expect = 3e-93
Identities = 133/472 (28%), Positives = 200/472 (42%), Gaps = 71/472 (15%)
Query: 19 TSLGVSSASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCENFKGVFCNPDGFVDRIV 78
+ S S + L+ FK + D N L W S+ NPC F GV C V I
Sbjct: 1 SFQASPSQSLYREIHQLISFKDVLPDK--NLLPDWSSNKNPC-TFDGVTCRD-DKVTSID 56
Query: 79 LWNFSL---GGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGS 135
L + L +S +L L L L L + G++ + +L +++S N+LSG
Sbjct: 57 LSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGP 115
Query: 136 IPEF--IGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIA--- 190
+ +G ++ L++S N+ + + + LS N++SG+ +
Sbjct: 116 VTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSD 175
Query: 191 NCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSS 250
C L+ S N +SG++ S+C +++ LD+SS
Sbjct: 176 GCGELKHLAISGNKISGDVD--------------------------VSRCVNLEFLDVSS 209
Query: 251 NLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSIT 310
N F IP +G C +Q D S N+ G +I+
Sbjct: 210 ------------------------NNFSTGIPFLGDCSA-LQHLDISGNKLSGDFSRAIS 244
Query: 311 NCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNL-GSIELLEVLDLH 369
C LK+L++ N+ +G IP L+ L +SLA N G IP L G+ + L LDL
Sbjct: 245 TCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLS 302
Query: 370 NLNLRGEVPDDISNCRFLLLLDVSGNALGGDIP-QTLYNMTYLKILDLHQNHLNGSTPPS 428
+ G VP +C L L +S N G++P TL M LK+LDL N +G P S
Sbjct: 303 GNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPES 362
Query: 429 LGNLS-NLQVLDLSQNSLSGSIPSSLGN--LRNLTHFNLSSNNLSGTIPSTI 477
L NLS +L LDLS N+ SG I +L L L +N +G IP T+
Sbjct: 363 LTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTL 414
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-28
Identities = 43/154 (27%), Positives = 66/154 (42%), Gaps = 16/154 (10%)
Query: 81 NFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFI 140
G+ S L+ L + + + G+ + ++ +++S N LSG IP+ I
Sbjct: 593 LLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEI 652
Query: 141 GDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL-----SHNNLSGSIPLSIANCTYL 195
G +P + +L+L N SG IP + L S N L G IP +++ T L
Sbjct: 653 GSMPYLFILNLGHNDISGSIPDEV------GDLRGLNILDLSSNKLDGRIPQAMSALTML 706
Query: 196 EGFDFSFNNLSGELPS--QICNIPVLDFISVRGN 227
D S NNLSG +P Q P F+ N
Sbjct: 707 TEIDLSNNNLSGPIPEMGQFETFPPAKFL---NN 737
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 302 bits (777), Expect = 6e-96
Identities = 100/315 (31%), Positives = 172/315 (54%), Gaps = 18/315 (5%)
Query: 566 DSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKK 625
D V +G+L FS + + + + ++G G G VY+ G +AVK+
Sbjct: 9 DPEVHLGQLKRFS------LRELQVASDNF-SNKNILGRGGFGKVYKGRLADGTLVAVKR 61
Query: 626 LETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGV 685
L+ + +F+ E+ +S H NL+ +G+ + T +L++ ++ G++ L
Sbjct: 62 LKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121
Query: 686 NYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745
P L W +R IALG+AR L+YLH C P I+H ++K+ NILLDE +E
Sbjct: 122 PE--------SQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173
Query: 746 KLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRK 805
+ D+GLAKL+ D + T +G++APE + + S+K DV+ +GV+LLEL+TG++
Sbjct: 174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQR 233
Query: 806 PVES--PTTNEVVVLCEYVRELLERGSASACFDRSLRG-FAENELIQVMKLGLICTSEVP 862
+ ++ V+L ++V+ LL+ A D L+G + + E+ Q++++ L+CT P
Sbjct: 234 AFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSP 293
Query: 863 SRRPSMAEVVQVLES 877
RP M+EVV++LE
Sbjct: 294 MERPKMSEVVRMLEG 308
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 264 bits (676), Expect = 2e-81
Identities = 96/289 (33%), Positives = 140/289 (48%), Gaps = 24/289 (8%)
Query: 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ--EEFELEIGRLSNIRHFNLV 654
D + LIG G G VY+ G +A+K+ Q EEFE EI LS RH +LV
Sbjct: 42 DHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESS---QGIEEFETEIETLSFCRHPHLV 98
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+ G+ +++ +++ GNL +L+G + P S + W +R I +G AR
Sbjct: 99 SLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMS--------MSWEQRLEICIGAAR 150
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV--- 771
L YLH I+H ++KS NILLDEN+ PK++D+G++K LD T V
Sbjct: 151 GLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQ---THLSTVVKGT 204
Query: 772 -GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830
GY+ PE RL++K DVYSFGV+L E++ R + E+V L E+ E G
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 831 ASACFDRSLRG-FAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
D +L L + + C + RPSM +V+ LE
Sbjct: 265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA 313
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 2e-78
Identities = 81/294 (27%), Positives = 140/294 (47%), Gaps = 27/294 (9%)
Query: 593 KALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ---EEFELEIGRLSNIR 649
+ + +G G G VY+ +AVKKL + I + ++F+ EI ++ +
Sbjct: 30 RPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 650 HFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
H NLV G+ ++ ++P G+L D L ++ G P L W R IA
Sbjct: 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD---------GTPPLSWHMRCKIA 139
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN 769
G A +++LH + +H ++KS NILLDE + K+SD+GLA+ +T +
Sbjct: 140 QGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMT---S 193
Query: 770 AV----GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825
+ Y+APE A ++ K D+YSFGV+LLE++TG V+ E +L + E+
Sbjct: 194 RIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKEEI 250
Query: 826 L-ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
E + D+ + + + + C E ++RP + +V Q+L+ +
Sbjct: 251 EDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 250 bits (641), Expect = 2e-76
Identities = 82/328 (25%), Positives = 126/328 (38%), Gaps = 37/328 (11%)
Query: 184 SIPLSIANCTYL----EGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVE--EQF 237
I + N T L D G L ++ + + G L
Sbjct: 13 QIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSL 72
Query: 238 SQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIP-EVGICGEGMQVFDA 296
+ + L + N G IP + + +
Sbjct: 73 ANLPYLNFLYIGGI-----------------------NNLVGPIPPAIAKLTQ-LHYLYI 108
Query: 297 SWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN 356
+ G IP ++ + L LD +N L G++P I+ L L+ I+ N I G IP +
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDS 168
Query: 357 LGSI-ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILD 415
GS +L + + L G++P +N L +D+S N L GD + + +
Sbjct: 169 YGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIH 227
Query: 416 LHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
L +N L +G NL LDL N + G++P L L+ L N+S NNL G IP
Sbjct: 228 LAKNSLAFD-LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ 286
Query: 476 T--IQHFGVSTFLNNTGLCGPPLETSCS 501
+Q F VS + NN LCG PL +C+
Sbjct: 287 GGNLQRFDVSAYANNKCLCGSPLP-ACT 313
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 3e-67
Identities = 70/456 (15%), Positives = 152/456 (33%), Gaps = 69/456 (15%)
Query: 76 RIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTG-------------------NLPQEY 116
+I + ++ +S A+ L LR + + F ++
Sbjct: 187 QIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKW 245
Query: 117 AEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNS--------YSGEIPFALFKYC 168
++ L + V + +P F+ LP ++L++++ N +
Sbjct: 246 DNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPV-G 304
Query: 169 YKTKFVSLSHNNL-SGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGN 227
K + + + +NNL + + S+ L + +N L G+LP+ + L +++ N
Sbjct: 305 EKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPA-FGSEIKLASLNLAYN 363
Query: 228 ALTGTVEEQFSQCQSIKNLDLSSNLFIGL-APFGVLGLKNISYFNVSHNGFHGEIPEVGI 286
+T + ++NL + N + F + +S + S+N
Sbjct: 364 QITEIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDG---- 419
Query: 287 CGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLAN 346
FD + + N+ ++L N++ + L I+L
Sbjct: 420 ------------KNFDP-LDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMG 466
Query: 347 NSIGGI-------IPPNLGSIELLEVLDLHNLNLRGEVPDDI--SNCRFLLLLDVSGNAL 397
N + I N + LL +DL L + DD + +L+ +D+S N+
Sbjct: 467 NMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTLPYLVGIDLSYNSF 525
Query: 398 GGDIPQTLYNMTYLKILDLHQ------NHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS 451
P N + LK + N P + +L L + N + +
Sbjct: 526 SK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNE 583
Query: 452 SLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLN 487
+ N++ ++ N S + + +
Sbjct: 584 KI--TPNISVLDIKDNPNISIDLSYVCPYIEAGMYM 617
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 4e-67
Identities = 69/462 (14%), Positives = 144/462 (31%), Gaps = 44/462 (9%)
Query: 48 NKLASWVSSGNPCE--NFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFG 105
A+W + GV N +G V + L F G + A+ L L VL L
Sbjct: 55 QPGANWNFNKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGS 114
Query: 106 NRFTGN----LPQEYAEMQTLWKINVSSNALSGSIPEFIG--DLPNIRLLDLSRNSYSGE 159
+ N P+ + + + + ++ D ++ ++ +
Sbjct: 115 HGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKS 174
Query: 160 IPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVL 219
I + K + NN++ + ++ T L F + E +
Sbjct: 175 IKKSSRI-TLKDTQIGQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS 232
Query: 220 DFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHG 279
++ T + ++ + + ++++ + + P + L + NV+ N
Sbjct: 233 EY-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS 287
Query: 280 EIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLI-GSIPTGITDLRR 338
++++ +G+N L + T + +++
Sbjct: 288 GEQLKDDWQ----------------ALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKK 331
Query: 339 LLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALG 398
L + N + G P GS L L+L + + + L + N L
Sbjct: 332 LGMLECLYNQLEGK-LPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK 390
Query: 399 GDIPQTL--YNMTYLKILDLHQNHLNG-------STPPSLGNLSNLQVLDLSQNSLSGSI 449
IP +++ + +D N + P+ N+ ++LS N +S
Sbjct: 391 Y-IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFP 449
Query: 450 PSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGL 491
L+ NL N L+ IP F N L
Sbjct: 450 KELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFKNTYLL 490
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-40
Identities = 55/325 (16%), Positives = 98/325 (30%), Gaps = 29/325 (8%)
Query: 85 GGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLP 144
+ +L +K L +L N+ G + L +N++ N ++ F G
Sbjct: 319 TFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 145 NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG-------SIPLSIANCTYLEG 197
+ L + N K + S+N + + + +
Sbjct: 378 QVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSS 437
Query: 198 FDFSFNNLSGELPSQICNIPVLDFISVRGNALTG-------TVEEQFSQCQSIKNLDLSS 250
+ S N +S L I++ GN LT E F + ++DL
Sbjct: 438 INLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRF 497
Query: 251 NLFIGL-APFGVLGLKNISYFNVSHNGFHGEIPEVGICG-----EGMQVFDASWNEFDGV 304
N L F L + ++S+N F + DA N
Sbjct: 498 NKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLRE 557
Query: 305 IPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLE 364
P IT C +L L +G N + + I + + + +N I +
Sbjct: 558 WPEGITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYVCPYIEAG 614
Query: 365 VLDLHNLNLRGEVPDDISNCRFLLL 389
+ L + DI C L +
Sbjct: 615 MYMLFYDKTQ-----DIRGCDALDI 634
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 3e-64
Identities = 73/328 (22%), Positives = 126/328 (38%), Gaps = 47/328 (14%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEE 637
S + E+ + L E G G V++A +AVK + + +
Sbjct: 9 SSGVDLGTENLYFQSMPLQLLEV-KARGRFGCVWKAQLLNE-YVAVKIFPI--QDKQSWQ 64
Query: 638 FELEIGRLSNIRHFNLVAFQGY----YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTG 693
E E+ L ++H N++ F G +++ F KG+L D L
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLK---------- 114
Query: 694 GIGNPELHWSRRFHIALGTARALSYLHHD-------CKPPILHLNLKSTNILLDENYEPK 746
+ W+ HIA AR L+YLH D KP I H ++KS N+LL N
Sbjct: 115 ---ANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
Query: 747 LSDYGLAKLLPILDNYGLTKFHNAVG---YVAPELAQ-----SLRLSDKCDVYSFGVILL 798
++D+GLA + G T H VG Y+APE+ + + D+Y+ G++L
Sbjct: 172 IADFGLALKFEAGKSAGDT--HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLW 229
Query: 799 ELVTGRKPVESPTTNEVVVLCEYVREL--LERGSASACFDRSLR-----GFAENELIQVM 851
EL + + P ++ E + + LE + R + ++ + ++
Sbjct: 230 ELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKK-KRPVLRDYWQKHAGMAML 288
Query: 852 -KLGLICTSEVPSRRPSMAEVVQVLESI 878
+ C R S V + + +
Sbjct: 289 CETIEECWDHDAEARLSAGCVGERITQM 316
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 5e-64
Identities = 65/405 (16%), Positives = 126/405 (31%), Gaps = 27/405 (6%)
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGD 142
L + + + L L + N + P+ ++ L +N+ N LS +
Sbjct: 36 QLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAF 95
Query: 143 LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSF 202
N+ L L NS F + LSHN LS + + L+ S
Sbjct: 96 CTNLTELHLMSNSIQKIKNNP-FVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSN 154
Query: 203 NNLSGELPS--QICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAP-- 258
N + I L + + N + F + L L++
Sbjct: 155 NKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEK 214
Query: 259 -FGVLGLKNISYFNVSHNGFHGEIPEV--GICGEGMQVFDASWNEFDGVIPLSITNCRNL 315
L +I ++S++ G+ + + D S+N + V S L
Sbjct: 215 LCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRG 375
+ L +N + + L + ++L + + +L
Sbjct: 275 EYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRS---------------FTKQSISLASLPK 319
Query: 376 EVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLG----N 431
+ L L++ N + G + LK L L + + T +
Sbjct: 320 IDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLA 379
Query: 432 LSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST 476
S L +L+L++N +S + L +L +L N + +
Sbjct: 380 HSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ 424
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 7e-64
Identities = 74/426 (17%), Positives = 150/426 (35%), Gaps = 30/426 (7%)
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQE---YAEMQTLWKINVSSNALSGSIPEF 139
+ + L L L + +L ++ ++ +++S++ LS +
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 140 IGDLPNIRL--LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLE- 196
L L LDLS N+ + + F + + ++ L +NN+ S+ +
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 197 --------GFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDL 248
S +L + L+ +++ N + G F+ ++K L L
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSL 360
Query: 249 SSNLF----IGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGV 304
S++ + F L + N++ N + ++V D NE
Sbjct: 361 SNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQE 420
Query: 305 IPLS-ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGI--IPPNLGSIE 361
+ N+ + L +N+ + + L ++ L ++ + P +
Sbjct: 421 LTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 362 LLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGN--------ALGGDIPQTLYNMTYLKI 413
L +LDL N N+ D + L +LD+ N A G L +++L I
Sbjct: 481 NLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHI 540
Query: 414 LDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTI 473
L+L N + +L L+++DL N+L+ S N +L NL N ++
Sbjct: 541 LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVE 600
Query: 474 PSTIQH 479
Sbjct: 601 KKVFGP 606
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 2e-57
Identities = 76/352 (21%), Positives = 136/352 (38%), Gaps = 20/352 (5%)
Query: 145 NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNN 204
+ + D S + ++P L ++L+HN L + + L D FN
Sbjct: 5 SHEVADCSHLKLT-QVPDDLPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNT 60
Query: 205 LSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGL 264
+S P +P+L ++++ N L+ ++ F+ C ++ L L SN + +
Sbjct: 61 ISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQ 120
Query: 265 KNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIP--LSITNCRNLKVLDLGF 322
KN+ ++SHNG + E +Q S N+ + L I +LK L+L
Sbjct: 121 KNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSS 180
Query: 323 NRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIEL---LEVLDLHNLNLRGEVPD 379
N++ P + RL + L N +G + L + L L N L
Sbjct: 181 NQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNT 240
Query: 380 DISNCRF--LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQV 437
++ L +LD+S N L + + L+ L N++ SL L N++
Sbjct: 241 TFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRY 300
Query: 438 LDLSQN---------SLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHF 480
L+L ++ SL S L+ L H N+ N++ G +
Sbjct: 301 LNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGL 352
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 8e-54
Identities = 84/431 (19%), Positives = 146/431 (33%), Gaps = 31/431 (7%)
Query: 76 RIVLWNFSLGGVLSPALSGLK--SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALS 133
+ L N L + GLK +L +L L N +A + L + N +
Sbjct: 226 NLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQ 285
Query: 134 GSIPEFIGDLPNIRLLDLSRNSYSG--------EIPFALFKYCYKTKFVSLSHNNLSGSI 185
+ L N+R L+L R+ +I F++ + +++ N++ G
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 186 PLSIANCTYLEGFDFSFNNLS-GELPSQIC---NIPVLDFISVRGNALTGTVEEQFSQCQ 241
L+ S + S L ++ L +++ N ++ + FS
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLG 405
Query: 242 SIKNLDLSSNLFIGLAPFGVL-GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
++ LDL N GL+NI +S+N + +Q
Sbjct: 406 HLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVA 465
Query: 301 FDGV--IPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSI--------G 350
V P RNL +LDL N + + L +L + L +N++
Sbjct: 466 LKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANP 525
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTY 410
G L + L +L+L + + + L ++D+ N L N
Sbjct: 526 GGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVS 585
Query: 411 LKILDLHQNHLNGSTPPSLG-NLSNLQVLDLSQNSLSGSIPSSLG-----NLRNLTHFNL 464
LK L+L +N + G NL LD+ N + S N + L
Sbjct: 586 LKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPEL 645
Query: 465 SSNNLSGTIPS 475
SS+ L T P
Sbjct: 646 SSHYLCNTPPH 656
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-32
Identities = 37/168 (22%), Positives = 61/168 (36%), Gaps = 3/168 (1%)
Query: 314 NLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNL 373
+ +V D +L +P + + ++L +N + + N L LD+ +
Sbjct: 5 SHEVADCSHLKL-TQVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 374 RGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLS 433
P+ L +L++ N L +T T L L L N +
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 434 NLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFG 481
NL LDLS N LS + + L NL LS+N + + F
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFA 169
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 220 bits (563), Expect = 3e-62
Identities = 79/413 (19%), Positives = 151/413 (36%), Gaps = 26/413 (6%)
Query: 85 GGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTL----WKINVSSNALSGSIPEFI 140
L S L +L L L N+ + + + +++S N ++ P
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF 197
Query: 141 GDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPL------SIANCTY 194
++ + L L N S + + + L L ++
Sbjct: 198 KEI-RLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCN 256
Query: 195 LEGFDFSFNNLS---GELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSN 251
L +F L ++ + + S+ + + FS ++L+L +
Sbjct: 257 LTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNC 314
Query: 252 LFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWN--EFDGVIPLSI 309
F L LK++ + N EV + ++ D S N F G S
Sbjct: 315 KFGQFPT---LKLKSLKRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQSD 369
Query: 310 TNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLDL 368
+LK LDL FN +I + + L +L + ++++ + + S+ L LD+
Sbjct: 370 FGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDI 428
Query: 369 HNLNLRGEVPDDISNCRFLLLLDVSGNALGGDI-PQTLYNMTYLKILDLHQNHLNGSTPP 427
+ + R + L +L ++GN+ + P + L LDL Q L +P
Sbjct: 429 SHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
Query: 428 SLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHF 480
+ +LS+LQVL++S N+ L +L + S N++ + +QHF
Sbjct: 489 AFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHF 541
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 9e-57
Identities = 75/412 (18%), Positives = 137/412 (33%), Gaps = 34/412 (8%)
Query: 97 SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSY 156
S + L L N + L +++S + L ++ L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 157 SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNL-SGELPSQICN 215
A F + + NL+ I + L+ + + N + S +LP N
Sbjct: 89 QSLALGA-FSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 216 IPVLDFISVRGNALTGTVEEQFSQCQSIKN----LDLSSNLFIGLAPFGVLGLKNISYFN 271
+ L+ + + N + + LDLS N + P G +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQP-GAFKEIRLHKLT 206
Query: 272 VSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIPL------SITNCRNLKVLDLGFNR 324
+ +N + + I G G++V EF L ++ NL + +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 325 L---IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI 381
L + I L + SL + +I + + + L+L N +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 382 SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN--GSTPPSLGNLSNLQVLD 439
+ + L G + ++ L+ LDL +N L+ G S ++L+ LD
Sbjct: 325 KSLKRLTFTSNKGG-----NAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 440 LSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGL 491
LS N + + S+ L L H + +NL S FL+ L
Sbjct: 380 LSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEF-------SVFLSLRNL 423
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 3e-53
Identities = 76/414 (18%), Positives = 134/414 (32%), Gaps = 24/414 (5%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSGS------IPEFI 140
+ P L LTL N + N+ + + L + +
Sbjct: 192 IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSAL 251
Query: 141 GDLPNIRL--LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGF 198
L N+ + L+ Y + LF SL + S +
Sbjct: 252 EGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHL 309
Query: 199 DFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSN--LFIGL 256
+ ++ ++ L F S +G S++ LDLS N F G
Sbjct: 310 ELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS-----EVDLPSLEFLDLSRNGLSFKGC 364
Query: 257 APFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSI-TNCRNL 315
G ++ Y ++S NG E ++ D + + S+ + RNL
Sbjct: 365 CSQSDFGTTSLKYLDLSFNGVITMSSNFLGL-EQLEHLDFQHSNLKQMSEFSVFLSLRNL 423
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLDLHNLNLR 374
LD+ + L L + +A NS P+ + L LDL L
Sbjct: 424 IYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE 483
Query: 375 GEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL-S 433
P ++ L +L++S N + L++LD NH+ S L + S
Sbjct: 484 QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 543
Query: 434 NLQVLDLSQNSLSGSIPSS--LGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTF 485
+L L+L+QN + + L +++ + + PS Q V +
Sbjct: 544 SLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGMPVLSL 597
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 2e-51
Identities = 70/408 (17%), Positives = 122/408 (29%), Gaps = 38/408 (9%)
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGD 142
+ + A L L L L GN ++ + +L K+ L+ IG
Sbjct: 63 EIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGH 122
Query: 143 LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGF---- 198
L ++ L+++ N F + + LS N + + +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSL 182
Query: 199 DFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQ-FSQCQSIKNLDLSSNLFIG-- 255
D S N ++ P I L +++R N + V + ++ L F
Sbjct: 183 DLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEG 241
Query: 256 -LAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRN 314
L F L+ + + + + I N
Sbjct: 242 NLEKFDKSALEGLCNLTIEEFRLA------------------YLDYYLDDIIDLFNCLTN 283
Query: 315 LKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLR 374
+ L + + + L N G L S++ L N
Sbjct: 284 VSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF 341
Query: 375 GEVPDDISNCRFLLLLDVSGNALG--GDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL 432
E + L LD+S N L G Q+ + T LK LDL N + + L
Sbjct: 342 SE-----VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGL 395
Query: 433 SNLQVLDLSQNSLSGSIPSS-LGNLRNLTHFNLSSNNLSGTIPSTIQH 479
L+ LD ++L S +LRNL + ++S +
Sbjct: 396 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNG 443
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 8e-44
Identities = 70/363 (19%), Positives = 112/363 (30%), Gaps = 45/363 (12%)
Query: 142 DLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFS 201
+PNI + N Y IP L TK + LS N L S + L+ D S
Sbjct: 6 VVPNITYQCMELNFYK--IPDNLPFS---TKNLDLSFNPLRHLGSYSFFSFPELQVLDLS 60
Query: 202 FNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGV 261
+ ++ L + + GN + FS S++ L L F +
Sbjct: 61 RCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPI 120
Query: 262 LGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLG 321
LK + NV+HN +P +N NL+ LDL
Sbjct: 121 GHLKTLKELNVAHNLIQS-----------------------FKLPEYFSNLTNLEHLDLS 157
Query: 322 FNRLIGSIPTGITDLRRL----LKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEV 377
N++ T + L ++ L + L+ N + I P I L L L N V
Sbjct: 158 SNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNV 216
Query: 378 PDD-ISNCRFLLLLDVSGNALGGD------IPQTLYNMTYLKILDLHQNHLNGST---PP 427
I L + + + L + L I + +L+
Sbjct: 217 MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIID 276
Query: 428 SLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLN 487
L+N+ L ++ S H L + ++ TF +
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTS 334
Query: 488 NTG 490
N G
Sbjct: 335 NKG 337
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-32
Identities = 38/183 (20%), Positives = 73/183 (39%), Gaps = 7/183 (3%)
Query: 309 ITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLD 367
+ N+ + N IP + + L L+ N + + + S L+VLD
Sbjct: 4 VEVVPNITYQCMELN--FYKIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 368 LHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPP 427
L ++ + L L ++GN + ++ L+ L + +L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 428 SLGNLSNLQVLDLSQNSL-SGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFL 486
+G+L L+ L+++ N + S +P NL NL H +LSSN + + ++ L
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 487 NNT 489
N +
Sbjct: 179 NLS 181
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 47/258 (18%), Positives = 91/258 (35%), Gaps = 7/258 (2%)
Query: 79 LWNFSLGGVLSPALSGLKSLRVLTLFGNR--FTGNLPQEYAEMQTLWKINVSSNALSGSI 136
L S G + + L SL L L N F G Q +L +++S N +
Sbjct: 330 LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMS 389
Query: 137 PEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLE 196
F+G L + LD ++ F++F ++ +SH + + + LE
Sbjct: 390 SNFLG-LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448
Query: 197 GFDFSFNNLSGELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIG 255
+ N+ I + L F+ + L F+ S++ L++S N F
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFS 508
Query: 256 LAPFGVLGLKNISYFNVSHNGFHGEIPEV-GICGEGMQVFDASWNEFDGVIPLS--ITNC 312
L F L ++ + S N + + + + N+F +
Sbjct: 509 LDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWI 568
Query: 313 RNLKVLDLGFNRLIGSIP 330
++ + L + R+ + P
Sbjct: 569 KDQRQLLVEVERMECATP 586
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-15
Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 2/140 (1%)
Query: 84 LGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDL 143
L + L++L L L + P + + +L +N+S N L
Sbjct: 458 QENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCL 517
Query: 144 PNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLS--IANCTYLEGFDFS 201
++++LD S N L + F++L+ N+ + + +
Sbjct: 518 NSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVE 577
Query: 202 FNNLSGELPSQICNIPVLDF 221
+ PS +PVL
Sbjct: 578 VERMECATPSDKQGMPVLSL 597
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-58
Identities = 58/442 (13%), Positives = 133/442 (30%), Gaps = 62/442 (14%)
Query: 91 ALSGLKSLRVLTLFGNRFTGN-----LPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPN 145
L + L + L + N + ++ +I +N ++ I + I L
Sbjct: 391 FLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRIT-FISKAIQRLTK 449
Query: 146 IRLLDLSRNSYSGEIPFALFKYCYKT------------------KFVSLSHNNLSGSIPL 187
++++ + + ++ + ++ V L + +P
Sbjct: 450 LQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509
Query: 188 SIANCTYLEGFDFSFNNLSG---------ELPSQICNIPVLDFISVRGNALTG-TVEEQF 237
+ + L+ + + N L P + + N L
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASL 569
Query: 238 SQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDAS 297
+ + LD N L FG ++ + +N + + ++ S
Sbjct: 570 QKMVKLGLLDCVHNKVRHLEAFG--TNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFS 627
Query: 298 WNEFDGV-IPLSITNCRNLKVLDLGFNRLIGSIPTGITD------LRRLLKISLANNSIG 350
N+ + + + + +D +N+ IGS I+ ++L+ N I
Sbjct: 628 HNKLKYIPNIFNAKSVYVMGSVDFSYNK-IGSEGRNISCSMDDYKGINASTVTLSYNEIQ 686
Query: 351 GIIPPNLGSIELLEVLDLHN-------LNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQ 403
+ + + L N N + N L +D+ N L +
Sbjct: 687 KFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSD 745
Query: 404 TLY--NMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQ------NSLSGSIPSSLGN 455
+ YL +D+ N + S P N S L+ + N + P+ +
Sbjct: 746 DFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITT 804
Query: 456 LRNLTHFNLSSNNLSGTIPSTI 477
+L + SN++ + +
Sbjct: 805 CPSLIQLQIGSNDIR-KVDEKL 825
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 2e-56
Identities = 68/447 (15%), Positives = 133/447 (29%), Gaps = 51/447 (11%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIR 147
+S A+ L L+++ + FT + N + +L ++
Sbjct: 440 ISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEELSWSNLKDLT 494
Query: 148 LLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG---------SIPLSIANCTYLEGF 198
++L ++P L+ + + ++++ N + ++ F
Sbjct: 495 DVELYNCPNMTQLPDFLYD-LPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIF 553
Query: 199 DFSFNNLSGELPS--QICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256
+NNL E P+ + + L + N + +E F + +L L N +
Sbjct: 554 YMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEA-FGTNVKLTDLKLDYNQIEEI 610
Query: 257 APFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIP-----LSIT 310
+ SHN M D S+N+ +
Sbjct: 611 PEDFCAFTDQVEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY 670
Query: 311 NCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGI-------IPPNLGSIELL 363
N + L +N + + I L+NN + I N + LL
Sbjct: 671 KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLL 730
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLL--LDVSGNALGGDIPQTLYNMTYLKILDLHQ--- 418
+DL L + DD L +DVS N P N + LK +
Sbjct: 731 TTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLKAFGIRHQRD 788
Query: 419 ---NHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNL-SGTIP 474
N + P + +L L + N + + L L +++ N S +
Sbjct: 789 AEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVT 845
Query: 475 STIQHFGVSTFL----NNTGLCGPPLE 497
S + ++ + G
Sbjct: 846 SVCPYIEAGMYVLLYDKTQDIRGCDAL 872
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-56
Identities = 71/466 (15%), Positives = 147/466 (31%), Gaps = 44/466 (9%)
Query: 43 TDDPHNKLASWVSSGNPCE--NFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRV 100
T + +W + + GV + +G V + L F G + A+ L L+V
Sbjct: 292 TINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKV 351
Query: 101 LTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPE-FIGDLPNIRLLDLSRNSYS-- 157
L+ + T + E T + + + F+ + L DL +++ +
Sbjct: 352 LSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRN 411
Query: 158 ---GEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC 214
I T+ + N I +I T L+ F+ + + + +
Sbjct: 412 PEMKPIKKDSRISLKDTQI--GNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDW 469
Query: 215 NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSH 274
D+ E +S + + +++L + + P + L + N++
Sbjct: 470 EDANSDY-----AKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIAC 524
Query: 275 NGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIG-SIPTGI 333
N + +++ +G+N L +
Sbjct: 525 NRGISAAQLKADWTR---------------LADDEDTGPKIQIFYMGYNNLEEFPASASL 569
Query: 334 TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDV 392
+ +L + +N + + G+ L L L N E+P+D + + L
Sbjct: 570 QKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDY-NQIEEIPEDFCAFTDQVEGLGF 626
Query: 393 SGNALGGDIPQT--LYNMTYLKILDLHQNHL-----NGSTPPSLGNLSNLQVLDLSQNSL 445
S N L IP ++ + +D N + N S N + LS N +
Sbjct: 627 SHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEI 685
Query: 446 SGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGL 491
++ LS+N ++ +IP + N L
Sbjct: 686 QKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKNTYLL 730
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 1e-10
Identities = 23/156 (14%), Positives = 43/156 (27%), Gaps = 5/156 (3%)
Query: 360 IELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQN 419
+ E LD N ++ + + + G L N + L L
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSL-NWNFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333
Query: 420 HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTI-- 477
G P ++G L+ L+VL +S + S + +
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLD 393
Query: 478 --QHFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTS 511
Q +S L + P ++ + T
Sbjct: 394 YDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ 429
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 3e-55
Identities = 71/406 (17%), Positives = 128/406 (31%), Gaps = 13/406 (3%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLD 150
L L L N + + L + +S + + + L
Sbjct: 76 TFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLY 135
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEG--FDFSFNNLSGE 208
L N S I K K + +N + +++ + + N+++
Sbjct: 136 LGSNHISS-IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-G 193
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEE--QFSQCQSIKNLDLSSNLFIGLAP--FGVLGL 264
+ + V ++ G + + + S QS+ ++P F L
Sbjct: 194 IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCE 253
Query: 265 KNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNR 324
++ N+ + F C G+Q D + +P + LK L L N+
Sbjct: 254 MSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANK 312
Query: 325 LIGSIPTGITDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLDLHN--LNLRGEVPDDI 381
++ L +S+ N+ + L ++E L LDL + + +
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQL 372
Query: 382 SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPS-LGNLSNLQVLDL 440
N L L++S N + L++LDL L S NL L+VL+L
Sbjct: 373 RNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNL 432
Query: 441 SQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFL 486
S + L S L L H NL N+ L
Sbjct: 433 SHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRL 478
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-54
Identities = 79/431 (18%), Positives = 157/431 (36%), Gaps = 18/431 (4%)
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ--TLWKINVSSNALSGSIPEFI 140
+ + P + L+VL N ++ + +Q T +N++ N ++ I
Sbjct: 140 HISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA-GIEPGA 198
Query: 141 GDLPNIRLLDLSRNSYSGEIPFAL-FKYCYKTKFVSLSHNNLSGSIPLSIANC--TYLEG 197
D + L+ I L + + P +E
Sbjct: 199 FDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVES 258
Query: 198 FDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLA 257
+ + + L + + L+ + ++K L LS+N F L
Sbjct: 259 INLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLC 317
Query: 258 PFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWN--EFDGVIPLSITNCRN 314
++++ ++ N E+ + E ++ D S + E L + N +
Sbjct: 318 QISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSH 377
Query: 315 LKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLDLHNLNL 373
L+ L+L +N + + +L + LA + + ++ LL+VL+L + L
Sbjct: 378 LQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLL 437
Query: 374 RGEVPDDISNCRFLLLLDVSGNALGGDIPQ---TLYNMTYLKILDLHQNHLNGSTPPSLG 430
L L++ GN Q +L + L+IL L L+ +
Sbjct: 438 DISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFT 497
Query: 431 NLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTG 490
+L + +DLS N L+ S +L +L+ + NL+SN++S +PS + +N
Sbjct: 498 SLKMMNHVDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTIN--- 553
Query: 491 LCGPPLETSCS 501
L PL+ +CS
Sbjct: 554 LRQNPLDCTCS 564
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 9e-53
Identities = 79/410 (19%), Positives = 142/410 (34%), Gaps = 16/410 (3%)
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGD 142
+ + L K+L L L N + + + L ++ +NA+ E +
Sbjct: 116 GISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSS 175
Query: 143 LPNIRL--LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTY--LEGF 198
L L+L+ N I F + ++ I + N T L
Sbjct: 176 LQQATNLSLNLNGND-IAGIEPGAFD-SAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLG 233
Query: 199 DFSFNNLSGELPSQICNIPVLDFISVR--GNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256
F + P+ + + S+ + F ++ LDL++ L
Sbjct: 234 TFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSEL 293
Query: 257 APFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVI-PLSITNCRNL 315
P G++GL + +S N F + N + + N NL
Sbjct: 294 -PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENL 352
Query: 316 KVLDLGFNRL--IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNL 373
+ LDL + + + +L L ++L+ N + LE+LDL L
Sbjct: 353 RELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRL 412
Query: 374 RGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGST---PPSL 429
+ + N L +L++S + L Q + L+ L+L NH SL
Sbjct: 413 KVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 430 GNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
L L++L LS LS + +L+ + H +LS N L+ + + H
Sbjct: 473 QTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 7e-50
Identities = 58/334 (17%), Positives = 110/334 (32%), Gaps = 10/334 (2%)
Query: 147 RLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLS 206
+ + + EIP L T+ + S N L + + L D + +
Sbjct: 15 KTYNCENLGLN-EIPGTLPNS---TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 207 GELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKN 266
+ LD + + N L E S +++K+L + + K
Sbjct: 71 WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130
Query: 267 ISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRL- 325
+ + N G E ++V D N + +++ + L L N
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGND 190
Query: 326 IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIEL--LEVLDLHNLNLRGEVPDDISN 383
I I G D ++ +I L + + L + +++ P
Sbjct: 191 IAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 384 CRFLLL--LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLS 441
+ + +++ + T + + L+ LDL HL+ P L LS L+ L LS
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLS 309
Query: 442 QNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
N S N +LTH ++ N + +
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGT 343
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-44
Identities = 58/400 (14%), Positives = 119/400 (29%), Gaps = 59/400 (14%)
Query: 95 LKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRN 154
S L N ++ + L ++++ + + + L
Sbjct: 32 PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLV---- 87
Query: 155 SYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC 214
L+ N L +++ L+ F +S +
Sbjct: 88 ---------------------LTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLH 126
Query: 215 NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAP--FGVLGLKNISYFNV 272
N L+ + + N ++ + + +K LD +N L+ L N+
Sbjct: 127 NQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNL 186
Query: 273 SHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTG 332
+ N G I + + L+ G + + I G
Sbjct: 187 NGNDIAG-------------------------IEPGAFDSAVFQSLNFGGTQNLLVIFKG 221
Query: 333 I--TDLRRLLKISLANNSIGGIIPPNLGSIEL--LEVLDLHNLNLRGEVPDDISNCRFLL 388
+ + ++ L + + I P + +E ++L + L
Sbjct: 222 LKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQ 281
Query: 389 LLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGS 448
LD++ L ++P L ++ LK L L N S N +L L + N+
Sbjct: 282 ELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLE 340
Query: 449 IPS-SLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLN 487
+ + L NL NL +LS +++ T + L
Sbjct: 341 LGTGCLENLENLRELDLSHDDIE-TSDCCNLQLRNLSHLQ 379
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 9e-28
Identities = 44/203 (21%), Positives = 73/203 (35%), Gaps = 4/203 (1%)
Query: 286 ICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLA 345
I E + ++ + IP ++ N + + L+ FN L T + L L + L
Sbjct: 9 IEKEVNKTYNCENLGLN-EIPGTLPN--STECLEFSFNVLPTIQNTTFSRLINLTFLDLT 65
Query: 346 NNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTL 405
I I S L+ L L L +S + L L + L
Sbjct: 66 RCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPL 125
Query: 406 YNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLS 465
+N L+ L L NH++ P L+VLD N++ + +L+ T+ +L+
Sbjct: 126 HNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLN 185
Query: 466 -SNNLSGTIPSTIQHFGVSTFLN 487
+ N I V LN
Sbjct: 186 LNGNDIAGIEPGAFDSAVFQSLN 208
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-07
Identities = 21/105 (20%), Positives = 42/105 (40%), Gaps = 2/105 (1%)
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGD 142
+ +L L L +L L + + ++ + +++S N L+ S E +
Sbjct: 463 KGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH 522
Query: 143 LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPL 187
L I L +L+ N S I +L + + ++L N L +
Sbjct: 523 LKGIYL-NLASNHISI-ILPSLLPILSQQRTINLRQNPLDCTCSN 565
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 1e-54
Identities = 89/316 (28%), Positives = 142/316 (44%), Gaps = 28/316 (8%)
Query: 564 STDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAV 623
S+ I +D + L KE IG GS G+V+RA + G +AV
Sbjct: 8 HPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKE-KIGAGSFGTVHRAEWHG-SDVAV 65
Query: 624 KKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL 682
K L + EF E+ + +RH N+V F G I++E++ +G+LY L
Sbjct: 66 KILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 125
Query: 683 HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN 742
H +L RR +A A+ ++YLH+ PPI+H NLKS N+L+D+
Sbjct: 126 HKSG---------AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKK 175
Query: 743 YEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT 802
Y K+ D+GL++L ++APE+ + ++K DVYSFGVIL EL T
Sbjct: 176 YTVKVCDFGLSRLKA-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234
Query: 803 GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVP 862
++P + +VV V +R + + +I+ C + P
Sbjct: 235 LQQPWGNLNPAQVVAA---VGFKCKRLEIPRNLNPQVA-----AIIEG------CWTNEP 280
Query: 863 SRRPSMAEVVQVLESI 878
+RPS A ++ +L +
Sbjct: 281 WKRPSFATIMDLLRPL 296
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-53
Identities = 73/301 (24%), Positives = 136/301 (45%), Gaps = 45/301 (14%)
Query: 583 SKYE-DWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELE 641
S + D++ ++ E ++G G+ G V +A + +A+K++E+ ++ F +E
Sbjct: 1 SLHMIDYK-----EIEVEEVVGRGAFGVVCKAKWRA-KDVAIKQIES---ESERKAFIVE 51
Query: 642 IGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELH 701
+ +LS + H N+V G + ++ E+ G+LY+ LHG P
Sbjct: 52 LRQLSRVNHPNIVKLYGACLNPVC--LVMEYAEGGSLYNVLHGAEPL---------PYYT 100
Query: 702 WSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE-PKLSDYGLAKLLPILD 760
+ L ++ ++YLH ++H +LK N+LL K+ D+G A +
Sbjct: 101 AAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ--- 157
Query: 761 NYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV 817
T N G ++APE+ + S+KCDV+S+G+IL E++T RKP + +
Sbjct: 158 ----THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRI 213
Query: 818 LCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
+ R + + L+ C S+ PS+RPSM E+V+++
Sbjct: 214 MWAVHNGT--RPPLIKNLPKPIE-----SLMTR------CWSKDPSQRPSMEEIVKIMTH 260
Query: 878 I 878
+
Sbjct: 261 L 261
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 3e-53
Identities = 74/310 (23%), Positives = 131/310 (42%), Gaps = 45/310 (14%)
Query: 583 SKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEG-GVSIAVKKL------ETLGRIRNQ 635
K + ++ IG G G V++ +A+K L I
Sbjct: 9 PKSRLPTLADNEIEYEK-QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKF 67
Query: 636 EEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI 695
+EF+ E+ +SN+ H N+V G + ++ EFVP G+LY L +P
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHP------- 118
Query: 696 GNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE-----PKLSDY 750
+ WS + + L A + Y+ + PPI+H +L+S NI L E K++D+
Sbjct: 119 ----IKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173
Query: 751 GLAKLLPILDNYGLTKFHNAVGYVAPEL--AQSLRLSDKCDVYSFGVILLELVTGRKPVE 808
GL++ + ++ ++APE A+ ++K D YSF +IL ++TG P +
Sbjct: 174 GLSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 809 SPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM 868
+ ++ + E L R + LR +I+ +C S P +RP
Sbjct: 230 EYSYGKIKFINMIREEGL-RPTIPEDCPPRLR-----NVIE------LCWSGDPKKRPHF 277
Query: 869 AEVVQVLESI 878
+ +V+ L +
Sbjct: 278 SYIVKELSEL 287
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 1e-50
Identities = 66/418 (15%), Positives = 135/418 (32%), Gaps = 39/418 (9%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ----TLWKINVSSNALSGSIPEFIGDL 143
L S L +L + L N + ++ +++S N + I +
Sbjct: 145 LPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQG 203
Query: 144 PNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEG------ 197
+ L L N S I + L L I + +EG
Sbjct: 204 IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTI 263
Query: 198 --FDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQ------------------- 236
F ++ N + + + + +S+ G ++ +
Sbjct: 264 DEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFP 323
Query: 237 FSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEV--GICGEGMQVF 294
+K+L L+ N L ++SY ++S N + ++
Sbjct: 324 TLDLPFLKSLTLTMNKGSISFKKV--ALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHL 381
Query: 295 DASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTG-ITDLRRLLKISLANNSIGGII 353
D S+N ++ + L+ LD + L L +LL + ++ +
Sbjct: 382 DLSFNGA-IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDF 440
Query: 354 PPNLGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLK 412
+ L L + + + ++ +N L LD+S L + L+
Sbjct: 441 DGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQ 500
Query: 413 ILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
+L++ N+L L +L LD S N + S ++L FNL++N+++
Sbjct: 501 LLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 4e-46
Identities = 65/415 (15%), Positives = 133/415 (32%), Gaps = 29/415 (6%)
Query: 83 SLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGD 142
L + S + S L+ L L + + + L + ++ N + P
Sbjct: 43 PLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSG 102
Query: 143 LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG-SIPLSIANCTYLEGFDFS 201
L ++ L + + K ++++HN + +P +N T L D S
Sbjct: 103 LTSLENLVAVETKLA-SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLS 161
Query: 202 FNNLSGELPSQICNIPVLDFISVR----GNALTGTVEEQFSQCQSIKNLDLSSNLFIG-L 256
+N + + + + +++ N + +++Q Q + L L N +
Sbjct: 162 YNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTLRGNFNSSNI 220
Query: 257 APFGVLGLKNISYFNVSHNGFHGEIPEV--------GICGEGMQVFDASWNEFDGVIPLS 308
+ L + + F E G+C + F ++ +
Sbjct: 221 MKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVK 280
Query: 309 ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDL 368
N+ + L + + + +S+ + +L L+ L L
Sbjct: 281 FHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF---LKSLTL 335
Query: 369 -HNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNM--TYLKILDLHQNHLNGST 425
N +G + L LD+S NAL + ++ L+ LDL N
Sbjct: 336 TMN---KGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IM 391
Query: 426 PPSLGNLSNLQVLDLSQNSLSGSIP-SSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
+ L LQ LD ++L S+ +L L + ++S N
Sbjct: 392 SANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLG 446
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 6e-43
Identities = 65/394 (16%), Positives = 122/394 (30%), Gaps = 26/394 (6%)
Query: 97 SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSY 156
S + + L N ++ L +++S + + L ++ L L+ N
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 157 SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSG-ELPSQICN 215
F + + L+ I L+ + + N + +LP+ N
Sbjct: 93 QS-FSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 216 IPVLDFISVRGNALTGTVEEQFSQCQSIKN----LDLSSNLFIGLAPFGVLGLKNISYFN 271
+ L + + N + + LD+S N I +
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN-PIDFIQDQAFQGIKLHELT 210
Query: 272 VSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIPLSITNCR--------NLKVLDLGF 322
+ N I + + G+ V EF L I + L +
Sbjct: 211 LRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTY 270
Query: 323 NRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDIS 382
L + +SLA SI + ++ + L + L+ D+
Sbjct: 271 TNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFKWQSLSIIRCQLKQFPTLDLP 328
Query: 383 NCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL--SNLQVLDL 440
L L ++ N I + L LDL +N L+ S S +L ++L+ LDL
Sbjct: 329 F---LKSLTLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDL 383
Query: 441 SQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
S N + ++ L L H + + L
Sbjct: 384 SFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTE 416
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-36
Identities = 65/357 (18%), Positives = 112/357 (31%), Gaps = 25/357 (7%)
Query: 134 GSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCT 193
GS+ I +PNI S ++P + TK + LS N L S +N +
Sbjct: 2 GSLNPCIEVVPNITY-QCMDQKLS-KVPDDIPSS---TKNIDLSFNPLKILKSYSFSNFS 56
Query: 194 YLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLF 253
L+ D S + + L + + GN + FS S++NL
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 254 IGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIPLSITNC 312
L F + L + NV+HN H + D S+N + +
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 313 RNLK----VLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLD 367
R LD+ N I I +L +++L N I L ++ L V
Sbjct: 177 RENPQVNLSLDMSLNP-IDFIQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHR 235
Query: 368 LHNLNLRGEVPDDISNCRFL--------LLLDVSGNALGGDIPQTLYNMTYLKILDLHQN 419
L + E +I + ++ D + + + + L
Sbjct: 236 LILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGV 295
Query: 420 HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST 476
+ + Q L + + L L L++L L+ N S +
Sbjct: 296 SIK--YLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSL---TLTMNKGSISFKKV 347
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-26
Identities = 37/189 (19%), Positives = 73/189 (38%), Gaps = 7/189 (3%)
Query: 303 GVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIE 361
G + I N+ +L +P I + + + L+ N + + + +
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKL-SKVPDDIPSSTKNI---DLSFNPLKILKSYSFSNFS 56
Query: 362 LLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHL 421
L+ LDL + L L ++GN + P + +T L+ L + L
Sbjct: 57 ELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKL 116
Query: 422 NGSTPPSLGNLSNLQVLDLSQNSLSG-SIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHF 480
+G L L+ L+++ N + +P+ NL NL H +LS N + + +Q
Sbjct: 117 ASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFL 176
Query: 481 GVSTFLNNT 489
+ +N +
Sbjct: 177 RENPQVNLS 185
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-26
Identities = 37/173 (21%), Positives = 59/173 (34%), Gaps = 5/173 (2%)
Query: 313 RNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
+ K +DL FN L ++ L + L+ I I + L L L
Sbjct: 32 SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNP 91
Query: 373 LRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG-STPPSLGN 431
++ P S L L L + + LK L++ N ++ P N
Sbjct: 92 IQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSN 151
Query: 432 LSNLQVLDLSQNSLSGSIPSSLGNLRNLTHF----NLSSNNLSGTIPSTIQHF 480
L+NL +DLS N + + L LR ++S N + Q
Sbjct: 152 LTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQDQAFQGI 204
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 2e-50
Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 38/285 (13%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660
+ G +++ ++G I VK L+ R +F E RL H N++ G
Sbjct: 18 LNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 661 WSSTMQ--LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
S +++ ++P G+LY+ LH N + S+ AL AR +++
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVLHEGT----------NFVVDQSQAVKFALDMARGMAF 126
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
LH +P I L S ++++DE+ ++S + A +VAPE
Sbjct: 127 LHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY------APAWVAPEA 179
Query: 779 ---AQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
D++SF V+L ELVT P + E+ + V R +
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK---VALEGLRPTIPPGI 236
Query: 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880
+ +L++ IC +E P++RP +V +LE +++
Sbjct: 237 SPHVS-----KLMK------ICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 3e-49
Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 42/288 (14%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLG---RIRNQEEFELEIGRLSNIRHFNLVAFQG 658
IG G G VYRA + G +AVK + E E + ++H N++A +G
Sbjct: 15 IGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
++ EF G L L + + A+ AR ++Y
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLS-------------GKRIPPDILVNWAVQIARGMNY 120
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEP--------KLSDYGLAKLLPILDNYGLTKFHNA 770
LH + PI+H +LKS+NIL+ + E K++D+GLA+ A
Sbjct: 121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAGA 177
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830
++APE+ ++ S DV+S+GV+L EL+TG P V V
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA---YGVAMNKLALP 234
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+ +L++ C + P RPS ++ L +I
Sbjct: 235 IPSTCPEPFA-----KLMED------CWNPDPHSRPSFTNILDQLTTI 271
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 1e-47
Identities = 74/318 (23%), Positives = 127/318 (39%), Gaps = 62/318 (19%)
Query: 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+ +G G G V+R S+ G ++AVK + R E E+ +RH N++
Sbjct: 10 ITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS--RDEKSWFRETELYNTVMLRHENILG 66
Query: 656 FQGY---YWSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
F S+ QL +++ + G+LYD L L I L
Sbjct: 67 FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-------------LTTLDTVSCLRIVLS 113
Query: 712 TARALSYLHHD-----CKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK 766
A L++LH + KP I H +LKS NIL+ +N + ++D GLA + N
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 767 FHNAVG---YVAPE-LAQSLRLSD-----KCDVYSFGVILLELVTGRKPVES-------- 809
+ VG Y+APE L +++++ + D+++FG++L E+
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 810 -------PTTNEV--VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSE 860
P+ ++ VV + R + S SL +L++ C +
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLA-----KLMKE------CWYQ 282
Query: 861 VPSRRPSMAEVVQVLESI 878
PS R + + + L I
Sbjct: 283 NPSARLTALRIKKTLTKI 300
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 1e-47
Identities = 80/310 (25%), Positives = 136/310 (43%), Gaps = 41/310 (13%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRI--RNQ 635
+DWE + + IG GS G+VY+ + G V AVK L +
Sbjct: 9 HHGSRDAADDWEIPDGQITVGQ-RIGSGSFGTVYKGKWHGDV--AVKMLNV-TAPTPQQL 64
Query: 636 EEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ---LILSEFVPKGNLYDNLHGVNYPGTST 692
+ F+ E+G L RH N++ F GY + I++++ +LY +LH
Sbjct: 65 QAFKNEVGVLRKTRHVNILLFMGY----STAPQLAIVTQWCEGSSLYHHLHA-------- 112
Query: 693 GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752
+ + IA TAR + YLH I+H +LKS NI L E+ K+ D+GL
Sbjct: 113 ---SETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGL 166
Query: 753 AKLLPILDNYG-LTKFHNAVGYVAPELAQ---SLRLSDKCDVYSFGVILLELVTGRKPVE 808
A + ++ ++APE+ + S S + DVY+FG++L EL+TG+ P
Sbjct: 167 ATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS 226
Query: 809 SPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSM 868
+ + ++ E++ RGS S + + + ++M C + RPS
Sbjct: 227 NINNRDQII------EMVGRGSLSPDLSKVRSNCPK-RMKRLMAE---CLKKKRDERPSF 276
Query: 869 AEVVQVLESI 878
++ +E +
Sbjct: 277 PRILAEIEEL 286
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 4e-47
Identities = 64/316 (20%), Positives = 119/316 (37%), Gaps = 48/316 (15%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ-E 636
+ ++W+ + L E LIG G G VY + G V A++ ++ +Q +
Sbjct: 18 ASQTSIFLQEWDIPFEQLEIGE-LIGKGRFGQVYHGRWHGEV--AIRLIDIERDNEDQLK 74
Query: 637 EFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIG 696
F+ E+ RH N+V F G S I++ LY +
Sbjct: 75 AFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRD-----------A 123
Query: 697 NPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756
L ++ IA + + YLH ILH +LKS N+ D + ++D+GL +
Sbjct: 124 KIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSIS 179
Query: 757 PILDNY----GLTKFHNAVGYVAPELAQSLRL---------SDKCDVYSFGVILLELVTG 803
+L L + + ++APE+ + L S DV++ G I EL
Sbjct: 180 GVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239
Query: 804 RKPVESPTTNEVVVLCEY-VRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVP 862
P ++ ++ ++ L + E+ ++ C +
Sbjct: 240 EWPFKTQPAEAIIWQMGTGMKPNLSQIGMGK------------EISDILLF---CWAFEQ 284
Query: 863 SRRPSMAEVVQVLESI 878
RP+ +++ +LE +
Sbjct: 285 EERPTFTKLMDMLEKL 300
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 3e-46
Identities = 72/313 (23%), Positives = 116/313 (37%), Gaps = 62/313 (19%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY- 659
IG G G V+ + G +AVK T E EI + +RH N++ F
Sbjct: 44 QIGKGRYGEVWMGKW-RGEKVAVKVFFT--TEEASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 660 ---YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
S T +++++ G+LYD L + L +A + L
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLK-------------STTLDAKSMLKLAYSSVSGL 147
Query: 717 SYLH-----HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
+LH KP I H +LKS NIL+ +N ++D GLA N + V
Sbjct: 148 CHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 772 G---YVAPE-LAQSLRLSD-----KCDVYSFGVILLELVTGRKPVES------------- 809
G Y+ PE L +SL + D+YSFG+IL E+
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 810 --PTTNEV--VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRR 865
P+ ++ +V + +R +S R + +L+ C + P+ R
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMG-----KLMTE------CWAHNPASR 316
Query: 866 PSMAEVVQVLESI 878
+ V + L +
Sbjct: 317 LTALRVKKTLAKM 329
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 5e-46
Identities = 71/310 (22%), Positives = 127/310 (40%), Gaps = 46/310 (14%)
Query: 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+ + IG G G V+R + G +AVK + R E EI + +RH N++
Sbjct: 44 IVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS--REERSWFREAEIYQTVMLRHENILG 100
Query: 656 FQGY---YWSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
F + QL ++S++ G+L+D L+ + +AL
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-------------RYTVTVEGMIKLALS 147
Query: 712 TARALSYLHHD-----CKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK 766
TA L++LH + KP I H +LKS NIL+ +N ++D GLA +
Sbjct: 148 TASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIA 207
Query: 767 FHNAVG---YVAPE-LAQSLRLSD-----KCDVYSFGVILLELVTGRKPVESPTTNEVVV 817
++ VG Y+APE L S+ + + D+Y+ G++ E+ R + + +
Sbjct: 208 PNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIGGIHEDYQLP 266
Query: 818 LCEYVRE--LLERGSASACFDRSLR-----GFAENELIQVMKLGLI--CTSEVPSRRPSM 868
+ V +E C + LR + E ++VM ++ C + R +
Sbjct: 267 YYDLVPSDPSVEEMRKVVCEQK-LRPNIPNRWQSCEALRVMA-KIMRECWYANGAARLTA 324
Query: 869 AEVVQVLESI 878
+ + L +
Sbjct: 325 LRIKKTLSQL 334
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 9e-46
Identities = 63/334 (18%), Positives = 109/334 (32%), Gaps = 62/334 (18%)
Query: 585 YEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEF--ELEI 642
+ L E IG G G+VY+ S + +AVK N++ F E I
Sbjct: 5 ASEPSLDLDNLKLLEL-IGRGRYGAVYKGSLDER-PVAVKVF----SFANRQNFINEKNI 58
Query: 643 GRLSNIRHFNLVAFQGY-----YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGN 697
R+ + H N+ F L++ E+ P G+L L
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLS-------------L 105
Query: 698 PELHWSRRFHIALGTARALSYLHHD------CKPPILHLNLKSTNILLDENYEPKLSDYG 751
W +A R L+YLH + KP I H +L S N+L+ + +SD+G
Sbjct: 106 HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165
Query: 752 LAKLLPILDNYGLTKF----HNAVG---YVAPELAQSL-------RLSDKCDVYSFGVIL 797
L+ L + + VG Y+APE+ + + D+Y+ G+I
Sbjct: 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
Query: 798 LELVTGRKPVE--SPTTNEVVVLCEYVREL--LERGSASACFDR---------SLRGFAE 844
E+ + + V E ++ A
Sbjct: 226 WEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAV 285
Query: 845 NELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
L + ++ C + R + + + +
Sbjct: 286 RSLKETIED---CWDQDAEARLTAQXAEERMAEL 316
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 8e-45
Identities = 68/319 (21%), Positives = 119/319 (37%), Gaps = 47/319 (14%)
Query: 580 SLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEF 638
S+P + L ++G G G + + G + +K+L Q F
Sbjct: 1 SMPHRIFRPSD-----LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE-ETQRTF 54
Query: 639 ELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNP 698
E+ + + H N++ F G + ++E++ G L + +
Sbjct: 55 LKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS-----------MDS 103
Query: 699 ELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758
+ WS+R A A ++YLH I+H +L S N L+ EN ++D+GLA+L+
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVD 160
Query: 759 LDNYGLT----------KFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRK 805
K + VG ++APE+ +K DV+SFG++L E++
Sbjct: 161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
Query: 806 PVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRR 865
+ VR L+R C + C P +R
Sbjct: 221 ADPDYLPRTMDFG-LNVRGFLDRYCPPNC---------PPSFFPITVR---CCDLDPEKR 267
Query: 866 PSMAEVVQVLESIRNGLGS 884
PS ++ LE++R L
Sbjct: 268 PSFVKLEHWLETLRMHLAG 286
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-43
Identities = 69/379 (18%), Positives = 146/379 (38%), Gaps = 50/379 (13%)
Query: 92 LSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDL 151
+ L L T + QE E++++ K+ V+ ++ SI I L N+ L+L
Sbjct: 18 DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNL 73
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPS 211
+ N + P + K + + N ++ I ++ N T L + +N+S S
Sbjct: 74 NGNQITDISPLSNLV---KLTNLYIGTNKIT-DIS-ALQNLTNLRELYLNEDNISD--IS 126
Query: 212 QICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFN 271
+ N+ + +++ N + S + L ++ + + P L ++ +
Sbjct: 127 PLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVKDVTPIA--NLTDLYSLS 183
Query: 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPT 331
+++N P + + +L N++ P
Sbjct: 184 LNYNQIEDISP--------------------------LASLTSLHYFTAYVNQITDITP- 216
Query: 332 GITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLD 391
+ ++ RL + + NN I + P L ++ L L++ + + + + L +L+
Sbjct: 217 -VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKMLN 271
Query: 392 VSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS 451
V N + L N++ L L L+ N L +G L+NL L LSQN ++ P
Sbjct: 272 VGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328
Query: 452 SLGNLRNLTHFNLSSNNLS 470
L +L + + ++ +
Sbjct: 329 -LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 3e-41
Identities = 69/337 (20%), Positives = 133/337 (39%), Gaps = 24/337 (7%)
Query: 138 EFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEG 197
DL L + S + + + + ++ ++ SI I T LE
Sbjct: 16 FPDADLAEGIRAVLQKASVTDVVTQEELE---SITKLVVAGEKVA-SIQ-GIEYLTNLEY 70
Query: 198 FDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLA 257
+ + N ++ S + N+ L + + N +T +++ L L+ + ++
Sbjct: 71 LNLNGNQITD--ISPLSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDIS 126
Query: 258 PFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKV 317
P L + N+ N ++ + + + ++ V P++ N +L
Sbjct: 127 PLA--NLTKMYSLNLGANHNLSDLSPLSNMTG-LNYLTVTESKVKDVTPIA--NLTDLYS 181
Query: 318 LDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEV 377
L L +N++ P + L L + N I I P + ++ L L + N +
Sbjct: 182 LSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD-- 235
Query: 378 PDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQV 437
++N L L++ N + DI + ++T LK+L++ N + S L NLS L
Sbjct: 236 LSPLANLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNS 291
Query: 438 LDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
L L+ N L +G L NLT LS N+++ P
Sbjct: 292 LFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP 328
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 92.2 bits (230), Expect = 3e-20
Identities = 35/161 (21%), Positives = 64/161 (39%), Gaps = 12/161 (7%)
Query: 315 LKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLR 374
L I I DL ++ L S+ ++ +E + L + +
Sbjct: 2 AATLATLPAP-INQI-FPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 375 GEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSN 434
I L L+++GN + P L N+ L L + N + + +L NL+N
Sbjct: 58 S--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 435 LQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
L+ L L+++++S P L NL + NL +N+ +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSP 150
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 1e-17
Identities = 32/186 (17%), Positives = 69/186 (37%), Gaps = 13/186 (6%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
++ L L L+L N+ A + +L N ++ P + ++ + L
Sbjct: 171 TPIANLTDLYSLSLNYNQIED--ISPLASLTSLHYFTAYVNQITDITP--VANMTRLNSL 226
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
+ N + P A + ++ + N +S I ++ + T L+ + N +S
Sbjct: 227 KIGNNKITDLSPLA---NLSQLTWLEIGTNQIS-DIN-AVKDLTKLKMLNVGSNQISD-- 279
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
S + N+ L+ + + N L E ++ L LS N + P L +
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLA--SLSKMDS 337
Query: 270 FNVSHN 275
+ ++
Sbjct: 338 ADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 4e-07
Identities = 19/93 (20%), Positives = 36/93 (38%), Gaps = 5/93 (5%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
A+ L L++L + N+ + + L + +++N L E IG L N+ L
Sbjct: 259 NAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTL 316
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLS 182
LS+N + P K ++ +
Sbjct: 317 FLSQNHITDIRP---LASLSKMDSADFANQVIK 346
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-41
Identities = 86/435 (19%), Positives = 157/435 (36%), Gaps = 30/435 (6%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTL----WKINVSSNALSGSIPEFIGDL 143
L S L +L L L N+ + + + +++S N ++ I
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKE 199
Query: 144 PNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL------SHNNLSGSIPLSIANCTYLEG 197
+ L L N S + + + L + NL ++ L
Sbjct: 200 IRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTI 259
Query: 198 FDFSFNNLSG---ELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFI 254
+F L ++ + + S+ + + FS ++L+L + F
Sbjct: 260 EEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG 317
Query: 255 GLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE--FDGVIPLSITNC 312
L LK++ + N EV + ++ D S N F G S
Sbjct: 318 QFPT---LKLKSLKRLTFTSNKGGNAFSEVDL--PSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 313 RNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLDLHNL 371
+LK LDL FN +I ++ + L +L + ++++ + + S+ L LD+ +
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 372 NLRGEVPDDISNCRFLLLLDVSGNALGGDIPQ-TLYNMTYLKILDLHQNHLNGSTPPSLG 430
+ R + L +L ++GN+ + + L LDL Q L +P +
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 491
Query: 431 NLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTG 490
+LS+LQVL+++ N L L +L L +N + P I + S +LN
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPR-IDYL--SRWLNKNS 548
Query: 491 LCGPPLETSCSGRGK 505
CSG GK
Sbjct: 549 QKEQGSAK-CSGSGK 562
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-38
Identities = 81/405 (20%), Positives = 140/405 (34%), Gaps = 29/405 (7%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNAL-SGSIPEFIGDLPNIRLL 149
A SGL SL+ L ++TL ++NV+ N + S +PE+ +L N+ L
Sbjct: 95 AFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHL 154
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFV----SLSHNNLSGSIPLSIANCTYLEGFDFSFNNL 205
DLS N I + ++ + LS N ++ I L N
Sbjct: 155 DLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLTLRNNFD 212
Query: 206 SGELPSQIC-NIPVLDFIS------VRGNALTGTVEEQFSQCQS--IKNLDLSSNLFIGL 256
S + + L+ L + + I+ L+ +
Sbjct: 213 SLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLD 272
Query: 257 APFGVL-GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNL 315
+ L N+S F++ + + G Q + +F L ++L
Sbjct: 273 DIIDLFNCLTNVSSFSLVSVTIE-RVKD-FSYNFGWQHLELVNCKFGQFPTLK---LKSL 327
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIG--GIIPPNLGSIELLEVLDLHNLNL 373
K L N+ G+ + + DL L + L+ N + G + L+ LDL +
Sbjct: 328 KRLTFTSNK-GGNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 374 RGEVPDDISNCRFLLLLDVSGNALGGDIPQ-TLYNMTYLKILDLHQNHLNGSTPPSLGNL 432
+ + L LD + L ++ L LD+ H + L
Sbjct: 386 I-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGL 444
Query: 433 SNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSNNLSGTIPST 476
S+L+VL ++ NS + LRNLT +LS L P+
Sbjct: 445 SSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 489
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-35
Identities = 71/398 (17%), Positives = 135/398 (33%), Gaps = 27/398 (6%)
Query: 97 SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSY 156
S + L L N + L +++S + L ++ L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 157 SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNL-SGELPSQICN 215
+ F + + NL+ I + L+ + + N + S +LP N
Sbjct: 89 Q-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 216 IPVLDFISVRGNALTGTVEEQFSQCQSIKN----LDLSSNLFIGLAPFGVLGLKNISYFN 271
+ L+ + + N + + LDLS N + G +
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN-PMNFIQPGAFKEIRLHKLT 206
Query: 272 VSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIPLS------ITNCRNLKVLDLGFNR 324
+ +N + + I G G++V EF L + NL + +
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 325 L---IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI 381
L + I L + SL + +I + + + L+L N +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFGQFPTLKL 324
Query: 382 SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN--GSTPPSLGNLSNLQVLD 439
+ L L + N G + ++ L+ LDL +N L+ G S ++L+ LD
Sbjct: 325 KS---LKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLD 379
Query: 440 LSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTI 477
LS N + ++ S+ L L H + +NL ++
Sbjct: 380 LSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 9e-24
Identities = 71/376 (18%), Positives = 120/376 (31%), Gaps = 47/376 (12%)
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
++ +IP L TK + LS N L S + L+ D S +
Sbjct: 13 QCMELNFY-KIPDNLPFS---TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIE 68
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
++ L + + GN + FS S++ L L F + LK +
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKE 128
Query: 270 FNVSHNGF-HGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKV----LDLGFNR 324
NV+HN ++PE ++ D S N+ + + + + LDL N
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188
Query: 325 LIGSIPTGITDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLDL------HNLNLRGEV 377
+ I G RL K++L NN + + + LEV L + NL
Sbjct: 189 -MNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247
Query: 378 PDDISNCRFLLLLDVSGNAL---GGDIPQTLYNMTYLKILDLHQNHLNGSTPPSL----- 429
+ L + + L DI +T + L + S
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQ 307
Query: 430 --------------GNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
L +L+ L + N + S +L +L +LS N L
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGL------ 359
Query: 476 TIQHFGVSTFLNNTGL 491
+ + + T L
Sbjct: 360 SFKGCCSQSDFGTTSL 375
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-21
Identities = 37/183 (20%), Positives = 71/183 (38%), Gaps = 7/183 (3%)
Query: 309 ITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLD 367
+ N+ IP + + L L+ N + + + S L+VLD
Sbjct: 4 VEVVPNITY-QCMELNFY-KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLD 58
Query: 368 LHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPP 427
L ++ + L L ++GN + ++ L+ L + +L
Sbjct: 59 LSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENF 118
Query: 428 SLGNLSNLQVLDLSQNSL-SGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFL 486
+G+L L+ L+++ N + S +P NL NL H +LSSN + + ++ L
Sbjct: 119 PIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLL 178
Query: 487 NNT 489
N +
Sbjct: 179 NLS 181
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-40
Identities = 83/402 (20%), Positives = 156/402 (38%), Gaps = 34/402 (8%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
+ L +L + N+ T + L I +++N ++ P + +L N+ L
Sbjct: 62 DGVEYLNNLTQINFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGL 117
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
L N + P + LS N +S LS T L+ F N ++
Sbjct: 118 TLFNNQITDIDPLKNLT---NLNRLELSSNTISDISALS--GLTSLQQLSFG-NQVTDLK 171
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
P + N+ L+ + + N ++ ++ ++++L ++N + P G L N+
Sbjct: 172 P--LANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLG--ILTNLDE 225
Query: 270 FNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSI 329
+++ N +I + + D + N+ + PLS L L LG N++
Sbjct: 226 LSLNGNQLK-DIGTLASL-TNLTDLDLANNQISNLAPLS--GLTKLTELKLGANQISNIS 281
Query: 330 PTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
P + L L + L N + I P + +++ L L L+ N+ P +S+ L
Sbjct: 282 P--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR 335
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI 449
L N + +L N+T + L N + S L NL+ + L L+ + + +
Sbjct: 336 LFFYNNKVSD--VSSLANLTNINWLSAGHNQI--SDLTPLANLTRITQLGLNDQAWTNAP 391
Query: 450 PSSLGNLRNLTHFNLSSNNLSGTI-PSTIQHFGVSTFLNNTG 490
+ N+ N N I P+TI G T + T
Sbjct: 392 VNYKANVSIP---NTVKNVTGALIAPATISDGGSYTEPDITW 430
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 2e-37
Identities = 75/385 (19%), Positives = 134/385 (34%), Gaps = 76/385 (19%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
+ L L T + Q ++ + + + + + L N+ +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
+ S N + P K + +++N ++ PL+ N T L G N ++
Sbjct: 74 NFSNNQLTDITPLKNLT---KLVDILMNNNQIADITPLA--NLTNLTGLTLFNNQITDID 128
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
P ++ L+LSSN ++ GL ++
Sbjct: 129 P--------------------------LKNLTNLNRLELSSNTISDISALS--GLTSLQQ 160
Query: 270 FNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSI 329
+ + + N L+ LD+ N++ S
Sbjct: 161 LSFGNQVTD---------------------------LKPLANLTTLERLDISSNKV--SD 191
Query: 330 PTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
+ + L L + NN I I P LG + L+ L L+ L+ +++ L
Sbjct: 192 ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTD 247
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI 449
LD++ N + P L +T L L L N + S L L+ L L+L++N L
Sbjct: 248 LDLANNQISNLAP--LSGLTKLTELKLGANQI--SNISPLAGLTALTNLELNENQLEDIS 303
Query: 450 PSSLGNLRNLTHFNLSSNNLSGTIP 474
P + NL+NLT+ L NN+S P
Sbjct: 304 P--ISNLKNLTYLTLYFNNISDISP 326
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 5e-36
Identities = 76/386 (19%), Positives = 148/386 (38%), Gaps = 31/386 (8%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
L+ L +L LTLF N+ T + L ++ +SSN +S + L +++ L
Sbjct: 106 TPLANLTNLTGLTLFNNQITD--IDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQL 161
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
+ P A + + +S N +S +A T LE + N +S
Sbjct: 162 SFGNQV-TDLKPLA---NLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDIT 215
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
P + + LD +S+ GN L + ++ +LDL++N LAP GL ++
Sbjct: 216 P--LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQISNLAPLS--GLTKLTE 269
Query: 270 FNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSI 329
+ N I + + + + N+ + + P+S N +NL L L FN +
Sbjct: 270 LKLGANQISN-ISPLAGL-TALTNLELNENQLEDISPIS--NLKNLTYLTLYFNNISDIS 325
Query: 330 PTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
P ++ L +L ++ NN + + +L ++ + L + + P ++N +
Sbjct: 326 P--VSSLTKLQRLFFYNNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQ 379
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPS-LGNLSNLQVLDLSQNSLSGS 448
L ++ A N + I + +N P+ + + + D++ N S
Sbjct: 380 LGLNDQAWTNAPVNYKAN---VSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-Y 435
Query: 449 IPSSLGNLRNLTHFNLSSNNLSGTIP 474
+ SGT+
Sbjct: 436 TNEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 5/65 (7%), Positives = 19/65 (29%), Gaps = 6/65 (9%)
Query: 416 LHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
+N L+ L + +++ ++ +L +T +
Sbjct: 9 TQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSID 62
Query: 476 TIQHF 480
+++
Sbjct: 63 GVEYL 67
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-37
Identities = 65/390 (16%), Positives = 125/390 (32%), Gaps = 47/390 (12%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSI-PEFIGDLPNIRLLDL 151
L + L L N + ++ L + + S +I E +LPN+R+LDL
Sbjct: 21 QVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDL 80
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSI--PLSIANCTYLEGFDFSFNNLSG-E 208
+ + F+ + + L LS ++ N L D S N +
Sbjct: 81 GSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLY 139
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQ--SIKNLDLSSNLFIGLAPFGVLGLKN 266
L + L I N + E + Q ++ L++N N
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199
Query: 267 ------ISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDL 320
+ +VS NG+ +I N S+ ++
Sbjct: 200 PFRNMVLEILDVSGNGWTVDIT------------GNFSNAISKSQAFSLILAHHIMGAGF 247
Query: 321 GFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDD 380
GF+ + N+ G+ ++ LDL + +
Sbjct: 248 GFHNIK----------------DPDQNTFAGLARSSV------RHLDLSHGFVFSLNSRV 285
Query: 381 ISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDL 440
+ L +L+++ N + + Y + L++L+L N L + L + +DL
Sbjct: 286 FETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDL 345
Query: 441 SQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
+N ++ + L L +L N L+
Sbjct: 346 QKNHIAIIQDQTFKFLEKLQTLDLRDNALT 375
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-36
Identities = 85/428 (19%), Positives = 158/428 (36%), Gaps = 50/428 (11%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYA--EMQTLWKINVSSNALSG-SIPEFIGDLPNIR 147
A GL L L L+ + + ++ ++ L ++++S N + + G L +++
Sbjct: 92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLK 151
Query: 148 LLDLSRNSYSGEIPFALFKYCYKT--KFVSLSHNNLSGSIPLSIANC------TYLEGFD 199
+D S N + + F SL+ N+L + + C LE D
Sbjct: 152 SIDFSSNQIF-LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILD 210
Query: 200 FSFNNLSGELPSQICN-IPVLDFISVRGNALTGTVEEQFSQCQ-------------SIKN 245
S N + ++ N I S+ F + S+++
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRH 270
Query: 246 LDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGV 304
LDLS L LK++ N+++N + +I + G + +QV + S+N +
Sbjct: 271 LDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN-KIADEAFYGLDNLQVLNLSYNLLGEL 329
Query: 305 IPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGI-IPPNLGSIEL- 362
+ + +DL N + L +L + L +N++ I P++ I L
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLS 389
Query: 363 -------------LEVLDLHNLNLRG-EVPDDISNCRFLLLLDVSGNALGG-DIPQTLYN 407
++ L L ++ + L +L ++ N QT
Sbjct: 390 GNKLVTLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSE 449
Query: 408 MTYLKILDLHQNHLNGSTPPSL-----GNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHF 462
L+ L L +N L + L LS+LQVL L+ N L+ P +L L
Sbjct: 450 NPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGL 509
Query: 463 NLSSNNLS 470
+L+SN L+
Sbjct: 510 SLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-35
Identities = 69/393 (17%), Positives = 130/393 (33%), Gaps = 54/393 (13%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLD 150
+ L+ L++L L + E +LPN+R+LD
Sbjct: 43 SFPFLEQLQLLELGSQYTPLTID-----------------------KEAFRNLPNLRILD 79
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSI--PLSIANCTYLEGFDFSFNNLSG- 207
L + + F+ + + L LS ++ N L D S N +
Sbjct: 80 LGSSKIY-FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSL 138
Query: 208 ELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQ--SIKNLDLSSNLFIGLAPFGVLGLK 265
L + L I N + E + Q ++ L++N
Sbjct: 139 YLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCM 198
Query: 266 N------ISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLD 319
N + +VS NG+ +I N S+ ++
Sbjct: 199 NPFRNMVLEILDVSGNGWTVDIT------------GNFSNAISKSQAFSLILAHHIMGAG 246
Query: 320 LGFNRLIGSIPTGITDLRR--LLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEV 377
GF+ + L R + + L++ + + +++ L+VL+L +
Sbjct: 247 FGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIA 306
Query: 378 PDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQV 437
+ L +L++S N LG Y + + +DL +NH+ + L LQ
Sbjct: 307 DEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQT 366
Query: 438 LDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
LDL N+L +++ + ++ LS N L
Sbjct: 367 LDLRDNAL-----TTIHFIPSIPDIFLSGNKLV 394
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-23
Identities = 77/464 (16%), Positives = 145/464 (31%), Gaps = 110/464 (23%)
Query: 81 NFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFI 140
+ + + S LK L+VL L N+ + + + L +N+S N L
Sbjct: 275 HGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF 334
Query: 141 GDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDF 200
LP + +DL +N + I FK+ K + + L N L+ +I +
Sbjct: 335 YGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFL 388
Query: 201 SFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFG 260
S N L +P ++ + + LS N L
Sbjct: 389 SGNKLV--------TLPKINL--------------------TANLIHLSENRLENLDILY 420
Query: 261 VL-GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLD 319
L + ++ ++ N F +L+ L
Sbjct: 421 FLLRVPHLQILILNQNRFS-SCSGDQTPS----------------------ENPSLEQLF 457
Query: 320 LGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPD 379
LG N L + T + + L+VL L++ L +P
Sbjct: 458 LGENMLQLAWETELC-------------------WDVFEGLSHLQVLYLNHNYLN-SLP- 496
Query: 380 DISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLD 439
P ++T L+ L L+ N L + +NL++LD
Sbjct: 497 ----------------------PGVFSHLTALRGLSLNSNRL--TVLSHNDLPANLEILD 532
Query: 440 LSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLETS 499
+S+N L P +L+ +++ N + F N + GPP +
Sbjct: 533 ISRNQLLAPNPDV---FVSLSVLDITHNKFICECE--LSTFINWLNHTNVTIAGPPADIY 587
Query: 500 CS--GRGKGMTPTSKNPKVLSVSAIVAIVAAALILAGVCVVTIM 541
C G++ S + + ++ + +L + +T+
Sbjct: 588 CVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLF 631
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 5e-19
Identities = 37/176 (21%), Positives = 68/176 (38%), Gaps = 8/176 (4%)
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRG 375
++ F L +P + RL L+ N I + + +E L++L+L +
Sbjct: 7 RIAFYRFCNLT-QVPQVLNTTERL---LLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 376 EVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPS--LGNL 432
+ + N L +LD+ + + P + +L L L+ L+ + NL
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 433 SNLQVLDLSQNSLSG-SIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLN 487
L LDLS+N + + S G L +L + SSN + ++ T
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSF 178
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 2e-14
Identities = 26/129 (20%), Positives = 47/129 (36%), Gaps = 11/129 (8%)
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG 423
+ NL +VP ++ L +S N + + + L++L+L +
Sbjct: 7 RIAFYRFCNLT-QVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 424 STPP-SLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGV 482
+ + NL NL++LDL + + P + L +L L LS +
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKD------ 116
Query: 483 STFLNNTGL 491
F N L
Sbjct: 117 GYFRNLKAL 125
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 5e-14
Identities = 59/328 (17%), Positives = 107/328 (32%), Gaps = 30/328 (9%)
Query: 77 IVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSI 136
+ L LG + S GL + + L N Q + ++ L +++ NAL+
Sbjct: 319 LNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT--- 375
Query: 137 PEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG-SIPLSIANCTYL 195
I +P+I + LS N L K + LS N L I + +L
Sbjct: 376 --TIHFIPSIPDIFLSGNKLVT-----LPKINLTANLIHLSENRLENLDILYFLLRVPHL 428
Query: 196 EGFDFSFNNLSGELPSQICNIPV-LDFISVRGNALTGTVEEQ-----FSQCQSIKNLDLS 249
+ + N S Q + L+ + + N L E + F ++ L L+
Sbjct: 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488
Query: 250 SNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSI 309
N L P L + +++ N + + +++ D S N+ P
Sbjct: 489 HNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHNDLPA-NLEILDISRNQLLAPNP--- 543
Query: 310 TNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLH 369
+L VLD+ N+ I ++ L + I I +
Sbjct: 544 DVFVSLSVLDITHNKFICECE--LSTFINWLNHTNVT------IAGPPADIYCVYPDSFS 595
Query: 370 NLNLRGEVPDDISNCRFLLLLDVSGNAL 397
++L + L L S +
Sbjct: 596 GVSLFSLSTEGCDEEEVLKSLKFSLFIV 623
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 2e-05
Identities = 36/186 (19%), Positives = 66/186 (35%), Gaps = 14/186 (7%)
Query: 79 LWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPE 138
L + GL L+VL L N P ++ + L ++++SN L+ +
Sbjct: 463 LQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSH 521
Query: 139 FIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGF 198
N+ +LD+SRN P + ++HN LS T++
Sbjct: 522 ND-LPANLEILDISRNQLLAPNPDVFV----SLSVLDITHNKFICECELS----TFINWL 572
Query: 199 DFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAP 258
+ + ++G C P S G +L E + + +K+L S + +
Sbjct: 573 NHTNVTIAGPPADIYCVYP----DSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTL 628
Query: 259 FGVLGL 264
L
Sbjct: 629 TLFLMT 634
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 6e-37
Identities = 72/406 (17%), Positives = 146/406 (35%), Gaps = 64/406 (15%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIR 147
++P L+ + T +P E +++ + + + + P G+ +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 148 LLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSG 207
+ L + + L++ LS S+P + L S N+L+
Sbjct: 62 VSRLRDCLDR------------QAHELELNNLGLS-SLPELPPHLESL---VASCNSLT- 104
Query: 208 ELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNI 267
ELP ++ L + AL+ ++ L +S+N L +
Sbjct: 105 ELPELPQSLKSLLVDNNNLKALS-------DLPPLLEYLGVSNNQLEKLPELQ--NSSFL 155
Query: 268 SYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIG 327
+V +N ++P+ ++ A N+ + +P + N L + N L
Sbjct: 156 KIIDVDNNSLK-KLPD-LPP--SLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK- 208
Query: 328 SIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFL 387
+P L + NN + P L ++ L + N L+ +PD + L
Sbjct: 209 KLPDLPLSLESI---VAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEAL 262
Query: 388 LLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL--------------S 433
+ D D+P+ ++T+L + + + L+ PP+L L
Sbjct: 263 NVRDNYLT----DLPELPQSLTFLDVSENIFSGLS-ELPPNLYYLNASSNEIRSLCDLPP 317
Query: 434 NLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
+L+ L++S N L +P+ L L S N+L+ +P Q+
Sbjct: 318 SLEELNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQN 358
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 7e-33
Identities = 74/406 (18%), Positives = 138/406 (33%), Gaps = 76/406 (18%)
Query: 95 LKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRN 154
+ L L + +LP+ +++L S N+L+ +PE L ++ + + +
Sbjct: 70 DRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLK 124
Query: 155 SYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC 214
+ S P +++ +S+N L +P + N ++L+ D N+L +LP
Sbjct: 125 ALSDLPP--------LLEYLGVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPP 173
Query: 215 NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSH 274
++ + N L E + + +N L ++ +
Sbjct: 174 SLEFIA---AGNNQLEELPE--LQNLPFLTAIYADNNSLKKLPD----LPLSLESIVAGN 224
Query: 275 NGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGIT 334
N E+PE+ + A N +P + L V D +P
Sbjct: 225 NILE-ELPELQNL-PFLTTIYADNNLL-KTLPDLPPSLEALNVRDNYLT----DLPELPQ 277
Query: 335 DLRRLLKISLANNSIGGIIPPNLGSIEL--------------LEVLDLHNLNLRGEVPDD 380
L L + + + PPNL + LE L++ N L E+P
Sbjct: 278 SLTFLDVSENIFSGLSEL-PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL 335
Query: 381 ISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL-------- 432
L L S N L ++P+ N LK L + N L P ++
Sbjct: 336 PPR---LERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRMNSH 387
Query: 433 --------SNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
NL+ L + N L P ++ +L ++S +
Sbjct: 388 LAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVV 429
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 7e-30
Identities = 70/381 (18%), Positives = 127/381 (33%), Gaps = 74/381 (19%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
P L L+++ + N LP ++ + +N L +PE +LP + +
Sbjct: 147 PELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFI---AAGNNQLE-ELPEL-QNLPFLTAI 200
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
NS L + + +N L +P + N +L N L L
Sbjct: 201 YADNNSLK-----KLPDLPLSLESIVAGNNILE-ELP-ELQNLPFLTTIYADNNLLK-TL 252
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
P ++ L+ L QS+ LD+S N+F GL+ N+ Y
Sbjct: 253 PDLPPSLEALNVRDNYLTDLP-------ELPQSLTFLDVSENIFSGLSEL----PPNLYY 301
Query: 270 FNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSI 329
N S N + + +L+ L++ N+LI +
Sbjct: 302 LNASSNEIR-SLCD---------------------------LPPSLEELNVSNNKLI-EL 332
Query: 330 PTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
P L RL + N + + P + L+ L + LR E PD + L +
Sbjct: 333 PALPPRLERL---IASFNHLAEV-PELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 384
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI 449
N+ ++P+ N LK L + N L P + +++ L ++ +
Sbjct: 385 -----NSHLAEVPELPQN---LKQLHVETNPL--REFPDI--PESVEDLRMNSERVVDPY 432
Query: 450 PSSLGNLRNLTHFNLSSNNLS 470
+ L ++
Sbjct: 433 EFAHETTDKLEDDVFEHHHHH 453
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-35
Identities = 48/389 (12%), Positives = 113/389 (29%), Gaps = 21/389 (5%)
Query: 95 LKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRN 154
++ + + L + ++++S N LS + + LL+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 155 SYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC 214
+ + + L++N + + +E + NN+S +
Sbjct: 69 VLYETLDLESLS---TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-RVSCSRG 119
Query: 215 NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLG-LKNISYFNVS 273
I + N +T + ++ LDL N + + + + N+
Sbjct: 120 --QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQ 177
Query: 274 HNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI 333
+N + ++ + ++ D S N+ + + + + L N+L+ I +
Sbjct: 178 YNFIY-DVKG-QVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 334 TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVS 393
+ L L N + S + V + ++ + C L
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
Query: 394 GNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLG----NLSNLQVLDLSQNSLSGSI 449
+ LK + GS L N + + +D + I
Sbjct: 293 AYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVI 352
Query: 450 PSSLGNLRNLTHFNLSSNNLSGTIPSTIQ 478
+ L + + +
Sbjct: 353 DQVTLRKQAKITLEQKKKALDEQVSNGRR 381
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-32
Identities = 55/346 (15%), Positives = 122/346 (35%), Gaps = 19/346 (5%)
Query: 135 SIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTY 194
+I E + ++ ++ +S + +L + + K + LS N LS +A T
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 195 LEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFI 254
LE + S N L E + ++ L + + N + + SI+ L ++N
Sbjct: 60 LELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS 112
Query: 255 GLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGV-IPLSITNC 312
++ G KNI +++N + ++ +Q D NE D V +
Sbjct: 113 RVSCSRGQGKKNI---YLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASS 168
Query: 313 RNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
L+ L+L +N + + + +L + L++N + + P S + + L N
Sbjct: 169 DTLEHLNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNK 225
Query: 373 LRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL 432
L + + + L D+ GN + + ++ + + + T +
Sbjct: 226 LV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEEC 283
Query: 433 SNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQ 478
+ + L L + + G+ ++
Sbjct: 284 TVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLE 329
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 106 bits (265), Expect = 4e-24
Identities = 49/387 (12%), Positives = 115/387 (29%), Gaps = 21/387 (5%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
L L +LR L L N L ++ ++ ++N +S + + +
Sbjct: 74 LDLESLSTLRTLDLNNNYVQ-ELLV----GPSIETLHAANNNIS-RVSC--SRGQGKKNI 125
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG-SIPLSIANCTYLEGFDFSFNNLSGE 208
L+ N + + + +++ L N + + A+ LE + +N + +
Sbjct: 126 YLANNKIT-MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-D 183
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
+ Q+ L + + N L + +F + + L +N + + + +N+
Sbjct: 184 VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVLI-EKALRFSQNLE 240
Query: 269 YFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGS 328
+F++ NGFH + +V + + + C + G
Sbjct: 241 HFDLRGNGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 329 IPTGITDLRRLLKISLANNSIGG----IIPPNLGSIELLEVLDLHNLNLRGEVPDDISNC 384
L L + A S G + + +D R +
Sbjct: 300 PAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLRK 359
Query: 385 RFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNS 444
+ + L+ AL + L + S LQ+L
Sbjct: 360 QAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATE-EQSPLQLLRAIVKR 418
Query: 445 LS-GSIPSSLGNLRNLTHFNLSSNNLS 470
+ + +++ + +
Sbjct: 419 YEEMYVEQQSVQNNAIRDWDMYQHKET 445
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 10/50 (20%), Positives = 23/50 (46%)
Query: 430 GNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
N + ++ ++ +SL ++ S + N+ +LS N LS + +
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAP 56
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-35
Identities = 50/368 (13%), Positives = 107/368 (29%), Gaps = 53/368 (14%)
Query: 110 GNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCY 169
G+ + + + + + D +R + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS-----N 56
Query: 170 KTKFVSLSHNNLSGSIPLSIANCTY--LEGFDFSFNNLSGELPSQICNIPVLDFISVRGN 227
+ + + L + + + T + L + P Q + L +++
Sbjct: 57 NPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAA 114
Query: 228 ALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGIC 287
L + + Q ++ L L+ N L P + L + ++ E+PE +
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPE-PLA 171
Query: 288 GEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANN 347
NL+ L L + + S+P I +L+ L + + N+
Sbjct: 172 --------------STDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNS 216
Query: 348 SIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYN 407
+ + P + + LE LDL P L L +
Sbjct: 217 PLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC------------ 263
Query: 408 MTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467
++L + P + L+ L+ LDL +PS + L +
Sbjct: 264 -----------SNL-LTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILV-PP 310
Query: 468 NLSGTIPS 475
+L +
Sbjct: 311 HLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-34
Identities = 42/253 (16%), Positives = 85/253 (33%), Gaps = 19/253 (7%)
Query: 235 EQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGIC-GEGMQV 293
+ SQ Q N D + N + + G
Sbjct: 30 DVLSQWQRHYNADRNRWHSAWRQA----NSNNPQIETRTGRALKATADLLEDATQPGRVA 85
Query: 294 FDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGII 353
+ P +L+ + + L+ +P + L ++LA N + +
Sbjct: 86 LELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-AL 142
Query: 354 PPNLGSIELLEVLDLHNLNLRGEVPDDISNCRF---------LLLLDVSGNALGGDIPQT 404
P ++ S+ L L + E+P+ +++ L L + + +P +
Sbjct: 143 PASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPAS 201
Query: 405 LYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNL 464
+ N+ LK L + + L+ + P++ +L L+ LDL + + P G L L
Sbjct: 202 IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLIL 260
Query: 465 SSNNLSGTIPSTI 477
+ T+P I
Sbjct: 261 KDCSNLLTLPLDI 273
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 3e-24
Identities = 39/285 (13%), Positives = 90/285 (31%), Gaps = 20/285 (7%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQ--EYAEMQTLWKINVSSNALSGSIPEFIGDLPN 145
+ + + ++ T G E A + + S L P+ L +
Sbjct: 48 SAWRQANSNNPQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSH 105
Query: 146 IRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNL 205
++ + + E+P + + + ++L+ N L ++P SIA+ L
Sbjct: 106 LQHMTIDAAGLM-ELPDTMQQ-FAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPE 162
Query: 206 SGELPSQICNIPVLDFI---------SVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256
ELP + + + + ++ + Q++K+L + ++ L
Sbjct: 163 LTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSAL 221
Query: 257 APFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIPLSITNCRNL 315
+ L + ++ P G ++ +PL I L
Sbjct: 222 -GPAIHHLPKLEELDLRGCTALRNYPP-IFGGRAPLKRLILKDCSNLLTLPLDIHRLTQL 279
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
+ LDL + +P+ I L I + + + +
Sbjct: 280 EKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 4e-35
Identities = 60/399 (15%), Positives = 124/399 (31%), Gaps = 32/399 (8%)
Query: 81 NFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFI 140
+ + +GL SL L + Q ++ + + + + + + F
Sbjct: 133 VETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFA 192
Query: 141 GDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDF 200
L ++R L+L + + F+ + + S S L +
Sbjct: 193 DILSSVRYLELRDTNLA-RFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYIL 251
Query: 201 SFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFG 260
+ + + + + E + +I+ L +
Sbjct: 252 ELSEVE------FDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTV 305
Query: 261 VLGLKNISYFNVSHNGFHGEIPEVGICGEGM---QVFDASWNEFDGVI---PLSITNCRN 314
L+ + V ++ +P + + + D S N +
Sbjct: 306 YSLLEKVKRITVENSKVF-LVPCS--FSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPS 362
Query: 315 LKVLDLGFNRL--IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
L+ L L N L + + L+ L + ++ N+ +P + E + L+L +
Sbjct: 363 LQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTG 421
Query: 373 LRGEVPDDISNCRF--LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLG 430
+R + C L +LDVS N L + L+ L + +N L T P
Sbjct: 422 IR-----VVKTCIPQTLEVLDVSNNNLD-SFSL---FLPRLQELYISRNKL--KTLPDAS 470
Query: 431 NLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNL 469
L V+ +S+N L L +L L +N
Sbjct: 471 LFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-34
Identities = 62/387 (16%), Positives = 131/387 (33%), Gaps = 18/387 (4%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEY-AEMQTLWKINVSSNALSG-SIPEFIGDLPNIRL 148
A L SL L L N + +L + + +L +N+ N + +L N++
Sbjct: 69 AFYSLGSLEHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT 127
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
L + EI F + + +L S+ + + + +
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
L + + ++ +R L + + + L L +
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLL 247
Query: 269 YFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGS 328
+ + + + + + D + +E D V L ++ L + L
Sbjct: 248 RYILELSEVE--FDDCTL----NGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 329 IPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDL-HNL--NLRGEVPDDISNCR 385
+ T + L ++ +I++ N+ + + ++ LE LDL NL +
Sbjct: 302 LSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWP 361
Query: 386 FLLLLDVSGNALG--GDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQN 443
L L +S N L + L + L LD+ +N + P S ++ L+LS
Sbjct: 362 SLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSST 420
Query: 444 SLSGSIPSSLGNLRNLTHFNLSSNNLS 470
+ + + + L ++S+NNL
Sbjct: 421 GIR-VVKT--CIPQTLEVLDVSNNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-32
Identities = 69/394 (17%), Positives = 130/394 (32%), Gaps = 37/394 (9%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLD 150
L +L+VL L +R + + +L +++S N LS + G L +++ L+
Sbjct: 45 DLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLN 104
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIP-LSIANCTYLEGFDFSFNNLSGEL 209
L N Y +LF + + + + I + A T L + +L
Sbjct: 105 LMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQ 164
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
+ +I + +++ + +E S++ L+L + + S
Sbjct: 165 SQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSP 224
Query: 270 FNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSI 329
G + D S+NE + I ++ D N L
Sbjct: 225 MKKLAF-------------RGSVLTDESFNELL-KLLRYILELSEVEFDDCTLNGLGDFN 270
Query: 330 PTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
P+ + L K+ + L + L ++ S +
Sbjct: 271 PSESDVVSELGKVETVT----------------IRRLHIPQFYLFYDLSTVYSLLEKVKR 314
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQN---HLNGSTPPSLGNLSNLQVLDLSQNSLS 446
+ V + + ++ L+ LDL +N G +LQ L LSQN L
Sbjct: 315 ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
Query: 447 --GSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQ 478
L L+NLT ++S N +P + Q
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQ 407
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 49/364 (13%), Positives = 115/364 (31%), Gaps = 14/364 (3%)
Query: 126 NVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSI 185
+ S + + SIP + ++ LDLS N + I + C + + L + ++
Sbjct: 11 DGRSRSFT-SIPSGL--TAAMKSLDLSFNKIT-YIGHGDLRACANLQVLILKSSRINTIE 66
Query: 186 PLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTG-TVEEQFSQCQSIK 244
+ + LE D S N+LS S + L ++++ GN V F +++
Sbjct: 67 GDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQ 126
Query: 245 NLDLSSNLFIGLAPFGVL-GLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFD 302
L + + GL +++ + + + +E
Sbjct: 127 TLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESA 185
Query: 303 GVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIEL 362
++ + +++ L+L L + + + + + +
Sbjct: 186 FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245
Query: 363 LEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
L L + + +C L D + + ++ L + Q +L
Sbjct: 246 LLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 423 GSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGV 482
L ++ + + + + S +L++L +LS N + G
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGA 359
Query: 483 STFL 486
L
Sbjct: 360 WPSL 363
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 41/324 (12%), Positives = 105/324 (32%), Gaps = 25/324 (7%)
Query: 168 CYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGN 227
C + + + SIP + ++ D SFN ++ + L + ++ +
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 228 ALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGIC 287
+ + F S+++LDLS N L+ L ++ Y N+ N + + +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ-TLGVTSLF 119
Query: 288 GE--GMQVFD-ASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISL 344
+Q + F + + +L L++ L + +R + ++L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 345 ANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGG----- 399
+ ++ + + L+L + NL + +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDES 239
Query: 400 -----DIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLS--------NLQVLDLSQNSLS 446
+ + + ++ ++ D N L P +S ++ L + Q L
Sbjct: 240 FNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLF 299
Query: 447 GSIPSSLGNLRNLTHFNLSSNNLS 470
+ + L + + ++ +
Sbjct: 300 YDLSTVYSLLEKVKRITVENSKVF 323
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 4e-21
Identities = 40/204 (19%), Positives = 76/204 (37%), Gaps = 6/204 (2%)
Query: 292 QVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIG 350
+ D S+N+ + + C NL+VL L +R I +I L L + L++N +
Sbjct: 29 KSLDLSFNKITYIGHGDLRACANLQVLILKSSR-INTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDD--ISNCRFLLLLDVSGNALGGDIP-QTLYN 407
+ G + L+ L+L N + N L L + +I
Sbjct: 88 SLSSSWFGPLSSLKYLNLMG-NPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAG 146
Query: 408 MTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467
+T L L++ L SL ++ ++ L L + + + L ++ + L
Sbjct: 147 LTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 468 NLSGTIPSTIQHFGVSTFLNNTGL 491
NL+ S + VS+ +
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAF 230
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 3e-34
Identities = 51/288 (17%), Positives = 97/288 (33%), Gaps = 39/288 (13%)
Query: 184 SIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSI 243
+I N + + ++L L S + + + + GN L+ + +
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 244 KNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDG 303
+ L+LSSN+ L + ++++N
Sbjct: 61 ELLNLSSNVLYETLDLE--SLSTLRTLDLNNNYVQ------------------------- 93
Query: 304 VIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELL 363
+ +++ L N I + + I LANN I + + G +
Sbjct: 94 ----ELLVGPSIETLHAANNN-ISRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 364 EVLDLHNLNLRG-EVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
+ LDL + + ++ L L++ N + D+ + LK LDL N L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFI-YDVKGQV-VFAKLKTLDLSSNKLA 204
Query: 423 GSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
P + + + + L N L I +L +NL HF+L N
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 44/371 (11%), Positives = 104/371 (28%), Gaps = 63/371 (16%)
Query: 95 LKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRN 154
++ + + L + ++++S N LS + + LL+LS N
Sbjct: 9 GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 155 SYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC 214
+ + + L++N + + +E + NN+S
Sbjct: 69 VLYETLDLESLS---TLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS-------- 112
Query: 215 NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSH 274
+ Q KN+ L++N L + Y ++
Sbjct: 113 RVSCSRG-------------------QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKL 153
Query: 275 NGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGIT 334
N + + L+ L+L +N + + +
Sbjct: 154 NEID-TVNF----------------------AELAASSDTLEHLNLQYNFIY-DVKGQVV 189
Query: 335 DLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSG 394
+L + L++N + + P S + + L N L + + + L D+ G
Sbjct: 190 -FAKLKTLDLSSNKL-AFMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRG 246
Query: 395 NALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLG 454
N + + ++ + + + T + + +
Sbjct: 247 NGFHCGTLRDFF-SKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFAD 305
Query: 455 NLRNLTHFNLS 465
L L H +
Sbjct: 306 RLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 39/331 (11%), Positives = 97/331 (29%), Gaps = 68/331 (20%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLD 150
L+ L +L L N + + TL +++++N + + P+I L
Sbjct: 53 DLAPFTKLELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLH 105
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELP 210
+ N+ S + + + K + L++N ++ L + ++ D N +
Sbjct: 106 AANNNIS-RVSCSRGQ---GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID---- 157
Query: 211 SQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYF 270
+ + + ++++L+L N + + +
Sbjct: 158 ----TVNFAEL---------------AASSDTLEHLNLQYNFIYDVKGQ--VVFAKLKTL 196
Query: 271 NVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIP 330
++S N + + + + L N+L+ I
Sbjct: 197 DLSSNKLA-------------------------FMGPEFQSAAGVTWISLRNNKLV-LIE 230
Query: 331 TGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLL 390
+ + L L N + S + V + ++ + C L
Sbjct: 231 KALRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
Query: 391 DVSGNALGGDIPQTLYNMTYLKILDLHQNHL 421
D+P +++ L +H
Sbjct: 290 HYGAYCC-EDLPAPF----ADRLIALGHHHH 315
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 28/153 (18%), Positives = 61/153 (39%), Gaps = 10/153 (6%)
Query: 328 SIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFL 387
+I + R + ++S+ + S ++ LDL L D++ L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 388 LLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSG 447
LL++S N L L +++ L+ LDL+ N++ L +++ L + N++S
Sbjct: 61 ELLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 448 SIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHF 480
+ S + + L++N ++
Sbjct: 113 RVSCS--RGQGKKNIYLANNKITMLRDLDEGCR 143
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 34/178 (19%), Positives = 64/178 (35%), Gaps = 20/178 (11%)
Query: 90 PALSGLKSLRVLTLFGNRFT--GNLPQ--------------EYAEMQTLWKINVSSNALS 133
L L +LR L L N P + Q I +++N ++
Sbjct: 74 LDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRGQGKKNIYLANNKIT 133
Query: 134 GSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCT 193
G ++ LDL N L + ++L +N + + +
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFA 191
Query: 194 YLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSN 251
L+ D S N L+ + + + + +IS+R N L +E+ Q++++ DL N
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGN 247
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-33
Identities = 75/415 (18%), Positives = 134/415 (32%), Gaps = 78/415 (18%)
Query: 64 KGVFCNPDGFVDRIVLWNFSL-----GGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAE 118
C V ++ + L + +++T +
Sbjct: 8 PEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR--------- 58
Query: 119 MQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSH 178
+ + L + LL+L+ EI F Y + + + +
Sbjct: 59 -------KLPAALLDS--------FRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGF 102
Query: 179 NNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQI-CNIPVLDFISVRGNALTGTVEEQ 236
N + +P + N L N+LS LP I N P L +S+ N L ++
Sbjct: 103 NAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDT 160
Query: 237 FSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDA 296
F S++NL LSSN + + ++ + NVS+N
Sbjct: 161 FQATTSLQNLQLSSNRLTHV-DLS--LIPSLFHANVSYNLLS------------------ 199
Query: 297 SWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN 356
++ ++ LD N I + + L + L +N++
Sbjct: 200 -----------TLAIPIAVEELDASHNS-INVVRGPV--NVELTILKLQHNNLTDT--AW 243
Query: 357 LGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILD 415
L + L +DL L ++ + L L +S N L + + LK+LD
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLD 301
Query: 416 LHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
L NHL + L+ L L NS+ ++ L L + LS N+
Sbjct: 302 LSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-27
Identities = 74/391 (18%), Positives = 135/391 (34%), Gaps = 73/391 (18%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSGSIPEFI-GDLPNIRL 148
L + + +L L + + +A T+ K+ + NA+ +P + ++P + +
Sbjct: 64 LLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV 121
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
L L RN S +P +F K +S+S+NNL + T L+ S N L+
Sbjct: 122 LVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-H 179
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
+ IP L +V N L+ + +++ LD S N +I+
Sbjct: 180 VDLS--LIPSLFHANVSYNLLS-----TLAIPIAVEELDASHN--------------SIN 218
Query: 269 YFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGS 328
+ L +L L N L
Sbjct: 219 V-------------------------------------VRGPVNVELTILKLQHNNLT-D 240
Query: 329 IPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLL 388
+ + L+++ L+ N + I+ ++ LE L + N L + L
Sbjct: 241 TAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLK 298
Query: 389 LLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGS 448
+LD+S N L + + L+ L L N + L L+ L LS N +
Sbjct: 299 VLDLSHNHL-LHVERNQPQFDRLENLYLDHNSI---VTLKLSTHHTLKNLTLSHNDWDCN 354
Query: 449 IPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
+L RN+ + + I ++H
Sbjct: 355 SLRAL--FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 4e-26
Identities = 48/321 (14%), Positives = 97/321 (30%), Gaps = 41/321 (12%)
Query: 160 IPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVL 219
I L C V + + F + + + + + +
Sbjct: 13 IDSNLQYDCV-FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 220 DFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHG 279
+ +++ + F+ +I+ L + N L P + ++ + N
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS- 130
Query: 280 EIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRR 338
+P +F N L L + N + I
Sbjct: 131 SLPR--------GIF---------------HNTPKLTTLSMSNNN-LERIEDDTFQATTS 166
Query: 339 LLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALG 398
L + L++N + + + S L ++ L ++ + LD S N++
Sbjct: 167 LQNLQLSSNRLTHVDLSLIPS---LFHANVSYNLLS-----TLAIPIAVEELDASHNSIN 218
Query: 399 GDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRN 458
+ + L IL L N+L + L N L +DLS N L + ++
Sbjct: 219 -VVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQR 273
Query: 459 LTHFNLSSNNLSGTIPSTIQH 479
L +S+N L + Q
Sbjct: 274 LERLYISNNRLV-ALNLYGQP 293
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-32
Identities = 68/347 (19%), Positives = 118/347 (34%), Gaps = 45/347 (12%)
Query: 145 NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNN 204
+L++ + + +P L + + NNL+ S+P L + S N
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA---HITTLVIPDNNLT-SLPALPPELRTL---EVSGNQ 92
Query: 205 LSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGL 264
L+ LP + L S L + + L + N L
Sbjct: 93 LT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTSLPVL----P 140
Query: 265 KNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNR 324
+ +VS N +P + A N+ +P+ + L+ L + N+
Sbjct: 141 PGLQELSVSDNQL-ASLPA-LPSE--LCKLWAYNNQLT-SLPMLPSG---LQELSVSDNQ 192
Query: 325 LIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNC 384
L S+PT ++L +L NN + + P L+ L + L +P S
Sbjct: 193 LA-SLPTLPSELYKL---WAYNNRLTSL-PALPSG---LKELIVSGNRLT-SLPVLPSE- 242
Query: 385 RFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNS 444
L L VSGN L +P L L +++N L P SL +LS+ ++L N
Sbjct: 243 --LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNP 295
Query: 445 LSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGL 491
LS +L + + ++ S + L
Sbjct: 296 LSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWL 342
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 99 bits (249), Expect = 9e-22
Identities = 67/390 (17%), Positives = 115/390 (29%), Gaps = 99/390 (25%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152
+ LR L + GN+ T +LP + L + L + L
Sbjct: 78 ALPPELRTLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHLPAL-------PSGLCKLW-- 127
Query: 153 RNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQ 212
+ N L+ S+P+ L S N L+ LP+
Sbjct: 128 -----------------------IFGNQLT-SLPVLPPGLQEL---SVSDNQLA-SLPAL 159
Query: 213 ICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNV 272
+ L N LT ++ S ++ L +S N L P L +
Sbjct: 160 PSELCKLW---AYNNQLT-SLPMLPS---GLQELSVSDNQLASL-PTLPSELYKL---WA 208
Query: 273 SHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTG 332
+N +P + LK L + NRL S+P
Sbjct: 209 YNNRLT-------------------------SLPALPS---GLKELIVSGNRL-TSLPVL 239
Query: 333 ITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDV 392
++L+ L ++ N + +P L L ++ L +P+ + + +++
Sbjct: 240 PSELKEL---MVSGNRL-TSLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSETTVNL 291
Query: 393 SGNALGGDIPQTLYNMTYLKILDLHQNHLN------GSTPPSLGNLSNLQVLDLSQNSLS 446
GN L +TL + + + + S P L L
Sbjct: 292 EGNPL---SERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREG 348
Query: 447 GSIP----SSLGNLRNLTHFNLSSNNLSGT 472
P G N F+L + LS T
Sbjct: 349 EPAPADRWHMFGQEDNADAFSLFLDRLSET 378
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 9e-32
Identities = 61/347 (17%), Positives = 125/347 (36%), Gaps = 23/347 (6%)
Query: 125 INVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGS 184
I++ + + + L N +++ ++ ++P AL + + ++L+ +
Sbjct: 34 IDMQTQDVYFGFEDI--TLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 185 IPLSIANCTYLEGFDFSFNNLSGELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSI 243
+ A ++ FN + LP + N+P+L + + N L+ F +
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKL 149
Query: 244 KNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDG 303
L +S+N + ++ +S N + I + + S+N
Sbjct: 150 TTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVDLSLI--PSLFHANVSYNLLS- 205
Query: 304 VIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELL 363
++ ++ LD N I + + L + L +N++ L + L
Sbjct: 206 ----TLAIPIAVEELDASHNS-INVVRGPV--NVELTILKLQHNNL--TDTAWLLNYPGL 256
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG 423
+DL L + + L L +S N L + + LK+LDL NHL
Sbjct: 257 VEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLSHNHLL- 314
Query: 424 STPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
+ L+ L L NS+ ++ L L + LS N+
Sbjct: 315 HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-26
Identities = 49/330 (14%), Positives = 96/330 (29%), Gaps = 41/330 (12%)
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELP 210
R I L C V + + F + +
Sbjct: 10 KPRQPEYKCIDSNLQYDCV-FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPA 68
Query: 211 SQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYF 270
+ + + ++ +++ + F+ +I+ L + N L P + ++
Sbjct: 69 ALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVL 128
Query: 271 NVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIP 330
+ N +P +F N L L + N + I
Sbjct: 129 VLERNDLS-SLPR--------GIF---------------HNTPKLTTLSMSNNN-LERIE 163
Query: 331 TGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
L + L++N + + + S L ++ L ++ +
Sbjct: 164 DDTFQATTSLQNLQLSSNRLTHVDLSLIPS---LFHANVSYNLLS-----TLAIPIAVEE 215
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI 449
LD S N++ L IL L N+L + L N L +DLS N L +
Sbjct: 216 LDASHNSINVVRGPVNVE---LTILKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIM 270
Query: 450 PSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
++ L +S+N L + Q
Sbjct: 271 YHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 2e-25
Identities = 75/407 (18%), Positives = 139/407 (34%), Gaps = 75/407 (18%)
Query: 76 RIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSG 134
+ N ++ + + L + + +L L + + +A T+ K+ + NA+
Sbjct: 55 IVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR- 112
Query: 135 SIPEFI-GDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI-ANC 192
+P + ++P + +L L RN S +P +F K +S+S+NNL I
Sbjct: 113 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 170
Query: 193 TYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNL 252
T L+ S N L+ + S S+ + ++S NL
Sbjct: 171 TSLQNLQLSSNRLT-HVD--------------------------LSLIPSLFHANVSYNL 203
Query: 253 FIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNC 312
LA + + SHN + +
Sbjct: 204 LSTLAI-----PIAVEELDASHNSIN-VVRG--------------------------PVN 231
Query: 313 RNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
L +L L N L + + L+++ L+ N + I+ ++ LE L + N
Sbjct: 232 VELTILKLQHNNLT-DTAW-LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNR 289
Query: 373 LRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL 432
L + L +LD+S N L + + L+ L L N + L
Sbjct: 290 LV-ALNLYGQPIPTLKVLDLSHNHL-LHVERNQPQFDRLENLYLDHNSI---VTLKLSTH 344
Query: 433 SNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
L+ L LS N + +L RN+ + + I ++H
Sbjct: 345 HTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDADQHCKIDYQLEH 389
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 68/410 (16%), Positives = 141/410 (34%), Gaps = 54/410 (13%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
+ L VL L N + +LP+ + L +++S+N L + +++ L
Sbjct: 118 VFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNL 176
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
LS N + + +L ++S+N LS ++A +E D S N+++ +
Sbjct: 177 QLSSNRLT-HVDLSLIP---SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VV 226
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
+ L + ++ N LT T + +DLS N + + ++ +
Sbjct: 227 RGPVN--VELTILKLQHNNLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLER 282
Query: 270 FNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSI 329
+S+N + L LKVLDL N L+ +
Sbjct: 283 LYISNNRLV-------------------------ALNLYGQPIPTLKVLDLSHNHLL-HV 316
Query: 330 PTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
RL + L +NSI + L + L+ L L + + N L
Sbjct: 317 ERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD-------CNSLRALF 366
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLD-LSQNSLSGS 448
+V+ A+ D Q L+ + L ++ V++ + + S
Sbjct: 367 RNVARPAV-DDADQHCKIDYQLEHGLCCKESDKPYLDRLLQYIALTSVVEKVQRAQGRCS 425
Query: 449 IPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLET 498
++ ++++L+H+ + ++ L ++
Sbjct: 426 ATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNEQIQQ 475
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 62/416 (14%), Positives = 139/416 (33%), Gaps = 44/416 (10%)
Query: 77 IVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSI 136
V F + + + L +L L + T ++ ++ L K+ +SN ++ ++
Sbjct: 23 EVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSNNIT-TL 79
Query: 137 PEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLE 196
+ N+ L N + + K +++ N L+ L ++ L
Sbjct: 80 D--LSQNTNLTYLACDSNKLT-NLDVTPLT---KLTYLNCDTNKLT---KLDVSQNPLLT 130
Query: 197 GFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256
+ + N L+ E+ + + L + N ++ + + LD S N L
Sbjct: 131 YLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL 185
Query: 257 APFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIPLSITNCRNL 315
V K ++ N N I ++ + + D S N+ + +T L
Sbjct: 186 D---VSQNKLLNRLNCDTN----NITKLDLNQNIQLTFLDCSSNKLTE---IDVTPLTQL 235
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRG 375
D N L + ++ L +L + + I + + + +
Sbjct: 236 TYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEIDLTHNTQLIYFQAEGCRKIK--- 289
Query: 376 EVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNL 435
D+++ L LLD + ++ L L L L+ L T + + + L
Sbjct: 290 --ELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTEL---TELDVSHNTKL 341
Query: 436 QVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGL 491
+ L + S +G + L + + T+ + ++ ++ L
Sbjct: 342 KSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 53/373 (14%), Positives = 115/373 (30%), Gaps = 61/373 (16%)
Query: 98 LRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYS 157
++ TL ++ +++++ + I L + L + N+ +
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNIT 77
Query: 158 GEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIP 217
+ + +++ N L+ L + T L + N L+ +L + P
Sbjct: 78 -TLDLSQ---NTNLTYLACDSNKLTN---LDVTPLTKLTYLNCDTNKLT-KLD--VSQNP 127
Query: 218 VLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGF 277
+L +++ N LT E S + LD N I ++ + S N
Sbjct: 128 LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKITKLDVT--PQTQLTTLDCSFNKI 182
Query: 278 HGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLR 337
L ++ + L L+ N + + +
Sbjct: 183 TE---------------------------LDVSQNKLLNRLNCDTNNIT-KLD--LNQNI 212
Query: 338 RLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNAL 397
+L + ++N + I ++ + L D L D+S L L L
Sbjct: 213 QLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDL 266
Query: 398 GGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLR 457
+I L + T L + + + L +LD ++ + L
Sbjct: 267 L-EID--LTHNTQLIYFQA--EGCRKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNP 318
Query: 458 NLTHFNLSSNNLS 470
L + L++ L+
Sbjct: 319 KLVYLYLNNTELT 331
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 62/404 (15%), Positives = 129/404 (31%), Gaps = 50/404 (12%)
Query: 90 PALSGLKSLRVLTLFGNRFT----GNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPN 145
+ L L L N T L + SN L+ ++ + L
Sbjct: 58 TGIEKLTGLTKLICTSNNITTLDLSQNTN-------LTYLACDSNKLT-NLD--VTPLTK 107
Query: 146 IRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNL 205
+ L+ N + ++ + +++ + N L+ + +++ T L D N
Sbjct: 108 LTYLNCDTNKLT-KLDVSQNP---LLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKK 160
Query: 206 SGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLK 265
+L + L + N +T E SQ + + L+ +N + +
Sbjct: 161 ITKLD--VTPQTQLTTLDCSFNKIT---ELDVSQNKLLNRLNCDTNN---ITKLDLNQNI 212
Query: 266 NISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNR 324
+++ + S N ++ E+ + + FD S N L ++ L L
Sbjct: 213 QLTFLDCSSN----KLTEIDVTPLTQLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTD 265
Query: 325 LIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNC 384
L+ I +T +L+ I ++ L +LD + D+S
Sbjct: 266 LL-EID--LTHNTQLIYFQAEGCRK--IKELDVTHNTQLYLLDCQAAGIT---ELDLSQN 317
Query: 385 RFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNS 444
L+ L ++ L ++ + + T LK L H+ S+G + L ++
Sbjct: 318 PKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHI--QDFSSVGKIPALNNNFEAEGQ 372
Query: 445 LSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNN 488
+L N + + G + G
Sbjct: 373 TITMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQAT 416
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 29/161 (18%), Positives = 54/161 (33%), Gaps = 14/161 (8%)
Query: 314 NLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNL 373
N + + L L + N+SI + + + L L + N+
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNI 76
Query: 374 RGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLS 433
D+S L L N L ++ + +T L L+ N L T +
Sbjct: 77 TT---LDLSQNTNLTYLACDSNKL-TNLD--VTPLTKLTYLNCDTNKL---TKLDVSQNP 127
Query: 434 NLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
L L+ ++N+L+ I + + LT + N +
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 6e-29
Identities = 65/336 (19%), Positives = 122/336 (36%), Gaps = 33/336 (9%)
Query: 144 PNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFN 203
R + R + +P + T+ + L N + A+ +LE + + N
Sbjct: 11 AQDRAVLCHRKRFV-AVPEGIPTE---TRLLDLGKNRIKTLNQDEFASFPHLEELELNEN 66
Query: 204 NLSGELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVL 262
+S + N+ L + +R N L F+ ++ LD+S N + L +
Sbjct: 67 IVS-AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQ 125
Query: 263 GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGF 322
L N+ V N I + F +L+ L L
Sbjct: 126 DLYNLKSLEVGDNDLV-YISH--------RAFS---------------GLNSLEQLTLEK 161
Query: 323 NRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI 381
+ SIPT + L L+ + L + +I I + + L+VL++ + + +
Sbjct: 162 CN-LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNC 220
Query: 382 SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLS 441
L L ++ L + ++ YL+ L+L N ++ L L LQ + L
Sbjct: 221 LYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280
Query: 442 QNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTI 477
L+ P + L L N+S N L+ T+ ++
Sbjct: 281 GGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESV 315
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 56/321 (17%), Positives = 115/321 (35%), Gaps = 8/321 (2%)
Query: 128 SSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPL 187
++PE I RLLDL +N + F + + L+ N +S P
Sbjct: 19 HRKRFV-AVPEGI--PTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPG 74
Query: 188 SIANCTYLEGFDFSFNNLSGELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNL 246
+ N L N L +P + + L + + N + ++ F ++K+L
Sbjct: 75 AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133
Query: 247 DLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICG-EGMQVFDASWNEFDGVI 305
++ N + ++ GL ++ + IP + G+ V + +
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIR 192
Query: 306 PLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEV 365
S LKVL++ + ++ L +S+ + ++ + + + L
Sbjct: 193 DYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRF 252
Query: 366 LDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGST 425
L+L + + L + + G L P + YL++L++ N L
Sbjct: 253 LNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLE 312
Query: 426 PPSLGNLSNLQVLDLSQNSLS 446
++ NL+ L L N L+
Sbjct: 313 ESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 5e-25
Identities = 66/348 (18%), Positives = 127/348 (36%), Gaps = 53/348 (15%)
Query: 125 INVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGS 184
+++ N + + P++ L+L+ N S + F + + + L N L
Sbjct: 37 LDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNRLK-L 94
Query: 185 IPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIK 244
IPL + F LS L + + N + ++ F ++K
Sbjct: 95 IPLGV------------FTGLSN-----------LTKLDISENKIVILLDYMFQDLYNLK 131
Query: 245 NLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGV 304
+L++ N + ++ GL ++ + IP
Sbjct: 132 SLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIP---------------------- 168
Query: 305 IPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELL 363
++++ L VL L I +I L RL + +++ + PN L
Sbjct: 169 -TEALSHLHGLIVLRLRHLN-INAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNL 226
Query: 364 EVLDLHNLNLRGEVPDD-ISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
L + + NL VP + + +L L++S N + L+ + L+ + L L
Sbjct: 227 TSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLA 285
Query: 423 GSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
P + L+ L+VL++S N L+ S ++ NL L SN L+
Sbjct: 286 VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 95.9 bits (239), Expect = 7e-21
Identities = 59/310 (19%), Positives = 116/310 (37%), Gaps = 55/310 (17%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSGSIPEFI-GDLPNIRL 148
A + L +LR L L NR +P + + L K+++S N + + +++ DL N++
Sbjct: 75 AFNNLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKS 132
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
L++ N I F + ++L NL+ SIP + ++L G
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIP------------TEALSHLHG- 177
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
L + +R + + F + +K L++S ++ L N++
Sbjct: 178 ----------LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLT 227
Query: 269 YFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGS 328
+++H +P L++ + L+ L+L +N I +
Sbjct: 228 SLSITHCNLT-AVP-----------------------YLAVRHLVYLRFLNLSYNP-IST 262
Query: 329 IPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFL 387
I + +L RL +I L + + P + L VL++ L + L
Sbjct: 263 IEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNL 322
Query: 388 LLLDVSGNAL 397
L + N L
Sbjct: 323 ETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 5e-14
Identities = 37/190 (19%), Positives = 73/190 (38%), Gaps = 5/190 (2%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLD 150
A SGL SL LTL T + + + L + + ++ L +++L+
Sbjct: 147 AFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIP-LSIANCTYLEGFDFSFNNLSGEL 209
+S Y + +S++H NL+ ++P L++ + YL + S+N +S +
Sbjct: 207 ISHWPYLDTMTPNCLYGL-NLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TI 263
Query: 210 PSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
+ + L I + G L F ++ L++S N L + N+
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323
Query: 269 YFNVSHNGFH 278
+ N
Sbjct: 324 TLILDSNPLA 333
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 57/217 (26%), Positives = 95/217 (43%), Gaps = 32/217 (14%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQG 658
IG GS +VY+ E V +A +L+ +++ + F+ E L ++H N+V F
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 659 YYWSSTMQ----LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL-HWSRRFHIALGTA 713
+ S+ ++++E + G L L + L W R I G
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL-------KRFKVMKIKVLRSWCR--QILKG-- 141
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
L +LH PPI+H +LK NI + K+ D GLA L + +G
Sbjct: 142 --LQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK------RASFAKAVIG 192
Query: 773 ---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
++APE+ + + + DVY+FG+ +LE+ T P
Sbjct: 193 TPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYP 228
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-28
Identities = 70/312 (22%), Positives = 112/312 (35%), Gaps = 55/312 (17%)
Query: 582 PSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGG-VSIAVKKLETLGRIRNQ 635
+ W L+ E L IG G+ G V+ +AVK +
Sbjct: 103 AVPKDKWV------LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK 156
Query: 636 EEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI 695
+F E L H N+V G I+ E V G+ L
Sbjct: 157 AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT----------- 205
Query: 696 GNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755
L + A + YL +H +L + N L+ E K+SD+G+++
Sbjct: 206 EGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSRE 262
Query: 756 LPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPT 811
GL + V + APE R S + DV+SFG++L E + G P + +
Sbjct: 263 EADGVYAASGGLRQV--PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320
Query: 812 TNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
+ E +E+G C D + ++M+ C + P +RPS
Sbjct: 321 NQQTR-------EFVEKGGRLPCPELCPD---------AVFRLMEQ---CWAYEPGQRPS 361
Query: 868 MAEVVQVLESIR 879
+ + Q L+SIR
Sbjct: 362 FSTIYQELQSIR 373
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 7e-28
Identities = 69/331 (20%), Positives = 122/331 (36%), Gaps = 65/331 (19%)
Query: 578 SKSLPSKYED-WEAGTKALLDKECL-----IGGGSIGSVYRASFEG-----GVSIAVKKL 626
S+ P+ D +K L +G G G V ++ G +AVK L
Sbjct: 5 SEKKPATEVDPTH------FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL 58
Query: 627 ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ--LILSEFVPKGNLYDNLHG 684
+ + + + EI L N+ H N+V ++G ++ EF+P G+L + L
Sbjct: 59 KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLP- 117
Query: 685 VNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILLDENY 743
+ I + A+ + + YL +H +L + N+L++ +
Sbjct: 118 -----KNKNKINLKQQ-----LKYAVQICKGMDYLGSRQY----VHRDLAARNVLVESEH 163
Query: 744 EPKLSDYGLAKLLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLE 799
+ K+ D+GL K + Y V + APE + DV+SFGV L E
Sbjct: 164 QVKIGDFGLTKAIETDKEYYTVKDDRDS--PVFWYAPECLMQSKFYIASDVWSFGVTLHE 221
Query: 800 LVT-GRKPVESPTTNEVVVLCEY-------VRELLERG----SASACFDRSLRGFAENEL 847
L+T ++ + + L+ G C D E+
Sbjct: 222 LLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPD---------EV 272
Query: 848 IQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
Q+M+ C PS R S +++ E++
Sbjct: 273 YQLMRK---CWEFQPSNRTSFQNLIEGFEAL 300
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-26
Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 49/312 (15%)
Query: 582 PSKYEDWEAGTKAL-LDKECLIGGGSIGSVYRASFEGG----VSIAVK--KLETLGRIRN 634
P + G K L L ++ +G GS G V R ++ VS+AVK K + L +
Sbjct: 7 PLQSLTCLIGEKDLRLLEK--LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEA 64
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGG 694
++F E+ + ++ H NL+ G + M+++ E P G+L D L G
Sbjct: 65 MDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLR------KHQGH 117
Query: 695 IGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752
L A+ A + YL +H +L + N+LL K+ D+GL
Sbjct: 118 FLLGTL-----SRYAVQVAEGMGYLESKR-----FIHRDLAARNLLLATRDLVKIGDFGL 167
Query: 753 AKLLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPV 807
+ LP D++ K + APE ++ S D + FGV L E+ T G++P
Sbjct: 168 MRALPQNDDHYVMQEHRKV--PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
Query: 808 ESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
++++ + E L R C ++ VM + C + P RP+
Sbjct: 226 IGLNGSQILHKIDKEGERLPR--PEDCPQ---------DIYNVM---VQCWAHKPEDRPT 271
Query: 868 MAEVVQVLESIR 879
+ L +
Sbjct: 272 FVALRDFLLEAQ 283
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-26
Identities = 77/305 (25%), Positives = 127/305 (41%), Gaps = 51/305 (16%)
Query: 584 KYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEF 638
+ WE + +E L +G G G V+ ++ G +A+K L+ G + + E F
Sbjct: 175 AKDAWE------IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTM-SPEAF 226
Query: 639 ELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNP 698
E + +RH LV + I++E++ KG+L D L G
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLK-------GETG---K 275
Query: 699 ELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758
L + +A A ++Y+ +H +L++ NIL+ EN K++D+GLA+L+
Sbjct: 276 YLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332
Query: 759 LDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVV 817
+ + + APE A R + K DV+SFG++L EL T GR P EV+
Sbjct: 333 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL- 391
Query: 818 LCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ +ERG C + L +M C + P RP+ +
Sbjct: 392 ------DQVERGYRMPCPPECPE---------SLHDLM---CQCWRKEPEERPTFEYLQA 433
Query: 874 VLESI 878
LE
Sbjct: 434 FLEDY 438
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 61/314 (19%)
Query: 581 LPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRN 634
+ Y+ WE +++ + +GGG G VY ++ +++AVK L+ +
Sbjct: 208 VSPNYDKWE------MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTM-E 259
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGG 694
EEF E + I+H NLV G I++EF+ GNL D L N
Sbjct: 260 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN-------- 311
Query: 695 IGNPELHWSRRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753
E+ ++A + A+ YL + +H NL + N L+ EN+ K++D+GL+
Sbjct: 312 --RQEVSAVVLLYMATQISSAMEYLEKKNF----IHRNLAARNCLVGENHLVKVADFGLS 365
Query: 754 KLLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVE 808
+L + + KF + + APE + S K DV++FGV+L E+ T G P
Sbjct: 366 RL--MTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 421
Query: 809 SPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSR 864
++V ELLE+ C + ++ ++M+ C PS
Sbjct: 422 GIDLSQVY-------ELLEKDYRMERPEGCPE---------KVYELMRA---CWQWNPSD 462
Query: 865 RPSMAEVVQVLESI 878
RPS AE+ Q E++
Sbjct: 463 RPSFAEIHQAFETM 476
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 3e-26
Identities = 74/336 (22%), Positives = 129/336 (38%), Gaps = 68/336 (20%)
Query: 576 LFSKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEG-----GVSIAVKK 625
+ K L +G G G V ++ G +AVK
Sbjct: 14 ALEVLFQGPGDPTV------FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA 67
Query: 626 LETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG---YYWSSTMQLILSEFVPKGNLYDNL 682
L+ +++ ++ EI L + H +++ ++G ++++QL++ E+VP G+L D L
Sbjct: 68 LKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVM-EYVPLGSLRDYL 126
Query: 683 HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILLDE 741
+ ++ A ++YLH +H +L + N+LLD
Sbjct: 127 P-------------RHSIGLAQLLLFAQQICEGMAYLHAQHY----IHRDLAARNVLLDN 169
Query: 742 NYEPKLSDYGLAKLLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVIL 797
+ K+ D+GLAK +P Y V + APE + + DV+SFGV L
Sbjct: 170 DRLVKIGDFGLAKAVPEGHEYYRVREDGDS--PVFWYAPECLKEYKFYYASDVWSFGVTL 227
Query: 798 LELVT-GRKPVESPTTNEVVVLCEY-------VRELLERG----SASACFDRSLRGFAEN 845
EL+T PT ++ + ELLERG C
Sbjct: 228 YELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPA--------- 278
Query: 846 ELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881
E+ +MK C S RP+ ++ +L+++
Sbjct: 279 EVYHLMKN---CWETEASFRPTFENLIPILKTVHEK 311
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 4e-26
Identities = 76/314 (24%), Positives = 127/314 (40%), Gaps = 68/314 (21%)
Query: 588 WEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVK--KLETLGRIRNQEEFEL 640
W +D L IG G G V+ + +A+K + + ++E+F
Sbjct: 3 WV------IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM----SEEDFIE 52
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL 700
E + + H LV G +++EF+ G L D L T G L
Sbjct: 53 EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR------TQRGLFAAETL 106
Query: 701 HWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI 758
+ L ++YL ++H +L + N L+ EN K+SD+G+ + +
Sbjct: 107 -----LGMCLDVCEGMAYLEEAC-----VIHRDLAARNCLVGENQVIKVSDFGMTRF--V 154
Query: 759 LDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTN 813
LD+ TKF V + +PE+ R S K DV+SFGV++ E+ + G+ P E+ + +
Sbjct: 155 LDDQYTSSTGTKF--PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS 212
Query: 814 EVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA 869
EVV E + G + Q+M C E P RP+ +
Sbjct: 213 EVV-------EDISTGFRLYKPRLAST---------HVYQIM---NHCWRERPEDRPAFS 253
Query: 870 EVVQVLESI-RNGL 882
+++ L I +GL
Sbjct: 254 RLLRQLAEIAESGL 267
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-26
Identities = 69/317 (21%), Positives = 119/317 (37%), Gaps = 60/317 (18%)
Query: 586 EDWEAGTKALLDKECLIGGGSIGSVYRASF---EGGVSIAVKKLETLGRIRNQEEFELEI 642
+ LL + +G G+ GSV + + + + +A+K L+ + EE E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 643 GRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHW 702
+ + + +V G + + L++ E G L+ L G E+
Sbjct: 62 QIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVG-----------KREEIPV 109
Query: 703 SRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756
S + + + YL H D L + N+LL + K+SD+GL+K L
Sbjct: 110 SNVAELLHQVSMGMKYLEEKNFVHRD---------LAARNVLLVNRHYAKISDFGLSKAL 160
Query: 757 PILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPT 811
D+Y K+ + + APE + S + DV+S+GV + E ++ G+KP +
Sbjct: 161 GADDSYYTARSAGKW--PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
Query: 812 TNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
EV+ +E+G C EL +M C RP
Sbjct: 219 GPEVM-------AFIEQGKRMECPPECPP---------ELYALM---SDCWIYKWEDRPD 259
Query: 868 MAEVVQVLESIRNGLGS 884
V Q + + L S
Sbjct: 260 FLTVEQRMRACYYSLAS 276
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-26
Identities = 77/306 (25%), Positives = 128/306 (41%), Gaps = 53/306 (17%)
Query: 584 KYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEF 638
+ WE + +E L +G G G V+ ++ G +A+K L+ G + + E F
Sbjct: 258 AKDAWE------IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP-GTM-SPEAF 309
Query: 639 ELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNP 698
E + +RH LV + I++E++ KG+L D L G
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLK-------GETG---K 358
Query: 699 ELHWSRRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757
L + +A A ++Y+ + +H +L++ NIL+ EN K++D+GLA+L+
Sbjct: 359 YLRLPQLVDMAAQIASGMAYVERMNY----VHRDLRAANILVGENLVCKVADFGLARLIE 414
Query: 758 ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816
+ + + APE A R + K DV+SFG++L EL T GR P EV+
Sbjct: 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474
Query: 817 VLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872
+ +ERG C + L +M C + P RP+ +
Sbjct: 475 -------DQVERGYRMPCPPECPE---------SLHDLM---CQCWRKEPEERPTFEYLQ 515
Query: 873 QVLESI 878
LE
Sbjct: 516 AFLEDY 521
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-25
Identities = 65/312 (20%), Positives = 121/312 (38%), Gaps = 67/312 (21%)
Query: 585 YEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVK--KLETLGRIRNQEE 637
Y WE +D + L +G G G V + G +A+K K ++ +++E
Sbjct: 16 YGSWE------IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDE 65
Query: 638 FELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGN 697
F E + N+ H LV G I++E++ G L + L
Sbjct: 66 FIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE-----------MR 114
Query: 698 PELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755
+ + A+ YL LH +L + N L+++ K+SD+GL++
Sbjct: 115 HRFQTQQLLEMCKDVCEAMEYLESKQ-----FLHRDLAARNCLVNDQGVVKVSDFGLSRY 169
Query: 756 LPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESP 810
+LD+ +KF V + PE+ + S K D+++FGV++ E+ + G+ P E
Sbjct: 170 --VLDDEYTSSVGSKF--PVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 225
Query: 811 TTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP 866
T +E E + +G + ++ +M C E RP
Sbjct: 226 TNSETA-------EHIAQGLRLYRPHLASE---------KVYTIM---YSCWHEKADERP 266
Query: 867 SMAEVVQVLESI 878
+ ++ + +
Sbjct: 267 TFKILLSNILDV 278
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-25
Identities = 75/312 (24%), Positives = 130/312 (41%), Gaps = 61/312 (19%)
Query: 582 PSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQE 636
P + + WE + +E L +G G G V+ A++ +AVK ++ + E
Sbjct: 177 PWEKDAWE------IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP--GSMSVE 228
Query: 637 EFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIG 696
F E + ++H LV + I++EF+ KG+L D L
Sbjct: 229 AFLAEANVMKTLQHDKLVKLHAVVTKEPI-YIITEFMAKGSLLDFLKS----------DE 277
Query: 697 NPELHWSRRFHIALGTARALSYL-HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755
+ + + A ++++ + +H +L++ NIL+ + K++D+GLA++
Sbjct: 278 GSKQPLPKLIDFSAQIAEGMAFIEQRNY----IHRDLRAANILVSASLVCKIADFGLARV 333
Query: 756 LPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESP 810
I DN KF + + APE + K DV+SFG++L+E+VT GR P
Sbjct: 334 --IEDNEYTAREGAKF--PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 389
Query: 811 TTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP 866
+ EV+ LERG C + EL +M + C P RP
Sbjct: 390 SNPEVI-------RALERGYRMPRPENCPE---------ELYNIM---MRCWKNRPEERP 430
Query: 867 SMAEVVQVLESI 878
+ + VL+
Sbjct: 431 TFEYIQSVLDDF 442
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 62/292 (21%), Positives = 122/292 (41%), Gaps = 53/292 (18%)
Query: 602 IGGGSIGSVYRASF-----EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+G G+ G+VY+ + + + +A+K+L + +E E ++++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
G +ST+QLI + +P G L D + IG+ L + + A+ +
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVR------EHKDNIGSQYL-----LNWCVQIAKGM 130
Query: 717 SYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY---GLTKFHNAV 771
+YL ++H +L + N+L+ K++D+GLAKLL + K +
Sbjct: 131 NYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV--PI 183
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG- 829
++A E + + DV+S+GV + EL+T G KP + +E+ +LE+G
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGE 236
Query: 830 ---SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
C ++ +M C RP E++ +
Sbjct: 237 RLPQPPICTI---------DVYMIM---RKCWMIDADSRPKFRELIIEFSKM 276
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 83/338 (24%), Positives = 135/338 (39%), Gaps = 84/338 (24%)
Query: 580 SLPSKYED-WEAGTKALLDKECL-----IGGGSIGSVYRASFEG-----GVSIAVKKLET 628
+ +D ++ L +G G+ GSV ++ G +AVK+L+
Sbjct: 9 AQLYACQDPTI------FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH 62
Query: 629 LGRIRNQEEFELEIGRLSNIRHFNLVAFQG---YYWSSTMQLILSEFVPKGNLYDNLHGV 685
Q +F+ EI L + +V ++G +++L++ E++P G L D L
Sbjct: 63 -SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVM-EYLPSGCLRDFLQR- 119
Query: 686 NYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILLDENYE 744
L SR + + + YL C +H +L + NIL++
Sbjct: 120 ----------HRARLDASRLLLYSSQICKGMEYLGSRRC----VHRDLAARNILVESEAH 165
Query: 745 PKLSDYGLAKLLPILDNYGLTKFHNAVGYV------------APELAQSLRLSDKCDVYS 792
K++D+GLAKLLP+ +Y YV APE S + DV+S
Sbjct: 166 VKIADFGLAKLLPLDKDY----------YVVREPGQSPIFWYAPESLSDNIFSRQSDVWS 215
Query: 793 FGVILLELVT-GRKPVESPTTNEVVVLCEY-------VRELLERG----SASACFDRSLR 840
FGV+L EL T K ++ CE + ELLE G + AC
Sbjct: 216 FGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPA---- 271
Query: 841 GFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
E+ ++MKL C + P RPS + + L+ +
Sbjct: 272 -----EVHELMKL---CWAPSPQDRPSFSALGPQLDML 301
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-25
Identities = 61/305 (20%), Positives = 105/305 (34%), Gaps = 59/305 (19%)
Query: 172 KFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALT 230
+ + L+ S+P I ++ T L + N L LP
Sbjct: 10 TEIRCNSKGLT-SVPTGIPSSATRL---ELESNKLQ-SLPH------------------- 45
Query: 231 GTVEEQFSQCQSIKNLDLSSNL--FIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICG 288
F + + L LSSN F G G ++ Y ++S NG
Sbjct: 46 ----GVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI---------- 91
Query: 289 EGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANN 347
+ + L+ LD + L + LR L+ + +++
Sbjct: 92 ---------------TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 136
Query: 348 SIGGIIPPNLGSIELLEVLDL-HNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLY 406
+ LEVL + N +PD + R L LD+S L P
Sbjct: 137 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 407 NMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNL-RNLTHFNLS 465
+++ L++L++ N+ L++LQVLD S N + S L + +L NL+
Sbjct: 197 SLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
Query: 466 SNNLS 470
N+ +
Sbjct: 257 QNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 7e-13
Identities = 36/204 (17%), Positives = 71/204 (34%), Gaps = 11/204 (5%)
Query: 81 NFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPE-- 138
S G S + G SL+ L L N + + ++ L ++ + L + E
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFS 120
Query: 139 FIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI-ANCTYLEG 197
L N+ LD+S +F + + ++ N+ + I L
Sbjct: 121 VFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF 179
Query: 198 FDFSFNNLSGELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256
D S L +L ++ L +++ N + S++ LD S N +
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS 238
Query: 257 APFGVLG--LKNISYFNVSHNGFH 278
L ++++ N++ N F
Sbjct: 239 -KKQELQHFPSSLAFLNLTQNDFA 261
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 36/189 (19%), Positives = 68/189 (35%), Gaps = 6/189 (3%)
Query: 91 ALSGLKSLRVLTLFGNRFT--GNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRL 148
L L L+L N + G Q +L +++S N + ++ L +
Sbjct: 47 VFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEH 105
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSG 207
LD ++ F++F ++ +SH + I + LE + N+
Sbjct: 106 LDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGNSFQE 164
Query: 208 ELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKN 266
I + L F+ + L F+ S++ L++S N F L F L +
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNS 224
Query: 267 ISYFNVSHN 275
+ + S N
Sbjct: 225 LQVLDYSLN 233
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 71/315 (22%), Positives = 128/315 (40%), Gaps = 75/315 (23%)
Query: 588 WEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVK--KLETLGRIRNQEEFEL 640
E L +E + +G G G V ++G +AVK K ++ +++EF
Sbjct: 3 ME------LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM----SEDEFFQ 52
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL 700
E + + H LV F G I++E++ G L + L L
Sbjct: 53 EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRS-----------HGKGL 101
Query: 701 HWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
S+ + +++L H D L + N L+D + K+SD+G+ +
Sbjct: 102 EPSQLLEMCYDVCEGMAFLESHQFIHRD---------LAARNCLVDRDLCVKVSDFGMTR 152
Query: 755 LLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVES 809
+LD+ TKF V + APE+ + S K DV++FG+++ E+ + G+ P +
Sbjct: 153 Y--VLDDQYVSSVGTKF--PVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDL 208
Query: 810 PTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRR 865
T +EVV + +G D + Q+M C E+P +R
Sbjct: 209 YTNSEVV-------LKVSQGHRLYRPHLASD---------TIYQIM---YSCWHELPEKR 249
Query: 866 PSMAEVVQVLESIRN 880
P+ +++ +E +R
Sbjct: 250 PTFQQLLSSIEPLRE 264
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 5e-25
Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 48/288 (16%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQ 657
IG GS G + G + K+L+ G + E+ L E+ L ++H N+V +
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71
Query: 658 GYYWSSTMQL--ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE---LHWSRRFHIALGT 712
T I+ E+ G+L + E L + L
Sbjct: 72 DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL-----DEEFVLRVMT--QLTL-- 122
Query: 713 ARALSYLH--HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
AL H D +LH +LK N+ LD KL D+GLA++L N+ +
Sbjct: 123 --ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL----NHDTSFAKTF 176
Query: 771 VG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV--VLCEYVREL 825
VG Y++PE + ++K D++S G +L EL P + + E+ + R +
Sbjct: 177 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI 236
Query: 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ L E+I M L RPS+ E+++
Sbjct: 237 ------PYRYSDELN-----EIITRM---LNLK---DYHRPSVEEILE 267
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 55/308 (17%), Positives = 109/308 (35%), Gaps = 24/308 (7%)
Query: 172 KFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALT 230
+ V S L +P + + L D N ++ N+ L + + N ++
Sbjct: 34 RVVQCSDLGLE-KVPKDLPPDTALL---DLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 231 GTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICG-E 289
F+ ++ L LS N L P + K + V N ++ + G
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLKEL-PEKM--PKTLQELRVHENEIT-KVRKSVFNGLN 145
Query: 290 GMQVFDASWNEF--DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANN 347
M V + N G+ + + L + + I +IP G+ L ++ L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN-ITTIPQGL--PPSLTELHLDGN 202
Query: 348 SIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYN 407
I + +L + L L L ++ ++N L L ++ N L +P L +
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLAD 261
Query: 408 MTYLKILDLHQNHLNG------STPPSLGNLSNLQVLDLSQNSLSGSI--PSSLGNLRNL 459
Y++++ LH N+++ P ++ + L N + PS+ +
Sbjct: 262 HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 321
Query: 460 THFNLSSN 467
L +
Sbjct: 322 AAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 50/240 (20%), Positives = 86/240 (35%), Gaps = 33/240 (13%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
LDL +N + LKN+ + +N +I F
Sbjct: 53 DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS-KISP--------GAFA------ 97
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIE 361
L+ L L N+L +P + + L ++ + N I + +
Sbjct: 98 ---------PLVKLERLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLN 145
Query: 362 LLEVLDLHNLNLR-GEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQN 419
+ V++L L+ + + + L + ++ + IPQ L L L L N
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGN 202
Query: 420 HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
+ SL L+NL L LS NS+S SL N +L +L++N L +P +
Sbjct: 203 KITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLAD 261
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 8e-16
Identities = 42/265 (15%), Positives = 92/265 (34%), Gaps = 38/265 (14%)
Query: 91 ALSGLKSLRVLTLFGNRFT---GNLPQEYAEMQTLWKINVSSNALSGSIPEFI-GDLPNI 146
A + L L L L N+ +P +TL ++ V N ++ + + + L +
Sbjct: 95 AFAPLVKLERLYLSKNQLKELPEKMP------KTLQELRVHENEIT-KVRKSVFNGLNQM 147
Query: 147 RLLDLSRNSY-SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNL 205
+++L N S I F+ K ++ ++ N++ +IP + L N +
Sbjct: 148 IVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKI 204
Query: 206 SGELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGL 264
+ ++ + + L + + N+++ + ++ L L++N + + P G+
Sbjct: 205 T-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKV-PGGLADH 262
Query: 265 KNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNR 324
K I + +N I C G T + + L N
Sbjct: 263 KYIQVVYLHNNNIS-AIGSNDFCPPG-----------------YNTKKASYSGVSLFSNP 304
Query: 325 L-IGSIPTGI-TDLRRLLKISLANN 347
+ I + + L N
Sbjct: 305 VQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 48/292 (16%), Positives = 101/292 (34%), Gaps = 46/292 (15%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLD 150
LK+L L L N+ + P +A + L ++ +S N L +PE ++ L
Sbjct: 71 DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPKTLQELR 127
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSI--PLSIANCTYLEGFDFSFNNLSGE 208
+ N + ++ ++F + V L N L S + L + N++
Sbjct: 128 VHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-T 185
Query: 209 LPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNI 267
+P + ++ L GN +T ++ L LS N + + ++
Sbjct: 186 IPQGLPPSLTELHL---DGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 242
Query: 268 SYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIG 327
++++N +P + + + ++V+ L N I
Sbjct: 243 RELHLNNNKLV-------------------------KVPGGLADHKYIQVVYLHNNN-IS 276
Query: 328 SIPTG-------ITDLRRLLKISLANNSIGGI-IPPNL-GSIELLEVLDLHN 370
+I + T +SL +N + I P+ + + + L N
Sbjct: 277 AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGN 328
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 6e-08
Identities = 27/113 (23%), Positives = 36/113 (31%), Gaps = 28/113 (24%)
Query: 363 LEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
L V+ +L L +VP D+ +LDL N +
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--------------------------PDTALLDLQNNKIT 65
Query: 423 GSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
NL NL L L N +S P + L L LS N L +P
Sbjct: 66 EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPE 117
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 8e-25
Identities = 68/316 (21%), Positives = 119/316 (37%), Gaps = 62/316 (19%)
Query: 582 PSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGG---VSIAVKKL-ETLGRIRNQEE 637
+ ++ K L ++ +G G+ G+V + ++ ++AVK L ++E
Sbjct: 5 EIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDE 64
Query: 638 FELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGN 697
E + + + +V G + + L++ E G L L N
Sbjct: 65 LLAEANVMQQLDNPYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQ------------N 111
Query: 698 PELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751
+ + + + YL H D L + N+LL + K+SD+G
Sbjct: 112 RHVKDKNIIELVHQVSMGMKYLEESNFVHRD---------LAARNVLLVTQHYAKISDFG 162
Query: 752 LAKLLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKP 806
L+K L +NY K+ V + APE + S K DV+SFGV++ E + G+KP
Sbjct: 163 LSKALRADENYYKAQTHGKW--PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220
Query: 807 VESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVP 862
+EV +LE+G + C E+ +M +C +
Sbjct: 221 YRGMKGSEVT-------AMLEKGERMGCPAGCPR---------EMYDLM---NLCWTYDV 261
Query: 863 SRRPSMAEVVQVLESI 878
RP A V L +
Sbjct: 262 ENRPGFAAVELRLRNY 277
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 83/313 (26%), Positives = 137/313 (43%), Gaps = 65/313 (20%)
Query: 584 KYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGG-VSIAVK--KLETLGRIRNQ 635
Y+ WE +++ + +GGG G VY ++ +++AVK K +T+
Sbjct: 4 NYDKWE------MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EV 53
Query: 636 EEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI 695
EEF E + I+H NLV G I++EF+ GNL D L N
Sbjct: 54 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN--------- 104
Query: 696 GNPELHWSRRFHIALGTARALSYL-HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
E+ ++A + A+ YL + +H +L + N L+ EN+ K++D+GL++
Sbjct: 105 -RQEVSAVVLLYMATQISSAMEYLEKKNF----IHRDLAARNCLVGENHLVKVADFGLSR 159
Query: 755 LLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVES 809
L + + KF + + APE + S K DV++FGV+L E+ T G P
Sbjct: 160 L--MTGDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 215
Query: 810 PTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRR 865
++V ELLE+ C + ++ ++M C PS R
Sbjct: 216 IDLSQVY-------ELLEKDYRMERPEGCPE---------KVYELM---RACWQWNPSDR 256
Query: 866 PSMAEVVQVLESI 878
PS AE+ Q E++
Sbjct: 257 PSFAEIHQAFETM 269
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 80/315 (25%), Positives = 137/315 (43%), Gaps = 67/315 (21%)
Query: 582 PSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVK--KLETLGRIRN 634
P ++WE + +E L +G G G V+ + G +AVK K ++ +
Sbjct: 2 PWWEDEWE------VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----S 51
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ--LILSEFVPKGNLYDNLHGVNYPGTST 692
+ F E + ++H LV T + I++E++ G+L D L +
Sbjct: 52 PDAFLAEANLMKQLQHQRLVRLYA---VVTQEPIYIITEYMENGSLVDFLK-------TP 101
Query: 693 GGIGNPELHWSRRFHIALGTARALSYL-HHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751
G +L ++ +A A ++++ + +H +L++ NIL+ + K++D+G
Sbjct: 102 SG---IKLTINKLLDMAAQIAEGMAFIEERNY----IHRDLRAANILVSDTLSCKIADFG 154
Query: 752 LAKLLPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPV 807
LA+L+ + Y KF + + APE + K DV+SFG++L E+VT GR P
Sbjct: 155 LARLIED-NEYTAREGAKF--PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
Query: 808 ESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPS 863
T EV+ + LERG C + EL Q+M +C E P
Sbjct: 212 PGMTNPEVI-------QNLERGYRMVRPDNCPE---------ELYQLM---RLCWKERPE 252
Query: 864 RRPSMAEVVQVLESI 878
RP+ + VLE
Sbjct: 253 DRPTFDYLRSVLEDF 267
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 65/297 (21%), Positives = 107/297 (36%), Gaps = 53/297 (17%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G G V+ A + + A+K++ R +E+ E+ L+ + H +V +
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 660 YWSSTMQL------------ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH 707
+ I + K NL D ++G E S H
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRC---------TIEERERSVCLH 122
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL--------PIL 759
I L A A+ +LH ++H +LK +NI + K+ D+GL + +
Sbjct: 123 IFLQIAEAVEFLH-SKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 760 DNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
+ VG Y++PE S K D++S G+IL EL+ P T E V
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS--TQMERV 234
Query: 817 VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
VR F + E ++Q M S P RP +++
Sbjct: 235 RTLTDVRN----LKFPPLFTQKYP--CEYVMVQDM------LSPSPMERPEAINIIE 279
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 79/352 (22%), Positives = 148/352 (42%), Gaps = 69/352 (19%)
Query: 564 STDSNVIIGKLVLFSKSLPSKYED---WEAGTKALLDKECL-----IGGGSIGSVYRASF 615
D ++ + + F ++ S +ED + ++ L +G G+ GSV +
Sbjct: 9 HHDYDIPTTENLYFQGAMGSAFEDRDPTQ------FEERHLKFLQQLGKGNFGSVEMCRY 62
Query: 616 EG-----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ--LI 668
+ G +AVKKL+ + +FE EI L +++H N+V ++G +S+ + +
Sbjct: 63 DPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKL 121
Query: 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH-HDCKPPI 727
+ E++P G+L D L I + +L + + YL
Sbjct: 122 IMEYLPYGSLRDYLQ------KHKERIDHIKL-----LQYTSQICKGMEYLGTKRY---- 166
Query: 728 LHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY----GLTKFHNAVGYVAPELAQSLR 783
+H +L + NIL++ K+ D+GL K+LP Y + + + APE +
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES--PIFWYAPESLTESK 224
Query: 784 LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVL---------CEYVRELLERG----S 830
S DV+SFGV+L EL T + +SP + ++ ++ ELL+
Sbjct: 225 FSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPR 284
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882
C D E+ +M C + ++RPS ++ ++ IR+ +
Sbjct: 285 PDGCPD---------EIYMIMTE---CWNNNVNQRPSFRDLALRVDQIRDQM 324
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 63/311 (20%), Positives = 126/311 (40%), Gaps = 64/311 (20%)
Query: 588 WEAGTKALLDKECL-----IGGGSIGSVYRASF-----EGGVSIAVKKLETLGRIRNQEE 637
+ L +G G G+V++ + + + +K +E ++ +
Sbjct: 8 RI------FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQA 61
Query: 638 FELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGN 697
+ + ++ H ++V G S++QL+ +++P G+L D++ G +G
Sbjct: 62 VTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVR------QHRGALGP 114
Query: 698 PELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755
L + + A+ + YL H ++H NL + N+LL + +++D+G+A L
Sbjct: 115 QLL-----LNWGVQIAKGMYYLEEHG-----MVHRNLAARNVLLKSPSQVQVADFGVADL 164
Query: 756 LPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPT 811
LP D K + ++A E + + + DV+S+GV + EL+T G +P
Sbjct: 165 LPPDDKQLLYSEAKT--PIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLR 222
Query: 812 TNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
EV +LLE+G C ++ VM + C + RP+
Sbjct: 223 LAEVP-------DLLEKGERLAQPQICTI---------DVYMVM---VKCWMIDENIRPT 263
Query: 868 MAEVVQVLESI 878
E+ +
Sbjct: 264 FKELANEFTRM 274
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 72/307 (23%), Positives = 132/307 (42%), Gaps = 55/307 (17%)
Query: 602 IGGGSIGSVYRASFEG-----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+G G+ GSV ++ G +AVKKL+ + +FE EI L +++H N+V +
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH-STEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 657 QGYYWSSTMQ--LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+G +S+ + ++ E++P G+L D L I + +L +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQ------KHKERIDHIKL-----LQYTSQICK 125
Query: 715 ALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY----GLTKFHN 769
+ YL +H +L + NIL++ K+ D+GL K+LP + +
Sbjct: 126 GMEYLGTKRY----IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES-- 179
Query: 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVL---------CE 820
+ + APE + S DV+SFGV+L EL T + +SP + ++
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF 239
Query: 821 YVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
++ ELL+ C D E+ +M C + ++RPS ++ ++
Sbjct: 240 HLIELLKNNGRLPRPDGCPD---------EIYMIMTE---CWNNNVNQRPSFRDLALRVD 287
Query: 877 SIRNGLG 883
IR+ +
Sbjct: 288 QIRDNMA 294
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 69/394 (17%), Positives = 141/394 (35%), Gaps = 34/394 (8%)
Query: 94 GLKSLRVLTLFGNRFTG-NLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152
+L+ L L N F + +E+ M L + +S+ L S I L ++L +
Sbjct: 88 PTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVL 147
Query: 153 RNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQ 212
+Y + + SL + I + + + +N+ L
Sbjct: 148 GETYGEKEDPEGLQDFNTE---SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 213 ICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNV 272
C+ + ++ N ++ N++ + N FI + ++ + YF++
Sbjct: 205 KCSYFLSILAKLQTN--------PKLSNLTLNNIETTWNSFIRI--LQLVWHTTVWYFSI 254
Query: 273 SHNGFHGEIPEVGICG-----EGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIG 327
S+ G++ + + + + F N+ + + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGT-R 313
Query: 328 SIPTGITD-LRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHN-----LNLRGEVPDDI 381
+ + L + +NN + + N G + LE L L L+ E+ +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQM 373
Query: 382 SNCRFLLLLDVSGNALGGDIPQ-TLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDL 440
+ L LD+S N++ D + L L++ N L + L ++VLDL
Sbjct: 374 KS---LQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDL 428
Query: 441 SQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
N + SIP + L L N++SN L ++P
Sbjct: 429 HSNKIK-SIPKQVVKLEALQELNVASNQLK-SVP 460
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-23
Identities = 66/391 (16%), Positives = 124/391 (31%), Gaps = 26/391 (6%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIR 147
+ + L+ L L + A + + V L +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKED--PEGLQDFN 164
Query: 148 LLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSG 207
L + F +L +N+ + + L+
Sbjct: 165 TESLHIV-FPTNKEFHFILDVSVKTVANLELSNIK--------CVLEDNKCSYFLSILAK 215
Query: 208 ELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVL----- 262
+ + L+ I N+ + Q ++ +S+ G F
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRIL--QLVWHTTVWYFSISNVKLQGQLDFRDFDYSGT 273
Query: 263 GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGF 322
LK +S V + F + M + + + + V L + LD
Sbjct: 274 SLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSN 333
Query: 323 NRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIEL--LEVLDLHNLNLRGEVPDD 380
N L ++ L L + L N + + + ++ L+ LD+ ++ +
Sbjct: 334 NLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKG 393
Query: 381 I-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLD 439
S + LL L++S N L I + L +K+LDLH N + S P + L LQ L+
Sbjct: 394 DCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVVKLEALQELN 450
Query: 440 LSQNSLSGSIP-SSLGNLRNLTHFNLSSNNL 469
++ N L S+P L +L L +N
Sbjct: 451 VASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 3e-21
Identities = 64/375 (17%), Positives = 128/375 (34%), Gaps = 28/375 (7%)
Query: 125 INVSSNALSGSIPEFIGDLP-NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG 183
++ S N L +P+ DL +L++S+N S E+ + K + + +SHN +
Sbjct: 5 VDRSKNGLI-HVPK---DLSQKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQY 59
Query: 184 SIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTG-TVEEQFSQCQS 242
LE D S N L ++ L + + NA + ++F
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLDLSFNAFDALPICKEFGNMSQ 116
Query: 243 IKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICG---EGMQVFDASWN 299
+K L LS+ + + L V + + G+ E + + +
Sbjct: 117 LKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNK 176
Query: 300 EFDGVIPLSITNCRNLKVLDLGFN------RLIGSIPTGITDLRRLLKISLANNSI---G 350
EF ++ +S+ NL++ ++ SI + +L ++L N
Sbjct: 177 EFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNS 236
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRF-----LLLLDVSGNALGGDIPQTL 405
I L + + N+ L+G++ + L + V + G
Sbjct: 237 FIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIY 296
Query: 406 YNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLS 465
+ + I + + +S LD S N L+ ++ + G+L L L
Sbjct: 297 EIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQ 356
Query: 466 SNNLSGTIPSTIQHF 480
N L + +
Sbjct: 357 MNQLK-ELSKIAEMT 370
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 4e-17
Identities = 59/378 (15%), Positives = 125/378 (33%), Gaps = 30/378 (7%)
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
+N+S N +S I L +R+L +S N + ++FK+ + +++ LSHN
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVFKFNQELEYLDLSHNK 80
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNL-SGELPSQICNIPVLDFISVRGNALTGTVEEQFSQ 239
L +S L+ D SFN + + + N+ L F+ + L + +
Sbjct: 81 LVK---ISCHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAH 137
Query: 240 CQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWN 299
K L + + GL++ + ++ + + V + +
Sbjct: 138 LNISKVLLVLGETYGEKEDPE--GLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELS 195
Query: 300 EFDGV-----------IPLSITNCRNLKVLDLGFNRLIGSIPTGITDL---RRLLKISLA 345
V I + L L L + I L + S++
Sbjct: 196 NIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSIS 255
Query: 346 NNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL-----LDVSGNALGGD 400
N + G + + L + +V + + + + + +
Sbjct: 256 NVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMV 315
Query: 401 IPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLG---NLR 457
++ LD N L + + G+L+ L+ L L N L + ++
Sbjct: 316 HMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMK 374
Query: 458 NLTHFNLSSNNLSGTIPS 475
+L ++S N++S
Sbjct: 375 SLQQLDISQNSVSYDEKK 392
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 69.5 bits (170), Expect = 2e-12
Identities = 35/140 (25%), Positives = 55/140 (39%), Gaps = 8/140 (5%)
Query: 353 IPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLK 412
+P +L +L++ + DI + L +L +S N + L+
Sbjct: 15 VPKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELE 72
Query: 413 ILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSS--LGNLRNLTHFNLSSNNLS 470
LDL N L S NL+ LDLS N+ ++P GN+ L LS+ +L
Sbjct: 73 YLDLSHNKL---VKISCHPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLE 128
Query: 471 GTIPSTIQHFGVSTFLNNTG 490
+ I H +S L G
Sbjct: 129 KSSVLPIAHLNISKVLLVLG 148
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 6e-12
Identities = 46/359 (12%), Positives = 90/359 (25%), Gaps = 76/359 (21%)
Query: 173 FVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTG 231
V S N L +P + T L + S N +S S I ++ L + + N +
Sbjct: 4 LVDRSKNGLI-HVPKDLSQKTTIL---NISQNYISELWTSDILSLSKLRILIISHNRIQY 59
Query: 232 TVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGM 291
F Q ++ LDLS N + + N+ + ++S N F +P
Sbjct: 60 LDISVFKFNQELEYLDLSHNKLVKI-SCH--PTVNLKHLDLSFNAFD-ALPICK------ 109
Query: 292 QVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGG 351
F N LK L L L S I L + + +
Sbjct: 110 -EFG---------------NMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETY-- 151
Query: 352 IIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLY----- 406
+ ++ LH + + I + + ++ + + +
Sbjct: 152 GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLS 211
Query: 407 ------------------------------------NMTYLKILDLHQNHLNGSTPPSLG 430
+ Y I ++
Sbjct: 212 ILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYS 271
Query: 431 --NLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLN 487
+L L + + + N+ N + + L+
Sbjct: 272 GTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLD 330
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 1e-09
Identities = 45/254 (17%), Positives = 84/254 (33%), Gaps = 33/254 (12%)
Query: 74 VDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALS 133
+ + L + + LK+L + + + F Y + N + +
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313
Query: 134 GSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI---A 190
+ LD S N + + F + + + + L N L +
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLT-DTVFENCGHLTELETLILQMNQLK-ELSKIAEMTT 371
Query: 191 NCTYLEGFDFSFNNLSGELPSQICNIPV-LDFISVRGNALTGTVEEQFSQCQSIKNLDLS 249
L+ D S N++S + C+ L +++ N LT T+ IK LDL
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLP--PRIKVLDLH 429
Query: 250 SNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSI 309
SN + P V+ L+ + NV+ N +P+ +FD
Sbjct: 430 SNKIKSI-PKQVVKLEALQELNVASNQLK-SVPD--------GIFD-------------- 465
Query: 310 TNCRNLKVLDLGFN 323
+L+ + L N
Sbjct: 466 -RLTSLQKIWLHTN 478
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 61/292 (20%), Positives = 122/292 (41%), Gaps = 53/292 (18%)
Query: 602 IGGGSIGSVYRASF-----EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+G G+ G+VY+ + + + +A+K+L + +E E ++++ + ++
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 82
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
G +ST+QLI + +P G L D + IG+ L + + A+ +
Sbjct: 83 LGICLTSTVQLIT-QLMPFGCLLDYVR------EHKDNIGSQYL-----LNWCVQIAKGM 130
Query: 717 SYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---V 771
+YL ++H +L + N+L+ K++D+GLAKLL + +
Sbjct: 131 NYLEDRR-----LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE--YHAEGGKVPI 183
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG- 829
++A E + + DV+S+GV + EL+T G KP + +E+ +LE+G
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGE 236
Query: 830 ---SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
C ++ +M + C RP E++ +
Sbjct: 237 RLPQPPICTI---------DVYMIM---VKCWMIDADSRPKFRELIIEFSKM 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 59/291 (20%), Positives = 108/291 (37%), Gaps = 39/291 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQ 657
IG G VYRA GV +A+KK++ + + + EI L + H N++ +
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE---LHWSRRFHIALGTAR 714
+ I+ E G+L + PE + +
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI-----PERTVWKYFV--QLCS---- 147
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
AL ++ H + ++H ++K N+ + KL D GL + + T H+ VG
Sbjct: 148 ALEHM-HSRR--VMHRDIKPANVFITATGVVKLGDLGLGRFF----SSKTTAAHSLVGTP 200
Query: 773 -YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831
Y++PE + K D++S G +L E+ + P N + L ++
Sbjct: 201 YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--------LYSLCKKIE- 251
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882
+ EL Q++ + C + P +RP + V V + +
Sbjct: 252 QCDYPPLPSDHYSEELRQLVNM---CINPDPEKRPDVTYVYDVAKRMHACT 299
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 68/317 (21%), Positives = 118/317 (37%), Gaps = 60/317 (18%)
Query: 586 EDWEAGTKALLDKECLIGGGSIGSVYRASFEGG---VSIAVKKLETLGRIRNQEEFELEI 642
+ LL + +G G+ GSV + + + +A+K L+ + EE E
Sbjct: 328 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 387
Query: 643 GRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHW 702
+ + + +V G + + L++ E G L+ L G E+
Sbjct: 388 QIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVG-----------KREEIPV 435
Query: 703 SRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756
S + + + YL H + L + N+LL + K+SD+GL+K L
Sbjct: 436 SNVAELLHQVSMGMKYLEEKNFVHRN---------LAARNVLLVNRHYAKISDFGLSKAL 486
Query: 757 PILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPT 811
D+Y K+ + + APE + S + DV+S+GV + E ++ G+KP +
Sbjct: 487 GADDSYYTARSAGKW--PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 544
Query: 812 TNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
EV+ +E+G C EL +M C RP
Sbjct: 545 GPEVM-------AFIEQGKRMECPPECPP---------ELYALM---SDCWIYKWEDRPD 585
Query: 868 MAEVVQVLESIRNGLGS 884
V Q + + L S
Sbjct: 586 FLTVEQRMRACYYSLAS 602
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 55/220 (25%), Positives = 98/220 (44%), Gaps = 27/220 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G G G+VY A + +A+K L L + + + E+ S++RH N++
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
GY+ +T ++ E+ P G +Y L + + L A ALS
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYREL-------QKLSKFDEQR---TATYITEL--ANALS 123
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
Y H ++H ++K N+LL E K++D+G + P ++ + G Y+
Sbjct: 124 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP------SSRRTDLCGTLDYL 174
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
PE+ + +K D++S GV+ E + G+ P E+ T E
Sbjct: 175 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 58/243 (23%), Positives = 102/243 (41%), Gaps = 32/243 (13%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRN 634
+ + K ED++ G L+G GS VYRA S G+ +A+K + + + +
Sbjct: 3 ATCIGEKIEDFKVGN--------LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGM 54
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGG 694
+ + E+ ++H +++ Y+ S ++ E G + L
Sbjct: 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLK------NRVKP 108
Query: 695 IGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
E +R F + + YLH ILH +L +N+LL N K++D+GLA
Sbjct: 109 FSENE---ARHFMHQI--ITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLAT 160
Query: 755 LLPILDNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT 811
L + K + G Y++PE+A + DV+S G + L+ GR P ++ T
Sbjct: 161 QLKMPHE----KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDT 216
Query: 812 TNE 814
Sbjct: 217 VKN 219
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 56/220 (25%), Positives = 94/220 (42%), Gaps = 27/220 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G G G+VY A + +A+K L L + + + EI S++RH N++
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
Y+ ++ EF P+G LY L G S F L A AL
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKEL-------QKHGRFDEQR---SATFMEEL--ADALH 128
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
Y H + ++H ++K N+L+ E K++D+G + P + G Y+
Sbjct: 129 YCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP------SLRRRTMCGTLDYL 179
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
PE+ + +K D++ GV+ E + G P +SP+ E
Sbjct: 180 PPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 73/321 (22%), Positives = 124/321 (38%), Gaps = 59/321 (18%)
Query: 578 SKSLPSKYEDWE-AGTKALLDKECLIGGGSIGSVYRASFEGG----VSIAVKKLETLGRI 632
+L ++ +D + + + +IG G G VY + + A+K L + +
Sbjct: 4 DSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEM 63
Query: 633 RNQEEFELEIGRLSNIRHFNLVAFQGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTS 691
+ E F E + + H N++A G + +L ++ G+L +
Sbjct: 64 QQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS------- 116
Query: 692 TGGIGNPELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDENYEP 745
L AR + YL H D L + N +LDE++
Sbjct: 117 ----PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRD---------LAARNCMLDESFTV 163
Query: 746 KLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT 802
K++D+GLA+ + + Y + + +A V + A E Q+ R + K DV+SFGV+L EL+T
Sbjct: 164 KVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223
Query: 803 -GRKPVESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLIC 857
G P ++ L +G C D L QVM C
Sbjct: 224 RGAPPYRHIDPFDLT-------HFLAQGRRLPQPEYCPD---------SLYQVM---QQC 264
Query: 858 TSEVPSRRPSMAEVVQVLESI 878
P+ RP+ +V +E I
Sbjct: 265 WEADPAVRPTFRVLVGEVEQI 285
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 71/328 (21%), Positives = 124/328 (37%), Gaps = 67/328 (20%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGG----VSIAVKKL-E 627
S+ L +K ED +D+ L +G G GSV + + + +AVK +
Sbjct: 19 SEELQNKLEDVV------IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKL 72
Query: 628 TLGRIRNQEEFELEIGRLSNIRHFNLVA-----FQGYYWSSTMQLILSEFVPKGNLYDNL 682
R EEF E + + H N++ + +++ F+ G+L+ L
Sbjct: 73 DNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYL 132
Query: 683 HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTN 736
+ T I L + A + YL H D L + N
Sbjct: 133 LY-SRLETGPKHIPLQTLL-----KFMVDIALGMEYLSNRNFLHRD---------LAARN 177
Query: 737 ILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSF 793
+L ++ ++D+GL+K + D Y + A V ++A E + K DV++F
Sbjct: 178 CMLRDDMTVCVADFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRVYTSKSDVWAF 235
Query: 794 GVILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQV 850
GV + E+ T G P +E+ +Y+ L++ C D EL ++
Sbjct: 236 GVTMWEIATRGMTPYPGVQNHEMY---DYLLHGHRLKQ--PEDCLD---------ELYEI 281
Query: 851 MKLGLICTSEVPSRRPSMAEVVQVLESI 878
M C P RP+ + + LE +
Sbjct: 282 MYS---CWRTDPLDRPTFSVLRLQLEKL 306
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 77/310 (24%), Positives = 122/310 (39%), Gaps = 59/310 (19%)
Query: 582 PSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQE 636
W L+ + L IG G G V + G +AVK + +
Sbjct: 182 EFYRSGWA------LNMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVK---CIKNDATAQ 231
Query: 637 EFELEIGRLSNIRHFNLVAFQGYYWSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGI 695
F E ++ +RH NLV G L I++E++ KG+L D L
Sbjct: 232 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR---------- 281
Query: 696 GNPELHWSRRFHIALGTARALSYL-HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
G L +L A+ YL ++ +H +L + N+L+ E+ K+SD+GL K
Sbjct: 282 GRSVLGGDCLLKFSLDVCEAMEYLEGNNF----VHRDLAARNVLVSEDNVAKVSDFGLTK 337
Query: 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTN 813
+ G K V + APE + + S K DV+SFG++L E+ + GR P
Sbjct: 338 EASSTQDTG--KL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 393
Query: 814 EVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA 869
+VV +E+G + C + VM C + RP+
Sbjct: 394 DVV-------PRVEKGYKMDAPDGCPP---------AVYDVM---KNCWHLDAATRPTFL 434
Query: 870 EVVQVLESIR 879
++ + LE IR
Sbjct: 435 QLREQLEHIR 444
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-23
Identities = 69/321 (21%), Positives = 118/321 (36%), Gaps = 70/321 (21%)
Query: 580 SLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASF----EGGVSIAVKKLETLG 630
++ S D+E + +E + IG G G V++ + +++A+K +
Sbjct: 2 AMGSSTRDYE------IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT 55
Query: 631 RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGT 690
+E+F E + H ++V G + + I+ E G L L
Sbjct: 56 SDSVREKFLQEALTMRQFDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQV------ 108
Query: 691 STGGIGNPELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDENYE 744
L + A + AL+YL H D + + N+L+ N
Sbjct: 109 -----RKYSLDLASLILYAYQLSTALAYLESKRFVHRD---------IAARNVLVSSNDC 154
Query: 745 PKLSDYGLAKLLPILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT 802
KL D+GL++ + Y K + ++APE R + DV+ FGV + E++
Sbjct: 155 VKLGDFGLSRYMEDSTYYKASKGKL--PIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212
Query: 803 -GRKPVESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLIC 857
G KP + N+V+ +E G C L +M C
Sbjct: 213 HGVKPFQGVKNNDVI-------GRIENGERLPMPPNCPP---------TLYSLM---TKC 253
Query: 858 TSEVPSRRPSMAEVVQVLESI 878
+ PSRRP E+ L +I
Sbjct: 254 WAYDPSRRPRFTELKAQLSTI 274
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 57/308 (18%), Positives = 99/308 (32%), Gaps = 65/308 (21%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLVAF 656
+G G V G A+K++ Q++ E E H N++
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRI----LCHEQQDREEAQREADMHRLFNHPNILRL 91
Query: 657 QGYYWSSTMQ----LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF------ 706
Y +L F +G L++ +
Sbjct: 92 VAYCLRERGAKHEAWLLLPFFKRGTLWNEI--------------ERLKDKGNFLTEDQIL 137
Query: 707 HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL-----DN 761
+ LG R L +H H +LK TNILL + +P L D G I
Sbjct: 138 WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQA 194
Query: 762 YGLTKFHNAVG---YVAPELAQS---LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
L + Y APEL + ++ DV+S G +L ++ G P +
Sbjct: 195 LTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG- 253
Query: 816 VVLCEYVRELLERGS---ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVV 872
+ V ++ S +L +L+ M + + P +RP + ++
Sbjct: 254 ----DSVALAVQNQLSIPQSPRHSSALW-----QLLNSM-M-----TVDPHQRPHIPLLL 298
Query: 873 QVLESIRN 880
LE+++
Sbjct: 299 SQLEALQP 306
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 67/283 (23%), Positives = 113/283 (39%), Gaps = 33/283 (11%)
Query: 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKK--LETLGRIRNQEEFELEIGRLSNIRHFN 652
+K +G G+ G V++ S G+ +A K LE IRNQ EL++ L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQV--LHECNSPY 92
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+V F G ++S I E + G+L L G I L +++
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLK-------KAGRIPEQILG-----KVSIAV 140
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+ L+YL K I+H ++K +NIL++ E KL D+G++ L + + ++ VG
Sbjct: 141 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSG---QLID---SMANSFVG 192
Query: 773 ---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829
Y++PE Q S + D++S G+ L+E+ GR P+ P E+ ++ E
Sbjct: 193 TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAE 252
Query: 830 SASACFDRSLRGFAENELIQVMK-----LGLICTSEVPSRRPS 867
+ + L I P
Sbjct: 253 TPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSG 295
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-23
Identities = 69/329 (20%), Positives = 122/329 (37%), Gaps = 68/329 (20%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGG----VSIAVKKL-E 627
S L K ED + ++ +G G GSV A + V +AVK L
Sbjct: 8 SDELKEKLEDVL------IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61
Query: 628 TLGRIRNQEEFELEIGRLSNIRHFNLVAFQG------YYWSSTMQLILSEFVPKGNLYDN 681
+ + EEF E + H ++ G + +++ F+ G+L+
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 682 LHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKST 735
L + G + + L + A + YL H D L +
Sbjct: 122 LLA-SRIGENPFNLPLQTLV-----RFMVDIACGMEYLSSRNFIHRD---------LAAR 166
Query: 736 NILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYS 792
N +L E+ ++D+GL++ + D Y + + V ++A E + DV++
Sbjct: 167 NCMLAEDMTVCVADFGLSRKIYSGDYY--RQGCASKLPVKWLALESLADNLYTVHSDVWA 224
Query: 793 FGVILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQ 849
FGV + E++T G+ P E+ Y+ L++ C + E+
Sbjct: 225 FGVTMWEIMTRGQTPYAGIENAEIY---NYLIGGNRLKQ--PPECME---------EVYD 270
Query: 850 VMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+M C S P +RPS + LE+I
Sbjct: 271 LMYQ---CWSADPKQRPSFTCLRMELENI 296
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 8e-23
Identities = 66/284 (23%), Positives = 128/284 (45%), Gaps = 49/284 (17%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL--EIGRLSNIRHFNLVAFQ 657
IG GS G S E G +K++ + R+ ++E E E+ L+N++H N+V ++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEIN-ISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE---LHWSRRFHIALGTAR 714
+ + I+ ++ G+L+ ++ + G+ E L W I L
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRIN-------AQKGVLFQEDQILDWFV--QICL---- 136
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
AL ++H D K ILH ++KS NI L ++ +L D+G+A++L +G
Sbjct: 137 ALKHVH-DRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA----CIGTP 189
Query: 773 -YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV--VLCEYVRELLERG 829
Y++PE+ ++ ++K D+++ G +L EL T + E+ + +V ++ +
Sbjct: 190 YYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPV---- 245
Query: 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
S + LR L+ + P RPS+ +++
Sbjct: 246 --SLHYSYDLR-----SLVSQL-F-----KRNPRDRPSVNSILE 276
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-23
Identities = 64/374 (17%), Positives = 120/374 (32%), Gaps = 43/374 (11%)
Query: 124 KINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG 183
+++S N+++ L +++ L + + + I F+ + L +N
Sbjct: 34 YVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL- 92
Query: 184 SIPLSI-ANCTYLEGFDFSFNNL-SGELPSQI-CNIPVLDFISVRGNALTGTV-EEQFSQ 239
+ LE + NL L + L+ + +R N + F
Sbjct: 93 QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLN 152
Query: 240 CQSIKNLDLSSNLFIGLAP--FGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDAS 297
+ LDL+ N + K+ + +S + D +
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSI----------------TLQDMN 196
Query: 298 WNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNL 357
+ ++ LDL N S+ D KI S + +
Sbjct: 197 EYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSF 256
Query: 358 GSIEL---------------LEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDI 401
G ++ DL + + + S+ L L ++ N +
Sbjct: 257 GHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKID 315
Query: 402 PQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLT 460
+ +T+L L+L QN L NL L+VLDLS N + ++ S L NL
Sbjct: 316 DNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLK 374
Query: 461 HFNLSSNNLSGTIP 474
L +N L ++P
Sbjct: 375 ELALDTNQLK-SVP 387
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 50/338 (14%), Positives = 104/338 (30%), Gaps = 58/338 (17%)
Query: 171 TKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC-NIPVLDFISVRGNAL 229
+V LS N+++ S + L+ + + + L + + N
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 230 TGTVEEQFSQCQSIKNLDLSSNLFIGLA-PFGVL-GLKNISYFNVSHNGFHGEIPEVGIC 287
F+ +++ L L+ G L ++ + N +I
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK-KIQPASF- 149
Query: 288 GEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITD---LRRLLKISL 344
F + R VLDL FN+ + SI + + L
Sbjct: 150 -------------FLNM--------RRFHVLDLTFNK-VKSICEEDLLNFQGKHFTLLRL 187
Query: 345 ANNSIGGIIPPNLGSIEL--------LEVLDLHNLNLRGEVPDDIS-------------N 383
++ ++ + LG + + LDL + + +
Sbjct: 188 SSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILS 247
Query: 384 CRFLLLLDVSGNALGGDIPQTLYN---MTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDL 440
+ + D + + +K DL ++ + + ++L+ L L
Sbjct: 248 NSYNMGSSFGHTNF-KDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTL 306
Query: 441 SQNSLSGSIPS-SLGNLRNLTHFNLSSNNLSGTIPSTI 477
+QN ++ I + L +L NLS N L +I S +
Sbjct: 307 AQNEIN-KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRM 342
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 49/276 (17%), Positives = 87/276 (31%), Gaps = 52/276 (18%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDA----- 296
+ +DLS N L L+++ + V I F
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRN--------NTFRGLSSLI 82
Query: 297 ----SWNEFDGVIPLSITNCRNLKVLDLGFNRLIGS-IPTGI-TDLRRLLKISLANNSIG 350
+N+F + + NL+VL L L G+ + L L + L +N+I
Sbjct: 83 ILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIK 142
Query: 351 GIIP----PNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL----------LDVSGNA 396
I P N+ VLDL ++ +D+ N + D++
Sbjct: 143 KIQPASFFLNMRR---FHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYW 199
Query: 397 LGGDIPQTLYNMTYLKILDLHQNHLNGSTPP---SLGNLSNLQVLDLSQN-----SLSGS 448
LG + + T + LDL N S + +Q L LS + S +
Sbjct: 200 LGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHT 259
Query: 449 IPSSLGNL-------RNLTHFNLSSNNLSGTIPSTI 477
N + +LS + + + ++
Sbjct: 260 NFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSV 294
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 14/68 (20%), Positives = 26/68 (38%), Gaps = 2/68 (2%)
Query: 409 TYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSN 467
++ +DL N + S L +LQ L + Q + I + + L +L L N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 468 NLSGTIPS 475
+ +
Sbjct: 90 QFL-QLET 96
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 64/293 (21%), Positives = 113/293 (38%), Gaps = 63/293 (21%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
LIG G G V++A G + +K+++ N E+ E E+ L+ + H N+V + G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVK-----YNNEKAEREVKALAKLDHVNIVHYNGC 72
Query: 660 YWSSTMQL----------------ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWS 703
+ I EF KG L + G +
Sbjct: 73 WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE-------KRRGEKLDK---V 122
Query: 704 RRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG 763
+ + + Y+H +++ +LK +NI L + + K+ D+GL L
Sbjct: 123 LALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK-----N 174
Query: 764 LTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE 820
K + G Y++PE S + D+Y+ G+IL EL+ T++
Sbjct: 175 DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFF---- 228
Query: 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
L G S FD+ + L+Q + L S+ P RP+ +E+++
Sbjct: 229 ---TDLRDGIISDIFDKKEK-----TLLQKL-L-----SKKPEDRPNTSEILR 267
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 1e-22
Identities = 77/316 (24%), Positives = 119/316 (37%), Gaps = 75/316 (23%)
Query: 585 YEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFE 639
W L+ + L IG G G V + G +AVK + + F
Sbjct: 13 RSGWA------LNMKELKLLQTIGKGEFGDVMLGDYRG-NKVAVK---CIKNDATAQAFL 62
Query: 640 LEIGRLSNIRHFNLVAFQGYYWSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNP 698
E ++ +RH NLV G L I++E++ KG+L D L G
Sbjct: 63 AEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR----------GRS 112
Query: 699 ELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752
L +L A+ YL H D L + N+L+ E+ K+SD+GL
Sbjct: 113 VLGGDCLLKFSLDVCEAMEYLEGNNFVHRD---------LAARNVLVSEDNVAKVSDFGL 163
Query: 753 AKLLPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVE 808
K + K V + APE + + S K DV+SFG++L E+ + GR P
Sbjct: 164 TK-----EASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYP 216
Query: 809 SPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVPSR 864
+VV +E+G + C + +VM C +
Sbjct: 217 RIPLKDVV-------PRVEKGYKMDAPDGCPP---------AVYEVM---KNCWHLDAAM 257
Query: 865 RPSMAEVVQVLESIRN 880
RPS ++ + LE I+
Sbjct: 258 RPSFLQLREQLEHIKT 273
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-22
Identities = 60/282 (21%), Positives = 112/282 (39%), Gaps = 47/282 (16%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G G + + A K + L + +E+ +EI ++ H ++V F
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
G++ + ++ E + +L + + PE +R + +
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELH-------KRRKALTEPE---ARYYLRQI--VLGCQ 155
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
YLH + ++H +LK N+ L+E+ E K+ D+GLA + + G Y+
Sbjct: 156 YLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE----RKKVLCGTPNYI 208
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV---VVLCEYVRELLERGSA 831
APE+ S + DV+S G I+ L+ G+ P E+ E + EY
Sbjct: 209 APEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYS--------- 259
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ + A + LIQ M L P+ RP++ E++
Sbjct: 260 ---IPKHINPVAAS-LIQKM-LQT-----DPTARPTINELLN 291
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 3e-22
Identities = 60/315 (19%), Positives = 101/315 (32%), Gaps = 35/315 (11%)
Query: 184 SIPLSIANCTYLEGFDFSFNNLSG---ELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
SI L I N L + +N +SG + S N ++E
Sbjct: 2 SIMLPINNNFSLSQ-NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKE--CLI 58
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
L L+ L P + I+ ++ N +PE ++ DA N
Sbjct: 59 NQFSELQLNRLNLSSL-PDNLP--PQITVLEITQNALI-SLPE-LPAS--LEYLDACDNR 111
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
+P + ++L D+ N+L +P L + + NN + + P S
Sbjct: 112 LS-TLPELPASLKHL---DVDNNQLT-MLPELPALLEYI---NADNNQLTML-PELPTS- 161
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLK----ILDL 416
LEVL + N L +P+ + L LDVS N L +P + +
Sbjct: 162 --LEVLSVRNNQLT-FLPELPES---LEALDVSTNLLE-SLPAVPVRNHHSEETEIFFRC 214
Query: 417 HQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST 476
+N + P ++ +L + L N LS I SL ++ S +
Sbjct: 215 RENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ 273
Query: 477 IQHFGVSTFLNNTGL 491
Sbjct: 274 NTLHRPLADAVTAWF 288
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 83.5 bits (206), Expect = 9e-17
Identities = 59/402 (14%), Positives = 112/402 (27%), Gaps = 85/402 (21%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
+ L L + +LP + + ++ NAL S+PE L
Sbjct: 53 LKECLINQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPASL------ 102
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
+++ N LS ++P A+ +L D N L+ L
Sbjct: 103 ----------------------EYLDACDNRLS-TLPELPASLKHL---DVDNNQLT-ML 135
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
P L++I+ N LT E S++ L + +N L +++
Sbjct: 136 PELPAL---LEYINADNNQLTMLPE----LPTSLEVLSVRNNQLTFLPEL----PESLEA 184
Query: 270 FNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLK----VLDLGFNRL 325
+VS N +P + + NR
Sbjct: 185 LDVSTNLLES-------------------------LPAVPVRNHHSEETEIFFRCRENR- 218
Query: 326 IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCR 385
I IP I L I L +N + I +L + N
Sbjct: 219 ITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQ--NTL 276
Query: 386 FLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSL 445
L D + + + + + H N + + L + + + + +
Sbjct: 277 HRPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQV 335
Query: 446 SGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLN 487
+ + L L S ++ + + T+ N
Sbjct: 336 A----AWLEKLSASAELRQQSFAVAADATESCEDRVALTWNN 373
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 3e-22
Identities = 51/243 (20%), Positives = 100/243 (41%), Gaps = 27/243 (11%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRN 634
+K +P D + + + + +G G + + A K + L +
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGR--FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQ 58
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGG 694
+E+ +EI ++ H ++V F G++ + ++ E + +L +
Sbjct: 59 REKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH-------KRRKA 111
Query: 695 IGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
+ PE +R + + YLH + ++H +LK N+ L+E+ E K+ D+GLA
Sbjct: 112 LTEPE---ARYYLRQI--VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLAT 163
Query: 755 LLPILDNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT 811
+ + G Y+APE+ S + DV+S G I+ L+ G+ P E+
Sbjct: 164 KVEYDGE----RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 219
Query: 812 TNE 814
E
Sbjct: 220 LKE 222
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 4e-22
Identities = 70/322 (21%), Positives = 134/322 (41%), Gaps = 51/322 (15%)
Query: 576 LFSKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSIAVK 624
FS + ++WE + +E + +G GS G VY E +A+K
Sbjct: 8 YFSAADVYVPDEWE------VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIK 61
Query: 625 KLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHG 684
+ +R + EF E + ++V G L++ E + +G+L L
Sbjct: 62 TVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS 121
Query: 685 VNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDEN 742
+ + + P L S+ +A A ++YL + +H +L + N ++ E+
Sbjct: 122 LRPAMANNPVLAPPSL--SKMIQMAGEIADGMAYLNANK-----FVHRDLAARNCMVAED 174
Query: 743 YEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFGVILLE 799
+ K+ D+G+ + + D Y K V +++PE + + DV+SFGV+L E
Sbjct: 175 FTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWE 232
Query: 800 LVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLGLI 856
+ T +P + + +V+ +V E LL++ C D L ++M++
Sbjct: 233 IATLAEQPYQGLSNEQVL---RFVMEGGLLDK--PDNCPD---------MLFELMRM--- 275
Query: 857 CTSEVPSRRPSMAEVVQVLESI 878
C P RPS E++ ++
Sbjct: 276 CWQYNPKMRPSFLEIISSIKEE 297
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 4e-22
Identities = 76/322 (23%), Positives = 139/322 (43%), Gaps = 54/322 (16%)
Query: 583 SKYEDWEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSIAVKKLETLGR 631
S + + + +G G+ G V+ A + + +AVK L+
Sbjct: 5 SGIHVQH------IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKD-PT 57
Query: 632 IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL--HGVNYPG 689
+ +++F+ E L+N++H ++V F G +++ E++ G+L L HG +
Sbjct: 58 LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMI 117
Query: 690 TSTGGIGNP--ELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEP 745
G EL S+ HIA A + YL H +H +L + N L+ N
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH-----FVHRDLATRNCLVGANLLV 172
Query: 746 KLSDYGLAKLLPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT 802
K+ D+G+++ + D Y G T + ++ PE + + + DV+SFGVIL E+ T
Sbjct: 173 KIGDFGMSRDVYSTDYYRVGGHTML--PIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230
Query: 803 -GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLGLICTS 859
G++P + EV+ E + + +LER C E+ VM C
Sbjct: 231 YGKQPWFQLSNTEVI---ECITQGRVLER--PRVCPK---------EVYDVMLG---CWQ 273
Query: 860 EVPSRRPSMAEVVQVLESIRNG 881
P +R ++ E+ ++L ++
Sbjct: 274 REPQQRLNIKEIYKILHALGKA 295
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 5e-22
Identities = 69/329 (20%), Positives = 126/329 (38%), Gaps = 78/329 (23%)
Query: 582 PSKYED---------WEAGTKALLDKECL-----IGGGSIGSVYRASF----EGGVSIAV 623
P YE+ E ++ + IG G G V + V +A+
Sbjct: 29 PHTYEEPGRAGRSFTRE------IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAI 82
Query: 624 KKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLH 683
K L+ R + +F E + H N++ +G + +I++E++ G+L L
Sbjct: 83 KALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142
Query: 684 GVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNI 737
+ + + + G + YL H D L + N+
Sbjct: 143 T-----------HDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRD---------LAARNV 182
Query: 738 LLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFG 794
L+D N K+SD+GL+++L D + + APE S DV+SFG
Sbjct: 183 LVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFG 241
Query: 795 VILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQ 849
V++ E++ G +P + T +V+ +E G + C L Q
Sbjct: 242 VVMWEVLAYGERPYWNMTNRDVI-------SSVEEGYRLPAPMGCPH---------ALHQ 285
Query: 850 VMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+M L C + ++RP +++V VL+++
Sbjct: 286 LM---LDCWHKDRAQRPRFSQIVSVLDAL 311
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 5e-22
Identities = 66/316 (20%), Positives = 116/316 (36%), Gaps = 70/316 (22%)
Query: 585 YEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGG----VSIAVKKLETLGRIRNQ 635
+ + +E + +G G G VY + +++AVK + + N+
Sbjct: 4 GPQYG------IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK 57
Query: 636 EEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI 695
E+F E + N+ H ++V G +I+ E P G L L
Sbjct: 58 EKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIM-ELYPYGELGHYLER----------- 105
Query: 696 GNPELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDENYEPKLSD 749
L +L +A++YL H D + NIL+ KL D
Sbjct: 106 NKNSLKVLTLVLYSLQICKAMAYLESINCVHRD---------IAVRNILVASPECVKLGD 156
Query: 750 YGLAKLLPILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKP 806
+GL++ + D Y +T+ + +++PE R + DV+ F V + E+++ G++P
Sbjct: 157 FGLSRYIEDEDYYKASVTRL--PIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQP 214
Query: 807 VESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICTSEVP 862
+V+ +LE+G C L +M C P
Sbjct: 215 FFWLENKDVI-------GVLEKGDRLPKPDLCPP---------VLYTLM---TRCWDYDP 255
Query: 863 SRRPSMAEVVQVLESI 878
S RP E+V L +
Sbjct: 256 SDRPRFTELVCSLSDV 271
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-22
Identities = 78/403 (19%), Positives = 146/403 (36%), Gaps = 81/403 (20%)
Query: 511 SKNPKVLSVSAIVAIVAAALILAGVCVVTIMNIKAR--RRKRDDETMVVEGTPLGSTDSN 568
+ P ++ ++ A ++ G C + ++ R +++ E + L + +
Sbjct: 293 APEPLTVTAPSLTIAENMADLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQ 352
Query: 569 VIIGKLVLFSKSL--------PSKYE-----DWEAGTKALLDKECL-----IGGGSIGSV 610
+ V S++ Y D+E + +E + IG G G V
Sbjct: 353 GVRSHTVSVSETDDYAEIIDEEDTYTMPSTRDYE------IQRERIELGRCIGEGQFGDV 406
Query: 611 YRASF----EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ 666
++ + +++A+K + +E+F E + H ++V G + +
Sbjct: 407 HQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVW 466
Query: 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL------H 720
+I+ E G L L L + A + AL+YL H
Sbjct: 467 IIM-ELCTLGELRSFLQV-----------RKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 721 HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ 780
D + + N+L+ N KL D+GL++ + Y +K + ++APE
Sbjct: 515 RD---------IAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESIN 565
Query: 781 SLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG----SASACF 835
R + DV+ FGV + E++ G KP + N+V+ +E G C
Sbjct: 566 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-------GRIENGERLPMPPNC- 617
Query: 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
L +M C + PSRRP E+ L +I
Sbjct: 618 --------PPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTI 649
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-22
Identities = 71/294 (24%), Positives = 117/294 (39%), Gaps = 54/294 (18%)
Query: 602 IGGGSIGSVYRASFEGG----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
IG G G VY + + AVK L + I +F E + + H N+++
Sbjct: 33 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 658 GYYWSSTMQ-LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
G S L++ ++ G+L + + L A+ +
Sbjct: 93 GICLRSEGSPLVVLPYMKHGDLRNFIRN-----------ETHNPTVKDLIGFGLQVAKGM 141
Query: 717 SYL------HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
YL H D L + N +LDE + K++D+GLA+ + + Y + A
Sbjct: 142 KYLASKKFVHRD---------LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 771 ---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE-- 824
V ++A E Q+ + + K DV+SFGV+L EL+T G P T ++ Y+ +
Sbjct: 193 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGR 249
Query: 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
L + C D L +VM L C RPS +E+V + +I
Sbjct: 250 RLLQ--PEYCPD---------PLYEVM---LKCWHPKAEMRPSFSELVSRISAI 289
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 9e-22
Identities = 65/329 (19%), Positives = 125/329 (37%), Gaps = 78/329 (23%)
Query: 582 PSKYED---------WEAGTKALLDKECL-----IGGGSIGSVYRASF----EGGVSIAV 623
P +ED E LD + +G G G V + +S+A+
Sbjct: 25 PHTFEDPTQTVHEFAKE------LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 624 KKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLH 683
K L+ + + +F E + H N++ +G S +I++E++ G+L L
Sbjct: 79 KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138
Query: 684 GVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTNI 737
+ + + + G A + YL H D L + NI
Sbjct: 139 K-----------HDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRD---------LAARNI 178
Query: 738 LLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFG 794
L++ N K+SD+GL ++L D + + +PE + + DV+S+G
Sbjct: 179 LINSNLVCKVSDFGLGRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYG 237
Query: 795 VILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQ 849
++L E+++ G +P + +V+ + ++ G C L Q
Sbjct: 238 IVLWEVMSYGERPYWEMSNQDVI-------KAVDEGYRLPPPMDCPA---------ALYQ 281
Query: 850 VMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+M L C + + RP ++V +L+ +
Sbjct: 282 LM---LDCWQKDRNNRPKFEQIVSILDKL 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 64/348 (18%), Positives = 113/348 (32%), Gaps = 66/348 (18%)
Query: 128 SSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPL 187
S L ++P+ I P+ LLDL N S E+ FK + L +N +S I
Sbjct: 41 SDLGLK-AVPKEIS--PDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKIS-KIH- 94
Query: 188 SIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLD 247
+ +F+ L L + + N L S S+ L
Sbjct: 95 -----------EKAFSPLRK-----------LQKLYISKNHLVEIPPNLPS---SLVELR 129
Query: 248 LSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPL 307
+ N + GL+N++ + N + G FDG+
Sbjct: 130 IHDNRIRKVPKGVFSGLRNMNCIEMGGN----PLENSGF----------EPGAFDGL--- 172
Query: 308 SITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLD 367
L L + +L IP + L ++ L +N I I +L L L
Sbjct: 173 ------KLNYLRISEAKLT-GIPKDL--PETLNELHLDHNKIQAIELEDLLRYSKLYRLG 223
Query: 368 LHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG---- 423
L + +R +S L L + N L +P L ++ L+++ LH N++
Sbjct: 224 LGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNITKVGVN 282
Query: 424 --STPPSLGNLSNLQVLDLSQNSLSGSI--PSSLGNLRNLTHFNLSSN 467
+ + L N + P++ + + +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 63/310 (20%), Positives = 103/310 (33%), Gaps = 68/310 (21%)
Query: 172 KFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALT 230
+ V S L ++P I + T L D N++S +
Sbjct: 36 RVVQCSDLGLK-AVPKEISPDTTLL---DLQNNDIS--------ELR------------- 70
Query: 231 GTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEG 290
++ F Q + L L +N + L+ + +S N EIP
Sbjct: 71 ---KDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP------- 119
Query: 291 MQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSI 349
+ +L L + NR I +P G+ + LR + I + N +
Sbjct: 120 -NLP------------------SSLVELRIHDNR-IRKVPKGVFSGLRNMNCIEMGGNPL 159
Query: 350 GGI-IPPNLGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQ-TLY 406
P L L + L +P D+ L L + N + I L
Sbjct: 160 ENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDLPET---LNELHLDHNKIQ-AIELEDLL 214
Query: 407 NMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSS 466
+ L L L N + SL L L+ L L N LS +P+ L +L+ L L +
Sbjct: 215 RYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHT 273
Query: 467 NNLSGTIPST 476
NN++ +
Sbjct: 274 NNIT-KVGVN 282
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 48/239 (20%), Positives = 81/239 (33%), Gaps = 32/239 (13%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
LDL +N L GL+++ + +N +I E + F
Sbjct: 55 DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS-KIHE--------KAFS------ 99
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIE 361
R L+ L + N L+ IP + L+++ + +N I + +
Sbjct: 100 ---------PLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIRKVPKGVFSGLR 147
Query: 362 LLEVLDLHNLNLR-GEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
+ +++ L + L L +S L IP+ L L L L N
Sbjct: 148 NMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPKDL--PETLNELHLDHNK 204
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
+ L S L L L N + SL L L +L +N LS +P+ +
Sbjct: 205 IQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPD 262
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 42/265 (15%), Positives = 84/265 (31%), Gaps = 39/265 (14%)
Query: 91 ALSGLKSLRVLTLFGNRFT---GNLPQEYAEMQTLWKINVSSNALSGSIPEFI-GDLPNI 146
A S L+ L+ L + N NLP +L ++ + N + +P+ + L N+
Sbjct: 97 AFSPLRKLQKLYISKNHLVEIPPNLP------SSLVELRIHDNRIR-KVPKGVFSGLRNM 149
Query: 147 RLLDLSRNSY-SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNL 205
+++ N + F K ++ +S L+ IP + L N +
Sbjct: 150 NCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLT-GIPKDLP--ETLNELHLDHNKI 205
Query: 206 SGELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGL 264
+ + L + + N + S +++ L L +N + P G+ L
Sbjct: 206 Q-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSRV-PAGLPDL 263
Query: 265 KNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNR 324
K + + N ++ N+F V + L N
Sbjct: 264 KLLQVVYLHTNNIT-KVGV---------------NDFCPVGFG--VKRAYYNGISLFNNP 305
Query: 325 L-IGSIPTGI-TDLRRLLKISLANN 347
+ + + L I N
Sbjct: 306 VPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 57/356 (16%), Positives = 106/356 (29%), Gaps = 101/356 (28%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLD 150
GL+ L L L N+ + + ++ ++ L K+ +S N L IP + ++ L
Sbjct: 73 DFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELR 129
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELP 210
+ N ++P +F + + N L + +F+ L
Sbjct: 130 IHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLE-NSGFE----------PGAFDGLK---- 173
Query: 211 SQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYF 270
L+++ + LTG ++ ++ L L N I
Sbjct: 174 --------LNYLRISEAKLTGIPKDLPE---TLNELHLDHN--------------KIQ-- 206
Query: 271 NVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIP 330
I + L L LG N+ I I
Sbjct: 207 ---------AIE-----------------------LEDLLRYSKLYRLGLGHNQ-IRMIE 233
Query: 331 TGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
G + L L ++ L NN + +P L ++LL+V+ LH N+
Sbjct: 234 NGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT--------------- 277
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGST--PPSLGNLSNLQVLDLSQN 443
V N Y + L N + P + +++ +
Sbjct: 278 -KVGVNDFCP--VGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 2e-07
Identities = 26/113 (23%), Positives = 38/113 (33%), Gaps = 28/113 (24%)
Query: 363 LEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
L V+ +L L+ VP +IS +LDL N ++
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--------------------------PDTTLLDLQNNDIS 67
Query: 423 GSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
L +L L L N +S + LR L +S N+L IP
Sbjct: 68 ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV-EIPP 119
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.1 bits (239), Expect = 1e-21
Identities = 50/254 (19%), Positives = 86/254 (33%), Gaps = 44/254 (17%)
Query: 633 RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTST 692
+ ++I R+ N V I + K NL D ++
Sbjct: 103 SPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC------ 156
Query: 693 GGIGNPELHWSRRF--HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750
+ + E IA + +LH ++H +LK +NI + K+ D+
Sbjct: 157 -SLEDREHGVCLHIFIQIAEA----VEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDF 208
Query: 751 GLAKLL--------PILDNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLE 799
GL + + VG Y++PE S K D++S G+IL E
Sbjct: 209 GLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFE 268
Query: 800 LVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTS 859
L+ T E V + VR F + E+ ++Q M S
Sbjct: 269 LLYSF-----STQMERVRIITDVRN----LKFPLLFTQKYP--QEHMMVQDM------LS 311
Query: 860 EVPSRRPSMAEVVQ 873
P+ RP ++++
Sbjct: 312 PSPTERPEATDIIE 325
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 69/324 (21%), Positives = 125/324 (38%), Gaps = 57/324 (17%)
Query: 577 FSKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSIAVKK 625
F+ S + E + ++ + +G G+ G VY + + +AVK
Sbjct: 14 FAGKTSSISDLKE------VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 67
Query: 626 LETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGV 685
L + +++ +F +E +S H N+V G S + IL E + G+L L
Sbjct: 68 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET 127
Query: 686 NYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLD--- 740
+ + +L H+A A YL +H +H ++ + N LL
Sbjct: 128 RPRPSQPSSLAMLDL-----LHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPG 177
Query: 741 ENYEPKLSDYGLAKLLPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVIL 797
K+ D+G+A+ + Y G V ++ PE + K D +SFGV+L
Sbjct: 178 PGRVAKIGDFGMARDIYRASYYRKGGCAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
Query: 798 LELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLG 854
E+ + G P S + EV+ E+V ++ C + ++M
Sbjct: 236 WEIFSLGYMPYPSKSNQEVL---EFVTSGGRMDP--PKNCPG---------PVYRIMTQ- 280
Query: 855 LICTSEVPSRRPSMAEVVQVLESI 878
C P RP+ A +++ +E
Sbjct: 281 --CWQHQPEDRPNFAIILERIEYC 302
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 1e-21
Identities = 71/327 (21%), Positives = 124/327 (37%), Gaps = 60/327 (18%)
Query: 580 SLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSIAVKKLET 628
LP WE ++ L +G G+ G V A ++AVK L+
Sbjct: 14 RLPYDASKWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKE 67
Query: 629 LGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQ----LILSEFVPKGNLYDNL- 682
E+ L +I H N+V G + T +++ EF GNL L
Sbjct: 68 GATHSEHRALMSELKILIHIGHHLNVVNLLG---ACTKPGGPLMVIVEFCKFGNLSTYLR 124
Query: 683 ---HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNI 737
+ + + L + A+ + +L +H +L + NI
Sbjct: 125 SKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK-----CIHRDLAARNI 179
Query: 738 LLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFG 794
LL E K+ D+GLA+ + +Y + +A + ++APE + + DV+SFG
Sbjct: 180 LLSEKNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG 237
Query: 795 VILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVM 851
V+L E+ + G P +E ++E + + E+ Q M
Sbjct: 238 VLLWEIFSLGASPYPGVKIDEEFC--RRLKEGTRMRAPD-----------YTTPEMYQTM 284
Query: 852 KLGLICTSEVPSRRPSMAEVVQVLESI 878
C PS+RP+ +E+V+ L ++
Sbjct: 285 LD---CWHGEPSQRPTFSELVEHLGNL 308
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 2e-21
Identities = 69/333 (20%), Positives = 130/333 (39%), Gaps = 85/333 (25%)
Query: 582 PSKYED---------WEAGTKALLDKECL-----IGGGSIGSVYRA-----SFEGGVSIA 622
+ D E + C+ IG G G VY+ S + V +A
Sbjct: 24 GAMGSDPNQAVLKFTTE------IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVA 77
Query: 623 VKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL 682
+K L+ + + +F E G + H N++ +G +I++E++ G L L
Sbjct: 78 IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137
Query: 683 HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL------HHDCKPPILHLNLKSTN 736
+ E + + G A + YL H D L + N
Sbjct: 138 RE-----------KDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRD---------LAARN 177
Query: 737 ILLDENYEPKLSDYGLAKLLPILDNYGL------TKFHNAVGYVAPELAQSLRLSDKCDV 790
IL++ N K+SD+GL+++ + D+ K + + APE + + DV
Sbjct: 178 ILVNSNLVCKVSDFGLSRV--LEDDPEATYTTSGGKI--PIRWTAPEAISYRKFTSASDV 233
Query: 791 YSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAEN 845
+SFG+++ E++T G +P + +EV+ + + G + C
Sbjct: 234 WSFGIVMWEVMTYGERPYWELSNHEVM-------KAINDGFRLPTPMDCPS--------- 277
Query: 846 ELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+ Q+M + C + +RRP A++V +L+ +
Sbjct: 278 AIYQLM---MQCWQQERARRPKFADIVSILDKL 307
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-21
Identities = 28/166 (16%), Positives = 61/166 (36%), Gaps = 7/166 (4%)
Query: 306 PLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEV 365
++ +L + L + + TGI + +++ N P + + LE
Sbjct: 37 NITEAQMNSLTYITLANIN-VTDL-TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLER 92
Query: 366 LDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGST 425
L + ++ + ++S L LLD+S +A I + + + +DL N +
Sbjct: 93 LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAI-TD 151
Query: 426 PPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSG 471
L L L+ L++ + + + + L S + G
Sbjct: 152 IMPLKTLPELKSLNIQFDGVHDY--RGIEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 2e-16
Identities = 27/140 (19%), Positives = 54/140 (38%), Gaps = 7/140 (5%)
Query: 336 LRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGN 395
+ L L +S I + S L + L N+N+ I + L ++
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNS---LTYITLANINVTDLTG--IEYAHNIKDLTINNI 76
Query: 396 ALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGN 455
+ + ++ L+ L + + P+L L++L +LD+S ++ SI + +
Sbjct: 77 HAT-NY-NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 456 LRNLTHFNLSSNNLSGTIPS 475
L + +LS N I
Sbjct: 135 LPKVNSIDLSYNGAITDIMP 154
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 3e-13
Identities = 32/246 (13%), Positives = 72/246 (29%), Gaps = 57/246 (23%)
Query: 204 NLSGELPSQICNIPVLDFISVRGNAL--TGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGV 261
+ NIP F + L + T +Q S+ + L++ L
Sbjct: 5 QTGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTGIE- 63
Query: 262 LGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLG 321
NI +++ + + I+ NL+ L +
Sbjct: 64 -YAHNIKDLTINNI----------------HATNYN----------PISGLSNLERLRIM 96
Query: 322 FNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI 381
+ ++ L L + +++++ I + ++ + +DL
Sbjct: 97 GKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL------------- 143
Query: 382 SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLS 441
S N DI L + LK L++ + ++ + + L L
Sbjct: 144 -----------SYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAF 189
Query: 442 QNSLSG 447
++ G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 3e-10
Identities = 24/118 (20%), Positives = 48/118 (40%), Gaps = 4/118 (3%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLD 150
+SGL +L L + G T + + + +L +++S +A SI I LP + +D
Sbjct: 83 PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSID 142
Query: 151 LSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
LS N +I K + K +++ + + + + L + G+
Sbjct: 143 LSYNGAITDIMP--LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 19/159 (11%), Positives = 57/159 (35%), Gaps = 8/159 (5%)
Query: 117 AEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL 176
A+M +L I +++ ++ + I NI+ L ++ + P + + + +
Sbjct: 41 AQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINNIHATNYNPISGLS---NLERLRI 95
Query: 177 SHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQ 236
+++ +++ T L D S + + ++I +P ++ I + N +
Sbjct: 96 MGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP- 154
Query: 237 FSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHN 275
+K+L++ + ++
Sbjct: 155 LKTLPELKSLNIQFDGVHDYRGIE--DFPKLNQLYAFSQ 191
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 4e-09
Identities = 24/191 (12%), Positives = 65/191 (34%), Gaps = 35/191 (18%)
Query: 140 IGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFD 199
+ ++ + L+ + + ++ +Y + K +++++ + + P+S + LE
Sbjct: 40 EAQMNSLTYITLANINVT-DLTG--IEYAHNIKDLTINNIHATNYNPIS--GLSNLERLR 94
Query: 200 FSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIG-LAP 258
+++ + + + L + + +A ++ + + + ++DLS N I + P
Sbjct: 95 IMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMP 154
Query: 259 FGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVL 318
L + N+ + V D I + L L
Sbjct: 155 LK--TLPELKSLNIQFD----------------GVHDYR----------GIEDFPKLNQL 186
Query: 319 DLGFNRLIGSI 329
IG
Sbjct: 187 YAFSQT-IGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 1e-07
Identities = 11/86 (12%), Positives = 30/86 (34%), Gaps = 6/86 (6%)
Query: 394 GNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSL 453
G + +I + M L + L ++ T + N++ L ++ + + +
Sbjct: 31 GQSSTANITEA--QMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNY--NPI 84
Query: 454 GNLRNLTHFNLSSNNLSGTIPSTIQH 479
L NL + +++ +
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSG 110
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 4e-06
Identities = 18/120 (15%), Positives = 43/120 (35%), Gaps = 14/120 (11%)
Query: 92 LSGLKSLRVLTLFGNRFT-----GNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNI 146
+ +++ LT+ T L L ++ + ++ + L ++
Sbjct: 62 IEYAHNIKDLTINNIHATNYNPISGLSN-------LERLRIMGKDVTSDKIPNLSGLTSL 114
Query: 147 RLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLS 206
LLD+S +++ I + K + LS+N I + L+ + F+ +
Sbjct: 115 TLLDISHSAHDDSILTKI-NTLPKVNSIDLSYNGAITDIM-PLKTLPELKSLNIQFDGVH 172
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 55/215 (25%), Positives = 96/215 (44%), Gaps = 22/215 (10%)
Query: 598 KECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
++G G+ G VY V IA+K++ R + EI +++H N+V +
Sbjct: 26 DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIP-ERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTAR 714
G + + I E VP G+L L + G + + E + I G
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLR------SKWGPLKDNEQT-IGFYTKQILEG--- 134
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
L YLH + I+H ++K N+L++ + K+SD+G +K L ++ T F + Y
Sbjct: 135 -LKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET-FTGTLQY 189
Query: 774 VAPELAQSLRL--SDKCDVYSFGVILLELVTGRKP 806
+APE+ D++S G ++E+ TG+ P
Sbjct: 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPP 224
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 3e-21
Identities = 60/315 (19%), Positives = 110/315 (34%), Gaps = 44/315 (13%)
Query: 168 CYKTKFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRG 226
C + S +L+ SIP + L D S N ++ S + L + +
Sbjct: 30 CDRNGICKGSSGSLN-SIPSGLTEAVKSL---DLSNNRITYISNSDLQRCVNLQALVLTS 85
Query: 227 NALTGTVEEQ-FSQCQSIKNLDLSSNLFIGLAPFGVL-GLKNISYFNVSHNGFHGEIPEV 284
N + T+EE FS S+++LDLS N L+ L ++++ N+ N + + E
Sbjct: 86 NGIN-TIEEDSFSSLGSLEHLDLSYNYLSNLSS-SWFKPLSSLTFLNLLGNPYK-TLGET 142
Query: 285 GICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKIS 343
+ F + L++L +G I L L ++
Sbjct: 143 SL--------------FSHL--------TKLQILRVGNMDTFTKIQRKDFAGLTFLEELE 180
Query: 344 LANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGG---- 399
+ + + P +L SI+ + L LH + + + L++ L
Sbjct: 181 IDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFS 240
Query: 400 ----DIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSS-LG 454
+L + + + L L +S L L+ S+N L S+P
Sbjct: 241 ELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDGIFD 298
Query: 455 NLRNLTHFNLSSNNL 469
L +L L +N
Sbjct: 299 RLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 38/208 (18%), Positives = 72/208 (34%), Gaps = 14/208 (6%)
Query: 292 QVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIG 350
+ D S N + + C NL+ L L N I +I + L L + L+ N +
Sbjct: 55 KSLDLSNNRITYISNSDLQRCVNLQALVLTSNG-INTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 351 GIIPP----NLGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIP-QT 404
+ L S L L+L + + S+ L +L V I +
Sbjct: 114 -NLSSSWFKPLSS---LTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD 169
Query: 405 LYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFN 463
+T+L+ L++ + L P SL ++ N+ L L + + ++
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLE 228
Query: 464 LSSNNLSGTIPSTIQHFGVSTFLNNTGL 491
L +L S + ++ +
Sbjct: 229 LRDTDLDTFHFSELSTGETNSLIKKFTF 256
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 52/295 (17%), Positives = 96/295 (32%), Gaps = 62/295 (21%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
++K+LDLS+N ++ + N+ ++ NG + I E F
Sbjct: 53 AVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEE--------DSFS------ 97
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNL--G 358
+ +L+ LDL +N L ++ + L L ++L N + +L
Sbjct: 98 ---------SLGSLEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSH 147
Query: 359 SIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQ 418
+L + + D + FL L++ + L P++L ++ + L LH
Sbjct: 148 LTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
Query: 419 NHLNGSTPPSLGNLSNLQVLDLSQNSLSG------------------------------- 447
+ S+++ L+L L
Sbjct: 208 KQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
Query: 448 SIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLETSCSG 502
+ L + L S N L ++P I F T L L P + SC
Sbjct: 268 QVMKLLNQISGLLELEFSRNQLK-SVPDGI--FDRLTSLQKIWLHTNPWDCSCPR 319
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 39/282 (13%), Positives = 89/282 (31%), Gaps = 44/282 (15%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPE--FIGDLPNIRL 148
L +L+ L L N ++ + +L +++S N LS ++ F L ++
Sbjct: 71 DLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS-NLSSSWFKP-LSSLTF 128
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
L+L N Y +LF + K + + + + + I F L+
Sbjct: 129 LNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKD------------FAGLTF- 175
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
L+ + + + L + Q++ +L L I L V ++
Sbjct: 176 ----------LEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVE 225
Query: 269 YFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGS 328
+ ++E S+ + + + L
Sbjct: 226 CLELRDTDLDT----------------FHFSELSTGETNSLIKKFTFRNVKITDESLF-Q 268
Query: 329 IPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHN 370
+ + + LL++ + N + + + L+ + LH
Sbjct: 269 VMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHT 310
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 26/200 (13%), Positives = 57/200 (28%), Gaps = 16/200 (8%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYA--EMQTLWKINVSSNALSGSIPEFI-GDLPNIR 147
L SL L L GN + L + + L + V + I L +
Sbjct: 119 WFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLE 177
Query: 148 LLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIP-LSIANCTYLEGFDFSFNNLS 206
L++ + K + L + + + + +E + +L
Sbjct: 178 ELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLD 235
Query: 207 GELPSQICNI--------PVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAP 258
S++ + + +L V + +Q + L+ S N +
Sbjct: 236 TFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKSVPD 294
Query: 259 FGVLGLKNISYFNVSHNGFH 278
L ++ + N +
Sbjct: 295 GIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 24/172 (13%), Positives = 52/172 (30%), Gaps = 12/172 (6%)
Query: 65 GVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWK 124
+F + V + + +GL L L + + P+ +Q +
Sbjct: 143 SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSH 202
Query: 125 INVSSNALSGSIPEFIGD-LPNIRLLDLSRNSYSG-------EIPFALFKYCYKTKFVSL 176
+ + + E D ++ L+L + + V +
Sbjct: 203 LILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKI 261
Query: 177 SHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC-NIPVLDFISVRGN 227
+ +L + + + L +FS N L +P I + L I + N
Sbjct: 262 TDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 66/301 (21%), Positives = 116/301 (38%), Gaps = 50/301 (16%)
Query: 602 IGGGSIGSVYRASFEGG------VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G VY+ G ++A+K L+ +EEF E + ++H N+V
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHG----VNYPGTSTGGIGNPELHWSRRFHIALG 711
G ++ + G+L++ L + T L H+
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 712 TARALSYL------HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLT 765
A + YL H D L + N+L+ + K+SD GL + + D Y
Sbjct: 137 IAAGMEYLSSHHVVHKD---------LATRNVLVYDKLNVKISDLGLFREVYAADYY--K 185
Query: 766 KFHNA---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEY 821
N+ + ++APE + S D++S+GV+L E+ + G +P + +VV E
Sbjct: 186 LLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV---EM 242
Query: 822 VRE--LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
+R +L C + +M + C +E PSRRP ++ L +
Sbjct: 243 IRNRQVLPC--PDDC---------PAWVYALM---IECWNEFPSRRPRFKDIHSRLRAWG 288
Query: 880 N 880
N
Sbjct: 289 N 289
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 5e-21
Identities = 66/330 (20%), Positives = 130/330 (39%), Gaps = 57/330 (17%)
Query: 574 LVLFSKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSIA 622
+ E WE + L +G G+ G V A + + +A
Sbjct: 27 YTFIDPTQLPYNEKWE------FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVA 80
Query: 623 VKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQ---LILSEFVPKGNL 678
VK L++ +E E+ +S++ +H N+V G + T L+++E+ G+L
Sbjct: 81 VKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLG---ACTHGGPVLVITEYCCYGDL 137
Query: 679 YDNL--HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKS 734
+ L I N H + A+ +++L + +H ++ +
Sbjct: 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAA 192
Query: 735 TNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVY 791
N+LL + K+ D+GLA+ + NY NA V ++APE + + DV+
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNY--IVKGNARLPVKWMAPESIFDCVYTVQSDVW 250
Query: 792 SFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELI 848
S+G++L E+ + G P N + V++ + + + FA +
Sbjct: 251 SYGILLWEIFSLGLNPYPGILVNSKF--YKLVKDGYQMAQPA-----------FAPKNIY 297
Query: 849 QVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+M+ C + P+ RP+ ++ L+
Sbjct: 298 SIMQA---CWALEPTHRPTFQQICSFLQEQ 324
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 97.1 bits (241), Expect = 7e-21
Identities = 59/225 (26%), Positives = 93/225 (41%), Gaps = 28/225 (12%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF---- 656
+G G G V R + G +A+K+ +N+E + LEI + + H N+V+
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP 81
Query: 657 --QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGT 712
+ + L+ E+ G+L L N G E R I+
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYL---NQFENCCGL---KEGP-IRTLLSDISS-- 132
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEP---KLSDYGLAKLLPILDNYGLTKFHN 769
AL YLH + I+H +LK NI+L + K+ D G AK L T+F
Sbjct: 133 --ALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD--QGELCTEFVG 185
Query: 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
+ Y+APEL + + + D +SFG + E +TG +P
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV 230
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 67/294 (22%), Positives = 128/294 (43%), Gaps = 42/294 (14%)
Query: 602 IGGGSIGSVYRASFEGG------VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G+ G V+ A + +AVK L+ +++F+ E L+ ++H ++V
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKE-ASESARQDFQREAELLTMLQHQHIVR 107
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNP-ELHWSRRFHIALGT 712
F G L++ E++ G+L L HG + + G P L + +A
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 713 ARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
A + YL H +H +L + N L+ + K+ D+G+++ + D Y
Sbjct: 168 AAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY--RVGGRT 220
Query: 771 ---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE-- 824
+ ++ PE + + + DV+SFGV+L E+ T G++P + E + + + +
Sbjct: 221 MLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAI---DCITQGR 277
Query: 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
LER AC E+ +M+ C P +R S+ +V L+++
Sbjct: 278 ELER--PRACPP---------EVYAIMRG---CWQREPQQRHSIKDVHARLQAL 317
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 8e-21
Identities = 51/235 (21%), Positives = 89/235 (37%), Gaps = 30/235 (12%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
+ + L+L N + L ++ + N +I F+
Sbjct: 76 NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEV--------GAFN------ 120
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSI 360
+L L+L N + IP+G L +L ++ L NN I I +
Sbjct: 121 ---------GLASLNTLELFDNW-LTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRV 170
Query: 361 ELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQN 419
L LDL L + + L L++ + D+P L + L+ L++ N
Sbjct: 171 PSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGN 228
Query: 420 HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
H P S LS+L+ L + + +S ++ L +L NL+ NNLS ++P
Sbjct: 229 HFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLP 282
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 2e-20
Identities = 60/306 (19%), Positives = 107/306 (34%), Gaps = 59/306 (19%)
Query: 168 CY-KTKFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVR 225
C + V + LS +P I +N YL + NN+ ++ L+ + +
Sbjct: 52 CSNQFSKVVCTRRGLS-EVPQGIPSNTRYL---NLMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 226 GNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVG 285
N++ F+ S+ L+L N + L + + +N IP
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPS-- 164
Query: 286 ICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISL 344
F+ +L LDLG + + I G L L ++L
Sbjct: 165 ------YAFN---------------RVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNL 203
Query: 345 ANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQT 404
+I + PNL + LE L++ GN P +
Sbjct: 204 GMCNIKDM--PNLTPLVGLEELEMS------------------------GNHFPEIRPGS 237
Query: 405 LYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSS-LGNLRNLTHFN 463
+ ++ LK L + + ++ + L++L L+L+ N+LS S+P LR L +
Sbjct: 238 FHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELH 296
Query: 464 LSSNNL 469
L N
Sbjct: 297 LHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 29/143 (20%), Positives = 50/143 (34%), Gaps = 11/143 (7%)
Query: 337 RRLLKISLANNSIGGI---IPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVS 393
+ K+ + + IP N L+L N++ D + L +L +
Sbjct: 54 NQFSKVVCTRRGLSEVPQGIPSNT------RYLNLMENNIQMIQADTFRHLHHLEVLQLG 107
Query: 394 GNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS-S 452
N++ + L L+L N L + LS L+ L L N + SIPS +
Sbjct: 108 RNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYA 166
Query: 453 LGNLRNLTHFNLSSNNLSGTIPS 475
+ +L +L I
Sbjct: 167 FNRVPSLMRLDLGELKKLEYISE 189
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 54/303 (17%), Positives = 93/303 (30%), Gaps = 78/303 (25%)
Query: 97 SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSY 156
+ R L L N + ++ L ++ +L L RNS
Sbjct: 76 NTRYLNLMENNIQ----------------MIQADTFRH--------LHHLEVLQLGRNSI 111
Query: 157 SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNI 216
+I F + L N L+ IP +F L
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLT-VIP------------SGAFEYL----------- 146
Query: 217 PVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSS-NLFIGLAPFGVLGLKNISYFNVSHN 275
L + +R N + F++ S+ LDL ++ GL N+ Y N+
Sbjct: 147 SKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 276 GFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTG-IT 334
++P ++T L+ L++ N I G
Sbjct: 207 NIK-DMP-------------------------NLTPLVGLEELEMSGNH-FPEIRPGSFH 239
Query: 335 DLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSG 394
L L K+ + N+ + I + L L+L + NL D + R+L+ L +
Sbjct: 240 GLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHH 299
Query: 395 NAL 397
N
Sbjct: 300 NPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 6e-12
Identities = 41/189 (21%), Positives = 78/189 (41%), Gaps = 4/189 (2%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFI-GDLPNIRLL 149
A +GL SL L LF N T + + L ++ + +N + SIP + +P++ L
Sbjct: 118 AFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRL 176
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
DL I F+ + K+++L N+ +P ++ LE + S N+
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIR 234
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
P + L + V + ++ F S+ L+L+ N L L+ +
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVE 294
Query: 270 FNVSHNGFH 278
++ HN ++
Sbjct: 295 LHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 37/188 (19%), Positives = 65/188 (34%), Gaps = 8/188 (4%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPE--FIGDLPNIRL 148
L L VL L N + + +L + + N L+ IP F L +R
Sbjct: 94 TFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFEY-LSKLRE 151
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSG 207
L L N IP F + L I L+ + N+
Sbjct: 152 LWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK- 209
Query: 208 ELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNI 267
++P+ + + L+ + + GN F S+K L + ++ + GL ++
Sbjct: 210 DMPN-LTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASL 268
Query: 268 SYFNVSHN 275
N++HN
Sbjct: 269 VELNLAHN 276
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 2e-05
Identities = 23/93 (24%), Positives = 40/93 (43%), Gaps = 3/93 (3%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSGSIPEFIGDLPNIRL 148
P L+ L L L + GN F + + + +L K+ V ++ +S L ++
Sbjct: 212 PNLTPLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVE 270
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNL 181
L+L+ N+ S +P LF + L HN
Sbjct: 271 LNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 95.1 bits (236), Expect = 8e-21
Identities = 41/275 (14%), Positives = 77/275 (28%), Gaps = 48/275 (17%)
Query: 595 LLDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGR-----IRNQEEFELEIGRLSNI 648
L + ++G + A+ + G S V R I+ +E L + L I
Sbjct: 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 649 RH-------------------FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPG 689
++ +LS F + NL
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 690 TSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749
S +H R + L R L+ LHH ++H L+ +I+LD+ L+
Sbjct: 199 LSHSSTHKSLVHH-ARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTG 254
Query: 750 YGLAKLLPILDNYGLTKFHNAVG---YVAPELAQSLR-----LSDKCDVYSFGVILLELV 801
+ ++ A + + ++ D ++ G+ + +
Sbjct: 255 FEHLV---RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW 311
Query: 802 TGRKPVESPTTNEVVVLC--------EYVRELLER 828
P + VR LLE
Sbjct: 312 CADLPNTDDAALGGSEWIFRSCKNIPQPVRALLEG 346
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 9e-21
Identities = 69/324 (21%), Positives = 125/324 (38%), Gaps = 57/324 (17%)
Query: 577 FSKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSIAVKK 625
F+ S + E + ++ + +G G+ G VY + + +AVK
Sbjct: 55 FAGKTSSISDLKE------VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKT 108
Query: 626 LETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGV 685
L + +++ +F +E +S H N+V G S + IL E + G+L L
Sbjct: 109 LPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET 168
Query: 686 NYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLD--- 740
+ + +L H+A A YL +H +H ++ + N LL
Sbjct: 169 RPRPSQPSSLAMLDL-----LHVARDIACGCQYLEENH-----FIHRDIAARNCLLTCPG 218
Query: 741 ENYEPKLSDYGLAKLLPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVIL 797
K+ D+G+A+ + Y G V ++ PE + K D +SFGV+L
Sbjct: 219 PGRVAKIGDFGMARDIYRAGYYRKGGCAML--PVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
Query: 798 LELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLG 854
E+ + G P S + EV+ E+V ++ C + ++M
Sbjct: 277 WEIFSLGYMPYPSKSNQEVL---EFVTSGGRMDP--PKNCPG---------PVYRIMTQ- 321
Query: 855 LICTSEVPSRRPSMAEVVQVLESI 878
C P RP+ A +++ +E
Sbjct: 322 --CWQHQPEDRPNFAIILERIEYC 343
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 9e-21
Identities = 69/294 (23%), Positives = 116/294 (39%), Gaps = 54/294 (18%)
Query: 602 IGGGSIGSVYRASFEGG----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
IG G G VY + + AVK L + I +F E + + H N+++
Sbjct: 97 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 658 GYYWSSTMQ-LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
G S L++ ++ G+L + + L A+ +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRN-----------ETHNPTVKDLIGFGLQVAKGM 205
Query: 717 SYL------HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
+L H D L + N +LDE + K++D+GLA+ + + + A
Sbjct: 206 KFLASKKFVHRD---------LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 771 ---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE-- 824
V ++A E Q+ + + K DV+SFGV+L EL+T G P T ++ Y+ +
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT---VYLLQGR 313
Query: 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
L + C D L +VM L C RPS +E+V + +I
Sbjct: 314 RLLQ--PEYCPD---------PLYEVM---LKCWHPKAEMRPSFSELVSRISAI 353
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 1e-20
Identities = 51/218 (23%), Positives = 80/218 (36%), Gaps = 33/218 (15%)
Query: 598 KECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+ +G GS G V+R + G AVKK+ L R +E + + + +V
Sbjct: 62 HQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR-LEVFRVEE-----LVACAGLSSPRIVPL 115
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA--- 713
G I E + G+L + G + PE
Sbjct: 116 YGAVREGPWVNIFMELLEGGSLGQLI-------KQMGCL--PE------DRALYYLGQAL 160
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGLAK-LLPILDNYGLTKFHNAV 771
L YLH ILH ++K+ N+LL + L D+G A L P L
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 772 G---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
G ++APE+ K D++S ++L ++ G P
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 55/232 (23%), Positives = 92/232 (39%), Gaps = 46/232 (19%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
++G G+ G V +A + A+KK+ E+ L+++ H +V +
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRH--TEEKLSTILSEVMLLASLNHQYVVRYYAA 70
Query: 660 YWSSTMQL-------------ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF 706
+ + I E+ G LYD +H + + + R F
Sbjct: 71 WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH--------SENLNQQRDEYWRLF 122
Query: 707 H-IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL--------- 756
I ALSY+H I+H +LK NI +DE+ K+ D+GLAK +
Sbjct: 123 RQILE----ALSYIH-SQG--IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKL 175
Query: 757 -PILDNYGLTKFHNAVG---YVAPE-LAQSLRLSDKCDVYSFGVILLELVTG 803
+A+G YVA E L + ++K D+YS G+I E++
Sbjct: 176 DSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 1e-20
Identities = 59/322 (18%), Positives = 111/322 (34%), Gaps = 78/322 (24%)
Query: 588 WEAGTKALLDKECL-----IGGGSIGSVYRASF--------EGGVSIAVKKLETLGRIRN 634
+ + E L +G G+ +++ + +K L+
Sbjct: 3 HK------IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK-AHRNY 55
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGG 694
E F +S + H +LV G +++ EFV G+L L
Sbjct: 56 SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---------- 105
Query: 695 IGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEP------- 745
++ + +A A A+ +L + ++H N+ + NILL +
Sbjct: 106 -NKNCINILWKLEVAKQLAAAMHFLEENT-----LIHGNVCAKNILLIREEDRKTGNPPF 159
Query: 746 -KLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE-LAQSLRLSDKCDVYSFGVILLELVT- 802
KLSD G++ +L + + +V PE + L+ D +SFG L E+ +
Sbjct: 160 IKLSDPGISIT--VLPKDI-LQE--RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214
Query: 803 GRKPVESPTTNEVVVLCEYVRELLERG----SASACFDRSLRGFAENELIQVMKLGLICT 858
G KP+ + + + + E + A EL ++ C
Sbjct: 215 GDKPLSALDSQRKL-------QFYEDRHQLPAPKAA-----------ELANLI---NNCM 253
Query: 859 SEVPSRRPSMAEVVQVLESIRN 880
P RPS +++ L S+
Sbjct: 254 DYEPDHRPSFRAIIRDLNSLFT 275
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-20
Identities = 64/262 (24%), Positives = 100/262 (38%), Gaps = 32/262 (12%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
+ + L+L N + L+++ +S N I F+
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEI--------GAFN------ 109
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSI 360
NL L+L NR + +IP G L +L ++ L NN I I I
Sbjct: 110 ---------GLANLNTLELFDNR-LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRI 159
Query: 361 ELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQN 419
L LDL L + + L L+++ L +IP L + L LDL N
Sbjct: 160 PSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217
Query: 420 HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
HL+ P S L +LQ L + Q+ + ++ NL++L NL+ NNL+ +P +
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDL-- 274
Query: 480 FGVSTFLNNTGLCGPPLETSCS 501
F L L P +C
Sbjct: 275 FTPLHHLERIHLHHNPWNCNCD 296
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 2e-14
Identities = 55/246 (22%), Positives = 101/246 (41%), Gaps = 11/246 (4%)
Query: 128 SSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPL 187
L +P+ I N RLL+L N I FK+ + + LS N++
Sbjct: 51 VRKNLR-EVPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIG 106
Query: 188 SIANCTYLEGFDFSFNNLSGELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNL 246
+ L + N L+ +P+ + L + +R N + F++ S++ L
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRL 165
Query: 247 DLSSNLFIGLAPFGVL-GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVI 305
DL + G GL N+ Y N++ EIP + + + D S N +
Sbjct: 166 DLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIK-LDELDLSGNHLSAIR 223
Query: 306 PLSITNCRNLKVLDLGFNRLIGSIPTG-ITDLRRLLKISLANNSIGGIIPPNLGSIELLE 364
P S +L+ L + ++ I I +L+ L++I+LA+N++ + + LE
Sbjct: 224 PGSFQGLMHLQKLWMIQSQ-IQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE 282
Query: 365 VLDLHN 370
+ LH+
Sbjct: 283 RIHLHH 288
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 36/188 (19%), Positives = 70/188 (37%), Gaps = 8/188 (4%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPE--FIGDLPNIRL 148
+ L+ L +L L N + + L + + N L+ +IP F+ L ++
Sbjct: 83 SFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVY-LSKLKE 140
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSG 207
L L N IP F + + L I + L + + NL
Sbjct: 141 LWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR- 198
Query: 208 ELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNI 267
E+P+ + + LD + + GN L+ F ++ L + + + L+++
Sbjct: 199 EIPN-LTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSL 257
Query: 268 SYFNVSHN 275
N++HN
Sbjct: 258 VEINLAHN 265
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 34/114 (29%), Positives = 55/114 (48%), Gaps = 6/114 (5%)
Query: 363 LEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
+ NLR EVPD IS LL++ N + + ++ +L+IL L +NH+
Sbjct: 45 FSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR 101
Query: 423 GSTPPSLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSNNLSGTIPS 475
+ L+NL L+L N L+ +IP+ + L L L +N + +IPS
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPS 153
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 5e-12
Identities = 28/124 (22%), Positives = 45/124 (36%), Gaps = 8/124 (6%)
Query: 353 IPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLK 412
I N +L+LH ++ + + R L +L +S N + + L
Sbjct: 62 ISTNT------RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLN 115
Query: 413 ILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSL-GNLRNLTHFNLSSNNLSG 471
L+L N L + LS L+ L L N + SIPS + +L +L
Sbjct: 116 TLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS 174
Query: 472 TIPS 475
I
Sbjct: 175 YISE 178
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 1e-11
Identities = 45/190 (23%), Positives = 84/190 (44%), Gaps = 6/190 (3%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSGSIPEFI-GDLPNIRL 148
A +GL +L L LF NR T +P + + L ++ + +N + SIP + +P++R
Sbjct: 107 AFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRR 164
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
LDL I F+ ++++L+ NL IP ++ L+ D S N+LS
Sbjct: 165 LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLSAI 222
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
P + L + + + + F QS+ ++L+ N L L ++
Sbjct: 223 RPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLE 282
Query: 269 YFNVSHNGFH 278
++ HN ++
Sbjct: 283 RIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 20/92 (21%), Positives = 40/92 (43%), Gaps = 1/92 (1%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
P L+ L L L L GN + P + + L K+ + + + +L ++ +
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNL 181
+L+ N+ + +P LF + + + L HN
Sbjct: 261 NLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 2e-20
Identities = 77/322 (23%), Positives = 126/322 (39%), Gaps = 54/322 (16%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGG---VSIAVKKLETL 629
K+ P LD + IG G+ G V +A + + A+K+++
Sbjct: 10 GKNNPDPTIYPV------LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63
Query: 630 GRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL----HG 684
+ +F E+ L + H N++ G + E+ P GNL D L
Sbjct: 64 ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVL 123
Query: 685 VNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDEN 742
P + L + H A AR + YL +H +L + NIL+ EN
Sbjct: 124 ETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ-----FIHRDLAARNILVGEN 178
Query: 743 YEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFGVILLE 799
Y K++D+GL++ + Y K V ++A E + DV+S+GV+L E
Sbjct: 179 YVAKIADFGLSR---GQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWE 233
Query: 800 LVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLGLI 856
+V+ G P T E+ E + + LE+ C D E+ +M
Sbjct: 234 IVSLGGTPYCGMTCAELY---EKLPQGYRLEK--PLNCDD---------EVYDLM---RQ 276
Query: 857 CTSEVPSRRPSMAEVVQVLESI 878
C E P RPS A+++ L +
Sbjct: 277 CWREKPYERPSFAQILVSLNRM 298
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 58/317 (18%), Positives = 95/317 (29%), Gaps = 47/317 (14%)
Query: 180 NLSGSIP--LSIANCTYLEGFDFSFNNLSGELPSQICN----------------IPVLDF 221
N S P S NC + S E + + + L
Sbjct: 16 NFSDPKPDWSSAFNCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTV 75
Query: 222 ISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVL-----GLKNISYFNVSHNG 276
+ R + + ++ L L + G AP +L L ++ NVS
Sbjct: 76 RAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT 135
Query: 277 FHGEIPEVGIC-GEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITD 335
+ E+ G++V + + L LDL N +G
Sbjct: 136 RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERG----- 190
Query: 336 LRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGN 395
I + P ++++L + + G + L LD+S N
Sbjct: 191 ------------LISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHN 238
Query: 396 ALGGDIP-QTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLG 454
+L + + L L+L L P L + L VLDLS N L PS
Sbjct: 239 SLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGL--PAKLSVLDLSYNRLD-RNPSPDE 294
Query: 455 NLRNLTHFNLSSNNLSG 471
L + + +L N
Sbjct: 295 -LPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 83.8 bits (207), Expect = 1e-17
Identities = 48/281 (17%), Positives = 84/281 (29%), Gaps = 40/281 (14%)
Query: 130 NALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKF--VSLSHNNLSGSIPL 187
A G + I L +++ L + I F + + ++L + ++G+ P
Sbjct: 55 EADLGQFTDIIKSL-SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPP 113
Query: 188 SIANCTY--LEGFDFSFNNLSGELPS----QICNIPVLDFISVRGNALTGTVEEQFSQCQ 241
+ T L + + + Q P L +S+ EQ
Sbjct: 114 PLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP 173
Query: 242 SIKNLDLSSNLFIGLAPFG----VLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDAS 297
++ LDLS N +G L + + + G
Sbjct: 174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM-------------------- 213
Query: 298 WNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPN 356
GV L+ LDL N L + +L ++L+ + +P
Sbjct: 214 -ETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKG 271
Query: 357 LGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNAL 397
L + L VLDL L P + L + GN
Sbjct: 272 LPA--KLSVLDLSYNRLD-RNP-SPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 80.7 bits (199), Expect = 1e-16
Identities = 48/253 (18%), Positives = 94/253 (37%), Gaps = 21/253 (8%)
Query: 92 LSGLKSLRVLTLFGNRFTGNLPQEYAE---MQTLWKINVSSNALSGSIPEFIGDL--PNI 146
+ SL+ LT+ R + + L ++ + + ++G+ P + + P++
Sbjct: 64 IIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDL 123
Query: 147 RLLDLSRNSYSGEIPFALFKYCYKT---KFVSLSHNNLSGSIPLSIANCTYLEGFDFSFN 203
+L+L S++ + + K +S++ + + L D S N
Sbjct: 124 NILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDN 183
Query: 204 NLSGE--LPSQIC--NIPVLDFISVRGNALT---GTVEEQFSQCQSIKNLDLSSNLFIGL 256
GE L S +C P L +++R + G + ++ LDLS N
Sbjct: 184 PELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDA 243
Query: 257 APFGV-LGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNL 315
A ++ N+S G ++P+ G+ + V D S+N D S +
Sbjct: 244 AGAPSCDWPSQLNSLNLSFTGLK-QVPK-GL-PAKLSVLDLSYNRLDRN--PSPDELPQV 298
Query: 316 KVLDLGFNRLIGS 328
L L N + S
Sbjct: 299 GNLSLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 7e-14
Identities = 34/195 (17%), Positives = 57/195 (29%), Gaps = 29/195 (14%)
Query: 295 DASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP 354
D + + + + L V I + + L +++L N + G P
Sbjct: 53 DTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAP 112
Query: 355 PNLGSIEL--LEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLK 412
P L L +L+L N++ ++ + L LK
Sbjct: 113 PPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLK-------------------PGLK 152
Query: 413 ILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI-------PSSLGNLRNLTHFNLS 465
+L + Q H + + L LDLS N G P L+ L N
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 466 SNNLSGTIPSTIQHF 480
SG +
Sbjct: 213 METPSGVCSALAAAR 227
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 40/206 (19%), Positives = 67/206 (32%), Gaps = 22/206 (10%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQT-----LWKINVSSNALSGSIPEFIGD 142
+ L +L L + AE+Q L ++++ E +
Sbjct: 113 PPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRV 171
Query: 143 LPNIRLLDLSRNSYSGEIPFALFKYCYKT---KFVSLSHNN---LSGSIPLSIANCTYLE 196
P + LDLS N GE K + ++L + SG A L+
Sbjct: 172 FPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQ 231
Query: 197 GFDFSFNNLSGELPSQICNIPV-LDFISVRGNALTGTVEEQFSQC--QSIKNLDLSSNLF 253
G D S N+L + C+ P L+ +++ L Q + + LDLS N
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-----QVPKGLPAKLSVLDLSYNRL 286
Query: 254 IGLAPFGVLGLKNISYFNVSHNGFHG 279
L + ++ N F
Sbjct: 287 DRNPSP--DELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 32/163 (19%), Positives = 53/163 (32%), Gaps = 12/163 (7%)
Query: 76 RIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNL-------PQEYAEMQTLWKINVS 128
+ + + +L L L N G P ++ +Q L N
Sbjct: 153 VLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAG 212
Query: 129 SNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLS 188
SG ++ LDLS NS + + ++LS L +P
Sbjct: 213 METPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKG 271
Query: 189 IANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTG 231
+ L D S+N L PS +P + +S++GN
Sbjct: 272 LP--AKLSVLDLSYNRLD-RNPS-PDELPQVGNLSLKGNPFLD 310
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 54/220 (24%), Positives = 101/220 (45%), Gaps = 21/220 (9%)
Query: 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+ + +IG G+ V A +A+K++ + +E EI +S H N+V+
Sbjct: 18 ELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS 77
Query: 656 FQG-YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL---G 711
+ + + L++ + + G++ D + + G G+ + IA
Sbjct: 78 YYTSFVVKDELWLVM-KLLSGGSVLDIIKHIVAKGEHKSGVLDES-------TIATILRE 129
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL-AKLLPILDNYGLTKFHNA 770
L YLH + + +H ++K+ NILL E+ +++D+G+ A L D
Sbjct: 130 VLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTF 186
Query: 771 VG---YVAPELAQSLRLSD-KCDVYSFGVILLELVTGRKP 806
VG ++APE+ + +R D K D++SFG+ +EL TG P
Sbjct: 187 VGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.0 bits (233), Expect = 5e-20
Identities = 55/255 (21%), Positives = 90/255 (35%), Gaps = 18/255 (7%)
Query: 235 EQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVF 294
+L L +I +++ + + +
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQYL-PNVTKL 70
Query: 295 DASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP 354
+ N+ + PL+ N +NL L L N+ I + + + DL++L +SL +N I I
Sbjct: 71 FLNGNKLTDIKPLT--NLKNLGWLFLDENK-IKDL-SSLKDLKKLKSLSLEHNGISDI-- 124
Query: 355 PNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKIL 414
L + LE L L N + +S L L + N + DI L +T L+ L
Sbjct: 125 NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 180
Query: 415 DLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
L +NH+ S +L L NL VL+L + NL + +L P
Sbjct: 181 YLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTP 236
Query: 475 STIQHFGVSTFLNNT 489
I G N
Sbjct: 237 EIISDDGDYEKPNVK 251
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 73.6 bits (180), Expect = 1e-13
Identities = 44/322 (13%), Positives = 95/322 (29%), Gaps = 67/322 (20%)
Query: 92 LSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDL 151
L T + Q E+ ++ +I +++ + S+ + I LPN+ L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPS 211
+ N + P K ++ L N + + S+ + L+ N
Sbjct: 73 NGNKLTDIKPLTNLK---NLGWLFLDENKIK-DLS-SLKDLKKLKSLSLEHN-------- 119
Query: 212 QICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFN 271
I +I L +++L L +N + L + +
Sbjct: 120 GISDINGL------------------VHLPQLESLYLGNNKITDITVLS--RLTKLDTLS 159
Query: 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPT 331
+ N Q+ D + L+ L L N I +
Sbjct: 160 LEDN----------------QISDIV----------PLAGLTKLQNLYLSKNH-ISDLR- 191
Query: 332 GITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLD 391
+ L+ L + L + + ++ + + + +L P+ IS+ +
Sbjct: 192 ALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIISDDGDYEKPN 249
Query: 392 VSGNALGGDIPQTLYNMTYLKI 413
V + + + I
Sbjct: 250 VKWHLPEFTNEVSFIFYQPVTI 271
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 2e-06
Identities = 31/168 (18%), Positives = 64/168 (38%), Gaps = 21/168 (12%)
Query: 90 PALSGLKSLRVLTLFGNRFT-----GNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLP 144
+L LK L+ L+L N + +LPQ L + + +N + + + L
Sbjct: 103 SSLKDLKKLKSLSLEHNGISDINGLVHLPQ-------LESLYLGNNKI--TDITVLSRLT 153
Query: 145 NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNN 204
+ L L N S +I K + + LS N++S + ++A L+ +
Sbjct: 154 KLDTLSLEDNQIS-DIVP--LAGLTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFSQE 208
Query: 205 LSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNL 252
+ + N+ V + +V+ + E S + ++ +L
Sbjct: 209 CLNKPINHQSNLVVPN--TVKNTDGSLVTPEIISDDGDYEKPNVKWHL 254
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 5e-20
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 31/221 (14%)
Query: 593 KALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNI 648
+ LLD IG GS G V A G +AVK ++ +R Q+ EL E+ + +
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD----LRKQQRRELLFNEVVIMRDY 99
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
+HFN+V Y +L EF+ G L D + V E + +
Sbjct: 100 QHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLN----------EEQIA---TV 146
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
+AL+YLH ++H ++KS +ILL + KLSD+G + + + K
Sbjct: 147 CEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI----SKDVPKRK 199
Query: 769 NAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ VG ++APE+ + + D++S G++++E+V G P
Sbjct: 200 SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.8 bits (233), Expect = 5e-20
Identities = 77/383 (20%), Positives = 143/383 (37%), Gaps = 24/383 (6%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWK-INVSSNALSGSIPEFIGDLPNIRLLDL 151
L L L L +F A + +++ S + G E + N +L L
Sbjct: 143 GNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIP-NTTVLHL 201
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPS 211
+ P +LF +L H LS +I L+ NC L F L
Sbjct: 202 VFH------PNSLFSVQVNMSVNALGHLQLS-NIKLNDENCQRLMTFLSELTRGPTLLNV 254
Query: 212 QICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFN 271
+ +I SV+ L + + +I NL ++ + + LK++ +
Sbjct: 255 TLQHIETTWKCSVK---LFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEH 311
Query: 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPT 331
V + F + M + S ++ + + + + L+ N S+
Sbjct: 312 VKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQ 371
Query: 332 GITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRF----- 386
G + L+RL + L N + + + L+ +++L + +
Sbjct: 372 GCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNS-LNSHAYDRTCAWAES 429
Query: 387 LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLS 446
+L+L++S N L G + + L +K+LDLH N + S P + +L LQ L+++ N L
Sbjct: 430 ILVLNLSSNMLTGSVFRCL--PPKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK 486
Query: 447 GSIP-SSLGNLRNLTHFNLSSNN 468
S+P L +L + L N
Sbjct: 487 -SVPDGVFDRLTSLQYIWLHDNP 508
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-18
Identities = 69/386 (17%), Positives = 136/386 (35%), Gaps = 28/386 (7%)
Query: 125 INVSSNALSGSIPEFIGDLP-NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG 183
++ S+ L+ +P+ DLP + L LS+NS S E+ + + + + LSHN +
Sbjct: 36 VDYSNRNLT-HVPK---DLPPRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR- 89
Query: 184 SIPLSI-ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTG-TVEEQFSQCQ 241
S+ + LE D S N L + + L + + N V ++F
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLDLSFNDFDVLPVCKEFGNLT 146
Query: 242 SIKNLDLSSNLF--IGLAPFGVLGLKNISYFNVSHNGFHGEIPE-VGICGEGMQVFDASW 298
+ L LS+ F + L P L L I VS++ GE + +
Sbjct: 147 KLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPN 206
Query: 299 NEFDGVIPLSITNCRNLKVLDLGFNRL----IGSIPTGITDLRRLLKISLANNSIGGIIP 354
+ F + +S+ +L++ ++ N + + + +T LL ++L +
Sbjct: 207 SLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCS 266
Query: 355 PNLGSI---ELLEVLDLHNLNLRGEVPDDI-----SNCRFLLLLDVSGNALGGDIPQTLY 406
L +E L+++NL + + + + + L++ V
Sbjct: 267 VKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYS 326
Query: 407 NMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSS 466
+ I L + + S+ L+ +QN + S+ L+ L L
Sbjct: 327 VFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQR 386
Query: 467 NNLSGTIPSTIQHFGVSTFLNNTGLC 492
N L + L +
Sbjct: 387 NGLK-NFFKVALMTKNMSSLETLDVS 411
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 92.0 bits (228), Expect = 5e-20
Identities = 37/256 (14%), Positives = 74/256 (28%), Gaps = 28/256 (10%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEI-----GRLSNIRHFNLVA 655
L+G G+ VY A+ K+ L + +E I RL +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
F + +++ E G L + + Y T + A+
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAI--NLYKNTPEKVMPQGL-----VISFAMRMLYM 184
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEP-----------KLSDYGLAKLLPIL-DNYG 763
+ +H I+H ++K N +L + L D G + + +
Sbjct: 185 IEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 764 LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR 823
T G+ E+ + + + D + + ++ G ++ R
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG-TYMKVKNEGGECKPEGLFR 300
Query: 824 ELLERGSASACFDRSL 839
L + F L
Sbjct: 301 RLPHLDMWNEFFHVML 316
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 72/323 (22%), Positives = 125/323 (38%), Gaps = 63/323 (19%)
Query: 586 EDWEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSIAVKKLETLGRIRN 634
WE + L +G G+ G V A + +++AVK L+ +
Sbjct: 16 HKWE------FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE 69
Query: 635 QEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL----HGVNYPG 689
+E E+ LS + H N+V G L+++E+ G+L + L
Sbjct: 70 REALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129
Query: 690 TSTGGIGNPELHWSRR--FHIALGTARALSYL------HHDCKPPILHLNLKSTNILLDE 741
TS + + EL + A+ +++L H D L + NILL
Sbjct: 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRD---------LAARNILLTH 180
Query: 742 NYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFGVILL 798
K+ D+GLA+ + NY NA V ++APE + + + DV+S+G+ L
Sbjct: 181 GRITKICDFGLARDIKNDSNY--VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 799 ELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLGL 855
EL + G P + + ++E + A E+ +MK
Sbjct: 239 ELFSLGSSPYPGMPVDSKFY--KMIKEGFRMLSPE-----------HAPAEMYDIMKT-- 283
Query: 856 ICTSEVPSRRPSMAEVVQVLESI 878
C P +RP+ ++VQ++E
Sbjct: 284 -CWDADPLKRPTFKQIVQLIEKQ 305
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 6e-20
Identities = 75/327 (22%), Positives = 136/327 (41%), Gaps = 56/327 (17%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEG--------GVSIAVK 624
S+ + WE ++ L +G G+ G V A G V++AVK
Sbjct: 20 SEYELPEDPKWE------FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK 73
Query: 625 KLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL- 682
L+ ++ + E+ + I +H N++ G ++ E+ KGNL + L
Sbjct: 74 MLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLR 133
Query: 683 ---HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNI 737
+ ++ + AR + YL +H +L + N+
Sbjct: 134 ARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARNV 188
Query: 738 LLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFG 794
L+ EN K++D+GLA+ + +D Y K N V ++APE + + DV+SFG
Sbjct: 189 LVTENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG 246
Query: 795 VILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVM 851
V++ E+ T G P E+ + ++E +++ + C NEL +M
Sbjct: 247 VLMWEIFTLGGSPYPGIPVEELF---KLLKEGHRMDK--PANC---------TNELYMMM 292
Query: 852 KLGLICTSEVPSRRPSMAEVVQVLESI 878
+ C VPS+RP+ ++V+ L+ I
Sbjct: 293 RD---CWHAVPSQRPTFKQLVEDLDRI 316
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 7e-20
Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 35/224 (15%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
++G G+ +V+R + G A+K + +R + E L + H N+V
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 660 YWSSTMQ---LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTAR 714
+T + LI+ EF P G+LY L ++ G+ E +
Sbjct: 76 EEETTTRHKVLIM-EFCPCGSLYTVLEEP----SNAYGLPESE---FLIVLRDV----VG 123
Query: 715 ALSYLHHDCKPPILHLNLKSTNILL----DENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
+++L + I+H N+K NI+ D KL+D+G A+ L D+ +
Sbjct: 124 GMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGT 178
Query: 771 VGYVAPELAQSLRLSD--------KCDVYSFGVILLELVTGRKP 806
Y+ P++ + L D++S GV TG P
Sbjct: 179 EEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 7e-20
Identities = 72/340 (21%), Positives = 128/340 (37%), Gaps = 69/340 (20%)
Query: 575 VLFSKSLPSKYED--WEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSI 621
+ S ED WE ++ L +G G G V +A G ++
Sbjct: 3 LSLSVDAFKILEDPKWE------FPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTV 56
Query: 622 AVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ---LILSEFVPKGNL 678
AVK L+ + E L + H +++ G + + L++ E+ G+L
Sbjct: 57 AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYG---ACSQDGPLLLIVEYAKYGSL 113
Query: 679 YDNL------------HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCK 724
L G + +S L A ++ + YL
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--- 170
Query: 725 PPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQS 781
++H +L + NIL+ E + K+SD+GL++ + D+Y K V ++A E
Sbjct: 171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY--VKRSQGRIPVKWMAIESLFD 226
Query: 782 LRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRS 838
+ + DV+SFGV+L E+VT G P + ++ +ER C
Sbjct: 227 HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLF---NLLKTGHRMER--PDNC---- 277
Query: 839 LRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
E+ ++M C + P +RP A++ + LE +
Sbjct: 278 -----SEEMYRLMLQ---CWKQEPDKRPVFADISKDLEKM 309
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 8e-20
Identities = 80/333 (24%), Positives = 138/333 (41%), Gaps = 56/333 (16%)
Query: 572 GKLVLFSKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEG--------G 618
G L S+ + WE L ++ L +G G+ G V A G
Sbjct: 48 GMLAGVSEYELPEDPRWE------LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRV 101
Query: 619 VSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGN 677
+AVK L++ ++ + E+ + I +H N++ G ++ E+ KGN
Sbjct: 102 TKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 161
Query: 678 LYDNL----HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLN 731
L + L + +L A AR + YL +H +
Sbjct: 162 LREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK-----CIHRD 216
Query: 732 LKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKC 788
L + N+L+ E+ K++D+GLA+ + +D Y K N V ++APE + +
Sbjct: 217 LAARNVLVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDRIYTHQS 274
Query: 789 DVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAEN 845
DV+SFGV+L E+ T G P E+ + ++E +++ S C N
Sbjct: 275 DVWSFGVLLWEIFTLGGSPYPGVPVEELF---KLLKEGHRMDK--PSNC---------TN 320
Query: 846 ELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
EL +M+ C VPS+RP+ ++V+ L+ I
Sbjct: 321 ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 350
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 8e-20
Identities = 76/332 (22%), Positives = 134/332 (40%), Gaps = 61/332 (18%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRA------SFEGGVSIAVKKL 626
L K E + + IG G+ G V++A +E +AVK L
Sbjct: 32 PLLLNPKLLSLE------YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKML 85
Query: 627 ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL---- 682
+ Q +F+ E ++ + N+V G +L E++ G+L + L
Sbjct: 86 KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMS 145
Query: 683 --------HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNL 732
H G P L + + IA A ++YL +H +L
Sbjct: 146 PHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK-----FVHRDL 200
Query: 733 KSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCD 789
+ N L+ EN K++D+GL++ + D Y N + ++ PE R + + D
Sbjct: 201 ATRNCLVGENMVVKIADFGLSRNIYSADYY--KADGNDAIPIRWMPPESIFYNRYTTESD 258
Query: 790 VYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENE 846
V+++GV+L E+ + G +P EV+ YVR+ +L C E
Sbjct: 259 VWAYGVVLWEIFSYGLQPYYGMAHEEVI---YYVRDGNILAC--PENCPL---------E 304
Query: 847 LIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
L +M+L C S++P+ RPS + ++L+ +
Sbjct: 305 LYNLMRL---CWSKLPADRPSFCSIHRILQRM 333
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 91.3 bits (226), Expect = 9e-20
Identities = 30/298 (10%), Positives = 63/298 (21%), Gaps = 39/298 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+ G V+ E A+K E + + + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 658 GYYWSSTMQLIL-----SEFVPKGNLYDNLHGVNY------PGTSTGGIGN--------- 697
+ F D+ NY + +
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757
+ + R + L ++H + N+ + + L D
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 758 ILDNYGLTKFHNAVGYVAPELAQS--LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
V Y E + + + + G+ + + P T
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 816 VVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ S + L F + LI + RR E ++
Sbjct: 302 GSWKRPSLRVPGTDSLAFGSCTPLPDFVK-TLIG----RFLNFD--RRRRLLPLEAME 352
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 50/219 (22%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 595 LLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRH 650
+ IG G+ G+VY A G +A++++ ++ Q + EL EI + ++
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVMRENKN 76
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
N+V + Y ++ E++ G+L D + E + +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMD----------EGQIA---AVCR 123
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
+AL +LH + +H ++KS NILL + KL+D+G + +K
Sbjct: 124 ECLQALEFLHSNQV---IHRDIKSDNILLGMDGSVKLTDFGFCAQI----TPEQSKRSTM 176
Query: 771 VG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
VG ++APE+ K D++S G++ +E++ G P
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 1e-19
Identities = 37/227 (16%), Positives = 86/227 (37%), Gaps = 36/227 (15%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKL----------------ETLGRIRNQEEFELEIGRL 645
+ G + + A+KK + + ++F+ E+ +
Sbjct: 39 LNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 646 SNIRHFNLVAFQGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSR 704
++I++ + +G + + +I E++ ++ + + +
Sbjct: 98 TDIKNEYCLTCEGIITNYDEVYIIY-EYMENDSILKFD--EYFFVLDKNYTCFIPIQVIK 154
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL 764
+ SY+H+ + I H ++K +NIL+D+N KLSD+G ++ + D
Sbjct: 155 CI--IKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DK--- 205
Query: 765 TKFHNAVG---YVAPELAQSLRLSD--KCDVYSFGVILLELVTGRKP 806
K + G ++ PE + + K D++S G+ L + P
Sbjct: 206 -KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 2e-19
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 26/215 (12%)
Query: 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
K IG GS G V++ +A+K ++ E+ + EI LS +
Sbjct: 25 TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK 84
Query: 656 FQG-YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+ G Y + + +I+ E++ G+ D L G + E + I +
Sbjct: 85 YYGSYLKDTKLWIIM-EYLGGGSALDLLE--------PGPL--DETQIA---TILREILK 130
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
L YLH + K +H ++K+ N+LL E+ E KL+D+G+A L K + VG
Sbjct: 131 GLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQL----TDTQIKRNTFVGTP 183
Query: 773 -YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
++APE+ + K D++S G+ +EL G P
Sbjct: 184 FWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 2e-19
Identities = 75/328 (22%), Positives = 135/328 (41%), Gaps = 56/328 (17%)
Query: 577 FSKSLPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEG--------GVSIAV 623
S+ + WE ++ L +G G G V A G V++AV
Sbjct: 65 VSEYELPEDPKWE------FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAV 118
Query: 624 KKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL 682
K L+ ++ + E+ + I +H N++ G ++ E+ KGNL + L
Sbjct: 119 KMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYL 178
Query: 683 ----HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTN 736
+ ++ + AR + YL +H +L + N
Sbjct: 179 RARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK-----CIHRDLAARN 233
Query: 737 ILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSF 793
+L+ EN K++D+GLA+ + +D Y K N V ++APE + + DV+SF
Sbjct: 234 VLVTENNVMKIADFGLARDINNIDYY--KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF 291
Query: 794 GVILLELVT-GRKPVESPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQV 850
GV++ E+ T G P E+ + ++E +++ + C NEL +
Sbjct: 292 GVLMWEIFTLGGSPYPGIPVEELF---KLLKEGHRMDK--PANC---------TNELYMM 337
Query: 851 MKLGLICTSEVPSRRPSMAEVVQVLESI 878
M+ C VPS+RP+ ++V+ L+ I
Sbjct: 338 MRD---CWHAVPSQRPTFKQLVEDLDRI 362
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 52/227 (22%), Positives = 93/227 (40%), Gaps = 27/227 (11%)
Query: 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKK--LETLGRIRNQEEFELEIGRLSNIRHFN 652
L+ +G G+ G V + G +AVK+ + + + +L+I + +
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDIS-MRTVDCPF 67
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
V F G + I E + +L V G I L IA+
Sbjct: 68 TVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKG---QTIPEDILG-----KIAVSI 118
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+AL +LH ++H ++K +N+L++ + K+ D+G++ L +D+ G
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDID---AG 171
Query: 773 ---YVAPE----LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTT 812
Y+APE S K D++S G+ ++EL R P +S T
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT 218
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 3e-19
Identities = 58/218 (26%), Positives = 103/218 (47%), Gaps = 25/218 (11%)
Query: 593 KALLDKECLIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHF 651
+ + D +G GS GSVY+A E G +A+K++ + +E EI +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---QEIIKEISIMQQCDSP 84
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
++V + G Y+ +T I+ E+ G++ D + N T E + I
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLT--------EDEIA---TILQS 133
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
T + L YLH K +H ++K+ NILL+ KL+D+G+A L + K + +
Sbjct: 134 TLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQL----TDTMAKRNTVI 186
Query: 772 G---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
G ++APE+ Q + + D++S G+ +E+ G+ P
Sbjct: 187 GTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPP 224
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 4e-19
Identities = 55/254 (21%), Positives = 86/254 (33%), Gaps = 43/254 (16%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVK----KLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
IG GS G V A + A+K ++ E + E+ + + H N+
Sbjct: 34 IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL 93
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR-- 714
Y ++ E G+L D L+ T + +
Sbjct: 94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGS 153
Query: 715 --------------------------ALSYLHHDCKPPILHLNLKSTNILL--DENYEPK 746
AL YLH I H ++K N L ++++E K
Sbjct: 154 IHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPENFLFSTNKSFEIK 210
Query: 747 LSDYGLAKLLPILDNYGLTKFHNAVG---YVAPELAQSLRLS--DKCDVYSFGVILLELV 801
L D+GL+K L+N G +VAPE+ + S KCD +S GV+L L+
Sbjct: 211 LVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLL 270
Query: 802 TGRKPVESPTTNEV 815
G P +
Sbjct: 271 MGAVPFPGVNDADT 284
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 59/221 (26%), Positives = 93/221 (42%), Gaps = 26/221 (11%)
Query: 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKK--LETLGRIRNQEEFELEIGRLSNIRHFN 652
L IG G+ GSV + G +AVK+ + + Q +L++ + +
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVV-MRSSDCPY 82
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+V F G + I E + + V I L I L T
Sbjct: 83 IVQFYGALFREGDCWICMELMS-TSFDKFYKYV--YSVLDDVIPEEILG-----KITLAT 134
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+AL++L + K I+H ++K +NILLD + KL D+G++ L +D+ T+ G
Sbjct: 135 VKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRD---AG 187
Query: 773 ---YVAPELAQSLRLSD----KCDVYSFGVILLELVTGRKP 806
Y+APE + DV+S G+ L EL TGR P
Sbjct: 188 CRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 8e-19
Identities = 69/302 (22%), Positives = 112/302 (37%), Gaps = 52/302 (17%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQG 658
++ G VY A G A+K+L + E+ + + H N+V F
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEE-EKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 659 YYW-------SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
+ + +L + KG L + L + S G + + I
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKME----SRGPLSCDTV-----LKIFYQ 144
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
T RA+ ++H KPPI+H +LK N+LL KL D+G A + +Y + A+
Sbjct: 145 TCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 772 G-----------YVAPELAQSLR---LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV 817
Y PE+ + +K D+++ G IL L + P E +V
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN 263
Query: 818 LCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
+Y + + F + LI+ M L P R S+AEVV L+
Sbjct: 264 -GKY--SIPPHDTQYTVF---------HSLIRAM-L-----QVNPEERLSIAEVVHQLQE 305
Query: 878 IR 879
I
Sbjct: 306 IA 307
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 62/286 (21%), Positives = 111/286 (38%), Gaps = 43/286 (15%)
Query: 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKK--LETLGRIRNQEEFELEIGRLSNIRHFN 652
L+ +G G+ G V++ F + G IAVK+ + +L++ L +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVV-LKSHDCPY 85
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+V G + ++T I E + G I L + +
Sbjct: 86 IVQCFGTFITNTDVFIAMELMGTCAEKLKKR-------MQGPIPERILG-----KMTVAI 133
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+AL YL ++H ++K +NILLDE + KL D+G++ L +D+ + G
Sbjct: 134 VKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRS---AG 186
Query: 773 ---YVAPELAQSLRLSD-----KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824
Y+APE + + DV+S G+ L+EL TG+ P + VL + ++E
Sbjct: 187 CAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY-KNCKTDFEVLTKVLQE 245
Query: 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAE 870
F + F + C ++ +RP +
Sbjct: 246 EPPLLPGHMGFSGDFQSFVK-----------DCLTKDHRKRPKYNK 280
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 1e-18
Identities = 56/269 (20%), Positives = 97/269 (36%), Gaps = 22/269 (8%)
Query: 222 ISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEI 281
I+ + +T TV + I L + L N+ + N ++
Sbjct: 24 IAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQ--YLNNLIGLELKDNQIT-DL 78
Query: 282 PEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLK 341
+ + + S N V ++ +++K LDL + I + + L L
Sbjct: 79 APLKNL-TKITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQ-ITDVT-PLAGLSNLQV 133
Query: 342 ISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDI 401
+ L N I I L + L+ L + N + ++N L L N + DI
Sbjct: 134 LYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKIS-DI 188
Query: 402 PQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTH 461
L ++ L + L N + S L N SNL ++ L+ +++ + P N NL
Sbjct: 189 S-PLASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTIT-NQPVFYNN--NLVV 242
Query: 462 FNLSSNNLSGTI-PSTIQHFGVSTFLNNT 489
N+ I P+TI G N T
Sbjct: 243 PNVVKGPSGAPIAPATISDNGTYASPNLT 271
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 42/304 (13%), Positives = 100/304 (32%), Gaps = 45/304 (14%)
Query: 92 LSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDL 151
L + + + T + Q ++ + ++ ++ +I E + L N+ L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLEL 70
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPS 211
N + P K + LS N L ++ ++ D + ++ +
Sbjct: 71 KDNQITDLAPLKNLT---KITELELSGNPLKNVSAIA--GLQSIKTLDLTSTQITD--VT 123
Query: 212 QICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFN 271
+ + L + + N +T + +++ L + + L P L ++
Sbjct: 124 PLAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLK 179
Query: 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPT 331
N ++ D S + + NL + L N+ I +
Sbjct: 180 ADDN----------------KISDIS----------PLASLPNLIEVHLKNNQ-ISDVS- 211
Query: 332 GITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLD 391
+ + L ++L N +I P + L+ + + P IS+ +
Sbjct: 212 PLANTSNLFIVTLTNQTITNQ--PVFYNNNLVVPNVVKGPSGAPIAPATISDNGTYASPN 269
Query: 392 VSGN 395
++ N
Sbjct: 270 LTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 31/186 (16%), Positives = 72/186 (38%), Gaps = 16/186 (8%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
L L + L L GN A +Q++ ++++S ++ P + L N+++L
Sbjct: 79 APLKNLTKITELELSGNPLKN--VSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVL 134
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
L N + I +++S+ + +S PL+ N + L N +S ++
Sbjct: 135 YLDLNQIT-NISP--LAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADDNKIS-DI 188
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISY 269
+ ++P L + ++ N + + + ++ + L++ N+
Sbjct: 189 SP-LASLPNLIEVHLKNNQI--SDVSPLANTSNLFIVTLTNQTITNQPV---FYNNNLVV 242
Query: 270 FNVSHN 275
NV
Sbjct: 243 PNVVKG 248
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 29/165 (17%), Positives = 60/165 (36%), Gaps = 14/165 (8%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
A++GL+S++ L L + T P + L + + N ++ +I + L N++ L
Sbjct: 101 SAIAGLQSIKTLDLTSTQITDVTPLA--GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYL 156
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGEL 209
+ S P A K + N +S I +A+ L N +S
Sbjct: 157 SIGNAQVSDLTPLANLS---KLTTLKADDNKIS-DIS-PLASLPNLIEVHLKNNQISDVS 211
Query: 210 PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFI 254
P + N L +++ +T + ++ ++
Sbjct: 212 P--LANTSNLFIVTLTNQTIT---NQPVFYNNNLVVPNVVKGPSG 251
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 54/222 (24%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFN 652
+ +G G+ G VY+A + E G A K +E +++EE E EI L+ H
Sbjct: 22 EIVGELGDGAFGKVYKAKNKETGALAAAKVIE----TKSEEELEDYIVEIEILATCDHPY 77
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+V G Y+ I+ EF P G + + ++ T E +
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLT--------EPQIQ---VVCRQM 126
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
AL++LH +H +LK+ N+L+ + +L+D+G++ L K + +G
Sbjct: 127 LEALNFLHSKRI---IHRDLKAGNVLMTLEGDIRLADFGVSAKN----LKTLQKRDSFIG 179
Query: 773 ---YVAPELAQSLRLSD-----KCDVYSFGVILLELVTGRKP 806
++APE+ + D K D++S G+ L+E+ P
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 2e-18
Identities = 50/226 (22%), Positives = 87/226 (38%), Gaps = 39/226 (17%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
++G G+ +V+R + G A+K + +R + E L + H N+V
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAI 75
Query: 660 YWSSTMQ---LILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNPELHWSRRF--HIALGT 712
+T + LI+ EF P G+LY L + G+ E +
Sbjct: 76 EEETTTRHKVLIM-EFCPCGSLYTVLEEPS------NAYGLPESE---FLIVLRDVVG-- 123
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILL----DENYEPKLSDYGLAKLLPILDNYGLTKFH 768
+++L + I+H N+K NI+ D KL+D+G A+ L D+ +
Sbjct: 124 --GMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLY 176
Query: 769 NAVGYVAPELAQSLRLSD--------KCDVYSFGVILLELVTGRKP 806
Y+ P++ + L D++S GV TG P
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 52/221 (23%), Positives = 80/221 (36%), Gaps = 42/221 (19%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKL-ETLGRIRN-QEEFELE---IGRLSNIRHFNLV 654
L+G G +G VY A +A+K + ETL + + E GRL ++V
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ---EPHVV 97
Query: 655 A------FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
G + + + +L L P L R I
Sbjct: 98 PIHDFGEIDGQLY------VDMRLINGVDLAAMLRR-QGP-----------LAPPRAVAI 139
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
AL H H ++K NIL+ + L D+G+A + LT+
Sbjct: 140 VRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT---TDEKLTQLG 193
Query: 769 NAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
N VG Y+APE + + D+Y+ +L E +TG P
Sbjct: 194 NTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 35/226 (15%)
Query: 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLV 654
+ L+G G+ G VY+ + G A+K ++ G +EE + EI L H N+
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD--EEEEIKQEINMLKKYSHHRNIA 84
Query: 655 AFQGYY-----WSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
+ G + QL ++ EF G++ D + T + E + +I
Sbjct: 85 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKN-----TKGNTL--KEEWIA---YI 134
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFH 768
R LS+LH +H ++K N+LL EN E KL D+G++ L + + + +
Sbjct: 135 CREILRGLSHLHQHKV---IHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRN 187
Query: 769 NAVG---YVAPELAQSLRLSD-----KCDVYSFGVILLELVTGRKP 806
+G ++APE+ D K D++S G+ +E+ G P
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 39/166 (23%), Positives = 59/166 (35%), Gaps = 6/166 (3%)
Query: 313 RNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDL-HN 370
+ + L NR I +P R L + L +N + I + LLE LDL N
Sbjct: 32 AASQRIFLHGNR-ISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90
Query: 371 LNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQ-TLYNMTYLKILDLHQNHLNGSTPPSL 429
LR P L L + L ++ + L+ L L N L +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQALPDDTF 149
Query: 430 GNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
+L NL L L N +S + L +L L N ++ +
Sbjct: 150 RDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHP 194
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 50/190 (26%), Positives = 77/190 (40%), Gaps = 8/190 (4%)
Query: 292 QVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIG 350
Q N V S CRNL +L L N + I T L L ++ L++N+
Sbjct: 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNV-LARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 351 GIIPPN-LGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIP-QTLYN 407
+ P + L L L L+ E+ + L L + NAL +P T +
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 408 MTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467
+ L L LH N ++ + L +L L L QN ++ P + +L L L +N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 468 NLSGTIPSTI 477
NLS +P+
Sbjct: 212 NLS-ALPTEA 220
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 5e-12
Identities = 27/125 (21%), Positives = 42/125 (33%), Gaps = 6/125 (4%)
Query: 353 IPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLK 412
+P + + + + LH + CR L +L + N L + L+
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 413 ILDLHQNHLNGSTPPS-LGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSNNLS 470
LDL N S P+ L L L L + L + L L + L N L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 471 GTIPS 475
+P
Sbjct: 143 -ALPD 146
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 37/192 (19%), Positives = 72/192 (37%), Gaps = 8/192 (4%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPE--FIGDLPNIRL 148
+ ++L +L L N + + L ++++S NA S+ F G L +
Sbjct: 51 SFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHG-LGRLHT 109
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSG 207
L L R E+ LF+ +++ L N L ++P + L N +S
Sbjct: 110 LHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS- 166
Query: 208 ELPSQI-CNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKN 266
+P + + LD + + N + F + L L +N L + L+
Sbjct: 167 SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRA 226
Query: 267 ISYFNVSHNGFH 278
+ Y ++ N +
Sbjct: 227 LQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 8e-08
Identities = 16/76 (21%), Positives = 29/76 (38%), Gaps = 2/76 (2%)
Query: 400 DIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNL 459
+P + + + LH N ++ S NL +L L N L+ ++ L L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 460 THFNLSSNNLSGTIPS 475
+LS N ++
Sbjct: 83 EQLDLSDNAQLRSVDP 98
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 5e-18
Identities = 52/216 (24%), Positives = 88/216 (40%), Gaps = 27/216 (12%)
Query: 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRI-RNQEEFELEIGRLSNI-RHFNL 653
+ +G GS G V++ S E G AVK+ + R +++ E+G + +H
Sbjct: 60 QRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCC 119
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
V + + + + +E +L + G PE ++ + T
Sbjct: 120 VRLEQAWEEGGILYLQTELC-GPSLQQHC--------EAWGASLPE---AQVWGYLRDTL 167
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
AL++LH ++HL++K NI L KL D+GL L G + G
Sbjct: 168 LALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQ--EGD 219
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
Y+APEL Q DV+S G+ +LE+ +
Sbjct: 220 PRYMAPELLQG-SYGTAADVFSLGLTILEVACNMEL 254
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-18
Identities = 59/312 (18%), Positives = 113/312 (36%), Gaps = 57/312 (18%)
Query: 596 LDKECLIGGGSIGSVYRA------SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNI- 648
K +G G+ G V A + +AVK L+ +E E+ ++ +
Sbjct: 49 FGKV--LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106
Query: 649 RHFNLVAFQGYYWSSTMQ---LILSEFVPKGNLYDNL-----------HGVNYPGTSTGG 694
H N+V G + T+ ++ E+ G+L + L
Sbjct: 107 SHENIVNLLG---ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 163
Query: 695 IGNPELHWSRRFHIALGTARALSYL--HHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752
L + A A+ + +L +H +L + N+L+ K+ D+GL
Sbjct: 164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKS-----CVHRDLAARNVLVTHGKVVKICDFGL 218
Query: 753 AKLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVE 808
A+ + NY NA V ++APE + K DV+S+G++L E+ + G P
Sbjct: 219 ARDIMSDSNY--VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276
Query: 809 SPTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP 866
+ + ++ +++ +A E+ +M+ C + +RP
Sbjct: 277 GIPVDANFY--KLIQNGFKMDQPF-----------YATEEIYIIMQS---CWAFDSRKRP 320
Query: 867 SMAEVVQVLESI 878
S + L
Sbjct: 321 SFPNLTSFLGCQ 332
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 7e-18
Identities = 45/247 (18%), Positives = 84/247 (34%), Gaps = 40/247 (16%)
Query: 578 SKSLPSKYEDWEAGT----KALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIR 633
S SL D E K + ++G G+ G++ +AVK++
Sbjct: 4 SPSLEQDDGDEETSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRIL----PE 59
Query: 634 NQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL--HGVNYPGT 690
+ E+ L H N++ + Q I E L + + + G
Sbjct: 60 CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGL 118
Query: 691 STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYE-----P 745
+ T L++LH I+H +LK NIL+
Sbjct: 119 EP-------------ITLLQQTTSGLAHLH-SLN--IVHRDLKPHNILISMPNAHGKIKA 162
Query: 746 KLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPEL---AQSLRLSDKCDVYSFGVILLE 799
+SD+GL K L + + ++ G ++APE+ + D++S G +
Sbjct: 163 MISDFGLCKKLA-VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYY 221
Query: 800 LVTGRKP 806
+++
Sbjct: 222 VISEGSH 228
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 8e-18
Identities = 59/292 (20%), Positives = 121/292 (41%), Gaps = 44/292 (15%)
Query: 601 LIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEE----FELEIGRLSNIRHFNLVA 655
+GGG + +VY A + +A+K + R +EE FE E+ S + H N+V+
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFI--PPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
++ E++ L + + + L +
Sbjct: 76 MIDVDEEDDCYYLVMEYIEGPTLSEYIES------------HGPLSVDTAINFTNQILDG 123
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG--- 772
+ + H I+H ++K NIL+D N K+ D+G+AK L LT+ ++ +G
Sbjct: 124 IKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAK---ALSETSLTQTNHVLGTVQ 177
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV--ESPTTNEVVVLCEYVRELLERGS 830
Y +PE A+ + D+YS G++L E++ G P E+ V + +++++ +
Sbjct: 178 YFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA----VSIAIKHIQD--SVPN 231
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-SMAEVVQVLESIRNG 881
+ + + N +++ T + + R ++ E+ L S+ +
Sbjct: 232 VTTDVRKDIPQSLSN---VILR----ATEKDKANRYKTIQEMKDDLSSVLHE 276
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 49/219 (22%), Positives = 90/219 (41%), Gaps = 23/219 (10%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ G V V A+K + + + E+ L + H N++ +
Sbjct: 45 LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ ++ E G L+D + E+ + L ++YL
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIHRMK---------FNEVDAAVIIKQVLS---GVTYL 152
Query: 720 HHDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
H I+H +LK N+LL +++ K+ D+GL+ + + + + Y+AP
Sbjct: 153 HKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAV--FENQKKMKERLGTAYYIAP 207
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
E+ + + +KCDV+S GVIL L+ G P T E+
Sbjct: 208 EVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI 245
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 47/227 (20%), Positives = 83/227 (36%), Gaps = 44/227 (19%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ--EEFELEIGRLSNIRHFNL--VAF 656
IG G V++ E A+K + L NQ + + EI L+ ++ + +
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVN-LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTAR 714
Y + ++ E +L L I + + ++
Sbjct: 122 YDYEITDQYIYMVMECG-NIDLNSWLK-------KKKSI--DP-WERKSYWKNMLE---- 166
Query: 715 ALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
A+ +H H I+H +LK N L+ + KL D+G+A + + + VG
Sbjct: 167 AVHTIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ--PDTTSVVKDSQVGA 219
Query: 773 --YVAPEL-----------AQSLRLSDKCDVYSFGVILLELVTGRKP 806
Y+ PE ++S K DV+S G IL + G+ P
Sbjct: 220 VNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 44/224 (19%), Positives = 80/224 (35%), Gaps = 38/224 (16%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRI-RNQEEFELEIGRLSNIRHFNL--VAFQ 657
IG G V++ E A+K + + + + EI L+ ++ + +
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
Y + ++ E +L L I + + + A+
Sbjct: 95 DYEITDQYIYMVMECG-NIDLNSWLK-------KKKSI--DP-WERKSYWKNM--LEAVH 141
Query: 718 YLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---Y 773
+H H I+H +LK N L+ + KL D+G+A + + + VG Y
Sbjct: 142 TIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ--PDTTSVVKDSQVGTVNY 194
Query: 774 VAPEL-----------AQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ PE ++S K DV+S G IL + G+ P
Sbjct: 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 2e-17
Identities = 54/255 (21%), Positives = 90/255 (35%), Gaps = 18/255 (7%)
Query: 235 EQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVF 294
+L L +I +++ + + +
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQGIQYL-PNVTKL 73
Query: 295 DASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP 354
+ N+ + PL+ N +NL L L N+ + + + + DL++L +SL +N I I
Sbjct: 74 FLNGNKLTDIKPLA--NLKNLGWLFLDENK-VKDL-SSLKDLKKLKSLSLEHNGISDI-- 127
Query: 355 PNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKIL 414
L + LE L L N + +S L L + N + DI L +T L+ L
Sbjct: 128 NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNL 183
Query: 415 DLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
L +NH+ S +L L NL VL+L + NL + +L P
Sbjct: 184 YLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VTP 239
Query: 475 STIQHFGVSTFLNNT 489
I G N
Sbjct: 240 EIISDDGDYEKPNVK 254
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 3e-10
Identities = 49/287 (17%), Positives = 98/287 (34%), Gaps = 43/287 (14%)
Query: 92 LSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDL 151
L T + Q E+ ++ +I +++ + S+ + I LPN+ L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPS 211
+ N + P A K ++ L N + + S+ + L+ N +S ++
Sbjct: 76 NGNKLTDIKPLANLK---NLGWLFLDENKVK-DLS-SLKDLKKLKSLSLEHNGIS-DING 129
Query: 212 QICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFN 271
+ ++P L+ + + N +T S+ + L L N + P GL +
Sbjct: 130 -LVHLPQLESLYLGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLA--GLTKLQNLY 184
Query: 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPT 331
+S N I ++ ++ +NL VL+L +
Sbjct: 185 LSKN----HISDLR----------------------ALAGLKNLDVLELFSQECLNKPIN 218
Query: 332 GITDLRRLLKISLANNSIGGIIP-PNLGSIELLEVLDLHNLNLRGEV 377
++L + + S+ + G E V H EV
Sbjct: 219 HQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVK-WHLPEFTNEV 264
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 78/371 (21%), Positives = 129/371 (34%), Gaps = 100/371 (26%)
Query: 581 LPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEG------GVSIAVKKLETL 629
LP WE ++ L +G G+ G V A G ++AVK L+
Sbjct: 10 LPYDASKWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 63
Query: 630 GRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQL-ILSEFVPKGNLYDNLH---- 683
E+ L +I H N+V G L ++ EF GNL L
Sbjct: 64 ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 123
Query: 684 --------------GVNYPGT-------------------STGGIGNPELHWSRRF---- 706
G +Y G S+G + L
Sbjct: 124 EFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPE 183
Query: 707 -------------HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753
+ A+ + +L +H +L + NILL E K+ D+GLA
Sbjct: 184 DLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLA 240
Query: 754 KLLPILDNYGLTKFHNA---VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVES 809
+ + +Y + +A + ++APE + + DV+SFGV+L E+ + G P
Sbjct: 241 RDIYKDPDY--VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 298
Query: 810 PTTNEVVVLCEYVRE--LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS 867
+E C ++E + + E+ Q M C PS+RP+
Sbjct: 299 VKIDEEF--CRRLKEGTRMRAPD-----------YTTPEMYQTMLD---CWHGEPSQRPT 342
Query: 868 MAEVVQVLESI 878
+E+V+ L ++
Sbjct: 343 FSELVEHLGNL 353
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 4e-17
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ G V A + ++AVK ++ + E + EI + H N+V F G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH---IALGTARAL 716
+Q + E+ G L+D + G+ P+ ++RF +A +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-------EPDIGMPEPD---AQRFFHQLMA-----GV 118
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---Y 773
YLH I H ++K N+LLDE K+SD+GLA + + L + G Y
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL--LNKMCGTLPY 173
Query: 774 VAPELAQSLRLSDK------CDVYSFGVILLELVTGRKPVESPTTN 813
VAPEL L + DV+S G++L ++ G P + P+ +
Sbjct: 174 VAPEL-----LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-17
Identities = 44/224 (19%), Positives = 80/224 (35%), Gaps = 38/224 (16%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRI-RNQEEFELEIGRLSNIRHFNL--VAFQ 657
IG G V++ E A+K + + + + EI L+ ++ + +
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
Y + ++ E +L L I + + + A+
Sbjct: 76 DYEITDQYIYMVMECG-NIDLNSWLK-------KKKSI--DP-WERKSYWKNM--LEAVH 122
Query: 718 YLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---Y 773
+H H I+H +LK N L+ + KL D+G+A + + + VG Y
Sbjct: 123 TIHQHG----IVHSDLKPANFLIVDG-MLKLIDFGIANQMQ--PDTTSVVKDSQVGTVNY 175
Query: 774 VAPEL-----------AQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ PE ++S K DV+S G IL + G+ P
Sbjct: 176 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 34/220 (15%)
Query: 597 DKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL---EIGRLSNIRHFN 652
IG GS G+VY A +A+KK+ ++ E+++ E+ L +RH N
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMS-YSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ ++G Y ++ E+ G+ D L P E+ + + G
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ--------EVEIA---AVTHGA 163
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+ L+YLH +H ++K+ NILL E KL D+G A + ++ VG
Sbjct: 164 LQGLAYLHSHNM---IHRDVKAGNILLSEPGLVKLGDFGSAS--------IMAPANSFVG 212
Query: 773 ---YVAPELAQSLRLSD---KCDVYSFGVILLELVTGRKP 806
++APE+ ++ K DV+S G+ +EL + P
Sbjct: 213 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 7e-17
Identities = 42/254 (16%), Positives = 88/254 (34%), Gaps = 54/254 (21%)
Query: 580 SLPSKYE-DWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEE 637
+ S+Y ++ + IG G GSV++ G A+K+ + E+
Sbjct: 4 GMKSRYTTEFH--------ELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ 55
Query: 638 FEL-EIGRLSNI-RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI 695
L E+ + + +H ++V + + LI +E+ G+L D + +
Sbjct: 56 NALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI---SENYRIMSYF 112
Query: 696 GNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP---------- 745
EL + G L Y+H ++H+++K +NI + P
Sbjct: 113 KEAEL-KDLLLQVGRG----LRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDED 164
Query: 746 ---------KLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPE-LAQSLRLSDKCDVYS 792
K+ D G ++ G ++A E L ++ K D+++
Sbjct: 165 DWASNKVMFKIGDLGHVTR--------ISSPQVEEGDSRFLANEVLQENYTHLPKADIFA 216
Query: 793 FGVILLELVTGRKP 806
+ ++
Sbjct: 217 LALTVVCAAGAEPL 230
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 9e-17
Identities = 56/295 (18%), Positives = 96/295 (32%), Gaps = 60/295 (20%)
Query: 601 LIGGGSIGSVYRA--SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA--- 655
I G +G +Y A G + +K L G Q E L+ + H ++V
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 656 --FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+ I+ E+V +L + +L + L
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--------------KLPVAEAIAYLLEIL 192
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
ALSYLH +++ +LK NI+L E + KL D G + F G
Sbjct: 193 PALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS--------RINSFGYLYGT 240
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830
+ APE+ ++ + D+Y+ G L L YV L E
Sbjct: 241 PGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG----------RYVDGLPED-- 287
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-SMAEVVQVLESIRNGLGS 884
D L+ + + + + P +R + E+ L + + +
Sbjct: 288 -----DPVLKTYDSYGRL-LRR----AIDPDPRQRFTTAEEMSAQLTGVLREVVA 332
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 60/226 (26%), Positives = 100/226 (44%), Gaps = 38/226 (16%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ G V A + ++AVK ++ + E + EI + H N+V F G+
Sbjct: 14 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 73
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH---IALGTARAL 716
+Q + E+ G L+D + G+ P+ ++RF +A +
Sbjct: 74 RREGNIQYLFLEYCSGGELFDRI-------EPDIGMPEPD---AQRFFHQLMA-----GV 118
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---Y 773
YLH I H ++K N+LLDE K+SD+GLA + + L + G Y
Sbjct: 119 VYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL--LNKMCGTLPY 173
Query: 774 VAPELAQSLRLSDK------CDVYSFGVILLELVTGRKPVESPTTN 813
VAPEL L + DV+S G++L ++ G P + P+ +
Sbjct: 174 VAPEL-----LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 214
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 81.9 bits (202), Expect = 1e-16
Identities = 51/229 (22%), Positives = 95/229 (41%), Gaps = 39/229 (17%)
Query: 597 DKECLIGGG--SIGSVYRASFEG-GVSIAVKK--LETLGRIRNQEEFEL---EIGRLSNI 648
+ +IG G + +V A ++ G + V++ LE + E E+
Sbjct: 28 ELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC----SNEMVTFLQGELHVSKLF 83
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
H N+V ++ + + +++ F+ G+ D L ++ G EL I
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD-LICTHFMD------GMNELA------I 130
Query: 709 AL---GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG-LAKLLPILD--NY 762
A G +AL Y+HH +H ++K+++IL+ + + LS ++
Sbjct: 131 AYILQGVLKALDYIHHMGY---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRV 187
Query: 763 GLTKFHNAVG---YVAPE-LAQSLRLSD-KCDVYSFGVILLELVTGRKP 806
+V +++PE L Q+L+ D K D+YS G+ EL G P
Sbjct: 188 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 1e-16
Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 24/220 (10%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLET--LGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G GS G V G AVK + + + ++E E+ L + H N++
Sbjct: 34 LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE 93
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
++ ++ E G L+D + E+ +R L ++Y
Sbjct: 94 FFEDKGYFYLVGEVYTGGELFDEIISRKR---------FSEVDAARIIRQVLS---GITY 141
Query: 719 LHHDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVA 775
+H + I+H +LK N+LL ++ ++ D+GL+ + + Y+A
Sbjct: 142 MHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH--FEASKKMKDKIGTAYYIA 196
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
PE+ +KCDV+S GVIL L++G P ++
Sbjct: 197 PEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 80.8 bits (199), Expect = 2e-16
Identities = 38/308 (12%), Positives = 88/308 (28%), Gaps = 63/308 (20%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVK-----KLETLGRIRNQEEFELEIGRLSNIRHFNLV 654
++G + A E G S V + I+ +E L + L I++
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 655 AFQGYYWSSTMQLILSE---FVPKGNLYDNLHGVNY------PGTSTGGIGNPELHWSR- 704
+ + + + ++ ++ ++ G L S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 705 --------RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756
R + L R L+ LHH ++H L+ +I+LD+ L+ +
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR- 255
Query: 757 PILDNYGLTKFHNAVGYVAPELAQS-----------LRLSDKCDVYSFGVILLELVTGRK 805
+ + G+ PEL ++ D ++ G+++ +
Sbjct: 256 ----DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 806 PVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRR 865
P+ E++ + L++ G + R
Sbjct: 312 PITKDAALG---GSEWIFRSCKNIPQPVR-----------ALLE----GFLRYP--KEDR 351
Query: 866 PSMAEVVQ 873
+ ++
Sbjct: 352 LLPLQAME 359
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 45/189 (23%), Positives = 82/189 (43%), Gaps = 24/189 (12%)
Query: 700 LHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL 759
+ R + +AL++ H + I+H ++K NI++ K+ D+G+A+ +
Sbjct: 113 MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIAD- 168
Query: 760 DNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPV--ESPTTNE 814
+T+ +G Y++PE A+ + + DVYS G +L E++TG P +SP
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP---- 224
Query: 815 VVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-SMAEVVQ 873
V V ++VRE E + + L ++ P R + AE+
Sbjct: 225 VSVAYQHVREDPI----------PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRA 274
Query: 874 VLESIRNGL 882
L + NG
Sbjct: 275 DLVRVHNGE 283
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 5e-16
Identities = 48/277 (17%), Positives = 84/277 (30%), Gaps = 39/277 (14%)
Query: 174 VSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGT 232
+ ++ IP + N L F L L+ I + N +
Sbjct: 14 FLCQESKVT-EIPSDLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 233 VEEQ-FSQCQSIKNLDLSSNLFIGLAPFGVL-GLKNISYFNVSHNGFHGEIPEVGICGEG 290
+E FS + + + + L N+ Y +S+ G +P
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLP-------- 120
Query: 291 MQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTG-ITDLRRLLK-ISLANNS 348
+ + +LD+ N I +I L + L N
Sbjct: 121 ---------------DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNG 165
Query: 349 IGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYN 407
I I +L E+ N NL E+P+D+ ++LD+S + L N
Sbjct: 166 IQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLEN 224
Query: 408 MTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNS 444
+ L+ + P+L L L L+ S
Sbjct: 225 LKKLRARSTYNL----KKLPTLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 28/171 (16%), Positives = 71/171 (41%), Gaps = 7/171 (4%)
Query: 310 TNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLAN-NSIGGIIPPNLGSIELLEVLD 367
+ +L+ +++ N ++ I + ++L +L +I + N++ I P ++ L+ L
Sbjct: 51 SGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLL 110
Query: 368 LHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQ-TLYNMTY-LKILDLHQNHLNGS 424
+ N ++ +PD + +LLD+ N I + + +++ IL L++N +
Sbjct: 111 ISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEI 169
Query: 425 TPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
+ ++ N+L ++S + ++PS
Sbjct: 170 HNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-SLPS 219
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 67.9 bits (166), Expect = 3e-12
Identities = 40/240 (16%), Positives = 76/240 (31%), Gaps = 35/240 (14%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
+ L + G ++ +S N I VF
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA--------DVFS------ 76
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSI 360
N L + + + I +L L + ++N I + P++ I
Sbjct: 77 ---------NLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL--PDVHKI 125
Query: 361 EL--LEVLDL-HNLNLRGEVPDDISNCRFLL-LLDVSGNALGGDIPQTLYNMTYLKILDL 416
+LD+ N+N+ + F +L ++ N + ++
Sbjct: 126 HSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLS 185
Query: 417 HQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSNNLSGTIPS 475
N+L S +LD+S+ + S+PS L NL+ L S+ NL +P+
Sbjct: 186 DNNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA--RSTYNLK-KLPT 241
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 33/170 (19%), Positives = 62/170 (36%), Gaps = 7/170 (4%)
Query: 313 RNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLDLHN 370
RN L + + I G + L KI ++ N + +I + ++ L + +
Sbjct: 30 RNAIELRFVLTK-LRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK 88
Query: 371 LNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSL 429
N + + N L L +S + + +LD+ N + +
Sbjct: 89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 430 --GNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTI 477
G +L L++N + I +S N L NLS NN +P+ +
Sbjct: 149 FVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDV 197
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 34/191 (17%), Positives = 70/191 (36%), Gaps = 9/191 (4%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVS-SNALSGSIPEFI-GDLPNIR 147
A SG L + + N + + ++ + L +I + +N L I +LPN++
Sbjct: 49 AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQ 107
Query: 148 LLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIP-LSIANCTY-LEGFDFSFNNL 205
L +S +P + + + + N +I S ++ + N +
Sbjct: 108 YLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGI 166
Query: 206 SGELPSQICNIPVLDFISV-RGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGL 264
E+ + N LD +++ N L + F LD+S L +G+ L
Sbjct: 167 Q-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENL 225
Query: 265 KNISYFNVSHN 275
K + + +
Sbjct: 226 KKLRARSTYNL 236
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 1e-15
Identities = 70/439 (15%), Positives = 134/439 (30%), Gaps = 94/439 (21%)
Query: 96 KSLRVLTLFGNRFTGN-LPQEYAEMQTLWKINVSSNALS----GSIPEFIGDLPNIRLLD 150
++ L + + + +Q + + L+ I + P + L+
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 151 LSRNSYSGE----IPFALFKYCYKTKFVSLSHNNLS----GSIPLSIANCTYLEGFDFSF 202
L N + L K + +SL + L+ G + ++ L+ S
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 203 NNLSGELPSQICNI-----PVLDFISVRGNALTGTVEEQFS----QCQSIKNLDLSSNLF 253
N L +C L+ + + +L+ E + K L +S+N
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNN-- 180
Query: 254 IGLAPFGVLGLKNIS-----------YFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFD 302
G++ + + G + + +
Sbjct: 181 ----DINEAGVRVLCQGLKDSPCQLEALKLESCG---------VTSDNCRDLCGI----- 222
Query: 303 GVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDL--------RRLLKISLANNSIG---- 350
+ + +L+ L LG N+L G+ +L RL + + I
Sbjct: 223 ------VASKASLRELALGSNKLGDV---GMAELCPGLLHPSSRLRTLWIWECGITAKGC 273
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDDIS------NCRFLLLLDVSGNALGGD---- 400
G + L + E L+ L L L E + C+ L L V +
Sbjct: 274 GDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQ-LESLWVKSCSFTAACCSH 332
Query: 401 IPQTLYNMTYLKILDLHQNHLNGSTPPSLG-----NLSNLQVLDLSQNSLS----GSIPS 451
L +L L + N L + L S L+VL L+ +S S+ +
Sbjct: 333 FSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA 392
Query: 452 SLGNLRNLTHFNLSSNNLS 470
+L +L +LS+N L
Sbjct: 393 TLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-10
Identities = 62/378 (16%), Positives = 113/378 (29%), Gaps = 85/378 (22%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQ-----TLWKINVSSNALSGSIPEFIGD 142
LS L L +L+ L L N Q E L K+ + +LS + E +
Sbjct: 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164
Query: 143 L----PNIRLLDLSRNSYSGE----IPFALFKYCYKTKFVSLSHNNLS----GSIPLSIA 190
+ P+ + L +S N + + L + + + L ++ + +A
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 224
Query: 191 NCTYLEGFDFSFNNLSGELPSQICNI-----PVLDFISVRGNALTGTVEEQFSQ----CQ 241
+ L N L +++C L + + +T + +
Sbjct: 225 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKE 284
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
S+K L L+ N G G + + + G ++ F
Sbjct: 285 SLKELSLAGN------ELGDEGARLLC-------------ETLLEPGCQLESLWVKSCSF 325
Query: 302 --DGVIPLS--ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLK--------ISLANNSI 349
S + R L L + NRL + G+ +L + L + LA+ +
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLEDA---GVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 350 GGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTL---- 405
+ L L L LD+S N LG L
Sbjct: 383 S-----DSSCSSLAATL---------------LANHSLRELDLSNNCLGDAGILQLVESV 422
Query: 406 -YNMTYLKILDLHQNHLN 422
L+ L L+ + +
Sbjct: 423 RQPGCLLEQLVLYDIYWS 440
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 52/231 (22%), Positives = 89/231 (38%), Gaps = 36/231 (15%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVK-----KLETLGRI-------RNQEEFELEIGRLSNI 648
+G G+ G V G A+K + + + EE EI L ++
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 649 RHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
H N++ + +++EF G L++ + + E +
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK---------FDECDAANIMKQ 154
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLT 765
L + YLH I+H ++K NILL + K+ D+GL+ +Y L
Sbjct: 155 ILS---GICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSF--FSKDYKLR 206
Query: 766 KFHNAVGYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Y+APE L + ++KCDV+S GVI+ L+ G P ++
Sbjct: 207 DRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDI 255
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 2e-15
Identities = 57/227 (25%), Positives = 87/227 (38%), Gaps = 31/227 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEE-FELEIGRLSNIRHFNLVA- 655
L+G GS G V E AVK L + L RI N E + EI L +RH N++
Sbjct: 12 LLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQL 71
Query: 656 FQGYYWSSTMQLIL-SEFVPKGN--LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
Y ++ + E+ G + D++ + + + L
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQEMLDSV--------PEKRFPVCQ---AHGYFCQL-- 118
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
L YLH I+H ++K N+LL K+S G+A+ L + G
Sbjct: 119 IDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT--CRTSQG 173
Query: 773 ---YVAPELAQSLRLSD--KCDVYSFGVILLELVTGRKPVESPTTNE 814
+ PE+A L K D++S GV L + TG P E +
Sbjct: 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.4 bits (195), Expect = 2e-15
Identities = 46/295 (15%), Positives = 82/295 (27%), Gaps = 29/295 (9%)
Query: 198 FDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLA 257
FS G + + +SV G + L+ L
Sbjct: 259 VCFSRPLTVGSRMGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTF 318
Query: 258 PFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKV 317
G + + + + E + + S + V+ + +C+ L+
Sbjct: 319 RVIWTGSDSQKECVLLKDRPECWCRDSATD-EQLFRCELSVEKST-VLQSELESCKELQE 376
Query: 318 LDLGFN-------------RLIGSIPTGITDLRRLLKI--------SLANNSIGGIIPPN 356
L+ + + L + +
Sbjct: 377 LEPENKWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVL 436
Query: 357 LGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDL 416
+ VL L + +L V + + LD+S N L +P L + L++L
Sbjct: 437 KMEYADVRVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQA 493
Query: 417 HQNHLNGSTPPSLGNLSNLQVLDLSQNSLSG-SIPSSLGNLRNLTHFNLSSNNLS 470
N L + NL LQ L L N L + L + L NL N+L
Sbjct: 494 SDNAL--ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 43.2 bits (101), Expect = 4e-04
Identities = 22/112 (19%), Positives = 43/112 (38%), Gaps = 13/112 (11%)
Query: 99 RVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRN---S 155
RVL L T L ++ + +++S N L ++P + L + +L S N +
Sbjct: 444 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN 500
Query: 156 YSGEIPFALFKYCYKTKFVSLSHNNLSG-SIPLSIANCTYLEGFDFSFNNLS 206
G + + + L +N L + + +C L + N+L
Sbjct: 501 VDG------VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 546
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 78.7 bits (194), Expect = 2e-15
Identities = 52/230 (22%), Positives = 87/230 (37%), Gaps = 37/230 (16%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLS-NIRHFNLVAFQGY 659
++G GS G+V G +AVK++ I + +EI L+ + H N++ +
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRML----IDFCDIALMEIKLLTESDDHPNVIRYYCS 77
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ I E NL D + N + + A +++L
Sbjct: 78 ETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPI-----SLLRQIASGVAHL 131
Query: 720 HHDCKPPILHLNLKSTNILLD-------------ENYEPKLSDYGLAKLLPILDNYGLTK 766
H I+H +LK NIL+ EN +SD+GL K L + T
Sbjct: 132 HSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 767 FHNAVG---YVAPEL-------AQSLRLSDKCDVYSFGVILLELVTGRKP 806
+N G + APEL RL+ D++S G + +++ K
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 55/251 (21%), Positives = 101/251 (40%), Gaps = 37/251 (14%)
Query: 573 KLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR 631
+ + F ++ + ++ +G G+ G V+ G+ +K +
Sbjct: 12 ENLYFQGTIDDLFI---------FKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRS 60
Query: 632 IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTS 691
E+ E EI L ++ H N++ + I+ E G L + + G +
Sbjct: 61 QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKA 120
Query: 692 TGGIGNPELHWSRRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILL---DENYEPKL 747
E + + + AL+Y H ++H +LK NIL + K+
Sbjct: 121 L-----SEGYVAELMKQMMN---ALAYFHSQH----VVHKDLKPENILFQDTSPHSPIKI 168
Query: 748 SDYGLAKLLPILDNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804
D+GLA+L + NA G Y+APE+ + ++ KCD++S GV++ L+TG
Sbjct: 169 IDFGLAEL--FKSD---EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGC 222
Query: 805 KPVESPTTNEV 815
P + EV
Sbjct: 223 LPFTGTSLEEV 233
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 4e-15
Identities = 40/167 (23%), Positives = 66/167 (39%), Gaps = 13/167 (7%)
Query: 314 NLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
+ ++ L ++P + D L L+ N + L L L+L
Sbjct: 11 SHLEVNCDKRNL-TALPPDLPKDTTIL---HLSENLLYTFSLATLMPYTRLTQLNLDRAE 66
Query: 373 LRG-EVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGN 431
L +V + L LD+S N L +P + L +LD+ N L +L
Sbjct: 67 LTKLQVDGTLPV---LGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 432 LSNLQVLDLSQNSLSGSIPSSL-GNLRNLTHFNLSSNNLSGTIPSTI 477
L LQ L L N L ++P L L +L++NNL+ +P+ +
Sbjct: 123 LGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT-ELPAGL 167
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 8e-14
Identities = 45/164 (27%), Positives = 71/164 (43%), Gaps = 10/164 (6%)
Query: 314 NLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
+ +L L N + + RL +++L + + G++ +L LDL +
Sbjct: 32 DTTILHLSENL-LYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQ 88
Query: 373 LRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSL-GN 431
L+ +P L +LDVS N L L + L+ L L N L + PP L
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTP 146
Query: 432 LSNLQVLDLSQNSLSGSIPSSL-GNLRNLTHFNLSSNNLSGTIP 474
L+ L L+ N+L+ +P+ L L NL L N+L TIP
Sbjct: 147 TPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIP 188
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 4e-07
Identities = 45/221 (20%), Positives = 71/221 (32%), Gaps = 34/221 (15%)
Query: 128 SSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPL 187
L+ ++P + + +L LS N A + ++L L+ + +
Sbjct: 18 DKRNLT-ALPPDL--PKDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELT-KLQV 72
Query: 188 SIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLD 247
L D S N L LP +P L + V N LT ++ L
Sbjct: 73 D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY 130
Query: 248 LSSNLFIGLAPFGVL-GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIP 306
L N L P G+L + ++++N E+P +G+
Sbjct: 131 LKGNELKTL-PPGLLTPTPKLEKLSLANNNLT-ELPA---------------GLLNGL-- 171
Query: 307 LSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANN 347
NL L L N L +IP G L L N
Sbjct: 172 ------ENLDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 6e-05
Identities = 40/181 (22%), Positives = 66/181 (36%), Gaps = 9/181 (4%)
Query: 97 SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSY 156
+L L N L ++N+ L+ + G LP + LDLS N
Sbjct: 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQL 89
Query: 157 SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQIC- 214
+P L + + +S N L+ S+PL L+ N L LP +
Sbjct: 90 Q-SLP-LLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLT 145
Query: 215 NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSH 274
P L+ +S+ N LT + +++ L L N + P G G + + +
Sbjct: 146 PTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPFAFLHG 204
Query: 275 N 275
N
Sbjct: 205 N 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 41/179 (22%), Positives = 71/179 (39%), Gaps = 9/179 (5%)
Query: 75 DRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSG 134
+ L L L L L L T L + L +++S N L
Sbjct: 34 TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSHNQLQ- 90
Query: 135 SIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSI-ANCT 193
S+P LP + +LD+S N + +P + + + + L N L ++P +
Sbjct: 91 SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 194 YLEGFDFSFNNLSGELPSQIC-NIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSN 251
LE + NNL+ ELP+ + + LD + ++ N+L T+ + F + L N
Sbjct: 149 KLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 5e-15
Identities = 53/246 (21%), Positives = 93/246 (37%), Gaps = 38/246 (15%)
Query: 577 FSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRN 634
F + +Y + +G GS G V + AVK + + ++
Sbjct: 16 FQGTFAERYN---------IVCM--LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGG 694
E+ L + H N++ S+ I+ E G L+D +
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEI-------IKRK- 116
Query: 695 IGNPELHWSRR--FHIALGTARALSYLHHDCKPPILHLNLKSTNILL---DENYEPKLSD 749
+S I ++Y+H I+H +LK NILL +++ + K+ D
Sbjct: 117 ------RFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIID 167
Query: 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES 809
+GL+ N + Y+APE+ + +KCDV+S GVIL L++G P
Sbjct: 168 FGLSTC--FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYG 224
Query: 810 PTTNEV 815
++
Sbjct: 225 KNEYDI 230
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 77.6 bits (191), Expect = 7e-15
Identities = 55/234 (23%), Positives = 92/234 (39%), Gaps = 39/234 (16%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660
+G G+ G V+R + G + A K + T ++E EI +S +RH LV +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMT-PHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 661 WSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR----A 715
M +I EF+ G L++ + + S A+ R
Sbjct: 224 EDDNEMVMIY-EFMSGGELFEK-------------VADEHNKMSED--EAVEYMRQVCKG 267
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEP--KLSDYGLAKLLPILDNYGLTKFHNAVG- 772
L ++H + +HL+LK NI+ KL D+GL L G
Sbjct: 268 LCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-----PKQSVKVTTGT 319
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV---VVLCEY 821
+ APE+A+ + D++S GV+ L++G P +E V C++
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDW 373
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 8e-15
Identities = 67/285 (23%), Positives = 119/285 (41%), Gaps = 44/285 (15%)
Query: 547 RRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGS 606
+ KR V P D ++ K ++ S Y + K ++GGG
Sbjct: 55 KSKRTSALAVDIPAPPAPFDHRIVTAK----QGAVNSFYT---------VSKTEILGGGR 101
Query: 607 IGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST- 664
G V++ G+ +A K ++T ++++EE + EI ++ + H NL+ + S
Sbjct: 102 FGQVHKCEETATGLKLAAKIIKT-RGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND 160
Query: 665 MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCK 724
+ L++ E+V G L+D + +Y T EL + ++H +
Sbjct: 161 IVLVM-EYVDGGELFDRIIDESYNLT--------ELDTILFMKQICE---GIRHMH---Q 205
Query: 725 PPILHLNLKSTNILL--DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPELA 779
ILHL+LK NIL + + K+ D+GLA+ K G ++APE+
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK-----PREKLKVNFGTPEFLAPEVV 260
Query: 780 QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV---VVLCEY 821
+S D++S GVI L++G P E ++ C +
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 9e-15
Identities = 55/289 (19%), Positives = 102/289 (35%), Gaps = 47/289 (16%)
Query: 546 RRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSK-SLPSKYEDWEAGTKALLDKECLIGG 604
+ R + D + + + + V + S+ Y+ + +E +G
Sbjct: 13 KVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYD---------ILEE--LGS 61
Query: 605 GSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS 663
G+ G V+R G K + T ++ + EI ++ + H L+ +
Sbjct: 62 GAFGVVHRCVEKATGRVFVAKFINT-PYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK 120
Query: 664 T-MQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH 720
M LIL EF+ G L+D + E A L ++H
Sbjct: 121 YEMVLIL-EFLSGGELFDRIAAEDYKMS----------EAEVINYMRQACE---GLKHMH 166
Query: 721 HDCKPPILHLNLKSTNILL--DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVA 775
+ I+HL++K NI+ + K+ D+GLA L + A
Sbjct: 167 ---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN-----PDEIVKVTTATAEFAA 218
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV---VVLCEY 821
PE+ + D+++ GV+ L++G P E V C++
Sbjct: 219 PEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW 267
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 2e-14
Identities = 42/231 (18%), Positives = 80/231 (34%), Gaps = 34/231 (14%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
S + L L + L NIS VS + ++ F
Sbjct: 32 STQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLES--------HSFY------ 77
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPN--LG 358
N + +++ R + I +L L + + N + + P +
Sbjct: 78 ---------NLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVY 127
Query: 359 SIELLEVLDLHNLNLRGEVPDDI--SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDL 416
S ++ +L++ + +P + C L L + N + +N T L + L
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYL 186
Query: 417 HQNHLNGSTPPSL--GNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNL 464
++N G S +LD+SQ S++ ++PS L +L+ L N
Sbjct: 187 NKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 32/176 (18%), Positives = 68/176 (38%), Gaps = 11/176 (6%)
Query: 310 TNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLD 367
+N N+ + + + + + + +L ++ I + N I P+ L + LL+ L
Sbjct: 52 SNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLG 111
Query: 368 LHNLNLRGEVPDD--ISNCRFLLLLDVSGNALGGDIP-QTLYNMT-YLKILDLHQNHLNG 423
+ N L+ PD + + +L+++ N IP + L L+ N
Sbjct: 112 IFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT- 169
Query: 424 STPPSLGNLSNLQVLDLSQNSLSGSIPSSL--GNLRNLTHFNLSSNNLSGTIPSTI 477
S N + L + L++N I G + ++S +++ +PS
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 6e-08
Identities = 23/127 (18%), Positives = 48/127 (37%), Gaps = 11/127 (8%)
Query: 353 IPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIP-QTLYNMTYL 411
+PP+ + L L +LR SN + + VS + + + YN++ +
Sbjct: 29 LPPST------QTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKV 82
Query: 412 KILDLHQN-HLNGSTPPSLGNLSNLQVLDLSQNSLSGSIP--SSLGNLRNLTHFNLSSNN 468
+++ +L P +L L L+ L + L P + + + ++ N
Sbjct: 83 THIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNP 141
Query: 469 LSGTIPS 475
+IP
Sbjct: 142 YMTSIPV 148
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 19/93 (20%), Positives = 32/93 (34%), Gaps = 5/93 (5%)
Query: 384 CRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQN 443
C V+ + IP + L L + HL + NL N+ + +S +
Sbjct: 10 CHQEEDFRVTCKDIQ-RIPSLPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 444 SLSGSIPS-SLGNLRNLTHFNLSSNNLSGTIPS 475
+ S S NL +TH + + I
Sbjct: 66 VTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDP 98
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 7e-05
Identities = 34/284 (11%), Positives = 73/284 (25%), Gaps = 77/284 (27%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFI-GDLPNIRLLDL 151
S S + L L ++ + + +I VS + + +L + +++
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPS 211
I K KF+ + + L P D +
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP------------DLTK--------- 125
Query: 212 QICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVL-GLKNISYF 270
L+++ N ++ P GL N +
Sbjct: 126 -------------------------VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLT 160
Query: 271 -NVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSI 329
+ +NGF + F+G L + L N+ + I
Sbjct: 161 LKLYNNGFT-SVQG---------------YAFNGT---------KLDAVYLNKNKYLTVI 195
Query: 330 PTGI-TDLRRLLKI-SLANNSIGGIIPPNLGSIELLEVLDLHNL 371
+ + ++ S+ + L ++ L + L
Sbjct: 196 DKDAFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELIARNTWTL 239
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 52/220 (23%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVK-----KLETLGRIRNQEEFELEIGRLSNIRHF--N 652
L+G G GSVY + +A+K ++ G + N +E+ L +
Sbjct: 50 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 109
Query: 653 LVAFQGYYWSSTMQLILSEFV-PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
++ ++ +++ E P +L+D + T G + +R F +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFI-------TERGALQEEL---ARSFFWQV- 158
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENY-EPKLSDYGLAKLLPILDNYGLTKFHNA 770
A+ + H+ +LH ++K NIL+D N E KL D+G LL D T + +
Sbjct: 159 -LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLK--D----TVYTDF 208
Query: 771 VG---YVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKP 806
G Y PE + R V+S G++L ++V G P
Sbjct: 209 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 4e-14
Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 37/225 (16%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IG G+ G +AVK +E G E + EI ++RH N+V F+
Sbjct: 27 DIGSGNFGVARLMRDKLTKELVAVKYIER-GAA-IDENVQREIINHRSLRHPNIVRFKEV 84
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH---IALGTARAL 716
+ T I+ E+ G LY+ + + G E +R F ++ +
Sbjct: 85 ILTPTHLAIIMEYASGGELYERI-------CNAGRFSEDE---ARFFFQQLLS-----GV 129
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEP--KLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
SY H I H +LK N LLD + P K+ D+G +K +L + + + VG
Sbjct: 130 SYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHS----QPKSTVGTP 181
Query: 773 -YVAPELAQSLRLSD--KCDVYSFGVILLELVTGRKPVESPTTNE 814
Y+APE+ + D DV+S GV L ++ G P E P
Sbjct: 182 AYIAPEVLLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 4e-14
Identities = 56/217 (25%), Positives = 93/217 (42%), Gaps = 22/217 (10%)
Query: 602 IGGGSIGSVYRAS-FEGGVSIAVKKLE-TLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IG G+ V A G +A+K ++ T + ++ E+ + + H N+V
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ ++ E+ G ++D L + G + E +R + A+ Y
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYL-------VAHGRMKEKE---ARSKFRQI--VSAVQYC 130
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELA 779
H I+H +LK+ N+LLD + K++D+G + L F A Y APEL
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAPELF 185
Query: 780 QSLRLSD--KCDVYSFGVILLELVTGRKPVESPTTNE 814
Q + D + DV+S GVIL LV+G P + E
Sbjct: 186 QG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 5e-14
Identities = 54/221 (24%), Positives = 93/221 (42%), Gaps = 27/221 (12%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G G+ G V G +AVK L + + + + + EI L RH +++
Sbjct: 18 TLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY 77
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ T ++ E+V G L+D + G + E +RR + A+
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYI-------CKHGRVEEME---ARRLFQQI--LSAVD 125
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
Y H ++H +LK N+LLD + K++D+GL+ ++ D L + G Y
Sbjct: 126 YCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFL---RTSCGSPNYA 177
Query: 775 APELAQSLR-LSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
APE+ + D++S GVIL L+ G P +
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT 218
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 48/218 (22%), Positives = 86/218 (39%), Gaps = 31/218 (14%)
Query: 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLV 654
L+ IG GS G V A + A KK+ + + + F+ EI + ++ H N++
Sbjct: 13 LENT--IGRGSWGEVKIAVQKGTRIRRAAKKIPK-YFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNL--HGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ +T ++ E G L++ + + E +R L
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKR-VFR----------ESDAARIMKDVLS- 117
Query: 713 ARALSYLH-HDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFH 768
A++Y H + + H +LK N L + KL D+GLA +
Sbjct: 118 --AVAYCHKLN----VAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR--FKPGKMMRTKV 169
Query: 769 NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
YV+P++ + +CD +S GV++ L+ G P
Sbjct: 170 GTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPP 206
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 48/218 (22%), Positives = 81/218 (37%), Gaps = 33/218 (15%)
Query: 602 IGGGSIGSVYRAS-FEGGVSIAVK-------KLETLGRIRNQEEFELEIGRLSNIRHFNL 653
+G G+ G V+ A E + VK + + LEI LS + H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 654 VA-FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ + QL++ + +L+ + + P + L
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFI-------DRHPRLDEPL---ASYIFRQL-- 139
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
A+ YL I+H ++K NI++ E++ KL D+G A L F+ G
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-----LFYTFCG 191
Query: 773 ---YVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKP 806
Y APE+ + +++S GV L LV P
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 2e-13
Identities = 62/225 (27%), Positives = 94/225 (41%), Gaps = 37/225 (16%)
Query: 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVK-----KLETLGRIRNQEEFELEIGRLSNIR 649
+ +E +G G V + G A K +L + R ++EE E E+ L IR
Sbjct: 9 MGEE--LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 650 HFNLVAFQGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI 708
H N++ + + T + LIL E V G L+D L E ++
Sbjct: 67 HPNIITLHDIFENKTDVVLIL-ELVSGGELFDFLAEKESL---------TEDEATQFLKQ 116
Query: 709 ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP----KLSDYGLAKLLPILDNYGL 764
L + YLH I H +LK NI+L + P KL D+G+A +
Sbjct: 117 ILD---GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIE-----AG 165
Query: 765 TKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+F N G +VAPE+ L + D++S GVI L++G P
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 39/164 (23%), Positives = 63/164 (38%), Gaps = 11/164 (6%)
Query: 313 RNLKVLDLGFNRLIGSIPTGIT--DLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHN 370
+LDL N + + T L L + L++N + I + L LDL +
Sbjct: 39 SYTALLDLSHNN-LSRLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSS 97
Query: 371 LNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPP-- 427
+L + + + S+ + L +L + N + +M L+ L L QN ++ P
Sbjct: 98 NHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQIS-RFPVEL 155
Query: 428 --SLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLS-SNN 468
L L +LDLS N L + L L L NN
Sbjct: 156 IKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNN 199
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 34/181 (18%), Positives = 59/181 (32%), Gaps = 31/181 (17%)
Query: 310 TNCR-NLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLD 367
NC +L +L ++P + + L L++N++ +
Sbjct: 14 ANCLCASNILSCSKQQLP-NVPQSLPSYTALL---DLSHNNLS-RLRAEW---------T 59
Query: 368 LHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPP 427
L L L +S N L + + L+ LDL NHL+
Sbjct: 60 PTRL-------------TNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHTLDEF 106
Query: 428 SLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFL 486
+L L+VL L N + + + ++ L LS N +S I+ L
Sbjct: 107 LFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKL 165
Query: 487 N 487
Sbjct: 166 M 166
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 50.2 bits (120), Expect = 2e-06
Identities = 43/213 (20%), Positives = 78/213 (36%), Gaps = 42/213 (19%)
Query: 168 CYKTKFVSLSHNNLSGSIPLSI-ANCTYLEGFDFSFNNLSGELPSQI--CNIPVLDFISV 224
C +S S L ++P S+ + L D S NNLS L ++ + L + +
Sbjct: 18 CASN-ILSCSKQQLP-NVPQSLPSYTALL---DLSHNNLS-RLRAEWTPTRLTNLHSLLL 71
Query: 225 RGNALTGTVEEQ-FSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPE 283
N L + + F +++ LDLSSN L F L+ + + +N +
Sbjct: 72 SHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDR 129
Query: 284 VGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI----TDLRRL 339
F+ + L+ L L N++ P + L +L
Sbjct: 130 --------NAFE---------------DMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKL 165
Query: 340 LKISLANNSIGGIIPPNLGSIELL--EVLDLHN 370
+ + L++N + + +L + L LHN
Sbjct: 166 MLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 30/141 (21%), Positives = 53/141 (37%), Gaps = 10/141 (7%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSGSIPEFI-GDLPNIRL 148
+ L +L L L N + E + + L +++SSN L ++ EF+ DL + +
Sbjct: 59 TPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEV 116
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIP----LSIANCTYLEGFDFSFNN 204
L L N + F+ + + + LS N +S P L D S N
Sbjct: 117 LLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNK 174
Query: 205 LSGELPSQICNIPVLDFISVR 225
L + + +P +
Sbjct: 175 LKKLPLTDLQKLPAWVKNGLY 195
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 2e-13
Identities = 64/245 (26%), Positives = 97/245 (39%), Gaps = 54/245 (22%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVK-----KLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G V + G+ A K + R ++EE E E+ L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 656 FQGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHI----AL 710
Y + T + LIL E V G L+D L +++ + A
Sbjct: 80 LHDVYENRTDVVLIL-ELVSGGELFDFL--------------------AQKESLSEEEAT 118
Query: 711 GTAR----ALSYLHHDCKPPILHLNLKSTNILLDENYEP----KLSDYGLAKLLPILDNY 762
+ ++YLH I H +LK NI+L + P KL D+GLA I D
Sbjct: 119 SFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE--IEDG- 172
Query: 763 GLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV---V 816
+F N G +VAPE+ L + D++S GVI L++G P T E +
Sbjct: 173 --VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 817 VLCEY 821
Y
Sbjct: 231 TSVSY 235
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 73.3 bits (179), Expect = 3e-13
Identities = 70/507 (13%), Positives = 147/507 (28%), Gaps = 132/507 (26%)
Query: 39 KGNIT-DDPHNKLASWVSSGNPCENF---------KGVF----CNPDGFVDRI---VLWN 81
K N++ P+ KL + P +N K C ++ + W
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFW- 186
Query: 82 FSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIG 141
+L SP L +L + N I + +++ + +
Sbjct: 187 LNLKNCNSPETV----LEMLQKLLYQIDPNWTSRSDHSSN---IKLRIHSIQAELRRLLK 239
Query: 142 DLPNIR-LLDLSRNSYSGEIPFALFKY-CYK----TKFVSLSHNNLSGSIPLSIANCTYL 195
P LL L N + + + F C K T+F ++ + LS + I+ +
Sbjct: 240 SKPYENCLLVL-LNVQNAKA-WNAFNLSC-KILLTTRFKQVT-DFLSAATTTHISLDHHS 295
Query: 196 EGFD-------FS--FNNLSGELPSQICNI-PVL---------DFIS-------VRGNAL 229
+ +LP ++ P D ++ V + L
Sbjct: 296 MTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355
Query: 230 TGTVEEQFSQCQSIKNLD--LSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGIC 287
T +E S+ L+ +F L+ F + IP
Sbjct: 356 TTIIE------SSLNVLEPAEYRKMFDRLSVF----PPSA------------HIPT---- 389
Query: 288 GEGMQVFDASWNEFDGVIPLSITN-CRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLAN 346
+ W + + + N +++ SIP + LK+ L N
Sbjct: 390 ----ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIP----SIYLELKVKLEN 441
Query: 347 -----NSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL---LDVSGNALG 398
SI + + + D +L +P + + + L +
Sbjct: 442 EYALHRSI-------VDHYNIPKTFDSDDL-----IPPYLDQYFYSHIGHHLKNIEHPER 489
Query: 399 GDIPQTLYNMTYLKILDLH--QNHLNGSTPP--SLGNLSN-LQVLDLSQNSLSGSIPSSL 453
+ + ++ LD + + + + G++ N LQ L + + + P
Sbjct: 490 MTLFRMVF-------LDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYE 542
Query: 454 GNLRNLTHF--NLSSNNLSGTIPSTIQ 478
+ + F + N + ++
Sbjct: 543 RLVNAILDFLPKIEENLICSKYTDLLR 569
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 6e-10
Identities = 101/724 (13%), Positives = 204/724 (28%), Gaps = 271/724 (37%)
Query: 115 EYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFV 174
E E Q +K + LS F+ + + D+ ++ S E + +
Sbjct: 10 ETGEHQYQYK-----DILSVFEDAFVDNFDCKDVQDMPKSILSKE----------EIDHI 54
Query: 175 SLSHNNLSGSIPLSIANCTY----LEGF-------DFSFNNLSGELPSQI---CNIPVLD 220
+S + +SG++ L + ++ F ++ F L S I P +
Sbjct: 55 IMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKF------LMSPIKTEQRQPSMM 108
Query: 221 ---FISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGF 277
+I R + L + F++ ++ L L L L L+
Sbjct: 109 TRMYIEQR-DRLYNDNQV-FAK-YNVSRLQPYLKLRQAL-----LELR------------ 148
Query: 278 HGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRL----IGSIPTGI 333
P + +G+ +W +++ C + KV ++ + + +
Sbjct: 149 ----PAKNVLIDGVLGSGKTW--------VALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 334 TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVS 393
T L L K+ I PN S H+ N++ + + R LL
Sbjct: 197 TVLEMLQKLLY-------QIDPNWTS------RSDHSSNIKLRIHSIQAELRRLLKSKPY 243
Query: 394 GNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSL 453
N L L +L N+ N + +
Sbjct: 244 ENCL-------------L-VLL---------------NVQNAKAWN-------------- 260
Query: 454 GNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLETSCSGRGKGMTPTSKN 513
FNLS L T + V+ FL+ L+ +TP
Sbjct: 261 -------AFNLSCKILL-----TTRFKQVTDFLSAATTTHISLD----HHSMTLTP---- 300
Query: 514 PKVLSVSAIVAIVAAALILAGVCVVTIMNIKARRRKRDDETMVVEGTPLGSTDSNVIIGK 573
+V S +L ++ + + R+ V+ P + II +
Sbjct: 301 DEVKS------------LLL-----KYLDCRPQDLPRE----VLTTNPRRLS----IIAE 335
Query: 574 LVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIR 633
+ + + +++W+ DK + ++ +S
Sbjct: 336 SI---RDGLATWDNWK---HVNCDK--------LTTIIESSLN----------------- 364
Query: 634 NQEEFELEIGRLSNIRHF-NLVAFQ----------GYYW----SSTMQLILSEFVPKGNL 678
E E + F L F W S + +++++ +
Sbjct: 365 VLEPAEYR-------KMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLV 417
Query: 679 YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNIL 738
T + + + L LH +
Sbjct: 418 EKQ----PKESTIS-------IP-----------SIYLELKVKLENEYALH------RSI 449
Query: 739 LDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY--VAPELAQSLRLSDKCDVYSFGVI 796
+D +Y + + P LD Y F++ +G+ E + + L F ++
Sbjct: 450 VD-HYNIPKTFDSDDLIPPYLDQY----FYSHIGHHLKNIEHPERMTL--------FRMV 496
Query: 797 LLEL 800
L+
Sbjct: 497 FLDF 500
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 3e-13
Identities = 35/162 (21%), Positives = 62/162 (38%), Gaps = 13/162 (8%)
Query: 309 ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDL 368
N +LG + + +L + + N++I + + L+ L L
Sbjct: 15 DPGLANAVKQNLGKQSV--TDLVSQKELSGVQNFNGDNSNIQSL--AGMQFFTNLKELHL 70
Query: 369 HNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPS 428
+ + + + L L V+ N L ++ + + L L L N L S
Sbjct: 71 SHNQI--SDLSPLKDLTKLEELSVNRNRLK-NLN-GIPSAC-LSRLFLDNNEL--RDTDS 123
Query: 429 LGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
L +L NL++L + N L SI LG L L +L N ++
Sbjct: 124 LIHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEIT 163
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 44/234 (18%), Positives = 81/234 (34%), Gaps = 23/234 (9%)
Query: 259 FGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVL 318
F GL N N+ ++ G+Q F+ + + + NLK L
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVSQKEL-SGVQNFNGDNSNIQSLAGMQ--FFTNLKEL 68
Query: 319 DLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRG--- 375
L N+ I + + + DL +L ++S+ N + ++ + L L L
Sbjct: 69 HLSHNQ-ISDL-SPLKDLTKLEELSVNRNRLK--------NLNGIPSACLSRLFLDNNEL 118
Query: 376 EVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNL 435
D + + + L +L + N L I L ++ L++LDLH N + + L L +
Sbjct: 119 RDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEI--TNTGGLTRLKKV 174
Query: 436 QVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNT 489
+DL+ L + + P I + G
Sbjct: 175 NWIDLTGQKCVNEPVKYQPELYITN--TVKDPDGRWISPYYISNGGSYVDGCVL 226
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 24/146 (16%), Positives = 47/146 (32%), Gaps = 27/146 (18%)
Query: 344 LANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQ 403
I + P + +L ++ V + + + + +
Sbjct: 4 QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SL-A 57
Query: 404 TLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSG---------------- 447
+ T LK L L N + S L +L+ L+ L +++N L
Sbjct: 58 GMQFFTNLKELHLSHNQI--SDLSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFLDN 115
Query: 448 ---SIPSSLGNLRNLTHFNLSSNNLS 470
SL +L+NL ++ +N L
Sbjct: 116 NELRDTDSLIHLKNLEILSIRNNKLK 141
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-07
Identities = 42/246 (17%), Positives = 81/246 (32%), Gaps = 42/246 (17%)
Query: 138 EFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEG 197
L N +L + S + + + + ++N+ S+ + T L+
Sbjct: 13 FPDPGLANAVKQNLGKQSVTDLVSQKELS---GVQNFNGDNSNIQ-SLA-GMQFFTNLKE 67
Query: 198 FDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLA 257
S N +S +L S + ++ L+ +SV N L + L L +N
Sbjct: 68 LHLSHNQIS-DL-SPLKDLTKLEELSVNRNRLK---NLNGIPSACLSRLFLDNNELRDTD 122
Query: 258 PFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKV 317
LKN+ ++ +N ++ + L+V
Sbjct: 123 SLI--HLKNLEILSIRNN----------------KLKSIV----------MLGFLSKLEV 154
Query: 318 LDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEV 377
LDL N I + G+T L+++ I L + + + + + R
Sbjct: 155 LDLHGNE-ITNT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYIT--NTVKDPDGRWIS 210
Query: 378 PDDISN 383
P ISN
Sbjct: 211 PYYISN 216
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 3e-13
Identities = 49/238 (20%), Positives = 91/238 (38%), Gaps = 46/238 (19%)
Query: 579 KSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEE 637
K L KY + ++ +G G G V+R + K ++ + +Q
Sbjct: 1 KELYEKYM---------IAED--LGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVL 47
Query: 638 FELEIGRLSNIRHFNLVAFQGYYWSST-MQLILSEFVPKGNLYDNL--HGVNYPGTSTGG 694
+ EI L+ RH N++ + S + +I EF+ ++++ +
Sbjct: 48 VKKEISILNIARHRNILHLHESFESMEELVMIF-EFISGLDIFERINTSAFELN------ 100
Query: 695 IGNPELHWSRRFHIALGTARALSYLH-HDCKPPILHLNLKSTNILL--DENYEPKLSDYG 751
E H AL +LH H+ I H +++ NI+ + K+ ++G
Sbjct: 101 ----EREIVSYVHQVCE---ALQFLHSHN----IGHFDIRPENIIYQTRRSSTIKIIEFG 149
Query: 752 LAKLLPILDNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
A+ L F Y APE+ Q +S D++S G ++ L++G P
Sbjct: 150 QARQLK-----PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 5e-13
Identities = 45/219 (20%), Positives = 87/219 (39%), Gaps = 32/219 (14%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVK-------KLETLGRIRNQEEFELEIGRLSNIRHFNL 653
+G G+ G V A + +A++ + + E EI L + H +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+ + ++ + ++L E + G L+D + + + + +
Sbjct: 203 IKIKNFFDAEDYYIVL-ELMEGGELFDKV-------VGNKRLKEAT---CKLYFYQM--L 249
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEP---KLSDYGLAKLLPILDNYGLTKFHNA 770
A+ YLH + I+H +LK N+LL E K++D+G +K+ + + +
Sbjct: 250 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETSLMRTLCGT 304
Query: 771 VGYVAPE-LAQSLRL--SDKCDVYSFGVILLELVTGRKP 806
Y+APE L + D +S GVIL ++G P
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 69.9 bits (172), Expect = 5e-13
Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 35/207 (16%)
Query: 601 LIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
++G G+ V+ G A+K ++ E EI L I+H N+V +
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKS-PAFRDSSLENEIAVLKKIKHENIVTLEDI 74
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTARALS 717
Y S+T ++ + V G L+D + G ++ + + A+
Sbjct: 75 YESTTHYYLVMQLVSGGELFDRI-------LERG-------VYTEKDASLVIQQVLSAVK 120
Query: 718 YLH-HDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
YLH + I+H +LK N+L +EN + ++D+GL+K + N A G
Sbjct: 121 YLHENG----IVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQN---GIMSTACGT 170
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVIL 797
YVAPE+ S D +S GVI
Sbjct: 171 PGYVAPEVLAQKPYSKAVDCWSIGVIT 197
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 5e-13
Identities = 63/237 (26%), Positives = 94/237 (39%), Gaps = 38/237 (16%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVK-----KLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G V + G+ A K + R +EE E E+ L + H N++
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 656 FQGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
Y + T + LIL E V G L+D L E + L
Sbjct: 80 LHDVYENRTDVVLIL-ELVSGGELFDFLAQKESL---------SEEEATSFIKQILD--- 126
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEP----KLSDYGLAKLLPILDNYGLTKFHNA 770
++YLH I H +LK NI+L + P KL D+GLA +++ +F N
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDG--VEFKNI 178
Query: 771 VG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV---VVLCEY 821
G +VAPE+ L + D++S GVI L++G P T E + Y
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSY 235
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 6e-13
Identities = 57/223 (25%), Positives = 89/223 (39%), Gaps = 43/223 (19%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVK-----KLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G G V + G+ A K + ++ R ++E+ E E+ L I+H N++
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 656 FQGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
Y + T + LIL E V G L+D L + A +
Sbjct: 79 LHEVYENKTDVILIL-ELVAGGELFDFL-------AEKE-------SLTEE--EATEFLK 121
Query: 715 ----ALSYLHHDCKPPILHLNLKSTNILL----DENYEPKLSDYGLAKLLPILDNYGLTK 766
+ YLH I H +LK NI+L K+ D+GLA + +
Sbjct: 122 QILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID-----FGNE 173
Query: 767 FHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
F N G +VAPE+ L + D++S GVI L++G P
Sbjct: 174 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 71.0 bits (174), Expect = 6e-13
Identities = 53/224 (23%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G G+ G V G +AVK L + + + + EI L RH +++
Sbjct: 23 TLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLY 82
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFH---IALGTAR 714
+ + ++ E+V G L+D + G + E SRR ++
Sbjct: 83 QVISTPSDIFMVMEYVSGGELFDYI-------CKNGRLDEKE---SRRLFQQILS----- 127
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
+ Y H ++H +LK N+LLD + K++D+GL+ ++ D L + G
Sbjct: 128 GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFL---RTSCGSP 179
Query: 773 -YVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
Y APE+ + D++S GVIL L+ G P +
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT 223
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 2e-12
Identities = 57/266 (21%), Positives = 92/266 (34%), Gaps = 52/266 (19%)
Query: 559 GTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EG 617
G+P S I+ YE L + IG G V R E
Sbjct: 1 GSPGISGGGGGILDM-ADDDVLFEDVYE---------LCEV--IGKGPFSVVRRCINRET 48
Query: 618 GVSIAVK----KLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673
G AVK T + E+ + E ++H ++V Y S M ++ EF+
Sbjct: 49 GQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFM 108
Query: 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF------HIALGTARALSYLH-HDCKPP 726
+L + + H AL Y H ++
Sbjct: 109 DGADLCFEI-------VKRA-------DAGFVYSEAVASHYMRQILEALRYCHDNN---- 150
Query: 727 ILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPELAQ 780
I+H ++K +LL + + KL +G+A L ++ VG ++APE+ +
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG--ESG--LVAGGRVGTPHFMAPEVVK 206
Query: 781 SLRLSDKCDVYSFGVILLELVTGRKP 806
DV+ GVIL L++G P
Sbjct: 207 REPYGKPVDVWGCGVILFILLSGCLP 232
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 2e-12
Identities = 52/219 (23%), Positives = 96/219 (43%), Gaps = 43/219 (19%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEL-EIGRLSNIRHFNLVAFQGYY 660
IG GS G V++A +A+KK + + F+ E+ + ++H N+V + ++
Sbjct: 48 IGNGSFGVVFQAKLVESDEVAIKK------VLQDKRFKNRELQIMRIVKHPNVVDLKAFF 101
Query: 661 WSSTMQ-------LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+S+ + L+L E+VP + ++ + L + +
Sbjct: 102 YSNGDKKDEVFLNLVL-EYVP-----ETVYRASRHYAKLKQTMPMLLIKLYMYQLL---- 151
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
R+L+Y+H I H ++K N+LLD KL D+G AK+L + V
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN--------VS 200
Query: 773 YV------APEL-AQSLRLSDKCDVYSFGVILLELVTGR 804
Y+ APEL + + D++S G ++ EL+ G+
Sbjct: 201 YICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 47/222 (21%), Positives = 90/222 (40%), Gaps = 37/222 (16%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVK-----KLETLGRIRNQEEFELEIGRLSNIR----H 650
L+G G G+V+ + +A+K ++ + + LE+ L + H
Sbjct: 38 LLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGH 97
Query: 651 FNLVAFQGYYWSSTMQLILSEF-VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
++ ++ + +++ E +P +L+D + T G +G SR F
Sbjct: 98 PGVIRLLDWFETQEGFMLVLERPLPAQDLFDYI-------TEKGPLGEGP---SRCFFGQ 147
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLPILDNYGLTKFH 768
+ A+ + H ++H ++K NIL+D KL D+G LL D +
Sbjct: 148 V--VAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLH--D----EPYT 196
Query: 769 NAVG---YVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKP 806
+ G Y PE + + V+S G++L ++V G P
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 36/236 (15%)
Query: 577 FSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLET-LGRIRN 634
F + +Y + +G GS G V + AVK + + ++
Sbjct: 16 FQGTFAERYN---------IVCM--LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKD 64
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDN-LHGVNYPGTSTG 693
E+ L + H N++ S+ I+ E G L+D + +
Sbjct: 65 TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFS----- 119
Query: 694 GIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILL---DENYEPKLSDY 750
E +R ++Y+H I+H +LK NILL +++ + K+ D+
Sbjct: 120 -----EHDAARIIKQVFS---GITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDF 168
Query: 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
GL+ N + Y+APE+ + +KCDV+S GVIL L++G P
Sbjct: 169 GLSTC--FQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-12
Identities = 56/220 (25%), Positives = 97/220 (44%), Gaps = 44/220 (20%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL-EIGRLSNIRHFNLVAFQGY 659
IG GS G VY+A + G +A+KK + + F+ E+ + + H N+V + +
Sbjct: 62 IGNGSFGVVYQAKLCDSGELVAIKK------VLQDKRFKNRELQIMRKLDHCNIVRLRYF 115
Query: 660 YWSSTMQ-------LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
++SS + L+L ++VP + ++ V + + +
Sbjct: 116 FYSSGEKKDEVYLNLVL-DYVP-----ETVYRVARHYSRAKQTLPVIYVKLYMYQLF--- 166
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
R+L+Y+H I H ++K N+LLD + KL D+G AK L + V
Sbjct: 167 -RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN--------V 214
Query: 772 GYV------APEL-AQSLRLSDKCDVYSFGVILLELVTGR 804
Y+ APEL + + DV+S G +L EL+ G+
Sbjct: 215 SYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 35/152 (23%), Positives = 64/152 (42%), Gaps = 10/152 (6%)
Query: 328 SIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI-SNCR 385
IP + + L L+ N + + + S L+VLDL ++ + D +
Sbjct: 21 KIPDNLPFSTKNL---DLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLS 76
Query: 386 FLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSL 445
L L ++GN + ++ L+ L + +L +G+L L+ L+++ N +
Sbjct: 77 HLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI 136
Query: 446 SGSIPSS--LGNLRNLTHFNLSSNNLSGTIPS 475
S NL NL H +LSSN + +I
Sbjct: 137 Q-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYC 166
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 51/233 (21%), Positives = 89/233 (38%), Gaps = 34/233 (14%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
S KNLDLS N L + + ++S I + +
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIED--------GAYQ------ 73
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSI 360
+ +L L L N + S+ G + L L K+ ++ + +G +
Sbjct: 74 ---------SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 361 ELLEVLDLHNLNLRG-EVPDDISNCRFLLLLDVSGN---ALGGDIPQTLYNMTYLKI-LD 415
+ L+ L++ + ++ ++P+ SN L LD+S N ++ + L+ M L + LD
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
Query: 416 LHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSN 467
L N +N P L+ L L N L S+P L +L L +N
Sbjct: 184 LSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 40/176 (22%), Positives = 63/176 (35%), Gaps = 24/176 (13%)
Query: 314 NLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPP----NLGSIELLEVLDL 368
+ K LDL FN + + + L + L+ I I +L L L L
Sbjct: 29 STKNLDLSFNP-LRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSH---LSTLIL 83
Query: 369 HNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPP 427
++ + S L L L + ++ LK L++ N + +
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLI--QSFK 140
Query: 428 SLG---NLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFN----LSSNNLSGTIPS 475
NL+NL+ LDLS N + SI L L + N LS N ++ I
Sbjct: 141 LPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQP 194
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 5e-07
Identities = 52/232 (22%), Positives = 78/232 (33%), Gaps = 34/232 (14%)
Query: 171 TKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC-NIPVLDFISVRGNAL 229
TK + LS N L S + L+ D S + + ++ L + + GN +
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI 88
Query: 230 TGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGE 289
FS S++ L L F + LK + NV+HN
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ-SFKLPE---- 143
Query: 290 GMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITD-LRRL----LKISL 344
F N NL+ LDL N+ I SI L ++ L + L
Sbjct: 144 ---YFS---------------NLTNLEHLDLSSNK-IQSIYCTDLRVLHQMPLLNLSLDL 184
Query: 345 ANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGN 395
+ N + I P L+ L L L+ VPD I L + + N
Sbjct: 185 SLNPMNF-IQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-04
Identities = 33/169 (19%), Positives = 63/169 (37%), Gaps = 13/169 (7%)
Query: 91 ALSGLKSLRVLTLFGNRFTGNLPQE-YAEMQTLWKINVSSNALSGSIPEFI-GDLPNIRL 148
A L L L L GN +L ++ + +L K+ L+ S+ F G L ++
Sbjct: 71 AYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKE 128
Query: 149 LDLSRNSYSGEIPFA-LFKYCYKTKFVSLSHNNLSGSIPLSI-ANCTYLEGF----DFSF 202
L+++ N F + + LS N + SI + + D S
Sbjct: 129 LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 203 NNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSN 251
N ++ + L +++ N L + F + S++ + L +N
Sbjct: 187 NPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 55/221 (24%), Positives = 97/221 (43%), Gaps = 28/221 (12%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G GS G V A+ ++ +A+K + + L + E EI L +RH +++
Sbjct: 16 TLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLY 75
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ T +++ E+ G L+D + + E RRF + A+
Sbjct: 76 DVITTPTDIVMVIEYA-GGELFDYI-------VEKKRMTEDE---GRRFFQQI--ICAIE 122
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YV 774
Y H I+H +LK N+LLD+N K++D+GL+ ++ D L + G Y
Sbjct: 123 YCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMT--DGNFL---KTSCGSPNYA 174
Query: 775 APELAQSLR-LSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
APE+ + DV+S G++L ++ GR P +
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 4e-12
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 39/226 (17%)
Query: 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIR-NQEEFELEIGRLSNIRHF- 651
L KE +G G V + G A K L+ R + + E EI L +
Sbjct: 32 LTSKE--LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCP 89
Query: 652 NLVAFQGYYWSST-MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
++ Y +++ + LIL E+ G ++ + S +
Sbjct: 90 RVINLHEVYENTSEIILIL-EYAAGGEIFSLC------------LPELAEMVSEN--DVI 134
Query: 711 GTAR----ALSYLHHDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYG 763
+ + YLH + I+HL+LK NILL + K+ D+G+++ + +
Sbjct: 135 RLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI----GHA 187
Query: 764 LTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
+ +G Y+APE+ ++ D+++ G+I L+T P
Sbjct: 188 -CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 65.7 bits (161), Expect = 1e-11
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 45/231 (19%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLET-LGRIRNQ 635
S Y+ + +E +G G+ V R G+ A K + T R+
Sbjct: 1 STKFSDNYD---------VKEE--LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF 49
Query: 636 EEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI 695
++ E E ++H N+V + ++ + V G L++++ +
Sbjct: 50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDI-------VARE-- 100
Query: 696 GNPELHWSRRF--HIALGTARALSYLH-HDCKPPILHLNLKSTNILL---DENYEPKLSD 749
+S H +++Y H + I+H NLK N+LL + KL+D
Sbjct: 101 -----FYSEADASHCIQQILESIAYCHSNG----IVHRNLKPENLLLASKAKGAAVKLAD 151
Query: 750 YGLAKLLPILDNYGLTKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVIL 797
+GLA + D+ +H G Y++PE+ + S D+++ GVIL
Sbjct: 152 FGLAIEVN--DS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 55/250 (22%), Positives = 99/250 (39%), Gaps = 53/250 (21%)
Query: 576 LFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRAS-FEGGVSIAVK-------KLE 627
++ K+L +Y + K +G G+ G V A + +A+K +
Sbjct: 3 VYPKALRDEYI---------MSKT--LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIG 51
Query: 628 TLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNL--HGV 685
+ E EI L + H ++ + ++ + ++L E + G L+D + +
Sbjct: 52 SAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVL-ELMEGGELFDKVVGNK- 109
Query: 686 NYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILL---DEN 742
E F+ L A+ YLH + I+H +LK N+LL +E+
Sbjct: 110 RLK----------EATCKLYFYQMLL---AVQYLHENG---IIHRDLKPENVLLSSQEED 153
Query: 743 YEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAPE-LAQSLRL--SDKCDVYSFGVI 796
K++D+G +K+L + G Y+APE L + D +S GVI
Sbjct: 154 CLIKITDFGHSKILG-----ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVI 208
Query: 797 LLELVTGRKP 806
L ++G P
Sbjct: 209 LFICLSGYPP 218
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 50/217 (23%), Positives = 82/217 (37%), Gaps = 43/217 (19%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVK-------KLETLGRIRNQEE-FELEIGRLSNI-RHF 651
+G G V R AVK + ++ E E+ L + H
Sbjct: 25 LGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHP 84
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRR--FHIA 709
N++ + Y ++T ++ + + KG L+D L T S + I
Sbjct: 85 NIIQLKDTYETNTFFFLVFDLMKKGELFDYL-------TEKV-------TLSEKETRKIM 130
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN 769
+ LH I+H +LK NILLD++ KL+D+G + L K
Sbjct: 131 RALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLD-----PGEKLRE 182
Query: 770 AVG---YVAPE-LAQSLRLSDK-----CDVYSFGVIL 797
G Y+APE + S+ + D++S GVI+
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 53/251 (21%), Positives = 91/251 (36%), Gaps = 60/251 (23%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL------------------- 640
IG GS G V A + A+K L ++ Q F
Sbjct: 20 EIGKGSYGVVKLAYNENDNTYYAMKVLSK-KKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78
Query: 641 -------EIGRLSNIRHFNLVA-FQGYYWSSTMQLIL-SEFVPKGNLYDNLHGVNYPGTS 691
EI L + H N+V + + L + E V +G + + P +
Sbjct: 79 PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME------VP--T 130
Query: 692 TGGIGNPELHWSRRFH--IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749
+ + +R + + G + YLH+ I+H ++K +N+L+ E+ K++D
Sbjct: 131 LKPLSEDQ---ARFYFQDLIKG----IEYLHYQK---IIHRDIKPSNLLVGEDGHIKIAD 180
Query: 750 YGLAKLLPILDNYGLTKFHNAVG---YVAPELAQSLRLS---DKCDVYSFGVILLELVTG 803
+G++ + L N VG ++APE R DV++ GV L V G
Sbjct: 181 FGVSNEF--KGSDALL--SNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG 236
Query: 804 RKPVESPTTNE 814
+ P
Sbjct: 237 QCPFMDERIMC 247
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 2e-11
Identities = 48/207 (23%), Positives = 88/207 (42%), Gaps = 36/207 (17%)
Query: 601 LIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ VYR +G A+K L+ + +++ EIG L + H N++ +
Sbjct: 60 ELGRGATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTARALS 717
+ + T ++ E V G L+D + G ++S R A++
Sbjct: 117 FETPTEISLVLELVTGGELFDRI-------VEKG-------YYSERDAADAVKQILEAVA 162
Query: 718 YLH-HDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
YLH + I+H +LK N+L + K++D+GL+K++ G
Sbjct: 163 YLHENG----IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE-----HQVLMKTVCGT 213
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVIL 797
Y APE+ + + D++S G+I
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 2e-11
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 12/105 (11%)
Query: 715 ALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK-FHNAVG 772
AL YLH I+H +LK NILL+E+ +++D+G AK+L F VG
Sbjct: 142 ALEYLHGKG----IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF---VG 194
Query: 773 ---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
YV+PEL D+++ G I+ +LV G P +
Sbjct: 195 TAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-11
Identities = 42/207 (20%), Positives = 78/207 (37%), Gaps = 33/207 (15%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLET-LGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ V R G A + T R+ ++ E E ++H N+V
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTARALS 717
++ + V G L++++ + ++S H A+
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDI-------VARE-------YYSEADASHCIQQILEAVL 124
Query: 718 YLH-HDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
+ H ++H NLK N+LL + KL+D+GLA + + G
Sbjct: 125 HCHQMG----VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE----GEQQAWFGFAGT 176
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVIL 797
Y++PE+ + D+++ GVIL
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVIL 203
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 47/207 (22%), Positives = 86/207 (41%), Gaps = 34/207 (16%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLET-LGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ V R G+ A K + T R+ ++ E E ++H N+V
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTARALS 717
+ ++ + V G L++++ + +S H +++
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDI-------VARE-------FYSEADASHCIQQILESIA 142
Query: 718 YLH-HDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
Y H + I+H NLK N+LL + KL+D+GLA + D+ +H G
Sbjct: 143 YCHSNG----IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DS---EAWHGFAGT 193
Query: 773 --YVAPELAQSLRLSDKCDVYSFGVIL 797
Y++PE+ + S D+++ GVIL
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVIL 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 54/223 (24%), Positives = 91/223 (40%), Gaps = 44/223 (19%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEF---ELEIGR-LSNIRHFNLVAF 656
G G+ G+V G+S+A+KK + F EL+I + L+ + H N+V
Sbjct: 31 AGQGTFGTVQLGKEKSTGMSVAIKK------VIQDPRFRNRELQIMQDLAVLHHPNIVQL 84
Query: 657 QGYYWSSTMQ-------LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
Q Y+++ + ++ E+VP D LH P L F +
Sbjct: 85 QSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLPILDNYGLTKFH 768
R++ LH + H ++K N+L++ + KL D+G AK L +
Sbjct: 140 ----RSIGCLHLPSVN-VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN------ 188
Query: 769 NAVGYV------APEL-AQSLRLSDKCDVYSFGVILLELVTGR 804
V Y+ APEL + + D++S G I E++ G
Sbjct: 189 --VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 14/108 (12%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
A+ +H + +H ++K NIL+D N +L+D+G L G + AVG
Sbjct: 187 AIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL---MEDGTVQSSVAVGTP 240
Query: 773 -YVAPELAQSLRLSDK-----CDVYSFGVILLELVTGRKPVESPTTNE 814
Y++PE+ Q++ CD +S GV + E++ G P + + E
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE 288
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 35/143 (24%), Positives = 57/143 (39%), Gaps = 8/143 (5%)
Query: 328 SIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDI-SNCR 385
IPT + + + L N+I I P + L +DL N + E+ D R
Sbjct: 25 EIPTNLPETITEI---RLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLR 80
Query: 386 FLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPP-SLGNLSNLQVLDLSQNS 444
L L + GN + + L++L L+ N +N + +L NL +L L N
Sbjct: 81 SLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNK 139
Query: 445 LSGSIPSSLGNLRNLTHFNLSSN 467
L + LR + +L+ N
Sbjct: 140 LQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 19/86 (22%), Positives = 37/86 (43%), Gaps = 3/86 (3%)
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI 449
+ + N + P L+ +DL N ++ P + L +L L L N ++ +
Sbjct: 37 IRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT-EL 95
Query: 450 PSSL-GNLRNLTHFNLSSNNLSGTIP 474
P SL L +L L++N ++ +
Sbjct: 96 PKSLFEGLFSLQLLLLNANKIN-CLR 120
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 16/67 (23%), Positives = 30/67 (44%), Gaps = 3/67 (4%)
Query: 412 KILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSNNLS 470
+ L QN + P + L+ +DLS N +S + + LR+L L N ++
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 471 GTIPSTI 477
+P ++
Sbjct: 94 -ELPKSL 99
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 1e-10
Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 17/120 (14%)
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL 764
RF++A A+ +H + +H ++K NILLD +L+D+G L G
Sbjct: 165 RFYLA-EIVMAIDSVH---RLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGT 217
Query: 765 TKFHNAVG---YVAPELAQSLRLSDK-------CDVYSFGVILLELVTGRKPVESPTTNE 814
+ AVG Y++PE+ Q++ CD ++ GV E+ G+ P + +T E
Sbjct: 218 VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE 277
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 49/242 (20%), Positives = 87/242 (35%), Gaps = 56/242 (23%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFEL-EIGRLSNIRHFNLVAFQGY 659
+G GS G V E G A+KK + ++ E+ + + H N++ Y
Sbjct: 15 LGTGSFGIVCEVFDIESGKRFALKK------VLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE---------------LHWSR 704
++++ + P + I NP LH
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 705 RFHIALGTA--------------RALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSD 749
+ I G + RA+ ++H I H ++K N+L++ ++ KL D
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVNSKDNTLKLCD 185
Query: 750 YGLAKLLPILDNYGLTKFHNAVGYV------APEL-AQSLRLSDKCDVYSFGVILLELVT 802
+G AK L + V Y+ APEL + + D++S G + EL+
Sbjct: 186 FGSAKKLIPSEPS--------VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELIL 237
Query: 803 GR 804
G+
Sbjct: 238 GK 239
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 64/279 (22%), Positives = 99/279 (35%), Gaps = 59/279 (21%)
Query: 542 NIKARRRKRDDETMVVEGTPLGSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECL 601
N+ A +K +D + +K KY+
Sbjct: 53 NLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYD---------PKDV-- 101
Query: 602 IGGGSIGSVYRASFEG-GVSIAVK-------KLETLGRIRNQEEFELEIGRLSNIR-HFN 652
IG G V R G AVK +L +E E L + H +
Sbjct: 102 IGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPH 161
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRR-----FH 707
++ Y SS+ ++ + + KG L+D L T S +
Sbjct: 162 IITLIDSYESSSFMFLVFDLMRKGELFDYL-------TEKV-------ALSEKETRSIMR 207
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
L A+S+LH + I+H +LK NILLD+N + +LSD+G + L K
Sbjct: 208 SLLE---AVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE-----PGEKL 256
Query: 768 HNAVG---YVAPE-LAQSLRLSDK-----CDVYSFGVIL 797
G Y+APE L S+ + D+++ GVIL
Sbjct: 257 RELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 55/230 (23%), Positives = 98/230 (42%), Gaps = 41/230 (17%)
Query: 601 LIGGGSIGSVYRASFEGGVSI-AVKKLETLGRI-RNQEEF---ELEIGRLSNIRHFNLV- 654
+IG G+ G V + + A+K L I R+ F E +I ++ +V
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDI--MAFANSPWVVQ 133
Query: 655 ---AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
AFQ + +++ E++P G+L + + S + RF+ A
Sbjct: 134 LFYAFQD---DRYLYMVM-EYMPGGDLVNLM--------SNYDVPEKWA----RFYTAEV 177
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
AL +H +H ++K N+LLD++ KL+D+G ++ G+ + AV
Sbjct: 178 VL-ALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAV 230
Query: 772 G---YVAPELAQSLRLSDK----CDVYSFGVILLELVTGRKPVESPTTNE 814
G Y++PE+ +S CD +S GV L E++ G P + +
Sbjct: 231 GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG 280
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 3e-10
Identities = 25/225 (11%), Positives = 54/225 (24%), Gaps = 60/225 (26%)
Query: 601 LIGGGSIGSVYRASFEG-GVSIAVKKLETLGRI--RNQEEFELEIGRLSNIRHFNLVA-- 655
GG ++A +A+ ++ G + +E RLS I +
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 656 ----FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
+ +++E++ G+L + P
Sbjct: 98 DVVHTRAGGL------VVAEWIRGGSLQEVADTSPSP--------------VGAIRAMQS 137
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
A A H + + + + + + L+
Sbjct: 138 LAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAY---------------------P 173
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
+ Q D+ G L L+ R P+ +
Sbjct: 174 ATMPDANPQD-------DIRGIGASLYALLVNRWPLPEAGVRSGL 211
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 5e-10
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 30/215 (13%)
Query: 601 LIGGGSIGSVYRASFEGGVSI-AVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLV-- 654
++G G G V + A KKLE RI+ ++ + E L + +V
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEK-KRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 655 --AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSR-RFHIALG 711
A++ + L+L + G+L +++ + G +R F+ A
Sbjct: 250 AYAYET---KDALCLVL-TLMNGGDLKFHIYHM----------GQAGFPEARAVFYAA-E 294
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
L LH + I++ +LK NILLD++ ++SD GLA + + + V
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAV--HVPEGQTIKGRVGTV 349
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
GY+APE+ ++ R + D ++ G +L E++ G+ P
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 48/323 (14%), Positives = 96/323 (29%), Gaps = 72/323 (22%)
Query: 175 SLSHNNLSG----SIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALT 230
SL + ++ S+ + ++ S N + E + +
Sbjct: 10 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSE------------NI- 56
Query: 231 GTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEG 290
+ + ++ + S + L+ + + +
Sbjct: 57 -------ASKKDLEIAEFSDIFTGRVKDEIPEALRLLL--------------QALLKCPK 95
Query: 291 MQVFDASWNEF--DGVIPLS--ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLAN 346
+ S N F PL ++ L+ L L N +G P + R L+ N
Sbjct: 96 LHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNG-LG--PQAGAKIARALQELAVN 152
Query: 347 NSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDIS----NCRFLLLLDVSGNALGGD-- 400
+ L + L + + + R L + + N + +
Sbjct: 153 K--------KAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204
Query: 401 ---IPQTLYNMTYLKILDLHQNHL--NGSTP--PSLGNLSNLQVLDLSQNSLSG----SI 449
+ + L LK+LDL N GS+ +L + NL+ L L+ LS ++
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAV 264
Query: 450 PSSLGNLRN--LTHFNLSSNNLS 470
+ L N L L N +
Sbjct: 265 VDAFSKLENIGLQTLRLQYNEIE 287
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 61/348 (17%), Positives = 106/348 (30%), Gaps = 80/348 (22%)
Query: 96 KSLRVLTLFGNRFTG----NLPQEYAEMQTLWKINVSSNALSG----SIPEFIGDLPNIR 147
S+ +L + T ++ E ++ +I +S N + + E I ++
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 148 LLDLSRNSYS---GEIPFAL------FKYCYKTKFVSLSHNNLS--GSIPLS--IANCTY 194
+ + S EIP AL C K V LS N PL ++ T
Sbjct: 64 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 123
Query: 195 LEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALT-GTVEEQFSQCQSIKNLDLSSNLF 253
LE N L + ++I AL V ++ ++++ N
Sbjct: 124 LEHLYLHNNGLGPQAGAKIAR------------ALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 254 -----IGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICG-----EGMQVFDASWNEF-- 301
A + + + NG E E + + ++V D N F
Sbjct: 172 ENGSMKEWAK-TFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 230
Query: 302 DGVIPLS--ITNCRNLKVLDLGFNRLIGSIPTGITDL---------RRLLKISLANNSIG 350
G L+ + + NL+ L L + + G + L + L N I
Sbjct: 231 LGSSALAIALKSWPNLRELGLNDCL-LSA--RGAAAVVDAFSKLENIGLQTLRLQYNEIE 287
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALG 398
L V+D LL L+++GN
Sbjct: 288 -----LDAVRTLKTVID--------------EKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 1e-06
Identities = 55/365 (15%), Positives = 95/365 (26%), Gaps = 130/365 (35%)
Query: 87 VLSPALSGLKSLRVLTLFGNRFTGNLPQEYAE-----------MQTLWKINVSSNALSG- 134
LS ++ K L + FTG + E E L + +S NA
Sbjct: 51 WLSENIASKKDLEIAEFSDI-FTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPT 109
Query: 135 ---SIPEFIGDLPNIRLLDLSRNSYSGE----IPFALFKYCYKTKFVSLSHNNLSGSIPL 187
+ +F+ + L L N + I AL + K
Sbjct: 110 AQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK--------------- 154
Query: 188 SIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLD 247
N L N L + + F + + +
Sbjct: 155 -AKNAPPLRSIICGRNRLENGSMKEWA--------------------KTFQSHRLLHTVK 193
Query: 248 LSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPL 307
+ N GI EG++
Sbjct: 194 MVQN---------------------------------GIRPEGIEHLLLE---------- 210
Query: 308 SITNCRNLKVLDLGFNRLIG-----SIPTGITDLRRLLKISLANNSIGGIIPPNLGSIEL 362
+ C+ LKVLDL N ++ + L ++ L + + G+ +
Sbjct: 211 GLAYCQELKVLDLQDNT-FTHLGSSALAIALKSWPNLRELGLNDCLLS-----ARGAAAV 264
Query: 363 LEVL-DLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTL-----YNMTYLKILDL 416
++ L N+ L+ L + N + D +TL M L L+L
Sbjct: 265 VDAFSKLENIGLQ--------------TLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 310
Query: 417 HQNHL 421
+ N
Sbjct: 311 NGNRF 315
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 6e-10
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 16/150 (10%)
Query: 328 SIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLR---GEVPDDISN 383
+IP+ I D ++L L +N + + + L +L L++ L+ + ++ N
Sbjct: 30 AIPSNIPADTKKL---DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKN 86
Query: 384 CRFLLLLDVSGNALGGDIPQTLY-NMTYLKILDLHQNHLNGSTPPSL-GNLSNLQVLDLS 441
L L V+ N L +P ++ + L L L +N L S PP + +L+ L L L
Sbjct: 87 ---LETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLG 141
Query: 442 QNSLSGSIPSSL-GNLRNLTHFNLSSNNLS 470
N L S+P + L +L L +N L
Sbjct: 142 YNELQ-SLPKGVFDKLTSLKELRLYNNQLK 170
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 49/195 (25%), Positives = 83/195 (42%), Gaps = 15/195 (7%)
Query: 314 NLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNL-GSIELLEVLDLHNL 371
+ K LDL N+ + S+P+ L +L + L +N + + P + ++ LE L + +
Sbjct: 38 DTKKLDLQSNK-LSSLPSKAFHRLTKLRLLYLNDNKLQTL-PAGIFKELKNLETLWVTDN 95
Query: 372 NLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLY-NMTYLKILDLHQNHLNGSTPPSL 429
L+ +P + L L + N L +P ++ ++T L L L N L S P +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 430 -GNLSNLQVLDLSQNSLSGSIPSSL-GNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLN 487
L++L+ L L N L +P L L L +N L +P F L
Sbjct: 153 FDKLTSLKELRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLK-RVPEGA--FDSLEKLK 208
Query: 488 NTGLCGPPLETSCSG 502
L P + +C+G
Sbjct: 209 MLQLQENPWDCTCNG 223
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 41/164 (25%), Positives = 69/164 (42%), Gaps = 18/164 (10%)
Query: 313 RNLKVLDLGFNRLIGSIPTGI-TDLRRLLKISLANNSIGGI---IPPNLGSIELLEVLDL 368
L++L L N+L ++P GI +L+ L + + +N + + + L + L L L
Sbjct: 61 TKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVN---LAELRL 116
Query: 369 HNLN----LRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLY-NMTYLKILDLHQNHLNG 423
N L V D ++ L L + N L +P+ ++ +T LK L L+ N L
Sbjct: 117 DR-NQLKSLPPRVFDSLTK---LTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLKR 171
Query: 424 STPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467
+ L+ L+ L L N L + +L L L N
Sbjct: 172 VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 7e-10
Identities = 29/149 (19%), Positives = 57/149 (38%), Gaps = 19/149 (12%)
Query: 328 SIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIEL--LEVLDLHNLNLRGEVP----DD 380
IP I L L NN ++ +L L ++ N + ++ +
Sbjct: 25 KIPEHIPQYTAEL---RLNNNEFT-VLEATGIFKKLPQLRKINFSNNKIT-DIEEGAFEG 79
Query: 381 ISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPP-SLGNLSNLQVLD 439
S + + ++ N L + + LK L L N + S LS++++L
Sbjct: 80 ASG---VNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLS 135
Query: 440 LSQNSLSGSIP-SSLGNLRNLTHFNLSSN 467
L N ++ ++ + L +L+ NL +N
Sbjct: 136 LYDNQIT-TVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-08
Identities = 22/124 (17%), Positives = 41/124 (33%), Gaps = 10/124 (8%)
Query: 353 IPPNLGSIELLEVLDLHNLNLRGEVPDDI-SNCRFLLLLDVSGNALGGDIPQTLYNMTYL 411
IP L L+N I L ++ S N + + +
Sbjct: 30 IPQYT------AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGV 83
Query: 412 KILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSNNLS 470
+ L N L L +L+ L L N ++ + + S L ++ +L N ++
Sbjct: 84 NEILLTSNRLENVQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT 142
Query: 471 GTIP 474
T+
Sbjct: 143 -TVA 145
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 7e-10
Identities = 50/217 (23%), Positives = 91/217 (41%), Gaps = 31/217 (14%)
Query: 601 LIGGGSIGSVYRASFEGGVSI-AVKKLETLGRIRNQEEFEL---EIGRLSNIRHFNLV-- 654
++G G G V+ + + A KKL R++ ++ ++ E L+ + +V
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNK-KRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 655 --AFQGYYWSSTMQ---LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
AF+ T L++ + G++ +++ V G P F+ A
Sbjct: 251 AYAFE------TKTDLCLVM-TIMNGGDIRYHIYNV---DEDNPGFQEPRA----IFYTA 296
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHN 769
L +LH + I++ +LK N+LLD++ ++SD GLA L +
Sbjct: 297 -QIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL-KAGQTKTKGYAG 351
Query: 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
G++APEL D ++ GV L E++ R P
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 8e-10
Identities = 25/97 (25%), Positives = 47/97 (48%), Gaps = 17/97 (17%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
+ +LH I+H +LK +NI++ + K+ D+GLA+ ++ +T Y
Sbjct: 175 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMT------PY 223
Query: 774 V------APELAQSLRLSDKCDVYSFGVILLELVTGR 804
V APE+ + + D++S G I+ E+V +
Sbjct: 224 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 49/237 (20%), Positives = 93/237 (39%), Gaps = 38/237 (16%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEI-GRLSNIRHFNLVAFQGY 659
+G GS + + + AVK + R+ + E+ H N+V
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIISK--RMEANTQKEITALKLCEG--HPNIVKLHEV 74
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTARALS 717
+ ++ E + G L++ + H+S +I A+S
Sbjct: 75 FHDQLHTFLVMELLNGGELFERI-------KKKK-------HFSETEASYIMRKLVSAVS 120
Query: 718 YLHHDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG-- 772
++H ++H +LK N+L ++N E K+ D+G A+L P +
Sbjct: 121 HMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ----PLKTPCFTL 173
Query: 773 -YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828
Y APEL + CD++S GVIL +++G+ P +S + E++++
Sbjct: 174 HYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV---EIMKK 227
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 53/232 (22%), Positives = 84/232 (36%), Gaps = 38/232 (16%)
Query: 596 LDKECLIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEI-GRLSNIRHFNL 653
L K+ L G G G V G A+K L + R E++ + S ++
Sbjct: 32 LSKQVL-GLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ----EVDHHWQASG--GPHI 84
Query: 654 VAFQGYYWSSTMQ----LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
V Y + LI+ E + G L+ + G E +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRI-------QERGDQAFTEREAAEIMRDI 137
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTK 766
A+ +LH I H ++K N+L +++ KL+D+G AK
Sbjct: 138 GT---AIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAK---ETTQ---NA 185
Query: 767 FHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
YVAPE+ + CD++S GVI+ L+ G P S T +
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 9e-10
Identities = 69/347 (19%), Positives = 119/347 (34%), Gaps = 88/347 (25%)
Query: 563 GSTDSNVIIGKLVLFSKSLPSKYEDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSI 621
GSTDS FS Y+ L ++ L G G+ V +
Sbjct: 1 GSTDS---------FSGRFEDVYQ---------LQEDVL-GEGAHARVQTCINLITSQEY 41
Query: 622 AVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFVPKGNLYD 680
AVK +E + E+ L + H N++ ++ ++ E + G++
Sbjct: 42 AVKIIEK-QPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILS 100
Query: 681 NLHGVNYPGTSTGGIGNPELHWSRRF-------HIALGTARALSYLHHDCKPPILHLNLK 733
++H RR + A AL +LH I H +LK
Sbjct: 101 HIH-------------------KRRHFNELEASVVVQDVASALDFLH---NKGIAHRDLK 138
Query: 734 STNILL---DENYEPKLSDYGLAKLLPILDNY---GLTKFHNAVG---YVAPELAQSLRL 784
NIL ++ K+ D+ L + + + + G Y+APE+ ++
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 785 SDK-----CDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSL 839
CD++S GVIL L++G P ++ C + R + F+
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD----CGWDRGEACPACQNMLFESIQ 254
Query: 840 RG---FAENE----------LIQVMKLGLICTSEVPSRRPSMAEVVQ 873
G F + + LI L+ +R S A+V+Q
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLIS----KLLVRD--AKQRLSAAQVLQ 295
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 1e-09
Identities = 25/97 (25%), Positives = 47/97 (48%), Gaps = 17/97 (17%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
+ +LH I+H +LK +NI++ + K+ D+GLA+ ++ +T Y
Sbjct: 138 CGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMT------PY 186
Query: 774 V------APELAQSLRLSDKCDVYSFGVILLELVTGR 804
V APE+ + + D++S G I+ E++ G
Sbjct: 187 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-09
Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 10/110 (9%)
Query: 715 ALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
AL YL I+H ++K NILLDE+ ++D+ +A +LP +T Y
Sbjct: 127 ALDYLQNQR----IIHRDMKPDNILLDEHGHVHITDFNIAAMLP--RETQITTMAGTKPY 180
Query: 774 VAPELAQSLRLS--DKC-DVYSFGVILLELVTGRKPVESPTTNEVVVLCE 820
+APE+ S + + D +S GV EL+ GR+P ++ +
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 52/421 (12%), Positives = 121/421 (28%), Gaps = 64/421 (15%)
Query: 91 ALSGLKSLRVLTLFG-NRFTGNLPQEYAEM-QTLWKINVSSNALSGSIPEFIGDL----P 144
A + L L L + FT + + + + + ++ S +++ +L
Sbjct: 133 AKARADDLETLKLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNT 192
Query: 145 NIRLLDLSRNSYSG---EIPFALFKYCYKTKFVSLSH-NNLSGSIPLSIA-NCTYLEGFD 199
++ +L+ ++ + + + C V + L A N G
Sbjct: 193 SLEVLNFYMTEFAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGS 252
Query: 200 FSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPF 259
+ + E + L + + + F I+ LDL L
Sbjct: 253 LNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHC 311
Query: 260 GVL-GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVL 318
++ N+ + I G++V C+ LK L
Sbjct: 312 TLIQKCPNLEVLETRNV----------IGDRGLEVL--------------AQYCKQLKRL 347
Query: 319 DLGFNRLIGSI---PTGITD---------LRRLLKISLANNSIG--GI--IPPNLGSIEL 362
+ + ++ + L +++ + I + I L ++
Sbjct: 348 RIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESLESIGTYLKNLCD 407
Query: 363 LEVLDLHNLNLRGEVPDD------ISNCRFLLLLDVSGN--ALGGDIPQTL-YNMTYLKI 413
++ L ++P D + C+ L L + ++
Sbjct: 408 FRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLSYIGQYSPNVRW 467
Query: 414 LDLHQNHLNGSTPPSLG-NLSNLQVLDLSQNSLS-GSIPSSLGNLRNLTHFNLSSNNLSG 471
+ L + NLQ L++ S +I +++ L +L + + S
Sbjct: 468 MLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM 527
Query: 472 T 472
T
Sbjct: 528 T 528
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 56.5 bits (136), Expect = 2e-08
Identities = 51/381 (13%), Positives = 110/381 (28%), Gaps = 40/381 (10%)
Query: 129 SNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFK-YCYKTKFVSLSH-NNLSGSIP 186
++ + E +L ++ + R S L K + + L + +
Sbjct: 97 GGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETLKLDKCSGFTTDGL 156
Query: 187 LSIA-NCTYLEGFDFSFNNLSGELPSQICNIP-------VLDFISVRGNALT-GTVEEQF 237
LSI +C ++ ++ S + + + VL+F ++ +E
Sbjct: 157 LSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIA 216
Query: 238 SQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDAS 297
C+S+ ++ + + L F N+ F +PE + +
Sbjct: 217 RNCRSLVSVKVGDFEILELVGFFKA-AANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRL 275
Query: 298 --WNEFDGVIPLSITNCRNLKVLDLGFNRLIG-SIPTGITDLRRLLKISLAN----NSIG 350
+P+ ++ LDL + L T I L + N +
Sbjct: 276 GLSYMGPNEMPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLE 335
Query: 351 GIIP--PNLGSIELLEVLDLHNLNLRGEVPDDIS------NCRFLLLLDVSGNALGGD-- 400
+ L + + D + + C+ L + V + + +
Sbjct: 336 VLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQGCQELEYMAVYVSDITNESL 395
Query: 401 --IPQTLYNMTYLKILDLHQNHLNGSTPPSLG------NLSNLQVLDLSQNS--LSGSIP 450
I L N+ +++ L + P G L+ L+
Sbjct: 396 ESIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGL 455
Query: 451 SSLG-NLRNLTHFNLSSNNLS 470
S +G N+ L S
Sbjct: 456 SYIGQYSPNVRWMLLGYVGES 476
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 9/94 (9%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK-FHNAVGY 773
L ++H +++ +LK NILLDE+ ++SD GLA GY
Sbjct: 304 GLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS----KKKPHASVGTHGY 356
Query: 774 VAPELAQSLRLSDKC-DVYSFGVILLELVTGRKP 806
+APE+ Q D D +S G +L +L+ G P
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 3e-09
Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 29/212 (13%)
Query: 602 IGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660
IG GS R + + AVK ++ + EE E+ + R H N++ + Y
Sbjct: 30 IGVGSYSVCKRCIHKATNMEFAVKIIDK-SKRDPTEEIEI-LLRYGQ--HPNIITLKDVY 85
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF--HIALGTARALSY 718
+++E + G L D + +S R + + + Y
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILRQK--------------FFSEREASAVLFTITKTVEY 131
Query: 719 LHHDCKPPILHLNLKSTNILL---DENYEP-KLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
LH ++H +LK +NIL N E ++ D+G AK L +N L +V
Sbjct: 132 LH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTANFV 187
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ + CD++S GV+L ++TG P
Sbjct: 188 APEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 42/227 (18%), Positives = 79/227 (34%), Gaps = 43/227 (18%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G +V+ A +A+K + E E+++ L + +
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL--LQRVNDADNTKEDSM 83
Query: 660 YWSSTMQLILSEFVPKG---------------NLYDNLHGVNYPGTSTGGIGNPELHWSR 704
+ ++L L F KG NL + + G + +
Sbjct: 84 GANHILKL-LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV--------K 134
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP------KLSDYGLAKLLP- 757
+ + L Y+H C I+H ++K N+L++ P K++D G A
Sbjct: 135 QI--SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 190
Query: 758 ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804
N T+ Y +PE+ D++S ++ EL+TG
Sbjct: 191 HYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 4e-09
Identities = 34/124 (27%), Positives = 59/124 (47%), Gaps = 13/124 (10%)
Query: 700 LHWSRRFHIALGTAR--------ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751
L R F + AR AL YLH + +++ +LK N++LD++ K++D+G
Sbjct: 239 LSRERVF--SEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 294
Query: 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT 811
L K I D + F Y+APE+ + D + GV++ E++ GR P +
Sbjct: 295 LCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 353
Query: 812 TNEV 815
++
Sbjct: 354 HEKL 357
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 61/385 (15%), Positives = 110/385 (28%), Gaps = 95/385 (24%)
Query: 136 IPEFIGDLPNIRLLDLSRNSYSGE----IPFALFKYCYKTKFVSLSHNNLS--GSIPLSI 189
+ EF + LDLS N+ + A ++LS N+L S L
Sbjct: 14 VEEFTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQ 73
Query: 190 A---NCTYLEGFDFSFNNLSGE--------LPSQICNIPVLDFISVRGNALTGTVEEQFS 238
+ + S N LS + L + I VLD N + +F
Sbjct: 74 ILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDL---GWNDFSSKSSSEFK 130
Query: 239 Q-----CQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQV 293
Q SI +L+L N G+ + + +
Sbjct: 131 QAFSNLPASITSLNLRGN------DLGIKSSDELIQILAAIPA-------------NVNS 171
Query: 294 FDASWNEF--DGVIPLS---ITNCRNLKVLDLGFNRLIGSIPTGITDL--------RRLL 340
+ N L+ + ++ LDL N +G +L ++
Sbjct: 172 LNLRGNNLASKNCAELAKFLASIPASVTSLDLSANL-LG--LKSYAELAYIFSSIPNHVV 228
Query: 341 KISLANNSIGGIIPPNLGSIELLEVLD----LHNLNLRGEVPDDIS------------NC 384
++L N + L + D L + L ++ ++S N
Sbjct: 229 SLNLCLNCLH-----GPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNI 283
Query: 385 RFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNS 444
+ ++L+D +G + + N+ + PSL N + N
Sbjct: 284 QKIILVDKNGKEIHPSHSIPISNL-----IRELSGKA---DVPSLLNQCLIFAQKHQTNI 335
Query: 445 LSGSIPSSLGNLRNLTHFNLSSNNL 469
+IP L + L
Sbjct: 336 EDLNIPDEL------RESIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 1e-06
Identities = 44/261 (16%), Positives = 78/261 (29%), Gaps = 69/261 (26%)
Query: 238 SQCQSIKNLDLSSNLFIGLAPFGVLGL--------KNISYFNVSHNGFHGEIPEVGICGE 289
S + +LDLS N L + L +++ N+S N + +
Sbjct: 19 SIPHGVTSLDLSLN---NLYSISTVELIQAFANTPASVTSLNLSGNS---------LGFK 66
Query: 290 GMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRL----IGSIPTGITDL-RRLLKISL 344
L+ N+ L+L N L + + + + + L
Sbjct: 67 NSDELVQI---------LAAIPA-NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDL 116
Query: 345 ANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGD---- 400
N + S E + ++ L++ GN LG
Sbjct: 117 GWNDFS-----SKSSSEFKQAFSNLPASIT--------------SLNLRGNDLGIKSSDE 157
Query: 401 IPQTLYNM-TYLKILDLHQNHLNGSTPPSLGNL-----SNLQVLDLSQNSLSGSIPSSLG 454
+ Q L + + L+L N+L L +++ LDLS N L + L
Sbjct: 158 LIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGLKSYAELA 217
Query: 455 -----NLRNLTHFNLSSNNLS 470
++ NL N L
Sbjct: 218 YIFSSIPNHVVSLNLCLNCLH 238
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 36/200 (18%), Positives = 70/200 (35%), Gaps = 46/200 (23%)
Query: 309 ITNCRNLKVLDLGFNRLIGSIPTGITDL--------RRLLKISLANNSIGGIIPPNLGSI 360
+ + LDL N + +L + ++L+ NS+G S
Sbjct: 18 TSIPHGVTSLDLSLNN-LY--SISTVELIQAFANTPASVTSLNLSGNSLG-----FKNSD 69
Query: 361 ELLEVLD-----LHNLNLRGEVPDDI----------SNCRFLLLLDVSGNALGGDIPQTL 405
EL+++L + +LNL G + + +LD+ N
Sbjct: 70 ELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEF 129
Query: 406 YNM-----TYLKILDLHQNHLNGSTPPSLGNL-----SNLQVLDLSQNSLS----GSIPS 451
+ L+L N L + L + +N+ L+L N+L+ +
Sbjct: 130 KQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAK 189
Query: 452 SLGNL-RNLTHFNLSSNNLS 470
L ++ ++T +LS+N L
Sbjct: 190 FLASIPASVTSLDLSANLLG 209
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.8 bits (139), Expect = 6e-09
Identities = 28/103 (27%), Positives = 38/103 (36%), Gaps = 5/103 (4%)
Query: 400 DIPQTLYNMTYLKILDL-HQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRN 458
D L L L + +Q HL L L L+ L + ++ L P +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 459 LTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLETSCS 501
L+ NLS N L T+Q L L G PL SC+
Sbjct: 82 LSRLNLSFNALESLSWKTVQG----LSLQELVLSGNPLHCSCA 120
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 6e-06
Identities = 21/112 (18%), Positives = 35/112 (31%), Gaps = 3/112 (2%)
Query: 312 CRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN-LGSIELLEVLDLHN 370
L + + + L ++ + N + L + L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 371 LNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
LR PD L L++S NAL + L+ L L N L+
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 49/223 (21%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEF----ELEIGRLSNIRH----- 650
+IG GS G V +A + +A+K +RN++ F EI L ++R
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKM------VRNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 651 -FNLVAFQGY-YWSS----TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSR 704
N++ + + T +L LS NLY+ + + G S + R
Sbjct: 158 TMNVIHMLENFTFRNHICMTFEL-LSM-----NLYELIKKNKFQGFSLPLV--------R 203
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP--KLSDYGLAKLLP-ILDN 761
+F A + L LH + I+H +LK NILL + K+ D+G + +
Sbjct: 204 KF--AHSILQCLDALH-KNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYT 258
Query: 762 YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804
Y ++F Y APE+ R D++S G IL EL+TG
Sbjct: 259 YIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 9e-09
Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL-PILDNYGLTKFHNAVG 772
R L Y+H I+H +LK +N+ ++E+ E K+ D+GLA+ + Y T++
Sbjct: 143 RGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW----- 194
Query: 773 YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y APE + + + D++S G I+ EL+TGR
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 29/132 (21%), Positives = 59/132 (44%), Gaps = 8/132 (6%)
Query: 341 KISLANNSIGGIIPPNLGSIELLEVLDLHNLNLR-GEVPDDISNCRFLLLLDVSGNALGG 399
K + ++I E ++LH + ++ +S + L +S N +
Sbjct: 3 KATTIKDAIRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE- 61
Query: 400 DIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSN-LQVLDLSQNSLSGSIPSSLGNLRN 458
I +L M L+IL L +N + +L +++ L+ L +S N ++ S+ S + L N
Sbjct: 62 KI-SSLSGMENLRILSLGRNLI--KKIENLDAVADTLEELWISYNQIA-SL-SGIEKLVN 116
Query: 459 LTHFNLSSNNLS 470
L +S+N ++
Sbjct: 117 LRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 35/148 (23%), Positives = 58/148 (39%), Gaps = 20/148 (13%)
Query: 305 IPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGS-IELL 363
+ +++ + K L L N I I + ++ + L +SL N I I NL + + L
Sbjct: 40 MDATLSTLKACKHLALSTNN-IEKI-SSLSGMENLRILSLGRNLIKKI--ENLDAVADTL 95
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALG--GDIPQTLYNMTYLKILDLHQNHL 421
E L + + I L +L +S N + G+I L + L+ L L N L
Sbjct: 96 EELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEI-DKLAALDKLEDLLLAGNPL 152
Query: 422 NGSTPPS----------LGNLSNLQVLD 439
+ + L NL+ LD
Sbjct: 153 YNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 9e-08
Identities = 30/133 (22%), Positives = 54/133 (40%), Gaps = 11/133 (8%)
Query: 339 LLKISLANNSIGGI--IPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNA 396
K+ L + I I + L +++ + L L N ++ +S L +L + N
Sbjct: 25 AEKVEL-HGMIPPIEKMDATLSTLKACKHLALST-NNIEKI-SSLSGMENLRILSLGRNL 81
Query: 397 LGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLS--GSIPSSLG 454
+ I L+ L + N + ++ + L NL+VL +S N ++ G I L
Sbjct: 82 IK-KIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEI-DKLA 137
Query: 455 NLRNLTHFNLSSN 467
L L L+ N
Sbjct: 138 ALDKLEDLLLAGN 150
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 56/229 (24%), Positives = 91/229 (39%), Gaps = 59/229 (25%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEF----ELEIGRLSNIRH----- 650
LIG GS G V +A +A+K I+N++ F ++E+ L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKI------IKNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 651 -FNLVAFQGYYWSSTMQLILSEFVPKG-----------NLYDNLHGVNYPGTSTGGIGNP 698
+ +V + + F+ + NLYD L N+ G S
Sbjct: 115 KYYIVHLKRH------------FMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLT--- 159
Query: 699 ELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP--KLSDYGLAKLL 756
R+F A AL +L + I+H +LK NILL K+ D+G + L
Sbjct: 160 -----RKF--AQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL 211
Query: 757 P-ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804
+ Y ++F Y +PE+ + D++S G IL+E+ TG
Sbjct: 212 GQRIYQYIQSRF-----YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 57.3 bits (138), Expect = 2e-08
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 4/101 (3%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
L +L I++ +LK N++LD K++D+G+ K I D F Y+
Sbjct: 454 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK-ENIWDGVTTKTFCGTPDYI 509
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
APE+ D ++FGV+L E++ G+ P E +E+
Sbjct: 510 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 3e-08
Identities = 29/93 (31%), Positives = 53/93 (56%), Gaps = 10/93 (10%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL-PILDNYGLTKFHNAVG 772
+ L Y+H I+H +LK N+ ++E+ E K+ D+GLA+ + Y +T++
Sbjct: 139 KGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----- 190
Query: 773 YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y APE + +R + D++S G I+ E++TG+
Sbjct: 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 27/93 (29%), Positives = 52/93 (55%), Gaps = 10/93 (10%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL-PILDNYGLTKFHNAVG 772
+ L Y+H ++H +LK N+ ++E+ E K+ D+GLA+ + Y +T++
Sbjct: 137 KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----- 188
Query: 773 YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y APE + + + D++S G I+ E++TG+
Sbjct: 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 52/217 (23%), Positives = 77/217 (35%), Gaps = 36/217 (16%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEI-GRLSNIRHFNLVAFQGY 659
+G G G V + A+K L+ + R E+E+ R S ++V
Sbjct: 70 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQ--CPHIVRIVDV 123
Query: 660 Y----WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
Y LI+ E + G L+ + G E S A
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFTEREASEIMKSIGE---A 173
Query: 716 LSYLHHDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+ YLH I H ++K N+L N KL+D+G AK
Sbjct: 174 IQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT-----SHNSLTTPCY 225
Query: 773 ---YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
YVAPE+ + CD++S GVI+ L+ G P
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 7e-08
Identities = 31/101 (30%), Positives = 53/101 (52%), Gaps = 4/101 (3%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
L +LH I++ +LK NILLD++ K++D+G+ K +L + F Y+
Sbjct: 130 GLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCGTPDYI 185
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
APE+ + + D +SFGV+L E++ G+ P E+
Sbjct: 186 APEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 48/238 (20%), Positives = 84/238 (35%), Gaps = 71/238 (29%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKL-ETLGRIRNQEEFEL---------EIGRLSNIRHF 651
I GS G+V G+ +A+K++ T+ R EI L++ H
Sbjct: 30 ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 652 NLVA------------FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE 699
N++ Y +++E + +L V I +
Sbjct: 90 NILGLRDIFVHFEEPAMHKLY-------LVTELMRT-----DLAQV---------IHDQR 128
Query: 700 LHWSRRFHI------ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753
+ S HI L L LH + ++H +L NILL +N + + D+ LA
Sbjct: 129 IVISP-QHIQYFMYHIL---LGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLA 181
Query: 754 KLLPILDNYGLTKFHNAVGYV------APE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
+ + T YV APE + Q + D++S G ++ E+ +
Sbjct: 182 R--EDTADANKT------HYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 8e-08
Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 32/220 (14%)
Query: 602 IGGGSIGSVYRA---SFEGGVSIAVKKLETLGR----IRNQEEFELEIGRLSNIRHFNLV 654
+G G+ G VY+A + A+K++E G R EI L ++H N++
Sbjct: 29 VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACR-------EIALLRELKHPNVI 81
Query: 655 AFQGYYWSSTMQLI--LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ Q + S + + L ++ +D H + + S +L +
Sbjct: 82 SLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 137
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEP----KLSDYGLAKLLPILDNYGLTKFH 768
+ YLH + +LH +LK NIL+ K++D G A+L L
Sbjct: 138 LDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLD 193
Query: 769 NAV---GYVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
V Y APE L + + D+++ G I EL+T
Sbjct: 194 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 27/95 (28%), Positives = 45/95 (47%), Gaps = 7/95 (7%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG- 772
L Y+H + ILH ++K+ N+L+ + KL+D+GLA+ + N ++ N V
Sbjct: 135 NGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVT 191
Query: 773 --YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y PE L D++ G I+ E+ T
Sbjct: 192 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 27/102 (26%), Positives = 50/102 (49%), Gaps = 21/102 (20%)
Query: 714 RALSYLH-HDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
+AL Y H I+H ++K N+++D E+ + +L D+GLA+ Y + +N
Sbjct: 141 KALDYCHSMG----IMHRDVKPHNVMIDHEHRKLRLIDWGLAEF------YHPGQEYN-- 188
Query: 772 GYV------APELAQSLRLSDKC-DVYSFGVILLELVTGRKP 806
V PEL ++ D D++S G +L ++ ++P
Sbjct: 189 VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 29/97 (29%), Positives = 47/97 (48%), Gaps = 11/97 (11%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGLTKFHNAVG 772
+ L + H +LH +LK N+L++ N E KL+++GLA+ I + Y + V
Sbjct: 112 KGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY--S--AEVVT 164
Query: 773 --YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGRKP 806
Y P+ L + S D++S G I EL +P
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 1e-07
Identities = 36/101 (35%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL +LH I++ +LK NILLDE KL+D+GL+K I F V Y+
Sbjct: 138 ALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYM 193
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
APE+ + D +SFGV++ E++TG P + E
Sbjct: 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 29/101 (28%), Positives = 49/101 (48%), Gaps = 4/101 (3%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
L +L I++ +LK N++LD K++D+G+ K I D F Y+
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYI 188
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
APE+ D ++FGV+L E++ G+ P E +E+
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 13/101 (12%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV-- 771
RA+ LH ++H +LK +N+L++ N + K+ D+GLA+++
Sbjct: 123 RAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 772 -GYV------APE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
+V APE + S + S DV+S G IL EL R
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 53.8 bits (128), Expect = 1e-07
Identities = 29/163 (17%), Positives = 50/163 (30%), Gaps = 22/163 (13%)
Query: 330 PTGITDLRRLLK--ISLANNSIGGIIPPNLGSIEL--LEVLDLHNLNLRGEVPDDISNCR 385
DL +L L N I G ++G L+ L++ + L V +DI
Sbjct: 158 WIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSD 217
Query: 386 F-----LLLLDVSGNALGGDIPQTLY------NMTYLKILDLHQNHLNGSTPPSLGN--- 431
L+L + LK L +
Sbjct: 218 LPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDI 277
Query: 432 LSNLQVLDLSQNSLSGS----IPSSLGNLRNLTHFNLSSNNLS 470
L L+ +D+S L+ + + +++L N+ N LS
Sbjct: 278 LPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 48.8 bits (115), Expect = 4e-06
Identities = 25/187 (13%), Positives = 61/187 (32%), Gaps = 26/187 (13%)
Query: 295 DASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP 354
+ SW E + P+ + L L + + +L+ L + + + +
Sbjct: 155 EISWIEQVDLSPV-LDAMPLLNNLKIKGTNNLSIGKKPRPNLKSL---EIISGGLPDSVV 210
Query: 355 PNLGSIEL--LEVLDLH----NLNLRGEVPD-----DISNCRFLLLLDVSGNALGGDIPQ 403
++ +L LE L L+ + G++ L L + + +
Sbjct: 211 EDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVE 270
Query: 404 TLYN---MTYLKILDLHQNHLNGST----PPSLGNLSNLQVLDLSQNSLSG----SIPSS 452
+ L+ +D+ L + + +L+ +++ N LS + S
Sbjct: 271 MFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKS 330
Query: 453 LGNLRNL 459
L ++
Sbjct: 331 LPMKIDV 337
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 1e-07
Identities = 31/101 (30%), Positives = 52/101 (51%), Gaps = 4/101 (3%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL +LH I++ +LK N+LLD KL+D+G+ K I + F Y+
Sbjct: 136 ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFCGTPDYI 191
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
APE+ Q + D ++ GV+L E++ G P E+ +++
Sbjct: 192 APEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 53.3 bits (129), Expect = 1e-07
Identities = 52/227 (22%), Positives = 86/227 (37%), Gaps = 61/227 (26%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL-------EIGRLSNIRHFNL 653
IG GS G V++ + + G +A+KK E+ + EI L ++H NL
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKK------FLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 654 VAFQGYYWSSTMQLILSE-FVPKGNLY-------DNLHGVNYPGTSTGGIGNPELHWSRR 705
V L E F K L+ + G+ + +
Sbjct: 65 VN-------------LLEVFRRKRRLHLVFEYCDHTVLH--ELDRYQRGVPEHLV---KS 106
Query: 706 FHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGL 764
+A+++ H +H ++K NIL+ ++ KL D+G A+LL D Y
Sbjct: 107 ITWQT--LQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYY-- 159
Query: 765 TKFHNAVG--YVAPELAQSLRLSDKC-----DVYSFGVILLELVTGR 804
Y +PEL L + D DV++ G + EL++G
Sbjct: 160 D--DEVATRWYRSPEL---L-VGDTQYGPPVDVWAIGCVFAELLSGV 200
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 50/241 (20%), Positives = 76/241 (31%), Gaps = 69/241 (28%)
Query: 601 LIGGGSIGSVYRA--SFEGGVSIAVKKLETLGRIRNQEEF----ELEIGRLSNIRH---- 650
+G G+ G V G +A+K IRN ++ LEI L I+
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKI------IRNVGKYREAARLEINVLKKIKEKDKE 79
Query: 651 --FNLVAFQGYYWSSTMQLILSEFVPKG-----------NLYDNLHGVNYPGTSTGGIGN 697
F V + F G N ++ L N+ +
Sbjct: 80 NKFLCVLMSDW------------FNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHV-- 125
Query: 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757
R L AL +LH + + + H +LK NIL + L + +
Sbjct: 126 ------RHMAYQL--CHALRFLH-ENQ--LTHTDLKPENILFVNSEFETLYNEHKSCEEK 174
Query: 758 ILDNYGL--------TKFHNAVGYV-------APELAQSLRLSDKCDVYSFGVILLELVT 802
+ N + T H + PE+ L + CDV+S G IL E
Sbjct: 175 SVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYR 234
Query: 803 G 803
G
Sbjct: 235 G 235
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 54.1 bits (130), Expect = 2e-07
Identities = 51/407 (12%), Positives = 130/407 (31%), Gaps = 59/407 (14%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTG-------NLPQEYAEMQTLWKINVSSNALSGSIPEFI 140
L+ + ++L+ L L + + P Y + +L ++S ++ +
Sbjct: 148 LAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLV 207
Query: 141 GDLPNIRLLDLSRNSYSGEIPFALFKYC------YKTKFVSLSHNNLSGSIPLSIANCTY 194
PN++ L L+R ++ L + + + ++ + ++++ C
Sbjct: 208 TRCPNLKSLKLNRAVPLEKL-ATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKE 266
Query: 195 LEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGT-VEEQFSQCQSIKNLDLSSNLF 253
L ++ + LP+ L +++ + + + QC ++ L + +
Sbjct: 267 LRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIE 326
Query: 254 -IGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNC 312
GL K++ V + P V + +G+ C
Sbjct: 327 DAGLEVLA-STCKDLRELRVFPSEPFVMEPNVALTEQGLVSV--------------SMGC 371
Query: 313 RNLKVLDLGFNRLIGSIPTGITD--LRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHN 370
L+ + +T+ L + + PN+ L +
Sbjct: 372 PKLESVLYFC--------RQMTNAALITIARNR-----------PNMTRFRLCIIEPKAP 412
Query: 371 LNLRGEVPDD-----ISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGST 425
L E D + +C+ L L +SG +++L + +
Sbjct: 413 DYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG 472
Query: 426 PPSLG-NLSNLQVLDLSQNSLSG-SIPSSLGNLRNLTHFNLSSNNLS 470
+ +L+ L++ ++ ++ L + +SS ++S
Sbjct: 473 MHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWMSSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 38/251 (15%), Positives = 73/251 (29%), Gaps = 27/251 (10%)
Query: 237 FSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDA 296
+ +++++L G Y + E I + M V D
Sbjct: 62 IRRFPKVRSVELKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEE-IRLKRMVVTD- 119
Query: 297 SWNEFDGVIPLSITNCRNLKVLDLGFNRLIG--SIPTGITDLRRLLKISLANNSIGGIIP 354
D + ++ + +N KVL L + R L ++ L + + +
Sbjct: 120 -----DCLELIA-KSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSG 173
Query: 355 PNLGSIEL----LEVLDLHNLNLRGEVPDD-----ISNCRFLLLLDVSGNALGGDIPQTL 405
L L L++ L EV ++ C L L ++ + L
Sbjct: 174 HWLSHFPDTYTSLVSLNI--SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLL 231
Query: 406 YNMTYLKILDLHQNHLNGSTP------PSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNL 459
L+ L +L L+ L +++ +P+ L
Sbjct: 232 QRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRL 291
Query: 460 THFNLSSNNLS 470
T NLS +
Sbjct: 292 TTLNLSYATVQ 302
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 5e-05
Identities = 42/370 (11%), Positives = 107/370 (28%), Gaps = 50/370 (13%)
Query: 129 SNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSH-NNLSGSIPL 187
+ I + + L R + + + K K + LS S
Sbjct: 90 GGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLA 149
Query: 188 SIA-NCTYLEGFDFSFNNLSGELPSQICNIP-------VLDFISVRGNALTGTVEEQFSQ 239
+IA C L+ D +++ + + P L+ + +E ++
Sbjct: 150 AIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTR 209
Query: 240 CQSIKNLDLSSNLFIGLAPFGVLGLKNI------SYFNVSHNGFHGEIPEVGICGEGMQV 293
C ++K+L L+ + + + + Y + + + ++
Sbjct: 210 CPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRC 269
Query: 294 FDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIG-SIPTGITDLRRLLKISLANNSIGGI 352
W+ +P + C L L+L + + + + +L ++ + +
Sbjct: 270 LSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDY----- 324
Query: 353 IPPNLGSIELLEVL----DLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNM 408
+ L + DL L + P + L + ++
Sbjct: 325 ----IEDAGLEVLASTCKDLRELRVFPSEPFVMEPNV--ALTEQGLVSVS-------MGC 371
Query: 409 TYLKILDLHQNHLNGSTPPSLG-NLSNLQVLDLS-----------QNSLSGSIPSSLGNL 456
L+ + + + ++ N N+ L L + + +
Sbjct: 372 PKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHC 431
Query: 457 RNLTHFNLSS 466
++L +LS
Sbjct: 432 KDLRRLSLSG 441
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 9e-05
Identities = 50/316 (15%), Positives = 95/316 (30%), Gaps = 55/316 (17%)
Query: 165 FKYCYKTKFVSLSHNNLSGSIPLSI----ANCTYLEGFDFSFNNLSG---ELPSQIC-NI 216
K +L + G + I ++ T+LE ++ EL ++ N
Sbjct: 73 LKGKPHFADFNLVPDGWGGYVYPWIEAMSSSYTWLEEIRLKRMVVTDDCLELIAKSFKNF 132
Query: 217 PVLDFISVRGNALTGT-VEEQFSQCQSIKNLDLSSNLFIGLAPFGV----LGLKNISYFN 271
VL S G + + + C+++K LDL + ++ + ++ N
Sbjct: 133 KVLVLSSCEG--FSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLN 190
Query: 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPT 331
+S E+ F + L T C NLK L L
Sbjct: 191 IS--CLASEV------------------SFSALERLV-TRCPNLKSLKLNRAV------- 222
Query: 332 GITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLD 391
+ L LL+ + P L + ++ + +S C+ L L
Sbjct: 223 PLEKLATLLQRA-----------PQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLS 271
Query: 392 VSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSL-GNLSNLQVLDLSQNSLSGSIP 450
+A+ +P + L L+L + L LQ L + +
Sbjct: 272 GFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLE 331
Query: 451 SSLGNLRNLTHFNLSS 466
++L +
Sbjct: 332 VLASTCKDLRELRVFP 347
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 55/224 (24%), Positives = 85/224 (37%), Gaps = 45/224 (20%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL--------EIG---RLSNIR 649
IG G+ G+VY+A G +A+K + R+ N E+ RL
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 650 HFNLVA----FQGYYWSSTMQLILS-EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSR 704
H N+V +++ L E V + +L L PG I +
Sbjct: 73 HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETI--------K 123
Query: 705 RFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL 764
R L +LH +C I+H +LK NIL+ KL+D+GLA++ Y
Sbjct: 124 DLMRQF--LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI------YSY 172
Query: 765 -TKFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804
V Y APE+ + D++S G I E+ +
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 2e-07
Identities = 33/124 (26%), Positives = 56/124 (45%), Gaps = 14/124 (11%)
Query: 700 LHWSRRFHIALGTAR--------ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751
L R F AR AL YLH +++ ++K N++LD++ K++D+G
Sbjct: 96 LSRERVF--TEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFG 150
Query: 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT 811
L K I D + F Y+APE+ + D + GV++ E++ GR P +
Sbjct: 151 LCKE-GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 209
Query: 812 TNEV 815
+
Sbjct: 210 HERL 213
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 6/102 (5%)
Query: 715 ALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
AL +LH I++ +LK NI+L+ KL+D+GL K I D F + Y
Sbjct: 133 ALGHLHQKG----IIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEY 187
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
+APE+ + D +S G ++ +++TG P +
Sbjct: 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 3e-07
Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 43/222 (19%)
Query: 602 IGGGSIGSVYRA--SFEGGVSIAVKKLETLGRIRNQEE-FEL----EIG---RLSNIRHF 651
IG G+ G V++A GG +A+K++ R++ EE L E+ L H
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRV----RVQTGEEGMPLSTIREVAVLRHLETFEHP 74
Query: 652 NLVA----FQGYYWSSTMQLILS-EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRF 706
N+V +L L E V + +L L V PG T I +
Sbjct: 75 NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETI--------KDM 125
Query: 707 HIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGL-T 765
L R L +LH ++H +LK NIL+ + + KL+D+GLA++ Y
Sbjct: 126 MFQL--LRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI------YSFQM 174
Query: 766 KFHNAVG---YVAPELAQSLRLSDKCDVYSFGVILLELVTGR 804
+ V Y APE+ + D++S G I E+ +
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 17/89 (19%), Positives = 31/89 (34%), Gaps = 3/89 (3%)
Query: 382 SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLS 441
+N LD+ G + I + +D N + L L+ L ++
Sbjct: 16 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVN 72
Query: 442 QNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
N + L +LT L++N+L
Sbjct: 73 NNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 29/129 (22%), Positives = 48/129 (37%), Gaps = 8/129 (6%)
Query: 317 VLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGS-IELLEVLDLHNLNLRG 375
++ L LI T+ R ++ L I I NLG+ ++ + +D + +R
Sbjct: 1 MVKLTAE-LIEQAA-QYTNAVRDRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR- 55
Query: 376 EVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG-STPPSLGNLSN 434
D R L L V+ N + + L L L N L L +L +
Sbjct: 56 -KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKS 114
Query: 435 LQVLDLSQN 443
L L + +N
Sbjct: 115 LTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 22/87 (25%), Positives = 36/87 (41%), Gaps = 5/87 (5%)
Query: 311 NCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHN 370
+D N I + G LRRL + + NN I I ++ L L L N
Sbjct: 40 TLDQFDAIDFSDNE-IRKL-DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTN 97
Query: 371 LNLR--GEVPDDISNCRFLLLLDVSGN 395
+L G++ D +++ + L L + N
Sbjct: 98 NSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 45/158 (28%), Positives = 63/158 (39%), Gaps = 12/158 (7%)
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLR- 374
+ LDL L L +L ++L N + + + L L L N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 375 --GEVPDDISNCRFLLLLDVSGNALGGDIPQTLY-NMTYLKILDLHQNHLNGSTPPSL-G 430
V D ++ L L + GN L +P ++ +T LK L L+ N L S P
Sbjct: 98 LPLGVFDHLTQ---LDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFD 152
Query: 431 NLSNLQVLDLSQNSLSGSIP-SSLGNLRNLTHFNLSSN 467
L+NLQ L LS N L S+P + L L L N
Sbjct: 153 KLTNLQTLSLSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 11/97 (11%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL +LH K I++ ++K NILLD N L+D+GL+K + F + Y+
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 775 APELAQSLRLSDK-----CDVYSFGVILLELVTGRKP 806
AP++ +R D D +S GV++ EL+TG P
Sbjct: 228 APDI---VRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL+YLH + I++ +LK N+LLD KL+DYG+ K + + F Y+
Sbjct: 165 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 220
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ + D ++ GV++ E++ GR P
Sbjct: 221 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 4/101 (3%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL YLH I++ +LK NILLD L+D+GL K I N + F Y+
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYL 206
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
APE+ D + G +L E++ G P S T E+
Sbjct: 207 APEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 52.2 bits (126), Expect = 3e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 4/92 (4%)
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
AL+YLH + I++ +LK N+LLD KL+DYG+ K + + F Y+
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYI 177
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
APE+ + D ++ GV++ E++ GR P
Sbjct: 178 APEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 46/223 (20%), Positives = 82/223 (36%), Gaps = 53/223 (23%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL-------EIGRLSNIRHFNL 653
+G GS G V + + + G +A+KK ++ ++ EI L +RH NL
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKK------FLESDDDKMVKKIAMREIKLLKQLRHENL 86
Query: 654 VAFQGYYWSSTMQLILSE-FVPKGNLY-------DNLHGVNYPGTSTGGIGNPELHWSRR 705
V L E K Y + G+ + ++
Sbjct: 87 VN-------------LLEVCKKKKRWYLVFEFVDHTILD--DLELFPNGLDYQVV---QK 128
Query: 706 FHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGL 764
+ + + + H I+H ++K NIL+ ++ KL D+G A+ L + Y
Sbjct: 129 YLFQI--INGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY-- 181
Query: 765 TKFHNAVG--YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y APE L ++ DV++ G ++ E+ G
Sbjct: 182 D--DEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 5e-07
Identities = 34/106 (32%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG 423
L L N VP ++SN + L L+D+S N + Q+ NMT L L L N L
Sbjct: 34 TELYLDG-NQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR- 91
Query: 424 STPPSL-GNLSNLQVLDLSQNSLSGSIP-SSLGNLRNLTHFNLSSN 467
PP L +L++L L N +S +P + +L L+H + +N
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 26/86 (30%), Positives = 43/86 (50%), Gaps = 4/86 (4%)
Query: 390 LDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSI 449
L + GN +P+ L N +L ++DL N ++ + S N++ L L LS N L I
Sbjct: 36 LYLDGNQFTL-VPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR-CI 93
Query: 450 PSSL-GNLRNLTHFNLSSNNLSGTIP 474
P L++L +L N++S +P
Sbjct: 94 PPRTFDGLKSLRLLSLHGNDIS-VVP 118
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 19/59 (32%), Positives = 24/59 (40%), Gaps = 1/59 (1%)
Query: 412 KILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
L L N P L N +L ++DLS N +S S N+ L LS N L
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 5e-07
Identities = 31/109 (28%), Positives = 45/109 (41%), Gaps = 5/109 (4%)
Query: 388 LLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSG 447
L+LD + G I L+ L L L + +L L L+ L+LS+N + G
Sbjct: 29 LVLDNCKSNDG-KIEGLTAEFVNLEFLSLINVGL--ISVSNLPKLPKLKKLELSENRIFG 85
Query: 448 SIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPL 496
+ L NLTH NLS N L ST++ L + L +
Sbjct: 86 GLDMLAEKLPNLTHLNLSGNKLKD--ISTLEPLKKLECLKSLDLFNCEV 132
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 4e-06
Identities = 25/119 (21%), Positives = 43/119 (36%), Gaps = 8/119 (6%)
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIE 361
DG I NL+ L L + S+ + + L +L K+ L+ N I G + +
Sbjct: 38 DGKIEGLTAEFVNLEFLSLINV-GLISV-SNLPKLPKLKKLELSENRIFGGLDMLAEKLP 95
Query: 362 LLEVLDLHNLNLR--GEVPDDISNCRFLLLLDVSGNALGGDI---PQTLYNMTYLKILD 415
L L+L L+ + + + L LD+ + + L LD
Sbjct: 96 NLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 1e-05
Identities = 28/138 (20%), Positives = 45/138 (32%), Gaps = 28/138 (20%)
Query: 311 NCRNLKVLDLGFNRL-IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLH 369
++ L L + G I + L +SL N + + NL + L+ L+L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELS 79
Query: 370 NLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG-STPPS 428
N + G + + L L+L N L ST
Sbjct: 80 E------------------------NRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEP 115
Query: 429 LGNLSNLQVLDLSQNSLS 446
L L L+ LDL ++
Sbjct: 116 LKKLECLKSLDLFNCEVT 133
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 51.4 bits (122), Expect = 6e-07
Identities = 43/301 (14%), Positives = 90/301 (29%), Gaps = 63/301 (20%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKL----ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
IG G G V++ + +A+K + L +Q+ FE + + + +L++ +
Sbjct: 28 IGEGVFGEVFQTIADHT-PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 658 GYYWSSTMQLILSEFVPKGNL----------YDNLHGVNYP------------------- 688
+ + S +G+ Y++ G
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 689 GTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748
G + + I +L+ H +L N+LL + KL
Sbjct: 147 GIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 749 DYGLAK--------LLPILDNYGLTKFHNAVGYVAPELAQSLRL-----SDKCDVYSFGV 795
K L + +Y L++ V +++ L + D+Y
Sbjct: 205 YTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGDYQFDIYR--- 261
Query: 796 ILLELVTGRKPVESPTTNEVVVLCEYVRELL---------ERGSASACFDRSLRGFAENE 846
++ + R P +N V+ Y+ + + A R ++ F
Sbjct: 262 LMKKENNNRWGEYHPYSN--VLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319
Query: 847 L 847
L
Sbjct: 320 L 320
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 31/100 (31%), Positives = 51/100 (51%), Gaps = 18/100 (18%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG--LTKFHNAV 771
R L Y+H +LH +LK +N+LL+ + K+ D+GLA++ ++ LT
Sbjct: 139 RGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT------ 189
Query: 772 GYV------APE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
YV APE + S + D++S G IL E+++ R
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 51.5 bits (124), Expect = 7e-07
Identities = 25/102 (24%), Positives = 47/102 (46%), Gaps = 11/102 (10%)
Query: 715 ALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK-FHNAVG 772
YLH D +++ +LK N+L+D+ +++D+G AK + G T
Sbjct: 153 TFEYLHSLD----LIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPE 203
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
+APE+ S + D ++ GV++ E+ G P + +
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 8e-07
Identities = 27/135 (20%), Positives = 43/135 (31%), Gaps = 28/135 (20%)
Query: 311 NCRNLKVLDLGFNRL-IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLH 369
++K L L +R G + + L +S N + I
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI----------------- 57
Query: 370 NLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG-STPPS 428
++ L L++S N + G + L L+L N + ST
Sbjct: 58 ---------ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEP 108
Query: 429 LGNLSNLQVLDLSQN 443
L L NL+ LDL
Sbjct: 109 LKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 4e-06
Identities = 30/109 (27%), Positives = 46/109 (42%), Gaps = 5/109 (4%)
Query: 388 LLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSG 447
L+LD S + G + L+ L L ++ +L L+ L+ L+LS N +SG
Sbjct: 22 LVLDNSRSNEG-KLEGLTDEFEELEFLSTINVGL--TSIANLPKLNKLKKLELSDNRVSG 78
Query: 448 SIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPL 496
+ NLTH NLS N + STI+ L + L +
Sbjct: 79 GLEVLAEKCPNLTHLNLSGNKIKD--LSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 6e-06
Identities = 17/95 (17%), Positives = 34/95 (35%), Gaps = 3/95 (3%)
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIE 361
+G + L+ L + SI + L +L K+ L++N + G +
Sbjct: 31 EGKLEGLTDEFEELEFLSTINVG-LTSI-ANLPKLNKLKKLELSDNRVSGGLEVLAEKCP 88
Query: 362 LLEVLDLHNLNLRG-EVPDDISNCRFLLLLDVSGN 395
L L+L ++ + + L LD+
Sbjct: 89 NLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 1e-06
Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 54/223 (24%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFE-------LEIGRLSNIRHFNLV 654
IG G+ G VY+A G + A+KK IR ++E E EI L ++H N+V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKK------IRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 655 AFQGYYWSSTMQLILSE-FVPKGNLY--------DNLHGVNYPGTSTGGIGNPELHWSRR 705
L + K L D L GG+ + +
Sbjct: 64 K-------------LYDVIHTKKRLVLVFEHLDQD-LKK--LLDVCEGGLESVTA---KS 104
Query: 706 FHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGL 764
F + L ++Y H +LH +LK N+L++ E K++D+GLA+ I + Y
Sbjct: 105 FLLQL--LNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-- 157
Query: 765 TKFHNAVG--YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
T H V Y AP+ L S + S D++S G I E+V G
Sbjct: 158 T--HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 36/195 (18%), Positives = 61/195 (31%), Gaps = 24/195 (12%)
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIE 361
+ ++ C L+ L L RL I + L++++L+ S
Sbjct: 107 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS-------GFSEFA 159
Query: 362 LLEVLD----LHNLNLRG--EVPDDI------SNCRFLLLLDVSGNALG---GDIPQTLY 406
L +L L LNL + + + L++SG D+ +
Sbjct: 160 LQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVR 219
Query: 407 NMTYLKILDLHQ-NHLNGSTPPSLGNLSNLQVLDLSQ-NSLSGSIPSSLGNLRNLTHFNL 464
L LDL L L+ LQ L LS+ + LG + L +
Sbjct: 220 RCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQV 279
Query: 465 SSNNLSGTIPSTIQH 479
GT+ +
Sbjct: 280 FGIVPDGTLQLLKEA 294
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 34/204 (16%), Positives = 68/204 (33%), Gaps = 25/204 (12%)
Query: 292 QVFDASWNEFDGVIPLSITNCRNLKVLDLGF-----NRLIGSIPTGITDLRRLLKIS--- 343
Q I ++ NL L+L + ++ + + L L +S
Sbjct: 121 QNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDE-LNLSWCF 179
Query: 344 -LANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDD-----ISNCRFLLLLDVSG-NA 396
+ + + + L+L R + + C L+ LD+S
Sbjct: 180 DFTEKHVQVAVAHVSET---ITQLNLS--GYRKNLQKSDLSTLVRRCPNLVHLDLSDSVM 234
Query: 397 LGGDIPQTLYNMTYLKILDL-HQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGN 455
L D Q + + YL+ L L + T LG + L+ L + G++
Sbjct: 235 LKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEA 294
Query: 456 LRNLTHFNLSSNNLSGTIPSTIQH 479
L +L ++ ++ + TI +
Sbjct: 295 LPHL---QINCSHFTTIARPTIGN 315
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 33/95 (34%), Positives = 48/95 (50%), Gaps = 11/95 (11%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGLTKFHNAVG 772
R L+Y H +LH +LK N+L++E E KL+D+GLA+ I Y + V
Sbjct: 111 RGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY--D--NEVVT 163
Query: 773 --YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y P+ L S S + D++ G I E+ TGR
Sbjct: 164 LWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 2e-06
Identities = 53/227 (23%), Positives = 98/227 (43%), Gaps = 57/227 (25%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL----EIGRLSNIRHFNLVAF 656
+G G+ +VY+ + GV +A+K++ ++ ++E EI + ++H N+V
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVR- 67
Query: 657 QGYYWSSTMQLILSE-FVPKGNLY--------------DNLHGVNYPGTSTGGIGNPELH 701
L + + L D+ N P G+ +
Sbjct: 68 ------------LYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPR----GLELNLV- 110
Query: 702 WSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LD 760
+ F L + L++ H + ILH +LK N+L+++ + KL D+GLA+ I ++
Sbjct: 111 --KYFQWQL--LQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN 163
Query: 761 NYGLTKFHNAVG--YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
+ + V Y AP+ L S S D++S G IL E++TG+
Sbjct: 164 TF--S--SEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPI-LDNYGLTKFHNAVG 772
R +++ H ILH +LK N+L++ + KL+D+GLA+ I + +Y T H V
Sbjct: 130 RGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY--T--HEVVT 182
Query: 773 --YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
Y AP+ L S + S D++S G I E++TG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 47/241 (19%), Positives = 81/241 (33%), Gaps = 69/241 (28%)
Query: 601 LIGGGSIGSVYRA--SFEGGVSIAVKKLETLGRIRNQEEF----ELEIGRLSNIRH---- 650
+G G+ G V GG +AVK ++N + + EI L ++
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKI------VKNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 651 --FNLVAFQGYYWSSTMQLILSEFVPKG-----------NLYDNLHGVNYPGTSTGGIGN 697
F V + F G + YD + + I
Sbjct: 75 STFRCVQMLEW------------FEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHI-- 120
Query: 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757
R+ + +++++LH K + H +LK NIL ++ + + + +
Sbjct: 121 ------RKMAYQI--CKSVNFLH-SNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDER 169
Query: 758 ILDNYGL--------TKFHNAVGYV-------APELAQSLRLSDKCDVYSFGVILLELVT 802
L N + T + APE+ +L S CDV+S G IL+E
Sbjct: 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYL 229
Query: 803 G 803
G
Sbjct: 230 G 230
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 3e-06
Identities = 24/101 (23%), Positives = 46/101 (45%), Gaps = 19/101 (18%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLL--PILDNYGLTKFHNA 770
R L Y+H +LH +LK N+ ++ E+ K+ D+GLA+++ L+
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS----- 182
Query: 771 VGYV------APE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
+ +P L + D+++ G I E++TG+
Sbjct: 183 -EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 4e-06
Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 11/102 (10%)
Query: 715 ALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK-FHNAVG 772
AL YLH D I++ +LK NILLD+N K++D+G AK +P +T
Sbjct: 118 ALEYLHSKD----IIYRDLKPENILLDKNGHIKITDFGFAKYVP-----DVTYTLCGTPD 168
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE 814
Y+APE+ + + D +SFG+++ E++ G P T +
Sbjct: 169 YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 210
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 48.3 bits (116), Expect = 5e-06
Identities = 65/238 (27%), Positives = 95/238 (39%), Gaps = 71/238 (29%)
Query: 596 LDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFEL--------EIGRLS 646
LD +G G +VY+A +A+KK+ ++ ++ E + EI L
Sbjct: 15 LDF---LGEGQFATVYKARDKNTNQIVAIKKI----KLGHRSEAKDGINRTALREIKLLQ 67
Query: 647 NIRHFNLVAFQGYYWSSTMQLILSE-FVPKGNLY--------DNLHGVNYPGTSTGGIGN 697
+ H N++ L + F K N+ D L + I +
Sbjct: 68 ELSHPNIIG-------------LLDAFGHKSNISLVFDFMETD-LEVI---------IKD 104
Query: 698 PELHWSRRFHI---ALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
L + HI L T + L YLH ILH +LK N+LLDEN KL+D+GLAK
Sbjct: 105 NSLVLTPS-HIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
Query: 755 LLPILDNYG-----LTKFHNAVG--YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
+G T H V Y APE L + D+++ G IL EL+
Sbjct: 161 S------FGSPNRAYT--HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 55/245 (22%), Positives = 86/245 (35%), Gaps = 73/245 (29%)
Query: 601 LIGGGSIGSVYRAS-FEGGVSIAVKKLETLGRIRNQEEF----ELEIGRLSNIRH----- 650
+G G+ G V + AVK +RN +++ ++E L I++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKV------VRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKG-----------NLYDNLHGVNYPGTSTGGIGNPE 699
N+V + G F+ +LY+ + NY G I
Sbjct: 96 NNIVKYHGK------------FMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDI---- 139
Query: 700 LHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL 759
+ + I + +AL+YL + H +LK NILLD+ Y K
Sbjct: 140 ----KLYCIEI--LKALNYLR-KMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190
Query: 760 DNYGLTK--------F------HNAVG-------YVAPELAQSLRLSDKCDVYSFGVILL 798
TK F + G Y APE+ +L D++SFG +L
Sbjct: 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA 250
Query: 799 ELVTG 803
EL TG
Sbjct: 251 ELYTG 255
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 8e-06
Identities = 28/112 (25%), Positives = 49/112 (43%), Gaps = 24/112 (21%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV-- 771
+ + YLH +LH ++K +NILL+ K++D+GL++ + +
Sbjct: 120 KVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 772 ------------GYV------APE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
YV APE L S + + D++S G IL E++ G+
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 13/112 (11%)
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTL-----YNMTYLKILDLHQ 418
++L LH+ + P + L L + N L L ++T L +LDL
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-----GALPVGVFDSLTQLTVLDLGT 97
Query: 419 NHLNGSTPPSL-GNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNL 469
N L P ++ L +L+ L + N L+ +P + L +LTH L N L
Sbjct: 98 NQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 8e-05
Identities = 37/153 (24%), Positives = 62/153 (40%), Gaps = 27/153 (17%)
Query: 316 KVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRG 375
++L L N++ P L L ++ L +N +G +P
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVG------------------- 82
Query: 376 EVPDDISNCRFLLLLDVSGNALGGDIPQTLYN-MTYLKILDLHQNHLNGSTPPSLGNLSN 434
V D ++ L +LD+ N L +P +++ + +LK L + N L P + L++
Sbjct: 83 -VFDSLTQ---LTVLDLGTNQLTV-LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTH 136
Query: 435 LQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467
L L L QN L + L +LTH L N
Sbjct: 137 LTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 26/100 (26%), Positives = 42/100 (42%), Gaps = 16/100 (16%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEP-----KLSDYGLAKLLPI-LDNYGLTKF 767
+++ H LH +LK N+LL + K+ D+GLA+ I + + T
Sbjct: 143 NGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQF--T-- 195
Query: 768 HNAVG--YVAPE-LAQSLRLSDKCDVYSFGVILLELVTGR 804
H + Y PE L S S D++S I E++
Sbjct: 196 HEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 32/143 (22%), Positives = 54/143 (37%), Gaps = 31/143 (21%)
Query: 328 SIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRF 386
IP I LL L +N +G I + + +
Sbjct: 22 EIPRDIPLHTTELL---LNDNELGRISSDG--------------------LFGRLPH--- 55
Query: 387 LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSL-GNLSNLQVLDLSQNSL 445
L+ L++ N L G P ++++ L L +N + + L L+ L+L N +
Sbjct: 56 LVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQI 114
Query: 446 SGSIP-SSLGNLRNLTHFNLSSN 467
S + S +L +LT NL+SN
Sbjct: 115 S-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 3e-04
Identities = 24/87 (27%), Positives = 40/87 (45%), Gaps = 4/87 (4%)
Query: 390 LDVSGNALGGDIPQTLYN-MTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGS 448
L ++ N LG L+ + +L L+L +N L G P + S++Q L L +N +
Sbjct: 34 LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK-E 92
Query: 449 IPSSL-GNLRNLTHFNLSSNNLSGTIP 474
I + + L L NL N +S +
Sbjct: 93 ISNKMFLGLHQLKTLNLYDNQIS-CVM 118
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 41/146 (28%), Positives = 60/146 (41%), Gaps = 14/146 (9%)
Query: 328 SIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLR---GEVPDDISN 383
S+PTGI L L NS+ + + L L L L+ V + +++
Sbjct: 21 SVPTGIPAQTTYL---DLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTS 77
Query: 384 CRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSL-GNLSNLQVLDLSQ 442
L L++S N L +T LK L L+ N L S P + L+ L+ L L Q
Sbjct: 78 ---LTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQ 133
Query: 443 NSLSGSIPS-SLGNLRNLTHFNLSSN 467
N L S+P L +L + L N
Sbjct: 134 NQLK-SVPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 32/113 (28%), Positives = 44/113 (38%), Gaps = 14/113 (12%)
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTL-----YNMTYLKILDLHQ 418
LDL +L+ L L + GN L Q+L +T L L+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-----QSLPNGVFNKLTSLTYLNLST 85
Query: 419 NHLNGSTPPSL-GNLSNLQVLDLSQNSLSGSIPSSL-GNLRNLTHFNLSSNNL 469
N L S P + L+ L+ L L+ N L S+P + L L L N L
Sbjct: 86 NQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQL 136
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 4e-05
Identities = 25/122 (20%), Positives = 48/122 (39%), Gaps = 25/122 (20%)
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV-- 771
+++H + I+H +LK N LL+++ K+ D+GLA+ + + +
Sbjct: 140 LGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 772 -------------GYV------APE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPT 811
+V APE + + D++S G I EL+ + +
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256
Query: 812 TN 813
TN
Sbjct: 257 TN 258
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 45.3 bits (107), Expect = 7e-05
Identities = 40/248 (16%), Positives = 71/248 (28%), Gaps = 87/248 (35%)
Query: 707 HIALGTARALSYLHHDCKPPILHLNLKSTNILL--------------------------- 739
I + L YLH C+ I+H ++K NILL
Sbjct: 150 KIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 740 ----------------------DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
E + K++D G A + + T+ Y + E
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNAC---WVHKH-FTEDIQTRQYRSLE 263
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV----LCEYV-------RELL 826
+ + D++S + EL TG E + E + + R+L+
Sbjct: 264 VLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323
Query: 827 ERGSASA-CFDRSLR--------------------GFAENELIQVMKLGLICTSEVPSRR 865
G S F + +++ E L +P +R
Sbjct: 324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKR 383
Query: 866 PSMAEVVQ 873
+ AE ++
Sbjct: 384 ATAAECLR 391
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 8e-05
Identities = 45/158 (28%), Positives = 68/158 (43%), Gaps = 32/158 (20%)
Query: 314 NLKVLDLGFNRLIGSIPTGITD-LRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
NL L L N+L S+P G+ D L L ++ L N + + P
Sbjct: 86 NLTYLILTGNQL-QSLPNGVFDKLTNLKELVLVENQLQSL-PDG---------------- 127
Query: 373 LRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLY-NMTYLKILDLHQNHLNGSTPPSL-G 430
V D ++N L L+++ N L +P+ ++ +T L LDL N L S P +
Sbjct: 128 ----VFDKLTN---LTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFD 178
Query: 431 NLSNLQVLDLSQNSLSGSIPS-SLGNLRNLTHFNLSSN 467
L+ L+ L L QN L S+P L +L + L N
Sbjct: 179 KLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 7e-04
Identities = 25/118 (21%), Positives = 44/118 (37%), Gaps = 15/118 (12%)
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG 423
+L ++ V + N ++ + S I ++ L L N L+
Sbjct: 22 IKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYL----PNVRYLALGGNKLH- 76
Query: 424 STPPSLG---NLSNLQVLDLSQNSLSGSIPSSL-GNLRNLTHFNLSSNNLSGTIPSTI 477
+ L+NL L L+ N L S+P+ + L NL L N L ++P +
Sbjct: 77 ----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGV 128
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 9e-05
Identities = 48/215 (22%), Positives = 74/215 (34%), Gaps = 53/215 (24%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEI-GRLSNIRHFNLVAFQGY 659
+G G G V + A+K L+ + R E+E+ R S ++V
Sbjct: 26 LGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR----EVELHWRASQ--CPHIVRIVDV 79
Query: 660 YWSSTMQ----LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
Y + LI+ E + G L+ + G E S A
Sbjct: 80 YENLYAGRKCLLIVMECLDGGELFSRI-------QDRGDQAFTEREASEIMKSIGE---A 129
Query: 716 LSYLH-HDCKPPILHLNLKSTNILL---DENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
+ YLH + I H ++K N+L N KL+D+G AK + Y
Sbjct: 130 IQYLHSIN----IAHRDVKPENLLYTSKRPNAILKLTDFGFAKET-TGEKYDK------- 177
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKP 806
CD++S GVI+ L+ G P
Sbjct: 178 ---------------SCDMWSLGVIMYILLCGYPP 197
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 6e-04
Identities = 30/131 (22%), Positives = 50/131 (38%), Gaps = 38/131 (29%)
Query: 714 RALSYLH-HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAV- 771
+ Y+H ILH +LK N L++++ K+ D+GLA+ + +N +
Sbjct: 167 VGVKYVHSAG----ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222
Query: 772 -------------------GYV------APELAQSLRLSDKC----DVYSFGVILLELVT 802
G+V APEL + L + DV+S G I EL+
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPEL---ILLQENYTEAIDVWSIGCIFAELLN 279
Query: 803 GRKPVESPTTN 813
K + +
Sbjct: 280 MIKENVAYHAD 290
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 884 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-50 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-49 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-47 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-47 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-47 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-45 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-45 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 5e-45 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-44 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 4e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-44 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 8e-44 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-43 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-43 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-42 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-41 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-41 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-40 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 5e-40 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 9e-40 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-39 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 8e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-37 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-36 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-34 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-32 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 7e-32 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-32 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 9e-31 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-30 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 1e-29 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-29 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-29 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 9e-29 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-28 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-28 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-10 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 3e-06 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-28 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 8e-28 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-27 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-27 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-27 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-26 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-26 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-26 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-24 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-21 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 4e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 1e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-17 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-11 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-10 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-04 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-17 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-12 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-07 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-18 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-18 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 4e-18 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 6e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 9e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 7e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-06 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-09 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-08 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 6e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 9e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.001 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-07 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 1e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.003 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-07 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 9e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 6e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 4e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 1e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-06 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 4e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 6e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 8e-05 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 5e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 2e-56
Identities = 72/306 (23%), Positives = 133/306 (43%), Gaps = 41/306 (13%)
Query: 586 EDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEL 640
+DWE + + IG GS G+VY+ + G V++ + + + + F+
Sbjct: 1 DDWE------IPDGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTP-QQLQAFKN 53
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL 700
E+G L RH N++ F GY + + ++ ++ +LY +LH +
Sbjct: 54 EVGVLRKTRHVNILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHIIETK-----------F 101
Query: 701 HWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILD 760
+ IA TA+ + YLH I+H +LKS NI L E+ K+ D+GLA +
Sbjct: 102 EMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158
Query: 761 NYG-LTKFHNAVGYVAPELAQSLR---LSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
+ ++ ++APE+ + S + DVY+FG++L EL+TG+ P + + +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 817 VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
+ ++ RG L N + +L C + RP +++ +E
Sbjct: 219 I------FMVGRGY----LSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIE 268
Query: 877 SIRNGL 882
+ L
Sbjct: 269 LLARSL 274
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 4e-50
Identities = 71/298 (23%), Positives = 125/298 (41%), Gaps = 41/298 (13%)
Query: 586 EDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFEL 640
++WE + +E L +G G G V+ + G +AVK L+ + + F
Sbjct: 6 DEWE------VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQ--GSMSPDAFLA 57
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPEL 700
E + ++H LV + +I E++ G+L D L +L
Sbjct: 58 EANLMKQLQHQRLVRLYAVVTQEPIYIIT-EYMENGSLVDFLKT----------PSGIKL 106
Query: 701 HWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILD 760
++ +A A ++++ +H +L++ NIL+ + K++D+GLA+L+ +
Sbjct: 107 TINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163
Query: 761 NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE 820
+ + APE + K DV+SFG++L E+VT + TN V+
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVI--- 220
Query: 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+ LERG + EL Q+M+L C E P RP+ + VLE
Sbjct: 221 ---QNLERG-----YRMVRPDNCPEELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 174 bits (442), Expect = 2e-49
Identities = 67/296 (22%), Positives = 128/296 (43%), Gaps = 36/296 (12%)
Query: 602 IGGGSIGSVYRA------SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
IG G+ G V++A +E +AVK L+ Q +F+ E ++ + N+V
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 80
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTST------------GGIGNPELHWS 703
G +L E++ G+L + L ++ + G P L +
Sbjct: 81 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 140
Query: 704 RRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG 763
+ IA A ++YL +H +L + N L+ EN K++D+GL++ + D Y
Sbjct: 141 EQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 197
Query: 764 L-TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822
+ ++ PE R + + DV+++GV+L E+ + +E V+ YV
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI--YYV 255
Query: 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
R D ++ EN +++ L +C S++P+ RPS + ++L+ +
Sbjct: 256 R------------DGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM 299
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 3e-49
Identities = 70/303 (23%), Positives = 120/303 (39%), Gaps = 41/303 (13%)
Query: 585 YEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFE 639
+ WE + +E L +G G G V+ ++ G +A+K L+ + E F
Sbjct: 9 KDAWE------IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP--GTMSPEAFL 60
Query: 640 LEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE 699
E + +RH LV + ++ E++ KG+L D L G
Sbjct: 61 QEAQVMKKLRHEKLVQLYAVVSEEPIYIVT-EYMSKGSLLDFLKGETGKYL--------- 110
Query: 700 LHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPIL 759
+ +A A ++Y+ +H +L++ NIL+ EN K++D+GLA+L+
Sbjct: 111 -RLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDN 166
Query: 760 DNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC 819
+ + + APE A R + K DV+SFG++L EL T + N V+
Sbjct: 167 EYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-- 224
Query: 820 EYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
+ +ERG + L +M C + P RP+ + LE
Sbjct: 225 ----DQVERG-----YRMPCPPECPESLHDLMCQ---CWRKEPEERPTFEYLQAFLEDYF 272
Query: 880 NGL 882
Sbjct: 273 TST 275
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-48
Identities = 64/303 (21%), Positives = 116/303 (38%), Gaps = 40/303 (13%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
IG G G V+R + G +AVK + R E EI + +RH N++ F
Sbjct: 11 IGKGRFGEVWRGKWRGEE-VAVKIFSS--REERSWFREAEIYQTVMLRHENILGFIAADN 67
Query: 662 SS----TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
T ++S++ G+L+D L+ + +AL TA L+
Sbjct: 68 KDNGTWTQLWLVSDYHEHGSLFDYLN-------------RYTVTVEGMIKLALSTASGLA 114
Query: 718 YLHHDC-----KPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+LH + KP I H +LKS NIL+ +N ++D GLA + ++ VG
Sbjct: 115 HLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174
Query: 773 ---YVAPELAQS------LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV----VVLC 819
Y+APE+ + D+Y+ G++ E+ ++ +V
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS 234
Query: 820 EYVRELLERGSASACFDRSL--RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
+ E + + ++ R + L + K+ C + R + + + L
Sbjct: 235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294
Query: 878 IRN 880
+
Sbjct: 295 LSQ 297
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 1e-47
Identities = 62/278 (22%), Positives = 106/278 (38%), Gaps = 30/278 (10%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
IG G G V+ + +A+K + ++E+F E + + H LV G
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIRE--GAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH 721
++ EF+ G L D L + L + +
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFA-----------AETLLGMCLDVCEGM---AY 116
Query: 722 DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS 781
+ ++H +L + N L+ EN K+SD+G+ + + T V + +PE+
Sbjct: 117 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF 176
Query: 782 LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRG 841
R S K DV+SFGV++ E+ + K +N VV E + G F
Sbjct: 177 SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV------EDISTG-----FRLYKPR 225
Query: 842 FAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
A + Q+M C E P RP+ + +++ L I
Sbjct: 226 LASTHVYQIMNH---CWKERPEDRPAFSRLLRQLAEIA 260
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 4e-47
Identities = 69/281 (24%), Positives = 113/281 (40%), Gaps = 36/281 (12%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660
IG G G V + G +AVK ++ + F E ++ +RH NLV G
Sbjct: 14 TIGKGEFGDVMLGDYRGNK-VAVKCIK---NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69
Query: 661 WSSTMQL-ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
L I++E++ KG+L D L G L +L A+ YL
Sbjct: 70 VEEKGGLYIVTEYMAKGSLVDYLRSR----------GRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELA 779
+H +L + N+L+ E+ K+SD+GL K + V + APE
Sbjct: 120 E---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEAL 172
Query: 780 QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSL 839
+ + S K DV+SFG++L E+ + + + VV +E+G +
Sbjct: 173 REKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV------PRVEKG-----YKMDA 221
Query: 840 RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880
+ +VMK C + RPS ++ + LE I+
Sbjct: 222 PDGCPPAVYEVMKN---CWHLDAAMRPSFLQLREQLEHIKT 259
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 167 bits (424), Expect = 5e-47
Identities = 81/297 (27%), Positives = 124/297 (41%), Gaps = 31/297 (10%)
Query: 585 YEDWEAGTKALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIG 643
Y+ WE + K +GGG G VY + + +++AVK L+ EEF E
Sbjct: 9 YDKWEMERTDITMKH-KLGGGQYGEVYEGVWKKYSLTVAVKTLKE--DTMEVEEFLKEAA 65
Query: 644 RLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWS 703
+ I+H NLV G I++EF+ GNL D L N E+
Sbjct: 66 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN----------RQEVSAV 115
Query: 704 RRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG 763
++A + A+ YL K +H +L + N L+ EN+ K++D+GL++L+
Sbjct: 116 VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA 172
Query: 764 LTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR 823
+ + APE + S K DV++FGV+L E+ T V
Sbjct: 173 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VY 226
Query: 824 ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880
ELLE+ E +V +L C PS RPS AE+ Q E++
Sbjct: 227 ELLEKDYRME--------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-45
Identities = 60/288 (20%), Positives = 110/288 (38%), Gaps = 36/288 (12%)
Query: 601 LIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAF 656
+IG G G VY + + AVK L + I +F E + + H N+++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 93
Query: 657 QGYYW-SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
G S L++ ++ G+L + + L A+
Sbjct: 94 LGICLRSEGSPLVVLPYMKHGDLRNFIR-----------NETHNPTVKDLIGFGLQVAKG 142
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG--- 772
+ +H +L + N +LDE + K++D+GLA+ + + + A
Sbjct: 143 M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 199
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832
++A E Q+ + + K DV+SFGV+L EL+T P + + L +
Sbjct: 200 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE-- 257
Query: 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880
+ + L +VM C RPS +E+V + +I +
Sbjct: 258 ---------YCPDPLYEVMLK---CWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-45
Identities = 55/278 (19%), Positives = 111/278 (39%), Gaps = 32/278 (11%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYW 661
+G G G V + G +A+K ++ +++EF E + N+ H LV G
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKE--GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 662 SSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH 721
I++E++ G L + L + + + + A+ YL
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRHR-----------FQTQQLLEMCKDVCEAMEYLES 118
Query: 722 DCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS 781
LH +L + N L+++ K+SD+GL++ + + V + PE+
Sbjct: 119 ---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 782 LRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLR 840
+ S K D+++FGV++ E+ + G+ P E T +E E++ + L +
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETA---EHIAQGLRLYRPHLASE---- 228
Query: 841 GFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
++ +M C E RP+ ++ + +
Sbjct: 229 -----KVYTIMYS---CWHEKADERPTFKILLSNILDV 258
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-45
Identities = 58/291 (19%), Positives = 120/291 (41%), Gaps = 37/291 (12%)
Query: 596 LDKECLIGGGSIGSVYRASFEGG-----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRH 650
+ ++ +IG G G VY+ + V +A+K L+ + + +F E G + H
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
N++ +G +I++E++ G L L + E + +
Sbjct: 69 HNIIRLEGVISKYKPMMIITEYMENGALDKFLRE-----------KDGEFSVLQLVGMLR 117
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP--ILDNYGLTKFH 768
G A + + +H +L + NIL++ N K+SD+GL+++L Y +
Sbjct: 118 GIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGK 174
Query: 769 NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828
+ + APE + + DV+SFG+++ E++T + +N V+
Sbjct: 175 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM----------- 223
Query: 829 GSASACFDRSLRG-FAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+ R + + +L + C + +RRP A++V +L+ +
Sbjct: 224 ----KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 162 bits (410), Expect = 5e-45
Identities = 64/314 (20%), Positives = 126/314 (40%), Gaps = 46/314 (14%)
Query: 582 PSKYEDWEAGTKAL---LDKEC-----LIGGGSIGSVYRA----SFEGGVSIAVKKLETL 629
P +ED + +D C +IG G G V + + +A+K L++
Sbjct: 6 PFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG 65
Query: 630 GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPG 689
+ + +F E + H N++ +G ST +I++EF+ G+L L +
Sbjct: 66 YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF 125
Query: 690 TSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749
T + + G A + YL +H +L + NIL++ N K+SD
Sbjct: 126 T-----------VIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSD 171
Query: 750 YGLAKLLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GR 804
+GL++ L + + + APE Q + + DV+S+G+++ E+++ G
Sbjct: 172 FGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
Query: 805 KPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSR 864
+P T +V+ +E+ + + +L L C + +
Sbjct: 232 RPYWDMTNQDVI-------NAIEQDYRLP--------PPMDCPSALHQLMLDCWQKDRNH 276
Query: 865 RPSMAEVVQVLESI 878
RP ++V L+ +
Sbjct: 277 RPKFGQIVNTLDKM 290
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-44
Identities = 63/294 (21%), Positives = 116/294 (39%), Gaps = 30/294 (10%)
Query: 601 LIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNL 653
+G G+ G V A+ G +++AVK L+ + +E E+ LS + H N+
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI------GNPELHWSRRFH 707
V G L+++E+ G+L + L + L
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
+ A+ +++L +H +L + NILL K+ D+GLA+ + NY +
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGN 206
Query: 768 HN-AVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826
V ++APE + + + DV+S+G+ L EL + P + ++E
Sbjct: 207 ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY-PGMPVDSKFYKMIKEGF 265
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880
S E+ +MK C P +RP+ ++VQ++E +
Sbjct: 266 RMLSPEHA---------PAEMYDIMKT---CWDADPLKRPTFKQIVQLIEKQIS 307
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 4e-44
Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 27/287 (9%)
Query: 601 LIGGGSIGSVYRASFEGG---VSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAF 656
+IG G+ G V +A + + A+K+++ + +F E+ L + H N++
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 76
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNY----PGTSTGGIGNPELHWSRRFHIALGT 712
G + E+ P GNL D L P + L + H A
Sbjct: 77 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 136
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
AR + + + +H +L + NIL+ ENY K++D+GL++ + T V
Sbjct: 137 ARGM---DYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVR 191
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832
++A E + DV+S+GV+L E+V+ T + E L +G
Sbjct: 192 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------EKLPQG--- 242
Query: 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
+ ++E+ +M+ C E P RPS A+++ L +
Sbjct: 243 --YRLEKPLNCDDEVYDLMRQ---CWREKPYERPSFAQILVSLNRML 284
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 7e-44
Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 38/290 (13%)
Query: 595 LLDKECLIGGGSIGSVYRASF---EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHF 651
+ D E +G G+ GSV + + + + +A+K L+ + EE E + + +
Sbjct: 12 IADIE--LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNP 69
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
+V G + + L++ E G L+ L G E+ S +
Sbjct: 70 YIVRLIGVCQAEALMLVM-EMAGGGPLHKFLVG-----------KREEIPVSNVAELLHQ 117
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA- 770
+ + YL +H +L + N+LL + K+SD+GL+K L D+Y +
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 771 -VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLER 828
+ + APE + S + DV+S+GV + E ++ G+KP + EV+ E + +
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 234
Query: 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
EL +M C RP V Q + +
Sbjct: 235 PECPP------------ELYALMSD---CWIYKWEDRPDFLTVEQRMRAC 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 8e-44
Identities = 66/299 (22%), Positives = 113/299 (37%), Gaps = 42/299 (14%)
Query: 583 SKYEDWEAGTKALLDKECLIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQ-EEFEL 640
S+ ED+E +L IG GS G + G + K+L+ + +
Sbjct: 1 SRAEDYE-----VLYT---IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVS 52
Query: 641 EIGRLSNIRHFNLVAFQGYYWSSTMQL--ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNP 698
E+ L ++H N+V + T I+ E+ G+L + G
Sbjct: 53 EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK--------GTKERQ 104
Query: 699 ELHWSRRFHIALGTARALSYLH--HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLL 756
L + AL H D +LH +LK N+ LD KL D+GLA++L
Sbjct: 105 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164
Query: 757 PILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
D F Y++PE + ++K D++S G +L EL P + + E+
Sbjct: 165 N-HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 223
Query: 817 --VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ R + R S +EL +++ + RPS+ E+++
Sbjct: 224 GKIREGKFRRIPYRYS--------------DELNEIITR---MLNLKDYHRPSVEEILE 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 1e-43
Identities = 62/305 (20%), Positives = 120/305 (39%), Gaps = 37/305 (12%)
Query: 586 EDWEAGTKALLDKECL-----IGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRN 634
++WE + +E + +G GS G VY +G +A+K + +R
Sbjct: 13 DEWE------VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE 66
Query: 635 QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGG 694
+ EF E + ++V G L++ E + +G+L L +
Sbjct: 67 RIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPAMANN 124
Query: 695 IGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
S+ +A A ++YL+ +H +L + N ++ E++ K+ D+G+ +
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181
Query: 755 LLPILDNYGL-TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTN 813
+ D Y K V +++PE + + DV+SFGV+L E+ T + +N
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 814 EVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
E V+ + L +N + +L +C P RPS E++
Sbjct: 242 EQVL--------------RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287
Query: 874 VLESI 878
++
Sbjct: 288 SIKEE 292
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-43
Identities = 53/229 (23%), Positives = 98/229 (42%), Gaps = 18/229 (7%)
Query: 597 DKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+K +G G+ G V++ S G+ +A K + + + + E+ L +V
Sbjct: 9 EKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVG 68
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
F G ++S I E + G+L L + +++ +
Sbjct: 69 FYGAFYSDGEISICMEHMDGGSLDQVLKK------------AGRIPEQILGKVSIAVIKG 116
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVA 775
L+YL K I+H ++K +NIL++ E KL D+G++ L + F Y++
Sbjct: 117 LTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMS 171
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824
PE Q S + D++S G+ L+E+ GR P+ P E+ ++ E
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 220
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 1e-42
Identities = 69/291 (23%), Positives = 115/291 (39%), Gaps = 40/291 (13%)
Query: 595 LLDKECLIGGGSIGSVYRASFEG---GVSIAVKKL-ETLGRIRNQEEFELEIGRLSNIRH 650
L DKE +G G+ G+V + ++ ++AVK L ++E E + + +
Sbjct: 10 LEDKE--LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 67
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
+V G + + L++ E G L L N + +
Sbjct: 68 PYIVRMIGICEAESWMLVM-EMAELGPLNKYLQQ------------NRHVKDKNIIELVH 114
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
+ + YL +H +L + N+LL + K+SD+GL+K L +NY + H
Sbjct: 115 QVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171
Query: 771 --VGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827
V + APE + S K DV+SFGV++ E + G+KP +EV +LE
Sbjct: 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLE 224
Query: 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+G E+ +M L C + RP A V L +
Sbjct: 225 KG-----ERMGCPAGCPREMYDLMNL---CWTYDVENRPGFAAVELRLRNY 267
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-42
Identities = 60/297 (20%), Positives = 114/297 (38%), Gaps = 37/297 (12%)
Query: 601 LIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNL 653
++G G+ G V A+ G + +AVK L+ +E E+ ++ + H N+
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 654 VAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPE-----------LHW 702
V G S ++ E+ G+L + L + + L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 703 SRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY 762
A A+ + +L +H +L + N+L+ K+ D+GLA+ + NY
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220
Query: 763 GL-TKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCE 820
+ V ++APE + K DV+S+G++L E+ + G P +
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN----- 275
Query: 821 YVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLES 877
+L++ G F +A E+ +M+ C + +RPS + L
Sbjct: 276 -FYKLIQNG-----FKMDQPFYATEEIYIIMQS---CWAFDSRKRPSFPNLTSFLGC 323
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-41
Identities = 67/302 (22%), Positives = 119/302 (39%), Gaps = 46/302 (15%)
Query: 587 DWEAGTKALLDKECL-----IGGGSIGSVYRASF----EGGVSIAVKKLETLGRIRNQEE 637
D+E + +E + IG G G V++ + +++A+K + +E+
Sbjct: 1 DYE------IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREK 54
Query: 638 FELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGN 697
F E + H ++V G + + +I+ E G L L Y
Sbjct: 55 FLQEALTMRQFDHPHIVKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYS--------- 104
Query: 698 PELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757
L + A + AL+YL +H ++ + N+L+ N KL D+GL++ +
Sbjct: 105 --LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159
Query: 758 ILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVV 816
Y +K + ++APE R + DV+ FGV + E++ G KP + N+V+
Sbjct: 160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI 219
Query: 817 VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
+E G + L +M C + PSRRP E+ L
Sbjct: 220 -------GRIENGE-----RLPMPPNCPPTLYSLMTK---CWAYDPSRRPRFTELKAQLS 264
Query: 877 SI 878
+I
Sbjct: 265 TI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 3e-41
Identities = 59/285 (20%), Positives = 106/285 (37%), Gaps = 39/285 (13%)
Query: 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNL 653
D E IG GS +VY+ E V +A +L+ +++ + F+ E L ++H N+
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 654 VAFQGYYWSSTMQ----LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIA 709
V F + S+ ++++E + G L L +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR------------FKVMKIKVLRSWC 118
Query: 710 LGTARALSYLHHDCKPPILHLNLKSTNILL-DENYEPKLSDYGLAKLLPILDNYGLTKFH 768
+ L +LH PPI+H +LK NI + K+ D GLA L
Sbjct: 119 RQILKGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK---RASFAKAVI 174
Query: 769 NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828
++APE+ + + + DVY+FG+ +LE+ T P + V ++
Sbjct: 175 GTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKP 231
Query: 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
S ++ E C + R S+ +++
Sbjct: 232 ASFDKVAIPEVKEIIEG-----------CIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 37/276 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G G G+VY A + +A+K L L + + + E+ S++RH N++
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
GY+ +T ++ E+ P G +Y L ++ R A ALS
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLSK------------FDEQRTATYITELANALS 120
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
Y H ++H ++K N+LL E K++D+G + P + T + Y+ PE
Sbjct: 121 YCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPE 174
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
+ + +K D++S GV+ E + G+ P E+ T E Y R +
Sbjct: 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET-----YKRISRVEFTFPDFVTE 229
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
R PS+RP + EV++
Sbjct: 230 GARDLISR-----------LLKHNPSQRPMLREVLE 254
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 1e-40
Identities = 72/292 (24%), Positives = 121/292 (41%), Gaps = 31/292 (10%)
Query: 601 LIGGGSIGSVYRASFEG--------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHF 651
+G G+ G V A G +AVK L++ ++ + E+ + I +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTS----TGGIGNPELHWSRRFH 707
N++ G ++ E+ KGNL + L PG +L
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 708 IALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKF 767
A AR + YL +H +L + N+L+ E+ K++D+GLA+ + +D Y T
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 196
Query: 768 HN-AVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826
V ++APE + + DV+SFGV+L E+ T E + +LL
Sbjct: 197 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF------KLL 250
Query: 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
+ G NEL +M+ C VPS+RP+ ++V+ L+ I
Sbjct: 251 KEG-----HRMDKPSNCTNELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 148 bits (374), Expect = 5e-40
Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 42/279 (15%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQ--EEFELEIGRLSNIRHFNLVAFQG 658
IG GS G+VY A +A+KK+ G+ N+ ++ E+ L +RH N + ++G
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
Y ++ E+ L + G + L+Y
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVH------------KKPLQEVEIAAVTHGALQGLAY 130
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
LH ++H ++K+ NILL E KL D+G A ++ +++ T ++APE+
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT-----PYWMAPEV 182
Query: 779 AQSL---RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVV-LCEYVRELLERGSASAC 834
++ + K DV+S G+ +EL + P+ + + + + L+ G S
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWS-- 240
Query: 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ C ++P RP+ +++
Sbjct: 241 ----------EYFRNFVDS---CLQKIPQDRPTSEVLLK 266
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 9e-40
Identities = 71/316 (22%), Positives = 118/316 (37%), Gaps = 40/316 (12%)
Query: 581 LPSKYEDWEAGTKALLDKECL-----IGGGSIGSVYRASFEG------GVSIAVKKLETL 629
LP WE ++ L +G G+ G V A G ++AVK L+
Sbjct: 1 LPYDASKWE------FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG 54
Query: 630 GRIRNQEEFELEIGRLSNIRH-FNLVAFQGYYWSSTMQL-ILSEFVPKGNLYDNLHGVNY 687
E+ L +I H N+V G L ++ EF GNL L
Sbjct: 55 ATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN 114
Query: 688 P----GTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY 743
+ + L + A+ + +L +H +L + NILL E
Sbjct: 115 EFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKN 171
Query: 744 EPKLSDYGLAKLLPILDNYGLTK-FHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT 802
K+ D+GLA+ + +Y + ++APE + + DV+SFGV+L E+ +
Sbjct: 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 231
Query: 803 GRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVP 862
+ E L+ G+ D + E+ Q M C P
Sbjct: 232 LGASPYPGVKID-----EEFCRRLKEGTRMRAPD-----YTTPEMYQTMLD---CWHGEP 278
Query: 863 SRRPSMAEVVQVLESI 878
S+RP+ +E+V+ L ++
Sbjct: 279 SQRPTFSELVEHLGNL 294
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 2e-39
Identities = 63/278 (22%), Positives = 113/278 (40%), Gaps = 35/278 (12%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYY 660
+G G+ G VY+A E V A K ++T E++ +EI L++ H N+V +
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVIDT-KSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH 720
+ IL EF G + + + P L S+ + T AL+YLH
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELERP-----------LTESQIQVVCKQTLDALNYLH 127
Query: 721 HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ 780
I+H +LK+ NIL + + KL+D+G++ F ++APE+
Sbjct: 128 ---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVM 183
Query: 781 SLRLSD-----KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
D K DV+S G+ L+E+ P N + VL + + + + +
Sbjct: 184 CETSKDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTLAQPSRW 241
Query: 836 DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ + F + C + R + ++++Q
Sbjct: 242 SSNFKDFLKK-----------CLEKNVDARWTTSQLLQ 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 65/287 (22%), Positives = 116/287 (40%), Gaps = 38/287 (13%)
Query: 602 IGGGSIGSVYRASFEG----GVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
+G GS G V R ++ VS+AVK L + L + ++F E+ + ++ H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
G + M+++ E P G+L D L A+ A
Sbjct: 76 LYGVVLTPPMKMVT-ELAPLGSLLDRLRK-----------HQGHFLLGTLSRYAVQVAEG 123
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA--VGY 773
+ YL +H +L + N+LL K+ D+GL + LP D++ + + H +
Sbjct: 124 MGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSAS 832
APE ++ S D + FGV L E+ T G++P ++++ + E L R
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR---- 236
Query: 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879
E+ + + + C + P RP+ + L +
Sbjct: 237 ----------PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 3e-39
Identities = 58/287 (20%), Positives = 118/287 (41%), Gaps = 37/287 (12%)
Query: 601 LIGGGSIGSVYRASF-----EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA 655
++G G+ G+VY+ + + + +A+K+L + +E E ++++ + ++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 75
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
G +ST+QLI + +P G L D + + + A+
Sbjct: 76 LLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIG-----------SQYLLNWCVQIAKG 123
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTK-FHNAVGYV 774
++YL ++H +L + N+L+ K++D+GLAKLL + + + ++
Sbjct: 124 MNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 775 APELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASA 833
A E + + DV+S+GV + EL+T G KP + +E+ +LE+G
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-------SILEKGERLP 233
Query: 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880
I V + + C RP E++ +
Sbjct: 234 --------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 8e-39
Identities = 59/276 (21%), Positives = 111/276 (40%), Gaps = 31/276 (11%)
Query: 601 LIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ G V A ++AVK ++ + E + EI + H N+V F G+
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+Q + E+ G L+D + + + + YL
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIE------------PDIGMPEPDAQRFFHQLMAGVVYL 119
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAPEL 778
H I H ++K N+LLDE K+SD+GLA + + L K + YVAPEL
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176
Query: 779 AQSLRLSD-KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
+ DV+S G++L ++ G P + P+ + + + E+ + + +
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-----QEYSDWKEKKTYLNPWKK 231
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
++ + ++ E PS R ++ ++ +
Sbjct: 232 -----IDSAPLALLHK---ILVENPSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-37
Identities = 52/274 (18%), Positives = 104/274 (37%), Gaps = 32/274 (11%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IG G+ G+VY A G +A++++ L + +E EI + ++ N+V +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMN-LQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
Y ++ E++ G+L D + + + +AL +L
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD-------------EGQIAAVCRECLQALEFL 132
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELA 779
H ++H ++KS NILL + KL+D+G + + + ++APE+
Sbjct: 133 H---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVV 188
Query: 780 QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSL 839
K D++S G++ +E++ G P + + + G+ L
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQNPEKL 242
Query: 840 RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ C +R S E++Q
Sbjct: 243 ----SAIFRDFLNR---CLDMDVEKRGSAKELLQ 269
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 137 bits (347), Expect = 4e-36
Identities = 53/276 (19%), Positives = 102/276 (36%), Gaps = 32/276 (11%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ G V+R G + A K + T ++E EI +S +RH LV
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMT-PHESDKETVRKEIQTMSVLRHPTLVNLHDA 91
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ +++ EF+ G L++ + + + + L ++
Sbjct: 92 FEDDNEMVMIYEFMSGGELFEKVADEHNK-----------MSEDEAVEYMRQVCKGLCHM 140
Query: 720 HHDCKPPILHLNLKSTNILL--DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
H + +HL+LK NI+ + E KL D+GL L + + APE
Sbjct: 141 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPE 195
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
+A+ + D++S GV+ L++G P +E V+ D
Sbjct: 196 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVKSCDWN------MDD 246
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
S + ++ P+ R ++ + ++
Sbjct: 247 SAFSGISEDGKDFIRK---LLLADPNTRMTIHQALE 279
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-34
Identities = 52/276 (18%), Positives = 107/276 (38%), Gaps = 33/276 (11%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G G V+R + K ++ + +Q + EI L+ RH N++
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKV--KGTDQVLVKKEISILNIARHRNILHLHES 69
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ S +++ EF+ ++++ ++ + L+ AL +L
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFE-----------LNEREIVSYVHQVCEALQFL 118
Query: 720 HHDCKPPILHLNLKSTNILLD--ENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
H I H +++ NI+ + K+ ++G A+ L DN+ A Y APE
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF--RLLFTAPEYYAPE 173
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
+ Q +S D++S G ++ L++G P + T +++ E + + FD
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII-------ENIMNAEYT--FDE 224
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
E + + + R + +E +Q
Sbjct: 225 EAFKEISIEAMDFVDR---LLVKERKSRMTASEALQ 257
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 130 bits (327), Expect = 2e-33
Identities = 49/276 (17%), Positives = 104/276 (37%), Gaps = 32/276 (11%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G+ G V+R G K + T ++ + EI ++ + H L+
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINT-PYPLDKYTVKNEISIMNQLHHPKLINLHDA 94
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ +++ EF+ G L+D + +Y + + + L ++
Sbjct: 95 FEDKYEMVLILEFLSGGELFDRIAAEDYK-----------MSEAEVINYMRQACEGLKHM 143
Query: 720 HHDCKPPILHLNLKSTNILLDENYEP--KLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
H + I+HL++K NI+ + K+ D+GLA L + + + APE
Sbjct: 144 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPE 198
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDR 837
+ + D+++ GV+ L++G P E + + ++R FD
Sbjct: 199 IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL-------QNVKRCDWE--FDE 249
Query: 838 SLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
E +K + P +R ++ + ++
Sbjct: 250 DAFSSVSPEAKDFIKN---LLQKEPRKRLTVHDALE 282
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 126 bits (317), Expect = 1e-32
Identities = 55/274 (20%), Positives = 92/274 (33%), Gaps = 27/274 (9%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
++G G+ V A +A+K + + E EI L I+H N+VA
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
Y S ++ + V G L+D + + A+ YL
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIV------------EKGFYTERDASRLIFQVLDAVKYL 123
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELA 779
H LDE+ + +SD+GL+K+ L+ GYVAPE+
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVL 181
Query: 780 QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFDRSL 839
S D +S GVI L+ G P ++ + A FD
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL---------FEQILKAEYEFDSPY 232
Query: 840 RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ ++ + P +R + + +Q
Sbjct: 233 WDDISDSAKDFIRH---LMEKDPEKRFTCEQALQ 263
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-32
Identities = 50/280 (17%), Positives = 88/280 (31%), Gaps = 35/280 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
++G GS +V A A+K L + + E +S + H V
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ + G L + + + TA +S
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGS------------FDET---CTRFYTAEIVS 119
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG-LTKFHNAVGYVAP 776
L + I+H +LK NILL+E+ +++D+G AK+L F YV+P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836
EL D+++ G I+ +LV G P + + + + + F
Sbjct: 180 ELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI-----FQKIIKLEYDFPEKFF 234
Query: 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876
R E ++R E+
Sbjct: 235 PKARDLVEK-----------LLVLDATKRLGCEEMEGYGP 263
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (309), Expect = 7e-32
Identities = 57/291 (19%), Positives = 104/291 (35%), Gaps = 37/291 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
++G G + V+ A +AVK L + F E + + H +VA
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 658 GYYWSSTMQL----ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+ T I+ E+V L D +H + R +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------------MTPKRAIEVIADAC 121
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG--LTKFHNAV 771
+AL++ + I+H ++K NI++ K+ D+G+A+ + N
Sbjct: 122 QALNFS---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178
Query: 772 GYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831
Y++PE A+ + + DVYS G +L E++TG P + V +
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV---------AYQHVRE 229
Query: 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-SMAEVVQVLESIRNG 881
+ +L V+ ++ P R + AE+ L + NG
Sbjct: 230 DPIPPSARHEGLSADLDAVVLK---ALAKNPENRYQTAAEMRADLVRVHNG 277
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 124 bits (312), Expect = 8e-32
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 22/218 (10%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
+G GS G V+ S G A+K L E + R++ E E LS + H ++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
G + + ++ +++ G L+ L A
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKS---------------QRFPNPVAKFYAAEVCL 115
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
L + I++ +LK NILLD+N K++D+G AK +P + Y+APE
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT----YTLCGTPDYIAPE 171
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
+ + + D +SFG+++ E++ G P T +
Sbjct: 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT 209
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 120 bits (302), Expect = 9e-31
Identities = 51/286 (17%), Positives = 99/286 (34%), Gaps = 29/286 (10%)
Query: 602 IGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQGYY 660
IG G+ G VY+A G + A+KK+ EI L ++H N+V
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 661 WSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLH 720
+ +++ E + + L L ++Y H
Sbjct: 70 HTKKRLVLVFEHLDQDLKKLLDVC------------EGGLESVTAKSFLLQLLNGIAYCH 117
Query: 721 HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ 780
+LH +LK N+L++ E K++D+GLA+ I + L
Sbjct: 118 ---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMG 174
Query: 781 SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV-----VLCEYVRELLERGSASACF 835
S + S D++S G I E+V G + + + +L + + +
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY 234
Query: 836 DRSLRGFAENELIQVMK------LGLI--CTSEVPSRRPSMAEVVQ 873
D + + +K + L+ P++R + + ++
Sbjct: 235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 117 bits (295), Expect = 7e-30
Identities = 58/289 (20%), Positives = 101/289 (34%), Gaps = 45/289 (15%)
Query: 601 LIGGGSIGSVYRASF-EGGVSIAVKKLETLGRI--------RNQEEFELEIGRLSNIR-H 650
++G G V R AVK ++ G +E E+ L + H
Sbjct: 10 ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69
Query: 651 FNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIAL 710
N++ + Y ++T ++ + + KG L+D L L I
Sbjct: 70 PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE------------KVTLSEKETRKIMR 117
Query: 711 GTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNA 770
+ LH K I+H +LK NILLD++ KL+D+G + L L +
Sbjct: 118 ALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGT 172
Query: 771 VGYVAPELAQSLRL------SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824
Y+APE+ + + D++S GVI+ L+ G P +
Sbjct: 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM--------- 223
Query: 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
L S + F + + ++ P +R + E +
Sbjct: 224 LRMIMSGNYQFGSPEWDDYSDTVKDLVSR---FLVVQPQKRYTAEEALA 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 55/277 (19%), Positives = 100/277 (36%), Gaps = 28/277 (10%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
++G G G V + + A+K L+ + R + E + +I + ++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI-VDVYENL 77
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
Y LI+ E + G L+ + G+ I A+ YL
Sbjct: 78 YAGRKCLLIVMECLDGGELFSRIQDR----------GDQAFTEREASEIMKSIGEAIQYL 127
Query: 720 HHDCKPPILHLNLKSTNILLDENYEP---KLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
H I H ++K N+L KL+D+G AK ++ T YVAP
Sbjct: 128 H---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL--TTPCYTPYYVAP 182
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACFD 836
E+ + CD++S GVI+ L+ G P S + ++ + G F
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS---PGMKTRIRMGQYE--FP 237
Query: 837 RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
E+ +++ P++R ++ E +
Sbjct: 238 NPEWSEVSEEVKMLIRN---LLKTEPTQRMTITEFMN 271
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 4e-29
Identities = 51/288 (17%), Positives = 96/288 (33%), Gaps = 29/288 (10%)
Query: 601 LIGGGSIGSVYRASFEG-GVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQG 658
IG G+ G VY+A + G +A+KK+ EI L + H N+V
Sbjct: 9 KIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLD 68
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
+ ++ EF+ + + + L++
Sbjct: 69 VIHTENKLYLVFEFLHQDLKKFMDASALTG-----------IPLPLIKSYLFQLLQGLAF 117
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPEL 778
H +LH +LK N+L++ KL+D+GLA+ + + L
Sbjct: 118 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174
Query: 779 AQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV-----VLCEYVRELLERGSASA 833
S D++S G I E+VT R + + + L + ++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234
Query: 834 CFDRSLRGFAENELIQVMK------LGLI--CTSEVPSRRPSMAEVVQ 873
+ S +A + +V+ L+ P++R S +
Sbjct: 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 115 bits (288), Expect = 6e-29
Identities = 36/295 (12%), Positives = 78/295 (26%), Gaps = 37/295 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IG GS G ++ + +A+K R + + E + + Y
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFEP---RRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ + +L + +L D L A + +
Sbjct: 69 FGQEGLHNVLVIDLLGPSLEDLLDLCGRK-----------FSVKTVAMAAKQMLARVQSI 117
Query: 720 HHDCKPPILHLNLKSTNILLDENYEP-----KLSDYGLAKLLP------ILDNYGLTKFH 768
H +++ ++K N L+ + D+G+ K +
Sbjct: 118 HE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174
Query: 769 NAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828
Y++ S + D+ + G + + + G P + E + E +
Sbjct: 175 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234
Query: 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLG 883
R L E + M + P + + + L
Sbjct: 235 TPL-----RELCAGFPEEFYKYMHY---ARNLAFDATPDYDYLQGLFSKVLERLN 281
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 9e-29
Identities = 52/220 (23%), Positives = 92/220 (41%), Gaps = 20/220 (9%)
Query: 601 LIGGGSIGSVYRASF-EGGVSIAVKKL--ETLGRIRNQEEFELEIGRLS-NIRHFNLVAF 656
++G GS G V+ A F + A+K L + + + E +E LS H L
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 657 QGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
+ + + E++ G+L ++ + SR A L
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQS------------CHKFDLSRATFYAAEIILGL 116
Query: 717 SYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAP 776
+L I++ +LK NILLD++ K++D+G+ K +L + F Y+AP
Sbjct: 117 QFL---HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN-MLGDAKTNTFCGTPDYIAP 172
Query: 777 ELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV 816
E+ + + D +SFGV+L E++ G+ P E+
Sbjct: 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF 212
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 115 bits (289), Expect = 2e-28
Identities = 47/225 (20%), Positives = 84/225 (37%), Gaps = 25/225 (11%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEE-----FELEIGRLSNIRHFNLV 654
+IG G G VY + G A+K L+ Q E + + +S +V
Sbjct: 11 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 70
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
+ + + + + G+L+ +L + + A
Sbjct: 71 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQ------------HGVFSEADMRFYAAEIIL 118
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYV 774
L ++H+ +++ +LK NILLDE+ ++SD GLA GY+
Sbjct: 119 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACD---FSKKKPHASVGTHGYM 172
Query: 775 APE-LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVL 818
APE L + + D +S G +L +L+ G P T + +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 217
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 2e-28
Identities = 57/283 (20%), Positives = 104/283 (36%), Gaps = 39/283 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKL-----ETLGRIRNQEEFELEIGRLSNIRHFNLV 654
+G G V + G+ A K + ++ R ++E+ E E+ L I+H N++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 655 AFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTAR 714
Y + T +++ E V G L+D L L +
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAE------------KESLTEEEATEFL---KQ 121
Query: 715 ALSYLHHDCKPPILHLNLKSTNILLDENYEP----KLSDYGLAKLLPILDNYGLTKFHNA 770
L+ +++ I H +LK NI+L + P K+ D+GLA +
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNIFGT 179
Query: 771 VGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830
+VAPE+ L + D++S GVI L++G P T E L +
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---------LANVSA 230
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ F+ ++ + P +R ++ + +Q
Sbjct: 231 VNYEFEDEYFSNTSALAKDFIRR---LLVKDPKKRMTIQDSLQ 270
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 115 bits (289), Expect = 3e-28
Identities = 80/395 (20%), Positives = 132/395 (33%), Gaps = 50/395 (12%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152
+ L L T + Q ++ + + + SI + + L N+ ++ S
Sbjct: 19 TALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 74
Query: 153 RNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQ 212
N + P TK V + NN + +AN T L G N
Sbjct: 75 NNQLTDITPLKNL-----TKLVDILMNNNQIADITPLANLTNLTGLTLFNNQ--ITDIDP 127
Query: 213 ICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNV 272
+ N+ L+ + + N ++ + LA L +IS V
Sbjct: 128 LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKV 187
Query: 273 SHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTG 332
S ++ ++ A+ N+ + P + NL L L N+L
Sbjct: 188 SDISVLAKLTN-------LESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGT 236
Query: 333 ITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVP-------------- 378
+ L L + LANN I + P L + L L L + P
Sbjct: 237 LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNE 294
Query: 379 ------DDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNL 432
ISN + L L + N + P + ++T L+ L N + S SL NL
Sbjct: 295 NQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKV--SDVSSLANL 350
Query: 433 SNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467
+N+ L N +S P L NL +T L+
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.1 bits (235), Expect = 2e-21
Identities = 64/366 (17%), Positives = 115/366 (31%), Gaps = 50/366 (13%)
Query: 142 DLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFS 201
L L + + + + + + + SI + L +FS
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLD---QVTTLQADRLGIK-SID-GVEYLNNLTQINFS 74
Query: 202 FNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGV 261
N L+ P + N+ L I + N + + L + I
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 262 LGLKNISYFN-------------VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLS 308
+ N + F ++ ++ + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 309 ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDL 368
+ NL+ L N++ P GI L ++SL N + I L S+ L LDL
Sbjct: 193 LAKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GTLASLTNLTDLDL 248
Query: 369 HNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIP--------------------QTLYNM 408
N + P +S L L + N + P + N+
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNL 306
Query: 409 TYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNN 468
L L L+ N+++ +P + +L+ LQ L + N +S SSL NL N+ + N
Sbjct: 307 KNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQ 362
Query: 469 LSGTIP 474
+S P
Sbjct: 363 ISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 1e-17
Identities = 47/207 (22%), Positives = 82/207 (39%), Gaps = 16/207 (7%)
Query: 190 ANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLS 249
A T LE + N +S P I LD +S+ GN L + ++ +LDL+
Sbjct: 194 AKLTNLESLIATNNQISDITPLGIL--TNLDELSLNGNQLKDI--GTLASLTNLTDLDLA 249
Query: 250 SNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSI 309
+N LAP GL ++ + N P G+ + + E I
Sbjct: 250 NNQISNLAPLS--GLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPIS--- 304
Query: 310 TNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLH 369
N +NL L L FN + P ++ L +L ++ ANN + +L ++ + L
Sbjct: 305 -NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAG 359
Query: 370 NLNLRGEVPDDISNCRFLLLLDVSGNA 396
+ + P ++N + L ++ A
Sbjct: 360 HNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 6e-16
Identities = 38/224 (16%), Positives = 70/224 (31%), Gaps = 15/224 (6%)
Query: 52 SWVSSGNPCENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGN 111
+ + + N + L + L L +L L+L GN+
Sbjct: 175 TTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKD- 233
Query: 112 LPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKT 171
A + L +++++N +S P + L + L L N S P A
Sbjct: 234 -IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL 290
Query: 172 KFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTG 231
+ + I+N L FNN+S P + ++ L + N ++
Sbjct: 291 ELNENQLED-----ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD 343
Query: 232 TVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHN 275
+ +I L N L P L I+ ++
Sbjct: 344 V--SSLANLTNINWLSAGHNQISDLTPLA--NLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 61.6 bits (148), Expect = 2e-10
Identities = 33/170 (19%), Positives = 62/170 (36%), Gaps = 31/170 (18%)
Query: 79 LWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIP- 137
L L + L+ L +L L L N+ + P + + L ++ + +N +S P
Sbjct: 226 LNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPL 281
Query: 138 -------------------EFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSH 178
I +L N+ L L N+ S P + K + + ++
Sbjct: 282 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLT---KLQRLFFAN 338
Query: 179 NNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNA 228
N +S S+AN T + N +S P + N+ + + + A
Sbjct: 339 NKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 3e-06
Identities = 15/88 (17%), Positives = 32/88 (36%), Gaps = 8/88 (9%)
Query: 378 PDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQV 437
D + + + + QT ++ + L + + + + L+NL
Sbjct: 17 TDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK--SIDGVEYLNNLTQ 70
Query: 438 LDLSQNSLSGSIPSSLGNLRNLTHFNLS 465
++ S N L+ P L NL L ++
Sbjct: 71 INFSNNQLTDITP--LKNLTKLVDILMN 96
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 113 bits (282), Expect = 5e-28
Identities = 39/289 (13%), Positives = 80/289 (27%), Gaps = 37/289 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IG GS G +Y G +A+K + +E ++ + +
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLEC---VKTKHPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 660 YWSSTMQLIL-SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
+ ++ E + + + +A + Y
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFC------------SRKFSLKTVLLLADQMISRIEY 118
Query: 719 LHHDCKPPILHLNLKSTNIL---LDENYEPKLSDYGLAKLLP------ILDNYGLTKFHN 769
+H +H ++K N L + + D+GLAK +
Sbjct: 119 IH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175
Query: 770 AVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829
Y + + S + D+ S G +L+ G P + E + E
Sbjct: 176 TARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS- 234
Query: 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878
L +E + C S +P + + Q+ ++
Sbjct: 235 ----TPIEVLCKGYPSEFATYLNF---CRSLRFDDKPDYSYLRQLFRNL 276
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 6e-28
Identities = 56/296 (18%), Positives = 106/296 (35%), Gaps = 39/296 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
IG G+ G V A V +A+KK+ + EI L RH N++
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 660 YWSSTMQ----LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
+ T++ + L + +LY L L + R
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLK-------------TQHLSNDHICYFLYQILRG 121
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYG--LTKFHNAVGY 773
L Y+H +LH +LK +N+LL+ + K+ D+GLA++ ++ LT++ Y
Sbjct: 122 LKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178
Query: 774 VAPELAQSLRLSD-KCDVYSFGVILLELVTGRKPVESPTTNE----VVVLCEYVRELLER 828
APE+ + + D++S G IL E+++ R + ++ + +
Sbjct: 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 238
Query: 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEV-----------PSRRPSMAEVVQ 873
+ L + +L S+ P +R + + +
Sbjct: 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 8e-28
Identities = 64/293 (21%), Positives = 104/293 (35%), Gaps = 38/293 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEE----FELEIGRLSNIRHFNLVA 655
+G G +VY+A +A+KK++ R ++ EI L + H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
+ + ++ +F+ + L S L T +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDN------------SLVLTPSHIKAYMLMTLQG 112
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVA 775
L YLH ILH +LK N+LLDEN KL+D+GLAK N T Y A
Sbjct: 113 LEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-PNRAYTHQVVTRWYRA 168
Query: 776 PELAQSLRLSD-KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834
PEL R+ D+++ G IL EL+ + P +++ L L
Sbjct: 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFL--PGDSDLDQLTRIFETLGTPTEEQWP 226
Query: 835 FDRSLRGFAENELIQVMKLGLI--------------CTSEVPSRRPSMAEVVQ 873
SL + + + L I P R + + ++
Sbjct: 227 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 4e-27
Identities = 47/218 (21%), Positives = 84/218 (38%), Gaps = 19/218 (8%)
Query: 601 LIGGGSIGSVYRASFEG-GVSIAVKKL--ETLGRIRNQEEFELEIGRLSNIRHFNLVAFQ 657
L+G G+ G V + G A+K L E + E L N RH L A +
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 658 GYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALS 717
+ + + E+ G L+ +L R A +S
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSR------------ERVFTEERARFYG---AEIVS 116
Query: 718 YLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE 777
L + +++ ++K N++LD++ K++D+GL K D + F Y+APE
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTFCGTPEYLAPE 175
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
+ + D + GV++ E++ GR P + +
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 6e-27
Identities = 56/288 (19%), Positives = 97/288 (33%), Gaps = 31/288 (10%)
Query: 602 IGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQGY 659
IG G+ G+V++A + E +A+K++ EI L ++H N+V
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
S ++ EF + N +L + L L
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSC------------NGDLDPEIVKSFL---FQLLKGL 114
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELA 779
+LH +LK N+L++ N E KL+++GLA+ I + L
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLF 174
Query: 780 QSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV------VLCEYVRELLERGSASA 833
+ S D++S G I EL +P+ + +L E +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP 234
Query: 834 CFDRSLRGFAENELIQVMK------LGLI--CTSEVPSRRPSMAEVVQ 873
+ A L+ V+ L+ P +R S E +Q
Sbjct: 235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 9e-27
Identities = 50/289 (17%), Positives = 93/289 (32%), Gaps = 28/289 (9%)
Query: 602 IGGGSIGSVYRA--SFEGGVSIAVKKLETLGRIRNQEEFEL----EIGRLSNIRHFNLVA 655
IG G+ G V++A GG +A+K++ + + L H N+V
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 656 FQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARA 715
S + ++ +L + P + + R
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK------VPEPGVPTETIKDMMFQLLRG 128
Query: 716 LSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVA 775
L +LH ++H +LK NIL+ + + KL+D+GLA++ T + Y A
Sbjct: 129 LDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--TSVVVTLWYRA 183
Query: 776 PELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
PE+ + D++S G I E+ + + + + V L
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243
Query: 836 DRSLRGFAENELIQVMKLGLICTSEV-----------PSRRPSMAEVVQ 873
+ F + K P++R S +
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 4e-26
Identities = 62/299 (20%), Positives = 113/299 (37%), Gaps = 49/299 (16%)
Query: 601 LIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+IG GS G VY+A + G +A+KK+ ++++ E+ + + H N+V + +
Sbjct: 27 VIGNGSFGVVYQAKLCDSGELVAIKKV-----LQDKRFKNRELQIMRKLDHCNIVRLRYF 81
Query: 660 YWSST-------MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
++SS + L+L ++VP+ H L
Sbjct: 82 FYSSGEKKDEVYLNLVL-DYVPETVYRVARHYSR---------AKQTLPVIYVKLYMYQL 131
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
R+L+Y+H I H ++K N+LLD + KL D+G AK L + +
Sbjct: 132 FRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSR 186
Query: 772 GYVAP-ELAQSLRLSDKCDVYSFGVILLELVTGRKP----------------VESPTTNE 814
Y AP + + + DV+S G +L EL+ G+ + +PT +
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246
Query: 815 VVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
+ + E + + + R E I + P+ R + E
Sbjct: 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSR---LLEYTPTARLTPLEACA 302
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 107 bits (268), Expect = 5e-26
Identities = 59/296 (19%), Positives = 106/296 (35%), Gaps = 33/296 (11%)
Query: 602 IGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRN-QEEFELEIGRLSNIRHFNLVAFQGY 659
IG G+ G V++A + G +A+KK+ EI L ++H N+V
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYL 719
+ KG++Y + G+ + L I L+ L
Sbjct: 78 CRTKAS----PYNRCKGSIYLVFD---FCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 130
Query: 720 HHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG---YVAP 776
++ + ILH ++K+ N+L+ + KL+D+GLA+ + N ++ N V Y P
Sbjct: 131 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP 190
Query: 777 ELAQSLRL-SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASACF 835
EL R D++ G I+ E+ T + E L +
Sbjct: 191 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM--QGNTEQHQLALISQLCGSITPEVWPN 248
Query: 836 DRSLRGFAENELIQVMK----------------LGLI--CTSEVPSRRPSMAEVVQ 873
+ + + EL++ K L LI P++R + +
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 5e-26
Identities = 56/283 (19%), Positives = 97/283 (34%), Gaps = 49/283 (17%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLE-----TLGRIRNQEEFELEIGRLSNIR--HFN 652
L+G G GSVY + +A+K +E G + N +E+ L +
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
++ ++ +++ E + L
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-----------LQEELARSFFWQV 119
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDEN-YEPKLSDYGLAKLLPILDNYGLTKFHNAV 771
A+ + +LH ++K NIL+D N E KL D+G LL + T F
Sbjct: 120 LEAVRHC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTR 173
Query: 772 GYVAPELAQSLRLSDK-CDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830
Y PE + R + V+S G++L ++V G P E E +R +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--------EIIRGQVF--- 222
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873
R +E +++ C + PS RP+ E+
Sbjct: 223 --------FRQRVSSECQHLIRW---CLALRPSDRPTFEEIQN 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 104 bits (259), Expect = 1e-24
Identities = 46/244 (18%), Positives = 90/244 (36%), Gaps = 24/244 (9%)
Query: 578 SKSLPSKYEDWEAGTKALLDKECL--IGGGSIGSVYRA-SFEGGVSIAVKKL--ETLGRI 632
+ K+E T L + + +G GS G V E G A+K L + + ++
Sbjct: 23 KEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKL 82
Query: 633 RNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTST 692
+ E E L + LV + + ++ ++ E+V G ++ +L
Sbjct: 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-------- 134
Query: 693 GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752
A YLH +++ +LK N+L+D+ +++D+G
Sbjct: 135 ----IGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGF 187
Query: 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTT 812
AK +APE+ S + D ++ GV++ E+ G P +
Sbjct: 188 AKR----VKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243
Query: 813 NEVV 816
++
Sbjct: 244 IQIY 247
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (251), Expect = 1e-23
Identities = 53/291 (18%), Positives = 111/291 (38%), Gaps = 33/291 (11%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLE-TLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ G+V A G +A+KKL + E+ L ++RH N++
Sbjct: 25 PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLD 84
Query: 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSY 718
+ ++F G + + +L R + + L Y
Sbjct: 85 VFTPDETLDDFTDFYLVMPFMGTDLGKL--------MKHEKLGEDRIQFLVYQMLKGLRY 136
Query: 719 LHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPE- 777
+H H +LK N+ ++E+ E K+ D+GLA+ + +T + Y APE
Sbjct: 137 IHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQA----DSEMTGYVVTRWYRAPEV 189
Query: 778 LAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV-----VLCEYVRELLERGSA- 831
+ +R + D++S G I+ E++TG+ + + + V E ++R +
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249
Query: 832 -SACFDRSLRGFAENELIQVMK------LGLI--CTSEVPSRRPSMAEVVQ 873
+ + + L + + ++ + L+ +R + E +
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 99.1 bits (246), Expect = 3e-23
Identities = 55/280 (19%), Positives = 100/280 (35%), Gaps = 37/280 (13%)
Query: 601 LIGGGSIGSVYRA----SFEGGVSIAVKKL---ETLGRIRNQEEFELEIGRLSNIRHF-N 652
++G G+ G V+ + G A+K L + + + E E L +IR
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 653 LVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
LV + + T ++ +++ G L+ +L E
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQ---------RERFTEHEVQIYV------ 135
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+ L H K I++ ++K NILLD N L+D+GL+K + F +
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195
Query: 773 YVAPELAQSLRLSD--KCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830
Y+AP++ + D +S GV++ EL+TG P E E R +L+
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF--TVDGEKNSQAEISRRILK--- 250
Query: 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAE 870
+ +++ + P +R
Sbjct: 251 ----SEPPYPQEMSALAKDLIQR---LLMKDPKKRLGCGP 283
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 98.3 bits (243), Expect = 6e-23
Identities = 71/269 (26%), Positives = 105/269 (39%), Gaps = 7/269 (2%)
Query: 238 SQCQSIKNLDLSSNLFIGLA--PFGVLGLKNISYFNVSHN-GFHGEIPEVGICGEGMQVF 294
+Q + NLDLS P + L +++ + G IP +
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 295 DASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP 354
+ G IP ++ + L LD +N L G++P I+ L L+ I+ N I G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 355 PNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKIL 414
+ GS L + N L +D+S N L+
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM-LEGDASVLFGSDKNTQK 225
Query: 415 DLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
+ +G NL LDL N + G++P L L+ L N+S NNL G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 475 ST--IQHFGVSTFLNNTGLCGPPLETSCS 501
+Q F VS + NN LCG PL +C+
Sbjct: 286 QGGNLQRFDVSAYANNKCLCGSPLP-ACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 94.0 bits (232), Expect = 2e-21
Identities = 69/331 (20%), Positives = 118/331 (35%), Gaps = 58/331 (17%)
Query: 30 TDKEILLQFKGNITDDPHNKLASWVSSGNPC-ENFKGVFCNPDGFVDRIV---LWNFSLG 85
DK+ LLQ K ++ + L+SW+ + + C + GV C+ D R+ L +L
Sbjct: 6 QDKQALLQIKKDLGNP--TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 86 GV--LSPALSGLKSLRVLTLFGN-RFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGD 142
+ +L+ L L L + G G +P A++ L + ++ +SG+IP+F+
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 143 LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSF 202
+ + LD S N+ SG +P ++ N +SG+IP S + + L
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGIT-FDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 203 NN-----------------------LSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQ 239
N + S + +
Sbjct: 183 RNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 240 CQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWN 299
+++ LDL +N G P G+ LK + NVS N GEIP+ G
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG-------------- 288
Query: 300 EFDGVIPLSITNCRNLKVLDLGFNRLIGSIP 330
N + V N+ + P
Sbjct: 289 -----------NLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 56.7 bits (135), Expect = 5e-09
Identities = 17/75 (22%), Positives = 35/75 (46%), Gaps = 4/75 (5%)
Query: 119 MQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSH 178
+ L +++ +N + G++P+ + L + L++S N+ GEIP + + ++
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ--GGNLQRFDVSAYAN 300
Query: 179 NNLSGSIPLSIANCT 193
N PL CT
Sbjct: 301 NKCLCGSPLP--ACT 313
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 44.4 bits (103), Expect = 4e-05
Identities = 41/133 (30%), Positives = 64/133 (48%), Gaps = 3/133 (2%)
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRG--EVPDDISNCRFLLLLDVSGNA-LGGDIPQTLYN 407
G++ + LDL LNL +P ++N +L L + G L G IP +
Sbjct: 40 GVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAK 99
Query: 408 MTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSN 467
+T L L + +++G+ P L + L LD S N+LSG++P S+ +L NL N
Sbjct: 100 LTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159
Query: 468 NLSGTIPSTIQHF 480
+SG IP + F
Sbjct: 160 RISGAIPDSYGSF 172
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.3 bits (223), Expect = 5e-20
Identities = 55/295 (18%), Positives = 111/295 (37%), Gaps = 41/295 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLE-TLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658
+G G+ GSV A + G+ +AVKKL I + + E+ L +++H N++
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 659 YYWSST-----MQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTA 713
+ + + L + +L + + +L +
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-------------CQKLTDDHVQFLIYQIL 131
Query: 714 RALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGY 773
R L Y+H H +LK +N+ ++E+ E K+ D+GLA D+
Sbjct: 132 RGLKYIHSADII---HRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMTGYVATRWYR 185
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVV-----VLCEYVRELLER 828
+ + + D++S G I+ EL+TGR + + ++ ELL++
Sbjct: 186 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 245
Query: 829 GSASA--CFDRSLRGFAENELIQVMK------LGLI--CTSEVPSRRPSMAEVVQ 873
S+ + + +SL + V + L+ +R + A+ +
Sbjct: 246 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 88.2 bits (217), Expect = 1e-19
Identities = 48/302 (15%), Positives = 97/302 (32%), Gaps = 37/302 (12%)
Query: 171 TKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALT 230
T + L +N ++ N L N +S P + L+ + + N L
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 231 GTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEG 290
E+ Q L + N + GL + + N
Sbjct: 93 ELPEKMPKTLQ---ELRVHENEITKVRKSVFNGLNQMIVVELGTN--------------- 134
Query: 291 MQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIG 350
+ G+ + + L + + + +IP G+ L ++ L N I
Sbjct: 135 -------PLKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQGL--PPSLTELHLDGNKIT 184
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTY 410
+ +L + L L L ++ ++N L L ++ N L +P L + Y
Sbjct: 185 KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKY 243
Query: 411 LKILDLHQNHLNG------STPPSLGNLSNLQVLDLSQNSLSGS--IPSSLGNLRNLTHF 462
++++ LH N+++ P ++ + L N + PS+ +
Sbjct: 244 IQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAV 303
Query: 463 NL 464
L
Sbjct: 304 QL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.3 bits (207), Expect = 3e-18
Identities = 45/281 (16%), Positives = 94/281 (33%), Gaps = 14/281 (4%)
Query: 96 KSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNS 155
+L L N+ T ++ ++ L + + +N +S P L + L LS+N
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 156 YSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICN 215
E+P + K + + + S+ + +E SG
Sbjct: 91 LK-ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNP-LKSSGIENGAFQG 148
Query: 216 IPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHN 275
+ L +I + +T + S+ L L N + + GL N++ +S N
Sbjct: 149 MKKLSYIRIADTNITTIPQGLPP---SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 276 GFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIG------SI 329
++ + N+ +P + + + ++V+ L N +
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCP 264
Query: 330 PTGITDLRRLLKISLANNSI--GGIIPPNLGSIELLEVLDL 368
P T +SL +N + I P + + + L
Sbjct: 265 PGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 82.0 bits (201), Expect = 2e-17
Identities = 36/190 (18%), Positives = 72/190 (37%), Gaps = 4/190 (2%)
Query: 291 MQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIG 350
+ D N+ + N +NL L L N++ P L +L ++ L+ N +
Sbjct: 33 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 92
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTY 410
+ +++ L V + +R V + ++ ++ L + G M
Sbjct: 93 ELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMI-VVELGTNPLKSSGIENGAFQGMKK 151
Query: 411 LKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
L + + ++ T G +L L L N ++ +SL L NL LS N++S
Sbjct: 152 LSYIRIADTNI---TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSIS 208
Query: 471 GTIPSTIQHF 480
++ +
Sbjct: 209 AVDNGSLANT 218
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 77.8 bits (190), Expect = 4e-16
Identities = 45/261 (17%), Positives = 93/261 (35%), Gaps = 8/261 (3%)
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
LDL +N + LKN+ + +N P ++ S N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
+ + L+V + ++ S+ G+ ++++ GI +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLN-QMIVVELGTNPLKSSGIENGAFQGM 149
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
+ L + + + N+ +P + L L + GN + +L + L L L N
Sbjct: 150 KKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQ-- 478
++ SL N +L+ L L+ N L +P L + + + L +NN+S +
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 479 -HFGVSTFLNNTGLCGPPLET 498
+ + L P++
Sbjct: 266 GYNTKKASYSGVSLFSNPVQY 286
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 63.1 bits (152), Expect = 3e-11
Identities = 40/273 (14%), Positives = 88/273 (32%), Gaps = 30/273 (10%)
Query: 76 RIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGS 135
++L N + + A + L L L L N+ + +Q L N ++
Sbjct: 59 TLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRV---HENEITKV 115
Query: 136 IPEFIGDLPNIRLLDL--SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCT 193
L + +++L + SG A F+ K ++ ++ N++ +IP +
Sbjct: 116 RKSVFNGLNQMIVVELGTNPLKSSGIENGA-FQGMKKLSYIRIADTNIT-TIPQGL--PP 171
Query: 194 YLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLF 253
L N ++ + + + L + + N+++ + ++ L +N
Sbjct: 172 SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH-LNNNK 230
Query: 254 IGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCR 313
+ P G+ K I + +N I C P T
Sbjct: 231 LVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCP-----------------PGYNTKKA 272
Query: 314 NLKVLDLGFNRL--IGSIPTGITDLRRLLKISL 344
+ + L N + P+ + + L
Sbjct: 273 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 60.8 bits (146), Expect = 2e-10
Identities = 22/88 (25%), Positives = 29/88 (32%), Gaps = 2/88 (2%)
Query: 401 IPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLT 460
+P+ L +LDL N + NL NL L L N +S P + L L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 461 HFNLSSNNLSGTIPSTIQHFGVSTFLNN 488
LS N L + N
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHEN 110
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 59.3 bits (142), Expect = 5e-10
Identities = 29/140 (20%), Positives = 49/140 (35%), Gaps = 3/140 (2%)
Query: 363 LEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
L V+ +L L +VP D+ LLD+ N + N+ L L L N ++
Sbjct: 12 LRVVQCSDLGLE-KVPKDLPPD--TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 68
Query: 423 GSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGV 482
+P + L L+ L LS+N L L+ L + ++ + + V
Sbjct: 69 KISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIV 128
Query: 483 STFLNNTGLCGPPLETSCSG 502
N + G
Sbjct: 129 VELGTNPLKSSGIENGAFQG 148
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 40.4 bits (93), Expect = 7e-04
Identities = 30/174 (17%), Positives = 49/174 (28%), Gaps = 10/174 (5%)
Query: 41 NITDDPHNKLASWVSSGNPCENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSG--LKSL 98
+ N L + K F L + + SL
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL 173
Query: 99 RVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSG 158
L L GN+ T + L K+ +S N++S + + P++R L L+ N
Sbjct: 174 TELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK 233
Query: 159 EIPFALFKYCYKTKFVSLSHNNLSG------SIPLSIANCTYLEGFDFSFNNLS 206
+ V L +NN+S P G N +
Sbjct: 234 VPGG--LADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (213), Expect = 3e-19
Identities = 42/239 (17%), Positives = 75/239 (31%), Gaps = 2/239 (0%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
+ + + L N + +N++ + N ++ D S N
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 302 DGVI-PLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
+ P + L L L L P L L + L +N++ + +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 361 ELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNH 420
L L LH + L L + N + P ++ L L L N+
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 421 LNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
L+ +L L LQ L L+ N + L F SS+ + ++P +
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCR-ARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 83.7 bits (205), Expect = 3e-18
Identities = 39/255 (15%), Positives = 76/255 (29%), Gaps = 4/255 (1%)
Query: 121 TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180
+I + N +S N+ +L L N + A + +
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQ 92
Query: 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQC 240
L P + L L P + L ++ ++ NAL ++ F
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 241 QSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
++ +L L N + GL ++ + N P + N
Sbjct: 153 GNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANN 212
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI 360
+ ++ R L+ L L N + L K +++ + +P L
Sbjct: 213 LSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPCSLPQRLAGR 271
Query: 361 ELLEVLDLHNLNLRG 375
+L L +L+G
Sbjct: 272 DL---KRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.6 bits (197), Expect = 4e-17
Identities = 53/324 (16%), Positives = 92/324 (28%), Gaps = 57/324 (17%)
Query: 125 INVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGS 184
+ L ++P I + + L N +S
Sbjct: 16 TSCPQQGLQ-AVPVGIP--AASQRIF-------------------------LHGNRISHV 47
Query: 185 IPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTV-EEQFSQCQSI 243
S C L N L+ + + +L+ + + NA +V F +
Sbjct: 48 PAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRL 107
Query: 244 KNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDG 303
L L L P GL + Y + N + + N
Sbjct: 108 HTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167
Query: 304 VIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELL 363
V + +L L L NR+ P DL RL+ + L N++ + L + L
Sbjct: 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRAL 227
Query: 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNG 423
+ L L++ +CR L +L+ + +
Sbjct: 228 QYLRLNDNPWVC-------DCRARPLWA------------------WLQKFRGSSSEVPC 262
Query: 424 STPPSLGNLSNLQVLDLSQNSLSG 447
S P L+ + L+ N L G
Sbjct: 263 SLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.4 bits (160), Expect = 2e-12
Identities = 52/214 (24%), Positives = 72/214 (33%), Gaps = 4/214 (1%)
Query: 292 QVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLK-ISLANNSIG 350
Q N V S CRNL +L L N L T L L + N +
Sbjct: 35 QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94
Query: 351 GIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTY 410
+ P + L L L L+ P L L + NAL T ++
Sbjct: 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGN 154
Query: 411 LKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
L L LH N ++ + L +L L L QN ++ P + +L L L +NNLS
Sbjct: 155 LTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
Query: 471 GTIPSTIQHFGVSTFLNNTGLCGPPLETSCSGRG 504
+ +L L P C R
Sbjct: 215 ALPTEALAPLRALQYLR---LNDNPWVCDCRARP 245
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.7 bits (122), Expect = 1e-07
Identities = 31/161 (19%), Positives = 54/161 (33%), Gaps = 5/161 (3%)
Query: 47 HNKLASWVSSGNPCENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGN 106
L N + G + + L + V A GL SL L L N
Sbjct: 128 LAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQN 187
Query: 107 RFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFK 166
R P + ++ L + + +N LS E + L ++ L L+ N + +
Sbjct: 188 RVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLW 247
Query: 167 YCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSG 207
+ S + + S+P +A + N+L G
Sbjct: 248 AWLQK--FRGSSSEVPCSLPQRLAGRDLK---RLAANDLQG 283
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.4 bits (210), Expect = 2e-18
Identities = 39/223 (17%), Positives = 84/223 (37%), Gaps = 28/223 (12%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQ-EEFELEIGRLSNIRHFNLVAFQG 658
IG G+ G V A ++A+KKL + + + E+ + + H N+++
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 659 YYWSS------TMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGT 712
+ ++ E + ++ R ++
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD---------------HERMSYLLYQM 128
Query: 713 ARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNYGLTKFHNAVG 772
+ +LH I+H +LK +NI++ + K+ D+GLA+ ++ +T +
Sbjct: 129 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY 183
Query: 773 YVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEV 815
Y APE+ + + D++S G I+ E+V + +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQ 226
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 85.5 bits (210), Expect = 2e-18
Identities = 51/312 (16%), Positives = 96/312 (30%), Gaps = 43/312 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGY 659
+G G +V+ A +A+K + G E E EI L + +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77
Query: 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGI----GNPELHWSRRFHIALGTARA 715
+ ++L+ N + G + + + + I+
Sbjct: 78 GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137
Query: 716 LSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKL-LPILDNYGLTKFHNAVGY 773
L Y+H C I+H ++K N+L++ + L +A L + T Y
Sbjct: 138 LDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREY 195
Query: 774 VAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNE-----------VVVLCEYV 822
+PE+ D++S ++ EL+TG E + + +L E
Sbjct: 196 RSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255
Query: 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEV--------------------- 861
LL G + F S ++ L + T +
Sbjct: 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315
Query: 862 PSRRPSMAEVVQ 873
P +R +V
Sbjct: 316 PRKRADAGGLVN 327
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 84.5 bits (208), Expect = 4e-18
Identities = 42/219 (19%), Positives = 80/219 (36%), Gaps = 30/219 (13%)
Query: 601 LIGGGSIGSVYRA-SFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQG 658
+G G V+ A + + VK L + +++ + EI L N+R N++
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKIL----KPVKKKKIKREIKILENLRGGPNIITLAD 97
Query: 659 YYWSSTMQLI--LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARAL 716
+ + E V + L +AL
Sbjct: 98 IVKDPVSRTPALVFEHVNNTDFKQLYQT---------------LTDYDIRFYMYEILKAL 142
Query: 717 SYLHHDCKPPILHLNLKSTNILLD-ENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVA 775
Y H I+H ++K N+++D E+ + +L D+GLA+ Y + +
Sbjct: 143 DYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKG 197
Query: 776 PELAQSLRLSD-KCDVYSFGVILLELVTGRKPVESPTTN 813
PEL ++ D D++S G +L ++ ++P N
Sbjct: 198 PELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 236
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 33/291 (11%), Positives = 80/291 (27%), Gaps = 23/291 (7%)
Query: 149 LDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
LDL+ + ++ L + + + + ++ D S + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ--GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVS 61
Query: 209 -LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNI 267
L + L +S+ G L+ + ++ ++ L+LS L
Sbjct: 62 TLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCS 121
Query: 268 SYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIG 327
++ + + + G + + V +
Sbjct: 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL- 180
Query: 328 SIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN-LRGEVPDDISNCRF 386
+ + + L+ L L + E ++
Sbjct: 181 --------------DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226
Query: 387 LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQV 437
L L V G G + + +L+I + +H P++GN N ++
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALPHLQI---NCSHFTTIARPTIGNKKNQEI 274
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 38/267 (14%), Positives = 91/267 (34%), Gaps = 16/267 (5%)
Query: 222 ISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEI 281
+ + G L V + Q + + F+ + + ++S++
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRS-FMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 282 PEVGICG-EGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLI--GSIPTGITDLRR 338
+ +Q I ++ NL L+L ++ T ++ R
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 339 LLKISLANNSIGG------IIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDV 392
L +++L+ + +I L + + ++ + C L+ LD+
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 393 SGNALGGD-IPQTLYNMTYLKILDLHQ-NHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIP 450
S + + + Q + + YL+ L L + + T LG + L+ L + G++
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 451 SSLGNLRNLTHFNLSSNNLSGTIPSTI 477
L +L ++ ++ + TI
Sbjct: 243 LLKEALPHL---QINCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 6e-08
Identities = 41/245 (16%), Positives = 73/245 (29%), Gaps = 13/245 (5%)
Query: 246 LDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF-DGV 304
LDL+ +L + F + + E +Q D S +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAE-HFSPFRVQHMDLSNSVIEVST 62
Query: 305 IPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANN--------SIGGIIPPN 356
+ ++ C L+ L L RL I + L++++L+
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 357 LGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDL 416
L + L D +++ V L L N D+ + L LDL
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 417 HQNHL-NGSTPPSLGNLSNLQVLDLSQ-NSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474
+ + L+ LQ L LS+ + LG + L + GT+
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 475 STIQH 479
+
Sbjct: 243 LLKEA 247
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 1e-10
Identities = 35/208 (16%), Positives = 65/208 (31%), Gaps = 8/208 (3%)
Query: 140 IGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFD 199
+ + + ++ + + + +P L K T + LS N L ++ T L +
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLPKD---TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 200 FSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPF 259
+PVL + ++ ++ LD+S N L
Sbjct: 62 LD--RAELTKLQVDGTLPVL-GTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 260 GVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLD 319
+ GL + + N P + ++ + N + + NL L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 320 LGFNRLIGSIPTGITDLRRLLKISLANN 347
L N L +IP G L L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.1 bits (131), Expect = 9e-09
Identities = 39/186 (20%), Positives = 59/186 (31%), Gaps = 24/186 (12%)
Query: 305 IPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP----PNLGSI 360
+P + ++ +L L N L + RL +++L + + P LG++
Sbjct: 25 LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTL 82
Query: 361 ELLEVLDLHNLN-----------------LRGEVPDDISNCRFLLLLDVSGNALGGDIPQ 403
+L L + L L + GN L P
Sbjct: 83 DLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPG 142
Query: 404 TLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFN 463
L L+ L L N+L L L NL L L +NSL +IP L
Sbjct: 143 LLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 464 LSSNNL 469
L N
Sbjct: 202 LHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (124), Expect = 7e-08
Identities = 31/206 (15%), Positives = 61/206 (29%), Gaps = 24/206 (11%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152
S + S + T LP + + +++S N L + + L+L
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLD 63
Query: 153 RNSYSGEIPFALFK--------------------YCYKTKFVSLSHNNLSGSIPLSIANC 192
R + + +S N L+ ++
Sbjct: 64 RAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123
Query: 193 TYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNL 252
L+ N L P + P L+ +S+ N LT + +++ L L N
Sbjct: 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENS 183
Query: 253 FIGLAPFGVLGLKNISYFNVSHNGFH 278
+ P G G + + + N +
Sbjct: 184 LYTI-PKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 14/62 (22%), Positives = 25/62 (40%), Gaps = 3/62 (4%)
Query: 407 NMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSS 466
+ ++ + +L + PP L + +L LS+N L ++L LT NL
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 467 NN 468
Sbjct: 65 AE 66
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 55.6 bits (133), Expect = 2e-09
Identities = 24/163 (14%), Positives = 46/163 (28%), Gaps = 28/163 (17%)
Query: 601 LIGGGSIGSVYRASFEGGVSIAVKKLET---------LGRIRNQEEFELEIGRLSNIRHF 651
L+G G +V+ E VK + R F + R +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALG 711
L QG VPK ++ + + + +
Sbjct: 67 ALQKLQGLA------------VPKVYAWEGNAVLMELIDAKELYRVRVENPDE---VLDM 111
Query: 712 TARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754
++ +H I+H +L N+L+ E + D+ +
Sbjct: 112 ILEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQSV 150
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.4 bits (134), Expect = 6e-09
Identities = 21/87 (24%), Positives = 34/87 (39%), Gaps = 10/87 (11%)
Query: 395 NALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLG 454
NA +I L+ L++ N L P L + L S N L+ +P
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQ 324
Query: 455 NLRNLTHFNLSSNNLSG--TIPSTIQH 479
NL+ L ++ N L IP +++
Sbjct: 325 NLKQL---HVEYNPLREFPDIPESVED 348
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 4e-08
Identities = 56/338 (16%), Positives = 96/338 (28%), Gaps = 28/338 (8%)
Query: 122 LWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNL 181
++ +++ LS S+PE P++ L S NS + E+P K + + +NNL
Sbjct: 40 AHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQS----LKSLLVDNNNL 90
Query: 182 SGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQ 241
L LE S N L Q + + + +
Sbjct: 91 KALSDL----PPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIA 146
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
+ N L + N S + E G +
Sbjct: 147 AGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPF- 205
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIE 361
L+ N + L + L + + + +
Sbjct: 206 -----LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLS 260
Query: 362 LLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHL 421
L + E+ L L+VS N L ++P L+ L NHL
Sbjct: 261 ELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHL 316
Query: 422 NGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNL 459
+ P L NL+ L + N L P ++ +L
Sbjct: 317 --AEVPEL--PQNLKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 15/74 (20%), Positives = 29/74 (39%), Gaps = 5/74 (6%)
Query: 406 YNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLS 465
++ L + N + +L+ L++S N L +P+ L L S
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IAS 312
Query: 466 SNNLSGTIPSTIQH 479
N+L+ +P Q+
Sbjct: 313 FNHLA-EVPELPQN 325
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 48.3 bits (113), Expect = 3e-06
Identities = 21/93 (22%), Positives = 35/93 (37%), Gaps = 9/93 (9%)
Query: 297 SWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPN 356
N I +L+ L++ N+LI +P L RL + N + +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL---IASFNHLAE-VPEL 322
Query: 357 LGSIELLEVLDLHNLNLRGEVPDDISNCRFLLL 389
+ L+ L + LR E PD + L +
Sbjct: 323 PQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 45.2 bits (105), Expect = 3e-05
Identities = 15/56 (26%), Positives = 23/56 (41%), Gaps = 5/56 (8%)
Query: 433 SNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNN 488
L+L+ LS S+P +L +L S N+L+ +P Q NN
Sbjct: 38 RQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNN 88
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 18/65 (27%), Positives = 29/65 (44%), Gaps = 5/65 (7%)
Query: 411 LKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLS 470
L+L+ L+ S P +L + L S NSL+ +P +L++L N + LS
Sbjct: 40 AHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 471 GTIPS 475
P
Sbjct: 95 DLPPL 99
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 22/103 (21%), Positives = 37/103 (35%), Gaps = 10/103 (9%)
Query: 119 MQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSH 178
+ L NA S I P++ L++S N E+P + + + S
Sbjct: 259 LSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRL----ERLIASF 313
Query: 179 NNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDF 221
N+L+ +P N L +N L E P ++ L
Sbjct: 314 NHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.0 bits (89), Expect = 0.002
Identities = 11/56 (19%), Positives = 22/56 (39%), Gaps = 5/56 (8%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRL 148
+ L L N +P+ Q L +++V N L P+ + ++R+
Sbjct: 301 ALPPRLERLIASFNHLA-EVPE---LPQNLKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 52.8 bits (126), Expect = 6e-09
Identities = 30/108 (27%), Positives = 42/108 (38%), Gaps = 6/108 (5%)
Query: 365 VLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGS 424
VL L + +L V + + LD+S N L P L + L++L N L
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE-- 56
Query: 425 TPPSLGNLSNLQVLDLSQNSL-SGSIPSSLGNLRNLTHFNLSSNNLSG 471
+ NL LQ L L N L + L + L NL N+L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 50.5 bits (120), Expect = 4e-08
Identities = 29/119 (24%), Positives = 49/119 (41%), Gaps = 7/119 (5%)
Query: 342 ISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDI 401
+ LA+ + + +L + L+ LDL + LR P ++ R L +L S N +
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDN--ALEN 57
Query: 402 PQTLYNMTYLKILDLHQNHLNG-STPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNL 459
+ N+ L+ L L N L + L + L +L+L NSL L +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 4e-06
Identities = 22/84 (26%), Positives = 27/84 (32%), Gaps = 3/84 (3%)
Query: 412 KILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSG 471
++L L L + L L + LDLS N L P +L LR L S N L
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALEN 57
Query: 472 TIPSTIQHFGVSTFLNNTGLCGPP 495
L N L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSA 81
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 23/120 (19%), Positives = 38/120 (31%), Gaps = 7/120 (5%)
Query: 222 ISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEI 281
+ + LT Q + +LDLS N L P + L+ + S N
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALE--N 57
Query: 282 PEVGICGEGMQVFDASWNEFDGVIPL-SITNCRNLKVLDLGFNRLIGSIPTGITDLRRLL 340
+ +Q N + + +C L +L+L N L L +L
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEML 116
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 18/110 (16%), Positives = 38/110 (34%), Gaps = 6/110 (5%)
Query: 172 KFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTG 231
+ + L+H +L ++ + + D S N L P+ + + L+ + N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDN--AL 55
Query: 232 TVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLG-LKNISYFNVSHNGFHGE 280
+ + ++ L L +N A L + N+ N E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.5 bits (89), Expect = 6e-04
Identities = 16/105 (15%), Positives = 33/105 (31%), Gaps = 23/105 (21%)
Query: 125 INVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIP--------------------FAL 164
++++ L+ + + L + LDLS N P
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALENVDG 60
Query: 165 FKYCYKTKFVSLSHNNL-SGSIPLSIANCTYLEGFDFSFNNLSGE 208
+ + + L +N L + + +C L + N+L E
Sbjct: 61 VANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 9e-04
Identities = 20/94 (21%), Positives = 34/94 (36%), Gaps = 3/94 (3%)
Query: 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLL 149
L L + L L NR P A ++ L + S N + + + +LP ++ L
Sbjct: 14 CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--ALENVDGVANLPRLQEL 70
Query: 150 DLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG 183
L N C + ++L N+L
Sbjct: 71 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.8 bits (132), Expect = 1e-08
Identities = 13/98 (13%), Positives = 27/98 (27%), Gaps = 5/98 (5%)
Query: 387 LLLLDVSGNALG-GDIPQTLYNMTYLKILDLHQNHLNGST----PPSLGNLSNLQVLDLS 441
+ LD+ L + L + +++ L L + +L L L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 442 QNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQH 479
N L + + +L +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGC 101
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 3e-08
Identities = 18/83 (21%), Positives = 29/83 (34%), Gaps = 9/83 (10%)
Query: 405 LYNMTYLKILDLHQNHLNGSTPPSLG----NLSNLQVLDLSQNSLSGSIPSSLG-----N 455
+ L++L L ++ S+ SL +L+ LDLS N L + L
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 456 LRNLTHFNLSSNNLSGTIPSTIQ 478
L L S + +Q
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRLQ 447
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.4 bits (126), Expect = 7e-08
Identities = 17/85 (20%), Positives = 26/85 (30%), Gaps = 9/85 (10%)
Query: 382 SNCRFLLLLDVSGNALGGD----IPQTLYNMTYLKILDLHQNHLNGSTPPSLG-----NL 432
L +L ++ + + TL L+ LDL N L + L
Sbjct: 366 QPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPG 425
Query: 433 SNLQVLDLSQNSLSGSIPSSLGNLR 457
L+ L L S + L L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.1 bits (120), Expect = 4e-07
Identities = 12/75 (16%), Positives = 22/75 (29%), Gaps = 4/75 (5%)
Query: 145 NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG----SIPLSIANCTYLEGFDF 200
+I+ LD+ S L + + V L L+ I ++ L +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 201 SFNNLSGELPSQICN 215
N L +
Sbjct: 63 RSNELGDVGVHCVLQ 77
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 1e-06
Identities = 19/89 (21%), Positives = 32/89 (35%), Gaps = 13/89 (14%)
Query: 363 LEVLDLHNLNLRGE----VPDDISNCRFLLLLDVSGNALGGDIPQTL-----YNMTYLKI 413
L VL L + ++ + + L LD+S N LG L L+
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 414 LDLHQNHLNGSTPPSLGNLS----NLQVL 438
L L+ + + L L +L+V+
Sbjct: 431 LVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 2e-05
Identities = 14/90 (15%), Positives = 31/90 (34%), Gaps = 5/90 (5%)
Query: 291 MQVFDASWNEF-DGVIPLSITNCRNLKVLDLGFNRL----IGSIPTGITDLRRLLKISLA 345
+Q D E D + + +V+ L L I + + L +++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 346 NNSIGGIIPPNLGSIELLEVLDLHNLNLRG 375
+N +G + + + L+L+
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.4 bits (105), Expect = 2e-05
Identities = 18/80 (22%), Positives = 31/80 (38%), Gaps = 9/80 (11%)
Query: 311 NCRNLKVLDLGFNRL----IGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSI-----E 361
L+VL L + S+ + L ++ L+NN +G L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 362 LLEVLDLHNLNLRGEVPDDI 381
LLE L L+++ E+ D +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 13/59 (22%), Positives = 19/59 (32%), Gaps = 5/59 (8%)
Query: 434 NLQVLDLSQNSLSGS-IPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGL 491
++Q LD+ LS + L L+ L L+ I S N L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDI----SSALRVNPAL 57
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 9e-05
Identities = 13/113 (11%), Positives = 32/113 (28%), Gaps = 26/113 (23%)
Query: 314 NLKVLDLGFNRLIGS-IPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLN 372
+++ LD+ L + + L++ + L + + ++ S
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA------------ 50
Query: 373 LRGEVPDDISNCRFLLLLDVSGNALGGDIPQTL-----YNMTYLKILDLHQNH 420
+ L L++ N LG + ++ L L
Sbjct: 51 --------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 8/92 (8%), Positives = 25/92 (27%), Gaps = 9/92 (9%)
Query: 122 LWKINVSSNALSGS-IPEFIGDLPNIRLLDLSRNSYSGEIPFAL---FKYCYKTKFVSLS 177
+ +++ LS + E + L +++ L + + + ++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 178 HNNLSGSIPLSIA-----NCTYLEGFDFSFNN 204
N L + ++
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 3e-04
Identities = 19/113 (16%), Positives = 33/113 (29%), Gaps = 28/113 (24%)
Query: 119 MQTLWKINVSSNALSG----SIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFV 174
L + ++ +S S+ + ++R LDLS N L +
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE-------- 419
Query: 175 SLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNI----PVLDFIS 223
S+ LE S E+ ++ + P L IS
Sbjct: 420 SVRQPG------------CLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/96 (14%), Positives = 34/96 (35%), Gaps = 9/96 (9%)
Query: 159 EIPFALFKYCYKTKFVSLSHNNLSG----SIPLSIANCTYLEGFDFSFNNLSGELPSQIC 214
E+ L + + + L+ ++S S+ ++ L D S N L Q+
Sbjct: 359 ELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV 418
Query: 215 -----NIPVLDFISVRGNALTGTVEEQFSQCQSIKN 245
+L+ + + + +E++ + K
Sbjct: 419 ESVRQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKP 454
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 16/106 (15%), Positives = 36/106 (33%), Gaps = 9/106 (8%)
Query: 265 KNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGV----IPLSITNCRNLKVLDL 320
IS + G +G G ++V + + + ++ +L+ LDL
Sbjct: 345 LQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDL 404
Query: 321 GFNRLIGSIPTGITD-----LRRLLKISLANNSIGGIIPPNLGSIE 361
N L + + + L ++ L + + L ++E
Sbjct: 405 SNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.003
Identities = 10/92 (10%), Positives = 27/92 (29%), Gaps = 6/92 (6%)
Query: 97 SLRVLTLFGNRFTGN-LPQEYAEMQTLWKINVSSNALSG----SIPEFIGDLPNIRLLDL 151
++ L + + + +Q + + L+ I + P + L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 152 SRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG 183
N + + +T + +L
Sbjct: 63 RSNELGDVGVHCVLQ-GLQTPSCKIQKLSLQN 93
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 32/238 (13%), Positives = 68/238 (28%), Gaps = 21/238 (8%)
Query: 135 SIPEFIGD--LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANC 192
+I D L N + +++ + + A +S ++ +I +
Sbjct: 8 AINVIFPDPALANAIKIAAGKSNVTDTVTQADLD---GITTLSAFGTGVT-TIE-GVQYL 62
Query: 193 TYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNL 252
L G + N ++ P + +S + S +++
Sbjct: 63 NNLIGLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV 122
Query: 253 FIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNC 312
+ L + + G + S + N
Sbjct: 123 TPLAGLSNLQVLYLDLNQITNISPLAGL----------TNLQYLSIGNAQVSDLTPLANL 172
Query: 313 RNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHN 370
L L N++ P + L L+++ L NN I + P L + L ++ L N
Sbjct: 173 SKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.4 bits (119), Expect = 2e-07
Identities = 19/61 (31%), Positives = 26/61 (42%), Gaps = 4/61 (6%)
Query: 405 LYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNL 464
L N++ L L N + S L +L NL + L N +S P L N NL L
Sbjct: 169 LANLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
Query: 465 S 465
+
Sbjct: 225 T 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.1 bits (100), Expect = 6e-05
Identities = 35/192 (18%), Positives = 58/192 (30%), Gaps = 20/192 (10%)
Query: 297 SWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGI-IPP 355
+ + + + + L + +I G+ L L+ + L +N I +
Sbjct: 27 GKSNVTDTVTQA--DLDGITTLSAFGTG-VTTIE-GVQYLNNLIGLELKDNQITDLAPLK 82
Query: 356 NLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSG-------------NALGGDIP 402
NL I LE+ N+ L ++ I
Sbjct: 83 NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQIT 142
Query: 403 QTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHF 462
+ L + S L NLS L L N +S P L +L NL
Sbjct: 143 NISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEV 200
Query: 463 NLSSNNLSGTIP 474
+L +N +S P
Sbjct: 201 HLKNNQISDVSP 212
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 39.6 bits (91), Expect = 0.001
Identities = 8/63 (12%), Positives = 22/63 (34%), Gaps = 4/63 (6%)
Query: 407 NMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSS 466
+ + ++++ + +L + L ++ +I + L NL L
Sbjct: 17 ALANAIKIAAGKSNVTD--TVTQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKD 72
Query: 467 NNL 469
N +
Sbjct: 73 NQI 75
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 51.4 bits (121), Expect = 2e-07
Identities = 33/326 (10%), Positives = 78/326 (23%), Gaps = 48/326 (14%)
Query: 172 KFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTG 231
K +++ + S+ + ++ S N + E +
Sbjct: 11 KLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLS----------------- 52
Query: 232 TVEEQFSQCQSIKNLDLSSNLFIGL---APFGVLGLKNISYFNVSHNGFHGEIPEVGICG 288
E + + ++ + S + P + L + G
Sbjct: 53 ---ENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTA 109
Query: 289 EGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNS 348
+ + S + + L + ++ + L I N
Sbjct: 110 QEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNR 169
Query: 349 IGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLD-------------VSGN 395
+ L ++ + + L L +
Sbjct: 170 LENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTH 229
Query: 396 ALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGN------LSNLQVLDLSQNSLSGSI 449
+ L + L+ L L+ L+ ++ + LQ L L N +
Sbjct: 230 LGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDA 289
Query: 450 PSSL-----GNLRNLTHFNLSSNNLS 470
+L + +L L+ N S
Sbjct: 290 VRTLKTVIDEKMPDLLFLELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.4 bits (108), Expect = 1e-05
Identities = 11/86 (12%), Positives = 29/86 (33%), Gaps = 8/86 (9%)
Query: 411 LKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSG----SIPSSLGNLRNLTHFNLSS 466
LK+ + S L +++ + LS N++ + ++ + ++L S
Sbjct: 10 LKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 467 N---NLSGTIPSTIQHFGVSTFLNNT 489
+ IP ++ +
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPK 94
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.2 bits (92), Expect = 9e-04
Identities = 36/371 (9%), Positives = 95/371 (25%), Gaps = 58/371 (15%)
Query: 96 KSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSG----SIPEFIGDLPNIRLLDL 151
KSL++ + ++ E ++ +I +S N + + E I ++ + +
Sbjct: 8 KSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEF 66
Query: 152 SRNSY---SGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE 208
S EIP A + + + + S S +
Sbjct: 67 SDIFTGRVKDEIPEA-LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEH 125
Query: 209 LPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNIS 268
L + + V ++ ++++ N L+N S
Sbjct: 126 LYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRN-----------RLENGS 174
Query: 269 YFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGS 328
+ + + + + + + + +
Sbjct: 175 MKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSA 234
Query: 329 IPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLL 388
+ + L ++ L + + G+ +++ L
Sbjct: 235 LAIALKSWPNLRELGLNDCLLSAR-----GAAAVVDAFSKLEN-------------IGLQ 276
Query: 389 LLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGS 448
L + N + D +TL + + +L L+L+ N
Sbjct: 277 TLRLQYNEIELDAVRTLKTVI-------------------DEKMPDLLFLELNGNRF-SE 316
Query: 449 IPSSLGNLRNL 459
+ +R +
Sbjct: 317 EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 38.7 bits (88), Expect = 0.003
Identities = 42/313 (13%), Positives = 86/313 (27%), Gaps = 19/313 (6%)
Query: 88 LSPALSGLKSLRVLTLFGNRFTGN----LPQEYAEMQTLWKINVSSN---ALSGSIPEFI 140
+ L S++ + L GN L + A + L S + IPE +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 141 GDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDF 200
L L + A + LS + + L G
Sbjct: 83 RLLLQALL-KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 201 SFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFG 260
+ + + N P L I N L +++++ L + +
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 261 VLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDL 320
+ + ++ + G + + + L + +C +
Sbjct: 202 GIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCL---LSAR 258
Query: 321 GFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIEL-----LEVLDLHNLNLRG 375
G ++ + + L + L N I L ++ L L+L+ N
Sbjct: 259 GAAAVVDAFSKL--ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNG-NRFS 315
Query: 376 EVPDDISNCRFLL 388
E D + R +
Sbjct: 316 EEDDVVDEIREVF 328
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 49.2 bits (116), Expect = 4e-07
Identities = 32/204 (15%), Positives = 61/204 (29%), Gaps = 16/204 (7%)
Query: 263 GLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGF 322
N+ + + + + A+ ++ V + N+ L L
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNEL--NSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNG 77
Query: 323 NRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDIS 382
N+L T I L L + + + N ++ +
Sbjct: 78 NKL-----TDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 383 NCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQ 442
+ L + + L + L + D + + L L+ LQ L LS+
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLYLSK 187
Query: 443 NSLSGSIPSSLGNLRNLTHFNLSS 466
N +S +L L+NL L S
Sbjct: 188 NHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 41.5 bits (96), Expect = 2e-04
Identities = 34/198 (17%), Positives = 59/198 (29%), Gaps = 27/198 (13%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152
L T + Q E+ ++ +I +++ + I LPN+ L L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 153 RNSYSGEIPFALFKYCYKTKF-----------------VSLSHNNLSGSIPLSIANCTYL 195
N + P A K SLS + S + + L
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQL 136
Query: 196 EGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIG 255
E N ++ + N ++ V + ++NL LS N
Sbjct: 137 ESLYLGNNKITDITVLSRLTKLDTLSL--EDNQISDIVP--LAGLTKLQNLYLSKNHISD 192
Query: 256 LAPFGVLGLKNISYFNVS 273
L GLKN+ +
Sbjct: 193 LRALA--GLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 30/242 (12%), Positives = 67/242 (27%), Gaps = 47/242 (19%)
Query: 135 SIPEFIGD------LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLS 188
++P I +L + S + + + +++++ +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELN---SIDQIIANNSDIKSVQGIQ 65
Query: 189 IANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDL 248
+ + N L+ P F+ ++ S K L
Sbjct: 66 --YLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKV------KDLSSLKDLKKLKSL 117
Query: 249 SSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLS 308
S G++ L + + +N + + N+ ++PL+
Sbjct: 118 SLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTK--LDTLSLEDNQISDIVPLA 175
Query: 309 ITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDL 368
L+ L L N I+DL L ++ L+VL+L
Sbjct: 176 --GLTKLQNLYLSKNH--------ISDL------------------RALAGLKNLDVLEL 207
Query: 369 HN 370
+
Sbjct: 208 FS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 10/75 (13%), Positives = 28/75 (37%), Gaps = 6/75 (8%)
Query: 378 PDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQV 437
DD + ++ ++ + Q + + + + + + + + L N+
Sbjct: 19 SDD--AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDI--KSVQGIQYLPNVTK 72
Query: 438 LDLSQNSLSGSIPSS 452
L L+ N L+ P +
Sbjct: 73 LFLNGNKLTDIKPLA 87
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 9e-07
Identities = 13/70 (18%), Positives = 24/70 (34%), Gaps = 3/70 (4%)
Query: 406 YNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLS 465
++ N+L S +LD+S+ + L NL+ L +
Sbjct: 174 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST- 232
Query: 466 SNNLSGTIPS 475
NL +P+
Sbjct: 233 -YNLK-KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 9e-06
Identities = 24/214 (11%), Positives = 52/214 (24%), Gaps = 7/214 (3%)
Query: 242 SIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEF 301
+ L + G ++ +S N I
Sbjct: 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKAN 89
Query: 302 DGVIPLSITNCRNLKVLDLGFNRLI----GSIPTGITDLRRLLKISLANNSIGGIIPPNL 357
+ + + L + + + + LL I N +
Sbjct: 90 NLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 149
Query: 358 GSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLH 417
G +L L+ ++ + + L N L + + ILD+
Sbjct: 150 GLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDIS 209
Query: 418 QNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS 451
+ ++ L NL L+ +P+
Sbjct: 210 RTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 6e-05
Identities = 24/228 (10%), Positives = 63/228 (27%), Gaps = 8/228 (3%)
Query: 125 INVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGS 184
+ ++ IP + N L I F + + +S N++
Sbjct: 13 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEV 68
Query: 185 IPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIK 244
I + + + + + + + + + S++
Sbjct: 69 IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 128
Query: 245 NLDLSSNLFIGLAPFGVLGLKNISYF----NVSHNGFHGEIPEVGICGEGMQVFDASWNE 300
+ L I + +S+ ++ NG + ++ + N
Sbjct: 129 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNN 188
Query: 301 FDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNS 348
+ + +LD+ R+ G+ +L++L S N
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 4e-04
Identities = 29/229 (12%), Positives = 65/229 (28%), Gaps = 8/229 (3%)
Query: 147 RLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLS 206
R+ + + EIP L + + L + + LE + S N++
Sbjct: 11 RVFLCQESKVT-EIPSDLPR---NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66
Query: 207 GELPSQICNIPVLDFISVR---GNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLG 263
+ + + + N L E + L ++ + +
Sbjct: 67 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHS 126
Query: 264 LKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFN 323
L+ + + H + V I N L L+L N
Sbjct: 127 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDN 186
Query: 324 RLIGSIPTGI-TDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNL 371
+ +P + + + ++ I + L +++ L +NL
Sbjct: 187 NNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.2 bits (111), Expect = 1e-06
Identities = 28/140 (20%), Positives = 51/140 (36%), Gaps = 7/140 (5%)
Query: 307 LSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVL 366
TN + LDL + I I L + I ++N I + + L+ L
Sbjct: 12 AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTL 68
Query: 367 DLHNLNLRGEVPDDISNCRFLLLLDVSGNALGG----DIPQTLYNMTYLKILDLHQNHLN 422
++N + L L ++ N+L D +L ++TYL IL +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 423 GSTPPSLGNLSNLQVLDLSQ 442
+ + ++VLD +
Sbjct: 129 HYRLYVIYKVPQVRVLDFQK 148
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.5 bits (104), Expect = 9e-06
Identities = 8/43 (18%), Positives = 13/43 (30%), Gaps = 1/43 (2%)
Query: 427 PSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNL 469
N + LDL + I + L + S N +
Sbjct: 12 AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI 53
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.6 bits (99), Expect = 4e-05
Identities = 13/74 (17%), Positives = 21/74 (28%), Gaps = 3/74 (4%)
Query: 407 NMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSS 466
N + LDL + L +D S N + LR L +++
Sbjct: 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTLLVNN 72
Query: 467 NNLSGTIPSTIQHF 480
N + Q
Sbjct: 73 NRICRIGEGLDQAL 86
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (90), Expect = 7e-04
Identities = 20/122 (16%), Positives = 37/122 (30%), Gaps = 5/122 (4%)
Query: 382 SNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLS 441
+N LD+ G + I + +D N + L L+ L ++
Sbjct: 15 TNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR--KLDGFPLLRRLKTLLVN 71
Query: 442 QNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLETSCS 501
N + L +LT L++N+L + L + P+
Sbjct: 72 NNRICRIGEGLDQALPDLTELILTNNSLVEL--GDLDPLASLKSLTYLCILRNPVTNKKH 129
Query: 502 GR 503
R
Sbjct: 130 YR 131
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.2 bits (85), Expect = 0.003
Identities = 18/111 (16%), Positives = 34/111 (30%), Gaps = 6/111 (5%)
Query: 205 LSGEL---PSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGV 261
L+ EL +Q N + +RG + +E + +D S N L F
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP- 60
Query: 262 LGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNC 312
L+ + V++N + + + N + L
Sbjct: 61 -LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLAS 110
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 46.3 bits (108), Expect = 4e-06
Identities = 19/109 (17%), Positives = 41/109 (37%), Gaps = 4/109 (3%)
Query: 346 NNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTL 405
N I I + L+ L+L++ + +P + L L+++ N +
Sbjct: 87 ENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLA- 145
Query: 406 YNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLG 454
+ +L+ L+ P + ++Q+ DL + S +S G
Sbjct: 146 WFAEWLRKKSLNGGAARCGAPSK---VRDVQIKDLPHSEFKCSSENSEG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 2e-05
Identities = 31/172 (18%), Positives = 56/172 (32%), Gaps = 26/172 (15%)
Query: 353 IPPNLGSIELLEVLDL-HNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYL 411
IP ++ L L N R L+ L++ N L G P +++
Sbjct: 23 IPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHI 80
Query: 412 KILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHF--------- 462
+ L L +N + + L L+ L+L N +S +P S +L +LT
Sbjct: 81 QELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140
Query: 463 --------------NLSSNNLSGTIPSTIQHFGVSTFLNNTGLCGPPLETSC 500
+L+ PS ++ + ++ C C
Sbjct: 141 NCHLAWFAEWLRKKSLNGGAARCGAPSKVRDVQIKDLPHSEFKCSSENSEGC 192
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.1 bits (98), Expect = 6e-05
Identities = 26/116 (22%), Positives = 40/116 (34%), Gaps = 7/116 (6%)
Query: 363 LEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLN 422
+ LDL L D+ ++L+ + + N+ L L+L N L
Sbjct: 24 QQALDLKGLRS----DPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLY 78
Query: 423 GSTPPS--LGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPST 476
S + NL++L+LS N L L L N+LS T
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQ 134
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (95), Expect = 2e-04
Identities = 23/106 (21%), Positives = 34/106 (32%), Gaps = 7/106 (6%)
Query: 387 LLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLS 446
LD+ G D L +L+ ++ + + N+ L L+LS N L
Sbjct: 24 QQALDLKGLRSDPD----LVAQNIDVVLNR-RSSMAATLRIIEENIPELLSLNLSNNRLY 78
Query: 447 G--SIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFLNNTG 490
+ S + NL NLS N L L G
Sbjct: 79 RLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDG 124
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 2e-04
Identities = 27/120 (22%), Positives = 43/120 (35%), Gaps = 10/120 (8%)
Query: 353 IPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGG--DIPQTLYNMTY 410
P+L + + VL+ + ++ + N LL L++S N L D+ +
Sbjct: 34 SDPDLVAQNIDVVLNRRS-SMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPN 92
Query: 411 LKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSS-------LGNLRNLTHFN 463
LKIL+L N L L+ L L NSLS + L +
Sbjct: 93 LKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 31/170 (18%), Positives = 59/170 (34%), Gaps = 18/170 (10%)
Query: 306 PLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEV 365
+S T+ + L I SI G+ L L +I+ +NN + I P + + +
Sbjct: 33 TVSQTDLDQVTTLQADRLG-IKSI-DGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDIL 90
Query: 366 LDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLY--------------NMTYL 411
++ + + + + + L + + L
Sbjct: 91 MNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLT 150
Query: 412 KILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTH 461
+ L+ + + L NL+ L+ LD+S N +S S L L NL
Sbjct: 151 SLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLES 198
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.002
Identities = 14/65 (21%), Positives = 25/65 (38%), Gaps = 4/65 (6%)
Query: 407 NMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSS 466
+ L + ++ S +L + L + + SI + L NLT N S+
Sbjct: 16 ALAEKMKTVLGKTNVTD--TVSQTDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFSN 71
Query: 467 NNLSG 471
N L+
Sbjct: 72 NQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 21/183 (11%), Positives = 52/183 (28%), Gaps = 17/183 (9%)
Query: 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152
+ L L T + Q ++ + + + SI + + L N+ ++ S
Sbjct: 15 TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SI-DGVEYLNNLTQINFS 70
Query: 153 RNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDF------------ 200
N + P + +++ L+ L
Sbjct: 71 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 130
Query: 201 -SFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPF 259
S + + + ++ T + + +++ LD+SSN ++
Sbjct: 131 NRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSDISVL 190
Query: 260 GVL 262
L
Sbjct: 191 AKL 193
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 30/207 (14%), Positives = 65/207 (31%), Gaps = 18/207 (8%)
Query: 136 IPEFIGD--LPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCT 193
I + D L L + + + + + + + SI +
Sbjct: 8 INQIFTDTALAEKMKTVLGKTNVTDTVSQTDLD---QVTTLQADRLGIK-SID-GVEYLN 62
Query: 194 YLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLF 253
L +FS N L+ P + V ++ A + + + +++
Sbjct: 63 NLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDID 122
Query: 254 IGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCR 313
+ L+ S + +Q + S N+ + PL+ N
Sbjct: 123 PLKNLTNLNRLELSSNTISDISALS--------GLTSLQQLNFSSNQVTDLKPLA--NLT 172
Query: 314 NLKVLDLGFNRLIG-SIPTGITDLRRL 339
L+ LD+ N++ S+ +T+L L
Sbjct: 173 TLERLDISSNKVSDISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 40.4 bits (93), Expect = 3e-04
Identities = 15/62 (24%), Positives = 25/62 (40%), Gaps = 8/62 (12%)
Query: 408 MTYLKILDLHQNHLNGSTPP------SLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTH 461
+ + + L+G PP +L L + L LS N++ I SL + NL
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KIS-SLSGMENLRI 74
Query: 462 FN 463
+
Sbjct: 75 LS 76
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (90), Expect = 5e-04
Identities = 18/146 (12%), Positives = 41/146 (28%), Gaps = 11/146 (7%)
Query: 168 CYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQIC-NIPVLDFISVRG 226
+ + + + + + L L + + L +++
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 227 NALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGI 286
+ L + F + L+LS N L+ + ++ +S N H
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWK-TVQGLSLQELVLSGNPLH-------- 116
Query: 287 CGEGMQVFDASWNEFDGVIPLSITNC 312
C ++ E G +P C
Sbjct: 117 CSCALRWLQRWEEEGLGGVPEQKLQC 142
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.8 bits (86), Expect = 0.002
Identities = 16/145 (11%), Positives = 43/145 (29%), Gaps = 3/145 (2%)
Query: 125 INVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGS 184
+ + + + N+ L + + + + + + +++ + L
Sbjct: 13 LRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV 71
Query: 185 IPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQ-FSQCQSI 243
P + L + SFN L L + L + + GN L + + + +
Sbjct: 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEE 130
Query: 244 KNLDLSSNLFIGLAPFGVLGLKNIS 268
+ + + N S
Sbjct: 131 GLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.002
Identities = 6/49 (12%), Positives = 12/49 (24%), Gaps = 1/49 (2%)
Query: 427 PSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475
P L +++ L NLT + + +
Sbjct: 2 PDACCPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLEL 49
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.1 bits (84), Expect = 0.003
Identities = 25/116 (21%), Positives = 38/116 (32%), Gaps = 4/116 (3%)
Query: 384 CRFLLLLDVSGNALGGDIPQTLYNMTYLKILDL-HQNHLNGSTPPSLGNLSNLQVLDLSQ 442
L + + D L L L + +Q HL L L L+ L + +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 443 NSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPSTIQHFGVSTFL--NNTGLCGPPL 496
+ L P + L+ NLS N L T+Q + + N C L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCAL 121
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 884 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.98 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.97 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.96 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.95 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.93 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.92 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.91 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.87 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.85 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.85 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.85 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.77 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.7 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.69 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.66 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.94 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.83 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.61 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.39 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.16 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.15 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.8 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.52 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=369.77 Aligned_cols=268 Identities=23% Similarity=0.369 Sum_probs=212.6
Q ss_pred CHHHHHHHHHCC--------CCCCCEECCCCCEEEEEEEECC----CEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCC
Q ss_conf 978999974025--------5458432247960899999869----9099999811347657999999999997049999
Q 002759 584 KYEDWEAGTKAL--------LDKECLIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHF 651 (884)
Q Consensus 584 ~~~~~~~~~~~~--------~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~ 651 (884)
++++..+++.+| ++..+.||+|+||+||+|.++. ...||||++.........+.|.+|+.++++++||
T Consensus 8 t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~Hp 87 (299)
T d1jpaa_ 8 TFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHP 87 (299)
T ss_dssp GSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCT
T ss_pred CHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCC
T ss_conf 87989999960462208004278569802788299999995799788999999978445989999999999999857998
Q ss_pred CCCEEEEEEECCCCEEEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
Q ss_conf 72112448753990259997259985533201489999888999999889789999999999999998725999907505
Q 002759 652 NLVAFQGYYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLN 731 (884)
Q Consensus 652 niv~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~D 731 (884)
|||+++|++.+.+..++||||+++|+|.+++.... ..+++.++..++.|++.||+|||++ +++|||
T Consensus 88 nIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~-----------~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrD 153 (299)
T d1jpaa_ 88 NVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND-----------GQFTVIQLVGMLRGIAAGMKYLADM---NYVHRD 153 (299)
T ss_dssp TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT-----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred CCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCC
T ss_conf 88618999962887799997227985300210456-----------7999999999999999988988527---983576
Q ss_pred CCCCCEEECCCCCEEECCCCCCCCCCCCCCC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCC
Q ss_conf 7888657489997058334674214875676----5431245433238433488899973471449999999880-9999
Q 002759 732 LKSTNILLDENYEPKLSDYGLAKLLPILDNY----GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKP 806 (884)
Q Consensus 732 lk~~Nili~~~~~vki~Dfg~a~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p 806 (884)
|||+|||++.++.+||+|||+|+........ ......+++.|+|||.+.+..++.++|||||||++|||+| |+.|
T Consensus 154 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~P 233 (299)
T d1jpaa_ 154 LAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 233 (299)
T ss_dssp CCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCT
T ss_pred CCCCEEEECCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCC
T ss_conf 15044898899919988844315756777765365025666883003878883699786121445357899998679999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 99999731100999999999729876323645788769999999999943258998999998899999998440
Q 002759 807 VESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 880 (884)
|......+.. . . +..+.... .+.+...++.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 234 f~~~~~~~~~---~---~-i~~~~~~~--------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 234 YWDMTNQDVI---N---A-IEQDYRLP--------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp TTTCCHHHHH---H---H-HHTTCCCC--------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHH---H---H-HHCCCCCC--------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 9999999999---9---9-97378899--------974226999999999758797689299999999999841
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.30 Aligned_cols=255 Identities=25% Similarity=0.345 Sum_probs=209.9
Q ss_pred CCCCCEECCCCCEEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECCC
Q ss_conf 54584322479608999998699099999811347657999999999997049999721124487539902599972599
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+...+.||+|+||.||+|.+.++..||||++.... ...+.|.+|+.+++.++||||++++|++.+.+..++||||+++
T Consensus 7 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~ 84 (263)
T d1sm2a_ 7 LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEH 84 (263)
T ss_dssp EEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred CEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECCC
T ss_conf 58888982088829999998899999999987886--7689999999999966899756535243159933799983699
Q ss_pred CCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 85533201489999888999999889789999999999999998725999907505788865748999705833467421
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~~ 755 (884)
|+|.+++.... ..+++..++.++.|+|.||.|||+. +++||||||+|||++.++.+||+|||+++.
T Consensus 85 g~L~~~l~~~~-----------~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~ 150 (263)
T d1sm2a_ 85 GCLSDYLRTQR-----------GLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRF 150 (263)
T ss_dssp CBHHHHHHTTT-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----
T ss_pred CCHHHHHHCCC-----------CCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEE
T ss_conf 91899752013-----------4788999999999999987765316---431044315326666887768655321002
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 487567654312454332384334888999734714499999998809-9999999973110099999999972987632
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTG-RKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.............++..|+|||++.+..++.++||||||+++|||+|+ ++||......+.. ... ..+....
T Consensus 151 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~---~~i----~~~~~~~- 222 (263)
T d1sm2a_ 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV---EDI----STGFRLY- 222 (263)
T ss_dssp --------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHH---HHH----HHTCCCC-
T ss_pred CCCCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HHCCCCC-
T ss_conf 36887335043001766678578607999840332105999999987898887789999999---999----8068889-
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 36457887699999999999432589989999988999999984402
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 881 (884)
.+ .....++.+++.+||+.+|++||||+|+++.|+++++.
T Consensus 223 -~p------~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 -KP------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp -CC------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred -CC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf -95------43679999999997657976891999999999999857
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.10 Aligned_cols=267 Identities=28% Similarity=0.498 Sum_probs=209.9
Q ss_pred HHHHHHCCCCCCCEECCCCCEEEEEEEECCCEEEEEEECCCCC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 9997402554584322479608999998699099999811347-657999999999997049999721124487539902
Q 002759 588 WEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 588 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (884)
|+...++ +...+.||+|+||+||+|.+++ .||||+++... .....+.|.+|+.++++++||||++++|++.+ ...
T Consensus 3 wei~~~~-~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 3 WEIPDGQ-ITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CBCCTTC-CCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCCCCCC-EEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEE
T ss_conf 1315451-8998898307885899999999--89999997346998999999999999984799878645679715-589
Q ss_pred EEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 59997259985533201489999888999999889789999999999999998725999907505788865748999705
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vk 746 (884)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~K 144 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE-----------TKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVK 144 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEE
T ss_pred EEEEECCCCCCHHHHHHHCC-----------CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEE
T ss_conf 99996589988899985235-----------7899999999999999998887509---995161478997981899788
Q ss_pred ECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf 83346742148756-765431245433238433488---89997347144999999988099999999973110099999
Q 002759 747 LSDYGLAKLLPILD-NYGLTKFHNAVGYVAPELAQS---LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 747 i~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 822 (884)
|+|||+|+...... ........+|+.|+|||++.+ ..++.++|||||||++|||+||+.||.........
T Consensus 145 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~------ 218 (276)
T d1uwha_ 145 IGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI------ 218 (276)
T ss_dssp ECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH------
T ss_pred ECCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH------
T ss_conf 75002213335567763125665574317999995056899995315163599999999788998998969999------
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 999972987632364578876999999999994325899899999889999999844025
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~~ 882 (884)
......+... +.........+.++.+++.+||+.+|++||||.|+++.|+.+++.+
T Consensus 219 ~~~~~~~~~~----p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 219 IFMVGRGYLS----PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp HHHHHHTSCC----CCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHHCCCCC----CCCHHCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 9999658889----8600036555499999999975889768929999999999999709
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=366.72 Aligned_cols=268 Identities=29% Similarity=0.398 Sum_probs=215.5
Q ss_pred CHHHHHHHHHCCCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEEC
Q ss_conf 978999974025545843224796089999986-9909999981134765799999999999704999972112448753
Q 002759 584 KYEDWEAGTKALLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS 662 (884)
Q Consensus 584 ~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 662 (884)
.+++|+...+++ ...+.||+|+||+||+|.+. ++..||||+++... ...+.|.+|+.+++.++||||++++|++.+
T Consensus 8 ~~~~wei~~~~~-~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~ 84 (287)
T d1opja_ 8 NYDKWEMERTDI-TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT--MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 84 (287)
T ss_dssp TCCTTBCCGGGE-EEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCCCCEECHHHE-EEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC--CHHHHHHHHHHHHHHCCCCCEECCCCCEEE
T ss_conf 976517457993-98659820888089999999999699999977761--039999999999986799988267752745
Q ss_pred CCCEEEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf 99025999725998553320148999988899999988978999999999999999872599990750578886574899
Q 002759 663 STMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN 742 (884)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~ 742 (884)
.+..++||||+++|+|.+++.... ...+++..++.++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~----------~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~ 151 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECN----------RQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGEN 151 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSC----------TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGG
T ss_pred CCEEEEEEECCCCCCHHHHHHHCC----------CCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCC
T ss_conf 785478763146760677753035----------54157999999999999978889878---93057604576899899
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf 97058334674214875676543124543323843348889997347144999999988099999999973110099999
Q 002759 743 YEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 743 ~~vki~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 822 (884)
+.+||+|||+|+..............++..|+|||++.+..++.++||||||+++|||++|+.|+........ .
T Consensus 152 ~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~------~ 225 (287)
T d1opja_ 152 HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------V 225 (287)
T ss_dssp GCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH------H
T ss_pred CCEEECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------H
T ss_conf 9289832445465378872210355665466692787279998104302178999999867998877425999------9
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 99997298763236457887699999999999432589989999988999999984402
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 881 (884)
.+.+..+.... . ++....++.+++.+||+.+|++|||++|+++.|+.+.++
T Consensus 226 ~~~i~~~~~~~-----~---~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 226 YELLEKDYRME-----R---PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp HHHHHTTCCCC-----C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred HHHHHCCCCCC-----C---CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 99985588888-----8---743309999999997577976893999999999999875
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.99 Aligned_cols=263 Identities=25% Similarity=0.407 Sum_probs=210.1
Q ss_pred HHHHHHHHCCCCCCCEECCCCCEEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCC
Q ss_conf 89999740255458432247960899999869909999981134765799999999999704999972112448753990
Q 002759 586 EDWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTM 665 (884)
Q Consensus 586 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 665 (884)
++|+...++ ++..+.||+|+||+||+|.++++..||||+++... ...+.|.+|+.++++++||||++++|++.+ +.
T Consensus 6 ~~wei~~~~-~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~ 81 (272)
T d1qpca_ 6 DEWEVPRET-LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS--MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (272)
T ss_dssp CTTBCCGGG-EEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred CCEECCHHH-EEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CC
T ss_conf 770038899-38867981079828999999999999999986476--888999999999986799988578731045-97
Q ss_pred EEEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 25999725998553320148999988899999988978999999999999999872599990750578886574899970
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~v 745 (884)
.++||||+++|+|.+++.... ...+++..+++++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 82 ~~iv~Ey~~~g~L~~~~~~~~----------~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~ 148 (272)
T d1qpca_ 82 IYIITEYMENGSLVDFLKTPS----------GIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSC 148 (272)
T ss_dssp CEEEEECCTTCBHHHHTTSHH----------HHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred EEEEEEECCCCCHHHHHHHCC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCE
T ss_conf 699999578982888875147----------89887889999999999999999748---95467564225156202440
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC-CCCCCCHHHHHHHHHH
Q ss_conf 583346742148756765431245433238433488899973471449999999880999999-9997311009999999
Q 002759 746 KLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVE-SPTTNEVVVLCEYVRE 824 (884)
Q Consensus 746 ki~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~-~~~~~~~~~~~~~~~~ 824 (884)
||+|||+|+..............++..|+|||++.+..++.++||||||+++|||+||+.|+. .....+. . .
T Consensus 149 Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~------~-~ 221 (272)
T d1qpca_ 149 KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV------I-Q 221 (272)
T ss_dssp EECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH------H-H
T ss_pred EECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------H-H
T ss_conf 42341014773588644203567744445828983799982456452579999999689888888899999------9-9
Q ss_pred HHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 99729876323645788769999999999943258998999998899999998440
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 880 (884)
.+..+..... +.....++.+++.+||+.+|++||||.++++.|+++-.
T Consensus 222 ~i~~~~~~~~--------p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 222 NLERGYRMVR--------PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCCC--------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9970688889--------65571999999999758897689399999998611321
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.13 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=204.5
Q ss_pred EECCCCCEEEEEEEEC---CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECCCCC
Q ss_conf 3224796089999986---9909999981134765799999999999704999972112448753990259997259985
Q 002759 601 LIGGGSIGSVYRASFE---GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 601 ~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
.||+|+||+||+|.++ ++..||||+++........+.|.+|+.++++++||||++++|++.. +..++||||+++|+
T Consensus 16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP 94 (285)
T ss_dssp EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred EEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEEEEECCCCC
T ss_conf 87306080999999960897689999998820397899999999999986799888068656036-80799998078996
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCCCC
Q ss_conf 53320148999988899999988978999999999999999872599990750578886574899970583346742148
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKLLP 757 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~~~~ 757 (884)
|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||+|+...
T Consensus 95 L~~~l~~~~-----------~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 95 LHKFLVGKR-----------EEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp HHHHHTTCT-----------TTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred HHHHHHCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 899752125-----------6999999999999999987899868---81057676466045468854203313421155
Q ss_pred CCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 75676--5431245433238433488899973471449999999880-99999999973110099999999972987632
Q 002759 758 ILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 758 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
..... ......+++.|+|||++.+..++.++|||||||++|||+| |+.||......+.. . .+..+.....
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~---~----~i~~~~~~~~ 233 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM---A----FIEQGKRMEC 233 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH---H----HHHTTCCCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHH---H----HHHCCCCCCC
T ss_conf 43432113562113743358688727999954123220178999993899999997999999---9----9981899999
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 36457887699999999999432589989999988999999984402
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 881 (884)
++..+.++.+++.+||+.+|++||||.++.+.|+.+..+
T Consensus 234 --------p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 234 --------PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf --------976789999999997577976890999999999999998
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.61 Aligned_cols=252 Identities=22% Similarity=0.346 Sum_probs=211.4
Q ss_pred CCCCCEECCCCCEEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECCC
Q ss_conf 54584322479608999998699099999811347657999999999997049999721124487539902599972599
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVPK 675 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 675 (884)
+...+.||+|+||+||+|.++++..||||+++... ...+.|.+|+..+++++||||++++|++.+....++||||+++
T Consensus 6 ~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~--~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~ 83 (258)
T d1k2pa_ 6 LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS--MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMAN 83 (258)
T ss_dssp CCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS--SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTT
T ss_pred CEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCCC
T ss_conf 79968982078839999998899899999987475--7789999999999966898601588998507816999970489
Q ss_pred CCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 85533201489999888999999889789999999999999998725999907505788865748999705833467421
Q 002759 676 GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 676 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~~ 755 (884)
|++.+++.... ..+++..+.+++.|+++||+|||+. +++||||||+||+++.++.+||+|||+++.
T Consensus 84 g~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~ 149 (258)
T d1k2pa_ 84 GCLLNYLREMR-----------HRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY 149 (258)
T ss_dssp EEHHHHHHSGG-----------GCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCB
T ss_pred CCHHHHHHCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEE
T ss_conf 93888641024-----------6776899999999999999987546---843466541358876998479886144202
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 48756765431245433238433488899973471449999999880-99999999973110099999999972987632
Q 002759 756 LPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 756 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
.............++..|+|||.+.+..++.++||||||+++|||+| |+.||...+..+... .+..+....
T Consensus 150 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~-------~i~~~~~~~- 221 (258)
T d1k2pa_ 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE-------HIAQGLRLY- 221 (258)
T ss_dssp CSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH-------HHHTTCCCC-
T ss_pred CCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHH-------HHHHCCCCC-
T ss_conf 357872252465788775780786379988521033643246739755999988999999999-------998079789-
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 36457887699999999999432589989999988999999984
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESI 878 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l 878 (884)
.+ .....++..++.+||+.+|++|||++++++.|.++
T Consensus 222 -~p------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 -RP------HLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -CC------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -CC------CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf -96------54659999999997668976893999999874188
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.64 Aligned_cols=256 Identities=23% Similarity=0.394 Sum_probs=205.9
Q ss_pred CCCCCEECCCCCEEEEEEEECCC-----EEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEE
Q ss_conf 54584322479608999998699-----0999998113476579999999999970499997211244875399025999
Q 002759 596 LDKECLIGGGSIGSVYRASFEGG-----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 670 (884)
+...++||+|+||+||+|.++.. ..||||++...........|.+|+.++++++||||++++|++.+....++|+
T Consensus 9 ~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~ 88 (283)
T d1mqba_ 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIIT 88 (283)
T ss_dssp EEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEEEE
T ss_conf 68615981177909999999689987879999999884459689999999999998568987832367783388038999
Q ss_pred EECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 72599855332014899998889999998897899999999999999987259999075057888657489997058334
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Df 750 (884)
||+.++++.+++.... ..+++..++.++.|++.|++|||++ +|+||||||+|||++.++.+||+||
T Consensus 89 e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DF 154 (283)
T d1mqba_ 89 EYMENGALDKFLREKD-----------GEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDF 154 (283)
T ss_dssp ECCTTEEHHHHHHHTT-----------TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC
T ss_pred EECCCCCCHHHHHCCC-----------CCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCC
T ss_conf 7213574022210234-----------5420899999999999854121212---3425765644278889984998455
Q ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC-CCCCCHHHHHHHHHHHHH
Q ss_conf 67421487567--654312454332384334888999734714499999998809999999-997311009999999997
Q 002759 751 GLAKLLPILDN--YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVES-PTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 751 g~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~-~~~~~~~~~~~~~~~~~~ 827 (884)
|+|+....... .......++..|+|||++.+..++.++||||||+++|||++++.|+.. ....+. . +.+.
T Consensus 155 Gla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~------~-~~i~ 227 (283)
T d1mqba_ 155 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV------M-KAIN 227 (283)
T ss_dssp CC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------H-HHHH
T ss_pred CHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHH------H-HHHH
T ss_conf 10300357876526742677773434888870499997355634489899999679886556899999------9-9986
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 29876323645788769999999999943258998999998899999998440
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 880 (884)
.+... ..+...+.++.+++.+||+.+|++||||.|+++.|+++.+
T Consensus 228 ~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 228 DGFRL--------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp TTCCC--------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCCCC--------CCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 35789--------9850457999999999776797689399999999999866
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.91 Aligned_cols=266 Identities=21% Similarity=0.302 Sum_probs=205.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 25545843224796089999986-99099999811347657999999999997049999721124487539902599972
Q 002759 594 ALLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 594 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+-|+..+.||+|+||+||+|... ++..||+|+++..........+.+|+.+++.++||||+++++++.+....++||||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy 85 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 85 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 68889789712778099999998999699999987540978999999999999867999999499999989999999976
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748999705833467
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~ 752 (884)
+++|+|.+++...+ .+++..+..++.|++.||.|||++. +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~gg~L~~~l~~~~------------~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vkl~DFGl 151 (322)
T d1s9ja_ 86 MDGGSLDQVLKKAG------------RIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGV 151 (322)
T ss_dssp CTTEEHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCC
T ss_pred CCCCCHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHHC--CEECCCCCHHHEEECCCCCEEEEECCC
T ss_conf 79986899874249------------9999999999999999999999859--997144577994687899899954877
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH-HHHHHCC--
Q ss_conf 4214875676543124543323843348889997347144999999988099999999973110099999-9999729--
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV-RELLERG-- 829 (884)
Q Consensus 753 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~-- 829 (884)
|+.... .......||..|+|||++.+..|+.++||||+||++|||++|+.||...+..+........ .......
T Consensus 152 a~~~~~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (322)
T d1s9ja_ 152 SGQLID---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228 (322)
T ss_dssp CHHHHH---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-------------
T ss_pred CCCCCC---CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCC
T ss_conf 625678---86211137714119468758998948889989999999998889989988789999998875177545774
Q ss_pred ------C--CCC-------------------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHH
Q ss_conf ------8--763-------------------2364578876999999999994325899899999889999--99984
Q 002759 830 ------S--ASA-------------------CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ--VLESI 878 (884)
Q Consensus 830 ------~--~~~-------------------~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~--~L~~l 878 (884)
. ... ...+.... .....++..++.+||+.||++|||++|+++ .+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPS--GVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp -----------------CCCCHHHHHHHHHTSCCCCCCB--TTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC--CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHHHCCC
T ss_conf 212333221111222354134778876650268766764--4489999999999868994679089999609864769
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.38 Aligned_cols=272 Identities=22% Similarity=0.313 Sum_probs=211.2
Q ss_pred HHHHHHHCCCCCCCEECCCCCEEEEEEEECC------CEEEEEEECCCCCCCCCHHHHHHHHHHHHCC-CCCCCCEEEEE
Q ss_conf 9999740255458432247960899999869------9099999811347657999999999997049-99972112448
Q 002759 587 DWEAGTKALLDKECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGY 659 (884)
Q Consensus 587 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 659 (884)
.|+...++ ++..+.||+|+||+||+|.+.. ...||+|++...........+.+|+.++.++ +|||||+++++
T Consensus 31 kwei~~~~-~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~ 109 (325)
T d1rjba_ 31 KWEFPREN-LEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA 109 (325)
T ss_dssp GGBCCGGG-EEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCHHH-EEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEE
T ss_conf 46577899-39701983078819999998578855420499999966335878999999999999971589968687788
Q ss_pred EECCCCEEEEEEECCCCCHHHHCCCCCCCCCC-----------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf 75399025999725998553320148999988-----------8999999889789999999999999998725999907
Q 002759 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTS-----------TGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPIL 728 (884)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~-----------~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~iv 728 (884)
+.+.+..++||||+++|+|.++++........ ........+++..++.++.|++.||+|||++ +|+
T Consensus 110 ~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~Ii 186 (325)
T d1rjba_ 110 CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCV 186 (325)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEE
T ss_pred EEECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEE
T ss_conf 86299589999727999599999862577751022100001222001257789999999999999999999739---905
Q ss_pred ECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCC
Q ss_conf 5057888657489997058334674214875676-5431245433238433488899973471449999999880-9999
Q 002759 729 HLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKP 806 (884)
Q Consensus 729 H~Dlk~~Nili~~~~~vki~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p 806 (884)
||||||+||+++.++.+||+|||+|+........ ......+|+.|+|||++.+..++.++|||||||++|||+| |+.|
T Consensus 187 HRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~P 266 (325)
T d1rjba_ 187 HRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 266 (325)
T ss_dssp ETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred ECCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCC
T ss_conf 05270321443459828985142222045778615623435787657838872799996330300039999998389999
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 9999973110099999999972987632364578876999999999994325899899999889999999
Q 002759 807 VESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLE 876 (884)
Q Consensus 807 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~ 876 (884)
|...+..+.. ......+.... . +.....++.+++.+||+.+|++|||++||++.|.
T Consensus 267 f~~~~~~~~~------~~~~~~~~~~~-----~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 267 YPGIPVDANF------YKLIQNGFKMD-----Q---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp STTCCCSHHH------HHHHHTTCCCC-----C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCHHHHH------HHHHHCCCCCC-----C---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9998989999------99985699899-----8---8767899999999975889668939999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.24 Aligned_cols=247 Identities=21% Similarity=0.298 Sum_probs=203.7
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 54584322479608999998-69909999981134765799999999999704999972112448753990259997259
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|+||+||+|.. .++..||+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 22 Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 100 (293)
T d1yhwa1 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQ-QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLA 100 (293)
T ss_dssp BCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGG-CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred CEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCC-CHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEECC
T ss_conf 388789812858299999998999899999984301-7279999999999986799988058577988999899997037
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 98553320148999988899999988978999999999999999872599990750578886574899970583346742
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~ 754 (884)
+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 101 gg~L~~~~~~~-------------~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~ 164 (293)
T d1yhwa1 101 GGSLTDVVTET-------------CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCA 164 (293)
T ss_dssp TCBHHHHHHHS-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCCHHHHHHCC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHE
T ss_conf 98089886415-------------999999999999999999999987---97226776888688789968642515641
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC
Q ss_conf 14875676543124543323843348889997347144999999988099999999973110099999999972987632
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASAC 834 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 834 (884)
..... ........|++.|+|||++.+..++.++||||+||++|||+||+.||...+..+. .........+...
T Consensus 165 ~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~~~~~~ 237 (293)
T d1yhwa1 165 QITPE-QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNGTPELQ 237 (293)
T ss_dssp ECCST-TCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHCSCCCS
T ss_pred EECCC-CCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCCCC
T ss_conf 32136-6644444447773682664479988012031372999998048899899799999------9999857999888
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 364578876999999999994325899899999889999
Q 002759 835 FDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 835 ~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
. ++....++..++.+||+.||++|||+.|+++
T Consensus 238 ~-------~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 238 N-------PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp S-------GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C-------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8-------5537999999999986699668909999964
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.56 Aligned_cols=250 Identities=24% Similarity=0.328 Sum_probs=201.8
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 545843224796089999986-9909999981134765799999999999704999972112448753990259997259
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||+||+|... +++.||+|++.........+.+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 7 y~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~ 86 (271)
T d1nvra_ 7 WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86 (271)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECCC
T ss_conf 08998972174809999999999979999998456641279999999999985799888469654046743679886458
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 98553320148999988899999988978999999999999999872599990750578886574899970583346742
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~ 754 (884)
+|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+
T Consensus 87 gg~L~~~l~~~~------------~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~ 151 (271)
T d1nvra_ 87 GGELFDRIEPDI------------GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLAT 151 (271)
T ss_dssp TEEGGGGSBTTT------------BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred CCCHHHHHHCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHE
T ss_conf 980899975379------------999999999999999999999975---98357546899788789987983231422
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 148756-765431245433238433488899-973471449999999880999999999731100999999999729876
Q 002759 755 LLPILD-NYGLTKFHNAVGYVAPELAQSLRL-SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 755 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
...... ........||+.|+|||++.+..+ +.++||||+||++|||+||+.||......... ...........
T Consensus 152 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-----~~~~~~~~~~~ 226 (271)
T d1nvra_ 152 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-----YSDWKEKKTYL 226 (271)
T ss_dssp ECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-----HHHHHTTCTTS
T ss_pred EECCCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHH-----HHHHHCCCCCC
T ss_conf 4046886531113255747428728618999997101617379999998299788889859999-----99986388878
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32364578876999999999994325899899999889999
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
. .. .....++.+++.+||+.+|++|||++|+++
T Consensus 227 ~----~~----~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 N----PW----KKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp T----TG----GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred C----CC----CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8----64----469999999999976799668909999961
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.65 Aligned_cols=265 Identities=26% Similarity=0.387 Sum_probs=211.0
Q ss_pred HHHHHHHCCCCCCCEECCCCCEEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 99997402554584322479608999998699099999811347657999999999997049999721124487539902
Q 002759 587 DWEAGTKALLDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 587 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (884)
+|+...++ ++..+.||+|+||+||+|.++++..||||+++... ...+.|.+|+.++++++||||++++|++.+ +..
T Consensus 11 ~~~i~~~~-~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~--~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 11 AWEIPRES-LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT--MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp CSBCCGGG-EEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS--SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred CEECCHHH-EEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCE
T ss_conf 60747799-79846993079809999999999999999988044--888999999999986666788689999823-975
Q ss_pred EEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 59997259985533201489999888999999889789999999999999998725999907505788865748999705
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vk 746 (884)
++||||+++|+|..++.... ...++|..++.++.||+.||+|||++ +++||||||+|||++.++.+|
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~----------~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~k 153 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGET----------GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK 153 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHH----------HTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEECCCCCHHHHHHHCC----------CCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEE
T ss_conf 99999447994354200003----------55305999999999999999987541---143353123079998999299
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 83346742148756765431245433238433488899973471449999999880999999999731100999999999
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 747 i~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|+|||+|+..............++..|+|||++....++.++||||||+++|||+||+.|+........ . . ..+
T Consensus 154 l~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~--~---~-~~i 227 (285)
T d1fmka3 154 VADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--V---L-DQV 227 (285)
T ss_dssp ECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--H---H-HHH
T ss_pred ECCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHH--H---H-HHH
T ss_conf 844255542568873352454556654580898379989177413235899999868999998888999--9---9-999
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 72987632364578876999999999994325899899999889999999844025
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~~ 882 (884)
....... . ++....++.+++.+||+.+|++|||+++|++.|+......
T Consensus 228 ~~~~~~~-----~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 228 ERGYRMP-----C---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HTTCCCC-----C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHCCCCC-----C---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 8268999-----9---8323799999999975669758919999999876662389
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=352.84 Aligned_cols=277 Identities=24% Similarity=0.375 Sum_probs=217.3
Q ss_pred HHHHHHHHHCCCCCCCEECCCCCEEEEEEEEC------CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEE
Q ss_conf 78999974025545843224796089999986------990999998113476579999999999970499997211244
Q 002759 585 YEDWEAGTKALLDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658 (884)
Q Consensus 585 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (884)
+.+|+.++++ ++..+.||+|+||+||+|.++ ++..||||+++..........|.+|+.+++.++||||+++++
T Consensus 5 ~~~~e~p~~~-~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 83 (301)
T d1lufa_ 5 LLSLEYPRNN-IEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLG 83 (301)
T ss_dssp HHHTBCCGGG-CEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred HHHCCCCHHH-CEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEE
T ss_conf 3311389889-388679820788399999988876577882999999882108579999999999999668997655246
Q ss_pred EEECCCCEEEEEEECCCCCHHHHCCCCCCCCCC------------CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCC
Q ss_conf 875399025999725998553320148999988------------89999998897899999999999999987259999
Q 002759 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTS------------TGGIGNPELHWSRRFHIALGTARALSYLHHDCKPP 726 (884)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~------------~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ 726 (884)
++.+....++++||+++|+|.++++........ ........+++..++.++.|++.||+|||++ +
T Consensus 84 ~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ 160 (301)
T d1lufa_ 84 VCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---K 160 (301)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred EECCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---C
T ss_conf 6605980389998158992999998527554210000111001210346788989999999999999985541357---8
Q ss_pred EEECCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-
Q ss_conf 075057888657489997058334674214875676-543124543323843348889997347144999999988099-
Q 002759 727 ILHLNLKSTNILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGR- 804 (884)
Q Consensus 727 ivH~Dlk~~Nili~~~~~vki~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~- 804 (884)
++||||||+|||++.++.+||+|||+|+........ ..+...++..|+|||.+.+..++.++||||||+++|||++|.
T Consensus 161 ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred EEEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCC
T ss_conf 68548840116898999289833144211367764111577776767679899726889805630252362999980689
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 9999999731100999999999729876323645788769999999999943258998999998899999998440
Q 002759 805 KPVESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 805 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 880 (884)
+||...+..+.. .. +..+..... ++..+.++.+++..||+.+|++||||.||++.|+++.+
T Consensus 241 ~p~~~~~~~e~~------~~-v~~~~~~~~--------p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 241 QPYYGMAHEEVI------YY-VRDGNILAC--------PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp CTTTTSCHHHHH------HH-HHTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCCCHHHHH------HH-HHCCCCCCC--------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 999998999999------99-973997888--------73252999999999748896579399999999998429
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.66 Aligned_cols=250 Identities=25% Similarity=0.364 Sum_probs=202.1
Q ss_pred CCEECCCCCEEEEEEEECC---CEEEEEEECCCCC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 8432247960899999869---9099999811347-65799999999999704999972112448753990259997259
Q 002759 599 ECLIGGGSIGSVYRASFEG---GVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 599 ~~~ig~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
.+.||+|+||+||+|.++. ++.||||+++... .....+.+.+|+.++++++||||++++|++.. +..++||||++
T Consensus 12 ~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 12 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 87834587829999998169738599999988010898999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 98553320148999988899999988978999999999999999872599990750578886574899970583346742
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~ 754 (884)
+|+|.++++... .+++..++.++.|++.||+|||+. +++||||||+|||++.++.+|++|||+|+
T Consensus 91 ~g~L~~~l~~~~------------~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~ 155 (277)
T d1xbba_ 91 LGPLNKYLQQNR------------HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSK 155 (277)
T ss_dssp TEEHHHHHHHCT------------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHH
T ss_conf 896899975225------------789999999999999997668747---95567776113102356751234134533
Q ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 14875676--5431245433238433488899973471449999999880-99999999973110099999999972987
Q 002759 755 LLPILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 755 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
........ ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...+..+.. ..+..+..
T Consensus 156 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~-------~~i~~~~~ 228 (277)
T d1xbba_ 156 ALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT-------AMLEKGER 228 (277)
T ss_dssp ECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-------HHHHTTCC
T ss_pred HCCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHH-------HHHHCCCC
T ss_conf 13432344322445677842039166537999843443034031328965899999998999999-------99982899
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 632364578876999999999994325899899999889999999844
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 879 (884)
... +...+.++.+++.+||+.+|++|||++++.+.|+..-
T Consensus 229 ~~~--------p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 229 MGC--------PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp CCC--------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred CCC--------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf 999--------8656799999999975889768909899999852887
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.46 Aligned_cols=252 Identities=23% Similarity=0.295 Sum_probs=203.3
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 025545843224796089999986-9909999981134765799999999999704999972112448753990259997
Q 002759 593 KALLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 593 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
+++|+..+.||+|+||+||+|... ++..||+|++... .....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCC-CHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 03759847993077819999999999939999998728-99999999999999986799998849889800995899996
Q ss_pred ECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 25998553320148999988899999988978999999999999999872599990750578886574899970583346
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg 751 (884)
|+++|+|.+++.... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 90 y~~~g~L~~~~~~~~-----------~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG 155 (288)
T d2jfla1 90 FCAGGAVDAVMLELE-----------RPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFG 155 (288)
T ss_dssp CCTTEEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCCCCCHHHHHHHCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECH
T ss_conf 279981889998628-----------9999999999999999999999988---98871407003148789998997161
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 74214875676543124543323843348-----8899973471449999999880999999999731100999999999
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQ-----SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 752 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
+|+..... ........|++.|+|||++. ...++.++||||+||++|||+||+.||...+..+.. ....
T Consensus 156 ~a~~~~~~-~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~------~~i~ 228 (288)
T d2jfla1 156 VSAKNTRT-IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL------LKIA 228 (288)
T ss_dssp TCEECHHH-HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH------HHHH
T ss_pred HHHCCCCC-CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHH
T ss_conf 23035778-6410010256264799998320257888880665787899999982088999998999999------9997
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 72987632364578876999999999994325899899999889999
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
....+. .. .+.....++..++.+||+.||++|||++|+++
T Consensus 229 ~~~~~~-~~------~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 229 KSEPPT-LA------QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HSCCCC-CS------SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred CCCCCC-CC------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 079987-77------65669999999999976699668919999962
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=352.71 Aligned_cols=251 Identities=24% Similarity=0.307 Sum_probs=203.8
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 25545843224796089999986-99099999811347657999999999997049999721124487539902599972
Q 002759 594 ALLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 594 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+.|+..+.||+|+||+||+|... +++.||+|++...........+.+|+.+++.++||||+++++++.+.+..|+||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 66699889940658399999999999899999981577312899999999999867998999198999989988898852
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEECC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748---999705833
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD---ENYEPKLSD 749 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~---~~~~vki~D 749 (884)
+++|+|.+++...+ .+++..+..++.|++.||+|||++ +++||||||+||++. +++.+||+|
T Consensus 89 ~~gg~L~~~l~~~~------------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~D 153 (307)
T d1a06a_ 89 VSGGELFDRIVEKG------------FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISD 153 (307)
T ss_dssp CCSCBHHHHHHTCS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECC
T ss_pred CCCCCHHHHHHCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEEC
T ss_conf 68984888653036------------788789999999999998752413---055687046300110468882499831
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCC
Q ss_conf 46742148756765431245433238433488899973471449999999880999999999731100999999999729
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERG 829 (884)
Q Consensus 750 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~ 829 (884)
||+|+.... ........||+.|+|||++.+..+++++||||+||++|||++|+.||......+. ........
T Consensus 154 FG~a~~~~~--~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~------~~~i~~~~ 225 (307)
T d1a06a_ 154 FGLSKMEDP--GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL------FEQILKAE 225 (307)
T ss_dssp C--------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHHTTC
T ss_pred CCEEEECCC--CCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHCCC
T ss_conf 543587258--9704400328422591887379998078734515999999859799999899999------99986168
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 87632364578876999999999994325899899999889999
Q 002759 830 SASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 830 ~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
... +.... +....++..++.+||+.||++|||++|+++
T Consensus 226 ~~~---~~~~~---~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 263 (307)
T d1a06a_ 226 YEF---DSPYW---DDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263 (307)
T ss_dssp CCC---CTTTT---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCC---CCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 777---87666---678999999999976089757918999862
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.01 Aligned_cols=244 Identities=25% Similarity=0.419 Sum_probs=203.0
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCC--CCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 545843224796089999986-9909999981134--7657999999999997049999721124487539902599972
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|..+ +++.||+|++... ........+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 8 y~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy 87 (263)
T d2j4za1 8 FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEY 87 (263)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEE
T ss_conf 69988985177858999999899949999998168856768999999999999856888888599999989998999850
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748999705833467
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~ 752 (884)
+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 88 ~~~g~L~~~l~~~~------------~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~ 152 (263)
T d2j4za1 88 APLGTVYRELQKLS------------KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGW 152 (263)
T ss_dssp CTTCBHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCS
T ss_pred CCCCCHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCE
T ss_conf 47985898875048------------999999999999999999999988---946522023441466899871155563
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 42148756765431245433238433488899973471449999999880999999999731100999999999729876
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
|..... .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+.. ..... ...
T Consensus 153 a~~~~~---~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~-~~~- 221 (263)
T d2j4za1 153 SVHAPS---SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY------KRISR-VEF- 221 (263)
T ss_dssp CSCCCC---CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHT-TCC-
T ss_pred EEECCC---CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH------HHHHC-CCC-
T ss_conf 354488---8523557887634999975899893144046759999983299998889999999------99971-899-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32364578876999999999994325899899999889999
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
..... ...++..++.+||+.||++|||++|+++
T Consensus 222 -----~~p~~---~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 -----TFPDF---VTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp -----CCCTT---SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred -----CCCCC---CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----99866---8999999999976479768909999971
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.56 Aligned_cols=256 Identities=21% Similarity=0.350 Sum_probs=207.6
Q ss_pred CCCCCCEECCCCCEEEEEEEECC-C----EEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 55458432247960899999869-9----099999811347657999999999997049999721124487539902599
Q 002759 595 LLDKECLIGGGSIGSVYRASFEG-G----VSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~~~-~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (884)
.|+..+.||+|+||+||+|.+.. + ..||+|+++........+.+.+|+.++++++||||++++|++.++ ..+++
T Consensus 10 dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v 88 (317)
T d1xkka_ 10 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLI 88 (317)
T ss_dssp TEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEEE
T ss_conf 99783198208992999999958998898999999965134979999999999999867998881589999619-83699
Q ss_pred EEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 97259985533201489999888999999889789999999999999998725999907505788865748999705833
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~D 749 (884)
++++.+|+|.+++.... ..+++..++.++.|++.||+|||++ +|+||||||+|||++.++.+||+|
T Consensus 89 ~e~~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~D 154 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK-----------DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITD 154 (317)
T ss_dssp EECCTTCBHHHHHHHTS-----------SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECC
T ss_pred EEECCCCCCCCCCCCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEEC
T ss_conf 98426874010111334-----------5799999999999999999999876---950476212031167998758602
Q ss_pred CCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 4674214875676-5431245433238433488899973471449999999880-9999999997311009999999997
Q 002759 750 YGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 750 fg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
||+|+........ ......++..|+|||++.+..++.++||||||+++|||+| |+.||...+..+... ...
T Consensus 155 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~---~i~---- 227 (317)
T d1xkka_ 155 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISS---ILE---- 227 (317)
T ss_dssp CSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHH---HHH----
T ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHH----
T ss_conf 5522233544453223651058644670887469998356544079999999977999999999899999---997----
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 29876323645788769999999999943258998999998899999998440
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 880 (884)
.+.... .++....++.+++.+||+.+|.+|||+.|+++.|+.+.+
T Consensus 228 ~~~~~~--------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 228 KGERLP--------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp HTCCCC--------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCC--------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 599899--------985568999999998478993469199999999999875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.43 Aligned_cols=256 Identities=25% Similarity=0.355 Sum_probs=209.6
Q ss_pred CCCCCEECCCCCEEEEEEEECC----CEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 5458432247960899999869----909999981134765799999999999704999972112448753990259997
Q 002759 596 LDKECLIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
|+..+.||+|+||.||+|.+.. +..||||+++..........+.+|+.++++++||||++++|++. .+..++|||
T Consensus 9 ~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E 87 (273)
T d1mp8a_ 9 IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIME 87 (273)
T ss_dssp EEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred EEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEEE
T ss_conf 6987799307882999999936996449999999365668799999999999998689999856988995-374799998
Q ss_pred ECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 25998553320148999988899999988978999999999999999872599990750578886574899970583346
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg 751 (884)
|+++|++.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||
T Consensus 88 ~~~~g~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG 153 (273)
T d1mp8a_ 88 LCTLGELRSFLQVRK-----------YSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFG 153 (273)
T ss_dssp CCTTEEHHHHHHHTT-----------TTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC--
T ss_pred ECCCCCHHHHHHCCC-----------CCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCH
T ss_conf 406980776542247-----------8999999999999998775230226---74414102655320678967876503
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 742148756765431245433238433488899973471449999999880-9999999997311009999999997298
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 752 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+|+..............+|+.|+|||++.+..++.++||||||+++|||+| |..||......+... .+ ..+.
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~---~i----~~~~ 226 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---RI----ENGE 226 (273)
T ss_dssp -----------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH---HH----HTTC
T ss_pred HHEECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHH---HH----HCCC
T ss_conf 4213367762330540058310326675169988745244424789999826999988899999999---99----8189
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 763236457887699999999999432589989999988999999984402
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 881 (884)
... .+.....++.+++.+||+.+|++|||+.|+++.|+++.++
T Consensus 227 ~~~--------~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 227 RLP--------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp CCC--------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCC--------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 998--------9877799999999997687976892999999999999778
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=346.44 Aligned_cols=251 Identities=18% Similarity=0.273 Sum_probs=203.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 2554584322479608999998-699099999811347657999999999997049999721124487539902599972
Q 002759 594 ALLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 594 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
+.|+..+.||+|+||+||+|.. .++..||+|++.... ......+.+|+.++++++||||+++++++.+....|+||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY-PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 03599899931778299999998999799999988726-46799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEECCC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748--9997058334
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD--ENYEPKLSDY 750 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~--~~~~vki~Df 750 (884)
+++|+|.+++.... ..+++..+..++.||+.||.|||++ +|+||||||+|||++ .++.+||+||
T Consensus 108 ~~gg~L~~~~~~~~-----------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DF 173 (352)
T d1koba_ 108 LSGGELFDRIAAED-----------YKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDF 173 (352)
T ss_dssp CCCCBHHHHTTCTT-----------CCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCC
T ss_pred CCCCHHHHHHHHCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEEC
T ss_conf 89980888898638-----------9989999999999999999999977---926513144553113467884899525
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 67421487567654312454332384334888999734714499999998809999999997311009999999997298
Q 002759 751 GLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 751 g~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
|+|..... ........+++.|+|||++.+..++.++||||+||++|||+||+.||...+..+. .........
T Consensus 174 Gla~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~i~~~~~ 245 (352)
T d1koba_ 174 GLATKLNP--DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET------LQNVKRCDW 245 (352)
T ss_dssp TTCEECCT--TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH------HHHHHHCCC
T ss_pred CCCEECCC--CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCC
T ss_conf 63034378--8720100476453489997479989763338989999999968899899799999------999984788
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 7632364578876999999999994325899899999889999
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
. +...... ....++..++.+||++||.+|||++|+++
T Consensus 246 ~---~~~~~~~---~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 246 E---FDEDAFS---SVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp C---CCSSTTT---TSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred C---CCCCCCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9---8930024---79999999999975699668918999960
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.76 Aligned_cols=248 Identities=24% Similarity=0.369 Sum_probs=195.2
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEEC----CCCEEEE
Q ss_conf 545843224796089999986-99099999811347-65799999999999704999972112448753----9902599
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS----STMQLIL 669 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv 669 (884)
+.....||+|+||+||+|... ++..||+|++.... .....+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv 90 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEE
T ss_conf 88516970082849999999999959999998512279899999999999998579998506999984033458889999
Q ss_pred EEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEC
Q ss_conf 97259985533201489999888999999889789999999999999998725999907505788865748-99970583
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD-ENYEPKLS 748 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~-~~~~vki~ 748 (884)
|||+++|+|.+++.... .+++..+..++.|++.||+|||++ +++|+||||||+|||++ +++.+||+
T Consensus 91 mE~~~~g~L~~~l~~~~------------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~ 157 (270)
T d1t4ha_ 91 TELMTSGTLKTYLKRFK------------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG 157 (270)
T ss_dssp EECCCSCBHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred EECCCCCCHHHHHHCCC------------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEECCCCHHHCEEECCCCCEEEE
T ss_conf 95789894899975135------------546999999999999999999978-99799687674351166799988980
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 34674214875676543124543323843348889997347144999999988099999999973110099999999972
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 749 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|||+|+... ........||+.|+|||++.+ .++.++||||+||++|||++|+.||......+. ..+.+..
T Consensus 158 DFGla~~~~---~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~------~~~~i~~ 227 (270)
T d1t4ha_ 158 DLGLATLKR---ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ------IYRRVTS 227 (270)
T ss_dssp CTTGGGGCC---TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH------HHHHHTT
T ss_pred ECCCCEECC---CCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHH------HHHHHHC
T ss_conf 057654236---876677553813008988478-999867110079999999878899987655999------9999973
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 987632364578876999999999994325899899999889999
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
+.....++. . ...++.+++.+||+++|++|||++|+++
T Consensus 228 ~~~~~~~~~----~---~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 228 GVKPASFDK----V---AIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp TCCCGGGGG----C---CCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred CCCCCCCCC----C---CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 899865675----5---7899999999976379758929999967
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.48 Aligned_cols=255 Identities=21% Similarity=0.272 Sum_probs=201.4
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEEC--CCCEEEEE
Q ss_conf 5545843224796089999986-99099999811347-65799999999999704999972112448753--99025999
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--STMQLILS 670 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~ 670 (884)
.|+..+.||+|+||+||+|..+ ++..||+|++.... .....+.+.+|+.++++++||||+++++++.+ ....|+||
T Consensus 5 dy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivm 84 (269)
T d2java1 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVM 84 (269)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 37996798308891999999999997999999874657979999999999999977899982489999917899899999
Q ss_pred EECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf 72599855332014899998889999998897899999999999999987259--9990750578886574899970583
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDC--KPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~--~~~ivH~Dlk~~Nili~~~~~vki~ 748 (884)
||+++|+|.+++.... .....+++..++.++.|++.||.|||++. ..+|+||||||+|||++.++.+||+
T Consensus 85 Ey~~~g~L~~~i~~~~--------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~ 156 (269)
T d2java1 85 EYCEGGDLASVITKGT--------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG 156 (269)
T ss_dssp ECCTTEEHHHHHHHHH--------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEEC
T ss_pred ECCCCCCHHHHHHHCC--------CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEE
T ss_conf 5689993899998515--------45789999999999999999999999716778878858676542574788857980
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 34674214875676543124543323843348889997347144999999988099999999973110099999999972
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 749 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|||+|+..... ........|++.|+|||++.+..++.++||||+||++|||+||+.||...+..+.. .. +..
T Consensus 157 DFG~a~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~------~~-i~~ 228 (269)
T d2java1 157 DFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------GK-IRE 228 (269)
T ss_dssp CHHHHHHC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HH-HHH
T ss_pred ECCCEEECCCC-CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHH------HH-HHC
T ss_conf 01000322457-77556677882327999983999993898875278999980188998998999999------99-971
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 987632364578876999999999994325899899999889999
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
...... . .....++..++.+||+.||.+|||++|+++
T Consensus 229 ~~~~~~-----~---~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 229 GKFRRI-----P---YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp TCCCCC-----C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCCCCC-----C---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 899889-----7---435999999999976799557918999972
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=347.40 Aligned_cols=249 Identities=22% Similarity=0.304 Sum_probs=201.9
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 545843224796089999986-9909999981134765799999999999704999972112448753990259997259
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||.||+|... ++..||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||||++
T Consensus 28 Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~ 106 (350)
T d1koaa2 28 YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH-ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMS 106 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS-HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECCC
T ss_conf 589889840768199999988999899999984524-3169999999999986799799929999998999999998579
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEECCCCC
Q ss_conf 985533201489999888999999889789999999999999998725999907505788865748--999705833467
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD--ENYEPKLSDYGL 752 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~--~~~~vki~Dfg~ 752 (884)
+|+|.+++.... ..+++..+..++.||+.||.|||++ +++||||||+|||++ .++.+||+|||+
T Consensus 107 gg~L~~~l~~~~-----------~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~ 172 (350)
T d1koaa2 107 GGELFEKVADEH-----------NKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGL 172 (350)
T ss_dssp SCBHHHHHTCTT-----------SCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTT
T ss_pred CCCHHHHHHHHC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCH
T ss_conf 988999997623-----------7899999999999999999999756---97600015467364168898699954521
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 42148756765431245433238433488899973471449999999880999999999731100999999999729876
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
|+.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+. ...........
T Consensus 173 a~~~~~--~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~------~~~i~~~~~~~ 244 (350)
T d1koaa2 173 TAHLDP--KQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWNM 244 (350)
T ss_dssp CEECCT--TSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHTCCCS
T ss_pred HEECCC--CCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCC
T ss_conf 044256--5432000686242188997589987267655465999999859899899799999------99998478898
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32364578876999999999994325899899999889999
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
+..... ....++..++.+||+.||++|||++|+++
T Consensus 245 ---~~~~~~---~~s~~~~~li~~~L~~dP~~R~t~~eil~ 279 (350)
T d1koaa2 245 ---DDSAFS---GISEDGKDFIRKLLLADPNTRMTIHQALE 279 (350)
T ss_dssp ---CCGGGG---GCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred ---CCCCCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---942235---89999999999975689667908999862
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=343.19 Aligned_cols=245 Identities=23% Similarity=0.340 Sum_probs=197.3
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCC--CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 5545843224796089999986-990999998113476--5799999999999704999972112448753990259997
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
.|+..+.||+|+||+||+|... ++..||||++..... ....+.+.+|+.++++++||||+++++++.+.+..|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 25998553320148999988899999988978999999999999999872599990750578886574899970583346
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg 751 (884)
|+++|++..++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~g~l~~~~~~~~------------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG 160 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK------------PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFG 160 (309)
T ss_dssp CCSEEHHHHHHHHTS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCT
T ss_pred ECCCCCHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECC
T ss_conf 069994578997379------------999999999999999999999868---97666788421798799978984436
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 742148756765431245433238433488---89997347144999999988099999999973110099999999972
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQS---LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 752 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
+|+.... .....||+.|+|||++.+ ..|+.++||||+||++|||++|+.||......+. .......
T Consensus 161 ~a~~~~~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~~~ 229 (309)
T d1u5ra_ 161 SASIMAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN 229 (309)
T ss_dssp TCBSSSS-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHS
T ss_pred CCCCCCC-----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHC
T ss_conf 5334677-----8731347663688998346788867214545589999999878899999799999------9999828
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 987632364578876999999999994325899899999889999
Q 002759 829 GSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
..+. ... ...+ .++..++.+||+.||.+|||++|+++
T Consensus 230 ~~~~-~~~----~~~s---~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 230 ESPA-LQS----GHWS---EYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp CCCC-CSC----TTSC---HHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred CCCC-CCC----CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9998-887----8889---99999999977379657918999971
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.67 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=203.8
Q ss_pred HCCCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCC-----CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCE
Q ss_conf 025545843224796089999986-99099999811347-----657999999999997049999721124487539902
Q 002759 593 KALLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-----RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 593 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 666 (884)
++.|+..+.||+|+||+||+|... ++..||||++.... .....+.+.+|+.++++++||||+++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC---
Q ss_conf 59997259985533201489999888999999889789999999999999998725999907505788865748999---
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY--- 743 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~--- 743 (884)
|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +++||||||+||+++.++
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~------------~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~ 153 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE------------SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPK 153 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSS
T ss_pred EEEEECCCCCCCCCHHCCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCC
T ss_conf 99998677864310010356------------421557899999999998766625---422113330127982589866
Q ss_pred -CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf -7058334674214875676543124543323843348889997347144999999988099999999973110099999
Q 002759 744 -EPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 744 -~vki~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 822 (884)
.+|++|||+|..... ........++..|+|||++.+..++.++||||+||++|||++|+.||...+..+..
T Consensus 154 ~~vkl~DfG~a~~~~~--~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------ 225 (293)
T d1jksa_ 154 PRIKIIDFGLAHKIDF--GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL------ 225 (293)
T ss_dssp CCEEECCCTTCEECTT--SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------
T ss_pred CCEEECCHHHHHHCCC--CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHH------
T ss_conf 6469643344210577--76312247777430999981899997665221409999997088998899999999------
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999972987632364578876999999999994325899899999889999
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
....... .. +.... ......++..++.+||+.||++|||++|+++
T Consensus 226 ~~i~~~~-~~--~~~~~---~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 226 ANVSAVN-YE--FEDEY---FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHTTC-CC--CCHHH---HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHCC-CC--CCCHH---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9998168-88--87010---4788999999999986389668919999961
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.86 Aligned_cols=247 Identities=21% Similarity=0.260 Sum_probs=204.0
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCC--CCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 545843224796089999986-9909999981134--7657999999999997049999721124487539902599972
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|... +++.||||++... ......+.+.+|+.++++++||||+++++++.+.+..|+||||
T Consensus 10 y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy 89 (288)
T d1uu3a_ 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89 (288)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECC
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEC
T ss_conf 78988985087909999999899979999998657755777899999999999876888861799999989988999970
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748999705833467
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~ 752 (884)
+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||+++++.+||+|||+
T Consensus 90 ~~gg~L~~~~~~~~------------~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~ 154 (288)
T d1uu3a_ 90 AKNGELLKYIRKIG------------SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGT 154 (288)
T ss_dssp CTTEEHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred CCCCCHHHHHHCCC------------CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCC
T ss_conf 48987777653159------------999999999999999999762165---088476774123668885388603210
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 42148756-76543124543323843348889997347144999999988099999999973110099999999972987
Q 002759 753 AKLLPILD-NYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
|+.+.... ........||+.|+|||++.+..++.++||||+||++|||+||+.||...+..+.. ..... ...
T Consensus 155 a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~------~~i~~-~~~ 227 (288)
T d1uu3a_ 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF------QKIIK-LEY 227 (288)
T ss_dssp CEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHT-TCC
T ss_pred CEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHH------HHHHC-CCC
T ss_conf 24225677643335556775525844002689896662304569999980388998995999999------99971-899
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 632364578876999999999994325899899999889999
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
. . ++....++..++.+||+.||++|||++|++.
T Consensus 228 ~------~---p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 D------F---PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C------C---CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C------C---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf 9------9---8547999999999985579768919789737
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.03 Aligned_cols=256 Identities=24% Similarity=0.333 Sum_probs=204.0
Q ss_pred CCEECCCCCEEEEEEEECC----CEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCCEEEEEEEC
Q ss_conf 8432247960899999869----909999981134765799999999999704999972112448753-99025999725
Q 002759 599 ECLIGGGSIGSVYRASFEG----GVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS-STMQLILSEFV 673 (884)
Q Consensus 599 ~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~ 673 (884)
.++||+|+||+||+|.+.. ...||||+++........+.|.+|+.++++++||||++++|++.+ +...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99855332014899998889999998897899999999999999987259999075057888657489997058334674
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a 753 (884)
++|+|.+++.... ...++..+++++.|++.||.|+|+. +++||||||+|||+++++.+||+|||++
T Consensus 112 ~~g~l~~~~~~~~-----------~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~ 177 (311)
T d1r0pa_ 112 KHGDLRNFIRNET-----------HNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLA 177 (311)
T ss_dssp TTCBHHHHHHCTT-----------CCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGG
T ss_pred ECCCHHHHHCCCC-----------CCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCH
T ss_conf 0674144210134-----------5404899999999988765200336---7625776687576779998899106523
Q ss_pred CCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCC
Q ss_conf 214875676---54312454332384334888999734714499999998809999999997311009999999997298
Q 002759 754 KLLPILDNY---GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGS 830 (884)
Q Consensus 754 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~ 830 (884)
+........ ......++..|+|||.+....++.++||||||+++|||+||+.||........ . .... ..+.
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~---~~~i-~~g~ 251 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--I---TVYL-LQGR 251 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------C---HHHH-HTTC
T ss_pred HHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--H---HHHH-HCCC
T ss_conf 22556655531002565556455676887437999745746619999999978999988899999--9---9999-8089
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 7632364578876999999999994325899899999889999999844025
Q 002759 831 ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 831 ~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~~ 882 (884)
.... ++....++.+++.+||+.||++||++.||++.|+++....
T Consensus 252 ~~~~--------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 252 RLLQ--------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp CCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred CCCC--------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 8899--------6447599999999976889768939999999999999752
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.50 Aligned_cols=283 Identities=24% Similarity=0.321 Sum_probs=215.4
Q ss_pred CCCHHHHHHHHHCCCCCCCEECCCCCEEEEEEEECC------CEEEEEEECCCCCCCCCHHHHHHHHHHHHCC-CCCCCC
Q ss_conf 899789999740255458432247960899999869------9099999811347657999999999997049-999721
Q 002759 582 PSKYEDWEAGTKALLDKECLIGGGSIGSVYRASFEG------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLV 654 (884)
Q Consensus 582 ~~~~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 654 (884)
|+....|+...++ |+..+.||+|+||.||+|.+.. ++.||||+++........+.+.+|...+.++ +|+||+
T Consensus 2 p~~~~~wei~~~~-y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv 80 (299)
T d1ywna1 2 PYDASKWEFPRDR-LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 80 (299)
T ss_dssp CCCHHHHBCCGGG-EEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred CCCCCCCCCCHHH-EEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEE
T ss_conf 7898252616799-798449841678399999986777555783999999860017178999999999988614998499
Q ss_pred EEEEEEECC-CCEEEEEEECCCCCHHHHCCCCCCCC----CCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEE
Q ss_conf 124487539-90259997259985533201489999----8889999998897899999999999999987259999075
Q 002759 655 AFQGYYWSS-TMQLILSEFVPKGNLYDNLHGVNYPG----TSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILH 729 (884)
Q Consensus 655 ~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH 729 (884)
.+++++... ...++||||+++|+|.++++...... ..........+++..+..++.|++.||+|||++ +|+|
T Consensus 81 ~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivH 157 (299)
T d1ywna1 81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH 157 (299)
T ss_dssp CEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred EEEEEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCC
T ss_conf 7411540479757999984589929999985366666532220233214689999999999999999988737---9717
Q ss_pred CCCCCCCEEECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCC
Q ss_conf 057888657489997058334674214875676-54312454332384334888999734714499999998809-9999
Q 002759 730 LNLKSTNILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTG-RKPV 807 (884)
Q Consensus 730 ~Dlk~~Nili~~~~~vki~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~p~ 807 (884)
|||||+|||++.++.+||+|||+|+........ ......||+.|+|||++.+..++.++|||||||++|||+|| ..||
T Consensus 158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~ 237 (299)
T d1ywna1 158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237 (299)
T ss_dssp SCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred CCCCCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCC
T ss_conf 86773106577998289845752001135665222475166721020368646889966322136789999986889999
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 999973110099999999972987632364578876999999999994325899899999889999999844025
Q 002759 808 ESPTTNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 808 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~~ 882 (884)
......+. ....+..+..... ++....++.+++.+||+.+|++|||++|+++.|+++.+..
T Consensus 238 ~~~~~~~~------~~~~~~~~~~~~~--------~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~n 298 (299)
T d1ywna1 238 PGVKIDEE------FCRRLKEGTRMRA--------PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298 (299)
T ss_dssp TTCCCSHH------HHHHHHHTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred CCCCHHHH------HHHHHHCCCCCCC--------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 89998999------9999963898888--------8657899999999976779667919999999997998677
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.60 Aligned_cols=247 Identities=22% Similarity=0.254 Sum_probs=203.2
Q ss_pred CCCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCC--CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 554584322479608999998-699099999811347--65799999999999704999972112448753990259997
Q 002759 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG--RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
.|+..+.||+|+||.||+|.. .++..||+|++.... .......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e 85 (337)
T d1o6la_ 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME 85 (337)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCEE
T ss_conf 42898898317684999999989998999999815654497999999999999986799988778764035642111000
Q ss_pred ECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 25998553320148999988899999988978999999999999999872599990750578886574899970583346
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg 751 (884)
|+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||
T Consensus 86 y~~gg~L~~~~~~~~------------~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG 150 (337)
T d1o6la_ 86 YANGGELFFHLSRER------------VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG 150 (337)
T ss_dssp CCTTCBHHHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred CCCCCCHHHHHHCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECC
T ss_conf 357986055553256------------775999999999996521134315---96224647778476589988882056
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 74214875676543124543323843348889997347144999999988099999999973110099999999972987
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 752 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
+|+..... ........||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..+.. ..... ...
T Consensus 151 ~a~~~~~~-~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~i~~-~~~ 222 (337)
T d1o6la_ 151 LCKEGISD-GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF------ELILM-EEI 222 (337)
T ss_dssp TCBCSCCT-TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHHHH-CCC
T ss_pred CCCCCCCC-CCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHH------HHHHC-CCC
T ss_conf 52003567-86205510088996666504898883331022306788998789999996999999------99852-899
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 632364578876999999999994325899899999-----889999
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~ 873 (884)
. ... ....++..++.+||++||.+|++ ++|+++
T Consensus 223 ~------~p~---~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 R------FPR---TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C------CCT---TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C------CCC---CCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 8------986---6899999999866638934422565234999972
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.55 Aligned_cols=267 Identities=27% Similarity=0.379 Sum_probs=207.3
Q ss_pred CCCCCEECCCCCEEEEEEEECC-CE--EEEEEECCCCCCCCCHHHHHHHHHHHHCC-CCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 5458432247960899999869-90--99999811347657999999999997049-99972112448753990259997
Q 002759 596 LDKECLIGGGSIGSVYRASFEG-GV--SIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~~-~~--~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e 671 (884)
++..+.||+|+||+||+|.+++ +. .||||++.........+.+.+|+.++.++ +||||++++|++.+.+..++|||
T Consensus 12 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~e 91 (309)
T d1fvra_ 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE 91 (309)
T ss_dssp CEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEEEE
T ss_conf 68877982078828999999899969999999978233857999999999999862289988367888841873699998
Q ss_pred ECCCCCHHHHCCCCCCCCCC----CCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 25998553320148999988----89999998897899999999999999987259999075057888657489997058
Q 002759 672 FVPKGNLYDNLHGVNYPGTS----TGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki 747 (884)
|+++|+|.++++........ ........+++..+.+++.|+|.||.|+|++ +++||||||+|||++.++.+||
T Consensus 92 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 92 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp CCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred ECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCCEEE
T ss_conf 0289869999864035555512310123457899999999999999998766308---9545550520489868876387
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 334674214875676543124543323843348889997347144999999988099-9999999731100999999999
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGR-KPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 748 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
+|||+|+.... ........++..|+|||.+.+..++.++||||||+++|||++|. .||...+..+.. ..+
T Consensus 169 ~DfG~a~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~-------~~i 239 (309)
T d1fvra_ 169 ADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY-------EKL 239 (309)
T ss_dssp CCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH-------HHG
T ss_pred CCCCCCCCCCC--CCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHH-------HHH
T ss_conf 43443224442--234553013775555387526999962215313889999983689999999999999-------999
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 72987632364578876999999999994325899899999889999999844025
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGL 882 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~~ 882 (884)
..+... . .+.....++.+++.+||+.+|++||||.|+++.|+++.++.
T Consensus 240 ~~~~~~-----~---~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~ 287 (309)
T d1fvra_ 240 PQGYRL-----E---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER 287 (309)
T ss_dssp GGTCCC-----C---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred HHCCCC-----C---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 826888-----8---87667899999999976789668949999999999998618
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.70 Aligned_cols=267 Identities=22% Similarity=0.277 Sum_probs=200.7
Q ss_pred CCCCEECCCCCEEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCC----CEEEEEEE
Q ss_conf 45843224796089999986990999998113476579999999999970499997211244875399----02599972
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST----MQLILSEF 672 (884)
Q Consensus 597 ~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~e~ 672 (884)
...+.||+|+||.||+|.+. +..||||++.... ........|+..+..++||||++++|++.+.. ..++||||
T Consensus 6 ~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~--~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey 82 (303)
T d1vjya_ 6 VLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE--ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDY 82 (303)
T ss_dssp EEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEEC
T ss_pred EEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEEEEC
T ss_conf 99889820788199999999-9899999987200--46799999999996279986832688998379860489999964
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 59985533201489999888999999889789999999999999998725-----9999075057888657489997058
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHD-----CKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~-----~~~~ivH~Dlk~~Nili~~~~~vki 747 (884)
+++|+|.++++.. .++|..+++++.|+|.||+|+|+. ..++|+||||||+|||++.++.+||
T Consensus 83 ~~~g~L~~~l~~~-------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl 149 (303)
T d1vjya_ 83 HEHGSLFDYLNRY-------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI 149 (303)
T ss_dssp CTTCBHHHHHHHC-------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCCHHHHHHCC-------------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEE
T ss_conf 6698989998658-------------999899999999999999998876652046898661531731357868877688
Q ss_pred CCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCC------CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHH--
Q ss_conf 334674214875676---543124543323843348889------997347144999999988099999999973110--
Q 002759 748 SDYGLAKLLPILDNY---GLTKFHNAVGYVAPELAQSLR------LSDKCDVYSFGVILLELVTGRKPVESPTTNEVV-- 816 (884)
Q Consensus 748 ~Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~-- 816 (884)
+|||+++........ ......|++.|+|||++.+.. ++.++||||||+++|||+||..|+.........
T Consensus 150 ~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~ 229 (303)
T d1vjya_ 150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 229 (303)
T ss_dssp CCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTT
T ss_pred EECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHH
T ss_conf 76386623467776200135525035476782210565454677767501220159999999628998876631124101
Q ss_pred ------HHHHHHHHHHHCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf ------0999999999729876323645788--769999999999943258998999998899999998440259
Q 002759 817 ------VLCEYVRELLERGSASACFDRSLRG--FAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLG 883 (884)
Q Consensus 817 ------~~~~~~~~~~~~~~~~~~~d~~~~~--~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~~~ 883 (884)
............... ++.... ...+....+.+++.+||+.||++|||+.|+++.|+++.++-|
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 230 DLVPSDPSVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp TTSCSSCCHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HCCCCCCHHHHHHHHHHCCCC----CCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 225564309999998750246----88877655776899999999999760698589599999999998888659
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.35 Aligned_cols=277 Identities=23% Similarity=0.349 Sum_probs=214.7
Q ss_pred HHHHHHHCCCCCCCEECCCCCEEEEEEEEC------CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCC-CCCCCCEEEEE
Q ss_conf 999974025545843224796089999986------99099999811347657999999999997049-99972112448
Q 002759 587 DWEAGTKALLDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQGY 659 (884)
Q Consensus 587 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~ 659 (884)
.|+...++ ++..+.||+|+||.||+|.+. .+..||||+++..........+.+|+.+++.+ +||||++++|+
T Consensus 17 ~~~~~~~~-~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~ 95 (311)
T d1t46a_ 17 KWEFPRNR-LSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA 95 (311)
T ss_dssp GGBCCGGG-EEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCCHHH-EEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEE
T ss_conf 26377899-69854982068829999998066447788699999987424877999999999998762699988789989
Q ss_pred EECCCCEEEEEEECCCCCHHHHCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCC
Q ss_conf 753990259997259985533201489999888------99999988978999999999999999872599990750578
Q 002759 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTST------GGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLK 733 (884)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~------~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk 733 (884)
+.+....++||||+++|+|.++++......... .......+++..+..++.||+.|++|||++ +++|||||
T Consensus 96 ~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLK 172 (311)
T d1t46a_ 96 CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLA 172 (311)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred EEECCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCC
T ss_conf 831997899997379987999998535665444445332223345889999999999999999988757---92666241
Q ss_pred CCCEEECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCC
Q ss_conf 88657489997058334674214875676-5431245433238433488899973471449999999880-999999999
Q 002759 734 STNILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPT 811 (884)
Q Consensus 734 ~~Nili~~~~~vki~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~ 811 (884)
|+||+++.++.+|++|||.++........ ......+++.|+|||++.+..++.++||||||+++|||+| |.+|+....
T Consensus 173 p~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 173 ARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp GGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 02100002575210234010233678861586201359687677886179999740010258999999858998877899
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 7311009999999997298763236457887699999999999432589989999988999999984402
Q 002759 812 TNEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 812 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 881 (884)
..+.. .+.+..+.... . ++....++.+++.+||+.||++||||.++++.|+++..+
T Consensus 253 ~~~~~------~~~i~~~~~~~-----~---~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~ 308 (311)
T d1t46a_ 253 VDSKF------YKMIKEGFRML-----S---PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308 (311)
T ss_dssp SSHHH------HHHHHHTCCCC-----C---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHH------HHHHHCCCCCC-----C---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf 89999------99986689889-----8---543659999999997577965792999999999876534
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.40 Aligned_cols=275 Identities=22% Similarity=0.350 Sum_probs=212.8
Q ss_pred HHHHHHHHHCCCCCCCEECCCCCEEEEEEEEC------CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEE
Q ss_conf 78999974025545843224796089999986------990999998113476579999999999970499997211244
Q 002759 585 YEDWEAGTKALLDKECLIGGGSIGSVYRASFE------GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQG 658 (884)
Q Consensus 585 ~~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~ 658 (884)
+++|+...+++ ...+.||+|+||+||+|.+. .+..||||+++..........|.+|+.++++++||||++++|
T Consensus 12 ~~~~ei~~~~~-~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 12 PDEWEVAREKI-TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CCTTBCCGGGE-EEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred CCCEEECHHHE-EEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEE
T ss_conf 61004268991-88359820788189999987864477896899999870128689999999999999769998841254
Q ss_pred EEECCCCEEEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEE
Q ss_conf 87539902599972599855332014899998889999998897899999999999999987259999075057888657
Q 002759 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNIL 738 (884)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nil 738 (884)
++......++||||+++|+|.+++.......... .....+++..+.+++.|+|.||.|||++ +++||||||+|||
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiL 165 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANN--PVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM 165 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHC--TTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred EEECCCCEEEEEEECCCCCHHHHHHHCCCCCCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEE
T ss_conf 7842881067776048998899987503321134--4468879999999999999999987647---9654328677540
Q ss_pred ECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCCCCCCHH
Q ss_conf 489997058334674214875676-54312454332384334888999734714499999998809-9999999973110
Q 002759 739 LDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTG-RKPVESPTTNEVV 816 (884)
Q Consensus 739 i~~~~~vki~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg-~~p~~~~~~~~~~ 816 (884)
++.++.+||+|||+|+........ ......+++.|+|||.+.+..++.++||||||+++|||+|| +.||...+..+..
T Consensus 166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred ECCCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 35996499942454202357763031340231632378888736998833344437899999996899999998999999
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 0999999999729876323645788769999999999943258998999998899999998440
Q 002759 817 VLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 817 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 880 (884)
... ..+..... +......+.+++.+||+.+|++|||+.++++.|++..+
T Consensus 246 ------~~i-~~~~~~~~--------p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 246 ------RFV-MEGGLLDK--------PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ------HHH-HTTCCCCC--------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHH-HHCCCCCC--------CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf ------999-80888888--------63353999999999757796589399999999787617
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.96 Aligned_cols=250 Identities=28% Similarity=0.402 Sum_probs=203.9
Q ss_pred CCCCCEECCCCCEEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEEC-CCCEEEEEEECC
Q ss_conf 5458432247960899999869909999981134765799999999999704999972112448753-990259997259
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS-STMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~ 674 (884)
++..+.||+|+||.||+|.++ +..||||+++.. ...+.+.+|+.++++++||||++++|++.+ .+..++||||++
T Consensus 9 ~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~---~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 9 LKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND---ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp EEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC---C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred EEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH---HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf 488579820798089999999-909999998857---7799999999999867898985498788723892899996369
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 98553320148999988899999988978999999999999999872599990750578886574899970583346742
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~ 754 (884)
+|+|.+++.... ...+++..+++++.|++.||.|||+. +++||||||+||+++.++.+|++|||.++
T Consensus 85 ~g~L~~~l~~~~----------~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~ 151 (262)
T d1byga_ 85 KGSLVDYLRSRG----------RSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTK 151 (262)
T ss_dssp TEEHHHHHHHHH----------HHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred CCCHHHHHHHCC----------CCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCE
T ss_conf 998999987457----------88889999999999998523211337---65536665676014689977632456003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
Q ss_conf 148756765431245433238433488899973471449999999880-9999999997311009999999997298763
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
..... .....++..|+|||++.+..++.++||||||+++|||+| |+.||...+..+.. ..+ ..+....
T Consensus 152 ~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~~i----~~~~~~~ 220 (262)
T d1byga_ 152 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRV----EKGYKMD 220 (262)
T ss_dssp --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHH----TTTCCCC
T ss_pred ECCCC----CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH---HHH----HCCCCCC
T ss_conf 44787----765566646778178727988858877757999999997899999999999999---999----8089999
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 236457887699999999999432589989999988999999984402
Q 002759 834 CFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 834 ~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 881 (884)
.+.....++.+++.+||+.||.+||||.++++.|++++..
T Consensus 221 --------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~ 260 (262)
T d1byga_ 221 --------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260 (262)
T ss_dssp --------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf --------9765799999999997566976893999999999999867
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=333.36 Aligned_cols=248 Identities=21% Similarity=0.200 Sum_probs=194.8
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCC--CCCCCHHHHHH---HHHHHHCCCCCCCCEEEEEEECCCCEEE
Q ss_conf 5545843224796089999986-9909999981134--76579999999---9999704999972112448753990259
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFEL---EIGRLSNIRHFNLVAFQGYYWSSTMQLI 668 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~~---E~~~l~~l~h~niv~~~~~~~~~~~~~l 668 (884)
.|+..+.||+|+||.||+|... ++..||+|++... ........+.+ ++.+++.++||||+++++++.+.+..|+
T Consensus 5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i 84 (364)
T d1omwa3 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF 84 (364)
T ss_dssp TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEE
T ss_conf 68510188428890999999999997999999845875426679999999999999850899858899999998998899
Q ss_pred EEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf 99725998553320148999988899999988978999999999999999872599990750578886574899970583
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~ 748 (884)
||||+++|+|.+++.... .+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+
T Consensus 85 vmE~~~gg~L~~~l~~~~------------~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~ 149 (364)
T d1omwa3 85 ILDLMNGGDLHYHLSQHG------------VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRIS 149 (364)
T ss_dssp EECCCCSCBHHHHHHHHC------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEEC
T ss_pred EEEECCCCCHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEE
T ss_conf 999148983899987325------------532789999999999999999977---96220444221678588967982
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 34674214875676543124543323843348-88999734714499999998809999999997311009999999997
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ-SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 749 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
|||+|+..... ......||+.|+|||++. +..++.++||||+||++|||+||+.||......+...+ .+.
T Consensus 150 DFGla~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---~~~--- 220 (364)
T d1omwa3 150 DLGLACDFSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI---DRM--- 220 (364)
T ss_dssp CCTTCEECSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH---HHH---
T ss_pred EECEEEECCCC---CCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHH---
T ss_conf 20102333788---643311345542168760389998441046778999999859998888998999999---986---
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 2987632364578876999999999994325899899999-----889999
Q 002759 828 RGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVVQ 873 (884)
Q Consensus 828 ~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~ 873 (884)
.... ........ ..++..++.+||+.||.+||| ++|+++
T Consensus 221 -~~~~---~~~~~~~~---s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 221 -TLTM---AVELPDSF---SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp -SSSC---CCCCCSSS---CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred -CCCC---CCCCCCCC---CHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf -0468---88788778---99999999998566988808874357999974
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=334.40 Aligned_cols=243 Identities=24% Similarity=0.321 Sum_probs=201.5
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCC--CCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 545843224796089999986-9909999981134--7657999999999997049999721124487539902599972
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||+||+|..+ ++..||||+++.. ......+.+.+|+.+++.++||||+++++++.+....|+||||
T Consensus 6 y~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 85 (316)
T d1fota_ 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85 (316)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEEEE
T ss_conf 08888972076808999999899979999998457754889999999999999863696753303568528800567650
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748999705833467
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~ 752 (884)
+++|++..++.... .+++..+..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 86 ~~gg~l~~~~~~~~------------~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~ 150 (316)
T d1fota_ 86 IEGGELFSLLRKSQ------------RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGF 150 (316)
T ss_dssp CCSCBHHHHHHHTS------------SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSS
T ss_pred CCCCCCCCCCCCCC------------CCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCC
T ss_conf 37863223432222------------111007999999998765541247---677055681050386899889831752
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 42148756765431245433238433488899973471449999999880999999999731100999999999729876
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
|+..... .....|++.|+|||++.+..++.++||||+||++|||+||+.||...+..+. ..........
T Consensus 151 a~~~~~~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~~~- 219 (316)
T d1fota_ 151 AKYVPDV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT------YEKILNAELR- 219 (316)
T ss_dssp CEECSSC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHCCCC-
T ss_pred CEEECCC----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHH------HHHHHCCCCC-
T ss_conf 1671245----6434576343599998389998043046533368999759899999699999------9999708988-
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 3236457887699999999999432589989999-----9889999
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~ 873 (884)
+. +....++..++.+||+.+|.+|+ |++++++
T Consensus 220 --~p-------~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 220 --FP-------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp --CC-------TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred --CC-------CCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf --99-------77899999999999544997666431021999981
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.57 Aligned_cols=274 Identities=27% Similarity=0.395 Sum_probs=213.2
Q ss_pred HHHHHHCCCCCCCEECCCCCEEEEEEEECC--------CEEEEEEECCCCCCCCCHHHHHHHHHHHHCC-CCCCCCEEEE
Q ss_conf 999740255458432247960899999869--------9099999811347657999999999997049-9997211244
Q 002759 588 WEAGTKALLDKECLIGGGSIGSVYRASFEG--------GVSIAVKKLETLGRIRNQEEFELEIGRLSNI-RHFNLVAFQG 658 (884)
Q Consensus 588 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~ 658 (884)
|....+. |+..+.||+|+||.||+|.... +..||||+++..........+.+|...+.++ +||||+++++
T Consensus 8 ~~i~~~~-~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDR-LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGG-EEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCHHH-EEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCC
T ss_conf 7225899-697009851678289999985787555667549999998811286889999999999998139996973465
Q ss_pred EEECCCCEEEEEEECCCCCHHHHCCCCCCCCC----CCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 87539902599972599855332014899998----88999999889789999999999999998725999907505788
Q 002759 659 YYWSSTMQLILSEFVPKGNLYDNLHGVNYPGT----STGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKS 734 (884)
Q Consensus 659 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~----~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~ 734 (884)
++.++...++||||+++|+|.+++........ .........+++..+++++.|++.||+|||++ +++||||||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp 163 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAA 163 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSG
T ss_pred CCCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECC
T ss_conf 22018868999973699909999986067764322233457434679999999999999999876637---978630221
Q ss_pred CCEEECCCCCEEECCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 8657489997058334674214875676-5431245433238433488899973471449999999880-9999999997
Q 002759 735 TNILLDENYEPKLSDYGLAKLLPILDNY-GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTT 812 (884)
Q Consensus 735 ~Nili~~~~~vki~Dfg~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~ 812 (884)
+|||++.++.+||+|||.++........ ......+++.|+|||.+.+..++.++||||||+++|||++ |..||...+.
T Consensus 164 ~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 164 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp GGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCEEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH
T ss_conf 02245478976762211101135555543146678884663266751798882555477588888740179898999999
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 31100999999999729876323645788769999999999943258998999998899999998440
Q 002759 813 NEVVVLCEYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRN 880 (884)
Q Consensus 813 ~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 880 (884)
.+.. ..+..+..... . .....++.+++.+||+.+|.+|||+.|+++.|+++..
T Consensus 244 ~~~~-------~~i~~~~~~~~-----p---~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 244 EELF-------KLLKEGHRMDK-----P---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHH-------HHHHTTCCCCC-----C---SSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHH-------HHHHCCCCCCC-----C---CCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9999-------99972888898-----7---4352999999999766797679399999999988860
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=334.45 Aligned_cols=243 Identities=18% Similarity=0.253 Sum_probs=201.2
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCC--CCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 545843224796089999986-9909999981134--7657999999999997049999721124487539902599972
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETL--GRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
|+..+.||+|+||.||+|..+ ++..||||++... ......+.+.+|+.+++.++||||+++++++.+....++|+||
T Consensus 43 y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~ 122 (350)
T d1rdqe_ 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122 (350)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCCCC
T ss_conf 08988961176808999999899989999998267745889999999999999974877274034444322222322223
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748999705833467
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~ 752 (884)
+.+|+|..++.... .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+
T Consensus 123 ~~~g~l~~~l~~~~------------~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~ 187 (350)
T d1rdqe_ 123 VAGGEMFSHLRRIG------------RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGF 187 (350)
T ss_dssp CTTCBHHHHHHHHC------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred CCCCCHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEE
T ss_conf 34662266675158------------989999999999999989999859---986176799993607789788610103
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 42148756765431245433238433488899973471449999999880999999999731100999999999729876
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
|+..... .....|++.|+|||++.+..++.++||||+||++|||+||+.||...+.... ........ ..
T Consensus 188 a~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~i~~~~-~~ 256 (350)
T d1rdqe_ 188 AKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI------YEKIVSGK-VR 256 (350)
T ss_dssp CEECSSC----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCC-CC
T ss_pred EEECCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHH------HHHHHCCC-CC
T ss_conf 3322566----6433676356788997179988533114500789999758899899599999------99986179-88
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 3236457887699999999999432589989999-----9889999
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-----SMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-----t~~eil~ 873 (884)
. +.....++..++.+||+.||.+|+ |++++++
T Consensus 257 ------~---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 257 ------F---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp ------C---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred ------C---CCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf ------9---766899999999998340998606553454999971
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=332.45 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=207.7
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCC--CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCC----CEEE
Q ss_conf 54584322479608999998-6990999998113476--579999999999970499997211244875399----0259
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST----MQLI 668 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~l 668 (884)
|+..+.||+|+||+||+|.. .+++.||+|+++.... ......+.+|+.+++.++||||+++++++.... ..|+
T Consensus 9 Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~l 88 (277)
T d1o6ya_ 9 YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEEEE
T ss_conf 69868996089929999999999989999998556646989999999999999856999887311435432688766999
Q ss_pred EEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf 99725998553320148999988899999988978999999999999999872599990750578886574899970583
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~ 748 (884)
||||+++++|.+++...+ .+++..+..++.|++.||+|||++ +++||||||+|||++.++.++++
T Consensus 89 vmE~~~g~~L~~~~~~~~------------~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~ 153 (277)
T d1o6ya_ 89 VMEYVDGVTLRDIVHTEG------------PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVM 153 (277)
T ss_dssp EEECCCEEEHHHHHHHHC------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEEC
T ss_pred EEECCCCCEEHHHHCCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEE
T ss_conf 997788987101120358------------999999999999999999999857---95276346755665754320100
Q ss_pred CCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 3467421487567--65431245433238433488899973471449999999880999999999731100999999999
Q 002759 749 DYGLAKLLPILDN--YGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 749 Dfg~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
|||.+........ .......|++.|+|||++.+..+++++||||+||++|||+||+.||...+..+. .....
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~------~~~~~ 227 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV------AYQHV 227 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH------HHHHH
T ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH------HHHHH
T ss_conf 344432212354433334642576243699998399999663202652899999769799899699999------99998
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHCC
Q ss_conf 7298763236457887699999999999432589989999-988999999984402
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRP-SMAEVVQVLESIRNG 881 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RP-t~~eil~~L~~l~~~ 881 (884)
....... ...... ...++.+++.+||++||.+|| |++++++.|.++.++
T Consensus 228 ~~~~~~~---~~~~~~---~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ng 277 (277)
T d1o6ya_ 228 REDPIPP---SARHEG---LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHNG 277 (277)
T ss_dssp HCCCCCG---GGTSSS---CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC-
T ss_pred HCCCCCC---CHHCCC---CCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHCC
T ss_conf 4699997---100347---8999999999986679767773999999999997584
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.45 Aligned_cols=248 Identities=20% Similarity=0.288 Sum_probs=200.8
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 545843224796089999986-9909999981134765799999999999704999972112448753990259997259
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|...+.||+|+||+||+|... ++..||+|+++... .+...+.+|+.+++.++||||+++++++.+.+..|+||||++
T Consensus 7 Y~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~ 84 (321)
T d1tkia_ 7 YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG--TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFIS 84 (321)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT--HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECCC
T ss_conf 588789831778399999998999699999975786--659999999999985799798909899988998899995389
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEECCCCC
Q ss_conf 9855332014899998889999998897899999999999999987259999075057888657489--99705833467
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE--NYEPKLSDYGL 752 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~--~~~vki~Dfg~ 752 (884)
+|+|.+++...+ ..+++.++..++.|++.||+|||++ +|+||||||+|||++. ...+|++|||+
T Consensus 85 gg~L~~~i~~~~-----------~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~ 150 (321)
T d1tkia_ 85 GLDIFERINTSA-----------FELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQ 150 (321)
T ss_dssp CCBHHHHHTSSS-----------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTT
T ss_pred CCCHHHHHHHCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCH
T ss_conf 980889987538-----------9999999999999999999999876---99751355444344378851899764411
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 42148756765431245433238433488899973471449999999880999999999731100999999999729876
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 753 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
++.... ........+++.|+|||...+..++.++||||+||++|||++|+.||...+..+. ...........
T Consensus 151 ~~~~~~--~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~------~~~i~~~~~~~ 222 (321)
T d1tkia_ 151 ARQLKP--GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI------IENIMNAEYTF 222 (321)
T ss_dssp CEECCT--TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHHHHHTCCCC
T ss_pred HHCCCC--CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHH------HHHHHHCCCCC
T ss_conf 100346--7753212233222340210487778401130279999999828999999899999------99998389998
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32364578876999999999994325899899999889999
Q 002759 833 ACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
. ...... ...++..++.+|++.||++|||+.|+++
T Consensus 223 ~--~~~~~~----~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 223 D--EEAFKE----ISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp C--HHHHTT----SCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C--HHHCCC----CCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8--022367----8999999999986699668909999963
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.78 Aligned_cols=255 Identities=24% Similarity=0.377 Sum_probs=203.0
Q ss_pred CCCCCEECCCCCEEEEEEEECC----CEEEEEEECCCCCC--CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEE
Q ss_conf 5458432247960899999869----90999998113476--57999999999997049999721124487539902599
Q 002759 596 LDKECLIGGGSIGSVYRASFEG----GVSIAVKKLETLGR--IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 669 (884)
|+..+.||+|+||+||+|.+.. ...||||+++.... ....+.|.+|+.++++++||||++++|++.+ ...++|
T Consensus 10 ~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv 88 (273)
T d1u46a_ 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMV 88 (273)
T ss_dssp EEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred EEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHHEE
T ss_conf 1997898038883999999988999079999999983555798999999999999986899998789877740-100114
Q ss_pred EEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECC
Q ss_conf 97259985533201489999888999999889789999999999999998725999907505788865748999705833
Q 002759 670 SEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSD 749 (884)
Q Consensus 670 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~D 749 (884)
+||+++|++.+++.... ..+++..++.++.|++.||.|||++ +++||||||+||+++.++.+|++|
T Consensus 89 ~e~~~~~~l~~~~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~D 154 (273)
T d1u46a_ 89 TELAPLGSLLDRLRKHQ-----------GHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGD 154 (273)
T ss_dssp EECCTTCBHHHHHHHHG-----------GGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECC
T ss_pred EEEECCCCHHHHHHCCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECC
T ss_conf 65423861254442126-----------8999999999999999999875217---875205668881565565433256
Q ss_pred CCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 4674214875676--5431245433238433488899973471449999999880-999999999731100999999999
Q 002759 750 YGLAKLLPILDNY--GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVT-GRKPVESPTTNEVVVLCEYVRELL 826 (884)
Q Consensus 750 fg~a~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~ 826 (884)
||+++........ ......++..|+|||.+.+..++.++||||||+++|||+| |+.||...+..+. .....
T Consensus 155 fGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~------~~~i~ 228 (273)
T d1u46a_ 155 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKID 228 (273)
T ss_dssp CTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH------HHHHH
T ss_pred CHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHH------HHHHH
T ss_conf 115553035887526547632573107999983799994215661489999999689999999699999------99998
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 72987632364578876999999999994325899899999889999999844
Q 002759 827 ERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIR 879 (884)
Q Consensus 827 ~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~ 879 (884)
+.+.... . ++..+.++.+++.+||+.+|++||||.|+.+.|++.+
T Consensus 229 ~~~~~~~----~----~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 229 KEGERLP----R----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp TSCCCCC----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HCCCCCC----C----CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf 4799999----8----5445399999999976889667929999999999649
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.00 Aligned_cols=246 Identities=23% Similarity=0.329 Sum_probs=199.3
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCC--CCCCHHHHHHHHHHHH-CCCCCCCCEEEEEEECCCCEEEEEE
Q ss_conf 545843224796089999986-99099999811347--6579999999999970-4999972112448753990259997
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG--RIRNQEEFELEIGRLS-NIRHFNLVAFQGYYWSSTMQLILSE 671 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e 671 (884)
|+..+.||+|+||+||+|... +++.||||+++... .....+.+..|...+. .++||||+++++++.+.+..|+|||
T Consensus 4 y~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmE 83 (320)
T d1xjda_ 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83 (320)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEEEE
T ss_conf 18865894087828999999999989999998055533848999999999999984799968789889704983167775
Q ss_pred ECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCC
Q ss_conf 25998553320148999988899999988978999999999999999872599990750578886574899970583346
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYG 751 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg 751 (884)
|+++|+|.+++.... .+++..+..++.||+.||+|||++ +++||||||+|||++.++.+|++|||
T Consensus 84 y~~~g~L~~~i~~~~------------~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG 148 (320)
T d1xjda_ 84 YLNGGDLMYHIQSCH------------KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFG 148 (320)
T ss_dssp CCTTCBHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCT
T ss_pred ECCCCCHHHHHHCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCC
T ss_conf 037980899864047------------899999999999999999999868---93403476540444489963015553
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 74214875676543124543323843348889997347144999999988099999999973110099999999972987
Q 002759 752 LAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 752 ~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
.++..... ........|++.|+|||++.+..++.++||||+||++|||+||+.||...+..+.. ... ....+
T Consensus 149 ~a~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~------~~i-~~~~~ 220 (320)
T d1xjda_ 149 MCKENMLG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------HSI-RMDNP 220 (320)
T ss_dssp TCBCCCCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH------HHH-HHCCC
T ss_pred HHHHCCCC-CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHH-HCCCC
T ss_conf 02323566-53345457877768999982799883232011227898987388999998999999------999-71899
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 63236457887699999999999432589989999988-9999
Q 002759 832 SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMA-EVVQ 873 (884)
Q Consensus 832 ~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~ 873 (884)
......+ .++..++.+||+.+|.+|||+. ++++
T Consensus 221 ------~~p~~~s---~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 221 ------FYPRWLE---KEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp ------CCCTTSC---HHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred ------CCCCCCC---HHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf ------8975679---999999999654489878388999980
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.98 Aligned_cols=246 Identities=22% Similarity=0.256 Sum_probs=192.9
Q ss_pred CCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCCCCCHHHHHHHHHHHHC-CCCCCCCEEEEEEEC----CCCEEEEEE
Q ss_conf 584322479608999998-69909999981134765799999999999704-999972112448753----990259997
Q 002759 598 KECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSN-IRHFNLVAFQGYYWS----STMQLILSE 671 (884)
Q Consensus 598 ~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~~lv~e 671 (884)
..+.||+|+||.||+|.. .++..||||+++. ...+.+|+.++.+ .+||||+++++++.+ ....|+|||
T Consensus 16 ~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~------~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmE 89 (335)
T d2ozaa1 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQD------CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89 (335)
T ss_dssp EEEEEEECSSCEEEEEEETTTCCEEEEEEEEC------SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred EEEEEEECCCEEEEEEEECCCCCEEEEEEECC------CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEEEEEE
T ss_conf 10796545486999999889998999999897------477999999999866999978298999503468978999997
Q ss_pred ECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEC
Q ss_conf 2599855332014899998889999998897899999999999999987259999075057888657489---9970583
Q 002759 672 FVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE---NYEPKLS 748 (884)
Q Consensus 672 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~---~~~vki~ 748 (884)
|+++|+|.+++.... ...+++..+..++.|++.||+|||++ +|+||||||+|||++. .+.+||+
T Consensus 90 y~~gg~L~~~i~~~~----------~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~ 156 (335)
T d2ozaa1 90 CLDGGELFSRIQDRG----------DQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLT 156 (335)
T ss_dssp CCCSEEHHHHHHSCS----------CCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred CCCCCCHHHHHHHCC----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 789984999998627----------87757999999999999999999976---98644410022011355556631135
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 34674214875676543124543323843348889997347144999999988099999999973110099999999972
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLER 828 (884)
Q Consensus 749 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~ 828 (884)
|||+|+..... .......|++.|+|||++.+..++.++||||+||++|||+||+.||......+... ... ..
T Consensus 157 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~---~~ 228 (335)
T d2ozaa1 157 DFGFAKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMK---TR 228 (335)
T ss_dssp CCTTCEECCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------C
T ss_pred CCCEEEECCCC--CCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHH---HHH---HH
T ss_conf 45512333688--86432267756379277748988888888764516778865889988988778899---999---99
Q ss_pred CCCCCCCCCCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9876323645788-76999999999994325899899999889999
Q 002759 829 GSASACFDRSLRG-FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 829 ~~~~~~~d~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
.. ...+ .... .......++..++.+|++.||++|||+.|+++
T Consensus 229 i~-~~~~--~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 229 IR-MGQY--EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp CC-SCSS--SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HH-CCCC--CCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 85-3888--8898543469999999999975699657909999970
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=323.82 Aligned_cols=223 Identities=29% Similarity=0.497 Sum_probs=126.3
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCC--CCCCEEECCCC---CEEEEEECCCCCCC--CCCCCCCCCCCC
Q ss_conf 896427999999883058899886568668999978--77604966999---77799926753454--354122388888
Q 002759 26 ASAATDKEILLQFKGNITDDPHNKLASWVSSGNPCE--NFKGVFCNPDG---FVDRIVLWNFSLGG--VLSPALSGLKSL 98 (884)
Q Consensus 26 ~~~~~~~~~ll~~k~~~~~~~~~~~~sW~~~~~~c~--~w~gv~C~~~~---~v~~l~l~~~~l~g--~~~~~l~~l~~L 98 (884)
.|.++|++||++||+++++ | +.++||..++ +|| .|.||+|+..+ ||++++|.+.++.| .+|+.++.|++|
T Consensus 2 ~c~~~e~~aLl~~k~~~~~-~-~~l~sW~~~~-d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L 78 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGN-P-TTLSSWLPTT-DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYL 78 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTC-C-GGGTTCCTTS-CTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTC
T ss_pred CCCHHHHHHHHHHHHHCCC-C-CCCCCCCCCC-CCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCC
T ss_conf 9898999999999997799-9-8677889999-99889488969748999479889989899888888798478467533
Q ss_pred CEEEECC-CCCCCCCCHHHHCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEECC
Q ss_conf 8575017-737456961112014790761588978899885578999854572889866798862433104668499846
Q 002759 99 RVLTLFG-NRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLS 177 (884)
Q Consensus 99 ~~L~L~~-n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~~g~ip~~~~~~~~~L~~L~L~ 177 (884)
++|+|++ |++.|.+|.+|+++++|++|+|++|.+.+..+..+..+.+|+.++++.|.+.+.+|
T Consensus 79 ~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p---------------- 142 (313)
T d1ogqa_ 79 NFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLP---------------- 142 (313)
T ss_dssp SEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCC----------------
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC----------------
T ss_conf 5202026543330024311454200110203564344332222201110011112245555685----------------
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCEECEEECCCCCCCCC
Q ss_conf 885578756334356888826722487889989877889953-3898327846797521113578014898588845886
Q 002759 178 HNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVL-DFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256 (884)
Q Consensus 178 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L-~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 256 (884)
..+++++.|+.+++++|.+.+.+|..+..+..+ +.+.+++|++++..+..+..+..+ .++++.+.+.+.
T Consensus 143 ---------~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~ 212 (313)
T d1ogqa_ 143 ---------PSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGD 212 (313)
T ss_dssp ---------GGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEEC
T ss_pred ---------HHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCC
T ss_conf ---------1220674000000235533562031214431123231022464353324332222222-333333433222
Q ss_pred CCCCCCCCCCCCEEEEECCCC
Q ss_conf 888888999865899442732
Q 002759 257 APFGVLGLKNISYFNVSHNGF 277 (884)
Q Consensus 257 ~~~~~~~l~~L~~L~L~~N~l 277 (884)
.+..+..+++++.+++++|.+
T Consensus 213 ~~~~~~~~~~l~~l~~~~~~l 233 (313)
T d1ogqa_ 213 ASVLFGSDKNTQKIHLAKNSL 233 (313)
T ss_dssp CGGGCCTTSCCSEEECCSSEE
T ss_pred CCCCCCCCCCCCCCCCCCCCC
T ss_conf 222222222211122222222
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.28 Aligned_cols=257 Identities=24% Similarity=0.226 Sum_probs=196.0
Q ss_pred CCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCC----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 5843224796089999986-990999998113476579----99999999997049999721124487539902599972
Q 002759 598 KECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRN----QEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 598 ~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
..++||+|+||+||+|... +++.||||+++....... ...+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748999705833467
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~ 752 (884)
+.++++....... ..+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||.
T Consensus 82 ~~~~~~~~~~~~~------------~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~ 146 (299)
T d1ua2a_ 82 METDLEVIIKDNS------------LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL 146 (299)
T ss_dssp CSEEHHHHHTTCC------------SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred HCCHHHHHHHHCC------------CCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCC
T ss_conf 3450776554126------------6778999999999999999886316---355035776258853778411465761
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 421487567654312454332384334888-9997347144999999988099999999973110099999999972987
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
|+...... .......++..|+|||++.+. .++.++||||+||++|||+||+.||...+..+.. ....+.......
T Consensus 147 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~ 222 (299)
T d1ua2a_ 147 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTE 222 (299)
T ss_dssp GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCT
T ss_pred CCCCCCCC-CCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHH---HHHHHHCCCCCH
T ss_conf 00057875-54330204733363999726778880564363042899998596999999999999---999985189972
Q ss_pred CCCCCC----------CCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 632364----------578876-----999999999994325899899999889999
Q 002759 832 SACFDR----------SLRGFA-----ENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 832 ~~~~d~----------~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
....+. .....+ .....++..++.+|++.||++|||++|+++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp TTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 545210002134430347898867856568999999999976389456908999967
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=326.40 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=198.9
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCCCC-C-------HHHHHHHHHHHHCCC-CCCCCEEEEEEECCCC
Q ss_conf 54584322479608999998-699099999811347657-9-------999999999970499-9972112448753990
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIR-N-------QEEFELEIGRLSNIR-HFNLVAFQGYYWSSTM 665 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~-~-------~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 665 (884)
|+..+.||+|+||+||+|.. .+++.+|||++....... . .+.+.+|+.++++++ ||||+++++++.+.+.
T Consensus 5 y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~ 84 (277)
T d1phka_ 5 YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84 (277)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCC
T ss_conf 88852884176849999999999989999999624464114788899999999999999985079974799762146760
Q ss_pred EEEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 25999725998553320148999988899999988978999999999999999872599990750578886574899970
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~v 745 (884)
.|+||||+++|+|.+++...+ .+++..+..++.||+.||+|||++ +++||||||+||+++.++.+
T Consensus 85 ~~ivmE~~~~g~L~~~l~~~~------------~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~ 149 (277)
T d1phka_ 85 FFLVFDLMKKGELFDYLTEKV------------TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNI 149 (277)
T ss_dssp EEEEEECCTTCBHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCE
T ss_pred EEEEEECCCCCHHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCE
T ss_conf 599997689866899998659------------999999999999999999999875---99432346254898689983
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHH
Q ss_conf 58334674214875676543124543323843348------889997347144999999988099999999973110099
Q 002759 746 KLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQ------SLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC 819 (884)
Q Consensus 746 ki~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~ 819 (884)
||+|||+++.... ........|+..|+|||.+. ...++.++||||+|+++|||++|+.||...+..+..
T Consensus 150 kl~DFG~a~~~~~--~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~--- 224 (277)
T d1phka_ 150 KLTDFGFSCQLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLML--- 224 (277)
T ss_dssp EECCCTTCEECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---
T ss_pred EECCCHHEEECCC--CCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHH---
T ss_conf 8712403167268--87213452467888988860534456788992331856560231032288898899999999---
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999999972987632364578876999999999994325899899999889999
Q 002759 820 EYVRELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 820 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
.......... ..+...... .++..++.+||+.+|++|||++|+++
T Consensus 225 ---~~i~~~~~~~--~~~~~~~~s----~~~~~li~~~L~~~p~~R~s~~eil~ 269 (277)
T d1phka_ 225 ---RMIMSGNYQF--GSPEWDDYS----DTVKDLVSRFLVVQPQKRYTAEEALA 269 (277)
T ss_dssp ---HHHHHTCCCC--CTTTGGGSC----HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred ---HHHHHCCCCC--CCCCCCCCC----HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---9998189888--985434689----99999999976589668919999973
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.75 Aligned_cols=266 Identities=21% Similarity=0.244 Sum_probs=198.8
Q ss_pred CCCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCC-CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEE
Q ss_conf 554584322479608999998-6990999998113476-57999999999997049999721124487539902599972
Q 002759 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEF 672 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 672 (884)
-|...+.||+|+||+||+|.. .+++.||+|+++.... ......+.+|+.++++++||||+++++++.+....|+||||
T Consensus 3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~ 82 (298)
T d1gz8a_ 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 82 (298)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEE
T ss_conf 97765177237680999999999997999999802225758999999999999867998388744533224320378862
Q ss_pred CCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCC
Q ss_conf 59985533201489999888999999889789999999999999998725999907505788865748999705833467
Q 002759 673 VPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGL 752 (884)
Q Consensus 673 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~ 752 (884)
+.+ ++.+++.... ...+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|++|||.
T Consensus 83 ~~~-~~~~~~~~~~----------~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~ 148 (298)
T d1gz8a_ 83 LHQ-DLKKFMDASA----------LTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGL 148 (298)
T ss_dssp CSE-EHHHHHHHTT----------TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTH
T ss_pred CCC-CHHHHHHHHC----------CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCC
T ss_conf 377-4455544202----------56888899999999999999986528---899213571140113467621035786
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCC
Q ss_conf 4214875676543124543323843348889-997347144999999988099999999973110099999999972987
Q 002759 753 AKLLPILDNYGLTKFHNAVGYVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSA 831 (884)
Q Consensus 753 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 831 (884)
|+..... ........++..|+|||...... ++.++|+||+||++|+|++|+.||...+..+.. ...... ......
T Consensus 149 a~~~~~~-~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~--~~i~~~-~~~~~~ 224 (298)
T d1gz8a_ 149 ARAFGVP-VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIFRT-LGTPDE 224 (298)
T ss_dssp HHHHCCC-SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHH-HCCCCT
T ss_pred CEECCCC-CCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHH--HHHHHH-CCCCCH
T ss_conf 1343688-641001036521541122136657774221033331342796687998988999999--999983-289833
Q ss_pred C---C---------CCCCCCCCC----CHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH--HHHH
Q ss_conf 6---3---------236457887----69999999999943258998999998899999--9984
Q 002759 832 S---A---------CFDRSLRGF----AENELIQVMKLGLICTSEVPSRRPSMAEVVQV--LESI 878 (884)
Q Consensus 832 ~---~---------~~d~~~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~--L~~l 878 (884)
. . ......... ......++..++.+|++.||++|||++|+++- ++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 225 VVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDV 289 (298)
T ss_dssp TTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTC
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 31444222421243454322220444166789999999999763995579189999678701469
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=317.49 Aligned_cols=259 Identities=20% Similarity=0.230 Sum_probs=199.4
Q ss_pred CCCCCEECCCCCEEEEEEEECCCEEEEEEECCCCC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEECC
Q ss_conf 54584322479608999998699099999811347-65799999999999704999972112448753990259997259
Q 002759 596 LDKECLIGGGSIGSVYRASFEGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFVP 674 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 674 (884)
|+..+.||+|+||+||+|.+++++.||||++.... .......+.+|+.++++++||||+++++++.+.+..++++|++.
T Consensus 4 Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~ 83 (286)
T d1ob3a_ 4 YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD 83 (286)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS
T ss_pred CEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEEEH
T ss_conf 63431872277818999996899999999981232685899999999999986799868766012046773158997400
Q ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCCC
Q ss_conf 98553320148999988899999988978999999999999999872599990750578886574899970583346742
Q 002759 675 KGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLAK 754 (884)
Q Consensus 675 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~ 754 (884)
++.+..+.... ..+++..+..++.|++.||+|||+. +|+||||||+|||++.++.+|++|||.|.
T Consensus 84 ~~~~~~~~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~ 148 (286)
T d1ob3a_ 84 QDLKKLLDVCE------------GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLAR 148 (286)
T ss_dssp EEHHHHHHTST------------TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHH
T ss_pred HHHHHHHHHHC------------CCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCE
T ss_conf 45678998604------------7751445689999999999986057---48826787750568689978732366430
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCC
Q ss_conf 1487567654312454332384334888-999734714499999998809999999997311009999999997298763
Q 002759 755 LLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSASA 833 (884)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 833 (884)
..... ........++..|+|||.+.+. .++.++||||+|+++|||++|+.||...+..+.. .. ............
T Consensus 149 ~~~~~-~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~-i~~~~~~~~~~~ 224 (286)
T d1ob3a_ 149 AFGIP-VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MR-IFRILGTPNSKN 224 (286)
T ss_dssp HHCC----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HH-HHHHHCCCCTTT
T ss_pred ECCCC-CCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHH--HH-HHHHHCCCCHHH
T ss_conf 11467-654101024311013788717888884100211175899997797998988989999--99-998638997110
Q ss_pred CC--------CCCC--------CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 23--------6457--------8876999999999994325899899999889999
Q 002759 834 CF--------DRSL--------RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 834 ~~--------d~~~--------~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
.. +... ....+....++..++.+|++.||++|||++|+++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 225 WPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp STTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 42123332214333335676466651258999999999986689668909999856
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.35 Aligned_cols=261 Identities=20% Similarity=0.253 Sum_probs=191.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEE-CC-CEEEEEEECCCCC-CCCCHHHHHHHHHHHHC---CCCCCCCEEEEEEEC-----
Q ss_conf 2554584322479608999998-69-9099999811347-65799999999999704---999972112448753-----
Q 002759 594 ALLDKECLIGGGSIGSVYRASF-EG-GVSIAVKKLETLG-RIRNQEEFELEIGRLSN---IRHFNLVAFQGYYWS----- 662 (884)
Q Consensus 594 ~~~~~~~~ig~G~~g~V~~~~~-~~-~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~---l~h~niv~~~~~~~~----- 662 (884)
+-|+..+.||+|+||+||+|.. ++ ++.||||+++... .......+.+|+.+++. .+||||+++++++..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCC
T ss_conf 89798889921558699999998889989999998023245167999999999999874258988023663221466666
Q ss_pred CCCEEEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC
Q ss_conf 99025999725998553320148999988899999988978999999999999999872599990750578886574899
Q 002759 663 STMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDEN 742 (884)
Q Consensus 663 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~ 742 (884)
....++++|+++++.+....... ...+++..+..++.|++.||+|||++ +|+||||||+|||++.+
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~ 152 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVP-----------EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS 152 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSC-----------TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred CCEEEEEEEECCCCCHHHHHHCC-----------CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCC
T ss_conf 74699999740587144444303-----------78999899999999999999999758---89835798627898589
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf 97058334674214875676543124543323843348889997347144999999988099999999973110099999
Q 002759 743 YEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 743 ~~vki~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 822 (884)
+.+||+|||.++.... ........||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+... ..
T Consensus 153 ~~~kl~dfg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i 227 (305)
T d1blxa_ 153 GQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KI 227 (305)
T ss_dssp CCEEECSCCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HH
T ss_pred CCEEECCHHHHHHHCC--CCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHH---HH
T ss_conf 9754210001011002--345777654851148310017988811100032899999987879989989899999---99
Q ss_pred HHHHHCCCCCCC----------C----CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 999972987632----------3----64578876999999999994325899899999889999
Q 002759 823 RELLERGSASAC----------F----DRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 823 ~~~~~~~~~~~~----------~----d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
............ + ......+.......+..++.+||++||++|||+.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~ 292 (305)
T d1blxa_ 228 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292 (305)
T ss_dssp HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 98407996110532111103330223456454404458999999999987489667918999966
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.31 Aligned_cols=259 Identities=22% Similarity=0.263 Sum_probs=193.9
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCC----CEEEEE
Q ss_conf 54584322479608999998-6990999998113476579999999999970499997211244875399----025999
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST----MQLILS 670 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv~ 670 (884)
|+..+.||+|+||+||+|.. .+++.||||++...........+.+|+.+++.++||||+++++++.... ..++++
T Consensus 10 Y~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~ 89 (345)
T d1pmea_ 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89 (345)
T ss_dssp EEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 59978994064809999999999949999998031095899999999999997689898858889950564554149999
Q ss_pred EECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCC
Q ss_conf 72599855332014899998889999998897899999999999999987259999075057888657489997058334
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDY 750 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Df 750 (884)
+++.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+||
T Consensus 90 ~~~~~g~L~~~l~~~-------------~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~Df 153 (345)
T d1pmea_ 90 THLMGADLYKLLKTQ-------------HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDF 153 (345)
T ss_dssp EECCCEEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred EEECCCCHHHHHHCC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCC
T ss_conf 962598656644058-------------999999999999999999999978---9867778764378879997787545
Q ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 67421487567--65431245433238433488-8999734714499999998809999999997311009999999997
Q 002759 751 GLAKLLPILDN--YGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 751 g~a~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
|+|........ .......++..|+|||++.. ..++.++||||+|+++|||++|+.||...+..+.... ......
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~---~~~~~~ 230 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNH---ILGILG 230 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred CCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHH---HHHHCC
T ss_conf 70565047776410101102652000387860478887410100467013377669799788888999998---765206
Q ss_pred CCCCCC-------------CCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 298763-------------2364578876-----999999999994325899899999889999
Q 002759 828 RGSASA-------------CFDRSLRGFA-----ENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 828 ~~~~~~-------------~~d~~~~~~~-----~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
...... ...+.....+ .....++..++.+|++.||.+|||++|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~ 294 (345)
T d1pmea_ 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294 (345)
T ss_dssp SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9975664234332222024467755778777837899999999999976489567908999861
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=311.65 Aligned_cols=265 Identities=24% Similarity=0.274 Sum_probs=189.7
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECC------CCEEE
Q ss_conf 545843224796089999986-99099999811347657999999999997049999721124487539------90259
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS------TMQLI 668 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~l 668 (884)
|...++||+|+||+||+|... +++.||||++..... ...+|+.++++++||||+++++++... ...++
T Consensus 22 Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 6751698217683999999999997999999881606-----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEE
Q ss_conf 997259985533201489999888999999889789999999999999998725999907505788865748999-7058
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY-EPKL 747 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~-~vki 747 (884)
||||++++.+........ ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++ .+||
T Consensus 97 v~Ey~~~~~~~~l~~~~~---------~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl 164 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSR---------AKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKL 164 (350)
T ss_dssp EEECCSEEHHHHHHHHHH---------TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEE
T ss_pred EEECCCCCCHHHHHHHHH---------CCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEE
T ss_conf 984168860788886310---------368999999999999999999999866---87645788603787358971167
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHH------
Q ss_conf 3346742148756765431245433238433488-899973471449999999880999999999731100999------
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCE------ 820 (884)
Q Consensus 748 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~------ 820 (884)
+|||+++..... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+......
T Consensus 165 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~ 242 (350)
T d1q5ka_ 165 CDFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 242 (350)
T ss_dssp CCCTTCEECCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred ECCCCHHHCCCC--CCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCC
T ss_conf 336605440477--653200255555682776404688821000246527785502879989879999999999974898
Q ss_pred ---HHHHHHHCCCCCCCCCCCC----CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHHH
Q ss_conf ---9999997298763236457----8876999999999994325899899999889999--999844
Q 002759 821 ---YVRELLERGSASACFDRSL----RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ--VLESIR 879 (884)
Q Consensus 821 ---~~~~~~~~~~~~~~~d~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~--~L~~l~ 879 (884)
................... .........++..++.+|++.||++|||+.|+++ .++++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 243 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred HHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 17765430621011035544567444431568999999999997658955792999996698452466
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=307.15 Aligned_cols=260 Identities=15% Similarity=0.169 Sum_probs=196.6
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCCCCCCE-EEEEEECCCCEEEEEEEC
Q ss_conf 54584322479608999998-6990999998113476579999999999970499997211-244875399025999725
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRHFNLVA-FQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||+|+||+||+|.+ .+++.||||++..... ...+..|+.+++.++|++++. +.++..+....++||||+
T Consensus 9 Y~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK---HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT---SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC---CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEEC
T ss_conf 9996898507880999999988998999999721005---8889999999997038996017999995198778999873
Q ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEECCC
Q ss_conf 9985533201489999888999999889789999999999999998725999907505788865748---9997058334
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLD---ENYEPKLSDY 750 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~---~~~~vki~Df 750 (884)
++++.+.+.... ..+++..+..++.|++.||+|||++ +|+||||||+|||++ .+..+|++||
T Consensus 86 -~~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DF 150 (299)
T d1ckia_ 86 -GPSLEDLFNFCS-----------RKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDF 150 (299)
T ss_dssp -CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCC
T ss_pred -CCCHHHHHHHCC-----------CCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECC
T ss_conf -871333244306-----------8876899999999999999999979---9442667876606433577761565046
Q ss_pred CCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 674214875676------54312454332384334888999734714499999998809999999997311009999999
Q 002759 751 GLAKLLPILDNY------GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE 824 (884)
Q Consensus 751 g~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~ 824 (884)
|+|+........ ......||+.|+|||.+.+..++.++||||||+++|||+||+.||......+..........
T Consensus 151 G~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~ 230 (299)
T d1ckia_ 151 GLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 230 (299)
T ss_dssp SSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHH
T ss_pred CCCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHC
T ss_conf 75134255445541000135776787353299999189989832188617789999849876655305779999998523
Q ss_pred HHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCC
Q ss_conf 997298763236457887699999999999432589989999988999999984402
Q 002759 825 LLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNG 881 (884)
Q Consensus 825 ~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~ 881 (884)
........ ... ...+.++.+++..||+.+|++||++.++.+.|+.+..+
T Consensus 231 ~~~~~~~~-----~~~---~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~ 279 (299)
T d1ckia_ 231 KKMSTPIE-----VLC---KGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279 (299)
T ss_dssp HHHHSCHH-----HHT---TTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred CCCCCCHH-----HHC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 56789835-----753---47889999999998439955791999999999999997
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=307.60 Aligned_cols=260 Identities=20% Similarity=0.211 Sum_probs=194.5
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEEC--------CCC
Q ss_conf 54584322479608999998-699099999811347-65799999999999704999972112448753--------990
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWS--------STM 665 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------~~~ 665 (884)
|...+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.+++.++|||++++++++.. ...
T Consensus 12 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~ 91 (318)
T d3blha1 12 YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91 (318)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------C
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCCCE
T ss_conf 88999972274829999999899979999998422246378999999999999835999660676540246544445763
Q ss_pred EEEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 25999725998553320148999988899999988978999999999999999872599990750578886574899970
Q 002759 666 QLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEP 745 (884)
Q Consensus 666 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~v 745 (884)
.++||||+.++.+...... ...++...+..++.|++.||.|||++ +|+||||||+|||++.++.+
T Consensus 92 ~~iv~e~~~~~~~~~~~~~------------~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~ 156 (318)
T d3blha1 92 IYLVFDFCEHDLAGLLSNV------------LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVL 156 (318)
T ss_dssp EEEEEECCCEEHHHHHTCT------------TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred EEEEEECCCCCCCCHHHHC------------CCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCE
T ss_conf 8999853578741012220------------34433089999999999999885229---98856767222036689968
Q ss_pred EECCCCCCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Q ss_conf 58334674214875676---54312454332384334888-999734714499999998809999999997311009999
Q 002759 746 KLSDYGLAKLLPILDNY---GLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEY 821 (884)
Q Consensus 746 ki~Dfg~a~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~ 821 (884)
|++|||+++........ ......+|..|+|||++.+. .+++++||||+|+++|||++|+.||...+..+... .
T Consensus 157 kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~---~ 233 (318)
T d3blha1 157 KLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA---L 233 (318)
T ss_dssp EECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---H
T ss_pred EEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHH---H
T ss_conf 7631350022355444321135660249787428997079998917870067864661744879989989999999---9
Q ss_pred HHHHHHCCCCCCC--CC----------CCCCC-CCHHH------HHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 9999972987632--36----------45788-76999------999999994325899899999889999
Q 002759 822 VRELLERGSASAC--FD----------RSLRG-FAENE------LIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 822 ~~~~~~~~~~~~~--~d----------~~~~~-~~~~~------~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
..+.......... .+ ..... ...+. ..++..++.+||++||++|||++|+++
T Consensus 234 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~ 304 (318)
T d3blha1 234 ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304 (318)
T ss_dssp HHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 99841899825534432034443320133445550334044459989999999987389658909999974
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.57 Aligned_cols=239 Identities=23% Similarity=0.336 Sum_probs=190.3
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCC-----CCCHHHHHHHHHHHHCCC--CCCCCEEEEEEECCCCE
Q ss_conf 5545843224796089999986-990999998113476-----579999999999970499--99721124487539902
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-----IRNQEEFELEIGRLSNIR--HFNLVAFQGYYWSSTMQ 666 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~ 666 (884)
-|+..+.||+|+||+||+|... ++..||||++..... ......+.+|+.++++++ ||||+++++++.+.+..
T Consensus 5 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~ 84 (273)
T d1xwsa_ 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSF 84 (273)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEE
T ss_pred EEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCEE
T ss_conf 37996798408783999999999997999999856884433455679999999999997435898812799998309968
Q ss_pred EEEEEECCC-CCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCC
Q ss_conf 599972599-855332014899998889999998897899999999999999987259999075057888657489-997
Q 002759 667 LILSEFVPK-GNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-NYE 744 (884)
Q Consensus 667 ~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~-~~~ 744 (884)
++||||+.+ +++.+++.... .+++..+..++.|++.||+|||++ +++||||||+|||++. ++.
T Consensus 85 ~lv~e~~~~~~~l~~~~~~~~------------~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~ 149 (273)
T d1xwsa_ 85 VLILERPEPVQDLFDFITERG------------ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGE 149 (273)
T ss_dssp EEEEECCSSEEEHHHHHHHHC------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTE
T ss_pred EEEEEECCCCCHHHHHHHCCC------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCE
T ss_conf 999983368622899986158------------999999999999999999999877---97556676111477447884
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Q ss_conf 0583346742148756765431245433238433488899-973471449999999880999999999731100999999
Q 002759 745 PKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRL-SDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR 823 (884)
Q Consensus 745 vki~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~ 823 (884)
+||+|||+|+.... .......||..|+|||++.+..+ +.++||||+||++|||+||+.||...+
T Consensus 150 vkl~DFG~a~~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------------ 214 (273)
T d1xwsa_ 150 LKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------------ 214 (273)
T ss_dssp EEECCCTTCEECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------------
T ss_pred EEECCCCCCEECCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCH------------
T ss_conf 89775465353244---455665658774799998489978865332554034536756889988736------------
Q ss_pred HHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 99972987632364578876999999999994325899899999889999
Q 002759 824 ELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 824 ~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
....... .+. ...+ .++.+++.+||+.||++|||++|+++
T Consensus 215 ~i~~~~~---~~~----~~~s---~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 215 EIIRGQV---FFR----QRVS---SECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp HHHHCCC---CCS----SCCC---HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHCCC---CCC----CCCC---HHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 7761544---778----7799---99999999976089758939999853
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.80 Aligned_cols=258 Identities=21% Similarity=0.262 Sum_probs=193.4
Q ss_pred CCCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCC------CE
Q ss_conf 5545843224796089999986-99099999811347-6579999999999970499997211244875399------02
Q 002759 595 LLDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSST------MQ 666 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~ 666 (884)
-|...+.||+|+||+||+|... +++.||||+++... .......+.+|+.+++.++||||+++++++...+ ..
T Consensus 19 ~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 98 (346)
T d1cm8a_ 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDF 98 (346)
T ss_dssp SEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCC
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCEE
T ss_conf 18998898017781999999999998999999852225969999999999999866898754799986357655554159
Q ss_pred EEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEE
Q ss_conf 59997259985533201489999888999999889789999999999999998725999907505788865748999705
Q 002759 667 LILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPK 746 (884)
Q Consensus 667 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vk 746 (884)
++||||+ +.++....+.. .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|
T Consensus 99 ~lv~e~~-~~~l~~~~~~~-------------~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~k 161 (346)
T d1cm8a_ 99 YLVMPFM-GTDLGKLMKHE-------------KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELK 161 (346)
T ss_dssp EEEEECC-SEEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred EEEEECC-CCCHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCC
T ss_conf 9998405-52189998740-------------226999999999999999998737---876456685111121001221
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHH-
Q ss_conf 83346742148756765431245433238433488-8999734714499999998809999999997311009999999-
Q 002759 747 LSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQS-LRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRE- 824 (884)
Q Consensus 747 i~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~- 824 (884)
++|||.|+.... ......++..|+|||++.+ ..++.++||||+||++|||++|+.||...+..+..........
T Consensus 162 l~Dfg~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~ 237 (346)
T d1cm8a_ 162 ILDFGLARQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237 (346)
T ss_dssp ECCCTTCEECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred CCCCCCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 134310220687----6310245533358899817878996501030038999999786998889768999999850378
Q ss_pred ----HHHCCC----------CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ----997298----------7632364578876999999999994325899899999889999
Q 002759 825 ----LLERGS----------ASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 825 ----~~~~~~----------~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
...... ..................++..++.+|++.||++|||+.|+++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp CCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 848888653000344331157866655667755689999999999977299557929999963
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=305.17 Aligned_cols=262 Identities=12% Similarity=0.121 Sum_probs=203.6
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 545843224796089999986-990999998113476579999999999970499-997211244875399025999725
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|...+.||+|+||+||+|.+. +++.||||++..... ...+.+|++.++.+. |++++.+++++......++||||+
T Consensus 7 Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~ 83 (293)
T d1csna_ 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD---APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL 83 (293)
T ss_dssp EEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT---SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEEC
T ss_conf 6997998417882999999988997999999750258---2999999999999648999877999960188117999964
Q ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEC
Q ss_conf 99855332014899998889999998897899999999999999987259999075057888657489-----9970583
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDE-----NYEPKLS 748 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~-----~~~vki~ 748 (884)
+++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+||+++. ++.+||+
T Consensus 84 -~~~l~~~~~~~~-----------~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~ 148 (293)
T d1csna_ 84 -GPSLEDLLDLCG-----------RKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVV 148 (293)
T ss_dssp -CCBHHHHHHHTT-----------TCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEEC
T ss_pred -CCCHHHHHHHHC-----------CCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEEC
T ss_conf -888799997520-----------3110689999999999999999977---9662667713152347543447956872
Q ss_pred CCCCCCCCCCCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Q ss_conf 34674214875676------543124543323843348889997347144999999988099999999973110099999
Q 002759 749 DYGLAKLLPILDNY------GLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYV 822 (884)
Q Consensus 749 Dfg~a~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~ 822 (884)
|||+|+........ ......||+.|+|||.+.+..+++++||||+|+++|||+||+.||...............
T Consensus 149 DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i 228 (293)
T d1csna_ 149 DFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228 (293)
T ss_dssp CCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHH
T ss_pred CCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHH
T ss_conf 36605771467665411102467627751026798964888886999898319999998698767885302199999999
Q ss_pred HHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 9999729876323645788769999999999943258998999998899999998440259
Q 002759 823 RELLERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQVLESIRNGLG 883 (884)
Q Consensus 823 ~~~~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~~~ 883 (884)
..........+. .... +.++.+++..||..+|++||+++.+.+.++++.++.+
T Consensus 229 ~~~~~~~~~~~l----~~~~----p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~ 281 (293)
T d1csna_ 229 GEKKQSTPLREL----CAGF----PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281 (293)
T ss_dssp HHHHHHSCHHHH----TTTS----CHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred HHCCCCCCHHHH----CCCC----CHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCC
T ss_conf 705679995896----5799----8999999999843993008599999999999999759
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=308.42 Aligned_cols=251 Identities=22% Similarity=0.288 Sum_probs=199.9
Q ss_pred CCCCCEECCCCCEEEEEEEEC----CCEEEEEEECCCCC---CCCCHHHHHHHHHHHHCCCC-CCCCEEEEEEECCCCEE
Q ss_conf 545843224796089999986----99099999811347---65799999999999704999-97211244875399025
Q 002759 596 LDKECLIGGGSIGSVYRASFE----GGVSIAVKKLETLG---RIRNQEEFELEIGRLSNIRH-FNLVAFQGYYWSSTMQL 667 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~---~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~ 667 (884)
|+..+.||+|+||+||+|... ++..||+|+++... .....+.+.+|+.++++++| |||+++++++.+....+
T Consensus 26 y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~ 105 (322)
T d1vzoa_ 26 FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLH 105 (322)
T ss_dssp EEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCEE
T ss_conf 59998983287839999998765887948999998367721016899999999999986467983999620002487300
Q ss_pred EEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 99972599855332014899998889999998897899999999999999987259999075057888657489997058
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki 747 (884)
+++||+.+|+|.+++.... .+.......++.|++.|++|+|++ +++||||||+||+++.++.+||
T Consensus 106 ~v~e~~~~~~L~~~i~~~~------------~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL 170 (322)
T d1vzoa_ 106 LILDYINGGELFTHLSQRE------------RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVL 170 (322)
T ss_dssp EEECCCCSCBHHHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEE
T ss_pred EEEECCCCCHHHHHHHHCC------------CCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEE
T ss_conf 1231234117999987304------------543788888899999999885149---9896547732012469998887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 33467421487567654312454332384334888--9997347144999999988099999999973110099999999
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL--RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVREL 825 (884)
Q Consensus 748 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~ 825 (884)
+|||+++.+............++..|+|||.+.+. .++.++||||+||++|||++|+.||......+... ......
T Consensus 171 ~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~--~i~~~~ 248 (322)
T d1vzoa_ 171 TDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRI 248 (322)
T ss_dssp SCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHH
T ss_pred EECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHHHHC
T ss_conf 413202220344443221222333331068760577688713251777799999976899988887777999--999833
Q ss_pred HHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 972987632364578876999999999994325899899999-----889999
Q 002759 826 LERGSASACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPS-----MAEVVQ 873 (884)
Q Consensus 826 ~~~~~~~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt-----~~eil~ 873 (884)
...... . +.....++..++.+||+++|.+||| ++|+++
T Consensus 249 ~~~~~~-------~---~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 249 LKSEPP-------Y---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHCCCC-------C---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CCCCCC-------C---CCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 568998-------8---654799999999997445898819997450999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=299.05 Aligned_cols=254 Identities=18% Similarity=0.202 Sum_probs=191.3
Q ss_pred CCCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCC-CCCCCEEEEEEEC--CCCEEEEE
Q ss_conf 554584322479608999998-6990999998113476579999999999970499-9972112448753--99025999
Q 002759 595 LLDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWS--STMQLILS 670 (884)
Q Consensus 595 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv~ 670 (884)
-|+..+.||+|+||+||+|.. .+++.||+|+++. .....+.+|+.++..+. ||||+++++++.. ....++||
T Consensus 36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~----~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP----VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH----HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 71897898317481999999889997999999888----99999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEECC
Q ss_conf 7259985533201489999888999999889789999999999999998725999907505788865748999-705833
Q 002759 671 EFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENY-EPKLSD 749 (884)
Q Consensus 671 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~-~vki~D 749 (884)
||+++++|..+.+ .+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+|++|
T Consensus 112 e~~~~~~L~~~~~---------------~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~D 173 (328)
T d3bqca1 112 EHVNNTDFKQLYQ---------------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLID 173 (328)
T ss_dssp ECCCSCBGGGTTT---------------SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECC
T ss_pred EECCCCCHHHHHC---------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECC
T ss_conf 6317985899746---------------899999999999999999887643---3443456441237748998366415
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH-----
Q ss_conf 467421487567654312454332384334888-99973471449999999880999999999731100999999-----
Q 002759 750 YGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVR----- 823 (884)
Q Consensus 750 fg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~----- 823 (884)
||+|+..... .......++..|+|||.+.+. .++.++|+||+|+++|||++|+.||......... ......
T Consensus 174 FG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~-~~~i~~~~g~~ 250 (328)
T d3bqca1 174 WGLAEFYHPG--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTE 250 (328)
T ss_dssp GGGCEECCTT--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHH
T ss_pred CCCCEECCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHH-HHHHHHHHCCC
T ss_conf 6542664688--74443224864247610268888884523233545558760488999887601899-99999987884
Q ss_pred ---HHHHCCCC--CCCCC------------CCCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf ---99972987--63236------------45788-76999999999994325899899999889999
Q 002759 824 ---ELLERGSA--SACFD------------RSLRG-FAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 824 ---~~~~~~~~--~~~~d------------~~~~~-~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
........ ...+. ..... .......++..++.+|++.||++|||++|+++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 251 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 15555542254447430000033343311211552112448999999999986699568908999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=301.88 Aligned_cols=258 Identities=21% Similarity=0.242 Sum_probs=195.2
Q ss_pred CCCCCEECCCCCEEEEEEEEC-CCEEEEEEECCCCCC-CCCHHHHHHHHHHHHCCCCCCCCEEEEEEEC------CCCEE
Q ss_conf 545843224796089999986-990999998113476-5799999999999704999972112448753------99025
Q 002759 596 LDKECLIGGGSIGSVYRASFE-GGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWS------STMQL 667 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~ 667 (884)
|+..+.||+|+||+||+|... ++..||||++..... ......+.+|+.+++.++||||+++++++.. ....|
T Consensus 19 Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~ 98 (355)
T d2b1pa1 19 YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98 (355)
T ss_dssp EEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCEEE
T ss_conf 59988962175859999999999989999998823369799999999999998648987648998970256434576269
Q ss_pred EEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEE
Q ss_conf 99972599855332014899998889999998897899999999999999987259999075057888657489997058
Q 002759 668 ILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKL 747 (884)
Q Consensus 668 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki 747 (884)
+||||+.++ +.+.+. ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+|+
T Consensus 99 iv~Ey~~~~-l~~~~~--------------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl 160 (355)
T d2b1pa1 99 LVMELMDAN-LCQVIQ--------------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKI 160 (355)
T ss_dssp EEEECCSEE-HHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred EEEECCCHH-HHHHHH--------------CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEE
T ss_conf 998414467-787650--------------3899999999999999999886522---1124567763211365443132
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHH--------
Q ss_conf 334674214875676543124543323843348889997347144999999988099999999973110099--------
Q 002759 748 SDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLC-------- 819 (884)
Q Consensus 748 ~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~-------- 819 (884)
+|||.++.... ........++..|+|||++.+..+++++||||+||++|||++|+.||...+........
T Consensus 161 ~df~~~~~~~~--~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~ 238 (355)
T d2b1pa1 161 LDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_dssp CCCCC-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ECHHHHHCCCC--CCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCC
T ss_conf 01023211466--6553322146555581331477778774333566257898659899888977889999997205898
Q ss_pred --------HHHHHHHHCCCCCC------CCCCCC----CCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf --------99999997298763------236457----8876999999999994325899899999889999
Q 002759 820 --------EYVRELLERGSASA------CFDRSL----RGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 820 --------~~~~~~~~~~~~~~------~~d~~~----~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
.............. .+.... .........++..++.+|++.||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~ 310 (355)
T d2b1pa1 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310 (355)
T ss_dssp HHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 799987656677776417543566642126433354321013337999999999987699457908999966
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=296.11 Aligned_cols=260 Identities=22% Similarity=0.219 Sum_probs=198.3
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCC-CCCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCEEEEEEEC
Q ss_conf 54584322479608999998-6990999998113476-579999999999970499997211244875399025999725
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGR-IRNQEEFELEIGRLSNIRHFNLVAFQGYYWSSTMQLILSEFV 673 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 673 (884)
|+..+.||+|+||+||+|.. .+++.||||+++.... ......+.+|+.+++.++||||+++++++.+....++|++++
T Consensus 4 y~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~ 83 (292)
T d1unla_ 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83 (292)
T ss_dssp EEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred CEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEEEC
T ss_conf 78626971286819999999999969999998032178689999999999998567578882135444443115886302
Q ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEECCCCCC
Q ss_conf 99855332014899998889999998897899999999999999987259999075057888657489997058334674
Q 002759 674 PKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLSDYGLA 753 (884)
Q Consensus 674 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a 753 (884)
.++++..++...+ .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++|||.|
T Consensus 84 ~~~~l~~~~~~~~------------~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a 148 (292)
T d1unla_ 84 DQDLKKYFDSCNG------------DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLA 148 (292)
T ss_dssp SEEHHHHHHHTTT------------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCCCCCCCCCCCC------------CCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHH
T ss_conf 3322211212356------------540367899999999998774339---9860014676121133782665204601
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 214875676543124543323843348889-9973471449999999880999999999731100999999999729876
Q 002759 754 KLLPILDNYGLTKFHNAVGYVAPELAQSLR-LSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLERGSAS 832 (884)
Q Consensus 754 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 832 (884)
+...... .......++..|.|||.+.... ++.++||||+||++|||++|+.||........ ...............
T Consensus 149 ~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~ 225 (292)
T d1unla_ 149 RAFGIPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEE 225 (292)
T ss_dssp EECCSCC-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTT
T ss_pred HCCCCCC-CCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHH--HHHHHHHHCCCCCHH
T ss_conf 1046887-5100103443101466750698888044402654188998518999988999999--999998611899735
Q ss_pred CC--------------CC--CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 32--------------36--4578876999999999994325899899999889999
Q 002759 833 AC--------------FD--RSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ 873 (884)
Q Consensus 833 ~~--------------~d--~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 873 (884)
.. .. .............+..++.+|++.||.+|||++|+++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 226 QWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred HHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 513443222113344454431043306568999999999986499668909999964
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=299.40 Aligned_cols=260 Identities=22% Similarity=0.277 Sum_probs=193.9
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCC-CCCCHHHHHHHHHHHHCCCCCCCCEEEEEEECC-----CCEEE
Q ss_conf 54584322479608999998-699099999811347-657999999999997049999721124487539-----90259
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLG-RIRNQEEFELEIGRLSNIRHFNLVAFQGYYWSS-----TMQLI 668 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l 668 (884)
|+..+.||+|+||+||+|.. .+++.||||++.... .......+.+|+.+++.++|||++++++++... ...++
T Consensus 20 Y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 99 (348)
T d2gfsa1 20 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99 (348)
T ss_dssp EEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCE
T ss_pred EEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCCEEE
T ss_conf 18888983178839999999999979999998820028689999999999998668987425999996346456686499
Q ss_pred EEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEC
Q ss_conf 99725998553320148999988899999988978999999999999999872599990750578886574899970583
Q 002759 669 LSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILLDENYEPKLS 748 (884)
Q Consensus 669 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili~~~~~vki~ 748 (884)
+++++.+|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+|++
T Consensus 100 i~~~~~gg~L~~~~~~~-------------~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~ 163 (348)
T d2gfsa1 100 LVTHLMGADLNNIVKCQ-------------KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 163 (348)
T ss_dssp EEEECCSEEHHHHHTTC-------------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred EEEEECCCCHHHHCCCC-------------CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 99962588623200224-------------530999999999999999999738---87651667763345543220013
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 3467421487567654312454332384334888-999734714499999998809999999997311009999999997
Q 002759 749 DYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSL-RLSDKCDVYSFGVILLELVTGRKPVESPTTNEVVVLCEYVRELLE 827 (884)
Q Consensus 749 Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~ 827 (884)
|||.+.... .......++..|+|||...+. .++.++||||+|+++|+|++|+.||...+....... ..+...
T Consensus 164 dfg~a~~~~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~ 236 (348)
T d2gfsa1 164 DFGLARHTD----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVG 236 (348)
T ss_dssp CC----CCT----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHC
T ss_pred CCCHHCCCC----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHHCC
T ss_conf 210001257----5444434543555835533775678551243205899999768899788988999999---997307
Q ss_pred CCCC------------------CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH--HHHHH
Q ss_conf 2987------------------632364578876999999999994325899899999889999--99984
Q 002759 828 RGSA------------------SACFDRSLRGFAENELIQVMKLGLICTSEVPSRRPSMAEVVQ--VLESI 878 (884)
Q Consensus 828 ~~~~------------------~~~~d~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~--~L~~l 878 (884)
.... .................++..++.+|++.||.+|||+.|+++ .++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred CCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99757732001024454443035578755566267899999999999775883459389998559954879
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=269.38 Aligned_cols=259 Identities=17% Similarity=0.174 Sum_probs=186.4
Q ss_pred CCCCCEECCCCCEEEEEEEE-CCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCC-----------CCCCCEEEEEEEC-
Q ss_conf 54584322479608999998-6990999998113476579999999999970499-----------9972112448753-
Q 002759 596 LDKECLIGGGSIGSVYRASF-EGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-----------HFNLVAFQGYYWS- 662 (884)
Q Consensus 596 ~~~~~~ig~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~- 662 (884)
|...+.||+|+||+||+|.. .+++.||||+++... .....+.+|+.+++.++ |+||+++++++..
T Consensus 15 Y~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~--~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK--VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH--HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred EEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC--CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 799899750778189999999999799999983431--336899999999998401455555422767647899876312
Q ss_pred -CCCEEEEEEECCCCCH-HHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEE
Q ss_conf -9902599972599855-3320148999988899999988978999999999999999872-599990750578886574
Q 002759 663 -STMQLILSEFVPKGNL-YDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHH-DCKPPILHLNLKSTNILL 739 (884)
Q Consensus 663 -~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~-~~~~~ivH~Dlk~~Nili 739 (884)
....++++++...+.. ........ ...+++..+..++.|++.|++|||+ . +|+||||||+|||+
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll 159 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYE----------HRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLM 159 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTT----------TSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCCCC----------CCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEE
T ss_conf 56520234320003542000001223----------467868999999999999988876405---86465677057056
Q ss_pred CCCC------CEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 8999------7058334674214875676543124543323843348889997347144999999988099999999973
Q 002759 740 DENY------EPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVILLELVTGRKPVESPTTN 813 (884)
Q Consensus 740 ~~~~------~vki~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~elltg~~p~~~~~~~ 813 (884)
+.++ .++++|||.+..... ......++..|+|||++....++.++|+||+|++++||++|+.||......
T Consensus 160 ~~~~~~~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~ 235 (362)
T d1q8ya_ 160 EIVDSPENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 235 (362)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC------
T ss_pred ECCCCCCCCCEEEEEECCCCCCCCC----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 3057656443056753144212344----542236652105713214667776432012378999998788998987554
Q ss_pred CHHHHHHHHHHHHH-CCC--------------------CCCCCCC-----------CCCCCCHHHHHHHHHHHHHCCCCC
Q ss_conf 11009999999997-298--------------------7632364-----------578876999999999994325899
Q 002759 814 EVVVLCEYVRELLE-RGS--------------------ASACFDR-----------SLRGFAENELIQVMKLGLICTSEV 861 (884)
Q Consensus 814 ~~~~~~~~~~~~~~-~~~--------------------~~~~~d~-----------~~~~~~~~~~~~l~~li~~cl~~~ 861 (884)
.............. .+. ....+.. ...........++..++.+|+++|
T Consensus 236 ~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~d 315 (362)
T d1q8ya_ 236 SYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLD 315 (362)
T ss_dssp ---CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSS
T ss_pred CCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 32102689999999837998788624532200013201220243235776444210001567435899999999987799
Q ss_pred CCCCCCHHHHHH
Q ss_conf 899999889999
Q 002759 862 PSRRPSMAEVVQ 873 (884)
Q Consensus 862 p~~RPt~~eil~ 873 (884)
|.+|||++|+++
T Consensus 316 P~~Rpta~e~L~ 327 (362)
T d1q8ya_ 316 PRKRADAGGLVN 327 (362)
T ss_dssp TTTCBCHHHHHT
T ss_pred HHHCCCHHHHHC
T ss_conf 457908999966
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.3e-42 Score=236.24 Aligned_cols=344 Identities=21% Similarity=0.232 Sum_probs=242.9
Q ss_pred CCCCCCCEEEECCCCCCCCCCHHHHCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCC
Q ss_conf 38888885750177374569611120147907615889788998855789998545728898667988624331046684
Q 002759 93 SGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTK 172 (884)
Q Consensus 93 ~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~~g~ip~~~~~~~~~L~ 172 (884)
..+.+|++|++++++++. + ..+..+++|++|+|++|.+++. |. ++++++|++|++++|.+. .++. +..+++|+
T Consensus 41 ~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l-~~-l~~L~~L~~L~L~~n~i~-~i~~--l~~l~~L~ 113 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDI-TP-LKNLTKLVDILMNNNQIA-DITP--LANLTNLT 113 (384)
T ss_dssp HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEECCSSCCC-CCGG--GTTCTTCC
T ss_pred HHHCCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCCC-CC-CCCCCCCCCCCCCCCCCC-CCCC--CCCCCCCC
T ss_conf 895787899899989877-6-2424589999896818817988-63-347711010301343332-2221--11233433
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEECEEECCCCC
Q ss_conf 99846885578756334356888826722487889989877889953389832784679752111357801489858884
Q 002759 173 FVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNL 252 (884)
Q Consensus 173 ~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~ 252 (884)
.|+++++.+++..+ ......+..+....|.+....+................. ....+...+.........|.
T Consensus 114 ~L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 186 (384)
T d2omza2 114 GLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVT-----DLKPLANLTTLERLDISSNK 186 (384)
T ss_dssp EEECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCC-----CCGGGTTCTTCCEEECCSSC
T ss_pred CCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----HHHHHCCCCCCCCCCCCCCC
T ss_conf 34433222222222--222222211213466313100232222112222212322-----01111245421101122243
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCC
Q ss_conf 58868888889998658994427322655442346888828705778678978843445654554201477334568877
Q 002759 253 FIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTG 332 (884)
Q Consensus 253 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 332 (884)
... ...+..+++++.+++++|.+++..+. ....+|+.|++++|.++.. ..+..+++|+.|++++|.+++.. .
T Consensus 187 ~~~--~~~~~~l~~~~~l~l~~n~i~~~~~~--~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~ 258 (384)
T d2omza2 187 VSD--ISVLAKLTNLESLIATNNQISDITPL--GILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--P 258 (384)
T ss_dssp CCC--CGGGGGCTTCSEEECCSSCCCCCGGG--GGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--G
T ss_pred CCC--CCCCCCCCCCCEEECCCCCCCCCCCC--CCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--C
T ss_conf 332--11002235323330357744787864--4457787888877777896--13432565341004467447877--5
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCC
Q ss_conf 33546751899237866787898766766541894678757878886774778886885237547898611111885574
Q 002759 333 ITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLK 412 (884)
Q Consensus 333 ~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~ 412 (884)
+..+++|+.|++++|++++.. .+..++.++.+.+..|.+.+. ..+..+++++.|++++|++++.. .+..+++|+
T Consensus 259 ~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~ 332 (384)
T d2omza2 259 LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQ 332 (384)
T ss_dssp GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCC
T ss_pred CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCC
T ss_conf 355466877545674457877--323565222233232333332--21000024676777788778984--536689889
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCC
Q ss_conf 78713764678899564599999979854883577569976766756389845883
Q 002759 413 ILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNN 468 (884)
Q Consensus 413 ~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~ 468 (884)
.|++++|++++ ++ .+..+++|+.|++++|++++..| +.++++|+.|++++|.
T Consensus 333 ~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 333 RLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp EEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred EEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCCC
T ss_conf 89898998999-74-67089999989897995899800--0039999996397895
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=2.8e-45 Score=249.79 Aligned_cols=162 Identities=28% Similarity=0.427 Sum_probs=74.0
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 788434456545542014773345688773354675-1899237866787898766766541894678757878886774
Q 002759 304 VIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRL-LKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDIS 382 (884)
Q Consensus 304 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L-~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~ 382 (884)
.+|..+.++++++.+++++|.+.+.+|..+..+.++ +.+++++|++++..+..+..+..+ .++++.+...+..|..+.
T Consensus 140 ~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~~~~~~~~~ 218 (313)
T d1ogqa_ 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLEGDASVLFG 218 (313)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEEECCGGGCC
T ss_pred CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
T ss_conf 6851220674000000235533562031214431123231022464353324332222222-333333433222222222
Q ss_pred CCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 77888688523754789861111188557478713764678899564599999979854883577569976766756389
Q 002759 383 NCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHF 462 (884)
Q Consensus 383 ~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 462 (884)
.+++++.+++++|.+.+.+| .+..+++|+.|++++|+++|.+|..++++++|+.|+|++|+|+|.+|. +.++.+|+.+
T Consensus 219 ~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l 296 (313)
T d1ogqa_ 219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVS 296 (313)
T ss_dssp TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGG
T ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHH
T ss_conf 22221112222222222222-222455444444765706660876884799999897958835166898-6667998978
Q ss_pred ECCCCC
Q ss_conf 845883
Q 002759 463 NLSSNN 468 (884)
Q Consensus 463 ~ls~N~ 468 (884)
++++|+
T Consensus 297 ~l~~N~ 302 (313)
T d1ogqa_ 297 AYANNK 302 (313)
T ss_dssp GTCSSS
T ss_pred HHCCCC
T ss_conf 868895
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.5e-40 Score=225.53 Aligned_cols=339 Identities=19% Similarity=0.244 Sum_probs=197.9
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 77799926753454354122388888857501773745696111201479076158897889988557899985457288
Q 002759 73 FVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152 (884)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 152 (884)
.++++++.+.++... +.+..|++|++|+|++|++++. | .++++++|++|++++|.+++.. + ++.+++|+.|+++
T Consensus 45 ~l~~L~l~~~~I~~l--~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~-~-l~~l~~L~~L~~~ 118 (384)
T d2omza2 45 QVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADIT-P-LANLTNLTGLTLF 118 (384)
T ss_dssp TCCEEECCSSCCCCC--TTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCG-G-GTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCC
T ss_conf 878998999898776--2424589999896818817988-6-3347711010301343332222-1-1123343334433
Q ss_pred CCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 98667988624331046684998468855787563343568888267224878899898778899533898327846797
Q 002759 153 RNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGT 232 (884)
Q Consensus 153 ~n~~~g~ip~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 232 (884)
.|.+++..+. .....+..+....|.+..................... .....+...+.........|...
T Consensus 119 ~~~~~~~~~~---~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~-- 188 (384)
T d2omza2 119 NNQITDIDPL---KNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQV-----TDLKPLANLTTLERLDISSNKVS-- 188 (384)
T ss_dssp SSCCCCCGGG---TTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESC-----CCCGGGTTCTTCCEEECCSSCCC--
T ss_pred CCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----CHHHHHCCCCCCCCCCCCCCCCC--
T ss_conf 2222222222---2222221121346631310023222211222221232-----20111124542110112224333--
Q ss_pred CCCCCCCCCEECEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 52111357801489858884588688888899986589944273226554423468888287057786789788434456
Q 002759 233 VEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNC 312 (884)
Q Consensus 233 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 312 (884)
....+..+++++.+++++|.++++.+ +...++|+.|++++|+++.. + .+....+|+.+++++|.+.+..+ +..+
T Consensus 189 ~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--~~~~ 262 (384)
T d2omza2 189 DISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI-G-TLASLTNLTDLDLANNQISNLAP--LSGL 262 (384)
T ss_dssp CCGGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-G-GGGGCTTCSEEECCSSCCCCCGG--GTTC
T ss_pred CCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC-C-HHHCCCCCCHHCCCCCCCCCCCC--CCCC
T ss_conf 21100223532333035774478786--44457787888877777896-1-34325653410044674478775--3554
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 54554201477334568877335467518992378667878987667665418946787578788867747788868852
Q 002759 313 RNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDV 392 (884)
Q Consensus 313 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 392 (884)
++|+.|++++|++.+.. .+..++.++.+.+..|.+++. ..+..+++++.|++++|++++.. .+..+++|+.|++
T Consensus 263 ~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~~--~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L 336 (384)
T d2omza2 263 TKLTELKLGANQISNIS--PLAGLTALTNLELNENQLEDI--SPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFF 336 (384)
T ss_dssp TTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSCC--GGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEEC
T ss_pred CCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEEC
T ss_conf 66877545674457877--323565222233232333332--21000024676777788778984--5366898898989
Q ss_pred CCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 375478986111118855747871376467889956459999997985488
Q 002759 393 SGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQN 443 (884)
Q Consensus 393 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 443 (884)
++|++++ ++ .+..+++|+.|++++|++++..| +.++++|+.|+|++|
T Consensus 337 ~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 337 ANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp CSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred CCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 8998999-74-67089999989897995899800--003999999639789
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=3.4e-37 Score=207.99 Aligned_cols=124 Identities=16% Similarity=0.218 Sum_probs=56.6
Q ss_pred CCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 87760496699977799926753454354122388888857501773745696111201479076158897889988557
Q 002759 61 ENFKGVFCNPDGFVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFI 140 (884)
Q Consensus 61 ~~w~gv~C~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l 140 (884)
|.|.+|.|+. .++.- +|+.+. +.+++|+|++|+++...+..|.++++|++|++++|.+....|..|
T Consensus 10 c~~~~~~C~~-----------~~L~~-lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f 75 (305)
T d1xkua_ 10 CHLRVVQCSD-----------LGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75 (305)
T ss_dssp EETTEEECTT-----------SCCCS-CCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred ECCCEEEECC-----------CCCCC-CCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHH
T ss_conf 5599998559-----------99885-198889--997989784991898696576046565231123443445235665
Q ss_pred CCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 89998545728898667988624331046684998468855787563343568888267224
Q 002759 141 GDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSF 202 (884)
Q Consensus 141 ~~l~~L~~L~Ls~n~~~g~ip~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~ 202 (884)
.++++|++|++++|+++ .+|...+ ..+..|++.+|.+....+..+.....+..++...
T Consensus 76 ~~l~~L~~L~l~~n~l~-~l~~~~~---~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~ 133 (305)
T d1xkua_ 76 APLVKLERLYLSKNQLK-ELPEKMP---KTLQELRVHENEITKVRKSVFNGLNQMIVVELGT 133 (305)
T ss_dssp TTCTTCCEEECCSSCCS-BCCSSCC---TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCS
T ss_pred HCCCCCCEECCCCCCCC-CCCCCHH---HHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCC
T ss_conf 27985578315687567-6764001---1132321024610234444540133110000123
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.4e-37 Score=207.40 Aligned_cols=135 Identities=22% Similarity=0.229 Sum_probs=64.4
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCC
Q ss_conf 73354675189923786678789876676654189467875787888677477888688523754789861111188557
Q 002759 332 GITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYL 411 (884)
Q Consensus 332 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L 411 (884)
.+..+++|+.+++++|.+... +.. ..++|+.|++++|...+..+..+.+++.++.|++++|.+++..+..+..+++|
T Consensus 145 ~~~~l~~L~~l~l~~n~l~~l-~~~--~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L 221 (305)
T d1xkua_ 145 AFQGMKKLSYIRIADTNITTI-PQG--LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHL 221 (305)
T ss_dssp GGGGCTTCCEEECCSSCCCSC-CSS--CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTC
T ss_pred CCCCCCCCCCCCCCCCCCCCC-CCC--CCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 223456567120346774516-710--17766789897886778882676413413301544553322234543344332
Q ss_pred CEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC------CCCCCCCCCEEECCCCCCC
Q ss_conf 4787137646788995645999999798548835775699------7676675638984588375
Q 002759 412 KILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPS------SLGNLRNLTHFNLSSNNLS 470 (884)
Q Consensus 412 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~------~~~~l~~L~~L~ls~N~l~ 470 (884)
+.|+|++|+++ .+|..+..+++|+.|+|++|+|+..... ....+.+|+.|++++|++.
T Consensus 222 ~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 222 RELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp CEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred EEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCC
T ss_conf 24302554002-46311033467898989898657638100267210021588897889899576
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-36 Score=205.38 Aligned_cols=270 Identities=19% Similarity=0.185 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEECEEECCCCCCCCCCCCCCCCCCCCCEEEEE-C
Q ss_conf 826722487889989877889953389832784679752111357801489858884588688888899986589944-2
Q 002759 196 EGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVS-H 274 (884)
Q Consensus 196 ~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~-~ 274 (884)
..++.+++.++ .+|..+. +.++.|+|++|+|+...+..|.++++|++|++++|.+..+.+..+.....+..+... .
T Consensus 14 ~~v~c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~ 90 (284)
T d1ozna_ 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDN 90 (284)
T ss_dssp CEEECCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSC
T ss_pred EEEECCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 69984799989-4497889--99888977488179879778641421300001344543321112122222222222210
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 73226554423468888287057786789788434456545542014773345688773354675189923786678789
Q 002759 275 NGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIP 354 (884)
Q Consensus 275 N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 354 (884)
|.++...+..+..+.+|+.|+++.|.+....+..+...++|+.+++++|++++..+..|..+++|+.|++++|+++...+
T Consensus 91 ~~~~~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp TTCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCH
T ss_conf 22354462010101027787568854432013533200012110200143144580574043405022314176566256
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCC
Q ss_conf 87667665418946787578788867747788868852375478986111118855747871376467889956459999
Q 002759 355 PNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSN 434 (884)
Q Consensus 355 ~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 434 (884)
..|.++++|+.+++++|++++..|..|.++++|++|++++|.+.+..+..|..+++|+.|++++|.+. -.-....-...
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~-C~C~~~~l~~~ 249 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV-CDCRARPLWAW 249 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE-CSGGGHHHHHH
T ss_pred HHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC-CCCCCHHHHHH
T ss_conf 66546563413142114346628167665320002333335221000002355465688981199887-87564699999
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 99798548835775699767667563898458837555
Q 002759 435 LQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGT 472 (884)
Q Consensus 435 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~ 472 (884)
++.+....+.+....|..+.+.+-.. ++.+.++|.
T Consensus 250 l~~~~~~~~~~~C~~p~~l~g~~l~~---l~~~~l~gc 284 (284)
T d1ozna_ 250 LQKFRGSSSEVPCSLPQRLAGRDLKR---LAANDLQGC 284 (284)
T ss_dssp HHHCCSEECCCBEEESGGGTTCBGGG---SCGGGSCCC
T ss_pred HHHCCCCCCCEEECCCHHHCCCCCCC---CCHHHCCCC
T ss_conf 98673888866747966984985341---898887896
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-33 Score=189.83 Aligned_cols=166 Identities=24% Similarity=0.188 Sum_probs=112.1
Q ss_pred CCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 88434456545542014773345688773354675189923786678789876676654189467875787888677477
Q 002759 305 IPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNC 384 (884)
Q Consensus 305 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l 384 (884)
.+..|.++++|++|+|++|+|+. ++ .++.+++|+.|+|++|+++. .+..+..+++|+.|++++|.+....+..+..+
T Consensus 47 ~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l 123 (266)
T d1p9ag_ 47 SLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTSLPLGALRGL 123 (266)
T ss_dssp EGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEECCSSCCCCCCSSTTTTC
T ss_pred CHHHHHCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
T ss_conf 97786345655221356654444-31-11112232111112222211-11121222222222222231101100112222
Q ss_pred CCCCEEECCCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 88868852375478986111118855747871376467889956459999997985488357756997676675638984
Q 002759 385 RFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNL 464 (884)
Q Consensus 385 ~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~l 464 (884)
.++..|++++|.++...+..+..++.++.+++++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|++
T Consensus 124 ~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L 202 (266)
T d1p9ag_ 124 GELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202 (266)
T ss_dssp TTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEEC
T ss_pred CCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEE
T ss_conf 11112212434210221233322111000000015652237200134212423430139785-56866777888999983
Q ss_pred CCCCCCCCCC
Q ss_conf 5883755578
Q 002759 465 SSNNLSGTIP 474 (884)
Q Consensus 465 s~N~l~~~~p 474 (884)
++|+|.|.+.
T Consensus 203 ~~Np~~CdC~ 212 (266)
T d1p9ag_ 203 HGNPWLCNCE 212 (266)
T ss_dssp CSCCBCCSGG
T ss_pred CCCCCCCCCC
T ss_conf 6999878864
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-32 Score=182.69 Aligned_cols=134 Identities=23% Similarity=0.174 Sum_probs=76.1
Q ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 65455420147733456887733546751899237866787898766766541894678757878886774778886885
Q 002759 312 CRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLD 391 (884)
Q Consensus 312 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ 391 (884)
+++|++|+|++|+++ ..+..+..+++|+.|++++|.+.+..+..+..+.+++.|++++|.++...+..+..++.++.++
T Consensus 76 l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~ 154 (266)
T d1p9ag_ 76 LPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLS 154 (266)
T ss_dssp CTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred CCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCC
T ss_conf 223211111222221-1111212222222222222311011001122221111221243421022123332211100000
Q ss_pred CCCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 23754789861111188557478713764678899564599999979854883577
Q 002759 392 VSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSG 447 (884)
Q Consensus 392 ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 447 (884)
+++|++++..+..|..+++|+.|+|++|+|+ .+|..+..+++|+.|+|++|.+..
T Consensus 155 l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~C 209 (266)
T d1p9ag_ 155 LANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLC 209 (266)
T ss_dssp CTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHHCCCCCCCEEEECCCCCCC
T ss_conf 0015652237200134212423430139785-568667778889999836999878
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.98 E-value=3.4e-28 Score=161.01 Aligned_cols=302 Identities=22% Similarity=0.296 Sum_probs=158.8
Q ss_pred CCCEEEECCCCCCCCCCHHHHCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEEC
Q ss_conf 88857501773745696111201479076158897889988557899985457288986679886243310466849984
Q 002759 97 SLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL 176 (884)
Q Consensus 97 ~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~~g~ip~~~~~~~~~L~~L~L 176 (884)
++++|||++|+++ .+|.. .++|++|+|++|.++ .+|.. ..+|+.|++++|+++ .++. ....|++|++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~----lp~~L~~L~L 105 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSD----LPPLLEYLGV 105 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCS----CCTTCCEEEC
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-HHHH----HCCCCCCCCC
T ss_conf 9989993799988-78898---789888989999796-33620---332033266551432-0321----0221111133
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEECEEECCCCCCCCC
Q ss_conf 68855787563343568888267224878899898778899533898327846797521113578014898588845886
Q 002759 177 SHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGL 256 (884)
Q Consensus 177 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 256 (884)
++|.+.. +| .++.+++|++|++++|.+.. .+.. ...+..+.+..+... ....+..++.++.|+++.|.....
T Consensus 106 ~~n~l~~-lp-~~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 106 SNNQLEK-LP-ELQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp CSSCCSS-CC-CCTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred CCCCCCC-CC-CHHHHCCCEEECCCCCCCCC-CCCC---CCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCCCC
T ss_conf 4554322-21-00110131231135651001-3223---333210000122222--333200012220011123344322
Q ss_pred CCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCC
Q ss_conf 88888899986589944273226554423468888287057786789788434456545542014773345688773354
Q 002759 257 APFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDL 336 (884)
Q Consensus 257 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l 336 (884)
... .... ..+..+.+.+.. .+ .+..++.|+.+++++|... ..+.. .
T Consensus 178 ~~~----~~~~------------------------~~l~~~~~~~~~-~~-~~~~l~~L~~l~l~~n~~~-~~~~~---~ 223 (353)
T d1jl5a_ 178 PDL----PLSL------------------------ESIVAGNNILEE-LP-ELQNLPFLTTIYADNNLLK-TLPDL---P 223 (353)
T ss_dssp CCC----CTTC------------------------CEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCCS-SCCSC---C
T ss_pred CCC----CCCC------------------------CCCCCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCC-CCCCC---C
T ss_conf 221----2222------------------------223344432222-12-2345553331222542223-45532---3
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC-CCCCEEECCCCCCCCCCCHHHCCCCCCCEEE
Q ss_conf 675189923786678789876676654189467875787888677477-8886885237547898611111885574787
Q 002759 337 RRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNC-RFLLLLDVSGNALGGDIPQTLYNMTYLKILD 415 (884)
Q Consensus 337 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l-~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~ 415 (884)
.++..+.+.+|.+... +. ....+...++..+.+.+. ..+ ......++..+.+.+ + ...+++|+.|+
T Consensus 224 ~~l~~~~~~~~~~~~~-~~---~~~~l~~~~~~~~~~~~l-----~~l~~~~~~~~~~~~~~~~-~---~~~~~~L~~L~ 290 (353)
T d1jl5a_ 224 PSLEALNVRDNYLTDL-PE---LPQSLTFLDVSENIFSGL-----SELPPNLYYLNASSNEIRS-L---CDLPPSLEELN 290 (353)
T ss_dssp TTCCEEECCSSCCSCC-CC---CCTTCCEEECCSSCCSEE-----SCCCTTCCEEECCSSCCSE-E---CCCCTTCCEEE
T ss_pred CCCCCCCCCCCCCCCC-CC---CCCCCCCCCCCCCCCCCC-----CCCCCHHCCCCCCCCCCCC-C---CCCCCCCCEEE
T ss_conf 3433322233333444-33---344322222222333222-----3453000123333575323-4---56689889897
Q ss_pred ECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC
Q ss_conf 137646788995645999999798548835775699767667563898458837555783
Q 002759 416 LHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIPS 475 (884)
Q Consensus 416 l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 475 (884)
+++|+++ .+|.. +++|+.|+|++|+|+ .+|.. +.+|+.|++++|+++ .+|.
T Consensus 291 Ls~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~ 341 (353)
T d1jl5a_ 291 VSNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPD 341 (353)
T ss_dssp CCSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCC
T ss_pred CCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCC
T ss_conf 9799168-35665---487998989999687-54532---288898987699189-7776
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.97 E-value=1.6e-28 Score=162.77 Aligned_cols=314 Identities=22% Similarity=0.237 Sum_probs=201.0
Q ss_pred CEEEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 77799926753454354122388888857501773745696111201479076158897889988557899985457288
Q 002759 73 FVDRIVLWNFSLGGVLSPALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLS 152 (884)
Q Consensus 73 ~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 152 (884)
...+++|.+.+++. +|+ ..++|++|+|++|+++ .+|..+ .+|+.|++++|.++ .++.. .+.|++|+++
T Consensus 39 ~l~~LdLs~~~L~~-lp~---~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLSS-LPE---LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCSC-CCS---CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEECCCCCCC-CCC---CCCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCC-HHHHH---CCCCCCCCCC
T ss_conf 99899937999887-889---8789888989999796-336203---32033266551432-03210---2211111334
Q ss_pred CCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC
Q ss_conf 98667988624331046684998468855787563343568888267224878899898778899533898327846797
Q 002759 153 RNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGT 232 (884)
Q Consensus 153 ~n~~~g~ip~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 232 (884)
+|.+. .+|. +..+.+|+.|++++|.+..... ....+..+.+.++... .+..+..++.++.+.+..|.....
T Consensus 107 ~n~l~-~lp~--~~~l~~L~~L~l~~~~~~~~~~----~~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~~~ 177 (353)
T d1jl5a_ 107 NNQLE-KLPE--LQNSSFLKIIDVDNNSLKKLPD----LPPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLKKL 177 (353)
T ss_dssp SSCCS-SCCC--CTTCTTCCEEECCSSCCSCCCC----CCTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCSSC
T ss_pred CCCCC-CCCC--HHHHCCCEEECCCCCCCCCCCC----CCCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCCCC
T ss_conf 55432-2210--0110131231135651001322----3333210000122222--333200012220011123344322
Q ss_pred CCCCCCCCCEECEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 52111357801489858884588688888899986589944273226554423468888287057786789788434456
Q 002759 233 VEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNC 312 (884)
Q Consensus 233 ~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l 312 (884)
... ....+.+....+.+.... .+..++.|+.+++++|..... +. . .
T Consensus 178 ~~~----~~~~~~l~~~~~~~~~~~--~~~~l~~L~~l~l~~n~~~~~-~~---~------------------------~ 223 (353)
T d1jl5a_ 178 PDL----PLSLESIVAGNNILEELP--ELQNLPFLTTIYADNNLLKTL-PD---L------------------------P 223 (353)
T ss_dssp CCC----CTTCCEEECCSSCCSSCC--CCTTCTTCCEEECCSSCCSSC-CS---C------------------------C
T ss_pred CCC----CCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC-CC---C------------------------C
T ss_conf 221----222222334443222212--234555333122254222345-53---2------------------------3
Q ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 54554201477334568877335467518992378667878987667665418946787578788867747788868852
Q 002759 313 RNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDV 392 (884)
Q Consensus 313 ~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l 392 (884)
.++..+.+..+.+.. .+.. ...+...++..+.+.+... -.......++..+.+.+. ...+++|++|++
T Consensus 224 ~~l~~~~~~~~~~~~-~~~~---~~~l~~~~~~~~~~~~l~~----l~~~~~~~~~~~~~~~~~----~~~~~~L~~L~L 291 (353)
T d1jl5a_ 224 PSLEALNVRDNYLTD-LPEL---PQSLTFLDVSENIFSGLSE----LPPNLYYLNASSNEIRSL----CDLPPSLEELNV 291 (353)
T ss_dssp TTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCSEESC----CCTTCCEEECCSSCCSEE----CCCCTTCCEEEC
T ss_pred CCCCCCCCCCCCCCC-CCCC---CCCCCCCCCCCCCCCCCCC----CCCHHCCCCCCCCCCCCC----CCCCCCCCEEEC
T ss_conf 343332223333344-4333---4432222222233322234----530001233335753234----566898898979
Q ss_pred CCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 3754789861111188557478713764678899564599999979854883577569976766756389845
Q 002759 393 SGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLS 465 (884)
Q Consensus 393 s~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls 465 (884)
++|+++ .+|.. +++|+.|++++|+++ .+|.. +.+|+.|++++|+++ .+|... .+|+.|.+.
T Consensus 292 s~N~l~-~lp~~---~~~L~~L~L~~N~L~-~l~~~---~~~L~~L~L~~N~L~-~lp~~~---~~L~~L~~~ 352 (353)
T d1jl5a_ 292 SNNKLI-ELPAL---PPRLERLIASFNHLA-EVPEL---PQNLKQLHVEYNPLR-EFPDIP---ESVEDLRMN 352 (353)
T ss_dssp CSSCCS-CCCCC---CTTCCEEECCSSCCS-CCCCC---CTTCCEEECCSSCCS-SCCCCC---TTCCEEECC
T ss_pred CCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCC---CCCCEEECC
T ss_conf 799168-35665---487998989999687-54532---288898987699189-777652---656712896
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=7.9e-35 Score=195.65 Aligned_cols=380 Identities=17% Similarity=0.119 Sum_probs=215.3
Q ss_pred CCCEEEECCCCCCCC-CCHHHHCCCCCEEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCCCHHHH----HC
Q ss_conf 888575017737456-96111201479076158897889----9885578999854572889866798862433----10
Q 002759 97 SLRVLTLFGNRFTGN-LPQEYAEMQTLWKINVSSNALSG----SIPEFIGDLPNIRLLDLSRNSYSGEIPFALF----KY 167 (884)
Q Consensus 97 ~L~~L~L~~n~~~~~-~p~~~~~l~~L~~L~L~~n~l~~----~~p~~l~~l~~L~~L~Ls~n~~~g~ip~~~~----~~ 167 (884)
.|+.||++.|++++. +..-+..+++++.|+|++|.++. .+...+..+++|++|||++|.++..--..+. ..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCCC-----CCCCCCCEEECCCCCCCCCC----C
Q ss_conf 46684998468855787----56334356888826722487889989877-----88995338983278467975----2
Q 002759 168 CYKTKFVSLSHNNLSGS----IPLSIANCTYLEGFDFSFNNLSGELPSQI-----CNIPVLDFISVRGNALTGTV----E 234 (884)
Q Consensus 168 ~~~L~~L~L~~n~l~~~----~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l-----~~l~~L~~L~L~~n~l~~~~----~ 234 (884)
..+|+.|++++|+++.. ++..+..+++|++|++++|.++......+ ...............+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf 88778877888775432210121100003432002444332023455554430135543332222223222001100112
Q ss_pred CCCCCCCEECEEECCCCCCCCCCCCC----C-CCCCCCCEEEEECCCCCCCC----CCCCCCCCCCCEEECCCCCCCCC-
Q ss_conf 11135780148985888458868888----8-89998658994427322655----44234688882870577867897-
Q 002759 235 EQFSQCQSIKNLDLSSNLFIGLAPFG----V-LGLKNISYFNVSHNGFHGEI----PEVGICGEGMQVFDASWNEFDGV- 304 (884)
Q Consensus 235 ~~~~~l~~L~~L~L~~N~l~~~~~~~----~-~~l~~L~~L~L~~N~l~~~~----~~~~~~~~~L~~L~l~~n~l~~~- 304 (884)
..+.....++.++++.+......... + ........+++..+.+.... .........++.++++.|.+...
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 22333322222332222124555543234332112210012411245421011012233222222100100211223344
Q ss_pred ----CCCCCCCCCCCCEECCCCCCCCCCC----CCCCCCCCCCCEEECCCCCCCCCCCCCC-----CCCCCCCEEECCCC
Q ss_conf ----8843445654554201477334568----8773354675189923786678789876-----67665418946787
Q 002759 305 ----IPLSITNCRNLKVLDLGFNRLIGSI----PTGITDLRRLLKISLANNSIGGIIPPNL-----GSIELLEVLDLHNL 371 (884)
Q Consensus 305 ----~~~~~~~l~~L~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~n 371 (884)
..........++.+++++|.+.... ...+...+.++.+++++|.++......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred CCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCC
T ss_conf 20110001111111000013454332123343322111234333444443332245642111012333444333323334
Q ss_pred CCCCCCCCCC----CCCCCCCEEECCCCCCCCCC----CHHHC-CCCCCCEEEECCCCCCCC----CCCCCCCCCCCCEE
Q ss_conf 5787888677----47788868852375478986----11111-885574787137646788----99564599999979
Q 002759 372 NLRGEVPDDI----SNCRFLLLLDVSGNALGGDI----PQTLY-NMTYLKILDLHQNHLNGS----TPPSLGNLSNLQVL 438 (884)
Q Consensus 372 ~l~~~~~~~~----~~l~~L~~L~ls~N~l~~~~----p~~~~-~l~~L~~L~l~~N~l~~~----~~~~~~~l~~L~~L 438 (884)
.++......+ ....+|++|+|++|.+++.. +..+. ....|+.|++++|.+++. +...+..+++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred CHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEE
T ss_conf 10233443213322110111132012101357664001112204567778898979979759999999999629988989
Q ss_pred ECCCCCCCCCCCCCC----C-CCCCCCEEECCCCCCCCCCCCC
Q ss_conf 854883577569976----7-6675638984588375557830
Q 002759 439 DLSQNSLSGSIPSSL----G-NLRNLTHFNLSSNNLSGTIPST 476 (884)
Q Consensus 439 ~L~~N~l~~~~p~~~----~-~l~~L~~L~ls~N~l~~~~p~~ 476 (884)
+|++|+++......+ . ....|+.|++.+|.+....+..
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~ 445 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDR 445 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHH
T ss_pred ECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHH
T ss_conf 8999969879999999999747886678989898789899999
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.6e-27 Score=156.47 Aligned_cols=67 Identities=18% Similarity=0.178 Sum_probs=23.0
Q ss_pred CCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEECC-CCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 78999854572889866798862433104668499846-88557875633435688882672248788
Q 002759 140 IGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLS-HNNLSGSIPLSIANCTYLEGFDFSFNNLS 206 (884)
Q Consensus 140 l~~l~~L~~L~Ls~n~~~g~ip~~~~~~~~~L~~L~L~-~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~ 206 (884)
|.++++|++|++++|.+...++...|..+..++.+.+. .|.+....+..|.++++|+++++++|.+.
T Consensus 49 f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l~l~~~~l~ 116 (242)
T d1xwdc1 49 FSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK 116 (242)
T ss_dssp TTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEEEEESCCCC
T ss_pred HHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHC
T ss_conf 61464323211022112420100112222222221111123432222221222222222234211112
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=6.4e-32 Score=180.47 Aligned_cols=381 Identities=16% Similarity=0.068 Sum_probs=239.0
Q ss_pred CEEEEEECCCCCCCCC-CCCCCCCCCCCEEEECCCCCCC----CCCHHHHCCCCCEEEECCCCCCCCC----CCCCCC-C
Q ss_conf 7779992675345435-4122388888857501773745----6961112014790761588978899----885578-9
Q 002759 73 FVDRIVLWNFSLGGVL-SPALSGLKSLRVLTLFGNRFTG----NLPQEYAEMQTLWKINVSSNALSGS----IPEFIG-D 142 (884)
Q Consensus 73 ~v~~l~l~~~~l~g~~-~~~l~~l~~L~~L~L~~n~~~~----~~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~-~ 142 (884)
.+..+++..+.+++.. ...+..++++++|+|++|+++. .+...+..+++|++|+|++|.++.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCCCC---HHHHHCCCCCCEEECCCCCCCCCCCCCCC-----CCCCCCEEECCCCCCCCCC----C
Q ss_conf 9985457288986679886---24331046684998468855787563343-----5688882672248788998----9
Q 002759 143 LPNIRLLDLSRNSYSGEIP---FALFKYCYKTKFVSLSHNNLSGSIPLSIA-----NCTYLEGFDFSFNNLSGEL----P 210 (884)
Q Consensus 143 l~~L~~L~Ls~n~~~g~ip---~~~~~~~~~L~~L~L~~n~l~~~~~~~~~-----~l~~L~~L~Ls~N~l~~~~----p 210 (884)
..+|++|+|++|++++..- ...+..++.|++|++++|.++......+. ..............+.... .
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLA 162 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHHH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf 88778877888775432210121100003432002444332023455554430135543332222223222001100112
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCC----CCC-CCCEECEEECCCCCCCCCCC----CCCCCCCCCCEEEEECCCCCC--
Q ss_conf 8778899533898327846797521----113-57801489858884588688----888899986589944273226--
Q 002759 211 SQICNIPVLDFISVRGNALTGTVEE----QFS-QCQSIKNLDLSSNLFIGLAP----FGVLGLKNISYFNVSHNGFHG-- 279 (884)
Q Consensus 211 ~~l~~l~~L~~L~L~~n~l~~~~~~----~~~-~l~~L~~L~L~~N~l~~~~~----~~~~~l~~L~~L~L~~N~l~~-- 279 (884)
..+...+.++.+.++++.+...... .+. .......+++..+.+..... ..+.....++.+.++.|++..
T Consensus 163 ~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~~l~~~~n~~~~~~ 242 (460)
T d1z7xw1 163 SVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVG 242 (460)
T ss_dssp HHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHHHCTTCCEEECCSSBCHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 22333322222332222124555543234332112210012411245421011012233222222100100211223344
Q ss_pred ---CCCCCCCCCCCCCEEECCCCCCCCCC----CCCCCCCCCCCEECCCCCCCCCCCCCCC-----CCCCCCCEEECCCC
Q ss_conf ---55442346888828705778678978----8434456545542014773345688773-----35467518992378
Q 002759 280 ---EIPEVGICGEGMQVFDASWNEFDGVI----PLSITNCRNLKVLDLGFNRLIGSIPTGI-----TDLRRLLKISLANN 347 (884)
Q Consensus 280 ---~~~~~~~~~~~L~~L~l~~n~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~~~~~-----~~l~~L~~L~L~~N 347 (884)
...........++.+++++|.+.... ...+...+.++.+++++|.+.......+ .....|+.+++++|
T Consensus 243 ~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l~~~l~~~~~~L~~l~l~~~ 322 (460)
T d1z7xw1 243 MAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 322 (460)
T ss_dssp HHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTS
T ss_pred CCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCC
T ss_conf 20110001111111000013454332123343322111234333444443332245642111012333444333323334
Q ss_pred CCCCCCCCCCC----CCCCCCEEECCCCCCCCCC----CCCC-CCCCCCCEEECCCCCCCCC----CCHHHCCCCCCCEE
Q ss_conf 66787898766----7665418946787578788----8677-4778886885237547898----61111188557478
Q 002759 348 SIGGIIPPNLG----SIELLEVLDLHNLNLRGEV----PDDI-SNCRFLLLLDVSGNALGGD----IPQTLYNMTYLKIL 414 (884)
Q Consensus 348 ~l~~~~~~~~~----~l~~L~~L~L~~n~l~~~~----~~~~-~~l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L 414 (884)
.++......+. ..++|+.|+|++|++.+.. +..+ ...+.|+.|++++|.++.. ++..+...++|++|
T Consensus 323 ~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~L 402 (460)
T d1z7xw1 323 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLREL 402 (460)
T ss_dssp CCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEE
T ss_pred CHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCEE
T ss_conf 10233443213322110111132012101357664001112204567778898979979759999999999629988989
Q ss_pred EECCCCCCCCCCCCC----C-CCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 713764678899564----5-99999979854883577569976
Q 002759 415 DLHQNHLNGSTPPSL----G-NLSNLQVLDLSQNSLSGSIPSSL 453 (884)
Q Consensus 415 ~l~~N~l~~~~~~~~----~-~l~~L~~L~L~~N~l~~~~p~~~ 453 (884)
++++|++++.....+ . +...|+.|++.+|.+.+.....+
T Consensus 403 ~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~~~~~~l 446 (460)
T d1z7xw1 403 DLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRL 446 (460)
T ss_dssp ECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCHHHHHHH
T ss_pred ECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHH
T ss_conf 89999698799999999997478866789898987898999999
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=1.4e-27 Score=157.92 Aligned_cols=170 Identities=15% Similarity=0.079 Sum_probs=117.6
Q ss_pred CCCCEECCCCCEEEEEEEECCCEEEEEEECCCCCC----CC-------------CHHHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf 45843224796089999986990999998113476----57-------------99999999999704999972112448
Q 002759 597 DKECLIGGGSIGSVYRASFEGGVSIAVKKLETLGR----IR-------------NQEEFELEIGRLSNIRHFNLVAFQGY 659 (884)
Q Consensus 597 ~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~-------------~~~~~~~E~~~l~~l~h~niv~~~~~ 659 (884)
...+.||+|+||+||+|...+++.||||+++.... .. .......|...+.++.|++++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EECCCCEEEEEEECCCCCHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 75399025999725998553320148999988899999988978999999999999999872599990750578886574
Q 002759 660 YWSSTMQLILSEFVPKGNLYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDCKPPILHLNLKSTNILL 739 (884)
Q Consensus 660 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~~~~ivH~Dlk~~Nili 739 (884)
. ..+++|||+++..+.+ ++......++.|++.+++|||++ +++||||||+|||+
T Consensus 83 ~----~~~lvme~~~~~~~~~-------------------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv 136 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR-------------------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV 136 (191)
T ss_dssp E----TTEEEEECCCCEEGGG-------------------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred C----CCEEEEEEECCCCCCC-------------------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEE
T ss_conf 2----8889999504565420-------------------01578999999999999998268---88983689036114
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 8999705833467421487567654312454332384334888999734714499999
Q 002759 740 DENYEPKLSDYGLAKLLPILDNYGLTKFHNAVGYVAPELAQSLRLSDKCDVYSFGVIL 797 (884)
Q Consensus 740 ~~~~~vki~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil 797 (884)
+++ .++++|||.|.......... ....... ...+.+ ...|+.++|+||..--+
T Consensus 137 ~~~-~~~liDFG~a~~~~~~~~~~--~l~rd~~-~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 SEE-GIWIIDFPQSVEVGEEGWRE--ILERDVR-NIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ETT-EEEECCCTTCEETTSTTHHH--HHHHHHH-HHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred ECC-CEEEEECCCCCCCCCCCCHH--HHHHHHH-HHHHHH-CCCCCCCCCHHHHHHHH
T ss_conf 289-89998778843089987099--9987799-999997-57899844689999987
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.93 E-value=2.9e-25 Score=145.75 Aligned_cols=203 Identities=18% Similarity=0.241 Sum_probs=0.0
Q ss_pred EEECCCCCCCCCCHHHHCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEECCCCC
Q ss_conf 75017737456961112014790761588978899885578999854572889866798862433104668499846885
Q 002759 101 LTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNN 180 (884)
Q Consensus 101 L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~~g~ip~~~~~~~~~L~~L~L~~n~ 180 (884)
++++.+++++.+ .+..+.+|++|++++|.++ .+ ..+.++++|++|++++|.+++..| +..+++++++++++|.
T Consensus 24 ~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~-~l-~~l~~l~~L~~L~ls~n~i~~~~~---l~~l~~l~~l~~~~n~ 96 (227)
T d1h6ua2 24 IAAGKSNVTDTV--TQADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSGNP 96 (227)
T ss_dssp HHTTCSSTTSEE--CHHHHHTCCEEECTTSCCC-CC-TTGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEECCSCC
T ss_pred HHHCCCCCCCCC--CHHHCCCCCEEECCCCCCC-CC-HHHHCCCCCCEEECCCCEEECCCC---CCCCCCCCCCCCCCCC
T ss_conf 984888767757--9878488689977799997-66-457448888376357853202543---1123343201211122
Q ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEECEEECCCCCCCCCCCCC
Q ss_conf 57875633435688882672248788998987788995338983278467975211135780148985888458868888
Q 002759 181 LSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFG 260 (884)
Q Consensus 181 l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 260 (884)
++.... +.++++|+.++++++...+..+ +...+.+..+.+..+.+....+ +..+++|+.|++++|.+....+
T Consensus 97 ~~~i~~--l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~~-- 168 (227)
T d1h6ua2 97 LKNVSA--IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP-- 168 (227)
T ss_dssp CSCCGG--GTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--
T ss_pred CCCCCC--CCCCCCCCCCCCCCCCCCCCCH--HCCCCCHHHHHCHHHHHCHHHH--HCCCCCCCCCCCCCCCCCCCHH--
T ss_conf 222222--2222222122122244331100--0002301222000000000000--0102111002333333331001--
Q ss_pred CCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCC
Q ss_conf 88999865899442732265544234688882870577867897884344565455420147
Q 002759 261 VLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGF 322 (884)
Q Consensus 261 ~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~ 322 (884)
+.++++|+.|+|++|++++..+ +..+++|+.|++++|++++..| +.++++|+.|++++
T Consensus 169 l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred HCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf 0564633564458884177853--4479999989795996899802--03699989897129
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.92 E-value=6.8e-25 Score=143.82 Aligned_cols=180 Identities=17% Similarity=0.179 Sum_probs=0.0
Q ss_pred CCCEEECCCCCCCCCCCHHHHHCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 854572889866798862433104668499846885578-7563343568888267224878899898778899533898
Q 002759 145 NIRLLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSG-SIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFIS 223 (884)
Q Consensus 145 ~L~~L~Ls~n~~~g~ip~~~~~~~~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~ 223 (884)
+.+.++.++++++ .+|.++. ..+++|+|++|++++ ..+..|.++++|++|+|++|++....+..+..+++|+.|+
T Consensus 9 ~~~~v~Cs~~~L~-~iP~~lp---~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~ 84 (192)
T d1w8aa_ 9 EGTTVDCTGRGLK-EIPRDIP---LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ 84 (192)
T ss_dssp ETTEEECTTSCCS-SCCSCCC---TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred CCCEEEEECCCCC-CCCCCCC---CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEE
T ss_conf 6999997089967-0298989---78788984898775530200257876272130136322121212221122221010
Q ss_pred CCCCCCCCCCCCCCCCCCEECEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 32784679752111357801489858884588688888899986589944273226554423468888287057786789
Q 002759 224 VRGNALTGTVEEQFSQCQSIKNLDLSSNLFIGLAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDG 303 (884)
Q Consensus 224 L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~ 303 (884)
|++|+|+...+.+|.++++|++|+|++|+|+.+.+..|..+++|++|+|++|.+. ...........+..+.+..+.+..
T Consensus 85 Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~-~~~~~~~~~~~l~~~~l~~~~~~c 163 (192)
T d1w8aa_ 85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN-CNCHLAWFAEWLRKKSLNGGAARC 163 (192)
T ss_dssp CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC-CSGGGHHHHHHHHHHCCSGGGCBB
T ss_pred ECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC-CCCCHHHHHHHHHHHCCCCCCEEE
T ss_conf 0355344349799807974655245774535359778568753342000364434-353027776423540356898276
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCC
Q ss_conf 78843445654554201477334568877
Q 002759 304 VIPLSITNCRNLKVLDLGFNRLIGSIPTG 332 (884)
Q Consensus 304 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~ 332 (884)
..| ..+++++.++|+.|.++...+..
T Consensus 164 ~~p---~~l~~~~l~~L~~n~l~C~~~~~ 189 (192)
T d1w8aa_ 164 GAP---SKVRDVQIKDLPHSEFKCSSENS 189 (192)
T ss_dssp CSS---TTTTTSBGGGSCTTTCCCCCC--
T ss_pred CCC---HHHCCCEEEECCHHHCCCCCCCC
T ss_conf 898---43369886144875575899888
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.91 E-value=1.2e-23 Score=137.39 Aligned_cols=179 Identities=23% Similarity=0.284 Sum_probs=0.0
Q ss_pred EECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 44273226554423468888287057786789788434456545542014773345688773354675189923786678
Q 002759 272 VSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITDLRRLLKISLANNSIGG 351 (884)
Q Consensus 272 L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 351 (884)
++.+.+.+.++. ..+.+++.|++++|.+....+ +..+++|++|++++|++++..+ ++.+++|+.|++++|++++
T Consensus 31 l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~ 104 (210)
T d1h6ta2 31 LKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKD 104 (210)
T ss_dssp TTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 575765775188--795484589782798887444--7648998987698960258601--1358621201433333212
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCC
Q ss_conf 78987667665418946787578788867747788868852375478986111118855747871376467889956459
Q 002759 352 IIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGN 431 (884)
Q Consensus 352 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~ 431 (884)
+. .+..+++|+.|++++|.+. ....+..++.++.+++++|.++ .+..+..+++|+.+++++|++++..+ +.+
T Consensus 105 l~--~l~~l~~L~~L~l~~~~~~--~~~~l~~l~~l~~l~~~~n~l~--~~~~~~~l~~L~~l~l~~n~l~~i~~--l~~ 176 (210)
T d1h6ta2 105 LS--SLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAG 176 (210)
T ss_dssp GG--GGTTCTTCCEEECTTSCCC--CCGGGGGCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GTT
T ss_pred CC--CCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCC--CCC
T ss_conf 22--1212221112234565322--1122011111222112223334--54310001332100134643025645--367
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 99999798548835775699767667563898458
Q 002759 432 LSNLQVLDLSQNSLSGSIPSSLGNLRNLTHFNLSS 466 (884)
Q Consensus 432 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ls~ 466 (884)
+++|+.|+|++|+++ .++ .+..+++|+.|++++
T Consensus 177 l~~L~~L~Ls~N~i~-~l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 177 LTKLQNLYLSKNHIS-DLR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp CTTCCEEECCSSCCC-BCG-GGTTCTTCSEEEEEE
T ss_pred CCCCCEEECCCCCCC-CCH-HHCCCCCCCEEECCC
T ss_conf 898999989799899-872-116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=1.1e-22 Score=132.27 Aligned_cols=175 Identities=15% Similarity=0.252 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEECEEECCCCCCCC
Q ss_conf 46885578756334356888826722487889989877889953389832784679752111357801489858884588
Q 002759 176 LSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSNLFIG 255 (884)
Q Consensus 176 L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 255 (884)
++.+.+++.+. ...+.++++|++++|.+... ..+..+++|++|++++|++++..+ +.++++|+.|++++|.+..
T Consensus 25 l~~~~~~~~~~--~~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~ 98 (199)
T d2omxa2 25 LGKTNVTDTVS--QTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD 98 (199)
T ss_dssp TTCSSTTSEEC--HHHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC
T ss_pred HCCCCCCCCCC--HHHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCC
T ss_conf 67787788559--87946878998999999775--202137886757545655667640--1677522311112222222
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCC
Q ss_conf 68888889998658994427322655442346888828705778678978843445654554201477334568877335
Q 002759 256 LAPFGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVLDLGFNRLIGSIPTGITD 335 (884)
Q Consensus 256 ~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 335 (884)
+.+ +.++++|+.|++++|.+....+ +..+++|+.|++++|++..... +..+++|+.|++.+|++++..+ +.+
T Consensus 99 ~~~--l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~~~~~--l~~~~~L~~L~l~~n~l~~l~~--l~~ 170 (199)
T d2omxa2 99 ITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISA--LSGLTSLQQLNFSSNQVTDLKP--LAN 170 (199)
T ss_dssp CGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTT
T ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHHCCCCC--CCCCCCCCCCCCCCCCCCCCCC--CCC
T ss_conf 211--1112232221112222223210--0012236776431111002343--3321111112234555567701--167
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 4675189923786678789876676654189
Q 002759 336 LRRLLKISLANNSIGGIIPPNLGSIELLEVL 366 (884)
Q Consensus 336 l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 366 (884)
+++|++|++++|+++++ ..++++++|+.|
T Consensus 171 l~~L~~L~ls~N~i~~i--~~l~~L~~L~~L 199 (199)
T d2omxa2 171 LTTLERLDISSNKVSDI--SVLAKLTNLESL 199 (199)
T ss_dssp CTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred CCCCCEEECCCCCCCCC--CCCCCCCCCCCC
T ss_conf 99899997879979988--101278998949
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.87 E-value=1e-23 Score=137.73 Aligned_cols=101 Identities=16% Similarity=0.146 Sum_probs=45.1
Q ss_pred CEEEECCCCCCCCCCHHHHCCC--CCEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCEEEC
Q ss_conf 8575017737456961112014--79076158897889988557899985457288986679886243310466849984
Q 002759 99 RVLTLFGNRFTGNLPQEYAEMQ--TLWKINVSSNALSGSIPEFIGDLPNIRLLDLSRNSYSGEIPFALFKYCYKTKFVSL 176 (884)
Q Consensus 99 ~~L~L~~n~~~~~~p~~~~~l~--~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~~~g~ip~~~~~~~~~L~~L~L 176 (884)
+.+||+++.+.. ..++++. .+..+.++...+.... .......+|++||++++.++......++..+++|++|++
T Consensus 3 ~~lDLs~~~l~~---~~l~~l~~~~~~~lrl~~~~~~~~~-~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L 78 (284)
T d2astb2 3 QTLDLTGKNLHP---DVTGRLLSQGVIAFRCPRSFMDQPL-AEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSL 78 (284)
T ss_dssp SEEECTTCBCCH---HHHHHHHHTTCSEEECTTCEECSCC-CSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEEC
T ss_pred CEEECCCCCCCC---HHHHHHHHCCCEEEECCCCCCCCCH-HHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 779789997881---4799987455427465233345522-442567878878898984577799999974877651452
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 688557875633435688882672248
Q 002759 177 SHNNLSGSIPLSIANCTYLEGFDFSFN 203 (884)
Q Consensus 177 ~~n~l~~~~~~~~~~l~~L~~L~Ls~N 203 (884)
+++.+++..+..++.+++|++|++++|
T Consensus 79 ~~~~l~~~~~~~l~~~~~L~~L~Ls~c 105 (284)
T d2astb2 79 EGLRLSDPIVNTLAKNSNLVRLNLSGC 105 (284)
T ss_dssp TTCBCCHHHHHHHTTCTTCSEEECTTC
T ss_pred CCCCCCCHHHHHHHCCCCCCCCCCCCC
T ss_conf 346798678999851899757151001
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.85 E-value=5.3e-24 Score=139.18 Aligned_cols=45 Identities=16% Similarity=0.166 Sum_probs=19.7
Q ss_pred CCHHHHCCCCCEEEECCCCCCCCC----CCCCCCCCCCCCEEECCCCCC
Q ss_conf 961112014790761588978899----885578999854572889866
Q 002759 112 LPQEYAEMQTLWKINVSSNALSGS----IPEFIGDLPNIRLLDLSRNSY 156 (884)
Q Consensus 112 ~p~~~~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~n~~ 156 (884)
+...+.+...|+.|+|++|.+... +-..+...++|+.|+++.+..
T Consensus 23 l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~ 71 (344)
T d2ca6a1 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 71 (344)
T ss_dssp TSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCT
T ss_pred HHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCC
T ss_conf 9999963899788978498377899999999998589988888877754
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.85 E-value=2.9e-23 Score=135.35 Aligned_cols=14 Identities=29% Similarity=0.487 Sum_probs=6.1
Q ss_pred CCCCEEECCCCCCC
Q ss_conf 75638984588375
Q 002759 457 RNLTHFNLSSNNLS 470 (884)
Q Consensus 457 ~~L~~L~ls~N~l~ 470 (884)
++|+.|++++|++.
T Consensus 302 ~~L~~L~l~~N~~~ 315 (344)
T d2ca6a1 302 PDLLFLELNGNRFS 315 (344)
T ss_dssp TTCCEEECTTSBSC
T ss_pred CCCCEEECCCCCCC
T ss_conf 99998978798089
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.85 E-value=1.2e-22 Score=132.10 Aligned_cols=100 Identities=14% Similarity=0.175 Sum_probs=35.4
Q ss_pred EEECCCCCCCCCCCHHHHHCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCC
Q ss_conf 5728898667988624331046684998468855787563343568888267224878899-898778899533898327
Q 002759 148 LLDLSRNSYSGEIPFALFKYCYKTKFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGE-LPSQICNIPVLDFISVRG 226 (884)
Q Consensus 148 ~L~Ls~n~~~g~ip~~~~~~~~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~ 226 (884)
.+||+.+.+.......+.. .....+.++...+..... ......+|++||+++|.++.. +...+..+++|+.|++++
T Consensus 4 ~lDLs~~~l~~~~l~~l~~--~~~~~lrl~~~~~~~~~~-~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 4 TLDLTGKNLHPDVTGRLLS--QGVIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp EEECTTCBCCHHHHHHHHH--TTCSEEECTTCEECSCCC-SCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred EEECCCCCCCCHHHHHHHH--CCCEEEECCCCCCCCCHH-HHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 7978999788147999874--554274652333455224-4256787887889898457779999997487765145234
Q ss_pred CCCCCCCCCCCCCCCEECEEECCC
Q ss_conf 846797521113578014898588
Q 002759 227 NALTGTVEEQFSQCQSIKNLDLSS 250 (884)
Q Consensus 227 n~l~~~~~~~~~~l~~L~~L~L~~ 250 (884)
|.++......+..+++|+.|++++
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~ 104 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSG 104 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTT
T ss_pred CCCCCHHHHHHHCCCCCCCCCCCC
T ss_conf 679867899985189975715100
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.77 E-value=3.7e-19 Score=113.91 Aligned_cols=130 Identities=18% Similarity=0.149 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHCCCC
Q ss_conf 87733546751899237866787898766766541894678757878886774778886885237547898611111885
Q 002759 330 PTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLLLLDVSGNALGGDIPQTLYNMT 409 (884)
Q Consensus 330 ~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~ 409 (884)
...+.+..++++|+|++|+|+ .++..+..+++|+.|++++|+++.. +.+..+++|+.|++++|+++...+..+..++
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 175168574848978899788-6576200414599898979978764--7744576130643102134577763223345
Q ss_pred CCCEEEECCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCC----CCCCCCCCCEEE
Q ss_conf 57478713764678899-5645999999798548835775699----767667563898
Q 002759 410 YLKILDLHQNHLNGSTP-PSLGNLSNLQVLDLSQNSLSGSIPS----SLGNLRNLTHFN 463 (884)
Q Consensus 410 ~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~----~~~~l~~L~~L~ 463 (884)
+|+.|++++|+++.... ..+..+++|+.|++++|.++ ..|. .+..+++|+.||
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~-~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC-CCCCHHHHHHHHCCCCCEEC
T ss_conf 34434203000166542110013653206640799634-56106999998789958337
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.70 E-value=4.3e-17 Score=103.10 Aligned_cols=121 Identities=17% Similarity=0.274 Sum_probs=0.0
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCEECEEECCCC
Q ss_conf 49984688557875633435688882672248788998987788995338983278467975211135780148985888
Q 002759 172 KFVSLSHNNLSGSIPLSIANCTYLEGFDFSFNNLSGELPSQICNIPVLDFISVRGNALTGTVEEQFSQCQSIKNLDLSSN 251 (884)
Q Consensus 172 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N 251 (884)
++|+|++|+++ .++. ++.+++|++|++++|.++ .+|..++.+++|+.|++++|.++.... +..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~l~~--~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALENVDG--VANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSS
T ss_pred CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCC
T ss_conf 98986899898-8710-105898898979787168-652156554313545324321123574--123355576888898
Q ss_pred CCCCCCC-CCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 4588688-888899986589944273226554423468888287057786789788434456545542
Q 002759 252 LFIGLAP-FGVLGLKNISYFNVSHNGFHGEIPEVGICGEGMQVFDASWNEFDGVIPLSITNCRNLKVL 318 (884)
Q Consensus 252 ~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L 318 (884)
++..... ..+..+++|+.|++++|+++ .+.+........+++|+.|
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~---------------------~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLC---------------------QEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGG---------------------GSSSCTTHHHHHCTTCSEE
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCC---------------------CCCCHHHHHHHHCCCCCEE
T ss_conf 6588888256537999999989799688---------------------6826799999989673138
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.69 E-value=1.3e-19 Score=116.25 Aligned_cols=147 Identities=19% Similarity=0.238 Sum_probs=0.0
Q ss_pred CCCCCCEECCCCC--CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 5654554201477--33456887733546751899237866787898766766541894678757878886774778886
Q 002759 311 NCRNLKVLDLGFN--RLIGSIPTGITDLRRLLKISLANNSIGGIIPPNLGSIELLEVLDLHNLNLRGEVPDDISNCRFLL 388 (884)
Q Consensus 311 ~l~~L~~L~L~~N--~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~ 388 (884)
....++.+++.++ .+. .++..+..+++|++|+|++|+|+.+ ..+..+++|+.|++++|.++ .++..+..++.|+
T Consensus 21 ~~~~~~~~~l~~~~~~i~-~l~~sl~~L~~L~~L~Ls~n~I~~i--~~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~ 96 (198)
T d1m9la_ 21 VATEAEKVELHGMIPPIE-KMDATLSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96 (198)
T ss_dssp CCTTCSCEECCBCCTTCC-CCHHHHHHTTTCCEEECSEEEESCC--CCHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCC
T ss_pred CCCCCCEEEEECCCCCHH-HHHHHHHCCCCCCEEECCCCCCCCC--CCCCCCCCCCCHHHCCCCCC-CCCCCCCCCCCCC
T ss_conf 545331002555568520-0246776260461519944689986--44247825357341353432-1000033221233
Q ss_pred EEECCCCCCCCCCCHHHCCCCCCCEEEECCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCC----------CCCCC
Q ss_conf 88523754789861111188557478713764678899-56459999997985488357756997----------67667
Q 002759 389 LLDVSGNALGGDIPQTLYNMTYLKILDLHQNHLNGSTP-PSLGNLSNLQVLDLSQNSLSGSIPSS----------LGNLR 457 (884)
Q Consensus 389 ~L~ls~N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~----------~~~l~ 457 (884)
.|++++|.++.. ..+..+++|+.|++++|+++.... ..+..+++|+.|+|++|++....+.. +..++
T Consensus 97 ~L~l~~N~i~~l--~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~~~~r~~vi~~lp 174 (198)
T d1m9la_ 97 ELWISYNQIASL--SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLP 174 (198)
T ss_dssp EEECSEEECCCH--HHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHHCTTTTHHHHHHHHHHHCS
T ss_pred CCCCCCCCCCCC--CCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCHHHHHHHHHHHCC
T ss_conf 333333222222--222222234111234102125542212367776302342798434676322220558999998788
Q ss_pred CCCEEE
Q ss_conf 563898
Q 002759 458 NLTHFN 463 (884)
Q Consensus 458 ~L~~L~ 463 (884)
+|+.||
T Consensus 175 ~L~~LD 180 (198)
T d1m9la_ 175 NLKKLD 180 (198)
T ss_dssp SCCEES
T ss_pred CCCEEC
T ss_conf 958769
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=1.2e-15 Score=95.56 Aligned_cols=109 Identities=19% Similarity=0.116 Sum_probs=69.6
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCHHHCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 18946787578788867747788868852375-47898611111885574787137646788995645999999798548
Q 002759 364 EVLDLHNLNLRGEVPDDISNCRFLLLLDVSGN-ALGGDIPQTLYNMTYLKILDLHQNHLNGSTPPSLGNLSNLQVLDLSQ 442 (884)
Q Consensus 364 ~~L~L~~n~l~~~~~~~~~~l~~L~~L~ls~N-~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~ 442 (884)
+.++.+++.+. ..|..+..+++|++|++++| .++...+..|.++++|+.|++++|+|+.+.+..|..+++|+.|+|++
T Consensus 11 ~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~ 89 (156)
T d2ifga3 11 SGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSF 89 (156)
T ss_dssp SCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCS
T ss_pred CEEEECCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCC
T ss_conf 96985289976-58600257656574316898664436921225666667216202124774201112455433332267
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 83577569976766756389845883755578
Q 002759 443 NSLSGSIPSSLGNLRNLTHFNLSSNNLSGTIP 474 (884)
Q Consensus 443 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p 474 (884)
|+|+ .+|.......+|+.|++++|+|.+.+-
T Consensus 90 N~l~-~l~~~~~~~~~l~~L~L~~Np~~C~C~ 120 (156)
T d2ifga3 90 NALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120 (156)
T ss_dssp SCCS-CCCSTTTCSCCCCEEECCSSCCCCCGG
T ss_pred CCCC-CCCHHHHCCCCCCCCCCCCCCCCCCCH
T ss_conf 8785-157456335321243357986338811
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.94 E-value=4.9e-09 Score=61.09 Aligned_cols=134 Identities=13% Similarity=0.050 Sum_probs=86.9
Q ss_pred CCCCCEEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCEEEEEEECCCCCHHHH
Q ss_conf 24796089999986990999998113476579999999999970499-99721124487539902599972599855332
Q 002759 603 GGGSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLILSEFVPKGNLYDN 681 (884)
Q Consensus 603 g~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~gsL~~~ 681 (884)
+.+..+.||+....++ .+++|+..... ......+.+|...+..+. +--+.+++.+..+++..++||++.++.++.+.
T Consensus 23 ~G~s~~~v~rv~~~~~-~~vlk~~~~~~-~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 23 EGMSPAKVYKLVGENE-NLYLKMTDSRY-KGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CCCSSSEEEEEECSSC-EEEEEEECGGG-TTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCCCCCEEEEEECCC-EEEEEECCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCC
T ss_conf 8998771899990898-69999848876-532556999999999876069987289997508964999986043343543
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--------------------------------------
Q ss_conf 014899998889999998897899999999999999987259--------------------------------------
Q 002759 682 LHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHDC-------------------------------------- 723 (884)
Q Consensus 682 l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~~-------------------------------------- 723 (884)
.... .....++.++++.++.||+..
T Consensus 101 ~~~~-----------------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (263)
T d1j7la_ 101 YEDE-----------------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP 163 (263)
T ss_dssp TTTC-----------------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCS
T ss_pred CCCC-----------------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 3440-----------------26999999899999998556842143576446565557789987765555430332320
Q ss_pred ------------------CCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf ------------------99907505788865748999705833467421
Q 002759 724 ------------------KPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 724 ------------------~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~~ 755 (884)
.+.++|+|+.+.||+++++..+-++||+.+..
T Consensus 164 ~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 05799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.94 E-value=4e-11 Score=71.98 Aligned_cols=108 Identities=21% Similarity=0.154 Sum_probs=0.0
Q ss_pred CCCCCCCCCCEEEECCCCCCCCCCHHHHCCCCCEEEECCCCCCCCC--CCCCCCCCCCCCEEECCCCCCCCCCCHHHHHC
Q ss_conf 1223888888575017737456961112014790761588978899--88557899985457288986679886243310
Q 002759 90 PALSGLKSLRVLTLFGNRFTGNLPQEYAEMQTLWKINVSSNALSGS--IPEFIGDLPNIRLLDLSRNSYSGEIPFALFKY 167 (884)
Q Consensus 90 ~~l~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~--~p~~l~~l~~L~~L~Ls~n~~~g~ip~~~~~~ 167 (884)
+.+..+..+..+++..+... .++..+..++.|++|+|++|.++.. ++..+..+++|+.|+|++|.++ .++.-.+..
T Consensus 36 ~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~-~l~~l~~l~ 113 (162)
T d1koha1 36 PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELK-SERELDKIK 113 (162)
T ss_dssp TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCC-CGGGHHHHT
T ss_pred CHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCC-CCHHHHHHH
T ss_conf 21554664011225556766-6078897487878863777666677315889865885610004357213-423442220
Q ss_pred CCCCCEEECCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 466849984688557875633-------43568888267
Q 002759 168 CYKTKFVSLSHNNLSGSIPLS-------IANCTYLEGFD 199 (884)
Q Consensus 168 ~~~L~~L~L~~n~l~~~~~~~-------~~~l~~L~~L~ 199 (884)
...++.+++++|.+....... +..+++|+.||
T Consensus 114 ~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 114 GLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp TCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 331042664899767676661569999999889978799
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.83 E-value=9.2e-09 Score=59.66 Aligned_cols=131 Identities=21% Similarity=0.108 Sum_probs=83.1
Q ss_pred EECCCCC-EEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCC--CCCCCEEEEEEECCCCEEEEEEECCCCC
Q ss_conf 3224796-089999986990999998113476579999999999970499--9972112448753990259997259985
Q 002759 601 LIGGGSI-GSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIR--HFNLVAFQGYYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 601 ~ig~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~gs 677 (884)
.+..|.. +.||+....++..+++|...... ...+..|...+..+. .-.+.+++++..+++..++||+++++.+
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~----~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~ 92 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD 92 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC----HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCC
T ss_conf 7678654775899993898789999589667----768999999999998659998861322245661599987441355
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------
Q ss_conf 533201489999888999999889789999999999999998725-----------------------------------
Q 002759 678 LYDNLHGVNYPGTSTGGIGNPELHWSRRFHIALGTARALSYLHHD----------------------------------- 722 (884)
Q Consensus 678 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~~L~~LH~~----------------------------------- 722 (884)
+.+.. ... ...+.+++..+..||+.
T Consensus 93 ~~~~~-----------------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (255)
T d1nd4a_ 93 LLSSH-----------------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE 152 (255)
T ss_dssp TTTSC-----------------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred CCCCC-----------------CCH---HHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCH
T ss_conf 43221-----------------268---9999999999998736885448875541246889999998754110113401
Q ss_pred --------------------CCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf --------------------999907505788865748999705833467421
Q 002759 723 --------------------CKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 723 --------------------~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~~ 755 (884)
..+.++|+|+.+.||+++.+..+-|+||+.+..
T Consensus 153 ~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 153 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 12137999999998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.61 E-value=2.4e-07 Score=52.25 Aligned_cols=76 Identities=13% Similarity=0.098 Sum_probs=46.1
Q ss_pred EECCCCCEEEEEEEECC-CEEEEEEECCCC----C--CCCCHHHHHHHHHHHHCC-C-CC-CCCEEEEEEECCCCEEEEE
Q ss_conf 32247960899999869-909999981134----7--657999999999997049-9-99-7211244875399025999
Q 002759 601 LIGGGSIGSVYRASFEG-GVSIAVKKLETL----G--RIRNQEEFELEIGRLSNI-R-HF-NLVAFQGYYWSSTMQLILS 670 (884)
Q Consensus 601 ~ig~G~~g~V~~~~~~~-~~~vaiK~~~~~----~--~~~~~~~~~~E~~~l~~l-~-h~-niv~~~~~~~~~~~~~lv~ 670 (884)
.+|.|....||++...+ ++.+++|.-... . -+....+...|...+..+ . .| .+.+++.+ ++...++||
T Consensus 33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvm 110 (392)
T d2pula1 33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM 110 (392)
T ss_dssp ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred EECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEEE
T ss_conf 807985276899995799848999617713034677788877899999999998650579885528998--598877987
Q ss_pred EECCCCCH
Q ss_conf 72599855
Q 002759 671 EFVPKGNL 678 (884)
Q Consensus 671 e~~~~gsL 678 (884)
|+.++..+
T Consensus 111 E~L~~~~~ 118 (392)
T d2pula1 111 EDLSHLKI 118 (392)
T ss_dssp CCCTTSEE
T ss_pred ECCCCCCC
T ss_conf 13577653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.39 E-value=5.5e-08 Score=55.60 Aligned_cols=112 Identities=17% Similarity=0.223 Sum_probs=0.0
Q ss_pred CCCCCCCEEEECC-CCCCCC----CCHHHHCCCCCEEEECCCCCCC----CCCCCCCCCCCCCCEEECCCCCCCCCCCHH
Q ss_conf 3888888575017-737456----9611120147907615889788----998855789998545728898667988624
Q 002759 93 SGLKSLRVLTLFG-NRFTGN----LPQEYAEMQTLWKINVSSNALS----GSIPEFIGDLPNIRLLDLSRNSYSGEIPFA 163 (884)
Q Consensus 93 ~~l~~L~~L~L~~-n~~~~~----~p~~~~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~Ls~n~~~g~ip~~ 163 (884)
.+.++|++|+|++ +.++.. +-..+...+.|++|+|++|.+. ..+...+...+.|++|+|++|.++...-..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred HHHCCCC---CCEEECCCCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf 3310466---84998468855787-------56334356888826722487
Q 002759 164 LFKYCYK---TKFVSLSHNNLSGS-------IPLSIANCTYLEGFDFSFNN 204 (884)
Q Consensus 164 ~~~~~~~---L~~L~L~~n~l~~~-------~~~~~~~l~~L~~L~Ls~N~ 204 (884)
++..+.. |+.|++++|.+... +...+...++|+.|+++++.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.16 E-value=1.5e-05 Score=42.95 Aligned_cols=74 Identities=12% Similarity=0.112 Sum_probs=47.2
Q ss_pred CCEECCCCCEEEEEEEECCC--------EEEEEEECCCCCCCCCHHHHHHHHHHHHCCC-CCCCCEEEEEEECCCCEEEE
Q ss_conf 84322479608999998699--------0999998113476579999999999970499-99721124487539902599
Q 002759 599 ECLIGGGSIGSVYRASFEGG--------VSIAVKKLETLGRIRNQEEFELEIGRLSNIR-HFNLVAFQGYYWSSTMQLIL 669 (884)
Q Consensus 599 ~~~ig~G~~g~V~~~~~~~~--------~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv 669 (884)
...++.|-.-.+|++...++ ..|.+++... ........+|..+++.+. +.-..++++++.+ ..|
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~---~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I 119 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN---PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL 119 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS---CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC---CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEE
T ss_conf 99917853343489996887754457898179996599---61165899999999999757999808998189----569
Q ss_pred EEECCCCCHH
Q ss_conf 9725998553
Q 002759 670 SEFVPKGNLY 679 (884)
Q Consensus 670 ~e~~~~gsL~ 679 (884)
+||.++.++.
T Consensus 120 ~efi~g~~l~ 129 (395)
T d1nw1a_ 120 EEYIPSRPLS 129 (395)
T ss_dssp ECCCCEEECC
T ss_pred EEEECCCCCC
T ss_conf 9973455488
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.15 E-value=1e-05 Score=43.75 Aligned_cols=144 Identities=17% Similarity=0.096 Sum_probs=77.4
Q ss_pred CCCEEEEEEEECCCEEEEEEECCCCCCCCCHHHHHHHHHHHHCCCC-----CCCCEEEE--EEECCCCEEEEEEECCCCC
Q ss_conf 7960899999869909999981134765799999999999704999-----97211244--8753990259997259985
Q 002759 605 GSIGSVYRASFEGGVSIAVKKLETLGRIRNQEEFELEIGRLSNIRH-----FNLVAFQG--YYWSSTMQLILSEFVPKGN 677 (884)
Q Consensus 605 G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~~~~--~~~~~~~~~lv~e~~~~gs 677 (884)
+....||++..++|..+++|+..... ...+.+..|...+..+.. +..+..-+ ........+.++++.+|..
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~--~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER--WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT--SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCC
T ss_conf 61202699983899979999847877--8899999999999999855998787520689805665347999986527768
Q ss_pred HHH--------------HCCCCCCCCCCCCCCCCCCCCHH----------------------HHHHHHHHHHHHHHHH-H
Q ss_conf 533--------------20148999988899999988978----------------------9999999999999998-7
Q 002759 678 LYD--------------NLHGVNYPGTSTGGIGNPELHWS----------------------RRFHIALGTARALSYL-H 720 (884)
Q Consensus 678 L~~--------------~l~~~~~~~~~~~~~~~~~~~~~----------------------~~~~i~~~ia~~L~~L-H 720 (884)
+.. .++........ ..+...++. .....+..+...+... .
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~---~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLF---IHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCC---SSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCC---CCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 8999999999989999998863035786---5567789788766568999874769988989999999999999998454
Q ss_pred HCCCCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 25999907505788865748999705833467421
Q 002759 721 HDCKPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 721 ~~~~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~~ 755 (884)
+....+++|+|+.+.|||++++ ..++||+.++.
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 5687120247888042878389--35886520146
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.80 E-value=2e-06 Score=47.51 Aligned_cols=112 Identities=10% Similarity=0.047 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCCCCHHHHH---CCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEEECCCCCCCCCCC--
Q ss_conf 8999854572889-8667988624331---0466849984688557----8756334356888826722487889989--
Q 002759 141 GDLPNIRLLDLSR-NSYSGEIPFALFK---YCYKTKFVSLSHNNLS----GSIPLSIANCTYLEGFDFSFNNLSGELP-- 210 (884)
Q Consensus 141 ~~l~~L~~L~Ls~-n~~~g~ip~~~~~---~~~~L~~L~L~~n~l~----~~~~~~~~~l~~L~~L~Ls~N~l~~~~p-- 210 (884)
.+.++|++|+|++ +.++...-..++. ..+.|+.|++++|.++ ..+...+...++++.+++++|.+.....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred --CCCCCCCCCCEEECC--CCCCCC----CCCCCCCCCCEECEEECCCCC
Q ss_conf --877889953389832--784679----752111357801489858884
Q 002759 211 --SQICNIPVLDFISVR--GNALTG----TVEEQFSQCQSIKNLDLSSNL 252 (884)
Q Consensus 211 --~~l~~l~~L~~L~L~--~n~l~~----~~~~~~~~l~~L~~L~L~~N~ 252 (884)
..+...++|+.++|. +|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849984788581898
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.52 E-value=0.0011 Score=33.14 Aligned_cols=32 Identities=19% Similarity=0.216 Sum_probs=28.2
Q ss_pred CCCEEECCCCCCCEEECCCCCEEECCCCCCCC
Q ss_conf 99907505788865748999705833467421
Q 002759 724 KPPILHLNLKSTNILLDENYEPKLSDYGLAKL 755 (884)
Q Consensus 724 ~~~ivH~Dlk~~Nili~~~~~vki~Dfg~a~~ 755 (884)
..++||+|+.+.|++++.+...-+.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 45033378636564020454126742221236
|